PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, YF; Chen, HY; Lin, CC; Chen, MS; Chen, PC; Wang, IJ				Chen, Yuh-Fang; Chen, Hsin-Yi; Lin, Che-Chen; Chen, Muh-Shy; Chen, Pei-Chun; Wang, I-Jong			Retinitis Pigmentosa Reduces the Risk of Proliferative Diabetic Retinopathy: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL DEGENERATION; PHOTO-COAGULATION; MOUSE MODEL; ANGIOPOIETIN-2; COMPLICATIONS; INSURANCE; HYPOXIA; GLUCOSE; TAIWAN	Purpose: To study the association between retinitis pigmentosa (RP) and the progression of diabetic retinopathy (DR). Methods: Using the Longitudinal Health Insurance Database 2000 of Taiwan, we identified individuals with an initial diagnosis for RP during the period of 1997-2008. A non-RP comparison group, 10-fold frequency matched by sex, age, index year and the year of diabetes diagnosed, were randomly selected from the same database. The occurrence of DR was observed for all subjects until the end of 2009. The Kaplan-Meier curves were used to illustrate the cumulative probability of developing DR for the RP group and comparison groups. The hazard ratio (HR) of DR for the RP group relative to the comparison group was estimated using Cox proportional hazards model after adjusting for potential confounders. Results: The Kaplan-Meier curves were not statistically significant different between the RP group and the comparison group. However, the RP group had a higher cumulative probability of developing DR during the first six to seven years. The cumulative probability kept increasing and became higher in the comparison group but remained unchanged in the RP group. The HR for the RP patients comparing with the comparison group was 0.96 (95% confidence interval (CI) = 0.43-2.14). Stratified by severity, RP was associated with a non-statistically significant reduced risk of proliferative DR (PDR) (HR = 0.70, 95% CI = 0.16-3.14). The HR for non-proliferative DR (NPDR) was 1.08 (95% CI = 0.40-2.86). Conclusion: In this study, RP was not statistically significant associated with the incidence of DR.	[Chen, Yuh-Fang; Chen, Muh-Shy; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Yuh-Fang] New Taipei City Hosp, Dept Ophthalmol, New Taipei City, Taiwan; [Chen, Hsin-Yi; Wang, I-Jong] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Chen, Hsin-Yi] China Med Univ Hosp, Dept Ophthalmol, Taichung, Taiwan; [Lin, Che-Chen; Chen, Pei-Chun] China Med Univ & Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chen, Pei-Chun] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	ijong@ms8.hinet.net		Wang, I-Jong/0000-0002-3045-0614				Arden GB, 2001, BRIT J OPHTHALMOL, V85, P366, DOI 10.1136/bjo.85.3.366; Arden GB, 1998, VISION RES, V38, P1723, DOI 10.1016/S0042-6989(98)00004-2; BELLHORN RW, 1980, INVEST OPHTH VIS SCI, V19, P584; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; CHANDRA SR, 1982, INVEST OPHTH VIS SCI, V22, P783; de Gooyer TE, 2006, INVEST OPHTH VIS SCI, V47, P5561, DOI 10.1167/iovs.06-0647; Donders F., 1857, GRAEFES ARCH OPHTHAL, V3, P139; Duh E, 1999, DIABETES, V48, P1899, DOI 10.2337/diabetes.48.10.1899; Grunwald JE, 1996, AM J OPHTHALMOL, V122, P502, DOI 10.1016/S0002-9394(14)72109-9; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80; Kern TS, 1996, ARCH OPHTHALMOL-CHIC, V114, P306, DOI 10.1001/archopht.1996.01100130302013; Lahdenranta J, 2001, P NATL ACAD SCI USA, V98, P10368, DOI 10.1073/pnas.181329198; Landolt E, 1872, ARCH OPHTH 1, V18, P325; Lee YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-225; Leibreich R, 1861, DTSCH KLIN, V1861, P53; Lu M, 1998, J CLIN INVEST, V101, P1219, DOI 10.1172/JCI1277; Oh H, 1999, J BIOL CHEM, V274, P15732, DOI 10.1074/jbc.274.22.15732; Padnick-Silver L, 2006, INVEST OPHTH VIS SCI, V47, P3683, DOI 10.1167/iovs.05-1284; Penn JS, 2000, INVEST OPHTH VIS SCI, V41, P4007; Salom D, 2008, INVEST OPHTH VIS SCI, V49, P3499, DOI 10.1167/iovs.07-1168; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; STERNBERG P, 1984, AM J OPHTHALMOL, V97, P788, DOI 10.1016/0002-9394(84)90518-X; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; WEITER JJ, 1980, OPHTHALMOLOGY, V87, P1133; WOLTER JR, 1961, AM J OPHTHALMOL, V51, P1123; Xiao M, 1998, INVEST OPHTH VIS SCI, V39, P618; Xie L, 2008, INVEST OPHTH VIS SCI, V49, P4203, DOI 10.1167/iovs.07-1364; Yang NP, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-253	32	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45189	10.1371/journal.pone.0045189	http://dx.doi.org/10.1371/journal.pone.0045189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028838	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900031
J	Guasch, L; Sala, E; Ojeda, MJ; Valls, C; Blade, C; Mulero, M; Blay, M; Ardevol, A; Garcia-Vallve, S; Pujadas, G				Guasch, Laura; Sala, Esther; Jose Ojeda, Maria; Valls, Cristina; Blade, Cinta; Mulero, Miquel; Blay, Mayte; Ardevol, Anna; Garcia-Vallve, Santiago; Pujadas, Gerard			Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part II): In Silico Prediction in Antidiabetic Extracts	PLOS ONE			English	Article							INDUCED DIABETIC-RATS; HYPOGLYCEMIC ACTIVITY; RAUWOLFIA-VOMITORIA; MEDICINAL CHEMISTRY; ALKALOIDS; PLANTS; STREPTOZOTOCIN; DRUGS; DATABASE; PRODUCTS	Background: Natural extracts play an important role in traditional medicines for the treatment of diabetes mellitus and are also an essential resource for new drug discovery. Dipeptidyl peptidase IV (DPP-IV) inhibitors are potential candidates for the treatment of type 2 diabetes mellitus, and the effectiveness of certain antidiabetic extracts of natural origin could be, at least partially, explained by the inhibition of DPP-IV. Methodology/Principal Findings: Using an initial set of 29,779 natural products that are annotated with their natural source and an experimentally validated virtual screening procedure previously developed in our lab (Guasch et al.; 2012) [1], we have predicted 12 potential DPP-IV inhibitors from 12 different plant extracts that are known to have antidiabetic activity. Seven of these molecules are identical or similar to molecules with described antidiabetic activity (although their role as DPP-IV inhibitors has not been suggested as an explanation for their bioactivity). Therefore, it is plausible that these 12 molecules could be responsible, at least in part, for the antidiabetic activity of these extracts through their inhibitory effect on DPP-IV. In addition, we also identified as potential DPP-IV inhibitors 6 molecules from 6 different plants with no described antidiabetic activity but that share the same genus as plants with known antidiabetic properties. Moreover, none of the 18 molecules that we predicted as DPP-IV inhibitors exhibits chemical similarity with a group of 2,342 known DPP-IV inhibitors. Conclusions/Significance: Our study identified 18 potential DPP-IV inhibitors in 18 different plant extracts (12 of these plants have known antidiabetic properties, whereas, for the remaining 6, antidiabetic activity has been reported for other plant species from the same genus). Moreover, none of the 18 molecules exhibits chemical similarity with a large group of known DPP-IV inhibitors.	[Guasch, Laura; Sala, Esther; Jose Ojeda, Maria; Valls, Cristina; Blade, Cinta; Mulero, Miquel; Blay, Mayte; Ardevol, Anna; Garcia-Vallve, Santiago; Pujadas, Gerard] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigenom, Tarragona, Catalonia, Spain; [Garcia-Vallve, Santiago; Pujadas, Gerard] CEICS, TECNIO, CTNS, Reus, Catalonia, Spain	Universitat Rovira i Virgili	Pujadas, G (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigenom, Tarragona, Catalonia, Spain.	gerard.pujadas@urv.cat	Ardévol, Anna/AAO-6194-2021; Mulero, Miquel/L-4672-2014; Sala, Esther/AAB-4997-2022; MJosé, Ojeda/ABB-5745-2020; Garcia-Vallve, Santi/A-4226-2008; Blay, Mayte Dr/B-1680-2009; Valls-Bautista, Cristina/K-8769-2014; Pujadas, Gerard/B-1457-2010; PUJADAS, GERARD/W-9348-2019	Ardévol, Anna/0000-0003-0156-7538; Mulero, Miquel/0000-0003-2545-2065; Garcia-Vallve, Santi/0000-0002-0348-7497; Blay, Mayte Dr/0000-0002-6256-9847; Valls-Bautista, Cristina/0000-0001-5583-5695; Pujadas, Gerard/0000-0003-2598-8089; PUJADAS, GERARD/0000-0003-2598-8089; Blade, Cinta/0000-0003-2838-2402; Ojeda Montes, Maria Jose/0000-0002-9290-1935; Sala, Esther/0000-0002-5149-1992; Guasch, Laura/0000-0003-4990-7765	Ministerio de Educacion y Ciencia of the Spanish Government [AGL2011-25831/ALI, AGL2011-23879/ALI]; Generalitat de Catalunya [ACC1O/TECCT11-1-0012]; XRQTC grant; Spanish Government [BES-2009-026450]	Ministerio de Educacion y Ciencia of the Spanish Government(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); XRQTC grant; Spanish Government(Spanish GovernmentEuropean Commission)	This research was supported by grants from the Ministerio de Educacion y Ciencia of the Spanish Government (AGL2011-25831/ALI and AGL2011-23879/ALI) and from the Generalitat de Catalunya (ACC1O/TECCT11-1-0012 program and XRQTC grant). N.G.-A. was supported by a pre-doctoral fellowship BES-2009-026450 from the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Santamaria L, 2009, J ETHNOPHARMACOL, V124, P284, DOI 10.1016/j.jep.2009.04.033; Andrade-Cetto A, 2005, J ETHNOPHARMACOL, V99, P325, DOI 10.1016/j.jep.2005.04.019; Augeri DJ, 2005, J MED CHEM, V48, P5025, DOI 10.1021/jm050261p; Bae EY, 2006, PLANTA MED, V72, P945, DOI 10.1055/s-2006-946674; Beek T. A. van, 1984, Tetrahedron, V40, P737, DOI 10.1016/S0040-4020(01)91102-0; Benn MH, 1996, J AGR FOOD CHEM, V44, P2779, DOI 10.1021/jf960175l; BENZI G, 1984, FARMACO-ED SCI, V39, P44; BLACK O. F., 1927, AMER JOUR PHARM, V99, P748; Bnouham M, 2006, INT J DIABETES METAB, V14; BRACK A, 1962, ARCHIV PHARM BERICHT, V295, P510, DOI 10.1002/ardp.19622950706; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Campbell JIA, 2006, J ETHNOPHARMACOL, V104, P379, DOI 10.1016/j.jep.2005.12.029; Chatterjee A, 1955, NATURWISSENSCHAFTEN, V77, P3551; Costantino Luca, 2003, Farmaco, V58, P781; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; El Sayed KA, 1998, J NAT PROD, V61, P848, DOI 10.1021/np980042p; Fu Z, 2011, BRIT J NUTR, V105, P1218, DOI 10.1017/S0007114510004824; Fujii M, 2009, BIOMED PHARMACOTHER, V63, P710, DOI 10.1016/j.biopha.2009.01.006; GHOSH BP, 1958, NATURWISSENSCHAFTEN, V45, P365, DOI 10.1007/BF00600690; Giang PM, 2006, CHEM PHARM BULL, V54, P546, DOI 10.1248/cpb.54.546; Gilg E, 1930, ARCH PHARM WEINHEIM, P233; GORMAN M, 1957, TETRAHEDRON, V1, P328, DOI 10.1016/0040-4020(57)88008-9; GRUESORENSEN G, 1989, CAN J CHEM, V67, P998, DOI 10.1139/v89-152; Guasch L, 2012, IDENTIFICATION NOV 1; HAMMOUDA Y, 1964, J PHARM PHARMACOL, V16, P833, DOI 10.1111/j.2042-7158.1964.tb07420.x; Haque N, 2011, Pak J Biol Sci, V14, P13, DOI 10.3923/pjbs.2011.13.24; Havale SH, 2009, BIOORGAN MED CHEM, V17, P1783, DOI 10.1016/j.bmc.2009.01.061; HOCHSTEIN FA, 1955, J AM CHEM SOC, V77, P3551, DOI 10.1021/ja01618a037; Howes M, 2005, TRADITIONAL MED MODE; ITO K, 1975, YAKUGAKU ZASSHI, V95, P358, DOI 10.1248/yakushi1947.95.3_358; Kar DM, 2006, J ETHNOPHARMACOL, V108, P251, DOI 10.1016/j.jep.2006.05.016; Kashiwaba N, 1997, CHEM PHARM BULL, V45, P545; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; KONNO C, 1985, PLANTA MED, V51, P162, DOI 10.1055/s-2007-969437; KONNO C, 1985, PLANTA MED, V51, P160, DOI 10.1055/s-2007-969436; Kuhn B, 2007, CURR TOP MED CHEM, V7, P609, DOI 10.2174/156802607780091064; Kumar A, 2011, PHARM BIOL, V49, P577, DOI 10.3109/13880209.2010.529615; Latha M, 2004, J BIOCHEM MOL TOXIC, V18, P261, DOI 10.1002/jbt.20035; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Ly TT, 2011, DIABETES CARE, V34, P50, DOI 10.2337/dc10-1042; Malviya N, 2010, ACTA POL PHARM, V67, P113; Meier JJ, 2002, REGUL PEPTIDES, V107, P1, DOI 10.1016/S0167-0115(02)00039-3; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; MICHEL KH, 1967, ACTA PHARM SUEC, V4, P97; Modak M, 2007, J CLIN BIOCHEM NUTR, V40, P163, DOI 10.3164/jcbn.40.163; Montagut G, 2010, J NUTR BIOCHEM, V21, P476, DOI 10.1016/j.jnutbio.2009.02.003; Mosihuzzaman M, 1994, Diabetes Res, V26, P127; Na M, 2006, J NAT PROD, V69, P1572, DOI 10.1021/np0601861; NATH M C, 1945, Ann Biochem Exp Med, V5, P101; Nguyen PH, 2010, J NAT PROD, V73, P598, DOI 10.1021/np900745g; Oh WK, 2009, ARCH PHARM RES, V32, P43, DOI 10.1007/s12272-009-1116-2; Osadchii SA, 2007, RUSS CHEM B+, V56, P1261, DOI 10.1007/s11172-007-0191-0; Pinent M, 2004, ENDOCRINOLOGY, V145, P4985, DOI 10.1210/en.2004-0764; Prabhakar PK, 2008, CURR DIABETES REV, V4, P291, DOI 10.2174/157339908786241124; Prabhakar PK, 2011, CHIN J INTEGR MED, V17, P563, DOI 10.1007/s11655-011-0810-3; Qi LW, 2010, CURR TOP MED CHEM, V10, P434, DOI 10.2174/156802610790980620; Roland M., 1959, J PHARM BELG, V14, P347; RONCHETTI F, 1971, PHYTOCHEMISTRY, V10, P1385, DOI 10.1016/S0031-9422(00)84347-2; Sala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016903; Semwal DK, 2010, J ASIAN NAT PROD RES, V12, P99, DOI 10.1080/10286020903117325; SHABANA MM, 1990, ARCH EXP VET MED, V44, P389; Sheludko Y, 2002, J NAT PROD, V65, P1006, DOI 10.1021/np0200919; SHUKLA K, 1991, Indian Journal of Physiology and Pharmacology, V35, P249; Song EK, 2003, ARCH PHARM RES, V26, P559, DOI 10.1007/BF02976881; TAKAYAMA H, 1988, CHEM PHARM BULL, V36, P3210; Torres JL, 2001, J AGR FOOD CHEM, V49, P4627, DOI 10.1021/jf010368v; Tsutsumi T, 2003, BIOL PHARM BULL, V26, P313, DOI 10.1248/bpb.26.313; USUBILLAGA A, 1988, PHYTOCHEMISTRY, V27, P3031, DOI 10.1016/0031-9422(88)80726-X; van de Venter M, 2008, J ETHNOPHARMACOL, V119, P81, DOI 10.1016/j.jep.2008.05.031; Villasenor IM, 2006, J ETHNOPHARMACOL, V104, P129, DOI 10.1016/j.jep.2005.08.067; Villhauer EB, 2003, J MED CHEM, V46, P2774, DOI 10.1021/jm030091l; Vuksan V, 2005, NUTR METAB CARDIOVAS, V15, P149, DOI 10.1016/j.numecd.2005.05.001; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Yoshikawa M, 2007, J NAT PROD, V70, P210, DOI 10.1021/np0680580; Zettl H, 2010, CHEMMEDCHEM, V5, P179, DOI 10.1002/cmdc.200900448; Zhang H, 2007, J NAT PROD, V70, P54, DOI 10.1021/np060344o; Zsoldos Z, 2007, J MOL GRAPH MODEL, V26, P198, DOI 10.1016/j.jmgm.2006.06.002	79	14	17	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44972	10.1371/journal.pone.0044972	http://dx.doi.org/10.1371/journal.pone.0044972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028712	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800021
J	Mookherjee, S; Acharya, M; Banerjee, D; Bhattacharjee, A; Ray, K				Mookherjee, Suddhasil; Acharya, Moulinath; Banerjee, Deblina; Bhattacharjee, Ashima; Ray, Kunal			Molecular Basis for Involvement of CYP1B1 in MYOC Upregulation and Its Potential Implication in Glaucoma Pathogenesis	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PRIMARY CONGENITAL GLAUCOMA; CYTOCHROME P4501B1 CYP1B1; TRABECULAR MESHWORK CELLS; SPANISH PATIENTS; MESSENGER-RNAS; MUTATIONS; GENE; IDENTIFICATION; ASSOCIATION	CYP1B1 has been implicated in primary congenital glaucoma with autosomal recessive mode of inheritance. Mutations in CYP1B1 have also been reported in primary open angle glaucoma (POAG) cases and suggested to act as a modifier of the disease along with Myocilin (MYOC). Earlier reports suggest that over-expression of myocilin leads to POAG pathogenesis. Taken together, we propose a functional interaction between CYP1B1 and myocilin where 17 beta estradiol acts as a mediator. Therefore, we hypothesize that 17 beta estradiol can induce MYOC expression through the putative estrogen responsive elements (EREs) located in its promoter and CYP1B1 could manipulate MYOC expression by metabolizing 17 beta estradiol to 4-hydroxy estradiol, thus preventing it from binding to MYOC promoter. Hence any mutation in CYP1B1 that reduces its 17 beta estradiol metabolizing activity might lead to MYOC upregulation, which in turn might play a role in glaucoma pathogenesis. It was observed that 17 beta estradiol is present in Human Trabecular Meshwork cells (HTM) and Retinal Pigment Epithelial cells (RPE) by immunoflouresence and ELISA. Also, the expression of enzymes related to estrogen biosynthesis pathway was observed in both cell lines by RT-PCR. Subsequent evaluation of the EREs in the MYOC promoter by luciferase assay, with dose and time dependent treatment of 17 beta estradiol, showed that the EREs are indeed active. This observation was further validated by direct binding of estrogen receptors (ER) on EREs in MYOC promoter and subsequent upregulation in MYOC level in HTM cells on 17 beta estradiol treatment. Interestingly, CYP1B1 mutants with less than 10% enzymatic activity were found to increase the level of endogenous myocilin in HTM cells. Thus the experimental observations are consistent with our proposed hypothesis that mutant CYP1B1, lacking the 17 beta estradiol metabolizing activity, can cause MYOC upregulation, which might have a potential implication in glaucoma pathogenesis.	[Mookherjee, Suddhasil; Acharya, Moulinath; Banerjee, Deblina; Bhattacharjee, Ashima; Ray, Kunal] Indian Inst Chem Biol, CSIR, Mol & Human Genet Div, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ray, K (corresponding author), Indian Inst Chem Biol, CSIR, Mol & Human Genet Div, Kolkata, India.	kunalray@gmail.com	Ray, Kunal/E-6515-2011	Ray, Kunal/0000-0001-9989-1760; Mookherjee, Suddhasil/0000-0003-2796-2659; Acharya, Moulinath/0000-0001-8013-7426	Council of Scientific and Industrial Research, India [SIP-007, MLP-0016]; CSIR, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research, India [Grant number SIP-007 and MLP-0016.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. Frans Cremers, University Medical Center, Nijmegen, The Netherlands for providing the human RPE cells, Dr. Michael Walter, University of Alberta, Edmonton, Canada for the HTM cell line, Dr. Thomas. H. Friedberg University of Dundee, UK for the CYP1B1-pcDNA3 mammalian expression vector. We are thankful to Dr. Anupam Banerjee for helping us with the confocal imaging. We thank CSIR, India for providing pre-doctoral fellowships to SM, MA, DB and AB.	Acharya M, 2006, MOL VIS, V12, P399; Borras T, 2003, GENETICS, V163, P637; Campos-Mollo E, 2009, MOL VIS, V15, P417; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Chakrabarti S, 2005, MOL VIS, V11, P111; Chavarria-Soley G, 2008, HUM MUTAT, V29, P1147, DOI 10.1002/humu.20786; Chouldhary D, 2008, PHARMACOGENET GENOM, V18, P665, DOI 10.1097/FPC.0b013e3282ff5a36; Clark AF, 2009, EXP EYE RES, V88, P752, DOI 10.1016/j.exer.2008.10.004; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Coca-Prados M, 2003, J STEROID BIOCHEM, V86, P207, DOI 10.1016/j.jsbmb.2003.08.001; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Firasat S, 2008, MOL VIS, V14, P2002; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gong G, 2007, J NATL MED ASSOC, V99, P559; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Hanna IH, 2000, CANCER RES, V60, P3440; Hulsman CAA, 2001, AM J EPIDEMIOL, V154, P138, DOI 10.1093/aje/154.2.138; Ko Y, 2001, CANCER RES, V61, P4398; Kumar A, 2007, MOL VIS, V13, P667; Libby RT, 2005, ANNU REV GENOM HUM G, V6, P15, DOI 10.1146/annurev.genom.6.080604.162209; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Lopez-Garrido MP, 2010, CLIN GENET, V77, P70, DOI 10.1111/j.1399-0004.2009.01284.x; Lopez-Garrido MP, 2006, MOL VIS, V12, P748; McDowell CM, 2012, EXP EYE RES; Melki R, 2004, J MED GENET, V41, P647, DOI 10.1136/jmg.2004.020024; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pasutto F, 2010, INVEST OPHTH VIS SCI, V51, P249, DOI 10.1167/iovs.09-3880; Pasutto F, 2009, AM J HUM GENET, V85, P447, DOI 10.1016/j.ajhg.2009.08.016; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Ray K, 2009, J GENET, V88, P451, DOI 10.1007/s12041-009-0065-3; Reddy ABM, 2004, MOL VIS, V10, P696; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Schirra F, 2006, CORNEA, V25, P438, DOI 10.1097/01.ico.0000183664.80004.44; Shen X, 2008, J BIOL CHEM, V283, P603, DOI 10.1074/jbc.M708250200; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Vithana EN, 2010, MOL VIS, V16, P1640; Wickham LA, 2000, ACTA OPHTHALMOL SCAN, V78, P146, DOI 10.1034/j.1600-0420.2000.078002146.x	41	36	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45077	10.1371/journal.pone.0045077	http://dx.doi.org/10.1371/journal.pone.0045077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028769	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800024
J	Reiling, L; Richards, JS; Fowkes, FJI; Wilson, DW; Chokejindachai, W; Barry, AE; Tham, WH; Stubbs, J; Langer, C; Donelson, J; Michon, P; Tavul, L; Crabb, BS; Siba, PM; Cowman, AF; Mueller, I; Beeson, JG				Reiling, Linda; Richards, Jack S.; Fowkes, Freya J. I.; Wilson, Danny W.; Chokejindachai, Watcharee; Barry, Alyssa E.; Tham, Wai-Hong; Stubbs, Janine; Langer, Christine; Donelson, John; Michon, Pascal; Tavul, Livingstone; Crabb, Brendan S.; Siba, Peter M.; Cowman, Alan F.; Mueller, Ivo; Beeson, James G.			The Plasmodium falciparum Erythrocyte Invasion Ligand Pfrh4 as a Target of Functional and Protective Human Antibodies against Malaria	PLOS ONE			English	Article							PAPUA-NEW-GUINEA; GROWTH-INHIBITORY ANTIBODIES; APICAL MEMBRANE ANTIGEN-1; IN-VITRO; BALANCING SELECTION; MEROZOITE PROTEINS; BINDING; RECEPTOR; CHILDREN; COMPLEMENT	Background: Acquired antibodies are important in human immunity to malaria, but key targets remain largely unknown. Plasmodium falciparum reticulocyte-binding-homologue-4 (PfRh4) is important for invasion of human erythrocytes and may therefore be a target of protective immunity. Methods: IgG and IgG subclass-specific responses against different regions of PfRh4 were determined in a longitudinal cohort of 206 children in Papua New Guinea (PNG). Human PfRh4 antibodies were tested for functional invasion-inhibitory activity, and expression of PfRh4 by P. falciparum isolates and sequence polymorphisms were determined. Results: Antibodies to PfRh4 were acquired by children exposed to P. falciparum malaria, were predominantly comprised of IgG1 and IgG3 subclasses, and were associated with increasing age and active parasitemia. High levels of antibodies, particularly IgG3, were strongly predictive of protection against clinical malaria and high-density parasitemia. Human affinity-purified antibodies to the binding region of PfRh4 effectively inhibited erythrocyte invasion by P. falciparum merozoites and antibody levels in protected children were at functionally-active concentrations. Although expression of PfRh4 can vary, PfRh4 protein was expressed by most isolates derived from the cohort and showed limited sequence polymorphism. Conclusions: Evidence suggests that PfRh4 is a target of antibodies that contribute to protective immunity to malaria by inhibiting erythrocyte invasion and preventing high density parasitemia. These findings advance our understanding of the targets and mechanisms of human immunity and evaluating the potential of PfRh4 as a component of candidate malaria vaccines.	[Reiling, Linda; Richards, Jack S.; Fowkes, Freya J. I.; Barry, Alyssa E.; Stubbs, Janine; Langer, Christine; Crabb, Brendan S.; Beeson, James G.] Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Reiling, Linda; Richards, Jack S.; Fowkes, Freya J. I.; Wilson, Danny W.; Barry, Alyssa E.; Tham, Wai-Hong; Langer, Christine; Cowman, Alan F.; Mueller, Ivo; Beeson, James G.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Chokejindachai, Watcharee] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Richards, Jack S.; Tham, Wai-Hong] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Donelson, John] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Michon, Pascal; Tavul, Livingstone; Siba, Peter M.; Mueller, Ivo] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Mueller, Ivo] Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Fowkes, Freya J. I.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic 3010, Australia; [Chokejindachai, Watcharee] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Nakhon Pathom, Thailand	Burnet Institute; Walter & Eliza Hall Institute; Mahidol University; University of Melbourne; University of Iowa; PNG Institute Of Medical Research; ISGlobal; CRESIB; University of Melbourne; Mahidol University	Beeson, JG (corresponding author), Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia.	beeson@burnet.edu.au	Cowman, Alan F/C-7642-2013; Mueller, Ivo/C-7251-2013; Tham, Wai-Hong/L-3173-2018; Wilson, Danny W/E-6186-2019; Crabb, Brendan/F-5287-2013; Tham, Wai-Hong/P-6474-2019	Cowman, Alan F/0000-0001-5145-9004; Mueller, Ivo/0000-0001-6554-6889; Tham, Wai-Hong/0000-0001-7950-8699; Wilson, Danny W/0000-0002-5073-1405; Tham, Wai-Hong/0000-0001-7950-8699; Richards, Jack/0000-0001-5786-6989; Fowkes, Freya/0000-0001-5832-9464; Barry, Alyssa/0000-0002-1189-2310	National Health and Medical Research Council of Australia; Australia-India Strategic Research Fund of the Department of Innovation Industry Science and Research, Australia; Australian Research Council; Victorian State Government; International Nutrition Foundation/Ellison Medical Foundation Fellowship Program; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Faculty of Tropical Medicine, Mahidol University	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia-India Strategic Research Fund of the Department of Innovation Industry Science and Research, Australia(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council(Australian Research Council); Victorian State Government; International Nutrition Foundation/Ellison Medical Foundation Fellowship Program; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Faculty of Tropical Medicine, Mahidol University	Funding was provided by the National Health and Medical Research Council of Australia (project grant and career development award to J. Beeson; program grant to J. Beeson, B. Crabb, A. Cowman; training award to F. Fowkes, postgraduate research fellowship to J. Richards, D. Wilson; project grant to A. Barry; Infrastructure for Research Institutes Support Scheme Grant); Australia-India Strategic Research Fund of the Department of Innovation Industry Science and Research, Australia; Australian Research Council (Future Fellowship to J. Beeson); Victorian State Government Operational Infrastructure Support grant; and International Nutrition Foundation/Ellison Medical Foundation Fellowship Program (W. Chokejindachai), Research Grant from Faculty of Tropical Medicine, Mahidol University (W. Chokejindachai) and the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative (W. Chokejindachai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; COHEN S, 1969, NATURE, V223, P368, DOI 10.1038/223368a0; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Elliott SR, 2008, CLIN INFECT DIS, V46, P1794, DOI 10.1086/588049; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gaur D, 2006, MOL BIOCHEM PARASIT, V145, P205, DOI 10.1016/j.molbiopara.2005.10.004; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Gomez-Escobar N, 2010, J INFECT DIS, V201, P444, DOI 10.1086/649902; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Hommel M, 2010, INFECT IMMUN, P1; KUMARATILAKE LM, 1992, INFECT IMMUN, V60, P3731, DOI 10.1128/IAI.60.9.3731-3738.1992; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lin E, 2010, AM J TROP MED HYG, V83, P828, DOI 10.4269/ajtmh.2010.09-0713; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Nery S, 2006, MOL BIOCHEM PARASIT, V149, P208, DOI 10.1016/j.molbiopara.2006.05.014; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Reeder JC, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-126; Reiling L, 2010, J IMMUNOL, V185, P6157, DOI 10.4049/jimmunol.1001555; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Robinson LJ, 2009, INFECT IMMUN, V77, P3033, DOI 10.1128/IAI.00211-09; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Sahar T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017102; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; Triglia T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002075; WIENER E, 1987, IMMUNOLOGY, V62, P401; Wilson DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027705; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152	54	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45253	10.1371/journal.pone.0045253	http://dx.doi.org/10.1371/journal.pone.0045253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028883	gold, Green Published			2022-12-27	WOS:000309388900033
J	Gunnerud, UJ; Heinzle, C; Holst, JJ; Ostman, EM; Bjorck, IME				Gunnerud, Ulrika J.; Heinzle, Cornelia; Holst, Jens J.; Ostman, Elin M.; Bjorck, Inger M. E.			Effects of Pre-Meal Drinks with Protein and Amino Acids on Glycemic and Metabolic Responses at a Subsequent Composite Meal	PLOS ONE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; INSULIN-SECRETION; BLOOD-GLUCOSE; HEALTHY-SUBJECTS; ELDERLY SUBJECTS; WHEY-PROTEIN; FOOD-INTAKE; CONSUMPTION; SUPPLEMENTS; INGESTION	Background: Whey proteins have insulinogenic properties and the effect appears to originate from a specific postprandial plasma amino acid pattern. The insulinogenic effect can be mimicked by a specific mixture of the five amino acids iso, leu, lys, thr and val. Objective: The objective was to evaluate the efficacy of pre-meal boluses of whey or soy protein with or without added amino acids on glycaemia, insulinemia as well as on plasma responses of incretins and amino acids at a subsequent composite meal. Additionally, plasma ghrelin and subjective appetite responses were studied. Design: In randomized order, fourteen healthy volunteers were served a standardized composite ham sandwich meal with either water provided (250 ml) during the time course of the meal, or different pre-meal protein drinks (PMPD) (100 ml provided as a bolus) with additional water (150 ml) served to the meal. The PMPDs contained 9 g protein and were based on either whey or soy protein isolates, with or without addition of the five amino acids (iso, leu, lys, thr and val) or the five amino acids + arg. Results: All PMPD meals significantly reduced incremental area for plasma glucose response (iAUC) during the first 60 min. All whey based PMPD meals displayed lower glycemic indices compared to the reference meal. There were no significant differences for the insulinemic indices. The early insulin response (iAUC 0-15 min) correlated positively to plasma amino acids, GIP and GLP-1 as well as to the glycemic profile. Additionally, inverse correlations were found between insulin iAUC 0-15 min and the glucose peak. Conclusion: The data suggests that a pre-meal drink containing specific proteins/amino acids significantly reduces postprandial glycemia following a composite meal, in absence of elevated insulinemic excursions. An early phase insulinemic response induced by plasma amino acids and incretins appears to mediate the effect.	[Gunnerud, Ulrika J.; Heinzle, Cornelia; Ostman, Elin M.; Bjorck, Inger M. E.] Lund Univ, Dept Appl Nutr & Food Chem, Lund, Sweden; [Holst, Jens J.] Univ Copenhagen, Panum Inst, Dept Med Physiol, DK-2200 Copenhagen N, Denmark	Lund University; University of Copenhagen	Gunnerud, UJ (corresponding author), Lund Univ, Dept Appl Nutr & Food Chem, Lund, Sweden.	ulrika.gunnerud@appliednutrition.lth.se	Holst, Jens/AAA-8022-2022; Ostman, Elin/G-3975-2012	Holst, Jens Juul/0000-0001-6853-3805; Ostman, Elin/0000-0003-0831-6176	Lund University Antidiabetic Food Center, a VINNOVA VINN Excellence Center	Lund University Antidiabetic Food Center, a VINNOVA VINN Excellence Center	This study was funded by the Lund University Antidiabetic Food Center, a VINNOVA VINN Excellence Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Anderson GH, 2004, J NUTR, V134, p974S, DOI 10.1093/jn/134.4.974S; Azadbakht L, 2005, AM J CLIN NUTR, V82, P523, DOI 10.1093/ajcn/82.3.523; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511005460; Ceriello A, 2008, NUTR METAB CARDIOVAS, V18, pS17, DOI 10.1016/j.numecd.2008.01.012; Delzenne N, 2010, OBES REV, V11, P234, DOI 10.1111/j.1467-789X.2009.00707.x; Dickinson S, 2008, AM J CLIN NUTR, V87, P1188; Festa A, 2008, DIABETES, V57, P1638, DOI 10.2337/db07-0954; FLATT PR, 1991, J NUTR, V121, P1123, DOI 10.1093/jn/121.7.1123; Frid AH, 2005, AM J CLIN NUTR, V82, P69, DOI 10.1093/ajcn/82.1.69; Gannon MC, 2010, IUBMB LIFE, V62, P660, DOI 10.1002/iub.375; Graf S, 2011, CURR OPIN CLIN NUTR, V14, P569, DOI 10.1097/MCO.0b013e32834b89da; GREGERSEN S, 1990, AM J CLIN NUTR, V52, P515, DOI 10.1093/ajcn/52.3.515; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Jauhiainen T, 2007, J NUTR, V137, p825S, DOI 10.1093/jn/137.3.825S; KRARUP T, 1983, J CLIN ENDOCR METAB, V56, P1306, DOI 10.1210/jcem-56-6-1306; Laaksonen DE, 2004, DIABETOLOGIA, V47, P1403, DOI 10.1007/s00125-004-1472-x; Lucotti P, 2009, METABOLISM, V58, P1270, DOI 10.1016/j.metabol.2009.03.029; Luhovyy BL, 2007, J AM COLL NUTR, V26, p704S, DOI 10.1080/07315724.2007.10719651; Malik VS, 2011, AM J CLIN NUTR, V94, P854, DOI 10.3945/ajcn.110.009621; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Nilsson M, 2004, AM J CLIN NUTR, V80, P1246, DOI 10.1093/ajcn/80.5.1246; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; Noguchi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012057; Orskov C, 1996, SCAND J GASTROENTERO, V31, P665, DOI 10.3109/00365529609009147; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535; PFEIFER MA, 1981, AM J MED, V70, P579, DOI 10.1016/0002-9343(81)90579-9; Pfeuffer M, 2007, OBES REV, V8, P109, DOI 10.1111/j.1467-789X.2006.00265.x; Ronner P, 2001, DIABETES, V50, P291, DOI 10.2337/diabetes.50.2.291; Rosen LAH, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-42; Ruidavets JB, 2007, J EPIDEMIOL COMMUN H, V61, P810, DOI 10.1136/jech.2006.052126; Salehi AS, 2012, NUTR METABO IN PRESS; Shyangdan DS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006423.pub2; Solerte SB, 2008, AM J CARDIOL, V101, p82E, DOI 10.1016/j.amjcard.2008.03.006; Solerte SB, 2008, AM J CARDIOL, V101, p69E, DOI 10.1016/j.amjcard.2008.03.004; Tahrani AA, 2010, PHARMACOL THERAPEUT, V125, P328, DOI 10.1016/j.pharmthera.2009.11.001; THOMAS FB, 1978, GASTROENTEROLOGY, V74, P1261; Valerio A, 2011, AGING-US, V3, P464, DOI 10.18632/aging.100322; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; van Loon LJC, 2003, DIABETES CARE, V26, P625, DOI 10.2337/diacare.26.3.625; Velasquez Manuel T, 2007, Int J Med Sci, V4, P72; Veldhorst MAB, 2009, PHYSIOL BEHAV, V96, P675, DOI 10.1016/j.physbeh.2009.01.004; Veldhorst MAB, 2009, EUR J NUTR, V48, P92, DOI 10.1007/s00394-008-0767-y; Warensjo E, 2010, ADV FOOD NUTR RES, V59, P1, DOI 10.1016/S1043-4526(10)59001-6	46	47	47	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44731	10.1371/journal.pone.0044731	http://dx.doi.org/10.1371/journal.pone.0044731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028596	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400037
J	Liang, WL; Zhao, YB; Chen, CX; Cui, XY; Yu, J; Xiao, JF; Kan, BA				Liang, Weili; Zhao, Yongbing; Chen, Chunxia; Cui, Xiaoying; Yu, Jun; Xiao, Jingfa; Kan, Biao			Pan-Genomic Analysis Provides Insights into the Genomic Variation and Evolution of Salmonella Paratyphi A	PLOS ONE			English	Article							ENTERICA SEROTYPE PARATYPHI; HORIZONTAL GENE-TRANSFER; SEQUENCE; TYPHI; SEROVARS; FEVER; CONVERGENCE; DIVERGENCE; ORTHOLOGS; ALIGNMENT	Salmonella Paratyphi A (S. Paratyphi A) is a highly adapted, human-specific pathogen that causes paratyphoid fever. Cases of paratyphoid fever have recently been increasing, and the disease is becoming a major public health concern, especially in Eastern and Southern Asia. To investigate the genomic variation and evolution of S. Paratyphi A, a pan-genomic analysis was performed on five newly sequenced S. Paratyphi A strains and two other reference strains. A whole genome comparison revealed that the seven genomes are collinear and that their organization is highly conserved. The high rate of substitutions in part of the core genome indicates that there are frequent homologous recombination events. Based on the changes in the pan-genome size and cluster number (both in the core functional genes and core pseudogenes), it can be inferred that the sharply increasing number of pseudogene clusters may have strong correlation with the inactivation of functional genes, and indicates that the S. Paratyphi A genome is being degraded.	[Zhao, Yongbing; Yu, Jun; Xiao, Jingfa] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Liang, Weili; Chen, Chunxia; Cui, Xiaoying; Kan, Biao] Chinese Ctr Dis Control & Prevention, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Liang, Weili; Chen, Chunxia; Cui, Xiaoying; Kan, Biao] Chinese Ctr Dis Control & Prevention, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Zhao, Yongbing] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiao, JF (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	xiaojingfa@big.ac.cn; kanbiao@icdc.cn			special grant for the Prevention and Treatment of Infectious Diseases [2008ZX10004-013]; State Key Laboratory for Infectious Disease Prevention [2008SKLID204]	special grant for the Prevention and Treatment of Infectious Diseases; State Key Laboratory for Infectious Disease Prevention	This work was supported by a special grant for the Prevention and Treatment of Infectious Diseases (2008ZX10004-013) and a grant from the State Key Laboratory for Infectious Disease Prevention (2008SKLID204). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Borodovsky M, 2003, CURR PROTOC BIOINFOR, pt4; Chandel DS, 2000, EMERG INFECT DIS, V6, P420, DOI 10.3201/eid0604.000420; Chen CX, 2012, FOODBORNE PATHOG DIS, V9, P325, DOI 10.1089/fpd.2011.1023; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Eswarappa SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003829; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fierer J, 2000, CURR CLIN TOPICS INF, V20, P134; Fierer J, 2001, J CLIN INVEST, V107, P775, DOI 10.1172/JCI12561; Fu X, 2011, MOD PREV MED, V14, P2823; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Goh YL, 2002, J APPL MICROBIOL, V92, P1167, DOI 10.1046/j.1365-2672.2002.01655.x; Gong Z, 2006, DIS SURVEILLANCE, V21, P13; Han Hui, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P810; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lawrence Jeffrey G., 2005, V12, P255, DOI 10.1159/000081699; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu WQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004510; Lu C, 2006, PREV MED, P814; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rasmussen TB, 2008, APPL ENVIRON MICROB, V74, P4703, DOI 10.1128/AEM.00132-08; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; SELANDER RK, 1990, INFECT IMMUN, V58, P2262, DOI 10.1128/IAI.58.7.2262-2275.1990; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wang H, 2000, J DIS CONTROL, V4, P317; Wang H, 2007, CHIN J PUBLIC HLTH, V23, P369; Woods CW, 2006, T ROY SOC TROP MED H, V100, P1063, DOI 10.1016/j.trstmh.2005.12.011; Wu J, 2004, J GUIYANG MED COLL, V29, P541; Yan M., 2005, DIS SURVEILLANCE, V20, P401; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhou W, 2006, CHIN PREV MED, V17, P428	65	20	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45346	10.1371/journal.pone.0045346	http://dx.doi.org/10.1371/journal.pone.0045346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028950	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400077
J	Zhao, ZN; Bai, JX; Zhou, Q; Yan, B; Qin, WW; Jia, LT; Meng, YL; Jin, BQ; Yao, LB; Wang, T; Yang, AG				Zhao, Zhi-Ning; Bai, Jiu-Xu; Zhou, Qiang; Yan, Bo; Qin, Wei-Wei; Jia, Lin-Tao; Meng, Yan-Ling; Jin, Bo-Quan; Yao, Li-Bo; Wang, Tao; Yang, An-Gang			TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITORS; ENDOMETRIAL STROMAL CELLS; TRICHOSTATIN-A; CANCER-CELLS; PROSTATE-CANCER; CYCLE ARREST; GASTRIC-CANCER; C-MYC; MICRORNAS; PROMOTER	Histone deacetylase (HDAC) inhibitors are emerging as a novel class of anti-tumor agents and have manifested the ability to decrease proliferation and increase apoptosis in different cancer cells. A significant number of genes have been identified as potential effectors responsible for the anti-tumor function of HDAC inhibitor. However, the molecular mechanisms of these HDAC inhibitors in this process remain largely undefined. In the current study, we searched for microRNAs (miRs) that were affected by HDAC inhibitor trichostatin (TSA) and investigated their effects in endometrial cancer (EMC) cells. Our data showed that TSA significantly inhibited the growth of EMC cells and induced their apoptosis. Among the miRNAs that altered in the presence of TSA, the miR-106b-93-25 cluster, together with its host gene MCM7, were obviously down-regulated in EMC cells. p21 and BIM, which were identified as target genes of miR-106b-93-25 cluster, increased in TSA treated tumor cells and were responsible for cell cycle arrest and apoptosis. We further identified MYC as a regulator of miR-106b-93-25 cluster and demonstrated its down-regulation in the presence of TSA resulted in the reduction of miR-106b-93-25 cluster and up-regulation of p21 and BIM. More important, we found miR-106b-93-25 cluster was up-regulated in clinical EMC samples in association with the overexpression of MCM7 and MYC and the down-regulation of p21 and BIM. Thus our studies strongly indicated TSA inhibited EMC cell growth and induced cell apoptosis and cell cycle arrest at least partially through the down-regulation of the miR-106b-93-25 cluster and up-regulation of it's target genes p21 and BIM via MYC.	[Zhao, Zhi-Ning; Bai, Jiu-Xu; Meng, Yan-Ling; Jin, Bo-Quan; Wang, Tao; Yang, An-Gang] Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Yan, Bo; Jia, Lin-Tao; Yao, Li-Bo] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Shaanxi, Peoples R China; [Zhou, Qiang] Fourth Mil Med Univ, Sch Stomatol, Dept Gen Dent & Emergency, Xian 710032, Shaanxi, Peoples R China; [Qin, Wei-Wei] Fourth Mil Med Univ, Tangdu Hosp, Dept Hematol, Xian 710032, Shaanxi, Peoples R China; [Zhao, Zhi-Ning] 451 Hosp Chinese Peoples Liberat Army, Clin Lab, Xian, Shaanxi, Peoples R China; [Bai, Jiu-Xu] Shenyang Gen Hosp Peoples Liberat Army, Dept Blood Purificat, Shenyang, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wang, T (corresponding author), Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China.	wangtao@use.edu; agyang@fmmu.edu.cn	Wang, Tao/ABB-7764-2021; meng, yan/GSE-2653-2022; Meng, Yan/HGC-0394-2022; Wang, Tao/AEN-3843-2022		National High Technology Research and Development Program of China [2007AA021104]; National Basic Research Program of China [2010CB529905]; National Major Science and Technology Specialized Project for New Drugs Formulation [2009ZX09103-664]; Natural Science Foundation of China [81172289]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Major Science and Technology Specialized Project for New Drugs Formulation; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by National High Technology Research and Development Program of China grant 2007AA021104 (A.G. Yang), National Basic Research Program of China 2010CB529905 (L.T. Jia), National Major Science and Technology Specialized Project for New Drugs Formulation 2009ZX09103-664 (L.T. Jia), Natural Science Foundation of China 81172289 (T. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Boyd KE, 1997, MOL CELL BIOL, V17, P2529, DOI 10.1128/MCB.17.5.2529; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cole MD, 2006, CURR TOP MICROBIOL, V302, P33; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Donadelli M, 2003, MOL CARCINOGEN, V38, P59, DOI 10.1002/mc.10145; Dowdy SC, 2006, MOL CANCER THER, V5, P2767, DOI 10.1158/1535-7163.MCT-06-0209; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; HURLIN PJ, 1995, EMBO J, V14, P5646, DOI 10.1002/j.1460-2075.1995.tb00252.x; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Kan T, 2009, CURR OPIN PHARMACOL, V9, P727, DOI 10.1016/j.coph.2009.08.009; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Li H, 2004, BIOCHEM BIOPH RES CO, V324, P860, DOI 10.1016/j.bbrc.2004.09.130; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin HY, 2006, MED RES REV, V26, P397, DOI 10.1002/med.20056; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Noh EJ, 2003, BIOCHEM BIOPH RES CO, V310, P267, DOI 10.1016/j.bbrc.2003.09.013; Noh EL, 2009, BIOCHEM BIOPH RES CO, V378, P326, DOI 10.1016/j.bbrc.2008.11.057; O'Hagan RC, 2000, NAT GENET, V24, P113, DOI 10.1038/72761; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Santini V, 2007, CURR DRUG METAB, V8, P383, DOI 10.2174/138920007780655397; Shin S, 2009, INT J ONCOL, V35, P1343, DOI 10.3892/ijo_00000452; Smith LT, 2007, TRENDS GENET, V23, P449, DOI 10.1016/j.tig.2007.07.005; Suzuki S, 1998, GENE, V216, P85, DOI 10.1016/S0378-1119(98)00323-0; Szyf M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P533, DOI 10.1007/s10541-005-0147-7; Takai N, 2004, CLIN CANCER RES, V10, P1141, DOI 10.1158/1078-0432.CCR-03-0100; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wu Y, 2008, EUR J OBSTET GYN R B, V137, P198, DOI 10.1016/j.ejogrb.2007.02.014; Wu Y, 2007, EUR J OBSTET GYN R B, V135, P88, DOI 10.1016/j.ejogrb.2006.07.034; Wu Y, 2007, REPROD SCI, V14, P374, DOI 10.1177/1933719107302913; Wu Y, 2006, GYNECOL OBSTET INVES, V62, P193, DOI 10.1159/000093975; Wu Y, 2010, GYNECOL OBSTET INVES, V70, P23, DOI 10.1159/000279324; Xiao HY, 2000, J BIOL CHEM, V275, P1371, DOI 10.1074/jbc.275.2.1371; Xiong YN, 2006, GYNECOL ONCOL, V103, P321, DOI 10.1016/j.ygyno.2006.03.045	47	38	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45133	10.1371/journal.pone.0045133	http://dx.doi.org/10.1371/journal.pone.0045133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028803	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400063
J	Kato, Y; Matsuura, T; Watanabe, H				Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime			Genomic Integration and Germline Transmission of Plasmid Injected into Crustacean Daphnia magna Eggs	PLOS ONE			English	Article							WATER FLEA; GENE; TRANSGENESIS; MEDAKA; LINE; EXPRESSION; PROSPECTS; TOXICITY; REPORTER; SEQUENCE	The water flea, Daphnia, has been the subject of study in ecology, evolution, and environmental sciences for decades. Over the last few years, expressed sequence tags and a genome sequence have been determined. In addition, functional approaches of overexpression and gene silencing based on microinjection of RNAs into eggs have been established. However, the transient nature of these approaches prevents us from analyzing gene functions in later stages of development. To overcome this limitation, transgenesis would become a key tool. Here we report establishment of a transgenic line using microinjection of plasmid into Daphnia magna eggs. The green fluorescent protein (GFP) gene fused with the D. magna histone H2B gene under the control of a promoter/enhancer region of the elongation factor 1 alpha-1 (EF1 alpha-1) gene, EF1 alpha-1::H2B-GFP, was used as a reporter providing high resolution visualization of active chromatin. Transgenic lines were obtained from 0.67% of the total fertile adults that survived the injections. One of the transgenic animals, which exhibited fluorescence in the nuclei of cells during embryogenesis and oogenesis, had two copies of EF1 alpha-1::H2B-GFP in a head-to-tail array. This is the first report of a transgenesis technique in Daphnia and, together with emerging genome sequences, will be useful for advancing knowledge of the molecular biology of Daphnia.	[Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Osaka, Japan	Osaka University	Watanabe, H (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Osaka, Japan.	watanabe@bio.eng.osaka-u.ac.jp	WATANABE, Hajime/AAJ-8904-2021; Kato, Yasuhiko/AES-3929-2022; Watanabe, Hajime/S-8957-2019; Matsuura, Tomoaki/W-6086-2019; matsuura, tomoaki/O-7368-2018	Kato, Yasuhiko/0000-0002-1041-1044; Matsuura, Tomoaki/0000-0003-1015-6781; matsuura, tomoaki/0000-0003-1015-6781; Watanabe, Hajime/0000-0001-9657-6554	Ministry of Education, Culture, Sports, Science, and Technology; Asahi Glass Fundation Rsearch Grant	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Fundation Rsearch Grant	This study was partly supported through a grant from the Ministry of Education, Culture, Sports, Science, and Technology (H.W.) and The Asahi Glass Fundation Rsearch Grant (H.W.). Y.K. is a Research Fellow of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann R, 1996, NUCLEIC ACIDS RES, V24, P2452, DOI 10.1093/nar/24.12.2452; Cannon HG, 1921, Q J MICROSC SCI, V65, P627; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Eads BD, 2008, HEREDITY, V100, P184, DOI 10.1038/sj.hdy.6800999; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E; Fraser MJ, 2012, ANNU REV ENTOMOL, V57, P267, DOI 10.1146/annurev.ento.54.110807.090545; GORDON JW, 1989, INT REV CYTOL, V115, P171; Grabher Clemens, 2008, V461, P521, DOI 10.1007/978-1-60327-483-8_36; HANDLER AM, 1991, ANNU REV ENTOMOL, V36, P159, DOI 10.1146/annurev.en.36.010191.001111; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; Huang AM, 2000, DROSOPHILA PROTOCOLS; JOHNSON AD, 1995, DEV GENET, V17, P280, DOI 10.1002/dvg.1020170313; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kato Y, 2008, GENOMICS, V91, P94, DOI 10.1016/j.ygeno.2007.09.002; Kato Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001345; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; Kinoshita M, 2000, DEV GROWTH DIFFER, V42, P469; Kuhn Alfred, 1913, Zoologische Jahrbuecher Jena Abteilungen fur Anatomie, V35; Kurokawa H, 2006, DEV GROWTH DIFFER, V48, P209, DOI 10.1111/j.1440-169x.2006.00858.x; MILLER LH, 1987, SCIENCE, V237, P779, DOI 10.1126/science.3039658; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Sagawa K, 2005, GENE EXPR PATTERNS, V5, P669, DOI 10.1016/j.modgep.2005.02.007; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Shaw JR, 2008, DAPHNIA EMERGING MOD; Suster ML, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-477; Tatarazako N, 2003, CHEMOSPHERE, V53, P827, DOI 10.1016/S0045-6535(03)00761-6; Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038; Watanabe H, 2007, ENVIRON TOXICOL CHEM, V26, P669, DOI 10.1897/06-075R.1; Zaffagnini F., 1987, MEM I ITAL IDROBIOL, V45	30	27	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45318	10.1371/journal.pone.0045318	http://dx.doi.org/10.1371/journal.pone.0045318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028929	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900116
J	Ma, SY; Zhang, SL; Wang, F; Liu, Y; Liu, YY; Xu, HF; Liu, C; Lin, Y; Zhao, P; Xia, QY				Ma, Sanyuan; Zhang, Shengling; Wang, Feng; Liu, Yong; Liu, Yuanyuan; Xu, Hanfu; Liu, Chun; Lin, Ying; Zhao, Ping; Xia, Qingyou			Highly Efficient and Specific Genome Editing in Silkworm Using Custom TALENs	PLOS ONE			English	Article							DROSOPHILA; RECOMBINATION; REPLACEMENT; MUTAGENESIS; EFFECTORS; KNOCKOUT	Establishment of efficient genome editing tools is essential for fundamental research, genetic engineering, and gene therapy. Successful construction and application of transcription activator-like effector nucleases (TALENs) in several organisms herald an exciting new era for genome editing. We describe the production of two active TALENs and their successful application in the targeted mutagenesis of silkworm, Bombyx mori, whose genetic manipulation methods are parallel to those of Drosophila and other insects. We will also show that the simultaneous expression of two pairs of TALENs generates heritable large chromosomal deletion. Our results demonstrate that (i) TALENs can be used in silkworm and (ii) heritable large chromosomal deletions can be induced by two pairs of TALENs in whole organisms. The generation and the high frequency of TALENs-induced targeted mutagenesis in silkworm will promote the genetic modification of silkworm and other insect species.	[Ma, Sanyuan; Zhang, Shengling; Wang, Feng; Liu, Yong; Liu, Yuanyuan; Xu, Hanfu; Liu, Chun; Lin, Ying; Zhao, Ping; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Feng/P-7961-2019; Ma, Sanyuan/L-8057-2019; liu, yuanyuan/GWZ-5838-2022	Wang, Feng/0000-0001-7633-8284; Ma, Sanyuan/0000-0002-0364-5686; Xia, Qingyou/0000-0002-9263-2886	Chinese Ministry of Science and Technology [2012CB114600, 2011AA100306]; doctoral Innovation Fund of Southwest University [kb2010002, ky2009002]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); doctoral Innovation Fund of Southwest University	This work was supported by the Chinese Ministry of Science and Technology [2012CB114600, 2011AA100306] (http://www.most.gov.cn/); and the doctoral Innovation Fund of Southwest University [kb2010002, ky2009002] (http://www.swu.edu.cn/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bibikova M, 2002, GENETICS, V161, P1169; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cermak T, 2011, NUCLEIC ACIDS RES, V39, P7879, DOI 10.1093/nar/gkr739; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Fraser MJ, 2012, ANNU REV ENTOMOL, V57, P267, DOI 10.1146/annurev.ento.54.110807.090545; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Lee HJ, 2012, GENOME RES, V22, P539, DOI 10.1101/gr.129635.111; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Robbins J, 2011, CIRC RES, V109, P722, DOI 10.1161/CIRCRESAHA.111.249912; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Schetelig MF, 2011, GENETICA, V139, P71, DOI 10.1007/s10709-010-9494-4; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P759, DOI 10.1016/j.ibmb.2010.07.012; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhao AC, 2012, INSECT SCI, V19, P172, DOI 10.1111/j.1744-7917.2011.01422.x	34	135	164	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45035	10.1371/journal.pone.0045035	http://dx.doi.org/10.1371/journal.pone.0045035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028749	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900069
J	Moitra, K; Im, K; Limpert, K; Borsa, A; Sawitzke, J; Robey, R; Yuhki, N; Savan, R; Huang, DW; Lempicki, RA; Bates, S; Dean, M				Moitra, Karobi; Im, Kate; Limpert, Katy; Borsa, Alexander; Sawitzke, Julie; Robey, Rob; Yuhki, Naoya; Savan, Ram; Huang, Da Wei; Lempicki, Richard A.; Bates, Susan; Dean, Michael			Differential Gene and MicroRNA Expression between Etoposide Resistant and Etoposide Sensitive MCF7 Breast Cancer Cell Lines	PLOS ONE			English	Article							DRUG-RESISTANCE; ANTIBIOTIC RESISTOME; TOPOISOMERASE-II; ORAL ETOPOSIDE; COMBINATION; MECHANISM; TRANSPORT; PROFILES; DECADES	In order to develop targeted strategies for combating drug resistance it is essential to understand it's basic molecular mechanisms. In an exploratory study we have found several possible indicators of etoposide resistance operating in MCF7VP cells, including up-regulation of ABC transporter genes, modulation of miRNA, and alteration in copy numbers of genes.	[Moitra, Karobi; Im, Kate; Limpert, Katy; Borsa, Alexander; Sawitzke, Julie; Savan, Ram; Dean, Michael] Frederick Natl Lab Canc Res, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA; [Robey, Rob; Bates, Susan] NCI, Med Oncol Branch, Mol Therapeut Sect, Bethesda, MD 20892 USA; [Yuhki, Naoya] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Huang, Da Wei; Lempicki, Richard A.] SAIC Frederick, Lab Immunopathogenesis & Bioinformat, Clin Serv Program, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Science Applications International Corporation (SAIC); SAIC-Frederick	Dean, M (corresponding author), Frederick Natl Lab Canc Res, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA.	deanm@mail.nih.gov	Dean, Michael/R-7501-2019; Bates, Susan/AFP-9514-2022; Lempicki, Richard A/E-1844-2012; Dean, Michael C/G-8172-2012	Lempicki, Richard A/0000-0002-7059-409X; Dean, Michael C/0000-0003-2234-0631; Robey, Rob/0000-0002-0857-3650; Sawitzke, Julie/0000-0002-1715-4626; Savan, Ram/0000-0002-3087-1355; Borsa, Alexander/0000-0001-5349-7493	Intramural Research Program of the Frederick National Laboratory for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER	Intramural Research Program of the Frederick National Laboratory for Cancer Research, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported (in part) by the Intramural Research Program of the Frederick National Laboratory for Cancer Research, National Institutes of Health. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATIENZA DM, 1995, CANCER, V76, P2485, DOI 10.1002/1097-0142(19951215)76:12<2485::AID-CNCR2820761212>3.0.CO;2-J; Belinsky MG, 2002, CANCER RES, V62, P6172; COLE SPC, 1994, CANCER RES, V54, P5902; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dawood S, 2008, J CLIN ONCOL, V26, P4891, DOI 10.1200/JCO.2007.14.1168; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; HENWOOD JM, 1990, DRUGS, V39, P438, DOI 10.2165/00003495-199039030-00008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Icli F, 2005, BRIT J CANCER, V92, P639, DOI 10.1038/sj.bjc.6602388; Ikeda R, 2011, INT J ONCOL, V38, P513, DOI 10.3892/ijo.2010.866; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Liang Z, BIOCH PHARM, V79, P817; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; SCHNEIDER E, 1994, CANCER RES, V54, P152; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zelcer N, 2001, J BIOL CHEM, V276, P46400, DOI 10.1074/jbc.M107041200; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	25	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45268	10.1371/journal.pone.0045268	http://dx.doi.org/10.1371/journal.pone.0045268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028896	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900111
J	Thornbrough, JM; Worley, MJ				Thornbrough, Joshua M.; Worley, Micah J.			A Naturally Occurring Single Nucleotide Polymorphism in the Salmonella SPI-2 Type III Effector srfH/sseI Controls Early Extraintestinal Dissemination	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PATHOGENICITY ISLAND 2; CELL-MIGRATION; EPITHELIAL-CELLS; SECRETION SYSTEM; HOST; VIRULENCE; GENE; PROTEINS; IDENTIFICATION	CD18 expressing phagocytes associated with the gastro-intestinal (GI) epithelium can shuttle Salmonella directly into the bloodstream within a few minutes following microbial ingestion. We have previously demonstrated that Salmonella controls the CD18 pathway to deeper tissue, manipulating the migratory properties of infected cells as an unappreciated component of its pathogenesis. We have observed that one type III effector, SrfH (also called SseI) that Salmonella secretes into infected phagocytes manipulates the host protein TRIP6 to stimulate their migration. Paradoxically, SrfH was shown in another study to subvert a different host protein, IQGAP1, in a manner that inhibits the productive motility of such cells, perhaps to avoid interactions with T cells. Here, we resolve the discrepancy. We report that one naturally occurring allele of srfH promotes the migration of infected phagocytes into the bloodstream, while another naturally occurring allele that differs by only a single nucleotide polymorphism (SNP) does not. This SNP determines if the protein contains an aspartic acid or a glycine residue at position 103 and may determine if SrfH binds TRIP6. SrfH Gly103 is a rare allele, but is present in the highly invasive strain Salmonella enterica serovar Typhimurium UK-1 (stands for universal killer). It is also present in the genome of the only sequenced strain belonging to the emerging pandemic Salmonella enterica serovar 4, [5], 12, i:-, which is frequently associated with septicemia. Finally, we present evidence that suggests that Gifsy-2, the bacteriophage upon which srfH resides, is present in a clinical isolate of the human-specific pathogen, Salmonella enterica serovar Typhi. These observations may have interesting implications for our understanding of Salmonella pathogenesis.	[Thornbrough, Joshua M.; Worley, Micah J.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Worley, Micah J.] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Worley, MJ (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	micah.worley@louisville.edu			National Institute Of Allergy And Infectious Diseases [R56AI091766]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI091766] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Grant Number R56AI091766 from the National Institute Of Allergy And Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Allergy And Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasan A, 2002, J CLIN MICROBIOL, V40, P1924, DOI 10.1128/JCM.40.6.1924-1929.2002; Ausubel FM, CURRENT PROTOCOLS MO; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Galyov EE, 1997, MOL MICROBIOL, V25, P903, DOI 10.1111/j.1365-2958.1997.mmi525.x; Geddes K, 2005, INFECT IMMUN, V73, P6260, DOI 10.1128/IAI.73.10.6260-6271.2005; GROISMAN EA, 1993, EMBO J, V12, P3779, DOI 10.1002/j.1460-2075.1993.tb06056.x; Hansen-Wester I, 2002, INFECT IMMUN, V70, P1619, DOI 10.1128/IAI.70.3.1619-1622.2002; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Ho TD, 2001, J BACTERIOL, V183, P611, DOI 10.1128/JB.183.2.611-620.2001; Hobbie S, 1997, J IMMUNOL, V159, P5550; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hopkins K L, 2010, Euro Surveill, V15, P19580; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Komolpis P., 1999, Journal of Infectious Diseases and Antimicrobial Agents, V16, P49; Krishnakumar R, 2004, J BACTERIOL, V186, P5230, DOI 10.1128/JB.186.16.5230-5238.2004; Lai YJ, 2005, MOL CELL BIOL, V25, P5859, DOI 10.1128/MCB.25.14.5859-5868.2005; Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011; Luo YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040645; Luo YQ, 2011, J BACTERIOL, V193, P4035, DOI 10.1128/JB.05224-11; Maloy SR., 1996, GENETIC ANAL PATHOGE; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; McLaughlin LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000671; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Pesce A, 2000, J MOL BIOL, V302, P465, DOI 10.1006/jmbi.2000.4074; Pornruangwong Srirat, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P288; Pui C. F., 2011, International Food Research Journal, V18, P465; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Switt AIM, 2009, FOODBORNE PATHOG DIS, V6, P407, DOI 10.1089/fpd.2008.0213; Tavechio Ana T., 2004, Rev. Inst. Med. trop. S. Paulo, V46, P115, DOI 10.1590/S0036-46652004000200012; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Worley MJ, 2006, P NATL ACAD SCI USA, V103, P17915, DOI 10.1073/pnas.0604054103; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Zhang X, 1999, MICROB PATHOGENESIS, V26, P121, DOI 10.1006/mpat.1998.0245	43	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45245	10.1371/journal.pone.0045245	http://dx.doi.org/10.1371/journal.pone.0045245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028876	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900105
J	Ejaz, A; Ammann, CG; Werner, R; Huber, G; Oberhauser, V; Horl, S; Schimmer, S; Dittmer, U; von Laer, D; Stoiber, H; Banki, Z				Ejaz, Asim; Ammann, Christoph G.; Werner, Roland; Huber, Georg; Oberhauser, Verena; Hoerl, Susanne; Schimmer, Simone; Dittmer, Ulf; von Laer, Dorothee; Stoiber, Heribert; Banki, Zoltan			Targeting Viral Antigens to CD11c on Dendritic Cells Induces Retrovirus-Specific T Cell Responses	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; IN-VIVO; ANTIBODY-RESPONSES; CROSS-PRESENTATION; IMMUNITY; PROTECTION; INFECTION; FRIEND; VACCINATION; MICE	Dendritic cells (DC) represent the most potent antigen presenting cells and induce efficient cytotoxic T lymphocyte (CTL) responses against viral infections. Targeting antigens (Ag) to receptors on DCs is a promising strategy to enhance antitumor and antiviral immune responses induced by DCs. Here, we investigated the potential of CD11c-specific single-chain fragments (scFv) fused to an immunodominant peptide of Friend retrovirus for induction of virus-specific T cell responses by DCs. In vitro CD11c-specific scFv selectively targeted viral antigens to DCs and thereby significantly improved the activation of virus-specific T cells. In vaccination experiments DCs loaded with viral Ag targeted to CD11c provided improved rejection of FV-derived tumors and efficiently primed virus-specific CTL responses after virus challenge. Since the induction of strong virus-specific T cell responses is critical in viral infections, CD11c targeted protein vaccines might provide means to enhance the cellular immune response to prophylactic or therapeutic levels.	[Ejaz, Asim; Werner, Roland; Huber, Georg; Oberhauser, Verena; Hoerl, Susanne; von Laer, Dorothee; Stoiber, Heribert; Banki, Zoltan] Innsbruck Med Univ, Div Virol, Innsbruck, Austria; [Ammann, Christoph G.] Innsbruck Med Univ, Dept Internal Med 1, Innsbruck, Austria; [Schimmer, Simone; Dittmer, Ulf] Univ Duisburg Essen, Inst Virol, Essen, Germany	Medical University of Innsbruck; Medical University of Innsbruck; University of Duisburg Essen	Banki, Z (corresponding author), Innsbruck Med Univ, Div Virol, Innsbruck, Austria.	zoltan.banki@i-med.ac.at	Ejaz, Asim/J-9236-2019	von Laer, Dorothee/0000-0001-5825-7237; Banki, Zoltan/0000-0002-3826-5800; Huber, Georg/0000-0001-9680-2785; Ammann, Christoph/0000-0002-6267-1286	Austrian Science Fund (FWF) [P21508-B13]; EU [DEC-VAC 2005-018685]; Federal Government of Tyrol [Tiroler Wissenschaftsfonds TWF-2008-1-562]; Austrian Science Fund (FWF) [P 21508] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); EU(European Commission); Federal Government of Tyrol; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors are supported by grants of the Austrian Science Fund (FWF): P21508-B13 to ZB, the 6th frame work of the EU (DEC-VAC 2005-018685 to HS), and the Federal Government of Tyrol (Tiroler Wissenschaftsfonds TWF-2008-1-562 to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes I, 2008, IMMUNITY, V29, P782, DOI 10.1016/j.immuni.2008.09.016; Bajtay Z, 2006, IMMUNOL LETT, V104, P46, DOI 10.1016/j.imlet.2005.11.023; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banki Z, 2007, FRONT BIOSCI-LANDMRK, V12, P2096, DOI 10.2741/2214; Banki Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000891; Bayer W, 2010, J VIROL, V84, P1967, DOI 10.1128/JVI.01840-09; Beyer M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-70; Birkholz K, 2010, BLOOD, V116, P2277, DOI 10.1182/blood-2010-02-268425; Caminschi I, 2007, J EXP MED, V204, P2579, DOI 10.1084/jem.20071351; Castro FVV, 2008, EUR J IMMUNOL, V38, P2263, DOI 10.1002/eji.200838302; Chen W, 1996, J VIROL, V70, P7773, DOI 10.1128/JVI.70.11.7773-7782.1996; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Demangel C, 2005, MOL IMMUNOL, V42, P979, DOI 10.1016/j.molimm.2004.09.034; Dittmer U, 2002, J VIROL, V76, P450, DOI 10.1128/JVI.76.1.450-454.2002; Dittmer U, 1999, J VIROL, V73, P3753, DOI 10.1128/JVI.73.5.3753-3757.1999; Dittmer U, 1999, NAT MED, V5, P189, DOI 10.1038/5550; Faham A, 2010, INT J CANC; Flacher V, 2010, J INVEST DERMATOL, V130, P755, DOI 10.1038/jid.2009.343; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Hasenkrug KJ, 2007, FRONT BIOSCI-LANDMRK, V12, P1544, DOI 10.2741/2167; Hasenkrug KJ, 2000, VIROLOGY, V272, P244, DOI 10.1006/viro.2000.0387; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kanazawa N, 2007, J DERMATOL SCI, V45, P77, DOI 10.1016/j.jdermsci.2006.09.001; Kawabata H, 2006, INT IMMUNOL, V18, P183, DOI 10.1093/intimm/dxh361; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; Kurts C, 2008, EUR J IMMUNOL, V38, P2072, DOI 10.1002/eji.200838645; Lahoud MH, 2009, J IMMUNOL, V182, P7587, DOI 10.4049/jimmunol.0900464; LANDER MR, 1984, J VIROL, V52, P695, DOI 10.1128/JVI.52.2.695-698.1984; Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Ludewig B, 1998, J VIROL, V72, P3812, DOI 10.1128/JVI.72.5.3812-3818.1998; MAZZONE A, 1995, HAEMATOLOGICA, V80, P161; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Nchinda G, 2010, P NATL ACAD SCI USA, V107, P4281, DOI 10.1073/pnas.1000621107; Ohlen C, 2002, J EXP MED, V195, P1407, DOI 10.1084/jem.20011063; Racine R, 2008, J IMMUNOL, V181, P1375, DOI 10.4049/jimmunol.181.2.1375; Reuter T, 2004, VACCINE, V22, P2686, DOI 10.1016/j.vaccine.2004.01.005; Rubtsov AV, 2011, BLOOD; Segura E, 2009, CURR OPIN IMMUNOL, V21, P105, DOI 10.1016/j.coi.2009.03.011; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinman R.M., 2011, ANN REV IMMUNOL; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Sugahara D, 2004, J VIROL, V78, P6322, DOI 10.1128/JVI.78.12.6322-6334.2004; Suresh M, 2003, J IMMUNOL, V170, P788, DOI 10.4049/jimmunol.170.2.788; Tacken PJ, 2011, BLOOD, V118, P4111, DOI 10.1182/blood-2011-04-346957; Tagliani E, 2008, J IMMUNOL, V180, P3201, DOI 10.4049/jimmunol.180.5.3201; Trumpfheller C, 2012, J INTERN MED, V271, P183, DOI 10.1111/j.1365-2796.2011.02496.x; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Wei HF, 2009, CLIN CANCER RES, V15, P4612, DOI 10.1158/1078-0432.CCR-08-3321; Zanoni I, 2010, J MOL MED, V88, P873, DOI 10.1007/s00109-010-0638-x; Zelinskyy G, 2009, BLOOD, V114, P3199, DOI 10.1182/blood-2009-03-208736	53	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45102	10.1371/journal.pone.0045102	http://dx.doi.org/10.1371/journal.pone.0045102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028784	gold, Green Submitted, Green Published			2022-12-27	WOS:000309742800034
J	Sturm, M; Herebian, D; Mueller, M; Laryea, MD; Spiekerkoetter, U				Sturm, Marga; Herebian, Diran; Mueller, Martina; Laryea, Maurice D.; Spiekerkoetter, Ute			Functional Effects of Different Medium-Chain Acyl-CoA Dehydrogenase Genotypes and Identification of Asymptomatic Variants	PLOS ONE			English	Article							NEW-YORK-STATE; MCAD DEFICIENCY; MUTATION; POPULATION; CHALLENGES; PHENOTYPE; DEFECTS; GENE	Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency (OMIM 201450) is the most common inherited disorder of fatty acid metabolism presenting with hypoglycaemia, hepatopathy and Reye-like symptoms during catabolism. In the past, the majority of patients carried the prevalent c.985A>G mutation in the ACADM gene. Since the introduction of newborn screening many other mutations with unknown clinical relevance have been identified in asymptomatic newborns. In order to identify functional effects of these mutant genotypes we correlated residual MCAD (OMIM 607008) activities as measured by octanoyl-CoA oxidation in lymphocytes with both genotype and relevant medical reports in 65 newborns harbouring mutant alleles. We identified true disease-causing mutations with residual activities of 0 to 20%. In individuals carrying the c.199T>C or c.127G>A mutation on one allele, residual activities were much higher and in the range of heterozygotes (31%-60%). Therefore, both mutations cannot clearly be associated with a clinical phenotype. This demonstrates a correlation between the octanoyl-CoA oxidation rate in lymphocytes and the clinical outcome. With newborn screening, the natural course of disease is difficult to assess. The octanoyl-CoA oxidation rate, therefore, allows a risk assessment at birth and the identification of new ACADM genotypes associated with asymptomatic disease variants.	[Sturm, Marga; Herebian, Diran; Mueller, Martina; Laryea, Maurice D.; Spiekerkoetter, Ute] Univ Childrens Hosp, Dept Gen Pediat, Dusseldorf, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Sturm, M (corresponding author), Univ Childrens Hosp, Dept Gen Pediat, Dusseldorf, Germany.	marga.sturm@med.uni-duesseldorf.de	Herebian, Diran/A-1440-2017	Dr. Herebian, Diran/0000-0002-8528-0122; Spiekerkoetter, Ute/0000-0002-5385-6705	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 575]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding came from the Deutsche Forschungsgemeinschaft (DFG) Sonderforschungsbereich 575; http://gepris.dfg.de/gepris/OCTOPUS/;jsessionid = EF39209C33887676D2F9E16560913E60?module = gepris&task = showDetail&context = projekt&id = 57771397. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BS, 1997, HUM MOL GENET, V6, P695, DOI 10.1093/hmg/6.5.695; Arnold GL, 2010, MOL GENET METAB, V99, P263, DOI 10.1016/j.ymgme.2009.10.188; Gregersen N, 2008, J INHERIT METAB DIS, V31, P643, DOI 10.1007/s10545-008-0990-y; Grosse SD, 2006, GENET MED, V8, P205, DOI 10.1097/01.gim.0000204472.25153.8d; KOLVRAA S, 1982, CLIN CHIM ACTA, V126, P53, DOI 10.1016/0009-8981(82)90361-8; Liebig M, 2006, J INHERIT METAB DIS, V29, P343, DOI 10.1007/s10545-006-0249-4; Maier EM, 2005, HUM MUTAT, V25, P443, DOI 10.1002/humu.20163; Maier EM, 2009, HUM MOL GENET, V18, P1612, DOI 10.1093/hmg/ddp079; MATSUBARA Y, 1990, BIOCHEM BIOPH RES CO, V171, P498, DOI 10.1016/0006-291X(90)91421-N; McKinney JT, 2004, MOL GENET METAB, V82, P112, DOI 10.1016/j.ymgme.2004.04.004; Nichols MJ, 2008, AM J MED GENET A, V146A, P610, DOI 10.1002/ajmg.a.32192; Rhead WJ, 2006, J INHERIT METAB DIS, V29, P370, DOI 10.1007/s10545-006-0292-1; Schatz UA, 2010, J INHERIT METAB DIS, V33, P513, DOI 10.1007/s10545-010-9115-5; Smith EH, 2010, MOL GENET METAB, V100, P241, DOI 10.1016/j.ymgme.2010.04.001; Swigonova Z, 2009, J MOL EVOL, V69, P176, DOI 10.1007/s00239-009-9263-0; ter Veld F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006449; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; YOKOTA I, 1991, AM J HUM GENET, V49, P1280; Yusupova R, 2010, MOL GENET METAB, V101, P33, DOI 10.1016/j.ymgme.2010.05.007; ZIADEH R, 1995, PEDIATR RES, V37, P675, DOI 10.1203/00006450-199505000-00021; Zschocke J, 2001, HUM GENET, V108, P404, DOI 10.1007/s004390100501	21	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45110	10.1371/journal.pone.0045110	http://dx.doi.org/10.1371/journal.pone.0045110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028790	gold, Green Published, Green Submitted			2022-12-27	WOS:000309742800035
J	Xing, F; Matsumiya, T; Onomoto, K; Hayakari, R; Imaizumi, T; Yoshida, H; Yoneyama, M; Fujita, T; Satoh, K				Xing, Fei; Matsumiya, Tomoh; Onomoto, Koji; Hayakari, Ryo; Imaizumi, Tadaatsu; Yoshida, Hidemi; Yoneyama, Mitsutoshi; Fujita, Takashi; Satoh, Kei			Foreign RNA Induces the Degradation of Mitochondrial Antiviral Signaling Protein (MAVS): The Role of Intracellular Antiviral Factors	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; NF-KAPPA-B; HEPATITIS-C-VIRUS; IFN-BETA PROMOTER; INNATE IMMUNITY; RIG-I; ADAPTER PROTEIN; REGULATORY FACTOR-3; CELLS	Mitochondrial antiviral signaling protein (MAVS) is an essential adaptor molecule that is responsible for antiviral signaling triggered by retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), leading to the induction of type I interferon in innate immunity. Previous studies have shown that certain viruses evade the innate immune response by cleaving the MAVS protein. However, little is known about how MAVS is regulated in response to foreign RNA, including both single-stranded (ss) and double-stranded (ds) RNA, because most previous reports have shown that the cleavage of MAVS is executed by proteases that are induced or activated by the invading RNA viruses. Here, we report that MAVS mRNA is degraded in response to polyinosinic-polycytidylic acid (polyI:C), a synthetic dsRNA, in A549 cells. RNA interference (RNAi) experiments revealed that both ssRNA- and dsRNA-associated pattern-recognition receptors (PRRs) were not involved in the degradation of MAVS mRNA. Foreign RNA also induced the transient degradation of the MAVS protein. In the resting state, the MAVS protein was protected from degradation by interferon regulatory factor 3 (IRF3); moreover, the dimerization of IRF3 appeared to be correlated with the rescue of protein degradation in response to polyI: C. The overexpression of MAVS enhanced interferon-beta (IFN-beta) expression in response to polyI: C, suggesting that the degradation of MAVS contributes to the suppression of the hyper-immune reaction in late-phase antiviral signaling. Taken together, these results suggest that the comprehensive regulation of MAVS in response to foreign RNA may be essential to antiviral host defenses.	[Xing, Fei; Matsumiya, Tomoh; Hayakari, Ryo; Imaizumi, Tadaatsu; Yoshida, Hidemi; Satoh, Kei] Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori, Japan; [Onomoto, Koji; Yoneyama, Mitsutoshi] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba, Japan; [Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan; [Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Mol Cell Biol Lab, Kyoto, Japan	Hirosaki University; Chiba University; Kyoto University; Kyoto University	Matsumiya, T (corresponding author), Hirosaki Univ, Grad Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori, Japan.	tomo1027@cc.hirosaki-u.ac.jp	Matsumiya, Tomoh/ABA-5861-2021; Ryo, Hayakari/F-6564-2013; Yoneyama, Mitsutoshi/D-8244-2017	Yoneyama, Mitsutoshi/0000-0001-9512-0408	KAKENHI, Japan [23590560]	KAKENHI, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by the Grants-in-Aid for Scientific Research (KAKENHI) (grant number 23590560 to TM, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andersen JB, 2009, RNA BIOL, V6, P305, DOI 10.4161/rna.6.3.8526; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Barral PM, 2009, PHARMACOL THERAPEUT, V124, P219, DOI 10.1016/j.pharmthera.2009.06.012; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Drahos J, 2009, J VIROL, V83, P11581, DOI 10.1128/JVI.01490-09; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Matsumiya T, 2011, ARCH IMMUNOL THER EX, V59, P41, DOI 10.1007/s00005-010-0107-9; Matsumiya T, 2010, CRIT REV IMMUNOL, V30, P489, DOI 10.1615/CritRevImmunol.v30.i6.10; Matsumiya T, 2010, J IMMUNOL, V184, P4205, DOI 10.4049/jimmunol.0903212; Matsumiya T, 2009, J IMMUNOL, V182, P2717, DOI 10.4049/jimmunol.0802933; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Rebsamen M, 2008, CELL DEATH DIFFER, V15, P1804, DOI 10.1038/cdd.2008.119; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Scott I, 2008, BIOCHEM BIOPH RES CO, V375, P101, DOI 10.1016/j.bbrc.2008.07.147; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sobol PT, 2006, J VIROL, V80, P218, DOI 10.1128/JVI.80.1.218-225.2006; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Uno T, 2005, MOL CANCER THER, V4, P799, DOI 10.1158/1535-7163.MCT-04-0317; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yin RF, 2011, BIOCHEM BIOPH RES CO, V413, P537, DOI 10.1016/j.bbrc.2011.08.131; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yu CY, 2010, J VIROL, V84, P2421, DOI 10.1128/JVI.02174-09; Zhou X, 2011, CELL RES	40	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45136	10.1371/journal.pone.0045136	http://dx.doi.org/10.1371/journal.pone.0045136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028806	gold, Green Submitted, Green Published			2022-12-27	WOS:000309742800038
J	Bertero, T; Grosso, S; Robbe-Sermesant, K; Lebrigand, K; Henaoui, IS; Puissegur, MP; Fourre, S; Zaragosi, LE; Mazure, NM; Ponzio, G; Cardinaud, B; Barbry, P; Rezzonico, R; Mari, B				Bertero, Thomas; Grosso, Sebastien; Robbe-Sermesant, Karine; Lebrigand, Kevin; Henaoui, Imene-Sarah; Puissegur, Marie-Pierre; Fourre, Sandra; Zaragosi, Laure-Emmanuelle; Mazure, Nathalie M.; Ponzio, Gilles; Cardinaud, Bruno; Barbry, Pascal; Rezzonico, Roger; Mari, Bernard			"Seed-Milarity" Confers to hsa-miR-210 and hsa-miR-147b Similar Functional Activity	PLOS ONE			English	Article							TARGET RECOGNITION; MICRORNA BINDING; EXPRESSION; IDENTIFICATION; MIR-210; GENES; MECHANISMS; HYPOXIA; RNAS	Specificity of interaction between a microRNA (miRNA) and its targets crucially depends on the seed region located in its 59'end. It is often implicitly considered that two miRNAs sharing the same biological activity should display similarity beyond the strict six nucleotide region that forms the seed, in order to form specific complexes with the same mRNA targets. We have found that expression of hsa-miR-147b and hsa-miR-210, though triggered by different stimuli (i.e. lipopolysaccharides and hypoxia, respectively), induce very similar cellular effects in term of proliferation, migration and apoptosis. Hsa-miR-147b only shares a "minimal'' 6-nucleotides seed sequence with hsa-miR-210, but is identical with hsa-miR-147 a over 20 nucleotides, except for one base located in the seed region. Phenotypic changes induced after heterologous expression of miR-147a strikingly differ from those induced by miR-147b or miR-210. In particular, miR-147a behaves as a potent inhibitor of cell proliferation and migration. These data fit well with the gene expression profiles observed for miR-147b and miR-210, which are very similar, and the gene expression profile of miR-147a, which is distinct from the two others. Bioinformatics analysis of all human miRNA sequences indicates multiple cases of miRNAs from distinct families exhibiting the same kind of similarity that would need to be further characterized in terms of putative functional redundancy. Besides, it implies that functional impact of some miRNAs can be masked by robust expression of miRNAs belonging to distinct families.	[Bertero, Thomas; Grosso, Sebastien; Robbe-Sermesant, Karine; Lebrigand, Kevin; Henaoui, Imene-Sarah; Fourre, Sandra; Zaragosi, Laure-Emmanuelle; Ponzio, Gilles; Barbry, Pascal; Rezzonico, Roger; Mari, Bernard] CNRS, UMR 7275, IPMC, Sophia Antipolis, France; [Bertero, Thomas; Grosso, Sebastien; Robbe-Sermesant, Karine; Lebrigand, Kevin; Henaoui, Imene-Sarah; Fourre, Sandra; Zaragosi, Laure-Emmanuelle; Mazure, Nathalie M.; Ponzio, Gilles; Barbry, Pascal; Rezzonico, Roger; Mari, Bernard] Univ Nice Sophia Antipolis, Nice, France; [Puissegur, Marie-Pierre] Fac Med Toulouse, INSERM, U1081, IRCAN, F-31073 Toulouse, France; [Mazure, Nathalie M.] CNRS, UMR 7284, INSERM U1081, IRCAN, F-06034 Nice, France; [Cardinaud, Bruno] Univ Victor Segalen, INSERM U1035, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Mari, B (corresponding author), CNRS, UMR 7275, IPMC, Sophia Antipolis, France.	mari@unice.fr	REZZONICO, Roger/N-9626-2016; Barbry, Pascal/O-5021-2016; Zaragosi, Laure-Emmanuelle/P-9887-2016; Robbe-Sermesant, Karine/Q-2253-2016; Mari, Bernard P/F-8960-2013; Ponzio, Gilles/Q-1256-2016; Mari, Bernard P/GVS-3100-2022; Mari, Bernard P/D-7445-2015; Mari, Bernard/Q-5832-2019	REZZONICO, Roger/0000-0002-8460-1641; Barbry, Pascal/0000-0001-9632-6483; Zaragosi, Laure-Emmanuelle/0000-0001-6747-7928; Robbe-Sermesant, Karine/0000-0003-0580-3817; Mari, Bernard P/0000-0002-0422-9182; Ponzio, Gilles/0000-0003-2741-0248; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard/0000-0002-0422-9182; Puissegur, Marie-Pierre/0000-0001-9016-8621; BERTERO, Thomas/0000-0002-4801-9902	Association pour la Recherche contre le Cancer (ARC) [Libre SFI20101201798]; Canceropole PACA; European Community (MICROENVIMET) [FP7-HEALTH-F2-2008-201279]; Ministere de l'Enseignement Superieur et de la Recherche; Ville de Nice; region PACA'' (bourse Region-Entreprise); Association pour la Recherche contre le Cancer (ARC)	Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Canceropole PACA(Region Grand-Est); European Community (MICROENVIMET); Ministere de l'Enseignement Superieur et de la Recherche; Ville de Nice(Region Provence-Alpes-Cote d'Azur); region PACA'' (bourse Region-Entreprise)(Region Provence-Alpes-Cote d'Azur); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	This work was supported by Association pour la Recherche contre le Cancer (ARC, Projet Libre SFI20101201798 and post-doctoral fellowship to MPP), Canceropole PACA (PB, BM), European Community (MICROENVIMET, FP7-HEALTH-F2-2008-201279, PB, BM, KRS, KL). TB is a recipient of a fellowship from the "Ministere de l'Enseignement Superieur et de la Recherche'', SG is a recipient of a post-doctoral fellowship from the "Ville de Nice'', ISH is a recipient of a doctoral fellowship from the "region PACA'' (bourse Region-Entreprise) and LEZ is a recipient from a fellowship from the Association pour la Recherche contre le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Antonov AV, 2009, NUCLEIC ACIDS RES, V37, pW323, DOI 10.1093/nar/gkp313; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Cardinaud B, 2009, LEUKEMIA, V23, P2174, DOI 10.1038/leu.2009.125; Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Devlin C, 2011, IUBMB LIFE, V63, P94, DOI [10.1002/iub.00427, 10.1002/iub.427]; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Le Brigand K, 2010, BIOINFORMATICS, V26, P3131, DOI 10.1093/bioinformatics/btq589; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Marcet B, 2011, CELL CYCLE, V10, P2858, DOI 10.4161/cc.10.17.17011; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Marin RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032208; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Ranade AR, 2010, J THORAC ONCOL, V5, P1273, DOI 10.1097/JTO.0b013e3181dea6be; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199	50	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44919	10.1371/journal.pone.0044919	http://dx.doi.org/10.1371/journal.pone.0044919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028679	gold, Green Published, Green Submitted			2022-12-27	WOS:000308788700057
J	Djafarzadeh, S; Vuda, M; Takala, J; Jakob, SM				Djafarzadeh, Siamak; Vuda, Madhusudanarao; Takala, Jukka; Jakob, Stephan M.			Effect of Remifentanil on Mitochondrial Oxygen Consumption of Cultured Human Hepatocytes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HEPATOMA HEPG2 CELLS; K-ATP CHANNELS; POTASSIUM CHANNELS; NITRIC-OXIDE; COMPLEX-I; ORGAN DYSFUNCTION; UNITED-STATES; SEVERE SEPSIS; INTERLEUKIN-6	During sepsis, liver dysfunction is common, and failure of mitochondria to effectively couple oxygen consumption with energy production has been described. In addition to sepsis, pharmacological agents used to treat septic patients may contribute to mitochondrial dysfunction. This study addressed the hypothesis that remifentanil interacts with hepatic mitochondrial oxygen consumption. The human hepatoma cell line HepG2 and their isolated mitochondria were exposed to remifentanil, with or without further exposure to tumor necrosis factor-alpha (TNF-alpha). Mitochondrial oxygen consumption was measured by high-resolution respirometry, Caspase-3 protein levels by Western blotting, and cytokine levels by ELISA. Inhibitory kappa B alpha (I kappa B alpha) phosphorylation, measurement of the cellular ATP content and mitochondrial membrane potential in intact cells were analysed using commercial ELISA kits. Maximal cellular respiration increased after one hour of incubation with remifentanil, and phosphorylation of I kappa B alpha occurred, denoting stimulation of nuclear factor kappa B (NF-kappa B). The effect on cellular respiration was not present at 2, 4, 8 or 16 hours of incubation. Remifentanil increased the isolated mitochondrial respiratory control ratio of complex-I-dependent respiration without interfering with maximal respiration. Preincubation with the opioid receptor antagonist naloxone prevented a remifentanil-induced increase in cellular respiration. Remifentanil at 106 higher concentrations than therapeutic reduced mitochondrial membrane potential and ATP content without uncoupling oxygen consumption and basal respiration levels. TNF-alpha exposure reduced respiration of complex-I, -II and -IV, an effect which was prevented by prior remifentanil incubation. Furthermore, prior remifentanil incubation prevented TNF-alpha-induced IL-6 release of HepG2 cells, and attenuated fragmentation of pro-caspase-3 into cleaved active caspase 3 ( an early marker of apoptosis). Our data suggest that remifentanil increases cellular respiration of human hepatocytes and prevents TNF-alpha-induced mitochondrial dysfunction. The results were not explained by uncoupling of mitochondrial respiration.	[Djafarzadeh, Siamak] Univ Hosp Bern, Dept Intens Care Med, Inselspital, CH-3010 Bern, Switzerland; Univ Bern, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern	Djafarzadeh, S (corresponding author), Univ Hosp Bern, Dept Intens Care Med, Inselspital, CH-3010 Bern, Switzerland.	stephan.jakob@insel.ch		Vuda, Madhusudanarao/0000-0002-6489-8927	Dept. of Intensive Care Medicine, Bern University Hospital	Dept. of Intensive Care Medicine, Bern University Hospital	This study was supported by funds from the Dept. of Intensive Care Medicine, Bern University Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Abraham E, 2007, CRIT CARE MED, V35, P2408, DOI 10.1097/01.CCM.0000282072.56245.91; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Aronsohn A, 2011, CLIN LIVER DIS, V15, P183, DOI 10.1016/j.cld.2010.09.004; Bencsics A, 1997, J NEUROIMMUNOL, V73, P1, DOI 10.1016/S0165-5728(96)00163-4; Braun B, 2008, APPL PHYSIOL NUTR ME, V33, P61, DOI 10.1139/H07-144; Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; BROWN GC, 1990, EUR J BIOCHEM, V192, P355, DOI 10.1111/j.1432-1033.1990.tb19234.x; Cai SY, 2010, J LIPID RES, V51, P2265, DOI 10.1194/jlr.M005546; Chakass D, 2007, GUT, V56, P974, DOI 10.1136/gut.2006.105122; Crouser ED, 2004, CRIT CARE MED, V32, P478, DOI 10.1097/01.CCM.0000109449.99160.81; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Das M, 2003, J PHYSIOL-LONDON, V547, P893, DOI 10.1113/jphysiol.2002.035006; Debska G, 2002, BBA-BIOENERGETICS, V1556, P97, DOI 10.1016/S0005-2728(02)00340-7; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Dungel P, 2011, J BIOCHEM MOL TOXIC, V25, P297, DOI 10.1002/jbt.20389; Duthie DJR, 1998, BRIT J ANAESTH, V81, P51, DOI 10.1093/bja/81.1.51; Elbers PWG, 2006, CRIT CARE, V10, DOI 10.1186/cc4969; Frost MT, 2005, AM J PHYSIOL-REG I, V288, pR394, DOI 10.1152/ajpregu.00504.2004; Gabay C, 1999, BLOOD, V93, P1299, DOI 10.1182/blood.V93.4.1299.404k26_1299_1307; GLASS PSA, 1993, ANESTH ANALG, V77, P1031; Gnaiger E, 1997, TRANSPLANT P, V29, P3524, DOI 10.1016/S0041-1345(97)01006-3; GRAEVE L, 1993, CLIN INVESTIGATOR, V71, P664; GRANT MH, 1988, BIOCHEM PHARMACOL, V37, P4111, DOI 10.1016/0006-2952(88)90103-7; Grover GJ, 2000, J MOL CELL CARDIOL, V32, P677, DOI 10.1006/jmcc.2000.1111; HACK CE, 1989, BLOOD, V74, P1704; Hanley PJ, 2002, J PHYSIOL-LONDON, V544, P687, DOI 10.1113/jphysiol.2002.025015; Hoke JF, 1997, J PHARMACOL EXP THER, V281, P226; Holmuhamedov EL, 1998, AM J PHYSIOL-HEART C, V275, pH1567, DOI 10.1152/ajpheart.1998.275.5.H1567; Hou YN, 1996, NEUROSCI LETT, V212, P159, DOI 10.1016/0304-3940(96)12799-3; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Larche J, 2006, J AM COLL CARDIOL, V48, P377, DOI 10.1016/j.jacc.2006.02.069; Liguori MJ, 2008, DRUG METAB DISPOS, V36, P223, DOI 10.1124/dmd.107.017608; Liu YG, 1998, CIRCULATION, V97, P2463, DOI 10.1161/01.CIR.97.24.2463; Marian M, 1997, NEUROCHEM RES, V22, P287, DOI 10.1023/A:1022438805337; Michelsen LG, 2001, ANESTH ANALG, V93, P1100, DOI 10.1097/00000539-200111000-00006; Mousa SA, 2001, J NEUROIMMUNOL, V115, P71, DOI 10.1016/S0165-5728(01)00271-5; Muravchick S, 2006, ANESTHESIOLOGY, V105, P819, DOI 10.1097/00000542-200610000-00029; Novaes MAFP, 1999, INTENS CARE MED, V25, P1421, DOI 10.1007/s001340051091; O'Rourke B, 2000, CIRC RES, V87, P845, DOI 10.1161/01.RES.87.10.845; Pinti M, 2003, J BIOL REG HOMEOS AG, V17, P166; Porta F, 2009, INFLAMMATION, V32, P315, DOI 10.1007/s10753-009-9138-y; Regueira T, 2009, LIVER INT, V29, P1582, DOI 10.1111/j.1478-3231.2009.02109.x; Russell JA, 2000, CRIT CARE MED, V28, P3405, DOI 10.1097/00003246-200010000-00005; Said HM, 2007, AM J PHYSIOL-CELL PH, V293, pC1773, DOI 10.1152/ajpcell.00409.2007; Scandurra FM, 2010, ADV EXP MED BIOL, V662, P7, DOI 10.1007/978-1-4419-1241-1_2; Schenkman KA, 2000, CRIT CARE MED, V28, P172, DOI 10.1097/00003246-200001000-00028; SHALABY MR, 1989, CLIN IMMUNOL IMMUNOP, V53, P488, DOI 10.1016/0090-1229(89)90010-X; SHERON N, 1990, CLIN EXP IMMUNOL, V82, P427; STEIN C, 1988, NEUROSCI LETT, V84, P225, DOI 10.1016/0304-3940(88)90412-0; Stevanato R, 2002, BIOCHEM PHARMACOL, V64, P1133, DOI 10.1016/S0006-2952(02)01253-4; Vilela SMF, 2009, MITOCHONDRION, V9, P247, DOI 10.1016/j.mito.2009.03.002; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 2005, CRIT CARE, V9, pS9, DOI 10.1186/cc3748; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Westerink WMA, 2007, TOXICOL IN VITRO, V21, P1592, DOI 10.1016/j.tiv.2007.06.017; Weycker D, 2003, CRIT CARE MED, V31, P2316, DOI 10.1097/01.CCM.0000085178.80226.0B; Wu Y, 2009, MOL BIOL REP, V36, P1113, DOI 10.1007/s11033-008-9286-4; Xi JK, 2010, AM J PHYSIOL-HEART C, V298, pH601, DOI 10.1152/ajpheart.00453.2009	61	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45195	10.1371/journal.pone.0045195	http://dx.doi.org/10.1371/journal.pone.0045195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028840	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700093
J	Foster, R; Griffin, S; Grooby, S; Feltell, R; Christopherson, C; Chang, M; Sninsky, J; Kwok, S; Torrance, C				Foster, Rebecca; Griffin, Sue; Grooby, Suzanne; Feltell, Ruth; Christopherson, Cindy; Chang, Monica; Sninsky, John; Kwok, Shirley; Torrance, Chris			Multiple Metabolic Alterations Exist in Mutant PI3K Cancers, but Only Glucose Is Essential as a Nutrient Source	PLOS ONE			English	Article							AMINO-ACID RESTRICTION; CELL-GROWTH; AKT; ACTIVATION; EXPRESSION; MUTATIONS; GLUTAMINE; PATHWAY; BIOLOGY; GENE	Targeting tumour metabolism is becoming a major new area of pharmaceutical endeavour. Consequently, a systematic search to define whether there are specific energy source dependencies in tumours, and how these might be dictated by upstream driving genetic mutations, is required. The PI3K-AKT-mTOR signalling pathway has a seminal role in regulating diverse cellular processes including cell proliferation and survival, but has also been associated with metabolic dysregulation. In this study, we sought to define how mutations within PI3KCA may affect the metabolic dependency of a cancer cell, using precisely engineered isogenic cell lines. Studies revealed gene expression signatures in PIK3CA mutant cells indicative of a consistent up-regulation of glycolysis. Interestingly, the genes up- and down-regulated varied between isogenic models suggesting that the primary node of regulation is not the same between models. Additional gene expression changes were also observed, suggesting that metabolic pathways other than glycolysis, such as glutaminolysis, were also affected. Nutrient dependency studies revealed that growth of PIK3CA mutant cells is highly dependent on glucose, whereas glutamine dependency is independent of PIK3CA status. In addition, the glucose dependency exhibited by PIK3CA mutant cells could not be overridden by supplementation with other nutrients. This specific dependence on glucose for growth was further illustrated by studies evaluating the effects of targeted disruption of the glycolytic pathway using siRNA and was also found to be present across a wider panel of cancer cell lines harbouring endogenous PIK3CA mutations. In conclusion, we have found that PIK3CA mutations lead to a shift towards a highly glycolytic phenotype, and that despite suggestions that cancer cells are adept at utilising alternative nutrient sources, PIK3CA mutant cells are not able to compensate for glucose withdrawal. Understanding the metabolic dependencies of PIK3CA mutant cancers will provide critical information for the design of effective therapies and tumour visualisation strategies.	[Foster, Rebecca; Griffin, Sue; Grooby, Suzanne; Feltell, Ruth; Torrance, Chris] Horizon Discovery Ltd, Cambridge, Cambs, England; [Christopherson, Cindy; Chang, Monica; Sninsky, John; Kwok, Shirley] Celera Corp, Alameda, CA USA		Foster, R (corresponding author), Horizon Discovery Ltd, Cambridge, Cambs, England.	rebecca.foster@horizondiscovery.com	Foster, Rebecca/GSM-6886-2022		Horizon Discovery Ltd; Celera Corporation as part of an internal research programme	Horizon Discovery Ltd; Celera Corporation as part of an internal research programme	This study did not receive any external funding. The work was wholly funded by Horizon Discovery Ltd and Celera Corporation as part of an internal research programme. Study design, data collection and analysis, decision to publish and preparation of the manuscript were carried out by employees of Horizon Discovery Ltd and Celera Corporation.	Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Barger JF, 2010, ENDOCR-RELAT CANCER, V17, pR287, DOI 10.1677/ERC-10-0106; Baselga J, 2011, ONCOLOGIST, V16, P12, DOI 10.1634/theoncologist.2011-S1-12; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fu YM, 2010, J CELL PHYSIOL, V224, P491, DOI 10.1002/jcp.22148; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Liu XY, 2011, ONCOL LETT, V2, P349, DOI 10.3892/ol.2011.237; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meyer DS, 2011, CANCER RES, V71, P4344, DOI 10.1158/0008-5472.CAN-10-3827; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Samuels Y, 2011, CURR TOP MICROBIOL, V347, P21, DOI 10.1007/82_2010_68; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Tan SX, 2010, BIOCHEM J, V432, P191, DOI 10.1042/BJ20100750; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852; Zhang J, 2011, GASTROENTEROLOGY, V141, P50, DOI 10.1053/j.gastro.2011.05.010; Zhao YH, 2011, FRONT BIOSCI-LANDMRK, V16, P1844, DOI 10.2741/3826	36	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45061	10.1371/journal.pone.0045061	http://dx.doi.org/10.1371/journal.pone.0045061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028762	gold, Green Published, Green Submitted			2022-12-27	WOS:000308788700081
J	Murphy, RA; Marconi, VC; Gandhi, RT; Kuritzkes, DR; Sunpath, H				Murphy, Richard A.; Marconi, Vincent C.; Gandhi, Rajesh T.; Kuritzkes, Daniel R.; Sunpath, Henry			Coadministration of Lopinavir/Ritonavir and Rifampicin in HIV and Tuberculosis Co-Infected Adults in South Africa	PLOS ONE			English	Article							CLINICAL-EXPERIENCE; PHARMACOKINETICS; RITONAVIR	Background: In HIV-infected patients receiving rifampicin-based treatment for tuberculosis (TB), the dosage of lopinavir/ritonavir (LPV/r) is adjusted to prevent sub-therapeutic lopinavir concentrations. In this setting, South African clinicians were advised to administer super-boosted LPV/r (400 mg/400 mg) twice daily, instead of standard dosed LPV/r (400 mg/100 mg) twice daily. We sought to determine - in routine practice - the tolerability and HIV treatment outcomes associated with super-boosted LPV/r compared to unadjusted LPV/r in combination with rifampicin-based TB treatment. Methodology/Principle Findings: We conducted a retrospective review of HIV-infected patients who receiving second-line ART with a LPV/r-containing regimen who required concomitant TB treatment. We identified 29 patients; the median age was 36 years (IQR 29-40), 22 (76%) were female, the median CD4 cell count and viral load at first-line ART failure was 86 cells/mm(3) (IQR 21-159) and 39,457 copies/mL (IQR 6,025-157,500), respectively. According to physician preference, 15 (52%) of 29 patients received super-boosted LPV/r (400 mg/400 mg) every 12 hours during TB treatment and 14 (48%) of 29 patients received standard dose LPV/r (400 mg/100 mg) twice daily during TB treatment. Among patients who received super-boosted LPV/r there was a trend towards a higher rate of symptomatic transaminitis (27% vs. 7%; p = 0.3), gastrointestinal toxicity (20% vs. 0%; p = 0.2) and a significantly increased need for treatment discontinuation (47% vs. 7%; p = 0.035. The durability of coadministered treatment was significantly shorter in patients who received super-boosted lopinavir/ritonavir with TB treatment compared to patients who received standard lopinavir/ritonavir dosing (log rank, P = 0.036). The rate of virologic failure was not higher in patients with unadjusted LPV/r dosing. Conclusions/Significance: We observed a high rate of toxicity and need for treatment discontinuation among patients on standard rifampicin-based TB treatment who received super-boosted LPV/r.	[Murphy, Richard A.] Medecins Sans Frontieres Doctors Borders, Med Unit, New York, NY USA; [Marconi, Vincent C.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Gandhi, Rajesh T.] Massachusetts Gen Hosp, Dept Med, Infect Dis Unit, Boston, MA 02114 USA; [Kuritzkes, Daniel R.] Brigham & Womens Hosp, Dept Med, Div Infect Dis, Boston, MA 02115 USA; [Kuritzkes, Daniel R.] Harvard Univ, Sch Med, Boston, MA USA; [Sunpath, Henry] Nelson Mandela Sch Med, Infect Dis Unit, Durban, South Africa; [Sunpath, Henry] McCord Hosp, Dept Med, Durban, South Africa	Emory University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Kwazulu Natal	Murphy, RA (corresponding author), Medecins Sans Frontieres Doctors Borders, Med Unit, New York, NY USA.	ramurphy@gmail.com	Marconi, Vincent/N-3210-2014; Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/AFK-5812-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Murphy, Richard/0000-0003-2249-7452	IDSA Medical Scholars Program; Arnold P. Gold Foundation Medical Student Scholarship; Partners AIDS Research Center; McCord Hospital; National Institutes of Health [K24-RR016482, P30 AI060354]; Abbott; Boehringer-Ingelheim; Bristol-Myers Squibb; Gilead; Merck; Roche; ViiV; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR016482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	IDSA Medical Scholars Program; Arnold P. Gold Foundation Medical Student Scholarship; Partners AIDS Research Center; McCord Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott(Abbott Laboratories); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); Merck(Merck & Company); Roche(Roche Holding); ViiV; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported in part by the IDSA Medical Scholars Program, the Arnold P. Gold Foundation Medical Student Scholarship, Partners AIDS Research Center, McCord Hospital, and by National Institutes of Health grants K24-RR016482 and P30 AI060354. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D.R.K. is a consultant to, or has received research funding from, Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, Merck, Roche and ViiV. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors. All other authors have declared that no competing interests exist.	[Anonymous], 2011, MANAGING DRUG INTERA; [Anonymous], 2004, S AFR NAT ANT TREATM; Boulanger C, 2009, CLIN INFECT DIS, V49, P1305, DOI 10.1086/606056; Burger DM, 2006, ANTIMICROB AGENTS CH, V50, P3336, DOI 10.1128/AAC.00461-06; Burman WJ, 1999, CLIN INFECT DIS, V28, P419, DOI 10.1086/515174; Decloedt EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032173; Frohoff C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017273; L'homme RFA, 2009, AIDS, V23, P863, DOI 10.1097/QAD.0b013e328329148e; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; Matteelli A, 2012, J ANTIMICROB CHEMOTH; Mena A, 2011, J ANTIMICROB CHEMOTH, V66, P951, DOI 10.1093/jac/dkq540; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Nijland HMJ, 2008, AIDS, V22, P931, DOI 10.1097/QAD.0b013e3282faa71e; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2; World Health Organization, 2010, UN ACC SCAL PRIOR HI	16	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44793	10.1371/journal.pone.0044793	http://dx.doi.org/10.1371/journal.pone.0044793			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028623	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900017
J	Cheng, YZ; Eley, L; Hynes, AM; Overman, LM; Simms, RJ; Barker, A; Dawe, HR; Lindsay, S; Sayer, JA				Cheng, Yu-Zhu; Eley, Lorraine; Hynes, Ann-Marie; Overman, Lynne M.; Simms, Roslyn J.; Barker, Amy; Dawe, Helen R.; Lindsay, Susan; Sayer, John A.			Investigating Embryonic Expression Patterns and Evolution of AHI1 and CEP290 Genes, Implicated in Joubert Syndrome	PLOS ONE			English	Article							RETINAL DEGENERATION; CENTROSOMAL PROTEIN; MUTATIONS CAUSE; NPHP6 GENE; NEPHRONOPHTHISIS; INTERACTS; DELETION; REVEALS; IDENTIFICATION; INDIVIDUALS	Joubert syndrome and related diseases (JSRD) are developmental cerebello-oculo-renal syndromes with phenotypes including cerebellar hypoplasia, retinal dystrophy and nephronophthisis (a cystic kidney disease). We have utilised the MRC-Wellcome Trust Human Developmental Biology Resource (HDBR), to perform in-situ hybridisation studies on embryonic tissues, revealing an early onset neuronal, retinal and renal expression pattern for AHI1. An almost identical pattern of expression is seen with CEP290 in human embryonic and fetal tissue. A novel finding is that both AHI1 and CEP290 demonstrate strong expression within the developing choroid plexus, a ciliated structure important for central nervous system development. To test if AHI1 and CEP290 may have co-evolved, we carried out a genomic survey of a large group of organisms across eukaryotic evolution. We found that, in animals, ahi1 and cep290 are almost always found together; however in other organisms either one may be found independent of the other. Finally, we tested in murine epithelial cells if Ahi1 was required for recruitment of Cep290 to the centrosome. We found no obvious differences in Cep290 localisation in the presence or absence of Ahi1, suggesting that, while Ahi1 and Cep290 may function together in the whole organism, they are not interdependent for localisation within a single cell. Taken together these data support a role for AHI1 and CEP290 in multiple organs throughout development and we suggest that this accounts for the wide phenotypic spectrum of AHI1 and CEP290 mutations in man.	[Cheng, Yu-Zhu; Eley, Lorraine; Hynes, Ann-Marie; Overman, Lynne M.; Simms, Roslyn J.; Lindsay, Susan; Sayer, John A.] Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Barker, Amy; Dawe, Helen R.] Univ Exeter, Biosci Coll Life & Environm Sci, Exeter, Devon, England	Newcastle University - UK; University of Exeter	Sayer, JA (corresponding author), Newcastle Univ, Inst Med Genet, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	john.sayer@ncl.ac.uk	Lindsay, Susan/B-3828-2013; Sayer, John A./AAN-2729-2020	Lindsay, Susan/0000-0003-2980-4582; Sayer, John A./0000-0003-1881-3782	Medical Research Council [G9900837, G1001644]; Wellcome Trust [0688554/A/02/A]; Kids Kidney Research Fund; Northern Counties Kidney Research Fund; Newcastle Healthcare Charity; Kidney Research UK; Medical Research Council; GlaxoSmithKline; Kidney Research UK [JF1/2009] Funding Source: researchfish; Medical Research Council [G0802359, G0700089] Funding Source: researchfish; MRC [G1001644, G0802359, G0700089, G9900837] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Kids Kidney Research Fund(Kidney Research UK (KRUK)); Northern Counties Kidney Research Fund; Newcastle Healthcare Charity; Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline(GlaxoSmithKline); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	YZC is funded by the Medical Research Council (grant# G9900837) and the Wellcome Trust (grant# 0688554/A/02/A). The authors also acknowledge support from the Kids Kidney Research Fund (support for LE), the Northern Counties Kidney Research Fund and the Newcastle Healthcare Charity (support for AMH). HRD is funded by the Medical Research Council (grant #G1001644, support for AB). The authors are extremely grateful to Kidney Research UK and the Medical Research Council (Training Fellowship to RJS) and GlaxoSmithKline (Clinician Scientist Fellowship to JAS) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Bachmann-Gagescu R, 2012, J MED GENET, V49, P126, DOI 10.1136/jmedgenet-2011-100552; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; Brancati F, 2007, AM J HUM GENET, V81, P104, DOI 10.1086/519026; Brancati F, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-20; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Coppieters F, 2010, HUM MUTAT, V31, pE1709, DOI 10.1002/humu.21336; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Doering JE, 2008, J COMP NEUROL, V511, P238, DOI 10.1002/cne.21824; Edvardson S, 2010, AM J HUM GENET, V86, P93, DOI 10.1016/j.ajhg.2009.12.007; Eley L, 2008, KIDNEY INT, V74, P1139, DOI 10.1038/ki.2008.377; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Frank V, 2008, HUM MUTAT, V29, P45, DOI 10.1002/humu.20614; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Helou J, 2007, J MED GENET; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim J, 2008, HUM MOL GENET; LAMBERT SR, 1989, ARCH OPHTHALMOL-CHIC, V107, P709, DOI 10.1001/archopht.1989.01070010727035; Lancaster MA, 2011, NAT MED, V17, P726, DOI 10.1038/nm.2380; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Lee JH, 2012, SCIENCE, V335, P966, DOI 10.1126/science.1213506; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Lindsay S, 2005, TRENDS GENET, V21, P586, DOI 10.1016/j.tig.2005.08.011; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; McNeill H, 2009, J AM SOC NEPHROL, V20, P2104, DOI 10.1681/ASN.2008111173; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Narita K, 2010, TRAFFIC, V11, P287, DOI 10.1111/j.1600-0854.2009.01016.x; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Parisi MA, 2006, J MED GENET, V43, P334, DOI 10.1136/jmg.2005.036608; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Parisi MA, 2007, EUR J HUM GENET, V15, P511, DOI 10.1038/sj.ejhg.5201648; Parisi MA, 2009, AM J MED GENET C, V151C, P326, DOI 10.1002/ajmg.c.30229; Perrault Isabelle, 2007, Hum Mutat, V28, P416, DOI 10.1002/humu.9485; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Simms RJ, 2011, CELL MOL LIFE SCI; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Sturm V, 2010, EYE, V24, P222, DOI 10.1038/eye.2009.116; Takaki E, 2007, J BIOL CHEM, V282, P37285, DOI 10.1074/jbc.M704562200; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; Valente EM, 2006, ANN NEUROL, V59, P527, DOI 10.1002/ana.20749; Valente EM, 2008, EUR J MED GENET, V51, P1, DOI 10.1016/j.ejmg.2007.11.003; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; VANDORP DB, 1991, AM J MED GENET, V40, P100, DOI 10.1002/ajmg.1320400121; Westfall JE, 2010, J NEUROSCI, V30, P8759, DOI 10.1523/JNEUROSCI.5229-09.2010; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	71	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44975	10.1371/journal.pone.0044975	http://dx.doi.org/10.1371/journal.pone.0044975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028714	Green Published, gold, Green Accepted			2022-12-27	WOS:000309554700020
J	de Haan, AM; Anema, HA; Dijkerman, HC				de Haan, Alyanne M.; Anema, Helen A.; Dijkerman, H. Chris			Fingers Crossed! An Investigation of Somatotopic Representations Using Spatial Directional Judgements	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENTS; TACTILE PERCEPTION; DISCRIMINATION PERFORMANCE; BODY REPRESENTATION; HANDS DEFICIT; SPACE; VISION; TOUCH; INTEGRATION; ATTENTION	Processing of tactile stimuli requires both localising the stimuli on the body surface and combining this information with a representation of the current posture. When tactile stimuli are applied to crossed hands, the system first assumes a prototypical (e. g. uncrossed) positioning of the limbs. Remapping to include the crossed posture occurs within about 300 ms. Since fingers have been suggested to be represented in a mainly somatotopic reference frame we were interested in how the processing of tactile stimuli applied to the fingers would be affected by an unusual posture of the fingers. We asked participants to report the direction of movement of two tactile stimuli, applied successively to the crossed or uncrossed index and middle fingers of one hand at different inter-stimulus intervals (15 to 700 ms). Participants almost consistently reported perceiving the stimulus direction as opposite to what it was in the fingers crossed condition, even with SOAs of 700 ms, suggesting that on average they did not incorporate the unusual relative finger positions. Therefore our results are in agreement with the idea that, by default, the processing of tactile stimuli assumes a prototypical positioning of body parts. However, in contrast to what is generally found with tactile perception with crossed hands, performance did not improve with SOAs as long as 700 ms. This suggests that the localization of stimuli in a somatotopic reference and the integration of this representation with postural information are two separate processes that apply differently to the hands and fingers.	[de Haan, Alyanne M.; Anema, Helen A.; Dijkerman, H. Chris] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Anema, Helen A.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam	de Haan, AM (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	A.M.deHaan@uu.nl			Vici grant from NWO (Netherlands Organization for Scientific Research) [453-10-003]	Vici grant from NWO (Netherlands Organization for Scientific Research)	This work was supported by a Vici grant from NWO (Netherlands Organization for Scientific Research) 453-10-003 to H.C.Dijkerman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anema HA, 2011, NEUROPSYCHOLOGIA, V49, P138, DOI 10.1016/j.neuropsychologia.2010.11.006; Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; Azanon E, 2007, EXP BRAIN RES, V182, P537, DOI 10.1007/s00221-007-1011-3; Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Azanon E, 2010, EUR J NEUROSCI, V31, P1858, DOI 10.1111/j.1460-9568.2010.07233.x; BENEDETTI F, 1990, EXP BRAIN RES, V81, P70; BENEDETTI F, 1988, PERCEPT PSYCHOPHYS, V44, P281, DOI 10.3758/BF03206296; BENEDETTI F, 1988, J EXP PSYCHOL HUMAN, V14, P69, DOI 10.1037/0096-1523.14.1.69; BENEDETTI F, 1985, J EXP PSYCHOL HUMAN, V11, P517, DOI 10.1037/0096-1523.11.4.517; BENEDETTI F, 1991, J EXP PSYCHOL HUMAN, V17, P267, DOI 10.1037/0096-1523.17.1.267; Bresciani JP, 2006, J VISION, V6, P554, DOI 10.1167/6.5.2; Bresciani JP, 2007, NEUROREPORT, V18, P1157, DOI 10.1097/WNR.0b013e3281ace0ca; Cadieux ML, 2010, EXP BRAIN RES, V204, P431, DOI 10.1007/s00221-010-2268-5; Craig JC, 2006, PERCEPTION, V35, P1561, DOI 10.1068/p5481; Craig JC, 2003, PERCEPT PSYCHOPHYS, V65, P779, DOI 10.3758/BF03194814; Eimer M, 2001, EXP BRAIN RES, V139, P398, DOI 10.1007/s002210100773; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Gallace A, 2008, EXP BRAIN RES, V191, P171, DOI 10.1007/s00221-008-1510-x; Galvez-Garcia G, 2012, PSYCHOL RES-PSYCH FO, V76, P364, DOI 10.1007/s00426-011-0349-0; Gerstmann J, 1942, ARCH NEURO PSYCHIATR, V48, P890, DOI 10.1001/archneurpsyc.1942.02290120042003; Groh JM, 1996, J NEUROPHYSIOL, V75, P412, DOI 10.1152/jn.1996.75.1.412; Haggard P, 2006, EXP BRAIN RES, V172, P94, DOI 10.1007/s00221-005-0311-8; Heed T, 2012, J EXP PSYCHOL HUMAN, V38, P386, DOI 10.1037/a0024059; Heed T, 2010, J COGNITIVE NEUROSCI, V22, P184, DOI 10.1162/jocn.2008.21168; Kim DH, 2001, EXP BRAIN RES, V139, P76, DOI 10.1007/s002210100741; KINSBOURNE M, 1962, BRAIN, V85, P47, DOI 10.1093/brain/85.1.47; Kobor I, 2006, NEUROSCI LETT, V400, P163, DOI 10.1016/j.neulet.2006.02.037; Kuroki S, 2012, EXP BRAIN RES, V216, P311, DOI 10.1007/s00221-011-2936-0; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Medina J, 2010, NEUROPSYCHOLOGIA, V48, P645, DOI 10.1016/j.neuropsychologia.2009.08.017; Overvliet KE, 2011, EXP BRAIN RES, V208, P245, DOI 10.1007/s00221-010-2475-0; Overvliet KE, 2011, NEUROPSYCHOLOGIA, V49, P3046, DOI 10.1016/j.neuropsychologia.2011.07.005; Riemer M, 2010, EXP BRAIN RES, V206, P47, DOI 10.1007/s00221-010-2396-y; Roberts RD, 2008, J EXP PSYCHOL HUMAN, V34, P592, DOI 10.1037/0096-1523.34.3.592; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Roder B, 2008, EUR J NEUROSCI, V28, P475, DOI 10.1111/j.1460-9568.2008.06352.x; Sanabria D, 2005, EXP BRAIN RES, V165, P505, DOI 10.1007/s00221-005-2327-5; Schicke T, 2006, P NATL ACAD SCI USA, V103, P11808, DOI 10.1073/pnas.0601486103; Schweizer R, 2000, SOMATOSENS MOT RES, V17, P309; Sekine T, 2009, NEUROREPORT, V20, P467, DOI 10.1097/WNR.0b013e3283277087; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Soto-Faraco S, 2004, PERCEPT PSYCHOPHYS, V66, P1077, DOI 10.3758/BF03196837; Wada M, 2004, NEUROPSYCHOLOGIA, V42, P1887, DOI 10.1016/j.neuropsychologia.2004.05.009; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559; Zampini M, 2005, EXP BRAIN RES, V166, P498, DOI 10.1007/s00221-005-2390-y	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45408	10.1371/journal.pone.0045408	http://dx.doi.org/10.1371/journal.pone.0045408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028989	Green Submitted, gold, Green Published			2022-12-27	WOS:000309554700038
J	Montinaro, A; Forte, G; Sorrentino, R; Luciano, A; Palma, G; Arra, C; Adcock, IM; Pinto, A; Morello, S				Montinaro, Antonella; Forte, Giovanni; Sorrentino, Rosalinda; Luciano, Antonio; Palma, Giuseppe; Arra, Claudio; Adcock, Ian M.; Pinto, Aldo; Morello, Silvana			Adoptive Immunotherapy with Cl-IB-MECA-Treated CD8+T Cells Reduces Melanoma Growth in Mice	PLOS ONE			English	Article							CD8(+) T-CELLS; MEDIATED TUMOR REJECTION; A2A ADENOSINE RECEPTOR; IFN-GAMMA; TNF-ALPHA; IN-VITRO; METASTATIC MELANOMA; SKIN-CANCER; ANTITUMOR; PERFORIN	Cl-IB-MECA is a selective A3 adenosine receptor agonist, which plays a crucial role in limiting tumor progression. In mice, Cl-IB-MECA administration enhances the anti-tumor T cell-mediated response. However, little is known about the activity of Cl-IB-MECA on CD8+ T cells. The aim of this study was to investigate the effect of ex vivo Cl-IB-MECA treatment of CD8+ T cells, adoptively transferred in melanoma-bearing mice. Adoptive transfer of Cl-IB-MECA-treated CD8+ T cells or a single administration of Cl-IB-MECA (20 ng/mouse) inhibited tumor growth compared with the control group and significantly improved mouse survival. This was associated with the release of Th1-type cytokines and a greater influx of mature Langerin+ dendritic cells (LCs) into the tumor microenvironment. CD8+ T cells treated with Cl-IB-MECA released TNF-alpha which plays a critical role in the therapeutic efficacy of these cells when injected to mice. Indeed, neutralization of TNF-alpha by a specific monoclonal Ab significantly blocked the anti-tumor activity of Cl-IB-MECA-treated T cells. This was due to the reduction in levels of cytotoxic cytokines and the presence of fewer LCs. In conclusion, these studies reveal that ex vivo treatment with Cl-IB-MECA improves CD8+ T cell adoptive immunotherapy for melanoma in a TNF-alpha-dependent manner.	[Montinaro, Antonella; Forte, Giovanni; Sorrentino, Rosalinda; Pinto, Aldo; Morello, Silvana] Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy; [Luciano, Antonio; Palma, Giuseppe; Arra, Claudio] Natl Canc Inst G Pascale Naples, Naples, Italy; [Adcock, Ian M.] Univ London Imperial Coll Sci Technol & Med, NHLI, London, England	University of Salerno; Imperial College London	Morello, S (corresponding author), Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy.	smorello@unisa.it	Palma, Giuseppe/AAG-8960-2019; Sorrentino, Rosalinda/AAK-9540-2020; Giuseppe, Palma/K-5913-2016; Morello, Silvana/E-9328-2012; Adcock, Ian/L-3217-2019	Palma, Giuseppe/0000-0003-4385-5896; Giuseppe, Palma/0000-0003-4385-5896; Morello, Silvana/0000-0002-6541-0997; Sorrentino, Rosalinda/0000-0001-9201-9857; Luciano, Antonio/0000-0003-0183-6574; Adcock, Ian/0000-0003-2101-8843; Arra, Claudio/0000-0003-3162-2091	Provincia Avellino; FARB University of Salerno	Provincia Avellino; FARB University of Salerno	This work was supported by grants from Provincia Avellino and FARB University of Salerno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JS, 1992, IMMUNOL REV, V127, P5, DOI 10.1111/j.1600-065X.1992.tb01406.x; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; Dace DS, 2007, J IMMUNOL, V178, P6115, DOI 10.4049/jimmunol.178.10.6115; Dobrzanski MJ, 2001, CLIN IMMUNOL, V98, P70, DOI 10.1006/clim.2000.4945; Dudley ME, 2010, CLIN CANCER RES, V16, P6122, DOI 10.1158/1078-0432.CCR-10-1297; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Eberle J, 2007, BRIT J DERMATOL, V156, P18, DOI 10.1111/j.1365-2133.2007.07855.x; Fang L, 2008, J INVEST DERMATOL, V128, P2596, DOI 10.1038/jid.2008.101; Fishman P, 2009, Handb Exp Pharmacol, P399, DOI 10.1007/978-3-540-89615-9_14; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Harish A, 2003, INT J ONCOL, V23, P1245; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; MacGregor JN, 2006, CANCER RES, V66, P4913, DOI 10.1158/0008-5472.CAN-05-3507; Morello S, 2011, NEOPLASIA, V13, P365, DOI 10.1593/neo.101628; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Ohta A, 2009, J IMMUNOL, V183, P5487, DOI 10.4049/jimmunol.0901247; Peng LM, 2000, J IMMUNOL, V165, P7116, DOI 10.4049/jimmunol.165.12.7116; Poehlein CH, 2003, J IMMUNOL, V170, P2004, DOI 10.4049/jimmunol.170.4.2004; Prevost-Blondel A, 2000, EUR J IMMUNOL, V30, P2507, DOI 10.1002/1521-4141(200009)30:9<2507::AID-IMMU2507>3.0.CO;2-V; RAMKUMAR V, 1993, J BIOL CHEM, V268, P16887; Raskovalova T, 2007, CANCER RES, V67, P5949, DOI 10.1158/0008-5472.CAN-06-4249; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rosenberg SA, 2009, CURR OPIN IMMUNOL, V21, P233, DOI 10.1016/j.coi.2009.03.002; Seki N, 2002, J IMMUNOL, V168, P3484, DOI 10.4049/jimmunol.168.7.3484; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Stoitzner P, 2010, IMMUNOL CELL BIOL, V88, P431, DOI 10.1038/icb.2010.31; Suk K, 2001, J BIOL CHEM, V276, P13153, DOI 10.1074/jbc.M007646200; Trevejo JM, 2001, P NATL ACAD SCI USA, V98, P12162, DOI 10.1073/pnas.211423598; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646	35	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45401	10.1371/journal.pone.0045401	http://dx.doi.org/10.1371/journal.pone.0045401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028986	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700037
J	Bhashyam, AR; Mogayzel, PJ; McGrath-Morrow, S; Neptune, E; Malinina, A; Fox, J; Laube, BL				Bhashyam, Abhiram R.; Mogayzel, Peter J., Jr.; McGrath-Morrow, Sharon; Neptune, Enid; Malinina, Alla; Fox, James; Laube, Beth L.			A Pilot Study to Examine the Effect of Chronic Treatment with Immunosuppressive Drugs on Mucociliary Clearance in a Vagotomized Murine Model	PLOS ONE			English	Article							MYCOPHENOLATE-MOFETIL; LUNG TRANSPLANTATION; TRACHEAL EPITHELIUM; MOUSE; CELLS; MICE; OSCILLATIONS; TACROLIMUS; ANESTHESIA; DISEASE	Background: Previously, we have demonstrated that mucociliary clearance (MCC) is diminished within the first months after surgery in lung transplant patients and the explanation for the reduction in MCC is unknown. We hypothesized that chronic treatment with a commonly prescribed regimen of immunosuppressive drugs significantly impairs MCC. We tested this hypothesis in a murine model of lung transplantation. Methods: Fifteen C57BL/6 mice underwent vagotomy on the right side to simulate denervation associated with lung transplantation in humans. For 6 days, seven mice (controls) were intraperitoneally injected with three 100 mu L doses of phosphate buffered saline and eight mice (immunosuppressed) were injected with three 100 mL injections of tacrolimus (1 mg/kg), mycophenolate mofetil (30 mg/kg), and prednisone (2 mg/kg) once daily. Then, mice inhaled the radioisotope (99m)technetium and underwent gamma camera imaging of their lungs for 6.5 hrs. Counts in the right lung at 1-1.5 hrs and at 6-6.5 hrs were first background-corrected and then decay-corrected to time 0 counts. Decay-corrected counts were then divided by time 0 counts. Retention at each time point was subtracted from 1.00 and multiplied by 100% to obtain percent removed by mucociliary clearance. Results: Although there was a slowing of MCC at 1-1.5 hrs for the immunosuppressed mice, there was no statistical difference in MCC measured at 1-1.5 hrs for the two groups of mice. At 6-6.5 hrs, MCC was significantly slower in the immunosuppressed mice, compared to controls, with 7.78 +/- 5.9% cleared versus 23.01 +/- 11.7% cleared, respectively (p = 0.006). Conclusions: These preliminary results suggest that chronic treatment with immunosuppressive medications significantly slows MCC in vagotomized C57BL/6 mice. These findings could shed light on why MCC is reduced in lung transplant patients whose lungs are denervated during surgery and who are chronically treated with immunosuppressive drugs post surgery.	[Mogayzel, Peter J., Jr.; McGrath-Morrow, Sharon; Laube, Beth L.] Johns Hopkins Med Inst, Dept Pediat, Baltimore, MD 21205 USA; [Bhashyam, Abhiram R.] Johns Hopkins Med Inst, Dept Biomed Engn, Baltimore, MD 21205 USA; [Neptune, Enid; Malinina, Alla] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Fox, James] Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Laube, BL (corresponding author), Johns Hopkins Med Inst, Dept Pediat, Baltimore, MD 21205 USA.	blaube@jhmi.edu			National Cancer Institute [U24 CA92871]; Johns Hopkins University Provost Undergraduate Research Award; NATIONAL CANCER INSTITUTE [U24CA092871] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Johns Hopkins University Provost Undergraduate Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially funded by the National Cancer Institute (U24 CA92871) and the Johns Hopkins University Provost Undergraduate Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Berenbaum MC, 1997, CLIN EXP IMMUNOL, V28, P1; Bhashyam AR, 2010, AUTON NEUROSCI-BASIC, V154, P74, DOI 10.1016/j.autneu.2009.12.002; Christie JD, 2011, J HEART LUNG TRANSPL, V30, P1104, DOI 10.1016/j.healun.2011.08.004; Cransberg K, 2008, PEDIATR TRANSPLANT, V12, P201, DOI 10.1111/j.1399-3046.2007.00810.x; FORBES AR, 1977, ANESTHESIOLOGY, V46, P319, DOI 10.1097/00000542-197705000-00002; FORBES AR, 1979, ANESTHESIOLOGY, V50, P26, DOI 10.1097/00000542-197901000-00006; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Grand AG, 2002, J NEUROSURG, V96, P924, DOI 10.3171/jns.2002.96.5.0924; HASANI A, 1992, CHEST, V101, P1614, DOI 10.1378/chest.101.6.1614; Hofmann W, 2003, TOXICOL SCI, V73, P448, DOI 10.1093/toxsci/kfg075; Hollmen M, 2008, J HEART LUNG TRANSPL, V27, P856, DOI 10.1016/j.healun.2008.05.018; Huang PL, 2000, J AM SOC NEPHROL, V11, pS120; Kanoh S, 1999, AM J PHYSIOL-LUNG C, V276, pL891, DOI 10.1152/ajplung.1999.276.6.L891; Lake KD, 2001, SEMIN RESP CRIT CARE, V22, P559, DOI 10.1055/s-2001-18428; Laube BL, 2007, J HEART LUNG TRANSPL, V26, P138, DOI 10.1016/j.healun.2006.11.005; McGrath-Morrow S, 2006, AM J PHYSIOL-LUNG C, V291, pL837, DOI 10.1152/ajplung.00134.2006; NUNN JF, 1974, J CELL SCI, V15, P537; PACK RJ, 1980, CELL TISSUE RES, V208, P65; PACK RJ, 1981, J ANAT, V132, P71; Pazetti R, 2007, CLINICS, V62, P345, DOI 10.1590/S1807-59322007000300021; Ramos MA, 2003, NEPHROL DIAL TRANSPL, V18, P878, DOI 10.1093/ndt/gfg034; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; WOLFF R, 1991, TREATISE PULMONARY T, V1, P659; Zhang L, 2003, J PHYSIOL-LONDON, V546, P733, DOI 10.1113/jphysiol.2002.028704	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45312	10.1371/journal.pone.0045312	http://dx.doi.org/10.1371/journal.pone.0045312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028925	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900039
J	Bosak, S; Pletikapic, G; Hozic, A; Svetlicic, V; Sarno, D; Vilicic, D				Bosak, Suncica; Pletikapic, Galja; Hozic, Amela; Svetlicic, Vesna; Sarno, Diana; Vilicic, Damir			A Novel Type of Colony Formation in Marine Planktonic Diatoms Revealed by Atomic Force Microscopy	PLOS ONE			English	Article							RELEASE; CHAETOCEROTACEAE; PHYTOPLANKTON; PARTICLES; GULF	Diatoms have evolved a variety of colonial life forms in which cells are connected by organic threads, mucilage pads or silicate structures. In this study, we provide the first description of a novel strategy of colony formation among marine planktonic diatoms. Bacteriastrum jadranum forms loose but regular chains with distinct heterovalvate terminal cells. The colonial cells and their siliceous projections, the setae, are not in direct contact; instead, they are enclosed within the optically transparent organic matrix. This cell jacket structure was detected by staining procedure with Alcian Blue, which showed that the polysaccharides are predominant matrix constituents and revealed that the jacket reaches the span of the setae. The scanning electron microscopy (SEM) observations showed distinguishable fibrillar network firmly associated with cells. Using atomic force microscopy (AFM), we were able to visualise and characterise the cell jacket structure at molecular resolution. At nanoscale resolution, the cell jacket appears as a cross-linked fibrillar network organised into a recognisable structure. The circular patches of self-repeating pattern (hexagonal pores with openings of 8-100 nm) are connected through thicker surrounding fibrils and reinforced by branching fibrils. The pore-forming fibrils within the patches are only 0.6-1.6 nm high, the surrounding fibrils connecting patches are 2.0-2.8 nm high, and the branching fibrils are considerably wider but not higher than 4.0 nm. The discovered polysaccharide fibrillar network is highly organised and delicately structured with a monomolecular fibril height of 0.6 nm. We conclude that the Bacteriastrum polysaccharide jacket represents an essential part of the cell, as the conjunction of the polymer network with the frustule appears to be extremely tight and such specific and unique patterns have never been found in self-assembled polysaccharide gel networks, which are usually encountered in the marine environment.	[Bosak, Suncica; Vilicic, Damir] Univ Zagreb, Fac Sci, Div Biol, Zagreb 41000, Croatia; [Pletikapic, Galja; Hozic, Amela; Svetlicic, Vesna] Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb, Croatia; [Sarno, Diana] Stn Zool Anton Dohrn, Naples, Italy	University of Zagreb; Rudjer Boskovic Institute; Stazione Zoologica Anton Dohrn di Napoli	Bosak, S (corresponding author), Univ Zagreb, Fac Sci, Div Biol, Zagreb 41000, Croatia.	sbosak@biol.pmf.hr	Hozic, Amela/R-6086-2018; Bosak, Suncica/L-7149-2015; Svetličić, Vesna/C-6932-2011	Bosak, Suncica/0000-0002-4604-2324; Svetličić, Vesna/0000-0002-5127-5472; SARNO, DIANA/0000-0001-9697-5301	Ministry of Science, Education and Sport of the Republic of Croatia [0982934-2744, 119-1191189-1228]; European Community [227799]	Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); European Community(European Commission)	The research was funded by the Ministry of Science, Education and Sport of the Republic of Croatia (Project Nos. 0982934-2744, 119-1191189-1228). S.B. was partially supported by the European Community - Research Infrastructure Action under the FP7 "Capacities" Specific Programme (Ref. ASSEMBLE grant agreement no. 227799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; BRAY DF, 1993, MICROSC RES TECHNIQ, V26, P489, DOI 10.1002/jemt.1070260603; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Elbrachter M., 1978, UPWELLING ECOSYSTEMS, P24; Freire-Nordi CS, 2006, BRAZ J PHYS, V36, P75; Freire-Nordi CS, 1998, J PHYCOL, V34, P631, DOI 10.1046/j.1529-8817.1998.340631.x; Freire-Nordi CS, 2005, MICROSC MICROANAL, V11, P40; FRYXELL GA, 1984, BRIT PHYCOL J, V19, P141, DOI 10.1080/00071618400650151; Godrijan J, 2012, BOT MAR, V55, P415, DOI 10.1515/bot-2011-0021; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hamm Christian, 2007, P311, DOI 10.1016/B978-012370518-1/50015-1; Hasle G.R., 1978, PHYTOPLANKTON MANUAL, P136; Higgins MJ, 2011, LIFE AT THE NANOSCALE: ATOMIC FORCE MICROSCOPY OF LIVE CELLS, P405; Jensen K.G., 1998, OPERA BOT, V133, P5, DOI [10.1111/j.1756-1051.1998.tb01103.x, DOI 10.1111/J.1756-1051.1998.TB01103.X]; Kooistra WHCF, 2010, PHYCOLOGIA, V49, P471, DOI 10.2216/09-59.1; Long RA, 1996, AQUAT MICROB ECOL, V10, P213, DOI 10.3354/ame010213; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Misic Radic T, 2011, J MOL RECOGNIT, V24, P397, DOI 10.1002/jmr.1072; MYKLESTAD S, 1989, J PLANKTON RES, V11, P763, DOI 10.1093/plankt/11.4.763; MYKLESTAD S, 1972, Journal of Experimental Marine Biology and Ecology, V9, P137, DOI 10.1016/0022-0981(72)90042-1; MYKLESTAD SM, 1995, SCI TOTAL ENVIRON, V165, P155, DOI 10.1016/0048-9697(95)04549-G; PAULSEN BS, 1994, J PHYCOL, V30, P638, DOI 10.1111/j.0022-3646.1994.00638.x; Pletikapic G, 2011, J MOL RECOGNIT, V24, P436, DOI 10.1002/jmr.1114; PRASAD AKSK, 1990, PHYCOLOGIA, V29, P418, DOI 10.2216/i0031-8884-29-4-418.1; RAMUS J, 1977, J PHYCOL, V13, P345, DOI 10.1111/j.1529-8817.1977.tb02939.x; Round F. E., 1990, DIATOMS BIOL MORPHOL; Sarno D, 1997, PHYCOLOGIA, V36, P257, DOI 10.2216/i0031-8884-36-4-257.1; Supraha L, 2011, ACTA ADRIAT, V52, P29; Svetlicic V, 2011, MAR DRUGS, V9, P666, DOI 10.3390/md9040666; Troedsson C, 2007, LIMNOL OCEANOGR, V52, P416, DOI 10.4319/lo.2007.52.1.0416	30	18	18	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44851	10.1371/journal.pone.0044851	http://dx.doi.org/10.1371/journal.pone.0044851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028646	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388900014
J	Hubert, K; Pawlik, MC; Claus, H; Jarva, H; Meri, S; Vogel, U				Hubert, Kerstin; Pawlik, Marie-Christin; Claus, Heike; Jarva, Hanna; Meri, Seppo; Vogel, Ulrich			Opc Expression, LPS Immunotype Switch and Pilin Conversion Contribute to Serum Resistance of Unencapsulated Meningococci	PLOS ONE			English	Article							C-REACTIVE PROTEIN; B NEISSERIA-MENINGITIDIS; OUTER-MEMBRANE PROTEIN; PHASE VARIATION; SEROGROUP-B; BACTERICIDAL ACTIVITY; EPITHELIAL-CELLS; GENE CONVERSION; STRAIN MC58; FACTOR-H	Neisseria meningitidis employs polysaccharides and outer membrane proteins to cope with human serum complement attack. To screen for factors influencing serum resistance, an assay was developed based on a colorimetric serum bactericidal assay. The screening used a genetically modified sequence type (ST)-41/44 clonal complex (cc) strain lacking LPS sialylation, polysaccharide capsule, the factor H binding protein (fHbp) and MutS, a protein of the DNA repair mechanism. After killing of >99.9% of the bacterial cells by serum treatment, the colorimetric assay was used to screen 1000 colonies, of which 35 showed enhanced serum resistance. Three mutant classes were identified. In the first class of mutants, enhanced expression of Opc was identified. Opc expression was associated with vitronectin binding and reduced membrane attack complex deposition confirming recent observations. Lipopolysaccharide (LPS) immunotype switch from immunotype L3 to L8/L1 by lgtA and lgtC phase variation represented the second class. Isogenic mutant analysis demonstrated that in ST-41/44 cc strains the L8/L1 immunotype was more serum resistant than the L3 immunotype. Consecutive analysis revealed that the immunotypes L8 and L1 were frequently observed in ST-41/44 cc isolates from both carriage and disease. Immunotype switch to L8/L1 is therefore suggested to contribute to the adaptive capacity of this meningococcal lineage. The third mutant class displayed a pilE allelic exchange associated with enhanced autoaggregation. The mutation of the C terminal hypervariable region D of PilE included a residue previously associated with increased pilus bundle formation. We suggest that autoaggregation reduced the surface area accessible to serum complement and protected from killing. The study highlights the ability of meningococci to adapt to environmental stress by phase variation and intrachromosomal recombination affecting subcapsular antigens.	[Hubert, Kerstin; Pawlik, Marie-Christin; Claus, Heike; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany; [Jarva, Hanna; Meri, Seppo] Haartman Inst, Helsinki, Finland	University of Wurzburg	Vogel, U (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany.	uvogel@hygiene.uni-wuerzburg.de		Meri, Seppo/0000-0001-9142-501X; Jarva, Hanna/0000-0002-9154-354X	Federal Ministry of Education and Research [0315434]; Academy of Finland [10]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Academy of Finland(Academy of Finland)	The project was funded by grants to U.V. (from the Federal Ministry of Education and Research, reference number 0315434) and S.M. (from the Academy of Finland) within the 2nd joint call on PathoGenoMics of the EraNet (project No 10). Website: http://www.pathogenomics-era.net/2ndJointCall/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APICELLA MA, 1994, METHOD ENZYMOL, V235, P242; Baker M G, 2001, J Paediatr Child Health, V37, pS13, DOI 10.1046/j.1440-1754.2001.00722.x; Bayliss CD, 2008, INFECT IMMUN, V76, P5038, DOI 10.1128/IAI.00395-08; Berrington AW, 2002, FEMS IMMUNOL MED MIC, V34, P267, DOI 10.1016/S0928-8244(02)00369-3; Blom AM, 2001, J IMMUNOL, V166, P6764, DOI 10.4049/jimmunol.166.11.6764; Borud B, 2011, P NATL ACAD SCI USA, V108, P9643, DOI 10.1073/pnas.1103321108; Casey R, 2008, INFECT IMMUN, V76, P1298, DOI 10.1128/IAI.00741-07; CAUGANT DA, 1990, J INFECT DIS, V162, P867, DOI 10.1093/infdis/162.4.867; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; CHIANG SL, 1995, MOL MICROBIOL, V17, P1133, DOI 10.1111/j.1365-2958.1995.mmi_17061133.x; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Criss AK, 2010, J BACTERIOL, V192, P316, DOI 10.1128/JB.01228-09; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; DUNN KLR, 1995, MICROB PATHOGENESIS, V18, P81, DOI 10.1016/S0882-4010(95)90085-3; Elias J, 2010, EMERG INFECT DIS, V16, P464, DOI 10.3201/eid1603.091102; Geoffroy MC, 2003, GENOME RES, V13, P391, DOI 10.1101/gr.664303; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; HAAS R, 1987, P NATL ACAD SCI USA, V84, P9079, DOI 10.1073/pnas.84.24.9079; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; Hallstrom T, 2006, J IMMUNOL, V177, P430, DOI 10.4049/jimmunol.177.1.430; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Jennings MP, 1999, MICROBIOL-UK, V145, P3013, DOI 10.1099/00221287-145-11-3013; Jennings MP, 1998, MOL MICROBIOL, V29, P975, DOI 10.1046/j.1365-2958.1998.00962.x; JONES DM, 1992, MICROB PATHOGENESIS, V13, P219, DOI 10.1016/0882-4010(92)90022-G; Joseph B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018441; Kahler CM, 2001, INFECT IMMUN, V69, P3597, DOI 10.1128/IAI.69.6.3597-3604.2001; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Kurzai O, 2005, CELL MICROBIOL, V7, P1319, DOI 10.1111/j.1462-5822.2005.00559.x; Lappann M, 2006, MOL MICROBIOL, V62, P1292, DOI 10.1111/j.1365-2958.2006.05448.x; Lewis LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001027; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; MARCEAU M, 1995, MOL MICROBIOL, V17, P855, DOI 10.1111/j.1365-2958.1995.mmi_17050855.x; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Merker P, 1997, MOL MICROBIOL, V23, P281, DOI 10.1046/j.1365-2958.1997.2051567.x; MEYER TF, 1984, P NATL ACAD SCI-BIOL, V81, P6110, DOI 10.1073/pnas.81.19.6110; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Richardson AR, 2002, P NATL ACAD SCI USA, V99, P6103, DOI 10.1073/pnas.092568699; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; Rodriguez T, 2003, BIOLOGICALS, V31, P209, DOI 10.1016/S1045-1056(03)00060-5; Rodriguez T, 2002, CLIN DIAGN LAB IMMUN, V9, P109, DOI 10.1128/CDLI.9.1.109-114.2002; Rytkonen A, 2004, J INFECT DIS, V189, P402, DOI 10.1086/381271; SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Schmiel DH, 2011, INFECT IMMUN, V79, P4146, DOI 10.1128/IAI.05125-11; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; SCHOLTEN RJPM, 1994, J INFECT DIS, V169, P673, DOI 10.1093/infdis/169.3.673; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Singh B, 2011, MOL MICROBIOL, V81, P80, DOI 10.1111/j.1365-2958.2011.07678.x; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Singh B, 2010, MOL MICROBIOL, V75, P1426, DOI 10.1111/j.1365-2958.2010.07066.x; Sun YH, 2000, NAT MED, V6, P1269, DOI 10.1038/81380; SWANSON J, 1986, CELL, V47, P267, DOI 10.1016/0092-8674(86)90449-6; Unkmeir A, 2002, MOL MICROBIOL, V46, P933, DOI 10.1046/j.1365-2958.2002.03222.x; VIRJI M, 1989, J GEN MICROBIOL, V135, P3239; Vogel U, 1997, INFECT IMMUN, V65, P4022, DOI 10.1128/IAI.65.10.4022-4029.1997; Vogel U, 2004, J CLIN MICROBIOL, V42, P2898, DOI 10.1128/JCM.42.7.2898-2901.2004; Vogel U, 1997, MED MICROBIOL IMMUN, V186, P159, DOI 10.1007/s004300050059; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wakarchuk WW, 1998, EUR J BIOCHEM, V254, P626, DOI 10.1046/j.1432-1327.1998.2540626.x; Weiser JN, 1998, J EXP MED, V187, P631, DOI 10.1084/jem.187.4.631; Zhu PX, 1999, MOL MICROBIOL, V33, P635, DOI 10.1046/j.1365-2958.1999.01514.x; Zhu PX, 2002, MICROBIOL-SGM, V148, P1833, DOI 10.1099/00221287-148-6-1833; ZOLLINGER WD, 1977, INFECT IMMUN, V18, P424, DOI 10.1128/IAI.18.2.424-433.1977	70	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45132	10.1371/journal.pone.0045132	http://dx.doi.org/10.1371/journal.pone.0045132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028802	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900023
J	Paunescu, TG; Rodriguez, S; Benz, E; McKee, M; Tyszkowski, R; Albers, MW; Brown, D				Paunescu, Teodor G.; Rodriguez, Steven; Benz, Eric; McKee, Mary; Tyszkowski, Robert; Albers, Mark W.; Brown, Dennis			Loss of the V-ATPase B1 Subunit Isoform Expressed in Non-Neuronal Cells of the Mouse Olfactory Epithelium Impairs Olfactory Function	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; CARBONIC-ANHYDRASE ACTIVITY; VOMERONASAL ORGAN REMOVAL; KIDNEY COLLECTING DUCT; INTERCALATED CELLS; LUMINAL ACIDIFICATION; ADENYLYL-CYCLASE; NASAL ABSORPTION; PLASMA-MEMBRANE; RECEPTOR-CELLS	The vacuolar proton-pumping ATPase (V-ATPase) is the main mediator of intracellular organelle acidification and also regulates transmembrane proton (H+) secretion, which is necessary for an array of physiological functions fulfilled by organs such as the kidney, male reproductive tract, lung, bone, and ear. In this study we characterize expression of the V-ATPase in the main olfactory epithelium of the mouse, as well as a functional role for the V-ATPase in odor detection. We report that the V-ATPase localizes to the apical membrane microvilli of olfactory sustentacular cells and to the basolateral membrane of microvillar cells. Plasma membrane V-ATPases containing the B1 subunit isoform are not detected in olfactory sensory neurons or in the olfactory bulb. This precise localization of expression affords the opportunity to ascertain the functional relevance of V-ATPase expression upon innate, odor-evoked behaviors in B1-deficient mice. This animal model exhibits diminished innate avoidance behavior (revealed as a decrease in freezing time and an increase in the number of sniffs in the presence of trimethyl-thiazoline) and diminished innate appetitive behavior (a decrease in time spent investigating the urine of the opposite sex). We conclude that V-ATPase-mediated H+ secretion in the olfactory epithelium is required for optimal olfactory function.	[Paunescu, Teodor G.; McKee, Mary; Tyszkowski, Robert; Brown, Dennis] Massachusetts Gen Hosp, MGH Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA; [Paunescu, Teodor G.; McKee, Mary; Tyszkowski, Robert; Brown, Dennis] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Paunescu, Teodor G.; Rodriguez, Steven; Albers, Mark W.; Brown, Dennis] Harvard Univ, Sch Med, Boston, MA USA; [Rodriguez, Steven; Benz, Eric; Albers, Mark W.] MassGen Inst Neurodegenerat Dis, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Paunescu, TG (corresponding author), Massachusetts Gen Hosp, MGH Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA.	Paunescu.Teodor@mgh.harvard.edu	Albers, Mark/AAK-8718-2021; Paunescu, Teodor/AAX-7533-2020	Albers, Mark/0000-0001-7855-3455; Paunescu, Teodor/0000-0003-0227-9028	National Institutes of Health (NIH); NIH K01 grant [DK-73266]; NIH [OD006662, DK-42956]; Boston Area Diabetes and Endocrinology Research Center (NIH) [DK-57521]; Center for the Study of Inflammatory Bowel Disease (NIH) [DK-43341]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, R37DK042956, P30DK043351, R01DK042956, K01DK073266, R29DK043341] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006662] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH K01 grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes and Endocrinology Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for the Study of Inflammatory Bowel Disease (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the National Institutes of Health (NIH), www.nih.gov. T. G. Paunescu is supported by an NIH K01 grant DK-73266. Additional support was from NIH grants OD006662 (M. W. Albers) and DK-42956 (D. Brown). The Microscopy Core Facility of the Program in Membrane Biology receives additional support from the Boston Area Diabetes and Endocrinology Research Center (NIH grant DK-57521) and from the Center for the Study of Inflammatory Bowel Disease (NIH grant DK-43341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablimit A, 2006, ARCH HISTOL CYTOL, V69, P1, DOI 10.1679/aohc.69.1; Asan E, 2005, HISTOCHEM CELL BIOL, V123, P157, DOI 10.1007/s00418-005-0759-4; Baum MJ, 2002, HORM BEHAV, V41, P213, DOI 10.1006/hbeh.2001.1749; BILLS DD, 1969, J DAIRY SCI, V52, P1340, DOI 10.3168/jds.S0022-0302(69)86749-4; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; BOORMAN GA, 1994, ENVIRON HEALTH PERSP, V102, P318, DOI 10.1289/ehp.94102318; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Brisseau GF, 1996, J BIOL CHEM, V271, P2005, DOI 10.1074/jbc.271.4.2005; BROWN D, 1984, HISTOCHEMISTRY, V80, P307, DOI 10.1007/BF00495782; Brown D, 2000, J EXP BIOL, V203, P137; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Coates EL, 2001, RESP PHYSIOL, V129, P219, DOI 10.1016/S0034-5687(01)00292-4; Coates EL, 1998, J COMP PHYSIOL A, V182, P163, DOI 10.1007/s003590050167; Couloigner V, 2000, AM J PHYSIOL-REG I, V279, pR1695, DOI 10.1152/ajpregu.2000.279.5.R1695; Elsaesser R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-S3-S1; Ferrary E, 1998, KIDNEY INT, pS98; Ferris KE, 2007, CHEM SENSES, V32, P263, DOI 10.1093/chemse/bjl054; Finberg KE, 2005, P NATL ACAD SCI USA, V102, P13616, DOI 10.1073/pnas.0506769102; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; FRINGS S, 1991, J GEN PHYSIOL, V97, P725, DOI 10.1085/jgp.97.4.725; Futai M, 2000, J EXP BIOL, V203, P107; GETCHELL TV, 1980, BIOPHYS J, V29, P397, DOI 10.1016/S0006-3495(80)85142-3; GETCHELL TV, 1984, PROG NEUROBIOL, V23, P317, DOI 10.1016/0301-0082(84)90008-X; GOLDSMITH DJA, 1992, KIDNEY INT, V41, P43, DOI 10.1038/ki.1992.6; Grubb BR, 2007, AM J PHYSIOL-CELL PH, V293, pC574, DOI 10.1152/ajpcell.00106.2007; Hebb ALO, 2004, EUR J NEUROSCI, V20, P2415, DOI 10.1111/j.1460-9568.2004.03704.x; Hebb ALO, 2002, NEUROPSYCHOPHARMACOL, V27, P744, DOI 10.1016/S0893-133X(02)00354-8; HIRAI S, 1978, DIABETES, V27, P296, DOI 10.2337/diab.27.3.296; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kagatani S, 1998, PHARMACEUT RES, V15, P77, DOI 10.1023/A:1011952804479; Kato A, 2009, CELL MOL LIFE SCI, V66, P3743, DOI 10.1007/s00018-009-0111-6; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Lee BS, 1996, AM J PHYSIOL-CELL PH, V270, pC382, DOI 10.1152/ajpcell.1996.270.1.C382; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; Menco BPM, 1998, CHEM SENSES, V23, P137, DOI 10.1093/chemse/23.2.137; Merkulova M, 2011, AM J PHYSIOL-CELL PH, V300, pC1442, DOI 10.1152/ajpcell.00076.2010; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; OHWAKI T, 1987, J PHARM SCI, V76, P695, DOI 10.1002/jps.2600760905; Okamura H, 1996, BRAIN RES, V728, P263, DOI 10.1016/S0006-8993(96)00549-5; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; Pankevich DE, 2006, BEHAV NEUROSCI, V120, P925, DOI 10.1037/0735-7044.120.4.925; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Paunescu TG, 2008, AM J PHYSIOL-CELL PH, V295, pC923, DOI 10.1152/ajpcell.00237.2008; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Paunescu TG, 2007, AM J PHYSIOL-RENAL, V293, pF1915, DOI 10.1152/ajprenal.00160.2007; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Paunescu TG, 2004, AM J PHYSIOL-CELL PH, V287, pC149, DOI 10.1152/ajpcell.00464.2003; PUOPOLO K, 1992, J BIOL CHEM, V267, P3696; Rasmussen LEL, 2003, BIOCHEM SOC T, V31, P137, DOI 10.1042/BST0310137; Rochelle LG, 2000, AM J PHYSIOL-LUNG C, V279, pL14, DOI 10.1152/ajplung.2000.279.1.L14; Russo LM, 2006, AM J PHYSIOL-RENAL, V291, pF246, DOI 10.1152/ajprenal.00437.2005; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Stankovic KM, 1997, HEARING RES, V114, P21, DOI 10.1016/S0378-5955(97)00072-5; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P274, DOI 10.1016/j.conb.2010.02.013; Tarun AS, 2003, CHEM SENSES, V28, P621, DOI 10.1093/chemse/bjg054; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; VANDRONGELEN W, 1982, B MATH BIOL, V44, P411, DOI 10.1016/S0092-8240(82)80020-7; Vogalis F, 2005, J PHYSIOL-LONDON, V562, P785, DOI 10.1113/jphysiol.2004.079228; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wax MB, 1997, P NATL ACAD SCI USA, V94, P6752, DOI 10.1073/pnas.94.13.6752	73	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45395	10.1371/journal.pone.0045395	http://dx.doi.org/10.1371/journal.pone.0045395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028982	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900045
J	Duncan, JR; Dick, ALW; Egan, G; Kolbe, S; Gavrilescu, M; Wright, D; Lubman, DI; Lawrence, AJ				Duncan, Jhodie Rubina; Dick, Alec Lindsay Ward; Egan, Gary; Kolbe, Scott; Gavrilescu, Maria; Wright, David; Lubman, Dan Ian; Lawrence, Andrew John			Adolescent Toluene Inhalation in Rats Affects White Matter Maturation with the Potential for Recovery Following Abstinence	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CONDITIONED PLACE PREFERENCE; EARLY POSTNATAL-DEVELOPMENT; MEDIAL PREFRONTAL CORTEX; CHRONIC SOLVENT ABUSE; LOCOMOTOR-ACTIVITY; NUCLEUS-ACCUMBENS; CORPUS-CALLOSUM; ADULT RATS; COGNITIVE RECOVERY	Inhalant misuse is common during adolescence, with ongoing chronic misuse associated with neurobiological and cognitive abnormalities. While human imaging studies consistently report white matter abnormalities among long-term inhalant users, longitudinal studies have been lacking with limited data available regarding the progressive nature of such abnormalities, including the potential for recovery following periods of sustained abstinence. We exposed adolescent male Wistar rats (postnatal day 27) to chronic intermittent inhaled toluene (3,000 ppm) for 1 hour/day, 3 times/week for 8 weeks to model abuse patterns observed in adolescent and young adult human users. This dosing regimen resulted in a significant retardation in weight gain during the exposure period (p<0.05). In parallel, we performed longitudinal magnetic resonance imaging (T-2-weighted) and diffusion tensor imaging prior to exposure, and after 4 and 8 weeks, to examine the integrity of white matter tracts, including the anterior commissure and corpus callosum. We also conducted imaging after 8 weeks of abstinence to assess for potential recovery. Chronic intermittent toluene exposure during adolescence and early adulthood resulted in white matter abnormalities, including a decrease in axial(p<0.05) and radial (p<0.05) diffusivity. These abnormalities appeared region-specific, occurring in the anterior commissure but not the corpus callosum and were not present until after at least 4 weeks of exposure. Toluene-induced effects on both body weight and white matter parameters recovered following abstinence. Behaviourally, we observed a progressive decrease in rearing activity following toluene exposure but no difference in motor function, suggesting cognitive function may be more sensitive to the effects of toluene. Furthermore, deficits in rearing were present by 4 weeks suggesting that toluene may affect behaviour prior to detectable white matter abnormalities. Consequently, exposure to inhalants that contain toluene during adolescence and early adulthood appear to differentially affect white matter maturation and behavioural outcomes, although recovery can occur following abstinence.	[Duncan, Jhodie Rubina; Dick, Alec Lindsay Ward; Egan, Gary; Kolbe, Scott; Gavrilescu, Maria; Wright, David; Lawrence, Andrew John] Univ Melbourne, Florey Neurosci Inst, Div Behav Neurosci, Melbourne, Vic, Australia; [Duncan, Jhodie Rubina] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Dick, Alec Lindsay Ward; Lawrence, Andrew John] Univ Melbourne, Ctr Neurosci Res, Melbourne, Vic, Australia; [Lubman, Dan Ian] Eastern Hlth & Monash Univ, Turning Point Alcohol & Drug Ctr, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; Monash University; Turning Point Alcohol & Drug Centre - Australia	Duncan, JR (corresponding author), Univ Melbourne, Florey Neurosci Inst, Div Behav Neurosci, Melbourne, Vic, Australia.	Jhodie.duncan@florey.edu.au	Egan, Gary F./A-1381-2013; Maria, Gavrilescu/F-9265-2014	Maria, Gavrilescu/0000-0002-0663-0316; Dick, Alec/0000-0002-2303-9720; Kolbe, Scott/0000-0003-4685-1380; Egan, Gary/0000-0002-3186-4026; Lubman, Dan/0000-0002-6747-1937; Wright, David/0000-0002-7535-8651	National Health and Medical Research Council of Australia [1020737]; Australian Research Council [DP 110100379, 100100235]; Lew Carty Foundation; Alcohol and Health Research Grant Scheme	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Lew Carty Foundation; Alcohol and Health Research Grant Scheme	This research was supported by The National Health and Medical Research Council of Australia of which AJL is a Principal Fellow (1020737), the Australian Research Council (DP 110100379) of which JRD is a Future Fellow (100100235), The Lew Carty Foundation and the Alcohol and Health Research Grant Scheme. The authors also acknowledge the Victorian Government's Operational Infrastructure Support Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez EO, 2001, BEHAV BRAIN RES, V123, P143, DOI 10.1016/S0166-4328(01)00190-5; Abin-Carriquiry JA, 2010, EUR J PHARMACOL, V634, P89, DOI 10.1016/j.ejphar.2010.02.030; Arnone D, 2008, NEUROIMAGE, V41, P1067, DOI 10.1016/j.neuroimage.2008.02.064; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Aydin K, 2002, AM J NEURORADIOL, V23, P1173; Aydin K, 2003, MAGN RESON IMAGING, V21, P777, DOI 10.1016/S0730-725X(03)00175-9; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Batis JC, 2010, PHARMACOL BIOCHEM BE, V96, P438, DOI 10.1016/j.pbb.2010.07.003; Beckley JT, 2011, NEUROPSYCHOPHARMACOL, V36, P1531, DOI 10.1038/npp.2011.38; Beckstead MJ, 2000, MOL PHARMACOL, V57, P1199; Berenguer P, 2003, PHARMACOL BIOCHEM BE, V74, P997, DOI 10.1016/S0091-3057(03)00027-3; Berenguer P, 2004, PHYSIOL BEHAV, V81, P527, DOI 10.1016/j.physbeh.2004.02.017; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Bosnell R, 2008, DEV NEUROREHABIL, V11, P174, DOI 10.1080/17518420802289065; Bowen SE, 2007, NEUROTOXICOL TERATOL, V29, P599, DOI 10.1016/j.ntt.2007.08.001; Bowen SE, 2006, NEUROTOXICOL TERATOL, V28, P636, DOI 10.1016/j.ntt.2006.09.005; Bowen SE, 2005, NEUROTOXICOL TERATOL, V27, P105, DOI 10.1016/j.ntt.2004.09.007; Burns LH, 1996, BEHAV NEUROSCI, V110, P60, DOI 10.1037/0735-7044.110.1.60; Cairney S, 2005, NEUROPSYCHOPHARMACOL, V30, P1019, DOI 10.1038/sj.npp.1300682; Cairney S, 2004, DRUG ALCOHOL DEPEN, V73, P183, DOI 10.1016/j.drugalcdep.2003.10.010; CALDEMEYER KS, 1993, AM J ROENTGENOL, V161, P1259, DOI 10.2214/ajr.161.6.8249738; Chan KC, 2009, INT J DEV NEUROSCI, V27, P607, DOI 10.1016/j.ijdevneu.2009.05.012; Choi H, 2011, SCHIZOPHR RES, V130, P78, DOI 10.1016/j.schres.2011.04.016; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; Deleu D, 2000, J NEUROL NEUROSUR PS, V68, P118, DOI 10.1136/jnnp.68.1.118; Dingwall KM, 2011, DRUG ALCOHOL DEPEN, V118, P180, DOI 10.1016/j.drugalcdep.2011.03.017; Filley CM, 2004, J NEUROPATH EXP NEUR, V63, P1; FINK JS, 1980, BRAIN RES, V199, P359; Franco-Pons N, 2007, TOXICOL LETT, V169, P205, DOI 10.1016/j.toxlet.2007.01.010; Funada M, 2002, BRAIN RES PROTOC, V10, P47; Gerasimov MR, 2003, EUR J PHARMACOL, V477, P45, DOI 10.1016/j.ejphar.2003.08.022; HILLEFORSBERGLUND M, 1995, TOXICOLOGY, V100, P185, DOI 10.1016/0300-483X(95)03084-S; HINMAN DJ, 1987, PHARMACOL BIOCHEM BE, V26, P65, DOI 10.1016/0091-3057(87)90535-1; Jarosz PA, 2008, PHYSIOL BEHAV, V93, P984, DOI 10.1016/j.physbeh.2007.12.016; Jito J, 2008, J MAGN RESON IMAGING, V28, P847, DOI 10.1002/jmri.21496; Johnson EO, 1995, DRUG ALCOHOL DEPEN, V40, P159, DOI 10.1016/0376-8716(95)01201-X; Laviola G, 2001, PHARMACOL BIOCHEM BE, V68, P115, DOI 10.1016/S0091-3057(00)00430-5; Lever C, 2006, REV NEUROSCIENCE, V17, P111; Lubman DI, 2008, BRIT J PHARMACOL, V154, P316, DOI 10.1038/bjp.2008.76; Lubman DI, 2006, MED J AUSTRALIA, V185, P327, DOI 10.5694/j.1326-5377.2006.tb00588.x; Ma LS, 2009, DRUG ALCOHOL DEPEN, V104, P262, DOI 10.1016/j.drugalcdep.2009.05.020; McGarvey EL, 1999, AM J DRUG ALCOHOL AB, V25, P731, DOI 10.1081/ADA-100101889; McPherson CS, 2006, INT J NEUROPSYCHOPH, V9, P377, DOI 10.1017/S1461145705005845; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; O'Leary-Moore SK, 2009, NEUROTOXICOL TERATOL, V31, P382, DOI 10.1016/j.ntt.2009.07.005; Pawlak CR, 2002, PHARMACOL BIOCHEM BE, V73, P679, DOI 10.1016/S0091-3057(02)00852-3; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Perit KE, 2012, NEUROTOXICOL TERATOL, V34, P37, DOI 10.1016/j.ntt.2011.10.007; Perron BE, 2009, ADDICTION, V104, P1185, DOI 10.1111/j.1360-0443.2009.02557.x; Pitkonen M, 2012, BRAIN RES, V1445, P103, DOI 10.1016/j.brainres.2012.01.043; Qureshi SU, 2009, CAN J NEUROL SCI, V36, P388, DOI 10.1017/S0317167100007204; Riegel AC, 2003, NEUROPSYCHOPHARMACOL, V28, P1440, DOI 10.1038/sj.npp.1300193; Riegel AC, 2007, NEUROPSYCHOPHARMACOL, V32, P1558, DOI 10.1038/sj.npp.1301273; ROSENBERG NL, 1988, NEUROTOXICOL TERATOL, V10, P489, DOI 10.1016/0892-0362(88)90014-1; ROSENBERG NL, 1988, ANN NEUROL, V23, P611, DOI 10.1002/ana.410230614; Rosenberg NL, 2002, J TOXICOL-CLIN TOXIC, V40, P21, DOI 10.1081/CLT-120002883; Ryu YH, 1998, J NUCL MED, V39, P632; Shereen A, 2011, J CEREBR BLOOD F MET, V31, P1155, DOI 10.1038/jcbfm.2010.212; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; STINUS L, 1978, J COMP PHYSIOL PSYCH, V92, P289, DOI 10.1037/h0077467; Thiel CM, 1999, NEUROSCIENCE, V93, P243, DOI 10.1016/S0306-4522(99)00158-X; von Euler M, 2000, EXP NEUROL, V163, P1, DOI 10.1006/exnr.1999.7288; Wang LE, 2012, HUM BRAIN MAPP, V33, P2941, DOI 10.1002/hbm.21417; WEISS B, 1979, ENVIRON HEALTH PERSP, V30, P39, DOI 10.2307/3429100; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Xie MQ, 2010, J NEUROPATH EXP NEUR, V69, P704, DOI 10.1097/NEN.0b013e3181e3de90; YAMANOUCHI N, 1995, AM J NEURORADIOL, V16, P1643; Yucel M, 2008, NEUROSCI BIOBEHAV R, V32, P910, DOI 10.1016/j.neubiorev.2008.01.006; Yucel M, 2010, J PSYCHIATR NEUROSCI, V35, P409, DOI 10.1503/jpn.090177; Zhou WX, 2005, NEUROPSYCHOPHARMACOL, V30, P880, DOI 10.1038/sj.npp.1300635	72	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44790	10.1371/journal.pone.0044790	http://dx.doi.org/10.1371/journal.pone.0044790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028622	gold, Green Published			2022-12-27	WOS:000311313900041
J	Li, RT; Yan, GJ; Li, QL; Sun, HX; Hu, YL; Sun, JX; Xu, BA				Li, Ruotian; Yan, Guijun; Li, Qiaoling; Sun, Haixiang; Hu, Yali; Sun, Jianxin; Xu, Biao			MicroRNA-145 Protects Cardiomyocytes against Hydrogen Peroxide (H2O2)-Induced Apoptosis through Targeting the Mitochondria Apoptotic Pathway	PLOS ONE			English	Article							CELL-DEATH; ISCHEMIA-REPERFUSION; VENTRICULAR MYOCYTES; MYOCARDIAL-ISCHEMIA; PROSTATE-CANCER; BNIP3; INJURY; HYPOXIA; EXPRESSION; PROTEINS	MicroRNAs, a class of small and non-encoding RNAs that transcriptionally or post-transcriptionally modulate the expression of their target genes, has been implicated as critical regulatory molecules in many cardiovascular diseases, including ischemia/reperfusion induced cardiac injury. Here, we report microRNA-145, a tumor suppressor miRNA, can protect cardiomyocytes from hydrogen peroxide (H2O2)-induced apoptosis through targeting the mitochondrial pathway. Quantitative real-time PCR (qPCR) demonstrated that the expression of miR-145 in either ischemia/reperfused mice myocardial tissues or H2O2-treated neonatal rat ventricle myocytes (NRVMs) was markedly down-regulated. Over-expression of miR-145 significantly inhibited the H2O2-induced cellular apoptosis, ROS production, mitochondrial structure disruption as well as the activation of key signaling proteins in mitochondrial apoptotic pathway. These protective effects of miR-145 were abrogated by over-expression of Bnip3, an initiation factor of the mitochondrial apoptotic pathway in cardiomyocytes. Finally, we utilized both luciferase reporter assay and western blot analysis to identify Bnip3 as a direct target of miR-145. Our results suggest miR-145 plays an important role in regulating mitochondrial apoptotic pathway in heart challenged with oxidative stress. MiR-145 may represent a potential therapeutic target for treatment of oxidative stress-associated cardiovascular diseases, such as myocardial ischemia/reperfusion	[Sun, Jianxin] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Li, Ruotian; Yan, Guijun; Li, Qiaoling; Sun, Haixiang; Hu, Yali; Xu, Biao] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Jefferson University; Nanjing University	Sun, JX (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA.	jianxin.sun@jefferson.edu; xubiao@medmail.com.cn			National Natural Science Foundation of China [381170114, 81070508, 30900727, 81170570, 81070492]; National Institutes of Health [R01HL103869]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103869] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Natural Science Foundation of China (No. 381170114, No. 81070508, No. 30900727, No. 81170570, and No. 81070492) and the National Institutes of Health R01HL103869. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev I, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/293769; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Chen YR, 2007, J BIOL CHEM, V282, P32640, DOI 10.1074/jbc.M702294200; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Crow MT, 2002, CIRC RES, V91, P183, DOI 10.1161/01.RES.0000030195.38795.CF; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gang HY, 2011, CIRC RES, V108, P1084, DOI 10.1161/CIRCRESAHA.110.238709; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Javadov S, 2011, CELL PHYSIOL BIOCHEM, V27, P179, DOI 10.1159/000327943; Kubli DA, 2008, AM J PHYSIOL-HEART C, V295, pH2025, DOI 10.1152/ajpheart.00552.2008; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Oberst A, 2008, CELL DEATH DIFFER, V15, P1139, DOI 10.1038/cdd.2008.65; Ono K, 2011, FEBS J, V278, P1619, DOI 10.1111/j.1742-4658.2011.08090.x; Ostenfeld MS, 2010, ONCOGENE, V29, P1073, DOI 10.1038/onc.2009.395; Quinsay MN, 2010, J MOL CELL CARDIOL, V48, P1146, DOI 10.1016/j.yjmcc.2009.12.004; Regula KM, 2002, CIRC RES, V91, P226, DOI 10.1161/01.RES.0000029232.42227.16; Santos CXC, 2011, FREE RADICAL BIO MED, V50, P777, DOI 10.1016/j.freeradbiomed.2011.01.003; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Suh SO, 2011, CARCINOGENESIS, V32, P772, DOI 10.1093/carcin/bgr036; Sun JX, 2006, CIRC RES, V99, P468, DOI 10.1161/01.RES.0000239410.65551.b3; Wang JX, 2011, NAT MED, V17, P71, DOI 10.1038/nm.2282; Xu Q, 2012, NUCLEIC ACIDS RES, V40, P761, DOI 10.1093/nar/gkr730; Xu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014356; Xu ZL, 2001, AM J PHYSIOL-HEART C, V281, pH2585, DOI 10.1152/ajpheart.2001.281.6.H2585; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017998	32	20	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44907	10.1371/journal.pone.0044907	http://dx.doi.org/10.1371/journal.pone.0044907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028672	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900053
J	Schmidt, RL; Lenz, LL				Schmidt, Rebecca L.; Lenz, Laurel L.			Distinct Licensing of IL-18 and IL-1 beta Secretion in Response to NLRP3 Inflammasome Activation	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; MICE; INTERLEUKIN-18; INFECTION; GENE; SUSCEPTIBILITY; RECOGNITION; EXPRESSION; CASPASE-1; DEFENSE	Inflammasome activation permits processing of interleukins (IL)-1 beta and 18 and elicits cell death (pyroptosis). Whether these responses are independently licensed or are "hard-wired'' consequences of caspase-1 (casp1) activity has not been clear. Here, we show that that each of these responses is independently regulated following activation of NLRP3 inflammasomes by a "non-canonical'' stimulus, the secreted Listeria monocytogenes (Lm) p60 protein. Primed murine dendritic cells (DCs) responded to p60 stimulation with reactive oxygen species (ROS) production and secretion of IL-1 beta and IL-18 but not pyroptosis. Inhibitors of ROS production inhibited secretion of IL-1 beta, but did not impair IL-18 secretion. Furthermore, DCs from caspase-11 (casp11)-deficient 129S6 mice failed to secrete IL-1 beta in response to p60 but were fully responsive for IL-18 secretion. These findings reveal that there are distinct licensing requirements for processing of IL-18 versus IL-1 beta by NLRP3 inflammasomes.	[Schmidt, Rebecca L.; Lenz, Laurel L.] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Lenz, Laurel L.] Univ Colorado, Denver Sch Med, Dept Immunol, Denver, CO 80202 USA; [Lenz, Laurel L.] Univ Colorado, Denver Sch Med, Dept Microbiol, Denver, CO 80202 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Lenz, LL (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA.	LenzL@njhealth.org		Lenz, Laurel/0000-0002-4933-8913	NIH [AI065638, AI055701, T32-AI-074491]; Colorado Bioscience Discovery Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI065638, R01AI055701, R01AI065638, T32AI074491, R21AI055701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Bioscience Discovery Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI065638 and AI055701 and a Colorado Bioscience Discovery Grant to LLL. RLS was supported in part by NIH training grant T32-AI-074491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Andoh T, 2008, J IMMUNOL, V180, P2322, DOI 10.4049/jimmunol.180.4.2322; Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Biet F, 2002, J MOL MED-JMM, V80, P147, DOI 10.1007/s00109-001-0307-1; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Camejo A, 2011, VIRULENCE, V2, P379, DOI 10.4161/viru.2.5.17703; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Gust AA, 2012, TRENDS PLANT SCI, V17, P495, DOI 10.1016/j.tplants.2012.04.003; Hirsch E, 1996, P NATL ACAD SCI USA, V93, P11008, DOI 10.1073/pnas.93.20.11008; Hitzler I, 2012, J IMMUNOL; Humann J, 2007, J IMMUNOL, V178, P2407, DOI 10.4049/jimmunol.178.4.2407; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Jeudy S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022369; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Labow M, 1997, J IMMUNOL, V159, P2452; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; Leon E, 2010, NUCLEIC ACIDS RES, V38, P5226, DOI 10.1093/nar/gkq277; Lochner M, 2008, INFECT IMMUN, V76, P3881, DOI 10.1128/IAI.01651-07; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; MORTON CJ, 1994, CURR BIOL, V4, P615, DOI 10.1016/S0960-9822(00)00134-2; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Provoost S, 2011, J IMMUNOL, V187, P3331, DOI 10.4049/jimmunol.1004062; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Sahoo M, 2011, THESCIENTIFICWORLDJO, V11, P2037, DOI 10.1100/2011/212680; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Schmidt RL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002368; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sun HJ, 2005, J CELL BIOCHEM, V94, P566, DOI 10.1002/jcb.20194; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Warren SE, 2008, J IMMUNOL, V180, P7558, DOI 10.4049/jimmunol.180.11.7558; WUENSCHER MD, 1993, J BACTERIOL, V175, P3491, DOI 10.1128/jb.175.11.3491-3501.1993; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	53	62	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45186	10.1371/journal.pone.0045186	http://dx.doi.org/10.1371/journal.pone.0045186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028835	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900095
J	Landman, M; Schoeman, DS; Hall-Martin, AJ; Kerley, GIH				Landman, Marietjie; Schoeman, David S.; Hall-Martin, Anthony J.; Kerley, Graham I. H.			Understanding Long-Term Variations in an Elephant Piosphere Effect to Manage Impacts	PLOS ONE			English	Article							SEMIARID SUCCULENT THICKET; KRUGER-NATIONAL-PARK; WATERING POINTS; EASTERN CAPE; HERBACEOUS VEGETATION; LARGE HERBIVORES; SOUTH-AFRICA; HETEROGENEITY; LANDSCAPE; SAVANNA	Surface water availability is a key driver of elephant impacts on biological diversity. Thus, understanding the spatio-temporal variations of these impacts in relation to water is critical to their management. However, elephant piosphere effects (i.e. the radial pattern of attenuating impact) are poorly described, with few long-term quantitative studies. Our understanding is further confounded by the complexity of systems with elephant (i.e. fenced, multiple water points, seasonal water availability, varying population densities) that likely limit the use of conceptual models to predict these impacts. Using 31 years of data on shrub structure in the succulent thickets of the Addo Elephant National Park, South Africa, we tested elephant effects at a single water point. Shrub structure showed a clear sigmoid response with distance from water, declining at both the upper and lower limits of sampling. Adjacent to water, this decline caused a roughly 300-m radial expansion of the grass-dominated habitats that replace shrub communities. Despite the clear relationship between shrub structure and ecological functioning in thicket, the extent of elephant effects varied between these features with distance from water. Moreover, these patterns co-varied with other confounding variables (e. g. the location of neighboring water points), which limits our ability to predict such effects in the absence of long-term data. We predict that elephant have the ability to cause severe transformation in succulent thicket habitats with abundant water supply and elevated elephant numbers. However, these piosphere effects are complex, suggesting that a more integrated understanding of elephant impacts on ecological heterogeneity may be required before water availability is used as a tool to manage impacts. We caution against the establishment of water points in novel succulent thicket habitats, and advocate a significant reduction in water provisioning at our study site, albeit with greater impacts at each water point.	[Landman, Marietjie; Schoeman, David S.; Kerley, Graham I. H.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Schoeman, David S.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Dc, Qld, Australia; [Hall-Martin, Anthony J.] Hall Martin Consulting CC, Somerset W, South Africa	Nelson Mandela University; University of the Sunshine Coast	Landman, M (corresponding author), Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa.	Marietjie.landman@nmmu.ac.za		Schoeman, David/0000-0003-1258-0885	International Bank for Reconstruction and Development; Mazda Wildlife Fund	International Bank for Reconstruction and Development; Mazda Wildlife Fund	The International Bank for Reconstruction and Development provided financial support. Mazda Wildlife Fund provided field transportation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2005, LANDSCAPE ECOL, V20, P319, DOI 10.1007/s10980-005-0467-1; Barnes RFW, 2001, AFR J ECOL, V39, P1, DOI 10.1046/j.1365-2028.2001.00266.x; Barratt DG, 1991, P 1 VALL BUSHV SUBTR, P14; Brits J, 2002, AFR J ECOL, V40, P53, DOI 10.1046/j.0141-6707.2001.00344.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chamaille-Jammes S, 2007, J APPL ECOL, V44, P625, DOI 10.1111/j.1365-2664.2007.01300.x; Chamaille-Jammes S, 2009, ECOGRAPHY, V32, P871, DOI 10.1111/j.1600-0587.2009.05785.x; Clarke K.R., 2006, PRIMER V6 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Crawley M.J., 2007, R BOOK; Gaylard A., 2003, KRUGER EXPERIENCE EC, P171; Graetz R. D., 1978, Australian Rangeland Journal, V1, P126; Grant C. C., 2002, Koedoe, V45, P45; Hayward MW, 2010, ACTA THERIOL, V55, P289, DOI 10.4098/j.at.0001-7051.076.2009; Hayward MW, 2009, BIOL CONSERV, V142, P1, DOI 10.1016/j.biocon.2008.09.022; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; Kerley GIH, 1995, ENVIRON MONIT ASSESS, V37, P211, DOI 10.1007/BF00546890; Kerley GIH, 1999, 6 INT RANG C, V1, P116; Kerley GIH, 2006, S AFR J SCI, V102, P395; Kerley Graham I.H., 2008, P146; Landman M, 2008, J ZOOL, V274, P51, DOI 10.1111/j.1469-7998.2007.00356.x; Lechmere-Oertel RG, 2005, AUSTRAL ECOL, V30, P615, DOI 10.1111/j.1442-9993.2005.01495.x; Lechmere-Oertel RG, 2005, J ARID ENVIRON, V62, P459, DOI 10.1016/j.jaridenv.2004.11.016; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Ludwig JA, 1997, LANDSCAPE ECOLOGY FU; Mosugelo DK, 2002, AFR J ECOL, V40, P232, DOI 10.1046/j.1365-2028.2002.00361.x; Mucina Ladislav, 2006, V19, P2; O'Connor TG, 2007, BIOL CONSERV, V136, P329, DOI 10.1016/j.biocon.2006.12.014; Owen-Smith N, 2006, S AFR J SCI, V102, P389; OwenSmith N, 1996, S AFR J WILDL RES, V26, P107; Parker AH, 1999, J ARID ENVIRON, V41, P309, DOI 10.1006/jare.1998.0484; Pickett STA, 2007, ECOLOGICAL UNDERSTAN; Pickup G, 1998, J APPL ECOL, V35, P365, DOI 10.1046/j.1365-2664.1998.00319.x; Pienaar D, 1997, KRUGER PARK MANAGEME, V8; Pinheiro J, 2000, MIXED EFFECTS MODELS; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; R Core Team, 2021, R LANGUAGE ENV STAT; SANBI, 2012, PLANTS SO AFR ONL CH; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Smith J, 2012, THESIS U PORT ELIZAB; Stuart-Hill G. C., 1993, African Journal of Range and Forage Science, V10, P1, DOI 10.1080/10220119.1993.9638314; STUARTHILL GC, 1992, J APPL ECOL, V29, P699, DOI 10.2307/2404479; THRASH I, 1991, Koedoe, V34, P131; Thrash I, 1998, J ARID ENVIRON, V38, P315, DOI 10.1006/jare.1997.0331; Thrash I, 2000, J ARID ENVIRON, V44, P61, DOI 10.1006/jare.1999.0452; Thrash I., 1999, Koedoe, V42, P73; van Aarde RJ, 2006, S AFR J SCI, V102, P385; WALKER BH, 1987, J APPL ECOL, V24, P381, DOI 10.2307/2403882; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492; Young TP, 2005, BIOL CONSERV, V122, P351, DOI 10.1016/j.biocon.2004.08.007	51	29	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45334	10.1371/journal.pone.0045334	http://dx.doi.org/10.1371/journal.pone.0045334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028942	gold, Green Published, Green Submitted			2022-12-27	WOS:000309742800053
J	Zhang, YM; Tian, CF; Sui, XH; Chen, WF; Chen, WX				Zhang, Yan Ming; Tian, Chang Fu; Sui, Xin Hua; Chen, Wen Feng; Chen, Wen Xin			Robust Markers Reflecting Phylogeny and Taxonomy of Rhizobia	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; DNA-DNA HYBRIDIZATION; GENOME SEQUENCE; EVOLUTIONARY GENETICS; RECOMBINATION; BIOGEOGRAPHY; DIVERSITY; VERSATILE; ENSIFER	Genomic ANI (Average Nucleotide Identity) has been found to be able to replace DNA-DNA hybridization in prokaryote taxonomy. The ANI of each of the core genes that has a phylogeny congruent with the reference species tree of rhizobia was compared to the genomic ANI. This allowed us to identify three housekeeping genes (SMc00019-truA-thrA) whose ANI reflected the intraspecies and interspecies genomic ANI among rhizobial strains, revealing an ANI gap (>= 2%) between the inter-and intra-species comparisons. The intraspecies (96%) and interspecies (94%) ANI boundaries calculated from three genes (SMc00019-truA-thrA) provided a criterion for bacterial species definition and confirmed 621/629 of known interspecies relationships within Bradyrhizobium, Mesorhizobium, Sinorhizobium and Rhizobium. Some widely studied strains should be renamed. The SMc00019-truA-thrA ANI also correlates well with the genomic ANI of strains in Agrobacterium, Methylobacterium, Ralstonia, Rhodopseudomonas, Cupriavidus and Burkholderia, suggesting their wide applicability in other bacteria.	[Zhang, Yan Ming; Tian, Chang Fu; Sui, Xin Hua; Chen, Wen Feng; Chen, Wen Xin] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhang, Yan Ming; Tian, Chang Fu; Sui, Xin Hua; Chen, Wen Feng; Chen, Wen Xin] China Agr Univ, Key Lab Soil Microbiol, Minist Agr, Beijing 100094, Peoples R China; [Zhang, Yan Ming; Tian, Chang Fu; Sui, Xin Hua; Chen, Wen Feng; Chen, Wen Xin] China Agr Univ, Rhizobium Res Ctr, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Tian, CF (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	changfutian@gmail.com	Tian, Chang Fu/O-4482-2019; Tian, Chang Fu/C-2507-2012	Tian, Chang Fu/0000-0002-0479-363X; Tian, Chang Fu/0000-0002-0479-363X	National Basic Research Program of China (973 Program) [2010CB126500]; National Natural Science Foundation of China [31170002]; State Key Laboratory of Agrobiotechnology (SKLAB) [2012SKLAB01-9]; Chinese Universities Scientific Fund [2012QJ145]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Agrobiotechnology (SKLAB); Chinese Universities Scientific Fund	This study was funded by National Basic Research Program of China (973 Program, 2010CB126500), National Natural Science Foundation of China (31170002), Innovative Project of State Key Laboratory of Agrobiotechnology (SKLAB) Grant (2012SKLAB01-9), and Chinese Universities Scientific Fund (2012QJ145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Aserse AA, 2012, SYST APPL MICROBIOL, V35, P120, DOI 10.1016/j.syapm.2011.11.005; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020223; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Gaunt MW, 2001, INT J SYST EVOL MICR, V51, P2037, DOI 10.1099/00207713-51-6-2037; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Konstantinidis KT, 2006, APPL ENVIRON MICROB, V72, P7286, DOI 10.1128/AEM.01398-06; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lykidis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009729; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; Martens M, 2007, INT J SYST EVOL MICR, V57, P489, DOI 10.1099/ijs.0.64344-0; Nzoue A, 2009, SYST APPL MICROBIOL, V32, P400, DOI 10.1016/j.syapm.2009.06.002; Poehlein A, 2011, J BACTERIOL, V193, P5017, DOI 10.1128/JB.05660-11; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Retief J D, 2000, Methods Mol Biol, V132, P243; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rivas R, 2009, SYST APPL MICROBIOL, V32, P101, DOI 10.1016/j.syapm.2008.12.005; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Silva C, 2005, MOL ECOL, V14, P4033, DOI 10.1111/j.1365-294X.2005.02721.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian CF, 2012, P NATL ACAD SCI USA, V109, P8629, DOI 10.1073/pnas.1120436109; Tian CF, 2010, FEMS MICROBIOL ECOL, V73, P563, DOI 10.1111/j.1574-6941.2010.00909.x; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Vinuesa P, 2005, MOL PHYLOGENET EVOL, V34, P29, DOI 10.1016/j.ympev.2004.08.020; Vinuesa P, 2008, APPL ENVIRON MICROB, V74, P6987, DOI 10.1128/AEM.00875-08; Zhang YM, 2011, APPL ENVIRON MICROB, V77, P6331, DOI 10.1128/AEM.00542-11	34	50	57	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44936	10.1371/journal.pone.0044936	http://dx.doi.org/10.1371/journal.pone.0044936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028691	gold, Green Submitted, Green Published			2022-12-27	WOS:000309742800026
J	Cai, YJ; Wang, WS; Liang, HY; Sun, LH; Teitelbaum, DH; Yang, H				Cai, Yujiao; Wang, Wensheng; Liang, Hongying; Sun, Lihua; Teitelbaum, Daniel H.; Yang, Hua			Keratinocyte Growth Factor Improves Epithelial Structure and Function in a Mouse Model of Intestinal Ischemia/Reperfusion	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INFLAMMATORY-BOWEL-DISEASE; TIGHT JUNCTION PROTEINS; DELTA T-CELLS; BARRIER FUNCTION; MICE; MECHANISMS; APOPTOSIS; REPAIR; RATS	Background: Intestinal ischemia/reperfusion (I/R) induces the desquamation of the intestinal epithelium, increases the intestinal permeability, and in patients often causes fatal conditions including sepsis and multiple organ failure. Keratinocyte growth factor (KGF) increases intestinal growth, although little is known about KGF activity on intestinal function after intestinal I/R. We hypothesized that KGF administration would improve the intestinal function in a mouse model of intestinal I/R. Methods: Adult C57BL/6J mice were randomized to three groups: Sham, I/R group and I/R+KGF group. Mice were killed on day 5, and the small bowel was harvested for histology, wet weight, RNA and protein content analysis. Epithelial cell (EC) proliferation was detected by immunohistochemistry for PCNA, and apoptosis was determined by TUNEL staining. The expressions of Claudin-1 and ZO-1 were detected by immunohistochemistry. Epithelial barrier function was assessed with transepithelial resistance (TER). Results: KGF significantly increased the intestinal wet weight, contents of intestinal protein and RNA, villus height, crypt depth and crypt cell proliferation, while KGF resulted in the decrease of epithelial apoptosis. KGF also stimulated the recovery of mucosal structures and attenuated the disrupted distribution of TJ proteins. Moreover, KGF attenuated the intestinal I/R-induced decrease in TER and maintained the intestinal barrier function. Conclusion: KGF administration improves the epithelial structure and barrier function in a mouse model of intestinal I/R. This suggests that KGF may have clinical applicability.	[Cai, Yujiao; Wang, Wensheng; Liang, Hongying; Sun, Lihua; Yang, Hua] Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China; [Teitelbaum, Daniel H.; Yang, Hua] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI USA	Army Medical University; University of Michigan System; University of Michigan	Cai, YJ (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Gen Surg, Chongqing, Peoples R China.	hyang@umich.edu			National Natural Science Foundation of China [30973113, 81020108023, 81000830]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 30973113; No. 81020108023; No. 81000830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-316; Aranow JS, 1996, BRIT J ANAESTH, V77, P71, DOI 10.1093/bja/77.1.71; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Byrne FR, 2002, AM J PHYSIOL-GASTR L, V282, pG690, DOI 10.1152/ajpgi.00314.2001; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Drucker DJ, 1997, AM J PHYSIOL-GASTR L, V273, pG3, DOI 10.1152/ajpgi.1997.273.1.G3; Egger B, 1999, DIGEST DIS SCI, V44, P836, DOI 10.1023/A:1026642715764; Farrell CL, 1998, CANCER RES, V58, P933; Finch PW, 1996, GASTROENTEROLOGY, V110, P441, DOI 10.1053/gast.1996.v110.pm8566591; Finch PW, 2004, ADV CANCER RES, V91, P69, DOI 10.1016/S0065-230X(04)91003-2; Daniel RAF, 2011, ACTA CIR BRAS, V26, P463, DOI 10.1590/S0102-86502011000600010; GRANGER DN, 1995, ANNU REV PHYSIOL, V57, P311, DOI 10.1146/annurev.ph.57.030195.001523; Higuchi S, 2008, INT J CLIN EXP PATHO, V1, P409; HOUSLEY RM, 1994, J CLIN INVEST, V94, P1764, DOI 10.1172/JCI117524; Hung WT, 2004, J PEDIATR SURG, V39, P1077, DOI 10.1016/j.jpedsurg.2004.03.047; Johnson WF, 2000, VET SURG, V29, P17, DOI 10.1111/j.1532-950X.2000.00017.x; Kocogullari CU, 2008, SURG TODAY, V38, P237, DOI 10.1007/s00595-007-3614-5; Li QR, 2009, J CELL MOL MED, V13, P4061, DOI 10.1111/j.1582-4934.2009.00975.x; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Matthijsen RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007045; Moeser AJ, 2008, AM J PHYSIOL-GASTR L, V295, pG791, DOI 10.1152/ajpgi.00538.2007; Montalto M, 2004, DIGESTION, V69, P225, DOI 10.1159/000079152; Munro H.N., 1969, MAMMALIAN PROTEIN ME, P465; Parassol N, 2005, RES MICROBIOL, V156, P256, DOI 10.1016/j.resmic.2004.09.013; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Revest JM, 2001, J IMMUNOL, V167, P1954, DOI 10.4049/jimmunol.167.4.1954; Samak G, 2010, AM J PHYSIOL-GASTR L, V299, pG572, DOI 10.1152/ajpgi.00265.2010; Smith P L, 1996, Pharm Biotechnol, V8, P13; Strauman MC, 2010, INFECT IMMUN, V78, P4958, DOI 10.1128/IAI.00580-10; Ulrich K, 2005, AM J PHYSIOL-LUNG C, V288, pL1179, DOI 10.1152/ajplung.00450.2004; Yang H, 2002, JPEN-PARENTER ENTER, V26, P333, DOI 10.1177/0148607102026006333; Yang H, 2003, JPEN-PARENTER ENTER, V27, P198, DOI 10.1177/0148607103027003198; Yucel AF, 2011, J MOL HISTOL, V42, P579, DOI 10.1007/s10735-011-9364-0; Zeeh JM, 1996, GASTROENTEROLOGY, V110, P1077, DOI 10.1053/gast.1996.v110.pm8612996; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	39	24	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44772	10.1371/journal.pone.0044772	http://dx.doi.org/10.1371/journal.pone.0044772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028616	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700038
J	Hennus, PML; van der Heijden, GJMG; Bosch, JLHR; de Jong, TPVM; de Kort, LMO				Hennus, Pauline M. L.; van der Heijden, Geert J. M. G.; Bosch, J. L. H. Ruud; de Jong, Tom P. V. M.; de Kort, Laetitia M. O.			A Systematic Review on Renal and Bladder Dysfunction after Endoscopic Treatment of Infravesical Obstruction in Boys	PLOS ONE			English	Review							POSTERIOR URETHRAL VALVES; DETRUSOR HYPOCONTRACTILITY; TRANSURETHRAL INCISION; VESICOURETERAL REFLUX; URODYNAMIC FINDINGS; CHILDREN; ABLATION; INFANTS; COMPLICATIONS; DIVERSION	Background: Posterior urethral valves (PUV) may cause subtle to severe obstruction of the urethra, resulting in a broad clinical spectrum. PUV are the most common cause of chronic renal disease in boys. Our purpose was to report the incidences of kidney and bladder dysfunction in boys treated with endoscopic valve resection for PUV. Methodology: We searched MEDLINE and EMBASE databases until 1st of July 2011, to identify original papers that described outcome of endoscopic valve resection (EVR) in boys. We extracted information on (1) patient characteristics and clinical presentation of PUV related to outcomes and (2) the post-treatment absolute risks for kidney and bladder dysfunction. Principal findings: Thirty-four studies describing renal function, vesicoureteral reflux (VUR), incontinence, and urodynamic bladder function after EVR in 1474 patients were retrieved. Patients treated for PUV show high percentages of chronic kidney disease (CKD) or end stage renal disease (ESRD), 22% (0-32%) and 11% (0-20%), respectively. Elevated nadir serum creatinine was the only independent factor associated with renal failure. Before treatment, VUR was present in 43% of boys and after EVR, VUR was present in 22%. Post treatment, 19% (0-70%) was reported to suffer from urinary incontinence. Urodynamic bladder dysfunction was seen in many patients (55%, 0-72%) after treatment of PUV. Conclusions: The reported cumulative incidence of renal and bladder dysfunction in patients with PUV after endoscopic PUV treatment varies widely. This may reflect a broad clinical spectrum, which relates to the lack of a standardised quantification of obstruction and its severity. Moreover, the risk of bias is rather high, and therefore we put little confidence in the reported estimates of effect. We found elevated nadir serum creatinine as a predictor for renal dysfunction. In order to be able to predict outcomes for patients with PUV, an objective classification of severity of obstruction is mandatory.	[Hennus, Pauline M. L.; Bosch, J. L. H. Ruud; de Jong, Tom P. V. M.; de Kort, Laetitia M. O.] Univ Med Ctr Utrecht, Dept Urol, Utrecht, Netherlands; [van der Heijden, Geert J. M. G.] Univ Med Ctr Utrecht, Dept Epidemiol, Div Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van der Heijden, Geert J. M. G.] Univ Med Ctr Utrecht, Dept Otorhinolaryngol, Div Surg Specialties, Utrecht, Netherlands; [de Jong, Tom P. V. M.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [de Jong, Tom P. V. M.] Wilhelmina Childrens Hosp, Pediat Renal Ctr, Amsterdam, Netherlands; [de Jong, Tom P. V. M.] Elisabeth Childrens Hosp, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Wilhelmina Kinderziekenhuis	Hennus, PML (corresponding author), Univ Med Ctr Utrecht, Dept Urol, Utrecht, Netherlands.	P.M.L.Hennus@umcutrecht.nl	de Jong, Tom/AAG-5659-2020; van der Heijden, Geert/M-3733-2013	van der Heijden, Geert/0000-0003-4979-2099; de Jong, Tom P.V.M./0000-0002-9091-1099				Androulakakis PA, 2005, BJU INT, V96, P140, DOI 10.1111/j.1464-410X.2005.05583.x; Ansari MS, 2011, J UROLOGY, V185, P2329, DOI 10.1016/j.juro.2011.02.041; Ansari MS, 2010, J PEDIATR UROL, V6, P261, DOI 10.1016/j.jpurol.2009.09.001; Close CE, 1997, J UROLOGY, V157, P984, DOI 10.1016/S0022-5347(01)65125-5; De Gennaro M, 2001, J UROLOGY, V165, P2248, DOI 10.1016/S0022-5347(05)66176-9; De Gennaro M, 1998, BRIT J UROL, V81, P81, DOI 10.1046/j.1464-410x.1998.00014.x; De Gennaro M, 2000, BJU INT, V85, P1104, DOI 10.1046/j.1464-410x.2000.00700.x; DeGennaro M, 1996, EUR J PEDIATR SURG, V6, P163, DOI 10.1055/s-2008-1066497; Deshpande AV, 2011, J UROLOGY, V185, P2497, DOI 10.1016/j.juro.2011.01.020; Emir H, 2002, EUR J PEDIATR SURG, V12, P38, DOI 10.1055/s-2002-25093; Godbole P, 2007, J Pediatr Urol, V3, P273, DOI 10.1016/j.jpurol.2006.11.007; HENDREN WH, 1971, J UROLOGY, V106, P298, DOI 10.1016/S0022-5347(17)61278-3; Imaji R, 2002, PEDIATR SURG INT, V18, P444, DOI 10.1007/s00383-002-0809-0; JOHNSTON JH, 1979, BRIT J UROL, V51, P100, DOI 10.1111/j.1464-410X.1979.tb02840.x; Kajbafzadeh Abdol-Mohammad, 2007, J Pediatr Urol, V3, P295, DOI 10.1016/j.jpurol.2006.11.002; Kajbafzadeh AM, 2007, J UROLOGY, V178, P2142, DOI 10.1016/j.juro.2007.07.046; Kajbafzadeh Abdol-Mohammad, 2007, Pediatr Surg Int, V23, P873, DOI 10.1007/s00383-007-1966-y; Kibar Y, 2011, J PEDIATR UROL, V7, P538, DOI 10.1016/j.jpurol.2010.08.002; Kim YH, 1996, J UROLOGY, V156, P673, DOI 10.1016/S0022-5347(01)65781-1; Krishna A, 1998, PEDIATR SURG INT, V13, P504, DOI 10.1007/s003830050384; KURTH KH, 1981, J UROLOGY, V126, P517, DOI 10.1016/S0022-5347(17)54602-9; Lal R, 1998, J PEDIATR SURG, V33, P518, DOI 10.1016/S0022-3468(98)90102-6; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MININBERG DT, 1989, UROLOGY, V33, P205, DOI 10.1016/0090-4295(89)90392-0; Nakamura S, 2011, BJU INT, V107, P1304, DOI 10.1111/j.1464-410X.2010.09578.x; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3; NIJMAN RJM, 1991, BRIT J UROL, V67, P324, DOI 10.1111/j.1464-410X.1991.tb15145.x; Nonomura K, 1999, EUR UROL, V36, P144, DOI 10.1159/000067986; Pereira PL, 2003, BJU INT, V91, P687, DOI 10.1046/j.1464-410X.2003.04178.x; PIERETTI RV, 1993, J PEDIATR SURG, V28, P701, DOI 10.1016/0022-3468(93)90036-K; Podesta M, 2002, J UROLOGY, V168, P1830, DOI 10.1016/S0022-5347(05)64424-2; Priti K, 2004, PEDIATR SURG INT, V20, P136, DOI 10.1007/s00383-003-1107-1; Puri A, 2002, PEDIATR SURG INT, V18, P438, DOI 10.1007/s00383-002-0713-7; Sarhan O, 2008, J UROLOGY, V179, P307, DOI 10.1016/j.juro.2007.08.160; Sarhan O, 2010, J PEDIATR UROL, V6, P11, DOI 10.1016/j.jpurol.2009.05.016; Sarhan OM, 2011, J UROLOGY, V185, P2491, DOI 10.1016/j.juro.2011.01.023; Schober JM, 2004, BJU INT, V94, P616, DOI 10.1111/j.1464-410X.2004.05011.x; SCHWARTZ GJ, 1987, PEDIATR CLIN N AM, V34, P571; Smith GHH, 1996, J UROLOGY, V155, P1730, DOI 10.1016/S0022-5347(01)66186-X; TAMMINENMOBIUS T, 1992, J UROLOGY, V148, P1662, DOI 10.1016/S0022-5347(17)36997-5; Taskinen S, 2009, J UROLOGY, V182, P699, DOI 10.1016/j.juro.2009.04.035; Uthup S, 2010, Indian J Nephrol, V20, P72, DOI 10.4103/0971-4065.65298; Young HH, 2002, J UROLOGY, V167, P265, DOI 10.1016/S0022-5347(05)65444-4	44	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44663	10.1371/journal.pone.0044663	http://dx.doi.org/10.1371/journal.pone.0044663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028576	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700028
J	Watkins, AJ; Hamoudi, RA; Zeng, NY; Yan, QG; Huang, YX; Liu, HX; Zhang, JZ; Braggio, E; Fonseca, R; de Leval, L; Isaacson, PG; Wotherspoon, A; McPhail, ED; Dogan, A; Du, MQ				Watkins, A. James; Hamoudi, Rifat A.; Zeng, Naiyan; Yan, Qingguo; Huang, Yuanxue; Liu, Hongxiang; Zhang, Jianzhong; Braggio, Esteban; Fonseca, Rafael; de Leval, Laurence; Isaacson, Peter G.; Wotherspoon, Andrew; McPhail, Ellen D.; Dogan, Ahmet; Du, Ming-Qing			An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DIAGNOSIS; GENES; LYMPHOCYTES; METHYLATION; VARIANTS; CANCER; TISSUE; RISK	Splenic marginal zone lymphoma (SMZL) is an indolent B-cell lymphoproliferative disorder characterised by 7q32 deletion, but the target genes of this deletion remain unknown. In order to elucidate the genetic target of this deletion, we performed an integrative analysis of the genetic, epigenetic, transcriptomic and miRNomic data. High resolution array comparative genomic hybridization of 56 cases of SMZL delineated a minimally deleted region (2.8 Mb) at 7q32, but showed no evidence of any cryptic homozygous deletion or recurrent breakpoint in this region. Integrated transcriptomic analysis confirmed significant under-expression of a number of genes in this region in cases of SMZL with deletion, several of which showed hypermethylation. In addition, a cluster of 8 miRNA in this region showed under-expression in cases with the deletion, and three (miR-182/96/183) were also significantly under-expressed (P<0.05) in SMZL relative to other lymphomas. Genomic sequencing of these miRNA and IRF5, a strong candidate gene, did not show any evidence of somatic mutation in SMZL. These observations provide valuable guidance for further characterisation of 7q deletion.	[Watkins, A. James; Hamoudi, Rifat A.; Zeng, Naiyan; Yan, Qingguo; Huang, Yuanxue; Du, Ming-Qing] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Cambridge CB2 1QP, England; [Yan, Qingguo] Xijing Hosp, Dept Pathol, State Key Lab Canc Biol, Xian, Peoples R China; [Liu, Hongxiang; Du, Ming-Qing] Addenbrookes Hosp, Dept Histopathol, Cambridge CB2 2QQ, England; [Zhang, Jianzhong] 306 Hosp, Dept Pathol, Beijing, Peoples R China; [Braggio, Esteban] Mayo Clin Arizona, Ctr Comprehens Canc, Scottsdale, AZ USA; [Fonseca, Rafael] Mayo Clin Arizona, Div Hematol, Canc Ctr Oncol, Scottsdale, AZ USA; [de Leval, Laurence] Inst Univ Pathol, Lausanne, Switzerland; [Isaacson, Peter G.] Univ Coll London Hosp, Dept Histopathol, London, England; [Wotherspoon, Andrew] Royal Marsden Hosp, Dept Histopathol, London SW3 6JJ, England; [McPhail, Ellen D.; Dogan, Ahmet] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	University of Cambridge; Air Force Military Medical University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; University College London Hospitals NHS Foundation Trust; University of London; University College London; Royal Marsden NHS Foundation Trust; Mayo Clinic	Du, MQ (corresponding author), Univ Cambridge, Dept Pathol, Div Mol Histopathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mqd20@cam.ac.uk	McPhail, Ellen D. Remstein/AAF-3474-2020; de Leval, Laurence/M-4889-2017	McPhail, Ellen D. Remstein/0000-0001-6918-3376; de Leval, Laurence/0000-0003-3994-516X; Fonseca, Rafael/0000-0002-5938-3769; Watkins, James/0000-0002-2253-6653; Hamoudi, Rifat/0000-0002-1402-0868; Du, Ming-Qing/0000-0002-1017-5045	Clinical Research Training Fellowship as part of the Molecular Pathology of Cancer Programme; Cancer Research UK; Addenbrookes Charitable Trust; Leukaemia & Lymphoma Research, UK; Kay Kendall Leukaemia Fund UK; National Institute for Health Research Cambridge Biomedical Research Centre; Lymphoma SPORE Biospecimens Core [P50 CA097274]; National Natural Science Foundation of China [30770903]	Clinical Research Training Fellowship as part of the Molecular Pathology of Cancer Programme; Cancer Research UK(Cancer Research UK); Addenbrookes Charitable Trust; Leukaemia & Lymphoma Research, UK; Kay Kendall Leukaemia Fund UK; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Lymphoma SPORE Biospecimens Core; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	AJW was supported by a Clinical Research Training Fellowship as part of the Molecular Pathology of Cancer Programme, funded by Cancer Research UK and a research grant from the Addenbrookes Charitable Trust. The work in MQD's laboratory is supported by research grants from the Leukaemia & Lymphoma Research, UK, the Kay Kendall Leukaemia Fund UK and the National Institute for Health Research Cambridge Biomedical Research Centre. The work in AD's lab is supported by Lymphoma SPORE (P50 CA097274) Biospecimens Core. QY was supported by a research grant from the National Natural Science Foundation of China (No. 30770903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, NAT REV GENET, V5, P229; Bai AH, 2011, ACTA NEUROPATHOLOGIC; Basso K, 2009, IMMUNITY, V30, P744, DOI 10.1016/j.immuni.2009.03.017; Bouteloup M, 2012, BRIT J HAEMATOL, V156, P279, DOI 10.1111/j.1365-2141.2011.08848.x; Braggio E, 2012, MODERN PATHOL, V25, P651, DOI 10.1038/modpathol.2011.213; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Gruszka-Westwood AM, 2003, GENE CHROMOSOME CANC, V36, P57, DOI 10.1002/gcc.10142; Hamoudi RA, 2010, LEUKEMIA, V24, P1487, DOI 10.1038/leu.2010.118; Imura M, 2006, CANCER LETT, V241, P213, DOI 10.1016/j.canlet.2005.10.010; Isaacson PG, 2008, WHO CLASSIFICATION T, P185; Kim JH, 2009, ONCOL REP, V21, P1251, DOI 10.3892/or_00000348; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mateo M, 1999, AM J PATHOL, V154, P1583, DOI 10.1016/S0002-9440(10)65411-9; Mihelich BL, 2011, J BIOL CHEM; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; PAN LX, 1994, HISTOPATHOLOGY, V24, P323, DOI 10.1111/j.1365-2559.1994.tb00532.x; Pepper SD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-273; Peveling-Oberhag J, 2012, LEUKEMIA; Ruiz-Ballesteros E, 2007, LEUKEMIA, V21, P2547, DOI 10.1038/sj.leu.2404853; Ruiz-Ballesteros E, 2005, BLOOD, V106, P1831, DOI 10.1182/blood-2004-10-3898; Sabbah C, 2011, BIOINFORMATICS, V27, P1693, DOI 10.1093/bioinformatics/btr187; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; Sun YH, 2010, BIOCHEM BIOPH RES CO, V396, P501, DOI 10.1016/j.bbrc.2010.04.127; Thieblemont C, 2004, BLOOD, V103, P2727, DOI 10.1182/blood-2003-06-2160; Troen G, 2004, J MOL DIAGN, V6, P297, DOI 10.1016/S1525-1578(10)60525-9; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Varol N, 2011, MOL BIOL REP, V38, P1079, DOI 10.1007/s11033-010-0205-0; Watkins AJ, 2010, J PATHOL, V220, P461, DOI 10.1002/path.2665; Wieczorek S, 2010, J MOL MED, V88, P413, DOI 10.1007/s00109-009-0580-y; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509; Zhang LF, 2011, INT J MOL MED, V28, P381, DOI 10.3892/ijmm.2011.679	33	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44997	10.1371/journal.pone.0044997	http://dx.doi.org/10.1371/journal.pone.0044997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028731	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700074
J	Gao, CL; Morschhauser, EM; Varricchio, DJ; Liu, JY; Zhao, B				Gao, Chunling; Morschhauser, Eric M.; Varricchio, David J.; Liu, Jinyuan; Zhao, Bo			A Second Soundly Sleeping Dragon: New Anatomical Details of the Chinese Troodontid Mei long with Implications for Phylogeny and Taphonomy	PLOS ONE			English	Article							STENONYCHOSAURUS-INEQUALIS SAURISCHIA; RIVER OLDMAN FORMATION; OPISTHOTONIC-POSTURE; JURAVENATOR-STARKI; LIAONING PROVINCE; YIXIAN FORMATION; GROWTH-PATTERNS; EARLY EVOLUTION; THEROPOD; DINOSAUR	A second nearly complete, articulated specimen of the basal troodontid Mei long (DNHM D2154) is reported from the Early Cretaceous (Hauterivian-Valanginian) lower Yixian Formation, Liaoning Province, China. New diagnostic features of Mei long are identified, including: a uniquely shaped maxilla, low with small, low maxillary fenestra; sacrum with an extremely wide caudal portion and elongate 4th and 5th sacral processes; and a large distal articular surface on the tibiotarsus which continues caudally on the tibia. A phylogenetic analysis including new data from the second specimen recovered Mei as a basal troodontid, in keeping with previous analyses. Although the skeleton exhibits several juvenile-like features including free cervical ribs, unfused frontals and nasals, and a short snouted skull, other attributes, full fusion of all neurocentral synostoses and the sacrum, and dense exteriors to cortical bone, suggest a small, mature individual. Microscopic examination of tibia and fibula histology confirms maturity and suggests an individual greater than two years old with slowed growth. Despite being one of the smallest dinosaurs, Mei long exhibits multi-year growth and cortical bone consisting largely of fibro-lamellar tissue marked by lines of arrested growth as in much larger and more basal theropods. This Mei long specimen lies in a similar but mirrored sleeping position to that of the holotype, strengthening the hypothesis that both specimens were preserved in a stereotypical life position. Like many Liaoning specimens, the new specimen also lacks extensive taphonomic and stratigraphic data, making further behavioral inference problematic.	[Morschhauser, Eric M.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Gao, Chunling; Liu, Jinyuan; Zhao, Bo] Dalian Nat Hist Museum, Dalian, Liaoning, Peoples R China; [Varricchio, David J.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	University of Pennsylvania; Montana State University System; Montana State University Bozeman	Morschhauser, EM (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	mors@sas.upenn.edu	Morschhauser, Eric/I-2243-2015		Montana State University Department of Earth Sciences	Montana State University Department of Earth Sciences	Funding was provided by the Montana State University Department of Earth Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Averianov AO, 2007, J VERTEBR PALEONTOL, V27, P87, DOI 10.1671/0272-4634(2007)27[87:ANTDTF]2.0.CO;2; Balanoff AM, 2007, J VERTEBR PALEONTOL, V27, P1, DOI 10.1671/0272-4634(2007)27[1:ODOAES]2.0.CO;2; Barsbold R., 1990, P249; BARSBOLD R, 1987, Acta Palaeontologica Polonica, V32, P121; Barsbold R, 1974, PALEONTOLOGIA POLONI, V30, P6; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Calvo Jorge O., 2004, Arquivos do Museu Nacional Rio de Janeiro, V62, P549; Carpenter K, 2005, LIFE O PAST, P23; Chang MM, 2008, JEHOL FOSSILS: THE EMERGENCE OF FEATHERED DINOSAURS, BEAKED BIRDS AND FLOWERING PLANTS, P11; Chiappe LM, 2010, NEUES JAHRB GEOL P-A, V258, P257, DOI 10.1127/0077-7749/2010/0125; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Clark JM, 2004, DINOSAURIA, 2ND EDITION, P151; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; CURRIE PJ, 1988, CAN J EARTH SCI, V25, P972, DOI 10.1139/e88-097; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2224, DOI 10.1139/e93-193; Currie PJ, 2001, CAN J EARTH SCI, V38, P1753, DOI 10.1139/e01-065; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Czerkas Stephen A., 2002, Dinosaur Museum Journal, V1, P63; ELZANOWSKI A, 1992, NATURE, V359, P821, DOI 10.1038/359821a0; Elzanowski Andrzej, 2002, P129; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Faux CM, 2007, PALEOBIOLOGY, V33, P201, DOI 10.1666/06015.1; Francillon-Vieillot H., 1990, P471; GALTON P M, 1971, Arnoldia (Rhodesia), V5, P1; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gilmore CW., 1920, B US NATL MUSEUM, V110, P1, DOI [10.5479/si.03629236.110.i, DOI 10.5479/SI.03629236.110.I]; Gilmore CW, 1924, B DEP GEOL U ALBERTA, V1, P1; Goloboff P.A., 2003, TREE ANAL USING NEW; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Guo ZF, 2003, SCI CHINA SER D, V46, P1261, DOI 10.1360/03yd0071; Homer J. R., 1994, DINOSAUR EGGS BABIES, P312; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Hwang SH, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)381<0001:NSOMZT>2.0.CO;2; Jerzykiewicz T., 1996, Geological Society of India Memoirs, V37, P63; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Qiang, 2006, Journal of the Paleontological Society of Korea, V22, P111; Kobayashi Y, 2005, LIFE O PAST, P97; KURZANOV S M, 1991, Acta Palaeontologica Polonica, V36, P69; Lamm E. T., 2001, Journal of Vertebrate Paleontology, V21, p71A; Lamm Ellen-Therese, 1999, Journal of Vertebrate Paleontology, V19, p58A; Madsen JH., 1976, UTAH GEOLOGICAL MINI, V109, P1; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 2003, AM MUS NOVIT, P1; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mastrolorenzo G, 2001, NATURE, V410, P769, DOI 10.1038/35071167; Mastrolorenzo G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011127; Mayr G, 2005, SCIENCE, V310, P1483, DOI 10.1126/science.1120331; Meng QJ, 2004, NATURE, V431, P145, DOI 10.1038/431145a; Moodie RL, 1918, AM NAT, V52, P384, DOI 10.1086/279678; Nesbitt SJ, 2009, J MORPHOL, V270, P856, DOI 10.1002/jmor.10724; NICHOLLS EL, 1981, CAN J EARTH SCI, V18, P518, DOI 10.1139/e81-045; Norell MA, 2004, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2004)446<0001:ATDFUT>2.0.CO;2; Norell MA, 2000, J VERTEBR PALEONTOL, V20, P7, DOI 10.1671/0272-4634(2000)020[0007:ANTTFU]2.0.CO;2; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Norell MA, 2009, AM MUS NOVIT, P1; Novas FE, 2005, NATURE, V433, P858, DOI 10.1038/nature03285; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; OSMOLSKA H, 1987, Acta Palaeontologica Polonica, V32, P133; Ostrom J. H., 1969, Bulletin of the Peabody Museum of Natural History, VNo. 30, P1; OSTROM JH, 1976, BIOL J LINN SOC, V8, P91, DOI 10.1111/j.1095-8312.1976.tb00244.x; OSTROM JH, 1973, NATURE, V242, P136, DOI 10.1038/242136a0; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Pei R, 2011, SOC VERT PAL 71 ANN, P172; Qi Z, 2007, PALAEONTOLOGY, V50, P1023, DOI 10.1111/j.1475-4983.2007.00709.x; Reisdorf Achim G., 2012, Palaeobiodiversity Palaeoenvironments, V92, P119, DOI 10.1007/s12549-011-0068-y; Rougier GW, 2003, ACTA GEOL SIN-ENGL, V77, P7; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; RUSSELL DA, 1969, CAN J EARTH SCI, V6, P595, DOI 10.1139/e69-059; Sanz JL, 1997, SCIENCE, V276, P1543, DOI 10.1126/science.276.5318.1543; Sereno PC, 2007, ACTA PALAEONTOL POL, V52, P275; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Smith JB, 2001, J VERTEBR PALEONTOL, V21, P389, DOI 10.1671/0272-4634(2001)021[0389:ATPCTD]2.0.CO;2; Tumarkin-Deratzian AR, 2006, ZOOL J LINN SOC-LOND, V148, P133, DOI 10.1111/j.1096-3642.2006.00232.x; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2011, AM MUS NOVIT, P1, DOI 10.1206/3722.2; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; Varricchio DJ, 2002, J VERTEBR PALEONTOL, V22, P564, DOI 10.1671/0272-4634(2002)022[0564:EAEFTC]2.0.CO;2; Wellnhofer P., 1974, Palaeontographica Abt A, V147, P169; Wilson JW, 1993, VERTEBRATE PALEONTOL, P205; WILSON MC, 1985, CAN J EARTH SCI, V22, P1813, DOI 10.1139/e85-192; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; Xu X, 2004, ACTA GEOL SIN-ENGL, V78, P22; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X., 2002, THESIS CHINESE ACAD; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781; Xu Xing, 2012, Vertebrata Palasiatica, V50, P140; Xu X, 2011, NATURE, V475, P465, DOI 10.1038/nature10288; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Young R.G., 1991, P1; Zanno LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024487; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241; Zhou ZY, 2002, P SOC PHOTO-OPT INS, V4928, P160, DOI 10.1117/12.483166	114	49	51	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45203	10.1371/journal.pone.0045203	http://dx.doi.org/10.1371/journal.pone.0045203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028847	Green Published, gold			2022-12-27	WOS:000309517500019
J	Cockram, J; Thiel, T; Steuernagel, B; Stein, N; Taudien, S; Bailey, PC; O'Sullivan, DM				Cockram, James; Thiel, Thomas; Steuernagel, Burkhard; Stein, Nils; Taudien, Stefan; Bailey, Paul C.; O'Sullivan, Donal M.			Genome Dynamics Explain the Evolution of Flowering Time CCT Domain Gene Families in the Poaceae	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; BARLEY HORDEUM-VULGARE; CONSTANS-LIKE GENE; CIRCADIAN CLOCK; MOLECULAR CHARACTERIZATION; GROWTH HABIT; HEADING DATE; DNA-BINDING; PROTEIN; PHOTOPERIOD	Numerous CCT domain genes are known to control flowering in plants. They belong to the CONSTANS-like (COL) and PREUDORESPONSE REGULATOR (PRR) gene families, which in addition to a CCT domain possess B-box or response-regulator domains, respectively. Ghd7 is the most recently identified COL gene to have a proven role in the control of flowering time in the Poaceae. However, as it lacks B-box domains, its inclusion within the COL gene family, technically, is incorrect. Here, we show Ghd7 belongs to a larger family of previously uncharacterized Poaceae genes which possess just a single CCT domain, termed here CCT MOTIF FAMILY (CMF) genes. We molecularly describe the CMF (and related COL and PRR) gene families in four sequenced Poaceae species, as well as in the draft genome assembly of barley (Hordeum vulgare). Genetic mapping of the ten barley CMF genes identified, as well as twelve previously unmapped HvCOL and HvPRR genes, finds the majority map to colinear positions relative to their Poaceae orthologues. Combined inter-/intra-species comparative and phylogenetic analysis of CMF, COL and PRR gene families indicates they evolved prior to the monocot/dicot divergence similar to 200 mya, with Poaceae CMF evolution described as the interplay between whole genome duplication in the ancestral cereal, and subsequent clade-specific mutation, deletion and duplication events. Given the proven role of CMF genes in the modulation of cereals flowering, the molecular, phylogenetic and comparative analysis of the Poaceae CMF, COL and PRR gene families presented here provides the foundation from which functional investigation can be undertaken.	[Cockram, James; O'Sullivan, Donal M.] Natl Inst Agr Bot, John Bingham Lab, Cambridge, England; [Thiel, Thomas; Steuernagel, Burkhard; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Taudien, Stefan] Fritz Lipmann Inst FLI, Leibniz Inst Age Res, Jena, Germany; [Bailey, Paul C.] John Innes Ctr, Dept Computat & Syst Biol, Norwich, Norfolk, England	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Cockram, J (corresponding author), Natl Inst Agr Bot, John Bingham Lab, Huntington Rd, Cambridge, England.	james.cockram@niab.com	O'Sullivan, Donal/C-8157-2014; Stein, Nils/F-7507-2017	O'Sullivan, Donal/0000-0003-4889-056X; Stein, Nils/0000-0003-3011-8731; Cockram, James/0000-0002-1014-6463; Steuernagel, Burkhard/0000-0002-8284-7728	National Institute of Agricultural Botany (NIAB) Trust	National Institute of Agricultural Botany (NIAB) Trust	This work was funded by the National Institute of Agricultural Botany (NIAB) Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Borner A, 2002, PLANT BREEDING, V121, P129, DOI 10.1046/j.1439-0523.2002.00691.x; Cistue L, 2011, THEOR APPL GENET, V122, P1399, DOI 10.1007/s00122-011-1540-9; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cockram J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-16; Cockram J, 2007, GENETICS, V177, P2535, DOI 10.1534/genetics.107.074765; Cockram J, 2007, THEOR APPL GENET, V115, P993, DOI 10.1007/s00122-007-0626-x; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Cockram J, 2010, GENOME, V53, P231, DOI [10.1139/G09-101, 10.1139/g09-101]; Cockram J, 2009, CROP SCI, V49, P403, DOI 10.2135/cropsci2008.07.0398; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Costa JM, 2001, THEOR APPL GENET, V103, P415, DOI 10.1007/s001220100622; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Devos KM, 2005, CURR OPIN PLANT BIOL, V8, P155, DOI 10.1016/j.pbi.2005.01.005; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Dubcovsky J, 2005, MOL BREEDING, V15, P395, DOI 10.1007/s11032-005-0084-6; Emebiri LC, 2006, FIELD CROP RES, V96, P243, DOI 10.1016/j.fcr.2005.07.006; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Holm K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-109; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kim SK, 2008, PLANTA, V228, P355, DOI 10.1007/s00425-008-0742-0; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lang D, 2008, TRENDS PLANT SCI, V13, P542, DOI 10.1016/j.tplants.2008.07.002; Lazaro A, 2012, PLANT CELL, V24, P982, DOI 10.1105/tpc.110.081885; Malosetti M, 2011, THEOR APPL GENET, V122, P1605, DOI 10.1007/s00122-011-1558-z; Mameaux S, 2012, PLANT BIOTECHNOL J, V10, P67, DOI 10.1111/j.1467-7652.2011.00645.x; Masaki T, 2005, PLANT J, V43, P142, DOI 10.1111/j.1365-313X.2005.02439.x; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Mizuno T, 2005, PLANT CELL PHYSIOL, V46, P677, DOI 10.1093/pcp/pci087; Murakami M, 2005, BIOSCI BIOTECH BIOCH, V69, P410, DOI 10.1271/bbb.69.410; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Sameri M, 2006, BREEDING SCI, V56, P243, DOI 10.1270/jsbbs.56.243; Sameri M, 2011, BREEDING SCI, V61, P183, DOI 10.1270/jsbbs.61.183; Serrano G, 2009, CURR BIOL, V19, P359, DOI 10.1016/j.cub.2009.01.044; Shin BS, 2004, MOL CELLS, V17, P10; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Thiel T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-209; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Valverde F, 2011, J EXP BOT, V62, P2453, DOI 10.1093/jxb/erq449; VANOOIJEN JW, 2004, JOINMAP 3 0 SOFTWARE; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zhang HL, 2010, J EXP BOT, V61, P2549, DOI 10.1093/jxb/erq092	73	73	83	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45307	10.1371/journal.pone.0045307	http://dx.doi.org/10.1371/journal.pone.0045307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028921	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000309554700031
J	Shimizu, T; Ho, B; Deeley, K; Briseno-Ruiz, J; Faraco, IM; Schupack, BI; Brancher, JA; Pecharki, GD; Kuchler, EC; Tannure, PN; Lips, A; Vieira, TCS; Patir, A; Yildirim, M; Poletta, FA; Mereb, JC; Resick, JM; Brandon, CA; Orioli, IM; Castilla, EE; Marazita, ML; Seymen, F; Costa, MC; Granjeiro, JM; Trevilatto, PC; Vieira, AR				Shimizu, Takehiko; Ho, Bao; Deeley, Kathleen; Briseno-Ruiz, Jessica; Faraco, Italo M., Jr.; Schupack, Brett I.; Brancher, Joao A.; Pecharki, Giovana D.; Kuechler, Erika C.; Tannure, Patricia N.; Lips, Andrea; Vieira, Thays C. S.; Patir, Asli; Yildirim, Mine; Poletta, Fernando A.; Mereb, Juan C.; Resick, Judith M.; Brandon, Carla A.; Orioli, Ieda M.; Castilla, Eduardo E.; Marazita, Mary L.; Seymen, Figen; Costa, Marcelo C.; Granjeiro, Jose M.; Trevilatto, Paula C.; Vieira, Alexandre R.			Enamel Formation Genes Influence Enamel Microhardness Before and After Cariogenic Challenge	PLOS ONE			English	Article							HIGH CARIES EXPERIENCE; DENTAL-CARIES; ASSOCIATION; AMELOGENIN; FISSURE; PIT	There is evidence for a genetic component in caries susceptibility, and studies in humans have suggested that variation in enamel formation genes may contribute to caries. For the present study, we used DNA samples collected from 1,831 individuals from various population data sets. Single nucleotide polymorphism markers were genotyped in selected genes (ameloblastin, amelogenin, enamelin, tuftelin, and tuftelin interacting protein 11) that influence enamel formation. Allele and genotype frequencies were compared between groups with distinct caries experience. Associations with caries experience can be detected but they are not necessarily replicated in all population groups and the most expressive results was for a marker in AMELX (p = 0.0007). To help interpret these results, we evaluated if enamel microhardness changes under simulated cariogenic challenges are associated with genetic variations in these same genes. After creating an artificial caries lesion, associations could be seen between genetic variation in TUFT1 (p = 0.006) and TUIP11 (p = 0.0006) with enamel microhardness. Our results suggest that the influence of genetic variation of enamel formation genes may influence the dynamic interactions between the enamel surface and the oral cavity.	[Ho, Bao; Deeley, Kathleen; Briseno-Ruiz, Jessica; Faraco, Italo M., Jr.; Schupack, Brett I.; Resick, Judith M.; Brandon, Carla A.; Marazita, Mary L.; Vieira, Alexandre R.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA 15260 USA; [Shimizu, Takehiko] Nihon Univ Dent Matsudo, Dept Pediat Dent, Matsudo, Chiba, Japan; [Poletta, Fernando A.; Castilla, Eduardo E.] Ctr Med Educ & Clin Res CEMIC, Latin Amer Collaborat Study Congenital Malformat, Buenos Aires, DF, Argentina; [Brancher, Joao A.; Pecharki, Giovana D.; Trevilatto, Paula C.] Pontifical Catholic Univ Parana PUCPR, Ctr Hlth & Biol Sci, Curitiba, Parana, Brazil; [Kuechler, Erika C.; Vieira, Thays C. S.; Granjeiro, Jose M.] Univ Fed Fluminense, Inst Biol, Clin Res Unit, Niteroi, RJ, Brazil; [Tannure, Patricia N.] Veiga Almeida Univ, Discipline Pediat Dent, Rio De Janeiro, Brazil; [Lips, Andrea; Costa, Marcelo C.] Univ Fed Rio de Janeiro, Dept Pediat Dent & Orthodont, Rio De Janeiro, Brazil; [Patir, Asli] Istanbul Medipol Univ, Dept Pedodont, Istanbul, Turkey; [Yildirim, Mine; Seymen, Figen] Istanbul Univ, Fac Dent, Dept Pedodont, Istanbul, Turkey; [Mereb, Juan C.] Hosp Area El Bolson, Latin Amer Collaborat Study Congenital Malformat, Rio Negro, Argentina; [Orioli, Ieda M.] Univ Fed Rio de Janeiro, Natl Inst Populat Med Genet INAGEMP CNPq, Latin Amer Collaborat Study Congenital Malformat, Dept Genet,Inst Biol,Ctr Hlth Sci, Rio De Janeiro, Brazil; [Castilla, Eduardo E.] Fundacao Oswaldo Cruz, Latin Amer Collaborat Study Congenital Malformat, Natl Inst Populat Med Genet INAGEMP CNPq, Dept Genet, Rio De Janeiro, Brazil; [Marazita, Mary L.] Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Dept Human Genet & Clin & Translat Sci, Pittsburgh, PA USA; [Vieira, Alexandre R.] Univ Pittsburgh, Sch Dent Med & Clin & Translat Sci, Dept Pediat Dent, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Nihon University; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Pontificia Universidade Catolica do Parana; Universidade Federal Fluminense; Universidade Veiga de Almeida (UVA); Universidade Federal do Rio de Janeiro; Istanbul Medipol University; Istanbul University; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vieira, AR (corresponding author), Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA 15260 USA.	arv11@pitt.edu	Inagemp, Inct/J-9451-2013; Trevilatto, Paula/C-1848-2008; Brancher, João Armando/C-7758-2014; Seymen, Figen/AAC-6736-2020; Koruyucu, M/AAC-6713-2020; Granjeiro, Jose Mauro/D-8289-2012; Brancher, João Armando/AAQ-4858-2020; Tannure, Patricia Nivoloni/AAC-7447-2020; Küchler, Erika C/B-4669-2014	Trevilatto, Paula/0000-0001-5781-8629; Brancher, João Armando/0000-0002-8914-702X; Seymen, Figen/0000-0001-7010-2035; Koruyucu, M/0000-0002-2077-5095; Granjeiro, Jose Mauro/0000-0002-8027-8293; Brancher, João Armando/0000-0002-8914-702X; Tannure, Patricia Nivoloni/0000-0002-5129-8615; Poletta, Fernando/0000-0002-6102-8416; Kuchler, Erika/0000-0001-5351-2526	National Institutes of Health [R01-DE018914, R01-DE016148]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018914, R01DE016148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research is supported by National Institutes of Health grants R01-DE018914 and R01-DE016148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Brancher JA, 2011, INT J DENT, V2011, DOI 10.1155/2011/571726; Deeley K, 2008, CARIES RES, V42, P8, DOI 10.1159/000111744; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kim JW, 2006, EUR J ORAL SCI, V114, P3, DOI 10.1111/j.1600-0722.2006.00278.x; Kim JW, 2004, J DENT RES, V83, P378, DOI 10.1177/154405910408300505; LISS J, 1982, Journal of the American Dental Association, V105, P75; Olivier M, 2004, PHYSIOL GENOMICS, V16, P182, DOI 10.1152/physiolgenomics.00194.2003; Patir A, 2008, CARIES RES, V42, P394, DOI 10.1159/000154785; Queiroz Celso Silva, 2008, Braz. Dent. J., V19, P21, DOI 10.1590/S0103-64402008000100004; Rodrigues Eliana, 2010, Braz. Dent. J., V21, P446, DOI 10.1590/S0103-64402010000500012; Shaffer JR, 2012, CARIES RES, V46, P38, DOI 10.1159/000335099; Silva KG, 2010, ACTA ODONTOL SCAND, V68, P11, DOI 10.3109/00016350903260264; Slayton RL, 2005, J DENT RES, V84, P711, DOI 10.1177/154405910508400805; Tannukit S, 2009, BIOCHEM BIOPH RES CO, V390, P1044, DOI 10.1016/j.bbrc.2009.10.111; Tannure PN, 2012, J DENT, V40, P381, DOI 10.1016/j.jdent.2012.01.015; Vieira AR, 2008, J DENT RES, V87, P435, DOI 10.1177/154405910808700506; Vieira AR, 2012, CARIES RES, V46, P346, DOI 10.1159/000338851; Vieira AR, 2011, ISRN DENT, V2011; World Health Organization, 2003, WORLD OR HLTH REP 20	21	56	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45022	10.1371/journal.pone.0045022	http://dx.doi.org/10.1371/journal.pone.0045022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028741	Green Published, Green Accepted, gold			2022-12-27	WOS:000309554700021
J	Ostroumova, OS; Efimova, SS; Chulkov, EG; Schagina, LV				Ostroumova, Olga S.; Efimova, Svetlana S.; Chulkov, Evgeny G.; Schagina, Ludmila V.			The Interaction of Dipole Modifiers with Polyene-Sterol Complexes	PLOS ONE			English	Article							SELECTIVE-MEMBRANE TOXICITY; AMPHOTERICIN-B; GRAMICIDIN CHANNEL; PLANT FLAVONOIDS; LIPID-MEMBRANES; CHOLESTEROL; BILAYER; PERMEABILITY; ANTIBIOTICS; CONDUCTANCE	Recently, we showed that the effect of dipole modifiers (flavonoids and styrylpyridinium dyes) on the conductance of single amphotericin B (AmB) channels in sterol-containing lipid bilayers primarily resulted from changes in the membrane dipole potential. The present study examines the effect of dipole modifiers on the AmB multi-channel activity. The addition of phloretin to cholesterol-containing membranes leads to a significant increase in the steady-state AmB-induced transmembrane current. Quercetin significantly decreases and RH 421 increases the current through ergosterol-containing bilayers. Other tested flavonoids and styrylpyridinium dyes do not affect the channel-forming activity of AmB independently on the sterol composition of the bilayers. The effects obtained in these trials may instead be attributed to the direct interaction of dipole modifiers with AmB/sterol complexes and not to the effect of dipole potential changes. The presence of double bonds in the Delta 7 and Delta 22 positions of sterol molecules, the number of conjugated double bonds and amino sugar residues in polyene molecules, and the conformation and adsorption plane of dipole modifiers are important factors impacting this interaction.	[Ostroumova, Olga S.; Efimova, Svetlana S.; Chulkov, Evgeny G.; Schagina, Ludmila V.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Ostroumova, OS (corresponding author), Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia.	ostroumova@mail.cytspb.rssi.ru	Chulkov, Evgeny G/A-9696-2018; Ostroumova, Olga S./N-8636-2013; Efimova, Svetlana S./I-8716-2014	Chulkov, Evgeny G/0000-0001-8030-6031; Efimova, Svetlana S./0000-0002-2429-2007; Ostroumova, Olga/0000-0002-7312-4579	Russian Foundation for Basic Research; Program "Molecular and Cell Biology"; Russian Academy of Sciences; RF [MK-1813.2012.4]; Russian state contract	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program "Molecular and Cell Biology"; Russian Academy of Sciences(Russian Academy of Sciences); RF; Russian state contract	This work was partly supported by the Russian Foundation for Basic Research, the Program "Molecular and Cell Biology", the Russian Academy of Sciences, the grant of the President of RF (# MK-1813.2012.4) and Russian state contract (MES, FTP << SSEPIR >>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN OS, 1976, J GEN PHYSIOL, V67, P749, DOI 10.1085/jgp.67.6.749; ANDREOLI TE, 1974, ANN NY ACAD SCI, V235, P448, DOI 10.1111/j.1749-6632.1974.tb43283.x; Apetrei A, 2009, BBA-GEN SUBJECTS, V1790, P809, DOI 10.1016/j.bbagen.2009.04.002; Baran M, 2009, BIOPHYS CHEM, V141, P162, DOI 10.1016/j.bpc.2009.01.010; BOLARD J, 1986, DRUG EXP CLIN RES, V12, P613; Busath DD, 1998, BIOPHYS J, V75, P2830, DOI 10.1016/S0006-3495(98)77726-4; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Czub J, 2006, J PHYS CHEM B, V110, P16743, DOI 10.1021/jp061916g; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P30, DOI 10.1016/0005-2736(74)90330-7; Efimova SS, 2012, 56 ANN M BIOPH SOC, P482; Efimova SS, 2012, 3 C YOUNG SCI I CYT, V54, P340; Gabrielska J, 2006, FEBS LETT, V580, P2677, DOI 10.1016/j.febslet.2006.04.021; GALLIS HA, 1990, REV INFECT DIS, V12, P308; Gonzalez-Damian J, 2010, J MEMBRANE BIOL, V237, P41, DOI 10.1007/s00232-010-9301-2; HAMILTON.JM, 1973, BACTERIOL REV, V37, P166; HSUCHEN CC, 1973, ANTIMICROB AGENTS CH, V4, P316, DOI 10.1128/AAC.4.3.316; HSUCHEN CC, 1973, ANTIMICROB AGENTS CH, V4, P309, DOI 10.1128/AAC.4.3.309; Hwang TC, 2003, BIOCHEMISTRY-US, V42, P13646, DOI 10.1021/bi034887y; KASUMOV KM, 1979, BIOCHIM BIOPHYS ACTA, V551, P229, DOI 10.1016/0005-2736(89)90001-1; KRAWCZYK J, 1991, BIOCHIM BIOPHYS ACTA, V1063, P60, DOI 10.1016/0005-2736(91)90353-A; Lemke A, 2005, APPL MICROBIOL BIOT, V68, P151, DOI 10.1007/s00253-005-1955-9; Luchian T, 2006, LANGMUIR, V22, P8452, DOI 10.1021/la0613777; Malkov DY, 1996, BBA-BIOMEMBRANES, V1278, P197, DOI 10.1016/0005-2736(95)00197-2; MARTY A, 1975, J GEN PHYSIOL, V65, P515, DOI 10.1085/jgp.65.4.515; Matsuoka S, 2002, BBA-BIOMEMBRANES, V1564, P429, DOI 10.1016/S0005-2736(02)00491-1; Mereuta L, 2008, BIOCHEM BIOPH RES CO, V373, P467, DOI 10.1016/j.bbrc.2008.04.046; Mereuta L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025276; Middleton E, 2000, PHARMACOL REV, V52, P673; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Neumann A, 2010, J AM CHEM SOC, V132, P18266, DOI 10.1021/ja1074344; Ostrosky-Zeichner L, 2003, CLIN INFECT DIS, V37, P415, DOI 10.1086/376634; Ostroumova OS, 2007, LANGMUIR, V23, P6889, DOI 10.1021/la7005452; Ostroumova OS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030261; Ostroumova OS, 2011, BBA-BIOMEMBRANES, V1808, P2051, DOI 10.1016/j.bbamem.2011.04.005; Ostroumova OS, 2010, LANGMUIR, V26, P15092, DOI 10.1021/la102691y; Ostroumova OS, 2009, MEMBR CELL BIOL MOSC, V3, P281; Ostroumova OS, 2008, MEMBR CELL BIOL MOSC, V2, P259; Passechnik VI, 2002, BIOELECTROCHEMISTRY, V55, P47, DOI 10.1016/S1567-5394(01)00167-0; Recamier KS, 2010, J MEMBRANE BIOL, V237, P31, DOI 10.1007/s00232-010-9304-z; Richardson MD, 1997, J MED MICROBIOL, V46, P185, DOI 10.1099/00222615-46-3-185; Rog T, 2009, BBA-BIOMEMBRANES, V1788, P97, DOI 10.1016/j.bbamem.2008.08.022; Rokitskaya TI, 2002, BIOPHYS J, V82, P865, DOI 10.1016/S0006-3495(02)75448-9; Rokitskaya TI, 1997, BIOPHYS J, V73, P850, DOI 10.1016/S0006-3495(97)78117-7; Starke-Peterkovic T, 2006, AM J PHYSIOL-REG I, V288, P663; Tarahovsky YS, 2008, MOL CELL BIOCHEM, V314, P65, DOI 10.1007/s11010-008-9766-9; Zumbuehl A, 2004, ORG LETT, V6, P3683, DOI 10.1021/ol0487276	46	15	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45135	10.1371/journal.pone.0045135	http://dx.doi.org/10.1371/journal.pone.0045135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028805	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800027
J	Luan, S; Ilvarsonn, AM; Eissenberg, JC				Luan, Shan; Ilvarsonn, Anne M.; Eissenberg, Joel C.			The Unique GGA Clathrin Adaptor of Drosophila melanogaster Is Not Essential	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; EAR HOMOLOGY DOMAIN; GAMMA-ADAPTIN; BLUE-CHEESE; UBIQUITIN BINDING; PROTEIN; AUTOPHAGY; FAMILY; TRAFFICKING; STARVATION	The Golgi-localized, gamma-ear-containing, ARF binding proteins (GGAs) are a highly conserved family of monomeric clathrin adaptor proteins implicated in clathrin-mediated protein sorting between the trans-Golgi network and endosomes. GGA RNAi knockdowns in Drosophila have resulted in conflicting data concerning whether the Drosophila GGA (dGGA) is essential. The goal of this study was to define the null phenotype for the unique Drosophila GGA. We describe two independently derived dGGA mutations. Neither allele expresses detectable dGGA protein. Homozygous and hemizygous flies with each allele are viable and fertile. In contrast to a previous report using RNAi knockdown, GGA mutant flies show no evidence of age-dependent retinal degeneration or cathepsin missorting. Our results demonstrate that several of the previous RNAi knockdown phenotypes were the result of off-target effects. However, GGA null flies are hypersensitive to dietary chloroquine and to starvation, implicating GGA in lysosomal function and autophagy.	[Eissenberg, Joel C.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63103 USA; [Luan, Shan; Ilvarsonn, Anne M.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Saint Louis University; Saint Louis University	Eissenberg, JC (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63103 USA.	eissenjc@slu.edu			Saint Louis University	Saint Louis University	This work was supported by the Saint Louis University Presidents Research Fund grant; Saint Louis University Beaumont Fund Award; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Chen HY, 2009, GENESIS, V47, P305, DOI 10.1002/dvg.20501; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Dennes A, 2005, J BIOL CHEM, V280, P12849, DOI 10.1074/jbc.M410626200; Eissenberg JC, 2011, TRAFFIC, V12, P1821, DOI 10.1111/j.1600-0854.2011.01285.x; Finley KD, 2003, J NEUROSCI, V23, P1254, DOI 10.1523/JNEUROSCI.23-04-01254.2003; Gelfman CM, 2007, INVEST OPHTH VIS SCI, V48, P5221, DOI 10.1167/iovs.07-0452; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; Ghosh P, 2003, J BIOL CHEM, V278, P14543, DOI 10.1074/jbc.M212543200; Govero J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030184; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Hida T, 2007, ARCH HISTOL CYTOL, V70, P303, DOI 10.1679/aohc.70.303; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hirst J, 2001, MOL BIOL CELL, V12, P3573, DOI 10.1091/mbc.12.11.3573; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Hirst J, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-22; Hirst J, 2009, TRAFFIC, V10, P1696, DOI 10.1111/j.1600-0854.2009.00983.x; Hummel Thomas, 2008, V420, P97, DOI 10.1007/978-1-59745-583-1_6; Kametaka S, 2012, J CELL SCI, V125, P634, DOI 10.1242/jcs.090167; Kametaka S, 2010, J CELL SCI, V123, P460, DOI 10.1242/jcs.055103; Kamikura DM, 2006, TRAFFIC, V7, P324, DOI 10.1111/j.1600-0854.2006.00386.x; Kramer JM, 2008, GENOME, V51, P668, DOI 10.1139/G08-047; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lim A, 2009, J NEUROSCI, V29, P951, DOI 10.1523/JNEUROSCI.2582-08.2009; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; Mardones GA, 2007, MOL BIOL CELL, V18, P3486, DOI 10.1091/mbc.E07-02-0190; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Myllykangas L, 2005, NEUROBIOL DIS, V19, P194, DOI 10.1016/j.nbd.2004.12.019; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Shiba Y, 2004, J BIOL CHEM, V279, P7105, DOI 10.1074/jbc.M311702200; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; Simonsen A, 2007, AUTOPHAGY, V3, P499, DOI 10.4161/auto.4604; Simonsen A, 2007, GENETICS, V176, P1283, DOI 10.1534/genetics.106.065011; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Takatsu H, 2001, J BIOL CHEM, V276, P28541, DOI 10.1074/jbc.C100218200; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45163	10.1371/journal.pone.0045163	http://dx.doi.org/10.1371/journal.pone.0045163			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028818	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900026
J	Jorg, F; Ormel, J; Reijneveld, SA; Jansen, DEMC; Verhulst, FC; Oldehinkel, AJ				Jorg, Frederike; Ormel, Johan; Reijneveld, Sijmen A.; Jansen, Danielle E. M. C.; Verhulst, Frank C.; Oldehinkel, Albertine J.			Puzzling Findings in Studying the Outcome of "Real World" Adolescent Mental Health Services: The TRAILS Study	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; EXTERNALIZING PROBLEMS; DEPRESSIVE PROBLEMS; BEHAVIORAL-PROBLEMS; CHILDREN; TEMPERAMENT; CARE; PSYCHOTHERAPY; PARENTS; DETERMINANTS	Background: The increased use and costs of specialist child and adolescent mental health services (MHS) urge us to assess the effectiveness of these services. The aim of this paper is to compare the course of emotional and behavioural problems in adolescents with and without MHS use in a naturalistic setting. Method and Findings: Participants are 2230 (pre)adolescents that enrolled in a prospective cohort study, the TRacking Adolescents' Individual Lives Survey (TRAILS). Response rate was 76%, mean age at baseline 11.09 (SD 0.56), 50.8% girls. We used data from the first three assessment waves, covering a six year period. Multiple linear regression analysis, propensity score matching, and data validation were used to compare the course of emotional and behavioural problems of adolescents with and without MHS use. The association between MHS and follow-up problem score (beta 0.20, SE 0.03, p-value<0.001) was not confounded by baseline severity, markers of adolescent vulnerability or resilience nor stressful life events. The propensity score matching strategy revealed that follow-up problem scores of non-MHS-users decreased while the problem scores of MHS users remained high. When taking into account future MHS (non) use, it appeared that problem scores decreased with limited MHS use, albeit not as much as without any MHS use, and that problem scores with continuous MHS use remained high. Data validation showed that using a different outcome measure, multiple assessment waves and multiple imputation of missing values did not alter the results. A limitation of the study is that, although we know what type of MHS participants used, and during which period, we lack information on the duration of the treatment. Conclusions: The benefits of MHS are questionable. Replication studies should reveal whether a critical examination of everyday care is necessary or an artefact is responsible for these results.	[Jorg, Frederike; Ormel, Johan; Oldehinkel, Albertine J.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Reijneveld, Sijmen A.; Jansen, Danielle E. M. C.] Univ Groningen, Dept Hlth Sci, Univ Med Ctr Groningen, Groningen, Netherlands; [Verhulst, Frank C.] Erasmus Univ, Med Ctr, Sophia Childrens Hosp Rotterdam, Rotterdam, Netherlands	University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Jorg, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	F.Jorg@umcg.nl	ormel, johan/AAC-5584-2019; Jansen, Danielle/E-9281-2013; Jörg, Frederike/B-1325-2014; Ormel, Johan/C-6094-2013	ormel, johan/0000-0002-5463-037X; Jansen, Danielle/0000-0002-2654-1038; Reijneveld, Sijmen/0000-0002-1206-7523	Netherlands Organization for Scientific Research NWO (Medical Research Council) [GB-MW 940-38-011, 100-001-004, 60-60600-98-018, 60-60600-97-118, 261-98-710, 480-01-006, GB-MaGW 480-07-001, GB-MaGW 457-03-018, GB-MaGW 452-04-314, GB-MaGW 452-06-004, 175.010.2003.005, 481-08-013]; Sophia Foundation for Medical Research [301, 393]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]	Netherlands Organization for Scientific Research NWO (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Sophia Foundation for Medical Research; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project)	This research is part of the TRacking Adolescents' Individual Lives Survey (TRAILS). Participating centres of TRAILS include various departments of the University Medical Centre and University of Groningen, the Erasmus University Medical Centre Rotterdam, the University of Utrecht, the Radboud Medical Centre Nijmegen, and the Parnassia Bavo group, all in the Netherlands. TRAILS has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-98-018 and 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 457-03-018, GB-MaGW 452-04-314, and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005; NWO Longitudinal Survey and Panel Funding 481-08-013); the Sophia Foundation for Medical Research (projects 301 and 393), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), and the participating universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 1991, MANUAL SELF REPORT 1; Amone-P'Olak K, 2010, J AM ACAD CHILD PSY, V49, P647, DOI 10.1016/j.jaac.2010.03.007; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Angold A, 2000, J AM ACAD CHILD PSY, V39, P154, DOI 10.1097/00004583-200002000-00013; [Anonymous], 1991, MANUAL CHILD BEHAV C; Bakker MP, 2011, J EARLY ADOLESCENCE, V31, P633, DOI 10.1177/0272431610366251; Bartak A, 2011, PSYCHOTHER PSYCHOSOM, V80, P88, DOI 10.1159/000320587; Bartak A, 2009, PSYCHOTHER PSYCHOSOM, V78, P26, DOI 10.1159/000162298; Black N, 1996, BRIT MED J, V312, P1215; Bouma EMC, 2008, J AFFECT DISORDERS, V105, P185, DOI 10.1016/j.jad.2007.05.007; BREWIN CR, 1989, BRIT MED J, V299, P313, DOI 10.1136/bmj.299.6694.313; Brunnekreef JA, 2007, J CHILD PSYCHOL PSYC, V48, P185, DOI 10.1111/j.1469-7610.2006.01695.x; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dahl RE, 2009, DEV PSYCHOPATHOL, V21, P1, DOI 10.1017/S0954579409000017; de Maat S, 2007, PSYCHOTHER RES, V17, P59, DOI 10.1080/10503300600607605; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Eisner M, 2012, PREV SCI, V13, P252, DOI 10.1007/s11121-011-0266-x; Emond A, 2007, CHILD PSYCHIAT HUM D, V38, P221, DOI 10.1007/s10578-007-0058-5; Ganzeboom HBG, 1996, SOC SCI RES, V25, P201, DOI 10.1006/ssre.1996.0010; Garralda EM, 2009, BRIT J PSYCHIAT, V194, P389, DOI 10.1192/bjp.bp.108.059477; Goodin DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022444; Gresham F.M., 1990, SOCIAL SKILLS RATING; HARTER S, 1982, CHILD DEV, V53, P87, DOI 10.1111/j.1467-8624.1982.tb01295.x; Huisman M, 2008, INT J EPIDEMIOL, V37, P1227, DOI 10.1093/ije/dym273; KUPERSMIDT JB, 1990, CHILD DEV, V61, P1350, DOI 10.1111/j.1467-8624.1990.tb02866.x; Lazaratou H, 2000, PSYCHOTHER PSYCHOSOM, V69, P42, DOI 10.1159/000012365; Markus MT, 2003, PERS INDIV DIFFER, V34, P503, DOI 10.1016/S0191-8869(02)00090-9; McHugh RK, 2010, AM PSYCHOL, V65, P73, DOI 10.1037/a0018121; Moroi M, 2012, INT J CARDIOL, V158, P246, DOI 10.1016/j.ijcard.2011.01.040; Muris P, 2003, PERS INDIV DIFFER, V35, P1791, DOI 10.1016/S0191-8869(03)00004-7; Muris P, 2003, J PSYCHOPATHOL BEHAV, V25, P229, DOI 10.1023/A:1025894928131; NICE, 2005, NICE CLIN GUID DEPR; Oldehinkel AJ, 2004, DEV PSYCHOPATHOL, V16, P421, DOI 10.1017/S0954579404044591; Oldehinkel AJ, 2007, DEV PSYCHOPATHOL, V19, P523, DOI 10.1017/S0954579407070253; Oldehinkel AJ, 2007, J ABNORM CHILD PSYCH, V35, P417, DOI 10.1007/s10802-007-9100-0; Ormel J, 2005, PSYCHOL MED, V35, P1825, DOI 10.1017/S0033291705005829; Pescosolido BA, 2007, PSYCHIAT SERV, V58, P613, DOI 10.1176/appi.ps.58.5.613; Putnam SP., 2001, ADV RES TEMPERAMENT, P165; Rubin D. B., 2004, MULTIPLE IMPUTATION; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sayal K, 2006, J CHILD PSYCHOL PSYC, V47, P649, DOI 10.1111/j.1469-7610.2005.01543.x; Sentse M, 2010, J ABNORM CHILD PSYCH, V38, P119, DOI 10.1007/s10802-009-9351-z; Sentse M, 2009, DEV PSYCHOL, V45, P419, DOI 10.1037/a0014072; Spijker J, 2004, ACTA PSYCHIAT SCAND, V110, P208, DOI 10.1111/j.1600-0447.2004.00335.x; VERHULST FC, 1992, J CHILD PSYCHOL PSYC, V33, P1011, DOI 10.1111/j.1469-7610.1992.tb00922.x; Weersing VR, 2002, J CONSULT CLIN PSYCH, V70, P299, DOI 10.1037//0022-006X.70.2.299; Weisz JR, 2006, AM PSYCHOL, V61, P671, DOI 10.1037/0003-066X.61.7.671; Zwaanswijk M, 2006, EUR CHILD ADOLES PSY, V15, P127, DOI 10.1007/s00787-005-0513-4; Zwaanswijk M, 2003, EUR CHILD ADOLES PSY, V12, P153, DOI 10.1007/S00787-003-0322-6	50	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44704	10.1371/journal.pone.0044704	http://dx.doi.org/10.1371/journal.pone.0044704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028584	Green Published, gold			2022-12-27	WOS:000309388400033
J	Obura, D				Obura, David			The Diversity and Biogeography of Western Indian Ocean Reef-Building Corals	PLOS ONE			English	Article							SCLERACTINIAN CORALS; CLIMATE-CHANGE; BIODIVERSITY; COMMUNITIES; PHYLOGENY; CNIDARIA; COASTAL; ANTHOZOA	This study assesses the biogeographic classification of the Western Indian Ocean (WIO) on the basis of the species diversity and distribution of reef-building corals. Twenty one locations were sampled between 2002 and 2011. Presence/absence of scleractinian corals was noted on SCUBA, with the aid of underwater digital photographs and reference publications for species identification. Sampling effort varied from 7 to 37 samples per location, with 15 to 45 minutes per dive allocated to species observations, depending on the logistics on each trip. Species presence/absence was analyzed using the Bray-Curtis similarity coefficient, followed by cluster analysis and multi-dimensional scaling. Total (asymptotic) species number per location was estimated using the Michaelis-Menten equation. Three hundred and sixty nine coral species were named with stable identifications and used for analysis. At the location level, estimated maximum species richness ranged from 297 (Nacala, Mozambique) to 174 (Farquhar, Seychelles). Locations in the northern Mozambique Channel had the highest diversity and similarity, forming a core region defined by its unique oceanography of variable meso-scale eddies that confer high connectivity within this region. A distinction between mainland and island fauna was not found; instead, diversity decreased radially from the northern Mozambique Channel. The Chagos archipelago was closely related to the northern Mozambique Channel region, and analysis of hard coral data in the IUCN Red List found Chagos to be more closely related to the WIO than to the Maldives, India and Sri Lanka. Diversity patterns were consistent with primary oceanographic drivers in the WIO, reflecting inflow of the South Equatorial Current, maintenance of high diversity in the northern Mozambique Channel, and export from this central region to the north and south, and to the Seychelles and Mascarene islands.	CORDIO E Africa, Mombasa, Kenya		Obura, D (corresponding author), CORDIO E Africa, Mombasa, Kenya.	dobura@cordioea.net		Obura, David/0000-0003-2256-6649	Western Indian Ocean Marine Science Association's (WIOMSA) Marine Science for Management (MASMA) programme	Western Indian Ocean Marine Science Association's (WIOMSA) Marine Science for Management (MASMA) programme	Funding was provided by the Western Indian Ocean Marine Science Association's (WIOMSA) Marine Science for Management (MASMA) programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alusa AL, 1992, UNEP REGIONAL SEAS R, V149; [Anonymous], 2002, SAYA MALHA EXPEDITIO; Arrigoni R, 2012, MOL PHYLOGENET EVOL, V65, P183, DOI 10.1016/j.ympev.2012.06.001; Belkin IM, 2009, PROG OCEANOGR, V81, P223, DOI 10.1016/j.pocean.2009.04.015; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Benzoni F, 2010, ZOOL J LINN SOC, DOI 101111/j1096-3642201000622x; Benzoni F, SYSTEMATICS IN PRESS; Benzoni F, 2011, CONTRIB ZOOL, V80, P231, DOI 10.1163/18759866-08004002; BOSHOFF P H, 1981, Oceanographic Research Institute (Durban) Investigational Report, P1; Bouchon C., 1979, Cahiers de l'Indo-Pacifique, V1, P25; Braithwaite C.J.R., 1971, S ZOOL SOC LOND, V28, P39; Budd AF, 2011, J MORPHOL, V272, P66, DOI 10.1002/jmor.10899; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; Budd AF, 2009, ACTA ZOOL-STOCKHOLM, V90, P142, DOI 10.1111/j.1463-6395.2008.00345.x; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carpenter Kent E., 2011, Journal of Marine Biology, V2011, P1; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coles S. L., 1996, CORALS OMAN; Colwell R, 2009, ESTIMATES 8 2 US GUI; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cooke A., 2003, P179; DeVantier Lyndon, 2000, Fauna of Arabia, V18, P23; DeVantier Lyndon, 2004, V20, P117; Eble Jeff A., 2011, Journal of Marine Biology, V2011, P1; Everett BI, 2008, SPECIAL PUBLICATION, V8; Faure G., 1977, Atoll Res Bull, VNo. 203, P1; Faure G, 1982, ETUDE COMP RECIFS CO, P153; Faure G, 2008, LIST SCLERACTINIAN C; Flot Jean-Francois, 2011, BMC Ecology, V11, P22, DOI 10.1186/1472-6785-11-22; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Friedlander AM, 2009, MARINE ECOSYSTEM ASS; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Gabri?, 2012, ASSESSING MARINE WOR; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Gallienne CP, 2004, PHILOS T R SOC A, V363, P191; Griffiths CL, 2005, INDIAN J MAR SCI, V34, P35; HAMILTON HGH, 1984, B MAR SCI, V34, P248; HAYDEN BP, 1984, ENVIRON CONSERV, V11, P199, DOI 10.1017/S0376892900014211; Head SM, 1980, THESIS CAMBRIDGE U; Huang DW, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-37; Keating KA, 1998, OIKOS, V81, P411, DOI 10.2307/3547060; Keshavmurthy S, PNAS IN PRESS; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Lieske E., 1996, CORAL REEF FISHES IN; Lutjeharms JRE, 2006, AGULHAS CURRENT; McArthur RH, 1961, MONOGR POPUL BIOL, V1; MERGNER H, 1985, HELGOLANDER MEERESUN, V39, P375, DOI 10.1007/BF01987409; Miller KJ, 1997, B MAR SCI, V61, P907; Moothien Pillay R, 2002, FIELD GUIDE CORALS M; Mortimer JA, 2002, P 20 ANN S SEA TURTL, V477, P47; New AL, 2004, PHILOS T R SOC A, V363, P151; Novozhilov AV, 1992, ATOLL RES B, V366, P1; Obura D, 2007, ZOOL STUD, V46, P427; Obura DO, 2004, P 10 INT COR REEF S, P1077; Obura DO, 2004, CORAL REEF MONITORIN; Obura DO, 2012, P 12 INT COR REEF S; Obura DO, 2011, RAP B BIOL ASSESSMEN, V61; PICHON M., 1978, ATOLL RES B, V222, P1, DOI DOI 10.5479/SI.00775630.222.1]; Pichon M, 2010, FIELD GUIDE HARD COR; Pichon M, 2007, ZOOTAXA, P21, DOI 10.11646/zootaxa.1441.1.2; Pichon M, 2012, ZOOL STUD, V51, P93; Pillai CSG, 1970, ATOLL RES B, V141, P1; Potts D. C., 1985, PROC 5 INT CORAL REE, V4, P127; RIEGL B, 1995, ZOOL J LINN SOC-LOND, V113, P229, DOI 10.1006/zjls.1995.0009; Riegl B, 2003, CORAL REEFS, V22, P433, DOI 10.1007/s00338-003-0335-0; Riegl B, 2012, CORAL REEFS WORLD, V3; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Roman R, CIRCULATION TR UNPUB; Rosen B.R., 1971, S ZOOL SOC LOND, V28, P263; ROSEN BR, 1971, S ZOOL SOC LOND, V28, P163; Rudi E, 2012, ORYX, V46, P482, DOI 10.1017/S0030605312000178; Scheer G., 1983, Zoologica (Stuttgart), P1; Schleyer MH, 2008, MAR POLLUT BULL, V56, P493, DOI 10.1016/j.marpolbul.2007.11.011; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Schouten MW, 2003, DEEP-SEA RES PT II, V50, P1987, DOI 10.1016/S0967-0645(03)00042-0; Sheppard C, 2005, J NAT HIST, V39, P103, DOI 10.1080/00222930310001657900; SHEPPARD C R C, 1987, Atoll Research Bulletin, P1; Sheppard C.R.C., 1991, Fauna of Saudi Arabia, V12, P3; Sheppard C.R.C., 1999, ECOLOGY CHAGOS ARCHI, P53; Sheppard CRC, 2012, AQUAT CONSERV, DOI 101002/aqc1248; Sherman K, 1999, FISHERIES, V24, P15, DOI 10.1577/1548-8446(1999)024&lt;0015:LME&gt;2.0.CO;2; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stefani F, 2011, CORAL REEFS, DOI 101007/s00338-011-0797-4; Thomassin BA, 2004, TRAVAUX MILIEUX MARI; Turak E, 2007, FAUNA ARAB SER, V23, P1; Turner J, 2005, PHILOS T R SOC A, V363, P229, DOI 10.1098/rsta.2004.1489; Veron, 2002, NEW SPECIES DESCRIBE; Veron J.E.N., 2005, RAP Bulletin of Biological Assessment, V31, P23; Veron J.E.N., 2000, CORALS WORLD, V1-3; Veron J. E. N., 1976, AUSTR I MARINE SCI M, V1; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; Wafar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014613; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wallace CC, 2000, P 9 INT COR REEF S B, V1, P185; Wallace CC, 2012, MEMOIRS QUEENSLAND M; Wells J.W., 1956, TREATISE INVERTEBR F, P328; Wells S., 1995, GLOBAL REPRESENTATIV; Wolstenholme JK, 2003, CORAL REEFS, V22, P155, DOI 10.1007/s00338-003-0299-0; WWF Eastern African Marine Ecoregion, 2004, E AFR MAR EC VIS LAR	101	127	130	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45013	10.1371/journal.pone.0045013	http://dx.doi.org/10.1371/journal.pone.0045013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028737	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388400056
J	Jubair, M; Morris, JG; Ali, A				Jubair, Mohamma; Morris, J. Glenn, Jr.; Ali, Afsar			Survival of Vibrio cholerae in Nutrient-Poor Environments Is Associated with a Novel "Persister'' Phenotype	PLOS ONE			English	Article							EXOPOLYSACCHARIDE PRODUCTION; PSEUDOMONAS-AERUGINOSA; AQUATIC ENVIRONMENT; BACTERIAL BIOFILMS; RESISTANCE; CHLORINE; O1; VIBRIO-CHOLERAE-01; TOLERANCE; STRESS	In response to antibiotic and/or environmental stress, some species of bacteria shift to a "persister'' phenotype. Although toxigenic Vibrio cholerae, responsible for the disease cholera, can be found in nutrient-poor aquatic environments in endemic areas, the underlying mechanism(s) by which culturable cells persist in these environmental reservoirs is largely unknown. Here we report that introduction of V. cholerae into a nutrient-poor filter sterilized lake water (FSLW) microcosm promoted a shift to what we have defined as a "persister'' phenotype (PP) which was culturable for >700 days. Direct transfer of PP of V. cholerae from original microcosms to freshly prepared FSLW resulted in the same pattern of persistence seen in the original microcosms. Scanning electron microscopy of cells persisting for over 700 days demonstrated cell morphologies that were very small in size, with a high degree of aggregation associated with flagella emanating from all aspects of the cell. V. cholerae PP cells reverted to a typical V. cholerae morphology when transferred to nutrient-rich L-broth. Cell-free supernatants obtained from microcosms at 24 hours, 180 days, and 700 days all showed >2-fold increase in CAI-1 signaling molecules, consistent with quorum sensing activity, as has been described for Pseudomonas aeruginosa persister cells. Chitin and phosphate promoted cell growth. Our data suggest that nutrient stress can select a V. cholerae persister phenotype in environmental reservoirs, with these strains then seeding subsequent cholera epidemics in response to chitin and phosphate availability.	[Jubair, Mohamma; Ali, Afsar] Univ Florida, Dept Environm & Global Hlth, Sch Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Morris, J. Glenn, Jr.; Ali, Afsar] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ali, A (corresponding author), Univ Florida, Dept Environm & Global Hlth, Sch Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.	aali@epi.ufl.edu			National Institute of Health [RO1 AI097405, RO1AI3929]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097405, R01AI039129] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institute of Health grants RO1 AI097405 awarded to J G M, and RO1AI3929 awarded to R. Bradley Sack at Johns Hopkins University. A A is the subcontract PI of RO1AI3929 grant.	Alam M, 2007, P NATL ACAD SCI USA, V104, P17801, DOI 10.1073/pnas.0705599104; Ali A, 2002, APPL ENVIRON MICROB, V68, P5773, DOI 10.1128/AEM.68.11.5773-5778.2002; [Anonymous], [No title captured]; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Carrel M, 2009, HEALTH PLACE, V15, P771, DOI 10.1016/j.healthplace.2008.12.008; COLWELL RR, 1985, BIO-TECHNOL, V3, P817, DOI 10.1038/nbt0985-817; Colwell RR, 1994, VIBRIO CHOLERAE CHOL; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Franco AA, 1997, AM J EPIDEMIOL, V146, P1067, DOI 10.1093/oxfordjournals.aje.a009235; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; HUQ A, 1990, APPL ENVIRON MICROB, V56, P2370, DOI 10.1128/AEM.56.8.2370-2373.1990; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kayama S, 2009, FEMS MICROBIOL LETT, V298, P184, DOI 10.1111/j.1574-6968.2009.01717.x; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Meibom KL, 2004, P NATL ACA SCI; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Mols M, 2011, ENVIRON MICROBIOL, V13, P1387, DOI 10.1111/j.1462-2920.2011.02433.x; Morris JG, 2011, EMERG INFECT DIS, V17, P2099, DOI 10.3201/eid1711.111109; Morris JG, 1996, J INFECT DIS, V174, P1364, DOI 10.1093/infdis/174.6.1364; Nelson EJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000187; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; RICE EW, 1992, LANCET, V340, P740, DOI 10.1016/0140-6736(92)92289-R; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648; White PB, 1938, J PATHOL BACTERIOL, V46, P1, DOI 10.1002/path.1700460102; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028	32	40	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45187	10.1371/journal.pone.0045187	http://dx.doi.org/10.1371/journal.pone.0045187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028836	gold, Green Published			2022-12-27	WOS:000311313900096
J	Wang, K; Li, M; Gao, F; Li, SQ; Zhu, YG; Yang, PF				Wang, Kun; Li, Ming; Gao, Feng; Li, Shaoqing; Zhu, Yingguo; Yang, Pingfang			Identification of Conserved and Novel microRNAs from Liriodendron chinense Floral Tissues	PLOS ONE			English	Article							SMALL RNAS; EXPRESSION; GENES; TIME; QUANTIFICATION; BIOGENESIS; EVOLUTION; RESOURCE; GENOMICS; REVEALS	Background: Liriodendron chinense (L. chinense) is an endangered basal angiosperm plant in China because of its low reproductive efficiency. Recently, miRNAs have obtained great attention because they can play important roles. Through high throughput sequencing technique, large amount of miRNAs were identified from different plant species. But there were few studies about the miRNAs in the basal angiosperms especially in the sexual reproduction process. Results: Deep sequencing technology was applied to discover miRNAs in L. chinense flowers at different stages. After bioinformatic analysis, 496 putative conserved miRNAs representing 97 families and 2 novel miRNAs were found. Among them, one is previously regarded as gymnosperm specific. Their expressions were further validated by Real-time PCR for 13 selected miRNAs. Putative targeting genes were predicted and categorized with gene ontology (GO) analysis. About ten percents of the targets are involved in the reproduction process. Further expressional analysis showed that many of these miRNAs were highly related to the reproductive growth. Conclusions: This is the first comprehensive identification of conserved and novel miRNAs in L. chinense. The data presented here might not only help to fill the gap of miRNA registered about basal angiosperm plants but also contribute to understanding the evolution of miRNAs. The differential expression of some of the miRNAs and the prediction of their target genes are also helpful in understanding the regulation of L. chinense sexual reproduction.	[Wang, Kun; Li, Ming; Yang, Pingfang] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China; [Wang, Kun; Gao, Feng; Li, Shaoqing; Zhu, Yingguo] Wuhan Univ, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Wang, Kun; Gao, Feng; Li, Shaoqing; Zhu, Yingguo] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Wuhan University; Wuhan University	Yang, PF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China.	yangpf@wbgcas.cn		Li, Ming/0000-0002-2679-6137	Chinese Academy of Sciences	Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the 100 talents program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Barakat A, 2007, PLANT J, V51, P991, DOI 10.1111/j.1365-313X.2007.03197.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brady BS, 2010, GENE, V462, P18, DOI 10.1016/j.gene.2010.04.007; Cartolano M, 2007, NAT GENET, V39, P901, DOI 10.1038/ng2056; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen ZX, 2001, PLANT PHYSIOL, V126, P473, DOI 10.1104/pp.126.2.473; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai X, 2011, NUCL ACIDS RES; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Huang SQ, 2002, BOT J LINN SOC, V140, P31, DOI 10.1046/j.1095-8339.2002.00080.x; Ivanov R, 2009, PLANT CELL, V21, P2107, DOI 10.1105/tpc.108.063479; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jung JH, 2007, PLANTA, V225, P1327, DOI 10.1007/s00425-006-0439-1; KAMBOJ RK, 1987, PLANT PHYSIOL, V84, P688, DOI 10.1104/pp.84.3.688; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; KOLLOFFEL C, 1982, PLANT PHYSIOL, V69, P143, DOI 10.1104/pp.69.1.143; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li BS, 2009, BIOCHEM BIOPH RES CO, V388, P272, DOI 10.1016/j.bbrc.2009.07.161; Liang CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010698; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Mosher Rebecca A, 2010, Silence, V1, P13, DOI 10.1186/1758-907X-1-13; Ohtake Y, 2000, PLANT CELL PHYSIOL, V41, P1038, DOI 10.1093/pcp/pcd028; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puzey JR, 2009, GENE, V448, P46, DOI 10.1016/j.gene.2009.08.005; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	59	16	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44696	10.1371/journal.pone.0044696	http://dx.doi.org/10.1371/journal.pone.0044696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028583	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900035
J	Xie, M; Liu, M; He, CS				Xie, Mian; Liu, Ming; He, Chao-Sheng			SIRT1 Regulates Endothelial Notch Signaling in Lung Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION; ROLES; P300; HEY2	Background: Sirtuin 1 (SIRT1) acts as a key regulator of vascular endothelial homeostasis, angiogenesis, and endothelial dysfunction. However, the underlying mechanism for SIRT1-mediated lung carcinoma angiogenesis remains unknown. Herein, we report that the nicotinamide adenine dinucleotide 1 (NAD1)-dependent deacetylase SIRT1 can function as an intrinsic negative modulator of Delta-like ligand 4 (DLL4)/Notch signaling in Lewis lung carcinoma (LLC) xenograft-derived vascular endothelial cells (lung cancer-derived ECs). Principal Findings: SIRT1 negatively regulates Notch1 intracellular domain (N1IC) and Notch1 target genes HEY1 and HEY2 in response to Delta-like ligand 4 (DLL4) stimulation. Furthermore, SIRT1 deacetylated and repressed N1IC expression. Quantitative chromatin immunoprecipitation (qChIP) analysis and gene reporter assay demonstrated that SIRT1 bound to one highly conserved region, which was located at approximately -500 bp upstream of the transcriptional start site of Notch1, and repressed Notch1 transcription. Inhibition of endothelial cell growth and sprouting angiogenesis by DLL4/Notch signaling was enhanced in SIRT1-silenced lung cancer-derived EC and rescued by Notch inhibitor DAPT. In vivo, an increase in proangiogenic activity was observed in Matrigel plugs from endothelial-specific SIRT1 knock-in mice. SIRT1 also enhanced tumor neovascularization and tumor growth of LLC xenografts. Conclusions: Our results show that SIRT1 facilitates endothelial cell branching and proliferation to increase vessel density and promote lung tumor growth through down-regulation of DLL4/Notch signaling and deacetylation of N1IC. Thus, targeting SIRT1 activity or/and gene expression may represent a novel mechanism in the treatment of lung cancer.	[Xie, Mian; Liu, Ming] Guangzhou Med Univ, Affiliated Hosp 1, China State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Xie, Mian; Liu, Ming] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China; [He, Chao-Sheng] Guangdong Prov Peoples Hosp, Dept Internal Med, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Xie, M (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, China State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	mianxie@gird.cn			Science and Technology Planning Project of Guangdong Province, China [83050]; Medical Scientific Research Foundation of Guangdong Province, China [A2009265]	Science and Technology Planning Project of Guangdong Province, China; Medical Scientific Research Foundation of Guangdong Province, China	This work was supported by grants from the Science and Technology Planning Project of Guangdong Province, China (number 83050) and the Medical Scientific Research Foundation of Guangdong Province, China (number A2009265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Cen Y, 2011, CURR MED CHEM, V18, P1919, DOI 10.2174/092986711795590084; Chia JS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-175; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Guo SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021467; Hansson ML, 2009, NUCLEIC ACIDS RES, V37, P2996, DOI 10.1093/nar/gkp163; Hunkapiller NM, 2011, DEVELOPMENT, V138, P2987, DOI 10.1242/dev.066589; Johnson KD, 2006, P NATL ACAD SCI USA, V103, P15939, DOI 10.1073/pnas.0604041103; Kume T, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-8; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Laib AM, 2009, NAT PROTOC, V4, P1202, DOI 10.1038/nprot.2009.96; Mulligan P, 2011, MOL CELL, V42, P689, DOI 10.1016/j.molcel.2011.04.020; Mysliwiec MR, 2011, J BIOL CHEM, V286, P17193, DOI 10.1074/jbc.M110.205146; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Park HJ, 2008, J PROTEOME RES, V7, P1138, DOI 10.1021/pr7007237; Potente M, 2008, CELL CYCLE, V7, P2117, DOI 10.4161/cc.7.14.6267; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Qiu XL, 2010, BBA-PROTEINS PROTEOM, V1804, P1576, DOI 10.1016/j.bbapap.2009.09.015; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Yu Hai, 2007, Ai Zheng, V26, P148; Zhang JH, 2011, J BIOL CHEM, V286, P8055, DOI 10.1074/jbc.M110.192641; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	28	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45331	10.1371/journal.pone.0045331	http://dx.doi.org/10.1371/journal.pone.0045331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028940	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900121
J	Foley, TE; Brooks, LR; Gilligan, LJ; Burghardt, PR; Koch, LG; Britton, SL; Fleshner, M				Foley, Teresa E.; Brooks, Leah R.; Gilligan, Lori J.; Burghardt, Paul R.; Koch, Lauren G.; Britton, Steven L.; Fleshner, Monika			Brain Activation Patterns at Exhaustion in Rats That Differ in Inherent Exercise Capacity	PLOS ONE			English	Article							C-FOS EXPRESSION; CORTICOTROPIN-RELEASING-FACTOR; SKELETAL-MUSCLE CAPILLARITY; INTRINSIC AEROBIC CAPACITY; ARTIFICIAL SELECTION; VOLUNTARY ACTIVITY; GENETIC SELECTION; RUNNING CAPACITY; TREADMILL EXERCISE; PROTEOMIC ANALYSIS	In order to further understand the genetic basis for variation in inherent (untrained) exercise capacity, we examined the brains of 32 male rats selectively bred for high or low running capacity (HCR and LCR, respectively). The aim was to characterize the activation patterns of brain regions potentially involved in differences in inherent running capacity between HCR and LCR. Using quantitative in situ hybridization techniques, we measured messenger ribonuclease (mRNA) levels of c-Fos, a marker of neuronal activation, in the brains of HCR and LCR rats after a single bout of acute treadmill running (7.5-15 minutes, 15 degrees slope, 10 m/min) or after treadmill running to exhaustion (15-51 minutes, 15 degrees slope, initial velocity 10 m/min). During verification of trait differences, HCR rats ran six times farther and three times longer prior to exhaustion than LCR rats. Running to exhaustion significantly increased c-Fos mRNA activation of several brain areas in HCR, but LCR failed to show significant elevations of c-Fos mRNA at exhaustion in the majority of areas examined compared to acutely run controls. Results from these studies suggest that there are differences in central c-Fos mRNA expression, and potential brain activation patterns, between HCR and LCR rats during treadmill running to exhaustion and these differences could be involved in the variation in inherent running capacity between lines.	[Foley, Teresa E.; Brooks, Leah R.; Fleshner, Monika] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Foley, Teresa E.; Brooks, Leah R.; Fleshner, Monika] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Gilligan, Lori J.; Koch, Lauren G.; Britton, Steven L.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Burghardt, Paul R.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Burghardt, Paul R.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fleshner, M (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	fleshner@colorado.edu		Fleshner, Monika/0000-0002-0470-0827	National Institute of Health [RR17710, MH068283]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068283] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Health grants RR17710 (to Steven Britton and Lauren Koch) and MH068283 (to Monika Fleshner). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet GN, 2011, EXP PHYSIOL, V96, P1138, DOI 10.1113/expphysiol.2011.057711; Britton S L, 2001, Exerc Sport Sci Rev, V29, P7; Burghardt PR, 2011, NEUROPSYCHOPHARMACOL, V36, P390, DOI 10.1038/npp.2010.144; Burghardt PR, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-53; Burniston JG, 2011, PROTEOMICS, V11, P3369, DOI 10.1002/pmic.201000593; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Bye A, 2008, PHYSL GENOMICS; Bye A, 2008, PHYSIOL GENOMICS, V33, P100, DOI 10.1152/physiolgenomics.00269.2007; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Coleman MA, 1998, PHYSIOL BEHAV, V63, P279, DOI 10.1016/S0031-9384(97)00441-1; COOTE JH, 1971, J PHYSIOL-LONDON, V215, P789, DOI 10.1113/jphysiol.1971.sp009498; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Day HEW, 1996, NEUROENDOCRINOLOGY, V63, P207, DOI 10.1159/000126959; Fornal CA, 2006, BRAIN RES, V1072, P55, DOI 10.1016/j.brainres.2005.12.007; Garland T, 2005, EVOLUTION, V59, P1851, DOI 10.1111/j.0014-3820.2005.tb01832.x; Garland T, 2002, EVOLUTION, V56, P1267; Geisser ME, 2008, NEUROSCI LETT, V443, P37, DOI 10.1016/j.neulet.2008.07.040; Gomes FR, 2009, J EXP BIOL, V212, P238, DOI 10.1242/jeb.025296; Gonzalez NC, 2006, J APPL PHYSIOL, V101, P1288, DOI 10.1152/japplphysiol.01527.2005; Gonzalez NC, 2006, RESP PHYSIOL NEUROBI, V151, P141, DOI 10.1016/j.resp.2005.09.012; Greenwood BN, 2005, BRAIN RES, V1033, P164, DOI 10.1016/j.brainres.2004.11.037; Groves-Chapman JL, 2011, BRAIN RES, V1425, P90, DOI 10.1016/j.brainres.2011.09.059; Hagberg JM, 2011, MED SCI SPORT EXER, V43, P743, DOI 10.1249/MSS.0b013e3182155d21; HANSEN C, 1984, ALCOHOL CLIN EXP RES, V8, P477, DOI 10.1111/j.1530-0277.1984.tb05706.x; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; Hauber W, 1998, PROG NEUROBIOL, V56, P507, DOI 10.1016/S0301-0082(98)00041-0; Henderson KK, 2002, J APPL PHYSIOL, V93, P1265, DOI 10.1152/japplphysiol.00809.2001; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Houle-Leroy P, 2000, J APPL PHYSIOL, V89, P1608, DOI 10.1152/jappl.2000.89.4.1608; Howlett RA, 2003, J APPL PHYSIOL, V94, P1682, DOI 10.1152/japplphysiol.00556.2002; Howlett RA, 2008, J APPL PHYSL; Hoydal MA, 2007, EUR J CARDIOV PREV R, V14, P319, DOI 10.1097/01.hjr.0b013e3280128bef; Hunter CJ, 2008, FRONT BIOSCI-LANDMRK, V13, P347, DOI 10.2741/2684; Hussain SO, 2001, AM J PHYSIOL-REG I, V281, pR1787, DOI 10.1152/ajpregu.2001.281.6.R1787; Ioffe ME, 2007, CEREBELLUM, V6, P87, DOI 10.1080/14734220701216440; IWAMOTO GA, 1984, BRAIN RES, V304, P178, DOI 10.1016/0006-8993(84)90878-3; Iwamoto GA, 1996, BRAIN RES, V726, P109, DOI 10.1016/S0006-8993(96)00303-4; Jee YS, 2008, NEUROSCI LETT, V443, P188, DOI 10.1016/j.neulet.2008.07.078; JONES SL, 1991, PROG BRAIN RES, V88, P381; Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Lalonde R, 2007, PROG NEUROBIOL, V81, P45, DOI 10.1016/j.pneurobio.2006.11.005; Lee MH, 2003, LIFE SCI, V73, P3139, DOI 10.1016/j.lfs.2003.06.005; Liste I, 1997, EXP BRAIN RES, V115, P458, DOI 10.1007/PL00005715; Longhurst J C, 1979, Int Rev Physiol, V18, P125; Magherini F, 2012, J PROTEOMICS, V75, P978, DOI 10.1016/j.jprot.2011.10.017; MAYER DJ, 1984, PROG NEURO-PSYCHOPH, V8, P557, DOI 10.1016/0278-5846(84)90015-0; MITCHELL JH, 1983, ANNU REV PHYSIOL, V45, P229, DOI 10.1146/annurev.ph.45.030183.001305; Muncey AR, 2010, ANESTHESIOLOGY, V113, P1176, DOI 10.1097/ALN.0b013e3181f56248; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; Novak CM, 2010, HORM BEHAV, V58, P355, DOI 10.1016/j.yhbeh.2010.03.013; Oladehin A, 2001, EXP BRAIN RES, V137, P26, DOI 10.1007/s002210000634; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PLOTSKY PM, 1987, ENDOCRINOLOGY, V121, P924, DOI 10.1210/endo-121-3-924; Rezende EL, 2006, J APPL PHYSIOL, V101, P477, DOI 10.1152/japplphysiol.00042.2006; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1243, DOI 10.1037/0735-7044.117.6.1243; Rivas DA, 2011, AM J PHYSIOL-REG I, V300, pR835, DOI 10.1152/ajpregu.00659.2010; Rosenfeld J P, 1994, Int J Neurosci, V74, P161; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Scott SH, 2008, J PHYSIOL-LONDON, V586, P1217, DOI 10.1113/jphysiol.2007.146068; Shephard R J, 1975, Exerc Sport Sci Rev, V3, P1; Sim YJ, 2008, BRAIN DEV-JPN, V30, P118, DOI 10.1016/j.braindev.2007.07.003; Soya H, 2007, NEUROSCI RES, V58, P341, DOI 10.1016/j.neures.2007.04.004; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Spargo FJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1631, DOI 10.1152/ajpendo.00702.2006; STAMFORD JA, 1995, BRIT J ANAESTH, V75, P217, DOI 10.1093/bja/75.2.217; Swallow JG, 1998, J APPL PHYSIOL, V84, P69, DOI 10.1152/jappl.1998.84.1.69; Swallow JG, 2005, INTEGR COMP BIOL, V45, P426, DOI 10.1093/icb/45.3.426; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; Templeman NM, 2012, AM J PHYSL REGUL INT; Terjung R, 1979, Exerc Sport Sci Rev, V7, P153; THARP GD, 1975, MED SCI SPORT EXER, V7, P6; Thomas E, 2003, BRAIN RES, V960, P201, DOI 10.1016/S0006-8993(02)03882-9; Timofeeva E, 2003, NEUROENDOCRINOLOGY, V77, P388, DOI 10.1159/000071311; Tomita K, 2008, NEUROSCI LETT, V440, P327, DOI 10.1016/j.neulet.2008.05.109; Tweedie C, 2011, AM J PHYSIOL-REG I, V300, pR544, DOI 10.1152/ajpregu.00250.2010; Walsh B, 2006, J APPL PHYSIOL, V100, P1765, DOI 10.1152/japplphysiol.01533.2005; Waters RP, 2008, PHYSIOL BEHAV, V93, P1044, DOI 10.1016/j.physbeh.2008.01.013; Waters RP, 2010, BRAIN RES, V1357, P53, DOI 10.1016/j.brainres.2010.07.078; Weinberg MS, 2007, NEUROSCIENCE, V150, P478, DOI 10.1016/j.neuroscience.2007.09.013; Welsh JP, 2002, ANN NY ACAD SCI, V978, P188, DOI 10.1111/j.1749-6632.2002.tb07567.x; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yanagita S, 2007, LIFE SCI, V80, P356, DOI 10.1016/j.lfs.2006.09.027; Zhan WZ, 1999, J APPL PHYSIOL, V87, P2326, DOI 10.1152/jappl.1999.87.6.2326	84	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45415	10.1371/journal.pone.0045415	http://dx.doi.org/10.1371/journal.pone.0045415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028992	gold, Green Submitted, Green Published			2022-12-27	WOS:000309742800062
J	Ribas-Maynou, J; Garcia-Peiro, A; Fernandez-Encinas, A; Amengual, MJ; Prada, E; Cortes, P; Navarro, J; Benet, J				Ribas-Maynou, Jordi; Garcia-Peiro, Agustin; Fernandez-Encinas, Alba; Jose Amengual, Maria; Prada, Elena; Cortes, Pilar; Navarro, Joaquima; Benet, Jordi			Double Stranded Sperm DNA Breaks, Measured by Comet Assay, Are Associated with Unexplained Recurrent Miscarriage in Couples without a Female Factor	PLOS ONE			English	Article							OXIDATIVE STRESS; MALE-INFERTILITY; CHROMATIN STRUCTURE; HUMAN SPERMATOZOA; DAMAGE; FRAGMENTATION; MOUSE; CELLS; FERTILIZATION; HAMSTER	It is known that sperm samples from recurrent pregnancy loss (RPL) couples have an increase in their sperm DNA fragmentation (SDF), but no studies have been performed in order to identify differences between single stranded SDF (ssSDF) and double stranded SDF (dsSDF) in these patients. This could be relevant because the type of DNA damage could have different effects. Semen samples were classified attending their clinical status: 25 fertile donors and 20 RPL patients with at least two unexplained first trimester miscarriages. SDF was analysed using alkaline and neutral Comet assay, SCD test and pulsed-field gel electrophoresis (PFGE), and ROC analysis including data from 105 more infertile patients (n = 150) was performed to establish predictive threshold values. SDF for alkaline and neutral Comet, and the SCD test was analysed in these categories of individuals. Data revealed the presence of two subgroups within fertile donors. The values obtained were 21.10 +/- 9.13, 23.35 +/- 10.45 and 12.31 +/- 4.31, respectively, for fertile donors with low values for both ssSDF and dsSDF; 27.86 +/- 12.64, 80.69 +/- 12.67 and 12.43 +/- 5.22, for fertile donors with low ssSDF and high dsSDF; and 33.61 +/- 15.50, 84.64 +/- 11.28 and 19.28 +/- 6.05, for unexplained RPL patients, also showing a low ssSDF and high dsSDF profile. This latter profile was seen in 85% of unexplained RPL and 33% of fertile donors, suggesting that it may be associated to a male risk factor for undergoing RPL. ROC analysis regarding recurrent miscarriage set the cut-off value at 77.50% of dsDNA SDF. PFGE for low ssSDF and high dsSDF profile samples and positive controls treated with DNase, to induce dsDNA breaks, showed a more intense band of about 48 kb, which fits the toroid model of DNA compaction in sperm, pointing out that some nuclease activity may be affecting their sperm DNA in RPL patients. This work identifies a very specific SDF profile related to the paternal risk of having RPL.	[Ribas-Maynou, Jordi; Garcia-Peiro, Agustin; Fernandez-Encinas, Alba; Navarro, Joaquima; Benet, Jordi] Univ Autonoma Barcelona, Catedra Recerca Eugin UAB, Bellaterra, Spain; [Ribas-Maynou, Jordi; Garcia-Peiro, Agustin; Fernandez-Encinas, Alba; Navarro, Joaquima; Benet, Jordi] Univ Autonoma Barcelona, Dept Biol Cel lular Fisiol & Immunol, Bellaterra, Spain; [Jose Amengual, Maria] UAB, Inst Univ Parc Tauli, Corp Sanitaria Parc Tauli, Ctr Diag,UDIAT, Sabadell, Spain; [Prada, Elena] Hosp Univ Mutua de Terrassa, Serv Ginecol, Terrassa, Spain; [Cortes, Pilar] Univ Autonoma Barcelona, Dept Genet & Microbiol, Bellaterra, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Universitario Mutua Terrassa; Autonomous University of Barcelona	Benet, J (corresponding author), Univ Autonoma Barcelona, Catedra Recerca Eugin UAB, Bellaterra, Spain.	jordi.benet@uab.cat	Cortés, Pilar/E-4390-2010; Benet, Jordi/I-1690-2017; Amengual, Maria/AAQ-5543-2021; Ribas-Maynou, Jordi/AAU-3642-2020	Cortés, Pilar/0000-0002-5924-0653; Benet, Jordi/0000-0001-6185-2555; Ribas-Maynou, Jordi/0000-0002-9101-2044; Navarro, Joaquima/0000-0002-9245-2260; Amengual, Maria Jose/0000-0002-5385-3061; FERNANDEZ ENCINAS, ALBA/0000-0003-2701-4739	Fondo de Investigacion Sanitaria [PI080623, PI11/00630]; Generalitat de Catalunya [2009 SGR 1107]; Catedra de Recerca Eugin-UAB; Generalitat de Catalunya	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); Catedra de Recerca Eugin-UAB; Generalitat de Catalunya(Generalitat de Catalunya)	This work has been supported by Fondo de Investigacion Sanitaria (PI080623, PI11/00630), Generalitat de Catalunya (2009 SGR 1107) and Catedra de Recerca Eugin-UAB. J. Ribas-Maynou has a FI grant from the Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalan F, 2012, J ASSIST REPROD GEN, V29, P11, DOI 10.1007/s10815-011-9647-0; Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x; Aitken RJ, 2010, MOL HUM REPROD, V16, P3, DOI 10.1093/molehr/gap059; Aitken RJ, 2011, ASIAN J ANDROL, V13, P36, DOI 10.1038/aja.2010.68; Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x; Al-Hassan S, 2005, ARCH ANDROLOGY, V51, P69, DOI 10.1080/014850190518062; American Society for Reproductive Medicine (ASRM), 2008, REC PREGN LOSS PAT F; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; Bellver J, 2010, HUM REPROD, V25, P1713, DOI 10.1093/humrep/deq098; Bernardini LM, 2004, REPROD BIOMED ONLINE, V9, P312, DOI 10.1016/S1472-6483(10)62147-5; Brahem S, 2011, UROLOGY, V78, P792, DOI 10.1016/j.urology.2011.05.049; Carrell DT, 2003, ARCH ANDROLOGY, V49, P49, DOI 10.1080/01485010290099390; Collodel G, 2011, UROLOGY, V78, P796; Collodel G, 2011, UROLOGY, V41, P352; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; de la Calle JFV, 2008, FERTIL STERIL, V90, P1792, DOI 10.1016/j.fertnstert.2007.09.021; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Dewan S, 2006, FERTIL STERIL, V85, P441, DOI 10.1016/j.fertnstert.2005.08.035; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002859.pub2; Enciso M, 2009, REPROD BIOMED ONLINE, V18, P609, DOI 10.1016/S1472-6483(10)60003-X; Evenson Donald, 2000, Methods in Cell Science, V22, P169, DOI 10.1023/A:1009844109023; EVENSON DP, 1980, CHROMOSOMA, V78, P225, DOI 10.1007/BF00328394; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Fernandez JL, 2005, FERTIL STERIL, V84, P833, DOI 10.1016/j.fertnstert.2004.11.089; Garcia-Peiro A, 2011, INT J ANDROL, V34, pE546, DOI 10.1111/j.1365-2605.2011.01153.x; Gil-Villa AM, 2010, FERTIL STERIL, V94, P1465, DOI 10.1016/j.fertnstert.2009.05.042; GORCZYCA W, 1993, CANCER RES, V53, P1945; Karaer A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.013; Kovalevsky G, 2004, ARCH INTERN MED, V164, P558, DOI 10.1001/archinte.164.5.558; Lewis SEM, 2005, CELL TISSUE RES, V322, P33, DOI 10.1007/s00441-005-1097-5; Lewis SEM, 2007, REPRODUCTION, V134, P31, DOI 10.1530/REP-07-0152; Lewis SEM, 2010, HUM FERTIL, V13, P201, DOI 10.3109/14647273.2010.528823; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Maione B, 1997, DNA CELL BIOL, V16, P1087, DOI 10.1089/dna.1997.16.1087; Makker K, 2009, INDIAN J MED RES, V129, P357; Meseguer M, 2008, FERTIL STERIL, V89, P1191, DOI 10.1016/j.fertnstert.2007.05.005; Mitchell LA, 2011, INT J ANDROL, V34, P2, DOI 10.1111/j.1365-2605.2009.01042.x; Mudrak O, 2005, J CELL SCI, V118, P4541, DOI 10.1242/jcs.02581; Porter TF, 2005, BEST PRACT RES CL OB, V19, P85, DOI 10.1016/j.bpobgyn.2004.11.005; Ribas-Maynou J, 2012, HUM REPROD, V27, P652, DOI 10.1093/humrep/der461; Sailer BL, 1997, J ANDROL, V18, P294; Sakkas D, 2010, FERTIL STERIL, V93, P1027, DOI 10.1016/j.fertnstert.2009.10.046; Sharma RK, 2010, UROLOGY, V76, P1380, DOI 10.1016/j.urology.2010.04.036; Simon L, 2011, SYST BIOL REPROD MED, V57, P133, DOI 10.3109/19396368.2011.553984; Simon L, 2011, FERTIL STERIL, V95, P652, DOI 10.1016/j.fertnstert.2010.08.019; Solov'eva L, 2004, CHROMOSOME RES, V12, P817, DOI 10.1007/s10577-005-5513-1; Sotolongo B, 2005, J ANDROL, V26, P272; Sotolongo B, 2003, BIOL REPROD, V69, P2029, DOI 10.1095/biolreprod.103.020594; Tremellen K, 2008, HUM REPROD UPDATE, V14, P243, DOI 10.1093/humupd/dmn004; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Wold ASD, 2006, SEMIN REPROD MED, V24, P25; Yamauchi Y, 2007, BIOL REPROD, V77, P407, DOI 10.1095/biolreprod.107.061473; Zalenskaya IA, 2004, CHROMOSOME RES, V12, P163, DOI 10.1023/B:CHRO.0000013166.04629.97; Zini A, 2011, SYST BIOL REPROD MED, V57, P78, DOI 10.3109/19396368.2010.515704	54	74	77	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44679	10.1371/journal.pone.0044679	http://dx.doi.org/10.1371/journal.pone.0044679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028579	Green Submitted, Green Published, gold			2022-12-27	WOS:000309742800014
J	Amorim, JH; Bizerra, RSP; Alves, RPD; Sbrogio-Almeida, ME; Levi, JE; Capurro, ML; Ferreira, LCD				Amorim, Jaime Henrique; Pereira Bizerra, Raiza Sales; dos Santos Alves, Rubens Prince; Sbrogio-Almeida, Maria Elisabete; Levi, Jose Eduardo; Capurro, Margareth Lara; de Souza Ferreira, Luis Carlos			A Genetic and Pathologic Study of a DENV2 Clinical Isolate Capable of Inducing Encephalitis and Hematological Disturbances in Immunocompetent Mice	PLOS ONE			English	Article							DENGUE VIRUS-INFECTION; DOMAIN-III; HEMORRHAGIC-FEVER; NS1 PROTEIN; MOUSE MODEL; PATHOGENESIS; RECOMBINANT; MANIFESTATIONS; DETERMINANTS; REPLICATION	Dengue virus (DENV) is the causative agent of dengue fever (DF), a mosquito-borne illness endemic to tropical and subtropical regions. There is currently no effective drug or vaccine formulation for the prevention of DF and its more severe forms, i.e., dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). There are two generally available experimental models for the study of DENV pathogenicity as well as the evaluation of potential vaccine candidates. The first model consists of non-human primates, which do not develop symptoms but rather a transient viremia. Second, mouse-adapted virus strains or immunocompromised mouse lineages are utilized, which display some of the pathological features of the infection observed in humans but may not be relevant to the results with regard to the wild-type original virus strains or mouse lineages. In this study, we describe a genetic and pathological study of a DENV2 clinical isolate, named JHA1, which is naturally capable of infecting and killing Balb/c mice and reproduces some of the symptoms observed in DENV-infected subjects. Sequence analyses demonstrated that the JHA1 isolate belongs to the American genotype group and carries genetic markers previously associated with neurovirulence in mouse-adapted virus strains. The JHA1 strain was lethal to immunocompetent mice following intracranial (i.c.) inoculation with a LD50 of approximately 50 PFU. Mice infected with the JHA1 strain lost weight and exhibited general tissue damage and hematological disturbances, with similarity to those symptoms observed in infected humans. In addition, it was demonstrated that the JHA1 strain shares immunological determinants with the DENV2 NGC reference strain, as evaluated by cross-reactivity of anti-envelope glycoprotein (domain III) antibodies. The present results indicate that the JHA1 isolate may be a useful tool in the study of DENV pathogenicity and will help in the evaluation of anti-DENV vaccine formulations as well as potential therapeutic approaches.	[Amorim, Jaime Henrique; Pereira Bizerra, Raiza Sales; dos Santos Alves, Rubens Prince; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Dept Microbiol, Vaccine Dev Lab, BR-05508 Sao Paulo, Brazil; [dos Santos Alves, Rubens Prince] Univ Estadual Santa Cruz, Ilheus, Brazil; [Sbrogio-Almeida, Maria Elisabete] Butantan Inst, Sao Paulo, Brazil; [Levi, Jose Eduardo] Univ Sao Paulo, Inst Trop Med, BR-05508 Sao Paulo, Brazil; [Capurro, Margareth Lara] Univ Sao Paulo, Dept Parasitol, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Santa Cruz; Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Amorim, JH (corresponding author), Univ Sao Paulo, Dept Microbiol, Vaccine Dev Lab, BR-05508 Sao Paulo, Brazil.	lcsf@usp.br	Ferreira, Luis Carlos S/M-3954-2014; Capurro, Margareth L/F-8679-2012; Capurro, Margareth/M-5286-2019; Alves, Rubens/AAQ-9780-2021; Amorim, Jaime Henrique/O-9222-2017	Ferreira, Luis Carlos S/0000-0002-4883-1693; Capurro, Margareth L/0000-0002-7480-2116; Alves, Rubens/0000-0001-5538-6025; Amorim, Jaime Henrique/0000-0002-0623-2879	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant [2009/50033-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant process 2009/50033-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amaral DC, 2011, J NEUROINFLAMM, V9, P8; Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034; Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003; Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; Azevedo AS, 2011, PLOS ONE, V7; Bhardwaj S, 2001, J VIROL, V75, P4002, DOI 10.1128/JVI.75.8.4002-4007.2001; Blaney JE, 2005, J VIROL, V79, P5516, DOI 10.1128/JVI.79.9.5516-5528.2005; Bray M, 1998, J VIROL, V72, P1647, DOI 10.1128/JVI.72.2.1647-1651.1998; Chang SF, 2010, J CLIN MICROBIOL, V48, P4586, DOI 10.1128/JCM.01228-10; Chen MC, 2009, J IMMUNOL, V183, P1797, DOI 10.4049/jimmunol.0800672; Chin JFL, 2007, MICROBES INFECT, V9, P1, DOI 10.1016/j.micinf.2006.09.009; Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; COLE GA, 1969, AM J EPIDEMIOL, V89, P669, DOI 10.1093/oxfordjournals.aje.a120981; Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059; de Miranda AS, 2012, BEHAV BRAIN RES, V230, P237, DOI 10.1016/j.bbr.2012.02.020; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Ferreira GP, 2010, MICROBES INFECT, V12, P546, DOI 10.1016/j.micinf.2010.03.007; Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278; Gao GP, 2008, HUM GENE THER, V19, P927, DOI 10.1089/hum.2008.011; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Gulati S, 2007, TROP MED INT HEALTH, V12, P1087, DOI 10.1111/j.1365-3156.2007.01891.x; Guzman MG, 2006, REV PANAM SALUD PUBL, V19; Guzman MG, 2012, NAT REV MICROBIOL S, V12, pS7; HALSTEAD SB, 1973, J INFECT DIS, V128, P7, DOI 10.1093/infdis/128.1.7; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; KHO L K, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P83; Kumar SRP, 2010, J GEN VIROL, V91, P707, DOI 10.1099/vir.0.017954-0; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657; Lin CF, 2006, VIRAL IMMUNOL, V19, P127, DOI 10.1089/vim.2006.19.127; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Pandey Basu Dev, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P266; PATEY O, 1993, AM J TROP MED HYG, V48, P793, DOI 10.4269/ajtmh.1993.48.793; Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Row D, 1996, AM J TROP MED HYG, V54, P253, DOI 10.4269/ajtmh.1996.54.253; RUSSELL PK, 1967, J IMMUNOL, V99, P285; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Sambrook J, 1989, MOL CLONING LAB MANU, P1527; Serufo JC, 2006, REV SOC BRASILEIRA M, V5, P465; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; Sun W, 2006, J INFECT DIS, V193, P1658, DOI 10.1086/503372; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; Tan GK, 2009, CURR OPIN INFECT DIS, V22, P302, DOI 10.1097/QCO.0b013e328329ae32; Tanner L, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000196; Thomas L, 2010, AM J TROP MED HYG, V83, P696, DOI 10.4269/ajtmh.2010.10-0138; Velandia-Romero ML, 2012, J NEUROVIROL; Verrastro T, 1996, HEMATOLOGIA HEMOTERA, P1; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Williams KL, 2009, ANN NY ACAD SCI, V1171, pE12, DOI 10.1111/j.1749-6632.2009.05057.x; Yauch LE, 2008, ANTIVIR RES, V80, P87, DOI 10.1016/j.antiviral.2008.06.010; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW180, DOI 10.1093/nar/gki479; Zhang ZS, 2007, J VIROL METHODS, V143, P125, DOI 10.1016/j.jviromet.2007.02.012	66	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44984	10.1371/journal.pone.0044984	http://dx.doi.org/10.1371/journal.pone.0044984			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028722	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700070
J	Iyer, A; Zurolo, E; Prabowo, A; Fluiter, K; Spliet, WGM; van Rijen, PC; Gorter, JA; Aronica, E				Iyer, Anand; Zurolo, Emanuele; Prabowo, Avanita; Fluiter, Kees; Spliet, Wim G. M.; van Rijen, Peter C.; Gorter, Jan A.; Aronica, Eleonora			MicroRNA-146a: A Key Regulator of Astrocyte-Mediated Inflammatory Response	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; NF-KAPPA-B; CORTICAL DYSPLASIA; RAT MODEL; EXPRESSION; INTERLEUKIN-1; EPILEPSY; MALFORMATIONS; ACTIVATION; DISEASE	Increasing evidence supports the involvement of microRNAs (miRNA) in the regulation of inflammation in human neurological disorders. In the present study we investigated the role of miR-146a, a key regulator of the innate immune response, in the modulation of astrocyte-mediated inflammation. Using Taqman PCR and in situ hybridization, we studied the expression of miR-146a in epilepsy-associated glioneuronal lesions which are characterized by prominent activation of the innate immune response. In addition, cultured human astrocytes were used to study the regulation of miR-146a expression in response to proinflammatory cytokines. qPCR and western blot were used to evaluate the effects of overexpression or knockdown of miR-146a on IL-1 beta signaling. Downstream signaling in the IL-1 beta pathway, as well as the expression of IL-6 and COX-2 were evaluated by western blot and ELISA. Release several cytokines was evaluated using a human magnetic multiplex cytokine assay on a LuminexH (R) 100 (TM)/200 (TM) platform. Increased expression of miR-146a was observed in glioneuronal lesions by Taqman PCR. MiR-146a expression in human glial cell cultures was strongly induced by IL-1 beta and blocked by IL-1 beta receptor antagonist. Modulation of miR-146a expression by transfection of astrocytes with anti miR146a or mimic, regulated the mRNA expression levels of downstream targets of miR-146a (IRAK-1, IRAK-2 and TRAF-6) and the expression of IRAK-1 protein. In addition, the expression of IL-6 and COX-2 upon IL-1 beta stimulation was suppressed by increased levels of miR-146a and increased by the reduction of miR-146a. Modulation of miR-146a expression affected also the release of several cytokines such as IL-6 and TNF-alpha. Our observations indicate that in response to inflammatory cues, miR-146a was induced as a negative-feedback regulator of the astrocyte-mediated inflammatory response. This supports an important role of miR-146a in human neurological disorders associated with chronic inflammation and suggests that this miR may represent a novel target for therapeutic strategies.	[Iyer, Anand; Zurolo, Emanuele; Prabowo, Avanita; Aronica, Eleonora] Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, NL-1105 AZ Amsterdam, Netherlands; [Fluiter, Kees] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Spliet, Wim G. M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van Rijen, Peter C.] Univ Med Ctr Utrecht, Dept Neurosurg, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Gorter, Jan A.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Gorter, Jan A.; Aronica, Eleonora] Netherlands Fdn, SEIN Epilepsy Inst, Heemstede, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam	Iyer, A (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neuro Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.aronica@amc.uva.nl	Fluiter, Kees/H-2828-2015	Fluiter, Kees/0000-0003-0898-7260; Iyer, Anand/0000-0001-6821-1048; Aronica, Eleonora/0000-0002-3542-3770	National Epilepsy Fund - "Power of the Small"; Hersenstichting Nederland [NEF 09-05, NEF13-01]; EU [202167, 278486]; KIKA (Stichting Kinderen Kankervrij)	National Epilepsy Fund - "Power of the Small"; Hersenstichting Nederland; EU(European Commission); KIKA (Stichting Kinderen Kankervrij)	This work was supported by the National Epilepsy Fund - "Power of the Small'', the Hersenstichting Nederland (NEF 09-05; NEF13-01); EU FP7 project NeuroGlia (Grant Agreement No 202167) and EU FP7 project DEVELAGE (Grant Agreement No 278486) EA; KIKA (Stichting Kinderen Kankervrij; AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOISI F, 1992, J NEUROSCI RES, V32, P494, DOI 10.1002/jnr.490320405; Aronica E, 2008, NEUROSCIENCE, V151, P272, DOI 10.1016/j.neuroscience.2007.10.036; Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; Aronica E, 2005, EPILEPSIA, V46, P849, DOI 10.1111/j.1528-1167.2005.66604.x; Aronica E, 2005, J NEUROIMMUNOL, V160, P188, DOI 10.1016/j.jneuroim.2004.11.015; Aronica E, 2005, NEUROSCIENCE, V130, P927, DOI 10.1016/j.neuroscience.2004.10.024; Aronica E, 2003, EUR J NEUROSCI, V17, P2106, DOI 10.1046/j.1460-9568.2003.02657.x; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Aronica E, GLIA IN PRESS; Aronica E, 2007, NEUROSCIENTIST, V13, P100, DOI 10.1177/1073858406295832; Aronica E, 2011, EPILEPSIA, V52, P26, DOI 10.1111/j.1528-1167.2011.03033.x; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; Blumcke I, 2011, LANCET NEUROL, V10, P26, DOI 10.1016/S1474-4422(10)70225-8; Blumcke I, 2009, EPILEPTIC DISORD, V11, P181, DOI 10.1684/epd.2009.0261; Boer K, 2008, EPILEPSY RES, V78, P7, DOI 10.1016/j.eplepsyres.2007.10.002; Boer K, 2006, J NEUROIMMUNOL, V173, P188, DOI 10.1016/j.jneuroim.2006.01.002; Boer K, 2010, BRAIN PATHOL, V20, P704, DOI 10.1111/j.1750-3639.2009.00341.x; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Gantier MP, 2010, J INTERF CYTOK RES, V30, P283, DOI 10.1089/jir.2010.0037; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Iyer A, 2010, EPILEPSIA, V51, P1763, DOI 10.1111/j.1528-1167.2010.02547.x; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Li L, 2010, SCAND J IMMUNOL, V71, P227, DOI 10.1111/j.1365-3083.2010.02383.x; Li X, 2011, GENE, V480, P34, DOI 10.1016/j.gene.2011.03.003; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Maroso M, 2011, J INTERN MED, V270, P319, DOI 10.1111/j.1365-2796.2011.02431.x; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mei J, 2011, MOL CELL BIOL, V31, P3584, DOI 10.1128/MCB.05821-11; Omran A, 2012, EPILEPSIA, V53, P1215, DOI 10.1111/j.1528-1167.2012.03540.x; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ravizza T, 2006, NEUROBIOL DIS, V24, P128, DOI 10.1016/j.nbd.2006.06.003; Ravizza T, 2005, EPILEPSIA, V46, P274; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song YJ, 2011, BRAIN RES; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; The WHO, 2020, CLASSIFICATION TUMOU; Thom M, 2012, BRAIN PATHOL, V22, P350, DOI 10.1111/j.1750-3639.2012.00582.x; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Heteren JT, 2008, GLIA, V56, P568, DOI 10.1002/glia.20639; van Thiel PPAM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000428; Vezzani A, 2011, BRAIN BEHAV IMMUN; Vezzani A, 2011, EXP NEUROL; Vezzani A, 2008, EPILEPSIA, V49, P24, DOI 10.1111/j.1528-1167.2008.01490.x; Whichard ZL, 2011, J BIOL CHEM, V286, P4742, DOI 10.1074/jbc.M110.166348; Yasin SA, 2010, ACTA NEUROPATHOL, V120, P85, DOI 10.1007/s00401-010-0677-y; Zurolo E, 2011, BRAIN, V134, P1015, DOI 10.1093/brain/awr032	56	241	258	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44789	10.1371/journal.pone.0044789	http://dx.doi.org/10.1371/journal.pone.0044789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028621	gold, Green Published, Green Submitted			2022-12-27	WOS:000308788700040
J	Liu, SH; Xiao, L; Nelson, C; Hagedorn, C				Liu, Shuanghu; Xiao, Li; Nelson, Cassie; Hagedorn, Curt			A Cell Culture Adapted HCV JFH1 Variant That Increases Viral Titers and Permits the Production of High Titer Infectious Chimeric Reporter Viruses	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; NONSTRUCTURAL PROTEIN 5A; RNA REPLICATION; A VIRUS; COMPENSATORY MUTATIONS; DOMAIN-III; IN-VIVO; NS2; CONTRIBUTES; PROPAGATION	The unique properties of the hepatitis C virus (HCV) JFH1 isolate have made it possible to produce and study HCV in an infectious cell culture system. However, relatively low virus titers restrict some of the uses of this system and preparing infectious chimeric reporter viruses have been difficult. In this study, we report cell culture-adapted mutations in wild-type JFH1 yielding higher titers of infectious particles of both JFH1 and chimeric JFH1 viruses carrying reporter genes. Sequencing analyses determined that ten of the sixteen nonsynonymous mutations were in the NS5A region. Individual viruses harboring specific adaptive mutations were prepared and studied. The mutations in the NS5A region, which included all three domains, were most effective in increasing infectious virus production. Insertion of two reporter genes in JFH1 without the adaptive mutations ablated the production of infectious HCV particles. However, the introduction of specific adaptive mutations in the NS5A region permitted reporter genes, Renilla luciferase (Rluc) and EGFP, to be introduced into JHF1 to produce chimeric HCV-NS5A-EGFP and HCV-NS5A-Rluc reporter viruses at relatively high titers of infectious virus. The quantity of hyperphosphorylated NS5A (p58) was decreased in the adapted JFH1 compared wild type JFH1 and is likely be involved in increased production of infectious virus based on previous studies of p58. The JFH1-derived mutant viruses and chimeric reporter viruses described here provide new tools for studying HCV biology, identifying HCV antivirals, and enable new ways of engineering additional infectious chimeric viruses.	[Liu, Shuanghu; Xiao, Li; Nelson, Cassie; Hagedorn, Curt] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Liu, SH (corresponding author), Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA.	curt.hagedorn@hsc.utah.edu			National Institutes of Health (NIH) [CA63640, CA148068]; Taizhou People's Hospital, Taizhou, China; NATIONAL CANCER INSTITUTE [R21CA148068, R01CA063640, R55CA063640] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taizhou People's Hospital, Taizhou, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health (NIH) grants CA63640 and CA148068 to CH. LX was supported in part by a fellowship from Taizhou People's Hospital, Taizhou, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; ANDRE FE, 1990, PROG MED VIROL, V37, P72; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; BINN LN, 1984, J CLIN MICROBIOL, V20, P28, DOI 10.1128/JCM.20.1.28-33.1984; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Coelmont L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013687; DAEMER RJ, 1981, INFECT IMMUN, V32, P388, DOI 10.1128/IAI.32.1.388-393.1981; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Di Bisceglie AM, 2002, HEPATOLOGY, V36, pS121, DOI 10.1053/jhep.2002.36228; Folkers ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014697; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Han QX, 2009, VIRUS RES, V145, P63, DOI 10.1016/j.virusres.2009.06.005; Hughes M, 2009, J VIROL, V83, P10788, DOI 10.1128/JVI.02406-08; Hughes M, 2009, J GEN VIROL, V90, P1329, DOI 10.1099/vir.0.009332-0; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; Kato T, 2001, J MED VIROL, V64, P334, DOI 10.1002/jmv.1055; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kim S, 2011, J VIROL, V85, P6645, DOI 10.1128/JVI.02156-10; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krieger N, 2001, J VIROL, V75, P4614, DOI 10.1128/JVI.75.10.4614-4624.2001; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07; Liu SH, 2006, J GEN VIROL, V87, P323, DOI 10.1099/vir.0.81407-0; Liu SH, 2011, ANTIVIR RES, V89, P54, DOI 10.1016/j.antiviral.2010.11.004; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Manns MP, 2007, NAT REV DRUG DISCOV, V6, P991, DOI 10.1038/nrd2411; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; Murray CL, 2011, ANNU REV MICROBIOL, V65, P307, DOI 10.1146/annurev-micro-090110-102954; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; PROVOST PJ, 1979, P SOC EXP BIOL MED, V160, P213, DOI 10.3181/00379727-160-40422; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Steinmann E, 2007, PLOS PATHOG, V3, P962, DOI 10.1371/journal.ppat.0030103; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; van Regenmortel M.H.V., 2000, VIRUS TAXONOMY 7 REP; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhong J, 2006, J VIROL, V80, P11082, DOI 10.1128/JVI.01307-06	60	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44965	10.1371/journal.pone.0044965	http://dx.doi.org/10.1371/journal.pone.0044965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028707	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700065
J	Zhan, Z; He, K; Zhu, D; Jiang, D; Huang, YH; Li, Y; Sun, C; Jin, YH				Zhan, Zhuo; He, Kan; Zhu, Dan; Jiang, Dan; Huang, Ying-Hui; Li, Yang; Sun, Chao; Jin, Ying-Hua			Phosphorylation of Rad9 at Serine 328 by Cyclin A-Cdk2 Triggers Apoptosis via Interfering Bcl-xL	PLOS ONE			English	Article							DNA-DAMAGE; PROTEIN FAMILY; HUMAN HOMOLOG; CHECKPOINT; BAX; CDK2; MITOCHONDRIA; ETOPOSIDE; INTERACTS; TRANSLOCATION	Cyclin A-Cdk2, a cell cycle regulated Ser/Thr kinase, plays important roles in a variety of apoptoticprocesses. However, the mechanism of cyclin A-Cdk2 regulated apoptosis remains unclear. Here, we demonstrated that Rad9, a member of the BH3-only subfamily of Bcl-2 proteins, could be phosphorylated by cyclin A-Cdk2 in vitro and in vivo. Cyclin A-Cdk2 catalyzed the phosphorylation of Rad9 at serine 328 in HeLa cells during apoptosis induced by etoposide, an inhibitor of topoisomeraseII. The phosphorylation of Rad9 resulted in its translocation from the nucleus to the mitochondria and its interaction with BclxL. The forced activation of cyclin A-Cdk2 in these cells by the overexpression of cyclin A,triggered Rad9 phosphorylation at serine 328 and thereby promoted the interaction of Rad9 with Bcl-xL and the subsequent initiation of the apoptotic program. The pro-apoptotic effects regulated by the cyclin A-Cdk2 complex were significantly lower in cells transfected with Rad9S328A, an expression vector that encodes a Rad9 mutant that is resistant to cyclin A-Cdk2 phosphorylation. These findings suggest that cyclin A-Cdk2 regulates apoptosis through a mechanism that involves Rad9phosphorylation.	[Zhan, Zhuo; He, Kan; Zhu, Dan; Jiang, Dan; Li, Yang; Sun, Chao; Jin, Ying-Hua] Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Coll Life Sci, Changchun 130023, Peoples R China; [Zhan, Zhuo; Jin, Ying-Hua] Jilin Univ, State Key Lab Supramol Struct & Mat, Changchun 130023, Peoples R China; [Huang, Ying-Hui] Jilin Univ, Ctr Canc, China Japan Union Hosp, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Zhan, Z (corresponding author), Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Coll Life Sci, Changchun 130023, Peoples R China.	yhjin@jlu.edu.cn			National Nature Science Foundation of China [90813003, 30770447, 31070670]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation of China (Projects 90813003, 30770447 and 31070670). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bastin-Coyette L, 2011, BIOCHEM PHARMACOL, V81, P586, DOI 10.1016/j.bcp.2010.12.009; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; Calbo J, 2004, CELL DEATH DIFFER, V11, P1055, DOI 10.1038/sj.cdd.4401481; Card DAG, 2010, J BIOL CHEM, V285, P15653, DOI 10.1074/jbc.M109.096156; Choi JS, 2007, APOPTOSIS, V12, P1229, DOI 10.1007/s10495-006-0047-3; Coultas L, 2003, SEMIN CANCER BIOL, V13, P115, DOI 10.1016/S1044-579X(02)00129-3; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Guo XX, 2011, PROTEIN CELL, V2, P543, DOI 10.1007/s13238-011-1071-9; Hirai I, 2002, J BIOL CHEM, V277, P25722, DOI 10.1074/jbc.M203079200; Hiromura K, 2002, ONCOGENE, V21, P1750, DOI 10.1038/sj.onc.1205238; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Jin YH, 2000, J BIOL CHEM, V275, P30256, DOI 10.1074/jbc.M001902200; Jin YH, 2003, BIOCHEM BIOPH RES CO, V305, P974, DOI 10.1016/S0006-291X(03)00870-2; Komatsu K, 2000, FEBS LETT, V481, P122, DOI 10.1016/S0014-5793(00)01975-X; Komatsu K, 2000, NAT CELL BIOL, V2, P1, DOI 10.1038/71316; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759; Lieberman HB, 2004, CELL CYCLE, V3, P1008; Lieberman HB, 1996, P NATL ACAD SCI USA, V93, P13890, DOI 10.1073/pnas.93.24.13890; Lieberman HB, 2011, J MOL CELL BIOL, V3, P39, DOI 10.1093/jmcb/mjq039; Liu J, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-95; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MURRAY JM, 1991, NUCLEIC ACIDS RES, V19, P3525, DOI 10.1093/nar/19.13.3525; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Rossi R, 2006, CANCER RES, V66, P1675, DOI 10.1158/0008-5472.CAN-05-2741; St Onge RP, 2003, J BIOL CHEM, V278, P26620, DOI 10.1074/jbc.M303134200; St Onge RP, 1999, MOL BIOL CELL, V10, P1985; Volkmer E, 1999, J BIOL CHEM, V274, P567, DOI 10.1074/jbc.274.2.567; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, MOL CELL BIOL, V22, P3292, DOI 10.1128/MCB.22.10.3292-3300.2002; Zhao LX, 2012, J BIOL CHEM, V287, P1054, DOI 10.1074/jbc.M111.264481; Zhu YG, 2011, PROCEEDINGS OF THE ASME INTERNATIONAL MANUFACTURING SCIENCE AND ENGINEERING CONFERENCE 2010, VOL 2, P1, DOI 10.1109/CVPR.2011.5995650	36	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44923	10.1371/journal.pone.0044923	http://dx.doi.org/10.1371/journal.pone.0044923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028682	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700058
J	Mameli, G; Poddighe, L; Mei, A; Uleri, E; Sotgiu, S; Serra, C; Manetti, R; Dolei, A				Mameli, Giuseppe; Poddighe, Luciana; Mei, Alessandra; Uleri, Elena; Sotgiu, Stefano; Serra, Caterina; Manetti, Roberto; Dolei, Antonina			Expression and Activation by Epstein Barr Virus of Human Endogenous Retroviruses-W in Blood Cells and Astrocytes: Inference for Multiple Sclerosis	PLOS ONE			English	Article							REAL-TIME PCR; ENVELOPE GLYCOPROTEIN; HERV-K18 SUPERANTIGEN; INFECTIOUS-MONONUCLEOSIS; MS PATIENTS; B-CELLS; BRAIN; PROTEIN; RNA; IDENTIFICATION	Background: Proposed co-factors triggering the pathogenesis of multiple sclerosis (MS) are the Epstein Barr virus (EBV), and the potentially neuropathogenic MSRV (MS-associated retrovirus) and syncytin-1, of the W family of human endogenous retroviruses. Methodology/Principal Findings: In search of links, the expression of HERV-W/MSRV/syncytin-1, with/without exposure to EBV or to EBV glycoprotein350 (EBVgp350), was studied on peripheral blood mononuclear cells (PBMC) from healthy volunteers and MS patients, and on astrocytes, by discriminatory env-specific RT-PCR assays, and by flow cytometry. Basal expression of HERV-W/MSRV/syncytin-1 occurs in astrocytes and in monocytes, NK, and B, but not in T cells. This uneven expression is amplified in untreated MS patients, and dramatically reduced during therapy. In astrocytes, EBVgp350 stimulates the expression of HERV-W/MSRV/syncytin-1, with requirement of the NF-kappa B pathway. In EBVgp350-treated PBMC, MSRVenv and syncytin-1 transcription is activated in B cells and monocytes, but not in T cells, nor in the highly expressing NK cells. The latter cells, but not the T cells, are activated by proinflammatory cytokines. Conclusions/Significance: In vitro EBV activates the potentially immunopathogenic and neuropathogenic HERV-W/MSRV/syncytin-1, in cells deriving from blood and brain. In vivo, pathogenic outcomes would depend on abnormal situations, as in late EBV primary infection, that is often symptomatic, or/and in the presence of particular host genetic backgrounds. In the blood, HERV-Wenv activation might induce immunopathogenic phenomena linked to its superantigenic properties. In the brain, toxic mechanisms against oligodendrocytes could be established, inducing inflammation, demyelination and axonal damage. Local stimulation by proinflammatory cytokines and other factors might activate further HERV-Ws, contributing to the neuropathogenity. In MS pathogenesis, a possible model could include EBV as initial trigger of future MS, years later, and HERV-W/MSRV/syncytin-1 as actual contributor to MS pathogenicity, in striking parallelism with disease behaviour.	[Mameli, Giuseppe; Poddighe, Luciana; Mei, Alessandra; Uleri, Elena; Serra, Caterina; Dolei, Antonina] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Mameli, Giuseppe; Poddighe, Luciana; Mei, Alessandra; Uleri, Elena; Serra, Caterina; Dolei, Antonina] Univ Sassari, Ctr Excellence Biotechnol Dev & Biodivers Res, I-07100 Sassari, Italy; [Sotgiu, Stefano] Univ Sassari, Dept Neurosci, I-07100 Sassari, Italy; [Sotgiu, Stefano] Univ Sassari, MIS, I-07100 Sassari, Italy; [Manetti, Roberto] Univ Sassari, Dept Clin Expt & Oncol Med, I-07100 Sassari, Italy	University of Sassari; University of Sassari; University of Sassari; University of Sassari; University of Sassari	Dolei, A (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	doleivir@uniss.it	sotgiu, stefano/M-1011-2017	Uleri, Elena/0000-0003-1014-0042; mameli, giuseppe/0000-0002-0286-5433	Fondazione Italiana Sclerosi Multipla Onlus (FISM) [2010/R/16]; Regione Autonoma Sardegna [2010]; Regione Sardegna, POR Sardegna [L.R.7/2007]	Fondazione Italiana Sclerosi Multipla Onlus (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Regione Autonoma Sardegna(Regione Sardegna); Regione Sardegna, POR Sardegna	This work was supported in part by grants from Fondazione Italiana Sclerosi Multipla Onlus (FISM) (grant No 2010/R/16, AD), and from Regione Autonoma Sardegna (grant 2010, AD). AM was supported by a research fellowship of Regione Sardegna, POR Sardegna, FSE 2007-2013, L.R.7/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Annunziato F, 2001, J IMMUNOL, V22, P238; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Antony JM, 2011, BBA-MOL BASIS DIS, V1812, P162, DOI 10.1016/j.bbadis.2010.07.016; Arru Giannina, 2007, Int J Biomed Sci, V3, P292; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Banwell B, 2007, LANCET NEUROL, V6, P773, DOI 10.1016/S1474-4422(07)70196-5; Bhat RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019176; Brudek T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-104; Constantino AA, 2011, NEUROTOX RES, V20, P277, DOI 10.1007/s12640-011-9241-3; D'Addario M, 2000, J MOL BIOL, V298, P765, DOI 10.1006/jmbi.2000.3717; de Parseval N, 2003, J VIROL, V77, P10414, DOI 10.1128/JVI.77.19.10414-10422.2003; de Villiers JNP, 2006, METAB BRAIN DIS, V21, P163, DOI 10.1007/s11011-006-9016-3; Dolei A, 2002, NEUROLOGY, V58, P471, DOI 10.1212/WNL.58.3.471; Dolei Antonina, 2006, Expert Rev Clin Immunol, V2, P149, DOI 10.1586/1744666X.2.1.149; Dolei A, 2009, J NEUROVIROL, V15, P4, DOI 10.1080/13550280802448451; Elia C, 2007, J LEUKOCYTE BIOL, V82, P1212, DOI 10.1189/jlb.0407251; Fatima N, 2011, APPL IMMUNOHISTO M M, V19, P246, DOI 10.1097/PAI.0b013e3181fcf3b4; Firouzi R, 2003, J NEUROVIROL, V9, P79, DOI 10.1080/13550280390173328; Garson JA, 1998, LANCET, V351, P33, DOI 10.1016/S0140-6736(98)24001-3; Garson JA, 2009, AIDS RES HUM RETROV, V25, P377, DOI 10.1089/aid.2008.0270; Gasque P, 1996, J IMMUNOL, V156, P2247; Giovannoni G, 2011, Int MS J, V17, P44; Goldacre MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1032, DOI 10.1136/jech.2003.018366; Handel AE, 2010, PLOS ONE, V5; Hsiao FC, 2006, J IMMUNOL, V177, P2056, DOI 10.4049/jimmunol.177.4.2056; Hsiao FC, 2009, VIROLOGY, V385, P261, DOI 10.1016/j.virol.2008.11.025; Huynh G., 2011, MATH MED BIOL; Ifergan I, 2008, BRAIN, V131, P785, DOI 10.1093/brain/awm295; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Komurian-Pradel F, 1999, VIROLOGY, V260, P1, DOI 10.1006/viro.1999.9792; Lassmann H, 2011, BRAIN, V134, P2772, DOI 10.1093/brain/awr197; Laufer G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-37; Lavillette D, 2002, J VIROL, V76, P6442, DOI 10.1128/JVI.76.13.6442-6452.2002; Lee WJ, 2003, MOL CELLS, V15, P75; Li F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-22; Lucas RM, 2011, J NEUROL NEUROSUR PS, V82, P1142, DOI 10.1136/jnnp-2011-300174; Ludwin Sk, 2011, Int MS J, V17, P39; Lunemann JD, 2010, ANN NEUROL, V67, P159, DOI 10.1002/ana.21886; Mameli G, 2008, J NEUROVIROL, V14, P73, DOI 10.1080/13550280701801107; Mameli G, 2007, VIROLOGY, V362, P120, DOI 10.1016/j.virol.2006.12.019; Mameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0; Mameli G, 2009, J VIROL METHODS, V161, P98, DOI 10.1016/j.jviromet.2009.05.024; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McQualter JL, 2007, J NEUROCHEM, V100, P295, DOI 10.1111/j.1471-4159.2006.04232.x; Mendes A, 2011, ARQ NEURO-PSIQUIAT, V69, P536, DOI 10.1590/S0004-282X2011000400024; Menet C, 1999, J VIROL, V73, P7722, DOI 10.1128/JVI.73.9.7722-7733.1999; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Morandi B, 2008, PHARMACOL RES, V57, P1, DOI 10.1016/j.phrs.2007.11.003; Munger KL, 2011, MULT SCLER J, V17, P1185, DOI 10.1177/1352458511408991; Nellaker C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-44; Nielsen TR, 2009, MULT SCLER J, V15, P431, DOI 10.1177/1352458508100037; Nowak J, 2003, J NEUROVIROL, V9, P112, DOI 10.1080/13550280390173355; Pavlicek A, 2002, GENOME RES, V12, P391, DOI 10.1101/gr.216902; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; Perron H, 2005, J NEUROVIROL, V11, P23, DOI 10.1080/13550280590901741; PERRON H, 1993, J GEN VIROL, V74, P65, DOI 10.1099/0022-1317-74-1-65; Perron H, 2000, J NEUROVIROL, V6, pS67; PERRON H, 1989, RES VIROLOGY, V140, P551, DOI 10.1016/S0923-2516(89)80141-4; Perron H, 2012, MULT SCLER J, V18, P1721, DOI 10.1177/1352458512441381; Perron H, 2010, CLIN REV ALLERG IMMU, V39, P51, DOI 10.1007/s12016-009-8170-x; Petersen T, 2009, J NEUROIMMUNOL, V215, P108, DOI 10.1016/j.jneuroim.2009.08.015; Pfeiffer F, 2011, ACTA NEUROPATHOL, V122, P601, DOI 10.1007/s00401-011-0883-2; Roebke C, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-69; Rolland A, 2006, J IMMUNOL, V176, P7636, DOI 10.4049/jimmunol.176.12.7636; Ruprecht K, 2006, J NEUROVIROL, V12, P65, DOI 10.1080/13550280600614973; Santiago O, 2010, EUR J CLIN MICROBIOL, V29, P857, DOI 10.1007/s10096-010-0940-0; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Serra C, 2003, J NEUROVIROL, V9, P637, DOI 10.1080/714044485; Serra C, 2001, NEUROL SCI, V22, P171, DOI 10.1007/s100720170019; Serra C, 2008, AIDS RES HUM RETROV, V24, P173, DOI 10.1089/aid.2007.0198; Sotgiu S, 2006, MULT SCLER J, V12, P698, DOI 10.1177/1352458506070773; Sotgiu S, 2006, MULT SCLER J, V12, P357, DOI 10.1191/135248506ms1303sr; Sotgiu S, 2002, NEUROLOGY, V59, P1071, DOI 10.1212/WNL.59.7.1071; Sotgiu S, 2010, MULT SCLER, V16, P1248, DOI 10.1177/1352458510376956; Sugano N, 1997, J EXP MED, V186, P731, DOI 10.1084/jem.186.5.731; Surabhi RM, 2002, J VIROL, V76, P12963, DOI 10.1128/JVI.76.24.12963-12973.2002; Sutkowski N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2; Sutkowski N, 2004, J VIROL, V78, P7852, DOI 10.1128/JVI.78.14.7852-7860.2004; Tai AK, 2009, J CLIN VIROL, V46, P47, DOI 10.1016/j.jcv.2009.05.019; Turcanova VL, 2009, J CLIN VIROL, V46, P15, DOI 10.1016/j.jcv.2009.05.015; Weis S, 2007, J NEURAL TRANSM, V114, P261, DOI 10.1007/s00702-006-0544-0; Williams A, 2007, GLIA, V55, P1300, DOI 10.1002/glia.20546; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2	87	101	105	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44991	10.1371/journal.pone.0044991	http://dx.doi.org/10.1371/journal.pone.0044991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028727	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500016
J	Wang, XS; Han, ZZ; He, Y; Liu, L; Bi, YC				Wang, Xiaosha; Han, Zaizhu; He, Yong; Liu, Li; Bi, Yanchao			Resting-State Functional Connectivity Patterns Predict Chinese Word Reading Competency	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; HUMAN BRAIN; SEX-DIFFERENCES; MENTAL ROTATION; WORKING-MEMORY; VISUAL-CORTEX; FORM AREA; NETWORKS; LANGUAGE; MRI	Resting-state functional connectivity (RSFC) offers a novel approach to reveal the temporal synchronization of functionally related brain regions. Recent studies have identified several RSFCs whose strength was associated with reading competence in alphabetic languages. In the present study, we examined the role of intrinsic functional relations for reading a nonalphabetic language - Chinese - by correlating RSFC maps of nine Chinese reading-related seed regions and reaction time in the single-character reading task. We found that Chinese reading efficiency was positively correlated with the connection between left inferior occipital gyrus and left superior parietal lobule, between right posterior fusiform gyrus and right superior parietal lobule, and between left inferior temporal gyrus and left inferior parietal lobule. These results could not be attributed to inter-individual differences arising from the peripheral processes of the reading task such as visual input detection and articulation. The observed RSFC-reading correlation relationships are discussed in the framework of Chinese character reading, including visuospatial analyses and semantic/phonological processes.	[Wang, Xiaosha; Han, Zaizhu; He, Yong; Liu, Li; Bi, Yanchao] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	Bi, YC (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	ybi@bnu.edu.cn	He, Yong/C-2161-2009; He, Yong/Q-5756-2018	He, Yong/0000-0002-7039-2850	Natural Science Foundation of China [81030028, 30870667, 31000500]; Fundamental Research Funds for the Central Universities	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Natural Science Foundation of China (Grant Nos. 81030028, 30870667, 31000500) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Bi YC, 2007, NEUROPSYCHOLOGIA, V45, P2660, DOI 10.1016/j.neuropsychologia.2007.02.007; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burman DD, 2008, NEUROPSYCHOLOGIA, V46, P1349, DOI 10.1016/j.neuropsychologia.2007.12.021; Cao F, 2010, CEREB CORTEX, V20, P1223, DOI 10.1093/cercor/bhp186; Cao F, 2009, HUM BRAIN MAPP, V30, P797, DOI 10.1002/hbm.20546; Chou TL, 2009, EXP BRAIN RES, V198, P465, DOI 10.1007/s00221-009-1942-y; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Crosson B, 1999, BRAIN COGNITION, V40, P414, DOI 10.1006/brcg.1999.1088; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Di Martino A, 2009, AM J PSYCHIAT, V166, P891, DOI 10.1176/appi.ajp.2009.08121894; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frey S, 2004, NEUROIMAGE, V22, P1384, DOI 10.1016/j.neuroimage.2004.03.018; Fu SM, 2002, NEUROIMAGE, V17, P1538, DOI 10.1006/nimg.2002.1155; GIGUERE M, 1988, J COMP NEUROL, V277, P195, DOI 10.1002/cne.902770204; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Koyama MS, 2011, J NEUROSCI, V31, P8617, DOI 10.1523/JNEUROSCI.4865-10.2011; Kuo WJ, 2001, NEUROREPORT, V12, P3997, DOI 10.1097/00001756-200112210-00029; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liu L, 2009, J COGNITIVE NEUROSCI, V21, P1473, DOI 10.1162/jocn.2009.21141; Ma LS, 2011, NEUROIMAGE, V58, P226, DOI 10.1016/j.neuroimage.2011.06.014; Mahon BZ, 2011, TRENDS COGN SCI, V15, P97, DOI 10.1016/j.tics.2011.01.004; Maisog JM, 2008, ANN NY ACAD SCI, V1145, P237, DOI 10.1196/annals.1416.024; McBride-Chang Catherine., 2005, READ WRIT, V18, P99, DOI [10.1007/s11145-004-7343-5, DOI 10.1007/S11145-004-7343-5]; Nadeau SE, 1997, BRAIN LANG, V58, P355, DOI 10.1006/brln.1997.1707; Peng DL, 2003, HUM BRAIN MAPP, V18, P215, DOI 10.1002/hbm.10096; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shannon BJ, 2011, P NATL ACAD SCI USA, V108, P11241, DOI 10.1073/pnas.1108241108; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Siok WT, 2009, CURR BIOL, V19, pR890, DOI 10.1016/j.cub.2009.08.014; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Song X, 2011, PLOS ONE IN PRESS; Sun Y, 2011, BRAIN LANG IN PRESS; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wahl M, 2008, NEURON, V59, P695, DOI 10.1016/j.neuron.2008.07.011; Wechsler D, 2001, WECHSLER INDIVIDUAL, Vsecond; Wechsler D., 1997, WECHSLER ADULT INTEL; Wirth M, 2007, CEREB CORTEX, V17, P1987, DOI 10.1093/cercor/bhl121; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yin W, 1992, DEEP SURFACE DYSLEXI, P349; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zou QH, 2009, HUM BRAIN MAPP, V30, P3066, DOI 10.1002/hbm.20728	68	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44848	10.1371/journal.pone.0044848	http://dx.doi.org/10.1371/journal.pone.0044848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028644	Green Published, gold, Green Submitted			2022-12-27	WOS:000309554700018
J	Zhao, ZK; Wu, LK; Nian, FZ; Ding, GD; Shi, TX; Zhang, DD; Shi, L; Xu, FS; Meng, JL				Zhao, Zunkang; Wu, Likun; Nian, Fuzhao; Ding, Guangda; Shi, Taoxiong; Zhang, Didi; Shi, Lei; Xu, Fangsen; Meng, Jinling			Dissecting Quantitative Trait Loci for Boron Efficiency across Multiple Environments in Brassica napus	PLOS ONE			English	Article							BORIC-ACID; COMPLEX TRAITS; OILSEED RAPE; RHAMNOGALACTURONAN-II; GENETIC ARCHITECTURE; PLANT DEVELOPMENT; FLOWERING TIME; QTL; YIELD; TRANSPORTER	High yield is the most important goal in crop breeding, and boron (B) is an essential micronutrient for plants. However, B deficiency, leading to yield decreases, is an agricultural problem worldwide. Brassica napus is one of the most sensitive crops to B deficiency, and considerable genotypic variation exists among different cultivars in response to B deficiency. To dissect the genetic basis of tolerance to B deficiency in B. napus, we carried out QTL analysis for seed yield and yield-related traits under low and normal B conditions using the double haploid population (TNDH) by two-year and the BQDH population by three-year field trials. In total, 80 putative QTLs and 42 epistatic interactions for seed yield, plant height, branch number, pod number, seed number, seed weight and B efficiency coefficient (BEC) were identified under low and normal B conditions, singly explaining 4.15-23.16% and 0.53-14.38% of the phenotypic variation. An additive effect of putative QTLs was a more important controlling factor than the additive-additive effect of epistatic interactions. Four QTL-by-environment interactions and 7 interactions between epistatic interactions and the environment contributed to 1.27-4.95% and 1.17-3.68% of the phenotypic variation, respectively. The chromosome region on A2 of SYLB-A2 for seed yield under low B condition and BEC-A2 for BEC in the two populations was equivalent to the region of a reported major QTL, BE1. The B. napus homologous genes of Bra020592 and Bra020595 mapped to the A2 region and were speculated to be candidate genes for B efficiency. These findings reveal the complex genetic basis of B efficiency in B. napus. They provide a basis for the fine mapping and cloning of the B efficiency genes and for breeding B-efficient cultivars by marker-assisted selection (MAS).	[Zhao, Zunkang; Wu, Likun; Ding, Guangda; Shi, Taoxiong; Zhang, Didi; Shi, Lei; Xu, Fangsen; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [Zhao, Zunkang; Wu, Likun; Nian, Fuzhao; Ding, Guangda; Shi, Taoxiong; Zhang, Didi; Shi, Lei; Xu, Fangsen] Huazhong Agr Univ, Microelement Res Ctr, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Xu, FS (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	fangsenxu@mail.hzau.edu.cn	Ding, Guangda/AAH-5026-2021; Ding, Guangda/ABG-3651-2020	Ding, Guangda/0000-0003-3702-5087	National Natural Science Foundation of China [30971861]; Fundamental Research Funds for the Central Universities [2011PY150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by the National Natural Science Foundation of China [30971861]: http://www.nsfc.gov.cn/Portal0/default166.htm; and the Fundamental Research Funds for the Central Universities [2011PY150]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Chen W, 2007, THEOR APPL GENET, V115, P849, DOI 10.1007/s00122-007-0613-2; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; CHURCHILL GA, 1994, GENETICS, V138, P963; Cooper M, 2009, CURR OPIN PLANT BIOL, V12, P231, DOI 10.1016/j.pbi.2009.01.006; Dannel F, 2000, AUST J PLANT PHYSIOL, V27, P397; Ding GD, 2012, ANN BOT-LONDON, V109, P747, DOI 10.1093/aob/mcr323; Ding GD, 2011, EUPHYTICA, V181, P305, DOI 10.1007/s10681-011-0428-8; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Fan CC, 2010, THEOR APPL GENET, V121, P1289, DOI 10.1007/s00122-010-1388-4; Gonzalez-Fontes A, 2008, PLANT SIGNAL BEHAV, V3, P24, DOI 10.4161/psb.3.1.4812; Ishii T, 2001, PLANT PHYSIOL, V126, P1698, DOI 10.1104/pp.126.4.1698; Kasajima I, 2010, PHYSIOL PLANTARUM, V139, P80, DOI 10.1111/j.1399-3054.2010.01349.x; Kato Y, 2009, PLANT CELL PHYSIOL, V50, P58, DOI 10.1093/pcp/pcn168; Kaya A, 2009, MOL CELL BIOL, V29, P3665, DOI 10.1128/MCB.01646-08; Kobayashi M, 2004, J EXP BOT, V55, P1441, DOI 10.1093/jxb/erh142; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li HT, 2011, MOL BREEDING, V28, P585, DOI 10.1007/s11032-010-9509-y; Liu J, 2009, PLANT SOIL, V320, P255, DOI 10.1007/s11104-009-9891-6; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Marschner P, 1995, MARSCHNERS MINERAL N, VThird; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Meyer M, 2009, AGRARFORSCHUNG, V16, P262; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Nakagawa Y, 2007, PLANT CELL, V19, P2624, DOI 10.1105/tpc.106.049015; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Quijada PA, 2006, THEOR APPL GENET, V113, P549, DOI 10.1007/s00122-006-0323-1; Quirino BF, 2001, PLANT MOL BIOL, V46, P447, DOI 10.1023/A:1010639015959; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; RAVEN JA, 1980, NEW PHYTOL, V84, P231, DOI 10.1111/j.1469-8137.1980.tb04424.x; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Shi Lei, 2004, Chinese Journal of Oil Crop Sciences, V26, P50; Shi L, 2009, PEDOSPHERE, V19, P403, DOI 10.1016/S1002-0160(09)60132-6; Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069; Sun JH, 2012, MOL BIOL REP, V39, P1963, DOI 10.1007/s11033-011-0930-z; Suwabe K, 2002, THEOR APPL GENET, V104, P1092, DOI 10.1007/s00122-002-0875-7; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Wang Li-Xia, 2002, Acta Genetica Sinica, V29, P741; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang ZH, 2011, PLANT SOIL, V347, P195, DOI 10.1007/s11104-011-0838-3; Wang ZF, 2010, PLANT MOL BIOL, V74, P265, DOI 10.1007/s11103-010-9671-y; Warington K, 1923, ANN BOT-LONDON, V37, P629, DOI 10.1093/oxfordjournals.aob.a089871; Xu FS, 2001, PLANT BREEDING, V120, P319, DOI 10.1046/j.1439-0523.2001.00583.x; Xu G, 2011, ANNU REV PLANT BIOL, V2012.63, P51; Xu YB, 1997, PL BRED RE, V15, P85; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan XL, 2004, PLANT SOIL, V265, P17, DOI 10.1007/s11104-005-0693-1; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Yang M, 2010, THEOR APPL GENET, V121, P181, DOI 10.1007/s00122-010-1301-1; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Zeng CY, 2008, PLANT CELL ENVIRON, V31, P112, DOI 10.1111/j.1365-3040.2007.01745.x; ZENG ZB, 1994, GENETICS, V136, P1457; Zhao H, 2008, MOL BREEDING, V22, P495, DOI 10.1007/s11032-008-9193-3; Zhao JY, 2006, THEOR APPL GENET, V113, P33, DOI 10.1007/s00122-006-0267-5	68	77	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45215	10.1371/journal.pone.0045215	http://dx.doi.org/10.1371/journal.pone.0045215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028855	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700028
J	El-Turk, F; Fauvet, B; Ashrafi, A; Ouertatani-Sakouhi, H; Cho, MK; Neri, M; Cascella, M; Rothlisberger, U; Pojer, F; Zweckstetter, M; Lashuel, H				El-Turk, Farah; Fauvet, Bruno; Ashrafi, Amer; Ouertatani-Sakouhi, Hajer; Cho, Min-Kyu; Neri, Marilisa; Cascella, Michele; Rothlisberger, Ursula; Pojer, Florence; Zweckstetter, Markus; Lashuel, Hilal			Characterization of Molecular Determinants of the Conformational Stability of Macrophage Migration Inhibitory Factor: Leucine 46 Hydrophobic Pocket	PLOS ONE			English	Article							PHENYLPYRUVATE TAUTOMERASE ACTIVITY; FACTOR MIF; CRYSTAL-STRUCTURE; OLIGOMERIZATION STATE; THERAPEUTIC TARGET; PITUITARY-HORMONE; ENDOTOXIC-SHOCK; RECEPTOR CD74; CELL-CYCLE; CYTOKINE	Macrophage Migration Inhibitory Factor (MIF) is a key mediator of inflammatory responses and innate immunity and has been implicated in the pathogenesis of several inflammatory and autoimmune diseases. The oligomerization of MIF, more specifically trimer formation, is essential for its keto-enol tautomerase activity and probably mediates several of its interactions and biological activities, including its binding to its receptor CD74 and activation of certain signaling pathways. Therefore, understanding the molecular factors governing the oligomerization of MIF and the role of quaternary structure in modulating its structural stability and multifunctional properties is crucial for understanding the function of MIF in health and disease. Herein, we describe highly conserved intersubunit interactions involving the hydrophobic packing of the side chain of Leu46 onto the beta-strand beta 3 of one monomer within a hydrophobic pocket from the adjacent monomer constituted by residues Arg11, Val14, Phe18, Leu19, Val39, His40, Val41, Val42, and Pro43. To elucidate the structural significance of these intersubunit interactions and their relative contribution to MIF's trimerization, structural stability and catalytic activity, we generated three point mutations where Leu46 was replaced by glycine (L46G), alanine (L46A) and phenylalanine (L46F), and their structural properties, stability, oligomerization state, and catalytic activity were characterized using a battery of biophysical methods and X-ray crystallography. Our findings provide new insights into the role of the Leu46 hydrophobic pocket in stabilizing the conformational state of MIF in solution. Disrupting the Leu46 hydrophobic interaction perturbs the secondary and tertiary structure of the protein but has no effect on its oligomerization state.	[El-Turk, Farah; Fauvet, Bruno; Ashrafi, Amer; Ouertatani-Sakouhi, Hajer; Lashuel, Hilal] Swiss Fed Inst Technol, Dept Life Sci, Lab Mol & Chem Biol Neurodegenerat, CH-1015 Lausanne, Switzerland; [Cho, Min-Kyu; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Neri, Marilisa; Cascella, Michele; Rothlisberger, Ursula] Swiss Fed Inst Technol, Dept Chem, Lab Computat Chem & Biochem, CH-1015 Lausanne, Switzerland; [Pojer, Florence] Swiss Fed Inst Technol, Dept Life Sci, Global Hlth Inst GHI, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lashuel, H (corresponding author), Swiss Fed Inst Technol, Dept Life Sci, Lab Mol & Chem Biol Neurodegenerat, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Cascella, Michele/K-3256-2012; Lashuel, Hilal/M-3500-2017; Cascella, Michele/Q-6097-2019; Cho, Min-Kyu/H-1303-2011	Cascella, Michele/0000-0003-2266-5399; Cascella, Michele/0000-0003-2266-5399; Cho, Min-Kyu/0000-0003-0537-2340; Zweckstetter, Markus/0000-0002-2536-6581	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation [FE-310000-110027]; Max Planck society; DFG [ZW 71/3-1]	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG))	Financial support for these studies was provided by the Swiss Federal Institute of Technology Lausanne (HLA, FE, HOS), and a grant from the Swiss National Science Foundation (HLA, FE-310000-110027). This work was also supported by the Max Planck society and the DFG (ZW 71/3-1) to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar SMF, 2001, CANCER LETT, V171, P125, DOI 10.1016/S0304-3835(01)00606-1; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bendrat K, 1997, BIOCHEMISTRY-US, V36, P15356, DOI 10.1021/bi971153a; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Branden C, 1991, PREDICTION ENG DESIG, P252; BUCALA R, 1994, CIRC SHOCK, V44, P35; BUCALA R, 1994, IMMUNOL LETT, V43, P23, DOI 10.1016/0165-2478(94)00152-9; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30; Calandra T, 2003, J INFECT DIS, V187, pS385, DOI 10.1086/374752; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Case DAPD, 1999, AMBER 6; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; Cournia Z, 2009, J MED CHEM, V52, P416, DOI 10.1021/jm801100v; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; El-Turk F, 2008, BIOCHEMISTRY-US, V47, P10740, DOI 10.1021/bi800603x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Goddard T. D., SPARKY 3; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOFFMAN DW, 1991, TECHNIQUES IN PROTEIN CHEMISTRY II, P409; Hoi Alberta Y., 2007, Inflammation & Allergy Drug Targets, V6, P183, DOI 10.2174/187152807781696455; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; Kleemann R, 1998, FEBS LETT, V430, P191, DOI 10.1016/S0014-5793(98)00654-1; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Lin XC, 2005, SHOCK, V24, P556, DOI 10.1097/01.shk.0000183238.70374.a8; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Meyer-Siegler KL, 2007, GENES IMMUN, V8, P646, DOI 10.1038/sj.gene.6364427; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Mischke R, 1997, FEBS LETT, V414, P226, DOI 10.1016/S0014-5793(97)01039-9; Mischke R, 1998, FEBS LETT, V427, P85, DOI 10.1016/S0014-5793(98)00400-1; Mitchell RA, 2000, SEMIN CANCER BIOL, V10, P359, DOI 10.1006/scbi.2000.0328; Molnar V, 2005, INT IMMUNOPHARMACOL, V5, P849, DOI 10.1016/j.intimp.2004.12.017; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Morand EF, 2005, INTERN MED J, V35, P419, DOI 10.1111/j.1445-5994.2005.00853.x; Muhlhahn P, 1996, PROTEIN SCI, V5, P2095; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noels H, 2009, TRENDS CARDIOVAS MED, V19, P76, DOI 10.1016/j.tcm.2009.05.002; Orita M, 2001, J MED CHEM, V44, P540, DOI 10.1021/jm000386o; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Philo JS, 2004, BIOPHYS CHEM, V108, P77, DOI 10.1016/j.bpc.2003.10.010; Pyle ME, 2003, J ENDOCRINOL, V176, P103, DOI 10.1677/joe.0.1760103; Radstake Timothy R D J, 2007, Curr Rheumatol Rep, V9, P343, DOI 10.1007/s11926-007-0054-6; Richardson JM, 2009, BIOCHEM BIOPH RES CO, V380, P442, DOI 10.1016/j.bbrc.2009.01.030; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santos LL, 2006, WIEN MED WOCHENSCHR, V156, P11, DOI 10.1007/s10354-005-0243-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stamps SL, 2000, BIOCHEMISTRY-US, V39, P9671, DOI 10.1021/bi000373c; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Suzuki M, 2004, J BIOL CHEM, V279, P21406, DOI 10.1074/jbc.M311416200; Suzuki M, 1996, NAT STRUCT BIOL, V3, P259, DOI 10.1038/nsb0396-259; Swope MD, 1998, J BIOL CHEM, V273, P14877, DOI 10.1074/jbc.273.24.14877; Takahashi A, 1999, MICROBIOL IMMUNOL, V43, P61, DOI 10.1111/j.1348-0421.1999.tb02373.x; Taylor AB, 1999, BIOCHEMISTRY-US, V38, P7444, DOI 10.1021/bi9904048; Tohyama S, 2008, GENE THER, V15, P1513, DOI 10.1038/gt.2008.112; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Xu X, 2007, CANC LETT; Yabunaka N, 2000, DIABETES CARE, V23, P256, DOI 10.2337/diacare.23.2.256; Zerovnik E, 1999, EUR J BIOCHEM, V260, P609, DOI 10.1046/j.1432-1327.1999.00170.x	72	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45024	10.1371/journal.pone.0045024	http://dx.doi.org/10.1371/journal.pone.0045024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028743	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800023
J	Chen, T; Wu, Y; Zhang, YB; Wang, B; Hu, YW; Wang, CS; Jiang, HE				Chen, Tao; Wu, Yan; Zhang, Yongbing; Wang, Bo; Hu, Yaowu; Wang, Changsui; Jiang, Hongen			Archaeobotanical Study of Ancient Food and Cereal Remains at the Astana Cemeteries, Xinjiang, China	PLOS ONE			English	Article							STARCH GRAIN ANALYSIS; YANGHAI TOMBS; COPPER AGE; DIET; L.; MILLET; SITE; BP	Starch grain, phytolith and cereal bran fragments were analyzed in order to identify the food remains including cakes, dumplings, as well as porridge unearthed at the Astana Cemeteries in Turpan of Xinjiang, China. The results suggest that the cakes were made from Triticum aestivum while the dumplings were made from Triticum aestivum, along with Setaria italica. The ingredients of the porridge remains emanated from Panicum miliaceum. Moreover, direct macrobotantical evidence of the utilization of six cereal crops, such as Triticum aestivum, Hordeum vulgare var. coeleste, Panicum miliaceum, Setaria italica, Cannabis sativa, and Oryza sativa in the Turpan region during the Jin and Tang dynasties (about 3rd to 9th centuries) is also presented. All of these cereal crops not only provided food for the survival of the indigenous people, but also spiced up their daily life.	[Chen, Tao; Wu, Yan; Hu, Yaowu; Wang, Changsui; Jiang, Hongen] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Lab Human Evolut, Beijing, Peoples R China; [Chen, Tao; Wu, Yan; Hu, Yaowu; Wang, Changsui; Jiang, Hongen] Chinese Acad Sci, Grad Univ, Dept Sci Hist & Archaeometry, Beijing, Peoples R China; [Zhang, Yongbing] Acad Turfan Xinjiang Uygur Autonomous Reg, Turpan, Peoples R China; [Wang, Bo] Xinjiang Uygur Autonomous Reg Museum, Urumqi, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jiang, HE (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Lab Human Evolut, Beijing, Peoples R China.	jianghongen@gucas.ac.cn			Chinese Academy of Sciences [XDA05130501]; NSFC [41102114, 41002057]	Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the "Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues" of the Chinese Academy of Sciences, Grant No. XDA05130501, the NSFC (41102114), and the NSFC(41002057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton H, 1998, J ARCHAEOL SCI, V25, P1231, DOI 10.1006/jasc.1998.0300; BURTON JH, 1990, J ARCHAEOL SCI, V17, P547, DOI 10.1016/0305-4403(90)90035-4; Dickson C., 1987, CIRCAEA, V4, P95; Gong YW, 2011, J ARCHAEOL SCI, V38, P470, DOI 10.1016/j.jas.2010.10.006; Henry AG, 2008, J ARCHAEOL SCI, V35, P1943, DOI 10.1016/j.jas.2007.12.005; Holden T., 1990, CIRCAEA, V6, P97; Honch NV, 2006, J ARCHAEOL SCI, V33, P1493, DOI 10.1016/j.jas.2006.02.002; Jeraj M, 2009, VEG HIST ARCHAEOBOT, V18, P75, DOI 10.1007/s00334-008-0144-z; Jiang H, 2007, J PALAEOGEOGR, V5, P551; Jiang HE, 2007, J ETHNOPHARMACOL, V113, P409, DOI 10.1016/j.jep.2007.06.020; Jiang HE, 2006, J ETHNOPHARMACOL, V108, P414, DOI 10.1016/j.jep.2006.05.034; Jiang HE, 2007, J ARCHAEOL SCI, V34, P167, DOI 10.1016/j.jas.2006.04.003; Jiang HE, 2009, J ARCHAEOL SCI, V36, P1458, DOI 10.1016/j.jas.2009.02.010; Jones S, 2009, J ARCHAEOL SCI, V36, P2742, DOI 10.1016/j.jas.2009.08.014; KORBERGROHNE U, 1980, FLORA, V170, P189; [李明启 Li Mingqi], 2010, [第四纪研究, Quaternary Sciences], V30, P372; Lu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004448; Piperno DR, 2004, NATURE, V430, P670, DOI 10.1038/nature02734; Samuel D, 1996, SCIENCE, V273, P488, DOI 10.1126/science.273.5274.488; Song X. M., 2003, GAOCHANG KINGDOM IMM; Wang B.H., 1983, AGR ARCHAEOLOGY, P102; Wang BH, 2008, COLLECTED WORK ARCHA, P770; Xinjiang Institute of Archaeology, 2002, WENWU, V6, P4; Xinjiang Institute of Archaeology, 1983, 30 YEARS ARCH XINJ; Xinjiang Uighur Autonomous Region Museum Xinjiang Institute of Archaeology, 2001, SAMP XINJ CHIN REV S; Xinjiang wen wu kao gu yan jiu suo Turfan di qu bo wu guan, 2002, KAOGU, V6, P42; [杨晓燕 Yang Xiaoyan], 2010, [第四纪研究, Quaternary Sciences], V30, P364; Yang XY, 2009, SCI CHINA SER D, V52, P1164, DOI 10.1007/s11430-009-0089-9; 李明启, 2010, [中国科学：地球科学, Scientia Sinica Terrae], V40, P486	29	31	37	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45137	10.1371/journal.pone.0045137	http://dx.doi.org/10.1371/journal.pone.0045137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	014PT	23028807	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388900024
J	Callier, V; Nijhout, HF				Callier, Viviane; Nijhout, H. Frederik			Supply-Side Constraints Are Insufficient to Explain the Ontogenetic Scaling of Metabolic Rate in the Tobacco Hornworm, Manduca sexta	PLOS ONE			English	Article							SIZE; MODEL; SYMMORPHOSIS; BIOLOGY; GROWTH; MIDGUT	Explanations for the hypoallometric scaling of metabolic rate through ontogeny generally fall into two categories: supply-side constraints on delivery of oxygen, or decreased mass-specific intrinsic demand for oxygen. In many animals, supply and demand increase together as the body grows, thus making it impossible to tease apart the relative contributions of changing supply and demand to the observed scaling of metabolic rate. In larval insects, the large components of the tracheal system are set in size at each molt, but then remain constant in size until the next molt. Larvae of Manduca sexta increase up to ten-fold in mass between molts, leading to increased oxygen need without a concomitant increase in supply. At the molt, the tracheal system is shed and replaced with a new, larger one. Due to this discontinuous growth of the tracheal system, insect larvae present an ideal system in which to examine the relative contributions of supply and demand of oxygen to the ontogenetic scaling of metabolic rate. We observed that the metabolic rate at the beginning of successive instars scales hypoallometrically. This decrease in specific intrinsic demand could be due to a decrease in the proportion of highly metabolically active tissues (the midgut) or to a decrease in mitochondrial activity in individual cells. We found that decreased intrinsic demand, mediated by a decrease in the proportion of highly metabolically active tissues in the fifth instar, along with a decrease in the specific mitochondrial activity, contribute to the hypoallometric scaling of metabolic rate.	[Callier, Viviane; Nijhout, H. Frederik] Duke Univ, Dept Biol, Durham, NC USA	Duke University	Callier, V (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	vcallier@gmail.com		Callier, Viviane/0000-0002-9754-560X	National Science Foundation [NSF] [IOS-0641144, IOS-0744952]; Sigma Xi [G2009150531, G20101015155261]; Division Of Integrative Organismal Systems [0744952] Funding Source: National Science Foundation	National Science Foundation [NSF](National Science Foundation (NSF)); Sigma Xi; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation [NSF grants IOS-0641144 and IOS-0744952 to HFN] and Sigma Xi Grants in Aid [G2009150531 and G20101015155261 to VC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banavar JR, 2002, P NATL ACAD SCI USA, V99, P10506, DOI 10.1073/pnas.162216899; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bertalanffy L.von, 1952, Evolution, V6, P387; Blossman-Myer BL, 2010, PHYSIOL BIOCHEM ZOOL, V83, P215, DOI 10.1086/648393; Callier V, 2011, P NATL ACAD SCI USA, V108, P14664, DOI 10.1073/pnas.1106556108; Chown SL, 2007, FUNCT ECOL, V21, P282, DOI 10.1111/j.1365-2435.2007.01245.x; Clarke K. U., 1957, Proceedings of the Royal Entomological Society of London (A), V32, P67; Davies R, 2007, J EXP BIOL, V210, P3798, DOI 10.1242/jeb.003897; GIBELLATO CM, 1994, J EXP ZOOL, V270, P405, DOI 10.1002/jez.1402700410; Glazier DS, 2010, BIOL REV, V85, P111, DOI 10.1111/j.1469-185X.2009.00095.x; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Greenlee KJ, 2004, J EXP BIOL, V207, P509, DOI 10.1242/jeb.00766; Greenlee KJ, 2005, J EXP BIOL, V208, P1385, DOI 10.1242/jeb.01521; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; Ricklefs RE, 2003, FUNCT ECOL, V17, P384, DOI 10.1046/j.1365-2435.2003.00745.x; Savage VM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000171; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SCHNEIDERMAN HA, 1954, BIOL BULL, V106, P238, DOI 10.2307/1538716; Sears KE, 2012, PHYSIOL BIOCHEM ZOOL, V85, P159, DOI 10.1086/664619; SERNETZ M, 1985, J THEOR BIOL, V117, P209, DOI 10.1016/S0022-5193(85)80218-6; Sernetz M, 1982, EXPT BIOL MED, V7, P1; Speakman JR, 2011, J EXP BIOL, V214, P230, DOI 10.1242/jeb.048603; Vandock KP, 2010, J INSECT PHYSIOL, V56, P774, DOI 10.1016/j.jinsphys.2010.01.008; WEIBEL ER, 1992, RESP PHYSIOL, V87, P325, DOI 10.1016/0034-5687(92)90015-O; WEIBEL ER, 1991, P NATL ACAD SCI USA, V88, P10357, DOI 10.1073/pnas.88.22.10357; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2011, AM NAT, V178, P746, DOI 10.1086/662666; White CR, 2009, EVOLUTION, V63, P2658, DOI 10.1111/j.1558-5646.2009.00747.x	31	22	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45455	10.1371/journal.pone.0045455	http://dx.doi.org/10.1371/journal.pone.0045455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029018	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400086
J	Khunjar, WO; Sahin, A; West, AC; Chandran, K; Banta, S				Khunjar, Wendell O.; Sahin, Asli; West, Alan C.; Chandran, Kartik; Banta, Scott			Biomass Production from Electricity Using Ammonia as an Electron Carrier in a Reverse Microbial Fuel Cell	PLOS ONE			English	Article							NITRITE OXIDATION; GLASSY-CARBON; NITROSOMONAS-EUROPAEA; AUTOTROPHIC AMMONIA; CONVERSION; REDUCTION; PATHWAYS; NITRATE	The storage of renewable electrical energy within chemical bonds of biofuels and other chemicals is a route to decreasing petroleum usage. A critical challenge is the efficient transfer of electrons into a biological host that can covert this energy into high energy organic compounds. In this paper, we describe an approach whereby biomass is grown using energy obtained from a soluble mediator that is regenerated electrochemically. The net result is a separate-stage reverse microbial fuel cell (rMFC) that fixes CO2 into biomass using electrical energy. We selected ammonia as a low cost, abundant, safe, and soluble redox mediator that facilitated energy transfer to biomass. Nitrosomonas europaea, a chemolithoautotroph, was used as the biocatalyst due to its inherent capability to utilize ammonia as its sole energy source for growth. An electrochemical reactor was designed for the regeneration of ammonia from nitrite, and current efficiencies of 100% were achieved. Calculations indicated that overall bioproduction efficiency could approach 2.7 +/- 0.2% under optimal electrolysis conditions. The application of chemolithoautotrophy for industrial bioproduction has been largely unexplored, and results suggest that this and related rMFC platforms may enable biofuel and related biochemical production.	[Khunjar, Wendell O.; West, Alan C.; Chandran, Kartik] Columbia Univ, Dept Chem Engn, Dept Earth & Environm Engn, New York, NY 10027 USA	Columbia University	West, AC (corresponding author), Columbia Univ, Dept Chem Engn, Dept Earth & Environm Engn, New York, NY 10027 USA.	acw17@columbia.edu; kc2288@columbia.edu; sbanta@columbia.edu	Chandran, Kartik/O-1202-2013	Chandran, Kartik/0000-0002-7526-3724	Department of Energy through the ARPA-E (Advanced Research Projects Agency-Energy) electrofuels program [DE-AR000060]	Department of Energy through the ARPA-E (Advanced Research Projects Agency-Energy) electrofuels program	This work was funded by the Department of Energy through the ARPA-E (Advanced Research Projects Agency-Energy) electrofuels program (http://arpa-e.energy.gov/ProgramsProjects/Electrofuels.aspx) under grant number DE-AR000060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2008, BIOTECHNOL BIOENG, V100, P1078, DOI 10.1002/bit.21863; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; AWWA APHA WPCF, 1992, STANDARD METHODS EXA; BEADLE CL, 1985, BIOMASS, V8, P119, DOI 10.1016/0144-4565(85)90022-8; Bouzek K, 2001, J APPL ELECTROCHEM, V31, P1185, DOI 10.1023/A:1012755222981; Boyle NR, 2011, METAB ENG, V13, P150, DOI 10.1016/j.ymben.2011.01.005; Cann AF, 2008, APPL MICROBIOL BIOT, V81, P89, DOI 10.1007/s00253-008-1631-y; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Chandran K, 2005, WATER RES, V39, P4969, DOI 10.1016/j.watres.2005.10.001; Chandran K, 2001, WATER RES, V35, P3153, DOI 10.1016/S0043-1354(01)00022-7; Chandran K, 2008, APPL ENVIRON MICROB, V74, P2447, DOI 10.1128/AEM.01940-07; Connor MR, 2009, CURR OPIN BIOTECH, V20, P307, DOI 10.1016/j.copbio.2009.04.002; Cussler E.L., 1997, DIFFUSION MASS TRANS; Dekanski A, 2001, CARBON, V39, P1195, DOI 10.1016/S0008-6223(00)00228-1; Dooley J.J., 2008, LONG TERM AVERAGE CO; Durivault L, 2007, J ALLOY COMPD, V432, P323, DOI 10.1016/j.jallcom.2006.06.023; Gallaway J, 2008, BIOSENS BIOELECTRON, V23, P1229, DOI 10.1016/j.bios.2007.11.004; Gratzel M, 2007, PHILOS T R SOC A, V365, P993, DOI 10.1098/rsta.2006.1963; Guven D, 2009, PROCESS BIOCHEM, V44, P516, DOI 10.1016/j.procbio.2009.01.005; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Henze MG, 1987, FINAL REPORT ACTIVAT; Hoffman T, 1952, BIOCHEM J, V54, P579; HUCKE EE, 1973, J BIOMED MATER RES, V7, P263, DOI 10.1002/jbm.820070318; Jang Y.S., 2011, BIOTECHNOL ADV; Kelly T. D., 2010, HIST STAT MINERAL MA; Khunjar WO, 2011, ENV MICROBIOLO UNPUB; Larkum AWD, 2010, CURR OPIN BIOTECH, V21, P271, DOI 10.1016/j.copbio.2010.03.004; Li H, 2012, SCIENCE, V335, P1596, DOI 10.1126/science.1217643; Lindberg P, 2010, METAB ENG, V12, P70, DOI 10.1016/j.ymben.2009.10.001; Maalouf R, 2006, MAT SCI ENG C-BIO S, V26, P564, DOI 10.1016/j.msec.2005.10.005; Munz G, 2011, CHEMOSPHERE, V83, P720, DOI 10.1016/j.chemosphere.2011.01.058; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Pandit AV, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-76; POLLOCK JTA, 1987, J MATER SCI LETT, V6, P1023, DOI 10.1007/BF01729119; Rabaey K, 2011, CURR OPIN BIOTECH, V22, P371, DOI 10.1016/j.copbio.2011.01.010; Rittmann B.E., 2001, ENV BIOTECHNOLOGY PR, DOI [10.1016/S0958-1669(96)80047-4, DOI 10.1016/S0958-1669(96)80047-4]; Sahin A, 2012, J ELECTROCHEMI UNPUB; Schmachtel S, 2009, J APPL ELECTROCHEM, V39, P1835, DOI 10.1007/s10800-009-9887-1; Smith KM, 2010, APPL MICROBIOL BIOT, V87, P1045, DOI 10.1007/s00253-010-2522-6; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Walker DA, 2009, J APPL PHYCOL, V21, P509, DOI 10.1007/s10811-009-9446-5; Yu R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-70; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024; Zhu Z-G, 2008, CURRENT OPINION BIOT, V19, P152	46	34	38	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44846	10.1371/journal.pone.0044846	http://dx.doi.org/10.1371/journal.pone.0044846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028643	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400043
J	Moreira, RPP; Gomes, LG; Mendonca, BB; Bachega, TASS				Moreira, Ricardo P. P.; Gomes, Larissa G.; Mendonca, Berenice B.; Bachega, Tania A. S. S.			Impact of Glucocorticoid Receptor Gene Polymorphisms on the Metabolic Profile of Adult Patients with the Classical Form of 21-Hydroxylase Deficiency	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; BODY-COMPOSITION; OBESITY; LOCUS	Background: CAH patients have an increased risk of cardiovascular disease, and it remains unknown if lifelong glucocorticoid (GC) treatment is a contributing factor. In the general population, glucocorticoid receptor gene (NR3C1) polymorphisms are associated with an adverse metabolic profile. Our aim was to analyze the association between the NR3C1 polymorphisms and the metabolic profile of CAH patients. Methodology: Sixty-eight adult patients (34SV/34SW) with a mean age of 28.4 +/- 9 years received dexamethasone (mean 0.27 +/- 0.11 mg/day) to obtain normal androgen levels. SW patients also received fludrocortisone (50 mu g/day). Metabolic syndrome (MetS) was defined by the NCEP ATPIII criteria and obesity by BMI >= 30 kg/m(2). NR3C1 alleles were genotyped, and association analyses with phenotype were carried out with Chi-square, t-test and regression analysis. Results: Obesity and MetS were observed in 23.5% and 7.3% of patients, respectively, and were not correlated with GC doses and treatment duration. BMI was positively correlated with blood pressure (BP), triglycerides (TG), LDL-c levels and HOMA-IR and inversely correlated with HDL-c levels. BclI and A3669G variants were found in 26.4% and 9.6% of alleles, respectively. Heterozygotes for the BclI polymorphism presented with higher BMI (29 kg/m(2) +/- 5.3 vs. 26 kg/m(2) +/- 5.3, respectively) and waist circumference (89 cm +/- 12.7 vs. 81 cm +/- 13, respectively) compared to wild-type subjects. Hypertension was found in 12% of patients and heterozygotes for the BclI polymorphism presented higher systolic BP than wild type subjects. Low HDL-c and high TG levels were identified in 30% and 10% of patients, respectively, and were not associated with the NR3C1 polymorphisms. A3669G carriers and non-carriers did not differ. Conclusion: In addition to GC therapy, the BclI GR variant might play an important role in obesity susceptibility in CAH patients. Genotyping of GR polymorphisms could result in the identification of a subgroup at risk patients, allowing for the establishment of personalized treatment and the avoidance of long-term adverse consequences.	[Moreira, Ricardo P. P.; Gomes, Larissa G.; Mendonca, Berenice B.; Bachega, Tania A. S. S.] Univ Sao Paulo, Fac Med, Disciplina Endocrinol, Unidade Endocrinol Desenvolvimento,Lab Hormonios, Sao Paulo, Brazil	Universidade de Sao Paulo	Moreira, RPP (corresponding author), Univ Sao Paulo, Fac Med, Disciplina Endocrinol, Unidade Endocrinol Desenvolvimento,Lab Hormonios, Sao Paulo, Brazil.	paranhos@usp.br	Mendonca, Berenice B/J-6917-2015; Bachega, Tania A S S/C-3361-2013; Mendonca, Berenice/AAS-3742-2021	Mendonca, Berenice B/0000-0003-1762-1084; Bachega, Tania A S S/0000-0002-5219-3153; Mendonca, Berenice/0000-0003-1762-1084; Gomes, Larissa/0000-0002-0902-0142; Moreira, Ricardo/0000-0003-4941-977X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [09/54394-4, 09/54238-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [305117/2009-2, 301339/2008-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by grants from FAPESP #09/54238-2, Moreira RPP by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP #09/54394-4, Bachega TASS by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq #305117/2009-2 and Mendonca BB by CNPq #301339/2008-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Arlt W, J CLIN ENDOCRINOL ME, V95, P5110; Arlt W, 2007, HORM RES, V68, P158, DOI 10.1159/000110615; Bachega TASS, 1998, J CLIN ENDOCR METAB, V83, P4416, DOI 10.1210/jc.83.12.4416; Buemann B, 1997, OBES RES, V5, P186, DOI 10.1002/j.1550-8528.1997.tb00292.x; Charmandari E, 2006, ANN NY ACAD SCI, V1083, P37, DOI 10.1196/annals.1367.005; De Iudicibus S, 2007, GUT, V56, P1319, DOI 10.1136/gut.2006.116160; Debono M, 2009, EUR J ENDOCRINOL, V160, P719, DOI 10.1530/EJE-08-0874; ETXABE J, 1994, CLIN ENDOCRINOL, V40, P479, DOI 10.1111/j.1365-2265.1994.tb02486.x; Fain JN, 2001, PROSTAG OTH LIPID M, V65, P199, DOI 10.1016/S0090-6980(01)00136-8; Falhammar H, EUR J ENDOCRINOL, V164, P285; Falhammar H, 2007, J CLIN ENDOCR METAB, V92, P110, DOI 10.1210/jc.2006-1350; Gergics P, 2006, J STEROID BIOCHEM, V100, P161, DOI 10.1016/j.jsbmb.2006.04.004; KARL M, 1993, J CLIN ENDOCR METAB, V76, P683, DOI 10.1210/jc.76.3.683; Manenschijn L, 2009, ANN NY ACAD SCI, V1179, P179, DOI 10.1111/j.1749-6632.2009.05013.x; Merke DP, 2005, LANCET, V365, P2125, DOI 10.1016/S0140-6736(05)66736-0; Mooij CF, PLOS ONE, V6; Mooij CF, CLIN ENDOCRINOL OXF, V73, P137; Nakazone MA, 2007, REV ASSOC MED BRAS, V53, P407, DOI 10.1590/S0104-42302007000500016; Reisch N, HORM RES PAEDIAT, V76, P73; Rosmond R, 2000, OBES RES, V8, P211, DOI 10.1038/oby.2000.24; Speiser PW, 2003, NEW ENGL J MED, V349, P776, DOI 10.1056/NEJMra021561; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Syed AA, 2008, CLIN ENDOCRINOL, V68, P879, DOI 10.1111/j.1365-2265.2008.03175.x; Tremblay A, 2003, J CLIN ENDOCR METAB, V88, P3141, DOI 10.1210/jc.2002-021521; van den Akker ELT, 2008, ARCH INTERN MED, V168, P33, DOI 10.1001/archinternmed.2007.41; van Rossum EFC, 2004, RECENT PROG HORM RES, V59, P333, DOI 10.1210/rp.59.1.333; Volkl Thomas M K, 2006, Pediatrics, V117, pe98, DOI 10.1542/peds.2005-1005; WATT GCM, 1992, J HYPERTENS, V10, P473, DOI 10.1097/00004872-199205000-00011; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; Zhang HJ, ENDOCRINE, V38, P260; 2001, JAMA, V285, P2486	32	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44893	10.1371/journal.pone.0044893	http://dx.doi.org/10.1371/journal.pone.0044893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028665	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900051
J	Ohtsuka, S; Nishikawa-Torikai, S; Niwa, H				Ohtsuka, Satoshi; Nishikawa-Torikai, Satomi; Niwa, Hitoshi			E-Cadherin Promotes Incorporation of Mouse Epiblast Stem Cells into Normal Development	PLOS ONE			English	Article							PLURIPOTENCY; EMBRYOS; LINES; INACTIVATION; CULTURE; NANOG; OCT4	Mouse epiblast stem cells (mEpiSCs) are pluripotent stem cells derived from epiblasts of postimplantation mouse embryos. Their pluripotency is distinct from that of mouse embryonic stem cells (mESCs) in several cell biological criteria. One of the distinctions is that mEpiSCs contribute either not at all or at much lower efficiency to chimeric embryos after blastocyst injection compared to mESCs. However, here we showed that mEpiSCs can be incorporated into normal development after blastocyst injection by forced expression of the E-cadherin transgene for 2 days in culture. Using this strategy, mEpiSCs gave rise to live-born chimeras from 5% of the manipulated blastocysts. There were no obvious signs of reprogramming of mEpiSCs toward the mESC-like state during the 2 days after induction of the E-cadherin transgene, suggesting that mEpiSCs possess latent ability to integrate into the normal developmental process as its origin, epiblasts.	[Ohtsuka, Satoshi; Nishikawa-Torikai, Satomi; Niwa, Hitoshi] RIKEN Ctr Dev Biol CDB, Kobe, Hyogo, Japan; [Nishikawa-Torikai, Satomi; Niwa, Hitoshi] Japan Sci & Technol Agcy, CREST Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan	RIKEN; Japan Science & Technology Agency (JST)	Niwa, H (corresponding author), RIKEN Ctr Dev Biol CDB, Kobe, Hyogo, Japan.	niwa@cdb.riken.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; RIKEN (Center for Developmental Biology (CDB)) grant; Grants-in-Aid for Scientific Research [21116005] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN (Center for Developmental Biology (CDB)) grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and RIKEN (Center for Developmental Biology (CDB)) grant to H.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Honda A, 2008, REPROD BIOMED ONLINE, V17, P706, DOI 10.1016/S1472-6483(10)60320-3; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Murakami K, 2011, DEVELOPMENT, V138, P197, DOI 10.1242/dev.056606; Nagy A., 1993, Gene targeting: a practical approach., P147; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; TAKEICHI M, 1981, DEV BIOL, V87, P340, DOI 10.1016/0012-1606(81)90157-3; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310	24	49	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45220	10.1371/journal.pone.0045220	http://dx.doi.org/10.1371/journal.pone.0045220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028858	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900100
J	Ouassa, T; Borroni, E; Loukou, GY; Faye-Kette, H; Kouakou, J; Menan, H; Cirillo, DM				Ouassa, Timothee; Borroni, Emanuele; Loukou, Guillaume Yao; Faye-Kette, Hortense; Kouakou, Jacquemin; Menan, Herve; Cirillo, Daniela Maria			High Prevalence of Shared International Type 53 among Mycobacterium tuberculosis Complex Strains in Retreated Patients from Cote d'Ivoire	PLOS ONE			English	Article							GENETIC DIVERSITY; REPETITIVE UNITS; GUINEA-BISSAU; MIRU-VNTRPLUS; EPIDEMIOLOGY; IDENTIFICATION; POLYMORPHISM; RECOMMENDATIONS; INFECTIONS; EVOLUTION	Background: Genotyping methods are useful tools to provide information on tuberculosis epidemic. They can allow a better response from health authorities and the implementation of measures for tuberculosis control. This study aimed to identify the main lineages and clades of Mycobacterium tuberculosis complex strains circulating in Cote d'Ivoire. Methods/Main Findings: Strains isolated from sputum samples of patients ongoing retreatment from all the country were characterized by spoligotyping and by MIRU-VNTR. Profiles obtained by spoligotyping were first compared to the SITVIT/SpoIDB4 database for family assignment. Of 194 strains analysed, 146 (75.3%) belonged to the T lineage. The most predominant spoligotype was the shared international type 53 with 135 strains (69.6%). In contrast with neighbouring countries, LAM (11 strains, 5.7%) and H (9 strains 4.6%) lineages were slightly represented. Only 3 Beijing strains (1.5%) and 4 strains of Mycobacterium africanum (2%) were found. Analysis of the results obtained with MIRU-VNTR revealed also a high level of clustering. Conclusion/Significance: The population of Mycobacterium tuberculosis complex strains among retreatment cases in Cote d'Ivoire exhibits a low diversity, allowing to assume recent transmission and locally based infection.	[Ouassa, Timothee; Loukou, Guillaume Yao; Faye-Kette, Hortense] Univ Cocody, Fac Pharm, Dept Bacteriol & Virol, Abidjan, Cote Ivoire; [Ouassa, Timothee; Menan, Herve] Teaching Hosp Treichville, Ctr Diag & Res AIDS & Opportunist Infect, Abidjan, Cote Ivoire; [Borroni, Emanuele; Cirillo, Daniela Maria] Ist Sci San Raffaele, Emerging Bacterial Pathogen Unit, I-20132 Milan, Italy; [Kouakou, Jacquemin] Natl TB Program, Abidjan, Cote Ivoire	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Ouassa, T (corresponding author), Univ Cocody, Fac Pharm, Dept Bacteriol & Virol, Abidjan, Cote Ivoire.	timouassa@yahoo.fr	Cirillo, Daniela Maria/AAB-3646-2019; Borroni, Emanuele/K-5179-2016	Cirillo, Daniela Maria/0000-0001-6415-1535; Borroni, Emanuele/0000-0001-6780-5119; Ouassa, Timothee Dieudonne/0000-0002-5456-3103	World Health Organization (WHO) through the TB supranational reference laboratory at the San Raffaele (HSR) Scientific Institute; European Respiratory Society Fellowship [STRTF 413-2011]	World Health Organization (WHO) through the TB supranational reference laboratory at the San Raffaele (HSR) Scientific Institute; European Respiratory Society Fellowship	This work was supported by the World Health Organization (WHO) through the TB supranational reference laboratory at the San Raffaele (HSR) Scientific Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The technical assistance by the SRL-Milan (HSR) was partially supported by WHO. TDO was also the recipient of a European Respiratory Society Fellowship (STRTF 413-2011).	Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Ani A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-189; [Anonymous], 2011, GLOB TUB CONTR; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; de Jong BC, 2009, J CLIN MICROBIOL, V47, P994, DOI 10.1128/JCM.01216-08; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Godreuil S, 2007, J CLIN MICROBIOL, V45, P921, DOI 10.1128/JCM.01918-06; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Homolka S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-103; Kallenius G, 1999, J CLIN MICROBIOL, V37, P3872; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Koivula T, 2004, MICROBES INFECT, V6, P272, DOI 10.1016/j.micinf.2003.12.006; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Lazzarini LCO, 2012, INFECT GENET EVOL, V12, P798, DOI 10.1016/j.meegid.2011.08.028; N'guessan K, 2008, J PHARM BIOL SCI, V9, P53; Niang MN, 1999, MICROBES INFECT, V1, P1189, DOI 10.1016/S1286-4579(99)00243-9; Stavrum R, 2009, J CLIN MICROBIOL, V47, P1848, DOI 10.1128/JCM.02167-08; Sun YJ, 2004, J CLIN MICROBIOL, V42, P5058, DOI 10.1128/JCM.42.11.5058-5064.2004; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 1997, MOL MICROBIOL, V26, P991, DOI 10.1046/j.1365-2958.1997.6361999.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO/UNAIDS, 2010, GLOB REP UNAIDS REP; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906	33	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45363	10.1371/journal.pone.0045363	http://dx.doi.org/10.1371/journal.pone.0045363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028962	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900127
J	Wang, DP; Korban, SS; Pusey, PL; Zhao, YF				Wang, Dongping; Korban, Schuyler S.; Pusey, P. Lawrence; Zhao, Youfu			AmyR Is a Novel Negative Regulator of Amylovoran Production in Erwinia amylovora	PLOS ONE			English	Article							FIRE BLIGHT PATHOGEN; RCS PHOSPHORELAY SYSTEM; MOLECULAR ANALYSIS; VIRULENCE; GENE; EXOPOLYSACCHARIDE; IDENTIFICATION; LEVAN; BIOSYNTHESIS; CONSTRUCTION	In this study, we attempted to understand the role of an orphan gene amyR in Erwinia amylovora, a functionally conserved ortholog of ybjN in Escherichia coli, which has recently been characterized. Amylovoran, a high molecular weight acidic heteropolymer exopolysaccharide, is a virulent factor of E. amylovora. As reported earlier, amylovoran production in an amyR knockout mutant was about eight-fold higher than that in the wild type (WT) strain of E. amylovora. When a multicopy plasmid containing the amyR gene was introduced into the amyR mutant or WT strains, amylovoran production was strongly inhibited. Furthermore, amylovoran production was also suppressed in various amylovoran-over-producing mutants, such as grrSA containing multicopies of the amyR gene. Consistent with amylovoran production, an inverse correlation was observed between in vitro expression of amyR and that of amylovoran biosynthetic genes. However, both the amyR knockout mutant and over-expression strains showed reduced levan production, another exopolysaccharide produced by E. amylovora. Virulence assays demonstrated that while the amyR mutant was capable of inducing slightly greater disease severity than that of the WT strain, strains over-expressing the amyR gene did not incite disease on apple shoots or leaves, and only caused reduced disease on immature pear fruits. Microarray studies revealed that amylovoran biosynthesis and related membrane protein-encoding genes were highly expressed in the amyR mutant, but down-regulated in the amyR over-expression strains in vitro. Down-regulation of amylovoran biosynthesis genes in the amyR overexpression strain partially explained why over-expression of amyR led to non-pathogenic or reduced virulence in vivo. These results suggest that AmyR plays an important role in regulating exopolysaccharide production, and thus virulence in E. amylovora.	[Wang, Dongping; Zhao, Youfu] Univ Illinois, Dept Crop Sci, Urbana, IL 61802 USA; [Korban, Schuyler S.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL USA; [Pusey, P. Lawrence] USDA ARS, Tree Fruit Res Lab, Wenatchee, WA 98801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Zhao, YF (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61802 USA.	zhao888@illinois.edu	Wang, Dongping/L-2124-2013		Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2010-65110-20497]	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture	This project was supported by the Agriculture and Food Research Initiative Competitive Grants Program Grant no. 2010-65110-20497 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLEMANN P, 1994, INT J BIOL MACROMOL, V16, P290, DOI 10.1016/0141-8130(94)90058-2; BERNHARD F, 1990, MOL PLANT MICROBE IN, V3, P429, DOI 10.1094/MPMI-3-429; Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325; BUGERT P, 1995, MOL MICROBIOL, V15, P917, DOI 10.1111/j.1365-2958.1995.tb02361.x; Burse A, 2004, MOL PLANT MICROBE IN, V17, P43, DOI 10.1094/MPMI.2004.17.1.43; Chen XN, 2006, BIOCHEM BIOPH RES CO, V345, P834, DOI 10.1016/j.bbrc.2006.04.101; Clarke DJ, 2010, FUTURE MICROBIOL, V5, P1173, DOI 10.2217/FMB.10.83; Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904; Fredericks CE, 2006, MOL MICROBIOL, V61, P734, DOI 10.1111/j.1365-2958.2006.05260.x; GEIER G, 1993, PHYSIOL MOL PLANT P, V42, P387, DOI 10.1006/pmpp.1993.1029; GROSS M, 1992, PHYSIOL MOL PLANT P, V40, P371, DOI 10.1016/0885-5765(92)90029-U; Hildebrand M, 2006, MOL GENET GENOMICS, V275, P310, DOI 10.1007/s00438-005-0085-5; Khan MA, 2012, PLANT MOL BIOL REP, V30, P247, DOI 10.1007/s11105-011-0334-1; Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Mcnally RR, 2012, MOL PLANT PATHOL, V13, P160, DOI 10.1111/j.1364-3703.2011.00738.x; Narra HP, 2008, PROTEOMICS, V8, P4772, DOI 10.1002/pmic.200800061; Nimtz M, 1996, CARBOHYD RES, V287, P59, DOI 10.1016/0008-6215(96)00070-5; Oh CS, 2005, FEMS MICROBIOL LETT, V253, P185, DOI 10.1016/j.femsle.2005.09.051; Sambrook J., 2001, MOL CLONING LAB MANU; Sebaihia M, 2010, J Bacteriol, V192, P2020, DOI 10.1128/JB.00022-10; Wang DP, 2012, MOL PLANT MICROBE IN, V25, P6, DOI 10.1094/MPMI-08-11-0207; Wang DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025293; Wang DP, 2011, PHYTOPATHOLOGY, V101, P710, DOI 10.1094/PHYTO-09-10-0258; Wang DP, 2010, PHYTOPATHOLOGY, V100, P192, DOI 10.1094/PHYTO-100-2-0192; Wang DP, 2009, MOL PLANT PATHOL, V10, P277, DOI 10.1111/j.1364-3703.2008.00531.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Zhang XX, 2007, GENETICS, V176, P2165, DOI 10.1534/genetics.107.075713; Zhang Y, 1999, PHYSIOL MOL PLANT P, V54, P187, DOI 10.1006/pmpp.1999.0198; Zhao YF, 2005, J BACTERIOL, V187, P8088, DOI 10.1128/JB.187.23.8088-8103.2005; Zhao YF, 2006, MOL PLANT MICROBE IN, V19, P644, DOI 10.1094/MPMI-19-0644; Zhao YF, 2011, GENES-BASEL, V2, P627, DOI 10.3390/genes2030627; Zhao YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-245; Zhao YF, 2009, CAN J MICROBIOL, V55, P457, DOI [10.1139/W08-147, 10.1139/w08-147]	34	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45038	10.1371/journal.pone.0045038	http://dx.doi.org/10.1371/journal.pone.0045038			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028751	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900070
J	Waller, BM; Peirce, K; Mitchell, H; Micheletta, J				Waller, Bridget M.; Peirce, Kate; Mitchell, Heidi; Micheletta, Jerome			Evidence of Public Engagement with Science: Visitor Learning at a Zoo-Housed Primate Research Centre	PLOS ONE			English	Article							BEHAVIOR	Primate behavioural and cognitive research is increasingly conducted on direct public view in zoo settings. The potential of such facilities for public engagement with science is often heralded, but evidence of tangible, positive effects on public understanding is rare. Here, the effect of a new zoo-based primate research centre on visitor behaviour, learning and attitudes was assessed using a quasi-experimental design. Zoo visitors approached the primate research centre more often when a scientist was present and working with the primates, and reported greater awareness of primates (including conservation) compared to when the scientist was not present. Visitors also reported greater perceived learning when the scientist was present. Installation of information signage had no main effect on visitor attitudes or learning. Visitors who interacted with the signage, however, demonstrated increased knowledge and understanding when asked about the specific information present on the signs (which was related to the ongoing facial expression research at the research centre). The findings show that primate behaviour research centres on public view can have a demonstrable and beneficial effect on public understanding of science.	[Waller, Bridget M.; Peirce, Kate; Micheletta, Jerome] Univ Portsmouth, Dept Psychol, Ctr Comparat & Evolutionary Psychol, Portsmouth, Hants, England; [Waller, Bridget M.; Mitchell, Heidi; Micheletta, Jerome] Marwell Wildlife, Winchester, Hants, England	University of Portsmouth	Waller, BM (corresponding author), Univ Portsmouth, Dept Psychol, Ctr Comparat & Evolutionary Psychol, Portsmouth, Hants, England.	bridget.waller@port.ac.uk	Micheletta, Jérôme/E-4699-2014	Micheletta, Jérôme/0000-0002-4480-6781; Waller, Bridget/0000-0001-6303-7458				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson US, 2003, ENVIRON BEHAV, V35, P826, DOI 10.1177/0013916503254746; Borun M., 1996, CURATOR, V39, P123, DOI [DOI 10.1111/J.2151-6952.1996.TB01084.X, 10.1111/j.2151-6952.1996.tb01084.x]; Bowler MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034505; Guggisberg AG, 2010, NEUROSCI BIOBEHAV R, V34, P1267, DOI 10.1016/j.neubiorev.2010.03.008; HADIDIAN J, 1980, BEHAVIOUR, V75, P133, DOI 10.1163/156853980X00375; Hasserd J, 2002, ACCELERATING ACHIEVE; HEINRICH CJ, 1992, ANTHROZOOS, V5, P113, DOI 10.2752/089279392787011557; Micheletta J, 2012, ANIM BEHAV, V83, P459, DOI 10.1016/j.anbehav.2011.11.018; Ross SR, 2008, SCIENCE, V319, P1487, DOI 10.1126/science.1154490; Ross SR, 2005, VISITOR STUDIES TODA, V8, P4; Ross SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022050; Ross SR, 2009, ZOO BIOL, V28, P462, DOI 10.1002/zoo.20220; Visscher NC, 2009, ZOO BIOL, V28, P488, DOI 10.1002/zoo.20174; Waller BM, EMOTION REV IN PRESS	15	16	17	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44680	10.1371/journal.pone.0044680	http://dx.doi.org/10.1371/journal.pone.0044680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005ZK	23028580	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000308788700029
J	Hoffmann, CP; Torregrosa, G; Bardy, BG				Hoffmann, Charles P.; Torregrosa, Gerald; Bardy, Benoit G.			Sound Stabilizes Locomotor-Respiratory Coupling and Reduces Energy Cost	PLOS ONE			English	Article							COORDINATION; EXERCISE; RHYTHMS; ENTRAINMENT; FREQUENCY; VENTILATION; CONSTRAINTS; TRANSITION; WALKING; MUSIC	A natural synchronization between locomotor and respiratory systems is known to exist for various species and various forms of locomotion. This Locomotor-Respiratory Coupling (LRC) is fundamental for the energy transfer between the two subsystems during long duration exercise and originates from mechanical and neurological interactions. Different methodologies have been used to compute LRC, giving rise to various and often diverging results in terms of synchronization, (de-)stabilization via information, and associated energy cost. In this article, the theory of nonlinear-coupled oscillators was adopted to characterize LRC, through the model of the sine circle map, and tested it in the context of cycling. Our specific focus was the sound-induced stabilization of LRC and its associated change in energy consumption. In our experimental study, participants were instructed during a cycling exercise to synchronize either their respiration or their pedaling rate with an external auditory stimulus whose rhythm corresponded to their individual preferential breathing or cycling frequencies. Results showed a significant reduction in energy expenditure with auditory stimulation, accompanied by a stabilization of LRC. The sound-induced effect was asymmetrical, with a better stabilizing influence of the metronome on the locomotor system than on the respiratory system. A modification of the respiratory frequency was indeed observed when participants cycled in synchrony with the tone, leading to a transition toward more stable frequency ratios as predicted by the sine circle map. In addition to the classical mechanical and neurological origins of LRC, here we demonstrated using the sine circle map model that information plays an important modulatory role of the synchronization, and has global energetic consequences.	[Hoffmann, Charles P.; Torregrosa, Gerald; Bardy, Benoit G.] Univ Montpellier I, EuroMov, Movement Hlth Lab M2H, Montpellier, France; [Bardy, Benoit G.] Inst Univ France, Paris, France	Universite de Montpellier; Institut Universitaire de France	Hoffmann, CP (corresponding author), Univ Montpellier I, EuroMov, Movement Hlth Lab M2H, Montpellier, France.	charles.hoffmann@univ-montp1.fr	Bardy, Benoît/AAU-3078-2021		European Commission [035005]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by SKILLS, an integrated project (FP6-IST contract #035005) from the European Commission (http://www.skills-ip.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amazeen PG, 2001, J EXP PSYCHOL HUMAN, V27, P1243, DOI 10.1037//0096-1523.27.5.1243; ANSHEL MH, 1978, RES QUART, V49, P109, DOI 10.1080/10671315.1978.10615514; BAK P, 1985, PHYS SCRIPTA, VT9, P50, DOI 10.1088/0031-8949/1985/T9/007; BANZETT RB, 1992, J APPL PHYSIOL, V72, P1922, DOI 10.1152/jappl.1992.72.5.1922; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BECHBACHE RR, 1977, J PHYSIOL-LONDON, V272, P553, DOI 10.1113/jphysiol.1977.sp012059; BERNASCONI P, 1995, EUR J APPL PHYSIOL O, V70, P387, DOI 10.1007/BF00618488; BERNASCONI P, 1993, J PHYSIOL-LONDON, V471, P693, DOI 10.1113/jphysiol.1993.sp019923; Boggs DF, 2002, COMP BIOCHEM PHYS A, V133, P269, DOI 10.1016/S1095-6433(02)00160-5; Bonsignore MR, 1998, MED SCI SPORT EXER, V30, P239, DOI 10.1097/00005768-199802000-00011; BRAMBLE DM, 1983, SCIENCE, V219, P251, DOI 10.1126/science.6849136; BYBLOW WD, 1994, HUM MOVEMENT SCI, V13, P3, DOI 10.1016/0167-9457(94)90027-2; ELDRIDGE FL, 1981, SCIENCE, V211, P844, DOI 10.1126/science.7466362; Fink PW, 2000, EXP BRAIN RES, V134, P9, DOI 10.1007/s002210000439; Gonzales LM, 2010, ECOL PSYCHOL, V22, P1, DOI 10.1080/10407410903493129; Grappe F, 2005, CYCLISME OPTIMISATIO; HAAS F, 1986, J APPL PHYSIOL, V61, P1185, DOI 10.1152/jappl.1986.61.3.1185; Hessler EE, 2010, ACTA PSYCHOL, V133, P96, DOI 10.1016/j.actpsy.2009.10.005; JENSEN MH, 1984, PHYS REV A, V30, P1960, DOI 10.1103/PhysRevA.30.1960; Karageorghis C, 2008, INT J SPORTS MED, V29, P613, DOI 10.1055/s-2007-989266; Karageorghis CI., 2008, SPORT EXERCISE PSYCH, P109; Kelso JAS, 1988, NEURAL SYNERGETIC CO, P271; KOHL J, 1981, EUR J APPL PHYSIOL O, V47, P223, DOI 10.1007/BF00422468; Large EW, 2002, PSYCHOL RES-PSYCH FO, V66, P3, DOI 10.1007/s004260100069; Lee HT, 1997, NEWS PHYSIOL SCI, V12, P273; Lesiuk T., 2005, PSYCHOL MUSIC, V33, P173, DOI [10.1177/0305735605050650, DOI 10.1177/0305735605050650]; MACLENNAN SE, 1994, MED SCI SPORT EXER, V26, P610; MAHLER D A, 1991, Medicine and Science in Sports and Exercise, V23, P1362; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; McDermott WJ, 2003, EUR J APPL PHYSIOL, V89, P435, DOI 10.1007/s00421-003-0831-5; Morin D, 2002, J NEUROSCI, V22, P4756, DOI 10.1523/JNEUROSCI.22-11-04756.2002; PATERSON DJ, 1987, J APPL PHYSIOL, V62, P1767, DOI 10.1152/jappl.1987.62.5.1767; PEPER CE, 1995, BIOL CYBERN, V73, P301, DOI 10.1007/BF00199466; Pikovsky A., 2001, CAMBRIDGE NONLINEAR, V12; Rassler B, 1996, RESP PHYSIOL, V106, P317, DOI 10.1016/S0034-5687(96)00082-5; Rassler B, 2000, EUR J APPL PHYSIOL, V82, P280, DOI 10.1007/s004210000224; Roerdink M, 2008, EXP BRAIN RES, V184, P143, DOI 10.1007/s00221-007-1085-y; ROMANIUK JR, 1994, ACTA NEUROBIOL EXP, V54, P11; Takano N, 1997, EUR J APPL PHYSIOL, V76, P209, DOI 10.1007/s004210050238; Temprado JJ, 2002, NEUROSCI LETT, V329, P314, DOI 10.1016/S0304-3940(02)00455-X; TREFFNER PJ, 1993, J EXP PSYCHOL HUMAN, V19, P1221, DOI 10.1037/0096-1523.19.6.1221; VANALPHEN J, 1994, CAN J APPL PHYSIOL, V19, P432, DOI 10.1139/h94-035; VIALA D, 1987, NEUROSCI LETT, V74, P49, DOI 10.1016/0304-3940(87)90049-8; Villard S, 2005, NEUROSCI LETT, V383, P333, DOI 10.1016/j.neulet.2005.04.047; Wasserman K, 1986, HDB PHYSL 3, V2, P898	45	37	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45206	10.1371/journal.pone.0045206	http://dx.doi.org/10.1371/journal.pone.0045206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KQ	23028849	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500020
J	Keppeke, GD; Nunes, E; Ferraz, MLG; Silva, EAB; Granato, C; Chan, EKL; Andrade, LEC				Keppeke, Gerson Dierley; Nunes, Eunice; Gomes Ferraz, Maria Lucia; Benedito Silva, Eduardo Antonio; Granato, Celso; Chan, Edward K. L.; Andrade, Luis Eduardo C.			Longitudinal Study of a Human Drug-Induced Model of Autoantibody to Cytoplasmic Rods/Rings following HCV Therapy with Ribavirin and Interferon-alpha	PLOS ONE			English	Article							HEPATITIS-C VIRUS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE HEPATITIS; ANTINUCLEAR ANTIBODIES; ANTIVIRAL ACTIVITY; HEALTHY-INDIVIDUALS; DIAGNOSTIC-CRITERIA; REVISED CRITERIA; GENE-EXPRESSION; RNA-POLYMERASE	Background: A novel pattern in the indirect immunofluorescence antinuclear antibody assay on HEp-2 cells (IIF-HEp-2) characterized by cytoplasmic rods and rings (RR) was reported in HCV patients, but stringent disease specificity studies and longitudinal analysis are lacking. We investigated the clinical significance of anti-RR in an HCV cohort with up to a 12-month treatment follow up. Methodology/Results: 597 patients (342 HCV, 55 HCV/HIV, 200 non-HCV) were screened and titered for anti-RR. Serial samples were available from 78 of 176 treated and 27 of 166 untreated patients. Anti-RR was detected in 14.1% of 342 HCV patients, 9.1% of 55 HCV/HIV, 3.4% of 29 Hepatitis B, and none of 171 non-HCV (p<0.0001; HCV versus non-HCV). Anti-RR was present in 38% of 108 patients receiving interferon-alpha/ribavirin, but none in 26 receiving either interferon-alpha or ribavirin, or 166 untreated patients (p<0.0001). Other IIF-HEp-2 patterns were more frequently associated with interferon-alpha treatment alone (52.2%) as compared to interferon-alpha/ribavirin (25%), ribavirin alone (33.3%), and no therapy (26.5%). Anti-RR frequency was not associated with sex, age, ethnicity, HCV genotype or viral load. Anti-RR occurred only after initiation of treatment, beginning as early as 1 month (6%), but by the sixth month >47% tested positive for anti-RR. The anti-RR titer generally increased with sustained treatment and remained high in 53% of patients. After treatment, anti-RR titer was negative in 41%. Non-responders to HCV therapy were 77% in anti-RR-positive versus 64% in anti-RR-negative patients. Response to treatment was not associated with anti-RR titer or the dynamics of anti-RR reactivity during and after treatment. Conclusions: The exquisite association of anti-RR reactivity with combined interferon-a/ribavirin therapy in HCV patients represents a unique model for drug-induced autoantibody generation in humans as demonstrated by the fact that a significant fraction of patients who have anti-RR during therapy becomes anti-RR-negative after completion of therapy.	[Keppeke, Gerson Dierley; Andrade, Luis Eduardo C.] Univ Fed Sao Paulo, Div Rheumatol, Sao Paulo, Brazil; [Nunes, Eunice; Gomes Ferraz, Maria Lucia; Benedito Silva, Eduardo Antonio] Univ Fed Sao Paulo, Div Gastroenterol, Sao Paulo, Brazil; [Granato, Celso] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Granato, Celso; Andrade, Luis Eduardo C.] Fleury Med & Hlth Labs, Div Immunol, Sao Paulo, Brazil; [Chan, Edward K. L.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); State University System of Florida; University of Florida	Andrade, LEC (corresponding author), Univ Fed Sao Paulo, Div Rheumatol, Sao Paulo, Brazil.	Luis.andrade@unifesp.br	Silva, Antonio Eduardo Benedito/N-7911-2013; Andrade, Luis Eduardo C/D-1245-2012; Chan, Edward K. L./B-5671-2009; Keppeke, Gerson Dierley/P-2926-2014	Silva, Antonio Eduardo Benedito/0000-0002-5579-5416; Andrade, Luis Eduardo C/0000-0001-8742-9931; Chan, Edward K. L./0000-0003-3938-9503; Keppeke, Gerson Dierley/0000-0003-0660-2857	Sao Paulo State Research Foundation FAPESP [2010/50710-6]; Brazilian National Council for Research and Technological Development [305064/2011-8]	Sao Paulo State Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Research and Technological Development	This study was supported by grant #2010/50710-6 from Sao Paulo State Research Foundation FAPESP. Luis Andrade receives research grant #305064/2011-8 from Brazilian National Council for Research and Technological Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Bekisz J, 2004, GROWTH FACTORS, V22, P243, DOI 10.1080/08977190400000833; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; BOTTAZZO GF, 1976, J CLIN PATHOL, V29, P403, DOI 10.1136/jcp.29.5.403; Bougie I, 2003, J BIOL CHEM, V278, P52471, DOI 10.1074/jbc.M308917200; Carcamo W, 2009, 9 DRESD S AUT, P127; Carcamo WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029690; Chan EKL, 2008, CYTOPLASMIC RINGS RO; Chen Chih-Hung, 2010, Chang Gung Med J, V33, P258; Covini G, 2011, ANTIVIR THER; Dalekos G N., 2002, Eur J Intern Med, V13, P293, DOI 10.1016/S0953-6205(02)00089-4; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Gale M, 2003, HEPATOLOGY, V37, P975, DOI 10.1053/jhep.2003.50201; GARCIABUEY L, 1995, GASTROENTEROLOGY, V108, P1770, DOI 10.1016/0016-5085(95)90139-6; GILMOUR KC, 1995, GENE EXPRESSION, V5, P1; Guo JT, 2004, VIROLOGY, V325, P71, DOI 10.1016/j.virol.2004.04.031; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Himoto T, 2010, HEPATOL RES, V40, P786, DOI 10.1111/j.1872-034X.2010.00684.x; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hofmann WP, 2008, LIVER INT, V28, P1332, DOI 10.1111/j.1478-3231.2008.01896.x; HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1; Illei GG, 2004, ARTHRITIS RHEUM-US, V50, P1709, DOI 10.1002/art.20344; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Keppeke GD, 2010, AUTOANTIBODIES NOVEL, P108; Liu JL, 2011, BIOESSAYS, V33, P159, DOI 10.1002/bies.201000129; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Lonzetti LS, 2001, ARTHRITIS RHEUM-US, V44, P735; LopezLabrador FX, 1997, J HEPATOL, V27, P959, DOI 10.1016/S0168-8278(97)80137-7; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; MAHANEY K, 1994, HEPATOLOGY, V20, P1405, DOI 10.1002/hep.1840200605; Mariz HA, 2011, ARTHRITIS RHEUM-US, V63, P191, DOI 10.1002/art.30084; Markland W, 2000, ANTIMICROB AGENTS CH, V44, P859, DOI 10.1128/AAC.44.4.859-866.2000; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miller FW, 2003, LANCET, V362, P1762, DOI 10.1016/S0140-6736(03)14862-3; MURATORI L, 1994, J HEPATOL, V21, P199, DOI 10.1016/S0168-8278(05)80395-2; Muratori P, 2002, AUTOIMMUNITY, V35, P497, DOI 10.1080/0891693021000054066; Muratori P, 2003, CLIN EXP IMMUNOL, V131, P118, DOI 10.1046/j.1365-2249.2003.02030.x; Narciso-Schiavon JL, 2009, EUR J GASTROEN HEPAT, V21, P350, DOI 10.1097/MEG.0b013e3283089392; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; NOUSBAUM JB, 1995, ANN INTERN MED, V122, P161, DOI 10.7326/0003-4819-122-3-199502010-00001; Ronnblom L, 2003, ARTHRITIS RES THER, V5, P68, DOI 10.1186/ar625; Ronnblom L, 2001, TRENDS IMMUNOL, V22, P427, DOI 10.1016/S1471-4906(01)01955-X; Satoh M, 2009, MOD RHEUMATOL, V19, P219, DOI 10.1007/s10165-009-0155-3; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Seelig HP, 2011, CLIN LAB, V57, P753; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; TAN EM, 1982, ADV IMMUNOL, V33, P167, DOI 10.1016/S0065-2776(08)60836-6; Williams MJ, 2009, J VIRAL HEPATITIS, V16, P325, DOI 10.1111/j.1365-2893.2008.01035.x; WILLINGHAM MC, 1987, EXP CELL RES, V171, P284, DOI 10.1016/0014-4827(87)90162-5; Yee LJ, 2004, J VIRAL HEPATITIS, V11, P459, DOI 10.1111/j.1365-2893.2004.00530.x; Zhu HZ, 2003, HEPATOLOGY, V37, P1180, DOI 10.1053/jhep.2003.50184; Zusinaite E, 2005, WORLD J GASTROENTERO, V11, P488, DOI 10.3748/wjg.v11.i4.488	58	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45392	10.1371/journal.pone.0045392	http://dx.doi.org/10.1371/journal.pone.0045392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028980	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700036
J	Periaswamy, B; Maier, L; Vishwakarma, V; Slack, E; Kremer, M; Andrews-Polymenis, HL; McClelland, M; Grant, AJ; Suar, M; Hardt, WD				Periaswamy, Balamurugan; Maier, Lisa; Vishwakarma, Vikalp; Slack, Emma; Kremer, Marcus; Andrews-Polymenis, Helene L.; McClelland, Michael; Grant, Andrew J.; Suar, Mrutyunjay; Hardt, Wolf-Dietrich			Live Attenuated S. Typhimurium Vaccine with Improved Safety in Immuno-Compromised Mice	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NADPH PHAGOCYTE OXIDASE; TYPHOIDAL SALMONELLA BACTEREMIA; PHASE-I; ANTIMICROBIAL ACTIONS; INTERFERON-GAMMA; OXIDATIVE BURST; RATIONAL DESIGN; YERSINIA-PESTIS; VIRULENCE GENES	Live attenuated vaccines are of great value for preventing infectious diseases. They represent a delicate compromise between sufficient colonization-mediated adaptive immunity and minimizing the risk for infection by the vaccine strain itself. Immune defects can predispose to vaccine strain infections. It has remained unclear whether vaccine safety could be improved via mutations attenuating a vaccine in immune-deficient individuals without compromising the vaccine's performance in the normal host. We have addressed this hypothesis using a mouse model for Salmonella diarrhea and a live attenuated Salmonella Typhimurium strain (ssaV). Vaccination with this strain elicited protective immunity in wild type mice, but a fatal systemic infection in immune-deficient cybb(-/-) nos2(-/-) animals lacking NADPH oxidase and inducible NO synthase. In cybb(-/-) nos2(-/-) mice, we analyzed the attenuation of 35 ssaV strains carrying one additional mutation each. One strain, Z234 (ssaV SL1344_3093), was >1000-fold attenuated in cybb(-/-) nos2(-/-) mice and approximate to 100 fold attenuated in tnfr1(-/-) animals. However, in wt mice, Z234 was as efficient as ssaV with respect to host colonization and the elicitation of a protective, O-antigen specific mucosal secretory IgA (sIgA) response. These data suggest that it is possible to engineer live attenuated vaccines which are specifically attenuated in immuno-compromised hosts. This might help to improve vaccine safety.	[Periaswamy, Balamurugan; Maier, Lisa; Slack, Emma; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, D BIOL, CH-8092 Zurich, Switzerland; [Vishwakarma, Vikalp; Suar, Mrutyunjay] KIIT Univ, Sch Biotechnol, Bhubaneswar, Orissa, India; [Kremer, Marcus] Stadt Klinikum Munchen, Munich, Germany; [Andrews-Polymenis, Helene L.; McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [Grant, Andrew J.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Grant, Andrew J.] Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; Kalinga Institute of Industrial Technology (KIIT); Munchen Klinik; University of Cambridge; University of Cambridge	Hardt, WD (corresponding author), ETH, Inst Microbiol, D BIOL, CH-8092 Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Slack, Emma/B-1612-2016; Slack, Emma/AAD-5837-2019; Maier, Lisa/ABH-1893-2021	Slack, Emma/0000-0002-2473-1145; Slack, Emma/0000-0002-2473-1145; Maier, Lisa/0000-0002-6473-4762; Hardt, Wolf-Dietrich/0000-0002-9892-6420; McClelland, Michael/0000-0003-1788-9347; Suar, Mrutyunjay/0000-0003-4815-5477; VISHWAKARMA, VIKALP/0000-0001-5555-2126	UBS Optimus Foundation; National Institutes of Health [AI075093]; BBSRC [BBS/B/02266]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075093] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/B/02266] Funding Source: researchfish; Medical Research Council [G0801161] Funding Source: researchfish; MRC [G0801161] Funding Source: UKRI	UBS Optimus Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The support came from the UBS Optimus Foundation (to M. S. and W. D. H.) and National Institutes of Health grant AI075093 (M. M.). A. G. was supported by the BBSRC (BBS/B/02266 to P. Mastroeni and D. Maskell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067; Angelakopoulos H, 2000, INFECT IMMUN, V68, P2135, DOI 10.1128/IAI.68.4.2135-2141.2000; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Booth IR, 2003, BIOCHEM SOC T, V31, P1406; Cheminay C, 2008, INT J MED MICROBIOL, V298, P87, DOI 10.1016/j.ijmm.2007.08.006; Chen PL, 2007, J INTERN MED, V261, P91, DOI 10.1111/j.1365-2796.2006.01748.x; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COLLINS FM, 1974, BACTERIOL REV, V38, P371, DOI 10.1128/MMBR.38.4.371-402.1974; Coster TS, 1999, INFECT IMMUN, V67, P3437, DOI 10.1128/IAI.67.7.3437-3443.1999; Dilts DA, 2000, VACCINE, V18, P1473, DOI 10.1016/S0264-410X(99)00424-7; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; EISENSTEIN TK, 1984, J INFECT DIS, V150, P425, DOI 10.1093/infdis/150.3.425; Endt K, 2012, ANTIMICROB AGENTS CH; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Everest P, 1998, INFECT IMMUN, V66, P3355, DOI 10.1128/IAI.66.7.3355-3364.1998; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, J INFECTION, V56, P413, DOI 10.1016/j.jinf.2008.03.012; Goulding CW, 2007, J MOL BIOL, V365, P275, DOI 10.1016/j.jmb.2006.09.086; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Gruenheid S, 2000, CURR OPIN MICROBIOL, V3, P43, DOI 10.1016/S1369-5274(99)00049-1; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hegazy WAH, 2012, FUTURE MICROBIOL, V7, P111, DOI [10.2217/fmb.11.144, 10.2217/FMB.11.144]; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hess J, 1996, J IMMUNOL, V156, P3321; Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002; HOCHADEL JF, 1977, J INFECT DIS, V135, P813, DOI 10.1093/infdis/135.5.813; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HONE DM, 1992, J CLIN INVEST, V90, P412, DOI 10.1172/JCI115876; Ilg K, 2009, INFECT IMMUN, V77, P2568, DOI 10.1128/IAI.01537-08; Jantsch J, 2011, IMMUNOL REV, V240, P185, DOI 10.1111/j.1600-065X.2010.00981.x; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; KARNELL A, 1995, VACCINE, V13, P88, DOI 10.1016/0264-410X(95)80017-8; KETLEY JM, 1993, FEMS MICROBIOL LETT, V111, P15; Kotloff KL, 2002, INFECT IMMUN, V70, P2016, DOI 10.1128/IAI.70.4.2016-2021.2002; Kotloff KL, 1996, INFECT IMMUN, V64, P4542, DOI 10.1128/IAI.64.11.4542-4548.1996; Kotton CN, 2006, VACCINE, V24, P6216, DOI 10.1016/j.vaccine.2006.05.094; Kuijpers T, 2012, CELL MOL LIFE SCI, V69, P7, DOI 10.1007/s00018-011-0834-z; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; LEVINE MM, 1988, LANCET, V2, P468, DOI 10.1016/S0140-6736(88)90120-1; Levine MM, 2006, VACCINE, V24, P3865, DOI 10.1016/j.vaccine.2006.03.039; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Norouzi S, 2012, J INFECT; OKAMURA H, 1976, J BACTERIOL, V127, P24, DOI 10.1128/JB.127.1.24-31.1976; Peters RPH, 2004, TROP MED INT HEALTH, V9, P928, DOI 10.1111/j.1365-3156.2004.01288.x; Pujol C, 2005, P NATL ACAD SCI USA, V102, P12909, DOI 10.1073/pnas.0502849102; Rosenzweig SD, 2005, IMMUNOL REV, V203, P38, DOI 10.1111/j.0105-2896.2005.00227.x; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Shah DH, 2005, MICROBIOL-SGM, V151, P3957, DOI 10.1099/mic.0.28126-0; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; Siggins MK, 2011, J IMMUNOL, V186, P2365, DOI 10.4049/jimmunol.1000284; Simon R, 2011, VACCINE, V29, P5094, DOI 10.1016/j.vaccine.2011.05.022; Sinha K, 1997, INFECT IMMUN, V65, P1566, DOI 10.1128/IAI.65.4.1566-1569.1997; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; Songhet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022459; Spreng S, 2006, METHODS, V38, P133, DOI 10.1016/j.ymeth.2005.09.012; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Suar M, 2006, INFECT IMMUN, V74, P632, DOI 10.1128/IAI.74.1.632-644.2006; Suar M, 2009, INFECT IMMUN, V77, P3569, DOI 10.1128/IAI.00511-09; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; TACKET CO, 1992, INFECT IMMUN, V60, P536, DOI 10.1128/IAI.60.2.536-541.1992; Tamma Pranita, 2010, Pediatr Rev, V31, P38, DOI 10.1542/pir.31-1-38; Torres R, 2012, ACTA CRYSTALLOGR F, V68, P2, DOI 10.1107/S1744309111048056; Torres R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025084; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; Ugrinovic S, 2003, INFECT IMMUN, V71, P6808, DOI 10.1128/IAI.71.12.6808-6819.2003; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; Vazquez-Torres A, 2001, P NATL ACAD SCI USA, V98, P2561, DOI 10.1073/pnas.041618998; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; WOLFE LC, 1978, J BIOL CHEM, V253, P3336; Zhao YX, 2002, INFECT IMMUN, V70, P5319, DOI 10.1128/IAI.70.9.5319-5321.2002	81	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45433	10.1371/journal.pone.0045433	http://dx.doi.org/10.1371/journal.pone.0045433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029007	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700039
J	Burbelo, PD; Lebovitz, EE; Bren, KE; Bayat, A; Paviol, S; Wenzlau, JM; Barriga, KJ; Rewers, M; Harlan, DM; Iadarola, MJ				Burbelo, Peter D.; Lebovitz, Evan E.; Bren, Kathleen E.; Bayat, Ahmad; Paviol, Scott; Wenzlau, Janet M.; Barriga, Katherine J.; Rewers, Marian; Harlan, David M.; Iadarola, Michael J.			Extrapancreatic Autoantibody Profiles in Type I Diabetes	PLOS ONE			English	Article							ANTIBODY-POSITIVE RELATIVES; PARIETAL-CELL ANTIBODIES; LUCIFERASE IMMUNOPRECIPITATION; AUTOIMMUNE MANIFESTATIONS; 1ST-DEGREE RELATIVES; ISLET-CELL; PREDICTION; CHILDREN; MELLITUS; RISK	Type I diabetes (T1D) is an autoimmune disease characterized by destruction of insulin-producing beta-cells in the pancreas. Although several islet cell autoantigens are known, the breadth and spectrum of autoantibody targets has not been fully explored. Here the luciferase immunoprecipitation systems (LIPS) antibody profiling technology was used to study islet and other organ-specific autoantibody responses in parallel. Examination of an initial cohort of 93 controls and 50 T1D subjects revealed that 16% of the diabetic subjects showed anti-gastric ATPase autoantibodies which did not correlate with autoantibodies against GAD65, IA2, or IA2-beta. A more detailed study of a second cohort with 18 potential autoantibody targets revealed marked heterogeneity in autoantibody responses against islet cell autoantigens including two polymorphic variants of ZnT8. A subset of T1D subjects exhibited autoantibodies against several organ-specific targets including gastric ATPase (11%), thyroid peroxidase (14%), and anti-IgA autoantibodies against tissue transglutaminase (12%). Although a few T1D subjects showed autoantibodies against a lung-associated protein KCNRG (6%) and S100-beta (8%), no statistically significant autoantibodies were detected against several cytokines. Analysis of the overall autoantibody profiles using a heatmap revealed two major subgroups of approximately similar numbers, consisting of T1D subjects with and without organ-specific autoantibodies. Within the organ-specific subgroup, there was minimal overlap among anti-gastric ATPase, anti-thyroid peroxidase, and anti-transglutaminase seropositivity, and these autoantibodies did not correlate with islet cell autoantibodies. Examination of a third cohort, comprising prospectively collected longitudinal samples from high-risk individuals, revealed that anti-gastric ATPase autoantibodies were present in several individuals prior to detection of islet autoantibodies and before clinical onset of T1D. Taken together, these results suggest that autoantibody portraits derived from islet and organ-specific targets will likely be useful for enhancing the clinical management of T1D.	[Burbelo, Peter D.; Lebovitz, Evan E.; Bren, Kathleen E.; Bayat, Ahmad; Iadarola, Michael J.] NIH, Neurobiol & Pain Therapeut Sect, Lab Sensory Biol, Bethesda, MD 20892 USA; [Burbelo, Peter D.; Lebovitz, Evan E.; Bren, Kathleen E.; Bayat, Ahmad; Iadarola, Michael J.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; [Paviol, Scott; Harlan, David M.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA USA; [Wenzlau, Janet M.; Barriga, Katherine J.; Rewers, Marian] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Massachusetts System; University of Massachusetts Worcester; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Burbelo, PD (corresponding author), NIH, Neurobiol & Pain Therapeut Sect, Lab Sensory Biol, Bldg 10, Bethesda, MD 20892 USA.	burbelop@nidcr.nih.gov; David.Harlan@umassmemorial.org		Lebovitz, MD, Evan E./0000-0003-0903-6598	Division of Intramural Research, National Institute of Dental and Craniofacial Research; Diabetes and Endocrinology Research Center United States National Institutes of Health [P3057516]; Juvenile Diabetes Research Foundation Autoimmunity Prevention Center [-2007-1056];  [RO1 DK32493]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032493] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090034] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Diabetes and Endocrinology Research Center United States National Institutes of Health; Juvenile Diabetes Research Foundation Autoimmunity Prevention Center(Juvenile Diabetes Research Foundation); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CLINICAL CENTER	This work was supported by the Division of Intramural Research, National Institute of Dental and Craniofacial Research and from RO1 DK32493, Diabetes and Endocrinology Research Center United States National Institutes of Health P3057516 and a Juvenile Diabetes Research Foundation Autoimmunity Prevention Center Grant -2007-1056, Project 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2004, J CLIN INVEST, V114, P589, DOI 10.1172/JCI200421307; Achenbach P, 2004, DIABETES, V53, P384, DOI 10.2337/diabetes.53.2.384; Alimohammadi M, 2009, P NATL ACAD SCI USA, V106, P4396, DOI 10.1073/pnas.0809986106; Barker JM, 2006, J CLIN ENDOCR METAB, V91, P1210, DOI 10.1210/jc.2005-1679; Barker JM, 2005, DIABETES CARE, V28, P850, DOI 10.2337/diacare.28.4.850; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; BETTERLE C, 1984, DIABETOLOGIA, V26, P431; BINGLEY PJ, 1994, DIABETES, V43, P1304, DOI 10.2337/diabetes.43.11.1304; Bingley PJ, 1997, DIABETES, V46, P1701, DOI 10.2337/diabetes.46.11.1701; Bingley PJ, 2010, J CLIN ENDOCR METAB, V95, P25, DOI 10.1210/jc.2009-1365; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Burbelo PD, 2008, DIABETES CARE, V31, P1824, DOI 10.2337/dc08-0286; Burbelo PD, 2011, EXPERT REV PROTEOMIC, V8, P309, DOI [10.1586/EPR.11.23, 10.1586/epr.11.23]; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Burbelo PD, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-97; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Burbelo PD, 2010, DIABETES CARE, V33, P754, DOI 10.2337/dc09-1938; BUREK CL, 1990, AUTOIMMUNITY, V7, P157, DOI 10.3109/08916939008993388; Ching KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032001; De Block CEM, 2003, DIABETES CARE, V26, P82, DOI 10.2337/diacare.26.1.82; De Block CEM, 2000, DIABETIC MED, V17, P618, DOI 10.1046/j.1464-5491.2000.00354.x; De Block CEM, 1999, J CLIN ENDOCR METAB, V84, P4062, DOI 10.1210/jc.84.11.4062; Hanukoglu A, 2003, DIABETES CARE, V26, P1235, DOI 10.2337/diacare.26.4.1235; Krischer JP, 2003, J CLIN ENDOCR METAB, V88, P103, DOI 10.1210/jc.2002-020760; Lampasona V, 1999, DIABETOLOGIA, V42, P1195, DOI 10.1007/s001250051291; Lampasona V, 2011, CLIN CHEM, V8; LANDINOLSSON M, 1992, DIABETES, V41, P1022, DOI 10.2337/diabetes.41.8.1022; Liu E, 2007, CLIN IMMUNOL, V125, P120, DOI 10.1016/j.clim.2007.08.005; Mayr A, 2007, DIABETES, V56, P1527, DOI 10.2337/db06-1715; Orban T, 2009, DIABETES CARE, V32, P2269, DOI 10.2337/dc09-0934; Pihoker C, 2005, DIABETES, V54, pS52, DOI 10.2337/diabetes.54.suppl_2.S52; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; RADETTI G, 1995, ACTA DIABETOL, V32, P121, DOI 10.1007/BF00569570; Seissler J, 1999, DIABETOLOGIA, V42, P1440; Triolo TM, 2011, DIABETES CARE, V34, P1211, DOI 10.2337/dc10-1756; Umpierrez GE, 2003, DIABETES CARE, V26, P1181, DOI 10.2337/diacare.26.4.1181; Wenzlau JM, 2011, DIABETES-METAB RES, V27, P887, DOI 10.1002/dmrr.1267; Wenzlau JM, 2008, DIABETES, V57, P2693, DOI 10.2337/db08-0522; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818	40	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45216	10.1371/journal.pone.0045216	http://dx.doi.org/10.1371/journal.pone.0045216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028856	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800030
J	Yamashita, T; Fang, J; Gao, JG; Yu, YL; Lagarde, MM; Zuo, J				Yamashita, Tetsuji; Fang, Jie; Gao, Jiangang; Yu, Yiling; Lagarde, Marcia Mellado; Zuo, Jian			Normal Hearing Sensitivity at Low-to-Middle Frequencies with 34% Prestin-Charge Density	PLOS ONE			English	Article							OUTER HAIR CELL; MAMMALIAN COCHLEAR AMPLIFICATION; BASILAR-MEMBRANE NONLINEARITY; RATE-INTENSITY FUNCTIONS; PLASMA-MEMBRANE; KNOCKOUT MICE; MOTOR PROTEIN; LATERAL WALL; MOTILITY; MOUSE	The mammalian outer hair cells (OHCs) provide a positive mechanical feedback to enhance the cochlea's hearing sensitivity and frequency selectivity. Although the OHC-specific, somatic motor protein prestin is required for cochlear amplification, it remains unclear whether prestin can provide sufficient cycle-by-cycle feedback. In cochlear mechanical modeling, varying amounts of OHC motor activity should provide varying degrees of feedback efficiency to adjust the gain of cochlear amplifier at resonant frequencies. Here we created and characterized two new prestin-hypomorphic mouse models with reduced levels of wild-type prestin. OHCs from these mice exhibited length, total elementary charge movement (Q(max)), charge density, and electromotility intermediate between those of wild-type and prestin-null mice. Remarkably, measurements of auditory brainstem responses and distortion product otoacoustic emissions from these mice displayed wild-type like hearing sensitivities at 4-22 kHz. These results indicate that as low as 26.7% Q(max), 34.0% charge density and 44.0% electromotility in OHCs were sufficient for wild-type-like hearing sensitivity in mice at 4-22 kHz, and that these in vitro parameters of OHCs did not correlate linearly with the feedback efficiency for in vivo gain of the cochlear amplifier. Our results thus provide valuable data for modeling cochlear mechanics and will stimulate further mechanistic analysis of the cochlear amplifier.	[Yamashita, Tetsuji; Fang, Jie; Gao, Jiangang; Yu, Yiling; Lagarde, Marcia Mellado; Zuo, Jian] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Zuo, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org			National Institutes of Health (NIH) [DC006471, DC008800, CA21765]; Office of Naval Research [N000140911014]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; Sir Henry Wellcome Trust Fellowship; National Organization for Hearing Research Foundation; Hartwell Individual Biomedical Research Award; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006471, R21DC008800] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Sir Henry Wellcome Trust Fellowship; National Organization for Hearing Research Foundation; Hartwell Individual Biomedical Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by grants from the National Institutes of Health (NIH) (DC006471, DC008800, and CA21765), Office of Naval Research (N000140911014), American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital, Sir Henry Wellcome Trust Fellowship, and National Organization for Hearing Research Foundation. J. Zuo is a recipient of The Hartwell Individual Biomedical Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Breneman KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005201; Brownell WE, 2011, PFLUG ARCH EUR J PHY, V461, P677, DOI 10.1007/s00424-011-0942-5; Cheatham MA, 2007, AUDIOL NEURO-OTOL, V12, P378, DOI 10.1159/000106481; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; Cheatham MA, 2009, J NEUROSCI, V29, P12000, DOI 10.1523/JNEUROSCI.1651-09.2009; Corbitt C, 2012, BIOPHYS J, V102, P2715, DOI 10.1016/j.bpj.2012.04.054; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Fang J, 2007, BIOPHYS J, V93, P1809, DOI 10.1529/biophysj.106.100834; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Gao JG, 2007, P NATL ACAD SCI USA, V104, P12542, DOI 10.1073/pnas.0700356104; He DZZ, 2010, CYTOSKELETON, V67, P43, DOI 10.1002/cm.20423; Iwasa KH, 1997, BIOPHYS J, V73, P546, DOI 10.1016/S0006-3495(97)78092-5; Lagarde MMM, 2008, NAT NEUROSCI, V11, P746, DOI 10.1038/nn.2129; Lagarde MMM, 2008, CURR BIOL, V18, P200, DOI 10.1016/j.cub.2008.01.006; Legendre K, 2008, J CELL SCI, V121, P3347, DOI 10.1242/jcs.028134; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liberman MC, 2004, J ACOUST SOC AM, V116, P1649, DOI 10.1121/1.1775275; Mahendrasingam S, 2010, EUR J NEUROSCI, V31, P1595, DOI 10.1111/j.1460-9568.2010.07182.x; Maison SF, 2007, J NEUROPHYSIOL, V97, P2930, DOI 10.1152/jn.01183.2006; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Murugasu E., 1995, AUDIT NEUROSCI, V1, P139; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; PATUZZI RB, 1989, HEARING RES, V42, P47, DOI 10.1016/0378-5955(89)90117-2; Rabbitt RD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000444; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Ruggero MA, 1996, SCIENTIFIC BASIS OF NOISE-INDUCED HEARING LOSS, P23; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Taberner AM, 2005, J NEUROPHYSIOL, V93, P557, DOI 10.1152/jn.00574.2004; Wu XD, 2004, MOL BRAIN RES, V126, P30, DOI 10.1016/j.molbrainres.2004.03.020; YATES GK, 1990, HEARING RES, V50, P145, DOI 10.1016/0378-5955(90)90041-M; YATES GK, 1990, HEARING RES, V45, P203, DOI 10.1016/0378-5955(90)90121-5; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	38	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45453	10.1371/journal.pone.0045453	http://dx.doi.org/10.1371/journal.pone.0045453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029017	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800050
J	Letra, A; Fakhouri, W; Fonseca, RF; Menezes, R; Kempa, I; Prasad, JL; McHenry, TG; Lidral, AC; Moreno, L; Murray, JC; Daack-Hirsch, S; Marazita, ML; Castilla, EE; Lace, B; Orioli, IM; Granjeiro, JM; Schutte, BC; Vieira, AR				Letra, Ariadne; Fakhouri, Walid; Fonseca, Renata F.; Menezes, Renato; Kempa, Inga; Prasad, Joanne L.; McHenry, Toby G.; Lidral, Andrew C.; Moreno, Lina; Murray, Jeffrey C.; Daack-Hirsch, Sandra; Marazita, Mary L.; Castilla, Eduardo E.; Lace, Baiba; Orioli, Ieda M.; Granjeiro, Jose M.; Schutte, Brian C.; Vieira, Alexandre R.			Interaction between IRF6 and TGFA Genes Contribute to the Risk of Nonsyndromic Cleft Lip/Palate	PLOS ONE			English	Article							FACTOR-ALPHA-GENE; HUMAN TOOTH AGENESIS; LINKAGE DISEQUILIBRIUM; OROFACIAL CLEFTS; CANDIDATE GENES; ORAL CLEFTS; INTERFERON-REGULATORY-FACTOR-6 IRF6; FAMILY-HISTORY; FACIAL CLEFTS; BINDING-SITE	Previous evidence from tooth agenesis studies suggested IRF6 and TGFA interact. Since tooth agenesis is commonly found in individuals with cleft lip/palate (CL/P), we used four large cohorts to evaluate if IRF6 and TGFA interaction contributes to CL/P. Markers within and flanking IRF6 and TGFA genes were tested using Taqman or SYBR green chemistries for case-control analyses in 1,000 Brazilian individuals. We looked for evidence of gene-gene interaction between IRF6 and TGFA by testing if markers associated with CL/P were overtransmitted together in the case-control Brazilian dataset and in the additional family datasets. Genotypes for an additional 142 case-parent trios from South America drawn from the Latin American Collaborative Study of Congenital Malformations (ECLAMC), 154 cases from Latvia, and 8,717 individuals from several cohorts were available for replication of tests for interaction. Tgfa and Irf6 expression at critical stages during palatogenesis was analyzed in wild type and Irf6 knockout mice. Markers in and near IRF6 and TGFA were associated with CL/P in the Brazilian cohort (p<10(-6)). IRF6 was also associated with cleft palate (CP) with impaction of permanent teeth (p<10(-6)). Statistical evidence of interaction between IRF6 and TGFA was found in all data sets (p = 0.013 for Brazilians; p = 0.046 for ECLAMC; p = 10(-6) for Latvians, and p = 0.003 for the 8,717 individuals). Tgfa was not expressed in the palatal tissues of Irf6 knockout mice. IRF6 and TGFA contribute to subsets of CL/P with specific dental anomalies. Moreover, this potential IRF6-TGFA interaction may account for as much as 1% to 10% of CL/P cases. The Irf6-knockout model further supports the evidence of IRF6-TGFA interaction found in humans.	[Letra, Ariadne; Menezes, Renato; McHenry, Toby G.; Marazita, Mary L.; Vieira, Alexandre R.] Univ Pittsburgh, Dept Oral Biol, Sch Dent Med, Pittsburgh, PA 15260 USA; [Vieira, Alexandre R.] Univ Pittsburgh, Dept Pediat Dent, Sch Dent Med, Pittsburgh, PA USA; [Prasad, Joanne L.] Univ Pittsburgh, Dept Diagnost Sci, Sch Dent Med, Pittsburgh, PA USA; [Letra, Ariadne; Menezes, Renato; McHenry, Toby G.; Marazita, Mary L.; Vieira, Alexandre R.] Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Sch Dent Med, Pittsburgh, PA USA; [Fakhouri, Walid; Orioli, Ieda M.; Schutte, Brian C.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Fonseca, Renata F.] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Ctr Hlth Sci, Rio De Janeiro, RJ, Brazil; [Kempa, Inga; Lace, Baiba] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Kempa, Inga] Riga Stradins Univ, Dept Biol & Microbiol, Riga, Latvia; [Lidral, Andrew C.; Moreno, Lina] Univ Iowa, Coll Dent, Dept Orthodont, Iowa City, IA 52242 USA; [Murray, Jeffrey C.; Daack-Hirsch, Sandra] Univ Iowa, Dept Pediat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Marazita, Mary L.; Vieira, Alexandre R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Marazita, Mary L.; Vieira, Alexandre R.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Castilla, Eduardo E.] CEMIC Ctr Med Educ & Clin Res Norberto Quirno, ECLAMC Latin Amer Collaborat Study Congenital Mal, Buenos Aires, DF, Argentina; [Castilla, Eduardo E.] CONICET Natl Res Council Argentina, Buenos Aires, DF, Argentina; [Castilla, Eduardo E.; Orioli, Ieda M.] iNaGeMP CNPq Natl Inst Populat Med Genet, Porto Alegre, RS, Brazil; [Granjeiro, Jose M.] Univ Fed Fluminense, Dept Cell & Mol Biol, Niteroi, RJ, Brazil; [Granjeiro, Jose M.] INMETRO, Duque De Caxias, RJ, Brazil	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Michigan State University; Universidade Federal do Rio de Janeiro; Latvian Biomedical Research & Study Centre; Riga Stradins University; University of Iowa; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal Fluminense; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO)	Vieira, AR (corresponding author), Univ Pittsburgh, Dept Oral Biol, Sch Dent Med, Pittsburgh, PA 15260 USA.	arv11@pitt.edu	Inagemp, Inct/J-9451-2013; Lace, Baiba/AAY-9362-2020; Letra, Ariadne/Q-7007-2019; Granjeiro, Jose Mauro/D-8289-2012; Fakhouri, Walid/I-5297-2019	Lace, Baiba/0000-0001-5371-6756; Letra, Ariadne/0000-0002-7197-6735; Granjeiro, Jose Mauro/0000-0002-8027-8293; Fakhouri, Walid/0000-0002-2199-3828; Daack-Hirsch, Sandra/0000-0003-1192-7154; Kempa, Inga/0000-0003-4456-5778	National Institutes of Health [K99 018954-01, K99 018913-02, R21-DE016718, R01-DE14899, R01-DE16148]; National Research Council of Brazil (CNPq) [308885/2006-0, 401467/2004-0]; FAPERJ [E-26/152.831/2006]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina; CNPq (National Research council of Brazil) [573993/2008-4]; INAGEMP; Latvian Science Council [09.1115]; European Social Fund project;  [31101]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014899, R01DE016148, R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE016718, R01DE013513, R01DE008559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Council of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CNPq (National Research council of Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INAGEMP; Latvian Science Council; European Social Fund project(European Social Fund (ESF)); ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants from the National Institutes of Health: K99 018954-01 to AL; K99 018913-02 to RM; R21-DE016718 to ARV, R01-DE14899 and R01-DE16148 to MLM. Support also came from grants from the National Research Council of Brazil (CNPq # 308885/2006-0 and 401467/2004-0) to IMO; a grant from FAPERJ (E-26/152.831/2006) to IMO; by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina, Grant number: PICTO-CRUP 2005 # 31101; by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina; and for ECLAMC financial support from CNPq (National Research council of Brazil), process # 573993/2008-4; INAGEMP. In Latvia, support came from the Latvian Science Council grant No. 09.1115 and the European Social Fund project, which supports the doctoral study program and PhD degree qualification in Riga Stradins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Aidar Marisi, 2007, Braz. Dent. J., V18, P148, DOI 10.1590/S0103-64402007000200012; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; Bailey CM, 2008, CELL CYCLE, V7, P1925, DOI 10.4161/cc.7.13.6221; Birnbaum S, 2009, EUR J ORAL SCI, V117, P766, DOI 10.1111/j.1600-0722.2009.00680.x; Blanton SH, 2005, AM J MED GENET A, V137A, P259, DOI 10.1002/ajmg.a.30887; Blanton SH, 2010, CLEFT PALATE-CRAN J, V47, P574, DOI 10.1597/09-153; Callahan N, 2009, EUR J ORAL SCI, V117, P20, DOI 10.1111/j.1600-0722.2008.00593.x; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Christensen K, 2004, BRIT MED J, V328, P1405, DOI 10.1136/bmj.38106.559120.7C; DIXON MJ, 1991, ANAT EMBRYOL, V184, P83, DOI 10.1007/BF01744264; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Ghassibe M, 2005, EUR J HUM GENET, V13, P1239, DOI 10.1038/sj.ejhg.5201486; Gorlin RJ., 2001, SYNDROMES HEAD NECK, DOI 10.17245/jdapm.2019.19.5.261; Gritli-Linde A, 2010, J CLIN INVEST, V120, P1386, DOI 10.1172/JCI42821; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Huang Y, 2009, J DENT RES, V88, P715, DOI 10.1177/0022034509341040; HUJOEL PP, 1992, CLEFT PALATE-CRAN J, V29, P451, DOI 10.1597/1545-1569(1992)029<0451:FYMAIW>2.3.CO;2; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jia ZL, 2009, DNA CELL BIOL, V28, P249, DOI 10.1089/dna.2008.0837; Jindal A, 2012, AM J MED GENET A, V158A, P678, DOI 10.1002/ajmg.a.34430; Jugessur A, 2008, GENET EPIDEMIOL, V32, P413, DOI 10.1002/gepi.20314; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Larrabee YC, 2011, LARYNGOSCOPE, V121, P1756, DOI 10.1002/lary.21870; Letra A, 2007, J DENT RES, V86, P986, DOI 10.1177/154405910708601013; Lidral AC, 2005, CURR OPIN PEDIATR, V17, P731, DOI 10.1097/01.mop.0000185138.65820.7f; LOFFREDO LDM, 1994, REV SAUDE PUBL, V28, P213; Marazita ML, 2009, HUM HERED, V68, P151, DOI 10.1159/000224636; Menezes R, 2009, J AM DENT ASSOC, V140, P80, DOI 10.14219/jada.archive.2009.0022; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Mitchell LE, 1997, GENET EPIDEMIOL, V14, P231; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Mostowska A, 2010, BIRTH DEFECTS RES A, V88, P538, DOI 10.1002/bdra.20687; Nikopensius T, 2010, BIRTH DEFECTS RES A, V88, P748, DOI 10.1002/bdra.20700; Pan YC, 2010, AM J MED GENET A, V152A, P2505, DOI 10.1002/ajmg.a.33624; Park JW, 2007, GENET MED, V9, P219, DOI 10.1097/GIM.0b013e3180423cca; Patja K, 2009, PREV MED, V49, P240, DOI 10.1016/j.ypmed.2009.05.014; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Scapoli L, 2005, AM J HUM GENET, V76, P180, DOI 10.1086/427344; Schliekelman P, 2002, AM J HUM GENET, V71, P1369, DOI 10.1086/344779; Shi M, 2004, BIRTH DEFECTS RES A, V70, P65, DOI 10.1002/bdra.10153; Srichomthong C, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032235; Sull JW, 2009, HUM GENET, V126, P385, DOI 10.1007/s00439-009-0680-3; Taioli E, 2010, CANCER INVEST, V28, P958, DOI 10.3109/07357907.2010.483510; TAKAHAMA Y, 1982, EUR J ORTHODONT, V4, P275, DOI 10.1093/ejo/4.4.275; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; Trevilatto P C, 2000, J Forensic Odontostomatol, V18, P6; Vieira AR, 2008, J DENT RES, V87, P119, DOI 10.1177/154405910808700202; Vieira AR, 2008, ARCH ORAL BIOL, V53, P780, DOI 10.1016/j.archoralbio.2008.03.006; Vieira AR, 2007, AM J MED GENET A, V143A, P2075, DOI 10.1002/ajmg.a.31884; Vieira AR, 2007, AM J MED GENET A, V143A, P538, DOI 10.1002/ajmg.a.31620; Vieira AR, 2012, AM J MED GENET A, V158A, P1503, DOI 10.1002/ajmg.a.35359; Vieira AR, 2006, AM J EPIDEMIOL, V163, P790, DOI 10.1093/aje/kwj103; Vieira AR, 2004, J DENT RES, V83, P723, DOI 10.1177/154405910408300913; Wang DYQ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-118; Yildirim M, 2012, J DENT RES, V91, P556, DOI 10.1177/0022034512444928; Yoshikawa M, 2006, ARCH OTOLARYNGOL, V132, P734, DOI 10.1001/archotol.132.7.734; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	61	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45441	10.1371/journal.pone.0045441	http://dx.doi.org/10.1371/journal.pone.0045441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029012	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000309388900054
J	Thomas, N; Matejovicova, L; Srikusalanukul, W; Shawe-Taylor, J; Chain, B				Thomas, Niclas; Matejovicova, Lenka; Srikusalanukul, Wichat; Shawe-Taylor, John; Chain, Benny			Directional Migration of Recirculating Lymphocytes through Lymph Nodes via Random Walks	PLOS ONE			English	Article							T-CELL MOTILITY; DYNAMICS; TRACKING; SYSTEM; NAIVE	Naive T lymphocytes exhibit extensive antigen-independent recirculation between blood and lymph nodes, where they may encounter dendritic cells carrying cognate antigen. We examine how long different T cells may spend in an individual lymph node by examining data from long term cannulation of blood and efferent lymphatics of a single lymph node in the sheep. We determine empirically the distribution of transit times of migrating T cells by applying the Least Absolute Shrinkage & Selection Operator (LASSO) or regularised S-LASSO to fit experimental data describing the proportion of labelled infused cells in blood and efferent lymphatics over time. The optimal inferred solution reveals a distribution with high variance and strong skew. The mode transit time is typically between 10 and 20 hours, but a significant number of cells spend more than 70 hours before exiting. We complement the empirical machine learning based approach by modelling lymphocyte passage through the lymph node insilico. On the basis of previous two photon analysis of lymphocyte movement, we optimised distributions which describe the transit times (first passage times) of discrete one dimensional and continuous (Brownian) three dimensional random walks with drift. The optimal fit is obtained when drift is small, i.e. the ratio of probabilities of migrating forward and backward within the node is close to one. These distributions are qualitatively similar to the inferred empirical distribution, with high variance and strong skew. In contrast, an optimised normal distribution of transit times (symmetrical around mean) fitted the data poorly. The results demonstrate that the rapid recirculation of lymphocytes observed at a macro level is compatible with predominantly randomised movement within lymph nodes, and significant probabilities of long transit times. We discuss how this pattern of migration may contribute to facilitating interactions between low frequency T cells and antigen presenting cells carrying cognate antigen.	[Chain, Benny] Div Infect & Immun, London, England; [Thomas, Niclas; Matejovicova, Lenka] UCL, CoMPLEX, London, England; [Srikusalanukul, Wichat] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Shawe-Taylor, John] UCL, Dept Comp Sci, London, England	University of London; University College London; Australian National University; John Curtin School of Medical Research; University of London; University College London	Chain, B (corresponding author), Div Infect & Immun, London, England.	b.chain@ucl.ac.uk		Chain, Benny/0000-0002-7417-3970; Shawe-Taylor, John/0000-0002-2030-0073	CoMPLEX; MRC [G0900950] Funding Source: UKRI; Medical Research Council [G0900950B, G0900950] Funding Source: researchfish	CoMPLEX; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NT was supported by a studentship from CoMPLEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade W, 1996, J IMMUNOL METHODS, V194, P181, DOI 10.1016/0022-1759(96)00083-X; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Bogle G, 2008, IMMUNOL CELL BIOL, V86, P676, DOI 10.1038/icb.2008.60; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; FOLKS JL, 1978, J ROY STAT SOC B MET, V40, P263; FORD WL, 1972, CELL TISSUE KINET, V5, P175, DOI 10.1111/j.1365-2184.1972.tb01014.x; FROST H, 1975, EUR J IMMUNOL, V5, P839, DOI 10.1002/eji.1830051208; Grant M., 2011, CVX MATLAB SOFTWARE; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; HALL JG, 1962, Q J EXP PHYSIOL CMS, V47, P360, DOI 10.1113/expphysiol.1962.sp001620; Hastie T., 2009, UNSUPERVISED LEARNIN; Hebiri M, 2010, 1003 ARXIV; Kastenmuller W, 2010, EUR J IMMUNOL, V40, P2103, DOI 10.1002/eji.201040482; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Osborne MR, 2000, J COMPUTATIONAL GRAP, V9; PEDERSEN NC, 1970, J EXP MED, V131, P936, DOI 10.1084/jem.131.5.936; REYNOLDS J, 1982, IMMUNOLOGY, V47, P415; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Sheshadri V., 1999, INVERSE GAUSSIAN DIS; SPRENT J, 1973, CELL IMMUNOL, V7, P40, DOI 10.1016/0008-8749(73)90181-0; Srikusalanukul W, 2000, IMMUNOL CELL BIOL, V78, P288, DOI 10.1046/j.1440-1711.2000.00907.x; Stekel DJ, 1997, IMMUNOL TODAY, V18, P216; Stekel DJ, 1998, SCAND J IMMUNOL, V47, P426; TEARE GF, 1991, CELL IMMUNOL, V134, P157, DOI 10.1016/0008-8749(91)90339-D; Textor J, 2011, P NATL ACAD SCI USA, V108, P12401, DOI 10.1073/pnas.1102288108; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wichat Srikusalanukul W, 1999, THESIS AUSTR NATL U; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163	31	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45262	10.1371/journal.pone.0045262	http://dx.doi.org/10.1371/journal.pone.0045262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028891	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900034
J	Loiseau, C; Harrigan, RJ; Cornel, AJ; Guers, SL; Dodge, M; Marzec, T; Carlson, JS; Seppi, B; Sehgal, RNM				Loiseau, Claire; Harrigan, Ryan J.; Cornel, Anthony J.; Guers, Sue L.; Dodge, Molly; Marzec, Timothy; Carlson, Jenny S.; Seppi, Bruce; Sehgal, Ravinder N. M.			First Evidence and Predictions of Plasmodium Transmission in Alaskan Bird Populations	PLOS ONE			English	Article							CLIMATE-CHANGE; BLOOD PARASITES; AVIAN MALARIA; TEMPERATURE; HOST; RISK; VARIABILITY; INFECTIONS; PREVALENCE; ABUNDANCE	The unprecedented rate of change in the Arctic climate is expected to have major impacts on the emergence of infectious diseases and host susceptibility to these diseases. It is predicted that malaria parasites will spread to both higher altitudes and latitudes with global warming. Here we show for the first time that avian Plasmodium transmission occurs in the North American Arctic. Over a latitudinal gradient in Alaska, from 61 degrees N to 67 degrees N, we collected blood samples of resident and migratory bird species. We found both residents and hatch year birds infected with Plasmodium as far north as 64 degrees N, providing clear evidence that malaria transmission occurs in these climates. Based on our empirical data, we make the first projections of the habitat suitability for Plasmodium under a future-warming scenario in Alaska. These findings raise new concerns about the spread of malaria to naive host populations.	[Loiseau, Claire; Dodge, Molly; Marzec, Timothy; Sehgal, Ravinder N. M.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Harrigan, Ryan J.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Ctr Trop Res, Los Angeles, CA USA; [Cornel, Anthony J.; Carlson, Jenny S.] Univ Calif Davis, Dept Entomol, Mosquito Control & Res Lab, Parlier, CA USA; [Guers, Sue L.] Alaska Bird Observ, Fairbanks, AK USA; [Seppi, Bruce] Anchorage Field Off, Bur Land Management, Anchorage, AK USA	California State University System; San Francisco State University; University of California System; University of California Los Angeles; University of California System; University of California Davis	Loiseau, C (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	clair.loiseau@gmail.com	B, A N/E-9182-2011	SEHGAL, Ravinder/0000-0002-5255-4641; Loiseau, Claire/0000-0002-0407-2904	AXA Research Fund; The National Geographic Committee for Research and Exploration grant [9072-12he]	AXA Research Fund(AXA Research Fund); The National Geographic Committee for Research and Exploration grant	AXA Research Fund and The National Geographic Committee for Research and Exploration grant 9072-12he supported this work by funding equipment and field expenses as well as the salary of one post doctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020; Anisimov OA, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P653; Ball MC, 2001, CAN J ZOOL, V79, P1265, DOI 10.1139/cjz-79-7-1265; Barnard WH, 2010, CONDOR, V112, P849, DOI 10.1525/cond.2010.100143; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brooks DR, 2007, TRENDS PARASITOL, V23, P571, DOI 10.1016/j.pt.2007.08.016; Davidson R, 2011, TRENDS PARASITOL, V27, P238, DOI 10.1016/j.pt.2011.02.001; Deviche P, 2001, J WILDLIFE DIS, V37, P28, DOI 10.7589/0090-3558-37.1.28; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x; Gardner AM, 2012, J MED ENTOMOL, V49, P270, DOI 10.1603/ME11073; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Gjullin CM, 1961, AGR HDB, V182; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hellgren O, 2005, J ORNITHOL, V146, P55, DOI 10.1007/s10336-004-0055-4; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Krams I, 2010, ANN ZOOL FENN, V47, P335, DOI 10.5735/086.047.0504; Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Laaksonen S, 2010, ECOHEALTH, V7, P7, DOI 10.1007/s10393-010-0308-z; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Loiseau C, 2012, MOL ECOL, V21, P431, DOI 10.1111/j.1365-294X.2011.05341.x; MacDonald GM, 2010, J EXP BIOL, V213, P855, DOI 10.1242/jeb.039511; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Matthews KR, 2011, SCIENCE, V332, P421; MEYER CL, 1976, CAN J ZOOL, V54, P133, DOI 10.1139/z76-014; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Pyle P, 1997, IDENTIFICATION GUIDE; *R DEV COR TEAM, 2004, LANG ENV STAT COMP; Ramirez J, 2008, HIGH RESOLUTION STAT; Sainz-Elipe S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-221; Sehgal RNM, 2011, P ROY SOC B-BIOL SCI, V278, P1025, DOI 10.1098/rspb.2010.1720; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Yohannes E, 2009, J ORNITHOL, V150, P287, DOI 10.1007/s10336-008-0349-z	41	78	80	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44729	10.1371/journal.pone.0044729	http://dx.doi.org/10.1371/journal.pone.0044729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028595	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400036
J	Chen, CL; Kuo, HC; Tung, SY; Hsu, PWC; Wang, CL; Seibel, C; Schmoll, M; Chen, RS; Wang, TF				Chen, Chia-Ling; Kuo, Hsiao-Che; Tung, Shu-Yu; Hsu, Paul Wei-Che; Wang, Chih-Li; Seibel, Christian; Schmoll, Monika; Chen, Ruey-Shyang; Wang, Ting-Fang			Blue Light Acts as a Double-Edged Sword in Regulating Sexual Development of Hypocrea jecorina (Trichoderma reesei)	PLOS ONE			English	Article							CONIDIATION-SPECIFIC GENES; NEUROSPORA-CRASSA; WHITE-COLLAR; PHYSICAL INTERACTION; PROTEIN; FUNGI; ENVOY; PHOTORECEPTOR; EXPRESSION; INDUCTION	The industrially important cellulolytic filamentous fungus Trichoderma reesei is the anamorph of the pantropical ascomycete Hypocrea jecorina. H. jecorina CBS999.97 strain undergoes a heterothallic reproductive cycle, and the mating yields fertilized perithecia imbedded in stromata. Asci in the perithecia contain 16 linearly arranged ascospores. Here, we investigated H. jecorina sexual development under different light regimes, and found that visible light was dispensable for sexual development (stroma formation and ascospore discharge). By contrast, constant illumination inhibited stroma formation, and an interruption of the darkness facilitated timely stroma formation in a 12 h/12 h light-dark photoperiod. The results of genetic analyses further revealed that H. jecorina blue-light photoreceptors (BLR1, BLR2) and the photoadaptation protein ENV1 were not essential for sexual development in general. BLR1, BLR2 and ENV1 are orthologues of the conserved Neurospora crassa WC-1, WC-2 and VVD, respectively. Moreover, BLR1 and BLR2 mediate both positive and negative light-dependent regulation on sexual development, whereas ENV1 is required for dampening the light-dependent inhibitory effect in response to changes in illumination. Comparative genome-wide microarray analysis demonstrated an overview of light-dependent gene expression versus sexual potency in CBS999.97 (MAT1-2) haploid cells. Constant illumination promotes abundant asexual conidiation and high levels of hpp1 transcripts. hpp1 encodes a h (hybrid)-type propheromone that exhibits features of both yeast a and a pheromone precursors. Deletion of hpp1 could rescue stroma formation but not ascospore generation under constant illumination. We inferred that the HPP1-dependent pheromone signaling system might directly prevent stroma formation or simply disallow the haploid cells to acquire sexual potency due to abundant asexual conidiation upon constant illumination.	[Chen, Ruey-Shyang] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan; [Chen, Chia-Ling; Kuo, Hsiao-Che; Tung, Shu-Yu; Hsu, Paul Wei-Che; Wang, Chih-Li; Wang, Ting-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Seibel, Christian; Schmoll, Monika] Vienna Univ Technol, Res Area Gene Technol & Appl Biochem, Inst Chem Engn, A-1040 Vienna, Austria	National Chiayi University; Academia Sinica - Taiwan; Technische Universitat Wien	Chen, RS (corresponding author), Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan.	rschen@mail.ncyu.edu.tw; tfwang@gate.sinica.edu.tw	Schmoll, Monika/I-6541-2016; Wang, Ting-Fang/ABI-3818-2020	Schmoll, Monika/0000-0003-3918-0574; Wang, Ting-Fang/0000-0001-6306-9505; Wang, Chih-Li/0000-0001-6262-9945	Institute of Molecular Biology (IMB), Academia Sinica; National Science Council, Taiwan; Austrian Science Fund (FWF) [P20004, V152-B12]	Institute of Molecular Biology (IMB), Academia Sinica; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants to TFW from the Institute of Molecular Biology (IMB), Academia Sinica. HCK was supported by a postdoctoral fellowship to TFW by the National Science Council, Taiwan. CS and MS were supported by grants (P20004 and V152-B12) from the Austrian Science Fund (FWF) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Berrocal-Tito GM, 2000, PHOTOCHEM PHOTOBIOL, V71, P662, DOI 10.1562/0031-8655(2000)071<0662:COBLAD>2.0.CO;2; Carreras-Villasenor N, 2011, MICROBIOLOGY, V158, P3; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; Castellanos F, 2010, FUNGAL GENET BIOL, V47, P468, DOI 10.1016/j.fgb.2010.02.001; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; Franchi L, 2005, MOL MICROBIOL, V56, P334, DOI 10.1111/j.1365-2958.2005.04545.x; HARDING RW, 1983, PLANT PHYSIOL, V72, P996, DOI 10.1104/pp.72.4.996; HARDING RW, 1981, PLANT PHYSIOL, V68, P745, DOI 10.1104/pp.68.3.745; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Herrera-Estrella A, 2007, MOL MICROBIOL, V64, P5, DOI 10.1111/j.1365-2958.2007.05632.x; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; INNOCENTI FD, 1983, PHOTOCHEM PHOTOBIOL, V37, P49, DOI 10.1111/j.1751-1097.1983.tb04432.x; Kuhls K, 1996, P NATL ACAD SCI USA, V93, P7755, DOI 10.1073/pnas.93.15.7755; LAUTER FR, 1991, NUCLEIC ACIDS RES, V19, P6883, DOI 10.1093/nar/19.24.6883; Liu B, 2000, MOL GEN GENET, V263, P375, DOI 10.1007/s004380051181; Lu YK, 2005, MOL MICROBIOL, V56, P480, DOI 10.1111/j.1365-2958.2005.04549.x; Pettersson N, 2005, BIOL CELL, V97, P487, DOI 10.1042/BC20040144; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; ROBERTS AN, 1988, MOL CELL BIOL, V8, P2411, DOI 10.1128/MCB.8.6.2411; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Ruger-Herreros C, 2011, GENETICS, V188, P809, DOI 10.1534/genetics.111.130096; Schafmeier T, 2011, FEBS LETT, V585, P1467, DOI 10.1016/j.febslet.2011.03.050; Schmoll M, 2005, EUKARYOT CELL, V4, P1998, DOI 10.1128/EC.4.12.1998-2007.2005; Schmoll M, 2004, FUNGAL GENET BIOL, V41, P877, DOI 10.1016/j.fgb.2004.06.002; Schmoll M, 2010, FUNGAL GENET BIOL, V47, P909, DOI 10.1016/j.fgb.2010.04.010; Schmoll M, 2010, MOL MICROBIOL, V77, P1483, DOI 10.1111/j.1365-2958.2010.07295.x; Schmoll M, 2009, EUKARYOT CELL, V8, P410, DOI 10.1128/EC.00256-08; Schuster A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-449; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Seibel C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-58; Seibel C, 2012, EUKARYOT CELL, V11, P885, DOI 10.1128/EC.05321-11; Seidl V, 2009, P NATL ACAD SCI USA, V106, P13909, DOI 10.1073/pnas.0904936106; Shrode LB, 2001, FUNGAL GENET BIOL, V32, P169, DOI 10.1006/fgbi.2001.1264; Steyaert JM, 2010, MICROBIOL-SGM, V156, P2887, DOI 10.1099/mic.0.041715-0; Tisch D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-613; Tisch D, 2011, FUNGAL GENET BIOL, V48, P631, DOI 10.1016/j.fgb.2010.12.009; Tisch D, 2010, APPL MICROBIOL BIOT, V85, P1259, DOI 10.1007/s00253-009-2320-1; WHITE BT, 1993, DEV BIOL, V160, P254, DOI 10.1006/dbio.1993.1303; Zickler D, 2009, METHODS MOL BIOL, V558, P91, DOI 10.1007/978-1-60761-103-5_7	43	31	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44969	10.1371/journal.pone.0044969	http://dx.doi.org/10.1371/journal.pone.0044969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028710	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900060
J	dos Santos, M; Mercante, AMD; Louro, ID; Goncalves, AJ; de Carvalho, MB; da Silva, EHT; da Silva, AMA				dos Santos, Marcelo; da Cunha Mercante, Ana Maria; Louro, Iuri Drumond; Goncalves, Antonio Jose; de Carvalho, Marcos Brasilino; Tajara da Silva, Eloiza Helena; Alvares da Silva, Adriana Madeira			HIF1-Alpha Expression Predicts Survival of Patients with Squamous Cell Carcinoma of the Oral Cavity	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; NECK-CANCER; UNFAVORABLE PROGNOSIS; PROLYL HYDROXYLATION; FACTOR 1-ALPHA; FACTOR-1-ALPHA EXPRESSION; FACTORS HIF-1-ALPHA; TISSUE MICROARRAY; RADIATION-THERAPY; O-2 HOMEOSTASIS	Background: Oral squamous cell carcinoma is an important cause of death and morbidity wordwide and effective prognostic markers are still to be discovered. HIF1 alpha protein is associated with hypoxia response and neovascularization, essential conditions for solid tumors survival. The relationship between HIF1 alpha expression, tumor progression and treatment response in head and neck cancer is still poorly understood. Patients and Methods: In this study, we investigated HIF1 alpha expression by immunohistochemistry in tissue microarrays and its relationship with clinical findings, histopathological results and survival of 66 patients with squamous cell carcinoma of the lower mouth. Results: Our results demonstrated that high HIF1 alpha expression is associated with local disease-free survival, independently from the choice of treatment. Furthermore, high expression of HIF1 alpha in patients treated with postoperative radiotherapy was associated with survival, therefore being a novel prognostic marker in squamous cell carcinoma of the mouth. Additionally, our results showed that MVD was associated with HIF1 alpha expression and local disease relapse. Conclusion: These findings suggest that HIF1 alpha expression can be used as a prognostic marker and predictor of postoperative radiotherapy response, helping the oncologist choose the best treatment for each patient.	[Alvares da Silva, Adriana Madeira] Univ Fed Espirito Santo, Dept Biol, Alegre, Espirito Santos, Brazil; [dos Santos, Marcelo; Goncalves, Antonio Jose] Fac Ciencias Med Santa Casa Sao Paulo, Programa Pos Grad, Sao Paulo, Brazil; [dos Santos, Marcelo; de Carvalho, Marcos Brasilino] Hosp Heliopolis, Mol Biol Lab, Sao Paulo, Brazil; [da Cunha Mercante, Ana Maria] Hosp Heliopolis, Dept Anat Patol, Sao Paulo, Brazil; [Louro, Iuri Drumond] Univ Fed Espirito Santo, Dept Ciencias Biol, Nucleo Genet Humana & Mol, Vitoria, Espirito Santos, Spain; [Tajara da Silva, Eloiza Helena] Fac Med Sao Jose Do Rio Preto, Dept Biol Mol, Sao Jose Do Rio Preto, SP, Brazil	Universidade Federal do Espirito Santo; Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	da Silva, AMA (corresponding author), Univ Fed Espirito Santo, Dept Biol, Alegre, Espirito Santos, Brazil.	adriana.biomol@gmail.com	Álvares-da-Silva, Adriana M/J-2912-2018; dos Santos, Marcelo/K-2582-2012; Louro, Iuri D/I-8641-2012; Brasilino de Carvalho, Marcos/C-1869-2014	Álvares-da-Silva, Adriana M/0000-0002-8078-0304; dos Santos, Marcelo/0000-0001-7321-7479; Brasilino de Carvalho, Marcos/0000-0001-6854-2680; Louro, Iuri/0000-0001-5160-9615	Fundacao Amparo a Pesquisa do Estado de Sao Paulo/FAPESP [04/12054-9]	Fundacao Amparo a Pesquisa do Estado de Sao Paulo/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Fundacao Amparo a Pesquisa do Estado de Sao Paulo/FAPESP (Grant 04/12054-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold DM, 2001, CANCER RES, V61, P2911; Astekar Madhusudan, 2012, J Oral Maxillofac Pathol, V16, P22, DOI 10.4103/0973-029X.92968; Bauman JE, 2012, CURR OPIN ONCOL, V24, P235, DOI 10.1097/CCO.0b013e3283517920; Beasley NJP, 2002, CANCER RES, V62, P2493; Birner P, 2000, CANCER RES, V60, P4693; Blancher C, 2000, CANCER RES, V60, P7106; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Burri P, 2003, INT J RADIAT ONCOL, V56, P494, DOI 10.1016/S0360-3016(02)04579-0; Campos AHJFM, 2009, MOL CELL BIOCHEM, V321, P95, DOI 10.1007/s11010-008-9923-1; Clottes T, 2005, B CANCER, V92, P119; Deschler DG, 2008, POCKET GUIDE NECK DI; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferlay J, 2010, IARC CANCERBASE; Fillies T, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-84; GATENBY RA, 1988, INT J RADIAT ONCOL, V14, P831, DOI 10.1016/0360-3016(88)90002-8; Giordano FJ, 2001, CURR OPIN GENET DEV, V11, P35, DOI 10.1016/S0959-437X(00)00153-2; Hedvat CV, 2002, HUM PATHOL, V33, P968, DOI 10.1053/hupa.2002.127438; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; Huang LE, 2003, J BIOL CHEM, V278, P19575, DOI 10.1074/jbc.R200030200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KOLSTAD P, 1968, SCAND J CLIN LAB INV, VS 22, P145; Koukourakis MI, 2002, INT J RADIAT ONCOL, V53, P1192, DOI 10.1016/S0360-3016(02)02848-1; Koukourakis MI, 2008, INT J RADIAT BIOL, V84, P47, DOI 10.1080/09553000701616114; Kuwai T, 2003, INT J CANCER, V105, P176, DOI 10.1002/ijc.11068; Lagerlof JH, 2011, MED PHYS, V38, P4888, DOI 10.1118/1.3615164; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Myers EN, 1998, OTOLARYNG CLIN N AM, V31, P671, DOI 10.1016/S0030-6665(05)70079-7; Na X, 2003, J UROLOGY, V170, P588, DOI 10.1097/01.ju.0000074870.54671.98; Nakayama K, 2002, CANCER LETT, V176, P215, DOI 10.1016/S0304-3835(01)00762-5; Nordsmark M, 2000, RADIOTHER ONCOL, V57, P39, DOI 10.1016/S0167-8140(00)00223-1; Pentenero M, 2005, HEAD NECK-J SCI SPEC, V27, P1080, DOI 10.1002/hed.20275; Ratcliffe PJ, 2000, NAT MED, V6, P1315, DOI 10.1038/82113; Rice C., 2011, CANC MAN RES, V3, P9; Rimm DL, 2001, CANCER J, V7, P24; Rosenberger C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017223.49823.2A; Ryan HE, 2000, CANCER RES, V60, P4010; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Soini Y, 2000, BRIT J CANCER, V83, P880, DOI 10.1054/bjoc.2000.1384; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Theodoropoulos VE, 2004, EUR UROL, V46, P200, DOI 10.1016/j.eururo.2004.04.008; Tomida A, 1999, ANTI-CANCER DRUG DES, V14, P169; Zhen WN, 2004, HEAD NECK-J SCI SPEC, V26, P660, DOI 10.1002/hed.20064; Zhong H, 1999, CANCER RES, V59, P5830; Zolzer F, 2002, INT J RADIAT ONCOL, V54, P910, DOI 10.1016/S0360-3016(02)02963-2	56	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45228	10.1371/journal.pone.0045228	http://dx.doi.org/10.1371/journal.pone.0045228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028863	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900103
J	Marinazzo, D; Wu, GR; Pellicoro, M; Angelini, L; Stramaglia, S				Marinazzo, Daniele; Wu, Guorong; Pellicoro, Mario; Angelini, Leonardo; Stramaglia, Sebastiano			Information Flow in Networks and the Law of Diminishing Marginal Returns: Evidence from Modeling and Human Electroencephalographic Recordings	PLOS ONE			English	Article							NEURAL-NETWORK; CONNECTIVITY	We analyze simple dynamical network models which describe the limited capacity of nodes to process the input information. For a proper range of their parameters, the information flow pattern in these models is characterized by exponential distribution of the incoming information and a fat-tailed distribution of the outgoing information, as a signature of the law of diminishing marginal returns. We apply this analysis to effective connectivity networks from human EEG signals, obtained by Granger Causality, which has recently been given an interpretation in the framework of information theory. From the distributions of the incoming versus the outgoing values of the information flow it is evident that the incoming information is exponentially distributed whilst the outgoing information shows a fat tail. This suggests that overall brain effective connectivity networks may also be considered in the light of the law of diminishing marginal returns. Interestingly, this pattern is reproduced locally but with a clear modulation: a topographic analysis has also been made considering the distribution of incoming and outgoing values at each electrode, suggesting a functional role for this phenomenon.	[Marinazzo, Daniele; Wu, Guorong] Univ Ghent, Dept Data Anal, Fac Psychol & Educ Sci, Ghent, Belgium; [Wu, Guorong] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Pellicoro, Mario; Angelini, Leonardo; Stramaglia, Sebastiano] Ist Nazl Fis Nucl, I-70126 Bari, Italy; [Pellicoro, Mario; Angelini, Leonardo; Stramaglia, Sebastiano] Univ Bari, Dipartmento Fis, Bari, Italy	Ghent University; University of Electronic Science & Technology of China; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro	Marinazzo, D (corresponding author), Univ Ghent, Dept Data Anal, Fac Psychol & Educ Sci, Ghent, Belgium.	daniele.marinazzo@ugent.be	stramaglia, sebastiano/H-7582-2015; Marinazzo, Daniele/H-4793-2019	stramaglia, sebastiano/0000-0002-5873-8564; Marinazzo, Daniele/0000-0002-9803-0122	China Scholarship Council [2011607033]	China Scholarship Council(China Scholarship Council)	GW is visiting Gent University with a grant of China Scholarship Council (no 2011607033). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendral JA, 2003, PHYSICA A, V324, P424, DOI 10.1016/S0378-4371(02)01994-5; Barab?si AL., 2002, AM J PHYS, V71, P409, DOI [10.1119/1.1538577, DOI 10.1119/1.1538577]; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Blinowska KJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.050902; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Chen YH, 2004, PHYS LETT A, V324, P26, DOI 10.1016/j.physleta.2004.02.032; DERRIDA B, 1987, EUROPHYS LETT, V4, P167, DOI 10.1209/0295-5075/4/2/007; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Dugladze T, 2012, SCIENCE, V336, P1458, DOI 10.1126/science.1222017; Erdos P., 1960, EVOLUTION RANDOM GRA; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Lattanzi G, 1997, PHYS REV E, V56, P4567, DOI 10.1103/PhysRevE.56.4567; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Lopez L, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036107; Marinazzo D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056215; Marinazzo D, 2011, NEUROIMAGE, V58, P330, DOI 10.1016/j.neuroimage.2010.01.099; Marinazzo D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.144103; Mehrkanoon S., 2011, NATURE PRECEDINGS; Napoletani D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026103; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Pellicoro M, 2010, PHYSICA A, V389, P4747, DOI 10.1016/j.physa.2010.06.028; Samuelson P. A., 2001, MICROECONOMICS; Schindler K., 2011, APPL MATH SCI, V5, P3637; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Smirnov DA, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046204; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; Takahashi DY, 2010, BIOL CYBERN, V103, P463, DOI 10.1007/s00422-010-0410-x; Vertes PE, 2012, P NATL ACAD SCI USA, V109, P5868, DOI 10.1073/pnas.1111738109; Wiener N, 1956, THEORY PREDICTION MO; Yu DC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.188701	36	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45026	10.1371/journal.pone.0045026	http://dx.doi.org/10.1371/journal.pone.0045026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028745	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900068
J	Maroui, MA; Kheddache-Atmane, S; El Asmi, F; Dianoux, L; Aubry, M; Chelbi-Alix, MK				Maroui, Mohamed Ali; Kheddache-Atmane, Sabrina; El Asmi, Faten; Dianoux, Laurent; Aubry, Muriel; Chelbi-Alix, Mounira K.			Requirement of PML SUMO Interacting Motif for RNF4-or Arsenic Trioxide-Induced Degradation of Nuclear PML Isoforms	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PROMYELOCYTIC LEUKEMIA PROTEIN; RING FINGER PROTEIN; ANTIVIRAL DEFENSE; LIVING CELLS; PROTEOLYTIC CLEAVAGE; GENE-TRANSCRIPTION; VIRUS-INFECTION; BODY FORMATION; TRANSFER BRET	PML, the organizer of nuclear bodies (NBs), is expressed in several isoforms designated PMLI to VII which differ in their C-terminal region due to alternative splicing of a single gene. This variability is important for the function of the different PML isoforms. PML NB formation requires the covalent linkage of SUMO to PML. Arsenic trioxide (As2O3) enhances PML SUMOylation leading to an increase in PML NB size and promotes its interaction with RNF4, a poly-SUMO-dependent ubiquitin E3 ligase responsible for proteasome-mediated PML degradation. Furthermore, the presence of a bona fide SUMO Interacting Motif (SIM) within the C-terminal region of PML seems to be required for recruitment of other SUMOylated proteins within PML NBs. This motif is present in all PML isoforms, except in the nuclear PMLVI and in the cytoplasmic PMLVII. Using a bioluminescence resonance energy transfer (BRET) assay in living cells, we found that As2O3 enhanced the SUMOylation and interaction with RNF4 of nuclear PML isoforms (I to VI). In addition, among the nuclear PML isoforms, only the one lacking the SIM sequence, PMLVI, was resistant to As2O3-induced PML degradation. Similarly, mutation of the SIM in PMLIII abrogated its sensitivity to As2O3-induced degradation. PMLVI and PMLIII-SIM mutant still interacted with RNF4. However, their resistance to the degradation process was due to their inability to be polyubiquitinated and to recruit efficiently the 20S core and the beta regulatory subunit of the 11S complex of the proteasome in PML NBs. Such resistance of PMLVI to As2O3-induced degradation was alleviated by overexpression of RNF4. Our results demonstrate that the SIM of PML is dispensable for PML SUMOylation and interaction with RNF4 but is required for efficient PML ubiquitination, recruitment of proteasome components within NBs and proteasome-dependent degradation of PML in response to As2O3.	[Aubry, Muriel] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Maroui, Mohamed Ali; Kheddache-Atmane, Sabrina; El Asmi, Faten; Dianoux, Laurent; Chelbi-Alix, Mounira K.] Univ Paris 05, CNRS, FRE 3235, Paris, France	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Aubry, M (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada.	muriel.aubry@umontreal.ca; mounira.chelbi-alix@parisdescartes.fr	Maroui, Mohamed ali/ABG-8538-2021		Ligue Nationale Contre le Cancer; Natural Sciences and Engineering Research Council of Canada; Universite Paris XI; Universite de Carthage, Tunisia	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Universite Paris XI; Universite de Carthage, Tunisia	This work was supported by grants from the Ligue Nationale Contre le Cancer to M.K.C-A. and from Natural Sciences and Engineering Research Council of Canada to M.A. F.E.A. is funded by Universite Paris XI and Universite de Carthage, Tunisia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Blondel D, 2010, J VIROL, V84, P10719, DOI 10.1128/JVI.01286-10; Boutell C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002245; Brand Peter, 2010, PMC Biophys, V3, P3, DOI 10.1186/1757-5036-3-3; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Chiariotti L, 1998, GENOMICS, V47, P258, DOI 10.1006/geno.1997.5105; Condemine W, 2007, J CELL SCI, V120, P3219, DOI 10.1242/jcs.007492; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Cuchet D, 2011, J CELL SCI, V124, P280, DOI 10.1242/jcs.075390; Cuchet-Lourenco D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002123; Dacres H, 2009, BIOSENS BIOELECTRON, V24, P1164, DOI 10.1016/j.bios.2008.07.021; Dacres H, 2009, ANAL BIOCHEM, V385, P194, DOI 10.1016/j.ab.2008.10.040; de la Vega L, 2011, BBA-MOL CELL RES, V1813, P283, DOI 10.1016/j.bbamcr.2010.11.022; El Mchichi B, 2010, J VIROL, V84, P11634, DOI 10.1128/JVI.01321-10; Escobar-Cabrera E, 2011, J BIOL CHEM, V286, P19816, DOI 10.1074/jbc.M111.231647; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Galisson F, 2010, MOL CELL PROTEOMICS; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Geoffroy MC, 2010, MOL BIOL CELL, V21, P4227, DOI 10.1091/mbc.E10-05-0449; Germain-Desprez D, 2003, J BIOL CHEM, V278, P22367, DOI 10.1074/jbc.M302234200; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kaiser FJ, 2003, J BIOL CHEM, V278, P38780, DOI 10.1074/jbc.M306259200; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Krieghoff-Henning E, 2008, BBA-MOL CELL RES, V1783, P2185, DOI 10.1016/j.bbamcr.2008.07.002; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Moilanen AM, 1998, MOL CELL BIOL, V18, P5128, DOI 10.1128/MCB.18.9.5128; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Nervi C, 1998, BLOOD, V92, P2244; Pampin M, 2006, J VIROL, V80, P8582, DOI 10.1128/JVI.00031-06; Peche L.Y., 2011, CELL DEATH DIFFER; Percherancier Y, 2009, J BIOL CHEM, V284, P16595, DOI 10.1074/jbc.M109.006387; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Rabellino A, 2012, CANC RES; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Sung KS, 2011, EXP CELL RES, V317, P1060, DOI 10.1016/j.yexcr.2010.12.016; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wei XL, 2003, J BIOL CHEM, V278, P29288, DOI 10.1074/jbc.M212215200; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	59	33	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44949	10.1371/journal.pone.0044949	http://dx.doi.org/10.1371/journal.pone.0044949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028697	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900056
J	Luz-Crawford, P; Noel, D; Fernandez, X; Khoury, M; Figueroa, F; Carrion, F; Jorgensen, C; Djouad, F				Luz-Crawford, Patricia; Noel, Daniele; Fernandez, Ximena; Khoury, Maroun; Figueroa, Fernando; Carrion, Flavio; Jorgensen, Christian; Djouad, Farida			Mesenchymal Stem Cells Repress Th17 Molecular Program through the PD-1 Pathway	PLOS ONE			English	Article							MARROW STROMAL CELLS; IFN-GAMMA; LYMPHOCYTE-PROLIFERATION; NOD MICE; PROSTAGLANDIN-E2; DIFFERENTIATION; RESPONSES; RECEPTOR; INDUCE; ROLES	MSC display potent suppressive properties initially described a decade ago. More recently, MSC suppressive activities on T-cell effector pathways have been investigated. MSC modulate CD4 differentiation through different mechanisms depending on culture conditions and display disparate activities on T cells according to their differentiation status. A significant amount of evidence for MSC effects on Th17 cells revealed that MSC could be suppressive under diverse circumstances but also enhance Th17 cell activity under other conditions. In the present study, we investigated the suppressive effects of MSC on Th1 and Th17 subsets of T cells using T cells undergoing Th1 and Th17 polarization or mature Th1 and Th17 cells. MSC inhibited the proliferation of T cells during their differentiation toward Th1 cells and mature Th1 cells. This suppressive effect was maintained in a transwell cell culture insert demonstrating the major role played by soluble factors. Using the transwell cell separation barrier, we observed that MSC decrease the number of T cells undergoing Th17 differentiation whereas they did not affect IL-17 production by mature Th17, demonstrating the need for cell contact for suppressing Th17 cell function. Moreover, we reported that PD-L1 is highly expressed on MSC co-cultured with differentiating or polarized Th1 and Th17 cells. Using neutralizing antibodies specific for PD-L1 and PD-1 we showed that the mechanisms by which MSC mediate Th17 cell repolarization depend on PD-L1 expression on MSC. Taken together our results demonstrated a cell-to-cell contact depend mechanism in the selective immunosuppression of MSC on mature Th17 cells through up-regulation of PD-L1.	[Luz-Crawford, Patricia; Noel, Daniele; Jorgensen, Christian; Djouad, Farida] INSERM, U 844, Montpellier, France; [Noel, Daniele; Jorgensen, Christian; Djouad, Farida] Univ Montpellier I, UFR Med, Montpellier, France; [Jorgensen, Christian] Hop Lapeyronie, Serv Immunorhumatol, Montpellier, France; [Luz-Crawford, Patricia; Fernandez, Ximena; Khoury, Maroun; Figueroa, Fernando; Carrion, Flavio] Univ Los Andes, Lab Immunol Celular & Mol, Santiago, Chile; [Luz-Crawford, Patricia] Univ Santiago Chile, Programa Doctorado Biotecnol, Santiago, Chile	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universidad de los Andes - Chile; Universidad de Santiago de Chile	Djouad, F (corresponding author), INSERM, U 844, Montpellier, France.	farida.djouad@inserm.fr	Fernández, Ximena/AAH-6629-2020; Noel, Daniele/E-5719-2016; CARRION, FLAVIO/AAP-7907-2021; Figueroa, Fernando E./AAO-5228-2020; Carrion, Flavio/AAC-5126-2022	Figueroa, Fernando E./0000-0002-9387-094X; Carrion, Flavio/0000-0002-4086-6867; Khoury, Maroun/0000-0002-9965-6266; Djouad, Farida/0000-0001-8248-6822; Noel, Daniele/0000-0002-3498-3776; jorgensen, christian/0000-0001-6947-8094; Luz Crawford, Patricia/0000-0003-0067-7743	Inserm; University of Montpellier I; Medical Research Foundation; Universidad de los Andes [MED-03-2011 INOGTO201127]; European Community [279174 EC]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Montpellier I; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Universidad de los Andes; European Community(European Commission)	This work was supported by Inserm, the University of Montpellier I and grants from the Medical Research Foundation (projet FRM 2011 "Comite Languedoc-Roussillon-Rouergue (LRR)"), MED-03-2011 INOGTO201127 from Universidad de los Andes and funding from the European Community's seventh framework programme for the collaborative project: "REGENER-AR:Bringing Regenerative Medicine into the market: Allogeneic eASCs Phase IB/IIA clinical trial for treating Rheumatoid Arthritis" (contract no. 279174 EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Blank C, 2004, CANCER RES, V64, P1140, DOI 10.1158/0008-5472.CAN-03-3259; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Boumaza I, 2009, J AUTOIMMUN, V32, P33, DOI 10.1016/j.jaut.2008.10.004; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Darlington PJ, 2010, ANN NEUROL, V68, P540, DOI 10.1002/ana.22065; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duffy MM, 2011, EUR J IMMUNOL, V41, P2840, DOI 10.1002/eji.201141499; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hegyi B, 2012, BIOCHEM BIOPH RES CO, V419, P215, DOI 10.1016/j.bbrc.2012.01.150; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Madec AM, 2009, DIABETOLOGIA, V52, P1391, DOI 10.1007/s00125-009-1374-z; Mariani E, 2012, CURR PHARM DESIGN, V18, P1821, DOI 10.2174/138161212799859666; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Napolitani G, 2009, EUR J IMMUNOL, V39, P1301, DOI 10.1002/eji.200838969; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; Rodriguez-Garcia M, 2011, J LEUKOCYTE BIOL, V89, P507, DOI 10.1189/jlb.0610327; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; Sumpter TL, 2011, EUR J IMMUNOL, V41, P286, DOI 10.1002/eji.201041353; Tatara R, 2011, CYTOTHERAPY, V13, P686, DOI 10.3109/14653249.2010.542456; Valdez PA, 2012, IMMUNITY, V36, P668, DOI 10.1016/j.immuni.2012.02.013; Wang JH, 2008, J AUTOIMMUN, V30, P222, DOI 10.1016/j.jaut.2007.10.001; Wolfle SJ, 2011, EUR J IMMUNOL, V41, P413, DOI 10.1002/eji.201040979; Xue Q, 2010, STEM CELLS DEV, V19, P27, DOI 10.1089/scd.2009.0076; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhao W, 2008, CELL IMMUNOL, V253, P23, DOI 10.1016/j.cellimm.2008.06.009	46	125	130	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45272	10.1371/journal.pone.0045272	http://dx.doi.org/10.1371/journal.pone.0045272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028899	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800047
J	Mishra, DK; Sakamoto, JH; Thrall, MJ; Baird, BN; Blackmon, SH; Ferrari, M; Kurie, JM; Kim, MP				Mishra, Dhruva K.; Sakamoto, Jason H.; Thrall, Michael J.; Baird, Brandi N.; Blackmon, Shanda H.; Ferrari, Mauro; Kurie, Jonathan M.; Kim, Min P.			Human Lung Cancer Cells Grown in an Ex Vivo 3D Lung Model Produce Matrix Metalloproteinases Not Produced in 2D Culture	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MMP-9 EXPRESSION	We compared the growth of human lung cancer cells in an ex vivo three-dimensional (3D) lung model and 2D culture to determine which better mimics lung cancer growth in patients. A549 cells were grown in an ex vivo 3D lung model and in 2D culture for 15 days. We measured the size and formation of tumor nodules and counted the cells after 15 days. We also stained the tissue/cells for Ki-67, and Caspase-3. We measured matrix metalloproteinase (MMP) levels in the conditioned media and in blood plasma from patients with adenocarcinoma of the lung. Organized tumor nodules with intact vascular space formed in the ex vivo 3D lung model but not in 2D culture. Proliferation and apoptosis were greater in the ex vivo 3D lung model compared to the 2D culture. After 15 days, there were significantly more cells in the 2D culture than the 3D model. MMP-1, MMP-9, and MMP-10 production were significantly greater in the ex vivo 3D lung model. There was no production of MMP-9 in the 2D culture. The patient samples contained MMP-1, MMP-2, MMP-9, and MMP-10. The human lung cancer cells grown on ex vivo 3D model form perfusable nodules that grow over time. It also produced MMPs that were not produced in 2D culture but seen in human lung cancer patients. The ex vivo 3D lung model may more closely mimic the biology of human lung cancer development than the 2D culture.	[Mishra, Dhruva K.; Blackmon, Shanda H.; Kim, Min P.] Methodist Hosp, Res Inst, Dept Surg, Houston, TX 77030 USA; [Sakamoto, Jason H.; Ferrari, Mauro] Methodist Hosp, Res Inst, Dept Nanomed, Houston, TX 77030 USA; [Thrall, Michael J.] Methodist Hosp, Res Inst, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Baird, Brandi N.; Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Blackmon, Shanda H.; Kim, Min P.] Methodist Hosp, Weill Cornell Med Coll, Dept Surg, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; UTMD Anderson Cancer Center; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Kim, MP (corresponding author), Methodist Hosp, Res Inst, Dept Surg, 6535 Fannin, Houston, TX 77030 USA.	mpkim@tmhs.org	Mishra, Dhruva/H-3880-2012	Mishra, Dhruva/0000-0001-8651-005X				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kiernan J, 2008, HISTOLOGICAL HISTOCH; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; KUTTAN R, 1981, LUNG, V159, P333, DOI 10.1007/BF02713933; Laack E, 2002, ANN ONCOL, V13, P1550, DOI 10.1093/annonc/mdf270; Lai MY, 2007, ANTICANCER RES, V27, P145; Mishra DK, 2012, ANN THORAC SURG, V93, P1075, DOI 10.1016/j.athoracsur.2012.01.011; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; Ylisirnio S, 2000, ANTICANCER RES, V20, P1311	25	58	60	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45308	10.1371/journal.pone.0045308	http://dx.doi.org/10.1371/journal.pone.0045308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028922	Green Submitted, Green Published, gold			2022-12-27	WOS:000309742800050
J	Shi, YD; Felley-Bosco, E; Marti, TM; Stahel, RA				Shi, Yandong; Felley-Bosco, Emanuela; Marti, Thomas M.; Stahel, Rolf A.			Differential Effects of Lovastatin on Cisplatin Responses in Normal Human Mesothelial Cells versus Cancer Cells: Implication for Therapy	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; IONIZING-RADIATION; DRUGS DOXORUBICIN; INDUCED APOPTOSIS; DNA-DAMAGE; INHIBITION; PROTECTS; STATINS; GROWTH; PHOSPHORYLATION	The cancer killing efficacy of standard chemotherapeutic agents such as cisplatin ( CDDP) is limited by their side effects to normal tissues. Therefore, research efforts optimizing the safety and efficacy of those agents are clinically relevant. We did screen for agents that specifically protect normal human mesothelial cells against CDDP without reducing the cancer cell killing efficacy. Lovastatin was identified from the screen. Lovastatin at a pharmacologically relevant concentration strongly arrested the proliferation of normal cells, whereas cancer cells were less affected. CDDP-induced DNA damage response was not activated and normal cells showed enhanced tolerance to CDDP when normal cells were treated with the combination of CDDP and lovastatin. We demonstrate that interfering with protein geranylgeranylation is involved in the lovastatin-mediated CDDP protective effect in normal cells. In contrast to normal cells, in cancer cells lovastatin did not change the CDDP-induced response, and cancer cells were not protected by lovastatin. Furthermore, lovastatin at the pharmacological relevant concentration per se induced DNA damage, oxidative stress and autophagy in cancer cells but not in normal mesothelial cells. Therefore, our data suggest that lovastatin has a potential to improve the therapeutic index of cisplatin-based therapy.	[Shi, Yandong; Felley-Bosco, Emanuela; Marti, Thomas M.; Stahel, Rolf A.] Univ Zurich, Univ Zurich Hosp, Mol Oncol Lab, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Shi, YD (corresponding author), Univ Zurich, Univ Zurich Hosp, Mol Oncol Lab, Zurich, Switzerland.	shiyandong@hotmail.com	Marti, Thomas/AAW-5232-2020; Felley-Bosco, Emanuela/E-7484-2017	Marti, Thomas/0000-0003-3005-220X; Felley-Bosco, Emanuela/0000-0002-3408-0294	Stiftung fur Angewande Krebs forschung, Winkelwiese, Zurich [3.41718.14]	Stiftung fur Angewande Krebs forschung, Winkelwiese, Zurich	This work was supported by the Stiftung fur Angewande Krebs forschung (3.41718.14), Winkelwiese 6, 8001 Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 1999, GASTROENTEROLOGY, V117, P838, DOI 10.1016/S0016-5085(99)70342-2; Agarwal B, 1999, CLIN CANCER RES, V5, P2223; Ahn KS, 2008, BIOCHEM PHARMACOL, V75, P907, DOI 10.1016/j.bcp.2007.10.010; APPLEGATE LA, 1991, CANCER RES, V51, P974; Asakura K, 2011, J SURG RES, V170, pE197, DOI 10.1016/j.jss.2011.06.037; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bardeleben RV, 2002, INT J MOL MED, V10, P473; BASERGA R, 1994, CELL, V79, P927, DOI 10.1016/0092-8674(94)90023-X; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Blagosklonny MV, 2002, CELL CYCLE, V1, P375, DOI 10.4161/cc.1.6.259; Blagosklonny MV, 2001, CANCER RES, V61, P4301; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Cafforio P, 2005, CARCINOGENESIS, V26, P883, DOI 10.1093/carcin/bgi036; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan DYL, 2008, J NEURO-ONCOL, V86, P273, DOI 10.1007/s11060-007-9475-3; COLE SPC, 1986, CANCER CHEMOTH PHARM, V17, P259; Damrot J, 2006, BRIT J PHARMACOL, V149, P988, DOI 10.1038/sj.bjp.0706953; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dimitroulakos J, 2001, CLIN CANCER RES, V7, P158; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Farwell WR, 2008, JNCI-J NATL CANCER I, V100, P134, DOI 10.1093/jnci/djm286; Feleszko W, 2000, CLIN CANCER RES, V6, P2044; Feleszko W, 1998, EUR J CANCER, V34, P406, DOI 10.1016/S0959-8049(97)10034-X; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Fritz G, 2011, BRIT MED BULL, V97, P17, DOI 10.1093/bmb/ldq044; Gibot L, 2009, BIOCHEM J, V420, P473, DOI 10.1042/BJ20082057; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Huelsenbeck J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.65; Jacobs EJ, 2011, CANCER RES, V71, P1763, DOI 10.1158/0008-5472.CAN-10-2953; JAKOBISIAK M, 1991, P NATL ACAD SCI USA, V88, P3628, DOI 10.1073/pnas.88.9.3628; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Klawitter J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2485; Knobel PA, 2011, NEOPLASIA, V13, P961, DOI 10.1593/neo.11828; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Lovric MM, 2010, ONCOGENE, V29, P5048, DOI 10.1038/onc.2010.242; McKnight JA, 2003, CLIN TECH SMALL AN P, V18, P67, DOI 10.1053/svms.2003.36617; McTaggart SJ, 2006, CELL MOL LIFE SCI, V63, P255, DOI 10.1007/s00018-005-5298-6; Nubel T, 2006, CLIN CANCER RES, V12, P933, DOI 10.1158/1078-0432.CCR-05-1903; Olive PL, 2009, CYTOM PART B-CLIN CY, V76B, P79, DOI 10.1002/cyto.b.20450; Ostrau C, 2009, RADIOTHER ONCOL, V92, P492, DOI 10.1016/j.radonc.2009.06.020; Parikh A, 2010, PROSTATE, V70, P971, DOI 10.1002/pros.21131; Rao S, 1998, ONCOGENE, V17, P2393, DOI 10.1038/sj.onc.1202322; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Sane KM, 2010, J PHARMACOL EXP THER, V333, P23, DOI 10.1124/jpet.109.160192; SCHMITTER D, 1992, INT J CANCER, V51, P296, DOI 10.1002/ijc.2910510220; Thibault A, 1996, CLIN CANCER RES, V2, P483	49	18	18	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45354	10.1371/journal.pone.0045354	http://dx.doi.org/10.1371/journal.pone.0045354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028957	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000309742800056
J	Hoffman, SJ; Psaltis, PJ; Clark, KJ; Spoon, DB; Chue, CD; Ekker, SC; Simari, RD				Hoffman, Scott J.; Psaltis, Peter J.; Clark, Karl J.; Spoon, Daniel B.; Chue, Colin D.; Ekker, Stephen C.; Simari, Robert D.			An In Vivo Method to Quantify Lymphangiogenesis in Zebrafish	PLOS ONE			English	Article							LYMPHATIC METASTASIS; TRANSGENIC ZEBRAFISH; ENDOTHELIAL-CELL; MAMMALIAN TARGET; RAPAMYCIN; ANGIOGENESIS; INHIBITION; LYMPHEDEMA; CANCER; MODEL	Background: Lymphangiogenesis is a highly regulated process involved in the pathogenesis of disease. Current in vivo models to assess lymphangiogenesis are largely unphysiologic. The zebrafish is a powerful model system for studying development, due to its rapid growth and transparency during early stages of life. Identification of a network of trunk lymphatic capillaries in zebrafish provides an opportunity to quantify lymphatic growth in vivo. Methods and Results: Late-phase microangiography was used to detect trunk lymphatic capillaries in zebrafish 2- and 3-days post-fertilization. Using this approach, real-time changes in lymphatic capillary development were measured in response to modulators of lymphangiogenesis. Recombinant human vascular endothelial growth factor (VEGF)-C added directly to the zebrafish aqueous environment as well as human endothelial and mouse melanoma cell transplantation resulted in increased lymphatic capillary growth, while morpholino-based knockdown of vegfc and chemical inhibitors of lymphangiogenesis added to the aqueous environment resulted in decreased lymphatic capillary growth. Conclusion: Lymphatic capillaries in embryonic and larval zebrafish can be quantified using late-phase microangiography. Human activators and small molecule inhibitors of lymphangiogenesis, as well as transplanted human endothelial and mouse melanoma cells, alter lymphatic capillary development in zebrafish. The ability to rapidly quantify changes in lymphatic growth under physiologic conditions will allow for broad screening of lymphangiogenesis modulators, as well as help define cellular roles and elucidate pathways of lymphatic development.	[Hoffman, Scott J.; Psaltis, Peter J.; Spoon, Daniel B.; Chue, Colin D.; Simari, Robert D.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Clark, Karl J.; Ekker, Stephen C.; Simari, Robert D.] Mayo Clin, Div Biochem & Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Hoffman, SJ (corresponding author), Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.	simari.robert@mayo.edu		Ekker, Stephen/0000-0003-0726-4212; Clark, Karl/0000-0002-9637-0967; Psaltis, Peter/0000-0003-0222-5468	National Institutes of Health grants [GM63904, HL7111-34]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904, R56GM063904] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM63904 and HL7111-34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Banziger-Tobler NE, 2008, AM J PATHOL, V173, P586, DOI 10.2353/ajpath.2008.080060; Bhang SH, 2009, ACS NANO, V3, P1389, DOI 10.1021/nn900138d; Bruyere F, 2010, FASEB J, V24, P8, DOI 10.1096/fj.09-132852; Cao RH, 2011, NAT PROTOC, V6, P817, DOI 10.1038/nprot.2011.359; Cooke JP, 2012, CIRCULATION, V125, P853, DOI 10.1161/CIRCULATIONAHA.111.083477; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Flores MV, 2010, DEV DYNAM, V239, P2128, DOI 10.1002/dvdy.22328; Henry CA, 2005, DEV BIOL, V287, P346, DOI 10.1016/j.ydbio.2005.08.049; Huber S, 2007, KIDNEY INT, V71, P771, DOI 10.1038/sj.ki.5002112; Jones Dennis, 2011, J Cardiovasc Dis Res, V2, P141, DOI 10.4103/0975-3583.85260; Kholova I, 2011, EUR J CLIN INVEST, V41, P487, DOI 10.1111/j.1365-2362.2010.02431.x; Kirkin V, 2004, INT J CANCER, V112, P986, DOI 10.1002/ijc.20509; Kobayashi S, 2007, CANCER SCI, V98, P726, DOI 10.1111/j.1349-7006.2007.00439.x; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005; Luo Y, 2012, NEOPLASIA, V14, P228, DOI 10.1593/neo.111570; Makky K, 2007, DEV BIOL, V303, P501, DOI 10.1016/j.ydbio.2006.11.030; Nakao S, 2011, BLOOD, V117, P1081, DOI 10.1182/blood-2010-02-267427; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nwariaku FE, 2004, BLOOD, V104, P3214, DOI 10.1182/blood-2004-05-1868; Ny A, 2008, BLOOD, V112, P1740, DOI 10.1182/blood-2007-08-106302; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Pan Da, 2006, Lymphatic Research and Biology, V4, P211, DOI 10.1089/lrb.2006.4405; Patel V, 2011, CANCER RES, V71, P7103, DOI 10.1158/0008-5472.CAN-10-3192; Pozzoli O, 2011, ARTERIOSCL THROM VAS, V31, P1589, DOI 10.1161/ATVBAHA.111.226969; Raghunath M, 2009, BIOCHEM BIOPH RES CO, V378, P766, DOI 10.1016/j.bbrc.2008.11.127; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029351; Weich HA, 2004, J IMMUNOL METHODS, V285, P145, DOI 10.1016/j.jim.2003.10.015; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	34	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45240	10.1371/journal.pone.0045240	http://dx.doi.org/10.1371/journal.pone.0045240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028871	Green Published, gold			2022-12-27	WOS:000308788700099
J	Furci, L; Tolazzi, M; Sironi, F; Vassena, L; Lusso, P				Furci, Lucinda; Tolazzi, Monica; Sironi, Francesca; Vassena, Lia; Lusso, Paolo			Inhibition of HIV-1 Infection by Human alpha-Defensin-5, a Natural Antimicrobial Peptide Expressed in the Genital and Intestinal Mucosae	PLOS ONE			English	Article							HUMAN ALPHA-DEFENSINS; FEMALE REPRODUCTIVE-TRACT; SEXUALLY-TRANSMITTED INFECTIONS; VIRUS TYPE-1 REPLICATION; INNATE IMMUNITY; CORECEPTOR CXCR4; HOST-DEFENSE; ENVELOPE GLYCOPROTEIN; NEISSERIA-GONORRHOEAE; STRUCTURAL BASIS	Background: alpha-defensin-5 (HD5) is a key effector of the innate immune system with broad anti-bacterial and anti-viral activities. Specialized epithelial cells secrete HD5 in the genital and gastrointestinal mucosae, two anatomical sites that are critically involved in HIV-1 transmission and pathogenesis. We previously found that human neutrophil defensins (HNP)-1 and -2 inhibit HIV-1 entry by specific bilateral interaction both with the viral envelope and with its primary cellular receptor, CD4. Despite low amino acid identity, human defensin-5 (HD5) shares with HNPs a high degree of structural homology. Methodology/Principal Findings: Here, we demonstrate that HD5 inhibits HIV-1 infection of primary CD4(+) T lymphocytes at low micromolar concentration under serum-free and low-ionic-strength conditions similar to those occurring in mucosal fluids. Blockade of HIV-1 infection was observed with both primary and laboratory-adapted strains and was independent of the viral coreceptor-usage phenotype. Similar to HNPs, HD5 inhibits HIV-1 entry into the target cell by interfering with the reciprocal interaction between the external envelope glycoprotein, gp120, and CD4. At high concentrations, HD5 was also found to downmodulate expression of the CXCR4 coreceptor, but not of CCR5. Consistent with its broad spectrum of activity, antibody competition studies showed that HD5 binds to a region overlapping with the CD4- and coreceptor-binding sites of gp120, but not to the V3 loop region, which contains the major determinants of coreceptor-usage specificity. Conclusion/Significance: These findings provide new insights into the first line of immune defense against HIV-1 at the mucosal level and open new perspectives for the development of preventive and therapeutic strategies.	[Furci, Lucinda; Tolazzi, Monica; Sironi, Francesca; Vassena, Lia] Ist Sci San Raffaele, Dept Biol & Technol Res, Unit Human Virol, I-20132 Milan, Italy; [Lusso, Paolo] Univ Cagliari, Sch Med, Dept Med Sci, Cagliari, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Cagliari	Furci, L (corresponding author), Ist Sci San Raffaele, Dept Biol & Technol Res, Unit Human Virol, I-20132 Milan, Italy.	lucinda.furci@hsr.it	Sironi, Francesca/ABH-7705-2020; Tolazzi, Monica/ABH-5652-2020	Sironi, Francesca/0000-0003-0908-6683; 	Istituto Superiore di Sanita (ISS)-AIDS Project, Rome; European Microbicides Project (EMPRO); Combined Highly Active Anti-Retroviral Microbicides (CHAARM), EU, Brussels; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001041, ZIAAI000976] Funding Source: NIH RePORTER	Istituto Superiore di Sanita (ISS)-AIDS Project, Rome; European Microbicides Project (EMPRO); Combined Highly Active Anti-Retroviral Microbicides (CHAARM), EU, Brussels; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Istituto Superiore di Sanita (ISS)-AIDS Project, Rome; the European Microbicides Project (EMPRO); and Combined Highly Active Anti-Retroviral Microbicides (CHAARM), EU, Brussels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Joseph, 2005, AIDS Res Ther, V2, P1, DOI 10.1186/1742-6405-2-1; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; Buck CB, 2008, CELL HOST MICROBE, V3, P3, DOI 10.1016/j.chom.2007.12.006; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; Cole AM, 2008, AM J REPROD IMMUNOL, V59, P27, DOI 10.1111/j.1600-0897.2007.00561.x; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; Demirkhanyan LH, 2012, J BIOL CHEM, V287, P28821, DOI 10.1074/jbc.M112.375949; Dugan AS, 2008, J BIOL CHEM, V283, P31125, DOI 10.1074/jbc.M805902200; Eade CR, 2012, CURR HIV RES, V10, P61, DOI 10.2174/157016212799304580; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Feng Z, 2006, J IMMUNOL, V177, P782, DOI 10.4049/jimmunol.177.2.782; Furci L, 2007, BLOOD, V109, P2928, DOI 10.1182/blood-2006-05-024489; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Grigat J, 2007, J IMMUNOL, V179, P3958, DOI 10.4049/jimmunol.179.6.3958; Hazrati E, 2006, J IMMUNOL, V177, P8658, DOI 10.4049/jimmunol.177.12.8658; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; HILL CP, 1991, SCIENCE, V251, P1481, DOI 10.1126/science.2006422; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; JAMESON BA, 1988, SCIENCE, V240, P1335, DOI 10.1126/science.2453925; Kaul R, 2008, AIDS, V22, P2049, DOI 10.1097/QAD.0b013e328311ac65; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Lagenaur LA, 2011, MUCOSAL IMMUNOL, V4, P648, DOI 10.1038/mi.2011.30; Lehrer RI, 2007, CURR OPIN HEMATOL, V14, P16, DOI 10.1097/00062752-200701000-00005; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Lehrer RI, 2009, J IMMUNOL, V183, P480, DOI 10.4049/jimmunol.0900244; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Levinson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031996; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Mandel ID, 1972, MUCOSAL SECRETIONS C, P242; McKnight A, 1997, J VIROL, V71, P1692, DOI 10.1128/JVI.71.2.1692-1696.1997; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Porter E, 2005, INFECT IMMUN, V73, P4823, DOI 10.1128/IAI.73.8.4823-4833.2005; Porter EM, 1997, INFECT IMMUN, V65, P2396, DOI 10.1128/IAI.65.6.2396-2401.1997; Quayle AJ, 1998, AM J PATHOL, V152, P1247; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rapista A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-45; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Seidel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009737; Shattock RJ, 2008, PLOS MED, V5, P537, DOI 10.1371/journal.pmed.0050081; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Smith JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000959; Sodora DL, 1998, AIDS RES HUM RETROV, V14, pS119; Svinarich DM, 1997, AM J OBSTET GYNECOL, V176, P470, DOI 10.1016/S0002-9378(97)70517-9; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, J VIROL, V78, P11622, DOI 10.1128/JVI.78.21.11622-11631.2004; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Wang W, 2004, J IMMUNOL, V173, P515, DOI 10.4049/jimmunol.173.1.515; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; WHO, AIDS EP UPD 2010; Wira CR, 2011, AM J REPROD IMMUNOL, V65, P196, DOI 10.1111/j.1600-0897.2011.00970.x; YAHI N, 1991, J VIROL METHODS, V34, P193, DOI 10.1016/0166-0934(91)90099-L; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zaragoza MM, 2011, J IMMUNOL, V186, P1589, DOI 10.4049/jimmunol.1002021; Zhou N, 2004, GENE THER, V11, P1703, DOI 10.1038/sj.gt.3302339; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	69	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45208	10.1371/journal.pone.0045208	http://dx.doi.org/10.1371/journal.pone.0045208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028850	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500021
J	Shi, Q; Hou, YY; Hou, J; Pan, PW; Liu, Z; Jiang, M; Gao, J; Bai, G				Shi, Qian; Hou, Yuanyuan; Hou, Jie; Pan, Penwei; Liu, Ze; Jiang, Min; Gao, Jie; Bai, Gang			Glycyrrhetic Acid Synergistically Enhances beta(2)-Adrenergic Receptor-Gs Signaling by Changing the Location of G alpha s in Lipid Rafts	PLOS ONE			English	Article							BETA-ADRENERGIC-RECEPTOR; PLASMA-MEMBRANE; CHOLESTEROL; PROTEIN; INTERNALIZATION; MICRODOMAINS; CAVEOLAE; DOMAINS; CELLS; FLUIDITY	Glycyrrhetic acid (GA) exerts synergistic anti-asthmatic effects via a beta(2)-adrenergic receptor (beta(2)AR)-mediated pathway. Cholesterol is an important component of the structure and function of lipid rafts, which play critical roles in the beta(2)AR-Gs-adenylate cyclase (AC)-mediated signaling pathway. Owing to the structural similarities between GA and cholesterol, we investigated the possibility that GA enhances beta(2)AR signaling by altering cholesterol distribution. Azide-terminal GA (ATGA) was synthesized and applied to human embryonic kidney 293 (HEK293) cells expressing fusion beta 2AR, and the electron spin resonance (ESR) technique was utilized. GA was determined to be localized predominantly on membrane and decreased their cholesterol contents. Thus, the fluidity of the hydrophobic region increased but not the polar surface of the cell membrane. The conformations of membrane proteins were also changed. GA further changed the localization of G alpha s from lipid rafts to non-raft regions, resulting the binding of beta(2)AR and G alpha s, as well as in reduced beta 2AR internalization. Co-localization of beta(2)AR, G alpha s, and AC increased isoproterenol-induced cAMP production and cholesterol reloading attenuated this effect. A speculation wherein GA enhances beta-adrenergic activity by increasing the functional linkage between the subcomponents of the membrane beta(2)AR-protein kinase A (PKA) signaling pathway was proposed. The enhanced efficacy of beta(2)AR agonists by this novel mechanism could prevent tachyphylaxis.	[Shi, Qian; Hou, Yuanyuan; Hou, Jie; Jiang, Min; Gao, Jie; Bai, Gang] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Shi, Qian; Hou, Yuanyuan; Hou, Jie; Jiang, Min; Gao, Jie; Bai, Gang] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300071, Peoples R China; [Pan, Penwei] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Liu, Ze] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University	Bai, G (corresponding author), Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	gangbai@nankai.edu.cn	Liu, Ze/GLS-9466-2022; Jiang, Min/HGT-8781-2022	Liu, Ze/0000-0002-1635-5573; Shi, Qian/0000-0003-2634-9553	National Natural Science Foundation of China [81173638, 81001682]; Fundamental Research Funds for the Central Universities [65011111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (numbers 81173638 and 81001682) and the Fundamental Research Funds for the Central Universities (number 65011111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMATSU H, 1991, PLANTA MED, V57, P119, DOI 10.1055/s-2006-960045; AKAO T, 1991, BIOCHEM PHARMACOL, V41, P1025; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; ALOUSI AA, 1991, FASEB J, V5, P2300, DOI 10.1096/fasebj.5.9.1650314; Bai G, 2008, ACTA PHARMACOL SIN, V29, P1187, DOI 10.1111/j.1745-7254.2008.00859.x; Baird B, 1999, BIOPHYS CHEM, V82, P109, DOI 10.1016/S0301-4622(99)00110-6; Bertin B, 1997, RECEPTOR CHANNEL, V5, P41; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; CERNEUS DP, 1993, J BIOL CHEM, V268, P3150; Di Certo MG, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-56; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Harada S, 2005, BIOCHEM J, V392, P191, DOI 10.1042/BJ20051069; Harada S, 2007, CELL MICROBIOL, V9, P196, DOI 10.1111/j.1462-5822.2006.00781.x; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; Kliewer SA, 2005, P NATL ACAD SCI USA, V102, P2675, DOI 10.1073/pnas.0500159102; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; Menegazzi M, 2008, PHARMACOL RES, V58, P22, DOI 10.1016/j.phrs.2008.05.012; Miura Y, 2001, BIOCHEMISTRY-US, V40, P15418, DOI 10.1021/bi015574a; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; MOORE RH, 1995, J CELL SCI, V108, P2983; Moore RH, 2007, AM J RESP CELL MOL, V36, P254, DOI 10.1165/rcmb.2006-0158OC; Osborne TF, 1998, CURR OPIN LIPIDOL, V9, P137, DOI 10.1097/00041433-199804000-00010; Ostermeyer AG, 1999, J BIOL CHEM, V274, P34459, DOI 10.1074/jbc.274.48.34459; Park EK, 2010, BRIT J PHARMACOL, V160, P1212, DOI 10.1111/j.1476-5381.2010.00768.x; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Pike LJ, 2002, BIOCHEMISTRY-US, V41, P10315, DOI 10.1021/bi025943i; POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0; PRIETO JC, 1990, GEN PHARMACOL-VASC S, V21, P931, DOI 10.1016/0306-3623(90)90457-W; Pucadyil TJ, 2004, BBA-BIOMEMBRANES, V1663, P188, DOI 10.1016/j.bbamem.2004.03.010; Ram A, 2006, INT IMMUNOPHARMACOL, V6, P1468, DOI 10.1016/j.intimp.2006.04.020; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sawa M, 2006, P NATL ACAD SCI USA, V103, P12371, DOI 10.1073/pnas.0605418103; Schrofelbauer B, 2009, BIOCHEM J, V421, P473, DOI 10.1042/BJ20082416; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Tamir S, 2000, CANCER RES, V60, P5704; Van Rossum TGJ, 1999, J GASTROEN HEPATOL, V14, P1093, DOI 10.1046/j.1440-1746.1999.02008.x; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; YAMAMURA Y, 1995, BIOL PHARM BULL, V18, P337, DOI 10.1248/bpb.18.337	53	16	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44921	10.1371/journal.pone.0044921	http://dx.doi.org/10.1371/journal.pone.0044921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028680	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517500011
J	Gardner, RS; Vogel, AT; Mainetti, M; Ascoli, GA				Gardner, Robert S.; Vogel, Adam T.; Mainetti, Matteo; Ascoli, Giorgio A.			Quantitative Measurements of Autobiographical Memory Content	PLOS ONE			English	Article							OLDER-ADULTS; SEMANTIC MEMORY; LIFE-SPAN; TERM-MEMORY; INVOLUNTARY; EVENTS; VOLUNTARY; AGE; TIME; SELF	Autobiographical memory (AM), subjective recollection of past experiences, is fundamental in everyday life. Nevertheless, characterization of the spontaneous occurrence of AM, as well as of the number and types of recollected details, remains limited. The CRAM (Cue-Recalled Autobiographical Memory) test (http://cramtest.info) adapts and combines the cue-word method with an assessment that collects counts of details recalled from different life periods. The SPAM (Spontaneous Probability of Autobiographical Memories) protocol samples introspection during everyday activity, recording memory duration and frequency. These measures provide detailed, naturalistic accounts of AM content and frequency, quantifying essential dimensions of recollection. AM content (similar to 20 details/recollection) decreased with the age of the episode, but less drastically than the probability of reporting remote compared to recent memories. AM retrieval was frequent (similar to 20/hour), each memory lasting similar to 30 seconds. Testable hypotheses of the specific content retrieved in a fixed time from given life periods are presented.	[Gardner, Robert S.; Vogel, Adam T.; Mainetti, Matteo; Ascoli, Giorgio A.] George Mason Univ, Ctr Neural Informat Struct & Plast, Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Gardner, Robert S.; Vogel, Adam T.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Ascoli, Giorgio A.] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA	George Mason University; George Mason University; George Mason University	Ascoli, GA (corresponding author), George Mason Univ, Ctr Neural Informat Struct & Plast, Krasnow Inst Adv Study, Fairfax, VA 22030 USA.	ascoli@gmu.edu	Vogel, Adam/ABD-7685-2020	Vogel, Adam/0000-0002-3505-2631	Air Force Office of Scientific Research (AFOSR) [FA9550-10-1-0385]	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	The authors thank the Air Force Office of Scientific Research (AFOSR) Award No: FA9550-10-1-0385. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2010, PSYCHOL AGING, V25, P369, DOI 10.1037/a0017280; Ascoli GA, 2008, BIOL BULL-US, V215, P204, DOI 10.2307/25470706; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Bauml KH, 2008, NEUROIMAGE, V41, P596, DOI 10.1016/j.neuroimage.2008.02.053; Barsalou L.W., 1988, REMEMBERING RECONSID, P193, DOI [10.1017/CBO9780511664014.009, DOI 10.1017/CBO9780511664014.009]; Bayley PJ, 2006, J NEUROSCI, V26, P13311, DOI 10.1523/JNEUROSCI.4262-06.2006; Berntsen D, 2004, MEM COGNITION, V32, P789, DOI 10.3758/BF03195869; Berntsen D, 2002, MEM COGNITION, V30, P1010, DOI 10.3758/BF03194319; Berntsen D, 2008, CONSCIOUS COGN, V17, P1093, DOI 10.1016/j.concog.2008.03.001; Bluck S, 2005, SOC COGNITION, V23, P91, DOI 10.1521/soco.23.1.91.59198; Brewer W.F., 1988, REMEMBERING RECONSID, P21, DOI DOI 10.1017/CBO9780511664014.004; Brewer WF, 1986, AUTOBIOGRAPHICAL MEM, P25, DOI DOI 10.1017/CBO9780511558313.006; Catal LL, 2004, MEM COGNITION, V32, P311, DOI 10.3758/BF03196861; Chu S, 2000, COGNITION, V75, pB41, DOI 10.1016/S0010-0277(00)00065-2; COHEN G, 1989, PSYCHOL AGING, V4, P10, DOI 10.1037/0882-7974.4.1.10; Cohen G, 1998, AUTOBIOGRAPHICAL MEMORY, P105; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; CROVITZ HF, 1974, B PSYCHONOMIC SOC, V4, P517; Dalgaard P, 2002, INTRO STAT R, P177; David DC, 1982, J VERB LEARN VERB BE, V21, P21, DOI [10.1016/S0022-5371(82)90423-6, DOI 10.1016/S0022-5371(82)90423-6]; Dawes J, 2008, INT J MARKET RES, V50, P61, DOI 10.1177/147078530805000106; Ezzyat Y, 2011, PSYCHOL SCI, V22, P243, DOI 10.1177/0956797610393742; FITZGERALD JM, 1984, J GERONTOL, V39, P692, DOI 10.1093/geronj/39.6.692; Fromholt P, 2003, MEMORY, V11, P81, DOI 10.1080/741938171; FROMHOLT P, 1991, J GERONTOL, V46, pP85, DOI 10.1093/geronj/46.3.P85; Galton F., 1879, BRAIN, V2, P149, DOI DOI 10.1093/BRAIN/2.2.149; Gibbs BR, 2004, COGNITIVE THER RES, V28, P511, DOI 10.1023/B:COTR.0000045561.72997.7c; HASHTROUDI S, 1990, PSYCHOL AGING, V5, P119, DOI 10.1037/0882-7974.5.1.119; HOWES JL, 1992, CAN J PSYCHOL, V46, P92, DOI 10.1037/h0084311; HUTTENLOCHER J, 1990, J EXP PSYCHOL LEARN, V16, P196, DOI 10.1037/0278-7393.16.2.196; Jansari A, 1996, PSYCHOL AGING, V11, P85, DOI 10.1037/0882-7974.11.1.85; Janssen SMJ, 2011, MEM COGNITION, V39, P1, DOI 10.3758/s13421-010-0003-x; Johannessen KB, 2010, CONSCIOUS COGN, V19, P847, DOI 10.1016/j.concog.2010.01.009; JOHNSON MK, 1984, J EXP PSYCHOL GEN, V113, P329, DOI 10.1037/0096-3445.113.3.329; JOHNSON MK, 1988, J EXP PSYCHOL GEN, V117, P371, DOI 10.1037/0096-3445.117.4.371; Johnson MK, 1997, PHILOS T R SOC B, V352, P1733, DOI 10.1098/rstb.1997.0156; Johnson MK, 1997, BRAIN COGNITION, V34, P189, DOI 10.1006/brcg.1997.0873; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037/0033-295X.88.1.67; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Linton M., 1986, AUTOBIOGRAPHICAL MEM, P50; Mace JH, 2005, MEMORY, V13, P874, DOI 10.1080/09658210444000485; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; MCCORMACK PD, 1979, CAN J PSYCHOL, V33, P118, DOI 10.1037/h0081705; Mitzner TL, 2010, COMPUT HUM BEHAV, V26, P1710, DOI 10.1016/j.chb.2010.06.020; Morillon B, 2009, J NEUROSCI, V29, P14803, DOI 10.1523/JNEUROSCI.3222-09.2009; Nadel L, 2000, AIDHIPOW30CO2D; Peeters F, 2003, J ABNORM PSYCHOL, V112, P203, DOI 10.1037/0021-843X.112.2.203; PILLEMER DB, 1992, EMORY S COG, V4, P236, DOI 10.1017/CBO9780511664069.013; Rah MJ, 2006, OPHTHAL PHYSL OPT, V26, P483, DOI 10.1111/j.1475-1313.2006.00372.x; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; ROBINSON JA, 1976, COGNITIVE PSYCHOL, V8, P578, DOI 10.1016/0010-0285(76)90020-7; Rubin DC, 2008, J EXP PSYCHOL GEN, V137, P591, DOI 10.1037/a0013165; Rubin DC, 1999, J ADULT DEV, V6, P61, DOI 10.1023/A:1021676309064; Rubin DC, 2000, MEMORY, V8, P265, DOI 10.1080/096582100406810; Rubin DC, 1996, PSYCHOL REV, V103, P734, DOI 10.1037/0033-295X.103.4.734; Rubin DC, 1998, MEM COGNITION, V26, P3, DOI 10.3758/BF03211366; Rubin DC, 1997, MEM COGNITION, V25, P859, DOI 10.3758/BF03211330; Rubin DC, 2003, MEM COGNITION, V31, P887, DOI 10.3758/BF03196443; RUBIN DC, 1984, AM J PSYCHOL, V97, P493, DOI 10.2307/1422158; Rubin DC, 1986, AUTOBIOGRAPHICAL MEM, P202, DOI DOI 10.1017/CBO9780511558313.018; Rybash JM, 1999, J GEN PSYCHOL, V126, P85, DOI 10.1080/00221309909595353; Schaie WK, 1977, HDB PSYCHOL AGING, P39; Schlagman S, 2008, MEM COGNITION, V36, P920, DOI 10.3758/MC.36.5.920; Schlagman S, 2009, PSYCHOL AGING, V24, P397, DOI 10.1037/a0015785; Spencer WD, 1995, PSYCHOL AGING, V10, P527, DOI 10.1037/0882-7974.10.4.527; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; Trull TJ, 2009, PSYCHOL ASSESSMENT, V21, P457, DOI 10.1037/a0017653; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; WAGENAAR WA, 1986, COGNITIVE PSYCHOL, V18, P225, DOI 10.1016/0010-0285(86)90013-7; WHITE RT, 1982, HUM LEARN, V1, P171	73	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44809	10.1371/journal.pone.0044809	http://dx.doi.org/10.1371/journal.pone.0044809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23028629	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800018
J	Lopes dos Santos Santiago, G; Tency, I; Verstraelen, H; Verhelst, R; Trog, M; Temmerman, M; Vancoillie, L; Decat, E; Cools, P; Vaneechoutte, M				Lopes dos Santos Santiago, Guido; Tency, Inge; Verstraelen, Hans; Verhelst, Rita; Trog, Marijke; Temmerman, Marleen; Vancoillie, Leen; Decat, Ellen; Cools, Piet; Vaneechoutte, Mario			Longitudinal qPCR Study of the Dynamics of L. crispatus, L. iners, A. vaginae, (Sialidase Positive) G. vaginalis, and P. bivia in the Vagina	PLOS ONE			English	Article							PEROXIDE-PRODUCING LACTOBACILLI; FEMALE GENITAL-TRACT; BACTERIAL VAGINOSIS; HYDROGEN-PEROXIDE; GARDNERELLA-VAGINALIS; ATOPOBIUM-VAGINAE; PREGNANT-WOMEN; MENSTRUAL-CYCLE; GRAM STAIN; MICROFLORA	Background: To obtain more detailed understanding of the causes of disturbance of the vaginal microflora (VMF), a longitudinal study was carried out for 17 women during two menstrual cycles. Methods: Vaginal swabs were obtained daily from 17 non-pregnant, menarchal volunteers. For each woman, Gram stains were scored, the quantitative changes of 5 key vaginal species, i.e. Atopobium vaginae, Lactobacillus crispatus, L. iners, (sialidase positive) Gardnerella vaginalis and Prevotella bivia were quantified with qPCR and hydrogen-peroxide production was assessed on TMB+ agar. Results: Women could be divided in 9 subjects with predominantly normal VMF (grades Ia, Ib and Iab, group N) and 8 with predominantly disturbed VMF (grades I-like, II, III and IV, group D). VMF was variable between women, but overall stable for most of the women. Menses were the strongest disturbing factor of the VMF. L. crispatus was present at log7-9 cells/ml in grade Ia, Iab and II VMF, but concentrations declined 100-fold during menses. L. crispatus below log7 cells/ml corresponded with poor H2O2-production. L. iners was present at log 10 cells/ml in grade Ib, II and III VMF. Sialidase negative G. vaginalis strains (average log5 cells/ml) were detected in grade I, I-like and IV VMF. In grade II VMF, predominantly a mixture of both sialidase negative and positive G. vaginalis strains (average log9 cells/ml) were present, and predominantly sialidase positive strains in grade III VMF. The presence of A. vaginae (average log9 cells/ml) coincided with grade II and III VMF. P. bivia (log4-8 cells/ml) was mostly present in grade III vaginal microflora. L. iners, G. vaginalis, A. vaginae and P. bivia all increased around menses for group N women, and as such L. iners was considered a member of disturbed VMF. Conclusions: This qPCR-based study confirms largely the results of previous culture-based, microscopy-based and pyrosequencing-based studies.	[Lopes dos Santos Santiago, Guido; Decat, Ellen; Cools, Piet; Vaneechoutte, Mario] Univ Ghent, Lab Bacteriol Res, Dept Clin Chem Microbiol & Immunol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Tency, Inge; Verstraelen, Hans; Verhelst, Rita; Trog, Marijke; Temmerman, Marleen] Univ Ghent, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Vancoillie, Leen] Univ Ghent, AIDS Reference Lab, Dept Clin Chem Microbiol & Immunol, Ghent Univ Hosp, B-9000 Ghent, Belgium; [Decat, Ellen] Univ Coll Ghent, Fac Hlth Care, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University Hospital; HOGENT University College of Applied Sciences & Arts	Lopes dos Santos Santiago, G (corresponding author), Univ Ghent, Lab Bacteriol Res, Dept Clin Chem Microbiol & Immunol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	Guido.LopesdosSantosSantiago@ugent.be	Verstraelen, Hans/AAA-8694-2019; Verstraelen, Hans/A-5602-2008; Vaneechoutte, Mario/A-6189-2009	Verstraelen, Hans/0000-0002-4070-1587; Vaneechoutte, Mario/0000-0002-4586-203X; Cools, Piet/0000-0003-2980-5307	Geconcerteerde OnderzoeksActie fund of the University of Ghent	Geconcerteerde OnderzoeksActie fund of the University of Ghent	The authors acknowledge the Geconcerteerde OnderzoeksActie fund of the University of Ghent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio MAD, 2005, J INFECT DIS, V192, P394, DOI 10.1086/430926; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Beigi RH, 2005, J INFECT DIS, V191, P924, DOI 10.1086/428288; Biagi E, 2009, EUR J CLIN MICROBIOL, V28, P281, DOI 10.1007/s10096-008-0617-0; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Brotman RM, 2010, SEX TRANSM INFECT, V86, P297, DOI 10.1136/sti.2009.040592; Burton JP, 2004, J CLIN MICROBIOL, V42, P1829, DOI 10.1128/JCM.42.4.1829-1831.2004; Cauci S, 2005, AM J OBSTET GYNECOL, V192, P489, DOI 10.1016/j.ajog.2004.07.023; Cauci S, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.035; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Clark P, 1994, Infect Dis Obstet Gynecol, V2, P179, DOI 10.1155/S106474499400061X; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; El Aila NA, 2011, RES MICROBIOL, V162, P506, DOI 10.1016/j.resmic.2011.04.004; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-167; Eschenbach DA, 2000, CLIN INFECT DIS, V30, P901, DOI 10.1086/313818; ESCHENBACH DA, 1989, J CLIN MICROBIOL, V27, P251, DOI 10.1128/JCM.27.2.251-256.1989; Ferris MJ, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-5; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Hay P, 2005, SEX TRANSM INFECT, V81, P100, DOI 10.1136/sti.2003.007161; Hay PE, 1997, INT J STD AIDS, V8, P603, DOI 10.1258/0956462971918850; HILLIER SL, 1992, OBSTET GYNECOL, V79, P369, DOI 10.1097/00006250-199203000-00008; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Kalra Apoorv, 2007, Curr Infect Dis Rep, V9, P485, DOI 10.1007/s11908-007-0074-4; Keane FEA, 1997, INT J STD AIDS, V8, P489, DOI 10.1258/0956462971920631; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; KLEBANOFF SJ, 1991, J INFECT DIS, V164, P94, DOI 10.1093/infdis/164.1.94; Lopes dos Santos Santiago G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028180; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Lopes dos Santos Santiago G, 2009, EUR J PHARM BIOPHARM, V73, P399, DOI 10.1016/j.ejpb.2009.08.009; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P732, DOI 10.1097/OLQ.0b013e3181fbbc95; Martin R, 2010, APPL ENVIRON MICROB, V76, P400, DOI 10.1128/AEM.01631-09; MCGREGOR JA, 1994, AM J OBSTET GYNECOL, V170, P1048, DOI 10.1016/S0002-9378(94)70098-2; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; O'Hanlon DE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-120; Priestley CJF, 1997, GENITOURIN MED, V73, P23; Pybus V, 1997, J INFECT DIS, V175, P406, DOI 10.1093/infdis/175.2.406; Rabe LK, 2003, J CLIN MICROBIOL, V41, P3260, DOI 10.1128/JCM.41.7.3260-3264.2003; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roberton AM, 2005, J CLIN MICROBIOL, V43, P5504, DOI 10.1128/JCM.43.11.5504-5508.2005; Roberton AM, 1997, CAN J GASTROENTEROL, V11, P361, DOI 10.1155/1997/642360; ROY S, 1994, INDIAN J MED RES, V100, P172; Schwebke JR, 1999, J INFECT DIS, V180, P1632, DOI 10.1086/315065; Smayevsky J, 2001, Infect Dis Obstet Gynecol, V9, P17, DOI 10.1155/S1064744901000047; Spear GT, 2011, APPL ENVIRON MICROB, V77, P378, DOI 10.1128/AEM.00973-10; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2010, GYNECOL OBSTET INVES, V70, P256, DOI 10.1159/000314015; Verhelst R, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-61; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Wiggins R, 2001, SEX TRANSM INFECT, V77, P402, DOI 10.1136/sti.77.6.402; Witkin SS, 2007, BEST PRACT RES CL OB, V21, P347, DOI 10.1016/j.bpobgyn.2006.12.004; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	57	63	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45281	10.1371/journal.pone.0045281	http://dx.doi.org/10.1371/journal.pone.0045281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028904	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800035
J	Jung, M; Koo, JS; Moon, YW; Park, BW; Kim, SI; Park, S; Lee, SH; Hong, S; Rha, SY; Chung, HC; Kim, JH; Sohn, J				Jung, Minkyu; Koo, Ja Seung; Moon, Young Wha; Park, Byeong-Woo; Kim, Seung Il; Park, Seho; Lee, Soo Hyun; Hong, Soojung; Rha, Sun Young; Chung, Hyun Cheol; Kim, Joo Hang; Sohn, Joohyuk			Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; CELL LUNG-CANCER; FC-GAMMA-RIIIA; SINGLE-AGENT; CLINICAL-EFFICACY; POLYMORPHISMS; CHEMOTHERAPY; EXPRESSION; AMPLIFICATION; RESISTANCE	Through this study, we aimed to validate several biomarkers that have been known to possibly predict the outcomes of the trastuzumab and paclitaxel (TP). Human epidermal growth factor 2 (HER2) positive metastatic breast cancer (MBC) patients who had been treated with TP in single institute from 2006 to 2009 were included in this study. For procured formalin fixed paraffin embedded tumor tissues, HER2 amplification index (AI) and polymorphisms of the immunoglobulin G fragment C receptors (FCGR) were assessed as biomarkers to the trastuzumab and expression of class III beta tubulin (bTubIII) was evaluated as a predictive factor to the paclitaxel. Of 46 patients treated with TP, 27 patients could be evaluated for HER2 AI, 31 for bTubIII, and 26 for FCGR gene polymorphism. The median of the HER2 AI was 5.0 (range, 1.4-15.5) and a higher HER2 AI (>= 5.0) was significantly correlated with better response rate (RR) (80% vs. 42%, P = 0.049) and longer progression-free survival (PFS) (13.6 vs. 6.9 months, P = 0.023). High bTubIII expression showed higher RRs than did low expression (81% vs. 40%, P = 0.040) in addition to longer PFS (16.2 months vs. 8.8 months, P = 0.04). However, polymorphisms in FCGR 2A-H131R or FCGR 3A-V158F were not predictive of RR or PFS. Our results suggest that a high HER2 AI and high bTubIII expression could be predictive of the outcomes to TP therapy but no evidence was found in terms of FCGR polymorphisms.	[Jung, Minkyu; Moon, Young Wha; Lee, Soo Hyun; Hong, Soojung; Rha, Sun Young; Chung, Hyun Cheol; Kim, Joo Hang; Sohn, Joohyuk] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol,Yonsei Canc Ctr, Seoul, South Korea; [Koo, Ja Seung] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Park, Byeong-Woo; Kim, Seung Il; Park, Seho] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Sohn, J (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol,Yonsei Canc Ctr, Seoul, South Korea.	oncosohn@yuhs.ac		Hong, Soojung/0000-0002-4350-2794; Lee, Soohyeon/0000-0001-9665-062X; koo, ja seung/0000-0003-4546-4709; Jung, Minkyu/0000-0001-8281-3387; Sohn, Joohyuk/0000-0002-2303-2764; Rha, Sun Young/0000-0002-2512-4531; Park, Byeong-Woo/0000-0003-1353-2607; Park, Seho/0000-0001-8089-2755; Chung, Hyun/0000-0002-0920-9471	Department of Internal Medicine, Yonsei University College of Medicine [7-2009-0601]	Department of Internal Medicine, Yonsei University College of Medicine	This study was supported by a faculty research grant of Department of Internal Medicine, Yonsei University College of Medicine, for 2009 (7-2009-0601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki D, 2009, CLIN CANCER RES, V15, P1473, DOI 10.1158/1078-0432.CCR-08-1274; Burkhart CA, 2001, BBA-REV CANCER, V1471, pO1, DOI 10.1016/S0304-419X(00)00022-6; Carlotti E, 2007, HAEMATOLOGICA, V92, P1127, DOI 10.3324/haematol.11288; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Chang H, 2009, ANN ONCOL, V20, P272, DOI 10.1093/annonc/mdn624; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferrandina G, 2006, CLIN CANCER RES, V12, P2774, DOI 10.1158/1078-0432.CCR-05-2715; Galmarini CM, 2008, CLIN CANCER RES, V14, P4511, DOI 10.1158/1078-0432.CCR-07-4741; Giuliani R, 2007, EUR J CANCER, V43, P725, DOI 10.1016/j.ejca.2006.11.019; Han HS, 2009, J KOREAN MED SCI, V24, P910, DOI 10.3346/jkms.2009.24.5.910; Hayes DF, 1998, BREAST CANCER RES TR, V52, P305, DOI 10.1023/A:1006197805041; Hurvitz SA, 2009, 32 ANN SAN ANT BREAS; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang XM, 1996, J IMMUNOL METHODS, V199, P55, DOI 10.1016/S0022-1759(96)00164-0; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Lebeau A, 2001, J CLIN ONCOL, V19, P354, DOI 10.1200/JCO.2001.19.2.354; Leppers-van de Straat FGJ, 2000, J IMMUNOL METHODS, V242, P127, DOI 10.1016/S0022-1759(00)00240-4; Liu B, 2001, J SURG RES, V99, P179, DOI 10.1006/jsre.2001.6126; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; NCI CTEP, 2010, COMM TERM CRIT ADV E; Paradiso A, 2005, ANN ONCOL, V16, P14, DOI 10.1093/annonc/mdi902; Ranganathan S, 1998, BRIT J CANCER, V77, P562, DOI 10.1038/bjc.1998.91; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; Rosenberg S.A., 2008, DEVITA HELLMAN ROSEN; Seve P, 2005, MOL CANCER THER, V4, P2001, DOI 10.1158/1535-7163.MCT-05-0244; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Seve P, 2007, CLIN CANCER RES, V13, P994, DOI 10.1158/1078-0432.CCR-06-1503; Seve P, 2007, CANCER CHEMOTH PHARM, V60, P27, DOI 10.1007/s00280-006-0343-1; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sliwkowski MX, 1999, SEMIN ONCOL, V26, P60; Taylor RJ, 2009, CANCER IMMUNOL IMMUN, V58, P997, DOI 10.1007/s00262-008-0613-3; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021	36	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45127	10.1371/journal.pone.0045127	http://dx.doi.org/10.1371/journal.pone.0045127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028798	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900022
J	Sverdlova, NS; Lambertz, M; Witzel, U; Perry, SF				Sverdlova, Nina S.; Lambertz, Markus; Witzel, Ulrich; Perry, Steven F.			Boundary Conditions for Heat Transfer and Evaporative Cooling in the Trachea and Air Sac System of the Domestic Fowl: A Two-Dimensional CFD Analysis	PLOS ONE			English	Article							RESPIRATORY EVAPORATION	Various parts of the respiratory system play an important role in temperature control in birds. We create a simplified computational fluid dynamics (CFD) model of heat exchange in the trachea and air sacs of the domestic fowl (Gallus domesticus) in order to investigate the boundary conditions for the convective and evaporative cooling in these parts of the respiratory system. The model is based upon published values for respiratory times, pressures and volumes and upon anatomical data for this species, and the calculated heat exchange is compared with experimentally determined values for the domestic fowl and a closely related, wild species. In addition, we studied the trachea histologically to estimate the thickness of the heat transfer barrier and determine the structure and function of moisture-producing glands. In the transient CFD simulation, the airflow in the trachea of a 2-dimensional model is evoked by changing the volume of the simplified air sac. The heat exchange between the respiratory system and the environment is simulated for different ambient temperatures and humidities, and using two different models of evaporation: constant water vapour concentration model and the droplet injection model. According to the histological results, small mucous glands are numerous but discrete serous glands are lacking on the tracheal surface. The amount of water and heat loss in the simulation is comparable with measured respiratory values previously reported. Tracheal temperature control in the avian respiratory system may be used as a model for extinct or rare animals and could have high relevance for explaining how gigantic, long-necked dinosaurs such as sauropoda might have maintained a high metabolic rate.	[Sverdlova, Nina S.; Witzel, Ulrich] Ruhr Univ Bochum, Inst Prod & Serv Engn, Bochum, Germany; [Lambertz, Markus; Perry, Steven F.] Univ Bonn, Inst Zool, Bonn, Germany	Ruhr University Bochum; University of Bonn	Sverdlova, NS (corresponding author), Ruhr Univ Bochum, Inst Prod & Serv Engn, Univ Str 150, Bochum, Germany.	sverdlova@lmk.rub.de	Lambertz, Markus/C-7328-2011	Lambertz, Markus/0000-0001-8348-9347	German Research Foundation (Deutsche Forschungsgemeinschaft: Biology of the Sauropod Dinosaurs: The Evolution of Gigantism) [FOR 533]	German Research Foundation (Deutsche Forschungsgemeinschaft: Biology of the Sauropod Dinosaurs: The Evolution of Gigantism)	The study was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft/FOR 533: Biology of the Sauropod Dinosaurs: The Evolution of Gigantism). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKESTER AR, 1960, J ANAT, V94, P487; Beitz W., 1981, DUBBEL TASCHENBUCH M; BOUVEROT P, 1971, RESP PHYSIOL, V13, P330, DOI 10.1016/0034-5687(71)90037-5; Brackenbury JH, 1973, PHYSIOL A, V44A, P599; CRAWFORD EC, 1968, CONDOR, V70, P333, DOI 10.2307/1365927; DAWSON WR, 1982, COMP BIOCHEM PHYS A, V71, P495, DOI 10.1016/0300-9629(82)90198-0; DUNCKER HR, 1972, RESP PHYSIOL, V14, P44, DOI 10.1016/0034-5687(72)90016-3; FRUMKIN R, 1986, PHYSIOL ZOOL, V59, P592, DOI 10.1086/physzool.59.6.30158607; Hinds DS, 1971, EVOLUTION, V25, P427; Hodges R.D, 1974, HISTOLOGY FOWL, P300; Maina JN, 2009, RESP PHYSIOL NEUROBI, V169, P262, DOI 10.1016/j.resp.2009.09.011; Marsh K. N., 1987, RECOMMENDED REFERENC; McLelland L, 1989, FORM FUNCTION BIRDS, V4, P69; MENUAM B, 1975, RESP PHYSIOL, V25, P39, DOI 10.1016/0034-5687(75)90049-3; Nickel R, 2004, LEHRBUCH ANATOMIE HA, V4th, P473; Pastor L.M., 1995, HISTOLOGY ULTRASTRUC, P155; Perry S.F., 1992, Lung Biology in Health and Disease, V56, P149; Perry SF, 2011, SAUROPOD DINOSAURS U, P83; Sander PM, 2011, SAUROPOD DINOSAURS U, P276	19	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45315	10.1371/journal.pone.0045315	http://dx.doi.org/10.1371/journal.pone.0045315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028927	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900040
J	Todt, TJ; Wels, M; Bongers, RS; Siezen, RS; van Hijum, SAFT; Kleerebezem, M				Todt, Tilman J.; Wels, Michiel; Bongers, Roger S.; Siezen, Roland S.; van Hijum, Sacha A. F. T.; Kleerebezem, Michiel			Genome-Wide Prediction and Validation of Sigma70 Promoters in Lactobacillus plantarum WCFS1	PLOS ONE			English	Article							TRANSCRIPTION START SITES; ESCHERICHIA-COLI; RNA-POLYMERASE; SEQUENCES; IDENTIFICATION; CONSERVATION; COMPILATION; ELEMENTS; MOTIFS; FAMILY	Background: In prokaryotes, sigma factors are essential for directing the transcription machinery towards promoters. Various sigma factors have been described that recognize, and bind to specific DNA sequence motifs in promoter sequences. The canonical sigma factor sigma(70) is commonly involved in transcription of the cell's housekeeping genes, which is mediated by the conserved sigma(70) promoter sequence motifs. In this study the sigma(70)-promoter sequences in Lactobacillus plantarum WCFS1 were predicted using a genome-wide analysis. The accuracy of the transcriptionally-active part of this promoter prediction was subsequently evaluated by correlating locations of predicted promoters with transcription start sites inferred from the 5'-ends of transcripts detected by high-resolution tiling array transcriptome datasets. Results: To identify sigma(70)-related promoter sequences, we performed a genome-wide sequence motif scan of the L. plantarum WCFS1 genome focussing on the regions upstream of protein-encoding genes. We obtained several highly conserved motifs including those resembling the conserved sigma(70)-promoter consensus. Position weight matrices-based models of the recovered sigma(70)-promoter sequence motif were employed to identify 3874 motifs with significant similarity (p-value<10(-4)) to the model-motif in the L. plantarum genome. Genome-wide transcript information deduced from whole genome tiling-array transcriptome datasets, was used to infer transcription start sites (TSSs) from the 5'-end of transcripts. By this procedure, 1167 putative TSSs were identified that were used to corroborate the transcriptionally active fraction of these predicted promoters. In total, 568 predicted promoters were found in proximity (<= 40 nucleotides) of the putative TSSs, showing a highly significant co-occurrence of predicted promoter and TSS (p-value, 10(-263)). Conclusions: High-resolution tiling arrays provide a suitable source to infer TSSs at a genome-wide level, and allow experimental verification of in silico predicted promoter sequence motifs.	[Todt, Tilman J.; Wels, Michiel; Siezen, Roland S.; van Hijum, Sacha A. F. T.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Todt, Tilman J.; Siezen, Roland S.] HAN Univ Appl Sci, Inst Appl Sci, Nijmegen, Netherlands; [Wels, Michiel; Bongers, Roger S.; Siezen, Roland S.; van Hijum, Sacha A. F. T.; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [Wels, Michiel; Bongers, Roger S.; Siezen, Roland S.; van Hijum, Sacha A. F. T.; Kleerebezem, Michiel] TI Food & Nutr, Wageningen, Netherlands; [Wels, Michiel; Siezen, Roland S.; van Hijum, Sacha A. F. T.; Kleerebezem, Michiel] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, Wageningen, Netherlands; [Siezen, Roland S.; van Hijum, Sacha A. F. T.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; NIZO Food Research; Top Institute Food & Nutrition; Wageningen University & Research	van Hijum, SAFT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands.	svhijum@cmbi.ru.nl	van Hijum, Sacha/F-6445-2014; Siezen, Roland J/P-5745-2015; Kleerebezem, Michiel/AAT-2078-2021	van Hijum, Sacha/0000-0003-0741-2991; Kleerebezem, Michiel/0000-0001-8552-2235	HAN University of Applied Sciences	HAN University of Applied Sciences	T.J. Todt was funded by HAN University of Applied Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Alkema WBL, 2004, GENOME RES, V14, P1362, DOI 10.1101/gr.2242604; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 1998, J COMPUT BIOL, V5, P211, DOI 10.1089/cmb.1998.5.211; Baxevanis AD, 2004, CURR PROTOC BIOINFOR, pChapter 4; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; Hertz GZ, 1996, METHOD ENZYMOL, V273, P30; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kanhere A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-1; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kroos L, 2000, CURR OPIN MICROBIOL, V3, P553, DOI 10.1016/S1369-5274(00)00140-5; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; Lloyd G, 2001, ESSAYS BIOCHEM, V37, P17, DOI 10.1042/bse0370017; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; McGuire AM, 2000, GENOME RES, V10, P744, DOI 10.1101/gr.10.6.744; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; MULLIGAN ME, 1984, NUCLEIC ACIDS RES, V12, P789, DOI 10.1093/nar/12.1Part2.789; Ozoline ON, 1997, NUCLEIC ACIDS RES, V25, P4703, DOI 10.1093/nar/25.23.4703; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Pedersen AG, 1999, COMPUT CHEM, V23, P191, DOI 10.1016/S0097-8485(99)00015-7; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Saulnier DAA, 2007, APPL ENVIRON MICROB, V73, P1753, DOI 10.1128/AEM.01151-06; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Siezen RJ, 2012, J BACTERIOL, V194, P195, DOI 10.1128/JB.06275-11; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Stevens MJA, 2010, MICROBIOL-SGM, V156, P695, DOI 10.1099/mic.0.034165-0; Stormo GD, 2000, GENOME RES, V10, P394, DOI 10.1101/gr.10.4.394; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399; Wels M, 2006, NUCLEIC ACIDS RES, V34, P1947, DOI 10.1093/nar/gkl138	45	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45097	10.1371/journal.pone.0045097	http://dx.doi.org/10.1371/journal.pone.0045097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028780	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900021
J	Bernardini, F; Tuniz, C; Coppa, A; Mancini, L; Dreossi, D; Eichert, D; Turco, G; Biasotto, M; Terrasi, F; De Cesare, N; Hua, Q; Levchenko, V				Bernardini, Federico; Tuniz, Claudio; Coppa, Alfredo; Mancini, Lucia; Dreossi, Diego; Eichert, Diane; Turco, Gianluca; Biasotto, Matteo; Terrasi, Filippo; De Cesare, Nicola; Hua, Quan; Levchenko, Vladimir			Beeswax as Dental Filling on a Neolithic Human Tooth	PLOS ONE			English	Article							AMS; CIRCE; TEETH; SAMPLE; WEAR; AGE; BC	Evidence of prehistoric dentistry has been limited to a few cases, the most ancient dating back to the Neolithic. Here we report a 6500-year-old human mandible from Slovenia whose left canine crown bears the traces of a filling with beeswax. The use of different analytical techniques, including synchrotron radiation computed micro-tomography (micro-CT), Accelerator Mass Spectrometry (AMS) radiocarbon dating, Infrared (IR) Spectroscopy and Scanning Electron Microscopy (SEM), has shown that the exposed area of dentine resulting from occlusal wear and the upper part of a vertical crack affecting enamel and dentin tissues were filled with beeswax shortly before or after the individual's death. If the filling was done when the person was still alive, the intervention was likely aimed to relieve tooth sensitivity derived from either exposed dentine and/or the pain resulting from chewing on a cracked tooth: this would provide the earliest known direct evidence of therapeutic-palliative dental filling.	[Bernardini, Federico; Tuniz, Claudio] Abdus Salam Int Ctr Theoret Phys, Multidisciplinary Lab, Trieste, Italy; [Tuniz, Claudio] Univ Wollongong, Ctr Archaeol Sci, Wollongong, NSW, Australia; [Coppa, Alfredo] Univ Roma La Sapienza, Dept Environm Biol, Rome, Italy; [Mancini, Lucia; Dreossi, Diego; Eichert, Diane] Sincrotrone Trieste SCpA, Trieste, Italy; [Turco, Gianluca; Biasotto, Matteo] Univ Trieste, Dept Med Sci, Trieste, Italy; [Terrasi, Filippo; De Cesare, Nicola] Univ Naples 2, CIRCE, INNOVA, Caserta, Italy; [Terrasi, Filippo] Univ Naples 2, Dept Environm Sci, Caserta, Italy; [De Cesare, Nicola] Univ Naples 2, Dept Life Sci, Caserta, Italy; [Hua, Quan; Levchenko, Vladimir] Australian Nucl Sci & Technol Org, Lucas Heights, NSW, Australia	Abdus Salam International Centre for Theoretical Physics (ICTP); University of Wollongong; Sapienza University Rome; Elettra Sincrotrone Trieste; University of Trieste; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Australian Nuclear Science & Technology Organisation	Bernardini, F (corresponding author), Abdus Salam Int Ctr Theoret Phys, Multidisciplinary Lab, Trieste, Italy.	fbernard@ictp.it	Terrasi, Filippo/AAI-5062-2020; Hua, Quan/F-9593-2014; Turco, Gianluca/J-5527-2016	Terrasi, Filippo/0000-0001-5641-8973; Hua, Quan/0000-0003-0179-8539; Mancini, Lucia/0000-0003-2416-3464; Bernardini, Federico/0000-0002-3282-8799; Turco, Gianluca/0000-0001-5699-2131; coppa, alfredo/0000-0002-7708-2484; BIASOTTO, Matteo/0000-0001-6024-6115	Friuli Venezia Giulia (Italy)	Friuli Venezia Giulia (Italy)	This work is part of the ICTP/Elettra EXACT Project (Elemental X-ray Analysis and computed Tomography) funded by Friuli Venezia Giulia (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCIATI G, 1993, QUADERNI ANATOMIA PR, V49, P73; Alciati G, 1995, B PALETN ITALIANA, V86, P153; Alvrus A, 1997, J PALEOPATHOLOGY, V9, P5; [Anonymous], 1995, ARCHAEOMETRY, DOI DOI 10.1111/J.1475-4754.1995.TB00730.X; Baeten J, 2010, MICROCHEM J, V95, P227, DOI 10.1016/j.microc.2009.12.005; BENSON GG, 1978, J PHARM PHARMACOL, V30, pP78, DOI 10.1111/j.2042-7158.1978.tb10785.x; Birshtein V. Y, 1977, CHEM NAT COMPD, V13, P232, DOI [10.1007%2FBF00563956, DOI 10.1007/BF00563956]; Boschian G., 2000, GEOARCHAEOLOGY, V15, P331; Cattani L, 1993, ANTROPOL CONT, V16, P55; Comelli D, 2005, APPL SPECTROSC, V59, P1174, DOI 10.1366/0003702055012663; Copley MS, 2005, J ARCHAEOL SCI, V32, P523, DOI 10.1016/j.jas.2004.08.006; Coppa A, 2006, NATURE, V440, P755, DOI 10.1038/440755a; Cristiani E, 2009, DOC PRAEHIST, V36, P191, DOI 10.4312/dp.36.12; Fink D, 2004, NUCL INSTRUM METH B, V223, P109, DOI 10.1016/j.nimb.2004.04.025; Forenbaher S, 2005, ANTIQUITY, V79, P514, DOI 10.1017/S0003598X00114474; Forenbaher S, 2006, ARCHAEOLOGY PUPICINA, P497; Garnier N, 2002, ANAL CHEM, V74, P4868, DOI 10.1021/ac025637a; HERON C, 1994, NATURWISSENSCHAFTEN, V81, P266, DOI 10.1007/BF01131579; Hua Q, 2001, RADIOCARBON, V43, P275; Hughes CE, 2009, J FORENSIC SCI, V54, P263, DOI 10.1111/j.1556-4029.2008.00976.x; Imbeni V, 2005, NAT MATER, V4, P229, DOI 10.1038/nmat1323; Irish J. D., 2004, DENT ANTHR, V17, P28, DOI [10.26575/daj.v17i1.142, DOI 10.26575/DAJ.V17I1.142]; Irish JD, 2004, INT J ORAL MAX IMPL, V19, P645; Leek F F, 1967, J Egypt Archaeol, V53, P51; Lepori R., 1937, ATTI MUSEO CIVICO ST, VXIII, P27; Loomba Kapil, 2010, J Oral Sci, V52, P517, DOI 10.2334/josnusd.52.517; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Lukacs JR, 2007, INT J OSTEOARCHAEOL, V17, P157, DOI 10.1002/oa.864; Luo WG, 2012, J ARCHAEOL SCI, V39, P1227, DOI 10.1016/j.jas.2011.12.035; Mantini S., 2007, ORIGINI, V29, P221; Martin N, 2010, AM J DENT, V23, P108; Marzaioli F, 2008, RADIOCARBON, V50, P139, DOI 10.1017/S0033822200043423; Molnar P, 2008, AM J PHYS ANTHROPOL, V136, P423, DOI 10.1002/ajpa.20824; Passariello I, 2007, RADIOCARBON, V49, P225, DOI 10.1017/S0033822200042156; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Regert M, 2001, ARCHAEOMETRY, V43, P549, DOI 10.1111/1475-4754.00036; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Terrasi F, 2008, NUCL INSTRUM METH B, V266, P2221, DOI 10.1016/j.nimb.2008.02.079; Viciano J, 2012, J ARCHAEOL SCI, V39, P566, DOI 10.1016/j.jas.2011.10.030; Zimnicka B., 2006, POLISH J ENV STUDIES, V15, P112; [No title captured]	41	46	47	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44904	10.1371/journal.pone.0044904	http://dx.doi.org/10.1371/journal.pone.0044904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028670	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400048
J	Fischer, F; Gertz, M; Suenkel, B; Lakshminarasimhan, M; Schutkowski, M; Steegborn, C				Fischer, Frank; Gertz, Melanie; Suenkel, Benjamin; Lakshminarasimhan, Mahadevan; Schutkowski, Mike; Steegborn, Clemens			Sirt5 Deacylation Activities Show Differential Sensitivities to Nicotinamide Inhibition	PLOS ONE			English	Article							MAMMALIAN SIRTUINS; STRUCTURAL BASIS; DEACETYLASE; SUBSTRATE; ASSAYS; MECHANISMS; PATHWAYS; INSIGHTS; TARGETS; FAMILY	Sirtuins are protein deacylases regulating metabolism and aging processes, and the seven human isoforms are considered attractive therapeutic targets. Sirtuins transfer acyl groups from lysine sidechains to ADP-ribose, formed from the cosubstrate NAD(+) by release of nicotinamide, which in turn is assumed to be a general Sirtuin inhibitor. Studies on Sirtuin regulation have been hampered, however, by shortcomings of available assays. Here, we describe a mass spectrometry-based, quantitative deacylation assay not requiring any substrate labeling. Using this assay, we show that the deacetylation activity of human Sirt5 features an unusual insensitivity to nicotinamide inhibition. In contrast, we find similar values for Sirt5 and Sirt3 for the intrinsic NAD(+) affinity as well as the apparent NAD(+) affinity in presence of peptide. Structure comparison and mutagenesis identify an Arg neighboring to the Sirt5 nicotinamide binding pocket as a mediator of nicotinamide resistance, and statistical sequence analyses along with testing further Sirtuins reveal a network of coevolved residues likely defining a nicotinamide-insensitive Sirtuin deacetylase family. The same Arg was recently reported to render Sirt5 a preferential desuccinylase, and we find that this Sirt5 activity is highly sensitive to nicotinamide inhibition. Analysis of Sirt5 structures and activity data suggest that an Arg/succinate interaction is the molecular basis of the differential nicotinamide sensitivities of the two Sirt5 activities. Our results thus indicate a Sirtuin subfamily with nicotinamide-insensitive deacetylase activity and suggest that the molecular features determining nicotinamide sensitivity overlap with those dominating deacylation specificity, possibly suggesting that other subfamily members might also prefer other acylations than acetylations.	[Fischer, Frank; Gertz, Melanie; Suenkel, Benjamin; Lakshminarasimhan, Mahadevan; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, Bayreuth, Germany; [Fischer, Frank; Gertz, Melanie; Suenkel, Benjamin; Lakshminarasimhan, Mahadevan; Steegborn, Clemens] Univ Bayreuth, Res Ctr Bio Macromol, Bayreuth, Germany; [Schutkowski, Mike] Univ Halle Wittenberg, Dept Enzymol, Inst Biochem & Biotechnol, Halle, Germany	University of Bayreuth; University of Bayreuth; Martin Luther University Halle Wittenberg	Steegborn, C (corresponding author), Univ Bayreuth, Dept Biochem, Bayreuth, Germany.	Clemens.Steegborn@uni-bayreuth.de		Schutkowski, MIke/0000-0003-0919-7076; Lakshminarasimhan, Mahadevan/0000-0001-9475-4927; Suenkel, Benjamin/0000-0001-9774-4492	Deutsche Forschungsgemeinschaft [STE1701/5]; BMBF [ProNet-T3]; elite network bavaria Graduate School "Lead structures of Cell Function"; German Research Foundation; University of Bayreuth	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); elite network bavaria Graduate School "Lead structures of Cell Function"; German Research Foundation(German Research Foundation (DFG)); University of Bayreuth	This work was supported by Deutsche Forschungsgemeinschaft (STE1701/5 to C. S.), BMBF (ProNet-T3 to M. S.), and elite network bavaria Graduate School "Lead structures of Cell Function" (M. L.). This publication was funded by the German Research Foundation and the University of Bayreuth in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Cen Y, 2010, BBA-PROTEINS PROTEOM, V1804, P1635, DOI 10.1016/j.bbapap.2009.11.010; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gertz M, 2010, BBA-PROTEINS PROTEOM, V1804, P1658, DOI 10.1016/j.bbapap.2009.09.011; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; He B, 2012, J AM CHEM SOC, V134, P1922, DOI 10.1021/ja2090417; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jin L, 2009, J BIOL CHEM, V284, P24394, DOI 10.1074/jbc.M109.014928; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lakshminarasimhan M, 2011, EXP GERONTOL, V46, P174, DOI 10.1016/j.exger.2010.08.024; Landry J, 2003, METHODS, V31, P33, DOI 10.1016/S1046-2023(03)00085-9; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu YC, 2008, ANAL BIOCHEM, V378, P53, DOI 10.1016/j.ab.2008.02.018; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mahlknecht U, 2006, CYTOGENET GENOME RES, V112, P208, DOI 10.1159/000089872; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Moniot S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00016; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sauve AA, 2010, BBA-PROTEINS PROTEOM, V1804, P1591, DOI 10.1016/j.bbapap.2010.01.021; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schlicker C, 2011, AGING-US, V3, P852, DOI 10.18632/aging.100388; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Smith JS, 2002, METHOD ENZYMOL, V353, P282; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472	44	64	65	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45098	10.1371/journal.pone.0045098	http://dx.doi.org/10.1371/journal.pone.0045098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028781	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400060
J	Pan, TH; Zhu, J; Hwu, WJ; Jankovic, J				Pan, Tianhong; Zhu, Julie; Hwu, Wen-Jen; Jankovic, Joseph			The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells	PLOS ONE			English	Article							PARKINSONS-DISEASE; SKIN-CANCER; ULTRAVIOLET-RADIATION; MALIGNANT-MELANOMA; HUMAN MELANOCYTES; GENE-EXPRESSION; NEUROMELANIN; TYROSINASE; PIGMENTATION; MELANOGENESIS	The relatively high co-occurrence of Parkinson's disease (PD) and melanoma has been established by a large number of epidemiological studies. However, a clear biological explanation for this finding is still lacking. Ultra-violet radiation (UVR)-induced skin melanin synthesis is a defense mechanism against UVR-induced damage relevant to the initiation of melanoma, whereas, increased neuromelanin (NM), the melanin synthesized in dopaminergic neurons, may enhance the susceptibility to oxidative stress-induced neuronal injury relevant to PD. SNCA is a PD-causing gene coding for alpha-Synuclein (alpha-Syn) that expresses not only in brain, but also in skin as well as in tumors, such as melanoma. The findings that alpha-Syn can interact with tyrosinase (TYR) and inhibit tyrosine hydroxylase (TH), both of which are enzymes involved in the biosynthesis of melanin and dopamine (DA), led us to propose that alpha-Syn may participate in the regulation of melanin synthesis. In this study, by applying ultraviolet B (UVB) light, a physiologically relevant stimulus of melanogenesis, we detected melanin synthesis in A375 and SK-MEL-28 melanoma cells and in SH-SY5Y and PC12 dopaminergic neuronal cells and determined effects of alpha-Syn on melanin synthesis. Our results showed that UVB light exposure increased melanin synthesis in all 4 cell lines. However, we found that alpha-Syn expression reduced UVB light-induced increase of melanin synthesis and that melanin content was lower when melanoma cells were expressed with alpha-Syn, indicating that alpha-Syn may have inhibitory effects on melanin synthesis in melanoma cells. Different from melanoma cells, the melanin content was higher in alpha-Syn-over-expressed dopaminergic neuronal SH-SY5Y and PC12 cells, cellular models of PD, than that in non-alpha-Syn-expressed control cells. We concluded that alpha-Syn could be one of the points responsible for the positive association between PD and melanoma via its differential roles in melanin synthesis in melanoma cells and in dopaminergic neuronal cells.	[Pan, Tianhong; Zhu, Julie; Jankovic, Joseph] Baylor Coll Med, Dept Neurol, Parkinson Dis Res Lab, Houston, TX 77030 USA; [Hwu, Wen-Jen] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Jankovic, Joseph] Baylor Coll Med, Parkinsons Dis Ctr, Houston, TX 77030 USA; [Jankovic, Joseph] Baylor Coll Med, Movement Disorder Clin, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine	Pan, TH (corresponding author), Baylor Coll Med, Dept Neurol, Parkinson Dis Res Lab, Houston, TX 77030 USA.	tpan@bcm.edu			Michael J. Fox Foundation for Parkinson's Research-Rapid Response Innovation Awards (RRIA)	Michael J. Fox Foundation for Parkinson's Research-Rapid Response Innovation Awards (RRIA)	This work was supported by Michael J. Fox Foundation for Parkinson's Research-Rapid Response Innovation Awards 2011 (RRIA 2011) (to T. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken JF, 2002, J MED SCREEN, V9, P33, DOI 10.1136/jms.9.1.33; Ando H, 1999, J LIPID RES, V40, P1312; Ando H, 2007, J INVEST DERMATOL, V127, P751, DOI 10.1038/sj.jid.5700683; Aoki Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1879, DOI 10.1271/bbb.70099; Baldea I., 2009, Experimental Oncology, V31, P200; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Bellei B, 2010, J BIOL CHEM, V285, P7288, DOI 10.1074/jbc.M109.070573; Bertoni JM, 2010, ARCH NEUROL-CHICAGO, V67, P347, DOI 10.1001/archneurol.2010.1; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Dahodwala N, 2009, MOVEMENT DISORD, V24, P1200, DOI 10.1002/mds.22557; De Marco F, 2004, BIOCHEM BIOPH RES CO, V314, P631, DOI 10.1016/j.bbrc.2003.12.127; Driver JA, 2007, CANCER EPIDEM BIOMAR, V16, P1260, DOI 10.1158/1055-9965.EPI-07-0038; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Dwyer T, 2002, AM J EPIDEMIOL, V155, P614, DOI 10.1093/aje/155.7.614; Elbaz A, 2008, CURR OPIN NEUROL, V21, P454, DOI 10.1097/WCO.0b013e3283050461; ENOCHS WS, 1994, J NEURAL TRANSM-PARK, V7, P83, DOI 10.1007/BF02260963; Fasano M, 2006, J NEUROCHEM, V96, P909, DOI 10.1111/j.1471-4159.2005.03638.x; Ferreira JJ, 2010, MOVEMENT DISORD, V25, P139, DOI 10.1002/mds.22855; Gao X, 2009, NEUROLOGY, V73, P1286, DOI 10.1212/WNL.0b013e3181bd13a1; Gebhardt C, 2007, EXP DERMATOL, V16, P636, DOI 10.1111/j.1600-0625.2007.00572.x; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; Harbour JW, 2004, BRIT J OPHTHALMOL, V88, P39, DOI 10.1136/bjo.88.1.39; Ikemura M, 2008, J NEUROPATH EXP NEUR, V67, P945, DOI 10.1097/NEN.0b013e318186de48; Inzelberg R, 2007, NEUROLOGY, V69, P1542, DOI 10.1212/01.wnl.0000277638.63767.b8; Inzelberg R, 2009, J NEURAL TRANSM, V116, P1503, DOI 10.1007/s00702-009-0322-x; IOZUMI K, 1993, J INVEST DERMATOL, V100, P806, DOI 10.1111/1523-1747.ep12476630; Izykowska I, 2009, IN VIVO, V23, P733; Jiang CT, 2007, BIOCHEMISTRY-US, V46, P602, DOI 10.1021/bi062068i; Jiang WD, 1999, ONCOGENE, V18, P4247, DOI 10.1038/sj.onc.1202789; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Li J, 2012, J NEURAL TRANSM, V119, P685, DOI 10.1007/s00702-011-0753-z; Lindsey JD, 2001, ARCH OPHTHALMOL-CHIC, V119, P853; Liu DM, 2008, NEUROCHEM RES, V33, P1401, DOI 10.1007/s11064-008-9599-7; Liu R, 2011, NEUROLOGY, V76, P2002, DOI 10.1212/WNL.0b013e31821e554e; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Matsuo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010481; Miller AJ, 2010, BRIT J DERMATOL, V162, P22, DOI 10.1111/j.1365-2133.2009.09565.x; Nicolaus BJR, 2005, MED HYPOTHESES, V65, P791, DOI 10.1016/j.mehy.2005.04.011; Olanow CW, 2009, P NATL ACAD SCI USA, V106, P12571, DOI 10.1073/pnas.0906759106; Paisan-Ruiz C, 2010, NEUROLOGY, V75, P1653, DOI 10.1212/WNL.0b013e3181fb4466; Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Pan TH, 2008, BRAIN RES, V1222, P222, DOI 10.1016/j.brainres.2008.05.022; Pan TH, 2011, INT J CANCER, V128, P2251, DOI 10.1002/ijc.25912; Park HY, 2009, CELL MOL LIFE SCI, V66, P1493, DOI 10.1007/s00018-009-8703-8; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Plun-Favreau H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001257; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; Shishido T, 2010, NEUROLOGY, V74, P608, DOI 10.1212/WNL.0b013e3181cff6d5; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stepien Krystyna, 2007, Wiad Lek, V60, P563; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Tessari I, 2008, J BIOL CHEM, V283, P16808, DOI 10.1074/jbc.M709014200; Verkrellis K, 2011, LANCET NEUROL, V10, P1015; Wakabayashi K, 2010, ACTA NEUROPATHOL, V120, P1, DOI 10.1007/s00401-010-0706-x; Weinstock M A, 2001, Med Health R I, V84, P234; Willis AW, 2010, NEUROEPIDEMIOLOGY, V34, P143, DOI 10.1159/000275491; Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516; Wu YC, 2010, NEUROCHEM INT, V57, P198, DOI 10.1016/j.neuint.2010.05.008; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Xuan Q, 2011, J NEURAL TRANSM, V118, P1575, DOI 10.1007/s00702-011-0636-3; Ye Q, 2010, ONCOL REP, V23, P429, DOI 10.3892/or_00000652; Zecca L, 2006, NEUROLOGY, V67, pS8, DOI 10.1212/WNL.67.7_suppl_2.S8; Zecca L, 2002, J NEURAL TRANSM, V109, P663, DOI 10.1007/s007020200055	71	70	75	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45183	10.1371/journal.pone.0045183	http://dx.doi.org/10.1371/journal.pone.0045183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028833	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400064
J	Rosenes, Z; Mulhern, TD; Hatters, DM; Ilag, LL; Power, BE; Hosking, C; Hensel, F; Howlett, GJ; Mok, YF				Rosenes, Zachary; Mulhern, Terrence D.; Hatters, Danny M.; Ilag, Leodevico L.; Power, Barbara E.; Hosking, Chris; Hensel, Frank; Howlett, Geoffrey J.; Mok, Yee-Foong			The Anti-Cancer IgM Monoclonal Antibody PAT-SM6 Binds with High Avidity to the Unfolded Protein Response Regulator GRP78	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; IMMUNOGLOBULIN-M; CONFORMATION; AUTOANTIBODIES; PURIFICATION; COMPLEXES; ATSAS-2.1; PROGRAM	The monoclonal IgM antibody PAT-SM6 derived from human tumours induces apoptosis in tumour cells and is considered a potential anti-cancer agent. A primary target for PAT-SM6 is the unfolded protein response regulator GRP78, over-expressed externally on the cell surface of tumour cells. Small angle X-ray scattering (SAXS) studies of human GRP78 showed a two-domain dumbbell-shaped monomer, while SAXS analysis of PAT-SM6 revealed a saucer-shaped structure accommodating five-fold symmetry, consistent with previous studies of related proteins. Sedimentation velocity analysis of GRP78 and PAT-SM6 mixtures indicated weak complex formation characterized by dissociation constants in the high micromolar concentration range. In contrast, enzyme-linked immunosorbant assays (ELISAs) showed strong and specific interactions between PAT-SM6 and immobilized GRP78. The apparent binding constant estimated from a PAT-SM6 saturation curve correlated strongly with the concentration of GRP78 used to coat the microtiter tray. Experiments using polyclonal antiGRP78 IgG antibodies or a monoclonal IgG derivative of PAT-SM6 did not show a similar dependence. Competition experiments with soluble GRP78 indicated more effective inhibition of PAT-SM6 binding at low GRP78 coating concentrations. These observations suggest an avidity-based binding mechanism that depends on the multi-point attachment of PAT-SM6 to GRP78 clustered on the surface of the tray. Analysis of ELISA data at high GRP78 coating concentrations yielded an apparent dissociation constant of approximately 4 nM. We propose that the biological action of PAT-SM6 in tumour cell apoptosis may depend on the multivalent nature of PAT-SM6 and the high avidity of its interaction with multiple GRP78 molecules clustered on the tumour cell surface.	[Rosenes, Zachary; Mulhern, Terrence D.; Hatters, Danny M.; Ilag, Leodevico L.; Howlett, Geoffrey J.; Mok, Yee-Foong] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Ilag, Leodevico L.; Power, Barbara E.; Hosking, Chris] Patrys Ltd, Melbourne, Vic, Australia; [Hensel, Frank] Patrys GmbH, Wurzburg, Germany	University of Melbourne	Howlett, GJ (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia.	ghowlett@unimelb.edu.au		Hatters, Danny/0000-0002-9965-2847; Mulhern, Terrence/0000-0002-1609-7498; Power, Barbara/0000-0002-4182-3375	Australian Research Council [LP100100392]; Patrys Ltd.	Australian Research Council(Australian Research Council); Patrys Ltd.	This research was supported by the Australian Research Council (LP100100392) with additional support provided by Patrys Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Brandlein S, 2003, CANCER RES, V63, P7995; Brandlein S, 2007, MOL CANCER THER, V6, P326, DOI 10.1158/1535-7163.MCT-06-0399; Czajkowsky DM, 2009, P NATL ACAD SCI USA, V106, P14960, DOI 10.1073/pnas.0903805106; Eisen HN, 2010, P NATL ACAD SCI USA, V107, P22373, DOI 10.1073/pnas.1012051108; FALLER G, 1990, BRIT J CANCER, V62, P595, DOI 10.1038/bjc.1990.336; FEINSTEIN A, 1969, NATURE, V224, P1307, DOI 10.1038/2241307a0; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gagnon P, 2008, BIOPHARM INT, P26; Gunn NJ, 2011, ACTA CRYSTALLOGR F, V67, P336, DOI 10.1107/S1744309110053728; JENKINS WT, 1991, ANAL BIOCHEM, V194, P136, DOI 10.1016/0003-2697(91)90160-U; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; LITMAN GW, 1971, BIOCHIM BIOPHYS ACTA, V236, P647, DOI 10.1016/0005-2795(71)90250-9; Mills RD, 2009, J MOL BIOL, V388, P1043, DOI 10.1016/j.jmb.2009.03.070; PERKINS SJ, 1991, J MOL BIOL, V221, P1345; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pohle T, 2004, CANCER RES, V64, P3900, DOI 10.1158/0008-5472.CAN-03-3149; POON PH, 1985, J BIOL CHEM, V260, P9357; POWER BE, 1992, GENE, V113, P95, DOI 10.1016/0378-1119(92)90674-E; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tarkoy M, 2010, J PHARMACEUT BIOMED, V51, P1084, DOI 10.1016/j.jpba.2009.11.003; Tchoudakova A, 2009, MABS, V1, P163, DOI 10.4161/mabs.1.2.7945; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vollmers HP, 2009, NEW BIOTECHNOL, V25, P294, DOI 10.1016/j.nbt.2009.03.016; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; WIERSMA EJ, 1995, J IMMUNOL, V154, P5265; WU R, 1995, CLIN EXP IMMUNOL, V102, P174	38	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44927	10.1371/journal.pone.0044927	http://dx.doi.org/10.1371/journal.pone.0044927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028685	Green Published, gold			2022-12-27	WOS:000309388400050
J	Katzir, Y; Stolovicki, E; Stern, S; Braun, E				Katzir, Yair; Stolovicki, Elad; Stern, Shay; Braun, Erez			Cellular Plasticity Enables Adaptation to Unforeseen Cell-Cycle Rewiring Challenges	PLOS ONE			English	Article							GENE-EXPRESSION; YEAST; IDENTIFICATION; NETWORK; GROWTH; MODEL	The fundamental dynamics of the cell cycle, underlying cell growth and reproduction, were previously found to be robust under a wide range of environmental and internal perturbations. This property was commonly attributed to its network structure, which enables the coordinated interactions among hundreds of proteins. Despite significant advances in deciphering the components and autonomous interactions of this network, understanding the interfaces of the cell cycle with other major cellular processes is still lacking. To gain insight into these interfaces, we used the process of genome-rewiring in yeast by placing an essential metabolic gene HIS3 from the histidine biosynthesis pathway, under the exclusive regulation of different cell-cycle promoters. In a medium lacking histidine and under partial inhibition of the HIS3p, the rewired cells encountered an unforeseen multitasking challenge; the cell-cycle regulatory genes were required to regulate the essential histidine-pathway gene in concert with the other metabolic demands, while simultaneously driving the cell cycle through its proper temporal phases. We show here that chemostat cell populations with rewired cell-cycle promoters adapted within a short time to accommodate the inhibition of HIS3p and stabilized a new phenotypic state. Furthermore, a significant fraction of the population was able to adapt and grow into mature colonies on plates under such inhibiting conditions. The adapted state was shown to be stably inherited across generations. These adaptation dynamics were accompanied by a non-specific and irreproducible genome-wide transcriptional response. Adaptation of the cell-cycle attests to its multitasking capabilities and flexible interface with cellular metabolic processes and requirements. Similar adaptation features were found in our previous work when rewiring HIS3 to the GAL system and switching cells from galactose to glucose. Thus, at the basis of cellular plasticity is the emergence of a yet-unknown general, non-specific mechanism allowing fast inherited adaptation to unforeseen challenges.	[Stolovicki, Elad; Braun, Erez] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Katzir, Yair] Technion Israel Inst Technol, Fac Med, IL-32000 Haifa, Israel; [Stolovicki, Elad; Braun, Erez] Technion Israel Inst Technol, Lab Network Biol, IL-32000 Haifa, Israel; [Stern, Shay] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Weizmann Institute of Science	Braun, E (corresponding author), Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel.	erez@physics.technion.ac.il	Stolovicki, Elad/AAT-1742-2021		United States-Israel Binational Science foundation; Israel Science Foundation [496/10]	United States-Israel Binational Science foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This work was supported in part by a United States-Israel Binational Science foundation grant and by the Israel Science Foundation (grant # 496/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Carroll S. B., 2001, DNA DIVERSITY MOL GE; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Csikasz-Nagy A, 2006, BIOPHYS J, V90, P4361, DOI 10.1529/biophysj.106.081240; David L, 2010, HFSP J, V4, P131, DOI 10.2976/1.3353782; Davidson E.H., 2006, REGULATORY GENOME; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Hartwell LH, 2002, BIOSCIENCE REP, V22, P373, DOI 10.1023/A:1020918107706; Horecka J, 2000, METHOD ENZYMOL, V326, P107; Ingolia NT, 2004, CURR BIOL, V14, pR771, DOI 10.1016/j.cub.2004.09.018; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kaizu K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.73; Khodjakov Alexey, 2009, Journal of Biology (London), V8, P1, DOI 10.1186/jbiol195; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Morgan D. O., 2006, CELL CYCLE PRINCIPLE; Murray A, 1993, CELL CYCLE INTRO; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; NOVICK A, 1950, P NATL ACAD SCI USA, V36, P708, DOI 10.1073/pnas.36.12.708; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stern S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100147; Stern S, 2012, CELL REP, V1, P528, DOI 10.1016/j.celrep.2012.03.012; Stolovicki E, 2006, GENETICS, V173, P75, DOI 10.1534/genetics.106.055442; Stolovicki E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020530; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; West-Eberhard Mary Jane, 2003, pi; Wilkins A.S., 2002, EVOLUTION DEV PATHWA	41	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45184	10.1371/journal.pone.0045184	http://dx.doi.org/10.1371/journal.pone.0045184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028834	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900094
J	Modulevsky, DJ; Tremblay, D; Gullekson, C; Bukoresthliev, NV; Pelling, AE				Modulevsky, Daniel J.; Tremblay, Dominique; Gullekson, Corinne; Bukoresthliev, Nickolay V.; Pelling, Andrew E.			The Physical Interaction of Myoblasts with the Microenvironment during Remodeling of the Cytoarchitecture	PLOS ONE			English	Article							INTERFERENCE-REFLECTION MICROSCOPY; FOCAL ADHESION KINASE; CELL-ADHESION; C2C12 MYOBLASTS; MYOSIN-II; VINCULIN RECRUITMENT; EXTRACELLULAR-MATRIX; INTEGRIN ACTIVATION; MUSCLE GROWTH; SINGLE CELLS	Integrins, focal adhesions, the cytoskeleton and the extracellular matrix, form a structural continuum between the external and internal environment of the cell and mediate the pathways associated with cellular mechanosensitivity and mechanotransduction. This continuum is important for the onset of muscle tissue generation, as muscle precursor cells (myoblasts) require a mechanical stimulus to initiate myogenesis. The ability to sense a mechanical cue requires an intact cytoskeleton and strong physical contact and adhesion to the microenvironment. Importantly, myoblasts also undergo reorientation, alignment and large scale remodeling of the cytoskeleton when they experience mechanical stretch and compression in muscle tissue. It remains unclear if such dramatic changes in cell architecture also inhibit physical contact and adhesion with the tissue microenvironment that are clearly important to myoblast physiology. In this study, we employed interference reflection microscopy to examine changes in the close physical contact of myoblasts with a substrate during induced remodeling of the cytoarchitecture (de-stabilization of the actin and microtubule cytoskeleton and inhibition of acto-myosin contractility). Our results demonstrate that while each remodeling pathway caused distinct effects on myoblast morphology and sub-cellular structure, we only observed similar to 13% decrease in close physical contact with the substrate, regardless of the pathway inhibited. However, this decrease did not correlate well with changes in cell adhesion strength. On the other hand, there was a close correlation between cell adhesion and beta 1-integrin expression and the presence of cell-secreted fibronectin, but not with the presence of intact focal adhesions. In this study, we have shown that myoblasts are able to maintain a large degree of physical contact and adhesion to the microenvironment, even during shot periods (<60 min) of large scale remodeling and physiological stress, which is essential to their in-vivo functionality.	[Modulevsky, Daniel J.; Tremblay, Dominique; Gullekson, Corinne; Bukoresthliev, Nickolay V.; Pelling, Andrew E.] Univ Ottawa, Dept Phys, Ctr Interdisciplinary NanoPhys, Ottawa, ON K1N 6N5, Canada; [Pelling, Andrew E.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Pelling, Andrew E.] Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Pelling, AE (corresponding author), Univ Ottawa, Dept Phys, Ctr Interdisciplinary NanoPhys, Ottawa, ON K1N 6N5, Canada.	a@pellinglab.net		Pelling, Andrew/0000-0003-3732-7472	Natural Sciences and Engineering Research Council (NSERC) Discovery Grant; Canada Research Chairs (CRC) program; Province of Ontario; Fond de recherche du Quebec - Nature et technologies (FQRNT); NSERC-CREATE	Natural Sciences and Engineering Research Council (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC) program(Canada Research Chairs); Province of Ontario; Fond de recherche du Quebec - Nature et technologies (FQRNT); NSERC-CREATE	This study was funded by the Natural Sciences and Engineering Research Council (NSERC) Discovery Grant and an NSERC Discovery Accelerator Supplement. A.E.P. gratefully acknowledges the support of the Canada Research Chairs (CRC) program and an Early Researcher Award from the Province of Ontario. D.T. is supported by a post-doctoral fellowship granted by the Fond de recherche du Quebec - Nature et technologies (FQRNT). C.G. and N.V.B. are supported by NSERC-CREATE graduate student and post-doctoral fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Barr Valarie A, 2009, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0423s45; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Choi CK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2993143; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Collinsworth AM, 2000, CELL TISSUE RES, V302, P243, DOI 10.1007/s004410000224; COUCHMAN JR, 1981, CANCER RES, V41, P263; CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199; Dhawan J, 2004, J CELL SCI, V117, P3735, DOI 10.1242/jcs.01197; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Formigli L, 2005, J CELL SCI, V118, P1161, DOI 10.1242/jcs.01695; Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170; Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; GOLDSPINK DF, 1991, J CARDIAC SURG, V6, P218; GOLDSPINK DF, 1995, AM J PHYSIOL-ENDOC M, V268, pE288, DOI 10.1152/ajpendo.1995.268.2.E288; Griffin MA, 2004, J CELL SCI, V117, P5855, DOI 10.1242/jcs.01496; GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697; Holt MR, 2008, J MICROSC-OXFORD, V232, P73, DOI 10.1111/j.1365-2818.2008.02069.x; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kuo JC, 2011, METHODS MOL BIOL, V757, P297, DOI 10.1007/978-1-61779-166-6_19; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Limozin L, 2009, CHEMPHYSCHEM, V10, P2752, DOI 10.1002/cphc.200900601; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Neveux I, 2010, AM J PHYSIOL-CELL PH, V298, pC1006, DOI 10.1152/ajpcell.00359.2009; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pelling AE, 2009, CELL MOTIL CYTOSKEL, V66, P409, DOI 10.1002/cm.20391; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sbrana F, 2008, AM J PHYSIOL-CELL PH, V295, pC160, DOI 10.1152/ajpcell.00014.2008; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Soltow QA, 2010, J MUSCLE RES CELL M, V31, P215, DOI 10.1007/s10974-010-9227-4; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tsuruta D, 2003, CELL MOTIL CYTOSKEL, V54, P122, DOI 10.1002/cm.10089; VANDENBURGH HH, 1989, AM J PHYSIOL, V256, pC674, DOI 10.1152/ajpcell.1989.256.3.C674; VANDENBURGH HH, 1991, FASEB J, V5, P2860, DOI 10.1096/fasebj.5.13.1916108; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; WECHEZAK AR, 1989, J CELL PHYSIOL, V139, P136, DOI 10.1002/jcp.1041390120; ZAND MS, 1989, CELL MOTIL CYTOSKEL, V13, P94, DOI 10.1002/cm.970130204	56	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45329	10.1371/journal.pone.0045329	http://dx.doi.org/10.1371/journal.pone.0045329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028938	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900120
J	Ospeck, M				Ospeck, Mark			Auditory Nerve Spike Generator Modeled as a Variable Attenuator Based on a Saddle Node on Invariant Circle Bifurcation	PLOS ONE			English	Article							CHANNELS; COCHLEA	Mammalian inner hair cells transduce the sound waves amplified by the cochlear amplifier (CA) into a graded neurotransmitter release that activates channels on auditory nerve fibers (ANF). These synaptic channels then charge its dendritic spike generator. While the outer hair cells of the CA employ positive feedback, poising on Andronov-Hopf type instabilities which make them extremely sensitive to faint sounds and make CA output strongly nonlinear, the ANF appears to be based on different principles and a different type of dynamical instability. Its spike generator "digitizes'' CA output into trains of action potentials and behaves as a linear filter, rate-coding sound intensity across a wide dynamic range. Here we model the spike generator as a 3 dimensional version of a saddle node on invariant circle (SNIC) bifurcation. The generic 2d SNIC increases its spike rate as the square root of the input current above its spiking threshold. We add negative feedback in the form of a low voltage-threshold potassium conductance that slows down the generator's rate of increase of its spike rate. A Poisson random source simulates an inner hair cell, outputting a series of noisy periodic current pulses to the model ANF whose spikes phase lock to these pulses and have a linear frequency to current relation with a wide dynamic range. Also, the spike generator compartment has a cholinergic feedback connection from the olive and experiments show that such feedback is able to alter the amount of H conductance inside the generator compartment. We show that an olive able to decrease H would be able to shift the spike generator's dynamic range to higher sound intensities. In a quiet environment by increasing H the olive would be able to make spike trains similar to those caused by synaptic input.				mospeck@yahoo.com						Abbott LF, 1992, SINGLE NEURON DYNAMI; Ermentrout B, 1998, NEURAL COMPUT, V10, P1721, DOI 10.1162/089976698300017106; Fuchs PA, 2010, OXFORD HDB AUDITORY, P259; Horowitz P, 1989, ART ELECT, P175; Hossain WA, 2005, J NEUROSCI, V25, P6857, DOI 10.1523/JNEUROSCI.0123-05.2005; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Kiang NYS, 1965, DISCHARGE PATTERNS S; Narayan SS, 1998, SCIENCE, V282, P1882, DOI 10.1126/science.282.5395.1882; Ospeck M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032384; Rinzel J., 1989, METHODS NEURONAL MOD, P251; Wang XJ, 1998, J NEUROPHYSIOL, V79, P1549, DOI 10.1152/jn.1998.79.3.1549; WINSLOW RL, 1987, J NEUROPHYSIOL, V57, P1002, DOI 10.1152/jn.1987.57.4.1002; Yi EY, 2010, J NEUROPHYSIOL, V103, P2532, DOI 10.1152/jn.00506.2009	13	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45326	10.1371/journal.pone.0045326	http://dx.doi.org/10.1371/journal.pone.0045326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028935	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900118
J	Wangsri, S; Subbalekha, K; Kitkumthorn, N; Mutirangura, A				Wangsri, Siriporn; Subbalekha, Keskanya; Kitkumthorn, Nakarin; Mutirangura, Apiwat			Patterns and Possible Roles of LINE-1 Methylation Changes in Smoke-Exposed Epithelia	PLOS ONE			English	Article							UPPER AERODIGESTIVE TRACT; SQUAMOUS-CELL CARCINOMA; GLOBAL DNA METHYLATION; HYPOMETHYLATION; TOBACCO; CANCER; EXPRESSION; RISK; HEAD; CESSATION	Tobacco smoking and reduced methylation of long interspersed element-1 (LINE-1) are crucial in oral carcinogenesis. 5'UTR of human LINE-1 sequence contains several CpG dinucleotides which are methylated in various proportions (0-100%). Methylation levels of many LINE-1s in cancer were reduced, hypomethylated. The hypomethylation of each LINE-1 locus can promote instability of genome and repress expression of a gene located on that same chromosome. This study investigated if cigarette smoking influences LINE-1 methylation of oral mucosal cells. The methylation of human LINE-1 in clinically normal oral mucosa of current smokers was compared to non-smokers. By using the combined bisulphite restriction analysis, each LINE-1 sequence was categorised into 4 patterns depending on the methylation status and location of the two 18-bp successive CpG from 5' to 3' including (CC)-C-m-C-m, (CC)-C-u-C-u, (CC)-C-m-C-u and (CC)-C-u-C-m. Of these, C-m and C-u represent methylated and unmethylated CpG, respectively. The DNA bisulphite sequence demonstrated that most CpGs of (CC)-C-m-C-m and (CC)-C-u-C-u were methylated and unmethylated, respectively. Nevertheless, some CpGs of each (CC)-C-m-C-u or (CC)-C-u-C-m allele were methylated. Imaging of the digestion products was used to generate % methylation value. No significant difference in the overall LINE-1 methylation level but the differences in percentages of some methylation patterns were discovered. The % (CC)-C-m-C-m and % (CC)-C-u-C-u increased, while the % (CC)-C-m-C-u decreased in current smokers (p = 0.002, 0.015, and <0.0001, respectively). Additionally, the lower % (CC)-C-m-C-u still persisted in persons who had stopped smoking for over 1 year (p = 0.001). The % (CC)-C-m-C-u also decreased in the higher pack-year smokers (p = 0.028). Smoking possibly altered (CC)-C-m-C-u to (CC)-C-m-C-m and (CC)-C-u-C-u forms, and changes (CC)-C-u-C-m to (CC)-C-u-C-u forms. In conclusion, smoking changes methylation levels of partial methylated LINE-1s and increased the number of hypo-and hypermethylated loci. These hypomethylated LINE-1s may possess carcinogenesis potential. Moreover, LINE-1 methylation patterns may be useful for monitoring oral carcinogenesis in smokers.	[Wangsri, Siriporn; Subbalekha, Keskanya] Chulalongkorn Univ, Fac Dent, Dept Oral & Maxillofacial Surg, Bangkok, Thailand; [Kitkumthorn, Nakarin] Mahidol Univ, Fac Dent, Dept Oral & Maxillofacial Pathol, Bangkok 10700, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Dept Anat, Fac Med, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok, Thailand	Chulalongkorn University; Mahidol University; Chulalongkorn University	Subbalekha, K (corresponding author), Chulalongkorn Univ, Fac Dent, Dept Oral & Maxillofacial Surg, Bangkok, Thailand.	skeskanya@gmail.com	Subbalekha, Keskanya/V-8912-2019	Subbalekha, Keskanya/0000-0002-1570-2289	Grant for Development of New Faculty Staff (Ratchadapiseksomphot Endowment Fund); Thailand Research Fund (Young Scientific Researcher) [MRG5380176]; Research Chair Grant; National Science and Technology Development Agency, Thailand; Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund); Four Seasons Hotel Bangkok's 4th Cancer Care charity fun run in coordination; Thai Red Cross Society; Chulalongkorn University	Grant for Development of New Faculty Staff (Ratchadapiseksomphot Endowment Fund); Thailand Research Fund (Young Scientific Researcher); Research Chair Grant; National Science and Technology Development Agency, Thailand; Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund)(Chulalongkorn University); Four Seasons Hotel Bangkok's 4th Cancer Care charity fun run in coordination; Thai Red Cross Society; Chulalongkorn University(Chulalongkorn University)	This study was financially supported by the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund). KS is supported by the Grant for Development of New Faculty Staff (Ratchadapiseksomphot Endowment Fund) and the Thailand Research Fund (Young Scientific Researcher Grant No. MRG5380176). Apiwat Mutirangura is supported in part by the Research Chair Grant 2011, the National Science and Technology Development Agency, Thailand, the Four Seasons Hotel Bangkok's 4th Cancer Care charity fun run in coordination with the Thai Red Cross Society and Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; BANOCZY J, 1962, B GROUP INT RECH SCI, V5, P543; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Dammann R, 2005, EUR J CANCER, V41, P1223, DOI 10.1016/j.ejca.2005.02.020; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Feber A, 2011, GENOME RES, V21, P515, DOI 10.1101/gr.109678.110; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hillemacher T, 2008, EUR NEUROPSYCHOPHARM, V18, P295, DOI 10.1016/j.euroneuro.2007.12.005; Ho SM, 2007, REPROD TOXICOL, V23, P267, DOI 10.1016/j.reprotox.2007.01.004; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Iacopetta B, 2007, CANCER SCI, V98, P1454, DOI 10.1111/j.1349-7006.2007.00548.x; Iramaneerat K, 2011, INT J GYNECOL CANCER, V21, P51, DOI 10.1097/IGC.0b013e3182021c1a; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; Jintaridth P, 2010, PHYSIOL GENOMICS, V41, P194, DOI 10.1152/physiolgenomics.00146.2009; Kitkumthorn N, 2011, CLIN EPIGENETICS, V2, P315, DOI 10.1007/s13148-011-0032-8; Kitkumthorn N, 2012, CLIN CHIM ACTA, V413, P869, DOI 10.1016/j.cca.2012.01.024; Kongruttanachok N, 2010, MOL CANCER, V9, DOI [10.1186/1476-4598-1189-1170, DOI 10.1186/1476-4598-1189-1170]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu F, 2010, ONCOGENE, V29, P3650, DOI 10.1038/onc.2010.129; MACFARLANE GJ, 1995, ORAL ONCOL, V31B, P181; Madrigano J, 2011, ENVIRON HEALTH PERSP, V119, P977, DOI 10.1289/ehp.1002773; MARASCHIO P, 1988, J MED GENET, V25, P173, DOI 10.1136/jmg.25.3.173; Martin GC, 1999, J AM DENT ASSOC, V130, P945, DOI 10.14219/jada.archive.1999.0335; MEYER J, 1970, ORAL SURG ORAL MED O, V30, P700, DOI 10.1016/0030-4220(70)90397-X; Nakkuntod J, 2011, CLIN CHIM ACTA, V412, P1457, DOI 10.1016/j.cca.2011.04.002; Olshan AF, 2000, CANCER EPIDEM BIOMAR, V9, P185; Patchsung M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037009; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; Pobsook T, 2011, CLIN CHIM ACTA, V412, P314, DOI 10.1016/j.cca.2010.10.030; Pornthanakasem W, 2008, NUCLEIC ACIDS RES, V36, P3667, DOI 10.1093/nar/gkn261; Romermann D, 2007, Verh Dtsch Ges Pathol, V91, P338; Salskov A, 2011, J ONCOL, V2011, DOI 10.1155/2011/950140; Schernhammer ES, 2010, GUT, V59, P794, DOI 10.1136/gut.2009.183707; Schlect NF, 1999, EPIDEMIOLOGY, V10, P412, DOI 10.1097/00001648-199907000-00012; Shibly O, 2008, J PERIODONTOL, V79, P1797, DOI [10.1902/jop.2008.070544, 10.1902/jop.2008.070544 ]; Shuangshoti S, 2007, ASIAN PAC J CANCER P, V8, P307; Smith IM, 2007, INT J CANCER, V121, P1724, DOI 10.1002/ijc.22889; Spitz MR, 1999, CANCER INVEST, V17, P645, DOI 10.3109/07357909909032849; SPITZ MR, 1988, CANCER, V61, P203, DOI 10.1002/1097-0142(19880101)61:1<203::AID-CNCR2820610134>3.0.CO;2-6; Subbalekha K, 2009, ORAL ONCOL, V45, P184, DOI 10.1016/j.oraloncology.2008.05.002; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Teneng I, 2011, EPIGENETICS-US, V6, P355, DOI 10.4161/epi.6.3.14282; Toyooka S, 2006, CANCER RES, V66, P1371, DOI 10.1158/0008-5472.CAN-05-2625	52	40	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45292	10.1371/journal.pone.0045292	http://dx.doi.org/10.1371/journal.pone.0045292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028911	gold, Green Submitted, Green Published			2022-12-27	WOS:000311313900115
J	Zhang, H; Copara, M; Ekstrom, AD				Zhang, Hui; Copara, Milagros; Ekstrom, Arne D.			Differential Recruitment of Brain Networks following Route and Cartographic Map Learning of Spatial Environments	PLOS ONE			English	Article							KNOWLEDGE; ACQUISITION; MEMORY; FMRI; REPRESENTATIONS; DISORIENTATION; PERSPECTIVES; NAVIGATION	An extensive neuroimaging literature has helped characterize the brain regions involved in navigating a spatial environment. Far less is known, however, about the brain networks involved when learning a spatial layout from a cartographic map. To compare the two means of acquiring a spatial representation, participants learned spatial environments either by directly navigating them or learning them from an aerial-view map. While undergoing functional magnetic resonance imaging (fMRI), participants then performed two different tasks to assess knowledge of the spatial environment: a scene and orientation dependent perceptual (SOP) pointing task and a judgment of relative direction (JRD) of landmarks pointing task. We found three brain regions showing significant effects of route vs. map learning during the two tasks. Parahippocampal and retrosplenial cortex showed greater activation following route compared to map learning during the JRD but not SOP task while inferior frontal gyrus showed greater activation following map compared to route learning during the SOP but not JRD task. We interpret our results to suggest that parahippocampal and retrosplenial cortex were involved in translating scene and orientation dependent coordinate information acquired during route learning to a landmark-referenced representation while inferior frontal gyrus played a role in converting primarily landmark-referenced coordinates acquired during map learning to a scene and orientation dependent coordinate system. Together, our results provide novel insight into the different brain networks underlying spatial representations formed during navigation vs. cartographic map learning and provide additional constraints on theoretical models of the neural basis of human spatial representation.	[Zhang, Hui; Copara, Milagros; Ekstrom, Arne D.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Copara, Milagros] Univ Calif Davis, Neurosci Grad Grp, Davis, CA 95616 USA; [Ekstrom, Arne D.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ekstrom, AD (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	adekstrom@ucdavis.edu	Ekstrom, Arne/A-1329-2013	Ekstrom, Arne/0000-0002-6812-2368	Sloan Foundation, Hellman Young Investigator Award	Sloan Foundation, Hellman Young Investigator Award	The work was supported by the Sloan Foundation, Hellman Young Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Burgess N, 2008, ANN NY ACAD SCI, V1124, P77, DOI 10.1196/annals.1440.002; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Epstein RA, 2007, CEREB CORTEX, V17, P1680, DOI 10.1093/cercor/bhl079; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Hashimoto R, 2010, EUR NEUROL, V63, P87, DOI 10.1159/000276398; HIRTLE SC, 1991, J ENVIRON PSYCHOL, V11, P335, DOI 10.1016/S0272-4944(05)80106-9; Holmes MC, 2005, J EXP PSYCHOL LEARN, V31, P1069, DOI 10.1037/0278-7393.31.5.1069; Kelly JW, 2007, J EXP PSYCHOL LEARN, V33, P1092, DOI 10.1037/0278-7393.33.6.1092; Klatzky R. L., 1998, Spatial Cognition. An Interdisciplinary Approach to Representing and Processing Spatial Knowledge, P1; Lambrey S, 2011, CEREBRAL CORTEX; Latini-Corazzini L, 2010, PSYCHOL RES-PSYCH FO, V74, P545, DOI 10.1007/s00426-010-0276-5; MCNAMARA TP, 1989, J EXP PSYCHOL LEARN, V15, P211, DOI 10.1037/0278-7393.15.2.211; MCNAUGHTON BL, 1991, J COGNITIVE NEUROSCI, V3, P192, DOI 10.1162/jocn.1991.3.2.190; MOESER SD, 1988, ENVIRON BEHAV, V20, P21, DOI 10.1177/0013916588201002; Mou WM, 2004, J EXP PSYCHOL LEARN, V30, P142, DOI 10.1037/0278-7393.30.1.142; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Richardson AE, 1999, MEM COGNITION, V27, P741, DOI 10.3758/BF03211566; RIESER JJ, 1989, J EXP PSYCHOL LEARN, V15, P1157, DOI 10.1037/0278-7393.15.6.1157; Rossano MJ, 1999, J ENVIRON PSYCHOL, V19, P101, DOI 10.1006/jevp.1998.0115; Shelton AL, 2004, J EXP PSYCHOL LEARN, V30, P158, DOI 10.1037/0278-7393.30.1.158; Shelton AL, 2002, J NEUROSCI, V22, P2711, DOI 10.1523/JNEUROSCI.22-07-02711.2002; Shelton AL, 2007, PSYCHOL RES-PSYCH FO, V71, P333, DOI 10.1007/s00426-006-0088-9; Sholl M. J., 1999, SPAT COGN COMPUT, V1, P475, DOI DOI 10.1023/A:1010047911951; Siegel AW, 1975, ADV CHILD DEV BEHAV; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Taylor HA, 1999, MEM COGNITION, V27, P309, DOI 10.3758/BF03211414; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; THORNDYKE PW, 1982, COGNITIVE PSYCHOL, V14, P560, DOI 10.1016/0010-0285(82)90019-6; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Waller D, 2006, J EXP PSYCHOL LEARN, V32, P867, DOI 10.1037/0278-7393.32.4.867; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005	33	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44886	10.1371/journal.pone.0044886	http://dx.doi.org/10.1371/journal.pone.0044886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040HS	23028661	Green Published, gold			2022-12-27	WOS:000311313900050
J	Gong, Z; Zhao, YJ; Chen, CJ; Xiao, Y				Gong, Zhou; Zhao, Yunjie; Chen, Changjun; Xiao, Yi			Computational Study of Unfolding and Regulation Mechanism of preQ(1) Riboswitches	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; AMBER FORCE-FIELDS; RNA SIMULATIONS; STABILITY; APTAMER; BINDING	Riboswitches are novel RNA regulatory elements. Each riboswitch molecule consists of two domains: aptamer and express platform. The three-dimensional (3D) structure of the aptamer domain, depending on ligand binding or not, controls that of the express platform, which then switches on or off transcriptional or translational process. Here we study the two types of preQ(1) riboswitch aptamers from T. Tengcongensis (denoted as Tte preQ(1) riboswitch for short below) and Bacillus subtilis (denoted as Bsu preQ(1) riboswitch for short below), respectively. The free-state 3D structure of the Tte preQ(1) riboswitch is the same as its bound state but the Bsu preQ(1) riboswitch is not. Therefore, it is very interesting to investigate how these riboswitches realize their different regulation functions. We simulated the unfolding of these two aptamers through all-atom molecular dynamic simulation and found that they have similar unfolding or folding pathways and ligand-binding processes. The main difference between them is the folding intermediate states. The similarity and difference of their unfolding or folding dynamics may suggest their similar regulation mechanisms and account for their different functions, respectively. These results are also useful to understand the regulation mechanism of other riboswitches with free-state 3D structures similar to their bound states.	[Gong, Zhou; Zhao, Yunjie; Chen, Changjun; Xiao, Yi] Huazhong Univ Sci & Technol, Dept Phys, Biomol Phys & Modeling Grp, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Xiao, Y (corresponding author), Huazhong Univ Sci & Technol, Dept Phys, Biomol Phys & Modeling Grp, Wuhan 430074, Hubei, Peoples R China.	yxiao@mail.hust.edu.cn			National Science Foundation of China [30970558, 11074084]; National High Technology Research and Development Program of China [2012AA020402]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work is supported by the National Science Foundation of China under grant no. 30970558 and 11074084 and the National High Technology Research and Development Program of China (2012AA020402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas P, 2010, J CHEM THEORY COMPUT, V6, P3836, DOI 10.1021/ct100481h; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Breaker R.R., 2012, COLD SPRING HARB PER, V4; Brooks CL, 1998, CURR OPIN STRUC BIOL, V8, P222, DOI 10.1016/S0959-440X(98)80043-2; Case D.A., 2022, AMBER 2020; Csaszar K, 2001, J MOL BIOL, V313, P1073, DOI 10.1006/jmbi.2001.5100; DAGGETT V, 1993, J MOL BIOL, V232, P600, DOI 10.1006/jmbi.1993.1414; Dinner AR, 1999, J MOL BIOL, V292, P403, DOI 10.1006/jmbi.1999.3051; Feng J, 2011, J AM CHEM SOC, V133, P4196, DOI 10.1021/ja110411m; Gong Z, 2010, J BIOMOL STRUCT DYN, V28, P431, DOI 10.1080/07391102.2010.10507372; Haller A, 2011, ACC CHEM RES; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jenkins JL, 2011, J BIOL CHEM, V286, P24626, DOI 10.1074/jbc.M111.230375; Kang M, 2009, MOL CELL, V33, P784, DOI 10.1016/j.molcel.2009.02.019; Klein DJ, 2009, NAT STRUCT MOL BIOL, V16, P343, DOI 10.1038/nsmb.1563; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Liberman JA, 2011, WILEY INTERDISCIP RE; LONCHARICH RJ, 1992, BIOPOLYMERS, V32, P523, DOI 10.1002/bip.360320508; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rieder U, 2010, P NATL ACAD SCI USA, V107, P10804, DOI 10.1073/pnas.0914925107; Sarkar K, 2010, RNA, V16, P2427, DOI 10.1261/rna.2253310; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2010, RNA BIOL, V7, P98, DOI 10.4161/rna.7.1.10756; Sorin EJ, 2002, J MOL BIOL, V317, P493, DOI 10.1006/jmbi.2002.5447; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Yildirim I, 2011, J PHYS CHEM B, V115, P9261, DOI 10.1021/jp2016006; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; Zhang Q, 2011, J AM CHEM SOC, V133, P5190, DOI 10.1021/ja111769g; Zhang YJ, 2011, J AM CHEM SOC, V133, P6882, DOI 10.1021/ja1109425; Zhao YJ, 2011, J BIOMOL STRUCT DYN, V28, P815, DOI 10.1080/07391102.2011.10508609	34	14	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45239	10.1371/journal.pone.0045239	http://dx.doi.org/10.1371/journal.pone.0045239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028870	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800043
J	Duan, CH; Zhu, LC; Xu, Y; Lau, GW				Duan, Chaohui; Zhu, Luchang; Xu, Ying; Lau, Gee W.			Saturated Alanine Scanning Mutagenesis of the Pneumococcus Competence Stimulating Peptide Identifies Analogs That Inhibit Genetic Transformation	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE VIRULENCE; GENUS STREPTOCOCCUS; HORIZONTAL TRANSFER; REGULATORY SYSTEM; PHEROMONE; RESISTANCE; COLONIZATION; SPECIFICITY; MECHANISMS; INDUCTION	Antibiotic resistance is a major challenge to modern medicine. Intraspecies and interspecies dissemination of antibiotic resistance genes among bacteria can occur through horizontal gene transfer. Competence-mediated gene transfer has been reported to contribute to the spread of antibiotic resistance genes in Streptococcus pneumoniae. Induction of the competence regulon is mediated by a 17-amino acid peptide pheromone called the competence stimulating peptide (CSP). Thus, synthetic analogs that competitively inhibit CSPs may reduce horizontal gene transfer. We performed saturated alanine scanning mutagenesis and other amino acid substitutions on CSP1 to screen for analogs that disable genetic transformation in S. pneumoniae. Substitution of the glutamate residue at the first position created analogs that could competitively inhibit CSP1-mediated competence development in a concentration-dependent manner. Additional substitutions of the negatively-charged glutamate residue with amino acids of different charge, acidity and hydrophobicity, as well as enantiomeric D-glutamate, generated analogs that efficiently outcompeted CSP1, suggesting the importance of negative charge and enantiomericity of the first glutamate residue for the function of CSP1. Collectively, these results indicate that glutamate residue at the first position is important for the ability of CSP1 to induce ComD, but is dispensable for the peptide to bind the receptor. Furthermore, these results demonstrate the potential applicability of competitive CSP analogs to control horizontal transfer of antibiotic resistance genes in S. pneumoniae.	[Duan, Chaohui; Zhu, Luchang; Xu, Ying; Lau, Gee W.] Univ Illinois, Dept Pathobiol, Urbana, IL USA; [Duan, Chaohui; Xu, Ying] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Clin Immunol Lab, Guangzhou 510275, Guangdong, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; Sun Yat Sen University	Duan, CH (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL USA.	geelau@illinois.edu	Zhu, Luchang/C-9784-2017; Lau, Gee W/H-4073-2018	Zhu, Luchang/0000-0002-4064-5781; 	National Institutes of Health [HL090699]; University of Illinois Research Board; Research Facilities Improvement Program from National Center for Research Resources, National Institutes of Health [C06 RR 16515-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016515] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois Research Board; Research Facilities Improvement Program from National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by the National Institutes of Health (HL090699) and a University of Illinois Research Board Arnold O. Beckman research award to G.W. Lau. This investigation was conducted in a facility constructed with the support from Research Facilities Improvement Program Grant Number C06 RR 16515-01 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY OT, 1979, J EXP MED, V149, P297, DOI 10.1084/jem.149.2.297; Bartilson M, 2001, MOL MICROBIOL, V39, P126, DOI 10.1046/j.1365-2958.2001.02218.x; Claverys JP, 2007, MOL MICROBIOL, V64, P1423, DOI 10.1111/j.1365-2958.2007.05757.x; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; COOMARASWAMY G, 1996, THESIS U ILLINOIS CH; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dorer MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001026; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Havarstein LS, 2010, MOL MICROBIOL, V78, P541, DOI 10.1111/j.1365-2958.2010.07380.x; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; Iannelli F, 2005, FEMS MICROBIOL LETT, V252, P321, DOI 10.1016/j.femsle.2005.09.008; Jacobs MR, 2008, EXPERT REV ANTI-INFE, V6, P619, DOI 10.1586/14787210.6.5.619; Johnsborg O, 2006, J BACTERIOL, V188, P1744, DOI 10.1128/JB.188.5.1744-1749.2006; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Jones RN, 2010, INT J ANTIMICROB AG, V36, P197, DOI 10.1016/j.ijantimicag.2010.04.013; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Klugman KP, 2005, EMERG INFECT DIS, V11, P802, DOI 10.3201/eid1106.050147; Kowalko JE, 2008, INFECT IMMUN, V76, P3131, DOI 10.1128/IAI.01696-07; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Luo P, 2003, MOL MICROBIOL, V50, P623, DOI 10.1046/j.1365-2958.2003.03714.x; Lynch JP, 2010, CURR OPIN PULM MED, V16, P217, DOI 10.1097/MCP.0b013e3283385653; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; Martin B, 2010, MOL MICROBIOL, V75, P1513, DOI 10.1111/j.1365-2958.2010.07071.x; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; MORRISON DA, 1979, NATURE, V282, P215, DOI 10.1038/282215a0; Morrison DA, 2000, RES MICROBIOL, V151, P445, DOI 10.1016/S0923-2508(00)00171-6; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Pozzi Gianni, 2004, Current Drug Targets - Infectious Disorders, V4, P203, DOI 10.2174/1568005043340641; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Shen XZ, 2008, MICROB DRUG RESIST, V14, P155, DOI 10.1089/mdr.2008.0773; Sung CK, 2005, J BACTERIOL, V187, P3052, DOI 10.1128/JB.187.9.3052-3061.2005; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999; Widdowson CA, 1998, MICROB DRUG RESIST, V4, P79, DOI 10.1089/mdr.1998.4.79; Zhu LC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002241	41	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44710	10.1371/journal.pone.0044710	http://dx.doi.org/10.1371/journal.pone.0044710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028586	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700030
J	Munk, AC; Gudlaugsson, E; Malpica, A; Fiane, B; Lovslett, KI; Kruse, AJ; Ovestad, IT; Voorhorst, F; Janssen, EAM; Baak, JPA				Munk, Ane Cecilie; Gudlaugsson, Einar; Malpica, Anais; Fiane, Bent; Lovslett, Kjell I.; Kruse, Arnold-Jan; Ovestad, Irene Tveiteras; Voorhorst, Feja; Janssen, Emiel A. M.; Baak, Jan P. A.			Consistent Condom Use Increases the Regression Rate of Cervical Intraepithelial Neoplasia 2-3	PLOS ONE			English	Article							USE PROMOTES REGRESSION; HUMAN-PAPILLOMAVIRUS; NATURAL-HISTORY; WOMEN; LESIONS; DYSPLASIA; CANCER; CONIZATION; BEHAVIOR; SEMEN	Objective: Cervical intraepithelial neoplasia grades 2-3 (CIN2-3) are usually treated by cone excision, although only 30% progress to cancer and 6-50% regress spontaneously. The aim of this study was to examine the influence of clinical factors like smoking habits, number of lifetime sexual partners, age at first sexual intercourse, sexual activity span and hormonal versus non-hormonal contraception type on the regression rate of CIN2-3. Methods: In this prospective population-based cohort study 170 women aged 25-40 with abnormal cytology and colposcopy-directed biopsies showing first time onset CIN2-3 were consecutively included. The interval between biopsy and cone excision was standardized to minimum 12 weeks. Regression was defined as <= CIN1 in the cone biopsy. Results: The regression rate was 22%. Consistent condom use, defined as those women whose partners used condoms for all instances of sexual intercourse, was infrequent (n = 20, 12%). In univariate analysis consistent condom use, hormonal contraception and age at first sexual intercourse significantly predicted regression. In a multivariate analysis only consistent condom use remained as an independent predictor of regression (regression rate 55%, p = 0.001, hazard ratio = 4.4). Conclusion: Consistent condom use between punch biopsy and cone excision in first-time onset CIN2-3 patients significantly increases the regression rate.	[Munk, Ane Cecilie; Fiane, Bent; Lovslett, Kjell I.] Stavanger Univ Hosp, Dept Obstet & Gynecol, Stavanger, Norway; [Gudlaugsson, Einar; Ovestad, Irene Tveiteras; Janssen, Emiel A. M.; Baak, Jan P. A.] Stavanger Univ Hosp, Dept Pathol, Stavanger, Norway; [Malpica, Anais] Univ Texas MD Anderson Canc Ctr, Dept Pathol & Gynecol Oncol, Houston, TX 77030 USA; [Kruse, Arnold-Jan] Univ Limburg, Acad Hosp Maastricht, Dept Gynecol, Maastricht, Netherlands; [Voorhorst, Feja] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Stavanger University Hospital; Stavanger University Hospital; University of Texas System; UTMD Anderson Cancer Center; Hasselt University; Maastricht University; Maastricht University Medical Centre (MUMC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Munk, AC (corresponding author), Stavanger Univ Hosp, Dept Obstet & Gynecol, Stavanger, Norway.	jpabaak47@yahoo.com	Øvestad, Irene Tveiterås/S-2555-2019; Janssen, Emiel A.M./AAM-2357-2020		Stavanger University Hospital [66]; Helse Vest [911634]	Stavanger University Hospital; Helse Vest	This study was financed by Stavanger University Hospital (project number: 66) and grants from Helse Vest (project number 911634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; Appleby P, 2009, CANCER EPIDEM BIOMAR, V18, P1060, DOI 10.1158/1055-9965.EPI-08-1186; Baak JPA, 2006, J CLIN PATHOL, V59, P1017, DOI 10.1136/jcp.2005.027839; Bleeker MCG, 2003, INT J CANCER, V107, P804, DOI 10.1002/ijc.11473; Collins S, 2010, EUR J CANCER, V46, P405, DOI 10.1016/j.ejca.2009.09.015; Discacciati MG, 2011, EUR J OBSTET GYN R B, V155, P204, DOI 10.1016/j.ejogrb.2010.12.002; Gadducci A, 2011, GYNECOL ENDOCRINOL, V27, P597, DOI 10.3109/09513590.2011.558953; Hagen B, 1998, ACTA OBSTET GYN SCAN, V77, P558, DOI 10.1034/j.1600-0412.1998.770515.x; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Hogewoning CJA, 2003, INT J CANCER, V107, P811, DOI 10.1002/ijc.11474; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; KATAJA V, 1989, EUR J EPIDEMIOL, V5, P1, DOI 10.1007/BF00145037; KELLY RW, 1995, HUM REPROD, V10, P1686, DOI 10.1093/oxfordjournals.humrep.a136156; Kelly RW, 1997, PROSTAG LEUKOTR ESS, V57, P113, DOI 10.1016/S0952-3278(97)90000-4; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Matsumoto K, 2010, CANCER SCI, V101, P2065, DOI 10.1111/j.1349-7006.2010.01642.x; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Munk AC, 2007, APMIS, V115, P1409, DOI 10.1111/j.1600-0463.2007.00769.x; Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; NASIELL K, 1983, OBSTET GYNECOL, V61, P609; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; Steen R, 2009, ARSRAPPORTEN 2008; SYRJANEN K, 1984, BRIT J VENER DIS, V60, P243; Trimble CL, 2005, CLIN CANCER RES, V11, P4717, DOI 10.1158/1078-0432.CCR-04-2599; VANOORTMARSSEN GJ, 1991, BRIT J CANCER, V64, P559, DOI 10.1038/bjc.1991.350; Wang XD, 2010, MED HYPOTHESES, V74, P1015, DOI 10.1016/j.mehy.2010.01.009	28	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45114	10.1371/journal.pone.0045114	http://dx.doi.org/10.1371/journal.pone.0045114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028792	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700089
J	Trobridge, GD; Beard, BC; Wu, RA; Ironside, C; Malik, P; Kiem, HP				Trobridge, Grant D.; Beard, Brian C.; Wu, Robert A.; Ironside, Christina; Malik, Punam; Kiem, Hans-Peter			Stem Cell Selection In Vivo Using Foamy Vectors Cures Canine Pyruvate Kinase Deficiency	PLOS ONE			English	Article							HEMATOPOIETIC REPOPULATING CELLS; INACTIVATING LENTIVIRAL VECTORS; HEREDITARY HEMOLYTIC-ANEMIA; MEDIATED GENE-TRANSFER; LARGE-ANIMAL MODEL; MARROW-TRANSPLANTATION; VIRUS VECTORS; GENOME BROWSER; LONG-TERM; TRANSDUCTION	Background: Hematopoietic stem cell (HSC) gene therapy has cured immunodeficiencies including X-linked severe combined immunodeficiency (SCID-X1) and adenine deaminase deficiency (ADA). For these immunodeficiencies corrected cells have a selective advantage in vivo, and low numbers of gene-modified cells are sufficient to provide therapeutic benefit. Strategies to efficiently transduce and/or expand long-term repopulating cells in vivo are needed for treatment of diseases that require higher levels of corrected cells, such as hemoglobinopathies. Here we expanded corrected stem cells in vivo in a canine model of a severe erythroid disease, pyruvate kinase deficiency. Methodology/Principal Findings: We used a foamy virus (FV) vector expressing the P140K mutant of methylguanine methyltransferase (MGMTP140K) for in vivo expansion of corrected hematopoietic repopulating cells. FV vectors are attractive gene transfer vectors for hematopoietic stem cell gene therapy since they efficiently transduce repopulating cells and may be safer than more commonly used gammaretroviral vectors. Following transplantation with HSCs transduced ex vivo using a tri-cistronic FV vector that expressed EGFP, R-type pyruvate kinase, and MGMTP140K, we were able to increase marking from approximately 3.5% to 33% in myeloid long-term repopulating cells resulting in a functional cure. Conclusions/Significance: Here we describe in one affected dog a functional cure for a severe erythroid disease using stem cell selection in vivo. In addition to providing a potential cure for patients with pyruvate kinase deficiency, in vivo selection using foamy vectors with MGMTP140K has broad potential for several hematopoietic diseases including hemoglobinopathies.	[Trobridge, Grant D.; Beard, Brian C.; Wu, Robert A.; Ironside, Christina; Kiem, Hans-Peter] Fred Hutchinson Canc Res Ctr, Clin Div, Seattle, WA 98104 USA; [Trobridge, Grant D.; Beard, Brian C.; Kiem, Hans-Peter] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Malik, Punam] Cincinnati Childrens Hosp Med Ctr, Dept Expt Hematol, Cincinnati, OH USA; [Kiem, Hans-Peter] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Cincinnati Children's Hospital Medical Center; University of Washington; University of Washington Seattle	Trobridge, GD (corresponding author), Washington State Univ, Dept Pharmaceut Sci, Pullman, WA 99164 USA.	hkiem@fhcrc.org		Wu, R. Alex/0000-0003-4190-4615	National Institutes of Health (NIH) [P01HL36444, R01HL098489, R01HL074162]; Heart, Lung, and Blood Institute (NHLBI) [P01HL053750]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R21DK77086]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098489, P01HL036444, P01HL053750, R01HL074162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465, R01DK077086] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by the National Institutes of Health (NIH) award numbers P01HL36444, R01HL098489, R01HL074162, and P01HL053750 from the Heart, Lung, and Blood Institute (NHLBI), and R21DK77086 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). HPK is a Markey Molecular Medicine Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; Beagles KE, 2005, HUM GENE THER, V16, P725, DOI 10.1089/hum.2005.16.725; Beard BC, 2010, J CLIN INVEST, V120, P2345, DOI 10.1172/JCI40767; Beutler E, 1984, RED CELL METABOLISM, P62; Black JA, 1978, RED CELL, P275; CRONE TM, 1994, CANCER RES, V54, P6221; Hendrie PC, 2008, MOL THER, V16, P534, DOI 10.1038/sj.mt.6300398; Josephson NC, 2004, HUM GENE THER, V15, P87, DOI 10.1089/10430340460732481; Josephson NC, 2002, P NATL ACAD SCI USA, V99, P8295, DOI 10.1073/pnas.122131099; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiem HP, 2010, GENE THER, V17, P37, DOI 10.1038/gt.2009.118; Kiem HP, 2007, BLOOD, V109, P65, DOI 10.1182/blood-2006-04-016741; Larochelle A, 2009, J CLIN INVEST, V119, P1952, DOI 10.1172/JCI37506; Leurs C, 2003, HUM GENE THER, V14, P509, DOI 10.1089/104303403764539305; Meza NW, 2009, MOL THER, V17, P2000, DOI 10.1038/mt.2009.200; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Mohamedali A, 2004, MOL THER, V10, P249, DOI 10.1016/j.ymthe.2004.05.002; Moreau-Gaudry F, 2001, BLOOD, V98, P2664, DOI 10.1182/blood.V98.9.2664; Neff T, 2005, BLOOD, V105, P997, DOI 10.1182/blood-2004-08-3169; Neff T, 2003, J CLIN INVEST, V112, P1581, DOI 10.1172/JCI200318782; Persons DA, 2004, SEMIN HEMATOL, V41, P279, DOI 10.1053/j.seminhematol.2004.07.004; Persons DA, 2001, BLOOD, V97, P3275, DOI 10.1182/blood.V97.10.3275; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Richard RE, 2004, BLOOD, V103, P4432, DOI 10.1182/blood-2003-10-3705; Sabatino DE, 2000, J BIOL CHEM, V275, P28549, DOI 10.1074/jbc.M004043200; SEARCY GP, 1979, AM J PATHOL, V94, P689; Takatu A, 2003, BIOL BLOOD MARROW TR, V9, P674, DOI 10.1016/j.bbmt.2003.08.005; TAKEGAWA S, 1983, BRIT J HAEMATOL, V54, P467, DOI 10.1111/j.1365-2141.1983.tb02121.x; TANI K, 1994, BLOOD, V83, P2305; Tanphaichitr VS, 2000, BONE MARROW TRANSPL, V26, P689, DOI 10.1038/sj.bmt.1702576; Trobridge G, 2005, HUM GENE THER, V16, P1355, DOI 10.1089/hum.2005.16.1355; Trobridge GD, 2006, P NATL ACAD SCI USA, V103, P1498, DOI 10.1073/pnas.0510046103; Trobridge GD, 2008, BLOOD, V111, P5537, DOI 10.1182/blood-2007-09-115022; Trobridge GD, 2009, HUM GENE THER, V20, P519, DOI 10.1089/hum.2008.170; Vassilopoulos G, 2001, BLOOD, V98, P604, DOI 10.1182/blood.V98.3.604; WEIDEN PL, 1976, BRIT J HAEMATOL, V33, P357, DOI 10.1111/j.1365-2141.1976.tb03551.x; WHITNEY KM, 1994, EXP HEMATOL, V22, P866	38	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45173	10.1371/journal.pone.0045173	http://dx.doi.org/10.1371/journal.pone.0045173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028826	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700091
J	Wang, WH; Qiu, CL; Qiu, C; Wang, Y; Zhang, XY; Xu, JQ				Wang, Wanhai; Qiu, Chenli; Qiu, Chao; Wang, Ying; Zhang, Xiaoyan; Xu, Jianqing			Development of Skewed Functionality of HIV-1-Specific Cytotoxic CD8(+) T Cells from Primary to Early Chronic Phase of HIV Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; VIRAL LOAD; TYPE-1 INFECTION; RESPONSES; VIREMIA; ESCAPE; REPLICATION; AVIDITY; CD4(+); NONPROGRESSORS	In recent years, the prevalence of HIV-1 infection has been rapidly increasing among men who have sex with men (MSM). However, it remains unknown how the host immune system responds to the infection in this population. We assessed the quantity of HIV-specific CD8(+) T-cell responses by using Elispot assay and their functionalities by measuring 5 CD8(+) T-cell evaluations (IL-2, MIP-1 beta, CD107a, TNF-alpha, IFN-gamma) with flow cytometry assays among 18 primarily and 37 early chronically HIV-infected MSM. Our results demonstrated that subjects at early chronic phase developed HIV-specific CD8(+) T-cell responses with higher magnitudes and more diversified functionalities in comparison with those at primary infection. However, populations with IL-2(+) CD107a(+) or in combination with other functionality failed to develop in parallel. The multifunctional but not monofunctional HIV-specific CD8(+) T cells were associated with higher CD4(+) T-cell counts and lower viral loads. These data revealed that prolonged infection from primary to early chronic infection could selectively increase the functionalities of HIV-specific CD8(+) T cells in HIV-infected MSM population, the failure to develop IL-2 and cytotoxic functionalities in parallel may explain why the increased HIV-specific CD8(+) T cells were unable to enhance the containment of HIV-1 replication at the early chronic stage.	[Wang, Wanhai; Qiu, Chenli; Qiu, Chao; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Key Lab Med Mol Virol, Shanghai Publ Hlth Clin Ctr, Inst Biomed Sci,Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Wanhai; Qiu, Chenli; Qiu, Chao; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Wang, Ying] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Zhang, Xiaoyan; Xu, Jianqing] China CDC, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Fudan University; Fudan University; Shanghai Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Wang, WH (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Clin Lab, Zhengzhou, Peoples R China.	zhang_xycn2002@yahoo.com.cn; jianqingxu2008@gmail.com	Qiu, Chao/M-6702-2014	Qiu, Chao/0000-0001-9401-5219	National Foundation for Nature Science [30872354]; National Grand Program on Key Infectious Disease Control and Prevention of China [2012ZX10001-006, 2012ZX10001-007]	National Foundation for Nature Science; National Grand Program on Key Infectious Disease Control and Prevention of China	This work was supported by National Foundation for Nature Science (30872354) and National Grand Program on Key Infectious Disease Control and Prevention (2012ZX10001-006 and -007) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Draenert R, 2004, J VIROL, V78, P630, DOI 10.1128/JVI.78.2.630-641.2004; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Geels MJ, 2006, VIROLOGY, V345, P209, DOI 10.1016/j.virol.2005.09.023; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Jones N, 2006, AIDS RES HUM RETROV, V22, P1007, DOI 10.1089/aid.2006.22.1007; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Kloverpris H, 2009, AIDS, V23, P1329, DOI 10.1097/QAD.0b013e32832d9b00; Lichterfeld M, 2004, J EXP MED, V200, P701, DOI 10.1084/jem.20041270; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Shanker P, 2000, BLOOD, V96, P3094, DOI 10.1182/blood.V96.9.3094.h8003094_3094_3101; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Streeck H, 2007, AIDS, V21, P889, DOI 10.1097/QAD.0b013e3280f77439; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; Wang WH, 2011, CURR HIV RES, V9, P136, DOI 10.2174/157016211795569096; Zhang XY, 2006, CHINESE MED J-PEKING, V119, P1958, DOI 10.1097/00029330-200612010-00004; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	36	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44983	10.1371/journal.pone.0044983	http://dx.doi.org/10.1371/journal.pone.0044983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028721	gold, Green Published			2022-12-27	WOS:000308788700069
J	Chen, LY; Ren, F; Zhang, HY; Wen, T; Piao, ZF; Zhou, L; Zheng, SJ; Zhang, J; Chen, Y; Han, YP; Duan, ZP; Ma, YJ				Chen, Liyan; Ren, Feng; Zhang, Haiyan; Wen, Tao; Piao, Zhengfu; Zhou, Li; Zheng, Sujun; Zhang, Jing; Chen, Yu; Han, Yuanping; Duan, Zhongping; Ma, Yingji			Inhibition of Glycogen Synthase Kinase 3 beta Ameliorates D-GalN/LPS-Induced Liver Injury by Reducing Endoplasmic Reticulum Stress-Triggered Apoptosis	PLOS ONE			English	Article							GALACTOSAMINE-SENSITIZED MICE; FULMINANT HEPATIC-FAILURE; CYTOKINE PRODUCTION; ALPHA; KINASE-3-BETA; ACTIVATION; MECHANISMS; SIGNAL	Background: Glycogen synthase kinase 3 beta(GSK3 beta) is a ubiquitous serine-threonine protein kinase that participates in numerous cellular processes and disease pathophysiology. We aimed to determine therapeutic potential of GSK3 beta inhibition and its mechanism in a well-characterized model of lipopolysaccharide (LPS)-induced model of acute liver failure (ALF). Methodology: In a murine ALF model induced by D-GalN(700 mg/kg)/LPS(10 mu g/kg), we analyzed GSK3 beta mechanisms using a specific chemical inhibitor, SB216763, and detected the role of endoplasmic reticulum stress (ERS). Mice were administered SB216763 at 2 h before or after D-GalN/LPS injection, respectively, and then sacrificed 6 h after D-GalN/LPS treatment to evaluate its prophylactic and therapeutic function. The lethality rate, liver damage, ERS, cytokine expression, MAP kinase, hepatocyte apoptosis and expression of TLR 4 were evaluated, respectively. Whether the inhibition of GSK3 beta activation protected hepatocyte from ERS-induced apoptosis was investigated in vitro. Principal Findings: GSK3 beta became quickly activated (dephosphorylated) upon D-GalN/LPS exposure. Administration of SB216763 not only ameliorated liver injury, as evidenced by reduced transaminase levels, and well-preserved liver architecture, but also decreased lethality. Moreover, GSK3 beta inhibition resulted in down-regulation of pro-apoptotic proteins C/EBP-homologous protein(CHOP) and caspase-12, which are related to ERS. To further demonstrate the role of ERS, we found that GSK3 beta inhibition protected hepatocyte from ERS-induced cell death. GSK3 beta inhibition down-regulated the MAPK pathways, reduced expression of inflammatory cytokines and decreased expression of TLR4. Conclusions: Our findings demonstrate the key function of GSK3 beta signaling in the pathophysiology of ALF, especially in regulating the ERS, and provide a rationale for targeting GSK3 beta as a potential therapeutic strategy to ameliorate ALF.	[Ma, Yingji] Harbin Med Univ, Affiliated Hosp 4, Dept Infect Dis, Harbin, Heilongjiang Pr, Peoples R China; [Chen, Liyan] Harbin Med Univ, Affiliated Hosp 2, Dept Infect Dis 2, Harbin, Heilongjiang Pr, Peoples R China; [Ren, Feng; Zhang, Haiyan; Wen, Tao; Piao, Zhengfu] Capital Med Univ, Beijing Inst Liver Dis, Beijing, Peoples R China; [Ren, Feng; Zhou, Li; Zheng, Sujun; Zhang, Jing; Chen, Yu; Han, Yuanping; Duan, Zhongping] Capital Med Univ, Beijing Youan Hosp, Beijing Artificial Liver Treatment & Training Ctr, Beijing, Peoples R China	Harbin Medical University; Harbin Medical University; Capital Medical University; Capital Medical University	Ma, YJ (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Infect Dis, Harbin, Heilongjiang Pr, Peoples R China.	mayingji20050929@163.com			Beijing Excellent Talents Training Funding [2011D003034000022]; Technology Projects of Fengtai Distinct of Beijing; Cooperation Research Project of CMU and Clinical [11JL60]; high technical personnel training item in Beijing Health System [2011-3-083]; Beijing Municipal Natural Science Foundation [7102085]	Beijing Excellent Talents Training Funding; Technology Projects of Fengtai Distinct of Beijing; Cooperation Research Project of CMU and Clinical; high technical personnel training item in Beijing Health System; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported, in part, by Beijing Excellent Talents Training Funding (2011D003034000022), Technology Projects of Fengtai Distinct of Beijing (2011), Cooperation Research Project of CMU and Clinical (11JL60), high technical personnel training item in Beijing Health System(2011-3-083) and Beijing Municipal Natural Science Foundation(7102085). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Eipel C, 2007, BRIT J PHARMACOL, V151, P406, DOI 10.1038/sj.bjp.0707230; Feng R, 2011, HEPATOLOGY, V54, P687; Ferkey DM, 2000, DEV BIOL, V225, P471, DOI 10.1006/dbio.2000.9816; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; HISHINUMA I, 1990, HEPATOLOGY, V12, P1187, DOI 10.1002/hep.1840120518; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HOOFNAGLE JH, 1995, HEPATOLOGY, V21, P240, DOI 10.1002/hep.1840210137; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaplowitz N, 2000, J HEPATOL, V32, P39, DOI 10.1016/S0168-8278(00)80414-6; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kim AJ, 2005, J CELL SCI, V118, P89, DOI 10.1242/jcs.01562; Kuhla A, 2008, APOPTOSIS, V13, P1427, DOI 10.1007/s10495-008-0269-7; LEE WM, 1993, NEW ENGL J MED, V329, P1862, DOI 10.1056/NEJM199312163292508; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mignon A, 1999, AM J RESP CRIT CARE, V159, P1308, DOI 10.1164/ajrccm.159.4.9712012; Nakama T, 2001, HEPATOLOGY, V33, P1441, DOI 10.1053/jhep.2001.24561; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Radinger M, 2010, J IMMUNOL, V184, P564, DOI 10.4049/jimmunol.0902931; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rust C, 2000, AM J MED, V108, P567, DOI 10.1016/S0002-9343(00)00370-3; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1016/S1527-6465(00)80005-2; Srinivasan S, 2005, DIABETES, V54, P968, DOI 10.2337/diabetes.54.4.968; Takadera T, 2006, NEUROSCI LETT, V408, P124, DOI 10.1016/j.neulet.2006.08.066; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; Wang HZ, 2008, J IMMUNOL, V181, P6797, DOI 10.4049/jimmunol.181.10.6797; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; [晏春根 Yan Chungen], 2004, [中华传染病杂志, Chinese Journal of Infections Diseases], V22, P189; Yan CL, 2008, LIVER INT, V28, P959, DOI 10.1111/j.1478-3231.2008.01775.x; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	36	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45202	10.1371/journal.pone.0045202	http://dx.doi.org/10.1371/journal.pone.0045202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028846	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900033
J	Christian, ML; Demorest, ZL; Starker, CG; Osborn, MJ; Nyquist, MD; Zhang, Y; Carlson, DF; Bradley, P; Bogdanove, AJ; Voytas, DF				Christian, Michelle L.; Demorest, Zachary L.; Starker, Colby G.; Osborn, Mark J.; Nyquist, Michael D.; Zhang, Yong; Carlson, Daniel F.; Bradley, Philip; Bogdanove, Adam J.; Voytas, Daniel F.			Targeting G with TAL Effectors: A Comparison of Activities of TALENs Constructed with NN and NK Repeat Variable Di-Residues	PLOS ONE			English	Article							DNA-BINDING SPECIFICITY; DOUBLE-STRAND BREAKS; III EFFECTORS; NUCLEASES; TRANSCRIPTION; DESIGN	The DNA binding domain of Transcription Activator-Like (TAL) effectors can easily be engineered to have new DNA sequence specificities. Consequently, engineered TAL effector proteins have become important reagents for manipulating genomes in vivo. DNA binding by TAL effectors is mediated by arrays of 34 amino acid repeats. In each repeat, one of two amino acids (repeat variable di-residues, RVDs) contacts a base in the DNA target. RVDs with specificity for C, T and A have been described; however, among RVDs that target G, the RVD NN also binds A, and NK is rare among naturally occurring TAL effectors. Here we show that TAL effector nucleases (TALENs) made with NK to specify G have less activity than their NN-containing counterparts: fourteen of fifteen TALEN pairs made with NN showed more activity in a yeast recombination assay than otherwise identical TALENs made with NK. Activity was assayed for three of these TALEN pairs in human cells, and the results paralleled the yeast data. The in vivo data is explained by in vitro measurements of binding affinity demonstrating that NK-containing TAL effectors have less affinity for targets with G than their NN-containing counterparts. On targets for which G was substituted with A, higher G-specificity was observed for NK-containing TALENs. TALENs with different N- and C-terminal truncations were also tested on targets that differed in the length of the spacer between the two TALEN binding sites. TALENs with C-termini of either 63 or 231 amino acids after the repeat array cleaved targets across a broad range of spacer lengths - from 14 to 33 bp. TALENs with only 18 aa after the repeat array, however, showed a clear optimum for spacers of 13 to 16 bp. The data presented here provide useful guidelines for increasing the specificity and activity of engineered TAL effector proteins.	[Christian, Michelle L.; Demorest, Zachary L.; Starker, Colby G.; Osborn, Mark J.; Nyquist, Michael D.; Zhang, Yong; Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Christian, Michelle L.; Demorest, Zachary L.; Starker, Colby G.; Osborn, Mark J.; Nyquist, Michael D.; Zhang, Yong; Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN USA; [Carlson, Daniel F.] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Bradley, Philip] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Bogdanove, Adam J.] Iowa State Univ, Dept Plant Pathol, Ames, IA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; Iowa State University	Voytas, DF (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	voytas@umn.edu	Zhang, Yong/R-6789-2019; Bogdanove, Adam/ABE-6252-2020; osborn, mark/ABD-4727-2020	Zhang, Yong/0000-0003-3704-4835; Voytas, Daniel/0000-0002-4944-1224; Starker, Colby/0000-0002-6774-7227	National Science Foundation [DBI 0923827]; National Institutes of Health [R01 GM098861]; Central Universities of China [ZYGX2009J084]; National Natural Science Foundation of China [30900779]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098861, R01GM088277] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Universities of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Science Foundation to DFV (DBI 0923827) and a grant from the National Institutes of Health to DFV and AJB (R01 GM098861). YZ received support from the Central Universities of China (ZYGX2009J084) and the National Natural Science Foundation of China (30900779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Mahfouz MM, 2011, P NATL ACAD SCI USA, V108, P2623, DOI 10.1073/pnas.1019533108; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	19	81	94	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45383	10.1371/journal.pone.0045383	http://dx.doi.org/10.1371/journal.pone.0045383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028976	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700035
J	Dhaneesh, KV; Noushad, KM; Kumar, TTA				Dhaneesh, Kottila Veettil; Noushad, Kunnamgalam Mohammed; Kumar, Thipramalai Thankappan Ajith			Nutritional Evaluation of Commercially Important Fish Species of Lakshadweep Archipelago, India	PLOS ONE			English	Article							FATTY-ACID PROFILES; AMINO-ACID; MUSCLE; TISSUE; N-3	Estimation of nutrition profile of edible fishes is essential and thus a bio-monitoring study was carried out to find out the nutritional composition of commonly available fishes in Agatti Island water of Lakshadweep Sea. Protein, carbohydrate, lipid, ash, vitamin, amino acid and fatty acid composition in the muscle of ten edible fish species were studied. Proximate analysis revealed that the protein, carbohydrate, lipid and ash contents were high in Thunnus albacares (13.69%), Parupeneus bifasciatus (6.12%), Hyporhamphus dussumieri (6.97%) and T. albacares (1.65%), respectively. Major amino acids were lysine, leucine and methionine, registering 2.84-4.56%, 2.67-4.18% and 2.64-3.91%, respectively. Fatty acid compositions ranged from 31.63% to 38.97% saturated (SFA), 21.99-26.30% monounsaturated (MUFAs), 30.32-35.11% polyunsaturated acids (PUFAs) and 2.86-7.79% branched fatty acids of the total fatty acids. The omega-3 and omega-6 PUFAs were ranged 13.05-21.14% and 6.88-9.82% of the total fatty acids, respectively. Hence, the fishes of Lakshadweep Sea are highly recommended for consumption, since these fishes are highly enriched with nutrition. The results can be used as a baseline data for comparing the various nutritional profiles of fishes in future.	[Dhaneesh, Kottila Veettil; Kumar, Thipramalai Thankappan Ajith] Annamalai Univ, Ctr Adv Study Marine Biol, Fac Marine Sci, Parangipettai, Tamil Nadu, India; [Noushad, Kunnamgalam Mohammed] Minist Earth Sci, Ctr Marine Living Resources & Ecol, Field Res Stn, Agatti Isl, UT Of Lakshadwe, India	Annamalai University; Ministry of Earth Sciences (MoES) - India; Centre for Marine Living Resources & Ecology (CMLRE)	Dhaneesh, KV (corresponding author), Annamalai Univ, Ctr Adv Study Marine Biol, Fac Marine Sci, Parangipettai, Tamil Nadu, India.	dhanee121@gmail.com	KV, Dhaneesh/AAQ-2898-2021					[Anonymous], 2000, SHERLOCK MICROBIAL I; AOAC, 1990, OFF METH AN ASS AN C; BAKER DH, 1994, POULTRY SCI, V73, P1441, DOI 10.3382/ps.0731441; CHYUN JH, 1984, J NUTR, V114, P1697, DOI 10.1093/jn/114.9.1697; Crawford Michael A., 1993, American Journal of Clinical Nutrition, V57, p703S, DOI 10.1093/ajcn/57.5.703S; DEY I, 1993, P NATL ACAD SCI USA, V90, P7498, DOI 10.1073/pnas.90.16.7498; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FEELEY RM, 1972, J AM DIET ASSOC, V61, P134; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galla NR, 2011, FOOD CHEM IN PRESS; GIBSON RA, 1983, LIPIDS, V18, P743, DOI 10.1007/BF02534631; Gurr M.I., 1992, ROLE FATS FOOD NUTR; HMSO UK, 1994, NUTR ASPECTS CARDIOV; HOOPER SN, 1973, LIPIDS, V8, P509, DOI 10.1007/BF02531986; Huynh MD, 2007, COMP BIOCHEM PHYS B, V146, P504, DOI 10.1016/j.cbpb.2006.11.023; Huynh MD, 2009, FOOD CHEM, V114, P912, DOI 10.1016/j.foodchem.2008.10.038; JHCI UK, 2004, EAT LONG CHAIN OM 3; Kiessling A, 2001, FOOD CHEM, V73, P271, DOI 10.1016/S0308-8146(00)00297-1; Kim JD, 2000, AQUACULTURE, V187, P367, DOI 10.1016/S0044-8486(00)00322-7; LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marichamy G., 2009, CURR RES J BIOL SCI, V1, P109; Moreira AB, 2001, J FOOD COMPOS ANAL, V14, P565, DOI 10.1006/jfca.2001.1025; NAS/NRC (National Academy of Sciences/National Research Council), 2005, DIET REF INT EN CARB; Ozogul Y, 2007, FOOD CHEM, V100, P1634, DOI 10.1016/j.foodchem.2005.11.047; RAHMAN SA, 1995, FOOD CHEM, V54, P45, DOI 10.1016/0308-8146(95)92660-C; Rasoarahona JRE, 2005, FOOD CHEM, V91, P683, DOI 10.1016/j.foodchem.2004.07.001; Sadasivam S, 1996, BIOCH METHODS; Saito H, 1999, LIPIDS, V34, P1073, DOI 10.1007/s11745-999-0459-4; Sargent JR, 1995, J APPL ICHTHYOL, V11, P183, DOI 10.1111/j.1439-0426.1995.tb00018.x; Sethi PD, 1997, QUANTITATIVE ANAL DR, P589; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Ward OP, 2005, PROCESS BIOCHEM, V40, P3627, DOI 10.1016/j.procbio.2005.02.020; Zhao F, 2010, FOOD CHEM, V118, P224, DOI 10.1016/j.foodchem.2009.04.110	35	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45439	10.1371/journal.pone.0045439	http://dx.doi.org/10.1371/journal.pone.0045439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029011	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800049
J	Wu, ZF; Xu, YZ; Zhu, YM; Sutton, AK; Zhao, RJ; Lowell, BB; Olson, DP; Tong, QC				Wu, Zhaofei; Xu, Yuanzhong; Zhu, Yaming; Sutton, Amy K.; Zhao, Rongjie; Lowell, Bradford B.; Olson, David P.; Tong, Qingchun			An Obligate Role of Oxytocin Neurons in Diet Induced Energy Expenditure	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; BROWN ADIPOSE-TISSUE; DEFICIENT MICE; FOOD-INTAKE; PARAVENTRICULAR NUCLEUS; LEPTIN ACTION; SYMPATHETIC OUTFLOW; EXPRESSING NEURONS; BODY-WEIGHT; OBESITY	Oxytocin neurons represent one of the major subsets of neurons in the paraventricular hypothalamus (PVH), a critical brain region for energy homeostasis. Despite substantial evidence supporting a role of oxytocin in body weight regulation, it remains controversial whether oxytocin neurons directly regulate body weight homeostasis, feeding or energy expenditure. Pharmacologic doses of oxytocin suppress feeding through a proposed melanocortin responsive projection from the PVH to the hindbrain. In contrast, deficiency in oxytocin or its receptor leads to reduced energy expenditure without feeding abnormalities. To test the physiological function of oxytocin neurons, we specifically ablated oxytocin neurons in adult mice. Our results show that oxytocin neuron ablation in adult animals has no effect on body weight, food intake or energy expenditure on a regular diet. Interestingly, male mice lacking oxytocin neurons are more sensitive to high fat diet-induced obesity due solely to reduced energy expenditure. In addition, despite a normal food intake, these mice exhibit a blunted food intake response to leptin administration. Thus, our study suggests that oxytocin neurons are required to resist the obesity associated with a high fat diet; but their role in feeding is permissive and can be compensated for by redundant pathways.	[Sutton, Amy K.; Olson, David P.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Sutton, Amy K.; Olson, David P.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wu, Zhaofei; Xu, Yuanzhong; Zhu, Yaming; Zhao, Rongjie; Tong, Qingchun] Univ Texas Houston, Med Sch Houston, Brown Fdn, Inst Mol Med, Houston, TX USA; [Tong, Qingchun] Univ Texas Houston, Med Sch Houston, Grad Program Biochem, Houston, TX USA; [Tong, Qingchun] Univ Texas Houston, Med Sch Houston, Grad Program Neurosci, Grad Sch Biomed Sci, Houston, TX USA; [Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Olson, DP (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	dpolson@med.umich.edu; qingchun.tong@uth.tmc.edu	Xu, Yuanzhong/N-8254-2013; wu, zhaofei/J-3149-2014	wu, zhaofei/0000-0002-2463-242X; Tong, Qingchun/0000-0002-4561-2540; Xu, Yuanzhong/0000-0002-5264-5324; ZHAO, RONGJIE/0000-0002-4899-672X; Olson, David/0000-0001-9249-7760	American Heart Association [10SDG3280017]; National Institute of Health [1R01DK092605-01A1, DK075632]; BNORC [DK046200]; BADERC [DK057521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, P30DK057521, K08DK071561, R01DK092605] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BNORC; BADERC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Scientist Development Award from the American Heart Association (10SDG3280017 to Q.T.), grants from National Institute of Health (1R01DK092605-01A1 to Q.T.; DK075632, BNORC (DK046200) and BADERC (DK057521) to B.B.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi T, 2009, EUR J PHARMACOL, V622, P32, DOI 10.1016/j.ejphar.2009.09.017; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Banno R, 2010, J CLIN INVEST, V120, P720, DOI 10.1172/JCI39620; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Camerino C, 2009, OBESITY, V17, P980, DOI 10.1038/oby.2009.12; Deblon N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025565; Fan W, 2004, NAT NEUROSCI, V7, P335, DOI 10.1038/nn1214; Gaetani S, 2010, J NEUROSCI, V30, P8096, DOI 10.1523/JNEUROSCI.0036-10.2010; Ghamari-Langroudi M, 2011, P NATL ACAD SCI USA, V108, P355, DOI 10.1073/pnas.1016785108; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Kasahara Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3122, DOI 10.1271/bbb.70498; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Leng G, 2008, PROG BRAIN RES, V170, P137, DOI 10.1016/S0079-6123(08)00413-5; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mantella RC, 2003, AM J PHYSIOL-REG I, V285, pR1037, DOI 10.1152/ajpregu.00383.2002; Mantella RC, 2003, ENDOCRINOLOGY, V144, P2291, DOI 10.1210/en.2002-0197; Martin A, 1998, BIOL PSYCHIAT, V44, P1349, DOI 10.1016/S0006-3223(98)00190-5; Morrison CD, 2007, NUTR REV, V65, P517, DOI 10.1111/j.1753-4887.2007.tb00277.x; Morton GJ, 2005, J CLIN INVEST, V115, P703, DOI 10.1172/JCI200522081; Morton GJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE134, DOI 10.1152/ajpendo.00296.2011; Olszewski PK, 2011, BIOCHEM BIOPH RES CO, V408, P422, DOI 10.1016/j.bbrc.2011.04.037; Olszewski PK, 2010, PHARMACOL BIOCHEM BE, V97, P47, DOI 10.1016/j.pbb.2010.05.026; Ozaki Y, 2004, J NEUROENDOCRINOL, V16, P39, DOI 10.1111/j.1365-2826.2004.01119.x; Ragnauth AK, 2004, NEUROENDOCRINOLOGY, V80, P92, DOI 10.1159/000081844; Rinaman L, 2005, AM J PHYSIOL-REG I, V288, pR1791, DOI 10.1152/ajpregu.00860.2004; Song CK, 2008, AM J PHYSIOL-REG I, V295, pR417, DOI 10.1152/ajpregu.00174.2008; SWAAB DF, 1995, J CLIN ENDOCR METAB, V80, P573, DOI 10.1210/jc.80.2.573; Takayanagi Y, 2008, NEUROREPORT, V19, P951, DOI 10.1097/WNR.0b013e3283021ca9; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Tong QC, 2011, NEURON, V69, P401, DOI 10.1016/j.neuron.2011.01.018; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wu Q, 2012, P NATL ACAD SCI USA, V109, P3155, DOI 10.1073/pnas.1120501109; Xi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036453; Xu YZ, 2012, ENDOCRINOLOGY, V153, P2223, DOI 10.1210/en.2011-2071; Zhang G, 2011, NEURON, V69, P523, DOI 10.1016/j.neuron.2010.12.036	40	109	110	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45167	10.1371/journal.pone.0045167	http://dx.doi.org/10.1371/journal.pone.0045167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028821	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900089
J	Hoopes, SL; Willcockson, HH; Caron, KM				Hoopes, Samantha L.; Willcockson, Helen H.; Caron, Kathleen M.			Characteristics of Multi-Organ Lymphangiectasia Resulting from Temporal Deletion of Calcitonin Receptor-Like Receptor in Adult Mice	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; LYMPHATIC ENDOTHELIAL-CELLS; DIET-INDUCED OBESITY; OF-THE-LITERATURE; IN-VITRO; INTESTINAL LYMPHANGIECTASIA; INTRAOCULAR-PRESSURE; BARRIER FUNCTION; HYDROPS-FETALIS; KNOCKOUT MICE	Adrenomedullin (AM) and its receptor complexes, calcitonin receptor-like receptor (Calcrl) and receptor activity modifying protein 2/3, are highly expressed in lymphatic endothelial cells and are required for embryonic lymphatic development. To determine the role of Calcrl in adulthood, we used an inducible Cre-loxP system to temporally and ubiquitously delete Calcrl in adult mice. Following tamoxifen injection, Calcrl(fl/fl)/CAGGCre-ER (TM) mice rapidly developed corneal edema and inflammation that was preceded by and persistently associated with dilated corneoscleral lymphatics. Lacteals and submucosal lymphatic capillaries of the intestine were also dilated, while mesenteric collecting lymphatics failed to properly transport chyle after an acute Western Diet, culminating in chronic failure of Calcrl(fl/fl)/CAGGCre-ER (TM) mice to gain weight. Dermal lymphatic capillaries were also dilated and chronic edema challenge confirmed significant and prolonged dermal lymphatic insufficiency. In vivo and in vitro imaging of lymphatics with either genetic or pharmacologic inhibition of AM signaling revealed markedly disorganized lymphatic junctional proteins ZO-1 and VE-cadherin. The maintenance of AM signaling during adulthood is required for preserving normal lymphatic permeability and function. Collectively, these studies reveal a spectrum of lymphatic defects in adult Calcrl(fl/fl)/CAGGCre-ER (TM) mice that closely recapitulate the clinical symptoms of patients with corneal, intestinal and peripheral lymphangiectasia.	[Hoopes, Samantha L.; Willcockson, Helen H.; Caron, Kathleen M.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Caron, Kathleen M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Caron, KM (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	kathleen_caron@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021	Caron, Kathleen/0000-0002-7033-9232	National Institutes of Health [T32HL069768]; NIH/NHLBI [HL091973]; American Heart Association Established Investigator Award; Burroughs Wellcome Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091973, T32HL069768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Established Investigator Award(American Heart Association); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by research funding from National Institutes of Health T32HL069768 training fellowship to SLH and NIH/NHLBI HL091973, American Heart Association Established Investigator Award and The Burroughs Wellcome Fund to KMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birke K, 2010, INVEST OPHTH VIS SCI, V51, P344, DOI 10.1167/iovs.08-3307; Brimnes J, 2000, CLIN IMMUNOL, V96, P222, DOI 10.1006/clim.2000.4891; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Dackor R, 2007, J BIOL CHEM, V282, P18094, DOI 10.1074/jbc.M703544200; Dixon JB, 2010, TRENDS ENDOCRIN MET, V21, P480, DOI 10.1016/j.tem.2010.04.003; Doods H, 2007, TRENDS PHARMACOL SCI, V28, P580, DOI 10.1016/j.tips.2007.10.005; Dunworth WP, 2008, PEPTIDES, V29, P2243, DOI 10.1016/j.peptides.2008.09.009; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Gangula PRR, 2000, HYPERTENSION, V35, P470, DOI 10.1161/01.HYP.35.1.470; Hay DL, 2004, J MOL NEUROSCI, V22, P105, DOI 10.1385/JMN:22:1-2:105; Hippenstiel S, 2002, CIRC RES, V91, P618, DOI 10.1161/01.RES.0000036603.61868.F9; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; HOLT PR, 1964, PEDIATRICS, V34, P629; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Ittner LM, 2008, CLIN SCI, V114, P49, DOI 10.1042/CS20070163; Jin DH, 2008, CARDIOVASC RES, V80, P339, DOI 10.1093/cvr/cvn228; Kadmiel M, 2011, MOL ENDOCRINOL, V25, P1244, DOI 10.1210/me.2010-0400; Kahn ML, 2008, J CLIN INVEST, V118, P23, DOI 10.1172/JCI34485; Kataoka Y, 2010, J CARDIOVASC PHARM, V56, P413, DOI 10.1097/FJC.0b013e3181f15b45; Kis B, 2003, ACT NEUR S, V86, P565; Kis B, 2001, NEUROREPORT, V12, P4139, DOI 10.1097/00001756-200112210-00055; Lu JT, 1999, MOL CELL NEUROSCI, V14, P99, DOI 10.1006/mcne.1999.0767; Manduch M, 2009, J CLIN PATHOL, V62, P808, DOI 10.1136/jcp.2009.066555; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Murakami M, 2011, J CLIN INVEST, V121, P2668, DOI 10.1172/JCI44762; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Radhakrisihnan K, 2008, ANN NY ACAD SCI, V1131, P155, DOI 10.1196/annals.1413.015; Rockson SG, 2008, J AM COLL CARDIOL, V52, P799, DOI 10.1016/j.jacc.2008.06.005; Saeki T, 2008, CURR EYE RES, V33, P247, DOI 10.1080/02713680801919716; Salvatore CA, 2010, J PHARMACOL EXP THER, V333, P152, DOI 10.1124/jpet.109.163816; Sawane M, 2011, AM J PATHOL, V179, P2691, DOI 10.1016/j.ajpath.2011.08.024; STACKER SA, 2007, NOVART FDN SYMP, V281, P208; STACKER SA, 2007, NOVART FDN SYMP, V281, P44; Stacker Steven A, 2007, Novartis Found Symp, V281, P38; Stackert Richelle A, 2006, Am J Psychother, V60, P357; Takahashi N, 2007, CELL METAB, V6, P506, DOI 10.1016/j.cmet.2007.10.011; TRAN M, 1994, J PEDIATR GASTR NUTR, V19, P299, DOI 10.1097/00005176-199410000-00007; Walker CS, 2010, ENDOCRINOLOGY, V151, P4257, DOI 10.1210/en.2010-0284; Wang WH, 2005, INVEST OPHTH VIS SCI, V46, P4617, DOI 10.1167/iovs.05-0781; Welch J, 2012, SURV OPHTHALMOL, V57, P136, DOI 10.1016/j.survophthal.2011.08.001; Wen J, 2010, DIGEST DIS SCI, V55, P3466, DOI 10.1007/s10620-010-1161-1; Wick N, 2007, PHYSIOL GENOMICS, V28, P179, DOI 10.1152/physiolgenomics.00037.2006; Yucel YH, 2009, EXP EYE RES, V89, P810, DOI 10.1016/j.exer.2009.08.010; Zhang LP, 2001, PAIN, V89, P265, DOI 10.1016/S0304-3959(00)00378-X	46	40	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45261	10.1371/journal.pone.0045261	http://dx.doi.org/10.1371/journal.pone.0045261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028890	Green Submitted, Green Published, gold			2022-12-27	WOS:000309742800046
J	Morrow, KM; Ritson-Williams, R; Ross, C; Liles, MR; Paul, VJ				Morrow, Kathleen M.; Ritson-Williams, Raphael; Ross, Cliff; Liles, Mark R.; Paul, Valerie J.			Macroalgal Extracts Induce Bacterial Assemblage Shifts and Sublethal Tissue Stress in Caribbean Corals	PLOS ONE			English	Article							ANTIFUNGAL CHEMICAL DEFENSE; LONG-TERM DYNAMICS; HARD CORAL; ANTIMICROBIAL ACTIVITIES; MICROBIAL-POPULATIONS; CELLULAR DIAGNOSTICS; MARINE PATHOGENS; BROWN ALGA; REEFS; COMPETITION	Benthic macroalgae can be abundant on present-day coral reefs, especially where rates of herbivory are low and/or dissolved nutrients are high. This study investigated the impact of macroalgal extracts on both coral-associated bacterial assemblages and sublethal stress response of corals. Crude extracts and live algal thalli from common Caribbean macroalgae were applied onto the surface of Montastraea faveolata and Porites astreoides corals on reefs in both Florida and Belize. Denaturing gradient gel electrophoresis (DGGE) of 16S rRNA gene amplicons was used to examine changes in the surface mucus layer (SML) bacteria in both coral species. Some of the extracts and live algae induced detectable shifts in coral-associated bacterial assemblages. However, one aqueous extract caused the bacterial assemblages to shift to an entirely new state (Lobophora variegata), whereas other organic extracts had little to no impact (e.g. Dictyota sp.). Macroalgal extracts more frequently induced sublethal stress responses in M. faveolata than in P. astreoides corals, suggesting that cellular integrity can be negatively impacted in selected corals when comparing co-occurring species. As modern reefs experience phase-shifts to a higher abundance of macroalgae with potent chemical defenses, these macroalgae are likely impacting the composition of microbial assemblages associated with corals and affecting overall reef health in unpredicted and unprecedented ways.	[Morrow, Kathleen M.; Liles, Mark R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Ritson-Williams, Raphael; Paul, Valerie J.] Smithsonian Inst, Smithsonian Marine Stn, Ft Pierce, FL USA; [Ross, Cliff] Univ N Florida, Dept Biol, Jacksonville, FL USA	Auburn University System; Auburn University; Smithsonian Institution; Smithsonian National Museum of Natural History; State University System of Florida; University of North Florida	Morrow, KM (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	morrow.kathleen@gmail.com	Ross, Cliff/B-8291-2011	Liles, Mark/0000-0002-9313-8150	National Oceanic and Atmospheric Administration National Marine Sanctuary Program Nancy Foster Scholarship [NA08NOS4290448]; Mote Protect our Reefs grant [POR-2009-16]	National Oceanic and Atmospheric Administration National Marine Sanctuary Program Nancy Foster Scholarship; Mote Protect our Reefs grant	Daily stipend and tuition support to KMM from National Oceanic and Atmospheric Administration National Marine Sanctuary Program Nancy Foster Scholarship #NA08NOS4290448. http://fosterscholars.noaa.gov/aboutscholarship.html. Mote Protect our Reefs grant #POR-2009-16; supported travel to field sites and stress enzyme analysis. http://www.mote.org/index.php? src = gendocs&link = Reefplategrantapp&category = Main. The Hunterdon Oceanographic Research Fund and the Smithsonian Caribbean Coral Reef Ecosystems Program supported field work at Carrie Bow Cay Field Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2009, AQUAT BIOL, V4, P289, DOI 10.3354/ab00102; Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Birrell CL, 2008, MAR ECOL PROG SER, V362, P129, DOI 10.3354/meps07524; Chadwick NE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P347, DOI 10.1007/978-94-007-0114-4_20; Cronin G, 1996, OECOLOGIA, V105, P361, DOI 10.1007/BF00328739; Dinsdale EA, 2008, NAT BIOTECHNOL, V26, P997, DOI 10.1038/nbt0908-997; Dobretsov S, 2011, BIOFOULING, V27, P869, DOI 10.1080/08927014.2011.607233; Downs CA, 2005, MAR POLLUT BULL, V51, P558, DOI 10.1016/j.marpolbul.2005.04.017; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Downs CA, 2006, ENVIRON TOXICOL CHEM, V25, P3171, DOI 10.1897/05-509R1.1; Downs CA, 2012, ECOTOXICOLOGY, V21, P768, DOI 10.1007/s10646-011-0837-4; Edmunds PJ, 2002, CORAL REEFS, V21, P357, DOI 10.1007/s00338-002-0258-1; Engel S, 2002, J CHEM ECOL, V28, P1971, DOI 10.1023/A:1020793726898; Engel S, 2006, MAR BIOL, V149, P991, DOI 10.1007/s00227-006-0264-x; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Fong P, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P241, DOI 10.1007/978-94-007-0114-4_17; Garzon-Ferreira J, 2001, HYDROBIOLOGIA, V460, P65, DOI 10.1023/A:1013133818360; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Haas AF, 2010, J EXP MAR BIOL ECOL, V389, P53, DOI 10.1016/j.jembe.2010.03.018; Halliwell B, 2006, PLANT PHYSIOL, V141, P312, DOI 10.1104/pp.106.077073; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jiang RW, 2008, J NAT PROD, V71, P1616, DOI 10.1021/np800307h; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Kubanek J, 2003, P NATL ACAD SCI USA, V100, P6916, DOI 10.1073/pnas.1131855100; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lane A. L., 2008, P229, DOI 10.1007/978-3-540-74181-7_11; Lane AL, 2009, P NATL ACAD SCI USA, V106, P7314, DOI 10.1073/pnas.0812020106; Leaver MJ, 1998, MAR ENVIRON RES, V46, P71, DOI 10.1016/S0141-1136(97)00071-8; Littler D, 2003, S PACIFIC REEF PLANT, P172; Maximilien R, 1998, AQUAT MICROB ECOL, V15, P233, DOI 10.3354/ame015233; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCune B., 2002, ANAL ECOLOGICAL COMM, P125; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Millar BC, 2002, J CLIN MICROBIOL, V40, P1575, DOI 10.1128/JCM.40.5.1575-1580.2002; Morgan MB, 2001, ENVIRON TOXICOL CHEM, V20, P537, DOI 10.1002/etc.5620200312; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Morrow KM, APPL ENV MI IN PRESS; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Norstrom AV, 2009, MAR ECOL PROG SER, V376, P295, DOI 10.3354/meps07815; Nugues MM, 2008, CORAL REEFS, V27, P389, DOI 10.1007/s00338-007-0346-3; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; Paul VJ, 2006, NAT PROD REP, V23, P153, DOI 10.1039/b404735b; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; Pawlik JR, 2007, LIMNOL OCEANOGR, V52, P907, DOI 10.4319/lo.2007.52.2.0907; Puglisi MP, 2007, MAR BIOL, V150, P531, DOI 10.1007/s00227-006-0376-3; Puglisi MP, 2004, TETRAHEDRON, V60, P7035, DOI 10.1016/j.tet.2003.10.131; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher Douglas B., 2010, Communicative & Integrative Biology, V3, P564, DOI 10.4161/cib.3.6.12978; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Rasmussen TB, 2000, MICROBIOL-UK, V146, P3237, DOI 10.1099/00221287-146-12-3237; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rougee L, 2006, ENVIRON TOXICOL CHEM, V25, P3181, DOI 10.1897/05-510R2.1; SCHMITT TM, 1995, ECOLOGY, V76, P107, DOI 10.2307/1940635; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Steinberg PD, 2002, J CHEM ECOL, V28, P1935, DOI 10.1023/A:1020789625989; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Targett NM, 1998, J PHYCOL, V34, P195, DOI 10.1046/j.1529-8817.1998.340195.x; Vairappan CS, 2010, J APPL PHYCOL, V22, P305, DOI 10.1007/s10811-009-9460-7; Wu GH, 1999, PLANT PHYSIOL, V120, P513, DOI 10.1104/pp.120.2.513	72	45	45	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44859	10.1371/journal.pone.0044859	http://dx.doi.org/10.1371/journal.pone.0044859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028648	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700046
J	Pandey, N; Fahey, MT; Jong, YJI; O'Malley, KL				Pandey, Neeraj; Fahey, Mark T.; Jong, Yuh-Jiin I.; O'Malley, Karen L.			Sequences Located within the N-Terminus of the PD-Linked LRRK2 Lead to Increased Aggregation and Attenuation of 6-Hydroxydopamine-Induced Cell Death	PLOS ONE			English	Article							REPEAT KINASE 2; DISEASE-ASSOCIATED MUTATIONS; UNFOLDED PROTEIN RESPONSE; PARKINSONS-DISEASE; MOLECULAR PATHOGENESIS; 14-3-3 BINDING; PREDICTION; SYNUCLEIN; INHIBITION; MODELS	Clinical symptoms of Parkinson's disease (PD) arise from the loss of substantia nigra neurons resulting in bradykinesia, rigidity, and tremor. Intracellular protein aggregates are a pathological hallmark of PD, but whether aggregates contribute to disease progression or represent a protective mechanism remains unknown. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene have been linked to PD in both familial cases and idiopathic cases and aggregates of the LRRK2 protein are present in postmortem PD brain samples. To determine whether LRRK2 contains a region of protein responsible for self-aggregation, two independent, bioinformatic algorithms were used to identify an N-terminal amino acid sequence as being aggregation-prone. Cells subsequently transfected with a construct containing this domain were found to have significantly increased protein aggregation compared to wild type protein or a construct containing only the last half of the molecule. Finally, in support of the hypothesis that aggregates represent a self-protection strategy, aggregated N-terminal LRRK2 constructs significantly attenuated cell death induced by the PD-mimetic, 6-hydroxydopamine (6-OHDA).	[Pandey, Neeraj; Fahey, Mark T.; Jong, Yuh-Jiin I.; O'Malley, Karen L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Pandey, N (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	omalleyk@pcg.wustl.edu		Pandey, Neeraj/0000-0003-4872-7201	National Institutes of Health [NS39084]; Howard Hughes Medical Institute Undergraduate Research Fellowship (HHMI SURF); Parkinson's Disease Foundation Summer Fellowship for Investigative Work in Parkinson's Disease; American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS039084, R01NS039084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Undergraduate Research Fellowship (HHMI SURF); Parkinson's Disease Foundation Summer Fellowship for Investigative Work in Parkinson's Disease; American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health Grants NS39084, Howard Hughes Medical Institute Undergraduate Research Fellowship (HHMI SURF, 2007), a Parkinson's Disease Foundation Summer Fellowship for Investigative Work in Parkinson's Disease (2008), and a grant from the 2009 American Recovery and Reinvestment Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009; Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; Cuervo AM, 2010, MOVEMENT DISORD, V25, pS49, DOI 10.1002/mds.22718; Dachsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79; Daniels V, 2011, NEUROSIGNALS, V19, P1, DOI 10.1159/000324488; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Gasser T, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001148; Gomez-Lazaro M, 2008, J NEUROCHEM, V104, P1599, DOI 10.1111/j.1471-4159.2007.05115.x; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-94; Greggio E, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-6; Higashi S, 2009, J NEUROPATH EXP NEUR, V68, P994, DOI 10.1097/NEN.0b013e3181b44ed8; Holtz WA, 2005, ANTIOXID REDOX SIGN, V7, P639, DOI 10.1089/ars.2005.7.639; Holtz WA, 2003, J BIOL CHEM, V278, P19367, DOI 10.1074/jbc.M211821200; Holtz WA, 2006, J NEUROCHEM, V99, P54, DOI 10.1111/j.1471-4159.2006.04025.x; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Lotharius J, 1999, J NEUROSCI, V19, P1284; Lu B, 2010, BBA-PROTEINS PROTEOM, V1804, P1780, DOI 10.1016/j.bbapap.2010.05.004; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Moore Darren J, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS92, DOI 10.1016/j.parkreldis.2008.04.010; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Oh YJ, 1995, NEUROBIOL DIS, V2, P157, DOI 10.1006/nbdi.1995.0017; Poulopoulos M, 2011, J MOL NEUROSCI; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Seol W, 2010, BMB REP, V43, P233, DOI 10.5483/BMBRep.2010.43.4.233; Tan JMM, 2009, ANTIOXID REDOX SIGN, V11, P2119, DOI 10.1089/ARS.2009.2490; Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Waxman EA, 2009, J NEUROPATH EXP NEUR, V68, P785, DOI 10.1097/NEN.0b013e3181aaf4fd; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wider C, 2010, NEURODEGENER DIS, V7, P175, DOI 10.1159/000289232; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB	41	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45149	10.1371/journal.pone.0045149	http://dx.doi.org/10.1371/journal.pone.0045149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028814	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700090
J	Shiheido, H; Naito, Y; Kimura, H; Genma, H; Takashima, H; Tokunaga, M; Ono, T; Hirano, T; Du, WL; Yamada, T; Doi, N; Iijima, S; Hattori, Y; Yanagawa, H				Shiheido, Hirokazu; Naito, Yuhei; Kimura, Hironobu; Genma, Hiroaki; Takashima, Hideaki; Tokunaga, Mayuko; Ono, Takao; Hirano, Tatsuya; Du, Wenlin; Yamada, Taketo; Doi, Nobuhide; Iijima, Shiro; Hattori, Yutaka; Yanagawa, Hiroshi			An Anilinoquinazoline Derivative Inhibits Tumor Growth through Interaction with hCAP-G2, a Subunit of Condensin II	PLOS ONE			English	Article							MESSENGER-RNA DISPLAY; PROTEIN-PROTEIN INTERACTIONS; IN-VITRO; MITOTIC CHROMOSOME; MYELOMA CELLS; SACCHAROMYCES-CEREVISIAE; MULTIPLE-MYELOMA; BINDING PROTEIN; SELECTION; COMPLEXES	We screened 46 novel anilinoquinazoline derivatives for activity to inhibit proliferation of a panel of human cancer cell lines. Among them, Q15 showed potent in vitro growth-inhibitory activity towards cancer cell lines derived from colorectal cancer, lung cancer and multiple myeloma. It also showed antitumor activity towards multiple myeloma KMS34 tumor xenografts in lcr/scid mice in vivo. Unlike the known anilinoquinazoline derivative gefitinib, Q15 did not inhibit cytokine-mediated intracellular tyrosine phosphorylation. Using our mRNA display technology, we identified hCAP-G2, a subunit of condensin II complex, which is regarded as a key player in mitotic chromosome condensation, as a Q15 binding partner. Immunofluorescence study indicated that Q15 compromises normal segregation of chromosomes, and therefore might induce apoptosis. Thus, our results indicate that hCAP-G2 is a novel therapeutic target for development of drugs active against currently intractable neoplasms.	[Shiheido, Hirokazu; Kimura, Hironobu; Genma, Hiroaki; Takashima, Hideaki; Tokunaga, Mayuko; Doi, Nobuhide; Yanagawa, Hiroshi] Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Naito, Yuhei; Iijima, Shiro; Hattori, Yutaka] Keio Univ, Fac Pharm, Minato Ku, Tokyo, Japan; [Ono, Takao; Hirano, Tatsuya] RIKEN Adv Sci Inst, Chromosome Dynam Lab, Wako, Saitama, Japan; [Du, Wenlin; Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 160, Japan	Keio University; Keio University; RIKEN; Keio University	Shiheido, H (corresponding author), Keio Univ, Dept Biosci & Informat, Kohoku Ku, Yokohama, Kanagawa 223, Japan.	hyana@bio.keio.ac.jp	Kimura, Hironobu/B-3731-2010; Ono, Takao/C-6065-2017; Doi, Nobuhide/C-4481-2014; Hirano, Tatsuya/F-6008-2011	Ono, Takao/0000-0002-0498-8293; Hirano, Tatsuya/0000-0002-4219-6473; Hattori, Yutaka/0000-0003-1080-9738; Shiheido, Hirokazu/0000-0002-1415-2019; Doi, Nobuhide/0000-0002-2402-6390	grants for a basic research program (CREST) of the Japan Science and Technology Agency; program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan; Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan [22310121, S0801008, S0901009]	grants for a basic research program (CREST) of the Japan Science and Technology Agency; program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants for a basic research program (CREST) of the Japan Science and Technology Agency and a program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Japan, as well as a Grant-in-Aid for Scientific Research (22310121) and a grant for Strategic Research Foundation Grant-aided Projects for Private Universities (S0801008 and S0901009) from Ministry of Education, Culture, Sport, Science, and Technology (MEXT), Japan. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOB BURD DIS 2004 U; Doi N, 2007, J BIOTECHNOL, V131, P231, DOI 10.1016/j.jbiotec.2007.07.947; Du WL, 2007, BLOOD, V109, P3042, DOI 10.1182/blood-2006-02-003103; Fukuda I, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl618; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Horisawa K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh167; Horisawa K, 2009, FEBS LETT, V583, P2429, DOI 10.1016/j.febslet.2009.06.045; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Mahtouk K, 2005, ONCOGENE, V24, P3512, DOI 10.1038/sj.onc.1208536; Matsumura N, 2010, FASEB J, V24, P2201, DOI 10.1096/fj.09-143008; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Miyamoto-Sato E, 2000, NUCLEIC ACIDS RES, V28, P1176, DOI 10.1093/nar/28.5.1176; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; MURO Y, 1990, J RHEUMATOL, V17, P1042; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Onn I, 2007, EMBO J, V26, P1024, DOI 10.1038/sj.emboj.7601562; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Otsuki T, 1999, INT J ONCOL, V15, P1205; Ozawa Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-350; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Schiller JH, 2001, ONCOLOGY-BASEL, V61, P3, DOI 10.1159/000055386; Shiheido H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017898; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Tabata N, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp184; Tateyama S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj025; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Yamori T, 1999, CANCER RES, V59, P4042	35	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44889	10.1371/journal.pone.0044889	http://dx.doi.org/10.1371/journal.pone.0044889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028663	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700050
J	Lu, Q; Xia, XY; Chen, R; Miao, DJ; Chen, SS; Quan, LJ; Li, HO				Lu, Qiang; Xia, Xiao-Yan; Chen, Rong; Miao, Da-Jun; Chen, Sha-Sha; Quan, Li-Jun; Li, Hai-Ou			When the Lowest Energy Does Not Induce Native Structures: Parallel Minimization of Multi-Energy Values by Hybridizing Searching Intelligences	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; ANT COLONY OPTIMIZATION; FEATURES; DOCKING; ACO	Background: Protein structure prediction (PSP), which is usually modeled as a computational optimization problem, remains one of the biggest challenges in computational biology. PSP encounters two difficult obstacles: the inaccurate energy function problem and the searching problem. Even if the lowest energy has been luckily found by the searching procedure, the correct protein structures are not guaranteed to obtain. Results: A general parallel metaheuristic approach is presented to tackle the above two problems. Multi-energy functions are employed to simultaneously guide the parallel searching threads. Searching trajectories are in fact controlled by the parameters of heuristic algorithms. The parallel approach allows the parameters to be perturbed during the searching threads are running in parallel, while each thread is searching the lowest energy value determined by an individual energy function. By hybridizing the intelligences of parallel ant colonies and Monte Carlo Metropolis search, this paper demonstrates an implementation of our parallel approach for PSP. 16 classical instances were tested to show that the parallel approach is competitive for solving PSP problem. Conclusions: This parallel approach combines various sources of both searching intelligences and energy functions, and thus predicts protein conformations with good quality jointly determined by all the parallel searching threads and energy functions. It provides a framework to combine different searching intelligence embedded in heuristic algorithms. It also constructs a container to hybridize different not-so-accurate objective functions which are usually derived from the domain expertise.	[Lu, Qiang; Xia, Xiao-Yan; Chen, Rong; Miao, Da-Jun; Chen, Sha-Sha; Quan, Li-Jun; Li, Hai-Ou] Soochow Univ, Sch Comp Sci & Technol, Suzhou, Peoples R China; [Lu, Qiang; Xia, Xiao-Yan] Jiangsu Prov Key Lab Informat Proc Technol, Suzhou, Peoples R China	Soochow University - China	Lu, Q (corresponding author), Soochow Univ, Sch Comp Sci & Technol, Suzhou, Peoples R China.	qiang@suda.edu.cn			National Natural Science Foundation of China [60970055, 61170125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn) under grant number 60970055 and 61170125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blum C, 2003, ACM COMPUT SURV, V35, P268, DOI 10.1145/937503.937505; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Calvo J, 2009, J SUPERCOMPUT, P1; Calvo JC, 2010, ADV INTEL SOFT COMPU, V74, P233, DOI 10.1007/978-3-642-13214-8_30; Chica Manuel, 2011, Memetic Computing, V3, P15, DOI 10.1007/s12293-010-0035-6; Chica M, 2010, INFORM SCIENCES, V180, P3465, DOI 10.1016/j.ins.2010.05.033; Coello CAC, 2000, ACM COMPUT SURV, V32, P109, DOI 10.1145/358923.358929; Crainic TG, 2010, INT SER OPER RES MAN, V146, P497, DOI 10.1007/978-1-4419-1665-5_17; Cutello V, 2006, J R SOC INTERFACE, V3, P139, DOI 10.1098/RSIF.2005.0083; Deb K., 2001, MULTIOBJECTIVE OPTIM; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Dorigo M, 2005, THEOR COMPUT SCI, V344, P243, DOI 10.1016/j.tcs.2005.05.020; Dorigo M., 1997, IEEE Transactions on Evolutionary Computation, V1, P53, DOI 10.1109/4235.585892; Dorigo M, 1996, IEEE T SYST MAN CY B, V26, P29, DOI 10.1109/3477.484436; Dorigo M, 2010, INT SER OPER RES MAN, V146, P227, DOI 10.1007/978-1-4419-1665-5_8; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; Ellabib I, 2007, INFORM SCIENCES, V177, P1248, DOI 10.1016/j.ins.2006.09.016; Slezak DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013283; GOSS S, 1989, NATURWISSENSCHAFTEN, V76, P579, DOI 10.1007/BF00462870; Gront D, 2006, BIOINFORMATICS, V22, P621, DOI 10.1093/bioinformatics/btk037; Guo H, 2009, 2009 2 INT C BIOMEDI, P1525; Hart WE, 1997, J COMPUT BIOL, V4, P1, DOI 10.1089/cmb.1997.4.1; Helles G, 2008, J R SOC INTERFACE, V5, P387, DOI 10.1098/rsif.2007.1278; Hoos H. H., 2004, STOCHASTIC LOCAL SEA; Jovanovic Raka, 2010, WSEAS Transactions on Computers, V9, P83; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Korb O, SWARM INTELLIGENCE, V1, P115; Korb O, LECT NOTES COMPUTER, V4150, P247; Korb O, 2011, J CHEM INF MODEL, V51, P865, DOI 10.1021/ci100459b; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Li W, 2006, P 20 INT C PAR DISTR, P60; Lu Q, SCIENCE CHI IN PRESS; Lu Q, 2006, LECT NOTES COMPUTER, V4150, P322; Lv Q, 2007, ICNC 2007: THIRD INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 5, PROCEEDINGS, P276; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Middendorf M, 2002, J HEURISTICS, V8, P305, DOI 10.1023/A:1015057701750; Pan J, 2007, CHINESE J COMPUTER S, V28, P651; Pedemonte M, 2011, APPL SOFT COMPUT, V11, P5181, DOI 10.1016/j.asoc.2011.05.042; Qiu J, 2008, PROTEINS, V71, P1175, DOI 10.1002/prot.21809; Raman S, 2008, IBM J RES DEV, V52, P7, DOI 10.1147/rd.521.0007; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Shmygelska A, 2009, P NATL ACAD SCI USA, V106, P1415, DOI 10.1073/pnas.0812510106; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; Stutzle T, 2000, FUTURE GENER COMP SY, V16, P889, DOI 10.1016/S0167-739X(00)00043-1; Stutzle T, 2004, ANT COLONY OPTIMIZAT; Tantar AA, 2007, FUTURE GENER COMP SY, V23, P398, DOI 10.1016/j.future.2006.09.001; Twomey C, 2010, INFORM SCIENCES, V180, P2390, DOI 10.1016/j.ins.2010.02.017; UNGER R, 1993, B MATH BIOL, V55, P1183, DOI 10.1016/S0092-8240(05)80169-7; Van Veldhuizen DA, 2003, IEEE T EVOLUT COMPUT, V7, P144, DOI 10.1109/TEVC.2003.810751; Vrugt JA, 2007, P NATL ACAD SCI USA, V104, P708, DOI 10.1073/pnas.0610471104; Wang Z, 2009, PROTEINS, V75, P638, DOI 10.1002/prot.22275; Yu B, 2011, J OPER RES SOC, V62, P183, DOI 10.1057/jors.2009.161; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004	57	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44967	10.1371/journal.pone.0044967	http://dx.doi.org/10.1371/journal.pone.0044967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028708	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900021
J	Brait, M; Ling, SZ; Nagpal, JK; Chang, XF; Park, HL; Lee, J; Okamura, J; Yamashita, K; Sidransky, D; Kim, MS				Brait, Mariana; Ling, Shizhang; Nagpal, Jatin K.; Chang, Xiaofei; Park, Hannah Lui; Lee, Juna; Okamura, Jun; Yamashita, Keishi; Sidransky, David; Kim, Myoung Sook			Cysteine Dioxygenase 1 Is a Tumor Suppressor Gene Silenced by Promoter Methylation in Multiple Human Cancers	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; TISSUE-SPECIFIC EXPRESSION; SQUAMOUS-CELL CARCINOMA; HYDROGEN-SULFIDE; ETHYLMALONIC ENCEPHALOPATHY; COLON-CANCER; STRUCTURAL ORGANIZATION; RHEUMATOID-ARTHRITIS; COLORECTAL-CARCINOMA; OXIDATIVE STRESS	The human cysteine dioxygenase 1 (CDO1) gene is a non-heme structured, iron-containing metalloenzyme involved in the conversion of cysteine to cysteine sulfinate, and plays a key role in taurine biosynthesis. In our search for novel methylated gene promoters, we have analyzed differential RNA expression profiles of colorectal cancer (CRC) cell lines with or without treatment of 5-aza-2'-deoxycytidine. Among the genes identified, the CDO1 promoter was found to be differentially methylated in primary CRC tissues with high frequency compared to normal colon tissues. In addition, a statistically significant difference in the frequency of CDO1 promoter methylation was observed between primary normal and tumor tissues derived from breast, esophagus, lung, bladder and stomach. Downregulation of CDO1 mRNA and protein levels were observed in cancer cell lines and tumors derived from these tissue types. Expression of CDO1 was tightly controlled by promoter methylation, suggesting that promoter methylation and silencing of CDO1 may be a common event in human carcinogenesis. Moreover, forced expression of full-length CDO1 in human cancer cells markedly decreased the tumor cell growth in an in vitro cell culture and/or an in vivo mouse model, whereas knockdown of CDO1 increased cell growth in culture. Our data implicate CDO1 as a novel tumor suppressor gene and a potentially valuable molecular marker for human cancer.	[Brait, Mariana; Nagpal, Jatin K.; Chang, Xiaofei; Lee, Juna; Okamura, Jun; Sidransky, David; Kim, Myoung Sook] Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Head & Neck Canc Res Div, Baltimore, MD 21205 USA; [Brait, Mariana] Brazilian Natl Canc Inst, Inst Nacl Canc INCA, Rio De Janeiro, Brazil; [Ling, Shizhang] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Park, Hannah Lui] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Yamashita, Keishi] Kitasato Univ Hosp, Dept Surg, Sagamihara, Kanagawa, Japan	Johns Hopkins University; National Cancer Institute (Inca); Johns Hopkins University; University of California System; University of California Irvine; Kitasato University	Sidransky, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol, Head & Neck Canc Res Div, Baltimore, MD 21205 USA.	dsidrans@jhmi.edu; mkim51@jhmi.edu	Ling, Shizhang/J-6114-2014	Ling, Shizhang/0000-0002-6856-3577; Brait, Mariana/0000-0002-1652-8921	National Cancer Institute [U01-CA84986]; Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE [U01CA084986] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute (U01-CA84986 Early Detection Research Network) and the Flight Attendant Medical Research Institute (Myoung S. Kim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Blachier F, 2010, AMINO ACIDS, V39, P335, DOI 10.1007/s00726-009-0445-2; Booken N, 2008, LEUKEMIA, V22, P393, DOI 10.1038/sj.leu.2405044; BRADLEY H, 1994, J RHEUMATOL, V21, P1192; Cai WJ, 2010, CELL BIOL INT, V34, P565, DOI 10.1042/CBI20090368; Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cho YG, 2011, INT J ONCOL, V39, P337, DOI 10.3892/ijo.2011.1050; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; DAVIES MH, 1995, J HEPATOL, V22, P551, DOI 10.1016/0168-8278(95)80450-1; Deplancke B, 2003, FASEB J, V17, P1310, DOI 10.1096/fj.02-0883fje; Di Meo I, 2011, ANTIOXID REDOX SIGN, V15, P353, DOI 10.1089/ars.2010.3520; Di Rocco M, 2006, MOL GENET METAB, V89, P395, DOI 10.1016/j.ymgme.2006.05.010; Dietrich D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-247; Dominy JE, 2004, NUTR REV, V62, P348, DOI 10.1301/nr.2004.sept.348-353; El-Khairy L, 2003, AM J CLIN NUTR, V77, P467, DOI 10.1093/ajcn/77.2.467; EMERY P, 1992, BRIT MED J, V305, P1387, DOI 10.1136/bmj.305.6866.1387; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fang LP, 2009, CAN J PHYSIOL PHARM, V87, P531, DOI [10.1139/Y09-039, 10.1139/y09-039]; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Fiorucci S, 2005, HEPATOLOGY, V42, P539, DOI 10.1002/hep.20817; Fried M, 1993, Rozhl Chir, V72, P173; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P1306, DOI 10.1111/j.1365-2982.2008.01201.x; Ganster F, 2010, CRIT CARE, V14, DOI 10.1186/cc9257; GREGORY WL, 1992, LANCET, V339, P616, DOI 10.1016/0140-6736(92)90902-F; HEAFIELD MT, 1990, NEUROSCI LETT, V110, P216, DOI 10.1016/0304-3940(90)90814-P; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Huang J, 1998, CHEM-BIOL INTERACT, V110, P189, DOI 10.1016/S0009-2797(98)00015-5; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KARLSEN RL, 1982, EXP EYE RES, V34, P65, DOI 10.1016/0014-4835(82)90009-4; Kim MS, 2008, ONCOGENE, V27, P3624, DOI 10.1038/sj.onc.1211021; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Kim MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009003; Kim MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006555; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; KONAMI Y, 1995, GLYCOCONJUGATE J, V12, P128, DOI 10.1007/BF00731356; Kwon YJ, 2011, J THORAC ONCOL; Li L, 2006, CURR OPIN PHARMACOL, V6, P125, DOI 10.1016/j.coph.2005.10.007; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Maschietto M, 2011, EUR J CANC; Merinero B, 2006, J INHERIT METAB DIS, V29, P685, DOI 10.1007/s10545-006-0342-8; Mossman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023127; Oien DB, 2007, BIOCHEM BIOPH RES CO, V352, P556, DOI 10.1016/j.bbrc.2006.11.063; Paz MF, 2003, CANCER RES, V63, P1114; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Satsu H, 2003, BIOCHEM J, V375, P441, DOI 10.1042/BJ20030535; Schreier SM, 2010, NEUROTOX RES, V17, P249, DOI 10.1007/s12640-009-9099-9; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Staub E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-37; Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Taniguchi S, 2011, BRIT J PHARMACOL, V162, P1171, DOI 10.1111/j.1476-5381.2010.01119.x; Tiong CX, 2010, BRIT J PHARMACOL, V161, P467, DOI 10.1111/j.1476-5381.2010.00887.x; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Tsuboyama N, 1996, GENE, V181, P161, DOI 10.1016/S0378-1119(96)00496-9; Tsuboyama-Kasaoka N, 1999, BIOSCI BIOTECH BIOCH, V63, P1017, DOI 10.1271/bbb.63.1017; Ueki I, 2011, AM J PHYSIOL-ENDOC M, V301, pE668, DOI 10.1152/ajpendo.00151.2011; Ueno K, 1998, HUM GENET, V102, P63, DOI 10.1007/s004390050655; Wagner CA, 2009, J NEPHROL, V22, P173; Wallace JL, 2007, TRENDS PHARMACOL SCI, V28, P501, DOI 10.1016/j.tips.2007.09.003; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2009, KIDNEY INT, V76, P700, DOI 10.1038/ki.2009.221; Whiteman M, 2010, ANN NY ACAD SCI, V1203, P146, DOI 10.1111/j.1749-6632.2010.05556.x; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Xu XL, 2004, WORLD J GASTROENTERO, V10, P3441; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yao LL, 2010, AM J PHYSIOL-HEART C, V298, pH1310, DOI 10.1152/ajpheart.00339.2009	79	77	80	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44951	10.1371/journal.pone.0044951	http://dx.doi.org/10.1371/journal.pone.0044951			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028699	gold, Green Published			2022-12-27	WOS:000309517500013
J	Villanea, FA; Perry, GH; Gutierrez-Espeleta, GA; Dominy, NJ				Villanea, Fernando A.; Perry, George H.; Gutierrez-Espeleta, Gustavo A.; Dominy, Nathaniel J.			ASPM and the Evolution of Cerebral Cortical Size in a Community of New World Monkeys	PLOS ONE			English	Article							ONGOING ADAPTIVE EVOLUTION; BRAIN SIZE; MAJOR DETERMINANT; MICROCEPHALY GENES; POSITIVE SELECTION; TOOL USE; INTELLIGENCE; PRIMATES; ADAPTATIONS; SOFTWARE	The ASPM (abnormal spindle-like microcephaly associated) gene has been proposed as a major determinant of cerebral cortical size among primates, including humans. Yet the specific functions of ASPM and its connection to human intelligence remain controversial. This debate is limited in part by a taxonomic focus on Old World monkeys and apes. Here we expand the comparative context of ASPM sequence analyses with a study of New World monkeys, a radiation of primates in which enlarged brain size has evolved in parallel in spider monkeys (genus Ateles) and capuchins (genus Cebus). The primate community of Costa Rica is perhaps a model system because it allows for independent pairwise comparisons of smaller- and larger-brained species within two taxonomic families. Accordingly, we analyzed the complete sequence of exon 18 of ASPM in Ateles geoffroyi, Alouatta palliata, Cebus capucinus, and Saimiri oerstedii. As the analysis of multiple species in a genus improves phylogenetic reconstruction, we also analyzed eleven published sequences from other New World monkeys. Our exon-wide, lineage-specific analysis of eleven genera and the ratio of rates of nonsynonymous to synonymous substitutions (d(N)/d(S)) on ASPM revealed no detectable evidence for positive selection in the lineages leading to Ateles or Cebus, as indicated by d(N)/d(S) ratios of < 1.0 (0.6502 and 0.4268, respectively). Our results suggest that a multitude of interacting genes have driven the evolution of larger brains among primates, with different genes involved in this process in different encephalized lineages, or at least with evidence for positive selection not readily apparent for the same genes in all lineages. The primate community of Costa Rica may serve as a model system for future studies that aim to elucidate the molecular mechanisms underlying cognitive capacity and cortical size.	[Villanea, Fernando A.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Villanea, Fernando A.] Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA; [Villanea, Fernando A.; Gutierrez-Espeleta, Gustavo A.] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Perry, George H.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Dominy, Nathaniel J.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Dominy, Nathaniel J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Washington State University; University of California System; University of California Santa Cruz; Universidad Costa Rica; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Dartmouth College; Dartmouth College	Villanea, FA (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	fervillanea@wsu.edu	Dominy, Nathaniel Jay/A-6151-2013	Dominy, Nathaniel Jay/0000-0001-5916-418X	Center for Tropical Research in Ecology, Agriculture, and Development (CenTREAD) at the University of California, Santa Cruz	Center for Tropical Research in Ecology, Agriculture, and Development (CenTREAD) at the University of California, Santa Cruz	This study was funded in part by a visiting graduate fellowship (to F.A.V.) from the Center for Tropical Research in Ecology, Agriculture, and Development (CenTREAD) at the University of California, Santa Cruz (http://centread.ucsc.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; We are grateful to the Ministerio de Ambiente y Energia of Costa Rica for permission to conduct this study and the Ministerio de Agricultura y Ganaderia and the U.S. Fish and Wildlife Service for permission to export and import samples. We thank J.W. Busch, G.S. Gilbert, D. Haussler, K.D. Holl, J.P. Jimenez, B.M. Kemp, B. King, C. Lowe, S. Salama, and J. Underwood for support, comments, and their assistance with sample processing and analysis. We are especially grateful to the Center for Tropical Research in Ecology, Agriculture, and Development (CenTREAD) at the University of California, Santa Cruz, for their support.	Ali F, 2008, MOL BIOL EVOL, V25, P2247, DOI 10.1093/molbev/msn184; Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; Dew JL, 2005, INT J PRIMATOL, V26, P1107, DOI 10.1007/s10764-005-6461-5; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gibson K.R., 1986, P93; Gibson KR, 2002, BRAIN BEHAV EVOLUT, V59, P10, DOI 10.1159/000063730; Glander K.E., 1978, P561; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; JANSON CH, 1992, AM J PHYS ANTHROPOL, V88, P483, DOI 10.1002/ajpa.1330880405; Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Laska M, 2003, PHYSIOL BEHAV, V78, P321, DOI 10.1016/S0031-9384(02)00976-9; MacNeilage PF, 1990, VISION ACTION CONTRO, P1; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Mekel-Bobrov N, 2007, SCIENCE, V317, DOI 10.1126/science.1143658; Mekel-Bobrov N, 2007, HUM MOL GENET, V16, P600, DOI 10.1093/hmg/ddl487; Montgomery SH, 2011, MOL BIOL EVOL, V28, P625, DOI 10.1093/molbev/msq237; Moura ACD, 2004, SCIENCE, V306, P1909, DOI 10.1126/science.1102558; Panger MA, 1998, AM J PHYS ANTHROPOL, V106, P311, DOI 10.1002/(SICI)1096-8644(199807)106:3<311::AID-AJPA4>3.0.CO;2-P; Panger MA, 2002, AM J PHYS ANTHROPOL, V119, P52, DOI 10.1002/ajpa.10103; PARKER ST, 1977, J HUM EVOL, V6, P623, DOI 10.1016/S0047-2484(77)80135-8; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; Ponting CP, 2006, BIOINFORMATICS, V22, P1031, DOI 10.1093/bioinformatics/btl022; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Timpson N, 2007, SCIENCE, V317, DOI 10.1126/science.1141705; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu FL, 2007, SCIENCE, V316, DOI 10.1126/science.1137568; Zhang JZ, 2003, GENETICS, V165, P2063	40	3	4	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44928	10.1371/journal.pone.0044928	http://dx.doi.org/10.1371/journal.pone.0044928			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028686	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517500012
J	Chang, LH; Huang, HS; Wu, PT; Jou, IM; Pan, MH; Chang, WC; Wang, DDH; Wang, JM				Chang, Ling-Hua; Huang, Huei-Sheng; Wu, Po-Ting; Jou, I-Ming; Pan, Min-Hsiung; Chang, Wen-Chang; Wang, Dennis Ding Hwa; Wang, Ju-Ming			Role of Macrophage CCAAT/Enhancer Binding Protein Delta in the Pathogenesis of Rheumatoid Arthritis in Collagen-Induced Arthritic Mice	PLOS ONE			English	Article							C/EBP-DELTA; COLORECTAL-CANCER; CELLS; INFLAMMATION; EXPRESSION; INDUCTION; CYCLOOXYGENASE-2; ANGIOGENESIS; ACTIVATION; DISEASE	Background: The up-regulation of CCAAT/enhancer binding protein delta (CEBPD) has frequently been observed in macrophages in age-associated disorders, including rheumatoid arthritis (RA). However, the role of macrophage CEBPD in the pathogenesis of RA is unclear. Methodology and Principal Findings: We found that the collagen-induced arthritis (CIA) score and the number of affected paws in Cebpd(-/-) mice were significantly decreased compared with the wild-type (WT) mice. The histological analysis revealed an attenuated CIA in Cebpd(-/-) mice, as shown by reduced pannus formation and greater integrity of joint architecture in affected paws of Cebpd(-/-) mice compared with WT mice. In addition, immunohistochemistry analysis revealed decreased pannus proliferation and angiogenesis in Cebpd(-/-) mice compared with WT mice. CEBPD activated in macrophages played a functional role in promoting the tube formation of endothelial cells and the migration and proliferation of synoviocytes. In vivo DNA binding assays and reporter assays showed that CEBPD up-regulated CCL20, CXCL1, IL23A and TNFAIP6 transcripts through direct binding to their promoter regions. CCL20, IL23A, CXCL1 and TNFAIP6 contributed to the migration and proliferation of synoviocytes, and the latter two proteins were involved in tube formation of endothelial cells. Finally, two anti-inflammatory chemicals, inotilone and rosmanol, reduced the expression of CEBPD and its downstream targets and mitigated the above phenomena. Conclusions and Significance: Collectively, our findings suggest that CEBPD and its downstream effectors could be biomarkers for the diagnosis of RA and potentially serve as therapeutic targets for RA therapy.	[Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Wang, Ju-Ming] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan; [Chang, Ling-Hua; Huang, Huei-Sheng] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Huang, Huei-Sheng] Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Wu, Po-Ting; Jou, I-Ming] Natl Cheng Kung Univ Hosp, Dept Orthoped, Tainan 70428, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Pan, Min-Hsiung] Natl Kaohsiung Marine Univ, Dept Seafood Sci, Kaohsiung, Taiwan; [Wang, Dennis Ding Hwa] Univ Calif Irvine, Dept Biol Chem, UC Irvine Sch Med, Irvine, CA 92717 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Medical University; National Kaohsiung University of Science & Technology; University of California System; University of California Irvine	Wang, JM (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan.	yumingw@mail.ncku.edu.tw	wang, ju-ming/A-1875-2011; Pan, Min-Hsiung/AAT-8865-2021; Huang, Huei-Sheng/F-9945-2011	Pan, Min-Hsiung/0000-0002-5188-7030; 	National Health Research Institutes [NHRI-EX101-10143HI]; National Science Council [NSC100-2320-B-006-020]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in whole or in part by grants NHRI-EX101-10143HI from the National Health Research Institutes and NSC100-2320-B-006-020 from the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2008, INFLAMMATION, V31, P365, DOI 10.1007/s10753-008-9087-x; Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344; Chen LC, 2009, J INFECTION, V58, P368, DOI 10.1016/j.jinf.2009.02.018; Chien CW, 2008, CLIN CANCER RES, V14, P8043, DOI 10.1158/1078-0432.CCR-08-1651; Clavel G, 2003, JOINT BONE SPINE, V70, P321, DOI 10.1016/S1297-319X(03)00088-5; Connell L, 2006, BEST PRACT RES CL RH, V20, P865, DOI 10.1016/j.berh.2006.05.011; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Glant TT, 2002, ARTHRITIS RHEUM-US, V46, P2207, DOI 10.1002/art.10555; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Hour TC, BIOCH PHARM, V80, P325; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Ko CY, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.017; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Kuo CF, 1999, INFECT IMMUN, V67, P126, DOI 10.1128/IAI.67.1.126-130.1999; Kuo YC, 2009, MOL NUTR FOOD RES, V53, P1386, DOI 10.1002/mnfr.200800583; Lai CS, 2009, J AGR FOOD CHEM, V57, P10990, DOI 10.1021/jf9025713; Lai PH, 2008, BBA-MOL CELL RES, V1783, P1803, DOI 10.1016/j.bbamcr.2008.06.008; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Li RN, 2004, NEUROBIOL AGING, V25, P991, DOI 10.1016/j.neurobiolaging.2003.10.016; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Marrero JG, 2002, J NAT PROD, V65, P986, DOI 10.1021/np010565o; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nishioka K, 2000, ARTHRITIS RHEUM-US, V43, P1591, DOI 10.1002/1529-0131(200007)43:7<1591::AID-ANR24>3.0.CO;2-9; Paleolog EM, 2002, ARTHRITIS RES THER, V4, pS81, DOI 10.1186/ar575; ROSENBAUM JT, 1992, ANN RHEUM DIS, V51, P198, DOI 10.1136/ard.51.2.198; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shahrara S, 2009, J IMMUNOL, V182, P3884, DOI 10.4049/jimmunol.0802246; Shamshina JL, 2007, TETRAHEDRON LETT, V48, P3767, DOI 10.1016/j.tetlet.2007.03.166; Shao WH, 2006, J IMMUNOL, V176, P6254, DOI 10.4049/jimmunol.176.10.6254; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Strand V, 2007, NAT REV DRUG DISCOV, V6, P75, DOI 10.1038/nrd2196; Takata Y, 2002, CIRC RES, V91, P427, DOI 10.1161/01.RES.0000031271.20771.4F; Takiguchi M, 1998, INT J EXP PATHOL, V79, P369, DOI 10.1046/j.1365-2613.1998.00082.x; Tanida S, 2009, CYTOKINE, V47, P112, DOI 10.1016/j.cyto.2009.05.009; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang JM, 2006, NUCLEIC ACIDS RES, V34, P217, DOI 10.1093/nar/gkj422; Wang JM, 2005, MOL BIOL CELL, V16, P3365, DOI 10.1091/mbc.E05-02-0105; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Youn J, 2002, CLIN EXP IMMUNOL, V129, P232, DOI 10.1046/j.1365-2249.2002.01922.x; Zhu P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1899	54	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45378	10.1371/journal.pone.0045378	http://dx.doi.org/10.1371/journal.pone.0045378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028973	Green Published, gold			2022-12-27	WOS:000309554700034
J	Laver, RJ; Purwandana, D; Ariefiandy, A; Imansyah, J; Forsyth, D; Ciofi, C; Jessop, TS				Laver, Rebecca J.; Purwandana, Deni; Ariefiandy, Achmad; Imansyah, Jeri; Forsyth, David; Ciofi, Claudio; Jessop, Tim S.			Life-History and Spatial Determinants of Somatic Growth Dynamics in Komodo Dragon Populations	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; MAXIMUM BODY-SIZE; INTRASPECIFIC COMPETITION; MICROSATELLITE LOCI; COMMON LIZARD; VIPERA-BERUS; RATES; EVOLUTION; SELECTION; SURVIVAL	Somatic growth patterns represent a major component of organismal fitness and may vary among sexes and populations due to genetic and environmental processes leading to profound differences in life-history and demography. This study considered the ontogenic, sex-specific and spatial dynamics of somatic growth patterns in ten populations of the world's largest lizard the Komodo dragon (Varanus komodoensis). The growth of 400 individual Komodo dragons was measured in a capture-mark-recapture study at ten sites on four islands in eastern Indonesia, from 2002 to 2010. Generalized Additive Mixed Models (GAMMs) and information-theoretic methods were used to examine how growth rates varied with size, age and sex, and across and within islands in relation to site-specific prey availability, lizard population density and inbreeding coefficients. Growth trajectories differed significantly with size and between sexes, indicating different energy allocation tactics and overall costs associated with reproduction. This leads to disparities in maximum body sizes and longevity. Spatial variation in growth was strongly supported by a curvilinear density-dependent growth model with highest growth rates occurring at intermediate population densities. Sex-specific trade-offs in growth underpin key differences in Komodo dragon life-history including evidence for high costs of reproduction in females. Further, inverse density-dependent growth may have profound effects on individual and population level processes that influence the demography of this species.	[Laver, Rebecca J.; Jessop, Tim S.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Purwandana, Deni; Ariefiandy, Achmad; Imansyah, Jeri] Komodo Survival Program, Denpasar, Bali, Indonesia; [Forsyth, David] Arthur Rylah Inst Environm Res, Dept Sustainabil & Environm, Melbourne, Vic, Australia; [Ciofi, Claudio] Univ Florence, Dept Anim Biol & Genet, Florence, Italy; [Jessop, Tim S.] Zoos Victoria, Dept Wildlife Conservat & Sci, Melbourne, Vic, Australia	University of Melbourne; Arthur Rylah Institute for Environmental Research (ARI); University of Florence	Jessop, TS (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	tjessop@unimelb.edu.au	Laver, Rebecca J./I-9457-2019; Jessop, Tim/Q-2473-2019; Ciofi, Claudio/AAH-9461-2019	Laver, Rebecca J./0000-0002-6319-7213; Forsyth, David/0000-0001-5356-9573; Jessop, Tim S./0000-0002-7712-4373; Ariefiandy, Achmad/0000-0003-4085-8354; CIOFI, CLAUDIO/0000-0001-8537-8659	Zoological Society of San Diego; National Geographic Society; American Zoo and Aquarium Association (Komodo National Park fieldwork); Ocean Park Conservation Foundation (OPCF) Hong Kong; Miami Metro Zoo; Mohamed Bin Zayed Species Conservation Fund	Zoological Society of San Diego; National Geographic Society(National Geographic Society); American Zoo and Aquarium Association (Komodo National Park fieldwork); Ocean Park Conservation Foundation (OPCF) Hong Kong; Miami Metro Zoo; Mohamed Bin Zayed Species Conservation Fund	Financial support for this research was provided by the Zoological Society of San Diego; the National Geographic Society; the American Zoo and Aquarium Association (Komodo National Park fieldwork); the Ocean Park Conservation Foundation (OPCF) Hong Kong; Miami Metro Zoo; and the Mohamed Bin Zayed Species Conservation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Andrews R.M., 1982, Biology of Reptilia, V13, P273; Ariefiandy A, 2011, WILDL BIOL IN PRESS; Balazs GH, 2004, MAR BIOL, V145, P1043, DOI 10.1007/s00227-004-1387-6; BALLINGER RE, 1980, COPEIA, P921; BELKHIR K, 2000, 9060 CNRS UPR U MONT; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.2307/2641001; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; BOOTH DJ, 1995, ECOLOGY, V76, P91, DOI 10.2307/1940634; Burnham K P, 2003, MODEL SELECT MULTIMO; Caley MJ, 2004, EVOLUTION, V58, P862; Caswell, 2000, MATRIX POPULATION MO; Chaloupka M, 2005, MAR BIOL, V147, P1251, DOI 10.1007/s00227-005-0026-1; Chaloupka MY, 1997, MAR ECOL PROG SER, V146, P1, DOI 10.3354/meps146001; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Ciofi C, 1999, MOL ECOL, V8, pS17, DOI 10.1046/j.1365-294X.1999.00734.x; Ciofi C, 2004, HERPETOL J, V14, P99; Ciofi C, 1998, MOL ECOL, V7, P134; Ciofi Claudio, 2002, P129; Civantos E, 1999, COPEIA, P1112, DOI 10.2307/1447988; CONGDON JD, 1989, PHYSIOL ZOOL, V62, P356, DOI 10.1086/physzool.62.2.30156175; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Cox RM, 2006, J ANIM ECOL, V75, P1361, DOI 10.1111/j.1365-2656.2006.01160.x; Cox RM, 2010, EVOLUTION, V64, P798, DOI 10.1111/j.1558-5646.2009.00851.x; DUNHAM AE, 1978, ECOLOGY, V59, P770, DOI 10.2307/1938781; English S., OECOLOGIA IN PRESS; FERGUSON GW, 1984, EVOLUTION, V38, P342, DOI 10.1111/j.1558-5646.1984.tb00292.x; FORSMAN A, 1993, OIKOS, V66, P279, DOI 10.2307/3544815; FORSMAN A, 1991, J ANIM ECOL, V60, P253, DOI 10.2307/5458; FORSMAN A, 1991, FUNCT ECOL, V5, P717, DOI 10.2307/2389533; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; GIBBONS J. WHITFIELD, 1967, HERPETOLOGICA, V23, P296; Halverson J, 2002, SEX DETERMINATION IT; Heino M, 1999, J EVOLUTION BIOL, V12, P423; Iraeta P, 2006, FUNCT ECOL, V20, P865, DOI 10.1111/j.1365-2435.2006.01162.x; Jessop TS, 2007, BIOL CONSERV, V135, P247, DOI 10.1016/j.biocon.2006.10.025; Jessop TS, 2006, OIKOS, V112, P422, DOI 10.1111/j.0030-1299.2006.14371.x; Johnston G, 2011, AUSTRAL ECOL, V36, P117, DOI 10.1111/j.1442-9993.2010.02113.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kirkpatrick M., 1988, P13; Krebs CJ, 1998, ECOLOGICAL METHODOLO, V2; Krueger BH, 2011, MAR ECOL PROG SER, V432, P269, DOI 10.3354/meps09125; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Lester NP, 2004, P ROY SOC B-BIOL SCI, V271, P1625, DOI 10.1098/rspb.2004.2778; Limpus C, 1997, MAR ECOL PROG SER, V149, P23, DOI 10.3354/meps149023; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; MASSOT M, 1992, ECOLOGY, V73, P1742, DOI 10.2307/1940026; McCarty JP, 2001, AUK, V118, P176, DOI 10.1642/0004-8038(2001)118[0176:VIGONT]2.0.CO;2; MILINSKI M, 1982, BEHAV ECOL SOCIOBIOL, V11, P109, DOI 10.1007/BF00300099; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROFF DA, 1983, CAN J FISH AQUAT SCI, V40, P1395, DOI 10.1139/f83-161; Roff Derek A., 1992; SCHOENER TW, 1973, THEOR POPUL BIOL, V4, P56, DOI 10.1016/0040-5809(73)90006-3; SCHOENER TW, 1978, COPEIA, P390, DOI 10.2307/1443602; Schoener TW, 1997, BIOL REPTILIA, P35; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.es.18.110187.002103; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SHINE R, 1980, OECOLOGIA, V46, P92, DOI 10.1007/BF00346972; SINERVO B, 1992, SCIENCE, V258, P1927, DOI 10.1126/science.258.5090.1927; Sorci G, 1996, J ANIM ECOL, V65, P781, DOI 10.2307/5676; Spencer RJ, 2006, ECOLOGY, V87, P3109, DOI 10.1890/0012-9658(2006)87[3109:CDGIAL]2.0.CO;2; Stearns S.C., 1992, pi; Taylor E.N., 2008, BIOL RATTLESNAKES, P91; Taylor EN, 2005, J EXP ZOOL PART A, V303A, P598, DOI 10.1002/jez.a.189; TINKLE DW, 1970, EVOLUTION, V24, P55, DOI 10.1111/j.1558-5646.1970.tb01740.x; TRIVERS RL, 1976, EVOLUTION, V30, P253, DOI 10.1111/j.1558-5646.1976.tb00908.x; Wainright SC, 1996, CAN J FISH AQUAT SCI, V53, P685, DOI 10.1139/cjfas-53-4-685; WARE DM, 1980, CAN J FISH AQUAT SCI, V37, P1012, DOI 10.1139/f80-129; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wikelski M, 1997, EVOLUTION, V51, P922, DOI 10.1111/j.1558-5646.1997.tb03673.x; Wikelski M, 2000, NATURE, V403, P37, DOI 10.1038/47396; Wood SN., 2006, GEN ADDITVE MODELS I; Wootton RJ, 1979, S ZOOL SOC LOND, P133	73	34	34	1	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45398	10.1371/journal.pone.0045398	http://dx.doi.org/10.1371/journal.pone.0045398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028983	gold, Green Published			2022-12-27	WOS:000309388400081
J	Martin, SL; Husband, BC				Martin, Sara L.; Husband, Brian C.			Whole Genome Duplication Affects Evolvability of Flowering Time in an Autotetraploid Plant	PLOS ONE			English	Article							EPILOBIUM-ANGUSTIFOLIUM; EVOLUTIONARY CONSEQUENCES; POLYPLOIDY; CONSTRAINTS; SELECTION; AUTOPOLYPLOIDY; REARRANGEMENTS; ANGIOSPERMS; BRASSICA; FIREWEED	Whole genome duplications have occurred recurrently throughout the evolutionary history of eukaryotes. The resulting genetic and phenotypic changes can influence physiological and ecological responses to the environment; however, the impact of genome copy number on evolvability has rarely been examined experimentally. Here, we evaluate the effect of genome duplication on the ability to respond to selection for early flowering time in lines drawn from naturally occurring diploid and autotetraploid populations of the plant Chamerion angustifolium (fireweed). We contrast this with the result of four generations of selection on synthesized neoautotetraploids, whose genic variability is similar to diploids but genome copy number is similar to autotetraploids. In addition, we examine correlated responses to selection in all three groups. Diploid and both extant tetraploid and neoautotetraploid lines responded to selection with significant reductions in time to flowering. Evolvability, measured as realized heritability, was significantly lower in extant tetraploids ((b) over cap (T) = 0.31) than diploids ((b) over cap (T) = 0.40). Neotetraploids exhibited the highest evolutionary response ((b) over cap (T) = 0.55). The rapid shift in flowering time in neotetraploids was associated with an increase in phenotypic variability across generations, but not with change in genome size or phenotypic correlations among traits. Our results suggest that whole genome duplications, without hybridization, may initially alter evolutionary rate, and that the dynamic nature of neoautopolyploids may contribute to the prevalence of polyploidy throughout eukaryotes.	[Martin, Sara L.; Husband, Brian C.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Martin, SL (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	slwmartin@gmail.com			Ontario Graduate Scholarship; Natural Science and Engineering Research Council of Canada; Premier's Research Excellence Award; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair Award; Canadian Foundation for Innovation	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Premier's Research Excellence Award; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair Award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation)	The authors gratefully acknowledge financial support from Ontario Graduate Scholarship and Natural Science and Engineering Research Council of Canada to SLM, and from Premier's Research Excellence Award, Natural Sciences and Engineering Research Council of Canada, Canada Research Chair Award and Canadian Foundation for Innovation to BCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2004, GENETICS, V168, P2217, DOI 10.1534/genetics.104.033522; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Anderson JB, 2003, GENETICS, V163, P1287; [Anonymous], 1907, SCIENCE, V26, P151; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Burgess KS, 2007, HEREDITY, V99, P641, DOI 10.1038/sj.hdy.6801043; Caruso CM, 2005, EVOLUTION, V59, P826; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Dart S, 2004, CAN J BOT, V82, P185, DOI [10.1139/B03-134, 10.1139/b03-134]; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Eilam T, 2009, GENOME, V52, P275, DOI 10.1139/G09-004; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; FOWLER NL, 1984, AM NAT, V124, P703, DOI 10.1086/284307; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Husband BC, 2004, NEW PHYTOL, V161, P703, DOI 10.1046/j.1469-8137.2004.00998.x; Husband BC, 1998, AM J BOT, V85, P1688, DOI 10.2307/2446502; HUSBAND BC, 1995, HEREDITY, V75, P206, DOI 10.1038/hdy.1995.125; Husband BC, 2000, P ROY SOC B-BIOL SCI, V267, P217, DOI 10.1098/rspb.2000.0990; Husband BC, 1997, EVOLUTION, V51, P737, DOI [10.2307/2411150, 10.1111/j.1558-5646.1997.tb03657.x]; Kashkush K, 2002, GENETICS, V160, P1651; Kelley K, 2011, MBESS; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; Levin D. A., 1975, Taxon, V24, P35, DOI 10.2307/1218997; Levin D. A, 2002, OX ECOL EV; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Lynch M, 2008, EVOLUTION SELECTION, P209; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; Maherali H, 2009, NEW PHYTOL, V184, P721, DOI 10.1111/j.1469-8137.2009.02997.x; Martelotto LG, 2007, PLANT SCI, V172, P970, DOI 10.1016/j.plantsci.2007.02.001; Martin SL, 2008, SIGNIFICANCE POLYPLO; MOSQUIN T, 1967, EVOLUTION, V21, P713, DOI 10.1111/j.1558-5646.1967.tb03428.x; Muntzing A, 1935, HEREDITAS, V21, P263; ONeil P, 1997, EVOLUTION, V51, P267, DOI [10.1111/j.1558-5646.1997.tb02408.x, 10.2307/2410980]; ORR HA, 1994, GENETICS, V136, P1475; Oswald BP, 2010, EVOLUTION, P1667; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Otto SP, 2008, CURR BIOL, V18, pR1121, DOI 10.1016/j.cub.2008.09.039; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Otto SP, 2002, ADV GENET, V46, P451; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Pires JC, 2004, BIOL J LINN SOC, V82, P675, DOI 10.1111/j.1095-8312.2004.00350.x; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; R Development Core Team, 2011, R LANG DAT AN GRAPH; RAINA SN, 1994, GENOME, V37, P560, DOI 10.1139/g94-080; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; Ramsey J, 2011, P NATL ACAD SCI USA, V108, P7096, DOI 10.1073/pnas.1016631108; Roy Y, 2008, EVOLUTIONARY HIST PO; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Schranz ME, 2000, J HERED, V91, P242, DOI 10.1093/jhered/91.3.242; SOLBRECK C, 1987, CAN J BOT, V65, P2177, DOI 10.1139/b87-299; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; Soltis DE, 2007, TAXON, V56, P13, DOI 10.2307/25065732; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Stebbins G. L., 1971, CHROMOSOMAL EVOLUTIO; Stebbins GL, 1940, AM NAT, V74, P54, DOI 10.1086/280872; Stupar RM, 2007, GENETICS, V176, P2055, DOI 10.1534/genetics.107.074286; Vamosi JC, 2006, INT J PLANT SCI, V167, P349, DOI 10.1086/499251; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Yu Z, 2010, P NATL ACAD SCI USA, V107, P17809, DOI 10.1073/pnas.1000852107; Zeyl C, 2003, SCIENCE, V299, P555, DOI 10.1126/science.1078417	68	30	31	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44784	10.1371/journal.pone.0044784	http://dx.doi.org/10.1371/journal.pone.0044784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028620	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400039
J	Miao, CY; Duan, QY; Yang, L; Borthwick, AGL				Miao, Chiyuan; Duan, Qingyun; Yang, Lin; Borthwick, Alistair G. L.			On the Applicability of Temperature and Precipitation Data from CMIP3 for China	PLOS ONE			English	Article							CLIMATE-CHANGE; SUMMER MONSOON; IMPACTS; MODELS; SIMULATION; ERA	Global Circulation Models (GCMs) contributed to the Intergovernmental Panel on Climate Change (IPCC) Fourth Assessment Report (AR4) and are widely used in global change research. This paper assesses the performance of the AR4 GCMs in simulating precipitation and temperature in China from 1960 to 1999 by comparison with observed data, using system bias (B), root-mean-square error (RMSE), Pearson correlation coefficient (R) and Nash-Sutcliffe model efficiency (E) metrics. Probability density functions (PDFs) are also fitted to the outputs of each model. It is shown that the performance of each GCM varies to different degrees across China. Based on the skill score derived from the four metrics, it is suggested that GCM 15 (ipsl_cm4) and GCM 3 (cccma_cgcm_t63) provide the best representations of temperature and precipitation, respectively, in terms of spatial distribution and trend over 10 years. The results also indicate that users should apply carefully the results of annual precipitation and annual temperature generated by AR4 GCMs in China due to poor performance. At a finer scale, the four metrics are also used to obtain best fit scores for ten river basins covering mainland China. Further research is proposed to improve the simulation accuracy of the AR4 GCMs regarding China.	[Miao, Chiyuan; Duan, Qingyun] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Yang, Lin] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Borthwick, Alistair G. L.] Univ Coll Cork, Dept Civil & Environm Engn, Cork, Ireland	Beijing Normal University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; University College Cork	Miao, CY (corresponding author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	miaocy@vip.sina.com	Yang, Lin/ABG-5551-2021; Duan, Qingyun/C-7652-2011; Miao, Chiyuan/E-6036-2011	Duan, Qingyun/0000-0001-9955-1512; Miao, Chiyuan/0000-0001-6413-7020; Yang, Lin/0000-0002-7576-4481	National Natural Science Foundation of China [41001153]; National Key Basic Special Foundation Project of China [2010CB951604, 2010CB428402]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Special Foundation Project of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the National Natural Science Foundation of China (no. 41001153), the National Key Basic Special Foundation Project of China (no. 2010CB951604 and no. 2010CB428402), and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfeld DP, 2006, P 16 INT C COMP METH; Beaulieu C, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007501; Black R, 2011, NATURE, V478, P447, DOI 10.1038/478477a; Brunsell NA, 2011, ACTA GEOSCI SIN, V30, P1178; Coquard J, 2004, CLIM DYNAM, V23, P455, DOI 10.1007/s00382-004-0437-6; Delire C, 2008, GLOBAL PLANET CHANGE, V64, P3, DOI 10.1016/j.gloplacha.2008.01.008; Duan QY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013654; Ducre-Robitaille JF, 2003, INT J CLIMATOL, V23, P1087, DOI 10.1002/joc.924; Dutton JA, 2002, B AM METEOROL SOC, V83, P1303, DOI 10.1175/1520-0477-83.9.1303; Errasti I, 2011, THEOR APPL CLIMATOL, V103, P61, DOI 10.1007/s00704-010-0282-y; Frame DJ, 2009, PHILOS T R SOC A, V367, P855, DOI 10.1098/rsta.2008.0240; Gao X, 2008, METEOROL ATMOS PHYS, V100, P73, DOI 10.1007/s00703-008-0296-5; Giorgi F, 2002, J CLIMATE, V15, P1141, DOI 10.1175/1520-0442(2002)015<1141:COAURA>2.0.CO;2; Im ES, 2007, CLIM DYNAM, V28, P759, DOI [10.1007/s00382-006-0203-z, 10.1007/s00382-006-0203-Z]; Kiktev D, 2003, J CLIMATE, V16, P3560, DOI 10.1175/1520-0442(2003)016<3560:COMAOT>2.0.CO;2; Lambert SJ, 2001, CLIM DYNAM, V17, P83, DOI 10.1007/PL00013736; Li HM, 2011, ADV ATMOS SCI, V28, P448, DOI 10.1007/s00376-010-0052-x; Li HM, 2011, ADV ATMOS SCI, V28, P433, DOI 10.1007/s00376-010-0013-4; Li LJ, 2007, CHINESE SCI BULL, V52, P3148, DOI 10.1007/s11434-007-0463-y; Li P, 2011, ENG SCI, V04, P29; Lofgren BM, 2004, 18 C HYDR 8 ANN M AM, P3; Masson D, 2011, J CLIMATE, V24, P2680, DOI 10.1175/2011JCLI3513.1; Maxino CC, 2008, INT J CLIMATOL, V28, P1097, DOI 10.1002/joc.1612; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030948; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nieto S, 2006, J CLIMATE, V19, P4254, DOI 10.1175/JCLI3859.1; Phillips TJ, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004313; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Reichler T, 2008, B AM METEOROL SOC, V89, P303, DOI 10.1175/BAMS-89-3-303; Ren G, 2005, CLIMATIC ENV RES, V10, P711; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stott PA, 2000, SCIENCE, V290, P2133, DOI 10.1126/science.290.5499.2133; Warner GS, 1997, T ASAE, V40, P585, DOI 10.13031/2013.21317; Watterson IG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014502; Yu RC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021270; Yu RC, 2007, J CLIMATE, V20, P5344, DOI 10.1175/2007JCLI1559.1; Zhao T, 2008, J CLIMATE, V21, P1440, DOI 10.1175/2007JCLI1463.1; Zhou TJ, 2006, J CLIMATE, V19, P5843, DOI 10.1175/JCLI3952.1; Zhou TJ, 2009, METEOROL Z, V18, P455, DOI 10.1127/0941-2948/2009/0396	40	26	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44659	10.1371/journal.pone.0044659	http://dx.doi.org/10.1371/journal.pone.0044659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028575	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400031
J	Stadelmann, B; Merino, MC; Persson, L; Svard, SG				Stadelmann, Britta; Merino, Maria C.; Persson, Lo; Svard, Staffan G.			Arginine Consumption by the Intestinal Parasite Giardia intestinalis Reduces Proliferation of Intestinal Epithelial Cells	PLOS ONE			English	Article							MURINE-GIARDIASIS; BARRIER FUNCTION; T-LYMPHOCYTES; LAMBLIA; EXPRESSION; APOPTOSIS; GROWTH; TRANSPORT; ENZYMES; LINE	In the field of infectious diseases the multifaceted amino acid arginine has reached special attention as substrate for the hosts production of the antimicrobial agent nitric oxide (NO). A variety of infectious organisms interfere with this part of the host immune response by reducing the availability of arginine. This prompted us to further investigate additional roles of arginine during pathogen infections. As a model we used the intestinal parasite Giardia intestinalis that actively consumes arginine as main energy source and secretes an arginine-consuming enzyme, arginine deiminase (ADI). Reduced intestinal epithelial cell (IEC) proliferation is a common theme during bacterial and viral intestinal infections, but it has never been connected to arginine-consumption. Our specific question was thereby, whether the arginine-consumption by Giardia leads to reduced IEC proliferation, in addition to NO reduction. In vitro cultivation of human IEC lines in arginine-free or arginine/citrulline-complemented medium, as well as in interaction with different G. intestinalis isolates, were used to study effects on host cell replication by MTT assay. IEC proliferation was further analyzed by DNA content analysis, polyamine measurements and expressional analysis of cell cycle regulatory genes. IEC proliferation was reduced upon arginine-withdrawal and also in an arginine-dependent manner upon interaction with G. intestinalis or addition of Giardia ADI. We show that arginine-withdrawal by intestinal pathogens leads to a halt in the cell cycle in IECs through reduced polyamine levels and upregulated cell cycle inhibitory genes. This is of importance with regards to intestinal tissue homeostasis that is affected through reduced cell proliferation. Thus, the slower epithelial cell turnover helps the pathogen to maintain a more stable niche for colonization. This study also shows why supplementation therapy of diarrhea patients with arginine/citrulline is helpful and that citrulline especially should gain further attention in future treatment strategies.	[Stadelmann, Britta; Svard, Staffan G.] Uppsala Univ, Dept Cell & Mol Biol, Uppsala Biomed Ctr, Uppsala, Sweden; [Merino, Maria C.] Inst Invest Med Mercedes & Martin Ferreyra Conice, Cordoba, Argentina; [Persson, Lo] Lund Univ, Dept Expt Med Sci, Biomed Ctr Lund, Lund, Sweden	Uppsala University; Lund University	Stadelmann, B (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala Biomed Ctr, Uppsala, Sweden.	britta.stadelmann@icm.uu.se	Lundström-Stadelmann, Britta/AFT-5452-2022; Lundström-Stadelmann, Britta/E-8042-2011	Lundström-Stadelmann, Britta/0000-0003-2672-5766; Lundström-Stadelmann, Britta/0000-0003-2672-5766; Svard, Staffan/0000-0002-7392-1746	Swiss National Foundation [SNF PBBEP3_133500]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina); Vetenskapsradet Medicin (Sweden) [VR-M 2009-3492]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Vetenskapsradet Medicin (Sweden)	BS was funded by a grant from the Swiss National Foundation (SNF PBBEP3_133500). MCM received a stipend from Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina). This work was carried out within a grant from Vetenskapsradet Medicin (VR-M 2009-3492, Sweden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; Alm K, 2009, ESSAYS BIOCHEM, V46, P63, DOI [10.1042/BSE0460005, 10.1042/bse0460005]; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741; BURET A, 1990, J PARASITOL, V76, P403, DOI 10.2307/3282675; BURET A, 1991, PARASITOL RES, V77, P109, DOI 10.1007/BF00935423; BURET A, 1992, GASTROENTEROLOGY, V103, P506, DOI 10.1016/0016-5085(92)90840-U; Buret AG, 2007, GUT, V56, P316, DOI 10.1136/gut.2006.107771; CENDAN JC, 1995, ANN SURG ONCOL, V2, P257, DOI 10.1007/BF02307033; Chaturvedi R, 2012, AMINO ACIDS, V42, P627, DOI 10.1007/s00726-011-1038-4; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; Das P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000899; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; GOROWARA S, 1992, BIOCHIM BIOPHYS ACTA, V1138, P122, DOI 10.1016/0925-4439(92)90051-N; Humen MA, 2011, CELL MICROBIOL, V13, P1683, DOI 10.1111/j.1462-5822.2011.01647.x; Jerlstrom-Hultqvist J, 2012, EUKARYOT CE IN PRESS; Jerlstrom-Hultqvist J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-543; Karbach S, 2011, J MOL CELL CARDIOL, V51, P855, DOI 10.1016/j.yjmcc.2011.07.024; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kelly MP, 2012, BRIT J CANCER, V106, P324, DOI 10.1038/bjc.2011.524; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; KNODLER LA, 1995, MICROBIOL-UK, V141, P2063, DOI 10.1099/13500872-141-9-2063; Kohler ES, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-107; Lenaerts K, 2007, PROTEOMICS, V7, P565, DOI 10.1002/pmic.200600715; Li E, 2007, INFECT IMMUN, V75, P4514, DOI 10.1128/IAI.00596-07; Morris SM, 2006, AM J CLIN NUTR, V83, p508S; Panaro MA, 2007, FEMS IMMUNOL MED MIC, V51, P302, DOI 10.1111/j.1574-695X.2007.00304.x; Pierce KK, 2009, CURR OPIN GASTROEN, V25, P12, DOI 10.1097/MOG.0b013e32831da7dd; Rhoads JM, 2009, AMINO ACIDS, V37, P111, DOI 10.1007/s00726-008-0225-4; Ringqvist E, 2008, MOL BIOCHEM PARASIT, V159, P85, DOI 10.1016/j.molbiopara.2008.02.005; Roxstrom-Lindquist K, 2005, INFECT IMMUN, V73, P8204, DOI 10.1128/IAI.73.12.8204-8208.2005; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Santosham M, 2010, LANCET, V376, P63, DOI 10.1016/S0140-6736(10)60356-X; SCHOFIELD PJ, 1992, MOL BIOCHEM PARASIT, V51, P29, DOI 10.1016/0166-6851(92)90197-R; SCHOFIELD PJ, 1990, INT J PARASITOL, V20, P697, DOI 10.1016/0020-7519(90)90133-8; Scott KGE, 2000, INFECT IMMUN, V68, P3412, DOI 10.1128/IAI.68.6.3412-3418.2000; Scott KGE, 2004, INFECT IMMUN, V72, P3536, DOI 10.1128/IAI.72.6.3536-3542.2004; SEILER N, 1980, J CHROMATOGR, V221, P227, DOI 10.1016/S0378-4347(00)84307-8; Svard SG, 2003, FEMS MICROBIOL LETT, V218, P3, DOI 10.1016/S0378-1097(02)01107-2; Troeger H, 2007, GUT, V56, P328, DOI 10.1136/gut.2006.100198; Wijnands KAP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037439; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1	45	69	71	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45325	10.1371/journal.pone.0045325	http://dx.doi.org/10.1371/journal.pone.0045325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028934	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400074
J	Gudlur, S; Sukthankar, P; Gao, J; Avila, LA; Hiromasa, Y; Chen, JH; Iwamoto, T; Tomich, JM				Gudlur, Sushanth; Sukthankar, Pinakin; Gao, Jian; Avila, L. Adriana; Hiromasa, Yasuaki; Chen, Jianhan; Iwamoto, Takeo; Tomich, John M.			Peptide Nanovesicles Formed by the Self-Assembly of Branched Amphiphilic Peptides	PLOS ONE			English	Article							SURFACTANT-LIKE PEPTIDES; POLYPEPTIDE VESICLES; CATIONIC LIPIDS; HIGH-CAPACITY; GENE-TRANSFER; FORCE-FIELD; PROTEIN; NANOTUBES; DYNAMICS; CARRIERS	Peptide-based packaging systems show great potential as safer drug delivery systems. They overcome problems associated with lipid-based or viral delivery systems, vis-a-vis stability, specificity, inflammation, antigenicity, and tune-ability. Here, we describe a set of 15 & 23-residue branched, amphiphilic peptides that mimic phosphoglycerides in molecular architecture. These peptides undergo supramolecular self-assembly and form solvent-filled, bilayer delimited spheres with 50-200 nm diameters as confirmed by TEM, STEM and DLS. Whereas weak hydrophobic forces drive and sustain lipid bilayer assemblies, these all-peptide structures are stabilized potentially by both hydrophobic interactions and hydrogen bonds and remain intact at low micromolar concentrations and higher temperatures. A linear peptide lacking the branch point showed no self-assembly properties. We have observed that these peptide vesicles can trap fluorescent dye molecules within their interior and are taken up by N/N 1003A rabbit lens epithelial cells grown in culture. These assemblies are thus potential drug delivery systems that can overcome some of the key limitations of the current packaging systems.	[Gudlur, Sushanth; Sukthankar, Pinakin; Gao, Jian; Avila, L. Adriana; Hiromasa, Yasuaki; Chen, Jianhan; Tomich, John M.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Iwamoto, Takeo] Jikei Univ, Core Res Facil, Div Biochem, Tokyo, Japan	Kansas State University; Jikei University	Tomich, JM (corresponding author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.	jtomich@ksu.edu	Chen, Jianhan/C-7680-2009	Sukthankar, Pinakin/0000-0002-9043-5846; Gudlur, Sushanth/0000-0002-0731-9116; TOMICH, JOHN/0000-0001-7848-8307	Public Health Service-National Institutes of Health [P20 RR016475]; Terry Johnson Cancer Center at Kansas State University; JSPS KAKENHI grant [23590649]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074096] Funding Source: NIH RePORTER	Public Health Service-National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Terry Johnson Cancer Center at Kansas State University; JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Partial support for this project was provided by Public Health Service-National Institutes of Health grant #P20 RR016475 and the Terry Johnson Cancer Center at Kansas State University and by JSPS KAKENHI grant #23590649 (TI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; [Anonymous], 2002, HUM GENE THER, V13, P3, DOI 10.1089/10430340152712610; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Baum C, 2003, BLOOD, V101, P2099, DOI 10.1182/blood-2002-07-2314; Bellomo EG, 2004, NAT MATER, V3, P244, DOI 10.1038/nmat1093; BILTONEN RL, 1993, CHEM PHYS LIPIDS, V64, P129, DOI 10.1016/0009-3084(93)90062-8; Breslauer DN, 2010, BIOMACROMOLECULES, V11, P643, DOI 10.1021/bm901209u; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Christian DA, 2009, EUR J PHARM BIOPHARM, V71, P463, DOI 10.1016/j.ejpb.2008.09.025; Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838; GROVE A, 1993, PROTEIN SCI, V2, P1918, DOI 10.1002/pro.5560021113; GROVE A, 1991, P NATL ACAD SCI USA, V88, P6418, DOI 10.1073/pnas.88.15.6418; GRUEN LC, 1970, ANAL CHIM ACTA, V50, P299, DOI 10.1016/0003-2670(70)80069-1; Holowka EP, 2005, J AM CHEM SOC, V127, P12423, DOI 10.1021/ja053557t; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; IWAMOTO T, 1994, INT J PEPT PROT RES, V43, P597, DOI 10.1111/j.1399-3011.1994.tb00562.x; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Kafri T, 1998, P NATL ACAD SCI USA, V95, P11377, DOI 10.1073/pnas.95.19.11377; Klyushnichenko V, 2001, J CHROMATOGR B, V755, P27, DOI 10.1016/S0378-4347(00)00597-1; Koynova R, 2007, BBA-BIOMEMBRANES, V1768, P375, DOI 10.1016/j.bbamem.2006.10.016; Krebs MRH, 2005, BIOPHYS J, V88, P2013, DOI 10.1529/biophysj.104.051896; Kumar VV, 2003, GENE THER, V10, P1206, DOI 10.1038/sj.gt.3301979; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d; Mo XQ, 2008, BIOPHYS J, V94, P1807, DOI 10.1529/biophysj.107.118299; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Ouali M, 2007, MOL MEMBR BIOL, V24, P225, DOI 10.1080/09687860601108911; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; Sanders CR, 1998, STRUCT FOLD DES, V6, P1227, DOI 10.1016/S0969-2126(98)00123-3; Santoso S, 2002, NANO LETT, V2, P687, DOI 10.1021/n1025563i; Shen XC, 2006, J NANOSCI NANOTECHNO, V6, P837, DOI 10.1166/jnn.2006.126; Tanaka T, 2008, EUR J IMMUNOL, V38, P1351, DOI 10.1002/eji.200737998; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; Thomas CE, 2001, HUM GENE THER, V12, P839, DOI 10.1089/104303401750148829; Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P1972, DOI 10.1073/pnas.0435906100; van Hell AJ, 2007, BIOMACROMOLECULES, V8, P2753, DOI 10.1021/bm0704267; Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599; Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002; Zhang JX, 2009, RECENT PAT NANOTECH, V3, P225, DOI 10.2174/187221009789177803; Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c	43	69	69	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45374	10.1371/journal.pone.0045374	http://dx.doi.org/10.1371/journal.pone.0045374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028970	Green Published, gold			2022-12-27	WOS:000311313900130
J	Young, MT; Brusatte, SL; de Andrade, MB; Desojo, JB; Beatty, BL; Steel, L; Fernandez, MS; Sakamoto, M; Ruiz-Omenaca, JI; Schoch, RR				Young, Mark T.; Brusatte, Stephen L.; de Andrade, Marco Brandalise; Desojo, Julia B.; Beatty, Brian L.; Steel, Lorna; Fernandez, Marta S.; Sakamoto, Manabu; Ignacio Ruiz-Omenaca, Jose; Schoch, Rainer R.			The Cranial Osteology and Feeding Ecology of the Metriorhynchid Crocodylomorph Genera Dakosaurus and Plesiosuchus from the Late Jurassic of Europe	PLOS ONE			English	Article							FUNCTIONAL-MORPHOLOGY; ANTORBITAL FENESTRA; PLIOSAUR REPTILIA; SALT-GLANDS; THALATTOSUCHIA; EVOLUTION; MESOEUCROCODYLIA; CROCODYLIFORM; MECHANICS; GEOSAURUS	Background: Dakosaurus and Plesiosuchus are characteristic genera of aquatic, large-bodied, macrophagous metriorhynchid crocodylomorphs. Recent studies show that these genera were apex predators in marine ecosystems during the latter part of the Late Jurassic, with robust skulls and strong bite forces optimized for feeding on large prey. Methodology/Principal Findings: Here we present comprehensive osteological descriptions and systematic revisions of the type species of both genera, and in doing so we resurrect the genus Plesiosuchus for the species Dakosaurus manselii. Both species are diagnosed with numerous autapomorphies. Dakosaurus maximus has premaxillary 'lateral plates'; strongly ornamented maxillae; macroziphodont dentition; tightly fitting tooth-to-tooth occlusion; and extensive macrowear on the mesial and distal margins. Plesiosuchus manselii is distinct in having: non-amblygnathous rostrum; long mandibular symphysis; microziphodont teeth; tooth-crown apices that lack spalled surfaces or breaks; and no evidence for occlusal wear facets. Our phylogenetic analysis finds Dakosaurus maximus to be the sister taxon of the South American Dakosaurus andiniensis, and Plesiosuchus manselii in a polytomy at the base of Geosaurini (the subclade of macrophagous metriorhynchids that includes Dakosaurus, Geosaurus and Torvoneustes). Conclusions/Significance: The sympatry of Dakosaurus and Plesiosuchus is curiously similar to North Atlantic killer whales, which have one larger 'type' that lacks tooth-crown breakage being sympatric with a smaller 'type' that has extensive crown breakage. Assuming this morphofunctional complex is indicative of diet, then Plesiosuchus would be a specialist feeding on other marine reptiles while Dakosaurus would be a generalist and possible suction-feeder. This hypothesis is supported by Plesiosuchus manselii having a very large optimum gape (gape at which multiple teeth come into contact with a prey-item), while Dakosaurus maximus possesses craniomandibular characteristics observed in extant suction-feeding odontocetes: shortened tooth-row, amblygnathous rostrum and a very short mandibular symphysis. We hypothesise that trophic specialisation enabled these two large-bodied species to coexist in the same ecosystem.	[Young, Mark T.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Brusatte, Stephen L.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Brusatte, Stephen L.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA; [de Andrade, Marco Brandalise] Univ Fed Rio Grande do Sul, Dept Paleontol & Estratig, Porto Alegre, RS, Brazil; [Desojo, Julia B.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleontol, Buenos Aires, DF, Argentina; [Beatty, Brian L.] New York Coll Osteopath Med, Dept Anat, Old Westbury, NY USA; [Steel, Lorna] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Fernandez, Marta S.] Museo La Plata, Dept Paleontol Vertebrados, La Plata, Argentina; [Sakamoto, Manabu] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Ignacio Ruiz-Omenaca, Jose] Museo Juras Asturias MUJA, Colunga, Spain; [Ignacio Ruiz-Omenaca, Jose] Univ Oviedo, Dept Geol, E-33005 Oviedo, Spain; [Schoch, Rainer R.] Staatliches Museum Nat Kunde, Stuttgart, Germany	University of Edinburgh; American Museum of Natural History (AMNH); Columbia University; Universidade Federal do Rio Grande do Sul; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); New York Institute Technology; Natural History Museum London; National University of La Plata; Museo La Plata; University of Bristol; University of Oviedo	Young, MT (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland.	zoologika@gmail.com	Andrade, Marco Brandalise de/D-2708-2014; Young, Mark T/P-3469-2014; Ruiz-Omeñaca, José Ignacio/D-6107-2011; Beatty, Brian/ABE-6078-2021; Brusatte, Stephen/O-9663-2014; Sakamoto, Manabu/F-6690-2010	Andrade, Marco Brandalise de/0000-0002-3452-801X; Young, Mark T/0000-0002-7263-6505; Ruiz-Omeñaca, José Ignacio/0000-0001-8791-9287; Beatty, Brian/0000-0002-5464-0041; Brusatte, Stephen/0000-0001-7525-7319; Fernandez, Marta/0000-0001-6935-7575; Desojo, Julia Brenda/0000-0002-2739-3276; Sakamoto, Manabu/0000-0001-6447-406X				ABLER WL, 1992, PALEOBIOLOGY, V18, P161, DOI 10.1017/S0094837300013956; Ainsworth C., 2001, FISH CENT RES REP, V9, P271; AMBAYRAC H, 1913, COMPTE RENDU ASS FRA, V42, P97; Andrews C. W., 1913, DESCRIPTIVE CATALOGU; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; Benton M.J., 1995, FOSSIL REPTILES GREA; Benton MJ, 2002, ZOOL J LINN SOC-LOND, V136, P25, DOI 10.1046/j.1096-3642.2002.00024.x; Bonaparte JF., 1991, REV MUSEO ARGENTINO, V4, P31; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brown D.S., 1981, Bulletin of the British Museum (Natural History) Geology, V35, P253; Buchy M.-C., 2007, THESIS U KARLSRUHE; Buchy MC, 2008, NEUES JAHRB GEOL P-A, V249, P1, DOI 10.1127/0077-7749/2008/0249-0001; Buchy MC, 2007, B SOC GEOL FR, V178, P391, DOI 10.2113/gssgfbull.178.5.391; Buffetaut E., 1982, Bulletin Trimestriel de la Societe Geologique de Normandie et des Amis du Museum du Havre, V69, P17; Buffetaut E, 1982, N JB GEOL PALAONTOL, V8, P469; Carvalho I.S., 1999, GEOLOGIA COLOMBIANA, V24, P83, DOI DOI 10.15446/GC; Cau A, 2011, GONDWANA RES, V19, P550, DOI 10.1016/j.gr.2010.07.007; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; Cuvier G., 1824, OSSEMENS FOSSILES 2, V5, P143; De Andrade MB, 2010, J VERTEBR PALEONTOL, V30, P1451, DOI 10.1080/02724634.2010.501442; Debelmas J., 1956, TRAVAUX LAB GEOLOGIE, V33, P89; DEBELMAS JACQUES, 1952, TRAV LAB GEOL FAC SCI UNIV GRENOBLE, V29, P101; Delair JB, 1960, P DORSET NATURAL HIS, V81, P59; Delfino M, 2006, GEOBIOS-LYON, V39, P346, DOI 10.1016/j.geobios.2005.01.001; Eudes-Deslongchamps E., 1867, NOTES PALEONTOLOGIQU, P320; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez M, 2000, LETHAIA, V33, P269; Fernandez M, 2008, NATURWISSENSCHAFTEN, V95, P79, DOI 10.1007/s00114-007-0296-1; Fernandez MS, 2011, J VERTEBR PALEONTOL, V31, P369, DOI 10.1080/02724634.2011.550361; Fernandez MS, 2009, J VERTEBR PALEONTOL, V29, P702, DOI 10.1671/039.029.0323; Fitzgerald EMG, 2012, BIOL LETTERS, V8, P94, DOI 10.1098/rsbl.2011.0690; Fitzinger LI, 1843, SYSTEMA REPTILIUM, P20; Foote AD, 2009, MOL ECOL, V18, P5207, DOI 10.1111/j.1365-294X.2009.04407.x; Ford JKB, 2011, AQUAT BIOL, V11, P213, DOI 10.3354/ab00307; FORDYCE RE, 1982, NEW ZEAL J ZOOL, V9, P419; Fraas E., 1902, PALAEONTOGRAPHICA, V49, P1; Fraas E, 1901, JAHRESHEFTE VEREINS, V57, P409; FRAZZETTA TH, 1988, ZOOMORPHOLOGY, V108, P93, DOI 10.1007/BF00539785; Gasparini Z, 2006, SCIENCE, V311, P70, DOI 10.1126/science.1120803; Gasparini Z, 1976, ACT 1 C GEOL CHIL, V1, pC1; Gasparini Z., 2008, REV GEOL CHILE, V35, P335; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Grange DR, 1996, PALAEONTOLOGY, V39, P497; Grubich JR, 2008, ZOOLOGY, V111, P16, DOI 10.1016/j.zool.2007.05.003; Hay O.P., 1930, 2 BIBLIO CATALOGUE F, V2; Holliday CM, 2009, J VERTEBR PALEONTOL, V29, P715, DOI 10.1671/039.029.0330; Hua S, 2000, GEOBIOS-LYON, V33, P467, DOI 10.1016/S0016-6995(00)80080-7; HUA S, 1993, CR ACAD SCI II, V317, P851; Hua Stephane, 1999, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V252, P141; Huene FV, 1925, ECLOGAE GEOL HELV, V19, P584; Hulke J.W., 1870, Q J GEOL SOC LOND, V26, P167; Hulke J.W., 1869, Q J GEOL SOC LOND, V25, P390, DOI DOI 10.1144/GSL.JGS.1869.025.01-02.67; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Karl Hans-Volker, 2006, Studia Geologica Salmanticensia, V42, P49; Leeds E. T., 1908, Q J GEOL SOC LOND, V64, P345; Lepage Yves, 2008, Bulletin de la Societe Geologique de Normandie et des Amis du Museum du Havre, V95, P5; Lydekk er R, 1890, Q J GEOLOGICAL SOC L, V46, P284; LYDEKKER R, 1889, Q J GEOL SOC LOND, V45, P41, DOI DOI 10.1144/GSL.JGS.1889.045.01-04.04; Lydekker R, 1888, CATALOGUE FOSSIL REP; Leardi JM, 2012, J VERTEBR PALEONTOL, V32, P490, DOI 10.1080/02724634.2012.639421; Mason JW, 1869, Q J GEOLOGICAL SOC, V25, P218; McGowan C, 1997, J VERTEBR PALEONTOL, V17, P428, DOI 10.1080/02724634.1997.10010986; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Nesbitt SJ, 2012, ANATOMY PHYLOGENY PA; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Noe LF, 2004, P GEOLOGIST ASSOC, V115, P13, DOI 10.1016/S0016-7878(04)80031-2; Noe LF, 2003, GEOL MAG, V140, P479, DOI 10.1017/S0016756803007829; Ochev V.G, 1981, PRIRODA, V1981, P103; Olsen PE, 2000, J VERTEBR PALEONTOL, V20, P633, DOI 10.1671/0272-4634(2000)020[0633:FROERA]2.0.CO;2; Ortega F, 2000, J VERTEBR PALEONTOL, V20, P57, DOI 10.1671/0272-4634(2000)020[0057:ANSOAC]2.0.CO;2; Owen R., 1884, Q J GEOL SOC LOND, V40, P153; Owen R., 1869, MONOGRAPH REPTILIA K, VIII; Owen R, 1849, HIST BRIT FOSSIL REP, VIII; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Owen R., 1840, REPORT BRIT ASS ADV, V9, P43; Pierce SE, 2009, J ANAT, V215, P555, DOI 10.1111/j.1469-7580.2009.01137.x; Pierce SE, 2009, PALAEONTOLOGY, V52, P1057, DOI 10.1111/j.1475-4983.2009.00904.x; PIVETEAU J, 1928, ANN PALEONTOL, V17, P30; Plieninger T, 1849, WURTT NATWISS JAHRES, V5, P252; Plieninger T, 1846, WURTTEMBERGISCHE NAT, V2, p[148, 129]; Pol D, 2009, J SYST PALAEONTOL, V7, P163, DOI 10.1017/S1477201908002605; Prasad Guntupalli V.R., 2002, Annales de Paleontologie, V88, P19, DOI 10.1016/S0753-3969(02)01036-4; Quenstedt F. A., 1843, FLOTZGEBIRGE WURTTEM; Quenstedt F.A., 1858, JURA; Quenstedt F.A., 1852, HDB PETREFAKTENKUNDE; Quenstedt F.A., 1885, HDB PETREFAKTENKUNDE; Quenstedt F.A., 1856, SONST JETZT POPULARE; Rayfield EJ, 2008, PALEOBIOLOGY, V34, P494, DOI 10.1666/07006.1; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Ruiz-Omenaca JI, 2010, COMM 5 C JUR ESP, P193; Saint-Hilaire Etienne Geoffroy, 1825, MEMOIRES MUSEUM DHIS, V12, P97; Sassoon J, 2012, PALAEONTOLOGY, V55, P743, DOI 10.1111/j.1475-4983.2012.01151.x; Sauvage H-E, 1873, B SOC GEOL FR, V3, P380; Sauvage H-E, 1871, CR HEBD ACAD SCI, V73, P141; Schlosser M, 1881, PALAEONTOGRAPHICA, V28, P109; Schubert BW, 2005, ACTA PALAEONTOL POL, V50, P93; SEELEY H. G., 1869, INDEX FOSSIL REMAINS; Spitz J, 2011, DEEP-SEA RES PT I, V58, P273, DOI 10.1016/j.dsr.2010.12.009; Steel R., 1973, HDB PALAOHERPETOL 16; TARLO L. B., 1960, BULL BRIT MUS [NAT HIST]GEOL, V4, P145; TAYLOR MA, 1993, PHILOS T ROY SOC B, V341, P399, DOI 10.1098/rstb.1993.0124; Verwaijen D, 2002, FUNCT ECOL, V16, P842, DOI 10.1046/j.1365-2435.2002.00696.x; Vignaud P., 1996, CR HEBD ACAD SCI, V2, P245; Vignaud P, 1995, THESIS U POITIERS PO; Vignaud Patrick, 1997, Palaeovertebrata (Montpellier), V26, P35; von Sommerring S.T., 1816, DENKSCHRIFTEN K NIGL, V6, P37; Wagner A, 1858, K BAYER AKAD WISS MP, V8, P415; Wagner A, 1853, K BAYER AKAD WISS MP, V7, P239; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; Wenz, 1968, ANN PALEONTOL, V54, P148; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Wilkinson LE, 2008, PALAEONTOLOGY, V51, P1307, DOI 10.1111/j.1475-4983.2008.00818.x; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Woodward A. S., 1885, Geological Magazine, V(3), P496; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y; Young MT, 2012, ANAT REC, V295, P1147, DOI 10.1002/ar.22491; Young MT, 2011, ZOOL J LINN SOC-LOND, V163, P1199, DOI 10.1111/j.1096-3642.2011.00734.x; Young MT, 2011, BIOL LETTERS, V7, P913, DOI 10.1098/rsbl.2011.0357; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Young MT, 2009, ZOOL J LINN SOC-LOND, V157, P551, DOI 10.1111/j.1096-3642.2009.00536.x; Young MT, 2012, J SYST PALA IN PRESS; Zittel K. von, 1887, HDB PALAONTOLOGIE, V3	122	97	100	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44985	10.1371/journal.pone.0044985	http://dx.doi.org/10.1371/journal.pone.0044985			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028723	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900063
J	Kalari, S; Moolky, N; Pendyala, S; Berdyshev, EV; Rolle, C; Kanteti, R; Kanteti, A; Ma, WL; He, DH; Husain, AN; Kindler, HL; Kanteti, P; Salgia, R; Natarajan, V				Kalari, Satish; Moolky, Nagabhushan; Pendyala, Srikanth; Berdyshev, Evgeny V.; Rolle, Cleo; Kanteti, Rajani; Kanteti, Archana; Ma, Wenli; He, Donghong; Husain, Aliya N.; Kindler, Hedy L.; Kanteti, Prasad; Salgia, Ravi; Natarajan, Viswanathan			Sphingosine Kinase 1 Is Required for Mesothelioma Cell Proliferation: Role of Histone Acetylation	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; DEACETYLASE INHIBITORS; POOR SURVIVAL; CANCER; 1-PHOSPHATE; EXPRESSION; PROGRESSION; ACTIVATION; GROWTH	Background: Malignant pleural mesothelioma (MPM) is a devastating disease with an overall poor prognosis. Despite the recent advances in targeted molecular therapies, there is a clear and urgent need for the identification of novel mesothelioma targets for the development of highly efficacious therapeutics. Methodology/Principal Findings: In this study, we report that the expression of Sphingosine Kinase 1 (SphK1) protein was preferentially elevated in MPM tumor tissues (49 epithelioid and 13 sarcomatoid) compared to normal tissue (n = 13). In addition, we also observed significantly elevated levels of SphK1 and SphK2 mRNA and SphK1 protein expression in MPM cell lines such as H2691, H513 and H2461 compared to the non-malignant mesothelial Met5 cells. The underlying mechanism appears to be mediated by SphK1 induced upregulation of select gene transcription programs such as that of CBP/p300 and PCAF, two histone acetyl transferases (HAT), and the down regulation of cell cycle dependent kinase inhibitor genes such as p27Kip1 and p21Cip1. In addition, using immunoprecipitates of anti-acetylated histone antibody from SphK inhibitor, SphK-I2 treated Met5A and H2691 cell lysates, we also showed activation of other cell proliferation related genes, such as Top2A (DNA replication), AKB (chromosome remodeling and mitotic spindle formation), and suppression of p21 CIP1 and p27KIP1. The CDK2, HAT1 and MYST2 were, however, unaffected in the above study. Using SphK inhibitor and specific siRNA targeting either SphK1 or SphK2, we also unequivocally established that SphK1, but not SphK2, promotes H2691 mesothelioma cell proliferation. Using a multi-walled carbon nanotubes induced peritoneal mesothelioma mouse model, we showed that the SphK1-/- null mice exhibited significantly less inflammation and granulamatous nodules compared to their wild type counterparts. Conclusions/Significance: The lipid kinase SphK1 plays a positive and essential role in the growth and development of malignant mesothelioma and is therefore a likely therapeutic target.	[Moolky, Nagabhushan; Pendyala, Srikanth; Kanteti, Archana; Ma, Wenli; He, Donghong; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60680 USA; [Kalari, Satish] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA USA; [Moolky, Nagabhushan; Pendyala, Srikanth; Berdyshev, Evgeny V.; Kanteti, Archana; Ma, Wenli; He, Donghong; Kanteti, Prasad; Natarajan, Viswanathan] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA; [Rolle, Cleo; Kanteti, Rajani; Kindler, Hedy L.; Salgia, Ravi] Univ Illinois, Hematol Oncol Sect, Pritzker Sch Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; City of Hope; Beckman Research Institute of City of Hope; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Natarajan, V (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60680 USA.	visnatar@uic.edu			National Institutes of Health (NIH); University of Illinois at Chicago (UIC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098050] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Chicago (UIC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH), start up funds, and the University of Illinois at Chicago (UIC). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Billich A, 2008, SUBCELL BIOCH, V49, P413; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Bonnaud S, 2007, CANCER RES, V67, P1803, DOI 10.1158/0008-5472.CAN-06-2802; Bots M, 2009, CLIN CANCER RES, V15, P3970, DOI 10.1158/1078-0432.CCR-08-2786; Campbell NP, 2011, SEMIN RESP CRIT CARE, V32, P102, DOI 10.1055/s-0031-1272874; Cuvillier O, 2008, EXPERT OPIN THER TAR, V12, P1009, DOI [10.1517/14728222.12.8.1009, 10.1517/14728222.12.8.1009 ]; Cuvillier O, 2007, ANTI-CANCER DRUG, V18, P105, DOI 10.1097/CAD.0b013e328011334d; Desdouets C, 2000, PATHOL BIOL, V48, P203; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guan HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019946; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Huwiler A, 2007, CRIT REV ONCOL HEMAT, V63, P150, DOI 10.1016/j.critrevonc.2007.04.010; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kwon YG, 2001, J BIOL CHEM, V276, P10627, DOI 10.1074/jbc.M011449200; Le Scolan E, 2005, BLOOD, V106, P1808, DOI 10.1182/blood-2004-12-4832; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Li W, 2009, CLIN CANCER RES, V15, P1393, DOI 10.1158/1078-0432.CCR-08-1158; Limaye V, 2005, BLOOD, V105, P3169, DOI 10.1182/blood-2004-02-0452; Liu GL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-495; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Loganathan Sivakumar, 2011, J Carcinog, V10, P4, DOI 10.4103/1477-3163.77274; Mackinnon AC, 2011, J CLIN PATHOL, V64, P16, DOI 10.1136/jcp.2010.075853; Malavaud B, 2010, EUR J CANCER, V46, P3417, DOI 10.1016/j.ejca.2010.07.053; Martin JL, 2009, J BIOL CHEM, V284, P25542, DOI 10.1074/jbc.M109.007120; Moriue T, 2008, BIOCHEM BIOPH RES CO, V368, P852, DOI 10.1016/j.bbrc.2008.01.155; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Paik PK, 2010, J THORAC ONCOL, V5, P275, DOI 10.1097/JTO.0b013e3181c5e366; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pogribny IP, 2007, J NUTR, V137, p216S, DOI 10.1093/jn/137.1.216S; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Rapizzi E, 2007, BIOCHEM BIOPH RES CO, V353, P268, DOI 10.1016/j.bbrc.2006.12.010; Riccio A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3103pe1; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Shirai K, 2011, CANCER PREV RES, V4, P454, DOI 10.1158/1940-6207.CAPR-10-0299; Sinha UK, 2011, HEAD NECK-J SCI SPEC, V33, P178, DOI 10.1002/hed.21418; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; TURNER BM, 1991, J CELL SCI, V99, P13; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Vivo C, 2003, BRIT J CANCER, V88, P388, DOI 10.1038/sj.bjc.6600736; WALDMAN T, 1995, CANCER RES, V55, P5187; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Young N, 2009, MOL CANCER RES, V7, P23, DOI 10.1158/1541-7786.MCR-08-0061; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200; Zheng DM, 2006, HEPATOLOGY, V44, P1278, DOI 10.1002/hep.21384	60	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45330	10.1371/journal.pone.0045330	http://dx.doi.org/10.1371/journal.pone.0045330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028939	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800052
J	Bennett, BD; Xiong, Q; Mukherjee, S; Furey, TS				Bennett, Brian D.; Xiong, Qing; Mukherjee, Sayan; Furey, Terrence S.			A Predictive Framework for Integrating Disparate Genomic Data Types Using Sample-Specific Gene Set Enrichment Analysis and Multi-Task Learning	PLOS ONE			English	Article							DNA COPY NUMBER; WIDE EXPRESSION PROFILES; BREAST-CANCER; MICROARRAY DATA; COLORECTAL CANCERS; ANALYSIS REVEALS; ASSOCIATION; PATHWAY; POLYMORPHISMS; GLIOBLASTOMA	Understanding the root molecular and genetic causes driving complex traits is a fundamental challenge in genomics and genetics. Numerous studies have used variation in gene expression to understand complex traits, but the underlying genomic variation that contributes to these expression changes is not well understood. In this study, we developed a framework to integrate gene expression and genotype data to identify biological differences between samples from opposing complex trait classes that are driven by expression changes and genotypic variation. This framework utilizes pathway analysis and multi-task learning to build a predictive model and discover pathways relevant to the complex trait of interest. We simulated expression and genotype data to test the predictive ability of our framework and to measure how well it uncovered pathways with genes both differentially expressed and genetically associated with a complex trait. We found that the predictive performance of the multi-task model was comparable to other similar methods. Also, methods like multi-task learning that considered enrichment analysis scores from both data sets found pathways with both genetic and expression differences related to the phenotype. We used our framework to analyze differences between estrogen receptor (ER) positive and negative breast cancer samples. An analysis of the top 15 gene sets from the multi-task model showed they were all related to estrogen, steroids, cell signaling, or the cell cycle. Although our study suggests that multi-task learning does not enhance predictive accuracy, the models generated by our framework do provide valuable biological pathway knowledge for complex traits.	[Bennett, Brian D.; Mukherjee, Sayan] Duke Univ, Inst Genome Sci & Policy, Dept Stat Sci, Durham, NC 27708 USA; [Bennett, Brian D.; Mukherjee, Sayan] Duke Univ, Dept Comp Sci, Inst Genome Sci & Policy, Durham, NC 27706 USA; [Bennett, Brian D.; Mukherjee, Sayan] Duke Univ, Dept Math, Inst Genome Sci & Policy, Durham, NC 27706 USA; [Bennett, Brian D.; Xiong, Qing; Furey, Terrence S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biol, Dept Genet, Chapel Hill, NC 27599 USA; [Bennett, Brian D.; Xiong, Qing; Furey, Terrence S.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bennett, BD (corresponding author), Duke Univ, Inst Genome Sci & Policy, Dept Stat Sci, Durham, NC 27708 USA.	sayan@stat.duke.edu; tsfurey@email.unc.edu		Furey, Terry/0000-0001-5546-9672; Mukherjee, Sayan/0000-0002-6715-3920; bennett, brian/0000-0002-0766-3195; Xiong, Qing/0000-0002-6069-2331	National Science Foundation [NSF DMS-1045153, NSF CCF-1049290]; Air Force Office of Scientific Research [AFOSR FA9550-10-1-0436]; University Cancer Research Fund at The University of North Carolina at Chapel Hill	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); University Cancer Research Fund at The University of North Carolina at Chapel Hill	The University Cancer Research Fund at The University of North Carolina at Chapel Hill (http://unclineberger.org/ucrf), National Science Foundation grants NSF DMS-1045153 and NSF CCF-1049290 (http://www.nsf.gov/), and the Air Force Office of Scientific Research grant AFOSR FA9550-10-1-0436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker B., 2003, J MACH LEARN RES, V4, P83, DOI DOI 10.1162/153244304322765658; Bild A, 2005, P NATL ACAD SCI USA, V102, P15278, DOI 10.1073/pnas.0507477102; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Chari R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-422; Chen J, 2005, CANCER RES, V65, P1606, DOI 10.1158/0008-5472.CAN-04-2630; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Drell TL, 2003, BREAST CANCER RES TR, V80, P63, DOI 10.1023/A:1024491219366; Edelman E, 2006, BIOINFORMATICS, V22, pE108, DOI 10.1093/bioinformatics/btl231; Evgeniou T, 2004, P 10 ACM SIGKDD INT, V1, P109; FURR BJA, 1984, PHARMACOL THERAPEUT, V25, P127, DOI 10.1016/0163-7258(84)90043-3; Glinsky GV, 2006, CELL CYCLE, V5, P2613, DOI 10.4161/cc.5.22.3498; Hawthorn L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-460; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Lee H, 2008, BIOINFORMATICS, V24, P889, DOI 10.1093/bioinformatics/btn034; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Liu FH, 2006, CANCER RES, V66, P10815, DOI 10.1158/0008-5472.CAN-06-1408; LOCHTER A, 1995, SEMIN CANCER BIOL, V6, P165, DOI 10.1006/scbi.1995.0017; Maglietta R, 2007, BIOINFORMATICS, V23, P2063, DOI 10.1093/bioinformatics/btm289; Maglietta R, 2010, J BIOMED INFORM, V43, P397, DOI 10.1016/j.jbi.2009.09.005; Menezes RX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-203; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Newton MA, 2007, ANN APPL STAT, V1, P85, DOI 10.1214/07-AOAS104; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; Osborne CK, 1998, BREAST CANCER RES TR, V51, P227, DOI 10.1023/A:1006132427948; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scholkopf B, 1999, IEEE T NEURAL NETWOR, V10, P1000, DOI 10.1109/72.788641; Shatalova EG, 2005, BREAST CANCER RES, V7, pR909, DOI 10.1186/bcr1318; Stoica GE, 2003, ONCOGENE, V22, P7998, DOI 10.1038/sj.onc.1206769; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TARTTER PI, 1981, CANCER, V47, P2222, DOI 10.1002/1097-0142(19810501)47:9<2222::AID-CNCR2820470919>3.0.CO;2-5; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Vapnik V., 1998, STAT LEARNING THEORY; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiong Q, 2012, GENOME RES, V22, P386, DOI 10.1101/gr.124370.111	41	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44635	10.1371/journal.pone.0044635	http://dx.doi.org/10.1371/journal.pone.0044635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028573	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700027
J	Cheng, JW; Cheng, SW; Gao, LD; Lu, GC; Wei, RL				Cheng, Jin-Wei; Cheng, Shi-Wei; Gao, Lian-Di; Lu, Guo-Cai; Wei, Rui-Li			Intraocular Pressure-Lowering Effects of Commonly Used Fixed-Combination Drugs with Timolol: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							OPEN-ANGLE GLAUCOMA; 0.5-PERCENT OPHTHALMIC SOLUTION; RANDOMIZED CLINICAL-TRIALS; BRINZOLAMIDE 1-PERCENT/TIMOLOL 0.5-PERCENT; DORZOLAMIDE 2-PERCENT/TIMOLOL 0.5-PERCENT; MALEATE 0.5-PERCENT/DORZOLAMIDE 2-PERCENT; OCULAR HYPERTENSION; INDIVIDUAL COMPONENTS; LATANOPROST-TIMOLOL; 24-HOUR CONTROL	Background: The first goal of medical therapy in glaucoma is to reduce intraocular pressure (IOP), and the fixed-combination medications are needed to achieve sufficiently low target IOP. The aim of this systematic review and meta-analysis is to evaluate IOP-lowering effect of the commonly used fixed-combination drugs containing 0.5% timolol. Methods: Pertinent publications were identified through systematic searches. Over 85% of the patients had to be diagnosed with primary open-angle glaucoma (POAG) or ocular hypertension (OHT). Forty-one randomized clinical trials were included in the meta-analysis. The main efficacy measures were the absolute and relative values of mean diurnal IOP reduction, and the highest and lowest IOP reductions on the diurnal IOP curve. The pooled 1- to 3-month IOP-lowering effects after a medicine-free washout period was calculated by performing meta-analysis using the random effects model, and relative treatment effects among different fixed combinations were assessed using a mixed-effects meta-regression model. Results: The relative reductions for mean diurnal IOP were 34.9% for travoprost/ timolol, 34.3% for bimatoprost/timolol, 33.9% for latanoprost/timolol, 32.7% for brinzolamide/timolol, 29.9% for dorzolamide/timolol, and 28.1% for brimonidine/timolol. For the highest IOP decrease, relative reductions ranged from 31.3% for dorzolamide/timolol to 35.5% for travoprost/ timolol; for the lowest IOP decrease, those varied from 25.9% for dorzolamide/timolol to 33.1% for bimatoprost/timolol. Both latanoprost/timolol and travoprost/ timolol were more effective in lowering mean diurnal IOP than brimonidine/timolol (WMD: 5.9 and 7.0) and dorzolamide/timolol (WMD: 3.8 and 3.3). Conclusions: All six commonly used fixed-combination drugs containing timolol can effectively lower IOP in patients with POAG and OHT, and both latanoprost/timolol and travoprost/ timolol might achieve better IOP-lowering effects among the six fixed-combination agents.	[Cheng, Jin-Wei; Gao, Lian-Di; Wei, Rui-Li] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Cheng, Shi-Wei] Ludong Univ, Sch Life Sci, Yantai, Peoples R China; [Lu, Guo-Cai] Second Mil Med Univ, Inst Basic Med Sci, Ctr New Drug Evaluat, Shanghai, Peoples R China	Naval Medical University; Ludong University; Naval Medical University	Cheng, JW (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Ophthalmol, Shanghai, Peoples R China.	newdrug@smmu.edu.cn; ruiliwei@gmail.com		Wei, Ruili/0000-0003-2696-6586	Shanghai Rising-Star Program; Shanghai Municipal Natural Science Foundation [10ZR1439300]; National Natural Science Foundation of China [81000374, 81170874]	Shanghai Rising-Star Program; Shanghai Municipal Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shanghai Rising-Star Program, Shanghai Municipal Natural Science Foundation (Grant No. 10ZR1439300) and the National Natural Science Foundation of China (Grant No. 81000374 and 81170874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcieri ES, 2007, CURR MED RES OPIN, V23, P683, DOI 10.1185/030079907X178694; Barnebey HS, 2005, AM J OPHTHALMOL, V140, P1, DOI 10.1016/j.ajo.2005.02.043; Boyle JE, 1998, OPHTHALMOLOGY, V105, P1945, DOI 10.1016/S0161-6420(98)91046-6; Brandt JD, 2008, J GLAUCOMA, V17, P211, DOI 10.1097/IJG.0b013e3181507313; Day DG, 2005, EUR J OPHTHALMOL, V15, P336, DOI 10.1177/112067210501500304; Denis P, 2006, EUR J OPHTHALMOL, V16, P407, DOI 10.1177/112067210601600308; Diestelhorst M, 2006, OPHTHALMOLOGY, V113, P70, DOI 10.1016/j.ophtha.2005.06.027; Dubiner HB, 2004, CLIN THER, V26, P84, DOI 10.1016/S0149-2918(04)90008-2; Facio AC, 2009, J OCUL PHARMACOL TH, V25, P447, DOI 10.1089/jop.2009.0018; Fechtner RD, 2004, ACTA OPHTHALMOL SCAN, V82, P42, DOI 10.1046/j.1600-0420.2004.0205.x; Fechtner Robert D, 2004, Curr Opin Ophthalmol, V15, P132, DOI 10.1097/00055735-200404000-00013; Feldman RM, 2008, CURR MED RES OPIN, V24, P2403, DOI 10.1185/03007990802243366; Garcia-Sanchez J, 2004, BRIT J OPHTHALMOL, V88, P877, DOI 10.1136/bjo.2003.029330; Glasziou PP, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-23; Hatanaka M, 2008, J GLAUCOMA, V17, P674, DOI 10.1097/IJG.0b013e318168f008; Higginbotham EJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P165, DOI 10.1001/archophthalmol.2009.384; Hughes BA, 2005, J GLAUCOMA, V14, P392, DOI 10.1097/01.ijg.0000176935.08392.14; Kaback M, 2008, OPHTHALMOLOGY, V115, P1728, DOI 10.1016/j.ophtha.2008.04.011; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Rigollet JPK, 2011, CLIN OPHTHALMOL, V5, P187, DOI 10.2147/OPTH.S16666; Khouri AS, 2007, DRUG AGING, V24, P1007, DOI 10.2165/00002512-200724120-00004; Konstas AGP, 2008, EYE, V22, P1391, DOI 10.1038/sj.eye.6702906; Konstas AGP, 2009, CURR EYE RES, V34, P369, DOI 10.1080/02713680902850075; Konstas AGP, 2009, BRIT J OPHTHALMOL, V93, P481, DOI 10.1136/bjo.2008.147322; Konstas AGP, 2005, ARCH OPHTHALMOL-CHIC, V123, P898, DOI 10.1001/archopht.123.7.898; Konstas AGP, 2003, OPHTHALMOLOGY, V110, P1357, DOI 10.1016/S0161-6420(03)00404-4; Konstas AGP, 2008, OPHTHALMOLOGY, V115, P99, DOI 10.1016/j.ophtha.2007.03.007; Konstas AGP, 2006, ARCH OPHTHALMOL-CHIC, V124, P1553, DOI 10.1001/archopht.124.11.1553; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Magacho L, 2006, OPHTHALMOLOGY, V113, P442, DOI 10.1016/j.ophtha.2005.11.011; Manni G, 2009, J GLAUCOMA, V18, P293, DOI 10.1097/IJG.0b013e31818fb434; Martinez-de-la-Casa JM, 2004, CURR MED RES OPIN, V20, P1333, DOI 10.1185/030079904125004529; Miglior S, 2010, EYE, V24, P1234, DOI 10.1038/eye.2009.307; Nixon DR, 2009, CURR MED RES OPIN, V25, P1645, DOI 10.1185/03007990902994041; Orzalesi N, 2003, ARCH OPHTHALMOL-CHIC, V121, P453, DOI 10.1001/archopht.121.4.453; Ozturk F, 2007, ACTA OPHTHALMOL SCAN, V85, P80, DOI 10.1111/j.1600-0420.2006.00754.x; Palmberg P, 2010, EUR J OPHTHALMOL, V20, P708, DOI 10.1177/112067211002000411; Quaranta L, 2008, INVEST OPHTH VIS SCI, V49, P4226, DOI 10.1167/iovs.08-1744; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Schuman JS, 2005, AM J OPHTHALMOL, V140, P242, DOI 10.1016/j.ajo.2005.02.058; Sharpe ED, 2008, J OCUL PHARMACOL TH, V24, P408, DOI 10.1089/jop.2008.0003; Sherwood MB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1230, DOI 10.1001/archopht.124.9.1230; Shin DH, 2004, OPHTHALMOLOGY, V111, P276, DOI 10.1016/j.ophtha.2003.05.019; Stewart WC, 2004, EYE, V18, P990, DOI 10.1038/sj.eye.6701375; Susanna R, 2004, CLIN THER, V26, P755; Suzuki ER, 2006, CURR MED RES OPIN, V22, P1799, DOI 10.1185/030079906X121020; Teus MA, 2009, CLIN OPHTHALMOL, V3, P629; van der Valk R, 2005, OPHTHALMOLOGY, V112, P1177, DOI 10.1016/j.ophtha.2005.01.042; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Webers CAB, 2007, OPHTHALMOLOGY, V114, P40, DOI 10.1016/j.ophtha.2006.07.018; Webers CAB, 2010, OPHTHALMOLOGY, V117, P2067, DOI 10.1016/j.ophtha.2010.03.024; Zabriskie N, 2003, ADV THER, V20, P92, DOI 10.1007/BF02850256	52	53	58	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45079	10.1371/journal.pone.0045079	http://dx.doi.org/10.1371/journal.pone.0045079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028770	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700084
J	Niedermeyer, THJ; Strohalm, M				Niedermeyer, Timo H. J.; Strohalm, Martin			mMass as a Software Tool for the Annotation of Cyclic Peptide Tandem Mass Spectra	PLOS ONE			English	Article							COLLISION-INDUCED DISSOCIATION; ELECTRON-CAPTURE DISSOCIATION; SIDE-CHAIN LOSSES; FRAGMENTATION PATHWAYS; REARRANGEMENT REACTIONS; PROTONATED PEPTIDES; STRUCTURAL-CHARACTERIZATION; HEPTAPEPTIDE MICROCYSTINS; ACTIVATED DECOMPOSITION; NONRIBOSOMAL PEPTIDES	Natural or synthetic cyclic peptides often possess pronounced bioactivity. Their mass spectrometric characterization is difficult due to the predominant occurrence of non-proteinogenic monomers and the complex fragmentation patterns observed. Even though several software tools for cyclic peptide tandem mass spectra annotation have been published, these tools are still unable to annotate a majority of the signals observed in experimentally obtained mass spectra. They are thus not suitable for extensive mass spectrometric characterization of these compounds. This lack of advanced and userfriendly software tools has motivated us to extend the fragmentation module of a freely available open-source software, mMass (http://www.mmass.org), to allow for cyclic peptide tandem mass spectra annotation and interpretation. The resulting software has been tested on several cyanobacterial and other naturally occurring peptides. It has been found to be superior to other currently available tools concerning both usability and annotation extensiveness. Thus it is highly useful for accelerating the structure confirmation and elucidation of cyclic as well as linear peptides and depsipeptides.	[Niedermeyer, Timo H. J.] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Greifswald, Germany; [Niedermeyer, Timo H. J.] Cyano Biotech GmbH, Berlin, Germany; [Strohalm, Martin] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic	Ernst Moritz Arndt Universitat Greifswald; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Niedermeyer, THJ (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Greifswald, Germany.	timo.niedermeyer@uni-greifswald.de		Niedermeyer, Timo/0000-0003-1779-7899	Czech Science Foundation [P206/12/1150]; Ministry of Education, Youth and Sports of the Czech Republic [ME10013]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Czech Science Foundation (P206/12/1150), the Ministry of Education, Youth and Sports of the Czech Republic (ME10013). The funders had no role in study design, data collection and analysis, or preparation of the manuscript. No additional external funding received for this study.	Arnold Randy J, 2006, Pac Symp Biocomput, P219; Barlow CK, 2008, J MASS SPECTROM, V43, P1301, DOI 10.1002/jms.1469; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; Bleiholder C, 2008, J AM CHEM SOC, V130, P17774, DOI 10.1021/ja805074d; Bythell BJ, 2010, J PHYS CHEM B, V114, P15092, DOI 10.1021/jp108452y; Bythell BJ, 2010, J AM CHEM SOC, V132, P14766, DOI 10.1021/ja101556g; Caboche S, 2008, NUCLEIC ACIDS RES, V36, pD326, DOI 10.1093/nar/gkm792; Caboche S, 2010, J BACTERIOL, V192, P5143, DOI 10.1128/JB.00315-10; Christiansen G, 2003, J BACTERIOL, V185, P564, DOI 10.1128/JB.185.2.564-572.2003; Colinge J, 2006, J PROTEOME RES, V5, P619, DOI 10.1021/pr0504236; Cooper HJ, 2002, J AM SOC MASS SPECTR, V13, P241, DOI 10.1016/S1044-0305(01)00357-9; Deery MJ, 1997, J AM SOC MASS SPECTR, V8, P253, DOI 10.1016/S1044-0305(96)00197-3; Dittmann E, 2001, APPL MICROBIOL BIOT, V57, P467; DREYFUSS M, 1976, EUR J APPL MICROBIOL, V3, P125, DOI 10.1007/BF00928431; ECKART K, 1985, J AM CHEM SOC, V107, P6765, DOI 10.1021/ja00310a003; ECKART K, 1994, MASS SPECTROM REV, V13, P23, DOI 10.1002/mas.1280130104; Fang SP, 2000, J AM SOC MASS SPECTR, V11, P345, DOI 10.1016/S1044-0305(99)00153-1; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Frank AM, 2009, J PROTEOME RES, V8, P2226, DOI 10.1021/pr800677f; Fuchs R, 2001, INT J MASS SPECTROM, V210, P603, DOI 10.1016/S1387-3806(01)00408-0; Gehrig PM, 2004, J AM SOC MASS SPECTR, V15, P142, DOI 10.1016/j.jasms.2003.10.002; Harrison AG, 2006, J AM CHEM SOC, V128, P10364, DOI 10.1021/ja062440h; Harrison AG, 2009, MASS SPECTROM REV, V28, P640, DOI 10.1002/mas.20228; Harrison AG, 2008, J AM SOC MASS SPECTR, V19, P1776, DOI 10.1016/j.jasms.2008.06.025; Institute for Systems Biology (ISB), PROT TOOLK; Jagannath S, 2007, RAPID COMMUN MASS SP, V21, P3033, DOI 10.1002/rcm.3179; Jaspars M, 1998, Curr Opin Drug Discov Devel, V1, P77; Jegorov A, 2004, J MASS SPECTROM, V39, P949, DOI 10.1002/jms.674; Jegorov A, 2001, J MASS SPECTROM, V36, P633, DOI 10.1002/jms.163; Jia CX, 2007, J AM SOC MASS SPECTR, V18, P663, DOI 10.1016/j.jasms.2006.12.002; Kubwabo C, 2005, RAPID COMMUN MASS SP, V19, P597, DOI 10.1002/rcm.1828; Leymarie N, 2003, J AM CHEM SOC, V125, P8949, DOI 10.1021/ja028831n; Li S, 2010, PEPTIDEART; Li SJ, 2011, ANAL CHEM, V83, P790, DOI 10.1021/ac102272r; Lioe H, 2007, ANAL BIOANAL CHEM, V389, P1429, DOI 10.1007/s00216-007-1535-1; Liu WT, 2009, ANAL CHEM, V81, P4200, DOI 10.1021/ac900114t; Marahiel MA, 2009, J PEPT SCI, V15, P799, DOI 10.1002/psc.1183; Masselot A, 2006, INSILICOSPECTRO; Mayumi T, 2007, RAPID COMMUN MASS SP, V21, P1025, DOI 10.1002/rcm.2920; Mayumi T, 2006, J ANTIBIOT, V59, P710, DOI 10.1038/ja.2006.95; McCormick M.H, 1956, ANTIBIOT ANN, V3, P606; Medzihradszky KF, 2005, METHOD ENZYMOL, V402, P209, DOI 10.1016/S0076-6879(05)02007-0; NAGARAJAN R, 1991, ANTIMICROB AGENTS CH, V35, P605, DOI 10.1128/AAC.35.4.605; Nakamura T, 1986, MASS SPECTROSC, V34, P307; NAMIKOSHI M, 1992, J ORG CHEM, V57, P866, DOI 10.1021/jo00029a016; Namikoshi M, 1996, J IND MICROBIOL BIOT, V17, P373, DOI 10.1007/BF01574768; Ngoka LCM, 1999, J AM SOC MASS SPECTR, V10, P360, DOI 10.1016/S1044-0305(99)00006-9; Paizs B, 2005, MASS SPECTROM REV, V24, P508, DOI 10.1002/mas.20024; PAPAYANNOPOULOS IA, 1995, MASS SPECTROM REV, V14, P49, DOI 10.1002/mas.1280140104; Polfer NC, 2005, J AM CHEM SOC, V127, P17154, DOI 10.1021/ja056553x; Polfer NC, 2007, J AM CHEM SOC, V129, P5887, DOI 10.1021/ja068014d; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rohr J, 2006, ACS CHEM BIOL, V1, P747, DOI 10.1021/cb6004678; Rusconi F, 2009, BIOINFORMATICS, V25, P2741, DOI 10.1093/bioinformatics/btp504; Sabareesh V, 2007, J NAT PROD, V70, P715, DOI 10.1021/np060532e; Sainis I, 2010, MAR DRUGS, V8, P629, DOI 10.3390/md8030629; Savitski MM, 2007, ANAL CHEM, V79, P2296, DOI 10.1021/ac0619332; Schafer M, 2006, J MASS SPECTROM, V41, P1162, DOI 10.1002/jms.1068; Schilling B, 1999, RAPID COMMUN MASS SP, V13, P2174, DOI 10.1002/(SICI)1097-0231(19991115)13:21<2174::AID-RCM771>3.0.CO;2-K; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Sielaff H, 2006, IDRUGS, V9, P119; Strieker M, 2010, CURR OPIN STRUC BIOL, V20, P234, DOI 10.1016/j.sbi.2010.01.009; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Swiderek KM, 1998, ELECTROPHORESIS, V19, P989, DOI 10.1002/elps.1150190614; TANG XJ, 1993, ANAL CHEM, V65, P2824, DOI 10.1021/ac00068a020; Tiburzi F, 2007, IUBMB LIFE, V59, P730, DOI 10.1080/15216540601055349; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Tilvi S, 2007, J MASS SPECTROM, V42, P70, DOI 10.1002/jms.1140; TOMER KB, 1984, ANAL CHEM, V56, P880, DOI 10.1021/ac00270a006; UCSF Mass Spectrometry Facility ProteinProspector., PROTEINPROSPECTOR; Velasquez JE, 2011, CURR OPIN CHEM BIOL, V15, P11, DOI 10.1016/j.cbpa.2010.10.027; von Wartburg A, 1988, Prog Med Chem, V25, P1, DOI 10.1016/S0079-6468(08)70276-5; Webb-Robertson BJM, 2007, BRIEF BIOINFORM, V8, P304, DOI 10.1093/bib/bbm023; Wysocki VH, 2005, METHODS, V35, P211, DOI 10.1016/j.ymeth.2004.08.013; Xia QW, 2011, J AM SOC MASS SPECTR, V22, P255, DOI 10.1007/s13361-010-0029-0; Yague J, 2003, ANAL CHEM, V75, P1524, DOI 10.1021/ac026280d; Yuan M, 1998, EUR MASS SPECTROM, V4, P287, DOI 10.1255/ejms.222; Yuan M, 1999, J MASS SPECTROM, V34, P33, DOI 10.1002/(SICI)1096-9888(199901)34:1<33::AID-JMS754>3.0.CO;2-L; Zhang ZQ, 2004, ANAL CHEM, V76, P3908, DOI 10.1021/ac049951b; Ziemert N, 2008, ANGEW CHEM INT EDIT, V47, P7756, DOI 10.1002/anie.200802730	80	202	207	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44913	10.1371/journal.pone.0044913	http://dx.doi.org/10.1371/journal.pone.0044913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028676	gold, Green Submitted, Green Published			2022-12-27	WOS:000308788700054
J	Nowak, I; Magott-Procelewska, M; Kowal, A; Miazga, M; Wagner, M; Niepieklo-Miniewska, W; Kaminska, M; Wisniewski, A; Majorczyk, E; Klinger, M; Luszczek, W; Pawlik, A; Ploski, R; Barcz, E; Senitzer, D; Kusnierczyk, P				Nowak, Izabela; Magott-Procelewska, Maria; Kowal, Agnieszka; Miazga, Maciej; Wagner, Marta; Niepieklo-Miniewska, Wanda; Kaminska, Malgorzata; Wisniewski, Andrzej; Majorczyk, Edyta; Klinger, Marian; Luszczek, Wioleta; Pawlik, Andrzej; Ploski, Rafal; Barcz, Ewa; Senitzer, David; Kusnierczyk, Piotr			Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation	PLOS ONE			English	Article							PCR-SSP METHOD; LIGAND INCOMPATIBILITY; HAPLOTYPE FREQUENCIES; GRAFT-REJECTION; T-CELLS; GENE; DISEASE; SUSCEPTIBILITY; ACTIVATION; BIOPSIES	Background: Recipient NK cells may detect the lack of recipient's (i.e., self) HLA antigens on donor renal tissue by means of their killer cell immunoglobulin-like receptors (KIRs). KIR genes are differently distributed in individuals, possibly contributing to differences in response to allogeneic graft. Methodology/Principal Findings: We compared frequencies of 10 KIR genes by PCR-SSP in 93 kidney graft recipients rejecting allogeneic renal transplants with those in 190 recipients accepting grafts and 690 healthy control individuals. HLA matching results were drawn from medical records. We observed associations of both a full-length KIR2DS4 gene and its variant with 22-bp deletion with kidney graft rejection. This effect was modulated by the HLA-B,-DR matching, particularly in recipients who did not have glomerulonephritis but had both forms of KIR2DS4 gene. In contrast, in recipients with glomerulonephritis, HLA compatibility seemed to be much less important for graft rejection than the presence of KIR2DS4 gene. Simultaneous presence of both KIR2DS4 variants strongly increased the probability of rejection. Interestingly, KIR2DS5 seemed to protect the graft in the presence of KIR2DS4fl but in the absence of KIR2DS4del. Conclusions/Significance: Our results suggest a protective role of KIR2DS5 in graft rejection and an association of KIR2DS4 with kidney rejection, particularly in recipients with glomerulonephritis.	[Nowak, Izabela; Kowal, Agnieszka; Miazga, Maciej; Wagner, Marta; Niepieklo-Miniewska, Wanda; Wisniewski, Andrzej; Majorczyk, Edyta; Luszczek, Wioleta; Kusnierczyk, Piotr] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Clin Immunol, Lab Immunogenet & Tissue Immunol, Wroclaw, Poland; [Magott-Procelewska, Maria; Klinger, Marian] Med Univ Wroclaw, Dept & Clin Nephrol & Transplant Med, Fac Med, Wroclaw, Poland; [Kaminska, Malgorzata] Ludwik Hirszfeld Inst Immunol & Expt Therapy, Hlth Care Ctr, Wroclaw, Poland; [Pawlik, Andrzej] Pomeranian Med Univ, Dept Pharmacokinet & Therapeut Drug Monitoring, Szczecin, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Ctr Biostruct Res, Warsaw, Poland; [Barcz, Ewa] Med Univ Warsaw, Chair & Clin Obstet & Gynecol 1, Warsaw, Poland; [Senitzer, David] City Hope Comprehens Canc Ctr, Duarte, CA USA	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw Medical University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Pomeranian Medical University; Medical University of Warsaw; Medical University of Warsaw; City of Hope	Nowak, I (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Clin Immunol, Lab Immunogenet & Tissue Immunol, Wroclaw, Poland.	pkusnier@iitd.pan.wroc.pl	Majorczyk, Edyta/P-3066-2019; Pawlik, Andrzej/A-9052-2015; Barcz, Ewa/AAS-7533-2020; Kusnierczyk, Piotr/ABB-6734-2020	Majorczyk, Edyta/0000-0001-7248-9544; Pawlik, Andrzej/0000-0001-6557-1208; Wagner, Marta/0000-0002-2710-2301; Kusnierczyk, Piotr/0000-0002-9224-8921; Wisniewski, Andrzej/0000-0002-1919-2298; Niepieklo-Miniewska, Wanda/0000-0002-3326-4059; Ploski, Rafal/0000-0001-6286-5526; Nowak, Izabela/0000-0002-9127-1089	Ministry of Science and High Education grant [N401077 31/1819]; Ludwik Hirszfeld Institute of Immunology and Experimental Therapy grant [14/2011]	Ministry of Science and High Education grant; Ludwik Hirszfeld Institute of Immunology and Experimental Therapy grant	This work was supported by the Ministry of Science and High Education grant No. N401077 31/1819 and by the Ludwik Hirszfeld Institute of Immunology and Experimental Therapy grant no. 14/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah JM, 2003, GENET SEL EVOL, V35, P513, DOI [10.1186/1297-9686-35-6-513, 10.1051/gse:2003037]; ANDERSEN CB, 1994, APMIS, V102, P23, DOI 10.1111/j.1699-0463.1994.tb04841.x; Betjes MGH, 2008, KIDNEY INT, V74, P760, DOI 10.1038/ki.2008.301; Bhasi K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl520; Cirocco RE, 2007, TISSUE ANTIGENS, V69, P123, DOI 10.1111/j.1399-0039.2006.76211.x; COOKSEY G, 1984, BRIT J SURG, V71, P874, DOI 10.1002/bjs.1800711124; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; HANCOCK WW, 1985, TRANSPLANTATION, V39, P430, DOI 10.1097/00007890-198504000-00018; Hanvesakul R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023631; Kreijveld E, 2007, TRANSPLANTATION, V84, P1045, DOI 10.1097/01.tp.0000286097.11173.70; Kunert K, 2007, TRANSPLANTATION, V84, P1527, DOI 10.1097/01.tp.0000290681.41859.41; Liu ZQ, 2005, GENET EPIDEMIOL, V29, P353, DOI 10.1002/gepi.20092; Lopez-Alvarez MR, 2011, HUM IMMUNOL, V72, P229, DOI 10.1016/j.humimm.2010.12.015; Luszczek W, 2004, HUM IMMUNOL, V65, P758, DOI 10.1016/j.humimm.2004.05.008; Majorczyk E, 2007, GENES IMMUN, V8, P678, DOI 10.1038/sj.gene.6364433; Middleton D, 2008, TISSUE ANTIGENS, V71, P105, DOI 10.1111/j.1399-0039.2007.00973.x; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Moretta L, 2011, BLOOD, V117, P764, DOI 10.1182/blood-2010-08-264085; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Nowak I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012381; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Pegram HJ, 2011, LEUKEMIA RES, V35, P14, DOI 10.1016/j.leukres.2010.07.030; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rajalingam R, 2011, AM J TRANSPLANT, V11, P1771, DOI 10.1111/j.1600-6143.2011.03619.x; Schmidt AH, 2011, HUM IMMUNOL, V72, P558, DOI 10.1016/j.humimm.2011.03.010; Shilling HG, 2002, J IMMUNOL, V169, P239, DOI 10.4049/jimmunol.169.1.239; Single RM, 2008, IMMUNOGENETICS, V60, P711, DOI 10.1007/s00251-008-0331-1; Snyder MR, 2004, J IMMUNOL, V173, P3725, DOI 10.4049/jimmunol.173.6.3725; Sun JY, 2004, TISSUE ANTIGENS, V64, P462, DOI 10.1111/j.1399-0039.2004.00303.x; Thewissen M, 2007, J IMMUNOL, V179, P6514, DOI 10.4049/jimmunol.179.10.6514; TOTTERMAN TH, 1989, TRANSPLANTATION, V47, P817, DOI 10.1097/00007890-198905000-00014; Tran TH, 2005, TRANSPLANTATION, V80, P1121, DOI 10.1097/01.tp.0000179110.15304.90; Vampa ML, 2003, TRANSPLANTATION, V76, P1220, DOI 10.1097/01.TP.0000083896.91215.C7; van Bergen J, 2011, AM J TRANSPLANT, V11, P1959, DOI 10.1111/j.1600-6143.2011.03621.x; van der Meer A, 2008, MOL IMMUNOL, V45, P3631, DOI 10.1016/j.molimm.2008.04.016; Velardi A, 2009, CURR OPIN IMMUNOL, V21, P525, DOI 10.1016/j.coi.2009.07.015; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Womer KL, 2009, AM J TRANSPLANT, V9, P1265, DOI 10.1111/j.1600-6143.2009.02639.x; Yadav AK, 2011, NEPHROL DIAL TRANSPL, V26, P1689, DOI 10.1093/ndt/gfr010; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159	43	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44718	10.1371/journal.pone.0044718	http://dx.doi.org/10.1371/journal.pone.0044718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028591	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700031
J	Park, EJ; Kwon, HK; Choi, YM; Shin, HJ; Choi, S				Park, Eun-Jung; Kwon, Hyuk-Kwon; Choi, Yong-Min; Shin, Hyeon-Jun; Choi, Sangdun			Doxorubicin Induces Cytotoxicity through Upregulation of pERK-Dependent ATF3	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; INDUCED CARDIOTOXICITY; SIGNALING PATHWAYS; INDUCED APOPTOSIS; GENE-EXPRESSION; TNF SUPERFAMILY; CELLS; AGENTS; KINASES; BIOLOGY	Although doxorubicin is commonly used in the treatment of many cancer types, its use in chemotherapy has been limited, largely because of its severe side effects, including cardiotoxicity and nephrotoxicity. In this study, we aimed to identify the mechanism of doxorubicin-induced cytotoxicity by using the human kidney proximal tubule cell line HK-2. Furthermore, we investigated the role of activating transcription factor 3 (ATF3) as a mediator of doxorubicin-induced cytotoxicity by using wild-type mouse embryonic fibroblasts (MEF) cells and ATF3 knockout (KO) cells. In HK-2 cells, doxorubicin decreased cell viability in a dose-dependent manner and induced an increase in cells in the sub G1 and G2/M phases at all doses. Doxorubicin treatment showed the following dose-dependent effects: increase in the secretion of tumor necrosis factor alpha; decrease in the expression of phosphorylated protein kinase A and Bcl-2; and increase in the expression of phosphorylated signal transducer and activator of transcription 3, phosphorylated extracellular signal-regulated kinase (ERK), and ATF3. Based on these results, we suggest that doxorubicin induces cytotoxicity through an ERK-dependent pathway, and ATF3 plays a pivotal role as a transcriptional regulator in this process.	[Park, Eun-Jung; Kwon, Hyuk-Kwon; Choi, Yong-Min; Shin, Hyeon-Jun; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea	Ajou University	Park, EJ (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	kwon, hyukkwon/GRS-1775-2022; kwon, hyuk-kwon/AAS-4154-2021; Park, Eun-Jung/Y-4427-2019	kwon, hyuk-kwon/0000-0002-4723-4061; 	Korea Food & Drug Administration [10182KFDA992-2302]; National Research Foundation of Korea; Ministry of Education, Science, and Technology [2012016803]; Priority Research Centers Program [NRF 2010-0028294]	Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Priority Research Centers Program	This work was supported by the Korea Food & Drug Administration (10182KFDA992-2302). This work was also partly supported by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (2012016803) and the Priority Research Centers Program (NRF 2010-0028294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aldieri E, 2002, TOXICOL APPL PHARM, V185, P85, DOI 10.1006/taap.2002.9527; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; BILLINGHAM ME, 1978, CANCER TREAT REP, V62, P865; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; Brantley-Finley C, 2003, BIOCHEM PHARMACOL, V66, P459, DOI 10.1016/S0006-2952(03)00255-7; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chang WT, 2011, J CELL BIOCHEM, V112, P2873, DOI 10.1002/jcb.23201; Chularojmontri L, 2005, BIOL PHARM BULL, V28, P1165, DOI 10.1248/bpb.28.1165; Deman A, 2001, NEPHROL DIAL TRANSPL, V16, P147, DOI 10.1093/ndt/16.1.147; DOROSHOW JH, 1986, BIOCHEM BIOPH RES CO, V135, P330, DOI 10.1016/0006-291X(86)90981-2; Dorr RT, 1996, SEMIN ONCOL, V23, P23; Dunkern TR, 2003, DNA REPAIR, V2, P49, DOI 10.1016/S1568-7864(02)00185-4; Fadillioglu E, 2004, J APPL TOXICOL, V24, P47, DOI 10.1002/jat.945; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Ghosh J, 2011, AMINO ACIDS; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Huigsloot M, 2002, J BIOL CHEM, V277, P35869, DOI 10.1074/jbc.M200378200; Kalivendi SV, 2001, J BIOL CHEM, V276, P47266, DOI 10.1074/jbc.M106829200; Khuu CH, 2007, MOL IMMUNOL, V44, P1598, DOI 10.1016/j.molimm.2006.08.006; Kim EY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014181; KOJIMA S, 1993, J PHARMACOL EXP THER, V266, P1699; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; MILNER LS, 1991, J LAB CLIN MED, V118, P427; MIMNAUGH EG, 1986, BIOCHEM PHARMACOL, V35, P4337, DOI 10.1016/0006-2952(86)90714-8; Navarro R, 2006, ANN NY ACAD SCI, V1090, P408, DOI 10.1196/annals.1378.044; Nawa T, 2000, BIOCHEM BIOPH RES CO, V275, P406, DOI 10.1006/bbrc.2000.3332; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; ODONNELL MP, 1985, J LAB CLIN MED, V106, P62; Park EJ, 2010, TOXICOL APPL PHARM, V244, P226, DOI 10.1016/j.taap.2009.12.036; Park EJ, 2009, TOXICOLOGY, V259, P113, DOI 10.1016/j.tox.2009.02.009; Pritsos CA, 2000, CHEM-BIOL INTERACT, V127, P1, DOI 10.1016/S0009-2797(00)00159-9; Safirstein RL, 2004, KIDNEY INT, V66, pS62, DOI 10.1111/j.1523-1755.2004.09110.x; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; St Germain C, 2010, NEOPLASIA, V12, P527, DOI 10.1593/neo.92048; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Xu MF, 2001, LIFE SCI, V68, P889, DOI 10.1016/S0024-3205(00)00990-5	40	61	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44990	10.1371/journal.pone.0044990	http://dx.doi.org/10.1371/journal.pone.0044990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028726	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700073
J	Brantley-Sieders, DM; Fan, KH; Deming-Halverson, SL; Shyr, Y; Cook, RS				Brantley-Sieders, Dana M.; Fan, Kang-Hsien; Deming-Halverson, Sandra L.; Shyr, Yu; Cook, Rebecca S.			Local Breast Cancer Spatial Patterning: A Tool for Community Health Resource Allocation to Address Local Disparities in Breast Cancer Mortality	PLOS ONE			English	Article							INSURANCE STATUS; UNITED-STATES; MAMMOGRAPHY; SURVIVAL; WOMEN; IMPACT; RATES; STAGE; ASSOCIATION; ETHNICITY	Despite available demographic data on the factors that contribute to breast cancer mortality in large population datasets, local patterns are often overlooked. Such local information could provide a valuable metric by which regional community health resources can be allocated to reduce breast cancer mortality. We used national and statewide datasets to assess geographical distribution of breast cancer mortality rates and known risk factors influencing breast cancer mortality in middle Tennessee. Each county in middle Tennessee, and each ZIP code within metropolitan Davidson County, was scored for risk factor prevalence and assigned quartile scores that were used as a metric to identify geographic areas of need. While breast cancer mortality often correlated with age and incidence, geographic areas were identified in which breast cancer mortality rates did not correlate with age and incidence, but correlated with additional risk factors, such as mammography screening and socioeconomic status. Geographical variability in specific risk factors was evident, demonstrating the utility of this approach to identify local areas of risk. This method revealed local patterns in breast cancer mortality that might otherwise be overlooked in a more broadly based analysis. Our data suggest that understanding the geographic distribution of breast cancer mortality, and the distribution of risk factors that contribute to breast cancer mortality, will not only identify communities with the greatest need of support, but will identify the types of resources that would provide the most benefit to reduce breast cancer mortality in the community.	[Fan, Kang-Hsien; Shyr, Yu; Cook, Rebecca S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Brantley-Sieders, Dana M.; Deming-Halverson, Sandra L.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Fan, Kang-Hsien; Shyr, Yu] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Shyr, Yu; Cook, Rebecca S.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37212 USA; [Deming-Halverson, Sandra L.] Social & Sci Syst Inc, Durham, NC USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Social & Scientific Systems	Cook, RS (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	rebecca.cook@Vanderbilt.Edu		Fan, Kang-hsien/0000-0003-0121-3959	National Center for Research Resources/National Institutes of Health through the Vanderbilt Institute for Clinical and Translational Research (VICTR) [VR1155, UL1 RR024975]; National Institutes of Health [R01CA143126, K01CA1179151, R01CA148934]; Susan G. Komen for the Cure [KG100677]; Vanderbilt-Ingram Cancer Center Biostatistics Shared Resource NCI [P30 CA68485]; NATIONAL CANCER INSTITUTE [R01CA143126, R01CA148934, P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978, KL2RR024977, UL1RR024975] Funding Source: NIH RePORTER	National Center for Research Resources/National Institutes of Health through the Vanderbilt Institute for Clinical and Translational Research (VICTR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Vanderbilt-Ingram Cancer Center Biostatistics Shared Resource NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Statistical analyses of demographic data sets were supported in part by the Vanderbilt Clinical and Translational Science Award grant UL1 RR024975 from the National Center for Research Resources/National Institutes of Health through the Vanderbilt Institute for Clinical and Translational Research (VICTR, VR1155). This work was supported by the National Institutes of Health R01CA143126 (RSC), Susan G. Komen for the Cure grant KG100677 (RSC), National Institutes of Health K01CA1179151 (DBS) and R01CA148934. Yu Shyr and Kang-Hsien Fan are supported by the Vanderbilt-Ingram Cancer Center Biostatistics Shared Resource NCI Grant P30 CA68485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain KS, 2009, JNCI-J NATL CANCER I, V101, P984, DOI 10.1093/jnci/djp175; Baron RC, 2010, AM J PREV MED, V38, P110, DOI 10.1016/j.amepre.2009.09.031; Blanchard K, 2004, CANCER-AM CANCER SOC, V101, P495, DOI 10.1002/cncr.20392; Bradley CJ, 2008, INQUIRY-J HEALTH CAR, V45, P323, DOI 10.5034/inquiryjrnl_45.03.323; Breen N, 2007, CANCER DETECT PREV, V31, P220, DOI 10.1016/j.cdp.2007.04.006; Buki LP, 2007, CANCER, V110, P1578, DOI 10.1002/cncr.22929; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Cardoso F, 2002, ANN ONCOL, V13, P197, DOI 10.1093/annonc/mdf101; Chu KC, 2007, J NATL MED ASSOC, V99, P1092; Coburn N, 2008, BREAST J, V14, P128, DOI 10.1111/j.1524-4741.2007.00542.x; Collins Sara R, 2011, Issue Brief (Commonw Fund), V5, P1; Dawood S, 2010, ANN ONCOL, V21, P2169, DOI 10.1093/annonc/mdq220; Giannotti Tierney E, 2006, Conn Med, V70, P509; Goodman M, 2009, J COMMUN HEALTH, V34, P23, DOI 10.1007/s10900-008-9123-7; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Halpern MT, 2008, LANCET ONCOL, V9, P222, DOI 10.1016/S1470-2045(08)70032-9; Henson DE, 2003, CANCER, V98, P908, DOI 10.1002/cncr.11558; Holmes Laurens Jr, 2010, Afr J Reprod Health, V14, P195; Joslyn SA, 2005, BREAST CANCER RES TR, V92, P97, DOI 10.1007/s10549-005-2112-y; Kinsey T, 2008, JNCI-J NATL CANCER I, V100, P1003, DOI 10.1093/jnci/djn207; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Li Christopher I, 2005, Ethn Dis, V15, pS5; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; NORMAN SA, 1993, PUBLIC HEALTH REP, V108, P395; NORTON L, 1991, NEW ENGL J MED, V325, P1370, DOI 10.1056/NEJM199111073251909; Okunade Albert A, 2003, Health Care Manag Sci, V6, P237, DOI 10.1023/A:1026281608207; Richardson L. C., 2010, Morbidity and Mortality Weekly Report, V59, P813; Robertson Ruth, 2011, Issue Brief (Commonw Fund), V3, P1; Robinson JM, 2008, J HEALTH CARE POOR U, V19, P842, DOI 10.1353/hpu.0.0048; Sabatino SA, 2008, MED CARE, V46, P692, DOI 10.1097/MLR.0b013e31817893b1; Schootman M, 2009, AM J EPIDEMIOL, V169, P554, DOI 10.1093/aje/kwn369; Shinagawa SM, 2000, CANCER, V88, P1217, DOI 10.1002/(SICI)1097-0142(20000301)88:5+<1217::AID-CNCR7>3.0.CO;2-K; Sprague BL, 2010, CANCER; Swan J, 2010, CANCER-AM CANCER SOC, V116, P4872, DOI 10.1002/cncr.25215; van Ravesteyn NT, 2011, CANCER EPIDEM BIOMAR, V20, P112, DOI 10.1158/1055-9965.EPI-10-0944; Ward E, 2008, CA-CANCER J CLIN, V58, P9, DOI 10.3322/CA.2007.0011; Welty T K, 1993, Alaska Med, V35, P265; Whitman S, 2007, CANCER DETECT PREV, V31, P166, DOI 10.1016/j.cdp.2006.12.008; Winer E, 2009, J CLIN ONCOL, V27, P812, DOI 10.1200/JCO.2008.21.2134	40	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45238	10.1371/journal.pone.0045238	http://dx.doi.org/10.1371/journal.pone.0045238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23028869	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900035
J	Watkins, ER; Maiden, MCJ				Watkins, Eleanor R.; Maiden, Martin C. J.			Persistence of Hyperinvasive Meningococcal Strain Types during Global Spread as Recorded in the PubMLST Database	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS SEROGROUP; POPULATION-STRUCTURE; ANTIGENIC DIVERSITY; TAILOR-MADE; VACCINE; DISEASE; SEQUENCE; EPIDEMIOLOGY; EVOLUTION; CLONES	Neisseria meningitidis is a major cause of septicaemia and meningitis worldwide. Most disease in Europe, the Americas and Australasia is caused by meningococci expressing serogroup B capsules, but no vaccine against this polysaccharide exists. Potential candidates for 'serogroup B substitute' vaccines are outer membrane protein antigens including the typing antigens PorA and FetA. The web-accessible PubMLST database (www.pubmlst.org) was used to investigate the temporal and geographical patterns of associations among PorA and FetA protein variants and lineages defined by combinations of housekeeping genes, known as clonal complexes. The sample contained 3460 isolates with genotypic information from 57 countries over a 74 year period. Although shifting associations among antigen variants and clonal complexes were evident, a subset of strain types associated with several serogroups persisted for decades and proliferated globally. Genetic stability among outer membrane proteins of serogroup A meningococci has been described previously, but here long-lived genetic associations were also observed among meningococci belonging to serogroups B and C. The patterns of variation were consistent with behaviour predicted by models that invoke inter-strain competition mediated by immune selection. There was also substantial geographic and temporal heterogeneity in antigenic repertoires, providing both opportunities and challenges for the design of broad coverage protein-based meningococcal vaccines.	[Watkins, Eleanor R.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Maiden, MCJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	martin.maiden@zoo.ox.ac.uk	Maiden, Martin/N-6805-2019; Maiden, Martin C J/C-5055-2014	Maiden, Martin/0000-0001-6321-5138; Maiden, Martin C J/0000-0001-6321-5138	Wellcome Trust [087622/Z/08/Z]; Merton College Oxford; European Union	Wellcome Trust(Wellcome TrustEuropean Commission); Merton College Oxford; European Union(European Commission)	This work was funded by the Wellcome Trust (grant number: 087622/Z/08/Z) and Merton College Oxford (Jackson Scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication made use of the Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford (Jolley & Maiden 2010, BMC Bioinformatics, 11:595). The development of this site has been funded by the Wellcome Trust and European Union.	Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Bart A, 2001, INFECT GENET EVOL, V1, P117, DOI 10.1016/S1567-1348(01)00011-9; BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Brehony C, 2009, MICROBIOL-SGM, V155, P4155, DOI 10.1099/mic.0.027995-0; Buckee CO, 2011, P NATL ACAD SCI USA, V108, P15504, DOI 10.1073/pnas.1102445108; Buckee CO, 2010, P ROY SOC B-BIOL SCI, V277, P1635, DOI 10.1098/rspb.2009.2033; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Callaghan MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000020; Caron F, 2011, LANCET INFECT DIS, V11, P455, DOI 10.1016/S1473-3099(11)70027-5; CARTWRIGHT KAV, 1986, LANCET, V2, P558; CAUGANT DA, 1987, J BACTERIOL, V169, P2781, DOI 10.1128/jb.169.6.2781-2792.1987; CAUGANT DA, 1986, P NATL ACAD SCI USA, V83, P4927, DOI 10.1073/pnas.83.13.4927; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; Diermayer M, 1999, JAMA-J AM MED ASSOC, V281, P1493, DOI 10.1001/jama.281.16.1493; Elias J, 2010, EMERG INFECT DIS, V16, P464, DOI 10.3201/eid1603.091102; Feavers IM, 1996, CLIN DIAGN LAB IMMUN, V3, P444, DOI 10.1128/CDLI.3.4.444-450.1996; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Harrison LH, 2006, J INFECT DIS, V193, P1266, DOI 10.1086/501371; Holst J, 2003, VACCINE, V21, P734, DOI 10.1016/S0264-410X(02)00591-1; Jodar L, 2002, LANCET, V359, P1499, DOI 10.1016/S0140-6736(02)08416-7; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Materu S, 2007, EMERG INFECT DIS, V13, P944, DOI 10.3201/eid1306.070042; OLYHOEK T, 1987, REV INFECT DIS, V9, P665; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Pillai S, 2005, VACCINE, V23, P2206, DOI 10.1016/j.vaccine.2005.01.056; Racloz VN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-175; Romero EC, 2011, J CLIN MICROBIOL, V49, P3940, DOI 10.1128/JCM.01119-11; Rouaud P, 2006, Euro Surveill, V11, P178, DOI 10.2807/esm.11.07.00635-en; Russell JE, 2008, MICROBIOL-SGM, V154, P1170, DOI 10.1099/mic.0.2007/014761-0; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Tondella MLC, 2000, J CLIN MICROBIOL, V38, P3323, DOI 10.1128/JCM.38.9.3323-3328.2000; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; WANG JF, 1993, J INFECT DIS, V167, P1320, DOI 10.1093/infdis/167.6.1320; Yang L, 2009, J INFECTION, V58, P358, DOI 10.1016/j.jinf.2009.02.020; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	53	33	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45349	10.1371/journal.pone.0045349	http://dx.doi.org/10.1371/journal.pone.0045349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028953	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900038
J	Ekpenyong, AE; Whyte, G; Chalut, K; Pagliara, S; Lautenschlager, F; Fiddler, C; Paschke, S; Keyser, UF; Chilvers, ER; Guck, J				Ekpenyong, Andrew E.; Whyte, Graeme; Chalut, Kevin; Pagliara, Stefano; Lautenschlaeger, Franziska; Fiddler, Christine; Paschke, Stephan; Keyser, Ulrich F.; Chilvers, Edwin R.; Guck, Jochen			Viscoelastic Properties of Differentiating Blood Cells Are Fate- and Function-Dependent	PLOS ONE			English	Article							OPTICAL DEFORMABILITY; MECHANICAL-PROPERTIES; SINGLE CELLS; STEM-CELLS; NEUTROPHIL; DYNAMICS; BEAM	Although cellular mechanical properties are known to alter during stem cell differentiation, understanding of the functional relevance of such alterations is incomplete. Here, we show that during the course of differentiation of human myeloid precursor cells into three different lineages, the cells alter their viscoelastic properties, measured using an optical stretcher, to suit their ultimate fate and function. Myeloid cells circulating in blood have to be advected through constrictions in blood vessels, engendering the need for compliance at short time-scales (< seconds). Intriguingly, only the two circulating myeloid cell types have increased short time scale compliance and flow better through microfluidic constrictions. Moreover, all three differentiated cell types reduce their steady-state viscosity by more than 50% and show over 140% relative increase in their ability to migrate through tissue-like pores at long time-scales (> minutes), compared to undifferentiated cells. These findings suggest that reduction in steady-state viscosity is a physiological adaptation for enhanced migration through tissues. Our results indicate that the material properties of cells define their function, can be used as a cell differentiation marker and could serve as target for novel therapies.	[Ekpenyong, Andrew E.; Whyte, Graeme; Chalut, Kevin; Pagliara, Stefano; Lautenschlaeger, Franziska; Keyser, Ulrich F.; Guck, Jochen] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Fiddler, Christine; Chilvers, Edwin R.] Univ Cambridge, Sch Clin Med, Addenbrookes & Papworth Hosp, Dept Med, Cambridge CB3 0HE, England; [Paschke, Stephan] Univ Ulm, Dept Surg, Ulm, Germany; [Guck, Jochen] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany	University of Cambridge; Papworth Hospital; University of Cambridge; Ulm University; Technische Universitat Dresden	Guck, J (corresponding author), Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England.	jochen.guck@biotec.tu-dresden.de	Lautenschläger, Franziska/L-3484-2016; Guck, Jochen/AAJ-9283-2021; Keyser, Ulrich/E-7696-2012; Pagliara, Stefano/F-2888-2012; Whyte, Graeme/A-2555-2012; Guck, Jochen/B-4412-2014	Lautenschläger, Franziska/0000-0001-8263-3386; Guck, Jochen/0000-0002-1453-6119; Keyser, Ulrich/0000-0003-3188-5414; Pagliara, Stefano/0000-0001-9796-1956; Whyte, Graeme/0000-0003-4147-2656; Guck, Jochen/0000-0002-1453-6119; Chalut, Kevin/0000-0001-6200-9690; Chilvers, Edwin/0000-0002-4230-9677; Ekpenyong, Andrew/0000-0003-0191-8393	Cambridge Commonwealth Trust; Medical Research Council [94185]; Human Frontier Science Program [RGP0015/2009-C]; European Research Council [282060]; MRC [MR/J00345X/1] Funding Source: UKRI; Medical Research Council [G0902319, MR/J00345X/1] Funding Source: researchfish	Cambridge Commonwealth Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge financial support by the Cambridge Commonwealth Trust (to AEE; http://www.cambridgetrusts.org), the Medical Research Council (to KC and JG; grant number: 94185; http://www.mrc.ac.uk), the Human Frontier Science Program (to GW and JG; grant number: RGP0015/2009-C; http://www.hfsp.org) and the European Research Council (to JG; grant number: 282060; http://erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldonyte R, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-11; Boyde L, 2009, J OPT SOC AM A, V26, P1814, DOI 10.1364/JOSAA.26.001814; Chalut KJ, 2012, INTEGR BIOL-UK, V4, P280, DOI 10.1039/c2ib00129b; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; COLLINS SJ, 1987, BLOOD, V70, P1233; Cowburn AS, 2008, CHEST, V134, P606, DOI 10.1378/chest.08-0422; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; DOERSCHUK CM, 1993, J APPL PHYSIOL, V74, P3040, DOI 10.1152/jappl.1993.74.6.3040; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gonzalez-Cruz RD, 2012, P NATL ACAD SCI USA, V109, pE1523, DOI 10.1073/pnas.1120349109; Gossett DR, 2012, P NATL ACAD SCI USA, V109, P7630, DOI 10.1073/pnas.1200107109; Guck J, 2000, PHYS REV LETT, V84, P5451, DOI 10.1103/PhysRevLett.84.5451; Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; HALLOWS KR, 1992, BIORHEOLOGY, V29, P295; Jain KK, 2010, HANDBOOK OF BIOMARKERS, P1, DOI 10.1007/978-1-60761-685-6_1; Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002; Lautenschlager F, 2009, P NATL ACAD SCI USA, V106, P15696, DOI 10.1073/pnas.0811261106; LEUNG MF, 1992, CANCER RES, V52, P949; Lincoln B, 2007, BIOMED MICRODEVICES, V9, P703, DOI 10.1007/s10544-007-9079-x; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Olins AL, 2009, EUR J CELL BIOL, V88, P203, DOI 10.1016/j.ejcb.2008.10.001; Olins AL, 1998, EXP CELL RES, V245, P91, DOI 10.1006/excr.1998.4210; Pagliara S, 2011, LAB CHIP, V11, P3365, DOI 10.1039/c1lc20399a; Pelling AE, 2009, CELL MOTIL CYTOSKEL, V66, P409, DOI 10.1002/cm.20391; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Stewart MP, 2012, NAT PROTOC, V7, P143, DOI 10.1038/nprot.2011.434; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Tsai MA, 1996, BIOPHYS J, V70, P2023, DOI 10.1016/S0006-3495(96)79768-0; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Verghese MW, 1996, J BIOL CHEM, V271, P15597, DOI 10.1074/jbc.271.26.15597; Wakatsuki T, 2001, J CELL SCI, V114, P1025; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103; Yu HY, 2010, BIOCHEM BIOPH RES CO, V393, P150, DOI 10.1016/j.bbrc.2010.01.107	38	136	137	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45237	10.1371/journal.pone.0045237	http://dx.doi.org/10.1371/journal.pone.0045237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028868	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500022
J	Susanti, D; Mukhopadhyay, B				Susanti, Dwi; Mukhopadhyay, Biswarup			An Intertwined Evolutionary History of Methanogenic Archaea and Sulfate Reduction	PLOS ONE			English	Article							DISSIMILATORY SULFITE REDUCTASE; DESULFOVIBRIO-VULGARIS HILDENBOROUGH; EXTREMELY THERMOPHILIC METHANOGEN; ALLOCHROMATIUM-VINOSUM; SULFUR OXIDATION; ARCHAEOGLOBUS-FULGIDUS; SP-NOV; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOCOCCUS-THERMOLITHOTROPHICUS; METHANOCALDOCOCCUS-JANNASCHII	Hydrogenotrophic methanogenesis and dissimilatory sulfate reduction, two of the oldest energy conserving respiratory systems on Earth, apparently could not have evolved in the same host, as sulfite, an intermediate of sulfate reduction, inhibits methanogenesis. However, certain methanogenic archaea metabolize sulfite employing a deazaflavin cofactor (F-420)-dependent sulfite reductase (Fsr) where N- and C-terminal halves (Fsr-N and Fsr-C) are homologs of F420H2 dehydrogenase and dissimilatory sulfite reductase (Dsr), respectively. From genome analysis we found that Fsr was likely assembled from freestanding Fsr-N homologs and Dsr-like proteins (Dsr-LP), both being abundant in methanogens. Dsr-LPs fell into two groups defined by following sequence features: Group I (simplest), carrying a coupled siroheme-[Fe-4-S-4] cluster and sulfite-binding Arg/Lys residues; Group III (most complex), with group I features, a Dsr-type peripheral [Fe-4-S-4] cluster and an additional [Fe-4-S-4] cluster. Group II Dsr-LPs with group I features and a Dsr-type peripheral [Fe-4-S-4] cluster were proposed as evolutionary intermediates. Group III is the precursor of Fsr-C. The freestanding Fsr-N homologs serve as F420H2 dehydrogenase unit of a putative novel glutamate synthase, previously described membrane-bound electron transport system in methanogens and of assimilatory type sulfite reductases in certain haloarchaea. Among archaea, only methanogens carried Dsr-LPs. They also possessed homologs of sulfate activation and reduction enzymes. This suggested a shared evolutionary history for methanogenesis and sulfate reduction, and Dsr-LPs could have been the source of the oldest (3.47-Gyr ago) biologically produced sulfide deposit.	[Susanti, Dwi; Mukhopadhyay, Biswarup] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Susanti, Dwi] Virginia Tech, Genet Bioinformat & Computat Biol PhD Program, Blacksburg, VA USA; [Mukhopadhyay, Biswarup] Virginia Tech, Dept Biochem, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Mukhopadhyay, B (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	biswarup@vt.edu		Mukhopadhyay, Biswarup/0000-0003-0736-0298	NASA Astrobiology: Exobiology and Evolutionary Biology grants [NNG05GP24G, NNX09AV28G]; National Science Foundation [MCB1020458]; Virginia Tech Genetics, Bioinformatics and Computational Biology Ph.D. program; Div Of Molecular and Cellular Bioscience [1020458] Funding Source: National Science Foundation	NASA Astrobiology: Exobiology and Evolutionary Biology grants; National Science Foundation(National Science Foundation (NSF)); Virginia Tech Genetics, Bioinformatics and Computational Biology Ph.D. program; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project has been supported by NASA Astrobiology: Exobiology and Evolutionary Biology grants NNG05GP24G and NNX09AV28G to BM and the National Science Foundation grant MCB1020458 to BM and Bob B. Buchanan. DS received a graduate fellowship from the Virginia Tech Genetics, Bioinformatics and Computational Biology Ph.D. program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDERSTON WL, 1976, APPL ENVIRON MICROB, V32, P264, DOI 10.1128/AEM.32.2.264-269.1976; Baumer S, 2000, J BIOL CHEM, V275, P17968, DOI 10.1074/jbc.M000650200; BELAY N, 1990, CURR MICROBIOL, V21, P193, DOI 10.1007/BF02092121; Branciamore S, 2008, FRONT BIOSCI, V13, P6886, DOI 10.2741/3196; Brochier C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-36; Brochier C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r17; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4759, DOI 10.1016/j.gca.2005.04.015; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CIULLA R, 1994, J BACTERIOL, V176, P3177, DOI 10.1128/jb.176.11.3177-3187.1994; Cort JR, 2008, J MOL BIOL, V382, P692, DOI 10.1016/j.jmb.2008.07.022; Crane BR, 1996, CURR OPIN STRUC BIOL, V6, P744, DOI 10.1016/S0959-440X(96)80003-0; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; DANIELS L, 1986, APPL ENVIRON MICROB, V51, P703, DOI 10.1128/AEM.51.4.703-709.1986; Deppenmeier U, 2004, J BIOENERG BIOMEMBR, V36, P55, DOI 10.1023/B:JOBB.0000019598.64642.97; Dhillon A, 2005, ASTROBIOLOGY, V5, P18, DOI 10.1089/ast.2005.5.18; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; FRANZMANN PD, 1992, SYST APPL MICROBIOL, V15, P573, DOI 10.1016/S0723-2020(11)80117-7; GOODWIN AM, 1976, ECON GEOL, V71, P870, DOI 10.2113/gsecongeo.71.5.870; Graham DE, 2002, J BIOL CHEM, V277, P13421, DOI 10.1074/jbc.M201011200; Grimm F, 2012, MICROBIOLOGY, V156, P764; Grimm F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00051; Grimm F, 2010, J BACTERIOL, V192, P1652, DOI 10.1128/JB.01269-09; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; HUBER H, 1982, ARCH MICROBIOL, V132, P47, DOI 10.1007/BF00690816; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; Jannasch H. W., 1989, AUTOTROPHIC BACTERIA, P147; JANNASCH HW, 1992, APPL ENVIRON MICROB, V58, P3472, DOI 10.1128/AEM.58.11.3472-3481.1992; Johnson EF, 2005, J BIOL CHEM, V280, P38776, DOI 10.1074/jbc.M503492200; Johnson EF, 2008, APPL ENVIRON MICROB, V74, P3591, DOI 10.1128/AEM.00098-08; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; Kah LC, 2004, NATURE, V431, P834, DOI 10.1038/nature02974; Kaster AK, 2011, ARCHAEA, V2011, DOI 10.1155/2011/973848; Kendall MM, 2006, INT J SYST EVOL MICR, V56, P1525, DOI 10.1099/ijs.0.64216-0; Klein M, 2001, J BACTERIOL, V183, P6028, DOI 10.1128/JB.183.20.6028-6035.2001; Klenk HP, 1997, NATURE, V390, P364, DOI 10.1038/37052; Lee JS, 2011, PROCESS BIOCHEM, V46, P154, DOI 10.1016/j.procbio.2010.08.004; Leigh JA, 2002, BIODIVERSITY MICROBI, P103; Lubbe YJ, 2006, FEMS MICROBIOL LETT, V261, P194, DOI 10.1111/j.1574-6968.2006.00343.x; McCollom TM, 1997, GEOCHIM COSMOCHIM AC, V61, P4375, DOI 10.1016/S0016-7037(97)00241-X; Mehta MP, 2006, SCIENCE, V314, P1783, DOI 10.1126/science.1134772; MOURA JJG, 1982, BIOCHEM BIOPH RES CO, V108, P1002, DOI 10.1016/0006-291X(82)92099-X; Oliveira TF, 2008, J STRUCT BIOL, V164, P236, DOI 10.1016/j.jsb.2008.07.007; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Parey K, 2010, BIOCHEMISTRY-US, V49, P8912, DOI 10.1021/bi100781f; Perevalova AA, 2005, INT J SYST EVOL MICR, V55, P995, DOI 10.1099/ijs.0.63378-0; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Ronquist F., 2012, SYST BIOL; Rothe O, 2000, EXTREMOPHILES, V4, P247, DOI 10.1007/PL00010716; Sander J, 2006, ARCH MICROBIOL, V186, P357, DOI 10.1007/s00203-006-0156-y; Schiffer A, 2008, J MOL BIOL, V379, P1063, DOI 10.1016/j.jmb.2008.04.027; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; SHUBER AP, 1986, J BIOL CHEM, V261, P2942; Slesarev AI, 2002, P NATL ACAD SCI USA, V99, P4644, DOI 10.1073/pnas.032671499; Stahl DA, 2002, ANTON LEEUW INT J G, V81, P189, DOI 10.1023/A:1020506415921; STETTER KO, 1981, ZBL BAKT MIK HYG I C, V2, P166, DOI 10.1016/S0721-9571(81)80038-5; TAN J, 1991, BIOCHEMISTRY-US, V30, P9900, DOI 10.1021/bi00105a013; Teske A, 2003, BIOL BULL-US, V204, P186, DOI 10.2307/1543556; van den Heuvel RHH, 2004, CELL MOL LIFE SCI, V61, P669, DOI 10.1007/s00018-003-3316-0; WEDZICHA BL, 1992, FOOD ADDIT CONTAM, V9, P449, DOI 10.1080/02652039209374097; WOLFE RS, 1992, BIOCHEM SOC SYMP, P41; ZEIKUS JG, 1972, J BACTERIOL, V109, P707, DOI 10.1128/JB.109.2.707-713.1972; ZHILINA TN, 1987, DOKL AKAD NAUK SSSR+, V293, P464	66	25	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45313	10.1371/journal.pone.0045313	http://dx.doi.org/10.1371/journal.pone.0045313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028926	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800038
J	Brown, HLD; Kaun, KR; Edgar, BA				Brown, Heather L. D.; Kaun, Karla R.; Edgar, Bruce A.			The Small GTPase Rheb Affects Central Brain Neuronal Morphology and Memory Formation in Drosophila	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; LONG-TERM-MEMORY; CELL-CYCLE PROGRESSION; INSULIN-LIKE PEPTIDES; MUSHROOM BODY; MTOR INHIBITORS; MODEL; GROWTH; TSC1; EXPRESSION	Mutations in either of two tumor suppressor genes, TSC1 or TSC2, cause tuberous sclerosis complex (TSC), a syndrome resulting in benign hamartomatous tumors and neurological disorders. Cellular growth defects and neuronal disorganization associated with TSC are believed to be due to upregulated TOR signaling. We overexpressed Rheb, an upstream regulator of TOR, in two different subsets of D. melanogaster central brain neurons in order to upregulate the Tsc-Rheb-TOR pathway. Overexpression of Rheb in either the mushroom bodies or the insulin producing cells resulted in enlarged axon projections and cell bodies, which continued to increase in size with prolonged Rheb expression as the animals aged. Additionally, Rheb overexpression in the mushroom bodies resulted in deficiencies in 3 hr but not immediate appetitive memory. Thus, Rheb overexpression in the central brain neurons of flies causes not only morphological phenotypes, but behavioral and aging phenotypes that may mirror symptoms of TSC.	[Brown, Heather L. D.; Edgar, Bruce A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Kaun, Karla R.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Fred Hutchinson Cancer Center; University of California System; University of California San Francisco	Edgar, BA (corresponding author), German Canc Res Ctr, Ctr Mol Biol Heidelberg Alliance, D-6900 Heidelberg, Germany.	b.edgar@zmbh.uni-heidelberg.de		Kaun, Karla/0000-0002-8756-9528	National Institutes of Health (NIH) [NS058230]; Heart and Stroke Foundation of Canada; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058230] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research was supported by National Institutes of Health (NIH) R01 grant NS058230 to BAE and by the Heart and Stroke Foundation of Canada Fellowship (to KRK) and NIH-R01 to Ulrike Heberlein (Dept. Anatomy, University of California San Francisco, San Francisco, CA, 94158, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIS JP, 1988, J CELL BIOL, V107, P17, DOI 10.1083/jcb.107.1.17; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Buckingham SD, 2004, HUM MOL GENET, V13, pR275, DOI 10.1093/hmg/ddh224; Burke CJ, 2011, CURR BIOL, V21, P746, DOI 10.1016/j.cub.2011.03.032; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Cervantes-Sandoval I, 2012, CURR BIOL, V22, P1; Chen CC, 2012, SCIENCE, V335, P678, DOI 10.1126/science.1212735; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Colomb J, 2009, GENES BRAIN BEHAV, V8, P407, DOI 10.1111/j.1601-183X.2009.00482.x; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Ehninger D, 2009, J INTELL DISABIL RES, V53, P838, DOI 10.1111/j.1365-2788.2009.01208.x; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Floricel F, 2007, BRAIN DEV-JPN, V29, P502, DOI 10.1016/j.braindev.2007.01.007; Fujita M, 2011, CURR BIOL, V21, P751, DOI 10.1016/j.cub.2011.03.058; Goldsmith AD, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-33; Goorden SMI, 2007, ANN NEUROL, V62, P648, DOI 10.1002/ana.21317; Habib SL, 2008, NEUROCHEM RES, V33, P1113, DOI 10.1007/s11064-007-9558-8; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito K, 1997, DEVELOPMENT, V124, P761; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; Karbowniczek M, 2010, J CLIN INVEST, V120, P93, DOI 10.1172/JCI40221; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; Keene AC, 2006, CURR BIOL, V16, P1524, DOI 10.1016/j.cub.2006.06.022; Knox S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000375; Krashes MJ, 2008, J NEUROSCI, V28, P3103, DOI 10.1523/JNEUROSCI.5333-07.2008; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee T, 1999, DEVELOPMENT, V126, P4065; Leung Alexander K C, 2007, J Pediatr Health Care, V21, P108, DOI 10.1016/j.pedhc.2006.05.004; Li YH, 2008, J BIOL CHEM, V283, P33784, DOI 10.1074/jbc.M802431200; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Nobukini Takahiro, 2004, Novartis Found Symp, V262, P148; Nouspikel T, 2003, BIOESSAYS, V25, P168, DOI 10.1002/bies.10227; Patel PH, 2006, J CELL SCI, V119, P4285, DOI 10.1242/jcs.03199; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Roscic A, 2011, J NEUROCHEM, V119, P398, DOI 10.1111/j.1471-4159.2011.07435.x; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Shohat-Ophir G, 2012, SCIENCE, V336, P541; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Talos DM, 2008, ANN NEUROL, V63, P454, DOI 10.1002/ana.21342; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Ueno S, 2011, DEV GROWTH DIFFER, V53, P924, DOI 10.1111/j.1440-169X.2011.01297.x; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; von der Brelie C, 2006, EUR J NEUROSCI, V23, P686, DOI 10.1111/j.1460-9568.2006.04594.x; Wang S, 2007, P NATL ACAD SCI USA, V104, P19873, DOI 10.1073/pnas.0707465104; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Wang YL, 2007, ANN NEUROL, V61, P139, DOI 10.1002/ana.21058; Way SW, 2009, HUM MOL GENET, V18, P1252, DOI 10.1093/hmg/ddp025; Wildonger J, 2008, GENE DEV, V22, P2447, DOI 10.1101/gad.1724108; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106; Zielke N, 2011, NATURE, V480, P123, DOI 10.1038/nature10579	73	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44888	10.1371/journal.pone.0044888	http://dx.doi.org/10.1371/journal.pone.0044888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028662	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400047
J	Hall, L; Johansson, P; Strandberg, T				Hall, Lars; Johansson, Petter; Strandberg, Thomas			Lifting the Veil of Morality: Choice Blindness and Attitude Reversals on a Self-Transforming Survey	PLOS ONE			English	Article							BEHAVIOR; COGNITION	Every day, thousands of polls, surveys, and rating scales are employed to elicit the attitudes of humankind. Given the ubiquitous use of these instruments, it seems we ought to have firm answers to what is measured by them, but unfortunately we do not. To help remedy this situation, we present a novel approach to investigate the nature of attitudes. We created a self-transforming paper survey of moral opinions, covering both foundational principles, and current dilemmas hotly debated in the media. This survey used a magic trick to expose participants to a reversal of their previously stated attitudes, allowing us to record whether they were prepared to endorse and argue for the opposite view of what they had stated only moments ago. The result showed that the majority of the reversals remained undetected, and a full 69% of the participants failed to detect at least one of two changes. In addition, participants often constructed coherent and unequivocal arguments supporting the opposite of their original position. These results suggest a dramatic potential for flexibility in our moral attitudes, and indicates a clear role for self-attribution and post-hoc rationalization in attitude formation and change.	[Hall, Lars; Johansson, Petter; Strandberg, Thomas] Lund Univ, Lund Univ Cognit Sci, Lund, Sweden; [Johansson, Petter] Uppsala Univ, Swedish Coll Adv Study, Uppsala, Sweden	Lund University; Swedish Collegium for Advanced Study (SCAS); Uppsala University	Johansson, P (corresponding author), Lund Univ, Lund Univ Cognit Sci, Lund, Sweden.	petter.johansson@lucs.lu.se			Foundation Natur and Kultur; Swedish Research Council; Crafoord Foundation; Bank of Sweden Tercentenary Foundation	Foundation Natur and Kultur; Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Bank of Sweden Tercentenary Foundation	The Foundation Natur and Kultur, The Swedish Research Council, The Crafoord Foundation and The Bank of Sweden Tercentenary Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2010, FRONT SOC PSYCHOL, P289; Albarracin D., 2005, HDB ATTITUDES; Ariely D, 2008, TRENDS COGN SCI, V12, P13, DOI 10.1016/j.tics.2007.10.008; Bassili JN, 1996, J PERS SOC PSYCHOL, V71, P637, DOI 10.1037/0022-3514.71.4.637; Bem DJ, 1972, ADV EXPT SOCIAL PSYC, V6, P1, DOI DOI 10.1016/S0065-2601(08)60024-6; Beshears J, 2008, J PUBLIC ECON, V92, P1787, DOI 10.1016/j.jpubeco.2008.04.010; Bishop George F, 2004, ILLUSION PUBLIC OPIN; Bohner G, 2011, ANNU REV PSYCHOL, V62, P391, DOI 10.1146/annurev.psych.121208.131609; Brinol P, 2012, J PERSONALITY SOCIAL; CONVERSE PE, 1964, IDEOLOGY DISCONTENT; Dennett D.C., 1991, CONSCIOUSNESS EXPLAI; Dennett D.C., 1987, INTENTIONAL STANCE, DOI [10.2307/2026682, DOI 10.2307/2026682]; Eaton AA, 2008, EUR REV SOC PSYCHOL, V19, P165, DOI 10.1080/10463280802383791; Ferguson MJ, 2012, LIKES DISLIKES SOCIA; Festinger L, 1957, THEORY COGNTIVE DISS; Fishbein, 2000, EUR REV SOC PSYCHOL, V11, P1, DOI [https://doi.org/10.1080/14792779943000116, DOI 10.1080/14792779943000116, 10.1080/14792779943000116]; Forgas J. P., 2010, PSYCHOL ATTITUDES AT; Gawronski B, 2007, SOC COGNITION, V25, P573, DOI 10.1521/soco.2007.25.5.573; Glasman LR, 2006, PSYCHOL BULL, V132, P778, DOI 10.1037/0033-2909.132.5.778; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; GROSS SJ, 1975, PUBLIC OPIN QUART, V39, P358, DOI 10.1086/268234; Grune-Yanoff T., 2004, ANAL KRITIK, V26, P382; Haddock G, 2004, CONTEMPORARY PERSPECTIVES ON THE PSYCHOLOGY OF ATTITUDES, P1; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J., 2007, MORAL PSYCHOL, V2, P181; Hall L, 2010, COGNITION, V117, P54, DOI 10.1016/j.cognition.2010.06.010; JANIS IL, 1954, J ABNORM SOC PSYCH, V49, P211, DOI 10.1037/h0056957; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; Johansson P, 2006, CONSCIOUS COGN, V15, P673, DOI 10.1016/j.concog.2006.09.004; Johansson P, 2012, NEUROSCIENCE OF PREFERENCE AND CHOICE: COGNITIVE AND NEURAL MECHANISMS, P121, DOI 10.1016/B978-0-12-381431-9.00006-1; Koriat A, 2012, PSYCHOL REV, V119, P80, DOI 10.1037/a0025648; Lawson SR, 2001, LEISURE SCI, V23, P179, DOI 10.1080/014904001316896864; Lowenthal D, 2001, POLIT PSYCHOL, V22, P65, DOI 10.1111/0162-895X.00226; Mercier H, 2011, BEHAV BRAIN SCI, V34, P57, DOI 10.1017/S0140525X10000968; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Petrocelli JV, 2007, J PERS SOC PSYCHOL, V92, P30, DOI 10.1037/0022-3514.92.1.30; Petrusic WM, 2003, PSYCHON B REV, V10, P177, DOI 10.3758/BF03196482; Schwarz N, 2001, AM J EVAL, V22, P127, DOI 10.1177/109821400102200202; Schwarz N, 2008, J CONSUM PSYCHOL, V18, P153, DOI 10.1016/j.jcps.2008.04.012; Thurstone LL, 1931, J SOC PSYCHOL, V2, P139, DOI 10.1080/00224545.1931.9918964; Tunney RJ, 2005, PSYCHON B REV, V12, P367, DOI 10.3758/BF03196386; Uhlmann EL, 2009, JUDGM DECIS MAK, V4, P479; Varian H. R., 2006, SAMUELSONIAN EC 21 C, P99	44	81	81	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45457	10.1371/journal.pone.0045457	http://dx.doi.org/10.1371/journal.pone.0045457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23029020	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400087
J	Yoshimoto, AN; Bernardazzi, C; Carneiro, AJV; Elia, CCS; Martinusso, CA; Ventura, GM; Castelo-Branco, MTL; de Souza, HSP				Yoshimoto, Agnes N.; Bernardazzi, Claudio; Carneiro, Antonio Jose V.; Elia, Celeste C. S.; Martinusso, Cesonia A.; Ventura, Grasiella M.; Castelo-Branco, Morgana T. L.; de Souza, Heitor S. P.			Hedgehog Pathway Signaling Regulates Human Colon Carcinoma HT-29 Epithelial Cell Line Apoptosis and Cytokine Secretion	PLOS ONE			English	Article							COLORECTAL-CANCER; GLI GENES; EXPRESSION; DIFFERENTIATION; REQUIREMENT; ANTAGONIST; CHEMOKINES; SURVIVAL; NETWORK; TARGET	The Hedgehog (Hh) pathway is involved in embryogenesis and physiologic processes including cell survival and proliferation. We used the HT-29 and other human colon carcinoma cell lines to investigate Hh signaling and biological functions in colonic epithelial cells. HT-29 cells were cultured under different conditions and exposed to various stimuli. The expression of Hh pathway components and related genes and proteins were assessed by real-time PCR and immunofluorescence. Viability, apoptosis and cell proliferation were measured by the MTT assay, Annexin-V/7-AAD staining and BrdU uptake, respectively. Chemokines production was measured by ELISA in culture supernatants. Indian and Sonic Hh mRNA levels and the downstream transcription factors Gli-1 and Gli-2 increased following treatment with Hh agonists and butyrate, but decreased upon exposure to cyclopamine or GANT61. BMP4 and BMP7 expression increased after stimulation with Hh agonists. Gli-1 protein expression increased after Hh agonists and decreased following cyclopamine. Exposure to Hh agonists promoted beta-catenin reduction and subcellular redistribution. Levels of IL-8 and MCP-1 decreased upon exposure to Hh agonists compared to Hh antagonists, LPS, IFN-gamma or EGF. Monocyte chemotaxis decreased upon exposure to supernatants of HT-29 cells treated with Shh compared to Hh antagonists, LPS and IFN-gamma. Cellular incorporation of BrdU and cell viability decreased following Hh blockade. Hh agonists abrogated the anti-CD95 induced apoptosis. Hh pathway is a key controller of colon cancer cells, as demonstrated by its effect in dampening inflammatory signals and antagonizing apoptosis. The differential expression of Hh components may underlie abnormalities in the local immune response and in epithelial barrier integrity, with potential homeostatic implications for the development of colonic inflammation and malignancies.	[Yoshimoto, Agnes N.; Bernardazzi, Claudio; Martinusso, Cesonia A.; de Souza, Heitor S. P.] Univ Fed Rio de Janeiro, Lab Multidisciplinar Pesquisa, Rio De Janeiro, Brazil; [Yoshimoto, Agnes N.; Carneiro, Antonio Jose V.; Elia, Celeste C. S.; de Souza, Heitor S. P.] Univ Fed Rio de Janeiro, Dept Clin Med, Serv Gastroenterol, Rio De Janeiro, Brazil; [Ventura, Grasiella M.] Univ Fed Rio de Janeiro, Unidade Microscopia Confocal, Rio De Janeiro, Brazil; [Castelo-Branco, Morgana T. L.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Imunol Celular, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	de Souza, HSP (corresponding author), Univ Fed Rio de Janeiro, Lab Multidisciplinar Pesquisa, Rio De Janeiro, Brazil.	hsouza@hucff.ufrj.br	de Souza, Heitor Siffert Pereira/G-3297-2012	de Souza, Heitor Siffert Pereira/0000-0002-3647-7324	Brazilian Research Council (CNPq); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)	Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from the Brazilian Research Council (CNPq; http://www.cnpq.br/) and the FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; http://www.faperj.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinger B, 2009, VIRCHOWS ARCH, V454, P369, DOI 10.1007/s00428-009-0753-7; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bai JW, 2002, DEVELOPMENT, V129, P5377, DOI 10.1242/dev.00115; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Chatel G, 2007, INT J CANCER, V121, P2622, DOI 10.1002/ijc.22998; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Douard R, 2006, SURGERY, V139, P665, DOI 10.1016/j.surg.2005.10.012; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Katoh Y, 2006, INT J MOL MED, V17, P171; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2006, INT J MOL MED, V18, P1019; Kobune M, 2009, CANCER SCI, V100, P948, DOI 10.1111/j.1349-7006.2009.01111.x; Kolligs FT, 2002, DIGESTION, V66, P131, DOI 10.1159/000066755; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Lees C, 2005, GASTROENTEROLOGY, V129, P1696, DOI 10.1053/j.gastro.2005.05.010; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Lu ZM, 2004, CELL CYCLE, V3, P571; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Mazumdar T, 2011, ONCOTARGET, V2, P638; Mazumdar T, 2011, CANCER RES, V71, P5904, DOI 10.1158/0008-5472.CAN-10-4173; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; Mazzucchelli L, 1996, J PATHOL, V178, P201, DOI 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Ohta M, 2005, CANCER RES, V65, P10822, DOI 10.1158/0008-5472.CAN-05-0777; Oniscu A, 2004, J PATHOL, V203, P909, DOI 10.1002/path.1591; Qualtrough D, 2004, INT J CANCER, V110, P831, DOI 10.1002/ijc.20227; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Saaf AM, 2007, MOL BIOL CELL, V18, P4245, DOI 10.1091/mbc.E07-04-0309; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; van den Brink GR, 2006, GUT, V55, P912, DOI 10.1136/gut.2005.085902; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van Dop WA, 2009, GASTROENTEROLOGY, V136, P2195, DOI 10.1053/j.gastro.2009.02.068; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Xu MH, 2012, MED ONCOL, V29, P1010, DOI 10.1007/s12032-011-9899-7; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yoshikawa K, 2009, J GASTROENTEROL, V44, P1113, DOI 10.1007/s00535-009-0110-2; You SH, 2010, UPSALA J MED SCI, V115, P169, DOI 10.3109/03009731003668316; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200; Yu T, 2011, MOL CANCER RES, V9, P161, DOI 10.1158/1541-7786.MCR-10-0386	49	31	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45332	10.1371/journal.pone.0045332	http://dx.doi.org/10.1371/journal.pone.0045332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028941	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400075
J	Al-Qahtani, A; Al-Anazi, M; Viswan, NA; Khalaf, N; Abdo, AA; Sanai, FM; Al-Ashgar, H; Al-Ahdal, M				Al-Qahtani, Ahmed; Al-Anazi, Mashael; Viswan, Nisha A.; Khalaf, Nisreen; Abdo, Ayman A.; Sanai, Faisal M.; Al-Ashgar, Hamad; Al-Ahdal, Mohammed			Role of Single Nucleotide Polymorphisms of KIF1B Gene in HBV-Associated Viral Hepatitis	PLOS ONE			English	Article							B-VIRUS INFECTION; 1P36 TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; POPULATION STRATIFICATION; INFLUENCES SUSCEPTIBILITY; CHINESE POPULATION; ALPHA; GENOTYPES; VARIANTS; MUTATION	Background/Aim: Kinesin family member 1B (KIF1B) gene resides in the chromosomal region 1p36.22 and has been reported to have frequent deletions in a variety of human cancers. A recent genome wide association study (GWAS) study conducted on a Chinese population has reported the involvement of a KIF1B genetic variant in Hepatitis B virus (HBV)related hepatocellular carcinoma (HCC). This study aims to investigate the significance of KIF1B genetic variations in HBVassociated hepatitis in patients of Saudi Arabian ethnicity. Methods: TaqMan genotyping assay was used to investigate the association of three SNPs (rs17401966, rs12734551, and rs3748578) in 584 normal healthy controls and 660 HBV-infected patients. The patients were categorized into inactive carriers (Case I), active carriers (Case II), Cirrhosis (Case III) and Cirrhosis-HCC (Case IV) sub-groups. Results: Since SNPs rs12734551 and rs3748578 are in strong linkage disequilibrium (LD) with rs17401966, only results for the latter SNP are reported. Therefore, the allele frequency of rs17401966 among HBV-infected patients and healthy controls were comparable and therefore, no significant association was observed (P = 0.2811, Odds Ratio (OR) 0.897). A similar analysis was performed among the different sub-groups in order to determine whether KIF1B SNPs were associated with the advancement of the disease. No significant differences were observed in any of the comparisons performed. Conclusion: Polymorphisms at KIF1B gene locus investigated in this study showed no significant association with HBV infection or with HBV-associated diseases such as liver cirrhosis or HCC.	[Al-Qahtani, Ahmed; Al-Anazi, Mashael; Viswan, Nisha A.; Khalaf, Nisreen; Al-Ahdal, Mohammed] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Res Ctr, Riyadh 11211, Saudi Arabia; [Al-Qahtani, Ahmed; Abdo, Ayman A.; Sanai, Faisal M.] King Saud Univ, Liver Dis Res Ctr, Riyadh, Saudi Arabia; [Abdo, Ayman A.] King Saud Univ, Coll Med, Dept Med, Riyadh 11461, Saudi Arabia; [Sanai, Faisal M.] King Abdul Aziz Med City, Dept Hepatobiliary Sci & Liver Transplantat, Riyadh, Saudi Arabia; [Al-Ashgar, Hamad] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia; [Al-Ahdal, Mohammed] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Saud University; King Saud University; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center	Al-Qahtani, A (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Res Ctr, Riyadh 11211, Saudi Arabia.	aqahtani@kfshrc.edu.sa		Viswan, Nisha/0000-0002-4509-5811	King Abdulaziz City for Science and Technology [ARP-27-18]; Research Center administration at King Faisal Specialist Hospital & Research Center	King Abdulaziz City for Science and Technology; Research Center administration at King Faisal Specialist Hospital & Research Center	This study was supported in part by a grant from King Abdulaziz City for Science and Technology [ARP-27-18]. This study was approved by Research Advisory Council of King Faisal Specialist Hospital and Research Centre, RAC # 2060040. The support of the Research Center administration at King Faisal Specialist Hospital & Research Center is highly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott W, 2007, IMMUNOGENETICS, V59, P187, DOI 10.1007/s00251-006-0184-4; Abdo AA, 2006, WORLD J GASTROENTERO, V12, P7019, DOI 10.3748/wjg.v12.i43.7019; Abdo AA, 2006, ANN SAUDI MED, V26, P261, DOI 10.5144/0256-4947.2006.261; Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Al-Qahtani A, 2012, GENET MOL RES, V11, P855, DOI 10.4238/2012.April.10.1; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Cheong JY, 2006, J GASTROEN HEPATOL, V21, P1163, DOI 10.1111/j.1440-1746.2006.04304.x; Danquah JO, 2012, J VIROL, V86, P844, DOI 10.1128/JVI.06109-11; Fung J, 2010, EXPERT REV ANTI-INFE, V8, P717, DOI 10.1586/ERI.10.45; Gasnereau I, 2012, AM J PATHOL, V180, P131, DOI 10.1016/j.ajpath.2011.09.040; Guo XC, 2011, HEPATOLOGY, V53, P422, DOI 10.1002/hep.24048; Hohler T, 1997, J HEPATOL, V26, P503, DOI 10.1016/S0168-8278(97)80414-X; Li S, 2011, INFECT GENET EVOL, V11, P2083, DOI 10.1016/j.meegid.2011.09.025; Migita K, 2007, J HEPATOL, V46, P381, DOI 10.1016/j.jhep.2006.09.015; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Qiu B, 2012, ACTA BIOCH BIOPHYS S; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Stacey SN, 2008, NAT GENET, V40, P1313, DOI 10.1038/ng.234; Strunze S, 2011, CELL HOST MICROBE, V10, P210, DOI 10.1016/j.chom.2011.08.010; Suneetha PV, 2006, J HEPATOL, V44, P856, DOI 10.1016/j.jhep.2006.01.028; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Xie H, 2007, DIGEST LIVER DIS, V39, P167, DOI 10.1016/j.dld.2006.10.015; Yan ZH, 2012, WORLD J GASTROENTERO, V18, P3119, DOI 10.3748/wjg.v18.i24.3119; Yan ZH, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-49; Yeh IT, 2008, HUM GENET, V124, P279, DOI 10.1007/s00439-008-0553-1; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zhong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028839	34	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45128	10.1371/journal.pone.0045128	http://dx.doi.org/10.1371/journal.pone.0045128			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028799	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900084
J	Eskat, A; Deng, W; Hofmeister, A; Rudolphi, S; Emmerth, S; Hellwig, D; Ulbricht, T; Doring, V; Bancroft, JM; McAinsh, AD; Cardoso, MC; Meraldi, P; Hoischen, C; Leonhardt, H; Diekmann, S				Eskat, Anja; Deng, Wen; Hofmeister, Antje; Rudolphi, Sven; Emmerth, Stephan; Hellwig, Daniela; Ulbricht, Tobias; Doering, Volker; Bancroft, James M.; McAinsh, Andrew D.; Cardoso, M. Cristina; Meraldi, Patrick; Hoischen, Christian; Leonhardt, Heinrich; Diekmann, Stephan			Step-Wise Assembly, Maturation and Dynamic Behavior of the Human CENP-P/O/R/Q/U Kinetochore SubComplex	PLOS ONE			English	Article							CONSTITUTIVE CENTROMERE COMPONENT; LIVING HUMAN-CELLS; OUTER KINETOCHORE; IN-VIVO; A NUCLEOSOMES; MLF1-INTERACTING PROTEIN; MICROTUBULE INTERACTIONS; VERTEBRATE KINETOCHORES; MOLECULAR ARCHITECTURE; CHROMOSOME SEGREGATION	Kinetochores are multi-protein megadalton assemblies that are required for attachment of microtubules to centromeres and, in turn, the segregation of chromosomes in mitosis. Kinetochore assembly is a cell cycle regulated multi-step process. The initial step occurs during interphase and involves loading of the 15-subunit constitutive centromere associated complex (CCAN), which contains a 5-subunit (CENP-P/O/R/Q/U) sub-complex. Here we show using a fluorescent three-hybrid (F3H) assay and fluorescence resonance energy transfer (FRET) in living mammalian cells that CENP-P/O/R/Q/U subunits exist in a tightly packed arrangement that involves multifold protein-protein interactions. This sub-complex is, however, not pre-assembled in the cytoplasm, but rather assembled on kinetochores through the step-wise recruitment of CENP-O/P heterodimers and the CENP-P, -O, -R, -Q and -U single protein units. SNAP-tag experiments and immuno-staining indicate that these loading events occur during S-phase in a manner similar to the nucleosome binding components of the CCAN, CENP-T/W/N. Furthermore, CENP-P/O/R/Q/U binding to the CCAN is largely mediated through interactions with the CENP-N binding protein CENP-L as well as CENP-K. Once assembled, CENP-P/O/R/Q/U exchanges slowly with the free nucleoplasmic pool indicating a low off-rate for individual CENP-P/O/R/Q/U subunits. Surprisingly, we then find that during late S-phase, following the kinetochore-binding step, both CENP-Q and -U but not -R undergo oligomerization. We propose that CENP-P/O/R/Q/U self-assembles on kinetochores with varying stoichiometry and undergoes a pre-mitotic maturation step that could be important for kinetochores switching into the correct conformation necessary for microtubule-attachment.	[Eskat, Anja; Hofmeister, Antje; Rudolphi, Sven; Hellwig, Daniela; Ulbricht, Tobias; Doering, Volker; Hoischen, Christian; Diekmann, Stephan] FLI, Jena, Germany; [Deng, Wen; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci, Dept Biol 2, Munich, Germany; [Emmerth, Stephan; Meraldi, Patrick] ETH, Inst Biochem, Zurich, Switzerland; [Bancroft, James M.; McAinsh, Andrew D.] Univ Warwick, Warwick Med Sch, Ctr Mechanochem Cell Biol, Coventry CV4 7AL, W Midlands, England; [Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany	Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Warwick; Technical University of Darmstadt	Diekmann, S (corresponding author), FLI, Jena, Germany.	diekmann@fli-leibniz.de	Deng, Wen/GQH-3160-2022; Meraldi, Patrick/D-6190-2013; McAinsh, Andrew/C-6438-2012; Leonhardt, Heinrich/B-2791-2014	Deng, Wen/0000-0003-3062-7843; Meraldi, Patrick/0000-0001-9742-8756; McAinsh, Andrew/0000-0001-6808-0711	Deutsche Forschungsgemeinschaft [DFG DI 258/17-1, SPP1128, SPP1395]; Thuringer Aufbaubank [2007 FE 9011]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Thuringer Aufbaubank	This work was supported by Deutsche Forschungsgemeinschaft (DFG DI 258/17-1, SPP1128, SPP1395), and Thuringer Aufbaubank (2007 FE 9011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; Bacia K, 2007, NATURE PROTOCOLS; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Bui M, 2012, CELL, V150, P317, DOI 10.1016/j.cell.2012.05.035; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; Digman MA, 2005, BIOPHYS J, V89, P1317, DOI 10.1529/biophysj.105.062836; Dong Y, 2010, NAT CELL BIOL, V9, P516; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fukagawa T, 2001, EMBO J, V20, P4603, DOI 10.1093/emboj/20.16.4603; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Hanissian SH, 2004, ONCOGENE, V23, P3700, DOI 10.1038/sj.onc.1207448; Hellwig D, 2009, EUR BIOPHYS J BIOPHY, V38, P781, DOI 10.1007/s00249-009-0498-x; Hellwig D, 2011, J CELL SCI, V124, P3871, DOI 10.1242/jcs.088625; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Hemmerich P, 2011, CHROMOSOME RES, V19, P131, DOI 10.1007/s10577-010-9161-8; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hua SS, 2011, J BIOL CHEM, V286, P1627, DOI 10.1074/jbc.M110.174946; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Johnston K, 2010, J CELL BIOL, V189, P937, DOI 10.1083/jcb.200912022; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kang YH, 2011, J BIOL CHEM, V286, P19744, DOI 10.1074/jbc.M111.224105; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; Kohl T, 2005, BIOPHYS J, V89, P2770, DOI 10.1529/biophysj.105.061127; Lawrimore J, 2011, J CELL BIOL, V195, P573, DOI 10.1083/jcb.201106036; Lee KS, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-4; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; McClelland SE, 2007, EMBO J, V26, P5033, DOI 10.1038/sj.emboj.7601927; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Milks KJ, 2009, MOL BIOL CELL, V20, P4246, DOI 10.1091/mbc.E09-05-0378; Minoshima Y, 2005, MOL CELL BIOL, V25, P10315, DOI 10.1128/MCB.25.23.10315-10328.2005; Moree B, 2011, J CELL BIOL, V194, P855, DOI 10.1083/jcb.201106079; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Orthaus S, 2009, NUCLEIC ACIDS RES, V37, P3391, DOI 10.1093/nar/gkp199; Orthaus S, 2008, CHEMBIOCHEM, V9, P77, DOI 10.1002/cbic.200700358; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Petrovic A, 2010, J CELL BIOL, V190, P835, DOI 10.1083/jcb.201002070; Prendergast L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001082; Przewloka MR, 2011, CURR BIOL, V21, P399, DOI 10.1016/j.cub.2011.02.005; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Qiu SL, 2009, SCI CHINA SER C, V52, P352, DOI 10.1007/s11427-009-0050-3; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Schmitzberger F, 2012, EMBO REP, V13, P216, DOI 10.1038/embor.2012.1; Sporbert A, 2005, NUCLEIC ACIDS RES, V33, P3521, DOI 10.1093/nar/gki665; Suzuki H, 2007, ANTICANCER RES, V27, P1423; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Takeuchi K, 2012, EXP CELL RES, V318, P1367, DOI 10.1016/j.yexcr.2012.02.016; Tanaka TU, 2008, CURR OPIN CELL BIOL, V20, P53, DOI 10.1016/j.ceb.2007.11.005; Toso A, 2009, J CELL BIOL, V184, P365, DOI 10.1083/jcb.200809055; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	70	27	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44717	10.1371/journal.pone.0044717	http://dx.doi.org/10.1371/journal.pone.0044717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028590	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900039
J	Heil, CSS; Noor, MAF				Heil, Caiti S. S.; Noor, Mohamed A. F.			Zinc Finger Binding Motifs Do Not Explain Recombination Rate Variation within or between Species of Drosophila	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; CHROMOSOME SEGREGATION; GENETIC-MAP; ROSY LOCUS; FRUIT-FLY; HOT-SPOTS; GENOME; PRDM9; HOTSPOTS; LANDSCAPE	In humans and mice, the Cys(2)His(2) zinc finger protein PRDM9 binds to a DNA sequence motif enriched in hotspots of recombination, possibly modifying nucleosomes, and recruiting recombination machinery to initiate Double Strand Breaks (DSBs). However, since its discovery, some researchers have suggested that the recombinational effect of PRDM9 is lineage or species specific. To test for a conserved role of PRDM9-like proteins across taxa, we use the Drosophila pseudoobscura species group in an attempt to identify recombination associated zinc finger proteins and motifs. We leveraged the conserved amino acid motifs in Cys(2)His(2) zinc fingers to predict nucleotide binding motifs for all Cys(2)His(2) zinc finger proteins in Drosophila pseudoobscura and identified associations with empirical measures of recombination rate. Additionally, we utilized recombination maps from D. pseudoobscura and D. miranda to explore whether changes in the binding motifs between species can account for changes in the recombination landscape, analogous to the effect observed in PRDM9 among human populations. We identified a handful of potential recombination-associated sequence motifs, but the associations are generally tenuous and their biological relevance remains uncertain. Furthermore, we found no evidence that changes in zinc finger DNA binding explains variation in recombination rate between species. We therefore conclude that there is no protein with a DNA sequence specific human-PRDM9-like function in Drosophila. We suggest these findings could be explained by the existence of a different recombination initiation system in Drosophila.	[Heil, Caiti S. S.; Noor, Mohamed A. F.] Duke Univ, Dept Biol, Durham, NC 27705 USA	Duke University	Heil, CSS (corresponding author), Duke Univ, Dept Biol, Durham, NC 27705 USA.	css25@duke.edu		Smukowski Heil, Caiti/0000-0002-2864-1315; Noor, Mohamed/0000-0002-5400-4408	National Science Foundation; SSE Rosemary Grant Award for Graduate Student Research; National Institutes of Health [GM086445]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086445] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); SSE Rosemary Grant Award for Graduate Student Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support and funding was provided by a National Science Foundation Graduate Research Fellowship (www.nsf.gov) to CSSH, a SSE Rosemary Grant Award for Graduate Student Research (www.evolutionsociety.org) to CSSH, and a National Institutes of Health grant awarded to MAFN (www.nih.gov, grant GM086445). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Aquadro CF, 2001, CURR OPIN GENET DEV, V11, P627, DOI 10.1016/S0959-437X(00)00245-8; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Axelsson E, 2012, GENOME RES, V22, P51, DOI 10.1101/gr.124123.111; Backstrom N, 2010, GENOME RES, V20, P485, DOI 10.1101/gr.101410.109; Barthes P, 2011, EPIGENETIC FACTORS R; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; CLARK SH, 1988, GENETICS, V118, P261; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Hawley R, 2002, MOL BIOL CELL, V13, p150A; HAWLEY RS, 1992, DEV GENET, V13, P440, DOI 10.1002/dvg.1020130608; Hey J, 2004, PLOS BIOL, V2, P730, DOI 10.1371/journal.pbio.0020190; HILLIKER AJ, 1991, GENETICS, V129, P779; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Jeffreys AJ, 2009, NAT GENET, V41, P625, DOI 10.1038/ng.346; Kaplan T, 2005, PLOS COMPUT BIOL, V1, P5, DOI 10.1371/journal.pcbi.0010001; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lake CM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002005; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; McGaugh SE, 2012, NATURE PRECEDINGS, DOI [10.1038/npre.2012.7005.1, DOI 10.1038/NPRE.2012.7005.1]; McKim KS, 2002, ANNU REV GENET, V36, P205, DOI 10.1146/annurev.genet.36.041102.113929; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Miller DE, 2012, G3-GENES GENOM GENET, V2, P249, DOI 10.1534/g3.111.001396; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; Munoz-Fuentes V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025498; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Oliver PL, 2009, PLOS GENETICS, V5; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Ponting CP, 2011, TRENDS GENET, V27, P165, DOI 10.1016/j.tig.2011.02.001; Radford SJ, 2007, GENETICS, V176, P53, DOI 10.1534/genetics.107.070367; RASMUSSEN SW, 1977, CHROMOSOMA, V60, P205, DOI 10.1007/BF00329771; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Singh ND, 2009, J MOL EVOL, V69, P42, DOI 10.1007/s00239-009-9250-5; Smukowski CS, 2011, HEREDITY, V107, P496, DOI 10.1038/hdy.2011.44; Steiner WW, 2011, GENETICS, V187, P385, DOI 10.1534/genetics.110.124636; Steiner WW, 2009, GENETICS, V182, P459, DOI 10.1534/genetics.109.101253; Stevison LS, 2010, J MOL EVOL, V71, P332, DOI 10.1007/s00239-010-9388-1; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wong AK, 2010, GENETICS, V184, P595, DOI 10.1534/genetics.109.106831; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439	66	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45055	10.1371/journal.pone.0045055	http://dx.doi.org/10.1371/journal.pone.0045055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028758	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900072
J	Ruscher, K; Inacio, AR; Valind, K; Ravan, AR; Kuric, E; Wieloch, T				Ruscher, Karsten; Inacio, Ana R.; Valind, Kristian; Ravan, Arman Rowshan; Kuric, Enida; Wieloch, Tadeusz			Effects of the Sigma-1 Receptor Agonist 1-(3,4-Dimethoxyphenethyl)-4-(3-Phenylpropyl)-Piperazine Dihydro-Chloride on Inflammation after Stroke	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ENRICHED ENVIRONMENT; RAT-BRAIN; IBA1; MICROGLIA; ACTIVATION; PROTEIN; CELLS; MECHANISMS; LIGAND	Activation of the sigma-1 receptor (Sig-1R) improves functional recovery in models of experimental stroke and is known to modulate microglia function. The present study was conducted to investigate if Sig-1R activation after experimental stroke affects mediators of the inflammatory response in the ischemic hemisphere. Male Wistar rats were subjected to transient occlusion of the middle cerebral artery (MCAO) and injected with the specific Sig-1R agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl) piperazine dihydrochloride (SA4503) or saline for 5 days starting on day 2 after MCAO. Treatment did not affect the increased levels of the pro-inflammatory cytokines interleukin 1 beta (IL-1 beta), tumor necrosis factor alpha (TNF-alpha), interferon gamma (IFN-gamma), interleukin 4 (IL-4), interleukin 5 (IL-5), and interleukin 13 (IL-13) in the infarct core and peri-infarct area after MCAO. In addition, treatment with SA4503 did not affect elevated levels of nitrite, TNF-alpha and IL-1 beta observed in primary cultures of microglia exposed to combined Hypoxia/Aglycemia, while the unspecific sigma receptor ligand 1,3-di-o-tolylguanidine (DTG) significantly decreased the production of nitrite and levels of TNF-alpha. Analysis of the ischemic hemisphere also revealed increased levels of ionized calcium binding adaptor molecule 1 (Iba1) levels in the infarct core of SA4503 treated animals. However, no difference in Iba1 immunoreactivity was detected in the infarct core. Also, levels of the proliferation marker proliferating cell nuclear antigen (PCNA) and OX-42 were not increased in the infarct core in rats treated with SA4503. Together, our results suggest that sigma-1 receptor activation affects Iba1 expression in microglia/macrophages of the ischemic hemisphere after experimental stroke but does not affect post-stroke inflammatory mediators.	[Ruscher, Karsten; Inacio, Ana R.; Valind, Kristian; Ravan, Arman Rowshan; Kuric, Enida; Wieloch, Tadeusz] Lund Univ, Expt Brain Res Lab, Wallenberg Neurosci Ctr, Dept Clin Sci,Div Neurosurg, S-22101 Lund, Sweden	Lund University	Ruscher, K (corresponding author), Lund Univ, Expt Brain Res Lab, Wallenberg Neurosci Ctr, Dept Clin Sci,Div Neurosurg, S-22101 Lund, Sweden.	karsten.ruscher@med.lu.se	Inacio, Ana/M-6905-2016	Wieloch, Tadeusz/0000-0002-7669-2520; Valind, Kristian/0000-0002-6796-9532	Swedish Research Council [2011-2684, 2011-2652]; EU through the European Stroke Network [201024]; Pia Stahls Foundation; The Swedish Brain Fund; Greta och Johan Kocks Stiftelser; Thorsten och Elsa Segerfalk stiftelse; Kungliga Fysiografiska Sallskapet i Lund; Anna-Lisa Rosenbergs fond	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU through the European Stroke Network; Pia Stahls Foundation; The Swedish Brain Fund; Greta och Johan Kocks Stiftelser; Thorsten och Elsa Segerfalk stiftelse; Kungliga Fysiografiska Sallskapet i Lund; Anna-Lisa Rosenbergs fond	This study was supported by the Swedish Research Council (grant 2011-2684 (KR) and grant 2011-2652 (TW)), the EU 7th workprogram through the European Stroke Network (grant No 201024), the Pia Stahls Foundation (TW), The Swedish Brain Fund (TW), the Greta och Johan Kocks Stiftelser (KR), the Thorsten och Elsa Segerfalk stiftelse (KR), the Kungliga Fysiografiska Sallskapet i Lund (KR) and the Anna-Lisa Rosenbergs fond (KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Ajmo CT, 2006, CURR NEUROVASC RES, V3, P89, DOI 10.2174/156720206776875849; Allahtavakoli M, 2011, BRAIN RES BULL, V85, P219, DOI 10.1016/j.brainresbull.2011.03.019; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; BEJANIAN M, 1991, J PHARMACOL EXP THER, V258, P88; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bourrie B, 2002, EUR J PHARMACOL, V456, P123, DOI 10.1016/S0014-2999(02)02646-8; Chapman KZ, 2009, J CEREBR BLOOD F MET, V29, P1764, DOI 10.1038/jcbfm.2009.113; Farber K, 2006, PFLUG ARCH EUR J PHY, V452, P615, DOI 10.1007/s00424-006-0064-7; Gannon C J, 2001, Surg Infect (Larchmt), V2, P267, DOI 10.1089/10962960152813304; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Hall AA, 2009, GLIA, V57, P744, DOI 10.1002/glia.20802; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Ishizaki T, 2010, J CEREBR BLOOD F MET, V30, P1756, DOI 10.1038/jcbfm.2010.39; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kanazawa H, 2002, J BIOL CHEM, V277, P20026, DOI 10.1074/jbc.M109218200; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Leonardo CC, 2010, TRANSL STROKE RES, V1, P135, DOI 10.1007/s12975-009-0005-9; Lever JR, 2006, SYNAPSE, V59, P350, DOI 10.1002/syn.20253; Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mitsios N, 2006, PATHOBIOLOGY, V73, P159, DOI 10.1159/000096017; Morgan SC, 2004, J NEUROCHEM, V90, P89, DOI 10.1111/j.1471-4159.2004.02461.x; Ohsawa K, 2000, J CELL SCI, V113, P3073; Rickhag M, 2008, J CEREBR BLOOD F MET, V28, P551, DOI 10.1038/sj.jcbfm.9600552; Ruscher K, 2011, BRAIN, V134, P732, DOI 10.1093/brain/awq367; Ruscher K, 2009, J CEREBR BLOOD F MET, V29, P1796, DOI 10.1038/jcbfm.2009.96; Schroeter M, 1999, NEUROSCIENCE, V89, P1367, DOI 10.1016/S0306-4522(98)00398-4; Smirkin A, 2010, J CEREBR BLOOD F MET, V30, P603, DOI 10.1038/jcbfm.2009.233; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; TAKASAKI Y, 1981, J EXP MED, V154, P1899, DOI 10.1084/jem.154.6.1899	37	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45118	10.1371/journal.pone.0045118	http://dx.doi.org/10.1371/journal.pone.0045118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028794	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900080
J	Smith, RA; Raugi, DN; Pan, C; Coyne, M; Hernandez, A; Church, B; Parker, K; Mullins, JI; Sow, PS; Gottlieb, GS				Smith, Robert A.; Raugi, Dana N.; Pan, Charlotte; Coyne, Matthew; Hernandez, Alexandra; Church, Brad; Parker, Kara; Mullins, James I.; Sow, Papa Salif; Gottlieb, Geoffrey S.		Univ Washington-Dakar HIV-2 Study	Three Main Mutational Pathways in HIV-2 Lead to High-Level Raltegravir and Elvitegravir Resistance: Implications for Emerging HIV-2 Treatment Regimens	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-2; VITRO PHENOTYPIC SUSCEPTIBILITY; INTEGRASE INHIBITOR RESISTANCE; ANTIRETROVIRAL DRUG-RESISTANCE; PROTEASE INHIBITORS; IN-VITRO; HIV-2-INFECTED INDIVIDUALS; WEST-AFRICA; EMERGENCE; SELECTION	Human immunodeficiency virus type 2 (HIV-2) is intrinsically resistant to non-nucleoside reverse transcriptase inhibitors and exhibits reduced susceptibility to several of the protease inhibitors used for antiretroviral therapy of HIV-1. Thus, there is a pressing need to identify new classes of antiretroviral agents that are active against HIV-2. Although recent data suggest that the integrase strand transfer inhibitors raltegravir and elvitegravir may be beneficial, mutations that are known to confer resistance to these drugs in HIV-1 have been reported in HIV-2 sequences from patients receiving raltegravir-containing regimens. To examine the phenotypic effects of mutations that emerge during raltegravir treatment, we constructed a panel of HIV-2 integrase variants using site-directed mutagenesis and measured the susceptibilities of the mutant strains to raltegravir and elvitegravir in culture. The effects of single and multiple amino acid changes on HIV-2 replication capacity were also evaluated. Our results demonstrate that secondary replacements in the integrase protein play key roles in the development of integrase inhibitor resistance in HIV-2. Collectively, our data define three major mutational pathways to high-level raltegravir and elvitegravir resistance: i) E92Q+Y143C or T97A+Y143C, ii) G140S+Q148R, and iii) E92Q+N155H. These findings preclude the sequential use of raltegravir and elvitegravir (or vice versa) for HIV-2 treatment and provide important information for clinical monitoring of integrase inhibitor resistance in HIV-2-infected individuals.	[Smith, Robert A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Raugi, Dana N.; Pan, Charlotte; Gottlieb, Geoffrey S.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA; [Coyne, Matthew; Hernandez, Alexandra; Church, Brad; Parker, Kara] Univ Washington, Coll Arts & Sci, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Sow, Papa Salif] Univ Cheikh Anta Diop, Ctr Hosp Univ Fann, Clin Malad Infect Ibrahima DIOP Mar, Dakar, Senegal	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University Cheikh Anta Diop Dakar	Smith, RA (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	smithra@u.washington.edu	Hernandez, Alexandra/AAJ-8735-2020	Hernandez, Alexandra/0000-0002-4012-6164; Gottlieb, Geoffrey/0000-0002-5749-481X	Public Health Service grant [R01 AI060466]; University of Washington Center for AIDS Research New Investigator Award [P30 AI27757]; University of Washington Royalty Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R01AI060466] Funding Source: NIH RePORTER	Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); University of Washington Center for AIDS Research New Investigator Award; University of Washington Royalty Research Fund(University of Washington); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant R01 AI060466 to GG and the University of Washington Center for AIDS Research New Investigator Award P30 AI27757 to RAS (http://depts.washington.edu/cfar/). Additional support was provided by the University of Washington Royalty Research Fund (http://www.washington.edu/research/main.php?page = rrf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard A, 2011, CLIN INFECT DIS, V52, P1257, DOI 10.1093/cid/cir123; Bercoff DP, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-98; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Camacho RJ, 2012, INTERVIROLOGY, V55, P179, DOI 10.1159/000332025; Charpentier C, 2011, ANTIMICROB AGENTS CH, V55, P1293, DOI 10.1128/AAC.00942-10; Charpentier C, 2010, AIDS, V24, P2753, DOI 10.1097/QAD.0b013e32833f9e36; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; Desbois D, 2008, ANTIMICROB AGENTS CH, V52, P1545, DOI 10.1128/AAC.01284-07; Garrett N, 2008, AIDS, V22, P1091, DOI 10.1097/QAD.0b013e3282f9b165; Gottlieb GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022204; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Jaffar S, 2004, B WORLD HEALTH ORGAN, V82, P462; Jallow S, 2009, J CLIN MICROBIOL, V47, P2200, DOI 10.1128/JCM.01654-08; Menendez-Arias L, 2008, TRENDS PHARMACOL SCI, V29, P42, DOI 10.1016/j.tips.2007.10.013; Ni XJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-68; Ntemgwa ML, 2009, ANTIMICROB AGENTS CH, V53, P3611, DOI 10.1128/AAC.00154-09; Peterson I, 2011, AIDS, V25, P2167, DOI 10.1097/QAD.0b013e32834c4adb; Piralla A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-149; Roquebert B, 2008, J ANTIMICROB CHEMOTH, V62, P914, DOI 10.1093/jac/dkn335; Roquebert B, 2008, AIDS, V22, P2045, DOI 10.1097/QAD.0b013e32830f4c7d; Salgado M, 2009, J CLIN VIROL, V46, P173, DOI 10.1016/j.jcv.2009.06.020; Smith RA, 2011, AIDS, V25, P2235, DOI 10.1097/QAD.0b013e32834d8e52; Smith RA, 2009, J INFECT DIS, V199, P1323, DOI 10.1086/597802; Trevino A, 2011, J ANTIMICROB CHEMOTH, V66, P1484, DOI 10.1093/jac/dkr164; Xu L, 2009, AIDS RES HUM RETROV, V25, P843, DOI 10.1089/aid.2009.0039	26	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45372	10.1371/journal.pone.0045372	http://dx.doi.org/10.1371/journal.pone.0045372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028968	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900129
J	Tanabe, N; Muro, S; Sato, S; Tanaka, S; Oguma, T; Kiyokawa, H; Takahashi, T; Kinose, D; Hoshino, Y; Kubo, T; Hirai, T; Mishima, M				Tanabe, Naoya; Muro, Shigeo; Sato, Susumu; Tanaka, Shiro; Oguma, Tsuyoshi; Kiyokawa, Hirofumi; Takahashi, Tamaki; Kinose, Daisuke; Hoshino, Yuma; Kubo, Takeshi; Hirai, Toyohiro; Mishima, Michiaki			Longitudinal Study of Spatially Heterogeneous Emphysema Progression in Current Smokers with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; MECHANICAL FORCES; CT DENSITOMETRY; LUNG DENSITY; QUANTIFICATION; SMOKING; ROLES; COPD; PATHOGENESIS; INFLAMMATION	Background: Cigarette smoke is the main risk factor for emphysema, which is a key pathology in chronic obstructive pulmonary disease (COPD). Low attenuation areas (LAA) in computed tomography (CT) images reflect emphysema, and the cumulative size distribution of LAA clusters follows a power law characterized by the exponent D. This property of LAA clusters can be explained by model simulation, where mechanical force breaks alveolar walls causing local heterogeneous lung tissue destruction. However, a longitudinal CT study has not investigated whether continuous smoking causes the spatially heterogeneous progression of emphysema. Methods: We measured annual changes in ratios of LAA (LAA%), D and numbers of LAA clusters (LAN) in CT images acquired at intervals of >= 3 years from 22 current and 31 former smokers with COPD to assess emphysema progression. We constructed model simulations using CT images to morphologically interpret changes in current smokers. Results: D was decreased in current and former smokers, whereas LAA% and LAN were increased only in current smokers. The annual changes in LAA%, D, and LAN were greater in current, than in former smokers (1.03 vs. 0.37%, p = 0.008; -0.045 vs. -0.01, p = 0.004; 13.9 vs. 1.1, p = 0.007, respectively). When LAA% increased in model simulations, the coalescence of neighboring LAA clusters decreased D, but the combination of changes in D and LAN in current smokers could not be explained by the homogeneous emphysema progression model despite cluster coalescence. Conversely, a model in which LAAs heterogeneously increased and LAA clusters merged somewhat in relatively advanced emphysematous regions could reflect actual changes. Conclusions: Susceptibility to parenchymal destruction induced by continuous smoking is not uniform over the lung, but might be higher in local regions of relatively advanced emphysema. These could result in the spatially heterogeneous progression of emphysema in current smokers.	[Tanabe, Naoya; Muro, Shigeo; Sato, Susumu; Oguma, Tsuyoshi; Kiyokawa, Hirofumi; Takahashi, Tamaki; Kinose, Daisuke; Hoshino, Yuma; Hirai, Toyohiro; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Tanaka, Shiro] Kyoto Univ, Div Clin Trial Design & Management, Translat Res Ctr, Kyoto, Japan; [Kubo, Takeshi] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University	Muro, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	smuro@kuhp.kyoto-u.ac.jp	Sato, Susumu/R-8976-2019; 田中, 司朗/GON-6916-2022	田中, 司朗/0000-0001-6817-5235	Ministry of Health, Labour and Welfare, Japan [16390234, 21590964]	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research (B) (No. 16390234) and (C) (No. 21590964) and a grant to the Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf H, 2011, THORAX, V66, P55, DOI 10.1136/thx.2009.132688; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Dirksen A, 2009, EUR RESPIR J, V33, P1345, DOI 10.1183/09031936.00159408; Gefen A, 1999, J BIOMECH, V32, P891, DOI 10.1016/S0021-9290(99)00092-5; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Gierada DS, 2010, ACAD RADIOL, V17, P146, DOI 10.1016/j.acra.2009.08.007; Global Initiative for Chronic Obstructive Lung Disease, GLOB IN CHRON OBSTR; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Ito S, 2006, AM J RESP CELL MOL, V34, P688, DOI 10.1165/rcmb.2006-0002OC; Jesudason R, 2010, BIOPHYS J, V99, P3076, DOI 10.1016/j.bpj.2010.09.018; Kononov S, 2001, AM J RESP CRIT CARE, V164, P1920, DOI 10.1164/ajrccm.164.10.2101083; Madani A, 2006, RADIOLOGY, V238, P1036, DOI 10.1148/radiol.2382042196; Mascalchi M, 2012, J THORAC IMAGING; Matsuoka S, 2006, J COMPUT ASSIST TOMO, V30, P669, DOI 10.1097/00004728-200607000-00019; Miller M, 2011, CHEST, V139, P1380, DOI 10.1378/chest.10-0705; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Ohara T, 2008, CHEST, V134, P1244, DOI 10.1378/chest.07-3054; Parr DG, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-21; Rahman I, 2005, CELL BIOCHEM BIOPHYS, V43, P167, DOI 10.1385/CBB:43:1:167; Shaker SB, 2004, ACTA RADIOL, V45, P417, DOI 10.1080/02841850410005525; SNIDER GL, 1985, AM REV RESPIR DIS, V132, P182; Soejima K, 2000, AM J RESP CRIT CARE, V161, P1264, DOI 10.1164/ajrccm.161.4.9905040; Stoel Berend C, 2008, Proc Am Thorac Soc, V5, P919, DOI 10.1513/pats.200804-040QC; Suki B, 2003, AM J RESP CRIT CARE, V168, P516, DOI 10.1164/rccm.200208-908PP; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; Vlahovic G, 1999, AM J RESP CRIT CARE, V160, P2086, DOI 10.1164/ajrccm.160.6.9706031; WALD NJ, 1981, THORAX, V36, P366, DOI 10.1136/thx.36.5.366; Winkler Tilo, 2011, Critical Reviews in Biomedical Engineering, V39, P263, DOI 10.1615/CritRevBiomedEng.v39.i4.20; Yuan R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-153; Zulueta JJ, 2011, CHEST	34	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44993	10.1371/journal.pone.0044993	http://dx.doi.org/10.1371/journal.pone.0044993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028728	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900064
J	Zhao, JP; Jiang, XL; Zhang, BY; Su, XH				Zhao, Jia-Ping; Jiang, Xiao-Ling; Zhang, Bing-Yu; Su, Xiao-Hua			Involvement of microRNA-Mediated Gene Expression Regulation in the Pathological Development of Stem Canker Disease in Populus trichocarpa	PLOS ONE			English	Article							STRESS-RESPONSIVE MICRORNAS; POWDERY MILDEW INFECTION; SMALL RNAS; ARABIDOPSIS; IDENTIFICATION; ROOT; PHOSPHATE; PROTEINS; SYNTHASE; CLONING	MicroRNAs (miRNAs), a type of short (21-23 nucleotides), non-coding RNA molecule, mediate repressive gene regulation through RNA silencing at the post-transcriptional level, and play an important role in defense and response to abiotic and biotic stresses. In the present study, Affymetrix (R) miRNA Array, real-time quantitative PCR (qPCR) for miRNAs and their targets, and miRNA promoter analysis were used to validate the gene expression patterns of miRNAs in Populus trichocarpa plantlets induced with the poplar stem canker pathogen, Botryosphaeria dothidea. Twelve miRNAs (miR156, miR159, miR160, miR164, miR166, miR168, miR172, miR319, miR398, miR408, miR1448, and miR1450) were upregulated in the stem bark of P. trichocarpa, but no downregulated miRNAs were found. Based on analysis of the miRNAs and their targets, a potential co-regulatory network was developed to describe post-transcriptional regulation in the pathological development of poplar stem canker. There was highly complex cross-talk between diverse miRNA pathway responses to biotic and abiotic stresses. The results suggest that miR156 is probably an integral component of the miRNA response to all environmental stresses in plants. Cis-regulatory elements were binding sites for the transcription factors (TFs) on DNA. Promoter analysis revealed that TC-rich repeats and a W1-box motif were both tightly related disease response motifs in Populus. Promoter analysis and target analysis of miRNAs also revealed that some TFs regulate their activation/repression. Furthermore, a feedback regulatory network in the pathological development of poplar stem canker is provided. The results confirm that miRNA pathways regulate gene expression during the pathological development of plant disease, and provide new insights into understanding the onset and development of poplar stem canker.	[Zhao, Jia-Ping] Beijing Forestry Univ, Coll Forestry, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Zhao, Jia-Ping; Jiang, Xiao-Ling] Chinese Acad Forestry, Inst New Forestry Technol, State Key Lab Forest Genet & Breeding, Beijing, Peoples R China; [Jiang, Xiao-Ling] Agr Univ Hebei, Coll Forestry, Baoding, Peoples R China; [Zhang, Bing-Yu; Su, Xiao-Hua] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Forestry; Research Institute of Forestry New Technology, CAF; Hebei Agricultural University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Zhao, JP (corresponding author), Beijing Forestry Univ, Coll Forestry, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China.	zhaojiaping@gmail.com; suxh@caf.ac.cn			National Program on Key Basic Research Project of China (973 Program) [2009CB119107]; National Natural Science Foundation of China [30872048]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China during the "12th Five-Year Plan" [2012BAD01B03]; China Postdoctoral Science Foundation [20110490302]	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China during the "12th Five-Year Plan"; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was financially supported by National Program on Key Basic Research Project of China (973 Program) (Grant No. 2009CB119107), National Natural Science Foundation of China (Grant No: 30872048), National Key Technology Research and Development Program of the Ministry of Science and Technology of China during the "12th Five-Year Plan" (Grant No: 2012BAD01B03), and JPZ thanks for China Postdoctoral Science Foundation (Grant No: 20110490302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Bilyeu KD, 2001, PLANT PHYSIOL, V125, P378, DOI 10.1104/pp.125.1.378; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen BJ, 2005, PLANT SCI, V168, P493, DOI 10.1016/j.plantsci.2004.09.013; Chen J, 2004, PLANT CELL, V16, P1302, DOI 10.1105/tpc.018986; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dong J, 2005, PLANT PHYSIOL, V138, P778, DOI 10.1104/pp.105.063388; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; Germain H, 2011, J EXPT BOT, DOI [10.1093/jxb/err1303, DOI 10.1093/JXB/ERR1303]; Gu M, 2010, PHYSIOL PLANTARUM, V138, P226, DOI 10.1111/j.1399-3054.2009.01320.x; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hampton CR, 2004, PLANT PHYSIOL, V136, P3824, DOI 10.1104/pp.104.046672; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jia XY, 2010, METHODS MOL BIOL, V639, P253, DOI 10.1007/978-1-60761-702-0_15; Jia XY, 2009, J PLANT PHYSIOL, V166, P2046, DOI 10.1016/j.jplph.2009.06.011; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li BS, 2009, BIOCHEM BIOPH RES CO, V388, P272, DOI 10.1016/j.bbrc.2009.07.161; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Megraw M, 2006, RNA, V12, P1612, DOI 10.1261/rna.130506; Meng YJ, 2010, PLANT SIGNAL BEHAV, V5, P252, DOI 10.4161/psb.5.3.10549; Meng YJ, 2009, PLANTA, V230, P883, DOI 10.1007/s00425-009-0994-3; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Nersissian AM, 1998, PROTEIN SCI, V7, P1915, DOI 10.1002/pro.5560070907; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schubert R, 1997, PLANT MOL BIOL, V34, P417, DOI 10.1023/A:1005830714852; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Siemens J, 2006, MOL PLANT MICROBE IN, V19, P480, DOI 10.1094/MPMI-19-0480; Song J, 2009, MOL BIOL REP, V36, P939, DOI 10.1007/s11033-008-9266-8; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Wang CT, 2011, PLANT MOL BIOL REP, V29, P60, DOI 10.1007/s11105-010-0210-4; Wang JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002012; Weston K, 1998, CURR OPIN GENET DEV, V8, P76, DOI 10.1016/S0959-437X(98)80065-8; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Xu WR, 2011, J EXP BOT, V62, P2745, DOI 10.1093/jxb/erq447; Xu WR, 2010, PLANTA, V231, P475, DOI 10.1007/s00425-009-1062-8; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang ZX, 2008, ANN BOT-LONDON, V102, P509, DOI 10.1093/aob/mcn129; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	67	69	72	11	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44968	10.1371/journal.pone.0044968	http://dx.doi.org/10.1371/journal.pone.0044968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028709	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900059
J	Liu, ZK; Wang, RC; Han, BC; Yang, Y; Peng, JP				Liu, Zhen-Kun; Wang, Rong-Chun; Han, Bing-Chen; Yang, Ying; Peng, Jing-Pian			A Novel Role of IGFBP7 in Mouse Uterus: Regulating Uterine Receptivity through Th1/Th2 Lymphocyte Balance and Decidualization	PLOS ONE			English	Article							PROTEIN-RELATED PROTEIN-1; GROWTH-FACTOR VEGF; T-CELLS; EARLY-PREGNANCY; DNA METHYLATION; IMPLANTATION; EXPRESSION; FETAL; ANGIOGENESIS; CYTOKINES	Previously we have screened out Insulin-like Growth Factor Binding Protein 7 (IGFBP7) as a differentially expressed gene in post-implantation uterus versus pre-implantation uterus by suppressive subtractive hybridation. However its function in uterus was not clearly identified. In this research, the expression and function of IGFBP7 during post-implantation were studied. We found that IGFBP7 was mainly located in the glandular epithelium and the stroma, and was upregulated after embryo implantation. The vector pCR3.1-IGFBP7-t expressing partial IGFBP7 was constructed. Inhibition of IGFBP7 by specific DNA immunization induced significant reduction of implanted embryos and pregnancy rate. The number of implanted embryos (5.68 +/- 0.46) was significantly reduced after immunization with pCR3.1-IGFBP7-t, as compared with that of the mice immunized with the control vector (12.29 +/- 0.36) or saline (14.58 +/- 0.40) (p<0.01). After specific inhibition of IGFBP7, the T helper type 1 (Th1) cytokine IFN gamma, was significantly elevated (p<0.05) and the Th2 cytokines IL-4 and IL-10, were reduced in uteri (p<0.05). The increase of Tbet and the decrease of Gata3 were found in mice peripheral lymphocytes by flow cytometry. The expression of decidualization marker IGFBP1 and angiogenesis regulator VEGF were declined in uteri (p<0.05). The expression of apoptosis-associated proteins, caspase3 and Bcl-2, were also declined (p<0.05). These results showed that inhibition of IGFBP7 induced pregnancy failure by shifting uterine cytokines to Th1 type dominance and repressing uterine decidualization.	[Liu, Zhen-Kun; Wang, Rong-Chun; Han, Bing-Chen; Yang, Ying; Peng, Jing-Pian] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Liu, Zhen-Kun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Peng, JP (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	pengjp@ioz.ac.cn			National Basic Research Program of China [2011CB944402]; National Natural Science Foundation of China [31171435]; National Key Technology RD Program [2012BAI31B07]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by grants from the National Basic Research Program of China (No. 2011CB944402; http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (No. 31171435; http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), and the National Key Technology R&D Program (2012BAI31B07; http://www.most.gov.cn/eng/programmes1/200610/t20061009_36224.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JJ, 2006, REPRODUCTION, V131, P183, DOI 10.1530/rep.1.00262; Chaouat G, 2003, AM J REPROD IMMUNOL, V50, P177, DOI 10.1034/j.1600-0897.2003.00080.x; Chen Y, 2002, MOL CELL BIOCHEM, V231, P89, DOI 10.1023/A:1014408713826; Collet C, 1998, MOL CELL ENDOCRINOL, V139, P1, DOI 10.1016/S0303-7207(98)00078-1; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dominguez F, 2003, J CLIN ENDOCR METAB, V88, P1849, DOI 10.1210/jc.2002-020724; Heesch S, 2011, CANCER SCI, V102, P253, DOI 10.1111/j.1349-7006.2010.01760.x; Hefler L, 2000, ACTA OBSTET GYN SCAN, V79, P77, DOI 10.1034/j.1600-0412.2000.079001077.x; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Krussell JS, 2001, MOL HUM REPROD, V7, P57, DOI 10.1093/molehr/7.1.57; Kutsukake M, 2007, MOL HUM REPROD, V13, P737, DOI 10.1093/molehr/gam058; Lai ZB, 2011, HYPERTENSION, V57, P505, DOI 10.1161/HYPERTENSIONAHA.110.163329; Leber A, 2010, AM J REPROD IMMUNOL, V63, P445, DOI 10.1111/j.1600-0897.2010.00821.x; Liu ZK, 2012, CELL BIOCHEM BIOPHYS, V63, P73, DOI 10.1007/s12013-012-9342-5; Lockwood CJ, 2007, SEMIN THROMB HEMOST, V33, P111, DOI 10.1055/s-2006-958469; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nevers T, 2011, AM J REPROD IMMUNOL, V66, P88, DOI 10.1111/j.1600-0897.2011.01040.x; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Peck A, 2010, IMMUNOLOGY, V129, P147, DOI 10.1111/j.1365-2567.2009.03189.x; Robertson SA, 2000, REV REPROD, V5, P164, DOI 10.1530/revreprod/5.3.164; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; SCHLAFKE S, 1985, ANAT REC, V212, P47, DOI 10.1002/ar.1092120107; Sherer DM, 2001, PLACENTA, V22, P1, DOI 10.1053/plac.2000.0588; Svensson L, 2001, J REPROD IMMUNOL, V51, P3, DOI 10.1016/S0165-0378(01)00065-1; Tamura K, 2004, ENDOCRINOLOGY, V145, P5243, DOI 10.1210/en.2004-0415; Tamura K, 2009, EUR J PHARMACOL, V610, P61, DOI 10.1016/j.ejphar.2009.01.045; Tseng L, 2002, FRONT BIOSCI, V7, pD1566, DOI 10.2741/tseng; Vairo G, 1996, ONCOGENE, V13, P1511; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Wheeler T, 1999, HUM REPROD, V14, P1619, DOI 10.1093/humrep/14.6.1619; Xiong GF, 2011, MOL CELL ENDOCRINOL, V331, P23, DOI 10.1016/j.mce.2010.06.003; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x; Ye F, 2007, J CANCER RES CLIN, V133, P305, DOI 10.1007/s00432-006-0171-z; Zenclussen AC, 2006, EUR J IMMUNOL, V36, P82, DOI 10.1002/eji.200535428; Zenclussen AC, 2006, SPRINGER SEMIN IMMUN, V28, P31, DOI 10.1007/s00281-006-0023-6; Zhang JH, 2011, CELL MOL IMMUNOL, V8, P1, DOI 10.1038/cmi.2010.38	39	13	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45224	10.1371/journal.pone.0045224	http://dx.doi.org/10.1371/journal.pone.0045224			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028860	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800041
J	Callari, M; Dugo, M; Musella, V; Marchesi, E; Chiorino, G; Grand, MM; Pierotti, MA; Daidone, MG; Canevari, S; De Cecco, L				Callari, Maurizio; Dugo, Matteo; Musella, Valeria; Marchesi, Edoardo; Chiorino, Giovanna; Grand, Maurizia Mello; Pierotti, Marco Alessandro; Daidone, Maria Grazia; Canevari, Silvana; De Cecco, Loris			Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues	PLOS ONE			English	Article							REAL-TIME PCR; COLORECTAL-CANCER; GENE-EXPRESSION; MIRNA; PROLIFERATION; TECHNOLOGIES; PROFILES; MIR-143	Background: Microarray technology applied to microRNA (miRNA) profiling is a promising tool in many research fields; nevertheless, independent studies characterizing the same pathology have often reported poorly overlapping results. miRNA analysis methods have only recently been systematically compared but only in few cases using clinical samples. Methodology/Principal Findings: We investigated the inter-platform reproducibility of four miRNA microarray platforms (Agilent, Exiqon, Illumina, and Miltenyi), comparing nine paired tumor/normal colon tissues. The most concordant and selected discordant miRNAs were further studied by quantitative RT-PCR. Globally, a poor overlap among differentially expressed miRNAs identified by each platform was found. Nevertheless, for eight miRNAs high agreement in differential expression among the four platforms and comparability to qRT-PCR was observed. Furthermore, most of the miRNA sets identified by each platform are coherently enriched in data from the other platforms and the great majority of colon cancer associated miRNA sets derived from the literature were validated in our data, independently from the platform. Computational integration of miRNA and gene expression profiles suggested that anti-correlated predicted target genes of differentially expressed miRNAs are commonly enriched in cancer-related pathways and in genes involved in glycolysis and nutrient transport. Conclusions: Technical and analytical challenges in measuring miRNAs still remain and further research is required in order to increase consistency between different microarray-based methodologies. However, a better inter-platform agreement was found by looking at miRNA sets instead of single miRNAs and through a miRNAs - gene expression integration approach.	[Callari, Maurizio; Dugo, Matteo; Marchesi, Edoardo; Canevari, Silvana; De Cecco, Loris] Fdn IRCCS Ist Nazl Tumori, Funct Genom Core Facil, Milan, Italy; [Callari, Maurizio; Musella, Valeria; Daidone, Maria Grazia] Fdn IRCCS Ist Nazl Tumori, Unit Biomarkers, Milan, Italy; [Chiorino, Giovanna; Grand, Maurizia Mello] Edo & Elvo Tempia Fdn, Canc Genom Lab, Biella, Italy; [Canevari, Silvana] Fdn IRCCS Ist Nazl Tumori, Unit Mol Therapies, Dept Expt Oncol & Mol Med, Milan, Italy; [Pierotti, Marco Alessandro] Fdn IRCCS Ist Nazl Tumori, Sci Directorate, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Callari, M (corresponding author), Fdn IRCCS Ist Nazl Tumori, Funct Genom Core Facil, Milan, Italy.	silvana.canevari@istitutotumori.mi.it	Pierotti, Marco Alessandro/AAC-4728-2022; De Cecco, Loris/K-7036-2016; Dugo, Matteo/H-6860-2014; Callari, Maurizio/AAF-7089-2019; Daidone, Maria Grazia/E-9232-2017; Musella, Valeria/H-4458-2016; Chiorino, Giovanna/K-5037-2016	Pierotti, Marco Alessandro/0000-0002-7431-8332; De Cecco, Loris/0000-0002-7066-473X; Dugo, Matteo/0000-0001-9786-2763; Callari, Maurizio/0000-0001-5239-0918; Daidone, Maria Grazia/0000-0002-4786-1321; Musella, Valeria/0000-0001-9517-2670; Chiorino, Giovanna/0000-0002-9502-6400	Cariplo Foundation [2007.1215/10.4890]; Associazione Italiana Ricerca sul Cancro [AIRC IG-10302 2010, AIRC 561000 n. 12162]; Ministry of Health (ACC grant); Regione Lombardia	Cariplo Foundation(Fondazione Cariplo); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministry of Health (ACC grant); Regione Lombardia(Regione Lombardia)	This work was supported by Cariplo Foundation (2007.1215/10.4890 to MAP), Associazione Italiana Ricerca sul Cancro (AIRC IG-10302 2010 to SC and AIRC 561000 n. 12162 to SC) and Ministry of Health (ACC grant to MGD), and by the support of Regione Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SA, 2011, J CELL BIOCHEM, V112, P1084, DOI 10.1002/jcb.23022; Aldridge Sarah, 2012, Methods Mol Biol, V822, P19, DOI 10.1007/978-1-61779-427-8_2; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dreher A, 2010, BIOCHEM BIOPH RES CO, V403, P357, DOI 10.1016/j.bbrc.2010.11.035; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fang R, 2012, J BIOL CHEM, V287, P23227, DOI 10.1074/jbc.M112.373084; Fu XN, 2011, EUR J CLIN INVEST, V41, P1245, DOI 10.1111/j.1365-2362.2011.02535.x; Gandellini P, 2011, EXPERT OPIN THER TAR, V15, P265, DOI 10.1517/14728222.2011.550878; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kern HB, 2012, DNA CELL BIOL, V31, P1403, DOI 10.1089/dna.2011.1469; Kitade Y, 2010, J PHARMACOL SCI, V114, P276, DOI 10.1254/jphs.10R12FM; Liang P, 2007, NAT BIOTECHNOL, V25, P27, DOI 10.1038/nbt0107-27; Nelson PT, 2008, BBA-GENE REGUL MECH, V1779, P758, DOI 10.1016/j.bbagrm.2008.03.012; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Oakman C, 2010, NAT REV CLIN ONCOL, V7, P725, DOI 10.1038/nrclinonc.2010.170; Peschiaroli A., 2012, ONCOGENE; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Reid JF, 2012, MOL CANCER RES, V10, P504, DOI 10.1158/1541-7786.MCR-11-0342; Sah Sachin, 2010, BMC Res Notes, V3, P80, DOI 10.1186/1756-0500-3-80; Saigusa S, 2012, SURG TODAY, V42, P460, DOI 10.1007/s00595-011-0027-2; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Savaskan NE, 2010, ANN ANAT, V192, P309, DOI 10.1016/j.aanat.2010.07.003; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Singh SK, 2008, FEBS J, V275, P4929, DOI 10.1111/j.1742-4658.2008.06624.x; Staub E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-37; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tseng CW, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-99; Wang XQ, 2012, MED ONCOL, V29, P919, DOI 10.1007/s12032-011-9880-5; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Yauk CL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-330	39	50	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45105	10.1371/journal.pone.0045105	http://dx.doi.org/10.1371/journal.pone.0045105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028787	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700086
J	Czachorowski, MJ; Amaral, AFS; Montes-Moreno, S; Lloreta, J; Carrato, A; Tardon, A; Morente, MM; Kogevinas, M; Real, FX; Malats, N				Czachorowski, Maciej J.; Amaral, Andre F. S.; Montes-Moreno, Santiago; Lloreta, Josep; Carrato, Alfredo; Tardon, Adonina; Morente, Manuel M.; Kogevinas, Manolis; Real, Francisco X.; Malats, Nuria		SBC EPICURO Investigators	Cyclooxygenase-2 Expression in Bladder Cancer and Patient Prognosis: Results from a Large Clinical Cohort and Meta-Analysis	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MICROARRAY-BASED ANALYSIS; PROTEIN EXPRESSION; TUMOR; COX-2; MARKERS; ASSOCIATION; RECURRENCE; SURVIVAL	Aberrant overexpression of cyclooxygenase-2 (COX2) is observed in urothelial carcinoma of the bladder (UCB). Studies evaluating COX2 as a prognostic marker in UCB report contradictory results. We determined the prognostic potential of COX2 expression in UCB and quantitatively summarize the results with those of the literature through a meta-analysis. Newly diagnosed UCB patients recruited between 1998-2001 in 18 Spanish hospitals were prospectively included in the study and followed-up (median, 70.7 months). Diagnostic slides were reviewed and uniformly classified by expert pathologists. Clinical data was retrieved from hospital charts. Tissue microarrays containing non-muscle invasive (n = 557) and muscle invasive (n = 216) tumours were analyzed by immunohistochemistry using quantitative image analysis. Expression was evaluated in Cox regression models to assess the risk of recurrence, progression and disease-specific mortality. Meta-hazard ratios were estimated using our results and those from 11 additional evaluable studies. COX2 expression was observed in 38% (211/557) of non-muscle invasive and 63% (137/216) of muscle invasive tumors. Expression was associated with advanced pathological stage and grade (p < 0.0001). In the univariable analyses, COX2 expression - as a categorical variable - was not associated with any of the outcomes analyzed. As a continuous variable, a weak association with recurrence in non- muscle invasive tumors was observed (p-value = 0.048). In the multivariable analyses, COX2 expression did not independently predict any of the considered outcomes. The meta-analysis confirmed these results. We did not find evidence that COX2 expression is an independent prognostic marker of recurrence, progression or survival in patients with UCB.	[Czachorowski, Maciej J.; Amaral, Andre F. S.; Malats, Nuria] Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Montes-Moreno, Santiago] Hosp Univ Marques de Valdecilla, Serv Anat Patol, Santander, Spain; [Lloreta, Josep] Hosp del Mar, Inst Municipal Invest Med, Barcelona, Spain; [Lloreta, Josep] Hosp del Mar, Dept Patol, Barcelona, Spain; [Lloreta, Josep; Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Carrato, Alfredo] Hosp Gen Univ Elche, Elche, Spain; [Carrato, Alfredo] Hosp Ramon & Cajal, E-28034 Madrid, Spain; [Tardon, Adonina] Univ Oviedo, Oviedo, Spain; [Morente, Manuel M.] Spanish Natl Canc Res Ctr CNIO, Tumor Bank Unit, Madrid, Spain; [Kogevinas, Manolis] Ctr Recerca Epidemiol Ambiental CREAL, Barcelona, Spain; [Real, Francisco X.] Spanish Natl Canc Res Ctr CNIO, Epithelial Carcinogenesis Grp, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario Marques de Valdecilla (HUMV); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Hospital Universitario Ramon y Cajal; University of Oviedo; Centro Nacional de Investigaciones Oncologicas (CNIO); Pompeu Fabra University; Centro Nacional de Investigaciones Oncologicas (CNIO)	Czachorowski, MJ (corresponding author), Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain.	nmalats@cnio.es	Montes-Moreno, Santiago/E-7008-2011; Amaral, Andre FS/A-7662-2008; Montes-Moreno, Santiago/AAB-2072-2020; Arribas, Francisco X Real/H-5275-2015; Lloreta, J/I-2112-2014; Malats, Nuria/H-7041-2015; Lloreta-Trull, Josep/GRR-9682-2022; Amaral, Andre F. S./M-4202-2019; TARDON, ADONINA/B-6563-2014; Lloreta-Trull, Josep/AAZ-1229-2020; Kogevinas, Manolis/C-3918-2017	Montes-Moreno, Santiago/0000-0002-3565-8262; Amaral, Andre FS/0000-0002-0369-9449; Montes-Moreno, Santiago/0000-0002-3565-8262; Arribas, Francisco X Real/0000-0001-9501-498X; Lloreta, J/0000-0003-1644-9470; Malats, Nuria/0000-0003-2538-3784; Amaral, Andre F. S./0000-0002-0369-9449; TARDON, ADONINA/0000-0001-5150-1209; Kogevinas, Manolis/0000-0002-9605-0461; CARRATO, ALFREDO/0000-0001-7749-8140; Morente, Manuel M/0000-0001-6004-330X	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain [G03/174, 00/0745, PI051436, PI061614]; Red Tematica de Investigacion Cooperativa [Cancer-RD06/0020-RTICC]; Consolider ONCOBIO [EU-FP6-STREP-37739-DRoP-ToP, EU-FP7-HEALTH-F2-2008-201663-UROMOL, EU-FP7-HEALTH-F2-2008-201333-DECanBio, USA-NIH-RO1-CA089715]; "la Caixa'' foundation, Spain; Fundacion Cientifica de la AECC	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain; Red Tematica de Investigacion Cooperativa; Consolider ONCOBIO; "la Caixa'' foundation, Spain(La Caixa Foundation); Fundacion Cientifica de la AECC	The work was partially supported by the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Ministry of Science and Innovation, Spain (G03/174, 00/0745, PI051436, PI061614 and G03/174); Red Tematica de Investigacion Cooperativa en Cancer-RD06/0020-RTICC; Consolider ONCOBIO; EU-FP6-STREP-37739-DRoP-ToP; EU-FP7-HEALTH-F2-2008-201663-UROMOL; EU-FP7-HEALTH-F2-2008-201333-DECanBio; USA-NIH-RO1-CA089715; and a PhD fellowship awarded to MJC from the "la Caixa'' foundation, Spain, and a postdoctoral fellowship awarded to AFSA from the Fundacion Cientifica de la AECC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz A, 2011, BJU INT, V108, P531, DOI 10.1111/j.1464-410X.2010.09909.x; Bamias A, 2008, ANTICANCER RES, V28, P2479; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Daugherty SE, 2011, AM J EPIDEMIOL, V173, P721, DOI 10.1093/aje/kwq437; Diamantopoulou K, 2005, ANTICANCER RES, V25, P4543; Eble J.N, 2004, PATHOLOGY GENETICS T; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eltze E, 2005, INT J ONCOL, V26, P1525; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Ferrandina G, 2002, BRIT J CANCER, V87, P1145, DOI 10.1038/sj.bjc.6600578; Fortuny J, 2006, CANCER EPIDEM BIOMAR, V15, P1696, DOI 10.1158/1055-9965.EPI-06-0038; Friedrich MG, 2003, BJU INT, V92, P389, DOI 10.1046/j.1464-410X.2003.04345.x; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Gudjonsson S, 2011, SCAND J UROL NEPHROL, V45, P270, DOI 10.3109/00365599.2011.568956; Harris Randall E, 2007, Subcell Biochem, V42, P93; Henriksen KL, 2007, J CLIN PATHOL, V60, P397, DOI 10.1136/jcp.2005.034447; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hilmy M, 2006, BRIT J CANCER, V95, P1234, DOI 10.1038/sj.bjc.6603415; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim SI, 2002, UROLOGY, V60, P816, DOI 10.1016/S0090-4295(02)01909-X; Komhoff M, 2000, AM J PATHOL, V157, P29, DOI 10.1016/S0002-9440(10)64513-0; Liedberg F, 2008, UROL ONCOL-SEMIN ORI, V26, P17, DOI 10.1016/j.urolonc.2006.08.021; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Lopez-Knowles E, 2006, CLIN CANCER RES, V12, P6029, DOI 10.1158/1078-0432.CCR-06-0206; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Margulis V, 2007, J UROLOGY, V177, P1163, DOI 10.1016/j.juro.2006.10.033; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Michaud DS, 2007, UROL ONCOL-SEMIN ORI, V25, P260, DOI 10.1016/j.urolonc.2006.10.002; Mohammed SI, 1999, CANCER RES, V59, P5647; Moher David, 2009, Open Med, V3, pe123; Mokos I, 2006, TUMORI J, V92, P124, DOI 10.1177/030089160609200207; Mostofi F, 1999, HISTOLOGICAL TYPING; Naruse K, 2010, ONCOL REP, V23, P1577, DOI 10.3892/or_00000798; Ristimaki A, 2001, AM J PATHOL, V158, P849, DOI 10.1016/S0002-9440(10)64033-3; Shariat SF, 2003, J UROLOGY, V170, P985, DOI 10.1097/01.ju.0000080401.85145.ee; Shariat SF, 2003, J UROLOGY, V169, P938, DOI 10.1097/01.ju.0000043638.89552.ed; Shirahama T, 2001, CANCER, V92, P188, DOI 10.1002/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W; Shirahama T, 2000, CLIN CANCER RES, V6, P2424; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tiguert R, 2002, WORLD J UROL, V20, P190, DOI 10.1007/s00345-002-0279-y; Wahlin BE, 2010, CLIN CANCER RES, V16, P637, DOI 10.1158/1078-0432.CCR-09-2487; Wheeler MA, 2002, J UROLOGY, V168, P1568, DOI 10.1016/S0022-5347(05)64522-3; Wild PJ, 2005, INT J ONCOL, V27, P385; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Wulfing C, 2004, EUR UROL, V45, P46, DOI 10.1016/j.eururo.2003.08.007; Yoshimura R, 2001, J UROLOGY, V165, P1468, DOI 10.1016/S0022-5347(05)66329-X; Youssef RF, 2011, J UROLOGY, V185, P6	50	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45025	10.1371/journal.pone.0045025	http://dx.doi.org/10.1371/journal.pone.0045025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028744	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700079
J	Shishido, SN; Nguyen, TA				Shishido, Stephanie N.; Nguyen, Thu A.			Gap Junction Enhancer Increases Efficacy of Cisplatin to Attenuate Mammary Tumor Growth	PLOS ONE			English	Article							GALLBLADDER ADENOCARCINOMA CELLS; ANTI-APOPTOSIS GENE; SUBSTITUTED QUINOLINES; BREAST-CANCER; TYROSINE KINASE; CONNEXIN GENES; ACTIVATED SRC; EXPRESSION; COMMUNICATION; RESISTANCE	Cisplatin treatment has an overall 19% response rate in animal models with malignant tumors. Increasing gap junction activity in tumor cells provides the targets to enhance antineoplastic therapies. Previously, a new class of substituted quinolines (PQs) acts as gap junction enhancer, ability to increase the gap junctional intercellular communication, in breast cancer cells. We examined the effect of combinational treatment of PQs and antineoplastic drugs in an animal model, showing an increase in efficacy of antineoplastic drugs via the enhancement of gap junctions. Mice were implanted with estradiol-17 beta (1.7 mg/pellet) before the injection of 1 x 10(7) T47D breast cancer cells subcutaneously into the inguinal region of mammary fat pad. Animals were treated intraperitoneally with DMSO (control), cisplatin (3.5 mg/kg), PQ (25 mg/kg), or a combining treatment of cisplatin and PQ. Cisplatin alone decreased mammary tumor growth by 85% while combinational treatment of cisplatin and PQ1 or PQ7 showed an additional reduction of 77% and 22% of tumor growth after 7 treatments at every 2 days, respectively. Histological results showed a significant increase of gap junction proteins, Cx43 and Cx26, in PQ-treated tissues compared to control or cisplatin. Furthermore, evidence of highly stained caspase 3 in tumors of combinational treatment (PQ and cisplatin) was seen compared to cisplatin alone. We have showed for the first time an increase in the efficacy of antineoplastic drugs through a combinational treatment with PQs, a specific class of gap junction enhancers.	[Shishido, Stephanie N.; Nguyen, Thu A.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University	Shishido, SN (corresponding author), Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	tnguyen@vet.k-state.edu			National Institutes of Health (NIH)-Centers of Biomedical Research Excellence; Center for Cancer Experimental Therapeutics [P30RR030926]; Kansas State University-Center for Basic Cancer Research;  [NIH-1R15CA152922]; NATIONAL CANCER INSTITUTE [R15CA152922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR030926] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Cancer Experimental Therapeutics; Kansas State University-Center for Basic Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Financial support from National Institutes of Health (NIH)-Centers of Biomedical Research Excellence, Center for Cancer Experimental Therapeutics (P30RR030926) (Hua and Nguyen), Kansas State University-Center for Basic Cancer Research, and NIH-1R15CA152922 (Nguyen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bu RF, 1996, P SOC EXP BIOL MED, V211, P257; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Ferlini C, 1996, CYTOMETRY, V24, P106; Gakhar G, 2008, DRUG DEVELOP RES, V69, P526, DOI 10.1002/ddr.20281; He B, 2009, CLIN CANCER RES, V15, P5803, DOI 10.1158/1078-0432.CCR-09-0811; Heiniger B, 2010, ANTICANCER RES, V30, P3927; Jensen R, 2004, P NATL ACAD SCI USA, V101, P6134, DOI 10.1073/pnas.0400051101; JIANG W, 1993, ONCOGENE, V8, P3447; KADLE R, 1991, MOL CELL BIOL, V11, P363, DOI 10.1128/MCB.11.1.363; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuwahara D, 2000, CANCER LETT, V148, P65, DOI 10.1016/S0304-3835(99)00315-8; LEONARD BJ, 1971, NATURE, V234, P43, DOI 10.1038/234043a0; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Liu B, 2011, CHINESE MED J-PEKING, V124, P1221, DOI 10.3760/cma.j.issn.0366-6999.2011.08.019; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; MADIAS NE, 1978, AM J MED, V65, P307, DOI 10.1016/0002-9343(78)90825-2; Masumoto N, 1999, INT J CANCER, V80, P731, DOI 10.1002/(SICI)1097-0215(19990301)80:5<731::AID-IJC17>3.0.CO;2-H; MAZURENKO NN, 1992, EUR J CANCER, V28A, P372, DOI 10.1016/S0959-8049(05)80056-5; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pengetnze Y, 2003, BIOCHEM BIOPH RES CO, V309, P377, DOI 10.1016/j.bbrc.2003.08.012; Peterson-Roth E, 2009, CANCER RES, V69, P3619, DOI 10.1158/0008-5472.CAN-08-0985; POZZI A, 1995, EXP CELL RES, V220, P212, DOI 10.1006/excr.1995.1308; Qin BL, 2006, CANCER CHEMOTH PHARM, V58, P577, DOI 10.1007/s00280-006-0219-4; Shi AB, 2008, BIOORG MED CHEM LETT, V18, P3364, DOI 10.1016/j.bmcl.2008.04.024; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; SIMPSON I, 1977, SCIENCE, V195, P294, DOI 10.1126/science.831276; Tanaka M, 2001, HUM GENE THER, V12, P2225, DOI 10.1089/10430340152710568; Wang Q, 2010, J PHARMACOL EXP THER, V333, P903, DOI 10.1124/jpet.109.165274; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; WILGENBUS KK, 1992, INT J CANCER, V51, P522, DOI 10.1002/ijc.2910510404; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199; ZAMBLE DB, 1995, TRENDS BIOCHEM SCI, V20, P435, DOI 10.1016/S0968-0004(00)89095-7	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44963	10.1371/journal.pone.0044963	http://dx.doi.org/10.1371/journal.pone.0044963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028705	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700064
J	McIntyre, S; Holcombe, AO; Birznieks, I; Seizova-Cajic, T				McIntyre, Sarah; Holcombe, Alex O.; Birznieks, Ingvars; Seizova-Cajic, Tatjana			Tactile Motion Adaptation Reduces Perceived Speed but Shows No Evidence of Direction Sensitivity	PLOS ONE			English	Article							CUTANEOUS MECHANORECEPTIVE AFFERENTS; VIBRATORY ADAPTATION; APPARENT MOVEMENT; FINGERTIP FORCES; PASSIVE TOUCH; STIMULI; MONKEYS; PERCEPTION; RESPONSES; DISCRIMINATION	Introduction: While the directionality of tactile motion processing has been studied extensively, tactile speed processing and its relationship to direction is little-researched and poorly understood. We investigated this relationship in humans using the 'tactile speed aftereffect' (tSAE), in which the speed of motion appears slower following prolonged exposure to a moving surface. Method: We used psychophysical methods to test whether the tSAE is direction sensitive. After adapting to a ridged moving surface with one hand, participants compared the speed of test stimuli on the adapted and unadapted hands. We varied the direction of the adapting stimulus relative to the test stimulus. Results: Perceived speed of the surface moving at 81 mms(-1) was reduced by about 30% regardless of the direction of the adapting stimulus (when adapted in the same direction, Mean reduction = 23 mms(-1), SD = 11; with opposite direction, Mean reduction = 26 mms(-1), SD = 9). In addition to a large reduction in perceived speed due to adaptation, we also report that this effect is not direction sensitive. Conclusions: Tactile motion is susceptible to speed adaptation. This result complements previous reports of reliable direction aftereffects when using a dynamic test stimulus as together they describe how perception of a moving stimulus in touch depends on the immediate history of stimulation. Given that the tSAE is not direction sensitive, we argue that peripheral adaptation does not explain it, because primary afferents are direction sensitive with friction-creating stimuli like ours (thus motion in their preferred direction should result in greater adaptation, and if perceived speed were critically dependent on these afferents' response intensity, the tSAE should be direction sensitive). The adaptation that reduces perceived speed therefore seems to be of central origin.	[McIntyre, Sarah; Seizova-Cajic, Tatjana] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [McIntyre, Sarah; Holcombe, Alex O.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Birznieks, Ingvars] Univ Western Sydney, Sch Biomed & Hlth Sci, Sydney, NSW, Australia; [Birznieks, Ingvars] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Birznieks, Ingvars] Neurosci Res Australia, Sydney, NSW, Australia	University of Sydney; University of Sydney; Western Sydney University; University of New South Wales Sydney; Neuroscience Research Australia	McIntyre, S (corresponding author), Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia.	sarah.mcintyre@sydney.edu.au	Birznieks, Ingvars/D-4181-2012; Seizova-Cajic, Tatjana/A-5916-2016; McIntyre, Sarah/L-7850-2014; B, Ingvars/Q-8634-2019	Birznieks, Ingvars/0000-0003-4916-1254; Seizova-Cajic, Tatjana/0000-0002-8319-4095; McIntyre, Sarah/0000-0002-0544-6533; B, Ingvars/0000-0003-4916-1254; Holcombe, Alex/0000-0003-2869-0085	Australian Research Council Future Fellowship; ARC Discovery Project [DP110104691]	Australian Research Council Future Fellowship(Australian Research Council); ARC Discovery Project(Australian Research Council)	The study was supported by the Australian Research Council Future Fellowship (http://arc.gov.au) to AOH and ARC Discovery Project ((http://arc.gov.au) DP110104691 to TS-C and IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; Bensmaia SJ, 2005, J NEUROPHYSIOL, V94, P3023, DOI 10.1152/jn.00002.2005; BICE RC, 1969, PERCEPT MOTOR SKILL, V29, P575, DOI 10.2466/pms.1969.29.2.575; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; Birznieks I, 2010, J PHYSIOL-LONDON, V588, P1057, DOI 10.1113/jphysiol.2009.185314; BLAKEMOR.C, 1969, SCIENCE, V166, P245, DOI 10.1126/science.166.3902.245; Burtt HE, 1917, J EXP PSYCHOL, V2, P371, DOI 10.1037/h0074614; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; Clifford C.W.G., 2005, FITTING MIND WORLD A; Costanzo M, 1980, J NEUROPHYSIOL, V43, P1319; DARIANSMITH I, 1980, J PHYSIOL-LONDON, V309, P117, DOI 10.1113/jphysiol.1980.sp013498; Depeault A, 2008, J NEUROPHYSIOL, V99, P1422, DOI 10.1152/jn.01209.2007; DiCarlo JJ, 1999, J NEUROSCI, V19, P401, DOI 10.1523/JNEUROSCI.19-01-00401.1999; EDIN BB, 1995, J NEUROSCI, V15, P830; Essick GK, 1998, ADV PSYCHOL, V127, P1; Essick GK, 1996, SOMESTHESIS NEUROBIO, P83; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; GOODWIN AW, 1987, J NEUROSCI, V7, P2192; Harrar V, 2008, PERCEPT PSYCHOPHYS, V70, P807, DOI 10.3758/PP.70.5.807; Harris RA, 2000, NEURON, V28, P595, DOI 10.1016/S0896-6273(00)00136-7; HAZLEWOOD V, 1971, AUST J PSYCHOL, V23, P59, DOI 10.1080/00049537108254596; HOLLINS M, 1994, SOMATOSENS MOT RES, V11, P153, DOI 10.3109/08990229409028868; KIRMAN JH, 1974, PERCEPT PSYCHOPHYS, V15, P1, DOI 10.3758/BF03205819; Konkle T, 2009, CURR BIOL, V19, P745, DOI 10.1016/j.cub.2009.03.035; Kuroki S, 2012, EXP BRAIN RES, V216, P311, DOI 10.1007/s00221-011-2936-0; LEDERMAN SJ, 1983, CAN J PSYCHOL, V37, P498, DOI 10.1037/h0080750; Lerner EA, 2002, SOMATOSENS MOT RES, V19, P24, DOI 10.1080/0899022012011309; Leung YY, 2005, J NEUROPHYSIOL, V94, P3037, DOI 10.1152/jn.00001.2005; LUNDSTROM R, 1986, ERGONOMICS, V29, P687, DOI 10.1080/00140138608968303; Marin-Franch I, 2010, MODELFREE MODEL FREE; Mather G, 2008, TRENDS COGN SCI, V12, P481, DOI 10.1016/j.tics.2008.09.002; McIntyre S, 2010, AUSTR EXPT PSYCHOL C, P27; Meftah E, 2000, EXP BRAIN RES, V132, P351, DOI 10.1007/s002210000348; MORLEY JW, 1983, EXP BRAIN RES, V49, P291; Pei YC, 2008, P NATL ACAD SCI USA, V105, P8130, DOI 10.1073/pnas.0800028105; Pei YC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000305; Planetta PJ, 2008, SOMATOSENS MOT RES, V25, P93, DOI 10.1080/08990220802045244; Planetta PJ, 2010, EXP BRAIN RES, V202, P377, DOI 10.1007/s00221-009-2144-3; Rausch Evon, 1960, PSYCHOL BEITR, V5, P232; RINKER MA, 1994, PERCEPT PSYCHOPHYS, V56, P356, DOI 10.3758/BF03209769; RUIZ S, 1995, J NEUROPHYSIOL, V73, P525, DOI 10.1152/jn.1995.73.2.525; SHERRICK CE, 1966, PERCEPT PSYCHOPHYS, V1, P175, DOI 10.3758/BF03210054; Smith AM, 2002, EXP BRAIN RES, V147, P209, DOI 10.1007/s00221-002-1240-4; SUTHERLAND NS, 1961, Q J EXP PSYCHOL, V13, P222, DOI 10.1080/17470216108416498; Thalman WA, 1922, AM J PSYCHOL, V33, P268, DOI 10.2307/1414139; Thompson P, 1998, MOTION AFTEREFFECT, P41; Tomassini A, 2010, VIS SCI SOC 10 ANN M; WALL PD, 1977, BRAIN, V100, P641, DOI 10.1093/brain/100.4.641; Watanabe J, 2007, EXP BRAIN RES, V180, P577, DOI 10.1007/s00221-007-0979-z; Watanabe J, 2010, NEUROREPORT, V21, P856, DOI 10.1097/WNR.0b013e32833d6bcb; Webster MA, 2011, J VISION, V11, DOI 10.1167/11.5.3; Wheat HE, 2010, J NEUROPHYSIOL, V103, P950, DOI 10.1152/jn.00502.2009; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wohlgemuth A, 1911, BRIT J PYSCHOL S	55	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45438	10.1371/journal.pone.0045438	http://dx.doi.org/10.1371/journal.pone.0045438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029010	Green Submitted, gold, Green Published			2022-12-27	WOS:000309554700041
J	Larena, M; Regner, M; Lobigs, M				Larena, Maximilian; Regner, Matthias; Lobigs, Mario			The Chemokine Receptor CCR5, a Therapeutic Target for HIV/AIDS Antagonists, Is Critical for Recovery in a Mouse Model of Japanese Encephalitis	PLOS ONE			English	Article							WEST-NILE-VIRUS; CD8(+) T-CELLS; MHC CLASS-I; GLYCOSAMINOGLYCAN-BINDING VARIANTS; ADAPTIVE IMMUNE-RESPONSES; CCR5-DEFICIENT MICE; UP-REGULATION; FLAVIVIRUS; INFECTION; DEFICIENCY	Japanese encephalitis is a severe central nervous system (CNS) inflammatory disease caused by the mosquito-borne flavivirus, Japanese encephalitis virus (JEV). In the current study we have investigated the immune responses against JEV in mice lacking expression of the chemokine receptor CCR5, which functions in activation and chemotaxis of leukocytes during infection. We show that CCR5 serves as a host antiviral factor against Japanese encephalitis, with CCR5 deficiency markedly increasing mortality, and viral burden in the CNS. Humoral immune responses, which are essential in recovery from JEV infection, were of similar magnitude in CCR5 sufficient and deficient mice. However, absence of CCR5 resulted in a multifaceted deficiency of cellular immune responses characterized by reduced natural killer and CD8(+) T cell activity, low splenic cellularity, and impaired trafficking of leukocytes to the brain. Interestingly, adoptive transfer of immune spleen cells, depleted of B lymphocytes, increased resistance of CCR5-deficient recipient mice against JEV regardless of whether the cells were obtained from CCR5-deficient or wild-type donor mice, and only when transferred at one but not at three days post-challenge. This result is consistent with a mechanism by which CCR5 expression enhances lymphocyte activation and thereby promotes host survival in Japanese encephalitis.	[Larena, Maximilian; Regner, Matthias; Lobigs, Mario] Australian Natl Univ, John Curtin Sch Med Res, Dept Emerging Pathogens & Vaccines, Canberra, ACT 2601, Australia; [Lobigs, Mario] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia	Australian National University; John Curtin School of Medical Research; University of Queensland	Lobigs, M (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Emerging Pathogens & Vaccines, Canberra, ACT 2601, Australia.	Mario.Lobigs@anu.edu.au	lobigs, mario/ABC-5711-2020	larena, maximilian/0000-0003-2327-3063; larena, maximilian/0000-0002-8799-7645				Algood HMS, 2004, J IMMUNOL, V173, P3287; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Ank N, 2005, J VIROL, V79, P9831, DOI 10.1128/JVI.79.15.9831-9841.2005; Belnoue E, 2003, BLOOD, V101, P4253, DOI 10.1182/blood-2002-05-1493; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Colombage G, 1998, VIROLOGY, V250, P151, DOI 10.1006/viro.1998.9357; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Fadell SA, 2008, EUR J IMMUNOL, V38, P3376, DOI 10.1002/eji.200838628; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Glass WG, 2003, J VIROL, V77, P191, DOI 10.1128/JVI.77.1.191-198.2003; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Halstead Scott B, 2003, Adv Virus Res, V61, P103, DOI 10.1016/S0065-3527(03)61003-1; Hardison JL, 2006, INFECT IMMUN, V74, P135, DOI 10.1128/IAI.74.1.135-143.2006; Hickman HD, 2011, J EXP MED, V208, P2511, DOI 10.1084/jem.20102545; Huffnagle GB, 1999, J IMMUNOL, V163, P4642; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Kesson AM, 2001, J INFECT DIS, V184, P947, DOI 10.1086/323603; KESSON AM, 1987, J GEN VIROL, V68, P2001, DOI 10.1099/0022-1317-68-7-2001; Khan IA, 2006, PLOS PATHOG, V2, P484, DOI 10.1371/journal.ppat.0020049; KIESSLING R, 1975, EUR J IMMUNOL, V5, P112, DOI 10.1002/eji.1830050208; Kindberg E, 2008, J INFECT DIS, V197, P266, DOI 10.1086/524709; KING NJC, 1988, J GEN VIROL, V69, P2535, DOI 10.1099/0022-1317-69-10-2535; Klein RS, 2008, J INFECT DIS, V197, P183, DOI 10.1086/524692; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kohlmeier JE, 2011, J EXP MED, V208, P1621, DOI 10.1084/jem.20102110; Komatsu K, 2008, CURR EYE RES, V33, P736, DOI 10.1080/02713680802344716; Kuziel WA, 2003, ATHEROSCLEROSIS, V167, P25, DOI 10.1016/S0021-9150(02)00382-9; Larena M, 2011, IMMUNOBIOLOGY JAPANE; Larena M, 2011, J VIROL, V85, P5446, DOI 10.1128/JVI.02611-10; Lee E, 2004, J VIROL, V78, P8271, DOI 10.1128/JVI.78.15.8271-8280.2004; Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002; Lim JK, 2006, TRENDS IMMUNOL, V27, P308, DOI 10.1016/j.it.2006.05.007; Lim JK, 2010, J INFECT DIS, V201, P178, DOI 10.1086/649426; Lobigs M, 1996, IMMUNOL REV, V152, P5, DOI 10.1111/j.1600-065X.1996.tb00908.x; Lobigs M, 2003, IMMUNOL CELL BIOL, V81, P217, DOI 10.1046/j.1440-1711.2003.01161.x; Lobigs M, 2010, J GEN VIROL, V91, P1407, DOI 10.1099/vir.0.019190-0; Luna RML, 2002, J VIROL, V76, P3202, DOI 10.1128/JVI.76.7.3202-3211.2002; Momburg F, 2001, J VIROL, V75, P5663, DOI 10.1128/JVI.75.12.5663-5671.2001; MULLBACHER A, 1995, IMMUNITY, V3, P207, DOI 10.1016/1074-7613(95)90090-X; Nansen A, 2002, BLOOD, V99, P1237, DOI 10.1182/blood.V99.4.1237; Olive AJ, 2011, MUCOSAL IMMUNOL, V4, P208, DOI 10.1038/mi.2010.58; Peterson KE, 2004, J VIROL, V78, P6449, DOI 10.1128/JVI.78.12.6449-6458.2004; Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sato N, 1999, J IMMUNOL, V163, P5519; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Sorce S, 2011, PROG NEUROBIOL, V93, P297, DOI 10.1016/j.pneurobio.2010.12.003; Souza ALS, 2011, INFECT IMMUN, V79, P1741, DOI 10.1128/IAI.00502-10; Thapa M, 2007, J VIROL, V81, P3704, DOI 10.1128/JVI.02626-06; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Weiss ID, 2011, CYTOKINE, V54, P249, DOI 10.1016/j.cyto.2011.01.011; Wilkin TJ, 2012, ANNU REV MED, V63, P81, DOI 10.1146/annurev-med-052010-145454; Zhong MX, 2004, INFECT IMMUN, V72, P1057, DOI 10.1128/IAI.72.2.1057-1064.2004	61	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44834	10.1371/journal.pone.0044834	http://dx.doi.org/10.1371/journal.pone.0044834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028638	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800019
J	Bahri, R; Bollinger, A; Bollinger, T; Orinska, Z; Bulfone-Paus, S				Bahri, Rajia; Bollinger, Annalena; Bollinger, Thomas; Orinska, Zane; Bulfone-Paus, Silvia			Ectonucleotidase CD38 Demarcates Regulatory, Memory-Like CD8(+) T Cells with IFN-gamma-Mediated Suppressor Activities	PLOS ONE			English	Article							ANTI-CD38 AUTOIMMUNITY; DENDRITIC CELLS; SUBSET; PROLIFERATION; ACTIVATION; GENERATION; RECEPTOR; DEFINES; PROTEIN; MICE	Regulatory CD8(+) T cells are critical for self-tolerance and restricting excessive immune responses. The variety of immune functions they fulfill, the heterogeneity of their phenotype, and the mechanism of action are still poorly understood. Here we describe that regulatory CD8(+) T cells exhibiting immunosuppressive actions in vitro and in vivo are recognized as CD38(high) T cells and present in naive mice. CD38 is a glycosylated membrane protein with ectonucleotidase properties. CD8(+)CD38(high) (CD44(+)CD122(+)CD62L(high)) lymphocytes suppress CD4(+) effector T-cell proliferation in an antigen-non specific manner via IFN-gamma. While direct cell-to-cell contact is needed for this suppressor activity, it is independent of membrane-bound TGF-beta and granzyme B release. IL-15 potentiates the suppressive activity of CD8(+)CD38(high) T cells and controls their survival and expansion. In humans CD8(+)CD38(high) T cells inhibit CD4(+) effector T cell proliferation. In vivo, CD8(+)CD38(high), but not CD8(+)CD38(-) T cells mitigate murine experimental autoimmune encephalomyelitis (EAE) by reducing the clinical score and delaying disease occurrence. EAE suppression is enhanced by pre-treatment of CD8(+)CD38(high) T cells with IL-15. These findings add evidence that the expression of ectoenzyme receptor family members positively correlates with suppressor functions and identifies CD8(+)CD38(high) T cells as potential inhibitors of excessive immune responses.	[Bahri, Rajia; Bollinger, Annalena; Orinska, Zane; Bulfone-Paus, Silvia] Res Ctr Borstel, Dept Immunol & Cell Biol, Borstel, Germany; [Bollinger, Thomas] Univ Lubeck, Inst Med Mikrobiol & Hyg, Lubeck, Germany; [Bulfone-Paus, Silvia] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England	Forschungszentrum Borstel; University of Lubeck; University of Manchester	Bulfone-Paus, S (corresponding author), Res Ctr Borstel, Dept Immunol & Cell Biol, Borstel, Germany.	sbulfone@fz-borstel.de	Bahri, Rajia/ABE-1725-2021		Seventh Framework Programme Inflacare [Health-2007-2.4.1-10];  [SFBTR22/A14]	Seventh Framework Programme Inflacare; 	This work was supported by Seventh Framework Programme Inflacare: Health-2007-2.4.1-10 and by SFBTR22/A14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2001, CLIN EXP IMMUNOL, V126, P426, DOI 10.1046/j.1365-2249.2001.01683.x; BEAN AGD, 1995, INT IMMUNOL, V7, P213, DOI 10.1093/intimm/7.2.213; Beeston T, 2010, J NEUROIMMUNOL, V229, P91, DOI 10.1016/j.jneuroim.2010.07.007; Ben-David H, 2007, P NATL ACAD SCI USA, V104, P17459, DOI 10.1073/pnas.0708577104; Bienvenu B, 2005, J IMMUNOL, V175, P246, DOI 10.4049/jimmunol.175.1.246; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chen J, 2006, J IMMUNOL, V176, P4590, DOI 10.4049/jimmunol.176.8.4590; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Dinesh RK, 2010, AUTOIMMUN REV, V9, P560, DOI 10.1016/j.autrev.2010.03.006; Endharti AT, 2011, J IMMUNOL, V186, P41, DOI 10.4049/jimmunol.1000800; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; FUNARO A, 1993, EUR J IMMUNOL, V23, P2407, DOI 10.1002/eji.1830231005; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Haag F, 2007, PURINERG SIGNAL, V3, P71, DOI 10.1007/s11302-006-9038-7; Hadley GA, 1997, J IMMUNOL, V159, P3748; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Jiang H, 2003, P NATL ACAD SCI USA, V100, P8378, DOI 10.1073/pnas.1432871100; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim HJ, 2011, P NATL ACAD SCI USA, V108, P2010, DOI 10.1073/pnas.1018974108; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Koch SD, 2008, HUM IMMUNOL, V69, P737, DOI 10.1016/j.humimm.2008.08.281; Krebs C, 2005, J IMMUNOL, V174, P3298, DOI 10.4049/jimmunol.174.6.3298; Lee YH, 2008, J IMMUNOL, V180, P825, DOI 10.4049/jimmunol.180.2.825; Mahic M, 2008, EUR J IMMUNOL, V38, P640, DOI 10.1002/eji.200737529; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Molloy MJ, 2011, J IMMUNOL, V186, P6218, DOI 10.4049/jimmunol.1003812; Munoz P, 2003, J BIOL CHEM, V278, P50791, DOI 10.1074/jbc.M308034200; Myers L, 2005, J IMMUNOL, V174, P7625, DOI 10.4049/jimmunol.174.12.7625; Najafian N, 2003, J CLIN INVEST, V112, P1037, DOI 10.1172/JCI200317935; Osborne LC, 2010, CYTOKINE, V50, P105, DOI 10.1016/j.cyto.2009.09.008; Patton DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017359; Pupilli C, 2005, J PEDIATR ENDOCR MET, V18, P1417; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Rifa'i M, 2004, J EXP MED, V200, P1123, DOI 10.1084/jem.20040395; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Schuber F, 2004, CURR MOL MED, V4, P249, DOI 10.2174/1566524043360708; Scotto L, 2004, HUM IMMUNOL, V65, P1297, DOI 10.1016/j.humimm.2004.09.004; Shi Z, 2009, EUR J IMMUNOL, V39, P2106, DOI 10.1002/eji.200939314; Smith TRF, 2008, TRENDS IMMUNOL, V29, P337, DOI 10.1016/j.it.2008.04.002; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Suzuki H, 2008, HUM IMMUNOL, V69, P751, DOI 10.1016/j.humimm.2008.08.285; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; Tsai S, 2011, CELL MOL LIFE SCI; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; Wei S, 2005, CANCER RES, V65, P5020, DOI 10.1158/0008-5472.CAN-04-4043; Yamada H, 2000, INT IMMUNOL, V12, P1677, DOI 10.1093/intimm/12.12.1677; Yamada H, 2001, EUR J IMMUNOL, V31, P1917, DOI 10.1002/1521-4141(200106)31:6<1917::AID-IMMU1917>3.0.CO;2-F; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014	53	42	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45234	10.1371/journal.pone.0045234	http://dx.doi.org/10.1371/journal.pone.0045234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028866	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800042
J	Han, MJ; Wang, HL; Zhang, HT; Han, ZZ				Han, Miaojun; Wang, Hailun; Zhang, Hua-Tang; Han, Zhaozhong			Expression of TIP-1 Confers Radioresistance of Malignant Glioma Cells	PLOS ONE			English	Article							PDZ PROTEIN TIP-1; GLUTAMINASE-INTERACTING PROTEIN; DNA-DAMAGE; CANCER CELLS; P53 PATHWAY; MDM2; ONCOPROTEIN; TARGET; DOMAIN; ACTIVATION	Background: Malignant gliomas represent one group of tumors that poorly respond to ionizing radiation (IR) alone or combined with chemotherapeutic agents because of the intrinsic or acquired resistance. In this study, TIP-1 was identified as one novel protein that confers resistance of glioma cells to IR. Methodology/Principal Findings: Meta-analysis indicated that high TIP-1 expression levels correlate with the poor prognosis of human malignant gliomas after radiotherapy. Studies with established human glioma cell lines demonstrated that TIP-1 depletion with specific shRNAs sensitized the cells to IR, whereas an ectopic expression of TIP-1 protected the glioma cells from the IR-induced DNA damage and cell death. Biochemical studies indicated that TIP-1 protein promoted p53 ubiquitination and resulted in a reduced p53 protein level. Furthermore, p53 and its ubiquitination are required for the TIP-1 regulated cellular response to IR. A yeast two-hybrid screening identified that TIP-1, through its single PDZ domain, binds to the carboxyl terminus of LZAP that has been studied as one tumor suppressor functioning through ARF binding and p53 activation. It was revealed that the presence of TIP-1 enhances the protein association between LZAP and ARF and modulates the functionality of ARF/HDM2 toward multi-ubiquitination of p53, while depleting TIP-1 rescued p53 from polyubiquitination and degradation in the irradiated glioma cells. Studies with a mouse xenograft model indicated that depleting TIP-1 within D54 cells improved the tumor growth control with IR. Conclusions/Significance: This study provided the first evidence showing that TIP-1 modulates p53 protein stability and is involved in the radioresistance of malignant gliomas, suggesting that antagonizing TIP-1 might be one novel approach to sensitize malignant gliomas to radiotherapy.	[Han, Miaojun; Wang, Hailun; Han, Zhaozhong] Vanderbilt Univ, Dept Radiat Oncol, Nashville, TN 37235 USA; [Han, Miaojun; Zhang, Hua-Tang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan Province, Peoples R China; [Han, Miaojun; Zhang, Hua-Tang] Kunming Inst Zool, Kunming, Yunnan Province, Peoples R China; [Han, Miaojun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Han, Zhaozhong] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA	Vanderbilt University; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Vanderbilt University	Han, ZZ (corresponding author), Vanderbilt Univ, Dept Radiat Oncol, Nashville, TN 37235 USA.	Zhaozhong.han@vanderbilt.edu	Wang, Hailun/T-5696-2019	Wang, Hailun/0000-0001-8651-2856	National Institutes of Health (NIH) [R01CA127482, P50 CA128323]; NATIONAL CANCER INSTITUTE [P50CA128323, R01CA127482] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Institutes of Health (NIH) grants R01CA127482 (ZH) and P50 CA128323 (J. Gore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alewine C, 2007, AM J PHYSIOL-CELL PH, V293, pC1733, DOI 10.1152/ajpcell.00323.2007; Alewine C, 2006, MOL BIOL CELL, V17, P4200, DOI 10.1091/mbc.E06-02-0129; Banerjee M, 2008, BIOCHEMISTRY-US, V47, P9208, DOI 10.1021/bi800287v; Besser J, 2007, DEV GROWTH DIFFER, V49, P205, DOI 10.1111/j.1440-169x.2007.00921.x; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Feng ZH, 2004, J BIOL CHEM, V279, P28574, DOI 10.1074/jbc.M404137200; Furukawa M, 2000, MOL CELL BIOL, V20, P8185, DOI 10.1128/MCB.20.21.8185-8197.2000; Hampson L, 2004, INT J ONCOL, V25, P1249; Han MJ, 2012, BIOCHEM BIOPH RES CO, V422, P139, DOI 10.1016/j.bbrc.2012.04.123; Han Z, 2008, NAT MED, V14, P343, DOI 10.1038/nm1691; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Kanamori M, 2003, J BIOL CHEM, V278, P38758, DOI 10.1074/jbc.M306324200; Mak GWY, 2011, CANCER RES, V71, P2949, DOI 10.1158/0008-5472.CAN-10-4046; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Morris EJ, 1999, BIOTECHNIQUES, V26, P282, DOI 10.2144/99262st02; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Oliver AW, 2011, BRIT J CANCER, V104, P324, DOI 10.1038/sj.bjc.6606026; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Pollack IF, 2002, NEW ENGL J MED, V346, P420, DOI 10.1056/NEJMoa012224; Reynaud C, 2000, J BIOL CHEM, V275, P33962, DOI 10.1074/jbc.M000465200; Roth JA, 1996, NAT MED, V2, P985, DOI 10.1038/nm0996-985; Rothkamm K, 2011, METHODS MOL BIOL, V704, P17, DOI 10.1007/978-1-61737-964-2_2; Rousset R, 1998, ONCOGENE, V16, P643, DOI 10.1038/sj.onc.1201567; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Wang HL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012051; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Zencir S, 2011, BIOCHEM BIOPH RES CO, V411, P792, DOI 10.1016/j.bbrc.2011.07.029; Zhang JX, 2008, J MOL BIOL, V384, P255, DOI 10.1016/j.jmb.2008.09.034	40	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45402	10.1371/journal.pone.0045402	http://dx.doi.org/10.1371/journal.pone.0045402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028987	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800061
J	Bitoun, JP; Liao, SM; Yao, X; Xie, GG; Wen, ZZT				Bitoun, Jacob P.; Liao, Sumei; Yao, Xin; Xie, Gary G.; Wen, Zezhang T.			The Redox-Sensing Regulator Rex Modulates Central Carbon Metabolism, Stress Tolerance Response and Biofilm Formation by Streptococcus mutans	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR REX; STRICTLY ANAEROBIC CONDITIONS; ORAL STREPTOCOCCI; OXIDATIVE STRESS; GENE-EXPRESSION; BACILLUS-SUBTILIS; PHOSPHOTRANSFERASE SYSTEM; LACTATE-DEHYDROGENASE; SUGAR METABOLISM; NADH OXIDASES	The Rex repressor has been implicated in regulation of central carbon and energy metabolism in Gram-positive bacteria. We have previously shown that Streptococcus mutans, the primary causative agent of dental caries, alters its transcriptome upon Rex-deficiency and renders S. mutans to have increased susceptibility to oxidative stress, aberrations in glucan production, and poor biofilm formation. In this study, we showed that rex in S. mutans is co-transcribed as an operon with downstream guaA, encoding a putative glutamine amidotransferase. Electrophoretic mobility shift assays showed that recombinant Rex bound promoters of target genes avidly and specifically, including those down-regulated in response to Rex-deficiency, and that the ability of recombinant Rex to bind to selected promoters was modulated by NADH and NAD(+). Results suggest that Rex in S. mutans can function as an activator in response to intracellular NADH/NAD(+) level, although the exact binding site for activator Rex remains unclear. Consistent with a role in oxidative stress tolerance, hydrogen peroxide challenge assays showed that the Rex-deficient mutant, TW239, and the Rex/GuaA double mutant, JB314, were more susceptible to hydrogen peroxide killing than the wildtype, UA159. Relative to UA159, JB314 displayed major defects in biofilm formation, with a decrease of more than 50-fold in biomass after 48-hours. Collectively, these results further suggest that Rex in S. mutans regulates fermentation pathways, oxidative stress tolerance, and biofilm formation in response to intracellular NADH/NAD(+) level. Current effort is being directed to further investigation of the role of GuaA in S. mutans cellular physiology.	[Bitoun, Jacob P.; Liao, Sumei; Yao, Xin; Wen, Zezhang T.] Louisiana State Univ, Sch Dent, Hlth Sci Ctr, Dept Oral & Craniofacial Biol, New Orleans, LA 70119 USA; [Xie, Gary G.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Wen, Zezhang T.] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; United States Department of Energy (DOE); Los Alamos National Laboratory; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bitoun, JP (corresponding author), Louisiana State Univ, Sch Dent, Hlth Sci Ctr, Dept Oral & Craniofacial Biol, New Orleans, LA 70119 USA.	zwen@lsuhsc.edu	Liao, Sumei/E-6589-2015	xie, gary/0000-0002-9176-924X	National Institute for Dental and Craniofacial Research, United States of America [R01 DE19452]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019452] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research, United States of America; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by grant R01 DE19452 from the National Institute for Dental and Craniofacial Research, United States of America (http://www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBE K, 1982, J BACTERIOL, V152, P175; Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; Ahn SJ, 2007, J BACTERIOL, V189, P8519, DOI 10.1128/JB.01180-07; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Ausubel FM, 1992, CURRENT PROTOCOLS MO; BELLI WA, 1991, APPL ENVIRON MICROB, V57, P1134, DOI 10.1128/AEM.57.4.1134-1138.1991; Bitoun JP, 2012, APPL ENVIRON MICROB, V78, P2914, DOI 10.1128/AEM.07823-11; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Brekasis D, 2003, EMBO J, V22, P4856, DOI 10.1093/emboj/cdg453; Burne RA, 1998, J DENT RES, V77, P445, DOI 10.1177/00220345980770030301; Burne RA, 2011, ORAL MICROBIAL COMMUNITIES: GENOMIC INQUIRY AND INTERSPECIES COMMUNICATION, P185; Derr AM, 2012, APPL ENVIRON MICROB, V78, P1215, DOI 10.1128/AEM.06890-11; Faustoferri RC, 2005, J BACTERIOL, V187, P2705, DOI 10.1128/JB.187.8.2705-2714.2005; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Hanna MN, 2001, J BACTERIOL, V183, P5964, DOI 10.1128/JB.183.20.5964-5973.2001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Higuchi M, 1999, J BACTERIOL, V181, P5940, DOI 10.1128/JB.181.19.5940-5947.1999; Higuchi M, 2000, J BIOSCI BIOENG, V90, P484, DOI 10.1016/S1389-1723(01)80028-1; IWAMI Y, 1985, INFECT IMMUN, V50, P378, DOI 10.1128/IAI.50.2.378-381.1985; Iwami Y, 2000, ORAL MICROBIOL IMMUN, V15, P325, DOI 10.1034/j.1399-302x.2000.150510.x; KENNEY EB, 1969, J PERIODONTOL, V40, P630, DOI 10.1902/jop.1969.40.11.630; KRUGER N, 1994, J BACTERIOL, V176, P3614; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Larsson JT, 2005, MICROBIOL-SGM, V151, P3323, DOI 10.1099/mic.0.28124-0; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LeBanc D., 1991, GENETICS MOL BIOL ST, P235; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; MARQUIS RE, 1995, J IND MICROBIOL, V15, P198, DOI 10.1007/BF01569826; Mehmeti I, 2011, APPL ENVIRON MICROB, V77, P2406, DOI 10.1128/AEM.02485-10; Nguyen PTM, 2002, CURR MICROBIOL, V44, P262, DOI 10.1007/s00284-001-0001-0; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Ravcheev DA, 2011, J BACTERIOL; Senadheera D, 2009, J BACTERIOL, V191, P6415, DOI 10.1128/JB.00793-09; Sheng JY, 2006, FEMS MICROBIOL LETT, V262, P93, DOI 10.1111/j.1574-6968.2006.00374.x; Sheng JY, 2010, CAN J MICROBIOL, V56, P539, DOI [10.1139/W10-039, 10.1139/w10-039]; Smith EG, 2011, J DENT RES; TAKAHASHI N, 1991, ORAL MICROBIOL IMMUN, V6, P299, DOI 10.1111/j.1399-302X.1991.tb00497.x; Tanzer JM, 2006, J DENT RES, V85, P369, DOI 10.1177/154405910608500417; Vadeboncoeur C, 1997, FEMS MICROBIOL REV, V19, P187, DOI 10.1016/S0168-6445(96)00029-0; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; Wen ZT, 2011, MOL ORAL MICROBIOL, V26, P2, DOI 10.1111/j.2041-1014.2010.00581.x; Wen ZZT, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-111; Wen ZT, 2005, INFECT IMMUN, V73, P219, DOI 10.1128/IAI.73.1.219-225.2005; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Wen ZZT, 2006, J BACTERIOL, V188, P2983, DOI 10.1128/JB.188.8.2983-2992.2006; YAMADA T, 1985, INFECT IMMUN, V47, P129, DOI 10.1128/IAI.47.1.129-134.1985; YAMADA T, 1975, J BACTERIOL, V124, P55, DOI 10.1128/JB.124.1.55-61.1975; YAMADA T, 1980, CARIES RES, V14, P239, DOI 10.1159/000260460; Yamamoto Y, 2000, INFECT IMMUN, V68, P4773, DOI 10.1128/IAI.68.8.4773-4777.2000; Yamamoto Y, 1999, BIOSCI BIOTECH BIOCH, V63, P1056, DOI 10.1271/bbb.63.1056; Zeng L, 2008, MOL MICROBIOL, V70, P197, DOI 10.1111/j.1365-2958.2008.06403.x; Zeng L, 2006, MOL MICROBIOL, V62, P187, DOI 10.1111/j.1365-2958.2006.05359.x	55	43	49	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44766	10.1371/journal.pone.0044766	http://dx.doi.org/10.1371/journal.pone.0044766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028612	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700036
J	Reikie, BA; Adams, RCM; Ruck, CE; Ho, K; Leligdowicz, A; Pillay, S; Naidoo, S; Fortuno, ES; de Beer, C; Preiser, W; Cotton, MF; Speert, DP; Esser, M; Kollmann, TR				Reikie, Brian A.; Adams, Rozanne C. M.; Ruck, Candice E.; Ho, Kevin; Leligdowicz, Aleksandra; Pillay, Santoshan; Naidoo, Shalena; Fortuno, Edgardo S., III; de Beer, Corena; Preiser, Wolfgang; Cotton, Mark F.; Speert, David P.; Esser, Monika; Kollmann, Tobias R.			Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of South African Infants throughout the First Year of Life	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; HUMAN NEWBORNS; B-CELLS; INDUCTION; MIFLOWCYT; CHILDREN; DISTINCT	The first year of life represents a time of marked susceptibility to infections; this is particularly true for regions in sub-Saharan Africa. As innate immunity directs the adaptive immune response, the observed increased risk for infection as well as a suboptimal response to vaccination in early life may be due to less effective innate immune function. In this study, we followed a longitudinal cohort of infants born and raised in South Africa over the first year of life, employing the most comprehensive analysis of innate immune response to stimulation published to date. Our findings reveal rapid changes in innate immune development over the first year of life. This is the first report depicting dramatic differences in innate immune ontogeny between different populations in the world, with important implications for global vaccination strategies.	[Reikie, Brian A.; Ruck, Candice E.; Ho, Kevin; Leligdowicz, Aleksandra; Fortuno, Edgardo S., III; Speert, David P.; Kollmann, Tobias R.] Univ British Columbia, Dept Pediat, Ctr Understanding & Preventing Infect Children, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada; [Adams, Rozanne C. M.; Pillay, Santoshan; Naidoo, Shalena; de Beer, Corena; Preiser, Wolfgang; Cotton, Mark F.; Esser, Monika] Univ Stellenbosch, Cape Town, South Africa; [Adams, Rozanne C. M.; Pillay, Santoshan; Naidoo, Shalena; Esser, Monika] NHLS, Dept Pathol, Div Med Microbiol, Immunol Unit, Cape Town, South Africa; [de Beer, Corena; Preiser, Wolfgang] NHLS, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Cotton, Mark F.] Tygerberg Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa; [Reikie, Brian A.] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada	University of British Columbia; Stellenbosch University; University of Cape Town; University of Cape Town; University of Calgary	Reikie, BA (corresponding author), Univ British Columbia, Dept Pediat, Ctr Understanding & Preventing Infect Children, Div Infect & Immunol Dis, Vancouver, BC V6T 1W5, Canada.	tkollm@mac.com	Leligdowicz, Aleksandra/GLS-9028-2022; Cotton, Mark/AAQ-9936-2020; Leligdowicz, Aleksandra/Q-2494-2016; Preiser, Wolfgang/J-4875-2016	Leligdowicz, Aleksandra/0000-0001-6055-4644; Cotton, Mark/0000-0003-2559-6034; Leligdowicz, Aleksandra/0000-0001-6055-4644; Preiser, Wolfgang/0000-0002-0254-7910; Kollmann, Tobias/0000-0003-2403-9762; Fortuno, Edgardo/0000-0001-5294-1679	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [N01 AI50023]; British Columbia Children's Hospital Foundation; Martha Piper Fund; Peter Wall Institute for Advanced Studies; Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; Candian Institute of Health Research (CIHR) Training Grant in Canadian Child Health Clinician Scientist Program; SickKids Foundation; Child & Family Research Institute (BC); Women & Children's Health Research Institute (Alberta); Manitoba Institute of Child Health; Michael Smith Foundation for Health Research [ST-SGS-02657(09-1)CLIN]; CIHR Canada-HOPE Scholarship; National Health Laboratory Service Research Trust [TY94171]; National Health Laboratory Service, K Fund [KNC97, KNC103]; Poliomyelitis Research Foundation [10/02, 10/31, 11/37]; Harry Crossley Foundation [5415, 5762]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050023] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); British Columbia Children's Hospital Foundation; Martha Piper Fund; Peter Wall Institute for Advanced Studies; Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Candian Institute of Health Research (CIHR) Training Grant in Canadian Child Health Clinician Scientist Program(Canadian Institutes of Health Research (CIHR)); SickKids Foundation; Child & Family Research Institute (BC); Women & Children's Health Research Institute (Alberta); Manitoba Institute of Child Health; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR Canada-HOPE Scholarship(Canadian Institutes of Health Research (CIHR)); National Health Laboratory Service Research Trust; National Health Laboratory Service, K Fund; Poliomyelitis Research Foundation; Harry Crossley Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); Grant number: N01 AI50023, British Columbia Children's Hospital Foundation, The Martha Piper Fund, and the Peter Wall Institute for Advanced Studies. TRK is supported in part by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, and by a Candian Institute of Health Research (CIHR) Training Grant in Canadian Child Health Clinician Scientist Program, in partnership with SickKids Foundation, Child & Family Research Institute (BC), Women & Children's Health Research Institute (Alberta), Manitoba Institute of Child Health. BAR is supported in full by the Michael Smith Foundation for Health Research (ST-SGS-02657(09-1)CLIN). ALS is supported by a CIHR Canada-HOPE Scholarship. DPS in the Sauder Family Professor of Pediatric Infectious Diseases. Laboratory analyses in South Africa were funded through National Health Laboratory Service Research Trust, Grant number TY94171; National Health Laboratory Service, K Fund numbers KNC97 and KNC103; Poliomyelitis Research Foundation, Short Term Research Grant number 10/02; and Harry Crossley Foundation, numbers 5415 and 5762. Student bursaries were awarded by Poliomyelitis Research Foundation, numbers 10/31 and 11/37. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; AIDS-denying mother sentenced, 2010, AUSTR IND; Arama C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018319; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blimkie D, 2011, J IMMUNOL METHODS, V366, P89, DOI 10.1016/j.jim.2011.01.009; Blimkie D, 2010, CYTOM PART A, V77A, P546, DOI 10.1002/cyto.a.20862; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Dauby N, 2012, LANCET INFECT DIS; Figueiredo CA, 2009, ENVIRON HEALTH PERSP, V117, P845, DOI 10.1289/ehp.0800366; Flanagan KL, 2010, EXPERT REV VACCINES, V9, P665, DOI 10.1586/ERV.10.41; Jansen K, 2008, J IMMUNOL METHODS, V336, P183, DOI 10.1016/j.jim.2008.04.013; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Klein J.O., 2006, CURRENT CONCEPTS INF; Kohler C, 2008, PEDIATR RES, V64, P631, DOI 10.1203/PDR.0b013e31818718ba; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Lewis D, 2006, DEV IMMUNOLOGY ROLE; Lewis D. B., 2006, INFECT DIS FETUS NEW, P25; Lisciandro JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036793; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; MCELHANEY JE, 2012, VACCINE; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Shey MS, 2011, J IMMUNOL METHODS; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Teran R, 2011, CLIN IMMUNOL, V138, P299, DOI 10.1016/j.clim.2010.12.011; Tulic MK, 2011, J ALLERGY CLIN IMMUN, V127, P470, DOI 10.1016/j.jaci.2010.09.020; Turvey SE, 2006, CLIN IMMUNOL, V120, P1, DOI 10.1016/j.clim.2006.02.003; Wilson CB, 2008, NESTLE NUTR WORKS SE, V61, P183, DOI 10.1159/0000113493	42	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44763	10.1371/journal.pone.0044763	http://dx.doi.org/10.1371/journal.pone.0044763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028609	gold, Green Published			2022-12-27	WOS:000308788700034
J	Schmidt, SK; Siepmann, S; Kuhlmann, K; Meyer, HE; Metzger, S; Pudelko, S; Leineweber, M; Daubener, W				Schmidt, Silvia K.; Siepmann, Stephan; Kuhlmann, Katja; Meyer, Helmut E.; Metzger, Sabine; Pudelko, Sabine; Leineweber, Margret; Daeubener, Walter			Influence of Tryptophan Contained in 1-Methyl-Tryptophan on Antimicrobial and Immunoregulatory Functions of Indoleamine 2,3-Dioxygenase	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELL; DEXTRO-1-METHYL TRYPTOPHAN; INHIBITION; INTERFERON; GROWTH; IDO; PROLIFERATION; CATABOLITES; TOLERANCE	Indoleamine 2,3-dioxygenase (IDO) has been identified as an important antimicrobial and immunoregulatory effector molecule essential for the establishment of tolerance by regulating local tryptophan (Trp) concentrations. On the other hand, the immunosuppressive capacity of IDO can have detrimental effects for the host as it can lead to deleterious alterations of the immune response by promoting tolerance to some types of tumors. To suppress this disadvantageous IDO effect, the competitive inhibitor 1-Methyl-Tryptophan (1-MT) is being tested in clinical trials. However, it remains inconclusive which stereoisomer of 1-MT is the more effective inhibitor of IDO-mediated immunosuppression. While IDO enzyme activity is more efficiently inhibited by 1-L-MT in cell-free or in vitro settings, 1-D-MT is superior to 1-L-MT in the enhancement of anti-tumor responses in vivo. Here, we present new data showing that commercially available 1-L-MT lots contain tryptophan in amounts sufficient to compensate for the IDO-mediated tryptophan depletion in vitro. The addition of 1-L-MT abrogated IDO-mediated antimicrobial effects and permitted the growth of the tryptophan-auxotroph microorganisms Staphylococcus aureus and Toxoplasma gondii. Consistent with this, the tryptophan within 1-L-MT lots was sufficient to antagonize IDO-mediated inhibition of T cell responses. Mass spectrometry (MS) analysis revealed not only tryptophan within 1-L-MT, but also the incorporation of this tryptophan in bacterial and human proteins that were generated in the presence of 1-L-MT in otherwise tryptophan-free conditions. In summary, these data reveal that tryptophan within 1-L-MT can affect the results of in vitro studies in an L-stereospecific and IDO-independent way.	[Schmidt, Silvia K.; Siepmann, Stephan; Pudelko, Sabine; Leineweber, Margret; Daeubener, Walter] Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany; [Schmidt, Silvia K.; Siepmann, Stephan; Pudelko, Sabine; Leineweber, Margret; Daeubener, Walter] Univ Dusseldorf, Hosp Hyg, D-40225 Dusseldorf, Germany; [Kuhlmann, Katja; Meyer, Helmut E.] Ruhr Univ Bochum, Med Proteome Ctr, Bochum, Germany; [Metzger, Sabine] Univ Dusseldorf, Biol Med Res Ctr, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Ruhr University Bochum; Heinrich Heine University Dusseldorf	Schmidt, SK (corresponding author), Univ Dusseldorf, Inst Med Microbiol, D-40225 Dusseldorf, Germany.	silvia.schmidt@uni-duesseldorf.de			German Federal Ministry of Education and Research (BMBF) [01GN0951, 01KI1002E]; German Research Concil (DFG) grant [RU 729]; Manchot Graduate School [TP 11]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Concil (DFG) grant(German Research Foundation (DFG)); Manchot Graduate School	This study was supported by German Federal Ministry of Education and Research (BMBF) grants no. 01GN0951 (WD) and no. 01KI1002E (WD), German Research Concil (DFG) grant no. RU 729 (WD) and Manchot Graduate School TP 11 (WD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams O, 2004, J VIROL, V78, P2632, DOI 10.1128/JVI.78.5.2632-2636.2004; Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; BILZER T, 1991, VIRCHOWS ARCH A, V418, P281, DOI 10.1007/BF01600156; CADY SG, 1991, ARCH BIOCHEM BIOPHYS, V291, P326, DOI 10.1016/0003-9861(91)90142-6; Capece L, 2010, PROTEINS, V78, P2961, DOI 10.1002/prot.22819; Chauhan N, 2009, J AM CHEM SOC, V131, P4186, DOI 10.1021/ja808326g; Curti A, 2010, HAEMATOL-HEMATOL J, V95, P2022, DOI 10.3324/haematol.2010.025924; DAUBENER W, 1994, J IMMUNOL METHODS, V168, P39, DOI 10.1016/0022-1759(94)90207-0; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Heseler K, 2008, FEMS IMMUNOL MED MIC, V52, P273, DOI 10.1111/j.1574-695X.2007.00374.x; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hucke C, 2004, INFECT IMMUN, V72, P2723, DOI 10.1128/IAI.72.5.2723-2730.2004; Liu XQ, 2009, CHINESE MED J-PEKING, V122, P3072, DOI 10.3760/cma.j.issn.0366-6999.2009.24.030; Liu XD, 2009, STUD FUZZ SOFT COMP, V244, P3; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; MacKenzie CR, 1999, J MED MICROBIOL, V48, P935, DOI 10.1099/00222615-48-10-935; Mellor AL, 1999, IMMUNOL TODAY, V20, P469, DOI 10.1016/S0167-5699(99)01520-0; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Okamoto T, 2007, CYTOTECHNOLOGY, V54, P107, DOI 10.1007/s10616-007-9081-4; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Qian F, 2009, CANCER RES, V69, P5498, DOI 10.1158/0008-5472.CAN-08-2106; Schmidt SK, 2009, EUR J IMMUNOL, V39, P2755, DOI 10.1002/eji.200939535; Schroten H, 2001, NEUROPEDIATRICS, V32, P206, DOI 10.1055/s-2001-17375; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; Terness P, 2006, TRENDS IMMUNOL, V27, P68, DOI 10.1016/j.it.2005.12.006; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Yuasa HJ, 2010, COMP BIOCHEM PHYS B, V157, P10, DOI 10.1016/j.cbpb.2010.04.006	32	20	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44797	10.1371/journal.pone.0044797	http://dx.doi.org/10.1371/journal.pone.0044797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028625	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700041
J	Valentine, ME; Wolyniak, MJ; Rutter, MT				Valentine, Megan E.; Wolyniak, Michael J.; Rutter, Matthew T.			Extensive Phenotypic Variation among Allelic T-DNA Inserts in Arabidopsis thaliana	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; GENE-FUNCTION; WIDE; INTEGRATION; CHROMATIN; SCREENS; PROTEIN; COHESIN; WAPL	T-DNA insertion mutants are a tool used widely in Arabidopsis thaliana to disrupt gene function. We phenotyped multiple homozygous T-DNA A. thaliana mutants at each of two loci (AT1G11060 and AT4G00210). We measured life history traits, including germination, size at reproduction and fruit production. Allelic T-DNA lines differed for most traits at AT1G11060 but not at AT4G00210. However, insertions in exons differed from other insertion positions in AT4G00210 but not in AT1G11060. We found evidence for additional insertions in approximately half of the lines, but found few phenotypic consequences. In general, our results suggest that a cautious interpretation of T-DNA phenotypes is warranted.	[Valentine, Megan E.; Rutter, Matthew T.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Wolyniak, Michael J.] Hampden Sydney Coll, Dept Biol, Hampden Sydney, VA 23943 USA	College of Charleston	Valentine, ME (corresponding author), Coll Charleston, Dept Biol, Charleston, SC 29424 USA.	rutterm@cofc.edu	Wolyniak, Michael/S-6451-2019		National Science Foundation [IOS-1052262, IOS-1050153, DEB-0845413]; Division Of Integrative Organismal Systems [1050153] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Science Foundation awards IOS-1052262 (MTR), IOS-1050153 (MJW) and DEB-0845413 (MTR and MEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Alonso JM, 2006, NAT REV GENET, V7, P524, DOI 10.1038/nrg1893; Bell G, 2010, P ROY SOC B-BIOL SCI, V277, P1459, DOI 10.1098/rspb.2009.2099; Bolle C, 2011, CURR GENOMICS, V12, P1, DOI 10.2174/138920211794520187; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gase K, 2011, MOL ECOL RESOUR, V11, P890, DOI 10.1111/j.1755-0998.2011.03017.x; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Gelvin SB, 2007, BBA-GENE STRUCT EXPR, V1769, P410, DOI 10.1016/j.bbaexp.2007.04.005; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Kihara T, 2006, BIOSCI BIOTECH BIOCH, V70, P1780, DOI 10.1271/bbb.50687; Kim SI, 2007, PLANT J, V51, P779, DOI 10.1111/j.1365-313X.2007.03183.x; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; O'Malley RC, 2007, NAT PROTOC, V2, P2910, DOI 10.1038/nprot.2007.425; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; Rutter MT, 2012, TRENDS PLANT SCI, V17, P204, DOI 10.1016/j.tplants.2012.01.006; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	20	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44981	10.1371/journal.pone.0044981	http://dx.doi.org/10.1371/journal.pone.0044981			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028719	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700067
J	Wang, N; Yin, D; Zhang, SL; Wei, H; Wang, SZ; Zhang, Y; Lu, YM; Dai, SY; Li, W; Zhang, Q; Zhang, Y				Wang, Ning; Yin, Duo; Zhang, Shulan; Wei, Heng; Wang, Shizhuo; Zhang, Yang; Lu, Yanming; Dai, Shuyan; Li, Wei; Zhang, Qiao; Zhang, Yao			TNF-Alpha rs1800629 Polymorphism Is Not Associated with HPV Infection or Cervical Cancer in the Chinese Population	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PROMOTER POLYMORPHISM; HUMAN-PAPILLOMAVIRUS; RISK; GENE; SUSCEPTIBILITY; INDUCTION; IL-10	Background: While HPV infection is the main cause of cervical cancer, genetic susceptibility to HPV infection is not well understood. Tumor necrosis factor alpha (TNF-alpha), involved in the defense against HPV infection, plays an important role in cervical cancer progression and regression. The aim of this study was to investigate the relationship between the TNF-alpha rs1800629 polymorphism and risk of HPV infection or cervical cancer. Methods: Three groups were involved in this study of Chinese women. Group 1 consisted of 285 high risk HPV positive cervical cancer patients, Group 2, 225 high risk HPV positive patients without cervical cancer, and Group 3, 318 HPV negative women with no cervical cancer. Blood samples were obtained from all patients and genotyped by PCR-RLFP. Fifty randomly selected samples were further sequenced. Results: The allele and genotype distributions of the TNF-alpha rs1800629 polymorphism were not significantly different between each of the groups (P>0.05). There are no significant relationship between rs1800629 polymorphism and high risk HPV infection (OR = 0.649, 95% CI: 0.253-1.670, P = 0.371), cervical cancer (OR = 0.993, 95% CI: 0.376-2.618, P = 0.988), or cervical cancer with HPV infection (OR = 0.663, 95% CI: 0.250-1.758, P = 0.409). Conclusions: We demonstrated that there is no association between TNF rs1800629 polymorphism and the HPV infection, or cervical cancer with HPV infection.	[Wang, Ning; Yin, Duo; Zhang, Shulan; Wei, Heng; Wang, Shizhuo; Lu, Yanming; Dai, Shuyan; Li, Wei; Zhang, Qiao; Zhang, Yao] China Med Univ, Dept Gynecol & Obstet, Shengjing Hosp, Shenyang, Peoples R China; [Zhang, Yang] China Med Univ, Dept Breast Surg, Shengjing Hosp, Shenyang, Peoples R China	China Medical University; China Medical University	Wang, N (corresponding author), China Med Univ, Dept Gynecol & Obstet, Shengjing Hosp, Shenyang, Peoples R China.	zsl0909@sina.com	Wang, Ning/N-2034-2018	Wang, Ning/0000-0003-1456-4475	National Nature Science Foundation of China [30973191]; Science and Technology Program of Liaoning Province [2008225004]; Peak Medical Construction Special Project of Liaoning Province [2010696]; Science and Technology Program of Shenyang City [F11-262-9-15]; Free Researcher Project of Shengjing Hospital [200806]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Liaoning Province; Peak Medical Construction Special Project of Liaoning Province; Science and Technology Program of Shenyang City; Free Researcher Project of Shengjing Hospital	This study was supported by the National Nature Science Foundation of China (No. 30973191), Science and Technology Program of Liaoning Province (No.2008225004), Peak Medical Construction Special Project of Liaoning Province (No.2010696), Science and Technology Program of Shenyang City (No. F11-262-9-15) and Free Researcher Project of Shengjing Hospital (No.200806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON J, 1993, AM J PEDIAT HEMATOL, V15, P364; ARDIZZOIA A, 1992, J BIOL REG HOMEOS AG, V6, P103; Azar KK, 2004, HUM PATHOL, V35, P1376, DOI 10.1016/j.humpath.2004.08.012; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; Calhoun ES, 2002, CLIN CHEM, V48, P1218; Deshpande A, 2005, J INFECT DIS, V191, P969, DOI 10.1086/427826; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Elahi MM, 2009, BBA-MOL BASIS DIS, V1792, P163, DOI 10.1016/j.bbadis.2009.01.007; Gostout BS, 2003, GYNECOL ONCOL, V88, P326, DOI 10.1016/S0090-8258(02)00074-4; Govan VA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-24; Ivansson EL, 2010, GYNECOL ONCOL, V116, P544, DOI 10.1016/j.ygyno.2009.10.084; Jang WH, 2001, CANCER LETT, V166, P41, DOI 10.1016/S0304-3835(01)00438-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kirkpatrick A, 2004, GYNECOL ONCOL, V92, P675, DOI 10.1016/j.ygyno.2003.11.025; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liu L, 2011, MOL BIOL REP; Liu X, INT J GYNECOL CANC, V20, P147; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Mocellin S, 2008, FRONT BIOSCI-LANDMRK, V13, P2774, DOI 10.2741/2884; POLUNOVSKY VA, 1994, EXP CELL RES, V214, P584, DOI 10.1006/excr.1994.1296; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Singh H, 2009, INT J GYNECOL CANCER, V19, P1190, DOI 10.1111/IGC.0b013e3181a3a3af; Stanczuk GA, 2003, INT J GYNECOL CANCER, V13, P148, DOI 10.1046/j.1525-1438.2003.13046.x; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; Wang SS, 2009, J INFECT DIS, V199, P20, DOI 10.1086/595563; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	28	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45246	10.1371/journal.pone.0045246	http://dx.doi.org/10.1371/journal.pone.0045246			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028877	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700100
J	Liu, Y; Howard, D; Rector, K; Swiderski, C; Brandon, J; Schook, L; Mehta, J; Bryson, JS; Bondada, S; Liang, Y				Liu, Yi; Howard, Dianna; Rector, Kyle; Swiderski, Carol; Brandon, Jason; Schook, Lawrence; Mehta, Jayesh; Bryson, J. Scott; Bondada, Subbarao; Liang, Ying			Latexin Is Down-Regulated in Hematopoietic Malignancies and Restoration of Expression Inhibits Lymphoma Growth	PLOS ONE			English	Article							TAZAROTENE-INDUCED GENE-1; RETINOID RESPONSE GENE; ACUTE MYELOID-LEUKEMIA; STEM-CELLS; CARBOXYPEPTIDASE INHIBITOR; CANCER; TIG1; PROTEIN; HYPERMETHYLATION; SPECIFICATION	Latexin is a negative regulator of hematopoietic stem cell number in mice. Its dysregulated expression in other tumors led us to hypothesize that latexin may have tumor suppressor properties in hematological malignancies. We found that latexin was down-regulated in a variety of leukemia and lymphoma cell lines as well as in CD34+ cells from the blood and marrow of patients with these malignancies. 5-aza-2'-deoxycytodine treatment and bisulfite sequencing revealed hypermethylation of latexin promoter in tumor cells. Retrovirus-mediated latexin overexpression in A20 mouse lymphoma cells inhibited their in vitro growth by 16 fold and in vivo tumor volume by 2 fold. Latexin caused growth inhibition of lymphoma cells by significantly increasing apoptosis through the down-regulation of anti-apoptotic genes Bcl-2 and Pim-2. The molecular mechanism underlying latexin-mediated tumor inhibition was not through its canonical carboxypeptidase inhibitor activity. These results are consistent with a tumor suppressor role for latexin and suggest that latexin may have clinical efficacy in the treatment of malignancies.	[Howard, Dianna; Swiderski, Carol; Bryson, J. Scott; Liang, Ying] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY 40536 USA; [Liu, Yi; Rector, Kyle] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY USA; [Brandon, Jason; Bryson, J. Scott; Bondada, Subbarao] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Schook, Lawrence] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Mehta, Jayesh] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Feinberg School of Medicine	Liang, Y (corresponding author), Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY 40536 USA.	ying.liang@uky.edu	LIU, YI/E-1977-2013	Schook, Lawrence/0000-0002-6580-8364	American Cancer Society [ACS178898]; BD Biosciences Research Grant Award; The Edward P. Evans Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL086341] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); BD Biosciences Research Grant Award; The Edward P. Evans Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Cancer Society ACS178898 (to YL) and BD Biosciences Research Grant Award (to YL) and the support of The Edward P. Evans Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard A, 2005, STRUCTURE, V13, P309, DOI 10.1016/j.str.2004.12.013; Agrawal-Singh S, 2010, BLOOD, V115, P4507, DOI 10.1182/blood-2009-03-210070; Arimatsu Y, 1999, NEUROSCIENCE, V88, P93, DOI 10.1016/S0306-4522(98)00185-7; Arimatsu Y, 2003, J COMP NEUROL, V466, P180, DOI 10.1002/cne.10875; ARIMATSU Y, 1994, NEUROSCI RES, V20, P131, DOI 10.1016/0168-0102(94)90030-2; Arimatsu Y, 1999, DEVELOPMENT, V126, P629; Blanco-Aparicio C, 1998, J BIOL CHEM, V273, P12370, DOI 10.1074/jbc.273.20.12370; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fraga MF, 2007, ANN NY ACAD SCI, V1100, P60, DOI 10.1196/annals.1395.005; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gomez-Abad C, 2011, BLOOD, V118, P5517, DOI 10.1182/blood-2011-03-344374; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; HATANAKA Y, 1994, EUR J NEUROSCI, V6, P973, DOI 10.1111/j.1460-9568.1994.tb00592.x; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Jin M, 2006, BRAIN RES, V1075, P117, DOI 10.1016/j.brainres.2005.12.099; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kwong J, 2005, INT J CANCER, V113, P386, DOI 10.1002/ijc.20593; Li Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-121; Liang Y, 2007, NAT GENET, V39, P178, DOI 10.1038/ng1938; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Marx J, 2007, SCIENCE, V317, P1029, DOI 10.1126/science.317.5841.1029; Mitsunaga K, 2012, J CELL PHYSIOL, V227, P1138, DOI 10.1002/jcp.22834; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Oakley EJ, 2007, LEUKEMIA, V21, P612, DOI 10.1038/sj.leu.2404530; Sahab ZJ, 2011, CANCER RES, V71, P1219, DOI 10.1158/0008-5472.CAN-10-2294; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; Termini L, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-29; Toyota M, 2005, SEMIN ONCOL, V32, P521, DOI 10.1053/j.seminoncol.2005.07.003; Uratani Y, 2000, BIOCHEM J, V346, P817, DOI 10.1042/0264-6021:3460817; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Youssef EM, 2004, CANCER RES, V64, P2411, DOI 10.1158/0008-5472.CAN-03-0164; Zhang JM, 2004, ONCOGENE, V23, P2241, DOI 10.1038/sj.onc.1207328	38	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44979	10.1371/journal.pone.0044979	http://dx.doi.org/10.1371/journal.pone.0044979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028717	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500014
J	Bovolenta, M; Erriquez, D; Valli, E; Brioschi, S; Scotton, C; Neri, M; Falzarano, MS; Gherardi, S; Fabris, M; Rimessi, P; Gualandi, F; Perini, G; Ferlini, A				Bovolenta, Matteo; Erriquez, Daniela; Valli, Emanuele; Brioschi, Simona; Scotton, Chiara; Neri, Marcella; Falzarano, Maria Sofia; Gherardi, Samuele; Fabris, Marina; Rimessi, Paola; Gualandi, Francesca; Perini, Giovanni; Ferlini, Alessandra			The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; GENE-EXPRESSION; GENOME; IDENTIFICATION; EVOLUTION; INTERFERENCE; MECHANISMS; PROTEINS; INTRONS; REVEAL	The 2.2 Mb long dystrophin (DMD) gene, the largest gene in the human genome, corresponds to roughly 0.1% of the entire human DNA sequence. Mutations in this gene cause Duchenne muscular dystrophy and other milder X-linked, recessive dystrophinopathies. Using a custom-made tiling array, specifically designed for the DMD locus, we identified a variety of novel long non-coding RNAs (lncRNAs), both sense and antisense oriented, whose expression profiles mirror that of DMD gene. Importantly, these transcripts are intronic in origin and specifically localized to the nucleus and are transcribed contextually with dystrophin isoforms or primed by MyoD-induced myogenic differentiation. Furthermore, their forced ectopic expression in both human muscle and neuronal cells causes a specific and negative regulation of endogenous dystrophin full length isoforms and significantly down-regulate the activity of a luciferase reporter construct carrying the minimal promoter regions of the muscle dystrophin isoform. Consistent with this apparently repressive role, we found that, in muscle samples of dystrophinopathic female carriers, lncRNAs expression levels inversely correlate with those of muscle full length DMD isoforms. Overall these findings unveil an unprecedented complexity of the transcriptional pattern of the DMD locus and reveal that DMD lncRNAs may contribute to the orchestration and homeostasis of the muscle dystrophin expression pattern by either selective targeting and down-modulating the dystrophin promoter transcriptional activity.	[Bovolenta, Matteo; Brioschi, Simona; Scotton, Chiara; Neri, Marcella; Falzarano, Maria Sofia; Fabris, Marina; Rimessi, Paola; Gualandi, Francesca; Ferlini, Alessandra] Univ Ferrara, Dept Med Sci, Med Genet Sect, I-44100 Ferrara, Italy; [Erriquez, Daniela; Valli, Emanuele] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Gherardi, Samuele; Perini, Giovanni] Univ Bologna, Dept Pharm & Biotechnol, HST ICIR, Bologna, Italy	University of Ferrara; University of Bologna; University of Bologna	Ferlini, A (corresponding author), Univ Ferrara, Dept Med Sci, Med Genet Sect, I-44100 Ferrara, Italy.	fla@unife.it	Valli, Emanuele/ABD-7213-2020; Neri, Marcella/GNP-6503-2022; Gualandi, Francesca/K-7513-2016	Valli, Emanuele/0000-0002-0928-8624; Neri, Marcella/0000-0001-6133-9831; Gualandi, Francesca/0000-0001-9551-057X; FERLINI, ALESSANDRA/0000-0001-8385-9870; Bovolenta, Matteo/0000-0002-9937-009X; scotton, chiara/0000-0002-8555-8542	Telethon [GGP05115]; UNIFE [FAR2008]; Industria Chimica Emiliana; BIO-NMD grant [EC] [241665]	Telethon(Fondazione Telethon); UNIFE; Industria Chimica Emiliana; BIO-NMD grant [EC]	This work was supported by the Telethon [GGP05115 to A. F.]; UNIFE [FAR2008 to A. F.]; Industria Chimica Emiliana [ICE Grant to A. F.]; and the BIO-NMD grant [EC, 7th FP, proposal #241665; www.bio-nmd.eu, to A. F. as coordinator]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Arechavala-Gomeza V, 2012, CURR GENE THER, V12, P152, DOI 10.2174/156652312800840621; Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bovolenta M, 2012, HUM MUTAT, V33, P572, DOI 10.1002/humu.22017; Brioschi S, 2012, BMC MED GEN IN PRESS; Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; CARNEIRO M, 1984, J MOL BIOL, V178, P869, DOI 10.1016/0022-2836(84)90316-4; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Ferlini A, 1999, NEUROMUSCULAR DISORD, V9, P339, DOI 10.1016/S0960-8966(99)00015-2; Ginger MR, 2006, P NATL ACAD SCI USA, V103, P5781, DOI 10.1073/pnas.0600745103; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrington JJ, 2001, NAT BIOTECHNOL, V19, P440, DOI 10.1038/88107; Hill AE, 2006, FRONT BIOSCI-LANDMRK, V11, P1998, DOI 10.2741/1941; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Horiuchi T, 2006, BIOL CELL, V98, P135, DOI 10.1042/BC20050002; Ikeda Y, 2008, CEREBELLUM, V7, P150, DOI 10.1007/s12311-008-0010-7; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; MATTICK JS, 1994, CURR OPIN GENET DEV, V4, P823, DOI 10.1016/0959-437X(94)90066-3; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Merlini L, 2012, MUSCLE NERVE, V45, P796, DOI 10.1002/mus.23272; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Moran VA, 2012, NUCL ACIDS RES; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Ohira M, 2003, ONCOGENE, V22, P5525, DOI 10.1038/sj.onc.1206853; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pauler FM, 2012, CURR OPIN GENET DEV, V22, P283, DOI 10.1016/j.gde.2012.02.005; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Soltanzadeh P, 2010, NEUROMUSCULAR DISORD, V20, P499, DOI 10.1016/j.nmd.2010.05.010; Spitali P, 2009, HUM MUTAT, V30, P1527, DOI 10.1002/humu.21092; Tedesco FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002342; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; Torelli S, 1999, NEUROMUSCULAR DISORD, V9, P541, DOI 10.1016/S0960-8966(99)00048-6; Van Deutekom JC, 2007, NEW ENGL J MED, V357, P2719; Wagner LA, 2007, BLOOD, V109, P5191, DOI 10.1182/blood-2006-06-027987; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wang XQD, 2011, CURR GENOMICS, V12, P307, DOI 10.2174/138920211796429772; Wood MJA, 2010, BRAIN, V133, P957, DOI 10.1093/brain/awq002; Wu QF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002803; Yan MD, 2005, HUM MOL GENET, V14, P1465, DOI 10.1093/hmg/ddi156; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhou HJ, 2008, BIOCHEM BIOPH RES CO, V368, P709, DOI 10.1016/j.bbrc.2008.01.117	69	39	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45328	10.1371/journal.pone.0045328	http://dx.doi.org/10.1371/journal.pone.0045328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028937	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800040
J	Hobson, KA; Van Wilgenburg, SL; Piersma, T; Wassenaar, LI				Hobson, Keith A.; Van Wilgenburg, Steven L.; Piersma, Theunis; Wassenaar, Leonard I.			Solving a Migration Riddle Using Isoscapes: House Martins from a Dutch Village Winter over West Africa	PLOS ONE			English	Article							ISOTOPES; CLIMATE; MOLT	Background: The ability to connect breeding, stopover and wintering locations of populations of migratory birds greatly enhances our understanding of the phenomenon of migration and improves our chances of effectively conserving these species. Among Palearctic-Afrotropical migratory species, aerial insectivores like the house martin (Delichon urbicum) are sensitive to factors influencing the availability of flying insects, and have declined in recent decades. The strict aerial behaviour of martins severely limits ring recoveries on wintering grounds and so there is a dearth of information on where European breeding populations over-winter in Africa, and the relative effects of population regulation on breeding vs. wintering grounds. We used a newly developed multi-isotope (delta H-2, delta C-13, delta N-15) feather isoscape for Africa together with inferences from summarized ring return data based on longitude, to assign winter origins to birds captured at a breeding colony in The Netherlands. Principal Findings: Based on isotopic analyses of winter-grown martin feathers, we used a likelihood-based assignment approach to describe potential wintering locations where molt occurred of individual house martins from a Dutch colony by assigning them to four potential isotopically distinct clusters in Africa. We found the overwhelming majority of Dutch martins were assigned to a geographical cluster associated with West Africa. Conclusions/Significance: The existence of strong isotopic gradients and patterns in African foodwebs that support migratory wildlife allows for the spatial assignment of tissues grown there. The assignment of Dutch house martins to wintering grounds primarily in West Africa was in strong agreement with independent and indirect methods used to infer winter origins of this species based on the association between the Normalized Difference Vegetation Index (NDVI) in Africa and population patterns in Italy and the United Kingdom. These confirmatory data-sets underscore the importance of suitable habitats in West Africa to the conservation of migratory aerial insectivores and other species.	[Hobson, Keith A.; Van Wilgenburg, Steven L.; Wassenaar, Leonard I.] Environm Canada, Saskatoon, SK, Canada; [Piersma, Theunis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands; [Piersma, Theunis] Royal Netherlands Inst Sea Res, Dept Marine Ecol, Den Burg, Texel, Netherlands	Environment & Climate Change Canada; University of Groningen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Hobson, KA (corresponding author), Environm Canada, Saskatoon, SK, Canada.	Keith.Hobson@ec.gc.ca	Wassenaar, Leonard/AAY-7081-2020; Piersma, Theunis/D-1871-2012; Hobson, Keith/Q-9306-2019	Wassenaar, Leonard/0000-0001-5532-0771; Van Wilgenburg, Steven/0000-0002-6742-4567; Piersma, Theunis/0000-0001-9668-466X	Environment Canada	Environment Canada(CGIAR)	Funding was provided by operating grants to KAH and LIW from Environment Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini R, 2011, AVIAN CONSERV ECOL, V6, DOI 10.5751/ACE-00439-060103; [Anonymous], 1985, ZUG EUROPAISCHER SIN; Barta Z, 2008, PHILOS T R SOC B, V363, P211, DOI 10.1098/rstb.2007.2136; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Christie DA, 2004, HDB BIRDS WORLD, P602; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Cramp S., 1985, HDB BIRDS EUROPE MID; Genz A., 2021, MVTNORM MULTIVARIATE; Genz A, 2009, LECT NOTES STAT; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Hill L.A., 1997, Safring News, V26, P7; Hobson KA, 2012, ECOSPHERE IN PRESS; HOLMGREN N, 1995, EVOL ECOL, V9, P354, DOI 10.1007/BF01237759; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Linnaeus C., 1757, MIGRATIONES AVIUM; Moreau R. E., 1972, PALEARCTIC AFRICAN B; Piersma T, 2009, BIRD STUDY, V56, P127, DOI 10.1080/00063650802648242; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinson Robert A., 2008, Ringing & Migration, V24, P1; Royle JA, 2004, ECOL APPL, V14, P1780; Shannon JP, 2003, ISOT ENVIRON HEALT S, V39, P1, DOI 10.1080/1025601031000102215; Still CJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P179, DOI 10.1007/978-90-481-3354-3_9; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Vuille M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023876; Wernham C., 2002, MIGRATION ATLAS MOVE; Williams CA, 2011, BIOGEOSCIENCES, V8, P27, DOI 10.5194/bg-8-27-2011; Zuur Alain F., 2009, P1	27	10	11	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45005	10.1371/journal.pone.0045005	http://dx.doi.org/10.1371/journal.pone.0045005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028734	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800022
J	Choe, DH; Villafuerte, DB; Tsutsui, ND				Choe, Dong-Hwan; Villafuerte, David B.; Tsutsui, Neil D.			Trail Pheromone of the Argentine Ant, Linepithema humile (Mayr) (Hymenoptera: Formicidae)	PLOS ONE			English	Article							CHEMICAL COMMUNICATION; LATREILLE HYMENOPTERA; PYGIDIAL GLAND; PONERINE ANT; RECRUITMENT; IDENTIFICATION; DISRUPTION; RESPONSES; COMPONENT; BEHAVIOR	The Argentine ant (Linepithema humile) is recognized as one of the world's most damaging invasive species. One reason for the ecological dominance of introduced Argentine ant populations is their ability to dominate food and habitat resources through the rapid mobilization and recruitment of thousands of workers. More than 30 years ago, studies showed that (Z)-9-hexadecenal strongly attracted Argentine ant workers in a multi-choice olfactometer, suggesting that (Z)-9-hexadecenal might be the trail pheromone, or a component of a trail pheromone mixture. Since then, numerous studies have considered (Z)-9-hexadecenal as the key component of the Argentine ant trails. Here, we report the first chemical analyses of the trails laid by living Argentine ants and find that (Z)-9-hexadecenal is not present in a detectible quantity. Instead, two iridoids, dolichodial and iridomyrmecin, appear to be the primary chemical constituents of the trails. Laboratory choice tests confirmed that Argentine ants were attracted to artificial trails comprised of these two chemicals significantly more often than control trails. Although (Z)-9-hexadecenal was not detected in natural trails, supplementation of artificial dolichodial+iridomyrmecin trails with an extremely low concentraion of (Z)-9-hexadecenal did increase the efficacy of the trail-following behavior. In stark contrast with previous dogma, our study suggests that dolichodial and iridomyrmecin are major components of the Argentine ant trail pheromone. (Z)-9-hexadecenal may act in an additive manner with these iridoids, but it does not occur in detectable quantities in Argentine ant recruitment trails.	[Choe, Dong-Hwan; Tsutsui, Neil D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Villafuerte, David B.] Univ Calif Berkeley, Environm Leadership Pathway Program, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Choe, DH (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	donghwan.choe@ucr.edu		Villafuerte, David/0000-0003-3991-9949	USDA [2008-35302-04680]; National Science Foundation STEP Award [0622598]	USDA(United States Department of Agriculture (USDA)); National Science Foundation STEP Award	This work was partially funded by a USDA grant (2008-35302-04680) to N. D. Tsutsui and a National Science Foundation STEP Award (#0622598) to the UC Berkeley Environmental Leadership Pathway Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 1971, INSECT SOC; ARON S, 1993, INSECT SOC, V40, P369, DOI 10.1007/BF01253900; ATTYGALLE AB, 1985, ADV INSECT PHYSIOL, V18, P1; ATTYGALLE AB, 1988, NATURWISSENSCHAFTEN, V75, P315, DOI 10.1007/BF00367327; Attygalle AB, 1998, NATURWISSENSCHAFTEN, V85, P275, DOI 10.1007/s001140050498; Blum MS, 1978, ARTHROPOD VENOMS, V48, P871; Cao TT, 2012, INSECT SOC, V59, P87, DOI 10.1007/s00040-011-0192-8; CAVILL GWK, 1979, EXPERIENTIA, V35, P989, DOI 10.1007/BF01949898; CAVILL GWK, 1980, J CHEM ECOL, V6, P371, DOI 10.1007/BF01402915; CAVILL GWK, 1974, J INSECT PHYSIOL, V20, P2049, DOI 10.1016/0022-1910(74)90112-7; CAVILL GWK, 1976, INSECT BIOCHEM, V6, P483, DOI 10.1016/0020-1790(76)90072-X; Choe DH, 2009, P NATL ACAD SCI USA, V106, P8251, DOI 10.1073/pnas.0901270106; Dossey AT, 2008, J CHEM ECOL, V34, P584, DOI 10.1007/s10886-008-9457-8; ERICKSON J M, 1971, Psyche (Cambridge), V78, P257, DOI 10.1155/1971/34713; Greenberg L, 2000, J ECON ENTOMOL, V93, P119, DOI 10.1603/0022-0493-93.1.119; HEFETZ A, 1983, J CHEM ECOL, V9, P607, DOI 10.1007/BF00990412; HOLLDOBLER B, 1994, J INSECT PHYSIOL, V40, P585, DOI 10.1016/0022-1910(94)90145-7; HOLLDOBLER B, 1978, BEHAV ECOL SOCIOBIOL, V3, P19, DOI 10.1007/BF00300045; Holldobler B., 1990, pi; Holway DA, 1998, OECOLOGIA, V116, P252, DOI 10.1007/s004420050586; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Jackson DE, 2007, BEHAV ECOL, V18, P444, DOI 10.1093/beheco/arl104; Janssen E, 1997, NATURWISSENSCHAFTEN, V84, P122, DOI 10.1007/s001140050360; KEY SEV, 1982, J CHEM ECOL, V8, P3, DOI 10.1007/BF00984000; KEY SEV, 1982, J CHEM ECOL, V8, P1057, DOI 10.1007/BF00987886; KEY SEVV, 1986, ANN ENTOMOL SOC AM, V79, P283, DOI 10.1093/aesa/79.2.283; KEY SEVV, 1981, J INSECT PHYSIOL, V27, P363, DOI 10.1016/0022-1910(81)90012-3; KUGLER C, 1979, ANN ENTOMOL SOC AM, V72, P532, DOI 10.1093/aesa/72.4.532; MASCHWITZ U, 1983, OECOLOGIA, V57, P175, DOI 10.1007/BF00379578; MCCONNELL JF, 1962, TETRAHEDRON LETT, P445; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Morgan ED, 2009, PHYSIOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-3032.2008.00658.x; Morgan E. David, 2008, Myrmecological News, V11, P79; Nishisue K, 2010, J ECON ENTOMOL, V103, P1784, DOI 10.1603/EC10008; OLDHAM NJ, 1994, EXPERIENTIA, V50, P763, DOI 10.1007/BF01919378; Pavan M., 1955, Atti della Societa Italiana di Scienze Naturali Milano, V94, P379; Scholes DR, 2009, INSECT SOC, V56, P413, DOI 10.1007/s00040-009-0039-8; SIMON T, 1991, INSECT SOC, V38, P17, DOI 10.1007/BF01242709; SMITH MARION R., 1928, ANN ENT SOC AMER, V21, P307, DOI 10.1093/aesa/21.2.307; Suckling DM, 2008, J CHEM ECOL, V34, P1602, DOI 10.1007/s10886-008-9566-4; Suckling DM, 2010, J CHEM ECOL, V36, P122, DOI 10.1007/s10886-009-9734-1; Sunamura E, 2011, PEST MANAG SCI, V67, P1230, DOI 10.1002/ps.2172; Tanaka Y, 2009, SOCIOBIOLOGY, V54, P139; Thomas ML, 2006, MOL ECOL, V15, P4303, DOI 10.1111/j.1365-294X.2006.03038.x; TOMALSKI MD, 1987, J CHEM ECOL, V13, P253, DOI 10.1007/BF01025886; TUMLINSON JH, 1971, NATURE, V234, P348, DOI 10.1038/234348b0; Vander Meer RK., 1998, PHEROMONE COMMUNICAT, P159; VANDERMEER RK, 1988, J CHEM ECOL, V14, P825, DOI 10.1007/BF01018776; VANVORHISKEY SE, 1982, ENTOMOL EXP APPL, V32, P232, DOI 10.1111/j.1570-7458.1982.tb03211.x; Wetterer JK, 2009, MYRMECOL NEWS, V12, P187; Wilkins KJ, 2006, AFR ENTOMOL, V14, P367; WILSON E. O., 1959, PSYCHE, V66, P70, DOI 10.1155/1959/45675; Witte V, 2007, CHEMOECOLOGY, V17, P57, DOI 10.1007/s00049-006-0364-6; Zar JH, 1999, BIOSTATISTICAL ANAL	55	29	29	6	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45016	10.1371/journal.pone.0045016	http://dx.doi.org/10.1371/journal.pone.0045016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028739	Green Published, gold			2022-12-27	WOS:000309388900016
J	Machler, E; Altermatt, F				Maechler, Elvira; Altermatt, Florian			Interaction of Species Traits and Environmental Disturbance Predicts Invasion Success of Aquatic Microorganisms	PLOS ONE			English	Article							PLANT TRAITS; BIODIVERSITY; TERRESTRIAL; DIVERSITY; PATTERNS	Factors such as increased mobility of humans, global trade and climate change are affecting the range of many species, and cause large-scale translocations of species beyond their native range. Many introduced species have a strong negative influence on the new local environment and lead to high economic costs. There is a strong interest to understand why some species are successful in invading new environments and others not. Most of our understanding and generalizations thereof, however, are based on studies of plants and animals, and little is known on invasion processes of microorganisms. We conducted a microcosm experiment to understand factors promoting the success of biological invasions of aquatic microorganisms. In a controlled lab experiment, protist and rotifer species originally isolated in North America invaded into a natural, field-collected community of microorganisms of European origin. To identify the importance of environmental disturbances on invasion success, we either repeatedly disturbed the local patches, or kept them as undisturbed controls. We measured both short-term establishment and long-term invasion success, and correlated it with species-specific life-history traits. We found that environmental disturbances significantly affected invasion success. Depending on the invading species' identity, disturbances were either promoting or decreasing invasion success. The interaction between habitat disturbance and species identity was especially pronounced for long-term invasion success. Growth rate was the most important trait promoting invasion success, especially when the species invaded into a disturbed local community. We conclude that neither species traits nor environmental factors alone conclusively predict invasion success, but an integration of both of them is necessary.	[Maechler, Elvira; Altermatt, Florian] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Maechler, Elvira] ETH, Dept Biol, CHN, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Altermatt, F (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland.	florian.altermatt@eawag.ch		Altermatt, Florian/0000-0002-4831-6958	Swiss National Science Foundation [31003A_135622]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was funded by the Swiss National Science Foundation Grant 31003A_135622 (to F. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2007, EVOL ECOL, V21, P561, DOI 10.1007/s10682-006-9136-6; Altermatt F, 2012, ECOLOGY, V93, P1125, DOI 10.1890/11-1190.1; Altermatt F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019525; Altermatt F, 2011, ECOLOGY, V92, P859, DOI 10.1890/10-1095.1; Carrara F, 2012, P NATL ACAD SCI USA, V109, P5761, DOI 10.1073/pnas.1119651109; Crawley M.J., 2007, R BOOK; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Foucaud J, 2010, EVOL APPL, V3, P363, DOI 10.1111/j.1752-4571.2010.00119.x; Funk JL, 2008, TRENDS ECOL EVOL, V23, P695, DOI 10.1016/j.tree.2008.07.013; Haddad NM, 2008, ECOL LETT, V11, P348, DOI 10.1111/j.1461-0248.2007.01149.x; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; HOLDICH DM, 1991, AQUAT CONSERV, V1, P139, DOI 10.1002/aqc.3270010204; Istvanovics V, 2000, FRESHWATER BIOL, V43, P257, DOI 10.1046/j.1365-2427.2000.00549.x; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P9990, DOI 10.1073/pnas.0504835102; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lake JC, 2004, BIOL CONSERV, V117, P215, DOI 10.1016/S0006-3207(03)00294-5; Litchman E, 2010, ECOL LETT, V13, P1560, DOI 10.1111/j.1461-0248.2010.01544.x; Lozon Joseph D., 1997, Environmental Reviews, V5, P131, DOI 10.1139/er-5-2-131; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Melbourne BA, 2009, SCIENCE, V325, P1536, DOI 10.1126/science.1176138; Pimentel D, 2002, INVASIVE ARTHROPODS IN AGRICULTURE: PROBLEMS AND SOLUTIONS, P107; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Spaulding S., 2007, INCREASE NUISANCE BL; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Thompson K, 2001, J ECOL, V89, P1054, DOI 10.1111/j.1365-2745.2001.00627.x; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Warren PH, 2005, CONCEPTUAL ECOLOGY I; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769	35	26	27	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45400	10.1371/journal.pone.0045400	http://dx.doi.org/10.1371/journal.pone.0045400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028985	Green Published, gold			2022-12-27	WOS:000309388900047
J	Banik, D; Khan, ANH; Walseng, E; Segal, BH; Abrams, SI				Banik, Debarati; Khan, A. Nazmul H.; Walseng, Even; Segal, Brahm H.; Abrams, Scott I.			Interferon Regulatory Factor-8 Is Important for Histone Deacetylase Inhibitor-Mediated Antitumor Activity	PLOS ONE			English	Article							SEQUENCE-BINDING-PROTEIN; COLON-CARCINOMA CELLS; UNPHOSPHORYLATED STAT1; ICSBP DEFICIENCY; GENE-EXPRESSION; IMMUNE ESCAPE; TUMOR; TRANSCRIPTION; APOPTOSIS; DECITABINE	The notion that epigenetic alterations in neoplasia are reversible has provided the rationale to identify epigenetic modifiers for their ability to induce or enhance tumor cell death. Histone deacetylase inhibitors (HDACi) represent one such class of anti-neoplastic agents. Despite great interest for clinical use, little is known regarding the molecular targets important for response to HDACi-based cancer therapy. We had previously shown that interferon regulatory factor (IRF)-8, originally discovered as a leukemia suppressor gene by regulating apoptosis, also regulates Fas-mediated killing in non-hematologic tumor models. Furthermore, we and others have shown that epigenetic mechanisms are involved in repression of IRF-8 in tumors. Therefore, in our preclinical tumor model, we tested the hypothesis that IRF-8 expression is important for response to HDACi-based antitumor activity. In the majority of experiments, we selected the pan-HDACi, Trichostatin A (TSA), because it was previously shown to restore Fas sensitivity to tumor cells. Overall, we found that: 1) TSA alone and more so in combination with IFN-gamma enhanced both IRF-8 expression and Fas-mediated death of tumor cells in vitro; 2) TSA treatment enhanced IRF-8 promoter activity via a STAT1-dependent pathway; and 3) IRF-8 was required for this death response, as tumor cells rendered IRF-8 incompetent were significantly less susceptible to Fas-mediated killing in vitro and to HDACi-mediated antitumor activity in vivo. Thus, IRF-8 status may underlie a novel molecular basis for response to HDACi-based antitumor treatment.	[Banik, Debarati; Khan, A. Nazmul H.; Segal, Brahm H.; Abrams, Scott I.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Khan, A. Nazmul H.; Segal, Brahm H.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Walseng, Even] Oslo Univ Hosp, Inst Canc Res, Dept Immunol, Oslo, Norway	Roswell Park Cancer Institute; Roswell Park Cancer Institute; University of Oslo	Abrams, SI (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	scott.abrams@roswellpark.org	Segal, Brahm/AAW-2706-2020; Khan, ANM Nazmul H/AAR-6749-2020		National Cancer Institute [R01CA140622]; Roswell Park Alliance Foundation; National Cancer Institute Cancer Center [CA016056]; NATIONAL CANCER INSTITUTE [R01CA140622, P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roswell Park Alliance Foundation; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by Grant Number R01CA140622 from the National Cancer Institute (to SIA), an Alliance Developmental Award from the Roswell Park Alliance Foundation (to SIA), and National Cancer Institute Cancer Center Support Grant to Roswell Park Cancer Institute (CA016056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SI, 2010, IMMUNOL RES, V46, P59, DOI 10.1007/s12026-009-8125-6; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Egwuagu CE, 2006, ONCOGENE, V25, P3670, DOI 10.1038/sj.onc.1209402; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Frew AJ, 2008, P NATL ACAD SCI USA, V105, P11317, DOI 10.1073/pnas.0801868105; Gabriele L, 1999, J EXP MED, V190, P411, DOI 10.1084/jem.190.3.411; Gebhard C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl437; Ghanim V, 2012, BLOOD, V119, P4242, DOI 10.1182/blood-2011-09-382770; Greeneltch KM, 2007, CANCER RES, V67, P10406, DOI 10.1158/0008-5472.CAN-07-1228; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Jo SH, 2010, BLOOD, V116, P2759, DOI 10.1182/blood-2009-07-234559; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; Kantarjian H, 2007, BLOOD, V109, P52, DOI 10.1182/blood-2006-05-021162; Khan ANH, 2008, IMMUNOL RES, V40, P164, DOI 10.1007/s12026-007-0085-0; Khan ANH, 2004, CANCER IMMUNOL IMMUN, V53, P748, DOI 10.1007/s00262-004-0513-0; Koenigsmann J, 2009, BLOOD, V113, P4690, DOI 10.1182/blood-2008-05-158485; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Lee KY, 2008, ONCOGENE, V27, P5267, DOI 10.1038/onc.2008.147; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Liu KB, 2005, CANCER RES, V65, P4376, DOI 10.1158/0008-5472.CAN-04-4269; Liu KB, 2003, J IMMUNOL, V170, P6329, DOI 10.4049/jimmunol.170.12.6329; Maecker HL, 2002, CANCER CELL, V2, P139, DOI 10.1016/S1535-6108(02)00095-8; Mayordomo JI, 1996, J EXP MED, V183, P1357, DOI 10.1084/jem.183.4.1357; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Roos WP, 2011, CANCER RES, V71, P4150, DOI 10.1158/0008-5472.CAN-10-3498; Schmidt M, 1998, BLOOD, V91, P22, DOI 10.1182/blood.V91.1.22.22_22_29; Schrump DS, 2009, CLIN CANCER RES, V15, P3947, DOI 10.1158/1078-0432.CCR-08-2787; Sunter NJ, 2012, BLOOD, V119, P196, DOI 10.1182/blood-2011-04-349803; Taghiyev AF, 2005, CANCER BIOL THER, V4, P382; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tomasi TB, 2006, CANCER IMMUNOL IMMUN, V55, P1159, DOI 10.1007/s00262-006-0164-4; Tshuikina M, 2008, EXP HEMATOL, V36, P1673, DOI 10.1016/j.exphem.2008.08.001; Vidovic K, 2010, LEUKEMIA, V24, P992, DOI 10.1038/leu.2010.33; Wijermans PW, 2008, LEUKEMIA RES, V32, P587, DOI 10.1016/j.leukres.2007.08.004; Yang DF, 2007, J IMMUNOL, V179, P4775, DOI 10.4049/jimmunol.179.7.4775; Yang DF, 2007, CANCER RES, V67, P3301, DOI 10.1158/0008-5472.CAN-06-4068; Yang DF, 2012, J IMMUNOL, V188, P4441, DOI 10.4049/jimmunol.1103035; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yang JN, 2011, J IMMUNOL, V187, P4426, DOI 10.4049/jimmunol.1101034; Zhang XH, 2008, CANCER BIOL THER, V7, P1390, DOI 10.4161/cbt.7.9.6415	50	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45422	10.1371/journal.pone.0045422	http://dx.doi.org/10.1371/journal.pone.0045422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028998	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400083
J	Mathias, RA; Fu, WQ; Akey, JM; Ainsworth, HC; Torgerson, DG; Ruczinski, I; Sergeant, S; Barnes, KC; Chilton, FH				Mathias, Rasika A.; Fu, Wenqing; Akey, Joshua M.; Ainsworth, Hannah C.; Torgerson, Dara G.; Ruczinski, Ingo; Sergeant, Susan; Barnes, Kathleen C.; Chilton, Floyd H.			Adaptive Evolution of the FADS Gene Cluster within Africa	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; DOCOSAHEXAENOIC ACID; HUMAN-POPULATIONS; MITOCHONDRIAL GENOMES; POSITIVE SELECTION; HUMANS; BRAIN; ENCEPHALIZATION; AMERICANS; VARIANTS	Long chain polyunsaturated fatty acids (LC-PUFAs) are essential for brain structure, development, and function, and adequate dietary quantities of LC-PUFAs are thought to have been necessary for both brain expansion and the increase in brain complexity observed during modern human evolution. Previous studies conducted in largely European populations suggest that humans have limited capacity to synthesize brain LC-PUFAs such as docosahexaenoic acid (DHA) from plant-based medium chain (MC) PUFAs due to limited desaturase activity. Population-based differences in LC-PUFA levels and their product-to-substrate ratios can, in part, be explained by polymorphisms in the fatty acid desaturase (FADS) gene cluster, which have been associated with increased conversion of MC-PUFAs to LC-PUFAs. Here, we show evidence that these high efficiency converter alleles in the FADS gene cluster were likely driven to near fixation in African populations by positive selection similar to 85 kya. We hypothesize that selection at FADS variants, which increase LC-PUFA synthesis from plant-based MC-PUFAs, played an important role in allowing African populations obligatorily tethered to marine sources for LC-PUFAs in isolated geographic regions, to rapidly expand throughout the African continent 60-80 kya.	[Mathias, Rasika A.] Johns Hopkins Univ, Div Gen Internal Med, Dept Med, Baltimore, MD 21218 USA; [Mathias, Rasika A.; Barnes, Kathleen C.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Fu, Wenqing; Akey, Joshua M.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Ainsworth, Hannah C.; Sergeant, Susan] Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC USA; [Ainsworth, Hannah C.; Sergeant, Susan; Chilton, Floyd H.] Wake Forest Univ Hlth Sci, Wake Forest Ctr Bot Lipids & Inflammatory Dis Pre, Winston Salem, NC USA; [Torgerson, Dara G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Ruczinski, Ingo] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Chilton, Floyd H.] Wake Forest Univ Hlth Sci, Dept Physiol Pharmacol, Winston Salem, NC USA	Johns Hopkins University; Johns Hopkins University; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wake Forest University; Wake Forest University School of Medicine	Mathias, RA (corresponding author), Johns Hopkins Univ, Div Gen Internal Med, Dept Med, Baltimore, MD 21218 USA.	rmathias@jhmi.edu		Akey, Joshua/0000-0002-4411-1330	National Institutes of Health [P50 AT002782]; CTSA; Wake Forest University Health Sciences Center for Public Health Genomics; Mary Beryl Patch Turnbull Scholar Program; MOSAIC initiative of Johns Hopkins University; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT002782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Wake Forest University Health Sciences Center for Public Health Genomics; Mary Beryl Patch Turnbull Scholar Program; MOSAIC initiative of Johns Hopkins University; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by National Institutes of Health grants P50 AT002782 (F. H. C.) and a CTSA grant to The Johns Hopkins Medical Institutions (R. A. M., I. R.). Additional support was received from the Wake Forest University Health Sciences Center for Public Health Genomics. K. C. B. was supported in part by the Mary Beryl Patch Turnbull Scholar Program and RAM by the MOSAIC initiative of Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brenna JT, 2009, PROSTAG LEUKOTR ESS, V80, P85, DOI 10.1016/j.plefa.2009.01.004; Broadhurst CL, 2002, COMP BIOCHEM PHYS B, V131, P653, DOI 10.1016/S1096-4959(02)00002-7; Burdge GC, 2006, PROSTAG LEUKOTR ESS, V75, P161, DOI 10.1016/j.plefa.2006.05.013; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carlson BA, 2007, AM J HUM BIOL, V19, P585, DOI 10.1002/ajhb.20683; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Cordain L, 2001, WORLD REV NUTR DIET, V90, P144; Crawford MA, 1999, LIPIDS, V34, pS39, DOI 10.1007/BF02562227; Crawford Michael A., 2006, Nutrition and Health (Bicester), V18, P263; Cunnane SC, 2007, AM J HUM BIOL, V19, P578, DOI 10.1002/ajhb.20673; Fay JC, 2000, GENETICS, V155, P1405; Flinn MV, 2005, EVOL HUM BEHAV, V26, P10, DOI 10.1016/j.evolhumbehav.2004.08.005; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Glaser C, 2011, MATERN CHILD NUTR, V7, P27, DOI 10.1111/j.1740-8709.2011.00319.x; Innis SM, 2011, MATERN CHILD NUTR, V7, P112, DOI 10.1111/j.1740-8709.2011.00318.x; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mathias RA, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-50; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; NEEL JV, 1972, GENETICS, V72, P639; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sergeant S, 2012, BRIT J NUTR, V107, P547, DOI 10.1017/S0007114511003230; TAJIMA F, 1989, GENETICS, V123, P585; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503	35	64	66	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44926	10.1371/journal.pone.0044926	http://dx.doi.org/10.1371/journal.pone.0044926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028684	Green Published, gold			2022-12-27	WOS:000309388400049
J	Pierce, MB; Silverwood, RJ; Nitsch, D; Adams, JE; Stephen, AM; Nip, W; Macfarlane, P; Wong, A; Richards, M; Hardy, R; Kuh, D				Pierce, Mary B.; Silverwood, Richard J.; Nitsch, Dorothea; Adams, Judith E.; Stephen, Alison M.; Nip, Wing; Macfarlane, Peter; Wong, Andrew; Richards, Marcus; Hardy, Rebecca; Kuh, Diana		NSHD Sci & Data Collection Teams	Clinical Disorders in a Post War British Cohort Reaching Retirement: Evidence from the First National Birth Cohort Study	PLOS ONE			English	Article							DISEASE; HEALTH; QUESTIONNAIRE; COMMUNITY	Background: The medical needs of older people are growing because the proportion of the older population is increasing and disease boundaries are widening. This study describes the distribution and clustering of 15 common clinical disorders requiring medical treatment or supervision in a representative British cohort approaching retirement, and how health tracked across adulthood. Methods and Findings: The data come from a cohort of 2661 men and women, 84% of the target sample, followed since birth in England, Scotland and Wales in 1946, and assessed at 60-64 years for: cardio and cerebro-vascular disease, hypertension, raised cholesterol, renal impairment, diabetes, obesity, hypothyroidism, hyperthyroidism, anaemia, respiratory disease, liver disease, psychiatric problems, cancers, atrial fibrillation on ECG and osteoporosis. We calculated the proportions disorder-free, with one or more disorders, and the level of undiagnosed disorders; and how these disorders cluster into latent classes and relate to health assessed at 36 years. Participants had, on average, two disorders (range 0-9); only 15% were disorder-free. The commonest disorders were hypertension (54.3%, 95% CI 51.8%-56.7%), obesity (31.1%, 28.8%-33.5%), raised cholesterol (25.6%, 23.1-28.26%), and diabetes or impaired fasting glucose (25.0%, 22.6-27.5%). A cluster of one in five individuals had a high probability of cardio-metabolic disorders and were twice as likely than others to have been in the poorest health at 36 years. The main limitations are that the native born sample is entirely white, and a combination of clinical assessments and self reports were used. Conclusions: Most British people reaching retirement already have clinical disorders requiring medical supervision. Widening disease definitions and the move from a disease-based to a risk-based medical model will increase pressure on health services. The promotion of healthy ageing should start earlier in life and consider the individual's ability to adapt to and self manage changes in health.	[Pierce, Mary B.; Wong, Andrew; Richards, Marcus; Hardy, Rebecca; Kuh, Diana] MRC Unit Lifelong Hlth & Ageing, London, England; [Silverwood, Richard J.; Nitsch, Dorothea] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Adams, Judith E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Stephen, Alison M.; Nip, Wing] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Macfarlane, Peter] Univ Glasgow, Royal Infirm, Electrocardiol Sect, Glasgow, Lanark, Scotland	University of London; London School of Hygiene & Tropical Medicine; University of Manchester; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Royal Infirmary of Edinburgh; University of Glasgow	Pierce, MB (corresponding author), MRC Unit Lifelong Hlth & Ageing, London, England.	m.pierce@nshd.mrc.ac.uk	Wong, Andrew/M-8899-2016; Wong, Andrew/AAE-6995-2019; Silverwood, Richard/A-1249-2014; Hardy, Rebecca/AFR-1989-2022; Kuh, Diana/L-6019-2014	Wong, Andrew/0000-0003-2079-4779; Wong, Andrew/0000-0003-2079-4779; Silverwood, Richard/0000-0002-2744-1194; Kuh, Diana/0000-0001-7386-2857; Nitsch, Dorothea/0000-0001-5767-248X	Medical Research Council [U1200632239, U123092720]; ESRC [ES/G00773X/1] Funding Source: UKRI; MRC [MC_U123092720, MC_U105960384] Funding Source: UKRI; Economic and Social Research Council [ES/G00773X/1] Funding Source: researchfish; Kidney Research UK [RP34/2009] Funding Source: researchfish; Medical Research Council [MC_U105960384, MC_U123092720] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council grant numbers U1200632239 and U123092720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1960, BMJ-BRIT MED J, V2, P1665; [Anonymous], 2008, WORLDW PREV AN 1993; Centres for Disease Control and prevention, 2012, NAT HLTH NUTR SURV; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Cornell JE, 2007, APPL MULTIVARIATE RE, V2007, P163, DOI [10.22329/amr.v12i3.658, DOI 10.22329/AMR.V12I3.658]; Deeg D, GLOBAL AGEING 21 CEN; Department of Health, 2008, PUTT PREV 1 VASC CHE; Ebrahim S, 2001, BMJ-BRIT MED J, V324, P861; Ferrucci L, 2012, HARRISONS PRINCIPLES, P570; Fries James F, 2011, J Aging Res, V2011, P261702, DOI 10.4061/2011/261702; Gielen E, 2011, BEST PRACT RES CL EN, V25, P321, DOI 10.1016/j.beem.2010.08.012; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Hippsley-Cox J, 2009, TRENDS CONSULTATION; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Hudon C, 2005, J CLIN EPIDEMIOL, V58, P603, DOI 10.1016/j.jclinepi.2004.10.017; Illich Ivan., 1975, MED NEMESIS EXPROPRI; Insighteast, 2001, CENS TABL S101 SEX A; Joint Committee of the Royal College of Obstetricians and Gynaecologists and the Population Investigation Committee, 1948, MAT GREAT BRIT; Kaplan GA, 2007, INT J EPIDEMIOL, V36, P542, DOI 10.1093/ije/dym008; Kaplan RM, 2007, ANNU REV PUBL HEALTH, V28, P321, DOI 10.1146/annurev.publhealth.28.021406.144141; Kivimaki M, 2011, INT J EPIDEMIOL, V40, P845, DOI 10.1093/ije/dyr114; Klungel OH, 1999, NETH J MED, V55, P177, DOI 10.1016/S0300-2977(99)00045-5; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; KUH DJL, 1993, SOC SCI MED, V37, P905, DOI 10.1016/0277-9536(93)90145-T; Lafortune G, 2007, OECD HLTH WORKING PA; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Little R.J.A., 2002, STAT ANAL MISSING DA; Martyn C, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2800; McManus S, 2007, ADULT PSYCHIAT MORBI; Moynihan R, 2011, BMJ-BRIT MED J, V342, P1054; Muthen B., 2010, MPLUS USERS GUIDE; Muthen & Muthen, 2010, MPLUS STAT SOFTW REL; [NHS National Institute for Clinical Excellence], 2008, EARL ID MAN REN DIS; NHS Information Centre, 2007, HLTH SURV ENGL 2007, V1; NHS Information centre, 2012, HLTH SURV ENGL; NHS Information Centre, 2009, HLTH SURV ENGL 2009; NHS Information Centre, 2005, HLTH SURV ENGL 2005; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; OECD, 2011, HLTH GLANC 2011 OECD, DOI [10.1787/health_glance-2011-29-en, DOI 10.1787/HEALTH_GLANCE-2011-29-EN]; Office for National Statistics, 2009, NAT POP PROJ 2008 BA; Pastorino S, 2011, DIABETIC MED, V28, P32; Pierce MB, 2009, DIABETIC MED, V26, P679, DOI 10.1111/j.1464-5491.2009.02755.x; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; Royal College of Physicians, 1999, OST GUID PREV TREATM, P63; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; The Scottish Government, 2012, SCOTT HLTH SURV; Tinetti ME, 2004, AM J MED, V116, P179, DOI 10.1016/j.amjmed.2003.09.031; Tisnado DM, 2006, MED CARE, V44, P132, DOI 10.1097/01.mlr.0000196952.15921.bf; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; Wadsworth M, 2006, INT J EPIDEMIOL, V35, P49, DOI 10.1093/ije/dyi201; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wilson S, 2006, J CLIN ENDOCR METAB, V91, P4809, DOI 10.1210/jc.2006-1557; World Health Organisation, 1994, ASS FRACT RISK ITS A; World Health Organization, 2004, OB PREV MAN GLOB EP; World Health Organization, 2006, DEF DIAGN DIAB MELL	59	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44857	10.1371/journal.pone.0044857	http://dx.doi.org/10.1371/journal.pone.0044857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028647	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000309388400044
J	Robinson, WS				Robinson, Willard S.			Migrating Giant Honey Bees (Apis dorsata) Congregate Annually at Stopover Site in Thailand	PLOS ONE			English	Article							DANCE COMMUNICATION; BIODIVERSITY; CONSERVATION; ENTOMOLOGY; COLONIES	Giant honey bees (Apis dorsata) of southern Asia are vital honey producers and pollinators of cultivated crops and wild plants. They are known to migrate seasonally up to 200 km. It has been assumed their migrations occur stepwise, with stops for rest and foraging, but bivouacking bees have rarely been seen by scientists. Here I report discovery of a site in northern Thailand where bivouacs appeared in large congregations during the wet seasons of 2009 and 2010. The bivouac congregation stopover site is a small mango orchard along the Pai River. Bivouacs rested in branches of mango and other tree species in the immediate vicinity. Departures were preceded by dances indicating approximate direction and apparently, distance of flights. Such consistent stopover sites likely occur throughout southern Asia and may support critical, vulnerable stages in the life history of giant honey bees that must be conserved for populations of the species to survive.	Casper Coll, Dept Biol, Casper, WY USA		Robinson, WS (corresponding author), Casper Coll, Dept Biol, Casper, WY USA.	wrobins@caspercollege.edu						AHMAD R, 1989, BEE WORLD, V70, P62, DOI 10.1080/0005772X.1989.11098989; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Basavarajappa S., 2009, Bioscan, V4, P647; Batchelet E., 1981, CIRCULAR STAT BIOL, V1st; Brower LP, 2002, CONSERV BIOL, V16, P346, DOI 10.1046/j.1523-1739.2002.00572.x; BROWER LP, 1991, AM ZOOL, V31, P265; Buchmann S.L., 1997, FORGOTTEN POLLINATOR; Corlett RT, 2011, HONEYBEES OF ASIA, P215, DOI 10.1007/978-3-642-16422-4_10; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; Deodikar G. B. (and 6 others), 1977, Indian Bee Journal, V39, P1; Duangphakdee O, 2011, HONEYBEES OF ASIA, P313, DOI 10.1007/978-3-642-16422-4_14; DYBAS HS, 1974, ECOL MONOGR, V44, P279, DOI 10.2307/2937032; DYER FC, 1994, INSECT SOC, V41, P129, DOI 10.1007/BF01240473; DYER FC, 1991, BEHAV ECOL SOCIOBIOL, V28, P227, DOI 10.1007/BF00175094; Food and Agriculture Organization of the United Nations, 2011, STAT WORLDS FOR 2011; Hepburn HR, 2011, HONEYBEES OF ASIA, P133, DOI 10.1007/978-3-642-16422-4_7; Hepburn HR, 2011, HONEYBEES OF ASIA, P51, DOI 10.1007/978-3-642-16422-4_3; Janzen D.H., 1986, P286; Koeniger G, 2011, HONEYBEES OF ASIA, P159, DOI 10.1007/978-3-642-16422-4_8; KOENIGER N, 1980, J APICULT RES, V19, P21, DOI 10.1080/00218839.1980.11099994; Laurance WF, 2007, CURR SCI INDIA, V93, P1544; Lewis LA, 2008, APIDOLOGIE, V39, P354, DOI 10.1051/apido:2008018; Lockwood J. A., 2005, LOCUST DEVASTATING R; LOCKWOOD JA, 1990, ENVIRON ENTOMOL, V19, P1194, DOI 10.1093/ee/19.5.1194; Lovejoy T.E., 1983, Bird Conservation (Madison), V1, P126; Mardan MB, 1989, THESIS U GUELPH; Matthews G.V.T., 1981, Society for Experimental Biology Seminar Series, P231; Mead R, 1993, STAT METHODS; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; National Research Council, 2007, STAT POLL N AM; Neumann P, 2000, NATURE, V406, P474, DOI 10.1038/35020193; Oldroyd BP, 2009, APIDOLOGIE, V40, P296, DOI 10.1051/apido/2009021; Oldroyd BP, 2006, ASIAN HONEY BEES BIO; Paar J, 2000, NATURE, V406, P475, DOI 10.1038/35020196; Partap U, 2011, HONEYBEES OF ASIA, P227, DOI 10.1007/978-3-642-16422-4_11; PUNCHIHEWA RWK, 1985, J APICULT RES, V24, P168, DOI 10.1080/00218839.1985.11100667; Robinson WS, 2010, P 9 INT C AP HLTH CA, P111; SCHNEIDER SS, 1994, INSECT SOC, V41, P115, DOI 10.1007/BF01240472; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Tan NQ, 1997, J APICULT RES, V36, P49, DOI 10.1080/00218839.1997.11100930; Thapa R, 2000, ASIAN BEES AND BEEKEEPING, P39; UNDERWOOD BA, 1990, NATL GEOGR RES, V6, P276; Underwood Benjamin A., 1992, P51; VENKATESH G, 1989, P INDIAN AS-ANIM SCI, V98, P425, DOI 10.1007/BF03179655; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wilcove D.S., 2010, NO WAY HOME DECLINE; Wilcove DS, 2008, ISSUES SCI TECHNOL, V24, P71; Woyke J, 2001, APIDOLOGIE, V32, P601, DOI 10.1051/apido:2001104	49	18	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44976	10.1371/journal.pone.0044976	http://dx.doi.org/10.1371/journal.pone.0044976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028715	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400055
J	Humphries, LA; Shaffer, MH; Sacirbegovic, F; Tomassian, T; McMahon, KA; Humbert, PO; Silva, O; Round, JL; Takamiya, K; Huganir, RL; Burkhardt, JK; Russell, SM; Miceli, MC				Humphries, Lisa A.; Shaffer, Meredith H.; Sacirbegovic, Faruk; Tomassian, Tamar; McMahon, Kerrie-Ann; Humbert, Patrick O.; Silva, Oscar; Round, June L.; Takamiya, Kogo; Huganir, Richard L.; Burkhardt, Janis K.; Russell, Sarah M.; Miceli, M. Carrie			Characterization of In Vivo Dlg1 Deletion on T Cell Development and Function	PLOS ONE			English	Article							ALDRICH-SYNDROME PROTEIN; IMMUNOLOGICAL SYNAPSE; LYMPHOCYTE DIVISION; LINEAGE COMMITMENT; IMMUNE-RESPONSES; RECEPTOR SIGNALS; ACTIVATION; POLARITY; SAP97; DOMAINS	Background: The polarized reorganization of the T cell membrane and intracellular signaling molecules in response to T cell receptor (TCR) engagement has been implicated in the modulation of T cell development and effector responses. In siRNA-based studies Dlg1, a MAGUK scaffold protein and member of the Scribble polarity complex, has been shown to play a role in T cell polarity and TCR signal specificity, however the role of Dlg1 in T cell development and function in vivo remains unclear. Methodology/Principal Findings: Here we present the combined data from three independently-derived dlg1-knockout mouse models; two germline deficient knockouts and one conditional knockout. While defects were not observed in T cell development, TCR-induced early phospho-signaling, actin-mediated events, or proliferation in any of the models, the acute knockdown of Dlg1 in Jurkat T cells diminished accumulation of actin at the IS. Further, while Th1-type cytokine production appeared unaffected in T cells derived from mice with a dlg1germline-deficiency, altered production of TCR-dependent Th1 and Th2-type cytokines was observed in T cells derived from mice with a conditional loss of dlg1 expression and T cells with acute Dlg1 suppression, suggesting a differential requirement for Dlg1 activity in signaling events leading to Th1 versus Th2 cytokine induction. The observed inconsistencies between these and other knockout models and siRNA strategies suggest that 1) compensatory upregulation of alternate gene(s) may be masking a role for dlg1 in controlling TCR-mediated events in dlg1 deficient mice and 2) the developmental stage during which dlg1 ablation begins may control the degree to which compensatory events occur. Conclusions/Significance: These findings provide a potential explanation for the discrepancies observed in various studies using different dlg1-deficient T cell models and underscore the importance of acute dlg1 ablation to avoid the upregulation of compensatory mechanisms for future functional studies of the Dlg1 protein.	[Humphries, Lisa A.; Tomassian, Tamar; Silva, Oscar; Round, June L.; Miceli, M. Carrie] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Shaffer, Meredith H.; Burkhardt, Janis K.] Univ Penn, Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Shaffer, Meredith H.; Burkhardt, Janis K.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sacirbegovic, Faruk; McMahon, Kerrie-Ann; Russell, Sarah M.] Peter MacCallum Canc Ctr, Immune Signalling Lab, Melbourne, Vic, Australia; [Sacirbegovic, Faruk; Humbert, Patrick O.; Russell, Sarah M.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Tomassian, Tamar; Miceli, M. Carrie] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Humbert, Patrick O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, Melbourne, Vic, Australia; [Humbert, Patrick O.; Russell, Sarah M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [McMahon, Kerrie-Ann; Russell, Sarah M.] Swinburne Univ Technol, Fac Engn & Ind Sci, Ctr Microphoton, Melbourne, Vic, Australia; [Takamiya, Kogo] Miyazaki Univ, Fac Med, Dept Neurosci, Miyazaki, Japan; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; [Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Brain Sci Inst, Baltimore, MD 21205 USA	University of California System; University of California Los Angeles; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Peter Maccallum Cancer Center; University of Melbourne; University of California System; University of California Los Angeles; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Swinburne University of Technology; University of Miyazaki; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Miceli, MC (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	cmiceli@ucla.edu	McMahon, Kerrie-Ann/J-1821-2014; Shaffer, Meredith/N-5984-2017; Humbert, Patrick O/L-4264-2016; Russell, Sarah M/B-9341-2009	McMahon, Kerrie-Ann/0000-0002-0833-5708; Humbert, Patrick O/0000-0002-1366-6691; Russell, Sarah M/0000-0001-5826-9641; Takamiya, Kogo/0000-0001-7240-6307; Burkhardt, Janis/0000-0002-8176-1375; Shaffer, Meredith/0000-0002-6982-7968	National Institutes of Health [P01 CA093615, T32-HD07516, R01-AI067253-10]; UCLA (University of California, Los Angeles) [2-T32-AI-07323]; Arthritis Foundation; Australian National Health and Medical Research Council; Australian Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA093615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007323, R01AI067253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA (University of California, Los Angeles)(University of California System); Arthritis Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work by J.K.B. was supported by National Institutes of Health (http://www.nih.gov) grant P01 CA093615 and work by M.H.S. was supported by National Institutes of Health training grant T32-HD07516. Work by M.C.M. was supported by National Institutes of Health grant R01-AI067253-10 and by a UCLA (University of California, Los Angeles) dissertation year fellowship to J.L.R., a UCLA (University of California, Los Angeles) Microbial Pathogenesis Training Grant 2-T32-AI-07323 to T.T. and an Arthritis Foundation Postdoctoral Fellowship to L.A.H. Work by S.M.R. and P.O.H. was supported by the Australian National Health and Medical Research Council and the Australian Research Council. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Affaticati P, 2011, CELL DEATH DIFFER, V18, P99, DOI 10.1038/cdd.2010.79; Allenspach EJ, 2001, IMMUNITY, V15, P739, DOI 10.1016/S1074-7613(01)00224-2; Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Carrizosa E, 2009, J IMMUNOL, V183, P7352, DOI 10.4049/jimmunol.0900973; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Cullinan P, 2002, IMMUNOL REV, V189, P111, DOI 10.1034/j.1600-065X.2002.18910.x; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Jirmanova L, 2009, BLOOD, V113, P2229, DOI 10.1182/blood-2008-04-153304; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Klocker N, 2002, EUR J NEUROSCI, V16, P1517, DOI 10.1046/j.1460-9568.2002.02228.x; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Ludford-Menting MJ, 2005, IMMUNITY, V22, P737, DOI 10.1016/j.immuni.2005.04.009; Lue RA, 1996, J CELL BIOL, V135, P1125, DOI 10.1083/jcb.135.4.1125; Madrenas J, 2003, IMMUNITY, V18, P459, DOI 10.1016/S1074-7613(03)00089-X; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Miceli MC, 2001, SEMIN IMMUNOL, V13, P115, DOI 10.1006/smim.2000.0303; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; Morales-Tirado V, 2004, J IMMUNOL, V173, P726, DOI 10.4049/jimmunol.173.2.726; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Round JL, 2005, J EXP MED, V201, P419, DOI 10.1084/jem.20041428; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Russell S, 2008, J CELL SCI, V121, P131, DOI 10.1242/jcs.021253; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Stephenson LM, 2007, MOL CELL BIOL, V27, P7574, DOI 10.1128/MCB.00439-07; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Teixeiro E, 2009, SCIENCE, V323, P502, DOI 10.1126/science.1163612; Thrasher AJ, 2010, NAT REV IMMUNOL, V10, P182, DOI 10.1038/nri2724; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Yeh JH, 2008, CELL, V132, P846, DOI 10.1016/j.cell.2008.01.013; Zanin-Zhorov A, 2012, P NATL ACAD SCI USA, V109, P1625, DOI 10.1073/pnas.1110120109; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	47	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45276	10.1371/journal.pone.0045276	http://dx.doi.org/10.1371/journal.pone.0045276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028902	gold, Green Submitted, Green Published			2022-12-27	WOS:000311313900112
J	Nauman, J; Aspenes, ST; Nilsen, TIL; Vatten, LJ; Wisloff, U				Nauman, Javaid; Aspenes, Stian Thoresen; Nilsen, Tom Ivar Lund; Vatten, Lars J.; Wisloff, Ulrik			A Prospective Population Study of Resting Heart Rate and Peak Oxygen Uptake (the HUNT Study, Norway)	PLOS ONE			English	Article							SYSTOLIC DYSFUNCTION BEAUTIFUL; CORONARY-ARTERY-DISEASE; ALL-CAUSE MORTALITY; CARDIORESPIRATORY FITNESS; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; RISK-FACTOR; EXERCISE; MEN; PREDICTOR	Objectives: We assessed the prospective association of resting heart rate (RHR) at baseline with peak oxygen uptake (VO2peak) 23 years later, and evaluated whether physical activity (PA) could modify this association. Background: Both RHR and VO2peak are strong and independent predictors of cardiovascular morbidity and mortality. However, the association of RHR with VO2peak and modifying effect of PA have not been prospectively assessed in population studies. Methods: In 807 men and 810 women free from cardiovascular disease both at baseline (1984-86) and follow-up 23 years later, RHR was recorded at both occasions, and VO2peak was measured by ergospirometry at follow-up. We used Generalized Linear Models to assess the association of baseline RHR with VO2peak, and to study combined effects of RHR and self-reported PA on later VO2peak. Results: There was an inverse association of RHR at baseline with VO2peak (p<0.01). Men and women with baseline RHR greater than 80 bpm had 4.6 mL.kg(-1).min(-1) (95% confidence interval [CI], 2.8 to 6.3) and 1.4 mL.kg(-1).min(-1) (95% CI, -0.4 to 3.1) lower VO2peak at follow-up compared with men and women with RHR below 60 bpm at baseline. We found a linear association of change in RHR with VO2peak (p = 0.03), suggesting that a decrease in RHR over time is likely to be beneficial for cardiovascular fitness. Participants with low RHR and high PA at baseline had higher VO2peak than inactive people with relatively high RHR. However, among participants with relatively high RHR and high PA at baseline, VO2peak was similar to inactive people with relatively low RHR. Conclusion: RHR is an important predictor of VO2peak, and serial assessments of RHR may provide useful and inexpensive information on cardiovascular fitness. The results suggest that high levels of PA may compensate for the lower VO2peak associated with a high RHR.	[Nauman, Javaid; Aspenes, Stian Thoresen; Vatten, Lars J.; Wisloff, Ulrik] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Nilsen, Tom Ivar Lund] Norwegian Univ Sci & Technol, Human Movement Sci Programme, Fac Social Sci & Technol Management, N-7034 Trondheim, Norway; [Vatten, Lars J.] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Nauman, J (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway.	Javaid.nauman@ntnu.no	Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022; Wisloff, Ulrik/K-2899-2012; Nauman, Javaid/AAF-2284-2019	Nauman, Javaid/0000-0003-1347-2448; Wisloff, Ulrik/0000-0002-7211-3587	K.G. Jebsen Foundation; Norwegian Council of Cardiovascular Disease; Norwegian Research Council; Funds for Cardiovascular and Medical Research at St. Olav's University Hospital, Trondheim; Torstein Erbo's Foundation, Trondheim	K.G. Jebsen Foundation; Norwegian Council of Cardiovascular Disease; Norwegian Research Council(Research Council of NorwayEuropean Commission); Funds for Cardiovascular and Medical Research at St. Olav's University Hospital, Trondheim; Torstein Erbo's Foundation, Trondheim	The present study was supported by grants from K.G. Jebsen Foundation, the Norwegian Council of Cardiovascular Disease, the Norwegian Research Council (Funding for Outstanding Young Investigators, UW), Funds for Cardiovascular and Medical Research at St. Olav's University Hospital, Trondheim, and the Torstein Erbo's Foundation, Trondheim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Bassett DR, 1997, MED SCI SPORT EXER, V29, P591, DOI 10.1097/00005768-199705000-00002; Black A, 2006, HEART, V92, P468, DOI 10.1136/hrt.2005.067777; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Buchheit M, 2006, AM J PHYSIOL-HEART C, V291, pH451, DOI 10.1152/ajpheart.00008.2006; Carnethon MR, 2003, JAMA-J AM MED ASSOC, V290, P3092, DOI 10.1001/jama.290.23.3092; Carnethon MR, 2005, JAMA-J AM MED ASSOC, V294, P2981, DOI 10.1001/jama.294.23.2981; Carter JB, 2003, SPORTS MED, V33, P33, DOI 10.2165/00007256-200333010-00003; ERIKSSEN J, 1979, EUR J APPL PHYSIOL O, V42, P61, DOI 10.1007/BF00421105; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Hardin JW., 2007, GEN LINEAR MODELS EX, V2, DOI DOI 10.1016/j.marpol.2012.12.026; Janssen I, 2005, AM J PREV MED, V29, P194, DOI 10.1016/j.amepre.2005.05.003; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Jouven X, 2009, AM J CARDIOL, V103, P279, DOI 10.1016/j.amjcard.2008.08.071; Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004; KANNEL WB, 1985, AM HEART J, V109, P876, DOI 10.1016/0002-8703(85)90653-2; Kemi OJ, 2010, J CARDIOPULM REHABIL, V30, P2, DOI 10.1097/HCR.0b013e3181c56b89; KENNEY WL, 1985, MED SCI SPORT EXER, V17, P451, DOI 10.1249/00005768-198508000-00008; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Laukkanen JA, 2004, EUR HEART J, V25, P1428, DOI 10.1016/j.ehj.2004.06.013; Laukkanen JA, 2009, AM J CARDIOL, V103, P1598, DOI 10.1016/j.amjcard.2009.01.371; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; Levine BD, 2008, J PHYSIOL-LONDON, V586, P25, DOI 10.1113/jphysiol.2007.147629; Lucini D, 2002, AM HEART J, V143, P977, DOI 10.1067/mhj.2002.123117; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; McCullagh P, 1989, GEN LINEAR MODELS; Mora S, 2005, CIRCULATION, V112, P1566, DOI 10.1161/CIRCULATIONAHA.105.542993; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Nauman J, 2010, J EPIDEMIOL COMMUN H, V64, P175, DOI 10.1136/jech.2009.093088; Palatini P, 1999, HYPERTENSION, V33, P622, DOI 10.1161/01.HYP.33.2.622; Palatini P, 2007, DRUGS, V67, P3, DOI 10.2165/00003495-200767002-00002; Plichart M, 2013, EUR J PREV CARDIOL, V20, P61, DOI 10.1177/2047487311434231; Rognmo O, 2004, EUR J CARDIOV PREV R, V11, P216, DOI 10.1097/01.hjr.0000131677.96762.0c; RUNCIE CJ, 1990, INTENS CARE MED, V16, P317, DOI 10.1007/BF01706357	37	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45021	10.1371/journal.pone.0045021	http://dx.doi.org/10.1371/journal.pone.0045021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028740	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900067
J	Quinn, MK; Bubi, TC; Pierce, MC; Kayembe, MK; Ramogola-Masire, D; Richards-Kortum, R				Quinn, Mary K.; Bubi, Tefo C.; Pierce, Mark C.; Kayembe, Mukendi K.; Ramogola-Masire, Doreen; Richards-Kortum, Rebecca			High-Resolution Microendoscopy for the Detection of Cervical Neoplasia in Low-Resource Settings	PLOS ONE			English	Article							VISUAL INSPECTION; CANCER; ACCURACY	Cervical cancer is the second leading cause of cancer death among women in developing countries. Developing countries often lack infrastructure, cytotechnologists, and pathologists necessary to implement current screening tools. Due to their low cost and ease of interpretation at the point-of-care, optical imaging technologies may serve as an appropriate solution for cervical cancer screening in low resource settings. We have developed a high-resolution optical imaging system, the High Resolution Microendoscope (HRME), which can be used to interrogate clinically suspicious areas with subcellular spatial resolution, revealing changes in nuclear to cytoplasmic area ratio. In this pilot study carried out at the women's clinic of Princess Marina Hospital in Botswana, 52 unique sites were imaged in 26 patients, and the results were compared to histopathology as a reference standard. Quantitative high resolution imaging achieved a sensitivity and specificity of 86% and 87%, respectively, in differentiating neoplastic (>= CIN 2) tissue from non-neoplastic tissue. These results suggest the potential promise of HRME to assist in the detection of cervical neoplasia in low-resource settings.	[Quinn, Mary K.; Bubi, Tefo C.; Richards-Kortum, Rebecca] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Pierce, Mark C.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Kayembe, Mukendi K.] Princess Marina Hosp, Natl Hlth Lab, Gaborone, Botswana; [Ramogola-Masire, Doreen] Univ Botswana, Sch Med, Gaborone, Botswana	Rice University; Rutgers State University New Brunswick; University of Botswana	Richards-Kortum, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.	rkortum@rice.edu	Richards-Kortum, Rebecca R/P-4074-2014; Ramogola-Masire, Doreen/AAP-2754-2020	Richards-Kortum, Rebecca R/0000-0003-2347-9467; Ramogola-Masire, Doreen/0000-0001-9624-8366; Pierce, Mark/0000-0003-4377-9547	National Institute of Biomedical Imaging and Bioengineering [R03EB013973]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB013973] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The project described was supported by Award Number R03EB013973 from the National Institute of Biomedical Imaging and Bioengineering. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Biomedical Imaging And Bioengineering or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baak I, 2009, ROBBOYS PATHOLOGY FE, P189; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; MAIMAN M, 1990, GYNECOL ONCOL, V38, P377, DOI 10.1016/0090-8258(90)90077-X; Muldoon TJ, 2012, HEAD NECK-J SCI SPEC, V34, P305, DOI 10.1002/hed.21735; Organization WH, 2005, HDB CANC PREVENTION; Pierce M, 2011, JOVE-J VIS EXP, DOI 10.3791/2306; Pierce MC, 2012, CANC PREV RES PHILA; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Ramogola-Masire D, 2012, JAIDS-J ACQ IMM DEF, V59, P308, DOI 10.1097/QAI.0b013e3182426227; RUBBO SD, 1947, BRIT J EXP PATHOL, V28, P1; Russell DS, 1941, BRIT J SURG, V28, P472, DOI 10.1002/bjs.18002811115; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sauvaget C, 2011, INT J GYNECOL OBSTET, V113, P14, DOI 10.1016/j.ijgo.2010.10.012; Sellors J. W., 2003, COLPOSCOPY TREATMENT; Tan J, 2009, BJOG-INT J OBSTET GY, V116, P1663, DOI 10.1111/j.1471-0528.2009.02261.x; Thekkek N, 2008, NAT REV CANCER, V8, P725, DOI 10.1038/nrc2462; Vila PM, 2011, MT SINAI J MED, V78, P894, DOI 10.1002/msj.20304; WHO, 2006, COMPR CERV CANC CONT	22	53	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44924	10.1371/journal.pone.0044924	http://dx.doi.org/10.1371/journal.pone.0044924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028683	Green Published, gold			2022-12-27	WOS:000311313900054
J	Smith, RV; Stafford, JD; Yetter, AP; Horath, MM; Hine, CS; Hoover, JP				Smith, Randolph V.; Stafford, Joshua D.; Yetter, Aaron P.; Horath, Michelle M.; Hine, Christopher S.; Hoover, Jeffery P.			Foraging Ecology of Fall-Migrating Shorebirds in the Illinois River Valley	PLOS ONE			English	Article							SPRING MIGRATION; LESSER SCAUP; FOOD-HABITS; BENTHIC INVERTEBRATES; VERTICAL-DISTRIBUTION; MIGRANT SHOREBIRDS; FEEDING ECOLOGY; GREATER SCAUP; PREY; ABUNDANCE	Populations of many shorebird species appear to be declining in North America, and food resources at stopover habitats may limit migratory bird populations. We investigated body condition of, and foraging habitat and diet selection by 4 species of shorebirds in the central Illinois River valley during fall migrations 2007 and 2008 (Killdeer [Charadrius vociferus], Least Sandpiper [Calidris minutilla], Pectoral Sandpiper [Calidris melanotos], and Lesser Yellowlegs [Tringa flavipes]). All species except Killdeer were in good to excellent condition, based on size-corrected body mass and fat scores. Shorebird diets were dominated by invertebrate taxa from Orders Diptera and Coleoptera. Additionally, Isopoda, Hemiptera, Hirudinea, Nematoda, and Cyprinodontiformes contribution to diets varied by shorebird species and year. We evaluated diet and foraging habitat selection by comparing aggregate percent dry mass of food items in shorebird diets and core samples from foraging substrates. Invertebrate abundances at shorebird collection sites and random sites were generally similar, indicating that birds did not select foraging patches within wetlands based on invertebrate abundance. Conversely, we found considerable evidence for selection of some diet items within particular foraging sites, and consistent avoidance of Oligochaeta. We suspect the diet selectivity we observed was a function of overall invertebrate biomass (51.2 +/- 4.4 [SE] kg/ha; dry mass) at our study sites, which was greater than estimates reported in most other food selection studies. Diet selectivity in shorebirds may follow tenants of optimal foraging theory; that is, at low food abundances shorebirds forage opportunistically, with the likelihood of selectivity increasing as food availability increases. Nonetheless, relationships between the abundance, availability, and consumption of Oligochaetes for and by waterbirds should be the focus of future research, because estimates of foraging carrying capacity would need to be revised downward if Oligochaetes are truly avoided or unavailable for consumption.	[Smith, Randolph V.; Stafford, Joshua D.; Yetter, Aaron P.; Horath, Michelle M.; Hine, Christopher S.] Univ Illinois, FC Bellrose Waterfowl Res Ctr, Forbes Biol Stn, Illinois Nat Hist Survey,Prairie Res Inst, Havana, IL 62644 USA; [Hoover, Jeffery P.] Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL USA	Illinois Natural History Survey; University of Illinois System; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Smith, RV (corresponding author), Univ Illinois, FC Bellrose Waterfowl Res Ctr, Forbes Biol Stn, Illinois Nat Hist Survey,Prairie Res Inst, Havana, IL 62644 USA.	rvsmith@illinois.edu	Stafford, Joshua D/H-4039-2011		U.S. Fish and Wildlife Service, Upper Mississippi River and Great Lakes Region Joint Venture [301817G038]; University of Illinois Urbana-Champaign; EnvironMetal Inc.	U.S. Fish and Wildlife Service, Upper Mississippi River and Great Lakes Region Joint Venture; University of Illinois Urbana-Champaign; EnvironMetal Inc.	Financial or in-kind support for this project was provided by: U.S. Fish and Wildlife Service, Upper Mississippi River and Great Lakes Region Joint Venture (http://www.uppermissgreatlakesjv.org/; grant/contract number: 301817G038), University of Illinois Urbana-Champaign (http://illinois.edu/), and EnvironMetal Inc. (http://www.hevishot.com/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; AFTON AD, 1991, CAN J ZOOL, V69, P328, DOI 10.1139/z91-053; Anderson JT, 1998, WETLANDS, V18, P437, DOI 10.1007/BF03161536; Andrei AE, 2009, WATERBIRDS, V32, P138, DOI 10.1675/063.032.0117; Anteau MJ, 2004, AUK, V121, P917, DOI 10.1642/0004-8038(2004)121[0917:NROLSA]2.0.CO;2; Ashley MC, 2000, WETLANDS, V20, P84, DOI 10.1672/0277-5212(2000)020[0084:DSSBAE]2.0.CO;2; Atkinson Philip W., 2006, P535; Augustin JC, 1999, WILDLIFE SOC B, V27, P552; Backwell PRY, 1998, ANIM BEHAV, V55, P1659, DOI 10.1006/anbe.1997.0713; Badzinski SS, 2006, WILDLIFE SOC B, V34, P664, DOI 10.2193/0091-7648(2006)34[664:DOLAGS]2.0.CO;2; BAILEY SD, 2003, MEADOWLARK J ILLINOI, V12, P54; BAKER MC, 1977, CONDOR, V79, P56, DOI 10.2307/1367530; BAKER MC, 1973, ECOL MONOGR, V43, P193, DOI 10.2307/1942194; BALDASSARRE GA, 1984, J FIELD ORNITHOL, V55, P220; Bellrose FC, 1983, ILL NAT HIST SURV BI, V119; Bingham RL, 2004, J WILDLIFE MANAGE, V68, P206, DOI 10.2193/0022-541X(2004)068[0206:COTIER]2.0.CO;2; Block William M., 1993, Current Ornithology, V11, P35; BROOKS WS, 1967, WILSON BULL, V79, P307; Brown S, 2001, US SHOREBIRD CONSERV; COLWELL MA, 1993, CONDOR, V95, P94, DOI 10.2307/1369390; COOPER JM, 1994, BIRDS N AM; DAVIS CA, 1998, WILDLIFE MONOGRAPHS, V140; DeSante D, 2008, INSTRUCTIONS ESTABLI; DILLERY DG, 1965, AUK, V82, P281, DOI 10.2307/4082949; Eldridge JL, 2009, J WILDLIFE MANAGE, V73, P248, DOI 10.2193/2006-416; ESTABROOK GF, 1976, AM NAT, V110, P401, DOI 10.1086/283076; Farmer AH, 1997, CONDOR, V99, P698, DOI 10.2307/1370481; Farmer AH, 1999, ECOLOGY, V80, P2566, DOI 10.2307/177241; FISHER JA, 1975, HYDROBIOLOGIA, V47, P273; Flinn MB, 2008, ENVIRON MANAGE, V41, P468, DOI 10.1007/s00267-008-9078-6; Fredrickson LH, 1982, US DEP INTERIOR FISH; Galat DL, 1998, BIOSCIENCE, V48, P721, DOI 10.2307/1313335; Gammonley JH, 2002, WETLANDS, V22, P499, DOI 10.1672/0277-5212(2002)022[0499:POFAFB]2.0.CO;2; GERRITSEN AFC, 1986, NETH J ZOOL, V36, P530, DOI 10.1163/002829686X00216; GOSSCUSTARD JD, 1969, IBIS, V111, P338, DOI 10.1111/j.1474-919X.1969.tb02549.x; GOSSCUSTARD JD, 1970, J ANIM ECOL, V39, P91, DOI 10.2307/2891; Gratto-Trevor CL, 1998, WILSON BULL, V110, P316; Grulkowski DP, 2010, THESIS SO ILLINOIS U; GUILLEMETTE M, 1992, J ANIM ECOL, V61, P599, DOI 10.2307/5615; Hamer GL, 2006, WILSON J ORNITHOL, V118, P152, DOI 10.1676/05-024.1; HAMER GL, 2004, THESIS U ILLINOIS UR; HANDS HM, 1991, WILDLIFE SOC B, V19, P457; Havera SP, 1984, WETLANDS, V4, P29; Havera SP, 1999, ILLINOIS NATURAL HIS, V21; Helmers DL, 1992, SHOREBIRD MANAGEMENT; HICKLIN PW, 1984, CAN J ZOOL, V62, P2201, DOI 10.1139/z84-321; Holmes R. T., 1998, BIRDS N AM; JACKSON BJS, 2000, BIRDS N AM; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; JORDANO P, 1988, ARDEA, V76, P193; KAMERMANS P, 1994, J EXP MAR BIOL ECOL, V175, P59, DOI 10.1016/0022-0981(94)90176-7; Merritt R.W., 1996, INTRO AQUATIC INSECT; MICHAUD G, 1990, CAN J ZOOL, V68, P1154, DOI 10.1139/z90-171; Mitchell DW, 2005, AM MIDL NAT, V154, P188, DOI 10.1674/0003-0031(2005)154[0188:IOSOMI]2.0.CO;2; Mitsch W. J., 1993, WETLANDS; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; Morrison RIG, 2000, WATERBIRDS, V23, P337, DOI 10.2307/1522172; OBrien M, 2006, THE SHOREBIRD GUIDE; ORING L, 2000, NATL SHOREBIRD RES N; Pearse AT, 2012, WETLANDS, V32, P859, DOI 10.1007/s13157-012-0317-5; Persson A, 2006, AQUAT ECOL, V40, P85, DOI 10.1007/s10452-005-9014-2; PIERSMA T, 1995, J ANIM ECOL, V64, P493, DOI 10.2307/5652; Piersma T, 1998, P ROY SOC B-BIOL SCI, V265, P1377, DOI 10.1098/rspb.1998.0445; Placyk JS, 2004, J FIELD ORNITHOL, V75, P223, DOI 10.1648/0273-8570-75.3.223; Pomeroy AC, 2008, AVIAN CONSERV ECOL, V3; Potter B. A., 2007, UPPER MISSISSIPPI RI; Ross RK, 2005, WILDLIFE SOC B, V33, P81, DOI 10.2193/0091-7648(2005)33[81:ADOGSL]2.0.CO;2; RUNDLE W D, 1981, Wildlife Society Bulletin, V9, P80; RUNDLE WD, 1982, J FIELD ORNITHOL, V53, P249; Russell R, 2003, MEADOWLARK, V12, P42; Safran RJ, 1997, WETLANDS, V17, P407, DOI 10.1007/BF03161430; SAS Institute, 2008, SAS STAT US GUID; SCHNEIDER DC, 1981, AUK, V98, P801; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Sherfy MH, 2000, WILDLIFE SOC B, V28, P124; SKAGEN SK, 1993, CONSERV BIOL, V7, P533, DOI 10.1046/j.1523-1739.1993.07030533.x; SKAGEN SK, 1994, CONDOR, V96, P949, DOI 10.2307/1369104; Skagen SK, 1996, CAN FIELD NAT, V110, P419; Smith, 2007, THESIS SO ILLINOIS U; Smith D.G., 2001, PENNAKS FRESHWATER I; SPRINGETT JA, 1970, OIKOS, V21, P16, DOI 10.2307/3543833; SWANSON GA, 1974, J WILDLIFE MANAGE, V38, P302, DOI 10.2307/3800737; SWANSON GA, 1970, J WILDLIFE MANAGE, V34, P739, DOI 10.2307/3799138; Taft OW, 2006, BIOL CONSERV, V128, P298, DOI 10.1016/j.biocon.2005.09.036; Taft OW, 2005, AGR ECOSYST ENVIRON, V110, P249, DOI 10.1016/j.agee.2005.04.012; Thomas NE, 2008, THESIS U S DAKOTA VE; Tibbitts T, 1999, BIRDS N AM; U.S. Fish and Wildlife Service, 1998, UPP MISS RIV GREAT L; US Shorebird Conservation Plan, 2004, HIGH PRIOR SHO UNPUB; Weber LM, 1997, J FIELD ORNITHOL, V68, P358; Wirwa D.W., 2009, THESIS U TENNESSEE K; Zydelis R, 2005, WILSON BULL, V117, P133, DOI 10.1676/04-045	92	19	20	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45121	10.1371/journal.pone.0045121	http://dx.doi.org/10.1371/journal.pone.0045121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028795	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900081
J	Delprato, A				Delprato, Anna			Topological and Functional Properties of the Small GTPases Protein Interaction Network	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PHAGOCYTE NADPH OXIDASE; RHO-GTPASES; BINDING-PROTEINS; STRUCTURAL BASIS; FAMILY PROTEINS; TYROSINE KINASE; RAN GTPASE; ROLES; ACTIVATION	Small GTP binding proteins of the Ras superfamily (Ras, Rho, Rab, Arf, and Ran) regulate key cellular processes such as signal transduction, cell proliferation, cell motility, and vesicle transport. A great deal of experimental evidence supports the existence of signaling cascades and feedback loops within and among the small GTPase subfamilies suggesting that these proteins function in a coordinated and cooperative manner. The interplay occurs largely through association with bi-partite regulatory and effector proteins but can also occur through the active form of the small GTPases themselves. In order to understand the connectivity of the small GTPases signaling routes, a systems-level approach that analyzes data describing direct and indirect interactions was used to construct the small GTPases protein interaction network. The data were curated from the Search Tool for the Retrieval of Interacting Genes (STRING) database and include only experimentally validated interactions. The network method enables the conceptualization of the overall structure as well as the underlying organization of the protein-protein interactions. The interaction network described here is comprised of 778 nodes and 1943 edges and has a scale-free topology. Rac1, Cdc42, RhoA, and HRas are identified as the hubs. Ten sub-network motifs are also identified in this study with themes in apoptosis, cell growth/proliferation, vesicle traffic, cell adhesion/junction dynamics, the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase response, transcription regulation, receptor-mediated endocytosis, gene silencing, and growth factor signaling. Bottleneck proteins that bridge signaling paths and proteins that overlap in multiple small GTPase networks are described along with the functional annotation of all proteins in the network.	BioSci Project, Wakefield, MA USA		Delprato, A (corresponding author), BioSci Project, Wakefield, MA USA.	delprato@bioscienceproject.org		Delprato, Anna/0000-0002-6134-2560				AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Badolato R, 2007, J ALLERGY CLIN IMMUN, V120, P735, DOI 10.1016/j.jaci.2007.08.039; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Berthold J, 2008, ACTA PHARMACOL SIN, V29, P285, DOI 10.1111/j.1745-7254.2008.00773.x; Bhan A, 2002, BIOINFORMATICS, V18, P1486, DOI 10.1093/bioinformatics/18.11.1486; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Billuart P, 2003, NEURON, V38, P843, DOI 10.1016/S0896-6273(03)00362-3; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chen Y, 2004, MOL CELL BIOL, V24, P3048, DOI 10.1128/MCB.24.7.3048-3056.2004; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chung F, 2003, J COMPUT BIOL, V10, P677, DOI 10.1089/106652703322539024; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Cox Adrienne D, 2010, Small GTPases, V1, P2; Curtin JF, 2003, CELL SIGNAL, V15, P983, DOI 10.1016/S0898-6568(03)00093-7; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; de la Vega Michelle, 2011, Small GTPases, V2, P192; de Toledo M, 2003, MOL BIOL CELL, V14, P4846, DOI 10.1091/mbc.E03-04-0254; Dewey T. Gregory, 2001, Functional and Integrative Genomics, V1, P269, DOI 10.1007/s101420000035; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Eathiraj S, 2006, J MOL BIOL, V364, P121, DOI 10.1016/j.jmb.2006.08.064; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Erdman RA, 2000, J BIOL CHEM, V275, P3848, DOI 10.1074/jbc.275.6.3848; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Flynn R, 2010, CHANNELS, V4, P434, DOI 10.4161/chan.4.6.12865; Foster DV, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031912; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Ghibelli L, 2010, MITOCHONDRION, V10, P604, DOI 10.1016/j.mito.2010.08.003; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Horgan CP, 2009, BIOCHEM SOC T, V37, P1032, DOI 10.1042/BST0371032; Hughes AL, 2005, J MOL EVOL, V61, P758, DOI 10.1007/s00239-005-0037-z; Jing J, 2009, HISTOL HISTOPATHOL, V24, P1171, DOI 10.14670/HH-24.1171; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kobayashi H, 2011, J BIOL CHEM, V286, P39259, DOI 10.1074/jbc.M111.255489; KORNBLUTH S, 1994, J CELL BIOL, V125, P705, DOI 10.1083/jcb.125.4.705; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; KRONTIRIS TG, 1981, P NATL ACAD SCI-BIOL, V78, P1181, DOI 10.1073/pnas.78.2.1181; Kumar S, 2005, CELL CYCLE, V4, P1667, DOI 10.4161/cc.4.11.2169; Lau ASN, 2003, ENDOCRINOLOGY, V144, P1549, DOI 10.1210/en.2002-220893; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lebowitz PF, 1997, CANCER RES, V57, P708; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lin CY, 2002, J CELL SCI, V115, P4433, DOI 10.1242/jcs.00123; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; McDonel P, 2011, DEV BIOL; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Minakami R, 2006, INT J HEMATOL, V84, P193, DOI 10.1532/IJH97.06133; Ming WY, 2007, MOL CELL BIOL, V27, P312, DOI 10.1128/MCB.00985-06; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Mukherjee S, 2000, P NATL ACAD SCI USA, V97, P5901, DOI 10.1073/pnas.100127097; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Nimnual AS, 2011, SMALL GTPASES, V1, P89; Ohno S., 1970, P1; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pavlopoulos GA, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-10; Pereira-Leal JB, 2005, GENOME RES, V15, P552, DOI 10.1101/gr.3102105; PERUCHO M, 1981, CELL, V27, P467, DOI 10.1016/0092-8674(81)90388-3; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Pylayeva-Gupta Y, NAT REV CANC, V11, P761; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Quang CT, 2000, EMBO J, V19, P4565, DOI 10.1093/emboj/19.17.4565; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rousseau M, 2011, BIOCHEM BIOPH RES CO, V414, P750, DOI 10.1016/j.bbrc.2011.09.150; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Sanchez-Miranda E, 2010, BIOCHEM BIOPH RES CO, V391, P1714, DOI 10.1016/j.bbrc.2009.12.139; Schulze Waltraud X, 2005, Mol Syst Biol, V1; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Seyed-allaei H, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046113; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Street CA, 2011, ANTICANCER RES, V31, P3645; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wittchen Erika S, 2011, Small GTPases, V2, P65; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Xu K, 2011, PROTEOMICS, V11, P1857, DOI 10.1002/pmic.201000684; Yamaguchi A, 1997, J BIOL CHEM, V272, P31230, DOI 10.1074/jbc.272.50.31230; Yamamura R, 2008, MOL BIOL CELL, V19, P971, DOI 10.1091/mbc.E07-06-0551; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yoshiki S, 2010, MOL BIOL CELL, V21, P1088, DOI 10.1091/mbc.E09-06-0455; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Yu HF, 2011, FRONT BIOSCI-LANDMRK, V16, P1536, DOI 10.2741/3803; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429	135	26	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44882	10.1371/journal.pone.0044882	http://dx.doi.org/10.1371/journal.pone.0044882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028658	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700048
J	Glazko, GV; Zybailov, BL; Rogozin, IB				Glazko, Galina V.; Zybailov, Boris L.; Rogozin, Igor B.			Computational Prediction of Polycomb-Associated Long Non-Coding RNAs	PLOS ONE			English	Article							DARK-MATTER; CHROMATIN; GENOME; IDENTIFICATION; TRANSCRIPTOME; BIOINFORMATICS; COMPLEXES; SEQUENCE; ELEMENTS; REVEALS	Among thousands of long non-coding RNAs (lncRNAs) only a small subset is functionally characterized and the functional annotation of lncRNAs on the genomic scale remains inadequate. In this study we computationally characterized two functionally different parts of human lncRNAs transcriptome based on their ability to bind the polycomb repressive complex, PRC2. This classification is enabled by the fact that while all lncRNAs constitute a diverse set of sequences, the classes of PRC2-binding and PRC2 non-binding lncRNAs possess characteristic combinations of sequence-structure patterns and, therefore, can be separated within the feature space. Based on the specific combination of features, we built several machine-learning classifiers and identified the SVM-based classifier as the best performing. We further showed that the SVM-based classifier is able to generalize on the independent data sets. We observed that this classifier, trained on the human lncRNAs, can predict up to 59.4% of PRC2-binding lncRNAs in mice. This suggests that, despite the low degree of sequence conservation, many lncRNAs play functionally conserved biological roles.	[Glazko, Galina V.] Univ Arkansas Med Sci, Div Biomed Informat, Little Rock, AR 72205 USA; [Zybailov, Boris L.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Rogozin, Igor B.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Glazko, GV (corresponding author), Univ Arkansas Med Sci, Div Biomed Informat, Little Rock, AR 72205 USA.	gvglazko@uams.edu; blzybaylov@uams.edu		Zybailov, Boris/0000-0003-2432-9145; Rogozin, Igor/0000-0003-0802-4851	Arkansas Translational Research Institute; academic home at the University of Arkansas for Medical Sciences (UAMS), National Institutes of Health (NIH) grant [UL1RR029884]; UAMS Biochemistry Department Chair special fund; Intramural Research Program of the National Library of Medicine at the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER	Arkansas Translational Research Institute; academic home at the University of Arkansas for Medical Sciences (UAMS), National Institutes of Health (NIH) grant; UAMS Biochemistry Department Chair special fund; Intramural Research Program of the National Library of Medicine at the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This publication in part was supported by the Arkansas Translational Research Institute, with an academic home at the University of Arkansas for Medical Sciences (UAMS), National Institutes of Health (NIH) grant UL1RR029884; and by the UAMS Biochemistry Department Chair special fund to Dr. Kevin Raney. IBR was supported by the Intramural Research Program of the National Library of Medicine at the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Da Sacco L, 2012, INT J MOL SCI, V13, P97, DOI 10.3390/ijms13010097; Duszczyk MM, 2008, NUCLEIC ACIDS RES, V36, P7068, DOI 10.1093/nar/gkn776; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Glazko GV, 2001, BBA-GENE STRUCT EXPR, V1517, P351, DOI 10.1016/S0167-4781(00)00297-9; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-102; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jelizarow M, 2010, BIOINFORMATICS, V26, P1990, DOI 10.1093/bioinformatics/btq323; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lee JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003749; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Li M., 2008, INTRO KOLMOGOROV COM; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Managadze D, 2011, GENOME BIOL EVOL, V3, P1390, DOI 10.1093/gbe/evr116; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meyer F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-214; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Moran VA, 2012, NUCL ACIDS RES; Morris KV, 2009, EPIGENETICS-US, V4, P296, DOI 10.4161/epi.4.5.9282; Noble W.S, 2004, SUPPORT VECTOR MACHI, DOI [10.7551/mitpress/4057.003.0005, DOI 10.7551/MITPRESS/4057.003.0005]; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robinson Richard, 2010, PLoS Biol, V8, pe1000370, DOI 10.1371/journal.pbio.1000370; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Slawski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-439; Spizzo R, 2012, ONCOGENE; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van Bakel H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000371; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XQD, 2011, CURR GENOMICS, V12, P307, DOI 10.2174/138920211796429772; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	56	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44878	10.1371/journal.pone.0044878	http://dx.doi.org/10.1371/journal.pone.0044878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028655	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700047
J	Anraku, I; Rajasuriar, R; Dobbin, C; Brown, R; Lewin, SR; Suhrbier, A				Anraku, Itaru; Rajasuriar, Reena; Dobbin, Caroline; Brown, Richard; Lewin, Sharon R.; Suhrbier, Andreas			Circulating Heat Shock Protein 60 Levels Are Elevated in HIV Patients and Are Reduced by Anti-Retroviral Therapy	PLOS ONE			English	Article							SOLUBLE HEAT-SHOCK-PROTEIN-60; MICROBIAL TRANSLOCATION; CARDIOVASCULAR-DISEASE; SERUM; HSP60; RISK; LIPOPOLYSACCHARIDE; ATHEROSCLEROSIS; INFECTION; RESPONSES	Circulating heat shock protein 60 (Hsp60) and heat shock protein 10 (Hsp10) have been associated with pro-and anti-inflammatory activity, respectively. To determine whether these heat shock proteins might be associated with the immune activation seen in HIV-infected patients, the plasma levels of Hsp60 and Hsp10 were determined in a cohort of 20 HIV-infected patients before and after effective combination anti-retroviral therapy (cART). We show for the first time that circulating Hsp60 levels are elevated in HIV-infected patients, with levels significantly reduced after cART, but still higher than those in HIV-negative individuals. Hsp60 levels correlated significantly with viral load, CD4 counts, and circulating soluble CD14 and lipopolysaccharide levels. No differences or correlations were seen for Hsp10 levels. Elevated circulating Hsp60 may contribute to the immune dysfunction and non-AIDS clinical events seen in HIV-infected patients.	[Anraku, Itaru; Suhrbier, Andreas] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Rajasuriar, Reena; Lewin, Sharon R.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Rajasuriar, Reena] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia; [Dobbin, Caroline; Brown, Richard] CBio Ltd, Brisbane, Qld, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic 3004, Australia; [Lewin, Sharon R.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Suhrbier, Andreas] Griffith Univ, Sch Biomol & Phys Sci, Brisbane, Qld 4111, Australia	QIMR Berghofer Medical Research Institute; Florey Institute of Neuroscience & Mental Health; Universiti Malaya; Monash University; Burnet Institute; Griffith University	Suhrbier, A (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	andreasS@qimr.edu.au	Rajasuriar, Reena/B-9569-2010; Lewin, Sharon/Z-3297-2019	Rajasuriar, Reena/0000-0003-3756-0629; Suhrbier, Andreas/0000-0001-8986-9025; Lewin, Sharon Ruth/0000-0002-0330-8241	Australian Centre for HIV and Hepatitis Virology Research; Australian Research Council	Australian Centre for HIV and Hepatitis Virology Research; Australian Research Council(Australian Research Council)	The work was funded by grants from the Australian Centre for HIV and Hepatitis Virology Research (http://napwa.org.au/services/australian-centre-for-hiv-and-hepatitis-virology-research-ach2) and the Australian Research Council (http://www.arc.gov.au/). AS is a Principle Research Fellow and SL is a Practitioner Fellow with the National Health and Medical Research Council, Australia (http://www.nhmrc.gov.au/grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Corrao S, 2010, LIFE SCI, V86, P145, DOI 10.1016/j.lfs.2009.11.004; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gaardbo JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/670957; Goh YC, 2011, CELL MOL LIFE SCI, V68, P1581, DOI 10.1007/s00018-010-0534-0; Grundtman C, 2011, ARTERIOSCL THROM VAS, V31, P960, DOI 10.1161/ATVBAHA.110.217877; Hamelin C, 2011, FEBS J, V278, P4845, DOI 10.1111/j.1742-4658.2011.08385.x; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kim SC, 2009, CIRC RES, V105, P1186, DOI 10.1161/CIRCRESAHA.109.209643; Kim YS, 2009, BONE, V45, P68, DOI 10.1016/j.bone.2009.03.658; Koh JM, 2009, BONE, V45, P650, DOI 10.1016/j.bone.2009.06.007; Kondo Y, 2010, J INFECT DIS, V202, P202, DOI 10.1086/653496; Kulkarni OP, 2012, NEPHROL DIAL TRANSPL, V27, P1358, DOI 10.1093/ndt/gfr544; Lewthwaite J, 2002, CIRCULATION, V106, P196, DOI 10.1161/01.CIR.0000021121.26290.2C; Li Y, 2011, J BIOL CHEM, V286, P31308, DOI 10.1074/jbc.M111.246124; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Ofotokun I, 2012, CURR HIV-AIDS REP, V9, P16, DOI 10.1007/s11904-011-0099-z; Osterloh A, 2007, J BIOL CHEM, V282, P4669, DOI 10.1074/jbc.M608666200; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Rea IM, 2001, EXP GERONTOL, V36, P341, DOI 10.1016/S0531-5565(00)00215-1; Rizzo M, 2012, CELL STRESS CHAPERON, V17, P399, DOI 10.1007/s12192-011-0315-1; Rizzo M, 2011, CURR PHARM DESIGN, V17, P3662, DOI 10.2174/138161211798220981; Shamaei-Tousi A, 2007, CELL STRESS CHAPERON, V12, P384, DOI 10.1379/CSC-300.1; Wu CTC, 2011, CLIN RHEUMATOL, V30, P959, DOI 10.1007/s10067-011-1709-2; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; Yuan J, 2011, CELL STRESS CHAPERON, V16, P689, DOI 10.1007/s12192-011-0281-7	27	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45291	10.1371/journal.pone.0045291	http://dx.doi.org/10.1371/journal.pone.0045291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028910	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900037
J	Bilbija, D; Haugen, F; Sagave, J; Baysa, A; Bastani, N; Levy, FO; Sirsjo, A; Blomhoff, R; Valen, G				Bilbija, Dusan; Haugen, Fred; Sagave, Julia; Baysa, Anton; Bastani, Nasser; Levy, Finn Olav; Sirsjo, Allan; Blomhoff, Rune; Valen, Guro			Retinoic Acid Signalling Is Activated in the Postischemic Heart and May Influence Remodelling	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; THERAPY; MEDIATE; GROWTH	Background: All-trans retinoic acid (atRA), an active derivative of vitamin A, regulates cell differentiation, proliferation and cardiac morphogenesis via transcriptional activation of retinoic acid receptors (RARs) acting on retinoic acid response elements (RARE). We hypothesized that the retinoic acid (RA) signalling pathway is activated in myocardial ischemia and postischemic remodelling. Methods and Findings: Myocardial infarction was induced through ligating the left coronary artery in mice. In vivo cardiac activation of the RARs was measured by imaging RARE-luciferase reporter mice, and analysing expression of RAR target genes and proteins by real time RT-PCR and western blot. Endogenous retinoids in postinfarcted hearts were analysed by triple-stage liquid chromatography/tandem mass spectrometry. Cardiomyocytes (CM) and cardiofibroblasts (CF) were isolated from infarcted and sham operated RARE luciferase reporter hearts and monitored for RAR activity and expression of target genes. The effect of atRA on CF proliferation was evaluated by EdU incorporation. Myocardial infarction increased thoracic RAR activity in vivo (p<0.001), which was ascribed to the heart through ex vivo imaging (p = 0.002) with the largest signal 1 week postinfarct. This was accompanied by increased cardiac gene and protein expression of the RAR target genes retinol binding protein 1 (p = 0.01 for RNA, p = 0,006 for protein) and aldehyde dehydrogenase 1A2 (p = 0.04 for RNA, p = 0,014 for protein), while gene expression of cytochrome P450 26B1 was downregulated (p = 0.007). Concomitantly, retinol accumulated in the infarcted zone (p = 0.02). CM and CF isolated from infarcted hearts had higher luminescence than those from sham operated hearts (p = 0.02 and p = 0.008). AtRA inhibited CF proliferation in vitro (p = 0.02). Conclusion: The RA signalling pathway is activated in postischemic hearts and may play a role in regulation of damage and repair during remodelling.	[Bilbija, Dusan; Haugen, Fred; Sagave, Julia; Baysa, Anton; Valen, Guro] Univ Oslo, Dept Physiol, Oslo, Norway; [Bastani, Nasser; Blomhoff, Rune] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Levy, Finn Olav] Univ Oslo, Inst Clin Med, Dept Pharmacol, Oslo, Norway; [Bilbija, Dusan; Haugen, Fred; Sagave, Julia; Baysa, Anton; Levy, Finn Olav; Valen, Guro] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Sirsjo, Allan] Univ Orebro, Dept Clin Med, Div Biomed, Orebro, Sweden	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Orebro University	Bilbija, D (corresponding author), Univ Oslo, Dept Physiol, Oslo, Norway.	dusan.bilbija@medisin.uio.no	Haugen, Fred/AAK-6703-2021; Haugen, Fred/I-6341-2018	Haugen, Fred/0000-0001-7201-7344	Norwegian Health Association; Throne Holst Foundation; Novo Nordisk Foundation; Freia Chocolate Factory's Medical Fund; Center for Heart Failure Research; University of Oslo	Norwegian Health Association; Throne Holst Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Freia Chocolate Factory's Medical Fund; Center for Heart Failure Research; University of Oslo	The study was supported by grants from the Norwegian Health Association, Throne Holst Foundation, The Novo Nordisk Foundation, Freia Chocolate Factory's Medical Fund, the Center for Heart Failure Research, and the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo PS, 2010, CELL PHYSIOL BIOCHEM, V26, P395, DOI 10.1159/000320563; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Colbert MC, 1997, J CLIN INVEST, V100, P1958, DOI 10.1172/JCI119727; Czibik G, 2011, LIFE SCI, V88, P543, DOI 10.1016/j.lfs.2011.01.006; Fenaux P, 2000, LEUKEMIA, V14, P1371, DOI 10.1038/sj.leu.2401859; Gudas LJ, 2011, BIOCH BIOPHYSICA ACT; Gundersen TE, 2007, RAPID COMMUN MASS SP, V21, P1176, DOI 10.1002/rcm.2946; Jacoby JJ, 2010, J THORAC ONCOL, V5, P940, DOI 10.1097/JTO.0b013e3181dc211f; Lee K, 2011, ARCH PHARM RES, V34, P1583, DOI 10.1007/s12272-011-1021-3; Lefebvre P, 1998, J BIOL CHEM, V273, P12288, DOI 10.1074/jbc.273.20.12288; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Minicucci MF, 2010, CELL PHYSIOL BIOCHEM, V26, P523, DOI 10.1159/000322320; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Oliveira LC, 2011, ACTA CARDIOL, V66, P3, DOI 10.1080/AC.66.1.2064960; Paiva SAR, 2005, J NUTR, V135, P2326, DOI 10.1093/jn/135.10.2326; Palm-Leis A, 2004, J BIOL CHEM, V279, P54905, DOI 10.1074/jbc.M407383200; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Tanaka R, 2003, GYNECOL ONCOL, V90, P297, DOI 10.1016/S0090-8258(03)00335-4; Tavani A, 2006, FREE RADICAL RES, V40, P659, DOI 10.1080/10715760600615649; Wang HJ, 2002, J APPL PHYSIOL, V92, P2162, DOI 10.1152/japplphysiol.01192.2001; Wolf G, 2008, NUTR REV, V66, P55, DOI 10.1111/j.1753-4887.2007.00006.x; Wu JM, 1996, J CLIN INVEST, V97, P1577, DOI 10.1172/JCI118582	25	40	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44740	10.1371/journal.pone.0044740	http://dx.doi.org/10.1371/journal.pone.0044740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028599	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900014
J	Chen, X; Xu, SZ; McClelland, M; Rahmatpanah, F; Sawyers, A; Jia, ZY; Mercola, D				Chen, Xin; Xu, Shizhong; McClelland, Michael; Rahmatpanah, Farah; Sawyers, Anne; Jia, Zhenyu; Mercola, Dan			An Accurate Prostate Cancer Prognosticator Using a Seven-Gene Signature Plus Gleason Score and Taking Cell Type Heterogeneity into Account	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; BIOCHEMICAL RECURRENCE; DISEASE RECURRENCE; GENE-EXPRESSION; MICROARRAYS; PROGRESSION; BIOMARKERS; PROGNOSIS; MODEL; RISK	One of the major challenges in the development of prostate cancer prognostic biomarkers is the cellular heterogeneity in tissue samples. We developed an objective Cluster-Correlation (CC) analysis to identify gene expression changes in various cell types that are associated with progression. In the Cluster step, samples were clustered (unsupervised) based on the expression values of each gene through a mixture model combined with a multiple linear regression model in which cell-type percent data were used for decomposition. In the Correlation step, a Chi-square test was used to select potential prognostic genes. With CC analysis, we identified 324 significantly expressed genes (68 tumor and 256 stroma cell expressed genes) which were strongly associated with the observed biochemical relapse status. Significance Analysis of Microarray (SAM) was then utilized to develop a seven-gene classifier. The Classifier has been validated using two independent Data Sets. The overall prediction accuracy and sensitivity is 71% and 76%, respectively. The inclusion of the Gleason sum to the seven-gene classifier raised the prediction accuracy and sensitivity to 83% and 76% respectively based on independent testing. These results indicated that our prognostic model that includes cell type adjustments and using Gleason score and the seven-gene signature has some utility for predicting outcomes for prostate cancer for individual patients at the time of prognosis. The strategy could have applications for improving marker performance in other cancers and other diseases.	[Chen, Xin; McClelland, Michael; Rahmatpanah, Farah; Sawyers, Anne; Jia, Zhenyu; Mercola, Dan] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92717 USA; [Xu, Shizhong] Univ Calif Riverside, Dept Genet & Geneticist Bot & Plant Sci, Riverside, CA 92521 USA; [McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA	University of California System; University of California Irvine; University of California System; University of California Riverside	Jia, ZY (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92717 USA.	zjia@uci.edu; dmercola@uci.edu	mercola, dan/L-4182-2013; Chen, Xin/ABA-3794-2020	mercola, dan/0000-0002-0281-9840; McClelland, Michael/0000-0003-1788-9347	National Institutes of Health Strategic Partners for the Evaluation of Cancer Signatures (SPECS) Consortium [U01 CA1148102]; National Cancer Institute Early Detection Research Network (EDRN) Consortium [U01 CA152738]; University of California of Irvine Faculty Career Development Award; Chao Family Comprehensive Cancer Center at University of California of Irvine [P30CA62203]; Department of Defense Congressionally Directed Medical Research Programs [W81XWH-08-1-0720]; University of California of Irvine Institute for Cancer Research Training Grant Fellowship from the National Cancer Institute [T32CA009054]; NATIONAL CANCER INSTITUTE [P30CA062203, U01CA152738, T32CA009054] Funding Source: NIH RePORTER	National Institutes of Health Strategic Partners for the Evaluation of Cancer Signatures (SPECS) Consortium; National Cancer Institute Early Detection Research Network (EDRN) Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of California of Irvine Faculty Career Development Award; Chao Family Comprehensive Cancer Center at University of California of Irvine; Department of Defense Congressionally Directed Medical Research Programs(United States Department of Defense); University of California of Irvine Institute for Cancer Research Training Grant Fellowship from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Strategic Partners for the Evaluation of Cancer Signatures (SPECS) Consortium grant U01 CA1148102 and National Cancer Institute Early Detection Research Network (EDRN) Consortium grant U01 CA152738. This work was also supported by a University of California of Irvine Faculty Career Development Award (ZJ) and grant P30CA62203 from the Chao Family Comprehensive Cancer Center at University of California of Irvine (ZJ and DAM). Also, this work was supported in part by Department of Defense Congressionally Directed Medical Research Programs grant W81XWH-08-1-0720, and by a University of California of Irvine Institute for Cancer Research Training Grant Fellowship (T32CA009054 from the National Cancer Institute) (FR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; ACS, 2011, AM CANC SOC CANC FAC; Barwick BG, 2010, BRIT J CANCER, V102, P570, DOI 10.1038/sj.bjc.6605519; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; Bickers B, 2009, ANTICANCER RES, V29, P3289; Bismar TA, 2006, NEOPLASIA, V8, P59, DOI 10.1593/neo.05664; Chen X, 2011, LECT N BIOINFORMAT, V7036, P63, DOI 10.1007/978-3-642-24855-9_6; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Gerber Glenn S., 1996, JAMA (Journal of the American Medical Association), V276, P615, DOI 10.1001/jama.276.8.615; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Jia ZY, 2011, CANCER RES, V71, P2476, DOI 10.1158/0008-5472.CAN-10-2585; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Sun YJ, 2009, PROSTATE, V69, P1119, DOI 10.1002/pros.20961; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Walsh PC, 2000, J UROLOGY, V163, P1802, DOI 10.1016/S0022-5347(05)67547-7; Wang YP, 2010, CANCER RES, V70, P6448, DOI 10.1158/0008-5472.CAN-10-0021	26	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45178	10.1371/journal.pone.0045178	http://dx.doi.org/10.1371/journal.pone.0045178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028830	Green Published, gold			2022-12-27	WOS:000309973900030
J	Le Boucher, R; Dupont-Nivet, M; Vandeputte, M; Kerneis, T; Goardon, L; Labbe, L; Chatain, B; Bothaire, MJ; Larroquet, L; Medale, F; Quillet, E				Le Boucher, Richard; Dupont-Nivet, Mathilde; Vandeputte, Marc; Kerneis, Thierry; Goardon, Lionel; Labbe, Laurent; Chatain, Beatrice; Bothaire, Marie Josee; Larroquet, Laurence; Medale, Francoise; Quillet, Edwige			Selection for Adaptation to Dietary Shifts: Towards Sustainable Breeding of Carnivorous Fish	PLOS ONE			English	Article							PLANT-BASED DIETS; RAINBOW-TROUT; FEED-EFFICIENCY; MEAL; GROWTH; OIL; EVOLUTION; REPLACEMENT; WEIGHT	Genetic adaptation to dietary environments is a key process in the evolution of natural populations and is of great interest in animal breeding. In fish farming, the use of fish meal and fish oil has been widely challenged, leading to the rapidly increasing use of plant-based products in feed. However, high substitution rates impair fish health and growth in carnivorous species. We demonstrated that survival rate, mean body weight and biomass can be improved in rainbow trout (Oncorhynchus mykiss) after a single generation of selection for the ability to adapt to a totally plant-based diet (15.1%, 35.3% and 54.4%, respectively). Individual variability in the ability to adapt to major diet changes can be effectively used to promote fish welfare and a more sustainable aquaculture.	[Le Boucher, Richard; Dupont-Nivet, Mathilde; Vandeputte, Marc; Quillet, Edwige] INRA, GABI Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Le Boucher, Richard; Vandeputte, Marc; Chatain, Beatrice] IFREMER, Intrepid UMR110, Palavas Les Flots, France; [Le Boucher, Richard; Vandeputte, Marc] AgroParisTech, GABI UMR1313, Paris, France; [Kerneis, Thierry; Goardon, Lionel; Labbe, Laurent] INRA, UE PEIMA 937, Sizun, France; [Bothaire, Marie Josee; Larroquet, Laurence; Medale, Francoise] INRA, NuMeA Nutr UMR1067, St Pee Sur Nivelle, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ifremer; AgroParisTech; INRAE; INRAE; Universite de Pau et des Pays de l'Adour	Le Boucher, R (corresponding author), INRA, GABI Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	richard.leboucher@rennes.inra.fr	Vandeputte, Marc/A-4734-2011; Vandeputte, Marc/I-7218-2019; , Dupont-Nivet/J-2850-2019	Vandeputte, Marc/0000-0001-9929-4587; Vandeputte, Marc/0000-0001-9929-4587; Medale, Francoise/0000-0002-8083-1298; Dupont-Nivet, Mathilde/0000-0002-9299-0560	French government (FUI); Region Bretagne; Region Languedoc-Roussillon; Region Nord-Pas-de Calais; Region Poitou-Charentes	French government (FUI); Region Bretagne(Region Bretagne); Region Languedoc-Roussillon(Region Ile-de-FranceRegion Occitanie); Region Nord-Pas-de Calais(Region Hauts-de-France); Region Poitou-Charentes(Region Nouvelle-Aquitaine)	This work was part of the VEGE-AQUA project. The project received the label of Poles AQUIMER, Mer Bretagne and Mer PACA and was funded by the French government (FUI) and the Regions Bretagne, Languedoc-Roussillon, Nord-Pas-de Calais and Poitou-Charentes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, STAT WORLD FISH AQ 2; Blanc JM, 2002, AQUAC RES, V33, P563, DOI 10.1046/j.1365-2109.2002.00679.x; Dupont-Nivet M, 2009, AQUACULTURE, V295, P15, DOI 10.1016/j.aquaculture.2009.06.031; FOLCH J, 1957, J BIOL CHEM, V226, P497; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Herrel A, 2004, J EVOLUTION BIOL, V17, P974, DOI 10.1111/j.1420-9101.2004.00758.x; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Knudsen R, 2010, J ANIM ECOL, V79, P161, DOI 10.1111/j.1365-2656.2009.01625.x; Kristensen TN, 2011, BIOL LETTERS, V7, P269, DOI 10.1098/rsbl.2010.0872; Le Boucher R, 2011, AQUACULTURE, V321, P41, DOI 10.1016/j.aquaculture.2011.08.010; Luca F, 2010, ANNU REV NUTR, V30, P291, DOI 10.1146/annurev-nutr-080508-141048; Montero D., 2010, FISH OIL REPLACEMENT, DOI [10.1201/9781439808634-c14, DOI 10.1201/9781439808634-C14]; National Research Council, 2011, NUTR REQ FISH; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Nielsen VH, 2006, J ANIM BREED GENET, V123, P362, DOI 10.1111/j.1439-0388.2006.00616.x; Overturf K, 2013, AQUAC RES, V44, P604, DOI 10.1111/j.1365-2109.2011.03065.x; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pierce LR, 2008, AQUACULTURE, V278, P37, DOI 10.1016/j.aquaculture.2008.03.017; Purnell MA, 2007, SCIENCE, V317, P1887, DOI 10.1126/science.1147337; Quinton CD, 2007, GENET SEL EVOL, V39, P431, DOI 10.1051/gse:2007013; Richard N, 2006, BRIT J NUTR, V96, P299, DOI 10.1079/BJN20061821; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Vandeputte M, 2002, AQUACULTURE, V204, P435, DOI 10.1016/S0044-8486(01)00829-8	29	29	30	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44898	10.1371/journal.pone.0044898	http://dx.doi.org/10.1371/journal.pone.0044898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028667	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900019
J	Li, CG; Li, ZG; Zhu, ML; Zhao, TJ; Chen, L; Ji, WD; Chen, HZ; Su, CQ				Li, Chunguang; Li, Zhigang; Zhu, Maoling; Zhao, Tiejun; Chen, Ling; Ji, Weidan; Chen, Hezhong; Su, Changqing			Clinicopathological and Prognostic Significance of Survivin Over-Expression in Patients with Esophageal Squamous Cell Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; LUNG-CANCER; BREAST-CANCER; APOPTOSIS; MORTALITY; BIOMARKER; GENE; VEGF	Background: The prognostic significance of survivin for survival of patients with esophageal squamous cell carcinoma (ESCC) remains controversial. Thus, meta-analysis of the literatures was performed in order to demonstrate its expression impact on ESCC clinicopathological features and prognosis. Methodology: Relevant literatures were searched using PubMed, EMBASE and Medline Databases. Revman5.0 software was used to pool eligible studies and summary hazard ratio (HR). Correlation between survivin expression and clinicopathological features of ESCC was analyzed. Principal Findings: Final analysis of 523 patients from 7 eligible studies was performed. Combined HR of survivin location in nuclei suggested that survivin expression has an unfavorable impact on ESCC patients' survival (n = 277 in 3 studies; HR = 1.89, 95% CI: 1.45-2.96; Z = 4.69; P<0.0001). Nevertheless, combined HR of survivin location in cytoplasm displayed that survivin expression has no significance for prognosis of ESCC patients (n = 113 in 2 studies; HR = 0.96, 95% CI: 0.96-5.69; Z = 0.04; P = 0.97); Combined odds ratio (OR) of survivin location in cytoplasm indicated that survivin expression is associated with ESCC advanced stage (n = 113 in 2 studies; OR = 0.36, 95% CI: 0.14-0.93; Z = 2.10; P = 0.04). Whereas, combined OR of survivin location in nuclei exhibited that survivin over-expression has no correlation with cell differentiation grade, lymph node status, depth of invasion, stage, and metastasis of ESCC. Conclusions: This study showed that survivin expression detected by immunohistochemistry seems to be associated with a worse prognosis of ESCC patients. Survivin subcellular location may be an important factor impacting on ESCC development. Larger prospective studies should be performed to evaluate the status of survivin in predicting prognosis of patients with ESCC.	[Li, Chunguang; Li, Zhigang; Zhao, Tiejun; Chen, Ling; Chen, Hezhong] Second Mil Med Univ, Changhai Hosp, Dept Thorac Surg, Shanghai, Peoples R China; [Zhu, Maoling] Shanghai Jiao Tong Univ, Peoples Hosp Shanghai 1, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Li, Chunguang; Ji, Weidan; Su, Changqing] Second Mil Med Univ, Dept Mol Oncol, Eastern Hepatobiliary Surg Hosp & Inst, Shanghai, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; Naval Medical University	Chen, HZ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Thorac Surg, Shanghai, Peoples R China.	drchenhz@163.com; suchangqing@gmail.com		Su, Changqing/0000-0002-3396-7248; Li, Zhigang/0000-0001-5086-5334	National Natural Scientific Foundation of China [30801106, 81172308, 30973469]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Scientific Foundation of China (30801106, 81172308, 30973469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek N, 2006, VIRCHOWS ARCH, V449, P164, DOI 10.1007/s00428-006-0239-9; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Dabrowski A, 2004, FOLIA HISTOCHEM CYTO, V42, P169; Duffy MJ, 2007, CANCER LETT, V249, P49, DOI 10.1016/j.canlet.2006.12.020; Fan J, 2008, LUNG CANCER, V61, P91, DOI 10.1016/j.lungcan.2007.11.011; Grabowski P, 2003, BRIT J CANCER, V88, P115, DOI 10.1038/sj.bjc.6600696; Hsu KF, 2009, DIS ESOPHAGUS, V22, P402, DOI 10.1111/j.1442-2050.2008.00921.x; Ikeguchi M, 2002, BRIT J CANCER, V87, P883, DOI 10.1038/sj.bjc.6600546; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Leonardi-Bee J, 2008, ARCH DIS CHILD-FETAL, V93, pF351, DOI 10.1136/adc.2007.133553; Liu BB, 2011, WORLD J CLIN ONCOL, V2, P164, DOI 10.5306/wjco.v2.i3.164; Mega S, 2006, DIS ESOPHAGUS, V19, P355, DOI 10.1111/j.1442-2050.2006.00604.x; Nakamura H, 2006, THORAX, V61, P140, DOI 10.1136/thx.2005.042275; Nakashima N, 2010, INT J ONCOL, V37, P687, DOI 10.3892/ijo_00000718; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Sah NK, 2006, CANCER LETT, V244, P164, DOI 10.1016/j.canlet.2006.03.007; Shariat SF, 2007, CANCER-AM CANCER SOC, V109, P1106, DOI 10.1002/cncr.22521; Sohn DM, 2006, BIOMED PHARMACOTHER, V60, P289, DOI 10.1016/j.biopha.2006.06.008; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Takeno S, 2010, EUR J CARDIO-THORAC, V37, P440, DOI 10.1016/j.ejcts.2009.05.056; Tamm I, 1998, CANCER RES, V58, P5315; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Tran J, 1999, BIOCHEM BIOPH RES CO, V264, P781, DOI 10.1006/bbrc.1999.1589; Wang L, 2006, CANCER INVEST, V24, P581, DOI 10.1080/07357900600894799; Yang D, 2004, P NATL ACAD SCI USA, V101, P15100, DOI 10.1073/pnas.0406665101; Yang Y, 2011, MED ONCOL, V28, P796, DOI 10.1007/s12032-010-9519-y; Zhang LQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034100; Zhu HX, 2011, TUMOR BIOL, V32, P1147, DOI 10.1007/s13277-011-0217-y	32	28	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44764	10.1371/journal.pone.0044764	http://dx.doi.org/10.1371/journal.pone.0044764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028610	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500007
J	Gabriel, E; Schievenbusch, S; Kolossov, E; Hengstler, JG; Rotshteyn, T; Bohlen, H; Nierhoff, D; Hescheler, J; Drobinskaya, I				Gabriel, Elke; Schievenbusch, Stephanie; Kolossov, Eugen; Hengstler, Jan G.; Rotshteyn, Tamara; Bohlen, Heribert; Nierhoff, Dirk; Hescheler, Juergen; Drobinskaya, Irina			Differentiation and Selection of Hepatocyte Precursors in Suspension Spheroid Culture of Transgenic Murine Embryonic Stem Cells	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; VISCERAL YOLK-SAC; MOUSE FETAL LIVER; ALPHA-FETOPROTEIN; GENE-EXPRESSION; HEPATIC DIFFERENTIATION; ENHANCED DIFFERENTIATION; DEFINITIVE ENDODERM; MESSENGER-RNA; END-POINTS	Embryonic stem cell-derived hepatocyte precursor cells represent a promising model for clinical transplantations to diseased livers, as well as for establishment of in vitro systems for drug metabolism and toxicology investigations. This study aimed to establish an in vitro culture system for scalable generation of hepatic progenitor cells. We used stable transgenic clones of murine embryonic stem cells possessing a reporter/selection vector, in which the enhanced green fluorescent protein-and puromycin N-acetyltransferase-coding genes are driven by a common alpha-fetoprotein gene promoter. This allowed for "live" monitoring and puromycin selection of the desired differentiating cell type possessing the activated alpha-fetoprotein gene. A rotary culture system was established, sequentially yielding initially partially selected hepatocyte lineage-committed cells, and finally, a highly purified cell population maintained as a dynamic suspension spheroid culture, which progressively developed the hepatic gene expression phenotype. The latter was confirmed by quantitative RT-PCR analysis, which showed a progressive up-regulation of hepatic genes during spheroid culture, indicating development of a mixed hepatocyte precursor-/fetal hepatocyte-like cell population. Adherent spheroids gave rise to advanced differentiated hepatocyte-like cells expressing hepatic proteins such as albumin, alpha-1-antitrypsin, cytokeratin 18, E-cadherin, and liver-specific organic anion transporter 1, as demonstrated by fluorescent immunostaining. A fraction of adherent cells was capable of glycogen storage and of reversible up-take of indocyanine green, demonstrating their hepatocyte-like functionality. Moreover, after transplantation of spheroids into the mouse liver, the spheroid-derived cells integrated into recipient. These results demonstrate that large-scale hepatocyte precursor-/hepatocyte-like cultures can be established for use in clinical trials, as well as in in vitro screening assays.	[Gabriel, Elke; Rotshteyn, Tamara; Hescheler, Juergen; Drobinskaya, Irina] Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, D-50931 Cologne, Germany; [Schievenbusch, Stephanie; Nierhoff, Dirk] Univ Cologne, Gastroenterol & Hepatol Clin, D-50931 Cologne, Germany; [Kolossov, Eugen; Bohlen, Heribert] Axiogenesis AG, Cologne, Germany; [Hengstler, Jan G.] Tech Univ Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	University of Cologne; University of Cologne; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Gabriel, E (corresponding author), Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, D-50931 Cologne, Germany.	egabriel@uni-koeln.de; j.hescheler@uni-koeln.de; irina.drobinskaya@uni-koeln.de	Hengstler, Jan G./O-1415-2013	Hengstler, Jan/0000-0002-1427-5246; Gabriel, Elke/0000-0001-7473-0530	German Federal Ministry of Education and Research (BMBF) [FKZ0315451, FKZ0315739]; Koln Fortune [149/2009]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Koln Fortune	This work was supported by grants FKZ0315451 (JH, ID) and FKZ0315739 (JGH) from the German Federal Ministry of Education and Research (BMBF) (http://www.bmbf.de/en/index.php) and 149/2009 (JH, ID) from Koln Fortune (http://www.medfak.uni-koeln.de/index.php?id = 195&L = 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 1996, CELL PROLIFERAT, V29, P373, DOI 10.1111/j.1365-2184.1996.tb00982.x; ANG SL, 1993, DEVELOPMENT, V119, P1301; Asahina K, 2004, GENES CELLS, V9, P1297, DOI 10.1111/j.1365-2443.2004.00809.x; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; BERK PD, 1986, PROG LIVER DIS, V8, P125; Bielinska M, 1997, MECH DEVELOP, V65, P43, DOI 10.1016/S0925-4773(97)00053-1; BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887; Brolen G, 2010, J BIOTECHNOL, V145, P284, DOI 10.1016/j.jbiotec.2009.11.007; Brulport M, 2007, HEPATOLOGY, V46, P861, DOI 10.1002/hep.21745; Butz S, 1995, CELL ADHES COMMUN, V3, P337, DOI 10.3109/15419069509081018; Carpenedo RL, 2007, STEM CELLS, V25, P2224, DOI 10.1634/stemcells.2006-0523; Choi D, 2005, STEM CELLS, V23, P817, DOI 10.1634/stemcells.2004-0262; CLAYTON DF, 1983, MOL CELL BIOL, V3, P1552, DOI 10.1128/MCB.3.9.1552; Coakley RJ, 2001, AM J MED SCI, V321, P33, DOI 10.1097/00000441-200101000-00006; Davila JC, 2004, TOXICOL SCI, V79, P214, DOI 10.1093/toxsci/kfh100; Dhawan A, 2006, J INHERIT METAB DIS, V29, P431, DOI 10.1007/s10545-006-0245-8; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dong XJ, 2009, WORLD J GASTROENTERO, V15, P5165, DOI 10.3748/wjg.15.5165; Drobinskaya I, 2008, STEM CELLS, V26, P2245, DOI 10.1634/stemcells.2008-0387; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; DZIADEK M, 1978, J EMBRYOL EXP MORPH, V46, P135; DZIADEK MA, 1983, EMBO J, V2, P549, DOI 10.1002/j.1460-2075.1983.tb01461.x; Edwards RG, 2004, REPROD BIOMED ONLINE, V8, P275, DOI 10.1016/S1472-6483(10)60910-8; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Fang S, 2007, ACTA PHARMACOL SIN, V28, P1924, DOI 10.1111/j.1745-7254.2007.00713.x; Farkas D, 2005, CURR DRUG METAB, V6, P111, DOI 10.2174/1389200053586118; FRANKE WW, 1979, BIOL CELLULAIRE, V34, P99; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Fukumitsu K, 2009, TISSUE ENG PT A, V15, P3847, DOI [10.1089/ten.tea.2009.0357, 10.1089/ten.TEA.2009.0357]; Gao B, 2004, J HEPATOL, V41, P201, DOI 10.1016/j.jhep.2004.04.029; Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880; Gordon GJ, 2000, AM J PATHOL, V157, P771, DOI 10.1016/S0002-9440(10)64591-9; Grebenok RJ, 1997, PLANT J, V11, P573, DOI 10.1046/j.1365-313X.1997.11030573.x; GREENGARD O, 1969, BIOCHEM J, V115, P19, DOI 10.1042/bj1150019; Grompe M, 1999, SEMIN LIVER DIS, V19, P7, DOI 10.1055/s-2007-1007093; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; Hamamoto R, 1998, J BIOCHEM, V124, P972, DOI 10.1093/oxfordjournals.jbchem.a022215; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Hengstler Jan G, 2005, Expert Opin Drug Metab Toxicol, V1, P61, DOI 10.1517/17425255.1.1.61; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Imamura T, 2004, TISSUE ENG, V10, P1716, DOI 10.1089/ten.2004.10.1716; Ishii T, 2005, EXP CELL RES, V309, P68, DOI 10.1016/j.yexcr.2005.05.028; Jin DK, 1998, P NATL ACAD SCI USA, V95, P8767, DOI 10.1073/pnas.95.15.8767; JUNGERMANN K, 1982, EUR J BIOCHEM, V123, P429, DOI 10.1111/j.1432-1033.1982.tb19786.x; Kakyo M, 1999, GASTROENTEROLOGY, V117, P770, DOI 10.1016/S0016-5085(99)70333-1; Kanda S, 2003, HEPATOL RES, V26, P225, DOI 10.1016/S1386-6346(03)00114-1; Kania G, 2004, BIOL CHEM, V385, P943, DOI 10.1515/BC.2004.123; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Kubota H, 2000, P NATL ACAD SCI USA, V97, P12132, DOI 10.1073/pnas.97.22.12132; Laconi E, 2002, SEMIN CELL DEV BIOL, V13, P433, DOI 10.1016/S1084952102001313; Lai Y, 2008, ADV DRUG DELIVER REV, V60, P146, DOI 10.1016/j.addr.2007.08.039; Lake JR, 1998, NEW ENGL J MED, V338, P1463, DOI 10.1056/NEJM199805143382012; Lee HJ, 2011, J CELL BIOCHEM, V112, P49, DOI 10.1002/jcb.22728; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Li Y, 2009, ELECTROPHORESIS, V30, P1431, DOI 10.1002/elps.200800836; Liu H, 2006, BIOMATERIALS, V27, P5978, DOI 10.1016/j.biomaterials.2006.05.053; Liu T, 2010, TISSUE ENG PT A, V16, P1115, DOI [10.1089/ten.tea.2009.0391, 10.1089/ten.TEA.2009.0391]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu H, 2008, TOXICOL SCI, V103, P35, DOI 10.1093/toxsci/kfn038; MEEHAN RR, 1984, EMBO J, V3, P1881, DOI 10.1002/j.1460-2075.1984.tb02062.x; MEIJER DKF, 1988, EUR J CLIN PHARMACOL, V35, P295, DOI 10.1007/BF00558268; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Moore RN, 2008, BIOTECHNOL BIOENG, V101, P1332, DOI 10.1002/bit.21987; Myllynen P, 2009, EXPERT OPIN DRUG MET, V5, P1483, DOI 10.1517/17425250903304049; Nierhoff D, 2005, HEPATOLOGY, V42, P130, DOI 10.1002/hep.20735; Nies AT, 2007, PFLUG ARCH EUR J PHY, V453, P643, DOI 10.1007/s00424-006-0109-y; Nussler A, 2006, J HEPATOL, V45, P144, DOI 10.1016/j.jhep.2006.04.002; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Paparella M, 2002, TOXICOL IN VITRO, V16, P589, DOI 10.1016/S0887-2333(02)00052-8; PROBST I, 1982, EUR J BIOCHEM, V126, P271; ROGERS J, 1983, BIOCHEM BIOPH RES CO, V116, P375, DOI 10.1016/0006-291X(83)90532-6; SASAKI H, 1993, DEVELOPMENT, V118, P47; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Seiler A, 2004, REPROD TOXICOL, V18, P231, DOI 10.1016/j.reprotox.2003.10.015; SELL S, 1976, CANCER RES, V36, P4239; SHEN MM, 1992, P NATL ACAD SCI USA, V89, P8240, DOI 10.1073/pnas.89.17.8240; Subramanian K, 2011, TISSUE ENG PT A, V17, P2331, DOI [10.1089/ten.tea.2010.0667, 10.1089/ten.TEA.2010.0667]; Tamai M, 2011, J BIOSCI BIOENG, V112, P495, DOI 10.1016/j.jbiosc.2011.07.005; Teratani T, 2005, HEPATOLOGY, V41, P836, DOI 10.1002/hep.20629; THOMAS T, 1990, PLACENTA, V11, P413, DOI 10.1016/S0143-4004(05)80216-4; Tsuchiya A, 2005, GASTROENTEROLOGY, V128, P2089, DOI 10.1053/j.gastro.2005.03.030; Tsutsui M, 2006, DRUG METAB DISPOS, V34, P696, DOI 10.1124/dmd.105.007674; Ueberham E, 2007, J MOL HISTOL, V38, P359, DOI 10.1007/s10735-007-9098-1; VESTWEBER D, 1984, CELL DIFFER DEV, V15, P269, DOI 10.1016/0045-6039(84)90084-8; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; XANTHOPOULOS KG, 1991, P NATL ACAD SCI USA, V88, P3807, DOI 10.1073/pnas.88.9.3807; Yamada T, 2002, STEM CELLS, V20, P146, DOI 10.1634/stemcells.20-2-146; Yin Y, 2002, STEM CELLS, V20, P338, DOI 10.1634/stemcells.20-4-338; Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8; Zellmer S, 2010, HEPATOLOGY, V52, P2127, DOI 10.1002/hep.23930	93	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44912	10.1371/journal.pone.0044912	http://dx.doi.org/10.1371/journal.pone.0044912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028675	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700019
J	Mi, YY; Zhang, LF; Feng, NH; Wu, S; You, XM; Shao, HB; Dai, F; Peng, T; Qin, F; Zou, JG; Zhu, LJ				Mi, Yuanyuan; Zhang, Lifeng; Feng, Ninghan; Wu, Sheng; You, Xiaoming; Shao, Hongbao; Dai, Feng; Peng, Tao; Qin, Feng; Zou, Jiangang; Zhu, Lijie			Impact of Two Common Xeroderma Pigmentosum Group D (XPD) Gene Polymorphisms on Risk of Prostate Cancer	PLOS ONE			English	Article							DNA-REPAIR GENES; SUSCEPTIBILITY; METAANALYSIS; ASSOCIATION; XRCC1; VARIANTS; ERCC2	Background: DNA repair genes (eg: xeroderma pigmentosum group D, XPD) may affect the capacity of encoded DNA repair enzymes to effectively remove DNA adducts or lesions, which may result in enhanced cancer risk. The association between XPD gene polymorphisms and the susceptibility of prostate cancer (PCa) was inconsistent in previous studies. Methodology/Principal Findings: A meta-analysis based on 9 independent case-control studies involving 3165 PCa patients and 3539 healthy controls for XPD Gln751Lys SNP (single nucleotide polymorphism) and 2555 cases and 3182 controls for Asn312Asp SNP was performed to address this association. Meanwhile, odds ratio (OR) and 95% confidence intervals (CIs) were used to evaluate this relationship. Statistical analysis was performed with STATA10.0. No significant association was found between XPD Gln751Lys SNP and PCa risk. On the other hand, in subgroup analysis based on ethnicity, associations were observed in Asian (eg. Asn vs. Asp: OR = 1.34, 95% CI = 1.16-1.55; Asn/Asn+Asn/Asp vs. Asp/Asp: OR = 1.23, 95% CI = 1.07-1.42) and African (eg. Asn vs. Asp: OR = 1.31, 95% CI = 1.01-1.70; Asn/Asn vs. Asp/Asp: OR = 1.71, 95% CI = 1.03-7.10) populations for Asn312Asp SNP. Moreover, similar associations were detected in hospital-based controls studies; the frequency of Asn/Asn genotype in early stage of PCa men was poorly higher than those in advanced stage of PCa men (OR = 1.45, 95% CI = 1.00-2.11). Conclusion/Significance: Our investigations demonstrate that XPD Asn312Asp SNP not the Gln751Lys SNP, might poorly increase PCa risk in Asians and Africans, moreover, this SNPs may associate with the tumor stage of PCa. Further studies based on larger sample size and gene-environment interactions should be conducted to determine the role of XPD gene polymorphisms in PCa risk.	[Zhang, Lifeng; Zou, Jiangang] Nanjing Med Univ, Affiliated Changzhou Hosp 2, Dept Urol, Changzhou, Jiangsu, Peoples R China; [Mi, Yuanyuan; Wu, Sheng; You, Xiaoming; Shao, Hongbao; Dai, Feng; Peng, Tao; Qin, Feng; Zhu, Lijie] Nantong Univ, Affiliated Hosp 3, Dept Urol, Wuxi, Jiangsu, Peoples R China; [Feng, Ninghan] Nanjing Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nantong University; Nanjing University	Zou, JG (corresponding author), Nanjing Med Univ, Affiliated Changzhou Hosp 2, Dept Urol, Changzhou, Jiangsu, Peoples R China.	zoujiangangmeta@hotmail.com; zhulijiemeta@hotmail.com	Feng, Ninghan/ABA-8996-2021; Feng, ninghan/ABB-3726-2021		Nature Science Foundation of Jiangsu Province [BK2010577]; Jiangsu Province's Outstanding Medical Academic Leader program [RC201178]	Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Outstanding Medical Academic Leader program	This study was supported by the Nature Science Foundation of Jiangsu Province (NO. BK2010577) and Jiangsu Province's Outstanding Medical Academic Leader program (RC201178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalliu I, 2010, CANCER CAUSE CONTROL, V21, P289, DOI 10.1007/s10552-009-9461-5; Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Bau DT, 2007, ANTICANCER RES, V27, P2893; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Bray F, 2010, EUR J CANCER, V46, P3040, DOI 10.1016/j.ejca.2010.09.013; Camps C, 2007, CLIN LUNG CANCER, V8, P369, DOI 10.3816/CLC.2007.n.017; Cleaver JE, 2000, J DERMATOL SCI, V23, P1, DOI 10.1016/S0923-1811(99)00088-2; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhillon VS, 2011, UROL ONCOL-SEMIN ORI, V29, P641, DOI 10.1016/j.urolonc.2009.08.013; Ding DP, 2012, MOL BIOL REP, V39, P2533, DOI 10.1007/s11033-011-1005-x; Dunn Mary Weinstein, 2011, Semin Oncol Nurs, V27, P241, DOI 10.1016/j.soncn.2011.07.002; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Feng Z, 2012, MOL BIOL REP, V39, P57, DOI 10.1007/s11033-011-0710-9; Gao R, 2010, CANCER BIOL THER, V10, P13, DOI 10.4161/cbt.10.1.12172; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Inoue R, 2000, PHARMACOGENETICS, V10, P59, DOI 10.1097/00008571-200002000-00008; Itin PH, 2001, J AM ACAD DERMATOL, V44, P891, DOI 10.1067/mjd.2001.114294; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanaar R, 1998, TRENDS CELL BIOL, V8, P483, DOI 10.1016/S0962-8924(98)01383-X; Lavender NA, 2010, PROSTATE, V70, P113, DOI 10.1002/pros.21048; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Mandal RK, 2010, DNA CELL BIOL, V29, P183, DOI 10.1089/dna.2009.0956; MANTEL N, 1959, J NATL CANCER I, V22, P719; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Pabalan N, 2010, BREAST CANCER RES TR, V124, P531, DOI 10.1007/s10549-010-0863-6; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Powell Isaac J., 2011, Archivos Espanoles de Urologia, V64, P711; Ritchey JD, 2005, CANCER EPIDEM BIOMAR, V14, P1703, DOI 10.1158/1055-9965.EPI-04-0809; Rybicki BA, 2004, CANCER EPIDEM BIOMAR, V13, P23, DOI 10.1158/1055-9965.EPI-03-0053; SANCAR A, 1993, PHOTOCHEM PHOTOBIOL, V57, P905, DOI 10.1111/j.1751-1097.1993.tb09233.x; Shen MR, 1998, CANCER RES, V58, P604; Sobti RC, 2012, MOL CELL BIOCHEM, V362, P263, DOI 10.1007/s11010-011-1152-3; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yuan H, 2011, GENET MOL RES, V10, P3356, DOI 10.4238/2011.November.22.6	39	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44756	10.1371/journal.pone.0044756	http://dx.doi.org/10.1371/journal.pone.0044756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028604	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800016
J	Chen, YJ; Tsai, RK; Wu, WC; He, MS; Kao, YH; Wu, WS				Chen, Yu Jung; Tsai, Rong Kung; Wu, Wen Chen; He, Ming Shan; Kao, Ying-Hsien; Wu, Wen Sheng			Enhanced PKC delta and ERK Signaling Mediate Cell Migration of Retinal Pigment Epithelial Cells Synergistically Induced by HGF and EGF	PLOS ONE			English	Article							PROTEIN-KINASE-C; PROLIFERATIVE DIABETIC-RETINOPATHY; GROWTH-FACTOR EXPRESSION; INDUCED RPE MIGRATION; IN-VITRO; TGF-BETA; FACTOR RECEPTOR; VITREORETINOPATHY; PDGF; CYTOKINES	Proliferative vitreoretinopathy (PVR) and proliferative diabetic retinopathy (PDR) are characterized by the development of epi-retinal membranes which may exert a tractional force on retina. A lot of inflammatory growth factors may disturb the local ocular cells such as retinal pigment epithelial (RPE) cells, causing them to migrate and proliferate in the vitreous cavity and ultimately forming the PVR membrane. In this study, the signal pathways mediating cell migration of RPE induced by growth factors were investigated. Hepatocyte growth factor (HGF), epidermal growth factor (EGF) or heparin-binding epidermal growth factor (HB-EGF) induced a greater extent of migration of RPE50 and ARPE19 cells, compared with other growth factors. According to inhibitor studies, migration of RPE cells induced by each growth factor was mediated by protein kinase C (PKC) and ERK (MAPK). Moreover, HGF coupled with EGF or HB-EGF had synergistic effects on cell migration and enhanced activation of PKC and ERK, which were attributed to cross activation of growth factor receptors by heterogeneous ligands. Furthermore, using the shRNA technique, PKC delta was found to be the most important PKC isozyme involved. Finally, vitreous fluids from PVR and PDR patients with high concentration of HGF may induce RPE cell migration in PKC delta- and ERK-dependent manner. In conclusion, migration of RPE cells can be synergistically induced by HGF coupled with HB-EGF or EGF, which were mediated by enhanced PKC delta activation and ERK phosphorylation.	[Chen, Yu Jung; Wu, Wen Sheng] Tzu Chi Univ, Coll Med, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Tsai, Rong Kung] Buddhist Tzu Chi Gen Hosp, Dept Ophthalmol, Hualien, Taiwan; [Tsai, Rong Kung; He, Ming Shan] Tzu Chi Univ, Dept Ophthalmol & Visual Sci, Hualien, Taiwan; [Wu, Wen Chen] Kaohsiung Med Univ, Dept Ophthalmol, Kaohsiung, Taiwan; [Kao, Ying-Hsien] I Shou Univ Coll, E DA Hosp, Dept Med Res, Kaohsiung, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Kaohsiung Medical University; E-Da Hospital	Wu, WS (corresponding author), Tzu Chi Univ, Coll Med, Dept Lab Med & Biotechnol, Hualien, Taiwan.	wuwstcu1234@yahoo.com.tw	Wu, Wen-Sheng/AAN-9078-2020; Kao, Ying-Hsien/H-4134-2019	he, mingshan/0000-0001-7873-0941; Kao, Ying-Hsien/0000-0001-7803-9384	National Science Council (NSC) in Taiwan	National Science Council (NSC) in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council (NSC) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; BAUDOUIN C, 1994, J FR OPHTALMOL, V17, P789; Bian ZM, 2007, INVEST OPHTH VIS SCI, V48, P2738, DOI 10.1167/iovs.06-1023; Chen Z, 2010, PATHOBIOLOGY, V77, P88, DOI 10.1159/000278290; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; Elner SG, CURRENT EYE RES, V14, P1045; Fan JH, 2006, J INVEST DERMATOL, V126, P1233, DOI 10.1038/sj.jid.5700149; Gao QY, 2009, MOL VIS, V15, P2683; Harada C, 2006, PROG RETIN EYE RES, V25, P149, DOI 10.1016/j.preteyeres.2005.09.001; He SK, 2010, INVEST OPHTH VIS SCI, V51, P543, DOI 10.1167/iovs.09-3475; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Hiscott P, 2002, EYE, V16, P393, DOI 10.1038/sj.eye.6700196; Hollborn M, 2005, MOL VIS, V11, P397; Hollborn M, 2006, BIOCHEM BIOPH RES CO, V344, P912, DOI 10.1016/j.bbrc.2006.03.185; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; HU DN, 1982, BIRTH DEFECTS-ORIG, V18, P67; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Jin S, 1997, Zhonghua Yan Ke Za Zhi, V33, P36; Kaven C, 2000, CURR EYE RES, V20, P480, DOI 10.1076/0271-3683(200006)20:6;1-Y;FT480; Kermorgant S, 2004, EMBO J, V23, P3721, DOI 10.1038/sj.emboj.7600396; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; KUPPNER MC, 1995, IMMUNOLOGY, V84, P265; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Li R, 2007, INVEST OPHTH VIS SCI, V48, P5722, DOI 10.1167/iovs.07-0327; Liou G, 2002, MOL VIS, V8, P494; Liou G, 2002, MOL VIS, V8, P483; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mitsuhiro MRKH, 2003, ACTA OPHTHALMOL SCAN, V81, P630, DOI 10.1111/j.1395-3907.2003.00170.x; Miura Y, 2003, JPN J OPHTHALMOL, V47, P268, DOI 10.1016/S0021-5155(03)00003-0; MURPHY TL, 1995, EXP EYE RES, V60, P683, DOI 10.1016/S0014-4835(05)80010-7; Nagineni CN, 2005, J CELL PHYSIOL, V203, P35, DOI 10.1002/jcp.20213; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Peng HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014750; RYAN SJ, 1985, AM J OPHTHALMOL, V100, P188, DOI 10.1016/S0002-9394(14)75004-4; RYAN SJ, 1993, AM J OPHTHALMOL, V115, P1; Sheu SJ, 2003, INVEST OPHTH VIS SCI, V44, P1237, DOI 10.1167/iovs.02-0330; WELLER M, 1990, INT OPHTHALMOL, V14, P105, DOI 10.1007/BF00154210; WIEDEMANN P, 1992, SURV OPHTHALMOL, V36, P373, DOI 10.1016/0039-6257(92)90115-A; Wu WC, 2007, EXP EYE RES, V85, P721, DOI 10.1016/j.exer.2007.08.005; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Yan F, 2007, OPHTHALMOLOGICA, V221, P244, DOI 10.1159/000101926; Zhao YT, 2007, CELL SIGNAL, V19, P2329, DOI 10.1016/j.cellsig.2007.07.005	42	17	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44937	10.1371/journal.pone.0044937	http://dx.doi.org/10.1371/journal.pone.0044937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028692	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388900015
J	Merschbaecher, K; Haettig, J; Mueller, U				Merschbaecher, Katja; Haettig, Jakob; Mueller, Uli			Acetylation-Mediated Suppression of Transcription-Independent Memory: Bidirectional Modulation of Memory by Acetylation	PLOS ONE			English	Article							LONG-TERM-MEMORY; CREB-BINDING-PROTEIN; HISTONE ACETYLATION; SYNAPTIC PLASTICITY; GENE-EXPRESSION; OBJECT RECOGNITION; TRUNCATED FORM; ACTINOMYCIN-D; KINASE-A; MICE	Learning induced changes in protein acetylation, mediated by histone acetyl transferases (HATs), and the antagonistic histone deacetylases (HDACs) play a critical role in memory formation. The status of histone acetylation affects the interaction between the transcription-complex and DNA and thus regulates transcription-dependent processes required for long-term memory (LTM). While the majority of studies report on the role of elevated acetylation in memory facilitation, we address the impact of both, increased and decreased acetylation on formation of appetitive olfactory memory in honeybees. We show that learning-induced changes in the acetylation of histone H3 at aminoacid-positions H3K9 and H3K18 exhibit distinct and different dynamics depending on the training strength. A strong training that induces LTM leads to an immediate increase in acetylation at H3K18 that stays elevated for hours. A weak training, not sufficient to trigger LTM, causes an initial increase in acetylation at H3K18, followed by a strong reduction in acetylation at H3K18 below the control group level. Acetylation at position H3K9 is not affected by associative conditioning, indicating specific learning-induced actions on the acetylation machinery. Elevating acetylation levels by blocking HDACs after conditioning leads to an improved memory. While memory after strong training is enhanced for at least 2 days, the enhancement after weak training is restricted to 1 day. Reducing acetylation levels by blocking HAT activity after strong training leads to a suppression of transcription-dependent LTM. The memory suppression is also observed in case of weak training, which does not require transcription processes. Thus, our findings demonstrate that acetylation-mediated processes act as bidirectional regulators of memory formation that facilitate or suppress memory independent of its transcription-requirement.	[Merschbaecher, Katja; Mueller, Uli] Univ Saarland, ZHMB Ctr Human & Mol Biol, Dept Biosci Zool Physiol Neurobiol 8 3, D-6600 Saarbrucken, Germany; [Haettig, Jakob] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Dept Neurobiol & Behav, Irvine, CA 92717 USA	Saarland University; University of California System; University of California Irvine	Mueller, U (corresponding author), Univ Saarland, ZHMB Ctr Human & Mol Biol, Dept Biosci Zool Physiol Neurobiol 8 3, D-6600 Saarbrucken, Germany.	uli.mueller@mx.uni-saarland.de						Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; AGRANOFF BW, 1967, SCIENCE, V158, P1600, DOI 10.1126/science.158.3808.1600; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chen GQ, 2010, J NEUROSCI, V30, P13066, DOI 10.1523/JNEUROSCI.2378-10.2010; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Chwang WB, 2006, LEARN MEMORY, V13, P322, DOI 10.1101/lm.152906; DAGOSTIN.RB, 1971, J EDUC MEAS, V8, P327, DOI 10.1111/j.1745-3984.1971.tb00947.x; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Federman N, 2009, LEARN MEMORY, V16, P600, DOI 10.1101/lm.1537009; Fiala A, 1999, J NEUROSCI, V19, P10125; Fontan-Lozano A, 2008, MOL CELL NEUROSCI, V39, P193, DOI 10.1016/j.mcn.2008.06.009; Friedrich A, 2004, J NEUROSCI, V24, P4460, DOI 10.1523/JNEUROSCI.0669-04.2004; Grunbaum L, 1998, J NEUROSCI, V18, P4384; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Maurice T, 2008, NEUROPSYCHOPHARMACOL, V33, P1584, DOI 10.1038/sj.npp.1301551; McQuown SC, 2011, NEUROBIOL LEARN MEM, V96, P27, DOI [10.1016/j.nlm.2011.04.005, 10.1016/j.nlm.2011.04.002]; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Muller U, 2002, ZOOLOGY, V105, P313, DOI 10.1078/0944-2006-00075; Muller U, 2008, LEARNING MEMORY COMP, V4, P91; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Pham H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100194; Reissner KJ, 2006, CELL MOL LIFE SCI, V63, P963, DOI 10.1007/s00018-006-6022-x; Sadoul K, 2008, BIOCHIMIE, V90, P306, DOI 10.1016/j.biochi.2007.06.009; Sharma SK, 2010, NEUROSCI BIOBEHAV R, V34, P1234, DOI 10.1016/j.neubiorev.2010.02.009; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Squire LR, 1970, NATURE, V225, P41; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Suzuki A, 2011, J NEUROSCI, V31, P8786, DOI 10.1523/JNEUROSCI.3257-10.2011; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Tian F, 2010, ANN NY ACAD SCI, V1199, P186, DOI 10.1111/j.1749-6632.2009.05175.x; Varier RA, 2004, BIOCHEM PHARMACOL, V68, P1215, DOI 10.1016/j.bcp.2004.05.038; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; WITTHOFT W., 1967, Z MORPHOL TIERE, V61, P160, DOI 10.1007/BF00298776; Wood MA, 2005, LEARN MEMORY, V12, P111, DOI 10.1101/lm.86605; Wustenberg D, 1998, EUR J NEUROSCI, V10, P2742, DOI 10.1046/j.1460-9568.1998.t01-1-00319.x; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286; Zhao ZR, 2012, J NEUROSCI, V32, P2344, DOI 10.1523/JNEUROSCI.5819-11.2012	52	22	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45131	10.1371/journal.pone.0045131	http://dx.doi.org/10.1371/journal.pone.0045131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028801	gold, Green Published			2022-12-27	WOS:000309388400062
J	Sampaoli, C; Cerquetti, L; El Gawhary, R; Bucci, B; Amendola, D; Marchese, R; Misiti, S; Novelli, G; Toscano, V; Stigliano, A				Sampaoli, Camilla; Cerquetti, Lidia; El Gawhary, Randa; Bucci, Barbara; Amendola, Donatella; Marchese, Rodolfo; Misiti, Silvia; Novelli, Giuseppe; Toscano, Vincenzo; Stigliano, Antonio			p53 Stabilization Induces Cell Growth Inhibition and Affects IGF2 Pathway in Response to Radiotherapy in Adrenocortical Cancer Cells	PLOS ONE			English	Article							WILD-TYPE P53; CARCINOMA; GENE; TUMORS; LINES; RADIOSENSITIVITY; EXPRESSION; MITOTANE; RECEPTOR; INCREASES	Adrenocortical carcinoma (ACC) is a very rare endocrine tumour, with variable prognosis, depending on tumour stage and time of diagnosis. However, it is generally fatal, with an overall survival of 5 years from detection. Radiotherapy usefulness for ACC treatment has been widely debated and seems to be dependent on molecular alterations, which in turn lead to increased radio-resistance. Many studies have shown that p53 loss is an important risk factor for malignant adrenocortical tumour onset and it has been reported that somatic mutations in TP53 gene occur in 27 to 70% of adult sporadic ACCs. In this study, we investigated the role of somatic mutations of the TP53 gene in response to ionizing radiation (IR). We studied the status of p53 in two adrenocortical cell lines, H295R and SW-13, harbouring non-functioning forms of this protein, owing to the lack of exons 8 and 9 and a point mutation in exon 6, respectively. Moreover, these cell lines show high levels of p-Akt and IGF2, especially H295R. We noticed that restoration of p53 activity led to inhibition of growth after transient transfection of cells with wild type p53. Evaluation of their response to IR in terms of cell proliferation and viability was determined by means of cell count and TUNEL assay. wt p53 over-expression also increased cell death by apoptosis following radiation in both cell lines. Moreover, RT-PCR and Western blotting analysis of some p53 target genes, such as BCL2, IGF2 and Akt demonstrated that p53 activation following IR led to a decrease in IGF2 expression. This was associated with a reduction in the active form of Akt. Taken together, these results highlight the role of p53 in response to radiation of ACC cell lines, suggesting its importance as a predictive factor for radiotherapy in malignant adrenocortical tumours cases.	[Sampaoli, Camilla; Cerquetti, Lidia; Toscano, Vincenzo; Stigliano, Antonio] Univ Roma La Sapienza, Fac Med & Psychol, St Andrea Hosp, Dept Clin & Mol Med, Rome, Italy; [Sampaoli, Camilla; Cerquetti, Lidia; Bucci, Barbara; Amendola, Donatella; Marchese, Rodolfo; Novelli, Giuseppe; Stigliano, Antonio] San Pietro Hosp, Res Ctr, Rome, Italy; [El Gawhary, Randa] San Pietro Hosp, Radiat Oncol Unit, Rome, Italy; [Misiti, Silvia] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome	Stigliano, A (corresponding author), Univ Roma La Sapienza, Fac Med & Psychol, St Andrea Hosp, Dept Clin & Mol Med, Rome, Italy.	antonio.stigliano@uniroma1.it	Novelli, Giuseppe/A-5195-2013; Novelli, Giuseppe/T-8822-2019; Stigliano, Antonio/AAN-2266-2020; Novelli, Giuseppe/GQB-3329-2022	Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Sampaoli, Camilla/0000-0003-2716-3320; STIGLIANO, Antonio/0000-0002-7143-0775	Italian Ministry for University and Research [20085P5S49_005]; Sapienza University of Rome [C26A1097KR]; Fondazione Guido Berlucchi per la Ricerca sul Cancro, research project: "Tumori del sistema endocrino" Borgonato di Corte Franca - Brescia, Italy	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Sapienza University of Rome; Fondazione Guido Berlucchi per la Ricerca sul Cancro, research project: "Tumori del sistema endocrino" Borgonato di Corte Franca - Brescia, Italy	This work was supported by the Italian Ministry for University and Research (20085P5S49_005), by Sapienza University of Rome (C26A1097KR), by Fondazione Guido Berlucchi per la Ricerca sul Cancro, research project: "Tumori del sistema endocrino" Borgonato di Corte Franca - Brescia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allolio B, 2006, J CLIN ENDOCR METAB, V91, P2027, DOI 10.1210/jc.2005-2639; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Assie G, 2007, J CLIN ENDOCR METAB, V92, P148, DOI 10.1210/jc.2006-0706; Barlaskar FM, 2009, J CLIN ENDOCR METAB, V94, P204, DOI 10.1210/jc.2008-1456; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Bielinska M, 2009, VET PATHOL, V46, P194, DOI 10.1354/vp.46-2-194; Bonafe M, 2003, CLIN CANCER RES, V9, P4860; Bristow RG, 1996, RADIOTHER ONCOL, V40, P197, DOI 10.1016/0167-8140(96)01806-3; Cerquetti L, 2008, ENDOCR-RELAT CANCER, V15, P623, DOI 10.1677/erc.1.1315; Cerquetti L, 2010, INT J ONCOL, V37, P493, DOI 10.3892/ijo_00000698; Concin N, 2000, CANCER LETT, V150, P191, DOI 10.1016/S0304-3835(99)00393-6; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; Fassnacht M, 2005, J CLIN ENDOCR METAB, V90, P4366, DOI 10.1210/jc.2004-2198; Fassnacht M, 2006, J CLIN ENDOCR METAB, V91, P4501, DOI 10.1210/jc.2006-1007; Figueiredo BC, 1999, J CLIN ENDOCR METAB, V84, P1116, DOI 10.1210/jc.84.3.1116; Gallardo D, 1996, CANCER RES, V56, P4891; Gicquel C, 2001, CANCER RES, V61, P6762; Giordano TJ, 2003, AM J PATHOL, V162, P521, DOI 10.1016/S0002-9440(10)63846-1; HALDAR S, 1994, CANCER RES, V54, P2095; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Kirschner LS, 2006, J CLIN ENDOCR METAB, V91, P14, DOI 10.1210/jc.2005-1739; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Libe R, 2007, ENDOCR-RELAT CANCER, V14, P13, DOI 10.1677/erc.1.01130; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; MCILWRATH AJ, 1994, CANCER RES, V54, P3718; Millau JF, 2009, MUTAT RES-REV MUTAT, V681, P118, DOI 10.1016/j.mrrev.2008.06.002; MIYASHITA T, 1994, CANCER RES, V54, P3131; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Park IY, 2005, J CELL BIOCHEM, V94, P585, DOI 10.1002/jcb.20263; Patalano A, 2009, HORM RES, V71, P99, DOI 10.1159/000178049; Polat B, 2009, CANCER, V115, P2816, DOI 10.1002/cncr.24331; REINCKE M, 1994, J CLIN ENDOCR METAB, V78, P790, DOI 10.1210/jc.78.3.790; Ribeiro RC, 2000, BRAZ J MED BIOL RES, V33, P1225, DOI 10.1590/S0100-879X2000001000013; Romer L, 2006, ANGEW CHEM INT EDIT, V45, P6440, DOI 10.1002/anie.200600611; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Stojadinovic A, 2002, J CLIN ONCOL, V20, P941, DOI 10.1200/JCO.2002.20.4.941; Valenciano A, 2012, TRANSL ONCOL, V5, P1, DOI 10.1593/tlo.11265; Wang T, 2012, MOL CELL ENDOCRINOL, V351, P58, DOI 10.1016/j.mce.2011.08.041; Wang WG, 2003, CANCER BIOL THER, V2, pS55; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wilkin F, 2000, J CLIN ENDOCR METAB, V85, P2048, DOI 10.1210/jc.85.5.2048; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; WOOTEN MD, 1993, CANCER, V72, P3145, DOI 10.1002/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N; YAGINUMA Y, 1992, CANCER RES, V52, P4196; Zhang LJ, 1996, CANCER RES, V56, P1367	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45129	10.1371/journal.pone.0045129	http://dx.doi.org/10.1371/journal.pone.0045129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028800	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400061
J	Furgerson, M; Fechheimer, M; Furukawa, R				Furgerson, Matthew; Fechheimer, Marcus; Furukawa, Ruth			Model Hirano Bodies Protect against Tau-Independent and Tau-Dependent Cell Death Initiated by the Amyloid Precursor Protein Intracellular Domain	PLOS ONE			English	Article							ROD-LIKE STRUCTURES; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; A-BETA; TRANSGENIC MICE; CASCADE HYPOTHESIS; INDUCED DEFECTS; FINE-STRUCTURE; MOUSE MODEL; PHOSPHORYLATION	The main pathological hallmarks of Alzheimer's disease are amyloid-beta plaques and neurofibrillary tangles, which are primarily composed of amyloid precursor protein (APP) and tau, respectively. These proteins and their role in the mechanism of neurodegeneration have been extensively studied. Hirano bodies are a frequently occurring pathology in Alzheimer's disease as well as other neurodegenerative diseases. However, the physiological role of Hirano bodies in neurodegenerative diseases has yet to be determined. We have established cell culture models to study the role of Hirano bodies in amyloid precursor protein and tau-induced cell death mechanisms. Exogenous expression of APP and either of its c-terminal fragments c31 or Amyloid Precursor Protein Intracellular Domain c58 (AICDc58) enhance cell death. The presence of tau is not required for this enhanced cell death. However, the addition of a hyperphosphorylated tau mimic 352PHPtau significantly increases cell death in the presence of both APP and c31 or AICDc58 alone. The mechanism of cell death induced by APP and its c-terminal fragments and tau was investigated. Fe65, Tip60, p53, and caspases play a role in tau-independent and tau-dependent cell death. In addition, apoptosis was determined to contribute to cell death. The presence of model Hirano bodies protected against cell death, indicating Hirano bodies may play a protective role in neurodegeneration.	[Fechheimer, Marcus; Furukawa, Ruth] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Furgerson, Matthew] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Furukawa, R (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	furukawa@uga.edu			United States National Institutes of Health [R01 N5046451]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046451] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by United States National Institutes of Health R01 N5046451 (www.ninds.nih.gov/) to R. Furukawa and M. Fechheimer. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Borquez DA, 2012, INT J ALZHEIMERS DIS, V2012; Bretteville A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004843; Cacucci F, 2008, P NATL ACAD SCI USA, V105, P7863, DOI 10.1073/pnas.0802908105; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Chang KA, 2010, BMB REP, V43, P656, DOI [10.3858/BMBRep.2010.43.10.656, 10.5483/BMBRep.2010.43.10.656]; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; Davis RC, 2008, ACTA NEUROPATHOL, V115, P205, DOI 10.1007/s00401-007-0275-9; Dickey Chad A., 2005, Current Alzheimer Research, V2, P231, DOI 10.2174/1567205053585927; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; Fath T, 2002, J NEUROSCI, V22, P9733; FU YS, 1975, ACTA NEUROPATHOL, V31, P129, DOI 10.1007/BF00688147; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; GALLOWAY PG, 1987, BRAIN RES, V403, P337, DOI 10.1016/0006-8993(87)90071-0; GALLOWAY PG, 1987, J NEUROPATH EXP NEUR, V46, P185, DOI 10.1097/00005072-198703000-00006; Gartinez-Saez E, 2011, NEUROPATHOL APPL NEU, DOI 10.111141M5-2990.2011.01208x; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Ghosal K, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.020; Ghosal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011866; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; GIBSON PH, 1978, ACTA NEUROPATHOL, V42, P165, DOI 10.1007/BF00690353; GIBSON PH, 1977, J NEUROL SCI, V33, P199, DOI 10.1016/0022-510X(77)90193-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDMAN JE, 1983, J NEUROPATH EXP NEUR, V42, P146, DOI 10.1097/00005072-198303000-00004; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Ha S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-97; Ha S, 2011, NEUROBIOL AGING, V32, P2287, DOI 10.1016/j.neurobiolaging.2010.01.003; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; HIRANO A, 1968, J NEUROPATH EXP NEUR, V27, P167, DOI 10.1097/00005072-196804000-00001; HIRANO A, 1994, NEUROPATH APPL NEURO, V20, P3, DOI 10.1111/j.1365-2990.1994.tb00951.x; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; IZUMIYAMA N, 1991, ACTA NEUROPATHOL, V81, P248, DOI 10.1007/BF00305865; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim DH, 2009, AUTOPHAGY, V5, P44, DOI 10.4161/auto.5.1.7228; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kinoshita A, 2002, J BIOL CHEM, V277, P28530, DOI 10.1074/jbc.M203372200; Koffie RM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-63; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; LAAS R, 1994, NEUROPATH APPL NEURO, V20, P12, DOI 10.1111/j.1365-2990.1994.tb00952.x; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Lu DC, 2003, ANN NEUROL, V54, P781, DOI 10.1002/ana.10761; Lu DC, 2003, J NEUROCHEM, V87, P733, DOI 10.1046/j.1471-4159.2003.02059.x; Marcello E, 2012, ADV EXP MED BIOL, V970, P573, DOI 10.1007/978-3-7091-0932-8_25; Maselli A, 2003, EUKARYOT CELL, V2, P778, DOI 10.1128/EC.2.4.778-787.2003; Maselli AG, 2002, J CELL SCI, V115, P1939; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mitake Shigehisa, 1997, Kaohsiung Journal of Medical Sciences, V13, P10; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; MORI H, 1986, ACTA NEUROPATHOL, V71, P32, DOI 10.1007/BF00687959; Mott RT, 2005, NEUROIMAG CLIN N AM, V15, P755, DOI 10.1016/j.nic.2005.09.003; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; MUNOZ DG, 1993, J NEUROPATH EXP NEUR, V52, P14, DOI 10.1097/00005072-199301000-00003; Nakayama K, 2008, NEUROSCI LETT, V444, P127, DOI 10.1016/j.neulet.2008.08.034; Niedowicz DM, 2011, CURR NEUROPHARMACOL, V9, P674, DOI 10.2174/157015911798376181; OGATA J, 1972, ACTA NEUROPATHOL, V21, P61, DOI 10.1007/BF00688000; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Santa-Maria I, 2008, J NEUROPATH EXP NEUR, V67, P428, DOI 10.1097/NEN.0b013e31816fc9b6; SCHOCHET SS, 1972, ACTA NEUROPATHOL, V21, P50, DOI 10.1007/BF00687999; SCHOCHET SS, 1968, ACTA NEUROPATHOL, V11, P330, DOI 10.1007/BF00686729; Sengupta S, 2006, BIOCHEMISTRY-US, V45, P15111, DOI 10.1021/bi061830d; Shahani N, 2006, J NEUROSCI, V26, P6103, DOI 10.1523/JNEUROSCI.4245-05.2006; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Sykes SM, 2009, J BIOL CHEM, V284, P20197, DOI 10.1074/jbc.M109.026096; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tsuboi Yoshio, 2009, Brain and Nerve (Tokyo), V61, P1285; Vogt DL, 2011, NEUROBIOL AGING, V32, P1725, DOI 10.1016/j.neurobiolaging.2009.09.002; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; YAMAMOTO T, 1985, ACTA NEUROPATHOL, V67, P167, DOI 10.1007/BF00688139; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Yokoo H, 1994, ACTA NEUROPATHOL BER, V88, P604; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	98	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44996	10.1371/journal.pone.0044996	http://dx.doi.org/10.1371/journal.pone.0044996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028730	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900065
J	Arioka, Y; Watanabe, A; Saito, K; Yamada, Y				Arioka, Yuko; Watanabe, Akira; Saito, Kuniaki; Yamada, Yasuhiro			Activation-Induced Cytidine Deaminase Alters the Subcellular Localization of Tet Family Proteins	PLOS ONE			English	Article							ACTIVE DNA DEMETHYLATION; SOMATIC HYPERMUTATION; NUCLEAR-EXPORT; AID; 5-METHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; MOUSE; METHYLTRANSFERASES; GLYCOSYLASE; METHYLATION	Activation-induced cytidine deminase (Aid), a unique enzyme that deaminates cytosine in DNA, shuttles between the nucleus and the cytoplasm. A recent study proposed a novel function of Aid in active DNA demethylation via deamination of 5-hydroxymethylcytosine, which is converted from 5-methylcytosine by the Ten-eleven translocation (Tet) family of enzymes. In this study, we examined the effect of simultaneous expression of Aid and Tet family proteins on the subcellular localization of each protein. We found that overexpressed Aid is mainly localized in the cytoplasm, whereas Tet1 and Tet2 are localized in the nucleus, and Tet3 is localized in both the cytoplasm and the nucleus. However, nuclear Tet proteins were gradually translocated to the cytoplasm when co-expressed with Aid. We also show that Aid-mediated translocation of Tet proteins is associated with Aid shuttling. Here we propose a possible role for Aid as a regulator of the subcellular localization of Tet family proteins.	[Arioka, Yuko; Watanabe, Akira; Yamada, Yasuhiro] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Arioka, Yuko; Saito, Kuniaki] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Arioka, Yuko; Saito, Kuniaki] Kyoto Univ, Fac Med, Kyoto, Japan; [Watanabe, Akira; Yamada, Yasuhiro] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Yamada, Y (corresponding author), Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan.	y-yamada@cira.kyoto-u.ac.jp	Arioka, Yuko/M-8834-2014	Arioka, Yuko/0000-0002-1792-8812	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [23130508, 24390096]; Naito Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation)	This work was supported by Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan, by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 23130508 and 24390096), and Grant from the Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guibert S, 2012, GENOME RES; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hung MC, 2011, J CELL SCI, V124, P3381, DOI 10.1242/jcs.089110; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Maeda K, 2010, J BIOL CHEM, V285, P23945, DOI 10.1074/jbc.M110.131441; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; Patenaude AM, 2010, NUCLEUS-PHILA, V1, P325, DOI 10.4161/nucl.1.4.12107; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Stavnezer J, 2011, TRENDS IMMUNOL, V32, P194, DOI 10.1016/j.it.2011.03.003; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Yang GB, 2005, P NATL ACAD SCI USA, V102, P17083, DOI 10.1073/pnas.0501338102; Zaitseva I, 2007, MOL REPROD DEV, V74, P1255, DOI 10.1002/mrd.20704	38	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45031	10.1371/journal.pone.0045031	http://dx.doi.org/10.1371/journal.pone.0045031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028748	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800030
J	Garrido-Allepuz, C; Gonzalez-Lamuno, D; Ros, MA				Garrido-Allepuz, Carlos; Gonzalez-Lamuno, Domingo; Ros, Maria A.			Sirenomelia Phenotype in Bmp7;Shh Compound Mutants: A Novel Experimental Model for Studies of Caudal Body Malformations	PLOS ONE			English	Article							SINGLE UMBILICAL ARTERY; SONIC-HEDGEHOG; RETINOIC ACID; MOUSE EMBRYO; REGRESSION SYNDROME; LIMB DEVELOPMENT; 2 FAMILIES; DEFECTS; MICE; DIFFERENTIATION	Sirenomelia is a severe congenital malformation of the lower body characterized by the fusion of the legs into a single lower limb. This striking external phenotype consistently associates severe visceral abnormalities, most commonly of the kidneys, intestine, and genitalia that generally make the condition lethal. Although the causes of sirenomelia remain unknown, clinical studies have yielded two major hypotheses: i) a primary defect in the generation of caudal mesoderm, ii) a primary vascular defect that leaves the caudal part of the embryo hypoperfused. Interestingly, Sirenomelia has been shown to have a genetic basis in mice, and although it has been considered a sporadic condition in humans, recently some possible familial cases have been reported. Here, we report that the removal of one or both functional alleles of Shh from the Bmp7-null background leads to a sirenomelia phenotype that faithfully replicates the constellation of external and internal malformations, typical of the human condition. These mutants represent an invaluable model in which we have analyzed the pathogenesis of sirenomelia. We show that the signaling defect predominantly impacts the morphogenesis of the hindgut and the development of the caudal end of the dorsal aortas. The deficient formation of ventral midline structures, including the interlimb mesoderm caudal to the umbilicus, leads to the approximation and merging of the hindlimb fields. Our study provides new insights for the understanding of the mechanisms resulting in caudal body malformations, including sirenomelia.	[Garrido-Allepuz, Carlos; Ros, Maria A.] Univ Cantabria, CSIC, SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, E-39005 Santander, Spain; [Gonzalez-Lamuno, Domingo] Univ Cantabria, Inst Formac & Invest Marques de Valdecilla IFIMAV, E-39005 Santander, Spain; [Gonzalez-Lamuno, Domingo] Univ Cantabria, Div Pediat, Hosp Marques de Valdecilla, E-39005 Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Ros, MA (corresponding author), Univ Cantabria, CSIC, SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, E-39005 Santander, Spain.	rosm@unican.es	Ros, Maria A./K-8160-2014; González-Lamuño, Domingo/ABG-3255-2020	Ros, Maria A./0000-0002-1224-7671; Garrido-Allepuz Herrera, Carlos/0000-0001-9808-2339; Gonzalez-Lamuno, Domingo/0000-0002-7578-241X	Spanish Ministery of Science and Innovation [BFU2011-24972]; Government of Cantabria; University of Cantabria; Spanish Ministry of Science and Innovation [BFU2011-24972]	Spanish Ministery of Science and Innovation(European Commission); Government of Cantabria; University of Cantabria; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The authors should acknowledge the support of the Spanish Ministery of Science and Innovation (BFU2011-24972 to MAR) and I+D+I cooperative projects in Biomedicine and Biotechnology from the Government and University of Cantabria. This work was supported by grant BFU2011-24972 from the Spanish Ministry of Science and Innovation to MAR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Ballantyne JW, 1904, MANUAL ANTENATAL PAT, P568; BARR M, 1988, TERATOLOGY, V38, P487, DOI 10.1002/tera.1420380513; Bastida MF, 2004, DEV DYNAM, V231, P148, DOI 10.1002/dvdy.20121; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Boulas Mari M, 2009, Adv Neonatal Care, V9, P61, DOI 10.1097/ANC.0b013e31819de44f; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cama A, 1996, EUR J PEDIATR SURG, V6, P44; Castilla EE, 2008, AM J MED GENET A, V146A, P2626, DOI 10.1002/ajmg.a.32506; Chen CP, 1998, PEDIATR RADIOL, V28, P293, DOI 10.1007/s002470050355; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; COFFIN JD, 1991, DEV BIOL, V148, P51, DOI 10.1016/0012-1606(91)90316-U; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; CSECSEI K, 1992, AM J MED GENET, V43, P524, DOI 10.1002/ajmg.1320430305; DEJONGE HJM, 1984, EUR J OBSTET GYN R B, V18, P85, DOI 10.1016/0028-2243(84)90040-6; Duesterhoeft SM, 2007, AM J MED GENET A, V143A, P3175, DOI 10.1002/ajmg.a.32028; DUHAMEL B, 1961, ARCH DIS CHILD, V36, P152, DOI 10.1136/adc.36.186.152; Dyer MA, 2001, DEVELOPMENT, V128, P1717; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Garrido-Allepuz C, 2011, DIS MODEL MECH, V4, P289, DOI 10.1242/dmm.007732; Gerard M, 2012, AM J MED GENET A, V158A, P1801, DOI 10.1002/ajmg.a.35408; Godin RE, 1998, DEVELOPMENT, V125, P3473; HEIFETZ SA, 1984, PERSPECT PEDIAT PATH, V8, P345; Hentschel J, 2006, J PERINATOL, V26, P445, DOI 10.1038/sj.jp.7211534; Itou J, 2012, DEVELOPMENT, V139, P1620, DOI 10.1242/dev.073056; Jena N, 1997, EXP CELL RES, V230, P28, DOI 10.1006/excr.1996.3411; Johnson BL, 1966, BR J CLIN PRACT, V20, P198; KALLEN B, 1974, TERATOLOGY, V9, P99, DOI 10.1002/tera.1420090113; KALLEN B, 1992, J MED GENET, V29, P30, DOI 10.1136/jmg.29.1.30; Kampmeier OF, 1927, ANAT REC, V34, P365, DOI 10.1002/ar.1090340507; Kawakami Y, 2011, DEVELOPMENT, V138, P4465, DOI 10.1242/dev.065359; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Li Y, 2007, DEV DYNAM, V236, P746, DOI 10.1002/dvdy.21075; Lopez-Valdez JA, 2012, FETAL PEDIA IN PRESS; Martinez-Frias ML, 2008, AM J MED GENET A, V146A, P15, DOI 10.1002/ajmg.a.31911; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Martinez-Frias ML, 1998, J MED GENET, V35, P263, DOI 10.1136/jmg.35.3.263-a; MARTINEZFRIAS ML, 1992, AM J MED GENET, V44, P583, DOI 10.1002/ajmg.1320440510; Matsumaru D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016260; Messineo A, 2006, PEDIATRICS, V118, pE220, DOI 10.1542/peds.2005-3001; Mitsiadis TA, 2003, DEVELOPMENT, V130, P4451, DOI 10.1242/dev.00631; Mo R, 2001, AM J PATHOL, V159, P765, DOI 10.1016/S0002-9440(10)61747-6; Moser M, 2005, THROMB HAEMOSTASIS, V94, P713, DOI 10.1160/TH05-05-0312; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Ohta S, 2007, DEVELOPMENT, V134, P4315, DOI 10.1242/dev.008151; Ohta S, 2010, CELL ADHES MIGR, V4, P440, DOI 10.4161/cam.4.3.12000; Opitz JM, 2002, AM J MED GENET, V115, P269, DOI 10.1002/ajmg.10983; ORAHILLY R, 1989, TERATOLOGY, V40, P409, DOI 10.1002/tera.1420400502; Orioli IM, 2011, AM J MED GENET C, V157C, P358, DOI 10.1002/ajmg.c.30324; Padmanabhan R, 1998, REPROD TOXICOL, V12, P139, DOI 10.1016/S0890-6238(97)00153-6; Patel S, 2004, ULTRASOUND OBST GYN, V24, P684, DOI 10.1002/uog.1758; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Pomikal C, 2010, J MORPHOL, V271, P116, DOI 10.1002/jmor.10785; Pyati UJ, 2006, DEVELOPMENT, V133, P2275, DOI 10.1242/dev.02388; Ribes V, 2007, DEV BIOL, V303, P66, DOI 10.1016/j.ydbio.2006.10.032; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Savory JGA, 2009, DEVELOPMENT, V136, P4099, DOI 10.1242/dev.041582; Singh SK, 2005, PEDIATR SURG INT, V21, P578, DOI 10.1007/s00383-005-1451-4; STEVENSON RE, 1986, PEDIATRICS, V78, P451; Stocker J T, 1987, Perspect Pediatr Pathol, V10, P7; Suzuki K, 2009, CURR OPIN GENET DEV, V19, P491, DOI 10.1016/j.gde.2009.08.004; Thottungal AD, 2010, AM J MED GENET A, V152A, P2578, DOI 10.1002/ajmg.a.33599; TOWFIGHI J, 1991, ACTA NEUROPATHOL, V81, P458, DOI 10.1007/BF00293468; TWICKLER D, 1993, J ULTRAS MED, V12, P323; Valenzano M, 1999, HUM REPROD UPDATE, V5, P82, DOI 10.1093/humupd/5.1.82; Vokes SA, 2002, DEVELOPMENT, V129, P775; Wu XY, 2009, GENE EXPR PATTERNS, V9, P224, DOI 10.1016/j.gep.2008.12.005; Xu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029372; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yang Y, 1997, DEVELOPMENT, V124, P4393; Young T, 2009, CURR TOP DEV BIOL, V88, P235, DOI 10.1016/S0070-2153(09)88008-3; Zakin L, 2005, DEVELOPMENT, V132, P2489, DOI 10.1242/dev.01822; Zakin L, 2004, DEVELOPMENT, V131, P413, DOI 10.1242/dev.00946	81	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44962	10.1371/journal.pone.0044962	http://dx.doi.org/10.1371/journal.pone.0044962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028704	gold, Green Published			2022-12-27	WOS:000309742800028
J	Kurillo, G; Han, JJ; Abresch, RT; Nicorici, A; Yan, PS; Bajcsy, R				Kurillo, Gregorij; Han, Jay J.; Abresch, Richard T.; Nicorici, Alina; Yan, Posu; Bajcsy, Ruzena			Development and Application of Stereo Camera-Based Upper Extremity Workspace Evaluation in Patients with Neuromuscular Diseases	PLOS ONE			English	Article							RELIABILITY; GONIOMETER; VALIDITY; MOTION; RANGE; LIMBS; MODEL	Background: The concept of reachable workspace is closely tied to upper limb joint range of motion and functional capability. Currently, no practical and cost-effective methods are available in clinical and research settings to provide arm-function evaluation using an individual's three-dimensional (3D) reachable workspace. A method to intuitively display and effectively analyze reachable workspace would not only complement traditional upper limb functional assessments, but also provide an innovative approach to quantify and monitor upper limb function. Methodology/Principal Findings: A simple stereo camera-based reachable workspace acquisition system combined with customized 3D workspace analysis algorithm was developed and compared against a sub-millimeter motion capture system. The stereo camera-based system was robust, with minimal loss of data points, and with the average hand trajectory error of about 40 mm, which resulted to similar to 5% error of the total arm distance. As a proof-of-concept, a pilot study was undertaken with healthy individuals (n = 20) and a select group of patients with various neuromuscular diseases and varying degrees of shoulder girdle weakness (n = 9). The workspace envelope surface areas generated from the 3D hand trajectory captured by the stereo camera were compared. Normalization of acquired reachable workspace surface areas to the surface area of the unit hemi-sphere allowed comparison between subjects. The healthy group's relative surface areas were 0.618 +/- 0.09 and 0.552 +/- 0.092 (right and left), while the surface areas for the individuals with neuromuscular diseases ranged from 0.03 and 0.09 (the most severely affected individual) to 0.62 and 0.50 (very mildly affected individual). Neuromuscular patients with severe arm weakness demonstrated movement largely limited to the ipsilateral lower quadrant of their reachable workspace. Conclusions/Significance: The findings indicate that the proposed stereo camera-based reachable workspace analysis system is capable of distinguishing individuals with varying degrees of proximal upper limb functional impairments.	[Kurillo, Gregorij; Yan, Posu; Bajcsy, Ruzena] Univ Calif Berkeley, Coll Engn, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Han, Jay J.; Abresch, Richard T.; Nicorici, Alina] Univ Calif Davis, Sch Med, Dept Phys Med & Rehabil, Sacramento, CA 95817 USA	University of California System; University of California Berkeley; University of California System; University of California Davis	Kurillo, G (corresponding author), Univ Calif Berkeley, Coll Engn, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	gregorij@eecs.berkeley.edu			Center for Information Technology Research in the Interest of Society (CITRIS) at University of California, Berkeley; National Science Foundation (NSF) [1111965]; National Institute for Disability and Rehabilitation Research (NIDRR) [H133B090001]; Division of Computing and Communication Foundations [1111965] Funding Source: National Science Foundation	Center for Information Technology Research in the Interest of Society (CITRIS) at University of California, Berkeley; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute for Disability and Rehabilitation Research (NIDRR); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This study was supported by the Center for Information Technology Research in the Interest of Society (CITRIS, http://citris-uc.org) at University of California, Berkeley; National Science Foundation (NSF, http://nsf.gov) grant # 1111965; The National Institute for Disability and Rehabilitation Research (NIDRR, http://www2.ed.gov/about/offices/list/osers/nidrr/index.html) grant # H133B090001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Malek K, 2004, ERGONOMICS, V47, P1386, DOI 10.1080/00140130410001724255; Behara DN, 2010, THEORETICAL ISSUES E, V12, P87; Bernardini F, 1997, 97013 PURD U DEP COM; GAJDOSIK RL, 1987, PHYS THER, V67, P1867, DOI 10.1093/ptj/67.12.1867; Kennedy KennethW., 1978, AMRLTR7750; Kloopcar N, 2005, MECCANICA, V40, P203, DOI 10.1007/s11012-005-3067-0; Klopcar N, 2007, J BIOMECH, V40, P86, DOI 10.1016/j.jbiomech.2005.11.010; Kolber Morey J., 2012, Physiotherapy Theory and Practice, V28, P161, DOI 10.3109/09593985.2011.574203; LI S, 1990, ERGONOMICS, V33, P967, DOI 10.1080/00140139008925304; Mori N, 2007, J ENG MECH, V133, P122, DOI 10.1061/(ASCE)0733-9399(2007)133:1(122); Mullaney Michael J., 2010, Physiotherapy Theory and Practice, V26, P327, DOI 10.3109/09593980903094230; Obdrzalek Stepan, 2012, Stud Health Technol Inform, V173, P320; PANDYA S, 1985, PHYS THER, V65, P1339, DOI 10.1093/ptj/65.9.1339; Roux E, 2001, PROCEEDINGS OF THE THIRD CONFERENCE OF THE INTERNATIONAL SHOULDER GROUP, P66; Roy JS, 2010, SPORTS MED ARTHROSC, V2, P1; Schiele A, 2006, IEEE T NEUR SYS REH, V14, P456, DOI 10.1109/TNSRE.2006.881565; Schmidt R, 1999, J BIOMECH, V32, P615, DOI 10.1016/S0021-9290(99)00036-6; Sengupta AK, 1998, ADV OCCUP ERGO SAF, V2, P256; Veeraraghavan A, 2006, P INT C AC SPEECH SI, P669; Zheng J, 2008, P 5 INT C VIS INF EN, P52; Zupan A, 1996, DISABIL REHABIL, V18, P69, DOI 10.3109/09638289609166020	21	29	31	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45341	10.1371/journal.pone.0045341	http://dx.doi.org/10.1371/journal.pone.0045341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028947	gold, Green Published			2022-12-27	WOS:000309742800054
J	Wetzel, CE; Bicudo, DD; Ector, L; Lobo, EA; Soininen, J; Landeiro, VL; Bini, LM				Wetzel, Carlos E.; Bicudo, Denise de C.; Ector, Luc; Lobo, Eduardo A.; Soininen, Janne; Landeiro, Victor L.; Bini, Luis M.			Distance Decay of Similarity in Neotropical Diatom Communities	PLOS ONE			English	Article							BETA-DIVERSITY; RICHNESS GRADIENTS; VASCULAR PLANTS; PATTERNS; BIOGEOGRAPHY; ASSEMBLAGES; DISPERSAL; SCALE; MICROORGANISMS; TURNOVER	Background: The regression of similarity against distance unites several ecological phenomena, and thus provides a highly useful approach for illustrating the spatial turnover across sites. Our aim was to test whether the rates of decay in community similarity differ between diatom growth forms suggested to show different dispersal ability. We hypothesized that the diatom group with lower dispersal ability (i.e. periphyton) would show higher distance decay rates than a group with higher dispersal ability (i.e. plankton). Methods/Principal findings: Periphyton and phytoplankton samples were gathered at sites distributed over an area of approximately 800 km length in the Negro River, Amazon basin, Brazil, South America (3 degrees 08'00 '' S; 59 degrees 54'30 '' W). Distance decay relationships were then estimated using distance-based regressions, and the coefficients of these regressions were compared among the groups with different dispersal abilities to assess our predictions. We found evidence that different tributaries and reaches of the Negro River harbor different diatom communities. As expected, the rates of distance decay in community similarity were higher for periphyton than for phytoplankton indicating the lower dispersal ability of periphytic taxa. Conclusions/Significance: Our study demonstrates that the comparison of distance decay relationships among taxa with similar ecological requirements, but with different growth form and thus dispersal ability provides a sound approach to evaluate the effects of dispersal ability on beta diversity patterns. Our results are also in line with the growing body of evidence indicating that microorganisms exhibit biogeographic patterns. Finally, we underscore that clumbing all microbial taxa into one group may be a flawed approach to test whether microbes exhibit biogeographic patterns.	[Wetzel, Carlos E.; Ector, Luc] Inst Bot, Nucleo Ecol, Sao Paulo, Brazil; [Wetzel, Carlos E.; Bicudo, Denise de C.] Publ Res Ctr Gabriel Lippmann, Dept Environm & Agro Biotechnol, Belvaux, Luxembourg; [Lobo, Eduardo A.] Univ Santa Cruz do Sul, Lab Limnol, Santa Cruz Do Sul, RS, Brazil; [Soininen, Janne] Univ Helsinki, Dept Geosci & Geog, FIN-00014 Helsinki, Finland; Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil	Instituto de Botanica - Sao Paulo; Luxembourg Institute of Science & Technology; Universidade de Santa Cruz do Sul; University of Helsinki; Universidade Federal de Goias	Wetzel, CE (corresponding author), Inst Bot, Nucleo Ecol, Sao Paulo, Brazil.	wetzel@lippmann.lu	Bicudo, Denise/K-5562-2012; Wetzel, Carlos/A-2839-2015; Bini, Luis Mauricio/D-5865-2013; Soininen, Janne/A-4205-2008; Landeiro, Victor/H-2195-2012	Bicudo, Denise/0000-0002-4248-3261; Wetzel, Carlos/0000-0001-5330-0494; Bini, Luis Mauricio/0000-0003-3398-9399; Landeiro, Victor/0000-0002-9341-6050; Ector, Luc/0000-0002-4573-9445; Soininen, Janne/0000-0002-8583-3137	Financiadora de Estudos e Projetos (FINEP) Ministerio da Ciencia e Tecnologia, Governo Federal, Brazil [01.04.10.95.00]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/51360-6]; Centre de Recherche Public - Gabriel Lippmann (Belvaux, Luxembourg); Brazilian National Research Council (CNPq)	Financiadora de Estudos e Projetos (FINEP) Ministerio da Ciencia e Tecnologia, Governo Federal, Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centre de Recherche Public - Gabriel Lippmann (Belvaux, Luxembourg); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support for this work was provided by Financiadora de Estudos e Projetos (FINEP) Ministerio da Ciencia e Tecnologia, Governo Federal, Brazil, Grant 01.04.10.95.00. CEW is grateful to Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for PhD Grant 07/51360-6, and to the Centre de Recherche Public - Gabriel Lippmann (Belvaux, Luxembourg) for support. DCB and LMB have been continuously supported by productivity grants from Brazilian National Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 1999, CAN J FISH AQUAT SCI, V56, P2029, DOI 10.1139/cjfas-56-11-2029; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2007, BIOLOGY LETT, V3, P642, DOI 10.1098/rsbl.2007.0449; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bjorholm Stine, 2008, BMC Ecology, V8, P11, DOI 10.1186/1472-6785-8-11; Brown BL, 2010, J ANIM ECOL, V79, P571, DOI 10.1111/j.1365-2656.2010.01668.x; Fellis KJ, 2005, J PARASITOL, V91, P1484, DOI 10.1645/GE-578R.1; Finlay BJ, 1999, PROTIST, V150, P229, DOI 10.1016/S1434-4610(99)70025-8; Finlay BJ, 2002, PROTIST, V153, P261, DOI 10.1078/1434-4610-00103; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; González Gil Adriana, 2009, Estud. polit., Medellín, P01; Gray DK, 2011, ECOL APPL, V21, P1241, DOI 10.1890/10-0364.1; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Heino J, 2011, FRESHWATER BIOL, V56, P1703, DOI 10.1111/j.1365-2427.2011.02610.x; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; Jurasinski G, 2009, OECOLOGIA, V159, P15, DOI 10.1007/s00442-008-1190-z; Kuchler IL, 2000, J BRAZIL CHEM SOC, V11, P286; La Sorte FA, 2008, GLOBAL ECOL BIOGEOGR, V17, P363, DOI 10.1111/j.1466-8238.2007.00369.x; La Sorte FA, 2006, DIVERS DISTRIB, V12, P679, DOI 10.1111/j.1472-4642.2006.00276.x; Latrubesse EM, 2005, GEOMORPHOLOGY, V70, P372, DOI 10.1016/j.geomorph.2005.02.014; Leprieur F, 2009, J BIOGEOGR, V36, P1899, DOI 10.1111/j.1365-2699.2009.02107.x; Maloney KO, 2011, ECOGRAPHY, V34, P287, DOI 10.1111/j.1600-0587.2010.06518.x; Manly BFJ, 1997, RANDOMIZATION BOOTST; Mann DG, 1996, HYDROBIOLOGIA, V336, P19, DOI 10.1007/BF00010816; Marquet PA, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P191; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mazaris AD, 2010, J BIOGEOGR, V37, P1341, DOI 10.1111/j.1365-2699.2010.02294.x; Mouquet N, 2002, AM NAT, V159, P420, DOI 10.1086/338996; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Noguez AM, 2005, GLOBAL ECOL BIOGEOGR, V14, P241, DOI 10.1111/j.1466-822x.2005.00156.x; O'Malley MA, 2008, STUD HIST PHI PART C, V39, P314, DOI 10.1016/j.shpsc.2008.06.005; Pappas JL, 1996, J PHYCOL, V32, P693, DOI 10.1111/j.0022-3646.1996.00693.x; Poulin R, 2003, J BIOGEOGR, V30, P1609, DOI 10.1046/j.1365-2699.2003.00949.x; Qian H, 2008, BASIC APPL ECOL, V9, P617, DOI 10.1016/j.baae.2007.11.004; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Qian H, 2006, ECOL LETT, V9, P1293, DOI 10.1111/j.1461-0248.2006.00982.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; R Core Team, 2020, R LANG ENV STAT COMP; Rimet F, 2011, ECOL INDIC, V11, P489, DOI 10.1016/j.ecolind.2010.07.004; Round F. E., 1990, DIATOMS BIOL MORPHOL; Sabbe K, 2001, EUR J PHYCOL, V36, P321, DOI 10.1080/09670260110001735478; Soininen J, 2007, ECOGRAPHY, V30, P842, DOI 10.1111/j.2007.0906-7590.05387.x; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Soininen J, 2011, LIMNOL OCEANOGR, V56, P508, DOI 10.4319/lo.2011.56.2.0508; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Telford RJ, 2006, SCIENCE, V312, P1015, DOI 10.1126/science.1125669; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Vanormelingen P, 2008, BIODIVERS CONSERV, V17, P393, DOI 10.1007/s10531-007-9257-4; Vyverman W, 2007, ECOLOGY, V88, P1924, DOI 10.1890/06-1564.1; Vyverman W, 2010, POLAR SCI, V4, P103, DOI 10.1016/j.polar.2010.03.006; Wetzel CE, 2010, NOVA HEDWIGIA, V91, P49, DOI 10.1127/0029-5035/2010/0091-0049	56	91	93	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45071	10.1371/journal.pone.0045071	http://dx.doi.org/10.1371/journal.pone.0045071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028767	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700082
J	Gao, TJ; Petrlova, J; He, W; Huser, T; Kudlick, W; Voss, J; Coleman, MA				Gao, Tingjuan; Petrlova, Jitka; He, Wei; Huser, Thomas; Kudlick, Wieslaw; Voss, John; Coleman, Matthew A.			Characterization of De Novo Synthesized GPCRs Supported in Nanolipoprotein Discs	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; INTEGRAL MEMBRANE-PROTEINS; FLUORESCENCE CORRELATION SPECTROSCOPY; HIGH-THROUGHPUT ASSAY; CELL-FREE EXPRESSION; SUBSTANCE-P; IN-VITRO; BILAYER; SYSTEM; RECONSTITUTION	The protein family known as G-protein coupled receptors (GPCRs) comprises an important class of membrane-associated proteins, which remains a difficult family of proteins to characterize because their function requires a native-like lipid membrane environment. This paper focuses on applying a single step method leading to the formation of nanolipoprotein particles (NLPs) capable of solubilizing functional GPCRs for biophysical characterization. NLPs were used to demonstrate increased solubility for multiple GPCRs such as the Neurokinin 1 Receptor (NK1R), the Adrenergic Receptor (a) over cap2 (ADRB2) and the Dopamine Receptor D1 (DRD1). All three GPCRs showed affinity for their specific ligands using a simple dot blot assay. The NK1R was characterized in greater detail to demonstrate correct folding of the ligand pocket with nanomolar specificity. Electron paramagnetic resonance (EPR) spectroscopy validated the correct folding of the NK1R binding pocket for Substance P (SP). Fluorescence correlation spectroscopy (FCS) was used to identify SP-bound NK1R-containing NLPs and measure their dissociation rate in an aqueous environment. The dissociation constant was found to be 83 nM and was consistent with dot blot assays. This study represents a unique combinational approach involving the single step de novo production of a functional GPCR combined with biophysical techniques to demonstrate receptor association with the NLPs and binding affinity to specific ligands. Such a combined approach provides a novel path forward to screen and characterize GPCRs for drug discovery as well as structural studies outside of the complex cellular environment.	[Gao, Tingjuan; Petrlova, Jitka; Voss, John] Univ Calif Davis, Med Ctr, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Gao, Tingjuan; Huser, Thomas; Coleman, Matthew A.] Univ Calif Davis, Med Ctr, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [He, Wei; Coleman, Matthew A.] Univ Calif Davis, Med Ctr, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Kudlick, Wieslaw] Life Technol, Carlsbad, CA USA; [Coleman, Matthew A.] Lawrence Livermore Natl Lab, Livermore, CA USA	University of California System; University of California Davis; National Science Foundation (NSF); University of California System; University of California Davis; University of California System; University of California Davis; Thermo Fisher Scientific; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Voss, J (corresponding author), Univ Calif Davis, Med Ctr, Dept Biochem & Mol Med, Sacramento, CA 95817 USA.	jcvoss@ucdavis.edu; macoleman@ucdavis.edu	He, Wei/X-1574-2019; Huser, Thomas/K-7291-2019	He, Wei/0000-0003-2795-0324; Huser, Thomas/0000-0003-2348-7416; Voss, John/0000-0001-9279-209X; Coleman, Matthew/0000-0003-1389-4018	University of California; Life Technologies Corporation; National Science Foundation through the Center for Biophotonics Science and Technology Center [PHY 0120999]; U.S. Department of Energy [DE-AC52-07NA27344]; Life Technologies, Carlsbad through the University of California	University of California(University of California System); Life Technologies Corporation; National Science Foundation through the Center for Biophotonics Science and Technology Center; U.S. Department of Energy(United States Department of Energy (DOE)); Life Technologies, Carlsbad through the University of California	This work was supported by funding from the University of California Discovery Grant Program, which is jointly funded by the University of California and Life Technologies Corporation. Funding was also provided by the National Science Foundation through the Center for Biophotonics Science and Technology Center, managed by the University of California, Davis under Cooperative Agreement No. PHY 0120999. Work was also performed under the auspices of the U.S. Department of Energy under contract number DE-AC52-07NA27344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Kudlicki is employed by Life Technologies. Life Technologies, (5791 Van Allen Way, Carlsbad), provided funding through the University of California Discovery Grant program. As a funder they had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript. They do have a financial interest through the marketing and sale of cell-free technologies. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; Bayburt TH, 1998, J STRUCT BIOL, V123, P37, DOI 10.1006/jsbi.1998.4007; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; Coleman MA, 2004, J PROTEOME RES, V3, P1024, DOI 10.1021/pr049912g; Datar P, 2004, CURR TOP MED CHEM, V4, P75, DOI 10.2174/1568026043451636; Doi N, 2002, GENOME RES, V12, P487, DOI 10.1101/gr.218802; Elson EL, 2004, J BIOMED OPT, V9, P857, DOI 10.1117/1.1779234; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Gao TJ, 2011, PROTEIN SCI, V20, P437, DOI 10.1002/pro.577; Jewett MC, 2004, BIOTECHNOL PROGR, V20, P102, DOI 10.1021/bp0341693; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Keppetipola S, 2006, J AM CHEM SOC, V128, P4508, DOI 10.1021/ja0580791; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2004, FASEB J, V18, pC170; Koglin A, 2006, MAGN RESON CHEM, V44, pS17, DOI 10.1002/mrc.1833; Kostenis E, 2004, PHARMACOL THERAPEUT, V102, P243, DOI 10.1016/j.pharmthera.2004.04.005; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Lundstrom K, 2005, BIOORG MED CHEM LETT, V15, P3654, DOI 10.1016/j.bmcl.2005.05.041; Lundstrom K, 2006, MOL BIOTECHNOL, V34, P205, DOI 10.1385/MB:34:2:205; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; MORI M, 1979, P NATL ACAD SCI USA, V76, P5071, DOI 10.1073/pnas.76.10.5071; Nath A, 2008, J AM CHEM SOC, V130, P15746, DOI 10.1021/ja805772r; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Schwarz J, 2006, FASEB J, V20, P935, DOI 10.1096/fj.05-5497com; Segelke Brent W., 2004, Journal of Structural and Functional Genomics, V5, P147, DOI 10.1023/B:JSFG.0000029193.82120.d1; Shafer AM, 2008, PEPTIDES, V29, P1919, DOI 10.1016/j.peptides.2008.08.002; Vukojevic V, 2005, CELL MOL LIFE SCI, V62, P535, DOI 10.1007/s00018-004-4305-7; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Yang JP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-57; Zeder-Lutz G, 2006, PROTEIN EXPRES PURIF, V50, P118, DOI 10.1016/j.pep.2006.05.017; Zhang ZW, 2008, BIOPOLYMERS, V89, P1125, DOI 10.1002/bip.21064	39	28	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44911	10.1371/journal.pone.0044911	http://dx.doi.org/10.1371/journal.pone.0044911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028674	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900020
J	Vohra, S; Cvijovic, K; Boon, H; Foster, BC; Jaeger, W; LeGatt, D; Cembrowski, G; Murty, M; Tsuyuki, RT; Barnes, J; Charrois, TL; Arnason, JT; Necyk, C; Ware, M; Rosychuk, RJ				Vohra, Sunita; Cvijovic, Kosta; Boon, Heather; Foster, Brian C.; Jaeger, Walter; LeGatt, Don; Cembrowski, George; Murty, Mano; Tsuyuki, Ross T.; Barnes, Joanne; Charrois, Theresa L.; Arnason, John T.; Necyk, Candace; Ware, Mark; Rosychuk, Rhonda J.			Study of Natural Health Product Adverse Reactions (SONAR): Active Surveillance of Adverse Events Following Concurrent Natural Health Product and Prescription Drug Use in Community Pharmacies	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; DIETARY-SUPPLEMENTS; HERBAL MEDICINE; METHODOLOGICAL ISSUES; GINKGO-BILOBA; COMPLEMENTARY; PHARMACOVIGILANCE; IDENTIFICATION; PREVALENCE; REMEDIES	Background: Many consumers use natural health products (NHPs) concurrently with prescription medications. As NHP-related harms are under-reported through passive surveillance, the safety of concurrent NHP-drug use remains unknown. To conduct active surveillance in participating community pharmacies to identify adverse events related to concurrent NHP-prescription drug use. Methodology/Principal Findings: Participating pharmacists asked individuals collecting prescription medications about (i) concurrent NHP/drug use in the previous three months and (ii) experiences of adverse events. If an adverse event was identified and if the patient provided written consent, a research pharmacist conducted a guided telephone interview to gather additional information after obtaining additional verbal consent and documenting so within the interview form. Over a total of 112 pharmacy weeks, 2615 patients were screened, of which 1037 (39.7%; 95% CI: 37.8% to 41.5%) reported concurrent NHP and prescription medication use. A total of 77 patients reported a possible AE (2.94%; 95% CI: 2.4% to 3.7%), which represents 7.4% of those using NHPs and prescription medications concurrently (95% CI: 6.0% to 9.2%). Of 15 patients available for an interview, 4 (26.7%: 95% CI: 4.3% to 49.0%) reported an AE that was determined to be "probably" due to NHP use. Conclusions/Significance: Active surveillance markedly improves identification and reporting of adverse events associated with concurrent NHP-drug use. Although not without challenges, active surveillance is feasible and can generate adverse event data of sufficient quality to allow for meaningful adjudication to assess potential harms.	[Vohra, Sunita; Necyk, Candace] Univ Alberta, Dept Pediat, Complementary & Alternat Res Program CARE Integra, Fac Med & Dent, Edmonton, AB, Canada; [Vohra, Sunita; Tsuyuki, Ross T.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Vohra, Sunita; Tsuyuki, Ross T.] Univ Alberta, Dept Med, Fac Med & Dent, Edmonton, AB, Canada; [Vohra, Sunita; Rosychuk, Rhonda J.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Cvijovic, Kosta; Boon, Heather] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Cvijovic, Kosta; Jaeger, Walter] Univ Vienna, Dept Clin Pharm & Diagnost, Vienna, Austria; [Foster, Brian C.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Foster, Brian C.] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [LeGatt, Don; Cembrowski, George] Univ Alberta, Fac Med & Dent, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Tsuyuki, Ross T.; Barnes, Joanne] Univ Auckland, Fac Med & Hlth Sci, Sch Pharm, Auckland 1, New Zealand; [Charrois, Theresa L.] Curtin Hlth Innovat Res Inst, Sch Pharm, Perth, WA, Australia; [Arnason, John T.] Univ Ottawa, Dept Biol, Fac Sci, Ottawa, ON, Canada; [Necyk, Candace] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada; [Ware, Mark] McGill Univ, Alan Edwards Pain Management Unit, Ctr Hlth, Montreal, PQ, Canada	University of Alberta; University of Alberta; University of Alberta; University of Toronto; University of Vienna; University of Ottawa; Health Canada; University of Alberta; University of Auckland; University of Ottawa; University of Alberta; McGill University	Vohra, S (corresponding author), Univ Alberta, Dept Pediat, Complementary & Alternat Res Program CARE Integra, Fac Med & Dent, Edmonton, AB, Canada.	CARE@med.ualberta.ca	Rosychuk, Rhonda J./AAG-8299-2019; Tsuyuki, Ross T/E-2462-2016; Arnason, John Thor/GXM-3860-2022; Vohra, Sunita/F-5755-2016; Jäger, Walter/I-6242-2013; Charrois, Theresa/AAA-4695-2021	Tsuyuki, Ross T/0000-0002-3724-598X; Vohra, Sunita/0000-0002-6210-7933; Jäger, Walter/0000-0002-4970-8179; Ware, Mark/0000-0002-1286-1719; Barnes, Joanne/0000-0002-1522-8433; Rosychuk, Rhonda J./0000-0001-8019-5466	Canadian Institutes of Health Research; Canadian Patient Safety Institute; Health Canada; Alberta Innovates-Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Patient Safety Institute; Health Canada; Alberta Innovates-Health Solutions	This study was funded by the Canadian Institutes of Health Research, the Canadian Patient Safety Institute, and Health Canada. Dr. Vohra and Dr. Rosychuk receive an investigator award from our provincial funder Alberta Innovates-Health Solutions (formerly called AHFMR (www.ahfmr.ab.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal AM, 2006, DRUG SAFETY, V29, P358; Al-Tajir GK, 2005, ANN PHARMACOTHER, V39, P1169, DOI 10.1345/aph.1E559; Alvarez-Requejo A, 1998, EUR J CLIN PHARMACOL, V54, P483, DOI 10.1007/s002280050498; [Anonymous], 2011, CANADA VIGILANE ADVE; [Anonymous], 2012, HLTH COUNC CAN COMM; [Anonymous], SAS SYST VERS 9 1; Australian Adverse Drug Reactions Advisory Committee, 2007, AUSTR ADV DRUG REACT, V26, P11; Barnes J, 2003, DRUG SAFETY, V26, P829, DOI 10.2165/00002018-200326120-00001; Barnes J, 1998, BRIT J CLIN PHARMACO, V45, P496, DOI 10.1046/j.1365-2125.1998.00715.x; Barnes J, 2001, THESIS U LONDON; Bodeker G., 2005, WHO GLOBAL ATLAS TRA; Boon H, 2001, DRUG INTERACTIONS NA; Boon Heather, 2009, Int J Pharm Pract, V17, P31; Bora KS, 2011, PHARM BIOL, V49, P101, DOI 10.3109/13880209.2010.497815; BORDEN EK, 1982, J CHRON DIS, V35, P803, DOI 10.1016/0021-9681(82)90092-3; Boullata Joseph, 2005, Nutr Clin Pract, V20, P33, DOI 10.1177/011542650502000133; Canter PH, 2004, DRUG AGING, V21, P597, DOI 10.2165/00002512-200421090-00004; Charrois TL, 2007, ANN PHARMACOTHER, V41, P1124, DOI 10.1345/aph.1H463; Chen SY, 2005, ASIA PAC J CLIN NUTR, V14, P230; Corazza M, 2009, J EUR ACAD DERMATOL, V23, P1298, DOI 10.1111/j.1468-3083.2009.03314.x; Costantino D, 1977, GIORNALE ITALIANO FA, V19, P33; Coulter DM, 2002, PHARMACOVIGILANCE, P345; Council for International Organizations of Medical Sciences, 2011, SUSP ADV REACT REP; Cvijovic K, 2011, CAN MED ASSOC J, V183, pE1085, DOI 10.1503/cmaj.091948; Cvijovic K, 2009, CAN PHARM J, V142, P224, DOI 10.3821/1913-701X-142.5.224; Davis S., 1999, PHARM J, V263, P786; Ernst E, 2000, EUR J CLIN PHARMACOL, V56, P523, DOI 10.1007/s002280000194; Farrell Jennifer, 2008, Pharmacy Pract (Granada), V6, P33; Gauld NJ, 2000, PHARMACOEPIDEM DR S, V9, P207, DOI 10.1002/1099-1557(200005/06)9:3<207::AID-PDS483>3.0.CO;2-S; Goldman Ran D, 2009, Paediatr Drugs, V11, P251, DOI 10.2165/00148581-200911040-00004; Hartmann H, 1977, THESIS JOHANN WOLFGA; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Horn JR, 2007, ANN PHARMACOTHER, V41, P674, DOI 10.1345/aph.1H423; ICH Steering Committee, 2011, ICH HARM TRIP GUID P; INMAN WHW, 1986, MONITORING DRUG SAFE, P13; Izzo AA, 2004, INT J CLIN PHARM TH, V42, P139; Jean D, 2007, PEDIATRICS, V120, pE138, DOI 10.1542/peds.2006-3105; Kelly JP, 2005, ARCH INTERN MED, V165, P281, DOI 10.1001/archinte.165.3.281; Kimbel K, 1986, GRUNDLAGEN ARZNEIMIT, P292; Della K, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-40; Lasek, 1988, DTSCH AERZTEBLATT, V5, P304; Layton D, 2002, PHARMACOEPIDEM DR S, V11, P503, DOI 10.1002/pds.734; Leung VWY, 2009, ANN PHARMACOTHER, V43, P875, DOI 10.1345/aph.1L631; MacLennan AH, 2006, MED J AUSTRALIA, V184, P27, DOI 10.5694/j.1326-5377.2006.tb00092.x; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Natural Health Products Directorate - Health Canada, 2011, BAS NAT HLTH PROD SU; Palmer ME, 2003, LANCET, V361, P101, DOI 10.1016/S0140-6736(03)12227-1; Patel N., 2007, J PHARM PRACT, V20, P341, DOI [DOI 10.1177/0897190007303051, 10.1177/0897190007303051]; Pereira J, 2008, CAN FAM PHYSICIAN, V54, P1142; Quandt SA, 2005, ARTHRIT RHEUM-ARTHR, V53, P748, DOI 10.1002/art.21443; Rao P.S.R.S., 2000, SAMPLING METHODOLOGI; Rao SR, 2008, HEALTH SERV OUTCOME, V8, P98, DOI 10.1007/s10742-008-0032-0; Roy-Byrne PP, 2005, PSYCHOSOMATICS, V46, P117, DOI 10.1176/appi.psy.46.2.117; Shakir SAW, 2002, PHARMACOVIGILANCE, P333; Tabali M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-274; Tam TW, 2011, J PHARM PHARM SCI, V14, P1, DOI 10.18433/J3N30W; Timbo BB, 2006, J AM DIET ASSOC, V106, P1966, DOI 10.1016/j.jada.2006.09.002; Tiralongo E, 2010, J COMPLEMENTARY INTE, V7; Ulbricht CE, 2005, NATURAL STANDARD H S; van Grootheest K, 2004, PHARMACOEPIDEM DR S, V13, P457, DOI 10.1002/pds.897; Vickers Kathryn A, 2006, BMC Complement Altern Med, V6, P40, DOI 10.1186/1472-6882-6-40; Wiegman DJ, 2009, AIDS, V23, P1184, DOI 10.1097/QAD.0b013e32832c412b; Winslow LC, 2002, ARCH INTERN MED, V162, P1176; Wood MJ, 2003, AM HEART J, V145, P806, DOI 10.1016/S0002-8703(03)00084-X	64	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45196	10.1371/journal.pone.0045196	http://dx.doi.org/10.1371/journal.pone.0045196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028841	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900032
J	Fransen, K; Mitrovic, M; van Diemen, CC; Thelma, BK; Sood, A; Franke, A; Schreiber, S; Midha, V; Juyal, G; Potocnik, U; Fu, JY; Nolte, I; Weersma, RK				Fransen, Karin; Mitrovic, Mitja; van Diemen, Cleo C.; Thelma, B. K.; Sood, Ajit; Franke, Andre; Schreiber, Stefan; Midha, Vandana; Juyal, Garima; Potocnik, Uros; Fu, Jingyuan; Nolte, Ilja; Weersma, Rinse K.			Limited Evidence for Parent-of-Origin Effects in Inflammatory Bowel Disease Associated Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY LOCI; IMPRINTED GENES; RISK LOCI; VARIANTS; PRDM1; IDENTIFICATION; HOMOZYGOSITY	Background: Genome-wide association studies of two main forms of inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), have identified 99 susceptibility loci, but these explain only similar to 23% of the genetic risk. Part of the 'hidden heritability' could be in transmissible genetic effects in which mRNA expression in the offspring depends on the parental origin of the allele (genomic imprinting), since children whose mothers have CD are more often affected than children with affected fathers. We analyzed parent-of-origin (POO) effects in Dutch and Indian cohorts of IBD patients. Methods: We selected 28 genetic loci associated with both CD and UC, and tested them for POO effects in 181 Dutch IBD case-parent trios. Three susceptibility variants in NOD2 were tested in 111 CD trios and a significant finding was re-evaluated in 598 German trios. The UC-associated gene, BTNL2, reportedly imprinted, was tested in 70 Dutch UC trios. Finally, we used 62 independent Indian UC trios to test POO effects of five established Indian UC risk loci. Results: We identified POO effects for NOD2 (L1007fs; OR = 21.0, P-value = 0.013) for CD; these results could not be replicated in an independent cohort (OR = 0.97, P-value = 0.95). A POO effect in IBD was observed for IL12B (OR = 3.2, P-value = 0.019) and PRDM1 (OR = 5.6, P-value = 0.04). In the Indian trios the IL10 locus showed a POO effect (OR = 0.2, P-value = 0.03). Conclusions: Little is known about the effect of genomic imprinting in complex diseases such as IBD. We present limited evidence for POO effects for the tested IBD loci. POO effects explain part of the hidden heritability for complex genetic diseases but need to be investigated further.	[Fransen, Karin; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Fransen, Karin; Mitrovic, Mitja; van Diemen, Cleo C.; Fu, Jingyuan] Univ Groningen, Dept Genet, Univ Med Ctr Groningen, Groningen, Netherlands; [Mitrovic, Mitja; Potocnik, Uros] Univ Maribor, Fac Med, Ctr Human Mol Genet & Pharmacogenom, SLO-2000 Maribor, Slovenia; [Thelma, B. K.; Juyal, Garima] Univ Delhi, Dept Genet, New Delhi, India; [Sood, Ajit; Midha, Vandana] Dayanand Med Coll & Hosp, Dept Med, Ludhiana, Punjab, India; [Franke, Andre; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan] Univ Clin Schleswig Holstein, Dept Gen Internal Med, Kiel, Germany; [Nolte, Ilja] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, Groningen, Netherlands; [Potocnik, Uros] Univ Maribor, Fac Chem & Chem Engn, SLO-2000 Maribor, Slovenia	University of Groningen; University of Groningen; University of Maribor; University of Delhi; Dayanand Medical College & Hospital; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Groningen; University of Maribor	Weersma, RK (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	r.k.weersma@umcg.nl	Weersma, Rinse/ABE-3807-2021; Fu, Jingyuan/E-8980-2012; Fu, JY/GRR-6179-2022; Fu, Jingyuan/ABE-6868-2020; Franke, Andre/B-2151-2010	Fu, Jingyuan/0000-0001-5578-1236; Franke, Andre/0000-0003-1530-5811; Thelma, B.K/0000-0002-2154-5443; Potocnik, Uros/0000-0003-1624-9428; Mitrovic, Mitja/0000-0002-7648-7674; juyal, garima/0000-0002-3857-9578	GUIDE at University Medical Center Groningen; Slovenian Research Agency [630-39/2012-1, J3-2175]; Netherlands Organization for Scientific Research (NWO) [90.700.281]; Broad Medical Research Program of The Broad Foundation	GUIDE at University Medical Center Groningen; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Broad Medical Research Program of The Broad Foundation	K. Fransen was supported by a MD/PhD grant from GUIDE at University Medical Center Groningen. M. Mitrovic was supported by a PhD grant from Slovenian Research Agency (Grant No. 630-39/2012-1). U. Potocnik was supported by a grant from Slovenian Research Agency (Grant No. J3-2175). R. K. Weersma is supported by a clinical fellowship grant (90.700.281) from the Netherlands Organization for Scientific Research (NWO) and the Broad Medical Research Program of The Broad Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolkar PN, 1997, AM J GASTROENTEROL, V92, P2241; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Best T, 2011, NAT MED, V17, P941, DOI 10.1038/nm.2407; Brand S, 2012, INFLAMM BOWEL DIS, V18, P393, DOI 10.1002/ibd.21914; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Di Sabatino A, 2011, INTERN EMERG MED, V6, P17, DOI 10.1007/s11739-011-0673-9; Fay JC, 2001, GENETICS, V158, P1227; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fransen K, 2011, GENOME MED, V3, DOI 10.1186/gm227; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gleason G, 2010, P NATL ACAD SCI USA, V107, P7592, DOI 10.1073/pnas.0914805107; Guilmatre A, 2011, CLIN GENET; Hanson RL, 2001, AM J HUM GENET, V68, P951, DOI 10.1086/319508; Hollis-Moffatt JE, 2009, ANN RHEUM DIS, V68, P1340, DOI 10.1136/ard.2008.090142; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jurgens M, 2010, J GASTROENTEROL, V45, P721, DOI 10.1007/s00535-010-0231-7; Juyal G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016565; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Mitrovic M, 2011, DIS MARKERS, V30, P265, DOI 10.3233/DMA-2011-0783; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Schnitzler F, 2012, INFLAMM BOWEL DIS, V18, P395, DOI 10.1002/ibd.21882; Sokol L, 2011, BLOOD, V118, P3192, DOI 10.1182/blood-2011-07-364364; Thompson SL, 2001, TOXICOL LETT, V120, P143, DOI 10.1016/S0378-4274(01)00292-2; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang S, 2011, HUM HERED, V71, P196, DOI 10.1159/000328006; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Yazbek SN, 2010, HUM MOL GENET, V19, P4134, DOI 10.1093/hmg/ddq332; Zelinkova Z, 2012, J CROHNS COLITIS	37	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45287	10.1371/journal.pone.0045287	http://dx.doi.org/10.1371/journal.pone.0045287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028907	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500026
J	Piao, HL; Wang, SC; Tao, Y; Zhu, R; Sun, C; Fu, Q; Du, MR; Li, DJ				Piao, Hai-Lan; Wang, Song-Cun; Tao, Yu; Zhu, Rui; Sun, Chan; Fu, Qiang; Du, Mei-Rong; Li, Da-Jin			Cyclosporine A Enhances Th2 Bias at the Maternal-Fetal Interface in Early Human Pregnancy with Aid of the Interaction between Maternal and Fetal Cells	PLOS ONE			English	Article							HUMAN TROPHOBLAST CELLS; ABORTION-PRONE MATINGS; DECIDUAL STROMAL CELLS; INVASIVENESS IN-VITRO; RENAL-TRANSPLANTATION; RHEUMATOID-ARTHRITIS; IL-10 SECRETION; IMMUNE-SYSTEM; EXPRESSION; PROMOTES	Our previous study has demonstrated that cyclosporine A (CsA) administration in vivo induces Th2 bias at the maternal-fetal interface, leading to improved murine pregnancy outcomes. Here, we investigated how CsA treatment in vitro induced Th2 bias at the human maternal-fetal interface in early pregnancy. The cell co-culture in vitro in different combination of component cells at the maternal-fetal interface was established to investigate the regulation of CsA on cytokine production from the interaction of these cells. It was found that interferon (IFN)-gamma was produced only by decidual immune cells (DICs), and not by trophoblasts or decidual stromal cells (DSCs); all these cells secreted interleukin (IL)-4, IL-10, and tumor necrosis factor (TNF)-alpha. Treatment with CsA completely blocked IFN-gamma production in DICs and inhibited TNF-alpha production in all examined cells. CsA increased IL-10 and IL-4 production in trophoblasts co-cultured with DSCs and DICs although CsA treatment did not affect IL-10 or IL-4 production in any of the cells when cultured alone. These results suggest that CsA promotes Th2 bias at the maternal-fetal interface by increasing Th2- type cytokine production in trophoblasts with the aid of DSCs and DICs, while inhibiting Th1-type cytokine production in DICs and TNF-alpha production in all investigated cells. Our study might be useful in clinical therapeutics for spontaneous pregnancy wastage and other pregnancy complications.	[Piao, Hai-Lan; Wang, Song-Cun; Tao, Yu; Zhu, Rui; Sun, Chan; Fu, Qiang; Du, Mei-Rong; Li, Da-Jin] Fudan Univ, Shanghai Med Coll, Hosp & Inst Obstet & Gynecol, Lab Reprod Immunol, Shanghai 200433, Peoples R China; [Li, Da-Jin] Affiliated Hosp, Hainan Med Coll, Dept Obstet & Gynecol, Haikou, Peoples R China	Fudan University; Hainan Medical University	Du, MR (corresponding author), Fudan Univ, Shanghai Med Coll, Hosp & Inst Obstet & Gynecol, Lab Reprod Immunol, Shanghai 200433, Peoples R China.	dmrlq1973@yahoo.com.cn; djli@shmu.edu.cn			Major International Joint Research Project of the National Natural Science Foundation of China (NSFC) [30730087, 30872768, 81070537, 31171437]; Program for Outstanding Medical Academic Leader; Shanghai PuJiang Talent Program [10PJ1401600]; Natural Science Research Program for colleges and universities of Jiangsu Province [10KJB320021]	Major International Joint Research Project of the National Natural Science Foundation of China (NSFC); Program for Outstanding Medical Academic Leader; Shanghai PuJiang Talent Program; Natural Science Research Program for colleges and universities of Jiangsu Province	This work was supported by the Major International Joint Research Project of the National Natural Science Foundation of China (NSFC) 30730087, NSFC 30872768, and the Program for Outstanding Medical Academic Leader (All to D-JL), NSFC 81070537, NSFC 31171437, and Shanghai PuJiang Talent Program 10PJ1401600 (to M-RD), and the Natural Science Research Program for colleges and universities of Jiangsu Province 10KJB320021 (to RZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Arroyo MV, 2002, CIRC RES, V91, P202, DOI 10.1161/01.RES.0000027562.91075.56; BACKMAN L, 1988, PHARMACOL TOXICOL, V62, P110; Calleja-Agius J, 2011, GYNECOL ENDOCRINOL, V27, P121, DOI 10.3109/09513590.2010.487614; Cochat P, 2004, TRANSPL P, V36, p208S, DOI 10.1016/j.transproceed.2004.01.012; Du MR, 2012, HUM REPROD, V27, P1955, DOI 10.1093/humrep/des111; Du MR, 2008, BIOL REPROD, V78, P1102, DOI 10.1095/biolreprod.107.063503; Du MR, 2007, HUM REPROD, V22, P2528, DOI 10.1093/humrep/dem222; Du MR, 2007, BIOL REPROD, V76, P906, DOI 10.1095/biolreprod.106.056648; Fan DX, 2011, CLIN IMMUNOL, V141, P284, DOI 10.1016/j.clim.2011.07.008; Fujinaga S, 2012, PEDIATR NEPHROL, V27, P671, DOI 10.1007/s00467-011-2076-6; Germano V, 2011, J BIOL REG HOMEOS AG, V25, P397; Giannubilo SR, 2012, CYTOKINE, V58, P50, DOI 10.1016/j.cyto.2011.12.019; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Guo PF, 2010, BLOOD, V116, P2061, DOI 10.1182/blood-2009-11-252940; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hetland ML, 2011, DAN MED BULL, V58; Kaur Amrit, 2011, J Hum Reprod Sci, V4, P91, DOI 10.4103/0974-1208.86090; Lablanche S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.15; Liu FJ, 2011, APMIS, V119, P597, DOI 10.1111/j.1600-0463.2011.02774.x; Matthiesen L, 2012, AM J REPROD IMMUNOL, V67, P334, DOI 10.1111/j.1600-0897.2012.01121.x; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Periyasamy S, 2010, ONCOGENE, V29, P1691, DOI 10.1038/onc.2009.458; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; Royle C, 2009, CYTOKINE, V47, P56, DOI 10.1016/j.cyto.2009.04.006; Scott VL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-336; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Sgro MD, 2002, TERATOLOGY, V65, P5, DOI 10.1002/tera.1092; SKETRIS I, 1995, CLIN BIOCHEM, V28, P195, DOI 10.1016/0009-9120(95)91341-Y; Torricelli M, 2009, AM J REPROD IMMUNOL, V62, P224, DOI 10.1111/j.1600-0897.2009.00729.x; TUGWELL P, 1990, LANCET, V335, P1051, DOI 10.1016/0140-6736(90)92630-Z; Wu X, 2004, BIOL REPROD, V70, P1877, DOI 10.1095/biolreprod.103.024729; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yang F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001118; Zhou WH, 2008, REPRODUCTION, V135, P385, DOI 10.1530/REP-07-0063; Zhou WH, 2007, HUM REPROD, V22, P2743, DOI 10.1093/humrep/dem097; Zhou WH, 2008, HUM REPROD, V23, P2669, DOI 10.1093/humrep/den308	38	17	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45275	10.1371/journal.pone.0045275	http://dx.doi.org/10.1371/journal.pone.0045275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028901	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500023
J	Chittoria, A; Mohanty, S; Jaiswal, YK; Das, A				Chittoria, Anita; Mohanty, Sujata; Jaiswal, Yogesh Kumar; Das, Aparup			Natural Selection Mediated Association of the Duffy (FY) Gene Polymorphisms with Plasmodium vivax Malaria in India	PLOS ONE			English	Article							RECENT ORIGIN; BLOOD-GROUPS; SEQUENCE; ANTIGEN; HUMANS	The Duffy (Fy) antigens act as receptors for chemokines as well as for Plasmodium vivax to invade human RBCs. A recent study has correlated the occurrence of the FY*A allele of Duffy gene with decreased susceptibility to vivax malaria, but no epidemiological correlation between the distribution of FY*A allele and incidences of vivax malaria has been established so far. Furthermore, if such correlations exist, whether natural selection has mediated the association, is an important question. Since India is highly endemic to P. vivax malaria with variable eco-climatic and varying vivax malaria epidemiology across different regions, such a question could well be answered in Indians. For this, we have genotyped the FY gene at the -33rd and the 125th nucleotide positions in 250 Indians sampled from six different zonal plus one tribal population covering the whole of India and studied possible correlations with eco-climatic and vivax malaria incidences. No FY*O allele was found, however, both the FY*A and FY*B alleles forming FY*A/FY*A, FY*A/FY*B and FY*B/FY*B genotypes were widely distributed among Indians. Five out of seven population samples significantly deviated from the Hardy-Weinberg equilibrium expectation, and two alleles (FY*A and FY*B) and the homozygote genotype, FY*B/FY*B were clinally distributed over the population coordinates. Furthermore, vivax malaria incidences over the past five years were significantly negatively and positively associated with the frequencies of the FY*A and FY*B alleles, respectively. The Northern Indians were highly differentiated from the other zonal population samples at the FY gene, as evidenced from the reconstructed Neighbor-Joining phylogenetic tree. The results specify the role of natural selection in the distribution of FY gene polymorphism in India. Furthermore, the hypotheses on the part of the FY*A allele in conferring protection to vivax malaria could be validated following population genetic studies in a vivax malaria epidemiological setting, such as India.	[Chittoria, Anita; Das, Aparup] Natl Inst Malaria Res, Div Genom & Bioinformat, New Delhi, India; [Mohanty, Sujata] Jaypee Inst Informat Technol, Dept Biotechnol, Noida, Uttar Pradesh, India; [Jaiswal, Yogesh Kumar] Jiwaji Univ, Sch Studies Biotechnol, Gwalior, Madhya Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Jaypee Institute of Information Technology (JIIT); Jiwaji University Gwalior	Das, A (corresponding author), Natl Inst Malaria Res, Div Genom & Bioinformat, New Delhi, India.	aparup@mrcindia.org			Council of Scientific and Industrial Research (CSIR), New Delhi, India; Indian Council of Medical Research (ICMR)	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	AC is recipient of Junior and Senior Research Fellowships from the Council of Scientific and Industrial Research (CSIR), New Delhi, India. AD thanks the Indian Council of Medical Research (ICMR) for intramural funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; CHAUDHURI A, 1993, P NATL ACAD SCI USA, V90, P10793, DOI 10.1073/pnas.90.22.10793; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; DAS A, 1991, NATURE, V350, P387, DOI 10.1038/350387a0; Das A, 2004, GENETICS, V168, P1975, DOI 10.1534/genetics.104.031567; Das A, 2012, ACTA TROP, V121, P267, DOI 10.1016/j.actatropica.2011.11.008; Das MK, 2005, TRANSFUSION MED, V15, P237, DOI 10.1111/j.1365-3148.2005.00583.x; Eanes WF, 2011, J EXP BIOL, V214, P165, DOI 10.1242/jeb.046458; Gupta B, 2012, MOL ECOL, V21, P1597, DOI 10.1111/j.1365-294X.2012.05480.x; Gupta B, 2010, TROP MED INT HEALTH, V15, P819, DOI 10.1111/j.1365-3156.2010.02549.x; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Iwamoto S, 1996, BLOOD, V87, P378; KAR S, 1991, HUM HERED, V41, P231, DOI 10.1159/000154007; Khan N, 2012, ANN HUM BIOL, V39, P281, DOI 10.3109/03014460.2012.689326; King CL, 2011, P NATL ACAD SCI USA, V108, P20113, DOI 10.1073/pnas.1109621108; Mendes C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001192; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Mohanty S. S., 2011, Journal of Rural and Tropical Public Health, V10, P53; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; PENROSE LS, 1955, PROC R SOC SER B-BIO, V144, P203, DOI 10.1098/rspb.1955.0047; Perna SJQ, 2007, GENET MOL RES, V6, P166; Pogo AO, 2000, SEMIN HEMATOL, V37, P122, DOI 10.1016/S0037-1963(00)90037-4; Rudan I, 2008, EUR J HUM GENET, V16, P1097, DOI 10.1038/ejhg.2008.48; Singh V, 2009, TRENDS PARASITOL, V25, P452, DOI 10.1016/j.pt.2009.06.004; Sucheston L, 2011, HUM MOL GENET, V20, P1502, DOI 10.1093/hmg/ddr028; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Tournamille C, 2004, IMMUNOGENETICS, V55, P682, DOI 10.1007/s00251-003-0633-2; VERMA IC, 1993, J GENET, V72, P15, DOI 10.1007/BF02933030	31	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45219	10.1371/journal.pone.0045219	http://dx.doi.org/10.1371/journal.pone.0045219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028857	Green Submitted, gold, Green Published			2022-12-27	WOS:000309392800031
J	Delli Pizzi, S; Madonna, R; Caulo, M; Romani, GL; De Caterina, R; Tartaro, A				Delli Pizzi, Stefano; Madonna, Rosalinda; Caulo, Massimo; Romani, Gian Luca; De Caterina, Raffaele; Tartaro, Armando			MR Angiography, MR Imaging and Proton MR Spectroscopy In-Vivo Assessment of Skeletal Muscle Ischemia in Diabetic Rats	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; ARTERY LIGATION MODEL; HIND-LIMB ISCHEMIA; GENE-THERAPY; 3 T; GROWTH; MICE; QUANTIFICATION; ANGIOGENESIS; CONTRAST	To prospectively evaluate the feasibility of using magnetic resonance (MR) techniques for in-vivo assessing a rat diabetic model of limb ischemia. Unilateral hind limb ischemia was induced by ligation of the iliac-femoral artery in male streptozotocin-treated and non-diabetic control rats. Four weeks after ligation, rats underwent MR Angiography (MRA), T-1-weighted and Short Time Inversion Recovery (STIR) sequences and muscle Proton MR Spectroscopy (H-1-MRS) on both hind limbs. After MR examinations, immunoblotting and immunofluorescence analysis were performed. MRA showed a signal void due to flow discontinuation distal to the artery ligation. T-1-weighted and STIR images showed, respectively, the presence of tissue swelling (p = 0.018 for non-diabetic; p = 0.027 for diabetic rats) and signal hyperintensity in tissue affected by occlusion. Mean total creatine/water for the occluded limb was significantly lower than for the non-occluded limbs in both non-diabetic (5.46 x 10(-4) vs 1.14 x 10(-3), p = 0.028) and diabetic rats (1.37 x 10(-4) vs 1.10 x 10(-3); p = 0.018). MR Imaging and H-1-MRS changes were more pronounced in diabetic than in non-diabetic occluded limbs (p = 0.032). MR findings were confirmed by using histological findings. Combined MR techniques can be used to demonstrate the presence of structural and metabolic changes produced by iliac-femoral artery occlusion in rat diabetic model of limb ischemia.	[Delli Pizzi, Stefano; Caulo, Massimo; Romani, Gian Luca; Tartaro, Armando] Univ G dAnnunzio, Dept Neurosci & Imaging, Inst Adv Biomed Technol, Chieti, Italy; [Madonna, Rosalinda; De Caterina, Raffaele] Univ G DAnnunzio, Dept Neurosci & Imaging, Div Cardiol, Ctr Excellence Aging, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Tartaro, A (corresponding author), Univ G dAnnunzio, Dept Neurosci & Imaging, Inst Adv Biomed Technol, Chieti, Italy.	tartaro@unich.it	tartaro, armando at/K-2184-2016; Pizzi, Stefano Delli/J-3935-2016; De Caterina, Raffaele/K-3857-2016	tartaro, armando at/0000-0003-0095-2792; Pizzi, Stefano Delli/0000-0003-4075-0132; De Caterina, Raffaele/0000-0003-1637-574X; Madonna, Rosalinda/0000-0001-6455-2777	Italian Ministry of University and Scientific Research; Istituto Nazionale Ricerche Cardiovascolari (INRC)	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Istituto Nazionale Ricerche Cardiovascolari (INRC)	This work was supported by grants from the Italian Ministry of University and Scientific Research and from the Istituto Nazionale Ricerche Cardiovascolari (INRC, to RDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreas M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-32; ARENA N, 1982, Bollettino Societa Italiana Biologia Sperimentale, V58, P1485; Asperio RM, 2001, RADIOLOGY, V220, P413, DOI 10.1148/radiology.220.2.r01au03413; Bottomley PA, 1998, LANCET, V351, P714, DOI 10.1016/S0140-6736(97)06402-7; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Cabanes E, 2001, J MAGN RESON, V150, P116, DOI 10.1006/jmre.2001.2318; de Lussanet QG, 2006, NMR BIOMED, V19, P77, DOI 10.1002/nbm.1003; de Lussanet QG, 2007, NMR BIOMED, V20, P717, DOI 10.1002/nbm.1133; Deten A, 2001, J MOL CELL CARDIOL, V33, P1191, DOI 10.1006/jmcc.2001.1383; Emanueli C, 2007, FRONT BIOSCI-LANDMRK, V12, P2003, DOI 10.2741/2205; Fissoune R, 2009, ACAD RADIOL, V16, P890, DOI 10.1016/j.acra.2008.12.007; Gianella A, 2010, CARDIOVASC RES, V85, P503, DOI 10.1093/cvr/cvp325; Gold GE, 2004, AM J ROENTGENOL, V183, P343, DOI 10.2214/ajr.183.2.1830343; GREENBERG B, 1987, PLAST RECONSTR SURG, V79, P959, DOI 10.1097/00006534-198706000-00018; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; HERFKENS RJ, 1983, RADIOLOGY, V147, P761, DOI 10.1148/radiology.147.3.6844611; Hsieh TJ, 2009, J COMPUT ASSIST TOMO, V33, P150, DOI 10.1097/RCT.0b013e318168f735; Huysman F, 2009, ACTA CHIR BELG, V109, P587; Jaspers K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016159; Kang J, 2008, J VASC SURG, V48, P701, DOI 10.1016/j.jvs.2008.04.006; Kattapuram TM, 2005, SKELETAL RADIOL, V34, P203, DOI 10.1007/s00256-004-0881-8; Korosoglou G, 2007, RADIOLOGY, V245, P761, DOI 10.1148/radiol.2452062067; Lee CW, 2010, CLIN IMAG, V34, P47, DOI 10.1016/j.clinimag.2009.03.013; Li XD, 2012, INT J CARDI IN PRESS; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Liu M, 2007, P NATL ACAD SCI USA, V104, P371, DOI 10.1073/pnas.0609870104; Lundberg G, 2003, EUR SURG RES, V35, P430, DOI 10.1159/000072228; Madonna R, 2010, INT J IMMUNOPATH PH, V23, P755, DOI 10.1177/039463201002300309; Madonna R, 2012, CIRC J, V76, P1517, DOI 10.1253/circj.CJ-11-1215; McMahon CJ, 2010, AM J ROENTGENOL, V194, pW284, DOI 10.2214/AJR.10.4247; Mompeo B, 1998, J SUBMICR CYTOL PATH, V30, P475; MORIKAWA S, 1991, MAGN RESON IMAGING, V9, P269, DOI 10.1016/0730-725X(91)90411-E; Nicholson C D, 1996, Vasc Med, V1, P43; Odaka K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025487; Rivard A, 1999, AM J PATHOL, V154, P355, DOI 10.1016/S0002-9440(10)65282-0; Schick F, 2005, EUR RADIOL, V15, P946, DOI 10.1007/s00330-005-2678-0; Sinha S, 2009, MAGN RESON IMAGING, V27, P94, DOI 10.1016/j.mri.2008.06.001; Stehouwer CDA, 1997, CARDIOVASC RES, V34, P55, DOI 10.1016/S0008-6363(96)00272-6; Stramare R, 2010, RADIOL MED, V115, P585, DOI 10.1007/s11547-010-0531-2; Stueckle CA, 2006, AM J ROENTGENOL, V187, P1322, DOI 10.2214/AJR.05.0819; 't Zandt HJAI, 1999, NMR BIOMED, V12, P327, DOI 10.1002/(SICI)1099-1492(199910)12:6<327::AID-NBM570>3.0.CO;2-9; Tamarat R, 2004, AM J PATHOL, V164, P457, DOI 10.1016/S0002-9440(10)63136-7; TOOKE JE, 1995, DIABETES, V44, P721, DOI 10.2337/diabetes.44.7.721; Torriani M, 2005, RADIOLOGY, V236, P609, DOI 10.1148/radiol.2362041661; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; VANSLYKE MA, 1995, MAGN RESON IMAGING, V13, P325, DOI 10.1016/0730-725X(94)00102-9; Verkman A. S., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000690; Westerweel PE, 2005, CARDIOVASC PATHOL, V14, P294, DOI 10.1016/j.carpath.2005.07.007; Yan JL, 2009, J VASC SURG, V50, P1412, DOI 10.1016/j.jvs.2009.08.007; Yang N, 2009, MED SPORT SCI, V54, P88, DOI 10.1159/000235698; Ye Q, 2011, NMR BIOMED, V24, P1295, DOI 10.1002/nbm.1691	52	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44752	10.1371/journal.pone.0044752	http://dx.doi.org/10.1371/journal.pone.0044752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028603	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800015
J	Selvapandiyan, A; Kumar, P; Salisbury, JL; Wang, CC; Nakhasi, HL				Selvapandiyan, Angamuthu; Kumar, Praveen; Salisbury, Jeffrey L.; Wang, Ching C.; Nakhasi, Hira L.			Role of Centrins 2 and 3 in Organelle Segregation and Cytokinesis in Trypanosoma brucei	PLOS ONE			English	Article							BASAL-BODY DUPLICATION; NUCLEOTIDE EXCISION-REPAIR; CELL-CYCLE PROGRESSION; FLAGELLUM ATTACHMENT; RNA INTERFERENCE; PROCYCLIC-FORM; YEAST CENTRIN; PROTEIN; GENE; EXPRESSION	Centrins are calcium binding proteins involved in cell division in eukaryotes. Previously, we have shown that depletion of centrin1 in Trypanosoma brucei (T. brucei) displayed arrested organelle segregation resulting in loss of cytokinesis. In this study we analyzed the role of T. brucei centrin2 (TbCen2) and T. brucei 3 (TbCen3) in the early events of T. brucei procyclic cell cycle. Both the immunofluorescence assay and electron microscopy showed that TbCen2 and 3-deficient cells were enlarged in size with duplicated basal bodies, multinuclei and new flagella that are detached along the length of the cell body. In both TbCen2 and TbCen3 depleted cells segregation of the organelles i.e. basal bodies, kinetoplast and nucleus was disrupted. Further analysis of the cells with defective organelle segregation identified three different sub configurations of organelle mis-segregations (Type 1-3). In addition, in majority of the TbCen2 depleted cells and in nearly half of the TbCen3 depleted cells, the kinetoplasts were enlarged and undivided. The abnormal segregations ultimately led to aborted cytokinesis and hence affected growth in these cells. Therefore, both centrin2 and 3 are involved in organelle segregation similar to centrin1 as was previously observed. In addition, we identified their role in kinetoplast division which may be also linked to overall mis-segregation.	[Selvapandiyan, Angamuthu; Nakhasi, Hira L.] US FDA, Ctr Biol Evaluat & Res, Div Emerging & Transfus Transmitted Dis, Bethesda, MD 20014 USA; [Selvapandiyan, Angamuthu] Okhla Ind Estate, Infect Dis, Inst Mol Med, New Delhi, India; [Kumar, Praveen; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Salisbury, Jeffrey L.] Mayo Clin, Dept Biochem & Mol Biol, Coll Med, Rochester, MN USA	US Food & Drug Administration (FDA); University of California System; University of California San Francisco; Mayo Clinic	Selvapandiyan, A (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Emerging & Transfus Transmitted Dis, Bethesda, MD 20014 USA.	selvapandiyan@immindia.org	Selvapandiyan, Angamuthu/AAY-2556-2021; Selvapandiyan, Angamuthu/AAA-8602-2021	Selvapandiyan, Angamuthu/0000-0002-2194-1534; Salisbury, Jeffrey/0000-0001-9257-4578	Department of Biotechnology, Government of India [BT/PR12883/AGR/36/618/2009]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Part of the study was supported by a grant from Department of Biotechnology, Government of India (Grant # BT/PR12883/AGR/36/618/2009) to A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; ERRABOLU R, 1994, J CELL SCI, V107, P9; Field MC, 2009, NAT REV MICROBIOL, V7, P775, DOI 10.1038/nrmicro2221; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Gavet O, 2003, MOL BIOL CELL, V14, P1818, DOI 10.1091/mbc.E02-11-0709; Gluenz E, 2011, MOL CELL BIOL, V31, P1012, DOI 10.1128/MCB.01176-10; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; hChanez AL, 2006, J CELL SCI, V119, P2968; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Ivanovska I, 2001, GENETICS, V157, P503; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Koblenz B, 2003, J CELL SCI, V116, P2635, DOI 10.1242/jcs.00497; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kohl L, 1998, MOL BIOCHEM PARASIT, V93, P1, DOI 10.1016/S0166-6851(98)00014-0; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; LaCount DJ, 2002, J BIOL CHEM, V277, P17580, DOI 10.1074/jbc.M200873200; Laoukili J, 2000, J CELL SCI, V113, P1355; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Middendorp S, 1997, P NATL ACAD SCI USA, V94, P9141, DOI 10.1073/pnas.94.17.9141; Molinier J, 2004, PLANT CELL, V16, P1633, DOI 10.1105/tpc.021378; Moreira-Leite FF, 2001, SCIENCE, V294, P610, DOI 10.1126/science.1063775; Morris JC, 2004, RNAI BASED GENOMIC L, P241; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nishi R, 2005, MOL CELL BIOL, V25, P5664, DOI 10.1128/MCB.25.13.5664-5674.2005; Paoletti A, 1996, J CELL SCI, V109, P3089; Ploubidou A, 1999, J CELL SCI, V112, P4641; Raslova H, 2006, BLOOD, V107, P2303, DOI 10.1182/blood-2005-07-3005; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Ruiz F, 2005, CURR BIOL, V15, P2097, DOI 10.1016/j.cub.2005.11.038; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Selvapandiyan A, 2004, J BIOL CHEM, V279, P25703, DOI 10.1074/jbc.M402794200; Selvapandiyan A, 2001, J BIOL CHEM, V276, P43253, DOI 10.1074/jbc.M106806200; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; Signorell A, 2009, MOL MICROBIOL, V72, P1068, DOI 10.1111/j.1365-2958.2009.06713.x; Stemm-Wolf AJ, 2005, MOL BIOL CELL, V16, P3606, DOI 10.1091/mbc.E04-10-0919; Sullivan DS, 1998, J CELL BIOL, V143, P751, DOI 10.1083/jcb.143.3.751; Tsang WY, 2006, MOL BIOL CELL, V17, P3423, DOI 10.1091/mbc.E06-04-0371; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Vonderfecht T, 2011, MOL BIOL CELL, V22, P2221, DOI 10.1091/mbc.E11-02-0151; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; WOODWARD R, 1990, J CELL SCI, V95, P49; Zamora I, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-15	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45288	10.1371/journal.pone.0045288	http://dx.doi.org/10.1371/journal.pone.0045288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028908	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800036
J	Wang, Q; Zhang, LB; Zhao, JM; You, LP; Wu, HF				Wang, Qing; Zhang, Linbao; Zhao, Jianmin; You, Liping; Wu, Huifeng			Two Goose-Type Lysozymes in Mytilus galloprovincialis: Possible Function Diversification and Adaptive Evolution	PLOS ONE			English	Article							OYSTER CRASSOSTREA-VIRGINICA; I-TYPE LYSOZYMES; LYTIC ACTIVITY; MOLECULAR ADAPTATION; RECOMBINANT PROTEIN; POSITIVE SELECTION; STOMACH LYSOZYMES; EASTERN OYSTER; EGG-WHITE; PHYLOGENETIC ANALYSIS	Two goose-type lysozymes (designated as MGgLYZ1 and MGgLYZ2) were identified from the mussel Mytilus galloprovincialis. MGgLYZ1 mRNA was widely expressed in the examined tissues and responded sensitively to bacterial challenge in hemocytes, while MGgLYZ2 mRNA was predominately expressed and performed its functions in hepatopancreas. However, immunolocalization analysis showed that both these lysozymes were expressed in all examined tissues with the exception of adductor muscle. Recombinant MGgLYZ1 and MGgLYZ2 could inhibit the growth of several Gram-positive and Gram-negative bacteria, and they both showed the highest activity against Pseudomonas putida with the minimum inhibitory concentration (MIC) of 0.95-1.91 mu M and 1.20-2.40 mu M, respectively. Protein sequences analysis revealed that MGgLYZ2 had lower isoelectric point and less protease cutting sites than MGgLYZ1. Recombinant MGgLYZ2 exhibited relative high activity at acidic pH of 4-5, while MGgLYZ1 have an optimum pH of 6. These results indicated MGgLYZ2 adapted to acidic environment and perhaps play an important role in digestion. Genomic structure analysis suggested that both MGgLYZ1 and MGgLYZ2 genes are composed of six exons with same length and five introns, indicating these genes were conserved and might originate from gene duplication during the evolution. Selection pressure analysis showed that MGgLYZ1 was under nearly neutral selection while MGgLYZ2 evolved under positive selection pressure with three positively selected amino acid residues (Y-102, L-200 and S-202) detected in the mature peptide. All these findings suggested MGgLYZ2 perhaps served as a digestive lysozyme under positive selection pressure during the evolution while MGgLYZ1 was mainly involved in innate immune responses.	[Wang, Qing; Zhang, Linbao; Zhao, Jianmin; You, Liping; Wu, Huifeng] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Zone Environm Proc, CAS,Shandong Prov Key Lab Coastal Zone Environm, Yantai, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS	Zhao, JM (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Zone Environm Proc, CAS,Shandong Prov Key Lab Coastal Zone Environm, Yantai, Peoples R China.	jmzhao@yic.ac.cn; hfwu@yic.ac.cn	Wang, Qing/O-1991-2013; Wu, Huifeng/E-4886-2016	Wang, Qing/0000-0002-5180-5154; Wu, Huifeng/0000-0002-4042-8103	NSFC [30901115, 31172388]; Chinese Academy of Sciences; Open Project Program of the Key Laboratory of Marine Bio-resources Sustainable Utilization; SCSIO; CAS; Department of Science and Technology of Yantai City of China [2011067]	NSFC(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Open Project Program of the Key Laboratory of Marine Bio-resources Sustainable Utilization; SCSIO; CAS(Chinese Academy of Sciences); Department of Science and Technology of Yantai City of China	This work was supported by grants from NSFC (30901115, 31172388), the 100 Talents Program of the Chinese Academy of Sciences, Open Project Program of the Key Laboratory of Marine Bio-resources Sustainable Utilization, SCSIO, CAS and the Department of Science and Technology of Yantai City of China grant 2011067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CANFIELD RE, 1967, BIOCHEM BIOPH RES CO, V26, P38, DOI 10.1016/0006-291X(67)90249-5; DOBSON DE, 1984, J BIOL CHEM, V259, P1607; Helland R, 2009, CELL MOL LIFE SCI, V66, P2585, DOI 10.1007/s00018-009-0063-x; Hikima J, 2001, BBA-GENE STRUCT EXPR, V1520, P35, DOI 10.1016/S0167-4781(01)00248-2; Huang P, 2011, MOL IMMUNOL, V48, P524, DOI 10.1016/j.molimm.2010.10.008; Hultmark D, 1996, LYSOZYMES MODEL ENZY, V75, P87; Irwin D.M., 1996, LYSOZYMES MODEL ENZY, P347; Irwin DM, 2003, J MOL EVOL, V56, P234, DOI 10.1007/s00239-002-2396-z; ITO Y, 1993, EUR J BIOCHEM, V213, P649, DOI 10.1111/j.1432-1033.1993.tb17805.x; Ito Y, 1999, EUR J BIOCHEM, V259, P456, DOI 10.1046/j.1432-1327.1999.00064.x; ITO Y, 1995, J BIOCHEM-TOKYO, V118, P546, DOI 10.1093/oxfordjournals.jbchem.a124943; Jiang H, 2009, PROTEOMICS, V9, P3353, DOI 10.1002/pmic.200800518; JOLLES J, 1977, MOL CELL BIOCHEM, V17, P39, DOI 10.1007/BF01732553; Jolles J, 1996, J MOL EVOL, V43, P525; KORNEGAY JR, 1994, MOL BIOL EVOL, V11, P921; Kyomuhendo P, 2007, CELL MOL LIFE SCI, V64, P2841, DOI 10.1007/s00018-007-7372-8; Kyomuhendo P, 2008, J MOL MODEL, V14, P777, DOI 10.1007/s00894-008-0317-9; LANGDON CJ, 1990, MAR ECOL PROG SER, V58, P299; Larsen AN, 2009, FISH SHELLFISH IMMUN, V26, P122, DOI 10.1016/j.fsi.2008.03.021; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto T, 2006, COMP BIOCHEM PHYS B, V145, P325, DOI 10.1016/j.cbpb.2006.08.003; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; Najbar LV, 1997, BIOCHEMISTRY-US, V36, P11525, DOI 10.1021/bi970730s; NAKANO T, 1991, BIOCHIM BIOPHYS ACTA, V1090, P273, DOI 10.1016/0167-4781(91)90118-6; Narmadha G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027659; Nilsen IW, 2003, CELL MOL LIFE SCI, V60, P2210, DOI 10.1007/s00018-003-3252-z; PIPE RK, 1990, HISTOCHEM J, V22, P595, DOI 10.1007/BF01072941; Pooart J, 2005, BIOSCI BIOTECH BIOCH, V69, P103, DOI 10.1271/bbb.69.103; PRAGER EM, 1996, LYSOZYMES MODEL ENZY, P323; Regel R, 1998, INSECT BIOCHEM MOLEC, V28, P309, DOI 10.1016/S0965-1748(97)00108-2; RUIZ MC, 1994, EXPERIENTIA, V50, P499, DOI 10.1007/BF01920757; Schmitt P, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-23; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; SWANSON KW, 1991, J MOL EVOL, V33, P418, DOI 10.1007/BF02103133; Thammasirirak S, 2001, BIOSCI BIOTECH BIOCH, V65, P584, DOI 10.1271/bbb.65.584; Vanderkelen L, 2011, CELL MOL LIFE SCI, V68, P1053, DOI 10.1007/s00018-010-0507-3; Whang I, 2011, FISH SHELLFISH IMMUN, V30, P532, DOI 10.1016/j.fsi.2010.11.025; Xue QG, 2007, CELL MOL LIFE SCI, V64, P82, DOI 10.1007/s00018-006-6386-y; Xue QG, 2004, COMP BIOCHEM PHYS B, V139, P11, DOI 10.1016/j.cbpc.2004.05.011; Xue QG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-213; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yin ZX, 2003, DIS AQUAT ORGAN, V55, P117, DOI 10.3354/dao055117; Yu M, 1996, MOL PHYLOGENET EVOL, V5, P298, DOI 10.1006/mpev.1996.0025; Yue X, 2011, FISH SHELLFISH IMMUN, V30, P550, DOI 10.1016/j.fsi.2010.11.022; Zhang H, 2009, FISH SHELLFISH IMMUN, V26, P56, DOI 10.1016/j.fsi.2008.07.019; Zhang SH, 2012, DEV COMP IMMUNOL, V36, P241, DOI 10.1016/j.dci.2011.06.014; Zhao J, 2007, MOL IMMUNOL, V44, P1198, DOI 10.1016/j.molimm.2006.06.008; Zhao L, 2011, FISH SHELLFISH IMMUN, V30, P630, DOI 10.1016/j.fsi.2010.12.012; [邹慧斌 Zou Huibin], 2005, [高技术通讯, High Technology Letters], V15, P101	56	31	32	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45148	10.1371/journal.pone.0045148	http://dx.doi.org/10.1371/journal.pone.0045148			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028813	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800028
J	Guo, YX; Mo, DL; Zhang, Y; Zhang, Y; Cong, PQ; Xiao, SQ; He, ZY; Liu, XH; Chen, YS				Guo, Yunxue; Mo, Delin; Zhang, Yue; Zhang, Yun; Cong, Peiqing; Xiao, Shuqi; He, Zuyong; Liu, Xiaohong; Chen, Yaosheng			MicroRNAome Comparison between Intramuscular and Subcutaneous Vascular Stem Cell Adipogenesis	PLOS ONE			English	Article							ADIPOSE-TISSUE; EXPRESSION; IDENTIFICATION; ADIPOCYTES; MECHANISM; PROFILE; MUSCLE	Background: As an important factor affecting meat quality, intramuscular fat (IMF) content is a topic of worldwide concern. Emerging evidences indicate that microRNAs play important roles in adipocyte differentiation. However, miRNAome has neither been studied during porcine intramuscular preadipocyte differentiation, nor compared with subcutaneous preadipocytes. The objectives of this study were to identify porcine miRNAs involved in adipogenesis in primary preadipocytes, and to determine whether intramuscular and subcutaneous adipocytes differ in the expression and regulation of miRNAs. Results: miRNAomes in primary intramuscular and subcutaneous adipocytes during differentiation were first sequenced using the Solexa deep sequencing method. The sequences and relative expression levels of 224 known (98.2% in miRbase 18.0) and 280 potential porcine miRNAs were identified. Fifty-four of them changed in similar pattern between intramuscular vascular stem cells (IVSC) and subcutaneous vascular stem cells (SVSC) differentiation, such as miR-210, miR-10b and miR-99a. Expression levels of 10 miRNAs were reversely up-or down-regulated between IVSC and SVSC differentiation, 19 were up-or down-regulated only during IVSC differentiation and 55 only during SVSC differentiation. Additionally, 30 miRNAs showed fat-depot specific expression pattern (24 in cells of intramuscular origin and 6 in cells of subcutaneous origin). These adipogenesis-related miRNAs mainly functioned by targeting similar pathways in adipogenesis, obesity and syndrome. Conclusion: Comparison of miRNAomes in IVSC and SVSC during differentiation revealed that many different miRNAs are involved in adipogenesis, and they regulate SVSC and IVSC differentiation through similar pathways. These miRNAs may serve as biomarkers or targets for enhancing IMF content, and uncovering their function in IMF development will be of great value in the near future.	[Guo, Yunxue; Mo, Delin; Zhang, Yue; Zhang, Yun; Cong, Peiqing; Xiao, Shuqi; He, Zuyong; Liu, Xiaohong; Chen, Yaosheng] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, YS (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	chyaosh@mail.sysu.edu.cn	He, Zuyong/AAU-9430-2021	Chen, Yaosheng/0000-0002-3871-7651; Mo, Delin/0000-0002-8738-4486	National Natural Science Foundation of China [U0731003, 30700568]; National High-Technology Research and Development Program of China (863 Program) [2011AA100304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Joint Funds of the National Natural Science Foundation of China (U0731003, 30700568) and the National High-Technology Research and Development Program of China (863 Program) (No. 2011AA100304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albu JB, 2005, AM J CLIN NUTR, V82, P1210, DOI 10.1093/ajcn/82.6.1210; Bjorndal B, 2011, J OBES, V2011, DOI 10.1155/2011/490650; Chen J, 2010, INT J BIOL SCI, V6, P80; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Gallagher D, 2009, AM J CLIN NUTR, V89, P807, DOI 10.3945/ajcn.2008.26955; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; Gondret F, 2008, J ANIM SCI, V86, P2115, DOI 10.2527/jas.2007-0750; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Gu ZL, 2007, FEBS LETT, V581, P981, DOI 10.1016/j.febslet.2007.01.081; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; HOOD RL, 1978, J ANIM SCI, V46, P1626, DOI 10.2527/jas1978.4661626x; HOOD RL, 1973, J LIPID RES, V14, P605; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Jin WW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-29; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kim YJ, 2009, STEM CELLS; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee S, 2010, J CLIN ENDOCR METAB, V95, P2426, DOI 10.1210/jc.2009-2175; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179; Nicholls PK, 2011, ENDOCRINOLOGY, V152, P1670, DOI 10.1210/en.2010-1341; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Rhoades RD, 2007, J ANIM SCI, V85, P1719, DOI 10.2527/jas.2006-498; Smith SB, 1998, COMP BIOCHEM PHYS B, V120, P165, DOI 10.1016/S0305-0491(98)10005-6; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhou GX, 2010, MEAT SCI, V86, P440, DOI 10.1016/j.meatsci.2010.05.031	40	23	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45410	10.1371/journal.pone.0045410	http://dx.doi.org/10.1371/journal.pone.0045410			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028990	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900048
J	Guirado, E; Arcos, J; Knaup, R; Reeder, R; Betz, B; Cotton, C; Patel, T; Pfaller, S; Torrelles, JB; Schlesinger, LS				Guirado, Evelyn; Arcos, Jesus; Knaup, Rose; Reeder, Rebecca; Betz, Bret; Cotton, Cassie; Patel, Tejal; Pfaller, Stacy; Torrelles, Jordi B.; Schlesinger, Larry S.			Characterization of Clinical and Environmental Mycobacterium avium Spp. Isolates and Their Interaction with Human Macrophages	PLOS ONE			English	Article							COMPLEMENT RECEPTORS CR-1; NONTUBERCULOUS MYCOBACTERIA; COLONY MORPHOLOGY; GLYCOPEPTIDOLIPIDS; PHAGOCYTOSIS; TUBERCULOSIS; VIRULENCE; INFECTION; WATER; EPIDEMIOLOGY	Members of the Mycobacterium avium complex (MAC) are naturally occurring bacteria in the environment. A link has been suggested between M. avium strains in drinking water and clinical isolates from infected individuals. There is a need to develop new screening methodologies that can identify specific virulence properties of M. avium isolates found in water that predict a level of risk to exposed individuals. In this work we have characterized 15 clinical and environmental M. avium spp. isolates provided by the US Environmental Protection Agency (EPA) to improve our understanding of the key processes involved in the binding, uptake and survival of these isolates in primary human macrophages. M. avium serovar 8 was predominant among the isolates studied. Different amounts and exposure of mannose-capped lipoarabinomannan (ManLAM) and glycopeptidolipids (GPLs), both major mycobacterial virulence factors, were found among the isolates studied. Reference clinical isolate 104 serovar 1 and clinical isolates 11 and 14 serovar 8 showed an increased association with macrophages. Serum opsonization increased the cell association and survival at 2 h post infection for all isolates. However, only the clinical isolates 104 and 3 among those tested showed an increased growth in primary human macrophages. The other isolates varied in their survival in these cells. Thus we conclude that the amounts of cell envelope ManLAM and GPL, as well as GPL serovar specificity are not the only important bacterial factors for dictating the early interactions of M. avium with human macrophages.	[Guirado, Evelyn; Arcos, Jesus; Knaup, Rose; Reeder, Rebecca; Betz, Bret; Cotton, Cassie; Patel, Tejal; Torrelles, Jordi B.; Schlesinger, Larry S.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Guirado, Evelyn; Arcos, Jesus; Torrelles, Jordi B.; Schlesinger, Larry S.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Guirado, Evelyn; Arcos, Jesus; Torrelles, Jordi B.; Schlesinger, Larry S.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Pfaller, Stacy] US EPA, Cincinnati, OH 45268 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; United States Environmental Protection Agency	Schlesinger, LS (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA.	larry.schlesinger@osumc.edu	Torrelles, Jordi/E-4204-2011		United States Environmental Protection Agency [CR-83278701-1]	United States Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by a grant from the United States Environmental Protection Agency (CR-83278701-1 to LSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspinall GO, 1995, ADV CARBOHYD CHEM BI, V51, P169, DOI 10.1016/S0065-2318(08)60194-8; BARROW WW, 1980, J BACTERIOL, V144, P814, DOI 10.1128/JB.144.2.814-822.1980; Bhatnagar S, 2006, CELL MICROBIOL, V8, P85, DOI 10.1111/j.1462-5822.2005.00602.x; BRENNAN PJ, 1984, MYCOBACTERIA SOURCEB, P467; CARSON LA, 1978, APPL ENVIRON MICROB, V36, P839, DOI 10.1128/AEM.36.6.839-846.1978; CHAN J, 1989, P NATL ACAD SCI USA, V86, P2453, DOI 10.1073/pnas.86.7.2453; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; CROWLE AJ, 1986, J CLIN MICROBIOL, V24, P812, DOI 10.1128/JCM.24.5.812-821.1986; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; Feazel LM, 2009, P NATL ACAD SCI USA, V106, P16393, DOI 10.1073/pnas.0908446106; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Hilborn ED, 2006, APPL ENVIRON MICROB, V72, P5864, DOI 10.1128/AEM.00759-06; Horan KL, 2006, J CLIN MICROBIOL, V44, P783, DOI 10.1128/JCM.44.3.783-789.2006; Horgen L, 2000, MICROB PATHOGENESIS, V29, P9, DOI 10.1006/mpat.2000.0358; HORSBURGH CR, 1986, ANTIMICROB AGENTS CH, V30, P955, DOI 10.1128/AAC.30.6.955; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Kansal RG, 1998, MICROB PATHOGENESIS, V25, P203, DOI 10.1006/mpat.1998.0227; Khoo HH, 2001, J BIOL CHEM, V276, P3863, DOI 10.1074/jbc.M004010200; Krzywinska E, 2005, MOL MICROBIOL, V56, P1262, DOI 10.1111/j.1365-2958.2005.04608.x; Marras TK, 2005, CHEST, V127, P664, DOI 10.1378/chest.127.2.664; Marras TK, 2002, CLIN CHEST MED, V23, P553, DOI 10.1016/S0272-5231(02)00019-9; OBRIEN RJ, 1989, CLIN CHEST MED, V10, P407; Olakanmi O, 2000, INFECT IMMUN, V68, P5619, DOI 10.1128/IAI.68.10.5619-5627.2000; Parker AE, 1997, MICROB PATHOGENESIS, V22, P193, DOI 10.1006/mpat.1996.0106; PEDROSA J, 1994, CLIN EXP IMMUNOL, V98, P210; Pfaller SL, 2007, J MED MICROBIOL, V56, P1152, DOI 10.1099/jmm.0.47075-0; PRINZIS S, 1993, J GEN MICROBIOL, V139, P2649, DOI 10.1099/00221287-139-11-2649; Reddy VM, 1996, MICROB PATHOGENESIS, V21, P97, DOI 10.1006/mpat.1996.0046; Rusin P A, 1997, Rev Environ Contam Toxicol, V152, P57; Saunders BM, 2002, IMMUNOL CELL BIOL, V80, P544, DOI 10.1046/j.1440-1711.2002.01121.x; SCHAEFER WB, 1970, AM REV RESPIR DIS, V102, P499; SCHLESINGER LS, 1990, J CLIN INVEST, V85, P1304, DOI 10.1172/JCI114568; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; SCHLESINGER LS, 1991, J IMMUNOL, V147, P1983; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Schorey JS, 2008, GLYCOBIOLOGY, V18, P832, DOI 10.1093/glycob/cwn076; Shi Libin, 2008, V465, P23, DOI 10.1007/978-1-59745-207-6_3; Sweet L, 2010, INFECT IMMUN, V78, P518, DOI 10.1128/IAI.00257-09; Tateishi Y, 2009, MICROB PATHOGENESIS, V46, P6, DOI 10.1016/j.micpath.2008.10.007; TERELETSKY MJ, 1983, INFECT IMMUN, V41, P1312, DOI 10.1128/IAI.41.3.1312-1321.1983; Torrelles JB, 2002, TUBERCULOSIS, V82, P293, DOI 10.1054/tube.2002.0373; Torrelles JB, 2000, J APPL MICROBIOL, V88, P266, DOI 10.1046/j.1365-2672.2000.00958.x; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; TSANG AY, 1992, J CLIN MICROBIOL, V30, P479, DOI 10.1128/JCM.30.2.479-484.1992; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; VERGNE I, 1995, FEBS LETT, V375, P254, DOI 10.1016/0014-5793(95)01219-5; VONREYN CF, 1994, LANCET, V343, P1137, DOI 10.1016/S0140-6736(94)90239-9; Winthrop KL, 2010, FUTURE MICROBIOL, V5, P343, DOI [10.2217/fmb.10.13, 10.2217/FMB.10.13]; WOLINSKY E, 1968, AM REV RESPIR DIS, V97, P1032	49	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45411	10.1371/journal.pone.0045411	http://dx.doi.org/10.1371/journal.pone.0045411			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028991	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388400082
J	Nawaz, S; Sanchez, P; Bodensiek, K; Li, S; Simons, M; Schaap, IAT				Nawaz, Schanila; Sanchez, Paula; Bodensiek, Kai; Li, Sai; Simons, Mikael; Schaap, Iwan A. T.			Cell Visco-Elasticity Measured with AFM and Optical Trapping at Sub-Micrometer Deformations	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CYTOSKELETAL STRUCTURE; MECHANICS; MICRORHEOLOGY; FIBROBLASTS; ELASTICITY; TWEEZERS; MORPHOLOGY; STIFFNESS; MEMBRANE	The measurement of the elastic properties of cells is widely used as an indicator for cellular changes during differentiation, upon drug treatment, or resulting from the interaction with the supporting matrix. Elasticity is routinely quantified by indenting the cell with a probe of an AFM while applying nano-Newton forces. Because the resulting deformations are in the micrometer range, the measurements will be affected by the finite thickness of the cell, viscous effects and even cell damage induced by the experiment itself. Here, we have analyzed the response of single 3T3 fibroblasts that were indented with a micrometer-sized bead attached to an AFM cantilever at forces from 30-600 pN, resulting in indentations ranging from 0.2 to 1.2 micrometer. To investigate the cellular response at lower forces up to 10 pN, we developed an optical trap to indent the cell in vertical direction, normal to the plane of the coverslip. Deformations of up to two hundred nanometers achieved at forces of up to 30 pN showed a reversible, thus truly elastic response that was independent on the rate of deformation. We found that at such small deformations, the elastic modulus of 100 Pa is largely determined by the presence of the actin cortex. At higher indentations, viscous effects led to an increase of the apparent elastic modulus. This viscous contribution that followed a weak power law, increased at larger cell indentations. Both AFM and optical trapping indentation experiments give consistent results for the cell elasticity. Optical trapping has the benefit of a lower force noise, which allows a more accurate determination of the absolute indentation. The combination of both techniques allows the investigation of single cells at small and large indentations and enables the separation of their viscous and elastic components.	[Nawaz, Schanila; Sanchez, Paula; Bodensiek, Kai; Li, Sai; Schaap, Iwan A. T.] Univ Gottingen, Fac Phys, Inst Phys 3, Gottingen, Germany; [Nawaz, Schanila; Sanchez, Paula; Bodensiek, Kai; Li, Sai; Schaap, Iwan A. T.] DFG Res Ctr Mol Physiol Brain CMPB Excellence Clu, Gottingen, Germany; [Simons, Mikael] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany; [Nawaz, Schanila; Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany	University of Gottingen; University of Gottingen; Max Planck Society	Schaap, IAT (corresponding author), Univ Gottingen, Fac Phys, Inst Phys 3, Gottingen, Germany.	ischaap@physik3.gwdg.de	Schaap, Iwan A. T./L-3177-2013; Li, Sai/AAC-5187-2019	Schaap, Iwan A. T./0000-0001-6665-5104; Li, Sai/0000-0002-9353-0355; Simons, Mikael/0000-0001-5329-192X	DFG Research Center for Molecular Physiology of the Brain(CMPB)/Excellence Cluster [171]; DFG Research Center [SFB860]	DFG Research Center for Molecular Physiology of the Brain(CMPB)/Excellence Cluster(German Research Foundation (DFG)); DFG Research Center(German Research Foundation (DFG))	The project was supported by the DFG Research Center for Molecular Physiology of the Brain(CMPB)/Excellence Cluster 171 (S.N., S.L, I.A.T.S.), and the DFG Research Center SFB860 (K.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi I, PLOS ONE, V7; Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Bacabac RG, 2008, J BIOMECH, V41, P1590, DOI 10.1016/j.jbiomech.2008.01.031; Balland M, 2005, EUR BIOPHYS J BIOPHY, V34, P255, DOI 10.1007/s00249-004-0447-7; Balland M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021911; Burnham NA, 2003, NANOTECHNOLOGY, V14, P1, DOI 10.1088/0957-4484/14/1/301; Clark AG, 2011, RESULTS PROBL CELL D, V53, P31, DOI 10.1007/978-3-642-19065-0_3; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Dreyer JK, 2004, APPL OPTICS, V43, P1991, DOI 10.1364/AO.43.001991; Eghiaian F, 2011, METHODS MOL BIOL, V778, P71, DOI 10.1007/978-1-61779-261-8_6; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fernandez P, 2006, BIOPHYS J, V90, P3796, DOI 10.1529/biophysj.105.072215; Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302; Gittes F, 1998, METHOD CELL BIOL, V55, P129; Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Liang H, 1996, BIOPHYS J, V70, P1529, DOI 10.1016/S0006-3495(96)79716-3; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Maloney JD, 2010, ILLUSTRATIVE HANDBOOK OF GENERAL SURGERY, P99, DOI 10.1007/978-1-84882-089-0_14; Massiera G, 2007, BIOPHYS J, V93, P3703, DOI 10.1529/biophysj.107.111641; Mizuno D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.168102; Puig-de-Morales M, 2001, J APPL PHYSIOL, V91, P1152, DOI 10.1152/jappl.2001.91.3.1152; Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Sleep J, 1999, BIOPHYS J, V77, P3085, DOI 10.1016/S0006-3495(99)77139-0; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Tee SY, 2009, CURR BIOL, V19, pR745, DOI 10.1016/j.cub.2009.06.034; Thoumine O, 1997, J CELL SCI, V110, P2109; TSAI MA, 1993, BIOPHYS J, V65, P2078, DOI 10.1016/S0006-3495(93)81238-4; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Vermeulen KC, 2006, APPL OPTICS, V45, P1812, DOI 10.1364/AO.45.001812; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; ZHELEV DV, 1994, BIOPHYS J, V67, P696, DOI 10.1016/S0006-3495(94)80529-6	41	130	131	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45297	10.1371/journal.pone.0045297	http://dx.doi.org/10.1371/journal.pone.0045297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028915	gold, Green Published			2022-12-27	WOS:000309388400071
J	Sun, M; Fu, SM; Wang, LF; Dong, GY; Wu, D; Wang, GX; Wu, YM				Sun, Mao; Fu, Shan-Min; Wang, Li-Feng; Dong, Guang-Ying; Wu, Dan; Wang, Guo-Xia; Wu, Yuanming			Hypervariable Region Polymorphism of mtDNA of Recurrent Oral Ulceration in Chinese	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; D-LOOP REGION; MITOCHONDRIAL-DNA; LENGTH HETEROPLASMY; DISEASE; ASSOCIATION; EXPRESSION; MUTATIONS; SEQUENCE	Background: MtDNA haplogroups could have important implication for understanding of the relationship between the mutations of the mitochondrial genome and diseases. Distribution of a variety of diseases among these haplogroups showed that some of the mitochondrial haplogroups are predisposed to disease. To examine the susceptibility of mtDNA haplogroups to ROU, we sequenced the mtDNA HV1, HV2 and HV3 in Chinese ROU. Methodology/Principal Findings: MtDNA haplogroups were analyzed in the 249 cases of ROU patients and the 237 cases of healthy controls respectively by means of primer extension analysis and DNA sequencing. Haplogroups G1 and H were found significantly more abundant in ROU patients than in healthy persons, while haplogroups D5 and R showed a trend toward a higher frequency in control as compared to those in patients. The distribution of C-stretch sequences polymorphism in mtDNA HV1, HV2 and HV3 regions was found in diversity. Conclusions/Significance: For the first time, the relationship of mtDNA haplogroups and ROU in Chinese was investigated. Our results indicated that mtDNA haplogroups G1 and H might constitute a risk factor for ROU, which possibly increasing the susceptibility of ROU. Meanwhile, haplogroups D5 and R were indicated as protective factors for ROU. The polymorphisms of C-stretch sequences might being unstable and influence the mtDNA replication fidelity.	[Sun, Mao; Wu, Dan; Wang, Guo-Xia; Wu, Yuanming] Fourth Mil Med Univ, Ctr DNA Typing, Xian 710032, Peoples R China; [Sun, Mao; Wang, Li-Feng; Wu, Dan; Wang, Guo-Xia; Wu, Yuanming] Fourth Mil Med Univ, Dept Biochem & Mol Biol, Xian 710032, Peoples R China; [Fu, Shan-Min] Fourth Mil Med Univ, Dept Orthodont, Xian 710032, Peoples R China; [Fu, Shan-Min; Dong, Guang-Ying] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China; [Dong, Guang-Ying] Fourth Mil Med Univ, Dept Periodont & Oral Med, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wu, YM (corresponding author), Fourth Mil Med Univ, Ctr DNA Typing, Xian 710032, Peoples R China.	wuym@fmmu.edu.cn		Sun, Mao/0000-0003-1379-6573	National Foundation of Natural Science of China [30600268]; Natural Science Foundation [2005C2-15]; National Natural Science Foundation of China [30901359]; Key Project Foundation of ShaanXi Science & Technology Commission [2010K01-194]	National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project Foundation of ShaanXi Science & Technology Commission	This project is supported by National Foundation of Natural Science of China (grant number 30600268), the Natural Science Foundation (grant number 2005C2-15), National Natural Science Foundation of China grant (grant number 30901359) and the Key Project Foundation (grant number 2010K01-194) of ShaanXi Science & Technology Commission. The funders had no role in study design, data collection and analysis, decision to publish.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arnestad M, 1999, PEDIATR RES, V45, p29A, DOI 10.1203/00006450-199905020-00114; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Clayton D A, 2000, Hum Reprod, V15 Suppl 2, P11; Darvishi K, 2007, CANCER LETT, V249, P249, DOI 10.1016/j.canlet.2006.09.005; Freysdottir J, 1997, IMMUNOL LETT, V56, P411; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Guo X, 2000, Zhonghua Kou Qiang Yi Xue Za Zhi, V35, P21; Hapa A, 2011, J DERMATOL TREAT, V22, P215, DOI 10.3109/09546631003675450; Hofmann S, 1997, HUM MOL GENET, V6, P1835, DOI 10.1093/hmg/6.11.1835; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Imaizumi K, 2002, INT J LEGAL MED, V116, P68, DOI 10.1007/s004140100211; Koybasi S, 2006, AM J OTOLARYNG, V27, P229, DOI 10.1016/j.amjoto.2005.09.022; LERTRIT P, 1994, HUM MOL GENET, V3, P1973, DOI 10.1093/hmg/3.11.1973; Li BQ, 2004, ORAL MUCOSAL, P52; Lutz S, 2000, FORENSIC SCI INT, V113, P97, DOI 10.1016/S0379-0738(00)00222-X; Malik S, 2002, HUM GENET, V110, P402, DOI 10.1007/s00439-002-0717-3; Malik S, 2002, J HUM GENET, V47, P122, DOI 10.1007/s100380200013; OBERMAIERKUSSER B, 1994, AM J HUM GENET, V55, P1063; Palacin M, 2011, MITOCHONDRION, V11, P176, DOI 10.1016/j.mito.2010.09.004; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Preeti L, 2011, J Oral Maxillofac Pathol, V15, P252, DOI 10.4103/0973-029X.86669; Rani DS, 2010, MITOCHONDRION, V10, P166, DOI 10.1016/j.mito.2009.12.146; Matute GR, 2011, REUMATOL CLIN, V7, P323, DOI 10.1016/j.reuma.2011.05.003; Scully C, 2008, ORAL SURG ORAL MED O, V106, P845, DOI 10.1016/j.tripleo.2008.07.014; Scully C, 2008, BRIT J ORAL MAX SURG, V46, P198, DOI 10.1016/j.bjoms.2007.07.201; Torroni A, 1997, AM J HUM GENET, V60, P1107; Tuo Ya, 2007, Fa Yi Xue Za Zhi, V23, P123; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zhang AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027750	30	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45359	10.1371/journal.pone.0045359	http://dx.doi.org/10.1371/journal.pone.0045359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028959	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400079
J	Nishikawa, T; Shimizu, K; Tanaka, T; Kuroda, K; Takayama, T; Yamamoto, T; Hanada, N; Hamada, Y				Nishikawa, Tomoko; Shimizu, Kazufumi; Tanaka, Torahiko; Kuroda, Kazumichi; Takayama, Tadatoshi; Yamamoto, Tatsuo; Hanada, Nobuhiro; Hamada, Yoshiki			Bacterial Neuraminidase Rescues Influenza Virus Replication from Inhibition by a Neuraminidase Inhibitor	PLOS ONE			English	Article							SIALIDASE NEURAMINIDASE; STREPTOCOCCUS-PNEUMONIAE; PANDEMIC INFLUENZA; VIBRIO-CHOLERAE; A VIRUSES; PURIFICATION; CULTURE; INFECTION; ACID; CONTRIBUTE	Influenza virus neuraminidase (NA) cleaves terminal sialic acid residues on oligosaccharide chains that are receptors for virus binding, thus playing an important role in the release of virions from infected cells to promote the spread of cell-to-cell infection. In addition, NA plays a role at the initial stage of viral infection in the respiratory tract by degrading hemagglutination inhibitors in body fluid which competitively inhibit receptor binding of the virus. Current first line anti-influenza drugs are viral NA-specific inhibitors, which do not inhibit bacterial neuraminidases. Since neuraminidase producing bacteria have been isolated from oral and upper respiratory commensal bacterial flora, we posited that bacterial neuraminidases could decrease the antiviral effectiveness of NA inhibitor drugs in respiratory organs when viral NA is inhibited. Using in vitro models of infection, we aimed to clarify the effects of bacterial neuraminidases on influenza virus infection in the presence of the NA inhibitor drug zanamivir. We found that zanamivir reduced progeny virus yield to less than 2% of that in its absence, however the yield was restored almost entirely by the exogenous addition of bacterial neuraminidase from Streptococcus pneumoniae. Furthermore, cell-to-cell infection was severely inhibited by zanamivir but restored by the addition of bacterial neuraminidase. Next we examined the effects of bacterial neuraminidase on hemagglutination inhibition and infectivity neutralization activities of human saliva in the presence of zanamivir. We found that the drug enhanced both inhibitory activities of saliva, while the addition of bacterial neuraminidase diminished this enhancement. Altogether, our results showed that bacterial neuraminidases functioned as the predominant NA when viral NA was inhibited to promote the spread of infection and to inactivate the neutralization activity of saliva. We propose that neuraminidase from bacterial flora in patients may reduce the efficacy of NA inhibitor drugs during influenza virus infection. (295 words).	[Nishikawa, Tomoko; Shimizu, Kazufumi; Tanaka, Torahiko; Kuroda, Kazumichi; Takayama, Tadatoshi; Yamamoto, Tatsuo; Hanada, Nobuhiro] Nihon Univ, Sch Med, SRBD Project, Itabashi Ku, Tokyo, Japan; [Nishikawa, Tomoko; Shimizu, Kazufumi; Yamamoto, Tatsuo] Nihon Univ, Sch Med, Div & Dept Obstet & Gynecol, Itabashi Ku, Tokyo, Japan; [Tanaka, Torahiko] Nihon Univ, Sch Med, Dept Biomed Sci, Div Biochem,Itabashi Ku, Tokyo, Japan; [Kuroda, Kazumichi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol,Itabashi Ku, Tokyo, Japan; [Takayama, Tadatoshi] Nihon Univ, Sch Med, Dept Surg, Div Digest Surg,Itabashi Ku, Tokyo, Japan; [Hanada, Nobuhiro] Tsurumi Univ, Sch Dent Med, Dept Translat Res, Turumi Ku, Yokohama, Kanagawa, Japan; [Hamada, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Turumi Ku, Yokohama, Kanagawa, Japan	Nihon University; Nihon University; Nihon University; Nihon University; Nihon University; Tsurumi University; Tsurumi University	Shimizu, K (corresponding author), Nihon Univ, Sch Med, SRBD Project, Itabashi Ku, Tokyo, Japan.	shimizu.kazufumi@nihon-u.ac.jp	Hanada, Nobuhiro/C-5308-2011		MEXT [S1091023]; Research Institute of the Japan Dental Association	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Institute of the Japan Dental Association	This work was supported, in part, by a grant from the Strategic Research Base Development Program for Private Universities subsidized by MEXT (S1091023 since 2010, http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm) and by a grant from the Research Institute of the Japan Dental Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA GL, 1961, J GEN MICROBIOL, V24, P409, DOI 10.1099/00221287-24-3-409; Bantia S, 2001, ANTIMICROB AGENTS CH, V45, P1162, DOI 10.1128/AAC.45.4.1162-1167.2001; BEIGHTON D, 1990, J CLIN MICROBIOL, V28, P1431, DOI 10.1128/JCM.28.6.1431-1433.1990; BOAT TF, 1978, BIOCHIM BIOPHYS ACTA, V540, P127, DOI 10.1016/0304-4165(78)90441-5; BURNET FM, 1947, AUST J EXP BIOL MED, V25, P227, DOI 10.1038/icb.1947.33; CASSIDY JT, 1965, J BIOL CHEM, V240, P3501; Chen CH, 2010, PROTEOMICS, V10, P2396, DOI 10.1002/pmic.200900775; CHU C M, 1948, Nature, V161, P607; Dhanoa A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-501; GOTTSCHALK A, 1957, BIOCHIM BIOPHYS ACTA, V23, P645, DOI 10.1016/0006-3002(57)90389-X; Hartshorn KL, 2003, AM J PHYSIOL-LUNG C, V285, pL1066, DOI 10.1152/ajplung.00057.2003; HAYANO S, 1969, J BACTERIOL, V97, P1328, DOI 10.1128/JB.97.3.1328-1333.1969; Homer KA, 1996, MICROBIOL-UK, V142, P1221, DOI 10.1099/13500872-142-5-1221; Hughes MT, 2000, J VIROL, V74, P5206, DOI 10.1128/JVI.74.11.5206-5212.2000; Li WX, 1998, ANTIMICROB AGENTS CH, V42, P647, DOI 10.1128/AAC.42.3.647; LIU CG, 1993, VIROLOGY, V194, P403, DOI 10.1006/viro.1993.1276; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; MONCLA BJ, 1989, J CLIN MICROBIOL, V27, P182, DOI 10.1128/JCM.27.1.182-184.1989; MONCLA BJ, 1990, J CLIN MICROBIOL, V28, P422, DOI 10.1128/JCM.28.3.422-425.1990; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; NONAKA H, 1983, J DENT RES, V62, P792, DOI 10.1177/00220345830620070301; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; Palese P, 2007, ORTHOMIXOVIRIDE VIRU; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Peng AW, 2000, ANTIMICROB AGENTS CH, V44, P1974, DOI 10.1128/AAC.44.7.1974-1976.2000; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; SCANLON KL, 1989, ENZYME, V41, P143, DOI 10.1159/000469069; SHIMIZU K, 1985, VACCINE, V3, P207, DOI 10.1016/0264-410X(85)90107-0; Shope R E, 1931, J Exp Med, V54, P373, DOI 10.1084/jem.54.3.373; STEWART FS, 1959, IMMUNOLOGY, V2, P285; Su CY, 2008, ANTIVIR RES, V79, P199, DOI 10.1016/j.antiviral.2008.03.002; TASHIRO M, 1987, VIROLOGY, V157, P421, DOI 10.1016/0042-6822(87)90284-4; TASHIRO M, 1987, NATURE, V325, P536, DOI 10.1038/325536a0; Taubenberger JK, 1997, SCIENCE, V275, P1793, DOI 10.1126/science.275.5307.1793; THONARD JC, 1965, J BACTERIOL, V89, P924, DOI 10.1128/JB.89.3.924-925.1965; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; WARREN L, 1963, J BACTERIOL, V86, P950, DOI 10.1128/JB.86.5.950-955.1963; White MR, 2009, ORAL MICROBIOL IMMUN, V24, P18, DOI 10.1111/j.1399-302X.2008.00468.x	42	42	42	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45371	10.1371/journal.pone.0045371	http://dx.doi.org/10.1371/journal.pone.0045371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028967	gold, Green Submitted, Green Published			2022-12-27	WOS:000311313900128
J	Brohlin, M; Kingham, PJ; Novikova, LN; Novikov, LN; Wiberg, M				Brohlin, Maria; Kingham, Paul J.; Novikova, Liudmila N.; Novikov, Lev N.; Wiberg, Mikael			Aging Effect on Neurotrophic Activity of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; PERIPHERAL-NERVE REGENERATION; BONE-MARROW; SCHWANN-CELLS; ADULT-RAT; DIFFERENTIATION; SENESCENCE; EXPRESS	Clinical efficacy of stem cells for nerve repair is likely to be influenced by issues including donor age and in vitro expansion time. We isolated human mesenchymal stem cells (MSC) from bone marrow of young (16-18 years) and old (67-75 years) donors and analyzed their capacity to differentiate and promote neurite outgrowth from dorsal root ganglia (DRG) neurons. Treatment of MSC with growth factors (forskolin, basic fibroblast growth factor, platelet derived growth factor-AA and glial growth factor-2) induced protein expression of the glial cell marker S100 in cultures from young but not old donors. MSC expressed various neurotrophic factor mRNA transcripts. Growth factor treatment enhanced the levels of BDNF and VEGF transcripts with corresponding increases in protein release in both donor cell groups. MSC in co-culture with DRG neurons significantly enhanced total neurite length which, in the case of young but not old donors, was further potentiated by treatment of the MSC with the growth factors. Stem cells from young donors maintained their proliferation rate over a time course of 9 weeks whereas those from the old donors showed increased population doubling times. MSC from young donors, differentiated with growth factors after long-term culture, maintained their ability to enhance neurite outgrowth of DRG. Therefore, MSC isolated from young donors are likely to be a favourable cell source for nerve repair.	[Brohlin, Maria; Kingham, Paul J.; Novikova, Liudmila N.; Novikov, Lev N.; Wiberg, Mikael] Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden; [Wiberg, Mikael] Umea Univ, Dept Surg & Perioperat Sci, Sect Hand & Plast Surg, Umea, Sweden	Umea University; Umea University	Kingham, PJ (corresponding author), Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden.	paul.kingham@anatomy.umu.se		Kingham, Paul/0000-0003-2596-5936; Novikov, Lev/0000-0001-5520-3890	Swedish Medical Research Council; European Union; Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Union(European Commission); Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation	This study was supported by the Swedish Medical Research Council, European Union, Umea University, County of Vasterbotten, Ake Wibergs Stiftelse, Magnus Bergvalls Stiftelse, Clas Groschinskys Minnesfond, and the Gunvor and Josef Aner Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Brohlin M, 2009, NEUROSCI RES, V64, P41, DOI 10.1016/j.neures.2009.01.010; Caddick J, 2006, GLIA, V54, P840, DOI 10.1002/glia.20421; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Fossett E, 2012, CURR STEM CELL RES T, V7, P282, DOI 10.2174/157488812800793027; GUENARD V, 1992, J NEUROSCI, V12, P3310; Habisch HJ, 2010, CYTOTHERAPY; Hermann A, 2010, CYTOTHERAPY, V12, P17, DOI 10.3109/14653240903313941; Khoo MLM, 2008, STEM CELLS DEV, V17, P883, DOI 10.1089/scd.2007.0185; Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1; Kim JM, 2013, J CELL PHYSIOL, V228, P216, DOI 10.1002/jcp.24123; Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006; Lazzarotto-Silva C, 2009, CYTOTHERAPY, V11, P268, DOI 10.1080/14653240902783268; Lu S, 2011, TOXICOLOGY, V279, P189, DOI 10.1016/j.tox.2010.10.011; Mahay D, 2008, EXP CELL RES, V314, P2692, DOI 10.1016/j.yexcr.2008.05.013; Mahay D, 2008, BIOTECHNOL APPL BIOC, V51, P167, DOI 10.1042/BA20070212; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Niehage C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020399; Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033; Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/00019052-200312000-00011; Oudega M, 1997, GLIA, V19, P247, DOI 10.1002/(SICI)1098-1136(199703)19:3<247::AID-GLIA7>3.0.CO;2-W; Park HW, 2010, GLIA, V58, P1118, DOI 10.1002/glia.20992; RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0; Rodrigues M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt32; Rutkowski GE, 2004, J NEURAL ENG, V1, P151, DOI 10.1088/1741-2560/1/3/004; Shimizu S, 2007, BIOCHEM BIOPH RES CO, V359, P915, DOI 10.1016/j.bbrc.2007.05.212; Singec I, 2007, ANNU REV MED, V58, P313, DOI 10.1146/annurev.med.58.070605.115252; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Tohill M, 2004, BIOTECHNOL APPL BIOC, V40, P17, DOI 10.1042/BA20030173; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wiberg Mikael, 2003, Surg Technol Int, V11, P303; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhang AX, 2007, MOL CELL BIOCHEM, V304, P167, DOI 10.1007/s11010-007-9497-3	40	36	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45052	10.1371/journal.pone.0045052	http://dx.doi.org/10.1371/journal.pone.0045052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028757	Green Submitted, Green Published, gold			2022-12-27	WOS:000309742800031
J	Temu, EA; Maxwell, C; Munyekenye, G; Howard, AFV; Munga, S; Avicor, SW; Poupardin, R; Jones, JJ; Allan, R; Kleinschmidt, I; Ranson, H				Temu, Emmanuel A.; Maxwell, Caroline; Munyekenye, Godwil; Howard, Annabel F. V.; Munga, Stephen; Avicor, Silas W.; Poupardin, Rodolphe; Jones, Joel J.; Allan, Richard; Kleinschmidt, Immo; Ranson, Hilary			Pyrethroid Resistance in Anopheles gambiae, in Bomi County, Liberia, Compromises Malaria Vector Control	PLOS ONE			English	Article							MOLECULAR-FORMS; INSECTICIDE	Background: Long Lasting Insecticidal Nets (LLIN) and Indoor Residual Spraying (IRS) have both proven to be effective malaria vector control strategies in Africa and the new technology of insecticide treated durable wall lining (DL) is being evaluated. Sustaining these interventions at high coverage levels is logistically challenging and, furthermore, the increase in insecticide resistance in African malaria vectors may reduce the efficacy of these chemical based interventions. Monitoring of vector populations and evaluation of the efficacy of insecticide based control approaches should be integral components of malaria control programmes. This study reports on entomological survey conducted in 2011 in Bomi County, Liberia. Methods: Anopheles gambiae larvae were collected from four sites in Bomi, Liberia, and reared in a field insectary. Two to five days old female adult An gambiae s.l. were tested using WHO tube (n = 2027) and cone (n = 580) bioassays in houses treated with DL or IRS. A sample of mosquitoes (n = 169) were identified to species/molecular form and screened for the presence of knock down resistance (kdr) alleles associated with pyrethroid resistance. Results: Anopheles gambiae s.l tested were resistant to deltamethrin but fully susceptible to bendiocarb and fenithrothion. The corrected mortality of local mosquitoes exposed to houses treated with deltamethrin either via IRS or DL was 12% and 59% respectively, suggesting that resistance may affect the efficacy of these interventions. The presence of pyrethroid resistance was associated with a high frequency of the 1014F kdr allele (90.5%) although this mutation alone cannot explain the resistance levels observed. Conclusion: High prevalence of resistance to deltamethrin in Bomi County may reduce the efficacy of malaria strategies relying on this class of insecticide. The findings highlight the urgent need to expand and sustain monitoring of insecticide resistance in Liberian malaria vectors, evaluate the effectiveness of existing interventions and develop appropriate resistance management strategies.	[Munyekenye, Godwil; Munga, Stephen] Kenya Med Res Inst KEMRI, Ctr Global Hlth Res, Nairobi, Kenya; [Poupardin, Rodolphe; Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Jones, Joel J.] Minist Hlth & Social Welf, Natl Malaria Control Program, Monrovia, CA, Liberia; [Kleinschmidt, Immo] London Sch Hyg & Trop Med, Trop Epidemiol Grp, MRC, London WC1, England; [Avicor, Silas W.] Univ Ghana, ARPPIS, Accra, Ghana; [Temu, Emmanuel A.; Munyekenye, Godwil] ABT Associates Inc, Liberia Africa Indoor Residual Spraying AIRS Prog, Bethesda, MD USA	Kenya Medical Research Institute; Liverpool School of Tropical Medicine; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of Ghana; ABT Associates		emmanuel.temu@gmail.com	Avicor, Silas/AAR-5527-2020; Poupardin, Rodolphe/K-3138-2014	avicor, silas wintuma/0000-0002-5806-6892; Poupardin, Rodolphe/0000-0001-5195-5155; Ranson, Hilary/0000-0003-2332-8247; Temu, Emmanuel/0000-0003-4234-2175	Comic Relief - Grant Advancing the Frontiers of Sustainable Malaria Control in Africa - A Model for Africa [GR002-12483]; NMCP; Bomi County Health Team (CHT)	Comic Relief - Grant Advancing the Frontiers of Sustainable Malaria Control in Africa - A Model for Africa; NMCP; Bomi County Health Team (CHT)	This project was funded by the Comic Relief - Grant Advancing the Frontiers of Sustainable Malaria Control in Africa - A Model for Africa (GR002-12483). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The MENTOR Initiative appreciates the support and contribution of NMCP and Bomi County Health Team (CHT) in the planning and coordination of baseline survey. This report reflects the hard work and dedication of The MENTOR team, NMCP and Bomi CHT. The assistance of Patricia Pignatelli and Angela Hughes from Liverpool School of Tropical Medicine, with DNA extraction and genotyping is also appreciated.	ABBOTT WS, 1987, J AM MOSQUITO CONTR, V3, P302; [Anonymous], 2004, COCHRANE DB SYST REV; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Chandre F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-65; Diabate A, 2006, TROP MED INT HEALTH, V11, P597, DOI 10.1111/j.1365-3156.2006.01605.x; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Gillies TM, 1987, ANOPHELES AFRICA S S; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; LIVAK KJ, 1984, GENETICS, V107, P611; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; National Malaria Control Program (NMCP) [Liberia] Ministry of Health and Social Welfare Liberia Institute of Statistics and Geo-Information Services (LISGIS) and ICF Macro, 2009, LIB MAL IND SURV 200; NMCP MOHSW LISGIS International I, 2011, LIB MAL IND SURV 201, P112; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Ramsdale CD, 1957, REPORT VISIT LIBERIA; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Vestergaard Frandsen, 2010, ZER VECT DUR LIN INF; Webb JLA, 2011, J HIST MED ALL SCI, V66, P347, DOI 10.1093/jhmas/jrq046; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 1998, WHO TEST PROC INS RE; WHO, 2006, GUIDELINES TESTING M; *WHO, 2002, MAN IND RES SPRAYING; World Health Organization (WHO), 1975, MAN PRACT ENT MAL 1	26	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44986	10.1371/journal.pone.0044986	http://dx.doi.org/10.1371/journal.pone.0044986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028724	Green Published, Green Accepted, gold			2022-12-27	WOS:000308788700071
J	Berings, M; Wehlou, C; Verrijken, A; Deschepper, E; Mertens, I; Kaufman, JM; Van Gaal, LF; Ouwens, DM; Ruige, JB				Berings, Margot; Wehlou, Charline; Verrijken, An; Deschepper, Ellen; Mertens, Ilse; Kaufman, Jean-Marc; Van Gaal, Luc F.; Ouwens, D. Margriet; Ruige, Johannes B.			Glucose Intolerance and the Amount of Visceral Adipose Tissue Contribute to an Increase in Circulating Triglyceride Concentrations in Caucasian Obese Females	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK; FAT; TIME	Context: Lipotoxicity is a risk factor for developing obesity-related metabolic complications, including non-alcoholic fatty liver disease, type 2 diabetes (DM2), cardiovascular disease and stroke. Yet, the mechanisms underlying the development of lipotoxicity itself remain poorly understood. Here, we investigated whether glucose intolerance aggravates lipotoxicity by evaluating the association between triglyceride (TG) concentrations and glucose tolerance status in a cross-sectional study on obese Caucasian women at risk for DM2. Methods: 913 obese females unknown to have diabetes were recruited (mean age: 41.2 +/- SD 12.3; median BMI: 36.2, IQR 32.9-40.2). Visceral (VAT) and subcutaneous abdominal adipose tissue volumes were quantified with computed tomography. Glucose, insulin, and triglyceride concentrations were determined in fasting state and following a 75 gram oral glucose tolerance test. Results: Based on fasting and 2 h post-load glucose levels, 27% of the women had impaired glucose tolerance (IGT), and 8% had newly diagnosed DM2. Fasting TG concentrations were similar between the IGT- and DM2-groups, and increased as compared to women with normal glucose tolerance (NGT). Even when adjusting for age, hip circumference and VAT, fasting TG concentrations remained elevated as compared to NGT. Mixed modelling analysis of post-load responses showed that TG concentrations declined more slowly in the DM2-group as compared to IGT and NGT. However, when adjusting for VAT the difference in decline between the glucose tolerance groups disappeared. Conclusions: Glucose intolerance associates with elevated fasting TG concentrations in obese Caucasian women. We propose that glucose intolerance and increased VAT reduce lipid disposal mechanisms and may accelerate lipotoxicity.	[Berings, Margot; Wehlou, Charline; Kaufman, Jean-Marc; Ruige, Johannes B.] Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium; [Verrijken, An; Mertens, Ilse; Van Gaal, Luc F.] Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab, Antwerp, Belgium; [Deschepper, Ellen] Univ Ghent, Biostat Unit, B-9000 Ghent, Belgium; [Ouwens, D. Margriet] German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany	Ghent University; Ghent University Hospital; University of Antwerp; Ghent University; Deutsches Diabetes-Zentrum (DDZ)	Ruige, JB (corresponding author), Ghent Univ Hosp, Dept Endocrinol, Ghent, Belgium.	johannes.ruige@ugent.be	Ouwens, Margriet/H-2442-2013	Ouwens, Margriet/0000-0001-6709-2702				De Naeyer H, 2011, OBESITY FACTS, V4, P407, DOI 10.1159/000333445; DeFronzo RA, 2011, AM J CARDIOL, V108, p3B, DOI 10.1016/j.amjcard.2011.03.013; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Genuth S, 2003, DIABETES CARE, V26, P3160; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Holloway GP, 2008, ACTA PHYSIOL, V194, P293, DOI 10.1111/j.1748-1716.2008.01878.x; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Lapauw B, 2010, DIABETES CARE, V33, P1831, DOI 10.2337/dc10-0515; Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85; Lodhi IJ, 2011, TRENDS ENDOCRIN MET, V22, P1, DOI 10.1016/j.tem.2010.09.002; Manco M, 2008, GUT, V57, P1283, DOI 10.1136/gut.2007.142919; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Matsushita Y, 2012, DIABETES CARE, V35, P1139, DOI 10.2337/dc11-1320; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Nseir W, 2011, DIGEST DIS SCI, V56, P3439, DOI 10.1007/s10620-011-1767-y; Perreault L, 2010, OBESITY, V18, P1524, DOI 10.1038/oby.2009.454; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Ruige JB, 2009, OBESITY, V17, P1621, DOI 10.1038/oby.2009.25; St-Pierre J, 2007, AM J CARDIOL, V99, P369, DOI 10.1016/j.amjcard.2006.08.041; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tirosh A, 2007, ANN INTERN MED, V147, P377, DOI 10.7326/0003-4819-147-6-200709180-00007; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; VANDERKOOY K, 1993, INT J OBESITY, V17, P187; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yu SSK, 2012, METAB SYNDR RELAT D, V10, P77, DOI 10.1089/met.2011.0108	27	6	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45145	10.1371/journal.pone.0045145	http://dx.doi.org/10.1371/journal.pone.0045145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028811	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900027
J	Sager, JJ; Torres, GE; Burton, EA				Sager, Jonathan J.; Torres, Gonzalo E.; Burton, Edward A.			The Zebrafish Homologue of the Human DYT1 Dystonia Gene Is Widely Expressed in CNS Neurons but Non-Essential for Early Motor System Development	PLOS ONE			English	Article							ONSET TORSION DYSTONIA; TRANSGENIC MOUSE MODEL; DELTA-E-TORSINA; DOPAMINERGIC-NEURONS; NUCLEAR-ENVELOPE; MUTANT TORSINA; PROTEIN; MICE; MOVEMENT; ATPASE	DYT1 dystonia is caused by mutation of the TOR1A gene, resulting in the loss of a single glutamic acid residue near the carboxyl terminal of TorsinA. The neuronal functions perturbed by TorsinA[Delta E] are a major unresolved issue in understanding the pathophysiology of dystonia, presenting a critical roadblock to developing effective treatments. We identified and characterized the zebrafish homologue of TOR1A, as a first step towards elucidating the functions of TorsinA in neurons, in vivo, using the genetically-manipulable zebrafish model. The zebrafish genome was found to contain a single alternatively-spliced tor1 gene, derived from a common ancestral locus shared with the dual TOR1A and TOR1B paralogues found in tertrapods. tor1 was expressed ubiquitously during early embryonic development and in multiple adult tissues, including the CNS. The 2.1 kb tor1 mRNA encodes Torsin1, which is 59% identical and 78% homologous to human TorsinA. Torsin1 was expressed as major 45 kDa and minor 47 kDa glycoproteins, within the cytoplasm of neurons and neuropil throughout the CNS. Similar to previous findings relating to human TorsinA, mutations of the ATP hydrolysis domain of Torsin1 resulted in relocalization of the protein in cultured cells from the endoplasmic reticulum to the nuclear envelope. Zebrafish embryos lacking tor1 during early development did not show impaired viability, overt morphological abnormalities, alterations in motor behavior, or developmental defects in the dopaminergic system. Torsin1 is thus nonessential for early development of the motor system, suggesting that important CNS functions may occur later in development, consistent with the critical time window in late childhood when dystonia symptoms usually emerge in DYT1 patients. The similarities between Torsin1 and human TorsinA in domain organization, expression pattern, and cellular localization suggest that the zebrafish will provide a useful model to understand the neuronal functions of Torsins in vivo.	[Sager, Jonathan J.; Burton, Edward A.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Sager, Jonathan J.; Torres, Gonzalo E.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Torres, Gonzalo E.] Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15261 USA; [Burton, Edward A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Sager, Jonathan J.; Torres, Gonzalo E.; Burton, Edward A.] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA USA; [Burton, Edward A.] Pittsburgh Vet Affairs Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Burton, Edward A.] Pittsburgh Vet Affairs Healthcare Syst, Dept Neurol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Geriatric Research Education & Clinical Center	Burton, EA (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA.	eab25@pitt.edu	Burton, Edward/ABB-1324-2021; Burton, Edward/AAO-9677-2021	Burton, Edward/0000-0002-8072-4636; 	Bachmann Strauss Foundation; Dystonia Medical Research Foundation	Bachmann Strauss Foundation; Dystonia Medical Research Foundation	The study was supported by the Bachmann Strauss Foundation (http://www.dystonia-parkinsons.org/) and the Dystonia Medical Research Foundation (http://www.dystonia-foundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Erica, 2010, J Vis Exp, DOI 10.3791/1726; Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106; Augood SJ, 1998, ANN NEUROL, V43, P669, DOI 10.1002/ana.410430518; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bai Q, 2009, NEUROSCIENCE, V164, P1138, DOI 10.1016/j.neuroscience.2009.09.014; Bai Q, 2007, NUCLEIC ACIDS RES, V35, P6501, DOI 10.1093/nar/gkm608; Bai Q, 2006, BRAIN RES, V1113, P33, DOI 10.1016/j.brainres.2006.07.057; Bai Q, 2011, J COMP NEUROL, V519, P1580, DOI 10.1002/cne.22587; Bai Q, 2009, NEUROSCI LETT, V449, P252, DOI 10.1016/j.neulet.2008.10.101; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Basham SE, 1999, DEV BIOL, V215, P253, DOI 10.1006/dbio.1999.9447; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; Cario CL, 2011, J PHYSIOL-LONDON, V589, P3703, DOI 10.1113/jphysiol.2011.207308; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; DelBene F, 2011, DEV NEUROBIOL; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farrell TC, 2011, NEUROBIOL DIS, V44, P9, DOI 10.1016/j.nbd.2011.05.016; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Grundmann K, 2007, NEUROBIOL DIS, V27, P190, DOI 10.1016/j.nbd.2007.04.015; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Issa FA, 2011, J NEUROSCI, V31, P6831, DOI 10.1523/JNEUROSCI.6572-10.2011; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; KRAMER PL, 1994, AM J HUM GENET, V55, P468; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levin ED, 2009, FRONT NEUROSCI, P293; Lumsden AL, 2007, HUM MOL GENET, V16, P1905, DOI 10.1093/hmg/ddm138; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; Milanese C, 2012, J BIOL CHEM, V287, P2971, DOI 10.1074/jbc.M111.308312; Muraro NI, 2006, J NEUROBIOL, V66, P1338, DOI 10.1002/neu.20313; Naismith TV, 2009, J BIOL CHEM, V284, P27866, DOI 10.1074/jbc.M109.020164; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ozelius LJ, 1999, GENOMICS, V62, P377, DOI 10.1006/geno.1999.6039; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Page ME, 2010, NEUROBIOL DIS, V39, P318, DOI 10.1016/j.nbd.2010.04.016; Panula P, 2010, NEUROBIOL DIS, V40, P46, DOI 10.1016/j.nbd.2010.05.010; Raz E, 1998, DEV BIOL, V203, P290, DOI 10.1006/dbio.1998.8999; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Sager JJ, 2010, BRAIN STRUCT FUNCT, V214, P285, DOI 10.1007/s00429-009-0237-1; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Stephenson-Jones M, 2011, CURR BIOL, V21, P1081, DOI 10.1016/j.cub.2011.05.001; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Wakabayashi-Ito N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026183; Watts RL, 2004, MOVEMENT DISORDERS N, Vxiii, P994; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Yokoi F, 2008, J BIOCHEM, V143, P39, DOI 10.1093/jb/mvm191	63	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45175	10.1371/journal.pone.0045175	http://dx.doi.org/10.1371/journal.pone.0045175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028827	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000309973900029
J	Nylund, C; Rappu, P; Pakula, E; Heino, A; Laato, L; Elo, LL; Vihinen, P; Pyrhonen, S; Owen, GR; Larjava, H; Kallajoki, M; Heino, J				Nylund, Camilla; Rappu, Pekka; Pakula, Eveliina; Heino, Aleksi; Laato, Laura; Elo, Laura L.; Vihinen, Pia; Pyrhonen, Seppo; Owen, Gethin R.; Larjava, Hannu; Kallajoki, Markku; Heino, Jyrki			Melanoma-Associated Cancer-Testis Antigen 16 (CT16) Regulates the Expression of Apoptotic and Antiapoptotic Genes and Promotes Cell Survival	PLOS ONE			English	Article							CANCER/TESTIS ANTIGENS; TUMOR-ANTIGENS; MAGE-A; MESSENGER-RNA; GAUGE FAMILY; PROTEIN; RESISTANCE; INHIBITORS; COMPLEXES; TARGET	Cancer-testis (CT) antigens are predominantly expressed in testis or placenta, but absent in most adult tissues. During malignant transformation CT genes are often activated. CT antigen 16 (CT16, PAGE5) is frequently expressed in advanced melanoma but its biological function has been unknown. To examine the role of CT16 in cell survival we knocked it down in A2058 melanoma cells using specific siRNAs and exposed the cells to cancer drug cisplatin known to induce apoptosis. As a result, cell survival was markedly decreased. To study the effects of CT16 on cell survival in more detail, the cellular gene expression profiles were investigated after CT16 silencing in CT16 positive A2058 melanoma cells, as well as after CT16 overexpression in CT16 negative WM-266-4 melanoma cells. Among the 11 genes both upregulated by CT16 silencing and downregulated by CT16 overexpression or vice versa, 4 genes were potentially apoptotic or antiapoptotic genes. CT16 was recognized as a positive regulator of antiapoptotic metallothionein 2A and interleukin 8 genes, whereas it inhibited the expression of apoptosis inducing dickkopf 1 (DKK1) gene. In addition CT16 enhanced the expression of fatty acid binding protein 7, a known promoter of melanoma progression. The effect of CT16 on DKK1 expression was p53 independent. Furthermore, CT16 did not regulate apoptotic genes via DNA methylation. In twenty melanoma metastasis tissue samples average DKK1 mRNA level was shown to be significantly (p<0.05) lower in high CT16 expressing tumors (n = 3) when compared to the tumors with low CT16 expression (n = 17). Thus, our results indicate that CT16 promotes the survival of melanoma cells and is therefore a potential target for future drug development.	[Nylund, Camilla; Rappu, Pekka; Pakula, Eveliina; Heino, Aleksi; Laato, Laura; Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, Turku, Finland; [Elo, Laura L.] Univ Turku, Dept Math, SF-20500 Turku, Finland; [Vihinen, Pia; Pyrhonen, Seppo] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Owen, Gethin R.; Larjava, Hannu] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V5Z 1M9, Canada; [Kallajoki, Markku] Univ Turku, Dept Pathol, Turku, Finland	University of Turku; University of Turku; University of Turku; University of British Columbia; University of Turku	Rappu, P (corresponding author), Univ Turku, Dept Biochem & Food Chem, Turku, Finland.	pekka.rappu@utu.fi	Elo, Laura/A-9449-2015; Vihinen, Pia/AAQ-5574-2021; Larjava, Hannu/GRO-4325-2022	Elo, Laura/0000-0001-5648-4532; Rappu, Pekka/0000-0002-5068-2842; Vihinen, Pia/0000-0003-1763-5363	Turku University Hospital EVO grant [13040, 13041]; Southwest Funds of the Finnish Cancer Research Foundation; Academy of Finland; Sigrid Juselius Foundation; Cancer Society of Finland	Turku University Hospital EVO grant; Southwest Funds of the Finnish Cancer Research Foundation; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland	This work was supported by Turku University Hospital EVO grant (projects 13040 and 13041, http://www.tyks.fi), Southwest Funds of the Finnish Cancer Research Foundation (http://www.cancer.fi), Academy of Finland (http://www.aka.fi), the Sigrid Juselius Foundation (http://www.sigridjuselius.fi), and the Cancer Society of Finland (http://www.cancer.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Anderson P, 1997, MICROBIOL MOL BIOL R, V61, P33, DOI 10.1128/.61.1.33-46.1997; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brinkmann U, 1999, CANCER RES, V59, P1445; Castello R, 2007, THROMB RES, V120, P753, DOI 10.1016/j.thromres.2006.12.016; Cilensek ZM, 2002, CANCER BIOL THER, V1, P380; de Bruijn DRH, 2006, CANCER RES, V66, P9474, DOI 10.1158/0008-5472.CAN-05-3726; de Bruijn DRH, 2002, GENE CHROMOSOME CANC, V34, P285, DOI 10.1002/gcc.10073; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Goto Y, 2006, CANCER RES, V66, P4443, DOI 10.1158/0008-5472.CAN-05-2505; Hellman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026633; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kular RK, 2009, J INTERF CYTOK RES, V29, P645, DOI 10.1089/jir.2008.0099; Kuphal S, 2006, ONCOGENE, V25, P5027, DOI 10.1038/sj.onc.1209508; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Luca M, 1997, AM J PATHOL, V151, P1105; Mantylahti S, 2011, J BIOMOL NMR, V49, P99, DOI 10.1007/s10858-011-9470-z; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Mikheev AM, 2007, BIOCHEM BIOPH RES CO, V352, P675, DOI 10.1016/j.bbrc.2006.11.079; Mirtti T, 2006, INT J CANCER, V118, P889, DOI 10.1002/ijc.21430; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; OBRIAN CA, 1990, J NATL CANCER I, V82, P1734, DOI 10.1093/jnci/82.22.1734; Old L J, 2001, Cancer Immun, V1, P1; Owen GR, 2010, MICROSC RES TECHNIQ, V73, P623, DOI 10.1002/jemt.20803; Rajagopalan K, 2011, J CELL BIOCHEM, V112, P3256, DOI 10.1002/jcb.23252; Rappu P, 2011, INT J CANCER, V128, P2382, DOI 10.1002/ijc.25571; Reinecke F, 2006, BIOCHEM J, V395, P405, DOI 10.1042/BJ20051253; Sandberg AA, 2002, CANCER GENET CYTOGEN, V132, P1, DOI 10.1016/S0165-4608(01)00528-3; Sasaki M, 2007, J BIOL CHEM, V282, P14626, DOI 10.1074/jbc.M610514200; Scanlan MJ, 2002, INT J CANCER, V98, P485, DOI 10.1002/ijc.10276; Shou J, 2002, ONCOGENE, V21, P878, DOI 10.1038/sj.onc.1205138; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Wilson C, 2008, MOL CANCER THER, V7, P2649, DOI 10.1158/1535-7163.MCT-08-0148; Xiao TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023747; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Zeng Y, 2011, J BIOL CHEM, V286, P13985, DOI 10.1074/jbc.M110.210765	51	13	16	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45382	10.1371/journal.pone.0045382	http://dx.doi.org/10.1371/journal.pone.0045382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028975	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800044
J	Pompei, S; Loreto, V; Tria, F				Pompei, Simone; Loreto, Vittorio; Tria, Francesca			Phylogenetic Properties of RNA Viruses	PLOS ONE			English	Article							TREE SHAPE STATISTICS; HUMAN INFLUENZA-A; EVOLUTION; RECONSTRUCTION; DYNAMICS; IMBALANCE; PATHOGENS; SELECTION; HISTORY; FITNESS	A new word, phylodynamics, was coined to emphasize the interconnection between phylogenetic properties, as observed for instance in a phylogenetic tree, and the epidemic dynamics of viruses, where selection, mediated by the host immune response, and transmission play a crucial role. The challenges faced when investigating the evolution of RNA viruses call for a virtuous loop of data collection, data analysis and modeling. This already resulted both in the collection of massive sequences databases and in the formulation of hypotheses on the main mechanisms driving qualitative differences observed in the (reconstructed) evolutionary patterns of different RNA viruses. Qualitatively, it has been observed that selection driven by the host immune response induces an uneven survival ability among co-existing strains. As a consequence, the imbalance level of the phylogenetic tree is manifestly more pronounced if compared to the case when the interaction with the host immune system does not play a central role in the evolutive dynamics. While many imbalance metrics have been introduced, reliable methods to discriminate in a quantitative way different level of imbalance are still lacking. In our work, we reconstruct and analyze the phylogenetic trees of six RNA viruses, with a special emphasis on the human Influenza A virus, due to its relevance for vaccine preparation as well as for the theoretical challenges it poses due to its peculiar evolutionary dynamics. We focus in particular on topological properties. We point out the limitation featured by standard imbalance metrics, and we introduce a new methodology with which we assign the correct imbalance level of the phylogenetic trees, in agreement with the phylodynamics of the viruses. Our thorough quantitative analysis allows for a deeper understanding of the evolutionary dynamics of the considered RNA viruses, which is crucial in order to provide a valuable framework for a quantitative assessment of theoretical predictions.	[Pompei, Simone; Loreto, Vittorio; Tria, Francesca] ISI, Complex Syst Lagrange Lab, Turin, Italy; [Pompei, Simone] Univ Turin, Dept Phys, Turin, Italy; [Loreto, Vittorio] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy	University of Turin; Sapienza University Rome	Pompei, S (corresponding author), ISI, Complex Syst Lagrange Lab, Turin, Italy.	simo.pompei@gmail.com			Q-Aracne Compagnia San Paolo Project	Q-Aracne Compagnia San Paolo Project	The authors acknowledge the Q-Aracne Compagnia San Paolo Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2002, SYST BIOL, V51, P866, DOI 10.1080/10635150290155845; Aldous D, 1995, PROBABILITY DISTRIBU; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; Blum MGB, 2006, SYST BIOL, V55, P685, DOI 10.1080/10635150600889625; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Bush RM, 2000, P NATL ACAD SCI USA, V97, P6974, DOI 10.1073/pnas.97.13.6974; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; Donoghue M, 1994, AM J BOT, V81, P183; DUARTE EA, 1994, J VIROL, V68, P4295, DOI 10.1128/JVI.68.7.4295-4301.1994; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eigen M, 1989, ADV CHEM PHYS, V75, P615; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Ford DJ, 2007, THESIS STANFORD U; Furuse Y, 2010, VIROL J, V4, P7; FUSCO G, 1995, J THEOR BIOL, V175, P235, DOI 10.1006/jtbi.1995.0136; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Herrada A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-155; Herrada EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002757; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; Jukes TH, 1969, EVOLUTION PROTEIN MO; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Keller-Schmidt S, 2010, ARXIV10123298V1QBIOP; KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI [10.2307/2409983, 10.1111/j.1558-5646.1993.tb02144.x]; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Lazaro E, 2003, P NATL ACAD SCI USA, V100, P10830, DOI 10.1073/pnas.1332668100; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Matsen FA, 2007, IEEE ACM T COMPUT BI, V4, P506, DOI 10.1109/TCBB.2007.1020; Matsen FA, 2006, SYST BIOL, V55, P652, DOI 10.1080/10635150600889617; Mooers AO, 1997, Q REV BIOL, V72, P31, DOI 10.1086/419657; NOWAK MA, 1992, TRENDS ECOL EVOL, V7, P118, DOI 10.1016/0169-5347(92)90145-2; Pompei S, 2010, MATH MOD METH APPL S, V20, P1511, DOI 10.1142/S0218202510004672; Pompei S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020109; Purvis A, 2002, SYST BIOL, V51, P844, DOI 10.1080/10635150290155809; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; SACKIN MJ, 1972, SYST ZOOL, V21, P225, DOI 10.2307/2412292; SHAO KT, 1990, SYST ZOOL, V39, P266, DOI 10.2307/2992186; Stich M, 2009, EUR PHYS J B, V70, P583, DOI 10.1140/epjb/e2009-00254-8; Stich M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-110; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; TRIA F, 2010, P BIOCOMP2010 2010 I; Tria F, 2010, MOL BIOL EVOL, V27, P2587, DOI 10.1093/molbev/msq154; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Whelan S, 2003, BIOINFORMATICS, V19, P1556, DOI 10.1093/bioinformatics/btg188; Willis JC, 1922, NATURE, V109, P177, DOI 10.1038/109177a0; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	51	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44849	10.1371/journal.pone.0044849	http://dx.doi.org/10.1371/journal.pone.0044849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028645	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900013
J	Thomas, KJ; Jacobson, MR				Thomas, Kelly Jean; Jacobson, Marty R.			Defects in Mitochondrial Fission Protein Dynamin-Related Protein 1 Are Linked to Apoptotic Resistance and Autophagy in a Lung Cancer Model	PLOS ONE			English	Article							FUSION; CELLS; DRP1; MEMBRANE; PHOSPHORYLATION; TUMORIGENICITY; DEGRADATION; INHIBITION; EXPRESSION; MEDIATORS	Evasion of apoptosis is implicated in almost all aspects of cancer progression, as well as treatment resistance. In this study, resistance to apoptosis was identified in tumorigenic lung epithelial (A549) cells as a consequence of defects in mitochondrial and autophagic function. Mitochondrial function is determined in part by mitochondrial morphology, a process regulated by mitochondrial dynamics whereby the joining of two mitochondria, fusion, inhibits apoptosis while fission, the division of a mitochondrion, initiates apoptosis. Mitochondrial morphology of A549 cells displayed an elongated phenotype-mimicking cells deficient in mitochondrial fission protein, Dynamin-related protein 1 (Drp1). A549 cells had impaired Drp1 mitochondrial recruitment and decreased Drp1-dependent fission. Cytochrome c release and caspase-3 and PARP cleavage were impaired both basally and with apoptotic stimuli in A549 cells. Increased mitochondrial mass was observed in A549 cells, suggesting defects in mitophagy (mitochondrial selective autophagy). A549 cells had decreased LC3-II lipidation and lysosomal inhibition suggesting defects in autophagy occur upstream of lysosomal degradation. Immunostaining indicated mitochondrial localized LC3 punctae in A549 cells increased after mitochondrial uncoupling or with a combination of mitochondrial depolarization and ectopic Drp1 expression. Increased inhibition of apoptosis in A549 cells is correlated with impeded mitochondrial fission and mitophagy. We suggest mitochondrial fission defects contribute to apoptotic resistance in A549 cells.	[Thomas, Kelly Jean] Colorado Mesa Univ, Dept Biol Sci, Grand Junction, CO USA; [Thomas, Kelly Jean; Jacobson, Marty R.] St Marys Hosp, Saccomanno Res Inst, Grand Junction, CO USA; [Thomas, Kelly Jean; Jacobson, Marty R.] Reg Med Ctr, Grand Junction, CO USA		Thomas, KJ (corresponding author), Colorado Mesa Univ, Dept Biol Sci, Grand Junction, CO USA.	kjcraig@coloradomesa.edu	Thomas Craig, Kelly Jean/ABE-6181-2021	Thomas Craig, Kelly Jean/0000-0002-9954-2795	St. Mary's Hospital; Regional Medical Center, St. Mary's Hospital Foundation; Div Of Biological Infrastructure [0923233] Funding Source: National Science Foundation	St. Mary's Hospital; Regional Medical Center, St. Mary's Hospital Foundation; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: St. Mary's Hospital and Regional Medical Center, St. Mary's Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello M, 2008, CYTOTECHNOLOGY, V56, P145, DOI 10.1007/s10616-008-9143-2; Autret A, 2010, CELL MOL LIFE SCI, V67, P1599, DOI 10.1007/s00018-010-0286-x; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Bellance N, 2009, FRONT BIOSCI-LANDMRK, V14, P4015, DOI 10.2741/3509; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Glinsky GV, 1997, CANCER LETT, V115, P185, DOI 10.1016/S0304-3835(97)04738-1; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kim KW, 2008, AUTOPHAGY, V4, P659, DOI 10.4161/auto.6058; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krebiehl G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009367; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; LEE HK, 1992, ARCH BIOCHEM BIOPHYS, V296, P271, DOI 10.1016/0003-9861(92)90572-E; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; LEHMAN TA, 1991, CANCER RES, V51, P4090; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mopert K, 2009, EXP CELL RES, V315, P2165, DOI 10.1016/j.yexcr.2009.04.016; MOMIKI S, 1991, INVAS METAST, V11, P66; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Petit PX, 1998, FEBS LETT, V426, P111, DOI 10.1016/S0014-5793(98)00318-4; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Ryang Dae-Yeul, 2007, Korean Journal of Internal Medicine, V22, P263, DOI 10.3904/kjim.2007.22.4.263; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; SATOH H, 1993, MOL CARCINOGEN, V7, P157, DOI 10.1002/mc.2940070306; Schiller JH, 1998, IN VITRO CELL DEV-AN, V34, P283, DOI 10.1007/s11626-998-0004-2; Shivapurkar N, 2003, J CELL BIOCHEM, V88, P885, DOI 10.1002/jcb.10440; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tan ML, 2009, PHARM RES-DORDR, V26, P1547, DOI 10.1007/s11095-009-9895-1; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	51	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45319	10.1371/journal.pone.0045319	http://dx.doi.org/10.1371/journal.pone.0045319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028930	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900041
J	Bonovas, S; Nikolopoulos, GK; Bagos, PG				Bonovas, Stefanos; Nikolopoulos, Georgios K.; Bagos, Pantelis G.			Use of Fibrates and Cancer Risk: A Systematic Review and Meta-Analysis of 17 Long-Term Randomized Placebo-Controlled Trials	PLOS ONE			English	Review							CLINICAL-TRIALS; CARDIOVASCULAR OUTCOMES; PROSTATE-CANCER; LOWERING DRUGS; HEART-DISEASE; STATIN USE; CHOLESTEROL; CORONARY; BEZAFIBRATE; PREVENTION	Background: Fibrates comprise a class of well-established antilipidemic agents that significantly reduce cardiovascular events. Given the concerns of cancer with fibrate therapy, we undertook a systematic review and meta-analysis to investigate the effects of fibrates on cancer outcomes. Methods: We systematically searched Medline, Scopus, SCI Expanded, and the Cochrane Library for studies published up to 2012. We included randomized controlled trials (RCTs) that evaluated a fibrate therapy compared with placebo, had a minimum duration of two years, and reported data on the incidence of and/or deaths from cancer during the trial. Reviews of each study were performed and the relative data were abstracted. Pooled relative risk estimates (RR) and 95% confidence intervals (CIs) were calculated using the inverse variance weighted approach. Subgroup, sensitivity and meta-regression analyses were also conducted. Results: Seventeen RCTs, involving 44,929 participants with an average follow-up of 5.2 years, contributed to the analysis. The degree of variability between trials was consistent with what would be expected to occur by chance alone. The quantitative synthesis of data retrieved from the RCTs was not indicative of a fibrate effect on cancer incidence (780 [fibrate] vs 814 [control]; RR = 1.02, 95% CI 0.92-1.12) or cancer death (385 [fibrate] vs 377 [control]; RR = 1.06, 95% CI: 0.92-1.22). When the analysis was restricted to major RCTs, the results did not substantially change. Similarly, we found no evidence of differential effects by length of follow-up or type of fibrate. Insignificant results were also obtained for the role of fibrates in cancers of the respiratory tract, breast, colon, gastrointestinal tract, prostate, genitourinary tract, or in melanoma. Conclusion: Our findings demonstrate that fibrates have a neutral effect on cancer outcomes. However, it is important to continue monitoring their long-term safety profiles.	[Bonovas, Stefanos] Univ Athens, Sch Med, Dept Pharmacol, GR-11527 Athens, Greece; [Bonovas, Stefanos; Nikolopoulos, Georgios K.] Hellen Ctr Dis Control & Prevent, Athens, Greece; [Bonovas, Stefanos; Bagos, Pantelis G.] Univ Cent Greece, Dept Comp Sci & Biomed Informat, Lamia, Greece	Athens Medical School; National & Kapodistrian University of Athens; University of Central Greece	Bonovas, S (corresponding author), Univ Athens, Sch Med, Dept Pharmacol, GR-11527 Athens, Greece.	sbonovas@med.uoa.gr	Bonovas, Stefanos/GZG-4609-2022; Bagos, Pantelis G/H-5658-2011; Bonovas, Stefanos/H-5653-2011; Bagos, Pantelis/U-7140-2019; Nikolopoulos, Georgios/H-5698-2011	Bagos, Pantelis G/0000-0003-4935-2325; Bagos, Pantelis/0000-0003-4935-2325; Nikolopoulos, Georgios/0000-0002-3307-0246; Bonovas, Stefanos/0000-0001-6102-6579				Abourbih S, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.03.030; ACHESON J, 1972, ATHEROSCLEROSIS, V15, P177, DOI 10.1016/0021-9150(72)90067-6; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; [Anonymous], 1978, JAMA-J AM MED ASSOC, V239, P2758; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Begg T B, 1971, Minerva Med, V62, P3469; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Bonovas S, 2005, J CLIN ONCOL, V23, P8606, DOI 10.1200/JCO.2005.02.7045; Bonovas S, 2008, AM J GASTROENTEROL, V103, P2646, DOI 10.1111/j.1572-0241.2008.02051.x; Bonovas S, 2008, INT J CANCER, V123, P899, DOI 10.1002/ijc.23550; Bonovas S, 2007, J CLIN ONCOL, V25, P3462, DOI 10.1200/JCO.2007.10.8936; Bonovas S, 2007, BRIT J CLIN PHARMACO, V64, P255, DOI 10.1111/j.1365-2125.2007.02959.x; Bonovas S, 2006, J CLIN ONCOL, V24, P4808, DOI 10.1200/JCO.2006.06.3560; Bonovas S, 2010, EUR J EPIDEMIOL, V25, P29, DOI 10.1007/s10654-009-9396-x; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cullen JF, 1972, T OPHTHAL SOC UK, V94, P554; Dalen JE, 1996, JAMA-J AM MED ASSOC, V275, P67, DOI 10.1001/jama.275.1.67; Despres JP, 2004, DRUGS, V64, P2177, DOI 10.2165/00003495-200464190-00003; DEWAR HA, 1972, BRIT MED J, V2, P228, DOI 10.1136/bmj.2.5807.228; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elkeles RS, 1998, DIABETES CARE, V21, P641, DOI 10.2337/diacare.21.4.641; Emberson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029849; Ericsson CG, 1996, LANCET, V347, P849, DOI 10.1016/S0140-6736(96)91343-4; Fortuny J, 2006, CANCER EPIDEM BIOMAR, V15, P921, DOI 10.1158/1055-9965.EPI-05-0866; Freeman SR, 2006, JNCI-J NATL CANCER I, V98, P1538, DOI 10.1093/jnci/djj412; FRICK MH, 1993, ANN MED, V25, P41, DOI 10.3109/07853899309147855; Frick MH, 1997, CIRCULATION, V96, P2137; Gardette V, 2009, AM J CARDIOL, V103, P381, DOI 10.1016/j.amjcard.2008.09.092; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; Group of physicians of the Newcastle upon Tyne region, 1971, BMJ-BRIT MED J, V4, P767; HANEFELD M, 1991, DIABETES CARE, V14, P308, DOI 10.2337/diacare.14.4.308; HEADY JA, 1992, LANCET, V340, P1405, DOI 10.1016/0140-6736(92)92588-7; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HULLEY SB, 1992, CIRCULATION, V86, P1026, DOI 10.1161/01.CIR.86.3.1026; HUTTUNEN JK, 1994, J INTERN MED, V235, P31, DOI 10.1111/j.1365-2796.1994.tb01029.x; Jackevicius CA, 2011, JAMA-J AM MED ASSOC, V305, P1217, DOI 10.1001/jama.2011.353; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Meade T, 2002, BRIT MED J, V325, P1139, DOI 10.1136/bmj.325.7373.1139; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; MULDOON MF, 1990, BMJ-BRIT MED J, V301, P309, DOI 10.1136/bmj.301.6747.309; Murtola TJ, 2007, CANCER EPIDEM BIOMAR, V16, P2226, DOI 10.1158/1055-9965.EPI-07-0599; Newman TB, 1996, JAMA-J AM MED ASSOC, V275, P55, DOI 10.1001/jama.275.1.55; OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069; OLIVER MF, 1991, LANCET, V337, P1529, DOI 10.1016/0140-6736(91)93208-Q; Olsen JH, 1999, J CLIN EPIDEMIOL, V52, P167, DOI 10.1016/S0895-4356(98)00147-4; Pedersen TR, 2009, CURR ATHEROSCLER REP, V11, P350, DOI 10.1007/s11883-009-0053-3; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Research Committee of the Scottish Society of Physicians, 1971, BMJ-BRIT MED J, V4, P775; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Saha SA, 2010, INT J CARDIOL, V141, P157, DOI 10.1016/j.ijcard.2008.11.211; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Sharp S, 1998, STATA TECH B, V7, DOI DOI 10.1002/SIM.1187/FULL); Smith GD, 2002, BMJ-BRIT MED J, V325, P1437; SMITH GD, 1992, BMJ-BRIT MED J, V304, P431, DOI 10.1136/bmj.304.6824.431; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Steiner G, 2001, LANCET, V357, P905; Tenenbaum A, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-18; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Vet Adm Cooperative Study Grp, 1973, STROKE, V4, P684; WHO Cooperative Trial Committee of Principal Investigators, 1985, LANCET, V2, P379	66	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45259	10.1371/journal.pone.0045259	http://dx.doi.org/10.1371/journal.pone.0045259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028888	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400069
J	Chong, ZZ; Shang, YC; Wang, SH; Maiese, K				Chong, Zhao Zhong; Shang, Yan Chen; Wang, Shaohui; Maiese, Kenneth			PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection	PLOS ONE			English	Article							NF-KAPPA-B; OXYGEN-GLUCOSE DEPRIVATION; MESSENGER-RNA TRANSLATION; SQUAMOUS-CELL CARCINOMA; BETA-AMYLOID TOXICITY; RAT CORTICAL-NEURONS; RICH AKT SUBSTRATE; OXIDATIVE STRESS; MAMMALIAN TARGET; PARKINSONS-DISEASE	Emerging strategies that center upon the mammalian target of rapamycin (mTOR) signaling for neurodegenerative disorders may bring effective treatment for a number of difficult disease entities. Here we show that erythropoietin (EPO), a novel agent for nervous system disorders, prevents apoptotic SH-SY5Y cell injury in an oxidative stress model of oxygen-glucose deprivation through phosphatidylinositol-3-kinase (PI 3-K)/protein kinase B (Akt) dependent activation of mTOR signaling and phosphorylation of the downstream pathways of p70 ribosomal S6 kinase (p70S6K), eukaryotic initiation factor 4E-binding protein 1 (4EBP1), and proline rich Akt substrate 40 kDa (PRAS40). PRAS40 is an important regulatory component either alone or in conjunction with EPO signal transduction that can determine cell survival through apoptotic caspase 3 activation. EPO and the PI 3-K/Akt pathways control cell survival and mTOR activity through the inhibitory post-translational phosphorylation of PRAS40 that leads to subcellular binding of PRAS40 to the cytoplasmic docking protein 14-3-3. However, modulation and phosphorylation of PRAS40 is independent of other protective pathways of EPO that involve extracellular signal related kinase (ERK 1/2) and signal transducer and activator of transcription (STAT5). Our studies highlight EPO and PRAS40 signaling in the mTOR pathway as potential therapeutic strategies for development against degenerative disorders that lead to cell demise.	[Chong, Zhao Zhong; Shang, Yan Chen; Wang, Shaohui; Maiese, Kenneth] Lab Cellular & Mol Signaling, Newark, NJ 07101 USA; [Maiese, Kenneth] Canc Inst New Jersey, New Brunswick, NJ USA; [Chong, Zhao Zhong; Shang, Yan Chen; Wang, Shaohui; Maiese, Kenneth] New Jersey Hlth Sci Univ, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Maiese, K (corresponding author), Lab Cellular & Mol Signaling, Newark, NJ 07101 USA.	wntin75@yahoo.com	Wang, Shaohui/G-7247-2012		American Diabetes Association; American Heart Association; National Institutes of Health; National Institute of Neurological Disorders and Stroke; National Institute of Aging; National Institute of Environmental Health Sciences; American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053946] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by the American Diabetes Association, American Heart Association, National Institutes of Health, National Institute of Neurological Disorders and Stroke, National Institute of Aging, National Institute of Environmental Health Sciences, American Recovery and Reinvestment Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar HI, 2011, AM J PHYSIOL-HEART C, V301, pH2413, DOI 10.1152/ajpheart.01096.2010; Andreucci M, 2009, CELL PROLIFERAT, V42, P554, DOI 10.1111/j.1365-2184.2009.00617.x; Bajda M, 2011, CURR MED CHEM, V18, P4949, DOI 10.2174/092986711797535245; Balan V, 2008, J BIOL CHEM, V283, P27810, DOI 10.1074/jbc.M804681200; Bhandari BK, 2001, KIDNEY INT, V59, P866; Canadillas S, 2010, AM J PHYSIOL-RENAL, V299, pF1278, DOI 10.1152/ajprenal.00343.2009; Caprara C, 2012, PROG RETIN EYE RES, V31, P89, DOI 10.1016/j.preteyeres.2011.11.003; Chen JX, 2012, EXP DIABETES RES, DOI 10.1155/2012/836759; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Choi KC, 2010, J NEUROCHEM, V112, P366, DOI 10.1111/j.1471-4159.2009.06463.x; Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251, DOI 10.14670/HH-22.1251; Chong ZZ, 2007, BRIT J PHARMACOL, V150, P839, DOI 10.1038/sj.bjp.0707161; Chong ZZ, 2007, CELL SIGNAL, V19, P1150, DOI 10.1016/j.cellsig.2006.12.009; Chong ZZ, 2007, INT J MOL MED, V19, P263; Chong ZZ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-45; Chong ZZ, 2012, EXPERT OPIN THER TAR, V16, P167, DOI 10.1517/14728222.2012.648926; Chong ZZ, 2011, CURR NEUROVASC RES, V8, P103; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P374, DOI 10.4161/oxim.3.6.14787; Chong ZZ, 2010, OXID MED CELL LONGEV, V3, P153, DOI 10.4161/oxim.3.2.11758; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Chong ZZ, 2003, J NEUROSCI RES, V71, P659, DOI 10.1002/jnr.10528; Chong ZZ, 2003, J CEREBR BLOOD F MET, V23, P320, DOI 10.1097/01.WCB.0000050061.57184.AE; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Chung CY, 2012, DIGEST DIS SCI, V57, P371, DOI 10.1007/s10620-011-1892-7; Dang J, 2010, BIOMED PHARMACOTHER, V64, P681, DOI 10.1016/j.biopha.2010.06.011; Das F, 2011, CELL SIGNAL, V23, P1311, DOI 10.1016/j.cellsig.2011.03.012; Deblon N, 2012, BRIT J PHARMACOL, V165, P2325, DOI 10.1111/j.1476-5381.2011.01716.x; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Pastor MD, 2009, J BIOL CHEM, V284, P22067, DOI 10.1074/jbc.M109.033100; Dormond O, 2007, J BIOL CHEM, V282, P23679, DOI 10.1074/jbc.M700563200; Eliopoulos N, 2011, MOL THER, V19, P2072, DOI 10.1038/mt.2011.162; Enz R, 2012, CURR DRUG TARGETS, V13, P145, DOI 10.2174/138945012798868452; Fokas E, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-48; Furuichi T, 2005, J NEUROSCI RES, V79, P816, DOI 10.1002/jnr.20402; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hamed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013986; Hancock CN, 2005, J MED CHEM, V48, P4586, DOI 10.1021/jm0501174; Hardee ME, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000549; Hedley BD, 2011, CLIN CANCER RES, V17, P6373, DOI 10.1158/1078-0432.CCR-10-2577; Hernandez G, 2011, EXP CELL RES, V317, P2938, DOI 10.1016/j.yexcr.2011.09.011; Holopainen IE, 2012, PHARMACOL BIOCHEM BE, V100, P825, DOI 10.1016/j.pbb.2011.03.016; Hong YK, 2012, BIOCHEM BIOPH RES CO, V419, P49, DOI 10.1016/j.bbrc.2012.01.122; Hou GQ, 2007, CANCER LETT, V253, P236, DOI 10.1016/j.canlet.2007.01.026; Hou JL, 2011, CURR NEUROVASC RES, V8, P220, DOI 10.2174/156720211796558069; Hou JL, 2010, MOL CELL ENDOCRINOL, V321, P194, DOI 10.1016/j.mce.2010.02.037; Hou JL, 2010, CURR NEUROVASC RES, V7, P95, DOI 10.2174/156720210791184899; Ioka T, 2009, CLIN PHARMACOL THER, V86, P154, DOI 10.1038/clpt.2009.74; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Ji YQ, 2011, INT J CLIN EXP PATHO, V4, P765; Kang JQ, 2003, MOL PHARMACOL, V64, P557, DOI 10.1124/mol.64.3.557; Kapoor V, 2012, CANCER LETT, V319, P39, DOI 10.1016/j.canlet.2011.12.032; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Kato S, 2011, J NEUROSCI RES, V89, P1566, DOI 10.1002/jnr.22702; Kigerl KA, 2012, EXP NEUROL, V233, P333, DOI 10.1016/j.expneurol.2011.10.025; Kim J, 2012, J CELL BIOCHEM, V113, P220, DOI 10.1002/jcb.23347; Kollensperger M, 2011, MOVEMENT DISORD, V26, P507, DOI 10.1002/mds.23474; Kook YH, 2011, BIOCHEM BIOPH RES CO, V411, P370, DOI 10.1016/j.bbrc.2011.06.151; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Kumral A, 2011, BRAIN DEV-JPN, V33, P632, DOI 10.1016/j.braindev.2010.10.014; L'Episcopo F, 2012, J NEUROSCI, V32, P2062, DOI 10.1523/JNEUROSCI.5259-11.2012; Lanfranconi S, 2011, J CELL MOL MED, V15, P1645, DOI 10.1111/j.1582-4934.2009.00987.x; Liu T, 2010, NEUROPHARMACOLOGY, V59, P595, DOI 10.1016/j.neuropharm.2010.08.013; Loeliger MM, 2011, INVEST OPHTH VIS SCI, V52, P2656, DOI 10.1167/iovs.10-6455; Lombardero M, 2011, PATHOBIOLOGY, V78, P41, DOI 10.1159/000322975; Magagnin MG, 2008, PROTEOMICS, V8, P1019, DOI 10.1002/pmic.200700551; Magri L, 2011, CELL STEM CELL, V9, P447, DOI 10.1016/j.stem.2011.09.008; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P1858, DOI 10.1001/jama.293.15.1858-b; Maiese K, 2011, ROM J MORPHOL EMBRYO, V52, P1173; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Maiese K, 2008, PROG NEUROBIOL, V85, P194, DOI 10.1016/j.pneurobio.2008.02.002; Maiese K, 2008, TRENDS MOL MED, V14, P219, DOI 10.1016/j.molmed.2008.03.002; Maiese K, 2008, CYTOKINE GROWTH F R, V19, P145, DOI 10.1016/j.cytogfr.2008.01.004; Maiese K, 2011, J CLIN PHARMACOL, V51, P128, DOI 10.1177/0091270010362904; Maiese K, 2010, EXP GERONTOL, V45, P217, DOI 10.1016/j.exger.2010.01.004; Maiese K, 2009, OXID MED CELL LONGEV, V2, P279, DOI 10.4161/oxim.2.5.9990; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Mastromarino V, 2011, CLIN SCI, V120, P51, DOI 10.1042/CS20100305; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Park KH, 2011, NEUROTOXICOLOGY, V32, P879, DOI 10.1016/j.neuro.2011.05.009; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sato A, 2010, NEUROSCI LETT, V470, P115, DOI 10.1016/j.neulet.2009.12.067; Shacka JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P718, DOI 10.2741/2714; Shang YC, 2012, AGING-US, V4, P187, DOI 10.18632/aging.100440; Shang YC, 2011, CURR NEUROVASC RES, V8, P270; Shang YC, 2010, CELL SIGNAL, V22, P1317, DOI 10.1016/j.cellsig.2010.04.009; Shang YC, 2009, CURR NEUROVASC RES, V6, P223, DOI 10.2174/156720209789630302; Shang YC, 2009, CURR NEUROVASC RES, V6, P20, DOI 10.2174/156720209787466064; Shen JF, 2010, INVEST OPHTH VIS SCI, V51, P35, DOI 10.1167/iovs.09-3544; Simon F, 2011, INTENS CARE MED, V37, P1525, DOI 10.1007/s00134-011-2303-4; Singh N, 2012, CELL MOL NEUROBIOL; Solling C., 2011, BASIC CLIN PHARM TOX; Srivastava S, 2011, CURR PHARM DESIGN, V17, P3418, DOI 10.2174/138161211798072526; Su KH, 2011, J CELL PHYSIOL, V226, P3330, DOI 10.1002/jcp.22678; Sung JH, 2012, J VET MED SCI, V74, P35, DOI 10.1292/jvms.11-0149; Takeyama T, 2012, CIRC-HEART FAIL, V5, P274, DOI 10.1161/CIRCHEARTFAILURE.111.965061; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; Troy CM, 2011, PROG MOL BIOL TRANSL, V99, P265, DOI 10.1016/S1877-1173(11)99007-3; Ullah N, 2012, J MOL NEUROSCI, V47, P67, DOI 10.1007/s12031-011-9685-1; Ullah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027093; Uzbay TI, 2012, NEUROSCI BIOBEHAV R, V36, P502, DOI 10.1016/j.neubiorev.2011.08.006; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang HT, 2012, CELL SIGNAL, V24, P17, DOI 10.1016/j.cellsig.2011.08.010; Wang J, 2012, J PINEAL RES; Wang JY, 2012, TOXICOL IN VITRO, V26, P32, DOI 10.1016/j.tiv.2011.10.004; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wang YP, 2011, EXP BIOL MED, V236, P1197, DOI 10.1258/ebm.2011.010317; Weih M, 2001, J CEREBR BLOOD F MET, V21, P1090, DOI 10.1097/00004647-200109000-00006; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Wymann MP, 1996, MOL CELL BIOL, V16, P1722; Xie ZG, 2012, CURR EYE RES, V37, P138, DOI 10.3109/02713683.2011.647225; Xu Y, 2011, NEUROSCIENCE, V181, P292, DOI 10.1016/j.neuroscience.2011.02.051; Yamada M, 2011, J PATHOL, V224, P101, DOI 10.1002/path.2862; Yang H, 2011, CLIN CHEM LAB MED, V49, P1773, DOI 10.1515/CCLM.2011.250; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhang GL, 2011, PHARMACOL BIOCHEM BE, V99, P42, DOI 10.1016/j.pbb.2011.03.019	127	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45456	10.1371/journal.pone.0045456	http://dx.doi.org/10.1371/journal.pone.0045456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029019	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900137
J	Gerc, AJ; Song, LJ; Challis, GL; Stanley-Wall, NR; Coulthurst, SJ				Gerc, Amy J.; Song, Lijiang; Challis, Gregory L.; Stanley-Wall, Nicola R.; Coulthurst, Sarah J.			The Insect Pathogen Serratia marcescens Db10 Uses a Hybrid Non-Ribosomal Peptide Synthetase-Polyketide Synthase to Produce the Antibiotic Althiomycin	PLOS ONE			English	Article							BACILLUS-SUBTILIS; PHOSPHOPANTETHEINYL TRANSFERASE; ADENYLATION DOMAINS; MYXOCOCCUS-XANTHUS; NATURAL-PRODUCTS; EXTENDER UNITS; GENE-CLUSTER; BIOSYNTHESIS; IDENTIFICATION; SUPERFAMILY	There is a continuing need to discover new bioactive natural products, such as antibiotics, in genetically-amenable microorganisms. We observed that the enteric insect pathogen, Serratia marcescens Db10, produced a diffusible compound that inhibited the growth of Bacillis subtilis and Staphyloccocus aureus. Mapping the genetic locus required for this activity revealed a putative natural product biosynthetic gene cluster, further defined to a six-gene operon named alb1-alb6. Bioinformatic analysis of the proteins encoded by alb1-6 predicted a hybrid non-ribosomal peptide synthetase-polyketide synthase (NRPS-PKS) assembly line (Alb4/5/6), tailoring enzymes (Alb2/3) and an export/resistance protein (Alb1), and suggested that the machinery assembled althiomycin or a related molecule. Althiomycin is a ribosome-inhibiting antibiotic whose biosynthetic machinery had been elusive for decades. Chromatographic and spectroscopic analyses confirmed that wild type S. marcescens produced althiomycin and that production was eliminated on disruption of the alb gene cluster. Construction of mutants with in-frame deletions of specific alb genes demonstrated that Alb2-Alb5 were essential for althiomycin production, whereas Alb6 was required for maximal production of the antibiotic. A phosphopantetheinyl transferase enzyme required for althiomycin biosynthesis was also identified. Expression of Alb1, a predicted major facilitator superfamily efflux pump, conferred althiomycin resistance on another, sensitive, strain of S. marcescens. This is the first report of althiomycin production outside of the Myxobacteria or Streptomyces and paves the way for future exploitation of the biosynthetic machinery, since S. marcescens represents a convenient and tractable producing organism.	[Song, Lijiang; Challis, Gregory L.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Gerc, Amy J.; Stanley-Wall, Nicola R.; Coulthurst, Sarah J.] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee, Scotland	University of Warwick; University of Dundee	Challis, GL (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	g.l.challis@warwick.ac.uk; r.stanleywall@dundee.ac.uk; s.j.coulthurst@dundee.ac.uk		Stanley-Wall, Nicola/0000-0002-5936-9721; Coulthurst, Sarah/0000-0002-0808-1875; Challis, Gregory/0000-0001-5976-3545	Royal Society of Edinburgh/Scottish Government Personal Research Fellowship; Wellcome Trust [093711/B/10/Z]	Royal Society of Edinburgh/Scottish Government Personal Research Fellowship; Wellcome Trust(Wellcome TrustEuropean Commission)	SJC is supported by a Royal Society of Edinburgh/Scottish Government Personal Research Fellowship (www.royalsoced.org.uk/). AJG is funded by a PhD studentship supported by the Wellcome Trust [093711/B/10/Z] (www.wellcome.ac.uk/). The Bruker MaXis mass spectrometer used in this research was obtained with support from Advantage West Midlands (AWM) and the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAI R, 1992, BIOCHEM PHARMACOL, V43, P2637, DOI 10.1016/0006-2952(92)90153-A; BURNS DJW, 1973, EUR J BIOCHEM, V37, P570, DOI 10.1111/j.1432-1033.1973.tb03020.x; CARDELLINA JH, 1979, J AM CHEM SOC, V101, P240, DOI 10.1021/ja00495a051; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Chan YA, 2006, P NATL ACAD SCI USA, V103, P14349, DOI 10.1073/pnas.0603748103; Chan YA, 2009, NAT PROD REP, V26, P90, DOI 10.1039/b801658p; Cortina NS, 2011, CHEMBIOCHEM, V12, P1411, DOI 10.1002/cbic.201100154; Coulthurst SJ, 2006, MICROBIOL-SGM, V152, P1899, DOI 10.1099/mic.0.28803-0; Coulthurst SJ, 2005, NAT REV MICROBIOL, V3, P295, DOI 10.1038/nrmicro1128; Coulthurst SJ, 2006, MOL PLANT PATHOL, V7, P31, DOI 10.1111/J.1364-3703.2005.00314.X; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fluman N, 2009, BBA-PROTEINS PROTEOM, V1794, P738, DOI 10.1016/j.bbapap.2008.11.020; FLYG C, 1980, J GEN MICROBIOL, V120, P173; FUJIMOTO H, 1970, J ANTIBIOT, V23, P271, DOI 10.7164/antibiotics.23.271; Gwynn MN, 2010, ANN NY ACAD SCI, V1213, P5, DOI 10.1111/j.1749-6632.2010.05828.x; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; HAYDOCK SF, 1995, FEBS LETT, V374, P246, DOI 10.1016/0014-5793(95)01119-Y; Hopwood DA, 2007, MOL MICROBIOL, V63, P937, DOI 10.1111/j.1365-2958.2006.05584.x; INAMI K, 1985, B CHEM SOC JPN, V58, P352, DOI 10.1246/bcsj.58.352; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Kiley TB, 2010, MOL MICROBIOL, V78, P947, DOI 10.1111/j.1365-2958.2010.07382.x; Kim J, 2009, J MICROBIOL BIOTECHN, V19, P51, DOI 10.4014/jmb.0711.775; Krebs C, 2007, BIOCHEMISTRY-US, V46, P10413, DOI 10.1021/bi701060g; KUNZE B, 1982, J ANTIBIOT, V35, P635, DOI 10.7164/antibiotics.35.635; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; PAIK SG, 1994, J AM CHEM SOC, V116, P8116, DOI 10.1021/ja00097a019; Pavlidou M, 2011, FEMS MICROBIOL LETT, V319, P26, DOI 10.1111/j.1574-6968.2011.02263.x; Petty NK, 2006, MICROBIOL-SGM, V152, P1701, DOI 10.1099/mic.0.28712-0; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Sadar MD, 2008, ORG LETT, V10, P4947, DOI 10.1021/ol802021w; SAKAKIBARA H, 1974, J ANTIBIOT, V27, P897, DOI 10.7164/antibiotics.27.897; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; YAMAGUCHI H, 1957, J ANTIBIOT, V10, P195; Zarantonello P, 2002, BIOORG MED CHEM LETT, V12, P561, DOI 10.1016/S0960-894X(01)00802-2; Zerikly M, 2009, CHEMBIOCHEM, V10, P625, DOI 10.1002/cbic.200800389	44	35	36	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44673	10.1371/journal.pone.0044673	http://dx.doi.org/10.1371/journal.pone.0044673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028578	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900034
J	Rossa, C; Sommer, G; Spolidorio, LC; Rosenzweig, SA; Watson, DK; Kirkwood, KL				Rossa, Carlos, Jr.; Sommer, Gunhild; Spolidorio, Luis C.; Rosenzweig, Steven A.; Watson, Dennis K.; Kirkwood, Keith L.			Loss of Expression and Function of SOCS3 Is an Early Event in HNSCC: Altered Subcellular Localization as a Possible Mechanism Involved in Proliferation, Migration and Invasion	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CYTOKINE SIGNALING-3; CONSTITUTIVE EXPRESSION; GROWTH-INHIBITION; BREAST-CANCER; IFN-ALPHA; SUPPRESSOR; LYMPHOMA; SITE; RESISTANCE	Background: Suppressor of cytokine signaling 3 (SOCS3) is an inducible endogenous negative regulator of signal transduction and activator of transcription 3 (STAT3). Epigenetic silencing of SOCS3 has been shown in head and neck squamous cell carcinoma (HNSCC), which is associated with increased activation of STAT3. There is scarce information on the functional role of the reduction of SOCS3 expression and no information on altered subcellular localization of SOCS3 in HNSCC. Methodology/Principal Findings: We assessed endogenous SOCS3 expression in different HNSCC cell lines by RT-qPCR and western blot. Immunofluorescence and western blot were used to study the subcellular localization of endogenous SOCS3 induced by IL-6. Overexpression of SOCS3 by CMV-driven plasmids and siRNA-mediated inhibition of endogenous SOCS3 were used to verify the role of SOCS3 on tumor cell proliferation, viability, invasion and migration in vitro. In vivo relevance of SOCS3 expression in HNSCC was studied by quantitative immunohistochemistry of commercially-available tissue microarrays. Endogenous expression of SOCS3 was heterogeneous in four HNSCC cell lines and surprisingly preserved in most of these cell lines. Subcellular localization of endogenous SOCS3 in the HNSCC cell lines was predominantly nuclear as opposed to cytoplasmic in non-neoplasic epithelial cells. Overexpression of SOCS3 produced a relative increase of the protein in the cytoplasmic compartment and significantly inhibited proliferation, migration and invasion, whereas inhibition of endogenous nuclear SOCS3 did not affect these events. Analysis of tissue microarrays indicated that loss of SOCS3 is an early event in HNSCC and was correlated with tumor size and histological grade of dysplasia, but a considerable proportion of cases presented detectable expression of SOCS3. Conclusion: Our data support a role for SOCS3 as a tumor suppressor gene in HNSCC with relevance on proliferation and invasion processes and suggests that abnormal subcellular localization impairs SOCS3 function in HNSCC cells.	[Rossa, Carlos, Jr.] Araraquara Univ Estadual Paulista UNESP, Dept Diag & Surg, Sch Dent, Sao Paulo, Brazil; [Sommer, Gunhild; Watson, Dennis K.] Med Univ S Carolina MUSC, Dept Biochem & Mol Biol, Charleston, SC USA; [Spolidorio, Luis C.] Araraquara Univ Estadual Paulista UNESP, Dept Physiol & Pathol, Sch Dent, Sao Paulo, Brazil; [Rosenzweig, Steven A.] Med Univ S Carolina MUSC, Dept Pharmacol, Charleston, SC USA; [Watson, Dennis K.] Med Univ S Carolina MUSC, Dept Pathol & Lab Med, Charleston, SC USA; [Kirkwood, Keith L.] Med Univ S Carolina MUSC, Dept Craniofacial Biol, Charleston, SC USA; [Kirkwood, Keith L.] Med Univ S Carolina MUSC, Ctr Oral Hlth, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Rossa, C (corresponding author), Araraquara Univ Estadual Paulista UNESP, Dept Diag & Surg, Sch Dent, Sao Paulo, Brazil.	crossajr@foar.unesp.br	Rossa, Carlos/D-8328-2012; Kirkwood, Keith L/L-4728-2018; Spolidorio, Luís Carlos/G-1857-2012; Rosenzweig, Steven A/O-5062-2018	Rossa, Carlos/0000-0003-1705-5481; Spolidorio, Luís Carlos/0000-0002-0592-542X; Rosenzweig, Steven/0000-0002-7022-6086; Kirkwood, Keith/0000-0003-4519-8973	National Institutes of Health -National Center for Research Resources [P20RR017696]; National Institute of Dental and Craniofacial Research [1R01DE018290]; NATIONAL CANCER INSTITUTE [R01CA134845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018290] Funding Source: NIH RePORTER	National Institutes of Health -National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health -National Center for Research Resources (P20RR017696) and National Institute of Dental and Craniofacial Research (1R01DE018290 to KLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Baetz A, 2008, FASEB J, V22, P4296, DOI 10.1096/fj.08-116079; Brender C, 2005, LEUKEMIA, V19, P209, DOI 10.1038/sj.leu.2403610; Brender C, 2001, BLOOD, V97, P1056, DOI 10.1182/blood.V97.4.1056; Chen JYF, 2004, CARCINOGENESIS, V25, P269, DOI 10.1093/carcin/bgh006; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Evans MK, 2007, ONCOGENE, V26, P1941, DOI 10.1038/sj.onc.1209993; Flowers LO, 2004, J IMMUNOL, V172, P7510, DOI 10.4049/jimmunol.172.12.7510; Frobose H, 2006, MOL ENDOCRINOL, V20, P1587, DOI 10.1210/me.2005-0301; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kuppens IELM, 2006, CURR CLIN PHARMACOL, V1, P57, DOI 10.2174/157488406775268200; Lee KH, 2008, FEBS LETT, V582, P2319, DOI 10.1016/j.febslet.2008.05.039; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu SY, 2008, BIOCHEM BIOPH RES CO, V366, P520, DOI 10.1016/j.bbrc.2007.11.179; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Masuda M, 2002, CANCER RES, V62, P3351; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Neuwirt H, 2007, ENDOCR-RELAT CANCER, V14, P1007, DOI 10.1677/ERC-07-0172; Nicholson SE, 2000, P NATL ACAD SCI USA, V97, P6493, DOI 10.1073/pnas.100135197; Ogata H, 2006, GASTROENTEROLOGY, V131, P179, DOI 10.1053/j.gastro.2006.04.025; Pierconti F, 2011, PROSTATE, V71, P318, DOI 10.1002/pros.21245; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Sasi W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-178; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Tokita T, 2007, INT J ONCOL, V30, P689; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Waiboci LW, 2007, J IMMUNOL, V178, P5058, DOI 10.4049/jimmunol.178.8.5058; Wang YM, 2011, CURR PROTEIN PEPT SC, V12, P68; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Yang SF, 2008, PATHOLOGY, V40, P558, DOI 10.1080/00313020802320432; Ying MZ, 2010, J CANCER RES CLIN, V136, P1617, DOI 10.1007/s00432-010-0819-6; Zou TT, 2008, FEBS LETT, V582, P4015, DOI 10.1016/j.febslet.2008.10.055	36	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45197	10.1371/journal.pone.0045197	http://dx.doi.org/10.1371/journal.pone.0045197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028842	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900098
J	Schafer, I				Schaefer, Ingmar			Does Multimorbidity Influence the Occurrence Rates of Chronic Conditions? A Claims Data Based Comparison of Expected and Observed Prevalence Rates	PLOS ONE			English	Article							BLOOD-PRESSURE; DISEASE; RISK; COMORBIDITY; PATTERNS; STROKE; ADULTS	Objective: Multimorbidity is a complex phenomenon with an almost endless number of possible disease combinations with unclear implications. One important aspect in analyzing the clustering of diseases is to distinguish between random coexistence and statistical dependency. We developed a model to account for random coexistence based on stochastic distribution. We analyzed if the number of diseases of the patients influences the occurrence rates of chronic conditions. Methods: We analyzed claims data of 121,389 persons aged 65+ using a list of 46 chronic conditions. Expected prevalences were simulated by drawing without replacement from all observed diseases using observed overall prevalences as initial probability weights. To determine if a disease occurs more or less frequently than expected by chance we calculated observed-minus-expected deltas for each disease. We defined clinical relevance as vertical bar delta vertical bar >= 5.0%. 18 conditions were excluded because of a prevalence < 5.0%. Results: We found that (1) two chronic conditions (e.g. hypertension) were more frequent than expected in patients with a low number of comorbidities; (2) four conditions (e.g. renal insufficiency) were more frequent in patients with many comorbidities; (3) six conditions (e.g. cancer) were less frequent with many comorbidities; and (4) 16 conditions had an average course of prevalences. Conclusion: A growing extent of multimorbidity goes along with a rapid growth of prevalences. This is for the largest part merely a stochastic effect. If we account for this effect we find that only few diseases deviate from the expected prevalence curves. Causes for these deviations are discussed. Our approach also has methodological implications: Naive analyses of multimorbidity might easily be affected by bias, because the prevalence of all chronic conditions necessarily increases with a growing extent of multimorbidity. We should therefore always examine and discuss the stochastic interrelations between the chronic conditions we analyze.	Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Schafer, I (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany.	in.schaefer@uke.uni-hamburg.de	Schafer, Ingo/B-7514-2017	Schafer, Ingo/0000-0002-9711-3559	German Federal Ministry of Education and Research [01ET0725, 01ET0731, 01ET1006A-K]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was funded by the German Federal Ministry of Education and Research (http://www.bmbf.bund.de/;grant numbers 01ET0725, 01ET0731 and 01ET1006A-K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busse R., 2007, WISSENSCHAFTLICHES G; Cases A, 2005, KIDNEY INT, V68, P87; Chaturvedi N, 2007, DIABETES RES CLIN PR, V76, pS3, DOI 10.1016/j.diabres.2007.01.019; Choi HK, 2008, RHEUMATOLOGY, V47, P1567, DOI 10.1093/rheumatology/ken305; COLEMAN M, 1993, TRENDS CANC INCIDENC; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Federal Association of SHI Physicians in Germany, 2007, BAS DAT SHI CAR GERM; Grobe TG, 2007, GEK REPORT AMBULANT; Hoffmann F, 2012, GESUNDHEITSWESEN, V74, P291, DOI 10.1055/s-0031-1275711; Kassenarztliche Bundesvereinigung, 2011, BUND; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Maier W, 1999, INT CLIN PSYCHOPHARM, V14, pS1; Marengoni A., 2008, PREVALENCE IMPACT CH; Marengoni A, 2011, J AM GERIATR SOC, V59, P2395, DOI 10.1111/j.1532-5415.2011.03687.x; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; MEYER JS, 1987, ARCH NEUROL-CHICAGO, V44, P418, DOI 10.1001/archneur.1987.00520160052014; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; Schafer I, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-89; Schafer I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015941; Schellevis FG, 1993, CHRONIC DIS GEN PRAC; Starfield B, 2006, ANN FAM MED, V4, P101, DOI 10.1370/afm.524; Stokes J 3rd, 1989, Hypertension, V13, pI13; Van den Akker M., 1996, EUR J GEN PRACT, V2, P15, DOI [10.3109/13814789609162146, DOI 10.3109/13814789609162146]; Van den Bussche H, 2012, J CLIN EPID IN PRESS; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; VINIK AI, 1992, DIABETES CARE, V15, P1926, DOI 10.2337/diacare.15.12.1926; Zentralinstitut fur die kassenarztliche Versorgung, 2007, DAT ADT PAN ZENTR KA	28	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45390	10.1371/journal.pone.0045390	http://dx.doi.org/10.1371/journal.pone.0045390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028979	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800060
J	Baccini, G; Mlinar, B; Audero, E; Gross, CT; Corradetti, R				Baccini, Gilda; Mlinar, Boris; Audero, Enrica; Gross, Cornelius Thilo; Corradetti, Renato			Impaired Chemosensitivity of Mouse Dorsal Raphe Serotonergic Neurons Overexpressing Serotonin 1A (Htr1a) Receptors	PLOS ONE			English	Article							INFANT-DEATH-SYNDROME; FREELY MOVING CATS; BRAIN-STEM; TRANSPORTER GENE; AROUSAL; SLEEP; RESPONSES; MICE; DIFFERENTIATION; ASSOCIATION	Background: Serotonergic system participates in a wide range of physiological processes and behaviors, but its role is generally considered as modulatory and noncrucial, especially concerning life-sustaining functions. We recently created a transgenic mouse line in which a functional deficit in serotonin homeostasis due to excessive serotonin autoinhibition was produced by inducing serotonin 1A receptor (Htr1a) overexpression selectively in serotonergic neurons (Htr1a raphe-overexpressing or Htr1a(RO) mice). Htr1a(RO) mice exhibit episodes of autonomic dysregulation, cardiovascular crises and death, resembling those of sudden infant death syndrome (SIDS) and revealing a life-supporting role of serotonergic system in autonomic control. Since midbrain serotonergic neurons are chemosensitive and are implicated in arousal we hypothesized that their chemosensitivity might be impaired in Htr1a(RO) mice. Principal findings: Loose-seal cell-attached recordings in brainstem slices revealed that serotonergic neurons in dorsal raphe nucleus of Htr1a(RO) mice have dramatically reduced responses to hypercapnic challenge as compared with control littermates. In control mice, application of 9% CO2 produced an increase in firing rate of serotonergic neurons (0.260 +/- 0.041 Hz, n = 20, p = 0.0001) and application of 3% CO2 decreased their firing rate (-0.142 +/- 0.025 Hz, n = 17, p = 0.0008). In contrast, in Htr1a(RO) mice, firing rate of serotonergic neurons was not significantly changed by 9% CO2 (0.021 +/- 0.034 Hz, n = 16, p = 0.49) and by 3% CO2 (0.012 +/- 0.046 Hz, n = 12, p = 0.97). Conclusions: Our findings support the hypothesis that chemosensitivity of midbrain serotonergic neurons provides a physiological mechanism for arousal responses to life-threatening episodes of hypercapnia and that functional impairment, such as excessive autoinhibition, of midbrain serotonergic neuron responses to hypercapnia may contribute to sudden death.	[Baccini, Gilda; Mlinar, Boris; Corradetti, Renato] Univ Florence, Dept Preclin & Clin Pharmacol Mario Aiazzi Mancin, Florence, Italy; [Audero, Enrica; Gross, Cornelius Thilo] EMBL, Mouse Biol Unit, Monterotondo, Italy	University of Florence; European Molecular Biology Laboratory (EMBL)	Baccini, G (corresponding author), Univ Florence, Dept Preclin & Clin Pharmacol Mario Aiazzi Mancin, Florence, Italy.	renato.corradetti@unifi.it	Corradetti, Renato/A-1604-2008; Mlinar, Boris/A-7034-2008	Corradetti, Renato/0000-0002-2588-0484; Mlinar, Boris/0000-0001-9082-0827; Audero, Enrica/0000-0002-6138-244X	Compagnia San Paolo [Programma Neuroscienze-2008.2265]; Regione Toscana (Programma Salute); Ente Cassa di Risparmio diFirenze [2007-0758]; European Commission (FP7-DEVANX); EMBL	Compagnia San Paolo(Compagnia di San Paolo); Regione Toscana (Programma Salute)(Regione Toscana); Ente Cassa di Risparmio diFirenze(Fondazione Cassa Risparmio Firenze); European Commission (FP7-DEVANX); EMBL	This research was supported by Compagnia San Paolo (Programma Neuroscienze-2008.2265), Regione Toscana (Programma Salute 2009), Ente Cassa di Risparmio diFirenze(2007-0758), European Commission (FP7-DEVANX, C.T.G.) and EMBL (E.A. and C.T.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1985, NATURE, V315, P501, DOI 10.1038/315501a0; Audero E, 2008, SCIENCE, V321, P130, DOI 10.1126/science.1157871; BERTHONJONES M, 1984, J APPL PHYSIOL, V57, P59, DOI 10.1152/jappl.1984.57.1.59; Buchanan GF, 2010, P NATL ACAD SCI USA, V107, P16354, DOI 10.1073/pnas.1004587107; Corcoran AE, 2009, RESP PHYSIOL NEUROBI, V168, P49, DOI 10.1016/j.resp.2009.04.014; Cummings KJ, 2011, J PHYSIOL-LONDON, V589, P5247, DOI 10.1113/jphysiol.2011.214445; Cummings KJ, 2011, J APPL PHYSIOL, V111, P825, DOI 10.1152/japplphysiol.00336.2011; Duncan JR, 2010, JAMA-J AM MED ASSOC, V303, P430, DOI 10.1001/jama.2010.45; Erickson JT, 2007, RESP PHYSIOL NEUROBI, V159, P85, DOI 10.1016/j.resp.2007.06.002; Franco P, 2010, SLEEP MED, V11, P603, DOI 10.1016/j.sleep.2009.12.014; Guyenet PG, 2010, J COMP NEUROL, V518, P3883, DOI 10.1002/cne.22435; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hodges MR, 2009, J NEUROSCI, V29, P10341, DOI 10.1523/JNEUROSCI.1963-09.2009; Kato I, 2003, AM J RESP CRIT CARE, V168, P1298, DOI 10.1164/rccm.200301-134OC; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; LEVINE ES, 1992, J NEUROSCI, V12, P4037; Moon RY, 2007, LANCET, V370, P1578, DOI 10.1016/S0140-6736(07)61662-6; Morley ME, 2008, AM J MED GENET A, V146A, P930, DOI 10.1002/ajmg.a.32112; Mulkey DK, 2007, J NEUROSCI, V27, P14049, DOI 10.1523/JNEUROSCI.4254-07.2007; Narita N, 2001, PEDIATRICS, V107, P690, DOI 10.1542/peds.107.4.690; NEWMAN NM, 1989, AUST PAEDIATR J, V25, P196; Nonnis Marzano F, 2008, GENOMICS, V91, P485, DOI 10.1016/j.ygeno.2008.01.010; Okado N, 2002, MED HYPOTHESES, V58, P232, DOI 10.1054/mehy.2001.1483; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Paterson DS, 2010, PEDIATR RES, V68, P409, DOI 10.1203/PDR.0b013e3181f2edf0; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Ray RS, 2011, SCIENCE, V333, P637, DOI 10.1126/science.1205295; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; Sakai K, 2000, NEUROREPORT, V11, P3237, DOI 10.1097/00001756-200009280-00037; Sakai K, 2001, NEUROSCIENCE, V104, P1141, DOI 10.1016/S0306-4522(01)00103-8; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Severson CA, 2003, NAT NEUROSCI, V6, P1139, DOI 10.1038/nn1130; Takahashi K, 2010, NEUROSCIENCE, V169, P1115, DOI 10.1016/j.neuroscience.2010.06.009; TRULSON ME, 1979, BRAIN RES, V163, P135, DOI 10.1016/0006-8993(79)90157-4; Urbain N, 2006, J PHYSIOL-LONDON, V573, P679, DOI 10.1113/jphysiol.2006.108514; VANDERMAELEN CP, 1983, BRAIN RES, V289, P109, DOI 10.1016/0006-8993(83)90011-2; Veasey SC, 1997, NEUROSCIENCE, V79, P161, DOI 10.1016/S0306-4522(96)00673-2; Washburn CP, 2002, J NEUROSCI, V22, P1256, DOI 10.1523/JNEUROSCI.22-04-01256.2002; Weese-Mayer DE, 2003, AM J MED GENET A, V122A, P238, DOI 10.1002/ajmg.a.20427	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45072	10.1371/journal.pone.0045072	http://dx.doi.org/10.1371/journal.pone.0045072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028768	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700083
J	Ruczynski, I; Barton, KA				Ruczynski, Ireneusz; Barton, Kamil A.			Modelling Sensory Limitation: The Role of Tree Selection, Memory and Information Transfer in Bats' Roost Searching Strategies	PLOS ONE			English	Article							NECTAR-FEEDING BATS; BIG BROWN BATS; LONG-TERM REUSE; NYCTALUS-NOCTULA; CHALINOLOBUS-TUBERCULATUS; SOCIAL CALLS; RAIN-FOREST; N-LEISLERI; ECHOLOCATION SIGNALS; INSECTIVOROUS BATS	Sensory limitation plays an important role in the evolution of animal behaviour. Animals have to find objects of interest (e.g. food, shelters, predators). When sensory abilities are strongly limited, animals adjust their behaviour to maximize chances for success. Bats are nocturnal, live in complex environments, are capable of flight and must confront numerous perceptual challenges (e.g. limited sensory range, interfering clutter echoes). This makes them an excellent model for studying the role of compensating behaviours to decrease costs of finding resources. Cavity roosting bats are especially interesting because the availability of tree cavities is often limited, and their quality is vital for bats during the breeding season. From a bat's sensory point of view, cavities are difficult to detect and finding them requires time and energy. However, tree cavities are also long lasting, allowing information transfer among conspecifics. Here, we use a simple simulation model to explore the benefits of tree selection, memory and eavesdropping (compensation behaviours) to searches for tree cavities by bats with short and long perception range. Our model suggests that memory and correct discrimination of tree suitability are the basic strategies decreasing the cost of roost finding, whereas perceptual range plays a minor role in this process. Additionally, eavesdropping constitutes a buffer that reduces the costs of finding new resources (such as roosts), especially when they occur in low density. We conclude that natural selection may promote different strategies of roost finding in relation to habitat conditions and cognitive skills of animals.	[Ruczynski, Ireneusz] Mammal Res Inst PAS, Bialowieza, Poland; [Barton, Kamil A.] Univ Wurzburg, Field Stn, Rauhenebrach, Germany	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; University of Wurzburg	Ruczynski, I (corresponding author), Mammal Res Inst PAS, Bialowieza, Poland.	iruczyns@ibs.bialowieza.pl		Ruczynski, Ireneusz/0000-0002-2308-3211; Barton, Kamil/0000-0001-5562-8274	EU FP6 program BiodivERsA (TenLamas)	EU FP6 program BiodivERsA (TenLamas)	The project was undertaken with the budget of the Mammal Research Institute PAS in Bialowieza, Poland. KB was supported by the EU FP6 program BiodivERsA (TenLamas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study	BARCLAY RMR, 1991, AM NAT, V137, P693, DOI 10.1086/285188; Britton ARC, 1997, J ZOOL, V241, P503, DOI 10.1111/j.1469-7998.1997.tb04842.x; Chaverri G, 2010, BIOL LETTERS, V6, P441, DOI 10.1098/rsbl.2009.0964; Chittka L, 2005, CURR BIOL, V15, pR869, DOI 10.1016/j.cub.2005.10.018; Ciechanowski M, 2005, FOLIA ZOOL, V54, P31; Czeszczewik D, 2008, CAN J ZOOL, V86, P286, DOI 10.1139/Z07-139; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Dechmann DKN, 2009, P ROY SOC B-BIOL SCI, V276, P2721, DOI 10.1098/rspb.2009.0473; Dittman AH, 1996, J EXP BIOL, V199, P83; Eklof J, 2003, ANIM BEHAV, V66, P949, DOI 10.1006/anbe.2003.2272; Eklof J, 2002, OIKOS, V99, P347, DOI 10.1034/j.1600-0706.2002.990216.x; Eklof J, 2003, VISION ECHOLOCATING; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; Fox JC, 2009, AUST FORESTRY, V72, P39, DOI 10.1080/00049158.2009.10676288; Furmankiewicz J, 2011, ETHOLOGY, V117, P480, DOI 10.1111/j.1439-0310.2011.01897.x; GAUDET CL, 1984, ANIM BEHAV, V32, P385, DOI 10.1016/S0003-3472(84)80273-0; Gillam EH, 2011, J MAMMAL, V92, P1253, DOI 10.1644/10-MAMM-A-393.1; Grunwald JE, 2004, P NATL ACAD SCI USA, V101, P5670, DOI 10.1073/pnas.0308029101; Hedenstrom A, 2009, J MAMMAL, V90, P1298, DOI 10.1644/09-MAMM-S-075R2.1; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Holland RA, 2007, BEHAV ECOL SOCIOBIOL, V61, P653, DOI 10.1007/s00265-006-0297-7; Jones G, 1999, J EXP BIOL, V202, P3359; Kalcounis-Ruppell MC, 2005, WILDLIFE SOC B, V33, P1123, DOI 10.2193/0091-7648(2005)33[1123:TRSBBA]2.0.CO;2; Kanuch P, 2007, MAMMALIA, V71, P126, DOI 10.1515/MAMM.2007.026; Kerth G, 2003, P ROY SOC B-BIOL SCI, V270, P511, DOI 10.1098/rspb.2002.2267; Kerth G, 2006, BEHAV PROCESS, V84, P662; Kerth G, 2006, P ROY SOC B-BIOL SCI, V273, P2785, DOI 10.1098/rspb.2006.3647; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; Koch AJ, 2008, FOREST ECOL MANAG, V255, P3938, DOI 10.1016/j.foreco.2008.03.025; Krause J, 2002, LIVING GROUPS; Krzanowski A., 1961, CHRO MY PRZYR OJCZYS, V17, P29; Kunz TH, 2003, BAT ECOLOGY, P3; Laland KN, 2004, LEARN BEHAV, V32, P4; LEWIS SE, 1995, J MAMMAL, V76, P481, DOI 10.2307/1382357; Lucan RK, 2009, FOREST ECOL MANAG, V258, P1301, DOI 10.1016/j.foreco.2009.06.032; Nevitt G, 1999, MAR ECOL PROG SER, V177, P235, DOI 10.3354/meps177235; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Ojeda VS, 2007, AUSTRAL ECOL, V32, P436, DOI 10.1111/j.1442-9993.2007.01705.x; Page RA, 2005, P ROY SOC B-BIOL SCI, V272, P841, DOI 10.1098/rspb.2004.2998; Reiter G, 2004, MAMMALIA, V68, P403, DOI 10.1515/mamm.2004.040; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Ruczynski I, 2005, J MAMMAL, V86, P921, DOI 10.1644/1545-1542(2005)86[921:RCSBNN]2.0.CO;2; Ruczynski I, 2010, FOREST ECOL MANAG, V259, P1633, DOI 10.1016/j.foreco.2010.01.041; Ruczynski I, 2008, J MAMMAL, V89, P942, DOI 10.1644/07-MAMM-A-134.1; Ruczynski I, 2007, J EXP BIOL, V210, P3607, DOI 10.1242/jeb.009837; Ruczynski I, 2006, CAN J ZOOL, V84, P900, DOI 10.1139/Z06-060; Ruczynski I, 2011, ACTA CHIROPTEROL, V13, P385, DOI 10.3161/150811011X624857; Ruczynski I, 2009, ETHOLOGY, V115, P167, DOI 10.1111/j.1439-0310.2008.01599.x; Russo D, 2004, BIOL CONSERV, V117, P73, DOI 10.1016/S0006-3207(03)00266-0; Rydell J, 2003, NATURWISSENSCHAFTEN, V90, P481, DOI 10.1007/s00114-003-0464-x; Safi K, 2007, AM NAT, V170, P465, DOI 10.1086/520116; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schoner CR, 2010, BEHAV ECOL SOCIOBIOL, V64, P2053, DOI 10.1007/s00265-010-1019-8; Sedgeley JA, 1999, J ZOOL, V249, P437, DOI 10.1111/j.1469-7998.1999.tb01213.x; Sedgeley JA, 1999, BIOL CONSERV, V88, P261, DOI 10.1016/S0006-3207(98)00069-X; Sedgeley JA, 2001, J APPL ECOL, V38, P425, DOI 10.1046/j.1365-2664.2001.00607.x; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2001, ACTA CHIROPTEROL, V3, P211; Siemers BM, 2000, BEHAV ECOL SOCIOBIOL, V47, P400, DOI 10.1007/s002650050683; SPEAKMAN JR, 1991, MAMMAL REV, V21, P123, DOI 10.1111/j.1365-2907.1991.tb00114.x; SUTHERS RA, 1970, VISION RES, V10, P1165, DOI 10.1016/0042-6989(70)90034-9; Tanner CJ, 2012, J ANIM ECOL, V81, P260, DOI 10.1111/j.1365-2656.2011.01879.x; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; Voigt CC, 1999, J COMP PHYSIOL B, V169, P38, DOI 10.1007/s003600050191; von Helversen D, 2004, J COMP PHYSIOL A, V190, P515, DOI 10.1007/s00359-004-0492-9; von Helversen D, 2003, J COMP PHYSIOL A, V189, P327, DOI 10.1007/s00359-003-0405-3; Vonhof MJ, 2010, ACTA CHIROPTEROL, V12, P283, DOI 10.3161/150811010X537864; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; WILKINSON GS, 1992, ANIM BEHAV, V44, P501, DOI 10.1016/0003-3472(92)90059-I; Willis CKR, 2003, ACTA CHIROPTEROL, V5, P85, DOI 10.3161/001.005.0107; Willis CKR, 2007, BEHAV ECOL SOCIOBIOL, V62, P97, DOI 10.1007/s00265-007-0442-y; Winter Y, 1999, J EXP BIOL, V202, P1917; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971; Wright GS, 2011, ANIM BEHAV, V82, P1075, DOI 10.1016/j.anbehav.2011.07.044; Yovel Y., 2009, PLOS COMPUTATIONAL B, V5; Yovel Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000032; Yovel Y, 2011, J COMP PHYSIOL A, V197, P475, DOI 10.1007/s00359-010-0584-7; Zahn A, 1999, J ZOOL, V247, P275, DOI 10.1111/j.1469-7998.1999.tb00991.x; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035	81	17	17	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44897	10.1371/journal.pone.0044897	http://dx.doi.org/10.1371/journal.pone.0044897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028666	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700051
J	Quinto, J; Marcos-Garcia, MA; Diaz-Castelazo, C; Rico-Gray, V; Brustel, H; Galante, E; Mico, E				Quinto, Javier; Angeles Marcos-Garcia, Ma; Diaz-Castelazo, Cecilia; Rico-Gray, Victor; Brustel, Herve; Galante, Eduardo; Mico, Estefania			Breaking down Complex Saproxylic Communities: Understanding Sub-Networks Structure and Implications to Network Robustness	PLOS ONE			English	Article							HOVERFLIES DIPTERA; ECOLOGICAL NETWORK; BIODIVERSITY LOSS; FOOD; NESTEDNESS; SYRPHIDAE; ECOSYSTEM; BEETLES; FOREST; COMPARTMENTS	Saproxylic insect communities inhabiting tree hollow microhabitats correspond with large food webs which simultaneously are constituted by multiple types of plant-animal and animal-animal interactions, according to the use of trophic resources (wood- and insect-dependent sub-networks), or to trophic habits or interaction types (xylophagous, saprophagous, xylomycetophagous, predators and commensals). We quantitatively assessed which properties of specialised networks were present in a complex networks involving different interacting types such as saproxylic community, and how they can be organised in trophic food webs. The architecture, interacting patterns and food web composition were evaluated along sub-networks, analysing their implications to network robustness from random and directed extinction simulations. A structure of large and cohesive modules with weakly connected nodes was observed throughout saproxylic sub-networks, composing the main food webs constituting this community. Insect-dependent sub-networks were more modular than wood-dependent sub-networks. Wood-dependent sub-networks presented higher species degree, connectance, links, linkage density, interaction strength, and were less specialised and more aggregated than insect-dependent sub-networks. These attributes defined high network robustness in wood-dependent sub-networks. Finally, our results emphasise the relevance of modularity, differences among interacting types and interrelations among them in modelling the structure of saproxylic communities and in determining their stability.	[Quinto, Javier; Angeles Marcos-Garcia, Ma; Galante, Eduardo; Mico, Estefania] Univ Alicante, Ctr Iberoamer Biodiversidad CIBIO, E-03080 Alicante, Spain; [Diaz-Castelazo, Cecilia; Rico-Gray, Victor] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Brustel, Herve] Univ Toulouse, Ecole Ingn Purpan, INPT, Toulouse, France	Universitat d'Alacant; Instituto de Ecologia - Mexico; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Rico-Gray, V (corresponding author), Univ Veracruzana, Inst Neuroetol, Xalapa 91000, Veracruz, Mexico.	vrico@uv.mx	Galante, Eduardo/B-8619-2015; Micó, Estefanía/H-1983-2015; Marcos García, Maria Angeles/H-7925-2015; Díaz Castelazo, Cecilia/Q-8973-2018; BRUSTEL, Hervé/AAS-2809-2020; Quinto, Javier/AAU-5098-2021	Galante, Eduardo/0000-0001-7935-6584; Micó, Estefanía/0000-0002-7361-4770; Marcos García, Maria Angeles/0000-0002-2439-2630; Díaz Castelazo, Cecilia/0000-0002-0185-6607; Quinto, Javier/0000-0002-0774-5852	Secretaria de Estado de Investigacion, Desarrollo Innovacion [CGL2008-04472, CGL2009-09656, CGL2011-23658]; Proyecto LIFE+Nature [LIFE07/NAT/E/000762]; D.G. Politica Cientifica, Generalitat Valenciana [ACOMP/2011/225]	Secretaria de Estado de Investigacion, Desarrollo Innovacion; Proyecto LIFE+Nature; D.G. Politica Cientifica, Generalitat Valenciana	This work was supported by Secretaria de Estado de Investigacion, Desarrollo Innovacion (CGL2008-04472, CGL2009-09656, CGL2011-23658) (http://www.micinn.es/portal/site/MICINN); Proyecto LIFE+Nature (LIFE07/NAT/E/000762) (http://ec.europa.eu/environment/life/index.htm); and D.G. Politica Cientifica, Generalitat Valenciana (ACOMP/2011/225) (http://www.edu.gva.es/poci/es/dgpoci_becas.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2009, PHILOS T R SOC B, V364, P1701, DOI 10.1098/rstb.2008.0214; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, FRONT ECOL ENVIRON, V7, P429, DOI 10.1890/080026; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Beggs J, 2001, BIOL CONSERV, V99, P17, DOI 10.1016/S0006-3207(00)00185-3; Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Bouget C, 2008, REV ECOL-TERRE VIE, P21; Bouget C, 2008, REV ECOL-TERRE VIE, P33; Bouget C, 2005, CR BIOL, V328, P936, DOI 10.1016/j.crvi.2005.08.003; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Canseco V. Garcia, 1997, PARQUE NACL CABANERO, P95; Colas G, 1974, GUIDE ENTOMOLOGISTE; Dajoz R., 1998, INSECTES FORET ROLE; Davies ZG, 2008, BIODIVERS CONSERV, V17, P209, DOI 10.1007/s10531-007-9242-y; De Nooy W., 2005, EXPLORATORY SOCIAL N; Diaz-Castelazo C, 2010, ECOLOGY, V91, P793, DOI 10.1890/08-1883.1; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Gouix N, 2012, BIODIVERS CONSERV, V21, P421, DOI 10.1007/s10531-011-0190-1; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2010, ECOLOGY, V91, P2941, DOI 10.1890/09-1175.1; Kadowaki K, 2010, EUR J ENTOMOL, V107, P89, DOI 10.14411/eje.2010.012; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Lawrence D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001330; Marcos-Garcia Ma. A., 2010, Cuadernos de Biodiversidad, V34, P3; Martinez-Falcon AP, 2010, ECOL ENTOMOL, V35, P754, DOI 10.1111/j.1365-2311.2010.01236.x; Melian CJ, 2009, OIKOS, V118, P122, DOI 10.1111/j.1600-0706.2008.16751.x; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2006, SFI S SCI C, P325; Mico E, 2011, J NAT HIST, V45, P2527, DOI 10.1080/00222933.2011.596953; Mico Estefania, 2010, Elytron (Barcelona), V24, P89; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ranius T, 2002, BIODIVERS CONSERV, V11, P1759, DOI 10.1023/A:1020343030085; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Ricarte A, 2009, J NAT HIST, V43, P583, DOI 10.1080/00222930802610527; Ricarte A, 2007, J NAT HIST, V41, P1717, DOI 10.1080/00222930701495046; Sirami C, 2008, REV ECOL-TERRE VIE, P101; Speight M.C.D., 2010, SYRPH NET CD; Speight M. C. D., 1989, NATURE ENV SERIES, V42; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson F. Christian, 1998, P81; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; Van Veen M. P., 2004, HOVERFLIES NW EUROPE; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Wilmers CC, 2007, TRENDS ECOL EVOL, V22, P504, DOI 10.1016/j.tree.2007.08.008; Winter S, 2008, FOREST ECOL MANAG, V255, P1251, DOI 10.1016/j.foreco.2007.10.029	62	37	39	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45062	10.1371/journal.pone.0045062	http://dx.doi.org/10.1371/journal.pone.0045062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028763	Green Published, gold			2022-12-27	WOS:000309973900024
J	Pan, ST; Thompson, RCA; Grigg, ME; Sundar, N; Smith, A; Lymbery, AJ				Pan, Shuting; Thompson, R. C. Andrew; Grigg, Michael E.; Sundar, Natarajan; Smith, Andrew; Lymbery, Alan J.			Western Australian Marsupials Are Multiply Infected with Genetically Diverse Strains of Toxoplasma gondii	PLOS ONE			English	Article							SEXUAL RECOMBINATION; POPULATION-STRUCTURE; SEROPREVALENCE; EXPANSION; PARASITES; DRIVEN	Five different organs from 16 asymptomatic free-ranging marsupial macropods (Macropus rufus, M. fuliginosus, and M. robustus) from inland Western Australia were tested for infection with Toxoplasma gondii by multi-locus PCR-DNA sequencing. All macropods were infected with T. gondii, and 13 had parasite DNA in at least 2 organs. In total, 45 distinct T. gondii genotypes were detected. Fourteen of the 16 macropods were multiply infected with genetically distinct T. gondii genotypes that often partitioned between different organs. The presence of multiple T. gondii infections in macropods suggests that native mammals have the potential to promote regular cycles of sexual reproduction in the definitive felid host in this environment.	[Lymbery, Alan J.] Murdoch Univ, Sch Vet & Biomed Sci, Fish Hlth Unit, Perth, WA, Australia; [Grigg, Michael E.; Sundar, Natarajan] NIAID, Mol Parasitol Unit, Parasit Dis Lab, Bethesda, MD 20892 USA	Murdoch University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lymbery, AJ (corresponding author), Murdoch Univ, Sch Vet & Biomed Sci, Fish Hlth Unit, Perth, WA, Australia.	a.lymbery@murdoch.edu.au	Lymbery, Alan/H-3096-2019	Lymbery, Alan/0000-0002-0542-3446	Australian Research Council; Murdoch University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001018] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); Murdoch University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Australian Research Council and Murdoch University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2004, INT J PARASITOL, V34, P1185, DOI 10.1016/j.ijpara.2004.06.007; Barnes TS, 2010, J WILDLIFE DIS, V46, P218, DOI 10.7589/0090-3558-46.1.218; Dao A, 2001, INT J PARASITOL, V31, P63, DOI 10.1016/S0020-7519(00)00151-X; Darde M. L., 2007, P49, DOI 10.1016/B978-012369542-0/50005-2; Dubey JP, 2008, J PARASITOL, V94, P929, DOI 10.1645/GE-1448.1; DUBEY JP, 1986, J AM VET MED ASSOC, V189, P166; Dubey JP, 2004, J PARASITOL, V90, P67, DOI 10.1645/GE-110R; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Grigg ME, 2009, INT J PARASITOL, V39, P925, DOI 10.1016/j.ijpara.2009.02.005; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; JOHNSON AM, 1988, AUST VET J, V65, P199, DOI 10.1111/j.1751-0813.1988.tb14456.x; Khan A, 2007, P NATL ACAD SCI USA, V104, P14872, DOI 10.1073/pnas.0702356104; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Lehmann T, 2006, P NATL ACAD SCI USA, V103, P11423, DOI 10.1073/pnas.0601438103; Lindstrom I, 2008, PARASITOLOGY, V135, P39, DOI 10.1017/S0031182007003654; Long JL, 2003, INTRO MAMMALS WORLD; Nutter FB, 1998, J PARASITOL, V84, P1048, DOI 10.2307/3284644; Parameswaran N, 2010, INT J PARASITOL, V40, P635, DOI 10.1016/j.ijpara.2010.02.008; Parameswaran N, 2009, PARASITOLOGY, V136, P939, DOI 10.1017/S0031182009006453; Parameswaran N, 2009, PARASITOL INT, V58, P161, DOI 10.1016/j.parint.2009.01.008; Richomme C, 2009, VET PARASITOL, V164, P296, DOI 10.1016/j.vetpar.2009.06.014; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Short J, 2005, WILDLIFE RES, V32, P489, DOI 10.1071/WR04102; Sibley LD, 2008, ANNU REV MICROBIOL, V62, P329, DOI 10.1146/annurev.micro.62.081307.162925; Sibley LD, 2009, PHILOS T R SOC B, V364, P2749, DOI 10.1098/rstb.2009.0087; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wendte JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001261; Yai LEO, 2009, VET PARASITOL, V162, P332, DOI 10.1016/j.vetpar.2009.03.007	29	30	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45147	10.1371/journal.pone.0045147	http://dx.doi.org/10.1371/journal.pone.0045147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028812	Green Published, gold			2022-12-27	WOS:000309554700025
J	Moubarac, JC; Cargo, M; Receveur, O; Daniel, M				Moubarac, Jean-Claude; Cargo, Margaret; Receveur, Olivier; Daniel, Mark			Describing the Situational Contexts of Sweetened Product Consumption in a Middle Eastern Canadian Community: Application of a Mixed Method Design	PLOS ONE			English	Article							FOOD-CHOICE; PHYSICAL-ACTIVITY; VENDING MACHINES; ENERGY-INTAKE; CHOCOLATE; OBESITY; NUTRITION; ATTITUDES; DIET; QUESTIONNAIRE	Little is known about the situational contexts in which individuals consume processed sources of dietary sugars. This study aimed to describe the situational contexts associated with the consumption of sweetened food and drink products in a Catholic Middle Eastern Canadian community. A two-stage exploratory sequential mixed-method design was employed with a rationale of triangulation. In stage 1 (n = 62), items and themes describing the situational contexts of sweetened food and drink product consumption were identified from semi-structured interviews and were used to develop the content for the Situational Context Instrument for Sweetened Product Consumption (SCISPC). Face validity, readability and cultural relevance of the instrument were assessed. In stage 2 (n = 192), a cross-sectional study was conducted and exploratory factor analysis was used to examine the structure of themes that emerged from the qualitative analysis as a means of furthering construct validation. The SCISPC reliability and predictive validity on the daily consumption of sweetened products were also assessed. In stage 1, six themes and 40-items describing the situational contexts of sweetened product consumption emerged from the qualitative analysis and were used to construct the first draft of the SCISPC. In stage 2, factor analysis enabled the clarification and/or expansion of the instrument's initial thematic structure. The revised SCISPC has seven factors and 31 items describing the situational contexts of sweetened product consumption. Initial validation of the instrument indicated it has excellent internal consistency and adequate test-retest reliability. Two factors of the SCISPC had predictive validity for the daily consumption of total sugar from sweetened products (Snacking and Energy demands) while the other factors (Socialization, Indulgence, Constraints, Visual Stimuli and Emotional needs) were rather associated to occasional consumption of these products.	[Moubarac, Jean-Claude] Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada; [Cargo, Margaret; Daniel, Mark] Univ S Australia, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Receveur, Olivier] Univ Sao Paulo, Dept Nutr, Sao Paulo, Brazil	Universite de Montreal; University of South Australia; Universidade de Sao Paulo	Moubarac, JC (corresponding author), Univ Sao Paulo, Nucleo Pesquisas Epidemiol Nutr & Saude, Sao Paulo, Brazil.	jcmoubarac@gmail.com	Cargo, Margaret D/B-2141-2010; Moubarac, Jean-Claude/ABE-6439-2020; Daniel, Mark/A-1151-2009; Moubarac, Jean-Claude/J-8235-2014	Daniel, Mark/0000-0001-9112-134X				Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Ahern K., 2016, INT J QUAL METHODS, V1, P70, DOI [10.1177/160940690200100305, DOI 10.1177/160940690200100305]; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2005, PRACTICAL ASSESMENT; Anschutz DJ, 2009, APPETITE, V53, P119, DOI 10.1016/j.appet.2009.03.016; ARNOW B, 1995, INT J EAT DISORDER, V18, P79, DOI 10.1002/1098-108X(199507)18:1<79::AID-EAT2260180109>3.0.CO;2-V; Ayala GX, 2008, OBESITY, V16, P1002, DOI 10.1038/oby.2008.34; Benton D, 1998, PERS INDIV DIFFER, V24, P513, DOI 10.1016/S0191-8869(97)00215-8; Blanchet C., 2009, CONSOMMATION ALIMENT; Cepeda-Benito A, 2000, BEHAV RES THER, V38, P1125, DOI 10.1016/S0005-7967(99)00141-2; Chapelot D, 2011, J NUTR, V141, P158, DOI 10.3945/jn.109.114330; Chaput JP, 2008, PSYCHOSOM MED, V70, P797, DOI 10.1097/PSY.0b013e31818426fa; Cholestech Corporation, 2004, TECHN FOC; Christensen L, 2001, APPETITE, V36, P137, DOI 10.1006/appe.2001.0390; Corsica Joyce A, 2008, Eat Behav, V9, P447, DOI 10.1016/j.eatbeh.2008.07.004; Creswell W. C., 2011, DESIGNING CONDUCTING; Devine CM, 2007, OBESITY, V15, p57S, DOI 10.1038/oby.2007.388; Devine CM, 2003, SOC SCI MED, V56, P617, DOI 10.1016/S0277-9536(02)00058-8; Elfhag K, 2007, PHYSIOL BEHAV, V91, P191, DOI 10.1016/j.physbeh.2007.02.005; Farley TA, 2010, AM J PUBLIC HEALTH, V100, P306, DOI 10.2105/AJPH.2009.178681; French SA, 2005, J NUTR, V135, P910, DOI 10.1093/jn/135.4.910; French SA, 2010, J OCCUP ENVIRON MED, V52, pS29, DOI 10.1097/JOM.0b013e3181c5c476; Galal OM, 2002, PUBLIC HEALTH NUTR, V5, P141, DOI 10.1079/PHN2001286; Garriguet Didier, 2007, Health Rep, V18, P17; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; Greene J.C., 1989, EDUC EVAL POLICY AN, V11, P255, DOI [10.3102/01623737011003255, DOI 10.3102/01623737011003255]; Guba E., 1989, 4 GENERATION EVALUAT; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Hassan-Wassef H, 2004, East Mediterr Health J, V10, P898; Hattersley L, 2009, PUBLIC HEALTH NUTR, V12, P1816, DOI 10.1017/S136898000800462X; Health Canada, 2010, CAN NUTR FIL VERS 20; Hendel-Paterson M, 2004, J AM DIET ASSOC, V104, P1597, DOI 10.1016/j.jada.2004.07.003; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; HETHERINGTON MM, 1995, PHYSIOL BEHAV, V57, P27, DOI 10.1016/0031-9384(94)00199-F; Issa C, 2009, INT J FOOD SCI NUTR, V60, P285, DOI 10.1080/09637480903107700; Jabs J, 2006, APPETITE, V47, P196, DOI 10.1016/j.appet.2006.02.014; Jaeger SR, 2009, APPETITE, V52, P318, DOI 10.1016/j.appet.2008.11.004; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Killaspy H, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-35; Larson N, 2009, ANN BEHAV MED, V38, pS56, DOI 10.1007/s12160-009-9120-9; Levine AS, 2003, AM J CLIN NUTR, V78, p834S, DOI 10.1093/ajcn/78.4.834S; Liu Richard, 2010, Open Med, V4, pe143; Lluch A, 2000, INT J OBESITY, V24, P1493, DOI 10.1038/sj.ijo.0801425; Lofland J, 2006, ANAL SOCIAL SETTINGS, V4th; Ludwig DS, 2011, JAMA-J AM MED ASSOC, V305, P1352, DOI 10.1001/jama.2011.380; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Macht M, 2007, J NERV MENT DIS, V195, P1024, DOI 10.1097/NMD.0b013e31815c0878; Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002; Mann J, 2007, EUR J CLIN NUTR, V61, pS132, DOI 10.1038/sj.ejcn.1602943; Marquis M, 2005, CAN J DIET PRACT RES, V66, P77, DOI 10.3148/66.2.2005.77; MCKENZIE TL, 1991, J APPL BEHAV ANAL, V24, P141, DOI 10.1901/jaba.1991.24-141; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Monteiro CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001252; Monteiro CA, 2010, AM J PUBLIC HEALTH, V100, P975, DOI 10.2105/AJPH.2009.187666; Monteiro CA, 2009, PUBLIC HEALTH NUTR, V12, P729, DOI 10.1017/S1368980009005291; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Monteiro CA, 2010, CAD SAUDE PUBLICA, V26, P2039, DOI 10.1590/S0102-311X2010001100005; Moubarac J-C, 2010, ETUDE COMPORTEMENT C; Moubarac J-C, 2011, WORLD NUTR, V3, P62; Muller J, 2008, APPETITE, V50, P499, DOI 10.1016/j.appet.2007.10.008; Nakanishi S, 2004, BIOMED PHARMACOTHER, V58, P571, DOI 10.1016/j.biopha.2004.10.001; Nielsen SJ, 2002, PREV MED, V35, P107, DOI 10.1006/pmed.2002.1037; Oliver G, 2000, PSYCHOSOM MED, V62, P853, DOI 10.1097/00006842-200011000-00016; Onwuegbuzie AJ, 2010, J MIX METHOD RES, V4, P56, DOI 10.1177/1558689809355805; Ovaskainen ML, 2006, EUR J CLIN NUTR, V60, P494, DOI 10.1038/sj.ejcn.1602343; Piernas C, 2010, J NUTR, V140, P325, DOI 10.3945/jn.109.112763; Poulain J-P, 2002, MANAGER AUJOURDHUI A; ROZIN P, 1991, APPETITE, V17, P199, DOI 10.1016/0195-6663(91)90022-K; Sabate J, 2004, BRIT J NUTR, V92, P199, DOI 10.1079/BJN20041229; Sallis JF, 2009, AM J PREV MED, V36, pS72, DOI 10.1016/j.amepre.2008.10.006; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Schachter AR, 1974, OBESE HUMAN RATS; Statistics Canada, 2007, AR COMM 2007; Statistics Canada, 2009, ENQ SANT COLL CAN CY; STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061; Stroebele N, 2004, NUTRITION, V20, P821, DOI 10.1016/j.nut.2004.05.012; Stroebele N, 2004, APPETITE, V42, P111, DOI 10.1016/j.appet.2003.09.001; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571; Vallianatos H., 2008, Food, Culture & Society, V11, P355, DOI 10.2752/175174408X347900; VANSTRIEN T, 1986, INT J OBESITY, V10, P29; White MA, 2002, OBES RES, V10, P107, DOI 10.1038/oby.2002.17; WHO, 2003, DIET NUTR PREVENTION, V916; Wiecha JL, 2006, J AM DIET ASSOC, V106, P1624, DOI 10.1016/j.jada.2006.07.007; World Cancer Research Fund/American Institute for Cancer Research, 2009, POL ACT CANC PREV FO; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	88	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44738	10.1371/journal.pone.0044738	http://dx.doi.org/10.1371/journal.pone.0044738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23028597	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000309392800014
J	Hebras, C; McDougall, A				Hebras, Celine; McDougall, Alex			Urochordate Ascidians Possess a Single Isoform of Aurora Kinase That Localizes to the Midbody via TPX2 in Eggs and Cleavage Stage Embryos	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; CHROMOSOMAL PASSENGER COMPLEX; CELL-CYCLE PROGRESSION; PROTEIN-KINASE; MOUSE OOCYTES; CYTOKINESIS FAILURE; MEIOSIS-I; SPINDLE; SEGREGATION; ANAPHASE	Aurora kinases are key proteins found throughout the eukaryotes that control mitotic progression. Vertebrate Aurora-A and B kinases are thought to have evolved from a single Aurora-kinase isoform closest to that found in present day urochordates. In urochordate ascidians Aurora binds both TPX2 (a vertebrate AURKA partner) and INCENP (a vertebrate AURKB partner) and localizes to centrosomes and spindle microtubules as well as chromosomes and midbody during both meiosis and mitosis. Ascidian Aurora also displays this localization pattern during mitosis in echinoderms, strengthening the idea that non-vertebrate deuterostomes such as the urochordates and echinoderms possess a single form of Aurora kinase that has properties of vertebrate Aurora-kinase A and B. In the ascidian, TPX2 localizes to the centrosome and the spindle poles also as in vertebrates. However, we were surprised to find that TPX2 also localized strongly to the midbody in ascidian eggs and embryos. We thus examined more closely Aurora localization to the midbody by creating two separate point mutations of ascidian Aurora predicted to perturb binding to TPX2. Both forms of mutated Aurora behaved as predicted: neither localized to spindle poles where TPX2 is enriched. Interestingly, neither form of mutated Aurora localized to the midbody where TPX2 is also enriched, suggesting that ascidian Aurora midbody localization required TPX2 binding in ascidians. Functional analysis revealed that inhibition of Aurora kinase with a pharmacological inhibitor or with a dominant negative kinase dead form of Aurora caused cytokinesis failure and perturbed midbody formation during polar body extrusion. Our data support the view that vertebrate Aurora-A and B kinases evolved from a single non-vertebrate deuterostome ancestor. Moreover, since TPX2 localizes to the midbody in ascidian eggs and cleavage stage embryos it may be worthwhile re-assessing whether Aurora A kinase or TPX2 localize to the midbody in eggs and cleavage stage embryos.	[McDougall, Alex] Univ Paris 06, Villefranche Sur Mer, France; CNRS, Dev Biol Unit, Villefranche Sur Mer, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	McDougall, A (corresponding author), Univ Paris 06, Villefranche Sur Mer, France.	alex-mc.dougall@obs-vlfr.fr	McDougall, Alex/J-1930-2014	McDougall, Alex/0000-0003-0324-3836	L'Agence National de la Recherche (ANR) [08-BLAN-0136-02]; Fondation ARC pour la Recherche sur le Cancer (ARC); Action Thematique et Incitative sur Programme (ATIP)	L'Agence National de la Recherche (ANR)(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer (ARC); Action Thematique et Incitative sur Programme (ATIP)	This work was supported by L'Agence National de la Recherche (ANR)(08-BLAN-0136-02), Fondation ARC pour la Recherche sur le Cancer (ARC) and Action Thematique et Incitative sur Programme (ATIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2010, J CELL SCI, V123, P3978, DOI 10.1242/jcs.076315; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bernard M, 1998, GENOMICS, V53, P406, DOI 10.1006/geno.1998.5522; Bibby RA, 2009, J BIOL CHEM, V284, P33177, DOI 10.1074/jbc.M109.032722; Brown JR, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-39; Brunet S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003338; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Crane R, 2004, BIOL CELL, V96, P215, DOI 10.1016/j.biolcel.2003.09.008; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Ding J, 2011, MOL REPROD DEV, V78, P80, DOI 10.1002/mrd.21272; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dorn JF, 2010, CURR BIOL, V20, P2046, DOI 10.1016/j.cub.2010.10.030; Dumollard R, 2011, DEVELOPMENT, V138, P885, DOI 10.1242/dev.057133; Evrard JL, 2009, PLANT SIGNAL BEHAV, V4, P69, DOI 10.4161/psb.4.1.7409; Floyd S, 2008, CURR BIOL, V18, P1649, DOI 10.1016/j.cub.2008.09.058; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Fu JY, 2009, P NATL ACAD SCI USA, V106, P6939, DOI 10.1073/pnas.0900833106; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Goshima G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028120; Iyer J, 2012, CELL SIGNAL, V24, P1677, DOI 10.1016/j.cellsig.2012.04.014; Lewellyn L, 2011, J CELL BIOL, V193, P155, DOI 10.1083/jcb.201008138; Li H, 2008, EUKARYOT CELL, V7, P894, DOI 10.1128/EC.00422-07; McDougall A, 1998, DEVELOPMENT, V125, P4451; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; O'Brien LL, 2006, J CELL BIOL, V173, P685, DOI 10.1083/jcb.200512107; Ozlu N, 2005, DEV CELL, V9, P237, DOI 10.1016/j.devcel.2005.07.002; Petersen J, 2001, J CELL SCI, V114, P4371; Prodon F, 2010, DEVELOPMENT, V137, P2011, DOI 10.1242/dev.047845; Reich A, 1999, DNA CELL BIOL, V18, P593, DOI 10.1089/104454999315141; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; Salaun P, 2008, ADV EXP MED BIOL, V617, P41; Sardet C, 2011, METHODS MOL BIOL, V770, P365, DOI 10.1007/978-1-61779-210-6_14; Saskova A, 2008, CELL CYCLE, V7, P2368, DOI 10.4161/cc.6361; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stewart S, 2005, MOL CELL BIOL, V25, P10516, DOI 10.1128/MCB.25.23.10516-10527.2005; Uzbekova S, 2008, BIOL REPROD, V78, P218, DOI 10.1095/biolreprod.107.061036; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Wittmann T, 1998, J CELL BIOL, V143, P673, DOI 10.1083/jcb.143.3.673; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Yang KT, 2010, MOL BIOL CELL, V21, P2371, DOI 10.1091/mbc.E10-02-0170	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45431	10.1371/journal.pone.0045431	http://dx.doi.org/10.1371/journal.pone.0045431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029005	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900052
J	Matesanz, S; Horgan-Kobelski, T; Sultan, SE				Matesanz, Silvia; Horgan-Kobelski, Tim; Sultan, Sonia E.			Phenotypic Plasticity and Population Differentiation in an Ongoing Species Invasion	PLOS ONE			English	Article							WATER-USE EFFICIENCY; NATURAL-SELECTION; LOCAL ADAPTATION; POLYGONUM-PERSICARIA; DEPENDENT SELECTION; ADAPTIVE EVOLUTION; GENETIC-VARIATION; RAPID EVOLUTION; PLANT; LIGHT	The ability to succeed in diverse conditions is a key factor allowing introduced species to successfully invade and spread across new areas. Two non-exclusive factors have been suggested to promote this ability: adaptive phenotypic plasticity of individuals, and the evolution of locally adapted populations in the new range. We investigated these individual and population-level factors in Polygonum cespitosum, an Asian annual that has recently become invasive in northeastern North America. We characterized individual fitness, life-history, and functional plasticity in response to two contrasting glasshouse habitat treatments (full sun/dry soil and understory shade/moist soil) in 165 genotypes sampled from nine geographically separate populations representing the range of light and soil moisture conditions the species inhabits in this region. Polygonum cespitosum genotypes from these introduced-range populations expressed broadly similar plasticity patterns. In response to full sun, dry conditions, genotypes from all populations increased photosynthetic rate, water use efficiency, and allocation to root tissues, dramatically increasing reproductive fitness compared to phenotypes expressed in simulated understory shade. Although there were subtle among-population differences in mean trait values as well as in the slope of plastic responses, these population differences did not reflect local adaptation to environmental conditions measured at the population sites of origin. Instead, certain populations expressed higher fitness in both glasshouse habitat treatments. We also compared the introduced-range populations to a single population from the native Asian range, and found that the native population had delayed phenology, limited functional plasticity, and lower fitness in both experimental environments compared with the introduced-range populations. Our results indicate that the future spread of P. cespitosum in its introduced range will likely be fueled by populations consisting of individuals able to express high fitness across diverse light and moisture conditions, rather than by the evolution of locally specialized populations.	[Horgan-Kobelski, Tim; Sultan, Sonia E.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; [Matesanz, Silvia] Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain	Wesleyan University; Universidad Rey Juan Carlos	Sultan, SE (corresponding author), Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA.	sesultan@wesleyan.edu	Matesanz, Silvia/U-3009-2019; Matesanz, Silvia/L-5153-2014	Matesanz, Silvia/0000-0003-0060-6136	Marie Curie IOF Fellowship (European Commission FP7); Wesleyan University; Howard Hughes Medical Institute	Marie Curie IOF Fellowship (European Commission FP7); Wesleyan University; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The study was funded by a Marie Curie IOF Fellowship (European Commission FP7) awarded to SM, and by a Wesleyan University Project Grant to SES. Student assistants were supported by the Howard Hughes Medical Institute and Wesleyan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2000, BIOSCIENCE, V50, P979, DOI 10.1641/0006-3568(2000)050[0979:TEOPET]2.0.CO;2; Baker H. G., 1965, The genetics of colonizing species., P147; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Bell DL, 2007, FUNCT ECOL, V21, P1146, DOI 10.1111/j.1365-2435.2007.01327.x; Bell DL, 2008, AM J BOT, V95, P59, DOI 10.3732/ajb.95.1.59; Bell DL, 1999, AM J BOT, V86, P807, DOI 10.2307/2656702; Blair AC, 2004, ECOLOGY, V85, P3035, DOI 10.1890/04-0341; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Bossdorf O, 2008, DIVERS DISTRIB, V14, P676, DOI 10.1111/j.1472-4642.2008.00471.x; Brachi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032069; Buswell JM, 2011, J ECOL, V99, P214, DOI 10.1111/j.1365-2745.2010.01759.x; Cano L, 2008, J ECOL, V96, P468, DOI 10.1111/j.1365-2745.2008.01363.x; CHAZDON RL, 1991, BIOSCIENCE, V41, P760, DOI 10.2307/1311725; CHEN JM, 1991, AGR FOREST METEOROL, V56, P129, DOI 10.1016/0168-1923(91)90108-3; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Donohue K, 2000, EVOLUTION, V54, P1956, DOI 10.1111/j.0014-3820.2000.tb01240.x; DONOVAN LA, 1994, AM J BOT, V81, P927, DOI 10.2307/2445774; Dudley SA, 1996, EVOLUTION, V50, P92, DOI [10.2307/2410783, 10.1111/j.1558-5646.1996.tb04475.x]; Dudley SA, 1996, AM NAT, V147, P445, DOI 10.1086/285860; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Fitter A.H., 2002, ENV PHYSL PLANTS; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Geng YP, 2007, BIOL INVASIONS, V9, P245, DOI 10.1007/s10530-006-9029-1; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gianoli E, 2005, EVOL ECOL, V19, P603, DOI 10.1007/s10682-005-2220-5; Griffith TM, 2005, NEW PHYTOL, V166, P141, DOI 10.1111/j.1469-8137.2004.01277.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Heschel MS, 2004, INT J PLANT SCI, V165, P817, DOI 10.1086/421477; Heschel MS, 2002, INT J PLANT SCI, V163, P907, DOI 10.1086/342519; Hill T., 2005, STAT METHODS APPL CO; Huey RB, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P139; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kim ST, 2008, SYST BOT, V33, P77, DOI 10.1600/036364408783887302; Kutner M.H., 2005, APPL LINEAR REGRESSI, V5; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lee CE, 2008, EVOL APPL, V1, P427, DOI 10.1111/j.1752-4571.2008.00039.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leger EA, 2007, J EVOLUTION BIOL, V20, P1090, DOI 10.1111/j.1420-9101.2006.01292.x; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Maron JL, 2004, ECOLOGY, V85, P3243, DOI 10.1890/04-0297; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Mehrhoff L.J., 2003, IPANE INVASIVE PLANT; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI [10.2307/2409084, 10.1111/j.1558-5646.1987.tb02457.x]; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Nicotra AB, 1999, ECOLOGY, V80, P1908, DOI 10.1890/0012-9658(1999)080[1908:SHOLAW]2.0.CO;2; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Paterson A.K., 2000, BARTONIA, V60, P57; Pysek Petr, 2007, V193, P97; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.1111/j.1558-5646.1992.tb02070.x; RICH PM, 1993, AGR FOREST METEOROL, V65, P107, DOI 10.1016/0168-1923(93)90040-O; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Richards CL, 2010, ESTUAR COAST, V33, P840, DOI 10.1007/s12237-009-9186-4; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Riis T, 2010, ANN BOT-LONDON, V106, P813, DOI 10.1093/aob/mcq176; Ross CA, 2009, BIOL INVASIONS, V11, P441, DOI 10.1007/s10530-008-9261-y; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Saldana A, 2005, Oecologia, V145, P252, DOI 10.1007/s00442-005-0116-2; Schmitt J, 2003, INTEGR COMP BIOL, V43, P459, DOI 10.1093/icb/43.3.459; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Stanton ML, 2000, EVOLUTION, V54, P93, DOI 10.1111/j.0014-3820.2000.tb00011.x; Steets JA, 2010, AM J BOT, V97, P1098, DOI 10.3732/ajb.0900362; Steinger T, 2003, J EVOLUTION BIOL, V16, P313, DOI 10.1046/j.1420-9101.2003.00518.x; Stinchcombe JR, 2002, AM NAT, V160, P511, DOI 10.1086/342069; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; SULTAN SE, 1993, EVOLUTION, V47, P1009, DOI 10.1111/j.1558-5646.1993.tb02132.x; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Sultan SE, 2001, ECOLOGY, V82, P328, DOI 10.1890/0012-9658(2001)082[0328:PPFFCI]2.0.CO;2; SULTAN SE, 1993, EVOLUTION, V47, P1032, DOI 10.2307/2409973; Sultan SE, 2004, PERSPECT PLANT ECOL, V6, P227, DOI 10.1078/1433-8319-00082; Sultan SE, 1998, OECOLOGIA, V115, P564, DOI 10.1007/s004420050554; Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Sultan SE, 2013, EVOL APPL, V6, P266, DOI 10.1111/j.1752-4571.2012.00287.x; Valladares F, 1997, PLANT CELL ENVIRON, V20, P25, DOI 10.1046/j.1365-3040.1997.d01-8.x; van Kleunen M, 2008, BASIC APPL ECOL, V9, P213, DOI 10.1016/j.baae.2007.03.006; WILLIAMS DG, 1995, ECOLOGY, V76, P1569, DOI 10.2307/1938158; Yonekura K., 2006, FLORA JAPAN A, P122; Zar J.H., 2010, BIOSTAT ANAL	85	58	59	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44955	10.1371/journal.pone.0044955	http://dx.doi.org/10.1371/journal.pone.0044955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028702	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400053
J	Eberle, C; Merki, E; Yamashita, T; Johnson, S; Armando, AM; Quehenberger, O; Napoli, C; Palinski, W				Eberle, Claudia; Merki, Esther; Yamashita, Tomoya; Johnson, Susie; Armando, Aaron M.; Quehenberger, Oswald; Napoli, Claudio; Palinski, Wulf			Maternal Immunization Affects In Utero Programming of Insulin Resistance and Type 2 Diabetes	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; RECEPTOR-DEFICIENT MICE; ANTIOXIDANT DEFENSE CAPACITY; FATTY STREAK FORMATION; ATHEROSCLEROTIC LESIONS; CARDIOVASCULAR RISK; OXIDATIVE STRESS; HYPERCHOLESTEROLEMIA; MECHANISMS; PREGNANCY	Maternal immunization with oxidized lipoproteins prior to pregnancy protects against atherogenic in utero programming by gestational hypercholesterolemia and enhances beneficial lymphocyte-dependent immune responses in offspring. To determine whether in utero programming and immunomodulation also affect insulin resistance (IR) and type 2 diabetes, we investigated the effects of immunization on glucose and insulin responses in LDL receptor-deficient mice fed regular or 60% sucrose diets, as well as in offspring fed 0.5% cholesterol or 60% sucrose diets. IR was assessed by fasting glucose and insulin levels, oral glucose tolerance tests, glucose clamps, pancreatic immunohistochemistry and plasma free fatty acid concentrations. Immunizations improved glucose responses in both genders and protected both immunized mice and their offspring against IR and type 2 diabetes. Protection occurred even under euglycemic conditions, but was greatest in obese males exposed to very obesogenic/diabetogenic conditions. Hyperinsulinemic euglycemic clamps confirmed that maternal immunization protected mainly by reducing IR, but pancreatic immunocytochemistry also indicated some protection against beta cell damage. Maternal immunization was associated with marked regulation in offspring of 4 genes relevant to diabetes and 19 genes of importance for oxidative stress, as well as increased hepatic activities of key antioxidant enzymes. These findings establish that targeted immunomodulation may be used to protect immunized subjects and their offspring against IR and type 2 diabetes, and thus to reduce cardiovascular risk. They also support the notion that in utero programming influences offspring disease not by a single mechanism, but by multiple systemic effects.	[Eberle, Claudia; Merki, Esther; Yamashita, Tomoya; Johnson, Susie; Quehenberger, Oswald; Palinski, Wulf] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Yamashita, Tomoya] Kobe Univ, Sch Med, Dept Internal Med, Kobe, Hyogo 650, Japan; [Armando, Aaron M.; Quehenberger, Oswald] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Napoli, Claudio] Univ Naples 2, Sch Med 1, Dept Gen Pathol, Naples, Italy; [Napoli, Claudio] Univ Naples 2, Sch Med 1, Excellence Res Ctr Cardiovasc Dis, Naples, Italy	University of California System; University of California San Diego; Kobe University; University of California System; University of California San Diego; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Palinski, W (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	wpalinski@ucsd.edu	Palinski, Wulf/AAW-8032-2021; Eberle, Claudia/J-8855-2017	Eberle, Claudia/0000-0001-7878-2020; Yamashita, Tomoya/0000-0003-0267-3842; Napoli, Claudio/0000-0002-5455-555X; Palinski, Wulf/0000-0002-5113-0169	NIH [HL067792, HL089559, GM069338]; Ellison Medical Foundation [AG-SS 1851]; Regione Campania (Italian regional government); German Cardiac Society (DGK) Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067792, R01HL089559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Regione Campania (Italian regional government); German Cardiac Society (DGK) Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was funded by NIH grants HL067792 and HL089559 (W.P.), Ellison Medical Foundation (www.ellisonfoundation.org) Senior Scholar Award AG-SS 1851 (W.P.), and the NIH LIPID MAPS Large Scale Collaborative Grant GM069338 (O.Q.). C.N. was the recipient of Regione Campania (Italian regional government) 2008 Research Funds. C.E. was supported by a German Cardiac Society (DGK) Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameli S, 1996, ARTERIOSCL THROM VAS, V16, P1074, DOI 10.1161/01.ATV.16.8.1074; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Baynes JW, 2000, FREE RADICAL BIO MED, V28, P1708, DOI 10.1016/S0891-5849(00)00228-8; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Burke KT, 2009, J LIPID RES, V50, P1146, DOI 10.1194/jlr.M800538-JLR200; Dabelea D, 1999, DIABETES CARE, V22, P944, DOI 10.2337/diacare.22.6.944; Elahi MM, 2008, HYPERTENSION, V51, P939, DOI 10.1161/HYPERTENSIONAHA.107.100982; Freigang S, 1998, ARTERIOSCL THROM VAS, V18, P1972, DOI 10.1161/01.ATV.18.12.1972; GOHARKHAY N, 2008, AM J OBSTET GYNECOL, V199, P273; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Khan IY, 2005, AM J PHYSIOL-REG I, V288, pR127, DOI 10.1152/ajpregu.00354.2004; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Liang CP, 2007, CIRC RES, V100, P1546, DOI 10.1161/CIRCRESAHA.107.152165; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Merat S, 1999, ARTERIOSCL THROM VAS, V19, P1223, DOI 10.1161/01.ATV.19.5.1223; Napoli C, 2000, FASEB J, V14, P1996, DOI 10.1096/fj.99-0986com; Napoli C, 1999, CIRCULATION, V99, P2003, DOI 10.1161/01.CIR.99.15.2003; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; Napoli C, 2002, CIRCULATION, V105, P1360, DOI 10.1161/01.CIR.0000013090.96919.FA; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; Napoli C, 2001, J CELL BIOCHEM, V82, P674, DOI 10.1002/jcb.1198; Napoli C, 2000, CIRC RES, V87, P946, DOI 10.1161/01.RES.87.10.946; Nilsson J, 1997, J AM COLL CARDIOL, V30, P1886, DOI 10.1016/S0735-1097(97)00366-5; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; PALINSKI W, 1995, ARTERIOSCL THROM VAS, V15, P571, DOI 10.1161/01.ATV.15.5.571; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; Palinski W, 2001, CIRC RES, V89, P991, DOI 10.1161/hh2301.099646; Palinski W, 2009, CIRC RES, V104, P569, DOI 10.1161/CIRCRESAHA.109.194191; Quehenberger O, 2011, BBA-MOL CELL BIOL L, V1811, P648, DOI 10.1016/j.bbalip.2011.07.006; Quehenberger O, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.044; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stefulj J, 2009, CIRC RES, V104, P600, DOI 10.1161/CIRCRESAHA.108.185066; Tarry-Adkins JL, 2008, FASEB J, V22, P2037, DOI 10.1096/fj.07-099523; Tarry-Adkins JL, 2010, FASEB J, V24, P2762, DOI 10.1096/fj.10-156075; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Versmissen J, 2011, ATHEROSCLEROSIS, V219, P690, DOI 10.1016/j.atherosclerosis.2011.08.039; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Yamashita T, 2006, CIRC RES, V99, pE51, DOI 10.1161/01.RES.0000244003.08127.cc	49	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45361	10.1371/journal.pone.0045361	http://dx.doi.org/10.1371/journal.pone.0045361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028961	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900126
J	Fernandez-Velasco, M; Prieto, P; Terron, V; Benito, G; Flores, JM; Delgado, C; Zaragoza, C; Lavin, B; Gomez-Parrizas, M; Lopez-Collazo, E; Martin-Sanz, P; Bosca, L				Fernandez-Velasco, Maria; Prieto, Patricia; Terron, Veronica; Benito, Gemma; Flores, Juana M.; Delgado, Carmen; Zaragoza, Carlos; Lavin, Begona; Gomez-Parrizas, Monica; Lopez-Collazo, Eduardo; Martin-Sanz, Paloma; Bosca, Lisardo			NOD1 Activation Induces Cardiac Dysfunction and Modulates Cardiac Fibrosis and Cardiomyocyte Apoptosis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; IN-VIVO; HOST RECOGNITION; DISEASE; PROTEINS; INFLAMMATION; IMMUNITY; CELLS; HEART	The innate immune system is responsible for the initial response of an organism to potentially harmful stressors, pathogens or tissue injury, and accordingly plays an essential role in the pathogenesis of many inflammatory processes, including some cardiovascular diseases. Toll like receptors (TLR) and nucleotide-binding oligomerization domain-like receptors (NLRs) are pattern recognition receptors that play an important role in the induction of innate immune and inflammatory responses. There is a line of evidence supporting that activation of TLRs contributes to the development and progression of cardiovascular diseases but less is known regarding the role of NLRs. Here we demonstrate the presence of the NLR member NOD1 (nucleotide-binding oligomerization domain containing 1) in the murine heart. Activation of NOD1 with the specific agonist C12-iEDAP, but not with the inactive analogue iE-Lys, induces a time-and dose-dependent cardiac dysfunction that occurs concomitantly with cardiac fibrosis and apoptosis. The administration of iEDAP promotes the activation of the NF-kappa B and TGF-beta pathways and induces apoptosis in whole hearts. At the cellular level, both native cardiomyocytes and cardiac fibroblasts expressed NOD1. The NLR activation in cardiomyocytes was associated with NF-kappa B activation and induction of apoptosis. NOD1 stimulation in fibroblasts was linked to NF-kappa B activation and to increased expression of pro-fibrotic mediators. The down-regulation of NOD1 by specific siRNAs blunted the effect of iEDAP on the pro-fibrotic TGF-beta pathway and cell apoptosis. In conclusion, our report uncovers a new pro-inflammatory target that is expressed in the heart, NOD1. The specific activation of this NLR induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis, pathological processes involved in several cardiac diseases such as heart failure.	[Fernandez-Velasco, Maria; Benito, Gemma; Lopez-Collazo, Eduardo; Martin-Sanz, Paloma; Bosca, Lisardo] Hosp La Paz, Inst Invest, TumorImmunol Lab, Madrid, Spain; [Fernandez-Velasco, Maria; Prieto, Patricia; Terron, Veronica; Martin-Sanz, Paloma; Bosca, Lisardo] UAM, CSIC, Ctr Mixto, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Flores, Juana M.] Univ Complutense Madrid, Fac Vet, Dept Med & Cirugia Anim, Madrid, Spain; [Delgado, Carmen] CSIC, Ctr Invest Biol, Madrid, Spain; [Delgado, Carmen] Univ Complutense Madrid, Fac Med, Dept Farmacol, Madrid, Spain; [Zaragoza, Carlos; Lavin, Begona; Gomez-Parrizas, Monica] Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Martin-Sanz, Paloma; Bosca, Lisardo] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Hospital Universitario La Paz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Complutense University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Fernandez-Velasco, M (corresponding author), Hosp La Paz, Inst Invest, TumorImmunol Lab, Madrid, Spain.	mvelasco@iib.uam.es; lbosca@iib.uam.es	velasco, maria fernandez/AAO-5062-2021; Bosca, Lisardo/A-2059-2008; Prieto, Patricia/ABG-8343-2020; Plaza, Begoña Lavin/AAB-1773-2021; Martín-Sanz, Paloma/K-1303-2014; Zaragoza, Carlos/AAH-9275-2019; Delgado, Carmen/H-2251-2016; de las Heras, Ana Isabel/AAB-1059-2020; Lopez-Collazo, Eduardo/U-6634-2018	Bosca, Lisardo/0000-0002-0253-5469; Prieto, Patricia/0000-0001-6943-7663; Delgado, Carmen/0000-0002-0047-4674; de las Heras, Ana Isabel/0000-0002-4446-7417; Lavin-Plaza, Begona/0000-0003-4671-1089; Lopez-Collazo, Eduardo/0000-0003-1957-877X; Zaragoza, Carlos/0000-0002-1706-8592	instituto de Sanidad Carlos III (Miguel Servet Program) [CP11/00080]; Ministerio de Innovacion y Ciencia [BFU2011-24760, SAF2010-16377]; Fondo de Investigacion Sanitario-Red Cardiovascular [FIS-RECAVA RD06/ 0014/0006, RD06/0014/0007]; Instituto Carlos III	instituto de Sanidad Carlos III (Miguel Servet Program); Ministerio de Innovacion y Ciencia(Spanish Government); Fondo de Investigacion Sanitario-Red Cardiovascular; Instituto Carlos III(Instituto de Salud Carlos III)	Maria Fernandez Velasco was supported by instituto de Sanidad Carlos III (Miguel Servet Program, CP11/00080). This work was supported by grants BFU2011-24760 and SAF2010-16377 from the Ministerio de Innovacion y Ciencia and Fondo de Investigacion Sanitario-Red Cardiovascular (FIS-RECAVA RD06/ 0014/0006 and RD06/0014/0007). The Red de Cardiovascular and Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas networks are funded by the Instituto Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birks EJ, 2004, J HEART LUNG TRANSPL, V23, P228, DOI 10.1016/S1053-2498(03)00106-2; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cartwright N, 2007, AM J RESP CRIT CARE, V175, P595, DOI 10.1164/rccm.200608-1103OC; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Correia JD, 2007, CELL DEATH DIFFER, V14, P830, DOI 10.1038/sj.cdd.4402070; Correia JD, 2006, P NATL ACAD SCI USA, V103, P1840, DOI 10.1073/pnas.0509228103; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Fernandez-Velasco M, 2009, CIRC RES, V104, P201, DOI 10.1161/CIRCRESAHA.108.177493; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095; Hua F, 2007, J IMMUNOL, V178, P7317, DOI 10.4049/jimmunol.178.11.7317; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Kvarnhammar AM, 2011, IMMUNOLOGY, V134, P314, DOI 10.1111/j.1365-2567.2011.03492.x; Lee KY, 2006, J IMMUNOL, V176, P603, DOI 10.4049/jimmunol.176.1.603; Li CF, 2004, CARDIOVASC RES, V61, P538, DOI 10.1016/j.cardiores.2003.09.007; Li CF, 1999, AM J PHYSIOL-HEART C, V276, pH543, DOI 10.1152/ajpheart.1999.276.2.H543; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Linde A, 2007, CARDIOVASC RES, V73, P26, DOI 10.1016/j.cardiores.2006.08.009; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moreno L, 2010, BRIT J PHARMACOL, V160, P1997, DOI 10.1111/j.1476-5381.2010.00814.x; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Nishio H, 2011, ARTERIOSCL THROM VAS, V31, P1093, DOI 10.1161/ATVBAHA.110.216325; Park JH, 2007, J IMMUNOL, V179, P514, DOI 10.4049/jimmunol.179.1.514; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Travassos LH, 2010, AUTOPHAGY, V6, P409, DOI 10.4161/auto.6.3.11305; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Woessner JF, 1998, CONNECT TISSUE RES, V39, P69, DOI 10.3109/03008209809023913; Wong FS, 2008, ANN NY ACAD SCI, V1150, P146, DOI 10.1196/annals.1447.039; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631	46	37	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45260	10.1371/journal.pone.0045260	http://dx.doi.org/10.1371/journal.pone.0045260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028889	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900108
J	Spang, HCL; Braathen, R; Bogen, B				Spang, Heidi Cecilie Larsen; Braathen, Ranveig; Bogen, Bjarne			Heterodimeric Barnase-Barstar Vaccine Molecules: Influence of One versus Two Targeting Units Specific for Antigen Presenting Cells	PLOS ONE			English	Article							COMPLEX CLASS-II; DNA VACCINE; DENDRITIC CELLS; SKIN ELECTROPORATION; IN-VITRO; DELIVERY; PROTEIN; FUSION; IMMUNOGENICITY; EXPRESSION	It is known that targeting of antigen to antigen presenting cells (APC) increases immune responses. However, it is unclear if more than one APC-specific targeting unit in the antigenic molecule will increase responses. To address this issue, we have here made heterodimeric vaccine molecules that each express four different fusion subunits. The bacterial ribonuclease barnase and its inhibitor barstar interact with high affinity, and the barnase-barstar complex was therefore used as a dimerization unit. Barnase and barstar were fused N-terminally with single chain fragment variable (scFv)s targeting units specific for either MHC class II molecules on APC or the hapten 5-iodo-4-hydroxy-3-nitrophenylacetyl (NIP). C-terminal antigenic fusions were either the fluorescent protein mCherry or scFv(315) derived from myeloma protein M315. The heterodimeric vaccine molecules were formed both in vitro and in vivo. Moreover, the four different fused moieties appeared to fold correctly since they retained their specificity and function. DNA vaccination with MHC class II-targeted vaccine induced higher mCherry-specific IgG1 responses compared to non-targeted control. Since mCherry and MHC class II are in trans in this heterodimer, this suggests that heterodimeric proteins are formed in vivo without prior protein purification. Surprisingly, one targeting moiety was sufficient for the increased IgG1 response, and addition of a second targeting moiety did not increase responses. Similar results were found in in vitro T cell assays; vaccine molecules with one targeting unit were as potent as those with two. In combination with the easy cloning strategy, the heterodimeric barnase-barstar vaccine molecule could provide a flexible platform for development of novel DNA vaccines with increased potency.	[Braathen, Ranveig] Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway; Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway	Braathen, R (corresponding author), Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway.	ranveig.braathen@rr-research.no			GLOBVAC program of the Research Council of Norway; South-Eastern Norway Regional Health Authority; University of Oslo	GLOBVAC program of the Research Council of Norway; South-Eastern Norway Regional Health Authority; University of Oslo	The study was supported by grants from the GLOBVAC program of the Research Council of Norway, South-Eastern Norway Regional Health Authority, and the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIER G, 1995, J VIROL, V69, P2357, DOI 10.1128/JVI.69.4.2357-2365.1995; Bergman PJ, 2003, CLIN CANCER RES, V9, P1284; BOGEN B, 1989, EMBO J, V8, P1947, DOI 10.1002/j.1460-2075.1989.tb03599.x; BOGEN B, 1992, EUR J IMMUNOL, V22, P703, DOI 10.1002/eji.1830220313; BOGEN B, 1986, EUR J IMMUNOL, V16, P1373, DOI 10.1002/eji.1830161110; BOGEN B, 1986, EUR J IMMUNOL, V16, P1379, DOI 10.1002/eji.1830161111; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; Castro FVV, 2008, EUR J IMMUNOL, V38, P2263, DOI 10.1002/eji.200838302; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Demangel C, 2005, MOL IMMUNOL, V42, P979, DOI 10.1016/j.molimm.2004.09.034; Deyev SM, 2003, NAT BIOTECHNOL, V21, P1486, DOI 10.1038/nbt916; Dormitzer PR, 2008, TRENDS BIOTECHNOL, V26, P659, DOI 10.1016/j.tibtech.2008.08.002; Fredriksen AB, 2006, MOL THER, V13, P776, DOI 10.1016/j.ymthe.2005.10.019; Fredriksen AB, 2007, BLOOD, V110, P1797, DOI 10.1182/blood-2006-06-032938; Glinka EM, 2006, GENE, V366, P97, DOI 10.1016/j.gene.2005.06.042; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; GUILLET V, 1993, STRUCTURE, V1, P165, DOI 10.1016/0969-2126(93)90018-C; Guyre PM, 1997, CANCER IMMUNOL IMMUN, V45, P146, DOI 10.1007/s002620050418; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; HARTLEY RW, 1993, BIOCHEMISTRY-US, V32, P5978, DOI 10.1021/bi00074a008; Hartley RW, 2001, METHOD ENZYMOL, V341, P599, DOI 10.1016/S0076-6879(01)41179-7; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; KAWAMURA H, 1986, J IMMUNOL, V136, P58; KIM KJ, 1979, J IMMUNOL, V122, P549; Liao Jack C F, 2006, Cancer Immun, V6, P8; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; Lunde E, 1999, NAT BIOTECHNOL, V17, P670, DOI 10.1038/10883; Lunde E, 2002, J IMMUNOL, V168, P2154, DOI 10.4049/jimmunol.168.5.2154; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Nikitin MP, 2010, P NATL ACAD SCI USA, V107, P5827, DOI 10.1073/pnas.1001142107; Oynebraten I, 2012, SCAND J IMMUNOL, V75, P379, DOI 10.1111/j.1365-3083.2011.02639.x; Oynebraten I, 2011, SCAND J IMMUNOL; Roos AK, 2006, MOL THER, V13, P320, DOI 10.1016/j.ymthe.2005.08.005; Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226; Roos AK, 2009, MOL THER, V17, P1637, DOI 10.1038/mt.2009.120; Ruffini PA, 2004, J LEUKOCYTE BIOL, V76, P77, DOI 10.1189/jlb.1003481; Ruffini PA, 2010, VACCINE, V29, P191, DOI 10.1016/j.vaccine.2010.10.057; Schjetne KW, 2007, J IMMUNOL, V178, P4169, DOI 10.4049/jimmunol.178.7.4169; Semenyuk EG, 2007, BIOCHIMIE, V89, P31, DOI 10.1016/j.biochi.2006.07.012; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SIRISINHA S, 1971, P NATL ACAD SCI USA, V68, P3130, DOI 10.1073/pnas.68.12.3130; SNIDER DP, 1987, J IMMUNOL, V139, P1609; Tjelle TE, 2004, MOL THER, V9, P328, DOI 10.1016/j.ymthe.2003.12.007; Tollefsen S, 2003, SCAND J IMMUNOL, V57, P229, DOI 10.1046/j.1365-3083.2003.01218.x; Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007; Wang SX, 2006, VACCINE, V24, P4531, DOI 10.1016/j.vaccine.2005.08.023; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635	47	9	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45393	10.1371/journal.pone.0045393	http://dx.doi.org/10.1371/journal.pone.0045393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028981	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900133
J	Wang, J; Wang, J; Zhang, Y; Yang, G; Zhou, WJ; Shang, AJ; Zou, LP				Wang, Jing; Wang, Juan; Zhang, Ying; Yang, Guang; Zhou, Wen-Jing; Shang, Ai-Jia; Zou, Li-Ping			Proteomic Analysis of Adrenocorticotropic Hormone Treatment of an Infantile Spasm Model Induced by N-Methyl-D-Aspartic Acid and Prenatal Stress	PLOS ONE			English	Article							BRAIN-DEVELOPMENT; SODIUM-BUTYRATE; CEREBRAL-CORTEX; WEST-SYNDROME; RAT-BRAIN; MECHANISMS; EXPRESSION; DISORDERS; MIGRATION; NETWORKS	Infantile spasms is an age-specific epileptic syndrome associated with poor developmental outcomes and poor response to nearly all traditional antiepileptic drugs except adrenocorticotropic hormone (ACTH). We investigated the protective mechanism of ACTH against brain damage. An infantile spasm rat model induced by N-methyl-D-aspartate (NMDA) in neonate rats was used. Pregnant rats were randomly divided into the stress-exposed and the non-stress exposed groups, and their offspring were randomly divided into ACTH-treated spasm model, untreated spasm model, and control groups. A proteomics-based approach was used to detect the proteome differences between ACTH-treated and untreated groups. Gel image analysis was followed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometric protein identification and bioinformatics analysis. Prenatal stress exposure resulted in more severe seizures, and ACTH treatment reduced and delayed the onset of seizures. The most significantly up-regulated proteins included isoform 1 of tubulin beta-5 chain, cofilin-1 (CFL1), synaptosomal-associated protein 25, malate dehydrogenase, N(G), N(G)-dimethylarginine dimethylaminohydrolase 1, annexin A3 (ANXA3), and rho GDP-dissociation inhibitor 1 (ARHGDIA). In contrast, tubulin alpha-1A chain was down-regulated. Three of the identified proteins, ARHGDIA, ANXA3, and CFL1, were validated using western blot analysis. ARHGDIA expression was assayed in the brain samples of five infantile spasm patients. These proteins are involved in the cytoskeleton, synapses, energy metabolism, vascular regulation, signal transduction, and acetylation. The mechanism underlying the effects of ACTH involves the molecular events affected by these proteins, and protein acetylation is the mechanism of action of the drug treatment.	[Wang, Jing; Wang, Juan; Zhang, Ying; Yang, Guang; Zou, Li-Ping] Gen Hosp Chinese Peoples Liberat Army, Dept Pediat, Beijing, Peoples R China; [Zhou, Wen-Jing; Shang, Ai-Jia] Tsinghua Univ, Yuquan Hosp, Dept Neurosurg, Beijing 100084, Peoples R China	Tsinghua University	Zou, LP (corresponding author), Gen Hosp Chinese Peoples Liberat Army, Dept Pediat, Beijing, Peoples R China.	zouliping21@sina.com			National Natural Science Foundation of China [30801249, 30770747, 81071055]; Natural Science Foundation of Beijing [7042024, 7081002]; Hygiene Industry-specific Research Projects of China [200802074]; National Basic Research Program of China (973) [2012CB517903]; Medical Neurobiology of the State Key Laboratory [09-08]; Military Medicine and Public Health Research Project [10BJZ04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Hygiene Industry-specific Research Projects of China; National Basic Research Program of China (973)(National Basic Research Program of China); Medical Neurobiology of the State Key Laboratory; Military Medicine and Public Health Research Project	The study was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn, Grant Nos. 30801249, 30770747, and 81071055), the Natural Science Foundation of Beijing (www.bjnsf.org, Grant Nos. 7042024 and 7081002), the Hygiene Industry-specific Research Projects of China (Grant No. 200802074), the National Basic Research Program of China (973) (www.973.gov.cn, Grant No. 2012CB517903), an open project from the Medical Neurobiology of the State Key Laboratory (http://www.skmn.fudan.edu.cn, Grant No. 09-08), and the Military Medicine and Public Health Research Project (Grant No. 10BJZ04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya MM, 2005, EXP NEUROL, V192, P79, DOI 10.1016/j.expneurol.2004.11.004; Bellenchi GC, 2007, GENE DEV, V21, P2347, DOI 10.1101/gad.434307; Braun JEA, 2000, J NEUROSCI, V20, P5997, DOI 10.1523/JNEUROSCI.20-16-05997.2000; Breckenridge RA, 2010, INT J DEV BIOL, V54, P215, DOI 10.1387/ijdb.072356rb; Brunson KL, 2002, INT REV NEUROBIOL, V49, P185; Chelly J, 1999, HUM MOL GENET, V8, P1833, DOI 10.1093/hmg/8.10.1833; Chen WQ, 2007, ELECTROPHORESIS, V28, P4392, DOI 10.1002/elps.200700336; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Corradini I, 2009, ANN NY ACAD SCI, V1152, P93, DOI 10.1111/j.1749-6632.2008.03995.x; Curie A, 2009, EUR J MED GENET, V52, P6, DOI 10.1016/j.ejmg.2008.09.003; Deutsch SI, 1997, PHARMACOL BIOCHEM BE, V58, P709, DOI 10.1016/S0091-3057(97)90014-9; Deutsch SI, 2008, EUR NEUROPSYCHOPHARM, V18, P565, DOI 10.1016/j.euroneuro.2007.11.004; Edwards HE, 2002, HORM BEHAV, V42, P437, DOI 10.1006/hbeh.2002.1839; Fallet-Bianco C, 2008, BRAIN, V131, P2304, DOI 10.1093/brain/awn155; Frost JD, 2005, J CLIN NEUROPHYSIOL, V22, P25, DOI 10.1097/01.WNP.0000149893.12678.44; Greene NDE, 2007, PROTEOMICS, V7, P1336, DOI 10.1002/pmic.200601027; Guerrini R, 2005, EPILEPSIA, V46, P32, DOI 10.1111/j.0013-9580.2005.461010.x; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kato M, 2006, EPILEPSY RES, V70, pS87, DOI 10.1016/j.eplepsyres.2006.02.008; Liu XY, 2008, PROTEOMICS, V8, P582, DOI 10.1002/pmic.200700514; Lux AL, 2004, EPILEPSIA, V45, P1416, DOI 10.1111/j.0013-9580.2004.02404.x; MCDONALD JW, 1993, BRAIN RES, V624, P239, DOI 10.1016/0006-8993(93)90083-Y; Rodionov RN, 2010, CIRC RES, V106, P551, DOI 10.1161/CIRCRESAHA.109.200360; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Shang NX, 2010, PEDIATR NEUROL, V42, P181, DOI 10.1016/j.pediatrneurol.2009.09.003; Stafstrom CE, 2011, J CHILD NEUROL, V26, P1411, DOI 10.1177/0883073811413129; Tafoya LCR, 2006, J NEUROSCI, V26, P7826, DOI 10.1523/JNEUROSCI.1866-06.2006; Van Den Hove DLA, 2006, NEUROSCIENCE, V137, P145, DOI 10.1016/j.neuroscience.2005.08.060; Velisek L, 2007, ANN NEUROL, V61, P109, DOI 10.1002/ana.21082; Wang J, 2007, PROTEOMICS, V7, P4008, DOI 10.1002/pmic.200700341; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weitzdorfer R, 2008, HIPPOCAMPUS, V18, P807, DOI 10.1002/hipo.20441; Yoon SJ, 2006, FERTIL STERIL, V86, P1129, DOI 10.1016/j.fertnstert.2006.02.105	37	8	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45347	10.1371/journal.pone.0045347	http://dx.doi.org/10.1371/journal.pone.0045347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028951	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900124
J	Wang, W; Zhang, M; Xiao, ZZ; Sun, L				Wang, Wei; Zhang, Min; Xiao, Zhi-zhong; Sun, Li			Cynoglossus semilaevis ISG15: A Secreted Cytokine-Like Protein That Stimulates Antiviral Immune Response in a LRGG Motif-Dependent Manner	PLOS ONE			English	Article							EXPRESSION ANALYSIS; ATLANTIC SALMON; I INTERFERON; GENE ISG15; UBIQUITIN; IDENTIFICATION; DEFENSE; VIRUS; CELLS; CHEMOATTRACTANT	ISG15 is an ubiquitin-like protein that is induced rapidly by interferon stimulation. Like ubiquitin, ISG15 forms covalent conjugates with its target proteins in a process called ISGylation, which in mammals is known to play a role in antiviral immunity. In contrast to mammalian ISG15, the function of teleost ISG15 is unclear. In this study, we identified and analyzed the function of an ISG15 homologue, CsISG15, from tongue sole (Cynoglossus semilaevis). CsISG15 is composed of 162 residues and possesses two tandem ubiquitin-like domains and the highly conserved LRGG motif found in all known ISG15. Expression of CsISG15 occurred in a wide range of tissues and was upregulated in kidney and spleen by viral and bacterial infection. In vitro study with primary head kidney (HK) lymphocytes showed that megalocytivirus infection caused induction of CsISG15 expression and extracellular release of CsISG15 protein. Purified recombinant CsISG15 (rCsISG15) activated HK macrophages and enhanced the expression of immune genes in HK lymphocytes, both these effects, however, were significantly reduced when the conserved LRGG sequence was mutated to LAAG. Further study showed that the presence of rCsISG15 during megalocytivirus infection of HK lymphocytes reduced intracellular viral load, whereas antibody blocking of CsISG15 enhanced viral infection. Likewise, interference with CsISG15 expression by RNAi promoted viral infection. Taken together, these results indicate that CsISG15, a teleost ISG15, promotes antiviral immune response and that, unlike mammalian ISG15, CsISG15 exerts its immunoregulatory effect in the form of an unconjugated extracellular cytokine. In addition, these results also suggest a role for the LRGG motif other than that in protein conjugation.	[Wang, Wei; Zhang, Min; Xiao, Zhi-zhong; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Wang, Wei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	lsun@qdio.ac.cn			National Basic Research Program of China [2012CB114406]; National Natural Science Foundation of China [31025030]; Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-Q213]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the grants from the National Basic Research Program of China (2012CB114406), the National Natural Science Foundation of China (31025030), and the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-EW-Q213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeck GW, 2008, FISH SHELLFISH IMMUN, V25, P679, DOI 10.1016/j.fsi.2008.08.005; Bibeau-Poirier A, 2008, CYTOKINE, V43, P359, DOI 10.1016/j.cyto.2008.07.012; CHUNG S, 1988, COMP BIOCHEM PHYS B, V89, P539, DOI 10.1016/0305-0491(88)90171-X; Dao CT, 2005, FRONT BIOSCI-LANDMRK, V10, P2701, DOI 10.2741/1730; Das BK, 2007, FISH SHELLFISH IMMUN, V23, P825, DOI 10.1016/j.fsi.2007.03.012; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; DCunha J, 1996, PNAS, V157, P4100; Furnes C, 2009, DEV COMP IMMUNOL, V33, P1239, DOI 10.1016/j.dci.2009.07.005; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hu YH, 2011, DEV COMP IMMUNOL, V35, P1030, DOI 10.1016/j.dci.2011.04.002; Hu YH, 2010, FISH SHELLFISH IMMUN, V28, P678, DOI 10.1016/j.fsi.2010.01.001; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kileng O, 2007, FISH SHELLFISH IMMUN, V23, P378, DOI 10.1016/j.fsi.2006.11.011; KNIGHT E, 1988, J BIOL CHEM, V263, P4520; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Li YX, 2012, DEV COMP IMMUNOL, V37, P55, DOI 10.1016/j.dci.2011.12.007; Li YX, 2011, FISH SHELLFISH IMMUN, V31, P446, DOI 10.1016/j.fsi.2011.06.017; Liu CS, 2010, FISH SHELLFISH IMMUN, V29, P167, DOI 10.1016/j.fsi.2010.03.012; Liu MJ, 2002, GENE, V298, P129, DOI 10.1016/S0378-1119(02)00932-0; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Milev-Milovanovic I, 2009, FISH SHELLFISH IMMUN, V26, P811, DOI 10.1016/j.fsi.2009.03.006; O'Farrell C, 2002, J VIROL, V76, P8040, DOI 10.1128/JVI.76.16.8040-8049.2002; Owhashi M, 2003, BIOCHEM BIOPH RES CO, V309, P533, DOI 10.1016/j.bbrc.2003.08.038; Padovan E, 2002, CANCER RES, V62, P3453; Pitha-Rowe IF, 2007, CYTOKINE GROWTH F R, V18, P409, DOI 10.1016/j.cytogfr.2007.06.017; RECHT M, 1991, J IMMUNOL, V147, P2617; Ritchie KJ, 2004, SEMIN CELL DEV BIOL, V15, P237, DOI 10.1016/j.semcdb.2003.12.005; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Rokenes TP, 2007, MOL IMMUNOL, V44, P950, DOI 10.1016/j.molimm.2006.03.016; Seppola M, 2007, DEV COMP IMMUNOL, V31, P156, DOI 10.1016/j.dci.2006.05.009; Sun JS, 2011, FISH SHELLFISH IMMUN, V30, P1362, DOI 10.1016/j.fsi.2011.03.023; Sun K, 2009, VACCINE, V27, P2733, DOI 10.1016/j.vaccine.2009.03.012; Tafalla C, 2000, DEV COMP IMMUNOL, V24, P623, DOI 10.1016/S0145-305X(99)00087-7; Wang W, 2011, FISH SHELLFISH IMMUN, V31, P269, DOI 10.1016/j.fsi.2011.05.012; Werneke SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002322; Workenhe ST, 2010, MOL IMMUNOL, V47, P2525, DOI 10.1016/j.molimm.2010.06.009; Yasuike M, 2011, COMP IMMUNOL MICROB, V34, P83, DOI 10.1016/j.cimid.2010.02.005; Zhang M, 2012, AQUAC RES, V43, P556, DOI 10.1111/j.1365-2109.2011.02861.x; Zhang WW, 2008, APPL ENVIRON MICROB, V74, P6254, DOI 10.1128/AEM.00109-08; Zhang YB, 2007, FISH SHELLFISH IMMUN, V23, P52, DOI 10.1016/j.fsi.2006.09.004; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zheng WJ, 2010, FISH SHELLFISH IMMUN, V28, P829, DOI 10.1016/j.fsi.2010.01.013; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001	46	33	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44884	10.1371/journal.pone.0044884	http://dx.doi.org/10.1371/journal.pone.0044884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028660	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900049
J	Kamath, AV; Williams, SP; Bullens, S; Cowan, KJ; Stenberg, Y; Cherry, SR; Rendig, S; Kukis, DL; Griesemer, C; Damico-Beyer, LA; Bunting, S				Kamath, Amrita V.; Williams, Simon P.; Bullens, Sherry; Cowan, Kyra J.; Stenberg, Yvonne; Cherry, Simon R.; Rendig, Stephen; Kukis, David L.; Griesemer, Chris; Damico-Beyer, Lisa A.; Bunting, Stuart			Pharmacokinetics and Biodistribution of a Human Monoclonal Antibody to Oxidized LDL in Cynomolgus Monkey Using PET Imaging	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ATHEROSCLEROSIS; DISEASE	Purpose: Oxidized low-density lipoprotein (LDL) plays an essential role in the pathogenesis of atherosclerosis. The purpose of this study was to characterize the pharmacokinetics (PK) of a human recombinant IgG1 antibody to oxidized LDL (anti-oxLDL) in cynomolgus monkey. The tissue biodistribution of anti-oxLDL was also investigated using positron emission tomography (PET) imaging. Methods: Anti-oxLDL was conjugated with the N-hydroxysuccinimide ester of DOTA (1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid) and radiolabeled by chelation of radioactive copper-64 (Cu-64) for detection by PET. Anti-oxLDL was administered as a single intravenous (IV) dose of 10 mg/kg (as a mixture of radiolabeled and non-labeled material) to two male and two female cynomolgus monkeys. Serum samples were collected over 29 days. Two ELISA methods were used to measure serum concentrations of anti-oxLDL; Assay A was a ligand binding assay that measured free anti-oxLDL (unbound and partially bound forms) and Assay B measured total anti-oxLDL. The biodistribution was observed over a 48-hour period following dose administration using PET imaging. Results: Anti-oxLDL serum concentration-time profiles showed a biphasic elimination pattern that could be best described by a two-compartment elimination model. The serum concentrations obtained using the two ELISA methods were comparable. Clearance values ranged from 8 to 17 ml/day/kg, while beta half-life ranged from 8 to 12 days. The initial volume of distribution and volume of distribution at steady state were approximately 55 mL/kg and 150 mL/kg, respectively. PET imaging showed distribution predominantly to the blood pool, visible as the heart and great vessels in the trunk and limbs, plus diffuse signals in the liver, kidney, spleen, and bone marrow. Conclusions: The clearance of anti-oxLDL is slightly higher than typical IgG1 antibodies in cynomolgus monkeys. The biodistribution pattern appears to be consistent with an antibody that has no large, rapid antigen sink outside the blood space.	[Kamath, Amrita V.; Williams, Simon P.; Bullens, Sherry; Cowan, Kyra J.; Damico-Beyer, Lisa A.; Bunting, Stuart] Genentech Inc, Genentech Res & Early Dev, San Francisco, CA 94080 USA; [Stenberg, Yvonne] BioInvent Int AB, Bioanalyt & Prot Chem, Lund, Sweden; [Cherry, Simon R.; Rendig, Stephen; Kukis, David L.; Griesemer, Chris] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA	Roche Holding; Genentech; University of California System; University of California Davis	Kamath, AV (corresponding author), Genentech Inc, Genentech Res & Early Dev, San Francisco, CA 94080 USA.	kamath.amrita@gene.com	Cherry, Simon/AAH-1000-2019	Cherry, Simon/0000-0002-0155-5644; Cowan, Kyra/0000-0002-4811-7748	Genentech, Inc.; BioInvent International AB; California National Primate Research Center [RR00169]; National Cancer Institute [CA86307]; NATIONAL CANCER INSTITUTE [R24CA086307, P30CA093373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER	Genentech, Inc.(Roche HoldingGenentech); BioInvent International AB; California National Primate Research Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for these studies was provided by Genentech, Inc. and BioInvent International AB. AVK, SPW, SB, KJC, YS, LAD, SB are current or former employees of either Genentech, Inc. or BioInvent International AB. These studies were also supported by the California National Primate Research Center base operating grant no. RR00169. The production of 64Cu at Washington University at St. Louis School of Medicine was supported by National Cancer Institute grant CA86307. The funders of the grants had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng Z, 2007, BIOCONJUGATE CHEM, V18, P765, DOI 10.1021/bc060306g; Deng R, 2011, MABS-AUSTIN, V3, P61, DOI 10.4161/mabs.3.1.13799; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HODIS HN, 1994, J LIPID RES, V35, P669; Holvoet P, 2003, ARTERIOSCL THROM VAS, V23, P1444, DOI 10.1161/01.ATV.0000080379.05071.22; Hoppin J, 2011, J PHARMACOL EXP THER, V337, P350, DOI 10.1124/jpet.110.172916; Lee JW, 2011, AAPS J, V13, P99, DOI 10.1208/s12248-011-9251-3; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Meisinger C, 2005, CIRCULATION, V112, P651, DOI 10.1161/CIRCULATIONAHA.104.529297; Nilsson J, 2007, CURR PHARM DESIGN, V13, P1021, DOI 10.2174/138161207780487557; Schiopu A, 2007, J AM COLL CARDIOL, V50, P2313, DOI 10.1016/j.jacc.2007.07.081; Strickland LA, 2009, J PATHOL, V218, P380, DOI 10.1002/path.2545; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499	13	4	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45116	10.1371/journal.pone.0045116	http://dx.doi.org/10.1371/journal.pone.0045116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028793	gold, Green Submitted, Green Published			2022-12-27	WOS:000309742800036
J	Ng, OT; Chow, AL; Lee, VJ; Chen, MIC; Win, MK; Tan, HH; Chua, A; Leo, YS				Ng, Oon Tek; Chow, Angela L.; Lee, Vernon J.; Chen, Mark I. C.; Win, Mar Kyaw; Tan, Hiok Hee; Chua, Arlene; Leo, Yee Sin			Accuracy and User-Acceptability of HIV Self-Testing Using an Oral Fluid-Based HIV Rapid Test	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HOME; INFECTION; PREVENTION; STRATEGIES; COLLECTION; SETTINGS; ADULTS; STATES	Background: The United States FDA approved an over-the-counter HIV self-test, to facilitate increased HIV testing and earlier linkage to care. We assessed the accuracy of self-testing by untrained participants compared to healthcare worker (HCW) testing, participants' ability to interpret sample results and user-acceptability of self-tests in Singapore. Methodology/Principal Findings: A cross-sectional study, involving 200 known HIV-positive patients and 794 unknown HIV status at-risk participants was conducted. Participants (all without prior self-test experience) performed self-testing guided solely by visual instructions, followed by HCW testing, both using the OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, with both results interpreted by the HCW. To assess ability to interpret results, participants were provided 3 sample results (positive, negative, and invalid) to interpret. Of 192 participants who tested positive on HCW testing, self-testing was positive in 186 (96.9%), negative in 5 (2.6%), and invalid in 1 (0.5%). Of 794 participants who tested negative on HCW testing, self-testing was negative in 791 (99.6%), positive in 1 (0.1%), and invalid in 2 (0.3%). Excluding invalid tests, self-testing had sensitivity of 97.4% (95% CI 95.1% to 99.7%) and specificity of 99.9% (95% CI: 99.6% to 100%). When interpreting results, 96%, 93.1% and 95.2% correctly read the positive, negative and invalid respectively. There were no significant demographic predictors for false negative self-testing or wrongly interpreting positive or invalid sample results as negative. Eighty-seven percent would purchase the kit over-the-counter; 89% preferred to take HIV tests in private. 72.5% and 74.9% felt the need for pre- and post-test counseling respectively. Only 28% would pay at least USD15 for the test. Conclusions/Significance: Self-testing was associated with high specificity, and a small but significant number of false negatives. Incorrectly identifying model results as invalid was a major reason for incorrect result interpretation. Survey responses were supportive of making self-testing available.	[Ng, Oon Tek; Chua, Arlene; Leo, Yee Sin] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Chow, Angela L.; Lee, Vernon J.; Chen, Mark I. C.; Win, Mar Kyaw] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Chow, Angela L.; Lee, Vernon J.; Chen, Mark I. C.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Tan, Hiok Hee] Natl Skin Ctr, Dept Sexually Transmitted Infect Control, Singapore 1130, Singapore	Tan Tock Seng Hospital; Tan Tock Seng Hospital; National University of Singapore; National Skin Centre	Ng, OT (corresponding author), Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore.	oontek@gmail.com	Chen, Mark/AGC-5338-2022; Chen, Mark/CAG-2949-2022	Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830; Chua, Arlene/0000-0001-6428-9083; Chow, Angela/0000-0002-4063-736X	National Healthcare Group, Singapore [NHG-SIG/08003]; GlaxoSmithKline	National Healthcare Group, Singapore; GlaxoSmithKline(GlaxoSmithKline)	Salary support for Amy Chan was provided by National Healthcare Group, Singapore grant NHG-SIG/08003. This study was approved by the National Healthcare Group ethics review board. Written informed consent was obtained from all study participants. All study healthcare workers received Singapore Ministry of Health accredited training on point-of-care HIV rapid testing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests: V J Lee reported receipt of GlaxoSmithKline funding for unrelated research. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson BM, 1998, JAMA-J AM MED ASSOC, V280, P1699, DOI 10.1001/jama.280.19.1699; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Chua AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034663; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cutter JL, 2004, AIDS EDUC PREV, V16, P110, DOI 10.1521/aeap.16.3.5.110.35528; Frith L, 2007, LANCET, V369, P243, DOI 10.1016/S0140-6736(07)60113-5; Gaydos CA, 2011, ANN EMERG MED, V58, pS74, DOI 10.1016/j.annemergmed.2011.03.029; Hodinka RL, 1998, CLIN DIAGN LAB IMMUN, V5, P419, DOI 10.1128/CDLI.5.4.419-426.1998; Hutchinson AB, 2006, AIDS, V20, P1597, DOI 10.1097/01.aids.0000238405.93249.16; Janssen RS, 2003, JAMA-J AM MED ASSOC, V289, P2493; Lee VJ, 2007, JAIDS-J ACQ IMM DEF, V45, P449, DOI 10.1097/QAI.0b013e318095a3f3; Ministry of Health Singapore, 2010, RAP HIV TEST NOW AV; Ministry of Health Singapore, 2012, HIV STAT UPD HIV AID; Mortimer P P, 1994, Clin Diagn Virol, V2, P231, DOI 10.1016/0928-0197(94)90048-5; Ng OT, 2011, CROI, P1075; O'Connell RJ, 2003, J CLIN MICROBIOL, V41, P2153, DOI 10.1128/JCM.41.5.2153-2155.2003; Phillips KA, 2003, AM J PREV MED, V24, P340, DOI 10.1016/S0749-3797(03)00019-9; Ryder K, 2005, AIDS BEHAV, V9, P459, DOI 10.1007/s10461-005-9032-z; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Skolnik HS, 2001, J ACQ IMMUN DEF SYND, V27, P292, DOI 10.1097/00126334-200107010-00013; Spielberg F, 2000, AIDS, V14, P1819, DOI 10.1097/00002030-200008180-00018; Spielberg F, 2005, JAIDS-J ACQ IMM DEF, V38, P348; U.S FDA, 2012, ORAQUICKH IN HOME HI; Walensky RP, 2006, ANN INTERN MED, V145, P459, DOI 10.7326/0003-4819-145-6-200609190-00010; Weinhardt LS, 1999, AM J PUBLIC HEALTH, V89, P1397, DOI 10.2105/AJPH.89.9.1397; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	28	86	92	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45168	10.1371/journal.pone.0045168	http://dx.doi.org/10.1371/journal.pone.0045168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028822	Green Submitted, gold, Green Published			2022-12-27	WOS:000309742800039
J	Jiang, PP; Jensen, ML; Cilieborg, MS; Thymann, T; Wan, JMF; Sit, WH; Tipoe, GL; Sangild, PT				Jiang, Pingping; Jensen, Michael Ladegaard; Cilieborg, Malene Skovsted; Thymann, Thomas; Wan, Jennifer Man-Fan; Sit, Wai-Hung; Tipoe, George L.; Sangild, Per Torp			Antibiotics Increase Gut Metabolism and Antioxidant Proteins and Decrease Acute Phase Response and Necrotizing Enterocolitis in Preterm Neonates	PLOS ONE			English	Article							ENTERAL NUTRITION; INFANTS; RECEPTOR; RAT; COLONIZATION; CONDUCTANCE; DYSFUNCTION; ACTIVATION; INTESTINE; APOPTOSIS	Background: The appropriate use of antibiotics for preterm infants, which are highly susceptible to develop necrotizing enterocolitis (NEC), is not clear. While antibiotic therapy is commonly used in neonates with NEC symptoms and sepsis, it remains unknown how antibiotics may affect the intestine and NEC sensitivity. We hypothesized that broad-spectrum antibiotics, given immediately after preterm birth, would reduce NEC sensitivity and support intestinal protective mechanisms. Methodology/ Principal Findings: Preterm pigs were treated with antibiotics for 5 d (oral and systemic doses of gentamycin, ampicillin and metrodinazole; AB group) and compared with untreated pigs. Only the untreated pigs showed evidence of NEC lesions and reduced digestive function, as indicated by lowered villus height and activity of brush border enzymes. In addition, 53 intestinal and 22 plasma proteins differed in expression between AB and untreated pigs. AB treatment increased the abundance of intestinal proteins related to carbohydrate and protein metabolism, actin filaments, iron homeostasis and antioxidants. Further, heat shock proteins and the complement system were affected suggesting that all these proteins were involved in the colonization-dependent early onset of NEC. In plasma, acute phase proteins (haptoglobin, complement proteins) decreased, while albumin, cleaved C3, ficolin and transferrin increased. Conclusions/Significance: Depressed bacterial colonization following AB treatment increases mucosal integrity and reduces bacteria-associated inflammatory responses in preterm neonates. The plasma proteins C3, ficolin, and transferrin are potential biomarkers of the colonization-dependent NEC progression in preterm neonates.	[Jiang, Pingping; Wan, Jennifer Man-Fan; Sit, Wai-Hung] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Tipoe, George L.] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Jiang, Pingping; Jensen, Michael Ladegaard; Cilieborg, Malene Skovsted; Thymann, Thomas; Sangild, Per Torp] Univ Copenhagen, Dept Human Nutr, Frederiksberg, Denmark	University of Hong Kong; University of Hong Kong; University of Copenhagen	Jiang, PP (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	psa@life.ku.dk		George, Tipoe/0000-0002-2603-0625; Thymann, Thomas/0000-0001-7480-6064; Jiang, Pingping/0000-0002-7393-9719; Sangild, Per Torp/0000-0002-5462-7760	Danish Research Councils	Danish Research Councils(Det Frie Forskningsrad (DFF))	The authors have no financial relationships relevant to this article to disclose. This work is supported by Danish Research Councils. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2005, DEV DYNAM, V234, P190, DOI 10.1002/dvdy.20511; Basavappa S, 2005, J CELL PHYSIOL, V202, P21, DOI 10.1002/jcp.20085; Bhattacharyya S, 2009, INFLAMM BOWEL DIS, V15, P673, DOI 10.1002/ibd.20821; Bicakci U, 2005, PEDIATR SURG INT, V21, P800, DOI 10.1007/s00383-005-1538-y; Bjornvad CR, 2008, AM J PHYSIOL-GASTR L, V295, pG1092, DOI 10.1152/ajpgi.00414.2007; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brook I, 2008, AM J PERINAT, V25, P111, DOI 10.1055/s-2008-1040346; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chakravortty D, 2000, BBA-MOL BASIS DIS, V1500, P125, DOI 10.1016/S0925-4439(99)00098-8; Chen CY, 2006, MOL BIOL CELL, V17, P3494, DOI 10.1091/mbc.E05-12-1096; Cilieborg MS, 2011, PEDIATR RES, V69, P10, DOI 10.1203/PDR.0b013e3181ff2a89; Daugaard M, 2005, CELL CYCLE, V4, P877, DOI 10.4161/cc.4.7.1838; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Fell JME, 2005, EARLY HUM DEV, V81, P117, DOI 10.1016/j.earlhumdev.2004.10.001; Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108; Haley B, 2009, INT J RADIAT BIOL, V85, P643, DOI 10.1080/09553000903009548; HAYANO T, 1995, GENE, V164, P377, DOI 10.1016/0378-1119(95)00474-K; Insenser M, 2010, J CLIN ENDOCRINOL ME, P2010; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Jiang P, 2011, PEDIAT RES, P69; Jiang PP, 2011, NEONATOLOGY, V99, P280, DOI 10.1159/000317807; Jiang PP, 2009, J PROTEOME RES, V8, P72, DOI 10.1021/pr800638w; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kinnebrew MA, 2010, J INFECT DIS, V201, P534, DOI 10.1086/650203; Ko KM, 2007, FEBS LETT, V581, P5445, DOI 10.1016/j.febslet.2007.10.047; Krediet TG, 2003, ACTA PAEDIATR, V92, P1180, DOI 10.1080/08035250310005233; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Loewen ME, 2002, AM J PHYSIOL-CELL PH, V283, pC412, DOI 10.1152/ajpcell.00477.2001; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mathur S, 1998, CANCER, V82, P816, DOI 10.1002/(SICI)1097-0142(19980301)82:5<816::AID-CNCR3>3.0.CO;2-H; MATSUSHIMA M, 1991, BIOCHEM BIOPH RES CO, V178, P1459, DOI 10.1016/0006-291X(91)91057-J; Neu J, 2005, ACTA PAEDIATR, V94, P100, DOI 10.1080/08035320510043637; Petrof Elaine O, 2004, Chin J Dig Dis, V5, P45, DOI 10.1111/j.1443-9573.2004.00154.x; Pope MR, 2010, MOL IMMUNOL, V48, P356, DOI 10.1016/j.molimm.2010.07.004; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; Sangild PT, 2006, EXP BIOL MED, V231, P1695, DOI 10.1177/153537020623101106; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; SANGILD PT, 1995, PEDIATR RES, V37, P207, DOI 10.1203/00006450-199502000-00014; Schlapbach LJ, 2008, PEDIATR RES, V64, P562, DOI 10.1203/PDR.0b013e3181841335; Schlapbach LJ, 2010, CLIN INFECT DIS, V51, P153, DOI 10.1086/653531; Schlapbach LJ, 2009, MOL IMMUNOL, V46, P2597, DOI 10.1016/j.molimm.2009.05.003; Schultheiss G, 2005, J MEMBRANE BIOL, V204, P117, DOI 10.1007/s00232-005-0757-4; Shi T, 2009, AM J PHYSIOL-GASTR L, V296, pG339, DOI 10.1152/ajpgi.90607.2008; Siggers J, 2011, AM J PHYSIOL-GASTR L, V301, pG435, DOI 10.1152/ajpgi.00400.2010; Siggers RH, 2011, J NUTR BIOCHEM, V22, P511, DOI 10.1016/j.jnutbio.2010.08.002; Soliman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015044; Sreedhar B, 2005, FREE RADICAL BIO MED, V39, P999, DOI 10.1016/j.freeradbiomed.2005.05.026; Taylor CA, 2007, EXP CELL RES, V313, P437, DOI 10.1016/j.yexcr.2006.09.030; Thompson AM, 2008, DRUGS, V68, P1227, DOI 10.2165/00003495-200868090-00004; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Vydra N, 2009, HISTOCHEM CELL BIOL, V132, P319, DOI 10.1007/s00418-009-0605-1; Wang CR, 2010, J BIOL CHEM, V285, P29398, DOI 10.1074/jbc.M110.141440; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Zhang An-Sheng, 2009, Hematology Am Soc Hematol Educ Program, P207, DOI 10.1182/asheducation-2009.1.207	59	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44929	10.1371/journal.pone.0044929	http://dx.doi.org/10.1371/journal.pone.0044929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028687	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700059
J	Melgert, BN; Spaans, F; Borghuis, T; Klok, PA; Groen, B; Bolt, A; de Vos, P; van Pampus, MG; Wong, TY; van Goor, H; Bakker, WW; Faas, MM				Melgert, Barbro N.; Spaans, Floor; Borghuis, Theo; Klok, Pieter A.; Groen, Bart; Bolt, Annemarie; de Vos, Paul; van Pampus, Maria G.; Wong, Tsz Y.; van Goor, Harry; Bakker, Winston W.; Faas, Marijke M.			Pregnancy and Preeclampsia Affect Monocyte Subsets in Humans and Rats	PLOS ONE			English	Article							LOW-DOSE ENDOTOXIN; BLOOD MONOCYTES; CYTOKINE PRODUCTION; L-SELECTIN; CELLS; SUBPOPULATIONS; EXPRESSION; DECIDUA; MACROPHAGES; ACTIVATION	Introduction: Both nonclassical and intermediate monocytes have been implicated in different inflammatory conditions. We hypothesized that these monocytes would increase during pregnancy, a condition associated with generalized activation of inflammatory responses and that they would increase even more during preeclampsia, in which inflammatory responses are further stimulated. In the present study we investigated changes in monocyte subsets during healthy pregnancy and preeclampsia in humans and rats. Methods: Blood monocyte subsets of nonpregnant, preeclamptic and healthy pregnant women were identified with CD14 and CD16. In nonpregnant and pregnant rats, blood monocytes were identified with CD172a and CD43, as well as in rats infused with adenosine triphosphate (ATP), a pro-inflammatory stimulus known to induce preeclampsia-like symptoms. Total and CD206-positive macrophages were quantified in placentas of these animals. Results: Lower percentages of classical monocytes were found in pregnant women (91%-[83-98%]) compared to nonpregnant women (94%-[90-98%]) and even less in preeclamptic patients (90%-[61-92%]). In contrast, the percentage of combined nonclassical/intermediate monocytes was higher in pregnant women (8.5%-[2.3-16.6%] vs. 5.6%-[1.9-9.5%]) and even higher in preeclamptic patients (9.9%-[7.8-38.7%]), which was caused by a selective increase of intermediate monocytes. In rats, we also found lower percentages of classical monocytes and higher percentages of nonclassical monocytes in pregnant versus nonpregnant rats. ATP infusion increased the percentage of nonclassical monocytes in pregnant rats even further but not in nonpregnant rats. These nonclassical monocytes showed a more activated phenotype in pregnant ATP-infused rats only. Mesometrial triangles of ATP-infused rats had less CD206-positive macrophages as compared to those of saline-infused rats. Conclusion: The higher percentage of nonclassical/intermediate monocytes found in pregnancy and preeclampsia confirms their association with inflammatory responses. The observation that ATP stimulated numbers/activation of nonclassical monocytes in pregnant rats only, suggests that nonclassical monocytes are specifically altered in pregnancy and may play a role in the pathophysiology of preeclampsia.	[Melgert, Barbro N.; Spaans, Floor; de Vos, Paul; Faas, Marijke M.] Univ Med Ctr Groningen, Div Med Biol, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [Melgert, Barbro N.] Univ Groningen, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands; [Groen, Bart; Bolt, Annemarie; van Pampus, Maria G.; Wong, Tsz Y.] Univ Med Ctr Groningen, Dept Obstet & Gynaecol, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Melgert, BN (corresponding author), Univ Med Ctr Groningen, Div Med Biol, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands.	f.spaans@umcg.nl	van+Goor, Harry/AAS-7712-2020; de Vos, Paul/A-3170-2013	van Pampus, Maria/0000-0002-3020-8908; de vos, paul/0000-0001-9618-2408; Melgert, Barbro/0000-0001-7091-907X; van Goor, Harry/0000-0002-6670-1577	Dutch Kidney Foundation [C08.2266]; Dutch Technology Foundation STW [10704]	Dutch Kidney Foundation; Dutch Technology Foundation STW(Technologiestichting STW)	This study was funded by the Dutch Kidney Foundation (grantnr. C08.2266) and the Dutch Technology Foundation STW (grantnr. 10704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHUJA V, 1995, CELL IMMUNOL, V163, P59, DOI 10.1006/cimm.1995.1099; Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bakker WW, 2007, HYPERTENS PREGNANCY, V26, P227, DOI 10.1080/10641950701274896; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; BUHRER C, 1994, PEDIATR RES, V36, P799; Engert S, 2007, AM J REPROD IMMUNOL, V58, P129, DOI 10.1111/j.1600-0897.2007.00498.x; Faas MM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.12.013; Faas MM, 2010, J REPROD IMMUNOL, V87, P28, DOI 10.1016/j.jri.2010.07.005; Faas MM, 2010, NEPHROL DIAL TRANSPL, V25, P2468, DOI 10.1093/ndt/gfq095; Faas MM, 2004, AM J OBSTET GYNECOL, V191, P1192, DOI 10.1016/j.ajog.2004.03.041; FAAS MM, 1995, AM J PATHOL, V147, P1510; Faas MM, 2000, AM J OBSTET GYNECOL, V182, P351, DOI 10.1016/S0002-9378(00)70223-7; Faas MM, 1999, AM J REPROD IMMUNOL, V41, P224; FINGERLE G, 1993, BLOOD, V82, P3170; Frankenberger M, 1996, BLOOD, V87, P373; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Houser BL, 2011, J IMMUNOL, V186, P2633, DOI 10.4049/jimmunol.1003153; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kammerer U, 2003, AM J PATHOL, V162, P887, DOI 10.1016/S0002-9440(10)63884-9; Keelan JA, 2007, FRONT BIOSCI-LANDMRK, V12, P2706, DOI 10.2741/2266; Kerner T, 1999, EUR J CLIN INVEST, V29, P1077; Kuhnert M, 1998, EUR J OBSTET GYN R B, V76, P147, DOI 10.1016/S0301-2115(97)00180-2; LESSIN DL, 1988, AM J REPROD IMMUNOL, V16, P1; Luppi P, 2002, J LEUKOCYTE BIOL, V72, P874; Messerli M, 2010, PLACENTA, V31, P106, DOI 10.1016/j.placenta.2009.11.011; Minagawa M, 1999, CELL IMMUNOL, V196, P1, DOI 10.1006/cimm.1999.1541; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Passacquale G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025595; Peracoli MT, 2011, AM J REPROD IMMUNOL; Poehlmann H, 2009, CRIT CARE, V13, DOI 10.1186/cc7969; Prins JR, 2012, PLACENTA, V33, P453, DOI 10.1016/j.placenta.2012.02.010; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; RIVIER A, 1995, CLIN EXP IMMUNOL, V100, P314; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Rossol M, 2011, ARTHR RHEUM; Sacks G, 1999, IMMUNOL TODAY, V20, P114, DOI 10.1016/S0167-5699(98)01393-0; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Sargent Ian L, 2007, Reprod Biomed Online, V14 Spec No 1, P111, DOI 10.1016/S1472-6483(10)61465-4; Scriba A, 1997, J LEUKOCYTE BIOL, V62, P741, DOI 10.1002/jlb.62.6.741; SHIBUYA T, 1987, AM J REPROD IMMUNOL, V15, P19; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SIEGEL I, 1981, DIAGN GYNECOL OBSTET, V3, P123; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; SMARASON AK, 1986, J CLIN LAB IMMUNOL, V21, P1; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Southcombe J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020245; Steiniger B, 2001, IMMUNOL REV, V184, P38, DOI 10.1034/j.1600-065x.2001.1840104.x; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; van der Post JAM, 2011, SEMIN THROMB HEMOST, V37, P146, DOI 10.1055/s-0030-1270342; van Nieuwenhoven ALV, 2003, HUM REPROD UPDATE, V9, P347, DOI 10.1093/humupd/dmg026; van Nieuwenhoven ALV, 2002, FERTIL STERIL, V77, P1032, DOI 10.1016/S0015-0282(02)02976-X; van Nieuwenhoven ALV, 2008, HYPERTENS PREGNANCY, V27, P207, DOI 10.1080/10641950701885006; Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360; Wong KL, 2012, IMMUNOL RES; Zawada AM, 2011, BLOOD; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	67	75	79	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45229	10.1371/journal.pone.0045229	http://dx.doi.org/10.1371/journal.pone.0045229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028864	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700097
J	Shen, X; Ying, HY; Yue, BYJT				Shen, Xiang; Ying, Hongyu; Yue, Beatrice Y. J. T.			Wnt Activation by Wild Type and Mutant Myocilin in Cultured Human Trabecular Meshwork Cells	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PROTEIN-KINASE-A; BETA-CATENIN; SIGNALING PATHWAY; OUTFLOW FACILITY; INTRAOCULAR-PRESSURE; EXTRACELLULAR-MATRIX; AQUEOUS-HUMOR; NON-SECRETION; ER STRESS	Background: Myocilin is a gene linked to the most prevalent form of glaucoma, a major blinding disease. The trabecular meshwork (TM), a specialized eye tissue, is believed to be involved, at least in part, in the development of glaucoma. The Pro(370) to Leu (P370L) mutation of myocilin is associated with severe glaucoma phenotypes and Gln(368) stop (Q368X) is the most common myocilin mutation reported. Myocilin, upon overexpression, has been shown to induce phenotypes that include a loss of actin stress fibers, an increase in the cAMP level and protein kinase A (PKA) activity, as well as a reduction in the RhoA activity. We examined herein whether Wnt signaling pathway is involved in the myocilin phenotypes and whether P370L and Q368X mutants also display biological effects similar to those of the wild type myocilin. Methodology/Principal Findings: Wild type myocilin, when transfected into cultured human TM cells, induced a loss of actin stress fibers as judged by phalloidin staining. Such a loss was averted by treatment of secreted Frizzled-related protein 1 (sFRP1), an inhibitor of Wnt signaling. Consistent with the notion that Wnt pathway mediates the myocilin phenotype, Wnt activation was demonstrated by TOP/FOP-Flash reporter assays. Treatment of human TM cells of a Wnt activator, SB216763, as well as transfection of myocilin P370L and Q368X mutants all resulted in actin stress fiber loss, PKA activation and RhoA inactivation. The PKA elevation was obviated by the sFRP1 treatment, indicating that Wnt signaling was upstream that of PKA. Conclusions/Significance: The present study demonstrated that following forced expression of wild type myocilin, Wnt was activated, triggering in turn other myocilin-related alterations. P370L and Q368X mutations induced similar phenotypes, suggesting one possible mechanism how the mutants may lead to TM cell damage and pathology.	[Shen, Xiang; Ying, Hongyu; Yue, Beatrice Y. J. T.] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shen, X (corresponding author), Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	beatyue@uic.edu			National Eye Institute [EY018828, EY005628, EY001792]; NATIONAL EYE INSTITUTE [R01EY018828, R01EY005628, P30EY001792] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by grants EY018828 and EY005628, and core grant EY001792 from the National Eye Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILL A, 1975, INVEST OPHTH VISUAL, V14, P1; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1576, DOI 10.1124/dmd.109.027821; Caballero M, 2000, BBA-MOL BASIS DIS, V1502, P447, DOI 10.1016/S0925-4439(00)00068-5; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Chen J, 2011, CLIN OPHTHALMOL, V5, P667, DOI 10.2147/OPTH.S15971; de Iongh RU, 2006, FRONT BIOSCI-LANDMRK, V11, P2442, DOI 10.2741/1982; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Ezzat MK, 2008, EXP EYE RES, V87, P376, DOI 10.1016/j.exer.2008.07.002; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; He Y, 2009, MOL VIS, V15, P815; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Keller KE, 2009, EXP EYE RES, V88, P676, DOI 10.1016/j.exer.2008.11.023; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuroda T, 2006, CANCER RES, V66, P10127, DOI 10.1158/0008-5472.CAN-06-2744; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Liu XY, 2005, MOL VIS, V11, P1112; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Mao WM, 2011, INVEST OPHTH VIS SCI, V52, P8068, DOI 10.1167/iovs.11-8133; Mii Y, 2011, DEV GROWTH DIFFER, V53, P911, DOI 10.1111/j.1440-169X.2011.01299.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Sakai H, 2006, INVEST OPHTH VIS SCI, V47, P4427, DOI 10.1167/iovs.06-0047; Shen X, 2008, J BIOL CHEM, V283, P603, DOI 10.1074/jbc.M708250200; Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Stumpff F, 2000, OPHTHALMOLOGICA, V214, P33, DOI 10.1159/000027471; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tian B, 2009, EXP EYE RES, V88, P713, DOI 10.1016/j.exer.2008.08.008; Ueda J, 2000, J HISTOCHEM CYTOCHEM, V48, P1321, DOI 10.1177/002215540004801003; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vittitow JL, 2002, MOL VIS, V8, P32; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wang WH, 2008, J CLIN INVEST, V118, P1056, DOI 10.1172/JCI33871; Wang W, 2011, CELL RES, V21, P730, DOI 10.1038/cr.2011.30; Wentz-Hunter K, 2004, EXP CELL RES, V297, P39, DOI 10.1016/j.yexcr.2004.02.024; Wentz-Hunter K, 2003, MOL VIS, V9, P308; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Yang ZQ, 2009, INT J CANCER, V125, P1613, DOI 10.1002/ijc.24518; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379; Zang M, 2008, AM J PHYSIOL, V295, pC1057; ZHOU LL, 1995, INVEST OPHTH VIS SCI, V36, P787; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	56	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44902	10.1371/journal.pone.0044902	http://dx.doi.org/10.1371/journal.pone.0044902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028669	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700052
J	Wagh, K; Bhatia, A; Alexe, G; Reddy, A; Ravikumar, V; Seiler, M; Boemo, M; Yao, M; Cronk, L; Naqvi, A; Ganesan, S; Levine, AJ; Bhanot, G				Wagh, Kshitij; Bhatia, Aatish; Alexe, Gabriela; Reddy, Anupama; Ravikumar, Vijay; Seiler, Michael; Boemo, Michael; Yao, Ming; Cronk, Lee; Naqvi, Asad; Ganesan, Shridar; Levine, Arnold J.; Bhanot, Gyan			Lactase Persistence and Lipid Pathway Selection in the Maasai	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RECENT POSITIVE SELECTION; GENETIC-BASIS; DIACYLGLYCEROL ACYLTRANSFERASE; SERUM-CHOLESTEROL; HEPATIC STEATOSIS; KETOGENIC DIET; HEART-DISEASE; DGAT2; AFRICA	The Maasai are a pastoral people in Kenya and Tanzania, whose traditional diet of milk, blood and meat is rich in lactose, fat and cholesterol. In spite of this, they have low levels of blood cholesterol, and seldom suffer from gallstones or cardiac diseases. Field studies in the 1970s suggested that the Maasai have a genetic adaptation for cholesterol homeostasis. Analysis of HapMap 3 data using Fixation Index (Fst) and two metrics of haplotype diversity: the integrated Haplotype Score (iHS) and the Cross Population Extended Haplotype Homozygosity (XP-EHH), identified genomic regions and single nucleotide polymorphisms (SNPs) as strong candidates for recent selection for lactase persistence and cholesterol regulation in 143-156 founder individuals from the Maasai population in Kinyawa, Kenya (MKK). The non-synonmous SNP with the highest genome-wide Fst was the TC polymorphism at rs2241883 in Fatty Acid Binding Protein 1(FABP1), known to reduce low density lipoprotein and tri-glyceride levels in Europeans. The strongest signal identified by all three metrics was a 1.7 Mb region on Chr2q21. This region contains the genes LCT (Lactase) and MCM6 (Minichromosome Maintenance Complex Component) involved in lactase persistence, and the gene Rab3GAP1 (Rab3 GTPase-activating Protein Catalytic Subunit), which contains polymorphisms associated with total cholesterol levels in a genome-wide association study of >100,000 individuals of European ancestry. Sanger sequencing of DNA from six MKK samples showed that the GC-14010 polymorphism in the MCM6 gene, known to be associated with lactase persistence in Africans, is segregating in MKK at high frequency (similar to 58%). The Cytochrome P450 Family 3 Subfamily A (CYP3A) cluster of genes, involved in cholesterol metabolism, was identified by Fst and iHS as candidate loci under selection. Overall, our study identified several specific genomic regions under selection in the Maasai which contain polymorphisms in genes associated with lactase persistence and cholesterol regulation.	[Yao, Ming; Ganesan, Shridar; Levine, Arnold J.; Bhanot, Gyan] Canc Inst New Jersey, New Brunswick, NJ USA; [Wagh, Kshitij; Bhatia, Aatish; Bhanot, Gyan] Rutgers State Univ, Dept Phys, Piscataway, NJ 08854 USA; [Alexe, Gabriela] Broad Inst, Cambridge, MA USA; [Alexe, Gabriela] Dana Farber Canc Inst, Boston, MA 02115 USA; [Reddy, Anupama; Seiler, Michael; Bhanot, Gyan] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ USA; [Ravikumar, Vijay; Boemo, Michael] Rutgers State Univ, Dept Math, Piscataway, NJ USA; [Cronk, Lee] Rutgers State Univ, Dept Anthropol, New Brunswick, NJ 08903 USA; [Naqvi, Asad; Levine, Arnold J.; Bhanot, Gyan] Inst Adv Study, Princeton, NJ 08540 USA; [Bhanot, Gyan] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Institute for Advanced Study - USA; Rutgers State University New Brunswick	Levine, AJ (corresponding author), Canc Inst New Jersey, New Brunswick, NJ USA.	alevine@ias.edu; gyanbhanot@gmail.com	Wagh, Kshitij/ABB-5002-2020; Cronk, Lee/V-1918-2019					Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; ARHEM K, 1989, ANTHROPOS, V84, P1; BANG HO, 1971, LANCET, V1, P1143, DOI 10.1016/S0140-6736(71)91658-8; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Best LG, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-77; BISS K, 1971, NEW ENGL J MED, V284, P694, DOI 10.1056/NEJM197104012841304; Brotons C, 1998, ATHEROSCLEROSIS, V139, P1, DOI 10.1016/S0021-9150(98)00056-2; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen XP, 2009, ENVIRON HEALTH PERSP, V117, P1541, DOI 10.1289/ehp.0800528; Coast E, 2001, MAASAI DEMOGRAPHY; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Cronk L., 2004, MUKOGODO MAASAI ETHN; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Dastani Z, 2010, EUR J HUM GENET, V18, P342, DOI 10.1038/ejhg.2009.157; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Fisher E, 2007, MOL GENET METAB, V91, P278, DOI 10.1016/j.ymgme.2007.03.002; GIBNEY MJ, 1980, ATHEROSCLEROSIS, V35, P339, DOI 10.1016/0021-9150(80)90131-8; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; HO KJ, 1971, ARCH PATHOL, V91, P387; HO KJ, 1972, AM J CLIN NUTR, V25, P737; Hollis AC, 1910, J R ANTHROPOL INST G, V40, P473, DOI 10.2307/2843267; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jacobs A. H., 1965, TRADITIONAL POLITICA; Jacobs AH, 1973, CULTURAL SOURCE MAT, V3; Johns T, 1999, J ETHNOPHARMACOL, V66, P1, DOI 10.1016/S0378-8741(98)00179-2; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kang HC, 2004, EPILEPSIA, V45, P1116, DOI 10.1111/j.0013-9580.2004.10004.x; Kantartzis K, 2009, CLIN SCI, V116, P531, DOI 10.1042/CS20080306; Kivisto KT, 2004, PHARMACOGENETICS, V14, P523, DOI 10.1097/01.fpc.0000114762.78957.a5; KROMHOUT D, 1995, PREV MED, V24, P308, DOI 10.1006/pmed.1995.1049; Ku CS, 2010, J HUM GENET, V55, P195, DOI 10.1038/jhg.2010.19; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lagor WR, 2009, ARTERIOSCL THROM VAS, V29, P40, DOI 10.1161/ATVBAHA.108.177105; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Lusis AJ, 2004, CIRCULATION, V110, P2066, DOI 10.1161/01.CIR.0000143098.98869.F8; Lusis AJ, 2004, CIRCULATION, V110, P1868, DOI 10.1161/01.CIR.0000143041.58692.CC; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ma L, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-55; MANN GV, 1965, LANCET, V2, P1308; Mann GV, J ATHEROSCLEROSIS RE, V4, P289; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; MATTSON FH, 1972, AM J CLIN NUTR, V25, P589; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2009, MOL CELL BIOCHEM, V326, P79, DOI 10.1007/s11010-008-0002-4; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; REYNOLDS J, 1983, GENETICS, V105, P767; Robitaille J, 2004, MOL GENET METAB, V82, P296, DOI 10.1016/j.ymgme.2004.06.002; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sankan SSO, 1973, MASAI; Shorvon S, 2004, TREATMENT EPILEPSY; Silander K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003615; Spencer P., 2003, TIME SPACE UNKNOWN M; Spencer Paul, 1988, MAASAI MATAPATO STUD; TAYLOR CB, 1971, AM J CLIN NUTR, V24, P1291; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; von Mitzlaff U, 1994, MAASAI WOMEN LIFE PA; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783	71	35	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44751	10.1371/journal.pone.0044751	http://dx.doi.org/10.1371/journal.pone.0044751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028602	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900016
J	Villegas-Mendez, A; Fender, P; Garin, MI; Rothe, R; Liguori, L; Marques, B; Lenormand, JL				Villegas-Mendez, Ana; Fender, Pascal; Garin, Marina I.; Rothe, Romy; Liguori, Lavinia; Marques, Bruno; Lenormand, Jean-Luc			Functional Characterisation of the WW Minimal Domain for Delivering Therapeutic Proteins by Adenovirus Dodecahedron	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; TAT-FUSION PROTEINS; IN-VIVO; HEPARAN-SULFATE; CELLULAR UPTAKE; LIVING CELLS; P53 RESTORATION; PENTON PARTICLE; INFECTED CELLS; GENE-TRANSFER	Protein transduction offers a great therapeutic potential by efficient delivery of biologically active cargo into cells. The Adenovirus Dd (Dodecahedron) has recently been shown to deliver proteins fused to the tandem WW2-3-4 structural domains from the E3 ubiquitin ligase Nedd4. In this study, we conclusively show that Dd is able to efficiently deliver cargo inside living cells, which mainly localize in fast moving endocytic vesicles, supporting active transport along the cytoskeleton. We further improve this delivery system by expressing a panel of 13 WW-GFP mutant forms to characterize their binding properties towards Dd. We identified the domain WW3 and its mutant form WW(3_)10_13 to be sufficient for optimal binding to Dd. We greatly minimise the interacting WW modules from 20 to 6 kDa without compromising its efficient delivery by Dd. Using these minimal WW domains fused to the tumor suppressor p53 protein, we show efficient cellular uptake and distribution into cancer cells, leading to specific induction of apoptosis in these cells. Taken together, these findings represent a step further towards the development of a Dd-based delivery system for future therapeutic application.	[Villegas-Mendez, Ana; Rothe, Romy; Liguori, Lavinia; Marques, Bruno; Lenormand, Jean-Luc] Univ Grenoble 1, UMR5525, TIMC IMAG Lab, HumProTher Lab,TheREx,CNRS, La Tronche, France; [Fender, Pascal] CNRS, UMI3265, UVHCI, UJF,EMBL, Grenoble, France; [Garin, Marina I.] CIEMAT CIBER Rare Dis, Hematopoiesis & Gene Therapy Div, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Lenormand, JL (corresponding author), Univ Grenoble 1, UMR5525, TIMC IMAG Lab, HumProTher Lab,TheREx,CNRS, La Tronche, France.	jllenormand@chu-grenoble.fr	Lenormand, Jean-Luc/M-6644-2014; Garin, Marina I/C-5094-2014; Lenormand, Jean-Luc/ABF-3850-2021	Garin, Marina I/0000-0001-7956-6792; Lenormand, Jean-Luc/0000-0002-2766-9180; Fender, Pascal/0000-0002-6698-3367; villegas-mendez, ana/0000-0002-8363-680X	European Commission [014320]; Fond d'Intervention of Joseph Fourier Grenoble University	European Commission(European CommissionEuropean Commission Joint Research Centre); Fond d'Intervention of Joseph Fourier Grenoble University	This work was supported by a Marie Curie Excellence Grant from the European Commission [#014320] and Fond d'Intervention of Joseph Fourier Grenoble University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer I, 2011, CANCER RES, V71, P7080, DOI 10.1158/0008-5472.CAN-11-2009; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2005, VIROLOGY, V340, P167, DOI 10.1016/j.virol.2005.06.030; Fender P, 2003, J VIROL, V77, P4960, DOI 10.1128/JVI.77.8.4960-4964.2003; Fender P, 2008, VIROLOGY, V371, P155, DOI 10.1016/j.virol.2007.09.026; Fuschiotti P, 2006, J GEN VIROL, V87, P2901, DOI 10.1099/vir.0.82025-0; Fuschiotti P, 2006, J MOL BIOL, V356, P510, DOI 10.1016/j.jmb.2005.11.048; Galinier R, 2002, BIOCHEMISTRY-US, V41, P14299, DOI 10.1021/bi020125b; Garcel A, 2006, J GENE MED, V8, P524, DOI 10.1002/jgm.862; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Haupts U, 1998, P NATL ACAD SCI USA, V95, P13573, DOI 10.1073/pnas.95.23.13573; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lott JS, 2002, BIOCHEM J, V361, P481, DOI 10.1042/0264-6021:3610481; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lundberg M, 2003, MOL THER, V8, P143, DOI 10.1016/S1525-0016(03)00135-7; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Miyazawa N, 1999, J VIROL, V73, P6056, DOI 10.1128/JVI.73.7.6056-6065.1999; Miyazawa N, 2001, J VIROL, V75, P1387, DOI 10.1128/JVI.75.3.1387-1400.2001; Mizuguchi H, 2004, HUM GENE THER, V15, P1034, DOI 10.1089/hum.2004.15.1034; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Okuyama M, 2007, NAT METHODS, V4, P153, DOI 10.1038/nmeth997; Patnaik A, 2002, J VIROL, V76, P2789, DOI 10.1128/JVI.76.6.2789-2795.2002; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Selivanova G, 2010, SEMIN CANCER BIOL, V20, P46, DOI 10.1016/j.semcancer.2010.02.006; Snyder EL, 2004, PLOS BIOL, V2, P186, DOI 10.1371/journal.pbio.0020036; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Sugita T, 2007, BIOCHEM BIOPH RES CO, V363, P1027, DOI 10.1016/j.bbrc.2007.09.077; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Villegas-Mendez A, 2010, MOL THER, V18, P1046, DOI 10.1038/mt.2010.16; Vives RR, 2004, VIROLOGY, V321, P332, DOI 10.1016/j.virol.2004.01.015; Vocero-Akbani AM, 1999, NAT MED, V5, P29, DOI 10.1038/4710; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang HJ, 2011, J VIROL, V85, P6390, DOI 10.1128/JVI.00514-11; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; WOHLFART C, 1988, J VIROL, V62, P2321, DOI 10.1128/JVI.62.7.2321-2328.1988; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; Zochowska M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005569	57	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45416	10.1371/journal.pone.0045416	http://dx.doi.org/10.1371/journal.pone.0045416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028993	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500029
J	Benhamou, L; Bronfeld, M; Bar-Gad, I; Cohen, D				Benhamou, Liora; Bronfeld, Maya; Bar-Gad, Izhar; Cohen, Dana			Globus Pallidus External Segment Neuron Classification in Freely Moving Rats: A Comparison to Primates	PLOS ONE			English	Article							BASAL GANGLIA; SPIKE TRAINS; IN-VITRO; PARALLEL; ORGANIZATION; STIMULATION; DISCHARGE; MOVEMENT; TASK; ELECTROPHYSIOLOGY	Globus Pallidus external segment (GPe) neurons are well-characterized in behaving primates. Based on their firing properties, these neurons are commonly divided into two distinct groups: high frequency pausers (HFP) and low frequency bursters (LFB). However, no such characterization has been made for behaving rats. The current study characterizes and categorizes extracellularly recorded GPe neurons in freely moving rats, and compares these results to those obtained by extracellular recordings in behaving primates using the same analysis methods. Analysis of our data recorded in rats revealed two distinct neuronal populations exhibiting firing-pattern characteristics that are similar to those obtained in primates. These characteristic firing patterns are conserved between species although the firing rate is significantly lower in rats than in primates. Significant differences in waveform duration and shape were insufficient to create a reliable waveform-based classification in either species. The firing pattern analogy may emphasize conserved processing properties over firing rate per-se. Given the similarity in GPe neuronal activity between human and non-human primates in different pathologies, our results encourage information transfer using complementary studies across species in the GPe to acquire a better understanding of the function of this nucleus in health and disease.	[Benhamou, Liora; Bronfeld, Maya; Bar-Gad, Izhar; Cohen, Dana] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel	Bar Ilan University	Cohen, D (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, Ramat Gan, Israel.	danacoh@gmail.com		Cohen, Dana/0000-0001-5562-3967; Bronfeld, Maya/0000-0001-9797-5418; Bar-Gad, Izhar/0000-0002-2999-4083	Israel Science Foundation (ISF) [861/06, 327/09]; Legacy Heritage Biomedical Program of ISF [981-10]	Israel Science Foundation (ISF)(Israel Science Foundation); Legacy Heritage Biomedical Program of ISF	This study was funded in part by Israel Science Foundation (ISF) grants 861/06 (DC) and 327/09 (IBG), and by the Legacy Heritage Biomedical Program of ISF grant 981-10 (IBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2012, J NEUROSCI, V32, P2473, DOI 10.1523/JNEUROSCI.4830-11.2012; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bar-Gad I, 2003, PROG NEUROBIOL, V71, P439, DOI 10.1016/j.pneurobio.2003.12.001; Bar-Gad I, 2003, J NEUROSCI, V23, P4012; Bronfeld M, 2011, J NEUROSCI, V31, P8713, DOI 10.1523/JNEUROSCI.0195-11.2011; Bronfeld M, 2010, J NEUROPHYSIOL, V104, P3261, DOI 10.1152/jn.00093.2010; Bugaysen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012001; Chang JY, 2006, EXP BRAIN RES, V172, P193, DOI 10.1007/s00221-005-0312-7; COCATREZILGIEN JH, 1992, J NEUROSCI METH, V41, P19, DOI 10.1016/0165-0270(92)90120-3; Cooper AJ, 2000, J PHYSIOL-LONDON, V527, P291, DOI 10.1111/j.1469-7793.2000.t01-1-00291.x; de Solages C, 2008, NEURON, V58, P775, DOI 10.1016/j.neuron.2008.05.008; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Elias S, 2007, J NEUROSCI, V27, P2525, DOI 10.1523/JNEUROSCI.4156-06.2007; Erez Y, 2009, J NEUROSCI, V29, P7797, DOI 10.1523/JNEUROSCI.0401-09.2009; FRANCOIS C, 1994, EXP BRAIN RES, V102, P305; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; GARDINER TW, 1992, EXP BRAIN RES, V88, P517; Goldberg JA, 2011, NEUROSCIENCE, V198, P171, DOI 10.1016/j.neuroscience.2011.08.068; Groenewegen HJ, 1999, J CHEM NEUROANAT, V16, P167, DOI 10.1016/S0891-0618(99)00009-5; Gunay C, 2008, J NEUROSCI, V28, P7476, DOI 10.1523/JNEUROSCI.4198-07.2008; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hashimoto T, 2003, J NEUROSCI, V23, P1916; HUTCHISON WD, 1994, NEUROREPORT, V5, P1533, DOI 10.1097/00001756-199407000-00031; Jacobson GA, 2009, P NATL ACAD SCI USA, V106, P3579, DOI 10.1073/pnas.0806661106; Joshua M, 2009, J NEUROPHYSIOL, V101, P758, DOI 10.1152/jn.90764.2008; KITA H, 1991, BRAIN RES, V564, P296, DOI 10.1016/0006-8993(91)91466-E; KITA H, 1994, BRAIN RES, V636, P308, DOI 10.1016/0006-8993(94)91030-8; Kita H, 2004, J NEUROPHYSIOL, V92, P3069, DOI 10.1152/jn.00346.2004; Kita H, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00042; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; MILLHOUSE OE, 1986, J COMP NEUROL, V254, P209, DOI 10.1002/cne.902540206; Nambu A, 1997, J COMP NEUROL, V377, P85; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127, DOI 10.1152/jn.1994.72.3.1127; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; NINI A, 1995, J NEUROPHYSIOL, V74, P1800, DOI 10.1152/jn.1995.74.4.1800; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PERCHERON G, 1991, TRENDS NEUROSCI, V14, P55, DOI 10.1016/0166-2236(91)90020-U; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; RICHARDSON RT, 1986, BRAIN RES, V399, P364, DOI 10.1016/0006-8993(86)91529-5; Schmitzer-Torbert NC, 2008, NEUROSCIENCE, V153, P349, DOI 10.1016/j.neuroscience.2008.01.081; Shin SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000485; Turner RS, 2005, J NEUROSCI, V25, P2965, DOI 10.1523/JNEUROSCI.4036-04.2005	47	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45421	10.1371/journal.pone.0045421	http://dx.doi.org/10.1371/journal.pone.0045421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028997	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800045
J	Durand, C; Decker, E; Roeth, R; Schneider, KU; Rappold, G				Durand, Claudia; Decker, Eva; Roeth, Ralph; Schneider, Katja U.; Rappold, Gudrun			The Homeobox Transcription Factor HOXA9 Is a Regulator of SHOX in U2OS Cells and Chicken Micromass Cultures	PLOS ONE			English	Article							LERI-WEILL DYSCHONDROSTEOSIS; APICAL ECTODERMAL RIDGE; FOOT-GENITAL SYNDROME; SHORT STATURE; TURNER-SYNDROME; GENE SHOX; LIMB DEVELOPMENT; GROWTH-PLATE; EXPRESSION; PHENOTYPES	The homeobox gene SHOX encodes for a transcription factor that plays an important role during limb development. Mutations or deletions of SHOX in humans cause short stature in Turner, Langer and Leri-Weill syndrome as well as idiopathic short stature. During embryonic development, SHOX is expressed in a complex spatio-temporal pattern that requires the presence of specific regulatory mechanisms. Up to now, it was known that SHOX is regulated by two upstream promoters and several enhancers on either side of the gene, but no regulators have been identified that can activate or repress the transcription of SHOX by binding to these regulatory elements. We have now identified the homeodomain protein HOXA9 as a positive regulator of SHOX expression in U2OS cells. Using luciferase assays, chromatin immunoprecipitation and electrophoretic mobility shift assays, we could narrow down the HOXA9 binding site to two AT-rich sequences of 31 bp within the SHOX promoter 2. Virus-induced Hoxa9 overexpression in a chicken micromass model validated the regulation of Shox by Hoxa9 (negative regulation). As Hoxa9 and Shox are both expressed in overlapping regions of the developing limb buds, a regulatory relationship of Hoxa9 and Shox during the process of limb development can be assumed.	[Durand, Claudia; Decker, Eva; Roeth, Ralph; Schneider, Katja U.; Rappold, Gudrun] Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Rappold, G (corresponding author), Univ Heidelberg, Dept Human Mol Genet, Heidelberg, Germany.	gudrun_rappold@med.uni-heidelberg.de			Landesgraduiertenforderung Baden-Wurttemberg; Deutsche Forschungsgemeinschaft (DFG) [RA 380/12-1]	Landesgraduiertenforderung Baden-Wurttemberg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Landesgraduiertenforderung Baden-Wurttemberg, http://www.graduateacademy.uni-heidelberg.de/stipendien/lgfg_en.html,(for CD), and the Deutsche Forschungsgemeinschaft (DFG), http://www.dfg.de,[RA 380/12-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Benito-Sanz S, 2005, AM J HUM GENET, V77, P533, DOI 10.1086/449313; Blaschke RJ, 2003, J BIOL CHEM, V278, P47820, DOI 10.1074/jbc.M306685200; Bleyl SB, 2007, AM J MED GENET A, V143A, P2785, DOI 10.1002/ajmg.a.32036; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen J, 2009, J MED GENET, V46, P834, DOI 10.1136/jmg.2009.067785; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Decker E, 2011, HUM MOL GENET; DOLLE P, 1989, EMBO J, V8, P1507, DOI 10.1002/j.1460-2075.1989.tb03535.x; Durand C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018115; Durand C, 2010, EUR J HUM GENET, V18, P527, DOI 10.1038/ejhg.2009.216; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Fukami M, 2006, AM J HUM GENET, V78, P167, DOI 10.1086/499254; Goff DJ, 1997, DEVELOPMENT, V124, P627; Goodman FR, 2000, AM J HUM GENET, V67, P197, DOI 10.1086/302961; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; HAACK H, 1993, DEV BIOL, V157, P410, DOI 10.1006/dbio.1993.1145; Huber C, 2006, J MED GENET, V43, P735, DOI 10.1136/jmg.2006.040998; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Marchini A, 2004, J BIOL CHEM, V279, P37103, DOI 10.1074/jbc.M307006200; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Mello MA, 1999, IN VITRO CELL DEV-AN, V35, P262; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Munns CJF, 2004, J CLIN ENDOCR METAB, V89, P4130, DOI 10.1210/jc.2003-032230; Nelson CE, 1996, DEVELOPMENT, V122, P1449; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Rappold G, 2007, J MED GENET, V44, P306, DOI 10.1136/jmg.2006.046581; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sabherwal N, 2007, HUM MOL GENET, V16, P210, DOI 10.1093/hmg/ddl470; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tiecke E, 2006, DEV BIOL, V298, P585, DOI 10.1016/j.ydbio.2006.07.008; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45369	10.1371/journal.pone.0045369	http://dx.doi.org/10.1371/journal.pone.0045369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028966	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388900043
J	Wei, YY; Shohag, MJI; Yang, XE				Wei, Yanyan; Shohag, M. J. I.; Yang, Xiaoe			Biofortification and Bioavailability of Rice Grain Zinc as Affected by Different Forms of Foliar Zinc Fertilization	PLOS ONE			English	Article							GERMINATED BROWN RICE; IRON; CALCIUM; WHEAT; TRANSLOCATION; ENVIRONMENT; GENOTYPE; PROTEIN; CEREALS; COPPER	Background: Zinc (Zn) biofortification through foliar Zn application is an attractive strategy to reduce human Zn deficiency. However, little is known about the biofortification efficiency and bioavailability of rice grain from different forms of foliar Zn fertilizers. Methodology/Principal Findings: Four different Zn forms were applied as a foliar treatment among three rice cultivars under field trial. Zinc bioavailability was assessed by in vitro digestion/Caco-2 cell model. Foliar Zn fertilization was an effective agronomic practice to promote grain Zn concentration and Zn bioavailability among three rice cultivars, especially, in case of Zn-amino acid and ZnSO4. On average, Zn-amino acid and ZnSO4 increased Zn concentration in polished rice up to 24.04% and 22.47%, respectively. On average, Zn-amino acid and ZnSO4 increased Zn bioavailability in polished rice up to 68.37% and 64.43%, respectively. The effectiveness of foliar applied Zn-amino acid and ZnSO4 were higher than Zn-EDTA and Zn-Citrate on improvement of Zn concentration, and reduction of phytic acid, as a results higher accumulation of bioavailable Zn in polished rice. Moreover, foliar Zn application could maintain grain yield, the protein and minerals (Fe and Ca) quality of the polished rice. Conclusions: Foliar application of Zn in rice offers a practical and useful approach to improve bioavailable Zn in polished rice. According to current study, Zn-amino acid and ZnSO4 are recommended as excellent foliar Zn forms to ongoing agronomic biofortification.	[Wei, Yanyan; Shohag, M. J. I.; Yang, Xiaoe] Zhejiang Univ, MOE, Key Lab Environm Remediat & Ecosyst Hlth, Coll Environm & Resources Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yang, XE (corresponding author), Zhejiang Univ, MOE, Key Lab Environm Remediat & Ecosyst Hlth, Coll Environm & Resources Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xyang571@yahoo.com	Shohag, Md. J. I./I-3060-2014	Shohag, Md. J. I./0000-0002-8799-4401	HarvestPlus-China Program [8234]; Ministry of Science and Technology, China [2006AA06Z386]; Zhejiang Provincial Department of Education, Zhejiang, China [20100339]; Fundamental Research Funds for the Central Universities [2012FZA6008]	HarvestPlus-China Program; Ministry of Science and Technology, China(Ministry of Science and Technology, China); Zhejiang Provincial Department of Education, Zhejiang, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research work was financially supported by the HarvestPlus-China Program (8234), International Cooperation Program from the Ministry of Science and Technology, China (2006AA06Z386), Project from the Zhejiang Provincial Department of Education, Zhejiang, China (20100339) and Fundamental Research Funds for the Central Universities (2012FZA6008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohn L, 2008, J ZHEJIANG UNIV-SC B, V9, P165, DOI 10.1631/jzus.B0710640; Bouis HE, 2002, J NUTR, V132, p491S, DOI 10.1093/jn/132.3.491S; Cakmak I, 2010, J AGR FOOD CHEM, V58, P9092, DOI 10.1021/jf101197h; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Cakmak I, 2009, J TRACE ELEM MED BIO, V23, P281, DOI 10.1016/j.jtemb.2009.05.002; Camara F, 2007, FOOD CHEM, V100, P1085, DOI 10.1016/j.foodchem.2005.11.010; Colle C, 2009, J ENVIRON RADIOACTIV, V100, P683, DOI 10.1016/j.jenvrad.2008.10.002; Dai F, 2007, FOOD CHEM, V105, P606, DOI 10.1016/j.foodchem.2007.04.019; Dobermann A., 2000, RICE NUTR DISORDERS; Falk MC, 2002, J NUTR, V132, P1384, DOI 10.1093/jn/132.6.1384; Fang Y, 2008, J AGR FOOD CHEM, V56, P2079, DOI 10.1021/jf800150z; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Frontela C, 2009, WORLD J GASTROENTERO, V15, P1977, DOI 10.3748/wjg.15.1977; Frossard E, 2000, J SCI FOOD AGR, V80, P861, DOI 10.1002/(SICI)1097-0010(20000515)80:7&lt;861::AID-JSFA601&gt;3.0.CO;2-P; Hambidge M, 2000, J NUTR, V130, p1344S, DOI 10.1093/jn/130.5.1344S; Hotz C, 2005, INT J VITAM NUTR RES, V75, P423, DOI 10.1024/0300-9831.75.6.423; House WA, 1999, FIELD CROP RES, V60, P115, DOI 10.1016/S0378-4290(98)00136-1; International Zinc Consultative Group, 2004, FOOD NUTR BULL, V25, pS99, DOI DOI 10.1177/15648265040251S205; Joshi AK, 2010, FIELD CROP RES, V116, P268, DOI 10.1016/j.fcr.2010.01.004; Lee S, 2011, PLANT BIOTECHNOL J, V9, P865, DOI 10.1111/j.1467-7652.2011.00606.x; [刘德辉 Liu Dehui], 2005, [土壤通报, Journal of Soil Science], V36, P917; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; Nasri M., 2011, Advances in Environmental Biology, V5, P839; Ohtsubo K, 2005, J FOOD COMPOS ANAL, V18, P303, DOI 10.1016/j.jfca.2004.10.003; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Pfeiffer WH, 2007, CROP SCI, V47, pS88, DOI 10.2135/cropsci2007.09.0020IPBS; Phattarakul N, 2012, PLANT SOIL, V361, P131, DOI 10.1007/s11104-012-1211-x; Rosado JL, 2009, J NUTR, V139, P1920, DOI 10.3945/jn.109.107755; Stacey SP, 2007, SOIL FERTILITY STUDI, P80; Stein AJ, 2010, PLANT SOIL, V335, P133, DOI 10.1007/s11104-009-0228-2; Van Campen DR, 1999, FIELD CROP RES, V60, P93, DOI 10.1016/S0378-4290(98)00135-X; Viadel B, 2006, NUTR RES, V26, P591, DOI 10.1016/j.nutres.2006.09.016; Wei YY, 2012, J AGR FOOD CHEM, V60, P1871, DOI 10.1021/jf205025b; Wissuwa M, 2008, PLANT SOIL, V306, P37, DOI 10.1007/s11104-007-9368-4; Wu CY, 2010, J AGR FOOD CHEM, V58, P6767, DOI 10.1021/jf100017e; Yang XW, 2011, AFR J BIOTECHNOL, V10, P14778, DOI 10.5897/AJB11.780; Zhang YQ, 2010, J AGR FOOD CHEM, V58, P12268, DOI 10.1021/jf103039k	39	65	73	5	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45428	10.1371/journal.pone.0045428	http://dx.doi.org/10.1371/journal.pone.0045428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029003	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900050
J	Heitz, FD; Erb, M; Anklin, C; Robay, D; Pernet, V; Gueven, N				Heitz, Fabrice D.; Erb, Michael; Anklin, Corinne; Robay, Dimitri; Pernet, Vincent; Gueven, Nuri			Idebenone Protects against Retinal Damage and Loss of Vision in a Mouse Model of Leber's Hereditary Optic Neuropathy	PLOS ONE			English	Article							BRAIN MITOCHONDRIA; GLUTAMINE-SYNTHETASE; LIPID-PEROXIDATION; MTDNA MUTATIONS; INHIBITION; TIME; TRANSPORT; CV-2619; DEATH; LHON	Leber's hereditary optic neuropathy(LHON) is an inherited disease caused by mutations in complex I of the mitochondrial respiratory chain. The disease is characterized by loss of central vision due to retinal ganglion cell (RGC) dysfunction and optic nerve atrophy. Despite progress towards a better understanding of the disease, no therapeutic treatment is currently approved for this devastating disease. Idebenone, a short-chain benzoquinone, has shown promising evidence of efficacy in protecting vision loss and in accelerating recovery of visual acuity in patients with LHON. It was therefore of interest to study suitable LHON models in vitro and in vivo to identify anatomical correlates for this protective activity. At nanomolar concentrations, idebenone protected the rodent RGC cell line RGC-5 against complex I dysfunction in vitro. Consistent with the reported dosing and observed effects in LHON patients, we describe that in mice, idebenone penetrated into the eye at concentrations equivalent to those which protected RGC-5 cells from complex I dysfunction in vitro. Consequently, we next investigated the protective effect of idebenone in a mouse model of LHON, whereby mitochondrial complex I dysfunction was caused by exposure to rotenone. In this model, idebenone protected against the loss of retinal ganglion cells, reduction in retinal thickness and gliosis. Furthermore, consistent with this protection of retinal integrity, idebenone restored the functional loss of vision in this disease model. These results support the pharmacological activity of idebenone and indicate that idebenone holds potential as an effective treatment for vision loss in LHON patients.	[Heitz, Fabrice D.; Erb, Michael; Anklin, Corinne; Robay, Dimitri; Gueven, Nuri] Santhera Pharmaceut, Liestal, Switzerland; [Pernet, Vincent] Univ Zurich, Brain Res Inst, Fac Med, Zurich, Switzerland; [Gueven, Nuri] Univ Tasmania, Sch Pharm, Hobart, Tas 7001, Australia	University of Geneva; University of Zurich; University of Tasmania	Gueven, N (corresponding author), Santhera Pharmaceut, Liestal, Switzerland.	nuri.guven@utas.edu.au		Pernet, Vincent/0000-0002-9618-972X; Guven, Nuri/0000-0003-3782-767X	Santhera Pharmaceuticals (Switzerland)	Santhera Pharmaceuticals (Switzerland)	Santhera Pharmaceuticals (Switzerland) funded and approved the publication of this work.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Barboni P, 2010, OPHTHALMOLOGY, V117, P623, DOI 10.1016/j.ophtha.2009.07.026; Barcella V, 2010, HUM BRAIN MAPP, V31, P1900, DOI 10.1002/hbm.20985; Barnils N., 2007, Arch Soc Esp Oftalmol, V82, P377; Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258; Beretta S, 2006, NEUROBIOL DIS, V24, P308, DOI 10.1016/j.nbd.2006.07.016; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791; Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8; Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Carelli V, 1998, J NEUROL SCI, V160, P183, DOI 10.1016/S0022-510X(98)00239-1; Carelli V, 2001, J NEUROL NEUROSUR PS, V71, P813, DOI 10.1136/jnnp.71.6.813; Carelli V, 2001, OPHTHALMOLOGY, V108, P1172, DOI 10.1016/S0161-6420(01)00618-2; Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180; Chadderton N, 2013, EUR J HUM GENET, V21, P62, DOI 10.1038/ejhg.2012.112; Cortelli P, 1997, J NEUROL SCI, V148, P25, DOI 10.1016/S0022-510X(96)00311-5; DEGOTTRAU P, 1992, J CLIN NEURO-OPHTHAL, V12, P89; Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Giorgio V, 2011, BIOCHIM BIOPHYS ACTA, V1817, P363; Haefeli RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017963; Hayworth CR, 2008, J TOXICOL ENV HEAL A, V71, P1582, DOI 10.1080/15287390802414190; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Ishikawa M, 2011, INVEST OPHTH VIS SCI, V52, P6604, DOI 10.1167/iovs.11-7375; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Marella M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011472; Mascialino B, 2012, EUR J OPHTHALMOL, V22, P461, DOI 10.5301/ejo.5000055; Mashima Y, 2000, J NEURO-OPHTHALMOL, V20, P166, DOI 10.1097/00041327-200020030-00006; MASHIMA Y, 1992, LANCET, V340, P368, DOI 10.1016/0140-6736(92)91442-B; Mordente A, 1998, CHEM RES TOXICOL, V11, P54, DOI 10.1021/tx970136j; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Rauchova H, 2008, J BIOENERG BIOMEMBR, V40, P85, DOI 10.1007/s10863-008-9134-1; Rauchova H, 2006, BIOCHEM BIOPH RES CO, V339, P362, DOI 10.1016/j.bbrc.2005.11.035; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rojas JC, 2008, BRAIN RES, V1215, P208, DOI 10.1016/j.brainres.2008.04.001; Sabet-Peyman EJ, 2012, J NEURO-OPHTHALMOL, V32, P54, DOI 10.1097/WNO.0b013e318241da45; Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223; Sadun AA, 2011, CURR TREAT OPTION NE, V13, P109, DOI 10.1007/s11940-010-0100-y; SMITH JL, 1990, J CLIN NEURO-OPHTHAL, V10, P231; SUGIYAMA Y, 1985, FEBS LETT, V184, P48, DOI 10.1016/0014-5793(85)80650-5; SUNO M, 1984, BIOCHEM BIOPH RES CO, V125, P1046, DOI 10.1016/0006-291X(84)91389-5; SUNO M, 1989, ARCH GERONTOL GERIAT, V8, P291, DOI 10.1016/0167-4943(89)90010-1; Tonska K, 2010, BBA-BIOENERGETICS, V1797, P1119, DOI 10.1016/j.bbabio.2010.02.032; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Yu XH, 2009, EXP EYE RES, V89, P967, DOI 10.1016/j.exer.2009.08.006; Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5; Zhang X, 2002, NEUROSCI LETT, V326, P97, DOI 10.1016/S0304-3940(02)00327-0	51	75	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45182	10.1371/journal.pone.0045182	http://dx.doi.org/10.1371/journal.pone.0045182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028832	Green Published, gold			2022-12-27	WOS:000311313900093
J	Hoffmann, F; Kloas, W				Hoffmann, Frauke; Kloas, Werner			The Antiestrogens Tamoxifen and Fulvestrant Abolish Estrogenic Impacts of 17 alpha-ethinylestradiol on Male Calling Behavior of Xenopus laevis	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING COMPOUNDS; AFFECTING REPRODUCTIVE-BIOLOGY; AFRICAN CLAWED FROGS; STICKLEBACK GASTEROSTEUS-ACULEATUS; MALE 3-SPINED STICKLEBACK; MESSENGER-RNA EXPRESSION; MALE SEX BEHAVIOR; BREAST-CANCER; ENVIRONMENTAL CHEMICALS; POMATOSCHISTUS-MINUTUS	Various synthetic chemicals released to the environment can interfere with the endocrine system of vertebrates. Many of these endocrine disrupting compounds (EDCs) exhibit estrogenic activity and can interfere with sexual development and reproductive physiology. More recently, also chemicals with different modes of action (MOAs), such as antiestrogenic, androgenic and antiandrogenic EDCs, have been shown to be present in the environment. However, to date EDC-research primarily focuses on exposure to EDCs with just one MOA, while studies examining the effects of simultaneous exposure to EDCs with different MOAs are rare, although they would reflect more real, natural exposure situations. In the present study the combined effects of estrogenic and antiestrogenic EDCs were assessed by analyzing the calling behavior of short-term exposed male Xenopus laevis. The estrogenic 17 alpha-ethinylestradiol (EE2), and the antiestrogenic EDCs tamoxifen (TAM) and fulvestrant (ICI) were used as model substances. As previously demonstrated, sole EE2 exposure (10-10 M) resulted in significant alterations of the male calling behavior, including altered temporal and spectral parameters of the advertisement calls. Sole TAM (10-7 M, 10-8 M, 10-10 M) or ICI (10-7 M) exposure, on the other hand, did not affect any of the measured parameters. If frogs were co-exposed to EE2 (10-10 M) and TAM (10-7 M) the effects of EE2 on some parameters were abolished, but co-exposure to EE2 and ICI (10-7 M) neutralized all estrogenic effects. Thus, although EDCs with antiestrogenic MOA might not exhibit any effects per se, they can alter the estrogenic effects of EE2. Our observations demonstrate that there is need to further investigate the combined effects of EDCs with various, not only opposing, MOAs as this would reflect realistic wildlife situations.	[Hoffmann, Frauke; Kloas, Werner] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany; [Kloas, Werner] Humboldt Univ, Inst Biol, Dept Endocrinol, D-10099 Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin	Hoffmann, F (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecophysiol & Aquaculture, Berlin, Germany.	f.hoffmann@igb-berlin.de	Hoffmann, Frauke/F-9114-2017; Hoffmann, Frauke/H-5994-2015		German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU), Osnabruck, Germany [AZ 20008/987]	German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU), Osnabruck, Germany	The authors would like to acknowledge the financial support provided by the German Environmental Foundation (Deutsche Bundesstiftung Umwelt, DBU), Osnabruck, Germany (support code AZ 20008/987). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREOLETTI GE, 1983, HORM BEHAV, V17, P103, DOI 10.1016/0018-506X(83)90020-X; Behrends T, 2010, GEN COMP ENDOCR, V168, P269, DOI 10.1016/j.ygcen.2010.01.017; Bell AM, 2004, HORM BEHAV, V45, P108, DOI 10.1016/j.yhbeh.2003.09.009; Bell AM, 2001, ANIM BEHAV, V62, P775, DOI 10.1006/anbe.2001.1824; Benotti MJ, 2009, ENVIRON SCI TECHNOL, V43, P597, DOI 10.1021/es801845a; Bentrem DJ, 2001, ENDOCRINOLOGY, V142, P838, DOI 10.1210/en.142.2.838; Brian JV, 2006, J FISH BIOL, V68, P1883, DOI 10.1111/j.0022-1112.2006.01053.x; Cevasco A, 2008, COMP BIOCHEM PHYS C, V147, P241, DOI 10.1016/j.cbpc.2007.10.001; Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x; Clotfelter ED, 2004, ANIM BEHAV, V68, P665, DOI 10.1016/j.anbehav.2004.05.004; Colman JR, 2009, AQUAT TOXICOL, V91, P346, DOI 10.1016/j.aquatox.2008.12.001; Doloresco F, 2011, AM J HEALTH-SYST PH, V68, P921, DOI 10.2146/ajhp100712; Falconer IR, 2006, ENVIRON TOXICOL, V21, P181, DOI 10.1002/tox.20172; Hilton MJ, 2003, J CHROMATOGR A, V1015, P129, DOI 10.1016/S0021-9673(03)01213-5; Hoffmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032097; Hoffmann F, 2012, GEN COMP ENDOCR, V176, P385, DOI 10.1016/j.ygcen.2012.02.009; Hoffmann F, 2012, CHEMOSPHERE, V87, P1246, DOI 10.1016/j.chemosphere.2012.01.030; Hoffmann F, 2010, HORM BEHAV, V58, P653, DOI 10.1016/j.yhbeh.2010.06.008; Hutchinson TH, 2000, ENVIRON HEALTH PERSP, V108, P1007, DOI 10.2307/3434950; Inadera H, 2006, TOXICOL LETT, V164, P191, DOI 10.1016/j.toxlet.2006.03.006; Jackson IM, 1991, MED MANAGEMENT BREAS, P51; Kawahara T, 2000, ZOOL SCI, V17, P65, DOI 10.2108/zsj.17.65; KELLEY DB, 1976, HORM BEHAV, V7, P159, DOI 10.1016/0018-506X(76)90045-3; Kelley DB, 1999, DESIGN OF ANIMAL COMMUNICATION, P9; Kloas W, 1999, SCI TOTAL ENVIRON, V225, P59, DOI 10.1016/S0048-9697(98)00332-5; Kloas W, 2002, INT REV CYTOL, V216, P1; Kloas W, 2009, ANN NY ACAD SCI, V1163, P187, DOI 10.1111/j.1749-6632.2009.04453.x; Long XH, 2006, J BIOL CHEM, V281, P9607, DOI 10.1074/jbc.M510809200; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Massari A, 2010, GEN COMP ENDOCR, V168, P262, DOI 10.1016/j.ygcen.2010.04.012; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; NICHOLSON RI, 1995, ANN NY ACAD SCI, V761, P148, DOI 10.1111/j.1749-6632.1995.tb31376.x; Opitz R, 2006, TOXICOL SCI, V90, P337, DOI 10.1093/toxsci/kfj083; Opitz R, 2005, ENVIRON TOXICOL CHEM, V24, P653, DOI 10.1897/04-214R.1; Osborne CK, 2004, BRIT J CANCER, V90, pS2, DOI 10.1038/sj.bjc.6601629; OSBORNE CK, 1995, J NATL CANCER I, V87, P746, DOI 10.1093/jnci/87.10.746; Partridge C, 2010, HORM BEHAV, V58, P800, DOI 10.1016/j.yhbeh.2010.08.002; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pottinger TG, 2003, PURE APPL CHEM, V75, P2321, DOI 10.1351/pac200375112321; Roberts PH, 2006, SCI TOTAL ENVIRON, V356, P143, DOI 10.1016/j.scitotenv.2005.04.031; Saaristo M, 2010, AQUAT TOXICOL, V97, P285, DOI 10.1016/j.aquatox.2009.12.015; Saaristo M, 2010, CHEMOSPHERE, V79, P541, DOI 10.1016/j.chemosphere.2010.02.019; Saaristo M, 2009, HORM BEHAV, V56, P315, DOI 10.1016/j.yhbeh.2009.06.010; Scott GR, 2004, AQUAT TOXICOL, V68, P369, DOI 10.1016/j.aquatox.2004.03.016; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Sun LW, 2009, AQUAT TOXICOL, V93, P83, DOI 10.1016/j.aquatox.2009.03.010; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P81, DOI 10.1016/S0048-9697(98)00334-9; Tobias ML, 1998, P NATL ACAD SCI USA, V95, P1870, DOI 10.1073/pnas.95.4.1870; Urbatzka R, 2006, GEN COMP ENDOCR, V146, P119, DOI 10.1016/j.ygcen.2005.10.005; Urbatzka R, 2009, J MOL ENDOCRINOL, V43, P209, DOI 10.1677/JME-09-0058; Urbatzka R, 2007, COMP BIOCHEM PHYS C, V144, P310, DOI 10.1016/j.cbpc.2006.10.008; WAKELING AE, 1995, BIOCHEM PHARMACOL, V49, P1545, DOI 10.1016/0006-2952(94)00528-T; WAKELING AE, 1988, J STEROID BIOCHEM, V31, P645, DOI 10.1016/0022-4731(88)90014-3; WAKELING AE, 1992, J STEROID BIOCHEM, V43, P173, DOI 10.1016/0960-0760(92)90204-V; Wardley AM, 2002, INT J CLIN PRACT, V56, P305; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; WETZEL DM, 1983, HORM BEHAV, V17, P388, DOI 10.1016/0018-506X(83)90048-X; Xu H, 2008, AQUAT TOXICOL, V88, P1, DOI 10.1016/j.aquatox.2008.01.020; YAGER D, 1982, AM ZOOL, V22, P887; Yang EJ, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P693; Zala SM, 2004, ANIM BEHAV, V68, P649, DOI 10.1016/j.anbehav.2004.01.005	62	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44715	10.1371/journal.pone.0044715	http://dx.doi.org/10.1371/journal.pone.0044715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028589	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900038
J	Li, Z; Chen, J; Li, L; Ran, JH; Li, XH; Liu, ZH; Liu, GJ; Gao, YC; Zhang, XL; Sun, HD				Li, Zhu; Chen, Juan; Li, Li; Ran, Jiang-Hua; Li, Xue-Hua; Liu, Zhi-Heng; Liu, Gui-Jie; Gao, Yan-Chao; Zhang, Xue-Li; Sun, Hiu-Dong			Human Hepatocyte Growth Factor (hHGF)-Modified Hepatic Oval Cells Improve Liver Transplant Survival	PLOS ONE			English	Article							2-ACETYLAMINOFLUORENE/PARTIAL HEPATECTOMY MODEL; STEM-CELLS; PROLIFERATION; REJECTION; RATS; COMPLICATIONS; REGENERATION; RECIPIENTS; INDUCTION; TOLERANCE	Despite progress in the field of immunosuppression, acute rejection is still a common postoperative complication following liver transplantation. This study aims to investigate the capacity of the human hepatocyte growth factor (hHGF) in modifying hepatic oval cells (HOCs) administered simultaneously with orthotopic liver transplantation as a means of improving graft survival. HOCs were activated and isolated using a modified 2-acetylaminofluorene/partial hepatectomy (2-AAF/PH) model in male Lewis rats. A HOC line stably expressing the HGF gene was established following stable transfection of the pBLAST2-hHGF plasmid. Our results demonstrated that hHGF-modified HOCs could efficiently differentiate into hepatocytes and bile duct epithelial cells in vitro. Administration of HOCs at the time of liver transplantation induced a wider distribution of SRY-positive donor cells in liver tissues. Administration of hHGF-HOC at the time of transplantation remarkably prolonged the median survival time and improved liver function for recipients compared to these parameters in the other treatment groups (P<0.05). Moreover, hHGF-HOC administration at the time of liver transplantation significantly suppressed elevation of interleukin-2 (IL-2), tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) levels while increasing the production of IL-10 and TGF-beta 1 (P<0.05). HOC or hHGF-HOC administration promoted cell proliferation, reduced cell apoptosis, and decreased liver allograft rejection rates. Furthermore, hHGF-modified HOCs more efficiently reduced acute allograft rejection (P<0.05 versus HOC transplantation only). Our results indicate that the combination of hHGF-modified HOCs with liver transplantation decreased host anti-graft immune responses resulting in a reduction of allograft rejection rates and prolonging graft survival in recipient rats. This suggests that HOC-based cell transplantation therapies can be developed as a means of treating severe liver injuries.	[Li, Zhu; Chen, Juan; Li, Xue-Hua; Liu, Zhi-Heng; Liu, Gui-Jie; Gao, Yan-Chao; Zhang, Xue-Li; Sun, Hiu-Dong] Liaocheng Peoples Hosp, Dept Hepatobiliary Surg, Liaocheng, Shandong, Peoples R China; [Li, Li; Ran, Jiang-Hua] First Peoples Hosp Kunming, Kunming, Yunnan, Peoples R China		Li, Z (corresponding author), Liaocheng Peoples Hosp, Dept Hepatobiliary Surg, Liaocheng, Shandong, Peoples R China.	lllllzhu@126.com						Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Azuma H, 2001, J AM SOC NEPHROL, V12, P1280, DOI 10.1681/ASN.V1261280; Chang John T, 2008, J Pediatr Gastroenterol Nutr, V46 Suppl 1, pE19, DOI 10.1097/01.mpg.0000313832.47207.0e; Chatzigeorgiou A, 2009, BIOFACTORS, V35, P474, DOI 10.1002/biof.62; Chung HW, 2007, TRANSPLANTATION, V83, P694, DOI 10.1097/01.tp.0000259386.59375.8a; Faris RA, 2001, ARTIF ORGANS, V25, P513, DOI 10.1046/j.1525-1594.2001.025007513.x; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Hasuike S, 2005, J GASTROEN HEPATOL, V20, P1753, DOI 10.1111/j.1440-1746.2005.03922.x; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kato H, 2007, HEPATO-GASTROENTEROL, V54, P821; Kaufman DB, 2004, AM J TRANSPLANT, V4, P38, DOI 10.1111/j.1600-6135.2004.00397.x; Knechtle SJ, 2009, SEMIN LIVER DIS, V29, P91, DOI 10.1055/s-0029-1192058; Locke Jayme E, 2009, Adv Surg, V43, P35; Marhaba R, 2004, J MOL HISTOL, V35, P211; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mukherjee S, 2009, J TRANSPLANT, V2009, DOI 10.1155/2009/701464; Patel H, 2007, LEUKEMIA LYMPHOMA, V48, P885, DOI 10.1080/10428190701223275; Shiota G, 2000, FEBS LETT, V470, P325, DOI 10.1016/S0014-5793(00)01337-5; Smets F, 2008, PEDIATR TRANSPLANT, V12, P6, DOI 10.1111/j.1399-3046.2007.00788.x; Solez K, 2010, CURR OPIN ORGAN TRAN, V15, P49, DOI 10.1097/MOT.0b013e328334fedb; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Strom TB, 1996, CURR OPIN IMMUNOL, V8, P688, DOI 10.1016/S0952-7915(96)80087-2; Tamsel S, 2007, ABDOM IMAGING, V32, P339, DOI 10.1007/s00261-006-9041-z; Tosh D, 2005, J HEPATOL, V42, pS75, DOI 10.1016/j.jhep.2004.12.009; VanBuskirk AM, 1996, TRANSPLANTATION, V62, P229, DOI 10.1097/00007890-199607270-00014; Xie R., 2006, J JIANGSU U MED EDIT, V16, P392; Yamaura K, 2004, CIRCULATION, V110, P1650, DOI 10.1161/01.CIR.0000143052.45956.71; Yang Y, 2007, EUR J NEUROSCI, V26, P2979, DOI 10.1111/j.1460-9568.2007.05914.x; ZIMMERMANN FA, 1983, TRANSPLANT P, V15, P1272	31	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44805	10.1371/journal.pone.0044805	http://dx.doi.org/10.1371/journal.pone.0044805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028627	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900044
J	Pabon, MM; Jernberg, JN; Morganti, J; Contreras, J; Hudson, CE; Klein, RL; Bickford, PC				Pabon, Mibel M.; Jernberg, Jennifer N.; Morganti, Josh; Contreras, Jessika; Hudson, Charles E.; Klein, Ronald L.; Bickford, Paula C.			A Spirulina-Enhanced Diet Provides Neuroprotection in an alpha-Synuclein Model of Parkinson's Disease	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; ACTIVATES MICROGLIA; SUBSTANTIA-NIGRA; GENE-TRANSFER; TNF-ALPHA; BRAIN; DEGENERATION; FRACTALKINE; INHIBITION; PLATENSIS	Inflammation in the brain plays a major role in neurodegenerative diseases. In particular, microglial cell activation is believed to be associated with the pathogenesis of neurodegenerative diseases, including Parkinson's disease (PD). An increase in microglia activation has been shown in the substantia nigra pars compacta (SNpc) of PD models when there has been a decrease in tyrosine hydroxylase (TH) positive cells. This may be a sign of neurotoxicity due to prolonged activation of microglia in both early and late stages of disease progression. Natural products, such as spirulina, derived from blue green algae, are believed to help reverse this effect due to its anti-inflammatory/anti-oxidant properties. An adeno-associated virus vector (AAV9) for alpha-synuclein was injected in the substantia nigra of rats to model Parkinson's disease and to study the effects of spirulina on the inflammatory response. One month prior to surgeries, rats were fed either a diet enhanced with spirulina or a control diet. Immunohistochemistry was analyzed with unbiased stereological methods to quantify lesion size and microglial activation. As hypothesized, spirulina was neuroprotective in this alpha-synuclein model of PD as more TH+ and NeuN+ cells were observed; spirulina concomitantly decreased the numbers of activated microglial cells as determined by MHCII expression. This decrease in microglia activation may have been due, in part, to the effect of spirulina to increase expression of the fractalkine receptor (CX3CR1) on microglia. With this study we hypothesize that alpha-synuclein neurotoxicity is mediated, at least in part, via an interaction with microglia. We observed a decrease in activated microglia in the rats that received a spirulina- enhanced diet concomitant to neuroprotection. The increase in CX3CR1 in the groups that received spirulina, suggests a potential mechanism of action.	[Pabon, Mibel M.; Morganti, Josh; Bickford, Paula C.] Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33606 USA; [Pabon, Mibel M.; Morganti, Josh; Contreras, Jessika; Bickford, Paula C.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg, Tampa, FL USA; [Hudson, Charles E.; Bickford, Paula C.] James A Haley Vet Adm Hosp, Tampa, FL USA; [Jernberg, Jennifer N.] Tulane Univ, Dept Neurosci, New Orleans, LA 70118 USA; [Klein, Ronald L.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Bickford, PC (corresponding author), Univ S Florida, Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33606 USA.	pbickfor@health.usf.edu	Bickford, Paula C/J-5970-2012; Morganti, Josh/AAL-9727-2020	Bickford, Paula C/0000-0001-9657-7725; Morganti, Josh/0000-0002-4183-0049; Contreras, Jessika/0000-0001-9563-6383	Veterans Administration Medical Research Service; M.J. Fox Foundation	Veterans Administration Medical Research Service; M.J. Fox Foundation	This work was supported by the Veterans Administration Medical Research Service to PCB. RLK was supported by the M.J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NEUROSCI RES, V69, P337, DOI 10.1016/j.neures.2010.12.020; ANNAPURNA VV, 1991, PLANT FOOD HUM NUTR, V41, P125, DOI 10.1007/BF02194081; Austin SA, 2006, J NEUROSCI, V26, P10558, DOI 10.1523/JNEUROSCI.1799-06.2006; Beraud D, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00080; Bhat VB, 2001, BIOCHEM BIOPH RES CO, V285, P262, DOI 10.1006/bbrc.2001.5195; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Careri M, 2001, J CHROMATOGR A, V912, P61, DOI 10.1016/S0021-9673(01)00545-3; Casadesus G, 2002, NEUROBIOL AGING, V23, P747, DOI 10.1016/S0197-4580(02)00079-9; Cearley CN, 2006, MOL THER, V13, P528, DOI 10.1016/j.ymthe.2005.11.015; Couch Y, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-166; Decressac M, 2012, EXP NEUROL, V235, P306, DOI 10.1016/j.expneurol.2012.02.012; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Fellner L, 2011, ACTA NEUROPATHOL, V121, P675, DOI 10.1007/s00401-011-0833-z; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao HM, 2002, J NEUROSCI, V22, P782, DOI 10.1523/JNEUROSCI.22-03-00782.2002; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Gemma C, 2007, BRAIN RES, V1147, P240, DOI 10.1016/j.brainres.2007.02.003; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klein RL, 2002, HUM GENE THER, V13, P605, DOI 10.1089/10430340252837206; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; Kruger R, 2001, NEUROLOGY, V56, P1355, DOI 10.1212/WNL.56.10.1355; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Lo B.C., 2008, J CLIN INVEST, V118, P3087; LO BC, 2004, NEUROBIOL DIS, V17, P283, DOI DOI 10.1016/J.NBD.2004.06.008; Magrone T, 2012, CURR PHARM DESIGN, V18, P34, DOI 10.2174/138161212798919057; McGeer EG, 1997, MOVEMENT DISORD, V12, P855, DOI 10.1002/mds.870120604; Miranda MS, 1998, BRAZ J MED BIOL RES, V31, P1075, DOI 10.1590/S0100-879X1998000800007; Pabon MM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-9; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reddy CM, 2000, BIOCHEM BIOPH RES CO, V277, P599, DOI 10.1006/bbrc.2000.3725; Reynolds AD, 2008, J NEUROCHEM, V104, P1504, DOI 10.1111/j.1471-4159.2007.05087.x; Rojanathammanee L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-44; Shih SR, 2003, J MED VIROL, V70, P119, DOI 10.1002/jmv.10363; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stefanova N, 2011, AM J PATHOL, V179, P954, DOI 10.1016/j.ajpath.2011.04.013; Stromberg I, 2005, EXP NEUROL, V196, P298, DOI 10.1016/j.expneurol.2005.08.013; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Su XM, 2009, NEUROTOX RES, V16, P238, DOI 10.1007/s12640-009-9053-x; Wang Y, 2005, EXP NEUROL, V193, P75, DOI 10.1016/j.expneurol.2004.12.014; West M J, 2001, Folia Morphol (Warsz), V60, P11; Yamada M, 2005, HUM GENE THER, V16, P262, DOI 10.1089/hum.2005.16.262; YAMADA T, 1992, ACTA NEUROPATHOL, V84, P157, DOI 10.1007/BF00311389; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zujovic V, 2001, J NEUROIMMUNOL, V115, P135, DOI 10.1016/S0165-5728(01)00259-4; Zujovic V, 2000, AID GLIA2 3 0 CO 2 V	46	55	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45256	10.1371/journal.pone.0045256	http://dx.doi.org/10.1371/journal.pone.0045256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028885	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900107
J	Sugihara, T; Murano, H; Tanaka, K				Sugihara, Takashi; Murano, Hayato; Tanaka, Kimio			Increased gamma-H2A.X Intensity in Response to Chronic Medium-Dose-Rate gamma-Ray Irradiation	PLOS ONE			English	Article							STRAND BREAK REPAIR; DEPENDENT PROTEIN-KINASE; IONIZING-RADIATION; HISTONE H2AX; HUMAN-CELLS; DNA-DAMAGE; CELLULAR-RESPONSE; MURINE CELLS; ATM KINASE; PHOSPHORYLATION	Background: The molecular mechanisms of DNA repair following chronic medium-dose-rate (MDR) gamma-ray-induced damage remain largely unknown. Methodology/Principal Findings: We used a cell function imager to quantitatively measure the fluorescence intensity of gamma-H2A.X foci in MDR (0.015 Gy/h and 0.06 Gy/h) or high-dose-rate (HDR) (54 Gy/h) gamma-ray irradiated embryonic fibroblasts derived from DNA-dependent protein kinase mutated mice (scid/scid mouse embryonic fibroblasts (scid/scid MEFs)). The obtained results are as follows: (1) Automatic measurement of the intensity of radiation-induced gamma-H2A.X foci by the cell function imager provides more accurate results compared to manual counting of gamma-H2A.X foci. (2) In high-dose-rate (HDR) irradiation, gamma-H2A.X foci with high fluorescence intensity were observed at 1 h after irradiation in both scid/scid and wild-type MEFs. These foci were gradually reduced through de-phosphorylation at 24 h or 72 h after irradiation. Furthermore, the fluorescence intensity at 24 h increased to a significantly greater extent in scid/scid MEFs than in wild-type MEFs in the G(1) phase, although no significant difference was observed in G(2)/M-phase MEFs, suggesting that DNA-PKcs might be associated with non-homologous-end-joining-dependent DNA repair in the G(1) phase following HDR c-ray irradiation. (3) The intensity of gamma-H2A.X foci for continuous MDR (0.06 Gy/h and 0.015 Gy/h) irradiation increased significantly and in a dose-dependent fashion. Furthermore, unlike HDR-irradiated scid/scid MEFs, the intensity of gamma-H2A.X foci in MDR-irradiated scid/scid MEFs showed no significant increase in the G(1) phase at 24 h, indicating that DNA repair systems using proteins other than DNA-PKcs might induce cell functioning that are subjected to MDR gamma-ray irradiation. Conclusions: Our results indicate that the mechanism of phosphorylation or de-phosphorylation of gamma-H2A.X foci induced by chronic MDR gamma-ray irradiation might be different from those induced by HDR gamma-ray irradiation.	[Sugihara, Takashi; Tanaka, Kimio] Inst Environm Sci, Dept Radiobiol, Aomori, Japan; [Murano, Hayato] Tohoku Environm Sci Serv Corp, Aomori, Japan		Sugihara, T (corresponding author), Inst Environm Sci, Dept Radiobiol, Aomori, Japan.	sugihara@ies.or.jp			Aomori Prefectural Government, Japan	Aomori Prefectural Government, Japan	The study was performed under contract with the Aomori Prefectural Government, Japan. Aomori Prefectural Government have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, Aomori Prefectural Government Japan is a rightful claimant of this study. Also note that the funding agency bears no commercial benefit from the study.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Anderson JA, 2010, RADIAT RES, V174, P195, DOI 10.1667/RR2071.1; Araki R, 1997, P NATL ACAD SCI USA, V94, P2438, DOI 10.1073/pnas.94.6.2438; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Budman J, 2007, J BIOL CHEM, V282, P11950, DOI 10.1074/jbc.M610058200; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Collis SJ, 2004, J BIOL CHEM, V279, P49624, DOI 10.1074/jbc.M409600200; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Ishizaki K, 2004, J RADIAT RES, V45, P521, DOI 10.1269/jrr.45.521; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; MANNIRONI C, 1989, NUCLEIC ACIDS RES, V17, P9113, DOI 10.1093/nar/17.22.9113; Nakamura H, 2006, RADIAT RES, V165, P277, DOI 10.1667/RR3519.1; Porcedda P, 2008, CYTOM PART A, V73A, P508, DOI 10.1002/cyto.a.20566; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Sugihara T, 2004, RADIAT RES, V162, P296, DOI 10.1667/RR3223; Sugihara T, 2008, J RADIAT RES, V49, P231, DOI 10.1269/jrr.07074; Sugihara T, 2011, RADIAT RES, V175, P328, DOI 10.1667/RR2446.1; Sugihara T, 2011, MOL CANCER RES, V9, P476, DOI 10.1158/1541-7786.MCR-10-0358; Tomita M, 2008, J RADIAT RES, V49, P557, DOI 10.1269/jrr.08036; UNSCEAR sources and effects of ionizing radiation, 2000, UNSCEAR SOURC EFF IO; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yoshida M, 2002, INT J RADIAT BIOL, V78, P503, DOI [10.1080/095530002317577321, 10.1080/09553000210123685]	31	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45320	10.1371/journal.pone.0045320	http://dx.doi.org/10.1371/journal.pone.0045320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028931	gold, Green Submitted, Green Published			2022-12-27	WOS:000311313900117
J	Wang, F; Gelernter, J; Kranzler, HR; Zhang, HP				Wang, Fan; Gelernter, Joel; Kranzler, Henry R.; Zhang, Huiping			Identification of POMC Exonic Variants Associated with Substance Dependence and Body Mass Index	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; PITUITARY-ADRENAL AXIS; BETA-ENDORPHIN; PROOPIOMELANOCORTIN POMC; DRUG-DEPENDENCE; SEMISTRUCTURED ASSESSMENT; ALCOHOL-CONSUMPTION; OBESITY; GENE; POPULATION	Background: Risk of substance dependence (SD) and obesity has been linked to the function of melanocortin peptides encoded by the proopiomelanocortin gene (POMC). Methods and Results: POMC exons were Sanger sequenced in 280 African Americans (AAs) and 308 European Americans (EAs). Among them, 311 (167 AAs and 114 EAs) were affected with substance (alcohol, cocaine, opioid and/or marijuana) dependence and 277 (113 AAs and 164 EAs) were screened controls. We identified 23 variants, including two common polymorphisms (rs10654394 and rs1042571) and 21 rare variants; 12 of which were novel. We used logistic regression to analyze the association between the two common variants and SD or body mass index (BMI), with sex, age, and ancestry proportion as covariates. The common variant rs1042571 in the 3'UTR was significantly associated with BMI in EAs (Overweight: P-adj = 0.005; Obese: P-adj = 0.018; Overweight+Obese: P-adj = 0.002) but not in AAs. The common variant, rs10654394, was not associated with BMI and neither common variant was associated with SD in either population. To evaluate the association between the rare variants and SD or BMI, we collapsed rare variants and tested their prevalence using Fisher's exact test. In AAs, rare variants were nominally associated with SD overall and with specific SD traits (SD: P-FET,(1df) = 0.026; alcohol dependence: P-FET,P-1df = 0.027; cocaine dependence: P-FET,P-1df = 0.007; marijuana dependence: P-FET,(1df) = 0.050) (the P-value from cocaine dependence analysis survived Bonferroni correction). There was no such effect in EAs. Although the frequency of the rare variants did not differ significantly between the normal-weight group and the overweight or obese group in either population, certain rare exonic variants occurred only in overweight or obese subjects without SD. Conclusion: These findings suggest that POMC exonic variants may influence risk for both SD and elevated BMI, in a population-specific manner. However, common and rare variants in this gene may exert different effects on these two phenotypes.	[Wang, Fan; Gelernter, Joel; Zhang, Huiping] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gelernter, Joel] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Wang, Fan; Gelernter, Joel; Zhang, Huiping] VA Connecticut Healthcare Syst, Vet Affairs VA Med Ctr, West Haven, CT USA; [Kranzler, Henry R.] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Kranzler, Henry R.] Philadelphia Vet Affairs Med Ctr VAMC, Educ & Clin Ctr MIRECC, VISN4 Mental Illness Res, Philadelphia, PA USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Pennsylvania; Pennsylvania Medicine	Zhang, HP (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	huiping.zhang@yale.edu	kranzler, henry/AAS-1113-2020	kranzler, henry/0000-0002-1018-0450; Zhang, Huiping/0000-0002-4902-0104; Gelernter, Joel/0000-0002-4067-1859	National Institutes of Health (NIH) [K99/R00 DA022891, R01 DA12690, R01 AA11330, R01 DA12849, R01 AA017535, R01 DA018432, K24 AA013736, P50 AA012870]; Veterans Affairs (VA) Connecticut (CT) Mental Illness Research, Education and Clinical Center (MIRECC); Alcoholic Beverage Medical Research Foundation (ABMRF); Alcohol Clinical Trials Initiative (ACTIVE); Eli Lilly; Schering Plough; Lundbeck; Alkermes; GlaxoSmithKline; Abbott; Johnson Johnson; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K24AA013736, R01AA011330, P50AA012870, R01AA017535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012690, R01DA012849, R00DA022891, K99DA022891, R01DA018432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs (VA) Connecticut (CT) Mental Illness Research, Education and Clinical Center (MIRECC)(US Department of Veterans Affairs); Alcoholic Beverage Medical Research Foundation (ABMRF); Alcohol Clinical Trials Initiative (ACTIVE); Eli Lilly(Eli Lilly); Schering Plough(Merck & CompanySchering Plough Corporation); Lundbeck(Lundbeck Corporation); Alkermes; GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institutes of Health (NIH) Grants K99/R00 DA022891 (HZ), R01 DA12690 (JG), R01 AA11330 (JG), R01 DA12849 (JG), R01 AA017535 (JG), R01 DA018432 (HRK), K24 AA013736 (HRK) and P50 AA012870 (JG); and grants from the Veterans Affairs (VA) Connecticut (CT) Mental Illness Research, Education and Clinical Center (MIRECC) to JG; and the Alcoholic Beverage Medical Research Foundation (ABMRF) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Kranzler has received compensation for professional services from the National Institutes of Health (National Institute on Alcohol Abuse and Alcoholism) (NIAAA) and National Institute on Drug Abuse (NIDA)) and for academic lectures and editorial functions in various scientific venues (including the ACNP). Dr. Kranzler has had consulting arrangements with the following pharmaceutical companies: Alkermes, Lilly, Lundbeck, Pfizer and Roche. Dr. Kranzler also receives support from the Alcohol Clinical Trials Initiative (ACTIVE), which Eli Lilly, Schering Plough, Lundbeck, Alkermes, GlaxoSmithKline, Abbott, and Johnson & Johnson support. Dr. Gelernter has received compensation for professional services in the previous three years from the following entities: Yale University School of Medicine, Veterans Affairs Healthcare System (VA), and the National Institutes of Health (NIAAA, NIDA, and NIMH), and related to academic lectures and editorial functions in various scientific venues (including the ACNP). Other authors have no conflict of interest to report. The competing interest does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arif AA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-126; Association AP, 1994, DIAGN STATISTICALMAN; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barry D, 2009, ADDICT BEHAV, V34, P51, DOI 10.1016/j.addbeh.2008.08.008; Bluml V, 2012, AM J ADDICTION, V21, P72, DOI 10.1111/j.1521-0391.2011.00192.x; Breslow RA, 2005, AM J EPIDEMIOL, V161, P368, DOI 10.1093/aje/kwi061; del Giudice EM, 2001, INT J OBESITY, V25, P61, DOI 10.1038/sj.ijo.0801485; Delplanque J, 2000, DIABETOLOGIA, V43, P1554, DOI 10.1007/s001250051568; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Duncan AE, 2009, J STUD ALCOHOL DRUGS, V70, P458, DOI 10.15288/jsad.2009.70.458; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Echwald SM, 1999, INT J OBESITY, V23, P293, DOI 10.1038/sj.ijo.0800814; Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395; Falush D, 2003, GENETICS, V164, P1567; Gearhardt AN, 2009, PSYCHOL ADDICT BEHAV, V23, P216, DOI 10.1037/a0015011; Gianoulakis C, 2003, ALCOHOL CLIN EXP RES, V27, P410, DOI 10.1097/01.ALC.0000056614.96137.B8; Hartwig A C, 1991, Anesth Prog, V38, P75; HEIJNEN C J, 1987, Brain Behavior and Immunity, V1, P284, DOI 10.1016/0889-1591(87)90031-6; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kendler KS, 2011, ALCOHOL CLIN EXP RES, V35, P963, DOI 10.1111/j.1530-0277.2010.01427.x; Kleiner KD, 2004, J ADDICT DIS, V23, P105, DOI 10.1300/J069v23n03_08; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Marchesi C, 1997, PSYCHIAT RES, V72, P187, DOI 10.1016/S0165-1781(97)00101-7; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Millington GWM, 2006, CLIN EXP DERMATOL, V31, P407, DOI 10.1111/j.1365-2230.2006.02128.x; OWERBACH D, 1981, SOMAT CELL GENET, V7, P359, DOI 10.1007/BF01538860; Pickering RP, 2007, J CLIN PSYCHIAT, V68, P998, DOI 10.4088/JCP.v68n0704; Pierucci-Lagha A, 2005, DRUG ALCOHOL DEPEN, V80, P303, DOI 10.1016/j.drugalcdep.2005.04.005; Pierucci-Lagha A, 2007, DRUG ALCOHOL DEPEN, V91, P85, DOI 10.1016/j.drugalcdep.2007.04.014; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Racz I, 2008, BIOL PSYCHIAT, V64, P989, DOI 10.1016/j.biopsych.2008.05.008; Rosmond R, 2002, METABOLISM, V51, P642, DOI 10.1053/meta.2002.31333; TAJIMA F, 1989, GENETICS, V123, P229; WEAVER JU, 1993, CLIN ENDOCRINOL, V39, P345, DOI 10.1111/j.1365-2265.1993.tb02375.x; Xie PX, 2011, BIOL PSYCHIAT, V70, P528, DOI 10.1016/j.biopsych.2011.04.017; Xie PX, 2009, ARCH GEN PSYCHIAT, V66, P1201, DOI 10.1001/archgenpsychiatry.2009.153; Xuei XL, 2007, AM J MED GENET B, V144B, P877, DOI 10.1002/ajmg.b.30531; Yang BZ, 2005, GENET EPIDEMIOL, V28, P302, DOI 10.1002/gepi.20070; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932; Zalewska-Kaszubska J, 2005, PEPTIDES, V26, P701, DOI 10.1016/j.peptides.2004.11.010; Zhang HP, 2009, BIOL PSYCHIAT, V66, P128, DOI 10.1016/j.biopsych.2008.12.021	42	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45300	10.1371/journal.pone.0045300	http://dx.doi.org/10.1371/journal.pone.0045300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019MC	23028917	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800048
J	Lee, JH; Yeon, JH; Kim, H; Roh, W; Chae, J; Park, HO; Kim, DM				Lee, Ju-Hee; Yeon, Ji-Hyun; Kim, Hanna; Roh, Whijae; Chae, Jeiwook; Park, Han-Oh; Kim, Dong-Myung			The Natural Anticancer Agent Plumbagin Induces Potent Cytotoxicity in MCF-7 Human Breast Cancer Cells by Inhibiting a PI-5 Kinase for ROS Generation	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 4-PHOSPHATE 5-KINASE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; INDUCED APOPTOSIS; PROSTATE-CANCER; PATHWAY; INVASION; PI3K/PTEN/AKT/MTOR; NAPHTHOQUINONE; INVOLVEMENT	Drug-induced haploinsufficiency (DIH) in yeast has been considered a valuable tool for drug target identification. A plant metabolite, plumbagin, has potent anticancer activity via reactive oxygen species (ROS) generation. However, the detailed molecular targets of plumbagin for ROS generation are not understood. Here, using DIH and heterozygous deletion mutants of the fission yeast Schizosaccharomyces pombe, we identified 1, 4-phopshatidylinositol 5-kinase (PI5K) its3 as a new molecular target of plumbagin for ROS generation. Plumbagin showed potent anti-proliferative activity (GI(50); 10 mu M) and induced cell elongation and septum formation in wild-type S. pombe. Furthermore, plumbagin dramatically increased the intracellular ROS level, and pretreatment with the ROS scavenger, N-acetyl cysteine (NAC), protected against growth inhibition by plumbagin, suggesting that ROS play a crucial role in the anti-proliferative activity in S. pombe. Interestingly, significant DIH was observed in an its3-deleted heterozygous mutant, in which ROS generation by plumbagin was higher than that in wild-type cells, implying that its3 contributes to ROS generation by plumbagin in this yeast. In MCF7 human breast cancer cells, plumbagin significantly decreased the level of a human ortholog, 1, 4-phopshatidylinositol 5-kinase (PI5K)-1B, of yeast its3, and knockdown of PI5K-1B using siPI5K-1B increased the ROS level and decreased cell viability. Taken together, these results clearly show that PI5K-1B plays a crucial role in ROS generation as a new molecular target of plumbagin. Moreover, drug target screening using DIH in S. pombe deletion mutants is a valuable tool for identifying molecular targets of anticancer agents.	[Lee, Ju-Hee; Yeon, Ji-Hyun; Kim, Hanna; Roh, Whijae; Chae, Jeiwook; Park, Han-Oh; Kim, Dong-Myung] Bioneer Corp, S Pombe Res Team, Gene To Drug Div, Taejon, South Korea		Lee, JH (corresponding author), Bioneer Corp, S Pombe Res Team, Gene To Drug Div, Taejon, South Korea.	dmkima@bioneer.co.kr		Roh, Whijae/0000-0002-7395-9939; Kim, Dong-Myung/0000-0001-7875-0694				Ahmad A, 2008, J CELL BIOCHEM, V105, P1461, DOI 10.1002/jcb.21966; Aziz MH, 2008, CANCER RES, V68, P9024, DOI 10.1158/0008-5472.CAN-08-2494; Checker R, 2010, J CELL BIOCHEM, V110, P1082, DOI 10.1002/jcb.22620; Chen CA, 2009, PANCREATOLOGY, V9, P797, DOI 10.1159/000210028; Chen JS, 2009, HEPATOL RES, V39, P177, DOI 10.1111/j.1872-034X.2008.00449.x; Choudhary S, 2011, J CANCER RES CLIN, V137, P471, DOI 10.1007/s00432-010-0910-z; Demma J, 2009, TOXICOL IN VITRO, V23, P266, DOI 10.1016/j.tiv.2008.12.007; Deng L, 2005, J BIOL CHEM, V280, P27561, DOI 10.1074/jbc.M502660200; Gomathinayagam R, 2008, ANTICANCER RES, V28, P785; Kavoosi G, 2009, PARASITOLOGY, V136, P1193, DOI 10.1017/S0031182009990473; Kawiak A, 2007, TOXICOL APPL PHARM, V223, P267, DOI 10.1016/j.taap.2007.05.018; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Leslie NR, 2001, CHEM REV, V101, P2365, DOI 10.1021/cr000091i; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; McCubrey JA, 2008, LEUKEMIA, V22, P708, DOI 10.1038/leu.2008.27; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nazeem S, 2009, MUTAGENESIS, V24, P413, DOI 10.1093/mutage/gep023; Powolny AA, 2008, PHARM RES-DORDR, V25, P2171, DOI 10.1007/s11095-008-9533-3; Sakamoto S, 2009, BIOL PHARM BULL, V32, P434, DOI 10.1248/bpb.32.434; Shih YW, 2009, HEPATOL RES, V39, P998, DOI 10.1111/j.1872-034X.2009.00540.x; Srinivas P, 2004, MOL CARCINOGEN, V40, P201, DOI 10.1002/mc.20031; Thasni KA, 2008, ANN ONCOL, V19, P696, DOI 10.1093/annonc/mdm557; Vancurova I, 1999, J BIOL CHEM, V274, P1147, DOI 10.1074/jbc.274.2.1147; Wang CCC, 2008, CANCER LETT, V259, P82, DOI 10.1016/j.canlet.2007.10.005; Xu KH, 2010, LEUKEMIA RES, V34, P658, DOI 10.1016/j.leukres.2009.08.017; Yamada H, 2006, LIFE SCI, V78, P926, DOI 10.1016/j.lfs.2005.05.106; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200	28	53	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45023	10.1371/journal.pone.0045023	http://dx.doi.org/10.1371/journal.pone.0045023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028742	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700078
J	Tran, M; Gallo, LA; Wadley, GD; Jefferies, AJ; Moritz, KM; Wlodek, ME				Tran, Melanie; Gallo, Linda A.; Wadley, Glenn D.; Jefferies, Andrew J.; Moritz, Karen M.; Wlodek, Mary E.			Effect of Pregnancy for Females Born Small on Later Life Metabolic Disease Risk	PLOS ONE			English	Article							BETA-CELL MASS; INTRAUTERINE GROWTH-RETARDATION; GESTATIONAL DIABETES-MELLITUS; REDUCING LITTER SIZE; UTEROPLACENTAL INSUFFICIENCY; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; BLOOD-PRESSURE; PANCREATIC MORPHOLOGY; SKELETAL-MUSCLE	There is a strong inverse relationship between a females own birth weight and her subsequent risk for gestational diabetes with increased risk of developing diabetes later in life. We have shown that growth restricted females develop loss of glucose tolerance during late pregnancy with normal pancreatic function. The aim of this study was to determine whether growth restricted females develop long-term impairment of metabolic control after an adverse pregnancy adaptation. Uteroplacental insufficiency was induced by bilateral uterine vessel ligation (Restricted) or sham surgery (Control) in late pregnancy (E18) in F0 female rats. F1 Control and Restricted female offspring were mated with normal males and allowed to deliver (termed Ex-Pregnant). Age-matched Control and Restricted Virgins were also studied and glucose tolerance and insulin secretion were determined. Pancreatic morphology and hepatic glycogen and triacylglycerol content were quantified respectively. Restricted females were born lighter than Control and remained lighter at all time points studied (p<0.05). Glucose tolerance, first phase insulin secretion and liver glycogen and triacylglycerol content were not different across groups, with no changes in beta-cell mass. Second phase insulin secretion was reduced in Restricted Virgins (-34%, p<0.05) compared to Control Virgins, suggestive of enhanced peripheral insulin sensitivity but this was lost after pregnancy. Growth restriction was associated with enhanced basal hepatic insulin sensitivity, which may provide compensatory benefits to prevent adverse metabolic outcomes often associated with being born small. A prior pregnancy was associated with reduced hepatic insulin sensitivity with effects more pronounced in Controls than Restricted. Our data suggests that pregnancy ameliorates the enhanced peripheral insulin sensitivity in growth restricted females and has deleterious effects for hepatic insulin sensitivity, regardless of maternal birth weight.	[Tran, Melanie; Gallo, Linda A.; Jefferies, Andrew J.; Wlodek, Mary E.] Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia; [Wadley, Glenn D.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Melbourne, Vic, Australia; [Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Melbourne; Deakin University; University of Queensland	Tran, M (corresponding author), Univ Melbourne, Dept Physiol, Melbourne, Vic, Australia.	m.wlodek@unimelb.edu.au	Moritz, Karen/G-2508-2015; Gallo, Linda A/M-3197-2014; wlodek, Mary/A-8939-2019	Moritz, Karen/0000-0002-8085-0034; Gallo, Linda A/0000-0002-0471-8517; wlodek, Mary/0000-0002-8490-9099; Tran, Melanie/0000-0003-1427-841X; Wadley, Glenn/0000-0002-6617-4359	National March of Dimes and Heart Foundation; National Heart Foundation of Australia Biomedical Scholarship; National Healthy Marriage Resource Center Fellowship	National March of Dimes and Heart Foundation; National Heart Foundation of Australia Biomedical Scholarship(National Heart Foundation of Australia); National Healthy Marriage Resource Center Fellowship	This study was supported by National March of Dimes and Heart Foundation grants to MEW and KMM. LAG was supported by a National Heart Foundation of Australia Biomedical Scholarship. KMM was supported by an National Healthy Marriage Resource Center Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x; Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Buchanan TA, 2001, J CLIN ENDOCR METAB, V86, P989, DOI 10.1210/jc.86.3.989; Chamson-Reig A, 2006, J ENDOCRINOL, V191, P83, DOI 10.1677/joe.1.06754; Claesson R, 2007, ACTA OBSTET GYN SCAN, V86, P652, DOI 10.1080/00016340701207682; D'Adamo E, 2010, DIABETES CARE, V33, P1817, DOI 10.2337/dc10-0284; De Blasio MJ, 2007, ENDOCRINOLOGY, V148, P1350, DOI 10.1210/en.2006-0653; DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Dolinsky VW, 2011, DIABETES, V60, P2274, DOI 10.2337/db11-0374; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Feig DS, 2008, CAN MED ASSOC J, V179, P229, DOI 10.1503/cmaj.080012; Fowden AL, 2001, BRIT MED BULL, V60, P123, DOI 10.1093/bmb/60.1.123; Gabbe SG, 2003, OBSTET GYNECOL, V102, P857, DOI 10.1016/j.obstetgynecol.2003.07.001; Galerneau F, 2004, OBSTET GYN CLIN N AM, V31, P907, DOI 10.1016/j.ogc.2004.09.002; Gallo LA, 2012, HYPERTENSION, V60, P206, DOI 10.1161/HYPERTENSIONAHA.112.195578; Gallo LA, 2012, J PHYSIOL-LONDON, V590, P617, DOI 10.1113/jphysiol.2011.219147; Gastaldelli A, 2007, GASTROENTEROLOGY, V133, P496, DOI 10.1053/j.gastro.2007.04.068; Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Innes KE, 2002, JAMA-J AM MED ASSOC, V287, P2534, DOI 10.1001/jama.287.19.2534; Jansson T, 1999, J HYPERTENS, V17, P1239, DOI 10.1097/00004872-199917090-00002; Kahn SE, 2008, DIABETES OBES METAB, V10, P63, DOI 10.1111/j.1463-1326.2008.00945.x; Korenblat KM, 2008, GASTROENTEROLOGY, V134, P1369, DOI 10.1053/j.gastro.2008.01.075; KUHL C, 1991, BAILLIERE CLIN OB GY, V5, P279, DOI 10.1016/S0950-3552(05)80098-7; Laker RC, 2011, AM J PHYSIOL-ENDOC M, V301, pE931, DOI 10.1152/ajpendo.00114.2011; Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183, DOI 10.1152/ajpregu.2001.280.1.R183; Lane RH, 1996, PEDIATR RES, V39, P390, DOI 10.1203/00006450-199603000-00003; Lim K, 2011, PEDIATR RES, V70, P339, DOI 10.1203/PDR.0b013e31822a65a3; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; O'Dowd R, 2008, AM J PHYSIOL-REG I, V294, pR539, DOI 10.1152/ajpregu.00628.2007; Owens JA, 2007, J PHYSIOL-LONDON, V584, P935, DOI 10.1113/jphysiol.2007.142141; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; REAVEN E, 1983, DIABETES, V32, P175, DOI 10.2337/diabetes.32.2.175; Retnakaran R, 2008, DIABETES CARE, V31, P2026, DOI 10.2337/dc08-0972; Retnakaran R, 2009, CURR DIABETES REV, V5, P239, DOI 10.2174/157339909789804378; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rincon J, 1996, DIABETES, V45, P615, DOI 10.2337/diabetes.45.5.615; Seghieri G, 2002, DIABETES CARE, V25, P1761, DOI 10.2337/diacare.25.10.1761; Shepherd PR, 1997, BRIT J NUTR, V78, P121, DOI 10.1079/BJN19970124; Siebel AL, 2010, J DEV ORIG HLTH DIS, V1, P234, DOI 10.1017/S2040174410000383; Siebel AL, 2008, ENDOCRINOLOGY, V149, P3067, DOI 10.1210/en.2008-0128; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Styrud J, 2005, BIOL NEONATE, V88, P122, DOI 10.1159/000086136; Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5; Wadley GD, 2008, AM J PHYSIOL-ENDOC M, V294, pE861, DOI 10.1152/ajpendo.00037.2008; Wlodek ME, 2008, KIDNEY INT, V74, P187, DOI 10.1038/ki.2008.153	54	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45188	10.1371/journal.pone.0045188	http://dx.doi.org/10.1371/journal.pone.0045188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028837	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700092
J	Xu, BL; Wang, J; Zhang, M; Wang, P; Wei, ZG; Sun, Y; Tao, QQ; Ren, LM; Hu, XX; Guo, Y; Fei, J; Zhang, L; Li, N; Zhao, YF				Xu, Beilei; Wang, Jing; Zhang, Min; Wang, Ping; Wei, Zhiguo; Sun, Yi; Tao, Qiqing; Ren, Liming; Hu, Xiaoxiang; Guo, Ying; Fei, Jing; Zhang, Lei; Li, Ning; Zhao, Yaofeng			Expressional Analysis of Immunoglobulin D in Cattle (Bos taurus), a Large Domesticated Ungulate	PLOS ONE			English	Article							B-CELL DEVELOPMENT; HEAVY-CHAIN LOCUS; CLASS SWITCH RECOMBINATION; EXCEPTIONALLY LONG CDR3H; CONSTANT-REGION DOMAIN; ILEAL PEYERS-PATCHES; H GENE FAMILY; HUMAN IGD; T-CELL; REPERTOIRE DEVELOPMENT	For decades, it has remained unknown whether artiodactyls, such as cattle, pigs, and sheep, express immunoglobulin D (IgD), although the delta gene was identified in these species nearly 10 years ago. By developing a mouse anti-bovine IgD heavy chain monoclonal antibody (13C2), we show that secreted bovine IgD was present mainly as a monomer in serum and was heavily glycosylated by N-linked saccharides. Nonetheless, IgD was detectable in some but not all of the Holstein cattle examined. Membrane-bound IgD was detected in the spleen by western blotting. Flow cytometric analysis demonstrated that IgD-positive B cells constituted a much lower percentage of B cells in the bovine spleen (similar to 6.8% of total B cells), jejunal Peyer's patches (similar to 0.8%), and peripheral blood leukocytes (similar to 1.2%) than in humans and mice. Furthermore, IgD-positive B cells were almost undetectable in bovine bone marrow and ileal Peyer's patches. We also demonstrated that the bovine delta gene can be expressed via class switch recombination. Accordingly, bovine delta germline transcription, which involves an I delta exon and is highly homologous to I mu, was confirmed. However, we could not identify an I delta promoter, despite bovine E mu demonstrating both enhancer and promoter activity. This study has answered a long-standing question in cattle B cell biology and significantly contributes to our understanding of B cell development in this species.	[Xu, Beilei; Wang, Jing; Zhang, Min; Wang, Ping; Sun, Yi; Tao, Qiqing; Ren, Liming; Hu, Xiaoxiang; Guo, Ying; Fei, Jing; Zhang, Lei; Li, Ning; Zhao, Yaofeng] China Agr Univ, Coll Biol Sci, Natl Engn Lab Anim Breeding, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhao, Yaofeng] Qingdao Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Reprod & Germplasm Enhancement Univ, Qingdao, Peoples R China	China Agricultural University; Qingdao Agricultural University	Xu, BL (corresponding author), China Agr Univ, Coll Biol Sci, Natl Engn Lab Anim Breeding, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	yaofengzhao@cau.edu.cn		wang, jing/0000-0002-7120-0857	National Science Fund for Distinguished Young Scholars [30725029]; Taishan Scholar Foundation of Shandong Province; National Basic Research Program of China (973 Program) [2010CB945300]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Taishan Scholar Foundation of Shandong Province; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Science Fund for Distinguished Young Scholars (30725029), the Taishan Scholar Foundation of Shandong Province, the National Basic Research Program of China (973 Program-2010CB945300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpin C, 1998, J EXP MED, V187, P1169, DOI 10.1084/jem.187.8.1169; Bernstein RM, 1996, P NATL ACAD SCI USA, V93, P3289, DOI 10.1073/pnas.93.8.3289; Butler JE, 1997, SCAND J IMMUNOL, V45, P455, DOI 10.1046/j.1365-3083.1997.d01-423.x; Butler JE, 1996, INT IMMUNOL, V8, P1897, DOI 10.1093/intimm/8.12.1897; Butler JE, 2011, J IMMUNOL, V187, P5141, DOI 10.4049/jimmunol.1101871; Chen K, 2010, IMMUNOL REV, V237, P160, DOI 10.1111/j.1600-065X.2010.00929.x; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Du LK, 2008, J EXP MED, V205, P3031, DOI 10.1084/jem.20081915; Ekman A, 2012, DEV COMP IMMUNOL, V37, P39, DOI 10.1016/j.dci.2011.12.009; Ellmeier W, 2000, J EXP MED, V192, P1611, DOI 10.1084/jem.192.11.1611; FINKELMAN FD, 1979, J IMMUNOL, V123, P1253; Hayakawa K, 2000, CURR OPIN IMMUNOL, V12, P346, DOI 10.1016/S0952-7915(00)00098-4; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kluin PM, 1995, EUR J IMMUNOL, V25, P3504, DOI 10.1002/eji.1830251244; Koelsch K, 2007, J CLIN INVEST, V117, P1558, DOI 10.1172/JCI27628; Koti M, 2010, MOL IMMUNOL, V47, P2119, DOI 10.1016/j.molimm.2010.02.014; Lanning DK, 2003, GENE, V309, P135, DOI 10.1016/S0378-1119(03)00500-6; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lopez O, 1998, IMMUNOL REV, V162, P55, DOI 10.1111/j.1600-065X.1998.tb01429.x; Lundqvist ML, 2001, J BIOL CHEM, V276, P46729, DOI 10.1074/jbc.M106221200; MacHugh ND, 1997, IMMUNOLOGY, V92, P340, DOI 10.1046/j.1365-2567.1997.00350.x; MAKI R, 1981, CELL, V24, P353, DOI 10.1016/0092-8674(81)90325-1; MELLIS SJ, 1983, J BIOL CHEM, V258, P1557; MOORE KW, 1981, P NATL ACAD SCI-BIOL, V78, P1800, DOI 10.1073/pnas.78.3.1800; NAESSENS J, 1992, EUR J IMMUNOL, V22, P1713, DOI 10.1002/eji.1830220708; Naessens J, 1997, INT IMMUNOL, V9, P349, DOI 10.1093/intimm/9.3.349; Ohta Y, 2006, P NATL ACAD SCI USA, V103, P10723, DOI 10.1073/pnas.0601407103; Ota T, 2003, P NATL ACAD SCI USA, V100, P2501, DOI 10.1073/pnas.0538029100; Overed-Sayer CL., 2009, CURR PROTOC IMMUNOL, V85, P291, DOI [10.1002/0471142735.im0209bs85, DOI 10.1002/0471142735.IM0209BS85]; Pessa-Morikawa T, 2004, DEV COMP IMMUNOL, V28, P77, DOI 10.1016/S0145-305X(03)00104-6; PUTNAM FW, 1981, P NATL ACAD SCI-BIOL, V78, P6168, DOI 10.1073/pnas.78.10.6168; Rogers AN, 2005, J IMMUNOL, V174, P3386, DOI 10.4049/jimmunol.174.6.3386; ROWE DS, 1965, J EXP MED, V121, P171, DOI 10.1084/jem.121.1.171; Saini SS, 1997, MOL IMMUNOL, V34, P641, DOI 10.1016/S0161-5890(97)00055-2; Saini SS, 2002, SCAND J IMMUNOL, V55, P140, DOI 10.1046/j.1365-3083.2002.01028.x; Saini SS, 1999, EUR J IMMUNOL, V29, P2420, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2420::AID-IMMU2420&gt;3.0.CO;2-A; Shojaei F, 2003, MOL IMMUNOL, V40, P61, DOI 10.1016/S0161-5890(03)00098-1; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Sinkora M, 2011, J IMMUNOL, V187, P5150, DOI 10.4049/jimmunol.1101879; Song HF, 2007, J IMMUNOL, V178, P926, DOI 10.4049/jimmunol.178.2.926; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; SU LK, 1990, MOL CELL BIOL, V10, P2619, DOI 10.1128/MCB.10.6.2619; Sun Y, 2011, DEV COMP IMMUNOL, V35, P975, DOI 10.1016/j.dci.2010.12.010; Swenson CD, 1998, EUR J IMMUNOL, V28, P2366, DOI 10.1002/(SICI)1521-4141(199808)28:08<2366::AID-IMMU2366>3.0.CO;2-D; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; Weill JC, 1998, DEV COMP IMMUNOL, V22, P379, DOI 10.1016/S0145-305X(98)00014-7; Wilson M, 1997, P NATL ACAD SCI USA, V94, P4593, DOI 10.1073/pnas.94.9.4593; Yasuda M, 2006, VET RES, V37, P401, DOI 10.1051/vetres:2006008; Zhao YF, 2006, P NATL ACAD SCI USA, V103, P12087, DOI 10.1073/pnas.0600291103; Zhao YF, 2003, J BIOL CHEM, V278, P35024, DOI 10.1074/jbc.M301337200; Zhao YF, 2003, J IMMUNOL, V171, P1312, DOI 10.4049/jimmunol.171.3.1312; Zhao YF, 2002, J IMMUNOL, V169, P4408, DOI 10.4049/jimmunol.169.8.4408	53	6	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44719	10.1371/journal.pone.0044719	http://dx.doi.org/10.1371/journal.pone.0044719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028592	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700032
J	Yun, SH; Ji, SC; Jeon, HJ; Wang, X; Kim, SW; Bak, G; Lee, Y; Lim, HM				Yun, Sang Hoon; Ji, Sang Chun; Jeon, Heung Jin; Wang, Xun; Kim, Si Wouk; Bak, Geunu; Lee, Younghoon; Lim, Heon M.			The CnuK9E H-NS Complex Antagonizes DNA Binding of DicA and Leads to Temperature-Dependent Filamentous Growth in E-coli	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEIN; DIVISION INHIBITION; CELL-DIVISION; YERSINIA-PSEUDOTUBERCULOSIS; VIRF PROMOTER; GENE DICB; HHA; VIRULENCE; SEQUENCE; REVEALS	Cnu (an OriC-binding nucleoid protein) associates with H-NS. A variant of Cnu was identified as a key factor for filamentous growth of a wild-type Escherichia coli strain at 37 degrees C. This variant (CnuK9E) bears a substitution of a lysine to glutamic acid, causing a charge reversal in the first helix. The temperature-dependent filamentous growth of E. coli bearing CnuK9E could be reversed by either lowering the temperature to 25 degrees C or lowering the CnuK9E concentration in the cell. Gene expression analysis suggested that downregulation of dicA by CnuK9E causes a burst of dicB transcription, which, in turn, elicits filamentous growth. In vivo assays indicated that DicA transcriptionally activates its own gene, by binding to its operator in a temperature-dependent manner. The antagonizing effect of CnuK9E with H-NS on DNA-binding activity of DicA was stronger at 37 degrees C, presumably due to the lower operator binding of DicA at 37 degrees C. These data suggest that the temperature-dependent negative effect of CnuK9E on DicA binding plays a major role in filamentous growth. The C-terminus of DicA shows significant amino acid sequence similarity to the DNA-binding domains of RovA and SlyA, regulators of pathogenic genes in Yersinia and Salmonella, respectively, which also show better DNA-binding activity at 25 degrees C.	[Yun, Sang Hoon; Ji, Sang Chun; Jeon, Heung Jin; Wang, Xun; Lim, Heon M.] Chungnam Natl Univ, Dept Biol, Coll Biol Sci & Biotechnol, Taejon, South Korea; [Kim, Si Wouk] Chosun Univ, Pioneer Res Ctr Controlling Harmful Algal Bloomin, Dept Environm Engn, Kwangju, South Korea; [Bak, Geunu; Lee, Younghoon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea	Chungnam National University; Chosun University; Korea Advanced Institute of Science & Technology (KAIST)	Yun, SH (corresponding author), Chungnam Natl Univ, Dept Biol, Coll Biol Sci & Biotechnol, Taejon, South Korea.	hmlim@cnu.ac.kr	Ji, Sang Chun/Y-6863-2019; Lee, Younghoon/C-1991-2011; Park, DongNyuk/F-5737-2013	Ji, Sang Chun/0000-0003-2858-1057; Lee, Younghoon/0000-0002-3841-719X; Lim, Heon/0000-0003-1711-2589; Kim, Si Wouk/0000-0001-8539-6777	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2011-0004864, 2008-2000122]; Pioneer Research Center Program through the National Research Program of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Pioneer Research Center Program through the National Research Program of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2011-0004864). This research was also supported by the Pioneer Research Center Program through the National Research Program of Korea funded by the Ministry of Education, Science and Technology (Grant No. 2008-2000122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arold ST, 2010, P NATL ACAD SCI USA, V107, P15728, DOI 10.1073/pnas.1006966107; Bae SH, 2008, BIOCHEMISTRY-US, V47, P1993, DOI 10.1021/bi701914t; BEJAR S, 1985, MOL GEN GENET, V201, P146, DOI 10.1007/BF00425651; BEJAR S, 1988, MOL GEN GENET, V212, P11, DOI 10.1007/BF00322439; BEJAR S, 1986, NUCLEIC ACIDS RES, V14, P6821, DOI 10.1093/nar/14.17.6821; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Bloch V, 2003, NAT STRUCT BIOL, V10, P212, DOI 10.1038/nsb904; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Esposito D, 2002, J MOL BIOL, V324, P841, DOI 10.1016/S0022-2836(02)01141-5; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; Ji SC, 2010, BMB REP, V43, P474, DOI 10.5483/BMBRep.2010.43.7.474; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Kim MS, 2005, J BACTERIOL, V187, P6998, DOI 10.1128/JB.187.20.6998-7008.2005; LABIE C, 1989, J BACTERIOL, V171, P4315, DOI 10.1128/JB.171.8.4315-4319.1989; LABIE C, 1990, J BACTERIOL, V172, P5852, DOI 10.1128/jb.172.10.5852-5855.1990; Lee SY, 1998, J BACTERIOL, V180, P5954, DOI 10.1128/JB.180.22.5954-5960.1998; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; LUCHT JM, 1994, J BIOL CHEM, V269, P6578; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Madrid C, 2007, J BACTERIOL, V189, P265, DOI 10.1128/JB.01124-06; Nieto JM, 1997, FEMS MICROBIOL LETT, V155, P39, DOI 10.1016/S0378-1097(97)00364-9; Nieto JM, 2002, J BACTERIOL, V184, P629, DOI 10.1128/JB.184.3.629-635.2002; Park JW, 2002, BIOCHEM BIOPH RES CO, V290, P1183, DOI 10.1006/bbrc.2001.6331; Paytubi S, 2004, MOL MICROBIOL, V54, P251, DOI 10.1111/j.1365-2958.2004.04268.x; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; Prosseda G, 2004, MOL MICROBIOL, V51, P523, DOI 10.1046/j.1365-2958.2003.03848.x; SHINDO H, 1995, FEBS LETT, V360, P125, DOI 10.1016/0014-5793(95)00079-O; TETART F, 1992, MOL MICROBIOL, V6, P615, DOI 10.1111/j.1365-2958.1992.tb01508.x; Tran HJ, 2005, J BIOL CHEM, V280, P42423, DOI 10.1074/jbc.M504464200; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wu RY, 2003, J BIOL CHEM, V278, P20240, DOI 10.1074/jbc.M300292200; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yun SH, 2012, MOL CELLS, V33, P211, DOI 10.1007/s10059-012-0006-5; ZHANG AX, 1992, NUCLEIC ACIDS RES, V20, P6735, DOI 10.1093/nar/20.24.6735	40	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45236	10.1371/journal.pone.0045236	http://dx.doi.org/10.1371/journal.pone.0045236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028867	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700098
J	Tohidi, M; Hasheminia, M; Mohebi, R; Khalili, D; Hosseinpanah, F; Yazdani, B; Nasiri, AA; Azizi, F; Hadaegh, F				Tohidi, Maryam; Hasheminia, Mitra; Mohebi, Reza; Khalili, Davood; Hosseinpanah, Farhad; Yazdani, Babak; Nasiri, Amir Ahmad; Azizi, Fereidoun; Hadaegh, Farzad			Incidence of Chronic Kidney Disease and Its Risk Factors, Results of Over 10 Year Follow Up in an Iranian Cohort	PLOS ONE			English	Article							STAGE RENAL-DISEASE; GLOMERULAR-FILTRATION-RATE; COMMUNITY-BASED POPULATION; HYPERTENSION; PREVALENCE; DECLINE; WOMEN; MEN	To examine, the predictors of incident chronic kidney disease (CKD) in a community-based cohort of Middle East population, during a mean follow-up of 9.9 years. In a sample of 3313 non-CKD Iranian adults >= 20 years the estimated glomerular filtration rate (eGFR) was calculated at baseline and at three year intervals during three consecutive phases. The eGFR <60 mL/min/1.73 m(2) was defined as CKD. Multivariate Logistic regression analysis was used to determine the independent variables associated with incident CKD. The incidence density rates of CKD were 285.3 and 132.6 per 10,000 person-year, among women and men, respectively. Female gender per se was associated with higher risk of CKD, compared with males. Among women, age, eGFR, known diabetes, being single or divorced/widowed, hypertension (marginally significant) and current smoking were independent risk factors for CKD; however the intermediate degree of education and family history of diabetes decreased the risk by 40% (P<0.05). Among male subjects, independent predictors of developing CKD included aging and hypertension (with significantly higher risk than in women, P for interaction<0.05), eGFR, new diagnosed diabetes, high normal blood pressure; abdominal obesity decreased the risk of CKD about 30% which was marginally significant. In the Iranian population, >2% of individuals develops CKD each year. Our findings confirmed that sex-specific risk predictors should be considered in primary prevention for incident CKD.	[Tohidi, Maryam; Hasheminia, Mitra; Mohebi, Reza; Khalili, Davood; Yazdani, Babak; Hadaegh, Farzad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Hosseinpanah, Farhad] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran; [Nasiri, Amir Ahmad] Shahid Beheshti Univ Med Sci, Masih Daneshvari Hosp, Dept Nephrol, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Hadaegh, F (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran.	fzhadaegh@endocrine.ac.ir	Tohidi, Maryam/V-2261-2019; Mohebi, Reza/G-5820-2012; hadaegh, farzad/K-2460-2017; Khalili, Davood/T-2913-2017; hosseinpanah, farhad/AAM-7277-2020; Mohebi, Reza/U-2192-2019; Azizi, Fereidoun/ABD-4136-2021; Mohebi, Reza/AAB-7178-2022	Khalili, Davood/0000-0003-4956-1039; hosseinpanah, farhad/0000-0001-5235-9451; Azizi, Fereidoun/0000-0002-6470-2517; hadaegh, farzad/0000-0002-0352-8666; Hadaegh, Farzad/0000-0002-8935-2744; Mohebi, Reza/0000-0002-6744-3119	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by grant number 121 from the National Research Council of the Islamic Republic of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi F, 2010, ARCH IRAN MED, V13, P243; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bang H, 2007, ARCH INTERN MED, V167, P374, DOI 10.1001/archinte.167.4.374; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Bash LD, 2009, AM J EPIDEMIOL, V170, P414, DOI 10.1093/aje/kwp151; Bozorgmanesh M, 2011, J HYPERTENS, V29, P1486, DOI 10.1097/HJH.0b013e328348fdb2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Emami H, 2004, IRANIAN J ENDOCRINOL, V6, P319; Esteghamati A, 2008, AM J HYPERTENS, V21, P620, DOI 10.1038/ajh.2008.154; Foster MC, 2008, AM J KIDNEY DIS, V52, P39, DOI 10.1053/j.ajkd.2008.03.003; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Halbesma N, 2008, KIDNEY INT, V74, P505, DOI 10.1038/ki.2008.200; Harati H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-186; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-44; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-426; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Jungers P, 1999, NEPHROL DIAL TRANSPL, V14, P2082, DOI 10.1093/ndt/14.9.2082; Kastarinen M, 2010, J INTERN MED, V267, P612, DOI 10.1111/j.1365-2796.2009.02197.x; Kshirsagar AV, 2008, ARCH INTERN MED, V168, P2466, DOI 10.1001/archinte.168.22.2466; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Najafi I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014216; Noori N, 2009, J RENAL NUTR, V19, P228, DOI 10.1053/j.jrn.2008.11.005; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017	32	92	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45304	10.1371/journal.pone.0045304	http://dx.doi.org/10.1371/journal.pone.0045304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028919	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500028
J	Rubenwolf, PC; Georgopoulos, NT; Kirkwood, LA; Baker, SC; Southgate, J				Rubenwolf, Peter C.; Georgopoulos, Nikolaos T.; Kirkwood, Lisa A.; Baker, Simon C.; Southgate, Jennifer			Aquaporin Expression Contributes to Human Transurothelial Permeability In Vitro and Is Modulated by NaCl	PLOS ONE			English	Article							RABBIT URINARY-BLADDER; HUMAN UROTHELIAL CELLS; GENE-EXPRESSION; SODIUM-CHANNELS; WATER CHANNELS; RAT UROTHELIA; VOIDED URINE; UREA; TRANSPORT; URETER	It is generally considered that the bladder is impervious and stores urine in unmodified form on account of the barrier imposed by the highly-specialised uro-epithelial lining. However, recent evidence, including demonstration of aquaporin (AQP) expression by human urothelium, suggests that urothelium may be able to modify urine content. Here we have we applied functional assays to an in vitro-differentiated normal human urothelial cell culture system and examined both whether AQP expression was responsive to changes in osmolality, and the effects of blocking AQP channels on water and urea transport. AQP3 expression was up-regulated by increased osmolality, but only in response to NaCl. A small but similar effect was seen with AQP9, but not AQP4 or AQP7. Differentiated urothelium revealed significant barrier function (mean TER 3862 Omega.cm(2)), with mean diffusive water and urea permeability coefficients of 6.33 x 10(-5) and 2.45 x 10(-5) cm/s, respectively. AQP blockade with mercuric chloride resulted in decreased water and urea flux. The diffusive permeability of urothelial cell sheets remained constant following conditioning in hyperosmotic NaCl, but there was a significant increase in water and urea flux across an osmotic gradient. Taken collectively with evidence emerging from studies in other species, our results support an active role for human urothelium in sensing and responding to hypertonic salt concentrations through alterations in AQP protein expression, with AQP channels providing a mechanism for modifying urine composition. These observations challenge the traditional concept of an impermeable bladder epithelium and suggest that the urothelium may play a modulatory role in water and salt homeostasis.	[Rubenwolf, Peter C.; Georgopoulos, Nikolaos T.; Kirkwood, Lisa A.; Baker, Simon C.; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England; [Georgopoulos, Nikolaos T.] Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England	University of York - UK; University of Huddersfield	Southgate, J (corresponding author), Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.	jennifer.southgate@york.ac.uk	Southgate, Jennifer/AAJ-9089-2021	Southgate, Jennifer/0000-0002-0135-480X; Georgopoulos, Nik/0000-0002-6330-4947; Baker, Simon/0000-0002-2755-6012	Deutsche Forschungsgemeinschaft; Engineering and Physical Sciences Research Council (EPSRC) [GR/S62338/01]; York Against Cancer; Yorkshire Kidney Research Fund; Engineering and Physical Sciences Research Council [GR/S62338/01] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); York Against Cancer; Yorkshire Kidney Research Fund; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	PR was in receipt of a clinical research fellowship from the Deutsche Forschungsgemeinschaft. NTG was funded by the Engineering and Physical Sciences Research Council (EPSRC; grant reference GR/S62338/01). LAK was a postgraduate student and JS holds a research chair, both supported by York Against Cancer. The study was funded by a research grant from Yorkshire Kidney Research Fund. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cahill DJ, 2003, J UROLOGY, V169, P871, DOI 10.1097/01.ju.0000052404.42651.55; Cross WR, 2005, AM J PHYSIOL-RENAL, V289, pF459, DOI 10.1152/ajprenal.00040.2005; DONALDSON PJ, 1990, AM J PHYSIOL, V258, pC248, DOI 10.1152/ajpcell.1990.258.2.C248; EATON DC, 1981, J PHYSIOL-LONDON, V316, P527, DOI 10.1113/jphysiol.1981.sp013804; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hall GD, 2006, J UROLOGY, V175, P337, DOI 10.1016/S0022-5347(05)00006-6; HILSON AJW, 1990, CONTRIB NEPHROL, V79, P41; Hoffert JD, 2000, J BIOL CHEM, V275, P9070, DOI 10.1074/jbc.275.12.9070; HOHLBRUGGER G, 1987, EUR UROL, V13, P83; King LS, 2000, AM J RESP CELL MOL, V22, P8, DOI 10.1165/ajrcmb.22.1.f176; Kwon ED, 1996, AM J PHYSIOL-RENAL, V271, pF230, DOI 10.1152/ajprenal.1996.271.1.F230; Lanaspa MA, J BIOL CHEM, V285, P31694; LEVINSKY NG, 1959, AM J PHYSIOL, V196, P549, DOI 10.1152/ajplegacy.1959.196.3.549; LEWIS SA, 1976, J MEMBRANE BIOL, V28, P1, DOI 10.1007/BF01869689; LEWIS SA, 1984, J MEMBRANE BIOL, V80, P135, DOI 10.1007/BF01868770; Matsuzaki T, 2001, AM J PHYSIOL-CELL PH, V281, pC55, DOI 10.1152/ajpcell.2001.281.1.C55; Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886, DOI 10.1152/ajprenal.1996.271.4.F886; NELSON RA, 1975, MAYO CLIN PROC, V50, P141; RAPOPORT A, 1960, AM J PHYSIOL, V198, P191, DOI 10.1152/ajplegacy.1960.198.1.191; Rubenwolf PC, 2009, EUR UROL, V56, P1013, DOI 10.1016/j.eururo.2008.08.013; Shafik A, 2005, UROL RES, V33, P426, DOI 10.1007/s00240-005-0499-x; Shafik A, 2004, SCAND J UROL NEPHROL, V38, P243, DOI 10.1080/00365590410025344; Shafik A, 2006, UROL RES, V34, P261, DOI 10.1007/s00240-006-0058-0; SOUTHGATE J, 1994, LAB INVEST, V71, P583; Southgate J, 2007, BJU INT, V99, P1506, DOI 10.1111/j.1464-410X.2007.06795.x; Spector DA, 2002, AM J PHYSIOL-RENAL, V282, pF1034, DOI 10.1152/ajprenal.00136.2001; Spector DA, 2007, AM J PHYSIOL-RENAL, V292, pF467, DOI 10.1152/ajprenal.00181.2006; Spector DA, 2011, AM J PHYSIOL-RENAL, V301, pF1208, DOI 10.1152/ajprenal.00386.2011; Sugiyama Y, 2001, BBA-GENE STRUCT EXPR, V1522, P82, DOI 10.1016/S0167-4781(01)00320-7; TURNBULL GJ, 1972, REV EUR ETUD CL BIOL, V17, P745; Varley CL, 2006, J CELL PHYSIOL, V208, P407, DOI 10.1002/jcp.20676; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; WALSER BL, 1988, AM J PHYSIOL, V255, pF244, DOI 10.1152/ajprenal.1988.255.2.F244; Zeidel ML, 1996, AM J PHYSIOL-RENAL, V271, pF243, DOI 10.1152/ajprenal.1996.271.2.F243	34	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45339	10.1371/journal.pone.0045339	http://dx.doi.org/10.1371/journal.pone.0045339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028946	Green Accepted, Green Published, gold			2022-12-27	WOS:000309554700033
J	Klug, JR; Mathur, BN; Kash, TL; Wang, HD; Matthews, RT; Robison, AJ; Anderson, ME; Deutch, AY; Lovinger, DM; Colbran, RJ; Winder, DG				Klug, Jason R.; Mathur, Brian N.; Kash, Thomas L.; Wang, Hui-Dong; Matthews, Robert T.; Robison, A. J.; Anderson, Mark E.; Deutch, Ariel Y.; Lovinger, David M.; Colbran, Roger J.; Winder, Danny G.			Genetic Inhibition of CaMKII in Dorsal Striatal Medium Spiny Neurons Reduces Functional Excitatory Synapses and Enhances Intrinsic Excitability	PLOS ONE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; GLUR-A-DEFICIENT; POSTSYNAPTICALLY SILENT SYNAPSES; AMPA RECEPTORS; SYNAPTIC PLASTICITY; DEVELOPMENTAL-CHANGES; BASAL GANGLIA; NMDA RECEPTOR; RAT-BRAIN	Ca2+/calmodulin-dependent protein kinase II (CaMKII) is abundant in striatal medium spiny neurons (MSNs). CaMKII is dynamically regulated by changes in dopamine signaling, as occurs in Parkinson's disease as well as addiction. Although CaMKII has been extensively studied in the hippocampus where it regulates excitatory synaptic transmission, relatively little is known about how it modulates neuronal function in the striatum. Therefore, we examined the impact of selectively overexpressing an EGFP-fused CaMKII inhibitory peptide (EAC3I) in striatal medium spiny neurons (MSNs) using a novel transgenic mouse model. EAC3I-expressing cells exhibited markedly decreased excitatory transmission, indicated by a decrease in the frequency of spontaneous excitatory postsynaptic currents (sEPSCs). This decrease was not accompanied by changes in the probability of release, levels of glutamate at the synapse, or changes in dendritic spine density. CaMKII regulation of the AMPA receptor subunit GluA1 is a major means by which the kinase regulates neuronal function in the hippocampus. We found that the decrease in striatal excitatory transmission seen in the EAC3I mice is mimicked by deletion of GluA1. Further, while CaMKII inhibition decreased excitatory transmission onto MSNs, it increased their intrinsic excitability. These data suggest that CaMKII plays a critical role in setting the excitability rheostat of striatal MSNs by coordinating excitatory synaptic drive and the resulting depolarization response.	[Klug, Jason R.; Kash, Thomas L.; Matthews, Robert T.; Robison, A. J.; Deutch, Ariel Y.; Colbran, Roger J.; Winder, Danny G.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Deutch, Ariel Y.; Colbran, Roger J.; Winder, Danny G.] Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37212 USA; [Matthews, Robert T.; Deutch, Ariel Y.; Colbran, Roger J.; Winder, Danny G.] Vanderbilt Univ, Sch Med, JF Kennedy Ctr Res Human Dev, Nashville, TN 37212 USA; [Wang, Hui-Dong; Deutch, Ariel Y.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Deutch, Ariel Y.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN USA; [Mathur, Brian N.; Lovinger, David M.] NIAAA, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA; [Anderson, Mark E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Anderson, Mark E.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Iowa; University of Iowa	Winder, DG (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	danny.winder@vanderbilt.edu	Colbran, Roger/AAU-7708-2021; Robison, Alfred J/P-8521-2018; Kash, Thomas/G-9625-2013; Mathur, Brian/P-5986-2018; Winder, Danny G./H-4857-2013	Colbran, Roger/0000-0001-7401-8244; Robison, Alfred J/0000-0002-4150-9570; Mathur, Brian/0000-0003-2912-8625; 	United States National Institutes of Health (NIH) [NIH R01-DA019112, NIH R01-AA019455, NIH R01-MH063232]; Hobbs Discovery grant [NIH R01 HL079031, NIH R01 HL62494, NIH R01 HL70250]; Fondation Leducq for the Alliance for CaMKII Signaling; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113001, R01HL070250, R01HL062494, R01HL079031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH064913, R01MH063232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000407, R01AA019455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019112] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hobbs Discovery grant; Fondation Leducq for the Alliance for CaMKII Signaling; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by the United States National Institutes of Health (NIH) NIH R01-DA019112, NIH R01-AA019455 (D. G. W.), NIH R01-MH063232, Hobbs Discovery grant (R.J.C.), NIH R01 HL079031, NIH R01 HL62494, and NIH R01 HL70250 and supported by a grant from the Fondation Leducq for the Alliance for CaMKII Signaling (M. E. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Ashpole NM, 2012, J BIOL CHEM; ATKINSON J, 1987, J NEUROCHEM, V49, P1241, DOI 10.1111/j.1471-4159.1987.tb10016.x; Bannerman DM, 2004, BEHAV NEUROSCI, V118, P643, DOI 10.1037/0735-7044.118.3.643; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Baucum AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031554; Bejar R, 2002, J NEUROSCI, V22, P5719; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; BRAUN AP, 1995, J PHYSIOL-LONDON, V488, P37, DOI 10.1113/jphysiol.1995.sp020944; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Carlier E, 2000, BIOCHEM BIOPH RES CO, V274, P394, DOI 10.1006/bbrc.2000.3145; Cazorla M, 2012, J NEUROSCI, V32, P2398, DOI 10.1523/JNEUROSCI.6056-11.2012; Chen HX, 2001, J NEUROPHYSIOL, V85, P1368, DOI 10.1152/jn.2001.85.4.1368; Chen M, 2011, J NEUROSCI, V31, P9563, DOI 10.1523/JNEUROSCI.1701-11.2011; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ding J, 2008, J NEUROSCI, V28, P6483, DOI 10.1523/JNEUROSCI.0435-08.2008; Ding JB, 2012, NAT NEUROSCI, V15, P215, DOI 10.1038/nn.3003; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Dosemeci A, 2010, BIOCHEM BIOPH RES CO, V391, P78, DOI 10.1016/j.bbrc.2009.10.167; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Feng BH, 2011, BRAIN RES, V1419, P46, DOI 10.1016/j.brainres.2011.08.051; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hinds HL, 1998, LEARN MEMORY, V5, P344; Hojjati MR, 2007, NAT NEUROSCI, V10, P1125, DOI 10.1038/nn1946; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jenner P, 2008, NAT REV NEUROSCI, V9, P665, DOI 10.1038/nrn2471; Jiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105; JONES EG, 1994, J NEUROSCI, V14, P611; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kaufman WL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn508; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; KELLY PT, 1987, J NEUROCHEM, V49, P1927, DOI 10.1111/j.1471-4159.1987.tb02456.x; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kourrich S, 2012, J NEUROSCI, V32, P6578, DOI 10.1523/JNEUROSCI.6391-11.2012; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lei SB, 2003, J PHYSIOL-LONDON, V546, P439, DOI 10.1113/jphysiol.2002.034017; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LI GD, 1992, MOL PHARMACOL, V42, P489; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LIN JW, 1990, P NATL ACAD SCI USA, V87, P8257, DOI 10.1073/pnas.87.21.8257; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman J., 2006, SCI STKE, V2006, pr; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; Lu Y, 2011, J BIOL CHEM, V286, P26496, DOI 10.1074/jbc.M111.254912; Lucchesi W, 2011, BRAIN RES BULL, V85, P2, DOI 10.1016/j.brainresbull.2010.10.009; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Milnerwood AJ, 2010, TRENDS NEUROSCI, V33, P513, DOI 10.1016/j.tins.2010.08.002; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Park D, 2002, J NEUROBIOL, V52, P24, DOI 10.1002/neu.10066; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Patel R, 1999, J BIOL CHEM, V274, P7958, DOI 10.1074/jbc.274.12.7958; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Picconi B, 2004, J NEUROSCI, V24, P5283, DOI 10.1523/JNEUROSCI.1224-04.2004; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Roeper J, 1997, J NEUROSCI, V17, P3379; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Schmitt WB, 2005, NAT NEUROSCI, V8, P270, DOI 10.1038/nn1412; Sharma G, 2008, J NEUROSCI, V28, P2563, DOI 10.1523/JNEUROSCI.5407-07.2008; Shen GF, 2010, NEUROPSYCHOPHARMACOL, V35, P1897, DOI 10.1038/npp.2010.61; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Smeal RM, 2007, J NEUROSCI METH, V159, P224, DOI 10.1016/j.jneumeth.2006.07.007; Stefani G, 1997, J PHYSIOL-LONDON, V504, P501, DOI 10.1111/j.1469-7793.1997.501bd.x; Stein IS, 2010, EMBO J, V29, P1943, DOI 10.1038/emboj.2010.105; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; SUGIURA H, 1992, BRAIN RES, V593, P97, DOI 10.1016/0006-8993(92)91269-K; SUGIURA H, 1994, BRAIN RES, V659, P42, DOI 10.1016/0006-8993(94)90861-3; SUGIURA H, 1994, FEBS LETT, V341, P299, DOI 10.1016/0014-5793(94)80477-X; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Verpelli C, 2011, J BIOL CHEM, V286, P34839, DOI 10.1074/jbc.M111.258384; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; Wan YH, 2011, J NEUROSCI, V31, P16685, DOI 10.1523/JNEUROSCI.2533-11.2011; WAXHAM MN, 1993, BRAIN RES, V609, P1; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wiedholz LM, 2008, MOL PSYCHIATR, V13, P631, DOI 10.1038/sj.mp.4002056; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wiltgen BJ, 2007, EUR J NEUROSCI, V25, P2491, DOI 10.1111/j.1460-9568.2007.05487.x; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; YAMAUCHI T, 1981, J BIOL CHEM, V256, P5404; Yang XW, 2011, CURR OPIN NEUROL, V24, P114, DOI 10.1097/WCO.0b013e32834451fb; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhou RL, 2009, EUR J NEUROSCI, V30, P2318, DOI 10.1111/j.1460-9568.2009.07022.x; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	133	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45323	10.1371/journal.pone.0045323	http://dx.doi.org/10.1371/journal.pone.0045323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028932	gold, Green Published, Green Submitted			2022-12-27	WOS:000309392800039
J	Zhou, Y; Robciuc, MR; Wabitsch, M; Juuti, A; Leivonen, M; Ehnholm, C; Yki-Jarvinen, H; Olkkonen, VM				Zhou, You; Robciuc, Marius R.; Wabitsch, Martin; Juuti, Anne; Leivonen, Marja; Ehnholm, Christian; Yki-Jarvinen, Hannele; Olkkonen, Vesa M.			OSBP-Related Proteins (ORPs) in Human Adipose Depots and Cultured Adipocytes: Evidence for Impacts on the Adipocyte Phenotype	PLOS ONE			English	Article							OXYSTEROL-BINDING-PROTEIN; OXIDATIVE STRESS; INTRACELLULAR-LOCALIZATION; ATHEROGENIC DYSLIPIDEMIA; CELL-DIFFERENTIATION; DEPENDENT ACTIVATION; STEROL TRANSPORT; LIPID DROPLETS; FATTY-ACIDS; AP2 GENE	Oxysterol-binding protein (OSBP) homologues, ORPs, are implicated in lipid homeostatic control, vesicle transport, and cell signaling. We analyzed here the quantity of ORP mRNAs in human subcutaneous (s.c.) and visceral adipose depots, as well as in the Simpson-Golabi-Behmel syndrome (SGBS) adipocyte cell model. All of the ORP mRNAs were present in the s.c and visceral adipose tissues, and the two depots shared an almost identical ORP mRNA expression pattern. SGBS adipocytes displayed a similar pattern, suggesting that the adipose tissue ORP expression pattern mainly derives from adipocytes. During SGBS cell adipogenic differentiation, ORP2, ORP3, ORP4, ORP7, and ORP8 mRNAs were down-regulated, while ORP11 was induced. To assess the impacts of ORPs on adipocyte differentiation, ORP3 and ORP8, proteins down-regulated during adipogenesis, were overexpressed in differentiating SGBS adipocytes, while ORP11, a protein induced during adipogenesis, was silenced. ORP8 overexpression resulted in reduced expression of the aP2 mRNA, while down-regulation of adiponectin and aP2 was observed in ORP11 silenced cells. Furthermore, ORP8 overexpression or silencing of ORP11 markedly decreased cellular triglyceride storage. These data identify the patterns of ORP expression in human adipose depots and SGBS adipocytes, and provide the first evidence for a functional impact of ORPs on the adipocyte phenotype.	[Zhou, You; Yki-Jarvinen, Hannele; Olkkonen, Vesa M.] Minerva Fdn, Inst Med Res, Helsinki, Finland; [Robciuc, Marius R.; Ehnholm, Christian] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Wabitsch, Martin] Univ Ulm, Div Paediat Endocrinol & Diabet, Dept Paediat & Adolescent Med, Ulm, Germany; [Juuti, Anne; Leivonen, Marja] Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland; [Yki-Jarvinen, Hannele] Univ Helsinki, Dept Med, Helsinki, Finland; [Olkkonen, Vesa M.] Univ Helsinki, Inst Biomed, Helsinki, Finland	Finland National Institute for Health & Welfare; Ulm University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Olkkonen, VM (corresponding author), Minerva Fdn, Inst Med Res, Helsinki, Finland.	vesa.olkkonen@helsinki.fi		ZHOU, YOU/0000-0002-1743-1291; Olkkonen, Vesa/0000-0001-5553-7997	Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Liv och Halsa Foundation; Novo Nordisk Foundation; Academy of Finland [121457]; EU FP7 (LipidomicNet) [202272]; Paulo Foundation; Orion-Farmos Research Foundation; University of Helsinki; Finnish Atherosclerosis Society; University of Helsinki Medicine Fund; University of Helsinki Jubilee Fund; Novo Nordisk Fonden [NNF11OC1014724] Funding Source: researchfish	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research; Magnus Ehrnrooth Foundation; Liv och Halsa Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Academy of Finland(Academy of Finland); EU FP7 (LipidomicNet); Paulo Foundation; Orion-Farmos Research Foundation; University of Helsinki; Finnish Atherosclerosis Society; University of Helsinki Medicine Fund; University of Helsinki Jubilee Fund; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Sigrid Juselius Foundation, the Finnish Foundation for Cardiovascular Research, the Magnus Ehrnrooth Foundation, the Liv och Halsa Foundation, the Novo Nordisk Foundation, the Academy of Finland (grant 121457 to VMO), the EU FP7 (LipidomicNet, agreement no 202272), the Paulo Foundation (YZ), the Orion-Farmos Research Foundation (YZ), the University of Helsinki Medicine Fund and Jubilee Fund (YZ), the Finnish Atherosclerosis Society (YZ) and a University of Helsinki Chancellor travel grant (YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkazemi D, 2008, J CLIN ENDOCR METAB, V93, P4282, DOI 10.1210/jc.2008-0586; AMRI EZ, 1991, J LIPID RES, V32, P1457; AMRI EZ, 1991, J LIPID RES, V32, P1449; Arca M, 2007, FREE RADICAL BIO MED, V42, P698, DOI 10.1016/j.freeradbiomed.2006.12.013; Banerji S, 2010, MOL BIOL CELL, V21, P4141, DOI 10.1091/mbc.E10-05-0424; Baranova A, 2005, OBES SURG, V15, P758, DOI 10.1381/0960892054222876; Bays HE, 2009, AM J MED, V122, pS26, DOI 10.1016/j.amjmed.2008.10.015; Beaslas O, 2012, EXP CELL RES, V318, P1933, DOI 10.1016/j.yexcr.2012.05.026; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Bouchard L, 2010, AM J CLIN NUTR, V91, P309, DOI 10.3945/ajcn.2009.28085; Bouchard L, 2009, OBESITY, V17, P1466, DOI 10.1038/oby.2009.71; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; Cabre A, 2012, ATHEROSCLEROSIS, V222, P229, DOI 10.1016/j.atherosclerosis.2012.02.003; Canagarajah BJ, 2008, J MOL BIOL, V378, P737, DOI 10.1016/j.jmb.2008.01.075; Cowart LA, 2009, TRENDS ENDOCRIN MET, V20, P34, DOI 10.1016/j.tem.2008.09.004; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Ferderbar S, 2007, DIABETES-METAB RES, V23, P35, DOI 10.1002/dmrr.645; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Gimeno RE, 2005, CURR OPIN PHARMACOL, V5, P122, DOI 10.1016/j.coph.2005.01.006; Hynynen R, 2009, J LIPID RES, V50, P1305, DOI 10.1194/jlr.M800661-JLR200; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Jaworski CJ, 2001, GENOMICS, V78, P185, DOI 10.1006/geno.2001.6663; Johansson M, 2003, MOL BIOL CELL, V14, P903, DOI 10.1091/mbc.E02-08-0459; Johnson JS, 2011, J CELL BIOCHEM, V112, P1673, DOI 10.1002/jcb.23082; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kim WK, 2007, J BONE MINER RES, V22, P1711, DOI 10.1359/JBMR.070710; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Laitinen S, 2002, J LIPID RES, V43, P245; Lee HK, 2006, PROTEOMICS, V6, P1223, DOI 10.1002/pmic.200500385; Lehto M, 2004, CELL TISSUE RES, V315, P39, DOI 10.1007/s00441-003-0817-y; Lehto M, 2001, J LIPID RES, V42, P1203; Lehto M, 2008, J CELL SCI, V121, P695, DOI 10.1242/jcs.016964; Lordan S, 2009, J BIOCHEM MOL TOXIC, V23, P324, DOI 10.1002/jbt.20295; Nagao K, 2008, PROG LIPID RES, V47, P127, DOI 10.1016/j.plipres.2007.12.002; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Olkkonen VM, 2012, BIOMOLECULES, V2, P76, DOI 10.3390/biom2010076; Olkkonen VM, 2012, EUR J LIPID SCI TECH, V114, P634, DOI 10.1002/ejlt.201200044; Olkkonen VM, 2004, ANN MED, V36, P562, DOI 10.1080/07853890410018907; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Szuchman A, 2008, BIOMARKERS, V13, P119, DOI 10.1080/13547500701614556; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Vihervaara T, 2012, BIOCHIMIE, DOI [10.1016/j.biochi.2012.05.004, DOI 10.1016/J.BIO-CHI.2012.05.004]; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wamil M, 2008, ENDOCRINOLOGY, V149, P5909, DOI 10.1210/en.2008-0420; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Yan DG, 2008, INT REV CYTOL, V265, P253, DOI 10.1016/S0074-7696(07)65007-4; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Zhou TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021078; Zhou Y, 2010, EXP CELL RES, V316, P3304, DOI 10.1016/j.yexcr.2010.06.008; Zieden B, 1999, ARTERIOSCL THROM VAS, V19, P967, DOI 10.1161/01.ATV.19.4.967	59	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45352	10.1371/journal.pone.0045352	http://dx.doi.org/10.1371/journal.pone.0045352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028956	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800041
J	Havecker, ER; Wallbridge, LM; Fedito, P; Hardcastle, TJ; Baulcombe, DC				Havecker, Ericka R.; Wallbridge, Laura M.; Fedito, Paola; Hardcastle, Thomas J.; Baulcombe, David C.			Metastable Differentially Methylated Regions within Arabidopsis Inbred Populations Are Associated with Modified Expression of Non-Coding Transcripts	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; NATURAL VARIATION; RNA; GENE; EPIGENOME; PATHWAYS; MUTATION; MUTANTS; HOMOLOG; ALLELES	Individual plants within a population may vary at both genetic and epigenetic levels. The rate of genetic divergence and its underlying mechanisms is well understood. Less is known about the factors contributing to epigenetic divergence among isogenic populations except that, despite the presence of mechanisms that faithfully maintain epigenetic marks, epigenetic differences are more frequent than genetic variation. Epigenetically divergent stretches of isogenic DNA sequence are called epialleles. Currently, it is not clear why certain regions exhibit variable epigenetic status. We identified and characterised two long RNA transcripts with altered expression and DNA methylation in an ago5 mutant. However, further investigation revealed that these changes were not dependent upon AGO5. Rather, the variable transcription of these loci in Arabidopsis mutant and wild-type populations corresponds to spontaneous differential methylated regions (DMRs) or epialleles. These two DMRs are delineated by RNAs which are highly expressed when the DMR is hypomethylated. Furthermore, they control the expression of 59 transcriptional start site mRNA variants of nearby protein coding genes. Our data support the recent observations that meiotically stable DMRs exist within inbred populations. We further demonstrate that DMR boundaries can be defined by putative non-coding promoter-associated transcripts.	[Havecker, Ericka R.; Wallbridge, Laura M.; Hardcastle, Thomas J.; Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Fedito, Paola] Univ Mediterranea Reggio Calabria, BIOMAA, Reggio Di Calabria, Italy	University of Cambridge; Universita Mediterranea di Reggio Calabria	Baulcombe, DC (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	dcb40@cam.ac.uk		Hardcastle, Thomas/0000-0002-9328-5011; Baulcombe, David/0000-0003-0780-6878	short term EMBO fellowship [ASTF158-2008]; Gatsby Charitable Foundation; European Union Sixth Framework Programme Integrated Project SIROCCO [LSHG-CT-2006-037900]; Royal Society	short term EMBO fellowship; Gatsby Charitable Foundation; European Union Sixth Framework Programme Integrated Project SIROCCO; Royal Society(Royal Society of London)	PF was supported by a short term EMBO fellowship ASTF158-2008. This work was supported by the Gatsby Charitable Foundation and the European Union Sixth Framework Programme Integrated Project SIROCCO (LSHG-CT-2006-037900). DCB was supported as a Royal Society Research Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; David Allis C., 2007, EPIGENETICS-US; Daxinger L, 2008, CELL, V135, P592, DOI 10.1016/j.cell.2008.10.027; Durand S, 2012, CURR BIOL, V22, P326, DOI 10.1016/j.cub.2011.12.054; Eichten SR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002372; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Goto DB, 2002, PLANT CELL PHYSIOL, V43, P923, DOI 10.1093/pcp/pcf107; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hernandez-Pinzon I, 2007, PLANT J, V50, P140, DOI 10.1111/j.1365-313X.2007.03043.x; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jauvion V, 2010, PLANT CELL, V22, P2697, DOI 10.1105/tpc.110.076638; Johnston AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r204; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; Laubinger S, 2010, P NATL ACAD SCI USA, V107, P17466, DOI 10.1073/pnas.1012891107; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Martin A, 2009, NATURE, V461, P1135, DOI 10.1038/nature08498; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Monaghan J, 2010, PLANT CELL PHYSIOL, V51, P742, DOI 10.1093/pcp/pcq038; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Rangwala SH, 2006, PLOS GENET, V2, P270, DOI 10.1371/journal.pgen.0020036; Riddle NC, 2002, GENETICS, V162, P355; Riggs A. D., 1996, EPIGENETIC MECH GENE, P29; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Searle IR, 2010, GENE DEV, V24, P986, DOI 10.1101/gad.579910; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Tan EH, 2012, CELL REP, V1, P208, DOI 10.1016/j.celrep.2012.01.004; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009	51	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45242	10.1371/journal.pone.0045242	http://dx.doi.org/10.1371/journal.pone.0045242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028873	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900031
J	Poelma, C; Kloosterman, A; Hierck, BP; Westerweel, J				Poelma, Christian; Kloosterman, Astrid; Hierck, Beerend P.; Westerweel, Jerry			Accurate Blood Flow Measurements: Are Artificial Tracers Necessary?	PLOS ONE			English	Article							PARTICLE IMAGE VELOCIMETRY; MICRO-PIV MEASUREMENTS; SHEAR RATE; VELOCITY; MICROVESSELS; PROFILES; HEMATOCRIT; ARTERIOLES; OUTFLOW; EMBRYOS	Imaging-based blood flow measurement techniques, such as particle image velocimetry, have become an important tool in cardiovascular research. They provide quantitative information about blood flow, which benefits applications ranging from developmental biology to tumor perfusion studies. Studies using these methods can be classified based on whether they use artificial tracers or red blood cells to visualize the fluid motion. We here present the first direct comparison in vivo of both methods. For high magnification cases, the experiments using red blood cells strongly underestimate the flow (up to 50% in the present case), as compared to the tracer results. For medium magnification cases, the results from both methods are indistinguishable as they give the same underestimation of the real velocities (approximately 33%, based on in vitro reference measurements). These results suggest that flow characteristics reported in literature cannot be compared without a careful evaluation of the imaging characteristics. A method to predict the expected flow averaging behavior for a particular facility is presented.	[Poelma, Christian; Kloosterman, Astrid; Westerweel, Jerry] Delft Univ Technol, Lab Aero & Hydrodynam, Delft, Netherlands; [Hierck, Beerend P.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands	Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Poelma, C (corresponding author), Delft Univ Technol, Lab Aero & Hydrodynam, Delft, Netherlands.	c.poelma@tudelft.nl	Westerweel, Jerry/G-9087-2011; Hierck, Beerend P/A-6488-2013; Poelma, Christian/A-1913-2014	Hierck, Beerend P/0000-0002-7170-1686; Poelma, Christian/0000-0001-8676-9221; Westerweel, Jerry/0000-0002-2799-5242	Medical Delta initiative	Medical Delta initiative	This work is financially supported by the Medical Delta initiative (www.medicaldelta.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian RJ., 2010, PARTICLE IMAGE VELOC; Al-Roubaie S, 2011, AM J PHYSIOL-HEART C, V301, pH2473, DOI 10.1152/ajpheart.00475.2011; BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0; Bourdon CJ, 2004, EXP FLUIDS, V37, P263, DOI 10.1007/s00348-004-0812-4; Cokelet GR, 1998, MICROCIRCULATION-LON, V5, P61, DOI 10.1080/713773812; ECKSTEIN EC, 1988, MICROVASC RES, V36, P31, DOI 10.1016/0026-2862(88)90036-2; Egorova AD, 2011, DEV DYNAM, V240, P1670, DOI 10.1002/dvdy.22660; Fouras A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2783978; Fung Y. C., 1997, BIOMECHANICS CIRCULA; Gijsen FJH, 1999, J BIOMECH, V32, P601, DOI 10.1016/S0021-9290(99)00015-9; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Kamoun WS, 2010, NAT METHODS, V7, P655, DOI [10.1038/NMETH.1475, 10.1038/nmeth.1475]; Kim S, 2007, AM J PHYSIOL-HEART C, V293, pH1526, DOI 10.1152/ajpheart.01090.2006; Kloosterman A, 2011, EXP FLUIDS, V50, P1587, DOI 10.1007/s00348-010-1015-9; Kloosterman A, 2011, EUROMECH C, P37, DOI 103929/ethz-a-00660037; Lee JY, 2007, PHYSIOL MEAS, V28, P1149, DOI 10.1088/0967-3334/28/10/002; Lee SJ, 2011, MICROVASC RES, V82, P296, DOI 10.1016/j.mvr.2011.09.005; Lima R, 2006, MEAS SCI TECHNOL, V17, P797, DOI 10.1088/0957-0233/17/4/026; Long DS, 2004, P NATL ACAD SCI USA, V101, P10060, DOI 10.1073/pnas.0402937101; Manner J, 2009, DEV DYNAM, V238, P3273, DOI 10.1002/dvdy.22159; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Nguyen CV, 2010, EXP FLUIDS, V49, P701, DOI 10.1007/s00348-010-0837-9; Olsen MG, 2000, EXP FLUIDS, V29, pS166, DOI 10.1007/s003480070018; Patrick MJ, 2011, EXP FLUIDS, V50, P887, DOI 10.1007/s00348-010-0943-8; PITTMAN RN, 1986, MICROVASC RES, V32, P371, DOI 10.1016/0026-2862(86)90072-5; Poelma C, 2008, EXP FLUIDS, V45, P703, DOI 10.1007/s00348-008-0476-6; Poelma C, 2011, EXP FLUIDS, V50, P1421, DOI 10.1007/s00348-010-1002-1; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Popel AS, 2005, ANNU REV FLUID MECH, V37, P43, DOI 10.1146/annurev.fluid.37.042604.133933; Reyes-Aldasoro CC, 2008, J MICROSC-OXFORD, V229, P162, DOI 10.1111/j.1365-2818.2007.01877.x; Rossi M, 2012, EXP FLUIDS, V52, P1063, DOI 10.1007/s00348-011-1194-z; Sugii Y, 2002, PHYSIOL MEAS, V23, P403, DOI 10.1088/0967-3334/23/2/315; TANGELDER GJ, 1988, AM J PHYSIOL, V254, pH1059, DOI 10.1152/ajpheart.1988.254.6.H1059; Vennemann P, 2006, J BIOMECH, V39, P1191, DOI 10.1016/j.jbiomech.2005.03.015; Wereley ST, 2010, ANNU REV FLUID MECH, V42, P557, DOI 10.1146/annurev-fluid-121108-145427; Willert C, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/7/075402	36	42	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45247	10.1371/journal.pone.0045247	http://dx.doi.org/10.1371/journal.pone.0045247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028878	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900032
J	Cheung, YF; Yu, W; Li, SN; Lam, WWM; Ho, YC; Wong, SJ; Chan, GCF; Ha, SY				Cheung, Yiu-fai; Yu, Wei; Li, Shu-na; Lam, Wendy W. M.; Ho, Yuen-chi; Wong, Sophia J.; Chan, Godfrey C. F.; Ha, Shau-yin			Dynamic Dyssynchrony and Impaired Contractile Reserve of the Left Ventricle in Beta-Thalassaemia Major: An Exercise Echocardiographic Study	PLOS ONE			English	Article							HEART-FAILURE PATIENTS; CARDIAC RESYNCHRONIZATION THERAPY; BUNDLE-BRANCH BLOCK; MECHANICAL DYSSYNCHRONY; MAGNETIC-RESONANCE; IRON OVERLOAD; MITRAL REGURGITATION; MYOCARDIAL IRON; ISOVOLUMIC ACCELERATION; NARROW QRS	Background: Performance of the left ventricle during exercise stress in thalassaemia patients is uncertain. We aimed to explore the phenomenon of dynamic dyssynchrony and assess contractile reserve in patients with beta-thalassaemia major and determine their relationships with myocardial iron load. Methods and Results: Thirty-two thalassaemia patients (16 males), aged 26.8 +/- 6.9 years, without heart failure and 17 healthy controls were studied. Their left ventricular (LV) volumes, ejection fraction, systolic dyssynchrony index (SDI), and myocardial acceleration during isovolumic LV contraction (IVA) were determined at rest and during submaximal bicycle exercise testing using 3-dimensional and tissue Doppler echocardiography. Myocardial iron load as assessed by T2* cardiac magnetic resonance in patients were further related to indices of LV dyssynchrony and contractile reserve. At rest, patients had significantly greater LV SDI (p<0.001) but similar IVA (p = 0.22) compared with controls. With exercise stress, the prevalence of mechanical dyssynchrony (SDI>4.6%, control+2SD) increased from baseline 25% to 84% in patients. Delta SDIexercise-baseline correlated with exercise-baseline differences in LV ejection fraction (p<0.001) and stroke volume (p = 0.006). Compared with controls, patients had significantly less exercise-induced increase in LV ejection fraction, cardiac index, and IVA (interaction, all p<0.05) and had impaired contractile reserve as reflected by the gentler IVA-heart rate slope (p = 0.018). Cardiac T2* in patients correlated with baseline LV SDI (r = -0.44, p = 0.011) and IVA-heart rate slope (r = 0.36, p = 0.044). Conclusions: Resting LV dyssynchrony is associated with myocardial iron load. Exercise stress further unveils LV dynamic dyssynchrony and impaired contractile reserve in patients with beta-thalassaemia major.	[Cheung, Yiu-fai; Yu, Wei; Li, Shu-na; Wong, Sophia J.] Univ Hong Kong, Queen Mary Hosp, Div Paediat Cardiol, Hong Kong, Hong Kong, Peoples R China; [Lam, Wendy W. M.; Ho, Yuen-chi] Univ Hong Kong, Queen Mary Hosp, Dept Radiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Godfrey C. F.; Ha, Shau-yin] Univ Hong Kong, Queen Mary Hosp, Div Paediat Haematol & Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Cheung, YF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Div Paediat Cardiol, Hong Kong, Hong Kong, Peoples R China.	xfcheung@hku.hk	Lam, Wendy/AAI-3016-2021; Cheung, Yiu Fai/C-4240-2009	Cheung, Yiu Fai/0000-0002-7279-4992; HA, Shau Yin/0000-0002-9191-8743	Research Grants Council of the Hong Kong Special Administrative Region, China [HKU763309M]; Children's Thalassaemia Foundation	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Children's Thalassaemia Foundation	This study was supported by the Research Grants Council of the Hong Kong Special Administrative Region, China (Project no. HKU763309M) and Children's Thalassaemia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajijola OA, 2008, AM J CARDIOL, V101, P1371, DOI 10.1016/j.amjcard.2007.12.037; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; Arnold R, 2008, ECHOCARDIOGR-J CARD, V25, P732, DOI 10.1111/j.1540-8175.2008.00686.x; Bader H, 2004, J AM COLL CARDIOL, V43, P248, DOI 10.1016/j.jacc.2003.08.038; Cheung YF, 2010, HEART, V96, P1137, DOI 10.1136/hrt.2010.194118; Cohen Alan R, 2004, Hematology Am Soc Hematol Educ Program, P14; D'Andrea A, 2007, EUR HEART J, V28, P1004, DOI 10.1093/eurheartj/ehm021; Endoh M, 2004, EUR J PHARMACOL, V500, P73, DOI 10.1016/j.ejphar.2004.07.013; Friedberg MK, 2007, J AM SOC ECHOCARDIOG, V20, P756, DOI 10.1016/j.echo.2006.11.007; Gujja P, 2010, J AM COLL CARDIOL, V56, P1001, DOI 10.1016/j.jacc.2010.03.083; He TG, 2006, J MAGN RESON IMAGING, V24, P580, DOI 10.1002/jmri.20681; He TG, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-11; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Izumo M, 2009, EUR J ECHOCARDIOGR, V10, P961, DOI 10.1093/ejechocard/jep114; Kapetanakis S, 2005, CIRCULATION, V112, P992, DOI 10.1161/CIRCULATIONAHA.104.474445; Karvounis HI, 2001, AM HEART J, V141, P281; KIM E, 1995, TOXICOL APPL PHARM, V130, P57, DOI 10.1006/taap.1995.1008; Kurita T, 2010, INT J CARDIOL, V140, P48, DOI 10.1016/j.ijcard.2008.10.047; Kyriacou K, 2000, ULTRASTRUCT PATHOL, V24, P75, DOI 10.1080/01913120050118549; Lafitte S, 2006, J AM COLL CARDIOL, V47, P2253, DOI 10.1016/j.jacc.2005.11.087; Lancellotti P, 2005, AM J CARDIOL, V96, P1304, DOI 10.1016/j.amjcard.2005.06.077; Leclercq C, 2004, CIRCULATION, V109, P296, DOI 10.1161/01.CIR.0000113458.76455.03; Lee APW, 2010, EUR HEART J, V31, P2642, DOI 10.1093/eurheartj/ehq248; LEON MB, 1979, NEW ENGL J MED, V301, P1143, DOI 10.1056/NEJM197911223012103; Mavrogeni SI, 2005, EUR J HAEMATOL, V75, P241, DOI 10.1111/j.1600-0609.2005.00474.x; Mavrogeni S, 2009, INT J CARDIOVAS IMAG, V25, P777, DOI 10.1007/s10554-009-9491-9; MIURA T, 1993, J APPL PHYSIOL, V75, P389, DOI 10.1152/jappl.1993.75.1.389; Parkes JG, 2000, J MOL CELL CARDIOL, V32, P233, DOI 10.1006/jmcc.1999.1068; Pepe A, 2009, HEART, V95, P1688, DOI 10.1136/hrt.2008.156497; Reynolds MR, 2011, ANN INTERN MED, V155, P470, DOI 10.7326/0003-4819-155-7-201110040-00010; Roche SL, 2011, J AM COLL CARDIOL, V57, P1100, DOI 10.1016/j.jacc.2010.09.063; Rouleau F, 2001, PACE, V24, P1500, DOI 10.1046/j.1460-9592.2001.01500.x; Spragg DD, 2006, PROG CARDIOVASC DIS, V49, P26, DOI 10.1016/j.pcad.2006.05.001; Spragg DD, 2003, CIRCULATION, V108, P929, DOI 10.1161/01.CIR.0000088782.99568.CA; Tan HW, 2008, J HYPERTENS, V26, P553, DOI 10.1097/HJH.0b013e3282f2b91f; Tanner MA, 2007, CIRCULATION, V115, P1876, DOI 10.1161/CIRCULATIONAHA.106.648790; Toiviainen-Salo S, 2008, PEDIATR BLOOD CANCER, V51, P461, DOI 10.1002/pbc.21686; van Dijk J, 2008, EUROPACE, V10, P63, DOI 10.1093/europace/eum262; van Dijk J, 2008, EUR J ECHOCARDIOGR, V9, P40, DOI 10.1016/j.euje.2007.03.003; Vernooy K, 2005, EUR HEART J, V26, P91, DOI 10.1093/eurheartj/ehi008; WIER WG, 1986, J PHYSIOL-LONDON, V376, P507, DOI 10.1113/jphysiol.1986.sp016167; Yu CM, 2006, J AM COLL CARDIOL, V48, P2251, DOI 10.1016/j.jacc.2006.07.054	42	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45265	10.1371/journal.pone.0045265	http://dx.doi.org/10.1371/journal.pone.0045265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028894	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900109
J	Jaffa, MA; Kobeissy, F; Al Hariri, M; Chalhoub, H; Eid, A; Ziyadeh, FN; Jaffa, AA				Jaffa, Miran A.; Kobeissy, Firas; Al Hariri, Moustafa; Chalhoub, Hussein; Eid, Assaad; Ziyadeh, Fuad N.; Jaffa, Ayad A.			Global Renal Gene Expression Profiling Analysis in B-2-Kinin Receptor Null Mice: Impact of Diabetes	PLOS ONE			English	Article							EARLY NATURAL-HISTORY; GROWTH-FACTOR-BETA; B2 RECEPTOR; KNOCKOUT MICE; KININ B1; NEPHROPATHY; KIDNEY; PATHOGENESIS; MODEL; COMPLICATIONS	Diabetic nephropathy (DN), the leading cause of end-stage renal failure, is clinically manifested by albuminuria and a progressive decline in glomerular filtration rate. The risk factors and mechanisms that contribute to the development and progression of DN are still incompletely defined. To address the involvement of bradykinin B-2-receptors (B2R) in DN, we used a genome wide approach to study the effects of diabetes on differential renal gene expression profile in wild type and B2R knockout (B2R-/-) mice. Diabetes was induced with streptozotocin and plasma glucose levels and albumin excretion rate (AER) were measured at predetermined times throughout the 23 week study period. Longitudinal analysis of AER indicated that diabetic B2R-/-D null mice had a significantly decreased AER levels compared to wild type B2R+/+ D mice (P = 0.0005). Results from the global microarray study comparing gene expression profiles among four groups of mice respectively: (B2R+/+C, B2R+/+D, B2R-/-C and B2R-/-D) highlighted the role of several altered pathological pathways in response to disruption of B2R and to the diabetic state that included: endothelial injury, oxidative stress, insulin and lipid metabolism and inflammatory process with a marked alteration in the pro-apoptotic genes. The findings of the present study provide a global genomics view of biomarkers that highlight the mechanisms and putative pathways involved in DN.	[Kobeissy, Firas; Al Hariri, Moustafa; Chalhoub, Hussein; Ziyadeh, Fuad N.; Jaffa, Ayad A.] Amer Univ Beirut, Dept Biochem, Beirut, Lebanon; [Kobeissy, Firas; Al Hariri, Moustafa; Chalhoub, Hussein; Ziyadeh, Fuad N.; Jaffa, Ayad A.] Amer Univ Beirut, Dept Mol Genet, Beirut, Lebanon; [Jaffa, Miran A.] Amer Univ Beirut, Fac Hlth Sci, Epidemiol & Populat Hlth Dept, Beirut, Lebanon; [Eid, Assaad] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Jaffa, Ayad A.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; Medical University of South Carolina	Jaffa, AA (corresponding author), Amer Univ Beirut, Dept Biochem, Beirut, Lebanon.	aj24@aub.edu.lb	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944	National Institutes of Health [HL077192, HL087986]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087986, R01HL077192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grants HL077192 and HL087986 (AAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvarov D, 2006, BIOL CHEM, V387, P15, DOI 10.1515/BC.2006.004; Balakumar P, 2009, J CARDIOVASC PHARM, V54, P129, DOI 10.1097/FJC.0b013e3181ad2190; Bascands JL, 2009, BIOCHEM BIOPH RES CO, V386, P407, DOI 10.1016/j.bbrc.2009.06.063; Blazquez-Medela AM, 2010, CURR DIABETES REV, V6, P68, DOI 10.2174/157339910790909422; Brown WV, 2008, AM J CARDIOL, V102, p10L, DOI 10.1016/j.amjcard.2008.09.068; Busch M, 2010, EUR J CLIN INVEST, V40, P742, DOI 10.1111/j.1365-2362.2010.02317.x; Christopher J, 2002, INT IMMUNOPHARMACOL, V2, P1771, DOI 10.1016/S1567-5769(02)00188-1; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Drummond K, 2002, DIABETES, V51, P1580, DOI 10.2337/diabetes.51.5.1580; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Haneda M, 1997, DIABETES, V46, P847, DOI 10.2337/diabetes.46.5.847; HARVEY JN, 1990, DIABETES, V39, P299, DOI 10.2337/diabetes.39.3.299; HARVEY JN, 1992, DIABETOLOGIA, V35, P857, DOI 10.1007/BF00399932; Haseyama T, 2002, TOHOKU J EXP MED, V198, P233, DOI 10.1620/tjem.198.233; Hedeker D, 1999, J EDUC BEHAV STAT, V24, P70, DOI 10.3102/10769986024001070; Jaffa AA, 2003, DIABETES, V52, P1215, DOI 10.2337/diabetes.52.5.1215; JAFFA AA, 1995, DIABETES, V44, P156, DOI 10.2337/diabetes.44.2.156; Jozwiak Lucyna, 2004, Mol Diagn, V8, P157, DOI 10.2165/00066982-200408030-00003; Kakoki M, 2004, P NATL ACAD SCI USA, V101, P13302, DOI 10.1073/pnas.0405449101; Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Maltais I, 2002, CAN J PHYSIOL PHARM, V80, P323, DOI 10.1139/Y02-036; Mauer M, 2002, DIABETES, V51, P1572, DOI 10.2337/diabetes.51.5.1572; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; Monti J, 2001, HYPERTENSION, V38, pE1, DOI 10.1161/01.HYP.38.1.e1; Mukhtar A, 2007, SAUDI J KIDNEY DIS T, V18, P100; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Panzer U, 1999, NEPHROLOGIE, V20, P335; Rincon-Choles H, 2002, KIDNEY INT, V62, pS8, DOI 10.1046/j.1523-1755.62.s82.3.x; Rutledge JC, 2010, NAT REV NEPHROL, V6, P361, DOI 10.1038/nrneph.2010.59; Sakharova OV, 2001, CURR OPIN NEPHROL HY, V10, P727, DOI 10.1097/00041552-200111000-00001; Schanstra JP, 2007, KIDNEY INT, V72, P442, DOI 10.1038/sj.ki.5002172; Singh DK, 2011, NAT REV ENDOCRINOL, V7, P176, DOI 10.1038/nrendo.2010.212; Stitt-Cavanagh E, 2009, THESCIENTIFICWORLDJO, V9, P1127, DOI 10.1100/tsw.2009.133; Tan Y, 2005, AM J PHYSIOL-RENAL, V288, pF483, DOI 10.1152/ajprenal.00165.2004; Tan Y, 2007, AM J PHYSIOL-RENAL, V293, pF1026, DOI 10.1152/ajprenal.00203.2007; Tang SCW, 2011, LAB INVEST, V91, P1351, DOI 10.1038/labinvest.2011.81; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097; Zuccollo A, 1996, CAN J PHYSIOL PHARM, V74, P586, DOI 10.1139/y96-047	41	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44714	10.1371/journal.pone.0044714	http://dx.doi.org/10.1371/journal.pone.0044714			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028588	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900037
J	Petrizzo, A; Tornesello, ML; Napolitano, M; D'Alessio, G; Megna, AS; Dolcetti, R; De Re, V; Wang, E; Marincola, FM; Buonaguro, FM; Buonaguro, L				Petrizzo, Annacarmen; Tornesello, Maria Lina; Napolitano, Maria; D'Alessio, Giovanna; Megna, Angelo Salomone; Dolcetti, Riccardo; De Re, Valli; Wang, Ena; Marincola, Franco M.; Buonaguro, Franco M.; Buonaguro, Luigi			Multiparametric Analyses of Human PBMCs Loaded Ex Vivo with a Candidate Idiotype Vaccine for HCV-Related Lymphoproliferative Disorders	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN DENDRITIC CELLS; NF-KAPPA-B; COLONY-STIMULATING FACTOR; BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION PROFILE; YELLOW-FEVER VACCINE; MIXED CRYOGLOBULINEMIA; FOLLICULAR LYMPHOMA; IMMUNE-RESPONSES	Hepatitis C virus (HCV) has been identified as one of the major risk factors for type II mixed cryoglobulinemia (MC), during the clinical evolution of chronic hepatitis, which may lead to development of B cell non-Hodgkin's lymphoma (NHL). We have previously shown that the candidate idiotype vaccine, based on the IGKV3-20 light chain protein, is able to induce activation and maturation of circulating antigen presenting cells (APCs) in both HCV-positive and HCV-negative healthy control subjects, with production of Th2-type cytokines. Here, the effect of the recombinant IGKV3-20 protein on human peripheral blood mononuclear cells (PBMCs) from HCV-positive subjects, with known blood levels of cryoglobulins, is shown via gene expression profiling analysis combined to multiparameter flow cytometry and multiplex analyses of cytokines.	[Petrizzo, Annacarmen; Tornesello, Maria Lina; Buonaguro, Franco M.; Buonaguro, Luigi] Natl Canc Inst Fond G Pascale, Lab Mol Biol & Viral Oncogenesis, Naples, Italy; [Napolitano, Maria] Natl Canc Inst Fond G Pascale, Clin Immunol Lab, Naples, Italy; [D'Alessio, Giovanna; Megna, Angelo Salomone] Rummo Hosp, Div Infect Dis, Benevento, Italy; [Dolcetti, Riccardo] Natl Canc Inst, Ctr Riferimento Oncol, Canc Bioimmunotherapy Unit, Aviano, Italy; [Wang, Ena; Marincola, Franco M.] NIH, IDIS, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Marincola, Franco M.] NIH, Trans NIH Ctr Human Immunol, Bethesda, MD 20892 USA	IRCCS Aviano (CRO); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA	Buonaguro, L (corresponding author), Natl Canc Inst Fond G Pascale, Lab Mol Biol & Viral Oncogenesis, Naples, Italy.	l.buonaguro@istitutotumori.na.it	Dolcetti, Riccardo/O-3832-2015; DE RE, VALLI/AAA-1374-2019; Buonaguro, Luigi/AAV-5655-2020; Buonaguro, Franco M./T-6028-2019; De Re, Valli/K-4121-2016; Maria, Buonaguro Franco/AAF-4888-2019; Tornesello, Maria Lina/A-1964-2008; napolitano, maria/K-1615-2016	Dolcetti, Riccardo/0000-0003-1625-9853; DE RE, VALLI/0000-0001-6100-9373; Buonaguro, Franco M./0000-0002-7491-7220; De Re, Valli/0000-0001-6100-9373; Tornesello, Maria Lina/0000-0002-3523-3264; Buonaguro, Luigi/0000-0002-6380-7114; napolitano, maria/0000-0002-8996-3297; Petrizzo, Annacarmen/0000-0003-3228-6958	Italian Ministry of Research [ACC 4]; Associazione Italiana per la ricerca sul Cancro [10301]; Fondazione Federica per la Vita; University of Udine	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Federica per la Vita; University of Udine	The study was funded by Italian Ministry of Research through the project "Alleanza Contro il Cancro'' (Contract No. ACC 4). AP was a Ph.D. student at University of Udine "Biomedical Science and Biotechnology'' and the recipient of a fellowship granted through the project. The work was partly supported by a grant from the Associazione Italiana per la ricerca sul Cancro (contract 10301 to RD) and the Fondazione Federica per la Vita (to RD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOUCHE M, 1990, LEUKEMIA RES, V14, P699, DOI 10.1016/0145-2126(90)90097-S; Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083; Arico E, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-45; Bendandi M, 1999, NAT MED, V5, P1171, DOI 10.1038/13928; Bende RJ, 2005, J EXP MED, V201, P1229, DOI 10.1084/jem.20050068; Briscoe J, 1996, PHILOS T ROY SOC B, V351, P167, DOI 10.1098/rstb.1996.0013; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Brown DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-56; Buonaguro L, 2006, J VIROL, V80, P9134, DOI 10.1128/JVI.00050-06; Buonaguro L, 2009, J VIROL, V83, P304, DOI 10.1128/JVI.01606-08; Buonaguro L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-18; Buonaguro L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S5; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; Chougnet C, 1999, J IMMUNOL, V163, P1666; Chung YM, 2001, BIOCHEM BIOPH RES CO, V284, P15, DOI 10.1006/bbrc.2001.4936; Cortesini NSF, 2004, TRANSPL IMMUNOL, V13, P73, DOI 10.1016/j.trim.2004.06.001; COSMAN D, 1994, STEM CELLS, V12, P440, DOI 10.1002/stem.5530120501; Croft M, 1997, CRIT REV IMMUNOL, V17, P89, DOI 10.1615/CritRevImmunol.v17.i1.40; Dammacco F, 1997, CLIN REV ALLERG IMMU, V15, P97, DOI 10.1007/BF02828280; De Re V, 2007, GASTROENTEROLOGY, V132, P1205, DOI 10.1053/j.gastro.2007.02.009; De Re V, 2000, INT J CANCER, V87, P211, DOI 10.1002/1097-0215(20000715)87:2&lt;211::AID-IJC9&gt;3.0.CO;2-8; De Re V, 2000, BLOOD, V96, P3578; de Re V, 2009, ANN NY ACAD SCI, V1173, P152, DOI 10.1111/j.1749-6632.2009.04677.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fairfax BP, 2011, J IMMUNOL, V186, P3058, DOI 10.4049/jimmunol.1001791; Fan Z, 2007, CLIN VACCINE IMMUNOL, V14, P1127, DOI 10.1128/CVI.00141-07; FERRI C, 1994, J INTERN MED, V236, P31, DOI 10.1111/j.1365-2796.1994.tb01116.x; FERRI C, 1994, BRIT J HAEMATOL, V88, P392, DOI 10.1111/j.1365-2141.1994.tb05036.x; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Ha Hyunil, 2009, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109ds87; Hollander N, 2009, CRIT REV IMMUNOL, V29, P399, DOI 10.1615/CritRevImmunol.v29.i5.30; Huang XL, 2005, J VIROL, V79, P3052, DOI 10.1128/JVI.79.5.3052-3062.2005; Inoges S, 2006, J NATL CANCER I, V98, P1292, DOI 10.1093/jnci/djj358; Ito T, 2009, J BIOL CHEM, V284, P24289, DOI 10.1074/jbc.M109.007286; Izuhara K, 2006, CURR MED CHEM, V13, P2291, DOI 10.2174/092986706777935140; Kostareli E, 2011, LEUKEMIA; KWAK LW, 1992, NEW ENGL J MED, V327, P1209, DOI 10.1056/NEJM199210223271705; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; LINSLEY PS, 1992, SCIENCE, V257, P792, DOI 10.1126/science.1496399; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Martorelli D, 2011, CANC IMMUNOL IMMUNOT; Martyak LA, 2009, CLIN GASTROENTEROL H, V7, P900, DOI 10.1016/j.cgh.2009.03.035; Marzio R, 1999, IMMUNOPHARM IMMUNOT, V21, P565, DOI 10.3109/08923979909007126; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Moradpour D, 2005, EUR J GASTROEN HEPAT, V17, P477, DOI 10.1097/00042737-200505000-00002; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; OJCIUS DM, 1990, CANCER CELL-MON REV, V2, P138; Perotti M, 2008, AUTOIMMUN REV, V7, P468, DOI 10.1016/j.autrev.2008.03.008; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pilsbury LE, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/536478; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Raglow Z, 2011, PHARMACOL THERAPEUT, V132, P30, DOI 10.1016/j.pharmthera.2011.05.005; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Smilevska T, 2008, BLOOD CELL MOL DIS, V41, P215, DOI 10.1016/j.bcmd.2008.06.002; Speiser DE, 1997, J EXP MED, V185, P1777, DOI 10.1084/jem.185.10.1777; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Stavenhagen JB, 2008, ADV ENZYME REGUL, V48, P152, DOI 10.1016/j.advenzreg.2007.11.011; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Tenca C, 2005, J IMMUNOL, V174, P6757, DOI 10.4049/jimmunol.174.11.6757; Uddin S, 1998, BRIT J HAEMATOL, V101, P446, DOI 10.1046/j.1365-2141.1998.00731.x; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Yasue T, 1997, P NATL ACAD SCI USA, V94, P10307, DOI 10.1073/pnas.94.19.10307; Young NT, 2008, BLOOD, V111, P3090, DOI 10.1182/blood-2007-05-089771; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502; Zignego AL, 2002, ANN INTERN MED, V137, P571, DOI 10.7326/0003-4819-137-7-200210010-00008; Zignego AL, 2007, WORLD J GASTROENTERO, V13, P2467, DOI 10.3748/wjg.v13.i17.2467; Zuckerman E, 1997, ANN INTERN MED, V127, P423, DOI 10.7326/0003-4819-127-6-199709150-00002	80	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44870	10.1371/journal.pone.0044870	http://dx.doi.org/10.1371/journal.pone.0044870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028651	gold, Green Published			2022-12-27	WOS:000311313900047
J	Yan, WS; Zhang, YH; Zhang, J; Cho, SJ; Chen, XB				Yan, Wensheng; Zhang, Yanhong; Zhang, Jin; Cho, Seong-Jun; Chen, Xinbin			HuR Is Necessary for Mammary Epithelial Cell Proliferation and Polarity at Least in Part via Delta Np63	PLOS ONE			English	Article							BINDING PROTEIN HUR; MESSENGER-RNA; BRANCHING MORPHOGENESIS; P53 HOMOLOG; P63; EXPRESSION; APOPTOSIS; BETA; TRANSLATION; RECEPTOR	HuR, a RNA binding protein, is known to function as a tumor maintenance gene in breast cancer and associated with tumor growth and poor prognosis. However, the cellular function of this protein remains largely unknown in normal mammary epithelial cells. Here, we showed that in immortalized MCF10A mammary epithelial cells, HuR knockdown inhibits cell proliferation and enhances premature senescence. We also showed that in three-dimensional culture, MCF10A cells with HuR knockdown form abnormal acini with filled lumen and an aberrant expression pattern of the extracellular matrix protein laminin V. In addition, we showed that HuR knockdown increases Delta Np63, but decreases wild-type p53, expression in MCF10A cells. Moreover, we showed that DNp63 knockdown partially rescues the proliferative defect induced by HuR knockdown in MCF10A cells. Consistent with this, we identified two U-rich elements in the 3'-untranslated region of p63 mRNA, to which HuR specifically binds. Finally, we showed that HuR knockdown enhances DNp63 mRNA translation but has no effect on p63 mRNA turnover. Together, our data suggest that HuR maintains cell proliferation and polarity of mammary epithelial cells at least in part via Delta Np63.	[Yan, Wensheng; Zhang, Yanhong; Zhang, Jin; Cho, Seong-Jun; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu	Cho, Seong-Jun/P-2491-2019		National Institutes of Health [R01 CA102188]; NATIONAL CANCER INSTITUTE [R01CA102188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by National Institutes of Health Grant R01 CA102188. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Barbieri CE, 2006, EXP CELL RES, V312, P695, DOI 10.1016/j.yexcr.2005.11.028; Buckley NE, CANC RES, V71, P1933; Carroll DK, 2007, CELL CYCLE, V6, P255, DOI 10.4161/cc.6.3.3799; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Gantt K, 2005, J BIOL CHEM, V280, P24768, DOI 10.1074/jbc.M502011200; Guo X, 2006, CANCER RES, V66, P7948, DOI 10.1158/0008-5472.CAN-05-4362; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Jonsson M, 2002, CANCER RES, V62, P409; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Kawai T, 2006, MOL CELL BIOL, V26, P3295, DOI 10.1128/MCB.26.8.3295-3307.2006; Leandersson K, 2006, NUCLEIC ACIDS RES, V34, P3988, DOI 10.1093/nar/gkl571; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Lopez de Silanes Isabel, 2005, RNA Biol, V2, P11; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Chi MN, 2011, MOL BIOL CELL, V22, P2875, DOI 10.1091/mbc.E11-03-0212; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakamura H, 2011, MOL CELL BIOL, V31, P1997, DOI 10.1128/MCB.01424-10; Niesporek S, 2008, INT J ONCOL, V32, P341; Pryzbylkowski P, 2008, BREAST CANCER RES TR, V111, P15, DOI 10.1007/s10549-007-9751-0; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Qian YJ, 2010, HISTOL HISTOPATHOL, V25, P515, DOI 10.14670/HH-25.515; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Saunus JM, 2008, CANCER RES, V68, P9469, DOI 10.1158/0008-5472.CAN-08-1159; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Sgantzis N, 2011, DEV BIOL, V354, P267, DOI 10.1016/j.ydbio.2011.04.003; SOULE HD, 1990, CANCER RES, V50, P6075; Trink B, 1998, NAT MED, V4, P747, DOI 10.1038/nm0798-747; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Yan WS, 2010, J BIOL CHEM, V285, P14229, DOI 10.1074/jbc.M109.097253; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107; Zhang YH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.214585	53	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45336	10.1371/journal.pone.0045336	http://dx.doi.org/10.1371/journal.pone.0045336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028944	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900122
J	Yang, Z; Zhang, QZ; Xu, K; Shan, JJ; Shen, JJ; Liu, LM; Xu, YM; Xia, F; Bie, P; Zhang, X; Cui, YH; Bian, XW; Qian, C				Yang, Zhi; Zhang, Qianzhen; Xu, Ke; Shan, Juanjuan; Shen, Junjie; Liu, Limei; Xu, Yanmin; Xia, Feng; Bie, Ping; Zhang, Xia; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng			Combined Therapy with Cytokine-Induced Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model	PLOS ONE			English	Article							IMMUNOLOGICAL EFFECTOR-CELLS; GENE-THERAPY; HEPATOCELLULAR-CARCINOMA; IN-VIVO; CANCER; INTERLEUKIN-12; IMMUNOTHERAPY; EFFICACY; VIRUS; CHEMOTHERAPY	Both adoptive immunotherapy and gene therapy hold a great promise for treatment of malignancies. However, these strategies exhibit limited anti-tumor activity, when they are used alone. In this study, we explore whether combination of cytokine-induced killer (CIK) adoptive immunotherapy with oncolytic adenovirus-mediated transfer of human interleukin-12 (hIL-12) gene induce the enhanced antitumor potency. Our results showed that oncolytic adenovirus carrying hIL-12 (AdCN205-IL12) could produce high levels of hIL-12 in liver cancer cells, as compared with replication-defective adenovirus expressing hIL-12 (Ad-IL12). AdCN205-IL12 could specifically induce cytotoxocity to liver cancer cells. Combination of CIK cells with AdCN205-IL12 could induce higher antitumor activity to liver cancer cells in vitro than that induced by either CIK or AdCN205-IL12 alone, or combination of CIK and control vector AdCN205-GFP. Furthermore, treatment of the established liver tumors with the combined therapy of CIK cells and AdCN205-IL12 resulted in tumor regression and long-term survival. High level expression of hIL-12 in tumor tissues could increase traffic of CIK cells to tumor tissues and enhance their antitumor activities. Our study provides a novel strategy for the therapy of cancer by the combination of CIK adoptive immunotherapy with oncolytic adenovirus-mediated transfer of immune stimulatory molecule hIL-12.	[Yang, Zhi; Zhang, Qianzhen; Xu, Ke; Shan, Juanjuan; Shen, Junjie; Liu, Limei; Xu, Yanmin; Zhang, Xia; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Yang, Zhi; Zhang, Qianzhen; Xu, Ke; Shan, Juanjuan; Shen, Junjie; Liu, Limei; Xu, Yanmin; Zhang, Xia; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng] Third Mil Med Univ, Southwest Hosp, SW Canc Ctr, Chongqing, Peoples R China; [Xia, Feng; Bie, Ping] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Qian, C (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China.	cqian3184@yahoo.com.cn	Zhang, Xia/B-8152-2008; Bian, Xiu-Wu/D-4736-2017	Zhang, Xia/0000-0002-9040-1486; Bian, Xiu-Wu/0000-0003-4383-0197; Zhi, Yang/0000-0002-3974-7297	National Basic Research Program of China (973 Program) [2010CB529406]; National Natural Sciences Foundation of China [81090423, 81020108026]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from National Basic Research Program of China (973 Program, No 2010CB529406) and National Natural Sciences Foundation of China (No. 81090423 and 81020108026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton E, 2007, GENE THER, V14, P1439, DOI 10.1038/sj.gt.3303001; Alves A, 2004, CANCER GENE THER, V11, P782, DOI 10.1038/sj.cgt.7700760; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Cui Q, 2008, HEPATOLOGY, V47, P105, DOI 10.1002/hep.21951; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Dudley ME, 2007, SEMIN ONCOL, V34, P524, DOI 10.1053/j.seminoncol.2007.09.002; Finke S, 1998, GENE THER, V5, P31, DOI 10.1038/sj.gt.3300560; He XP, 2011, HUM GENE THER, V22, P283, DOI 10.1089/hum.2010.058; Helms MW, 2010, CANCER IMMUNOL IMMUN, V59, P1325, DOI 10.1007/s00262-010-0860-y; Hontscha C, 2011, J CANCER RES CLIN, V137, P305, DOI 10.1007/s00432-010-0887-7; Hu WX, 2007, CANCER BIOL THER, V6, P1773, DOI 10.4161/cbt.6.11.4855; Jiang JT, 2006, ANTICANCER RES, V26, P2237; Jin J, 2011, ONCOL REP, V25, P33, DOI 10.3892/or_00001038; Kaino M, 1997, J GASTROENTEROL, V32, P40, DOI 10.1007/BF01213295; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Leonard JP, 1997, BLOOD, V90, P2541; Li HT, 2007, CANCER RES, V67, P7850, DOI 10.1158/0008-5472.CAN-07-1087; Li H, 2009, CYTOTHERAPY, V11, P1076, DOI 10.3109/14653240903121252; Liu Liang, 2012, CLIN CANC RES; Liu LX, 2009, HEPATOLOGY, V50, P1453, DOI 10.1002/hep.23143; LU PH, 1994, J IMMUNOL, V153, P1687; Luo JJ, 2008, CLIN CANCER RES, V14, P2450, DOI 10.1158/1078-0432.CCR-07-4596; Ma Y, 2012, CYTOTHERAPY; McCormick F, 2001, NAT REV CANCER, V1, P130, DOI 10.1038/35101008; MULE JJ, 1984, SCIENCE, V225, P1487, DOI 10.1126/science.6332379; Niam M, 2011, EXP HEMATOL, V39, P897, DOI 10.1016/j.exphem.2011.06.005; Niu Q, 2011, INT IMMUNOPHARMACOL, V11, P449, DOI 10.1016/j.intimp.2010.12.014; Nussler AK, 1999, IN VITRO CELL DEV-AN, V35, P190, DOI 10.1007/s11626-999-0026-4; Papadakis ED, 2004, CURR GENE THER, V4, P89, DOI 10.2174/1566523044578077; Pievani A, 2011, BLOOD; Pievani A, 2011, BLOOD, V117, P510, DOI 10.1182/blood-2010-06-290858; Qian C, 2006, CELL RES, V16, P182, DOI 10.1038/sj.cr.7310025; Qian C, 2002, GASTROENTEROLOGY, V123, P639, DOI 10.1053/gast.2002.35132; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Sacco S, 1997, BLOOD, V90, P4473; Sangro B, 2004, J CLIN ONCOL, V22, P1389, DOI 10.1200/JCO.2004.04.059; Sangro B, 2010, CURR OPIN MOL THER, V12, P561; Schmidt-Wolf IGH, 1999, BRIT J CANCER, V81, P1009, DOI 10.1038/sj.bjc.6690800; Thorne SH, 2006, SCIENCE, V311, P1780, DOI 10.1126/science.1121411; Varghese S, 2006, CANCER GENE THER, V13, P253, DOI 10.1038/sj.cgt.7700900; Wang B, 2012, HEPATO-GASTROENTEROL, V59, P515, DOI 10.5754/hge11534; Wong RJ, 2004, CLIN CANCER RES, V10, P4509, DOI 10.1158/1078-0432.CCR-04-0081; Yu L, 2007, ANTICANCER RES, V27, P2311; Zabala M, 2004, CANCER RES, V64, P2799, DOI 10.1158/0008-5472.CAN-03-3061; Zhang W, 2007, CANCER BIOL THER, V6, P1726, DOI 10.4161/cbt.6.11.4831; Zhou P, 2011, CANCER BIOL THER, V11, P450, DOI 10.4161/cbt.11.5.14669	47	34	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44802	10.1371/journal.pone.0044802	http://dx.doi.org/10.1371/journal.pone.0044802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028626	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900043
J	Zhang, YF; Kitano, Y; Nogata, Y; Zhang, Y; Qian, PY				Zhang, Yi-Fan; Kitano, Yoshikazu; Nogata, Yasuyuki; Zhang, Yu; Qian, Pei-Yuan			The Mode of Action of Isocyanide in Three Aquatic Organisms, Balanus amphitrite, Bugula neritina and Danio rerio	PLOS ONE			English	Article							NOTOCHORD DEVELOPMENT; ANTIFOULING COATINGS; ZEBRAFISH; EFFICIENT; TBT	Isocyanide is a potential antifouling compound in marine environments. In this study, we investigated its mode of action in three aquatic organisms. Two of them, the bryozoan Bugula neritina and the barnacle Balanus amphitrite, are major marine fouling invertebrates, and the other organism is the non-target species zebrafish Danio rerio. In the swimming larvae of B. neritina, isocyanide did not affect the total attachment rate (<= 50 mu g ml(-1)), but it did change the attachment site by increasing the percentage of attachment on the bottom of the container rather than on the wall or air-water inter-surface. Isocyanide binds several proteins in B. neritina as identified via SDS-PAGE-LC-MS/MS: 1) a 30 kD protein band containing two proteins similar to voltage dependent anion channels (VDAC), which control the direct coupling of the mitochondrial matrix to the energy maintenance of the cytosol and the release of apoptogenic factors from mitochondria of mammalian cells; and 2) an unknown 39 kD protein. In B. amphitrite cyprids, the isocyanide binding protein were 1) a protein similar to NADH-ubiquinone oxidoreductase, which is the "entry enzyme" of oxidative phosphorylation in mitochondria; and 2) cytochrome P450. In Danio rerio embryos, isocyanide caused "wavy" notochords, hydrocephalus, pericardial edema, poor blood circulation, and defects in pigmentation and hematopoiesis, which phenocopied copper deficiency. This is the first report on isocyanide binding proteins in fouling organisms, as well as the first description of its phenotype and potential toxicology in zebrafish.	[Zhang, Yi-Fan; Zhang, Yu; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China; [Kitano, Yoshikazu] Tokyo Univ Agr & Technol, Bioorgan Chem Lab, Tokyo, Japan; [Nogata, Yasuyuki] Cent Res Inst Elect Power Ind, Abiko Res Lab, Chiba, Japan	Hong Kong University of Science & Technology; Tokyo University of Agriculture & Technology; Central Research Institute of Electric Power Industry - Japan	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Kitano, Yoshikazu/C-2798-2013; Zhang, Yu/K-4912-2012; Zhang, Yifan/O-9621-2015	Kitano, Yoshikazu/0000-0001-8753-5646; Zhang, Yifan/0000-0002-0629-0200; Qian, Pei-Yuan/0000-0003-4074-9078	China Ocean Mineral Resources Research and Development Association [DY125-15-T-02]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]; Research Grants Council of the Hong Kong Special Administrative Region [N_HKUST602/09, AoE/P-04/04-II]	China Ocean Mineral Resources Research and Development Association; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council)	This study was supported by a research grant (DY125-15-T-02) from China Ocean Mineral Resources Research and Development Association, an award from King Abdullah University of Science and Technology (SA-C0040/UK-C0016) and grants from the Research Grants Council of the Hong Kong Special Administrative Region (N_HKUST602/09 and AoE/P-04/04-II) to Pei-Yuan Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzieu C, 2000, SCI TOTAL ENVIRON, V258, P99, DOI 10.1016/S0048-9697(00)00510-6; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Berg J., 2006, BIOCHEMISTRY-US, P509; Berg JM, 2006, BIOCHEMISTRY-US, P750; Callow Maureen E., 2002, Biologist (London), V49, P10; Chambers LD, 2006, SURF COAT TECH, V201, P3642, DOI 10.1016/j.surfcoat.2006.08.129; Fusetani N, 1996, J NAT TOXINS, V5, P249; Gansner JM, 2007, DEV BIOL, V307, P202, DOI 10.1016/j.ydbio.2007.04.029; Gansner JM, 2008, DEV DYNAM, V237, P3715, DOI 10.1002/dvdy.21779; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; International Maritime Organization, 2002, ANTIFOULING SYSTEMS; Kitano Y, 2001, SYNTHESIS-STUTTGART, P437; Mangos S, 2010, DIS MODEL MECH, V3, P354, DOI 10.1242/dmm.003194; Mendelsohn BA, 2006, CELL METAB, V4, P155, DOI 10.1016/j.cmet.2006.05.001; Mukai H, 1997, MICROSCOPIC ANATOMY, P69; Nogata Y, 2006, MAR MOL BIOTECHNOL, V42, P87; Rawls JF, 2001, DEV BIOL, V240, P301, DOI 10.1006/dbio.2001.0418; Sachidanandan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001947; Svavarsson J, 2000, MAR POLLUT BULL, V40, P893, DOI 10.1016/S0025-326X(00)00012-6; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; Thiyagarajan V, 2003, MAR BIOL, V143, P543, DOI 10.1007/s00227-003-1077-9; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Xu Y, 2010, BIORESOURCE TECHNOL, V101, P1331, DOI 10.1016/j.biortech.2009.09.046; Yebra DM, 2004, PROG ORG COAT, V50, P75, DOI 10.1016/j.porgcoat.2003.06.001; Yoshikawa E, 2007, RES RISK ASSESSMENT, P107; Zhang Y-F, 2012, ACS CHEM BI IN PRESS; Zhang YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023803; Zhang YF, 2011, BIOFOULING, V27, P467, DOI 10.1080/08927014.2011.583985	28	10	10	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45442	10.1371/journal.pone.0045442	http://dx.doi.org/10.1371/journal.pone.0045442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029013	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900136
J	Pesch, B; Casjens, S; Stricker, I; Westerwick, D; Taeger, D; Rabstein, S; Wiethege, T; Tannapfel, A; Bruning, T; Johnen, G				Pesch, Beate; Casjens, Swaantje; Stricker, Ingo; Westerwick, Daniela; Taeger, Dirk; Rabstein, Sylvia; Wiethege, Thorsten; Tannapfel, Andrea; Bruening, Thomas; Johnen, Georg			NOTCH1, HIF1A and Other Cancer-Related Proteins in Lung Tissue from Uranium Miners-Variation by Occupational Exposure and Subtype of Lung Cancer	PLOS ONE			English	Article							CHERNOBYL THYROID CANCERS; GENE-EXPRESSION; CELLS; RADON; GENOME; REPAIR; ADENOCARCINOMA; SIGNATURES; DISCOVERY; HISTOLOGY	Background: Radon and arsenic are established pulmonary carcinogens. We investigated the association of cumulative exposure to these carcinogens with NOTCH1, HIF1A and other cancer-specific proteins in lung tissue from uranium miners. Methodology/Principal Findings: Paraffin-embedded tissue of 147 miners was randomly selected from an autopsy repository by type of lung tissue, comprising adenocarcinoma (AdCa), squamous cell carcinoma (SqCC), small cell lung cancer (SCLC), and cancer-free tissue. Within each stratum, we additionally stratified by low or high level of exposure to radon or arsenic. Lifetime exposure to radon and arsenic was estimated using a quantitative job-exposure matrix developed for uranium mining. For 22 cancer-related proteins, immunohistochemical scores were calculated from the intensity and percentage of stained cells. We explored the associations of these scores with cumulative exposure to radon and arsenic with Spearman rank correlation coefficients (r(s)). Occupational exposure was associated with an up-regulation of NOTCH1 (radon r(s) = 0.18, 95% CI 0.02-0.33; arsenic: r(s) = 0.23, 95% CI 0.07-0.38). Moreover, we investigated whether these cancer-related proteins can classify lung cancer using supervised and unsupervised classification. MUC1 classified lung cancer from cancer-free tissue with a failure rate of 2.1%. A two-protein signature discriminated SCLC (HIF1A low), AdCa (NKX2-1 high), and SqCC (NKX2-1 low) with a failure rate of 8.4%. Conclusions/Significance: These results suggest that the radiation-sensitive protein NOTCH1 can be up-regulated in lung tissue from uranium miners by level of exposure to pulmonary carcinogens. We evaluated a three-protein signature consisting of a physiological protein (MUC1), a cancer-specific protein (HIF1A), and a lineage-specific protein (NKX2-1) that could discriminate lung cancer and its major subtypes with a low failure rate.	[Pesch, Beate; Casjens, Swaantje; Taeger, Dirk; Rabstein, Sylvia; Wiethege, Thorsten; Bruening, Thomas; Johnen, Georg] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany; [Stricker, Ingo; Westerwick, Daniela; Tannapfel, Andrea] Ruhr Univ Bochum, Inst Pathol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Pesch, B (corresponding author), Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany.	pesch@ipa-dguv.de	Johnen, Georg/AFG-8027-2022; Brüning, Thomas/G-8120-2015	Johnen, Georg/0000-0002-3773-5946; Brüning, Thomas/0000-0001-9560-5464; Taeger, Dirk/0000-0002-5340-5584; Wiethege, Thorsten/0000-0002-1035-190X	Federal Office for Radiation Protection, Neuherberg, Germany [StSch 4528]	Federal Office for Radiation Protection, Neuherberg, Germany	This study was supported by the Federal Office for Radiation Protection, Neuherberg, Germany, grant StSch 4528. The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2009, J SEP SCI, V32, P771, DOI 10.1002/jssc.200800622; Bailey KA, 2010, MOL CARCINOGEN, V49, P981, DOI 10.1002/mc.20677; Blair A, 2007, AM J IND MED, V50, P199, DOI 10.1002/ajim.20281; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Charloux A, 1997, INT J EPIDEMIOL, V26, P14, DOI 10.1093/ije/26.1.14; Cheung W, 2008, PANCREATOLOGY, V8, P608, DOI 10.1159/000161012; Dahmann D, 2008, INT ARCH OCC ENV HEA, V81, P949, DOI 10.1007/s00420-007-0287-8; Daniel VC, 2006, RESPIROLOGY, V11, P234, DOI 10.1111/j.1440-1843.2006.00838.x; Debeb BG, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-180; Detours V, 2007, BRIT J CANCER, V97, P818, DOI 10.1038/sj.bjc.6603938; Detours V, 2005, BRIT J CANCER, V92, P1545, DOI 10.1038/sj.bjc.6602521; Detours V, 2008, CURR OPIN ENDOCRINOL, V15, P440, DOI 10.1097/MED.0b013e32830eb874; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Hirsch FR, 2008, J THORAC ONCOL, V3, P1468, DOI 10.1097/JTO.0b013e318189f551; KAHN P, 1993, SCIENCE, V259, P448, DOI 10.1126/science.8424163; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kreuzer M, 2008, BRIT J CANCER, V99, P1946, DOI 10.1038/sj.bjc.6604776; Lam WK, 2007, RESPIROLOGY, V12, P471, DOI 10.1111/j.1440-1843.2007.01105.x; Landi MT, 2010, CLIN CANCER RES, V16, P430, DOI 10.1158/1078-0432.CCR-09-1736; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Linkert, 1998, BELASTUNG DURCH IONI; Liu HY, 2006, PLOS MED, V3, P1090, DOI 10.1371/journal.pmed.0030232; Liu Xiaoming, 2008, Proc Am Thorac Soc, V5, P682, DOI 10.1513/pats.200801-003AW; Luo WB, 2011, ONCOTARGET, V2, P551; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; NIOSH, 2000, STUD FEAS RES PATH T; Pesch B, 2012, INT J CANCER, V131, P1210, DOI 10.1002/ijc.27339; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rawlins Emma L, 2008, Proc Am Thorac Soc, V5, P675, DOI 10.1513/pats.200801-006AW; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Ruano-Ravina A, 2009, INT J RADIAT BIOL, V85, P614, DOI 10.1080/09553000902954504; Schroder C, 2002, INT ARCH OCC ENV HEA, V75, P235, DOI 10.1007/s00420-001-0295-z; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Taeger D, 2006, CANCER-AM CANCER SOC, V106, P881, DOI 10.1002/cncr.21677; Taeger D, 2009, INT ARCH OCC ENV HEA, V82, P867, DOI 10.1007/s00420-008-0386-1; Travis WD, 1999, HISTOLOGICAL TYPING; Tsuji H, 2003, CARCINOGENESIS, V24, P1257, DOI 10.1093/carcin/bgg071; Walsh L, 2010, RADIAT RES, V173, P79, DOI 10.1667/RR1803.1; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WESCH H, 2005, RADIOLOGISCHE ERFASS; Wiethege T, 1999, RADIAT RES, V152, pS52, DOI 10.2307/3580114; Williams OW, 2006, AM J RESP CELL MOL, V34, P527, DOI 10.1165/rcmb.2005-0436SF; Yohena T, 2009, J THORAC ONCOL, V4, P284, DOI 10.1097/JTO.0b013e31819852d5; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	51	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45305	10.1371/journal.pone.0045305	http://dx.doi.org/10.1371/journal.pone.0045305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028920	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800049
J	Romero, V; Coey, C; Schmidt, RC; Richardson, MJ				Romero, Veronica; Coey, Charles; Schmidt, R. C.; Richardson, Michael J.			Movement Coordination or Movement Interference: Visual Tracking and Spontaneous Coordination Modulate Rhythmic Movement Interference	PLOS ONE			English	Article							PHASE-TRANSITIONS; PERCEPTION; ENTRAINMENT; DYNAMICS; RECRUITMENT; PREDICTION; FREEDOM	When an actor performs a rhythmic limb movement while observing a spatially incongruent movement he or she exhibits increased movement orthogonal to the instructed motion. Known as rhythmic movement interference, this phenomenon has been interpreted as a motor contagion effect, whereby observing the incongruent movement interferes with the intended movement and results in a motor production error. Here we test the hypothesis that rhythmic movement interference is an emergent property of rhythmic coordination. Participants performed rhythmic limb movements at a self-selected tempo while observing a computer stimulus moving in a congruent or incongruent manner. The degree to which participants visually tracked the stimulus was manipulated to influence whether participants became spontaneously entrained to the stimulus or not. Consistent with the rhythmic coordination hypothesis, participants only exhibited the rhythmic movement interference effect when they became spontaneously entrained to the incongruent stimulus.	[Romero, Veronica; Coey, Charles; Richardson, Michael J.] Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA; [Romero, Veronica] Colby Coll, Dept Psychol, Waterville, ME 04901 USA; [Schmidt, R. C.] Coll Holy Cross, Dept Psychol, Worcester, MA USA	University System of Ohio; University of Cincinnati; Colby College; College of the Holy Cross	Romero, V (corresponding author), Univ Cincinnati, Dept Psychol, Ctr Cognit Act & Percept, Cincinnati, OH 45221 USA.	romerovc@mail.uc.edu	Romero, Veronica/ABI-1513-2020	Richardson, Michael/0000-0001-9159-2774; Romero, Veronica/0000-0003-4086-6303	National Science Foundation [BCS-0750190, BCS-0750187]	National Science Foundation(National Science Foundation (NSF))	Research supported by the National Science Foundation BCS-0750190 and BCS-0750187. http://www.nsf.gov/ (Behavioral and Cognitive Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAZEEN PG, 1995, BIOL CYBERN, V72, P511, DOI 10.1007/BF00199893; Blakemore SJ, 2005, NEUROPSYCHOLOGIA, V43, P260, DOI 10.1016/j.neuropsychologia.2004.11.012; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Buchanan JJ, 1997, HUM MOVEMENT SCI, V16, P1, DOI 10.1016/S0167-9457(96)00040-1; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Coey C. A., 2011, P 33 ANN C COGN SCI, P172; Coey CA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00164; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Duarte M, 2002, EXP BRAIN RES, V146, P60, DOI 10.1007/s00221-002-1154-1; Fink PW, 2000, J EXP PSYCHOL HUMAN, V26, P671, DOI 10.1037//0096-1523.26.2.671; Hajnal A, 2009, EXP BRAIN RES, V199, P89, DOI 10.1007/s00221-009-1958-3; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Haken H., 1977, SYNERGETICS NONEQUIL; Iacoboni M., 2005, PERSPECTIVES IMITATI, P77; Jansson E, 2007, EXP BRAIN RES, V182, P549, DOI 10.1007/s00221-007-1013-1; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kelso J, 1984, AM J PHYSIOL-REG I, V15, pR1000, DOI DOI 10.1152/ajpregu.1984.246.6.R1000; KELSO JAS, 1981, B PSYCHONOMIC SOC, V18, P63; Kelso S., 1995, DYNAMIC PATTERNS SEL; Keppel J., 1997, DATA ANAL RES DESIGN; Kilner J, 2007, SOC NEUROSCI-UK, V2, P158, DOI 10.1080/17470910701428190; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Knoblich G, 2006, CURR DIR PSYCHOL SCI, V15, P99, DOI 10.1111/j.0963-7214.2006.00415.x; Kugler P.N., 1980, ADV PSYCHOL, P3, DOI [10.1016/S0166-4115, DOI 10.1016/S0166-4115, 10.1016/S0166-4115(08)61936]; Kugler PN, 1987, INFORM NATURAL LAW S; Lopresti-Goodman SM, 2008, J MOTOR BEHAV, V40, P3, DOI 10.3200/JMBR.40.1.3-10; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Richardson MJ, 2009, NEUROSCI LETT, V449, P117, DOI 10.1016/j.neulet.2008.10.092; Riley MA, 2001, HUM MOVEMENT SCI, V20, P343, DOI 10.1016/S0167-9457(01)00051-3; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Schmidt RC, 2007, J EXP PSYCHOL HUMAN, V33, P860, DOI 10.1037/0096-1523.33.4.860; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Schuch S, 2010, EXP BRAIN RES, V205, P235, DOI 10.1007/s00221-010-2358-4; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Stanley J, 2007, J EXP PSYCHOL HUMAN, V33, P915, DOI 10.1037/0096-1523.33.4.915; Tipper SP, 2006, PSYCHON B REV, V13, P493, DOI 10.3758/BF03193875; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; Varlet M, 2012, HUM MOVEMENT SCI, V31, P541, DOI 10.1016/j.humov.2011.08.002; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; WIMMERS RH, 1992, HUM MOVEMENT SCI, V11, P217, DOI 10.1016/0167-9457(92)90062-G	47	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44761	10.1371/journal.pone.0044761	http://dx.doi.org/10.1371/journal.pone.0044761			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019MC	23028607	Green Submitted, gold, Green Published			2022-12-27	WOS:000309742800017
J	Guo, JJ; Morrell-Falvey, JL; Labbe, JL; Muchero, W; Kalluri, UC; Tuskan, GA; Chen, JG				Guo, Jianjun; Morrell-Falvey, Jennifer L.; Labbe, Jessy L.; Muchero, Wellington; Kalluri, Udaya C.; Tuskan, Gerald A.; Chen, Jin-Gui			Highly Efficient Isolation of Populus Mesophyll Protoplasts and Its Application in Transient Expression Assays	PLOS ONE			English	Article							GENE-EXPRESSION; POPLAR POPULUS; ARABIDOPSIS; TRANSFORMATION; GIBBERELLIN; COTTONWOOD; REGULATOR; BIOFUELS; ETHYLENE; PROTOCOL	Background: Populus is a model woody plant and a promising feedstock for lignocellulosic biofuel production. However, its lengthy life cycle impedes rapid characterization of gene function. Methodology/Principal Findings: We optimized a Populus leaf mesophyll protoplast isolation protocol and established a Populus protoplast transient expression system. We demonstrated that Populus protoplasts are able to respond to hormonal stimuli and that a series of organelle markers are correctly localized in the Populus protoplasts. Furthermore, we showed that the Populus protoplast transient expression system is suitable for studying protein-protein interaction, gene activation, and cellular signaling events. Conclusions/Significance: This study established a method for efficient isolation of protoplasts from Populus leaf and demonstrated the efficacy of using Populus protoplast transient expression assays as an in vivo system to characterize genes and pathways.	[Guo, Jianjun; Morrell-Falvey, Jennifer L.; Labbe, Jessy L.; Muchero, Wellington; Kalluri, Udaya C.; Tuskan, Gerald A.; Chen, Jin-Gui] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Guo, JJ (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	chenj@ornl.gov	Chen, Jin-Gui/A-4773-2011; Chen, Jin-Gui/AFV-6337-2022; Labbe, Jessy/G-9532-2011; Tuskan, Gerald/A-6225-2011; guo, jianjun/G-6852-2013; Morrell-Falvey, Jennifer L/A-6615-2011	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Labbe, Jessy/0000-0003-0368-2054; Tuskan, Gerald/0000-0003-0106-1289; Morrell-Falvey, Jennifer L/0000-0002-9362-7528; KALLURI, UDAYA/0000-0002-5963-8370; muchero, wellington/0000-0002-0200-9856	Plant-Microbe Interfaces Scientific Focus Area in the Genomic Science Program, United States Department of Energy, Office of Science, Biological and Environmental Research; UT-Battelle, LLC, for the United States Department of Energy [DE-AC05-00OR22725]; Natural Sciences and Engineering Research Council of Canada	Plant-Microbe Interfaces Scientific Focus Area in the Genomic Science Program, United States Department of Energy, Office of Science, Biological and Environmental Research(United States Department of Energy (DOE)); UT-Battelle, LLC, for the United States Department of Energy(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Plant-Microbe Interfaces Scientific Focus Area in the Genomic Science Program, United States Department of Energy, Office of Science, Biological and Environmental Research. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the United States Department of Energy under contract DE-AC05-00OR22725. JG was supported by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bjorklund S, 2007, PLANT J, V52, P499, DOI 10.1111/j.1365-313X.2007.03250.x; Bradshaw HD, 2000, J PLANT GROWTH REGUL, V19, P306, DOI 10.1007/s003440000030; Busov VB, 2010, PLANT GENET GENOMICS, V8, P113, DOI 10.1007/978-1-4419-1541-2_6; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Dinus RJ, 2001, APPL BIOCHEM BIOTECH, V91-3, P23, DOI 10.1385/ABAB:91-93:1-9:23; Faraco M, 2011, PLANT PHYSIOL, V156, P474, DOI 10.1104/pp.111.173708; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fukuda H, 1997, PLANT CELL, V9, P1147, DOI 10.1105/tpc.9.7.1147; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo JJ, 2011, PLANT PHYSIOL, V155, P370, DOI 10.1104/pp.110.160663; Han KH, 2000, PLANT CELL REP, V19, P315, DOI 10.1007/s002990050019; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Kang BG, 2009, PLANT CELL TISS ORG, V99, P251, DOI 10.1007/s11240-009-9596-9; Love J, 2009, P NATL ACAD SCI USA, V106, P5984, DOI 10.1073/pnas.0811660106; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nieminen K, 2008, P NATL ACAD SCI USA, V105, P20032, DOI 10.1073/pnas.0805617106; NORRIS SR, 1993, PLANT MOL BIOL, V21, P895, DOI 10.1007/BF00027120; Ohashi-Ito K, 2010, CURR OPIN PLANT BIOL, V13, P670, DOI 10.1016/j.pbi.2010.08.011; PALLARDY SG, 1980, NEW PHYTOL, V85, P363, DOI 10.1111/j.1469-8137.1980.tb03174.x; Qiao J, 1997, BIOSCI BIOTECH BIOCH, V61, P1580, DOI 10.1271/bbb.61.1580; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ramirez-Carvajal GA, 2008, NEW PHYTOL, V177, P77, DOI 10.1111/j.1469-8137.2007.02240.x; Rozen S, 2000, Methods Mol Biol, V132, P365; RUSSELL JA, 1986, PLANT CELL REP, V5, P284, DOI 10.1007/BF00269823; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Somerville C, 2006, SCIENCE, V312, P1277, DOI 10.1126/science.1130034; Song JY, 2006, PLANT CELL PHYSIOL, V47, P1582, DOI 10.1093/pcp/pcl018; Tang RJ, 2010, PLANT MOL BIOL, V74, P367, DOI 10.1007/s11103-010-9680-x; Tiwari Shiv, 2006, V323, P237; Turner S, 2007, ANNU REV PLANT BIOL, V58, P407, DOI 10.1146/annurev.arplant.57.032905.105236; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tzfira T, 1997, PLANT MOL BIOL REP, V15, P219, DOI 10.1023/A:1007484917759; Uggla C, 1998, PLANT PHYSIOL, V117, P113, DOI 10.1104/pp.117.1.113; Wang SY, 2005, ANN OPER RES, V135, P17, DOI 10.1007/s10479-005-6231-y; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan JS, 2008, TRENDS PLANT SCI, V13, P421, DOI 10.1016/j.tplants.2008.06.001; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2011, PLANT PHYSIOL, V157, P1452, DOI 10.1104/pp.111.181354; Zhong RQ, 2010, PLANT SIGNAL BEHAV, V5, P469, DOI 10.4161/psb.5.4.11400	44	51	61	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44908	10.1371/journal.pone.0044908	http://dx.doi.org/10.1371/journal.pone.0044908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028673	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700053
J	Zhao, Y; Chen, F; Zhai, RH; Lin, XH; Diao, N; Christiani, DC				Zhao, Yang; Chen, Feng; Zhai, Rihong; Lin, Xihong; Diao, Nancy; Christiani, David C.			Association Test Based on SNP Set: Logistic Kernel Machine Based Test vs. Prinicpal Component Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; SUSCEPTIBILITY LOCUS; PRINCIPAL-COMPONENTS; STRATIFICATION; PATHWAY; DISEASE; GENE	GWAS has facilitated greatly the discovery of risk SNPs associated with complex diseases. Traditional methods analyze SNP individually and are limited by low power and reproducibility since correction for multiple comparisons is necessary. Several methods have been proposed based on grouping SNPs into SNP sets using biological knowledge and/or genomic features. In this article, we compare the linear kernel machine based test (LKM) and principal components analysis based approach (PCA) using simulated datasets under the scenarios of 0 to 3 causal SNPs, as well as simple and complex linkage disequilibrium (LD) structures of the simulated regions. Our simulation study demonstrates that both LKM and PCA can control the type I error at the significance level of 0.05. If the causal SNP is in strong LD with the genotyped SNPs, both the PCA with a small number of principal components (PCs) and the LKM with kernel of linear or identical-by-state function are valid tests. However, if the LD structure is complex, such as several LD blocks in the SNP set, or when the causal SNP is not in the LD block in which most of the genotyped SNPs reside, more PCs should be included to capture the information of the causal SNP. Simulation studies also demonstrate the ability of LKM and PCA to combine information from multiple causal SNPs and to provide increased power over individual SNP analysis. We also apply LKM and PCA to analyze two SNP sets extracted from an actual GWAS dataset on non-small cell lung cancer.	[Zhao, Yang; Zhai, Rihong; Diao, Nancy; Christiani, David C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Zhao, Yang; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Nanjing Medical University; Harvard University; Harvard T.H. Chan School of Public Health	Zhao, Y (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	dchris@hsph.harvard.edu	zhao, yang/GXF-4424-2022		National Cancer Institute [CA092824]; National Institute of Health [ES00002, HL060710]; National Scientific Funding of China [NSFC30901232, NSFC81072389]; NATIONAL CANCER INSTITUTE [R01CA092824] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Scientific Funding of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Cancer Institute (CA092824 to DCC), National Institute of Health (ES00002 to DCC and HL060710 to DCC), and National Scientific Funding of China (NSFC30901232 to YZ and NSFC81072389 to FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Asomaning K, 2008, LUNG CANCER, V61, P13, DOI 10.1016/j.lungcan.2007.11.013; Chen X, 2010, GENET EPIDEMIOL, V34, P716, DOI 10.1002/gepi.20532; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Li CM, 1999, GENOMICS, V62, P223, DOI 10.1006/geno.1999.5940; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Liu PY, 2010, CANCER EPIDEM BIOMAR, V19, P517, DOI 10.1158/1055-9965.EPI-09-0791; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2008, HUM MOL GENET, V17, pR100, DOI 10.1093/hmg/ddn298; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Saad AF, 2007, CANCER BIOL THER, V6, P1455; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Zienolddiny S, 2009, CARCINOGENESIS, V30, P1368, DOI 10.1093/carcin/bgp131	22	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44978	10.1371/journal.pone.0044978	http://dx.doi.org/10.1371/journal.pone.0044978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028716	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700066
J	Ding, YB; Long, CL; Liu, XQ; Chen, XM; Guo, LR; Xia, YY; He, JL; Wang, YX				Ding, Yu-Bin; Long, Chun-Lan; Liu, Xue-Qing; Chen, Xue-Mei; Guo, Liang-Rui; Xia, Yin-Yin; He, Jun-Lin; Wang, Ying-Xiong			5-Aza-2 '-deoxycytidine Leads to Reduced Embryo Implantation and Reduced Expression of DNA Methyltransferases and Essential Endometrial Genes	PLOS ONE			English	Article							ESTROGEN-RECEPTOR GENE; CANCER-CELL-LINES; PROMOTER HYPERMETHYLATION; AGENT 5-AZA-2'-DEOXYCYTIDINE; UTERINE RECEPTIVITY; DOWN-REGULATION; ER-ALPHA; PR-B; METHYLATION; PROGESTERONE	Background: The DNA demethylating agent 5-aza-2'-deoxycytidine (5-aza-CdR) incorporates into DNA and decreases DNA methylation, sparking interest in its use as a potential therapeutic agent. We aimed to determine the effects of maternal 5-aza-CdR treatment on embryo implantation in the mouse and to evaluate whether these effects are associated with decreased levels of DNA methyltransferases (Dnmts) and three genes (estrogen receptor alpha [Esr1], progesterone receptor [Pgr], and homeobox A10 [Hoxa10]) that are vital for control of endometrial changes during implantation. Methods and Principal Findings: Mice treated with 5-aza-CdR had a dose-dependent decrease in number of implantation sites, with defected endometrial decidualization and stromal cell proliferation. Western blot analysis on pseudo-pregnant day 3 (PD3) showed that 0.1 mg/kg 5-aza-CdR significantly repressed Dnmt3a protein level, and 0.5 mg/kg 5-aza-CdR significantly repressed Dnmt1, Dnmt3a, and Dnmt3b protein levels in the endometrium. On PD5, mice showed significantly decreased Dnmt3a protein level with 0.1 mg/kg 5-aza-CdR, and significantly decreased Dnmt1 and Dnmt3a with 0.5 mg/kg 5-aza-CdR. Immunohistochemical staining showed that 5-aza-CdR repressed DNMT expression in a cell type-specific fashion within the uterus, including decreased expression of Dnmt1 in luminal and/or glandular epithelium and of Dnmt3a and Dnmt3b in stroma. Furthermore, the 5' flanking regions of the Esr1, Pgr, and Hoxa10 were hypomethylated on PD5. Interestingly, the higher (0.5 mg/kg) dose of 5-aza-CdR decreased protein expression of Esr1, Pgr, and Hoxa10 in the endometrium on PD5 in both methylation-dependent and methylation-independent manners. Conclusions: The effects of 5-aza-CdR on embryo implantation in mice were associated with altered expression of endometrial Dnmts and genes controlling endometrial changes, suggesting that altered gene methylation, and not cytotoxicity alone, contributes to implantation defects induced by 5-aza-CdR.	[Ding, Yu-Bin; Long, Chun-Lan; Liu, Xue-Qing; Chen, Xue-Mei; Guo, Liang-Rui; Xia, Yin-Yin; He, Jun-Lin; Wang, Ying-Xiong] Chongqing Med Univ, Dept Reprod Biol, Chongqing, Peoples R China	Chongqing Medical University	He, JL (corresponding author), Chongqing Med Univ, Dept Reprod Biol, Chongqing, Peoples R China.	hejunlin_11@yahoo.com.cn; wyx61221@yahoo.com.cn		Ding, Yubin/0000-0002-7870-9445	National Natural Science foundation of China [30700898]; Natural Science Foundation Project of CQ CSTC [2009BA5082, 2009BB5271, 2011jjA10085]; Excellent Doctoral Dissertation of Chongqing Medical University	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Excellent Doctoral Dissertation of Chongqing Medical University	This work was supported by the National Natural Science foundation of China (number 30700898), the Natural Science Foundation Project of CQ CSTC (numbers 2009BA5082, 2009BB5271, and 2011jjA10085), and Excellent Doctoral Dissertation of Chongqing Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2000, LEUKEMIA, V14, P1915, DOI 10.1038/sj.leu.2401914; Arai M, 2006, CANCER-AM CANCER SOC, V106, P2514, DOI 10.1002/cncr.21905; Benbrahim-Tallaa L, 2007, ENVIRON HEALTH PERSP, V115, P1454, DOI 10.1289/ehp.10207; Benson GV, 1996, DEVELOPMENT, V122, P2687; Branch S, 1996, TOXICOLOGY, V112, P37, DOI 10.1016/0300-483X(96)88183-2; Bromer JG, 2009, ENDOCRINOLOGY, V150, P3376, DOI 10.1210/en.2009-0071; Chai GL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002445; Cheng WJ, 2010, J CANCER RES CLIN, V136, P1221, DOI 10.1007/s00432-010-0772-4; Cisneros FJ, 2003, J APPL TOXICOL, V23, P115, DOI 10.1002/jat.898; Deng T, 2009, BIOMED PHARMACOTHER, V63, P492, DOI 10.1016/j.biopha.2008.08.013; Ding L, 2009, BIOL PHARM BULL, V32, P1105, DOI 10.1248/bpb.32.1105; Ding YB, 2012, REPRODUCTIO IN PRESS; Ferguson AT, 1997, J BIOL CHEM, V272, P32260, DOI 10.1074/jbc.272.51.32260; FINN CA, 1972, BIOL REPROD, V7, P82, DOI 10.1093/biolreprod/7.1.82; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; GRAHAM FL, 1970, CANCER RES, V30, P2636; Hill VK, 2011, CANCER RES, V71, P2988, DOI 10.1158/0008-5472.CAN-10-4026; Iwase H, 1999, BRIT J CANCER, V80, P1982, DOI 10.1038/sj.bjc.6690631; Jung Y, 2007, J MOL MED, V85, P1137, DOI 10.1007/s00109-007-0216-z; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Lessey BA, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-S1-S9; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Logan PC, 2010, HUM REPROD, V25, P2859, DOI 10.1093/humrep/deq238; Lu YA, 2010, FERTIL STERIL, V94, P1583, DOI 10.1016/j.fertnstert.2009.09.011; Mirza S, 2007, LIFE SCI, V81, P280, DOI 10.1016/j.lfs.2007.05.012; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Oka M, 2005, ONCOGENE, V24, P3091, DOI 10.1038/sj.onc.1208540; Pryzbylkowski P, 2008, BREAST CANCER RES TR, V111, P15, DOI 10.1007/s10549-007-9751-0; Qiu YY, 2002, CANCER DETECT PREV, V26, P444, DOI 10.1016/S0361-090X(02)00116-2; Rahnama F, 2009, ENDOCRINOLOGY, V150, P1466, DOI 10.1210/en.2008-1142; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Rosen MB, 2002, TERATOLOGY, V65, P180, DOI 10.1002/tera.10029; Sampath D, 2003, ONCOGENE, V22, P9063, DOI 10.1038/sj.onc.1207229; SCHMAHL W, 1984, ARCH TOXICOL, V55, P143, DOI 10.1007/BF00346054; Schmelz K, 2005, LEUKEMIA, V19, P103, DOI 10.1038/sj.leu.2403552; Shen RL, 2009, INT J CLIN EXP PATHO, V2, P21; Sun XF, 2012, P NATL ACAD SCI USA, V109, P1145, DOI 10.1073/pnas.1118411109; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Trundley AE, 2006, IMMUNOGENETICS, V57, P904, DOI 10.1007/s00251-005-0060-7; Vincent ZL, 2011, FERTIL STERIL, V95, P1522, DOI 10.1016/j.fertnstert.2010.09.030; Walton TJ, 2008, PROSTATE, V68, P210, DOI 10.1002/pros.20673; Wiley A, 2006, CANCER-AM CANCER SOC, V107, P299, DOI 10.1002/cncr.21992; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wu Y, 2005, AM J OBSTET GYNECOL, V193, P371, DOI 10.1016/j.ajog.2005.01.034; Wu Y, 2008, FERTIL STERIL, V90, P234, DOI 10.1016/j.fertnstert.2007.06.008; Wu Y, 2006, EPIGENETICS-US, V1, P106, DOI 10.4161/epi.1.2.2766; Xie R, 2007, MODERN PATHOL, V20, P1045, DOI 10.1038/modpathol.3800940; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Yamagata Y, 2009, HUM REPROD, V24, P1126, DOI 10.1093/humrep/dep015; Yap OWS, 2009, ANTICANCER RES, V29, P139; Yu JN, 2009, ZYGOTE, V17, P137, DOI 10.1017/S0967199408005169; Zhu LJ, 1998, ENDOCRINOLOGY, V139, P3923, DOI 10.1210/en.139.9.3923	55	40	46	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45364	10.1371/journal.pone.0045364	http://dx.doi.org/10.1371/journal.pone.0045364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028963	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900039
J	Kouvaris, NE; Kori, H; Mikhailov, AS				Kouvaris, Nikos E.; Kori, Hiroshi; Mikhailov, Alexander S.			Traveling and Pinned Fronts in Bistable Reaction-Diffusion Systems on Networks	PLOS ONE			English	Article							PATTERN; MODELS; WAVES	Traveling fronts and stationary localized patterns in bistable reaction-diffusion systems have been broadly studied for classical continuous media and regular lattices. Analogs of such non-equilibrium patterns are also possible in networks. Here, we consider traveling and stationary patterns in bistable one-component systems on random Erdos-Renyi, scale-free and hierarchical tree networks. As revealed through numerical simulations, traveling fronts exist in network-organized systems. They represent waves of transition from one stable state into another, spreading over the entire network. The fronts can furthermore be pinned, thus forming stationary structures. While pinning of fronts has previously been considered for chains of diffusively coupled bistable elements, the network architecture brings about significant differences. An important role is played by the degree (the number of connections) of a node. For regular trees with a fixed branching factor, the pinning conditions are analytically determined. For large Erdos-Renyi and scale-free networks, the mean-field theory for stationary patterns is constructed.	[Kouvaris, Nikos E.; Mikhailov, Alexander S.] Max Planck Gesell, Fritz Haber Inst, Dept Phys Chem, Berlin, Germany; [Kori, Hiroshi] Ochanomizu Univ, Dept Informat Sci, Tokyo 112, Japan	Max Planck Society; Fritz Haber Institute of the Max Planck Society; Ochanomizu University	Kouvaris, NE (corresponding author), Max Planck Gesell, Fritz Haber Inst, Dept Phys Chem, Berlin, Germany.	nkoub@fhi-berlin.mpg.de	Kouvaris, Nikos/B-5641-2013; Kouvaris, Nikos/I-3564-2015; Kori, Hiroshi/AAD-3700-2019	Kouvaris, Nikos/0000-0002-1975-2443; 	German Research Foundation Collaborative Research Center [SFB910]; Volkswagen Foundation in Germany	German Research Foundation Collaborative Research Center(German Research Foundation (DFG)); Volkswagen Foundation in Germany	Financial support from the German Research Foundation Collaborative Research Center SFB910 "Control of Self-Organizing Nonlinear Systems" (http://www.itp.tu-berlin.de/sfb910) and from the Volkswagen Foundation in Germany (http://www.volkswagenstiftung.de) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bignone FA, 2001, J BIOL PHYS, V27, P257, DOI 10.1023/A:1013178514397; BOOTH V, 1992, PHYSICA A, V188, P206, DOI 10.1016/0378-4371(92)90267-T; BOOTH V, 1994, J PHYS CHEM-US, V98, P6537, DOI 10.1021/j100077a019; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Cosenza MG, 1992, CHAOS, V2, P329, DOI 10.1063/1.165875; Desai R. C., 2009, DYNAMICS SELF ORG SE; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; ERNEUX T, 1993, PHYSICA D, V67, P237, DOI 10.1016/0167-2789(93)90208-I; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Holland MD, 2008, NATURE, V456, P792, DOI 10.1038/nature07395; Kapral R., 1995, CHEM WAVES PATTERNS; Karlsson A, 2001, NATURE, V409, P150, DOI 10.1038/35051656; Kori H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.254101; Kori H, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066115; Mikhailov A. S., 1994, FDN SYNERGETICS, VI; Mitkov I, 1998, PHYS REV LETT, V81, P5453, DOI 10.1103/PhysRevLett.81.5453; Nakao H, 2010, NAT PHYS, V6, P544, DOI 10.1038/NPHYS1651; Nakao H, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036214; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; PRIGOGIN.I, 1968, J CHEM PHYS, V48, P1695, DOI 10.1063/1.1668896; SCHLOGL F, 1972, Z PHYS, V253, P147, DOI 10.1007/BF01379769; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	27	37	37	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45029	10.1371/journal.pone.0045029	http://dx.doi.org/10.1371/journal.pone.0045029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028746	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900023
J	Felkl, M; Tomas, K; Smid, M; Mattes, J; Windoffer, R; Leube, RE				Felkl, Marco; Tomas, Kazmar; Smid, Matej; Mattes, Julian; Windoffer, Reinhard; Leube, Rudolf E.			Monitoring the Cytoskeletal EGF Response in Live Gastric Carcinoma Cells	PLOS ONE			English	Article							FOCAL ADHESION KINASE; CETUXIMAB SENSITIVITY; GROWTH; PHOSPHORYLATION; DYNAMICS; ACTIN; PAXILLIN; FAK; ACTIVATION; RECEPTOR	Altered cell motility is considered to be a key factor in determining tumor invasion and metastasis. Epidermal growth factor (EGF) signaling has been implicated in this process by affecting cytoskeletal organization and dynamics in multiple ways. To sort the temporal and spatial regulation of EGF-dependent cytoskeletal re-organization in relation to a cell's motile behavior time-lapse microscopy was performed on EGF-responsive gastric carcinoma-derived MKN1 cells co-expressing different fluorescently labeled cytoskeletal filaments and focal adhesion components in various combinations. The experiments showed that EGF almost instantaneously induces a considerable increase in membrane ruffling and lamellipodial activity that can be inhibited by Cetuximab EGF receptor antibodies and is not elicited in non-responsive gastric carcinoma Hs746T cells. The transient cell extensions are rich in actin but lack microtubules and keratin intermediate filaments. We show that this EGF-induced increase in membrane motility can be measured by a simple image processing routine. Microtubule plusends subsequently invade growing cell extensions, which start to accumulate focal complexes at the lamellipodium-lamellum junction. Such paxillin-positive complexes mature into focal adhesions by tyrosine phosphorylation and recruitment of zyxin. These adhesions then serve as nucleation sites for keratin filaments which are used to enlarge the neighboring peripheral keratin network. Focal adhesions are either disassembled or give rise to stable zyxin-rich fibrillar adhesions which disassemble in the presence of EGF to support formation of new focal adhesion sites in the cell periphery. Taken together the results serve as a basis for modeling the early cytoskeletal EGF response as a tightly coordinated and step-wise process which is relevant for the prediction of the effectiveness of anti-EGF receptor-based tumor therapy.	[Felkl, Marco; Windoffer, Reinhard; Leube, Rudolf E.] Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Aachen, Germany; [Tomas, Kazmar; Smid, Matej; Mattes, Julian] Software Competence Ctr Hagenberg GmbH, Hagenberg, Austria	RWTH Aachen University; Softwarepark Hagenberg	Leube, RE (corresponding author), Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Aachen, Germany.	rleube@ukaachen.de		Leube, Rudolf/0000-0002-5519-7379; Windoffer, Reinhard/0000-0003-1403-5880; Smid, Matej/0000-0002-5460-418X	German Federal Ministry of Education and Research; Austrian Federal Ministry for Science and Research in frame of the programme "Medizinische Systembiologie - MedSys'' (CANCERMOTISYS project); German Research Council [WI 1731 6-1, WI 1731 8-1, LE 566 18-1]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Austrian Federal Ministry for Science and Research in frame of the programme "Medizinische Systembiologie - MedSys'' (CANCERMOTISYS project); German Research Council(German Research Foundation (DFG))	The work was supported by grants from the German Federal Ministry of Education and Research, the Austrian Federal Ministry for Science and Research in frame of the programme "Medizinische Systembiologie - MedSys'' (CANCERMOTISYS project, www.cancermotisys.eu), and the German Research Council (WI 1731 6-1, WI 1731 8-1, LE 566 18-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Arteaga CL, 2003, J CLIN ONCOL, V21, p289S, DOI 10.1200/JCO.2003.10.523; Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794; BARIBAULT H, 1989, J CELL BIOL, V109, P1665, DOI 10.1083/jcb.109.4.1665; Bhatt A, 2002, J CELL SCI, V115, P3415; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; BRUNK U, 1976, EXP CELL RES, V103, P295, DOI 10.1016/0014-4827(76)90266-4; Capdevila J, 2009, CANCER TREAT REV, V35, P354, DOI 10.1016/j.ctrv.2009.02.001; Chen TH, 2011, ONCOGENE, V30, P153, DOI 10.1038/onc.2010.398; Chung BM, 2012, J BIOL CHEM; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Efimov A, 2009, CELL ADHES MIGR, V3, P285, DOI 10.4161/cam.3.3.8858; Franco C, 2010, MATH MODEL NAT PHENO, V5, P56, DOI 10.1051/mmnp/20105103; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Gerlich D, 2003, METHODS, V29, P3, DOI 10.1016/S1046-2023(02)00287-6; Heindl S, 2012, J CANCER RES CLIN, V138, P843, DOI 10.1007/s00432-011-1128-4; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Kassis J, 2001, SEMIN CANCER BIOL, V11, P105, DOI 10.1006/scbi.2000.0362; KESKIOJA J, 1981, J CELL BIOL, V90, P537, DOI 10.1083/jcb.90.2.537; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Kneissl J, 2012, INT J ONCOL, V41, P733, DOI 10.3892/ijo.2012.1479; Kodama A, 2004, J CELL BIOL, V167, P203, DOI 10.1083/jcb.200408047; Kolsch A, 2009, CELL MOTIL CYTOSKEL, V66, P976, DOI 10.1002/cm.20395; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; Lai IR, 2010, AM J PATHOL, V177, P1629, DOI 10.2353/ajpath.2010.100172; Lanyi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023653; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Mielke C, 2000, GENE, V254, P1, DOI 10.1016/S0378-1119(00)00294-8; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Pan XO, 2011, J BIOL CHEM, V286, P42403, DOI 10.1074/jbc.M111.302042; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Strnad P, 2002, J CELL SCI, V115, P4133, DOI 10.1242/jcs.00096; TAKEKURA N, 1991, INT J CANCER, V47, P938, DOI 10.1002/ijc.2910470626; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Vallotton P, 2009, J CELL SCI, V122, P1955, DOI 10.1242/jcs.042036; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wells A, 2002, ACTA ONCOL, V41, P124, DOI 10.1080/028418602753669481; Windoffer R, 2006, J CELL BIOL, V173, P341, DOI 10.1083/jcb.200511124; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x	54	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45280	10.1371/journal.pone.0045280	http://dx.doi.org/10.1371/journal.pone.0045280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028903	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517500024
J	Zhang, GH; Li, G				Zhang, Guohong; Li, Gang			Novel Multiple Markers to Distinguish Melanoma from Dysplastic Nevi	PLOS ONE			English	Article							HUMAN CUTANEOUS MELANOMAS; PROGNOSTIC-SIGNIFICANCE; MELANOCYTIC LESIONS; MALIGNANT-MELANOMA; CUL1 EXPRESSION; CELL-MIGRATION; BENIGN NEVI; DIAGNOSIS; ANGIOGENESIS; SUPPRESSOR	Background: Distinguishing melanoma from dysplastic nevi can be challenging. Objective: To assess which putative molecular biomarkers can be optimally combined to aid in the clinical diagnosis of melanoma from dysplastic nevi. Methods: Immunohistochemical expressions of 12 promising biomarkers (pAkt, Bim, BRG1, BRMS1, CTHRC1, Cul1, ING4, MCL1, NQO1, SKP2, SNF5 and SOX4) were studied in 122 melanomas and 33 dysplastic nevi on tissue microarrays. The expression difference between melanoma and dysplastic nevi was performed by univariate and multiple logistic regression analysis, diagnostic accuracy of single marker and optimal combinations were performed by receiver operating characteristic (ROC) curve and artificial neural network (ANN) analysis. Classification and regression tree (CART) was used to examine markers simultaneous optimizing the accuracy of melanoma. Ten-fold cross-validation was analyzed for estimating generalization error for classification. Results: Four (Bim, BRG1, Cul1 and ING4) of 12 markers were significantly differentially expressed in melanoma compared with dysplastic nevi by both univariate and multiple logistic regression analysis (p < 0.01). These four combined markers achieved 94.3% sensitivity, 81.8% specificity and attained 84.3% area under the ROC curve (AUC) and the ANN classified accuracy with training of 83.2% and testing of 81.2% for distinguishing melanoma from dysplastic nevi. The classification trees identified ING4, Cul1 and BRG1 were the most important classification parameters in ranking top-performing biomarkers with cross-validation error of 0.03. Conclusions: The multiple biomarkers ING4, Cul1, BRG1 and Bim described here can aid in the discrimination of melanoma from dysplastic nevi and provide a new insight to help clinicians recognize melanoma.	[Zhang, Guohong; Li, Gang] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Dept Dermatol & Skin Sci, Jack Bell Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Zhang, Guohong] Shantou Univ, Coll Med, Dept Pathol, Shantou, Guangdong, Peoples R China	University of British Columbia; Vancouver Coastal Health Research Institute; Shantou University	Li, G (corresponding author), Univ British Columbia, Vancouver Coastal Hlth Res Inst, Dept Dermatol & Skin Sci, Jack Bell Res Ctr, Vancouver, BC V5Z 1M9, Canada.	gangli@mail.ubc.ca			Canadian Institutes of Health Research [MOP-93810, MOP-110974]; Canadian Dermatology Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Dermatology Foundation	This work was funded by the Canadian Institutes of Health Research (MOP-93810 and MOP-110974) and Canadian Dermatology Foundation to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Breiman L., 1984, CLASSIFICATION REGRE; Cai LM, 2009, MELANOMA RES, V19, P1, DOI 10.1097/CMR.0b013e32831bc42f; Caron J, 2009, J CANCER RES CLIN, V135, P1257, DOI 10.1007/s00432-009-0567-7; Chen GD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017578; Chen GD, 2010, INT J ONCOL, V37, P1339, DOI 10.3892/ijo_00000786; Chen GD, 2010, PIGM CELL MELANOMA R, V23, P572, DOI 10.1111/j.1755-148X.2010.00725.x; Cheng YB, 2010, ONCOL REP, V23, P973, DOI 10.3892/or_00000722; Coles AH, 2010, P NATL ACAD SCI USA, V107, P11423, DOI 10.1073/pnas.0912116107; Dai DL, 2008, J INVEST DERMATOL, V128, P403, DOI 10.1038/sj.jid.5700989; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Duffy K, 2012, J AM ACAD DERMATOL, V67, p19e11; Harris K, 2011, ARCH DERMATOL; Hong WD, 2011, DIGEST DIS SCI, V56, P3664, DOI 10.1007/s10620-011-1849-x; Hsu DF, 2005, INFORM RETRIEVAL, V8, P449, DOI 10.1007/s10791-005-6994-4; Jafarnejad SM, 2010, AM J PATHOL, V177, P2741, DOI 10.2353/ajpath.2010.100377; Jakobiec FA, 2010, ARCH OPHTHALMOL-CHIC, V128, P174, DOI 10.1001/archophthalmol.2009.394; Kashani-Sabet M, 2009, P NATL ACAD SCI USA, V106, P6268, DOI 10.1073/pnas.0901185106; Li J, 2011, ONCOGENE, V30, P896, DOI 10.1038/onc.2010.470; Li J, 2008, CARCINOGENESIS, V29, P1373, DOI 10.1093/carcin/bgn086; Li J, 2010, CANCER RES, V70, P10445, DOI 10.1158/0008-5472.CAN-10-3040; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Lin H, 2009, CLIN CANCER RES, V15, P6404, DOI 10.1158/1078-0432.CCR-09-1135; Mathema VB, 2012, TUMOR BIOL, V33, P1, DOI 10.1007/s13277-011-0249-3; Matteucci P, 2011, J PLAST RECONSTR AES, V64, P1460, DOI 10.1016/j.bjps.2011.06.017; MCDONNELL JM, 1991, OPHTHALMOLOGY, V98, P453; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Orchard GE, 2000, HISTOCHEM J, V32, P475, DOI 10.1023/A:1004192232357; Patel JL, 2007, CURR CLIN PHARMACOL, V2, P217, DOI 10.2174/157488407781668811; Pellacani G, 2012, J AM ACAD DERMATOL, V66, pE109, DOI 10.1016/j.jaad.2011.05.017; Pollack LA, 2011, J AM ACAD DERMATOL, V65, pS78, DOI 10.1016/j.jaad.2011.05.030; Rabkin MS, 2008, J CUTAN PATHOL, V35, P20, DOI 10.1111/j.1600-0560.2008.01131.x; Rigel DS, 2010, ARCH DERMATOL, V146, P318, DOI 10.1001/archdermatol.2009.379; Salava Alexander, 2010, Duodecim, V126, P2492; Shinohara Michi M, 2009, Dermatol Online J, V15, P7; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; Troxel DB, 2003, AM J SURG PATHOL, V27, P1278, DOI 10.1097/00000478-200309000-00012; Wong RPC, 2008, ONCOL REP, V19, P933	41	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45037	10.1371/journal.pone.0045037	http://dx.doi.org/10.1371/journal.pone.0045037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028750	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500017
J	Park, SK; Yang, JJ; Oh, S; Cho, LY; Ma, SH; Shin, A; Ko, KP; Park, T; Yoo, KY; Kang, D				Park, Sue K.; Yang, Jae Jeong; Oh, Sohee; Cho, Lisa Y.; Ma, Seung Hyun; Shin, Aesun; Ko, Kwang-Pil; Park, Taesung; Yoo, Keun-Young; Kang, Daehee			Innate Immunity and Non-Hodgkin's Lymphoma (NHL) Related Genes in a Nested Case-Control Study for Gastric Cancer Risk	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; NF-KAPPA-B; ASSOCIATION; DEFENSINS; RECEPTOR; SUSCEPTIBILITY; POLYMORPHISM; EXPRESSION; MUTATIONS; INDUCTION	Objective: Genetic variants regulating the host immune system may contribute to the susceptibility for the development of gastric cancer. Little is known about the role of the innate immunity- and non-Hodgkin's lymphoma (NHL)-related genes for gastric cancer risk. This nested case-control study was conducted to identify candidate genes for gastric cancer risk for future studies. Methods: In the Discovery phase, 3,072 SNPs in 203 innate immunity-and 264 NHL-related genes using the Illumine GoldenGateTM OPA Panel were analyzed in 42 matched case-control sets selected from the Korean Multi-center Cancer Cohort (KMCC). Six significant SNPs in four innate immunity (DEFA6, DEFB1, JAK3, and ACAA1) and 11 SNPs in nine NHL-related genes (INSL3, CHMP7, BCL2L11, TNFRSF8, RAD50, CASP7, CHUK, CD79B, and CLDN9) with a permutated p-value <0.01 were re-genotyped in the Replication phase among 386 cases and 348 controls. Odds ratios (ORs) for gastric cancer risk were estimated adjusting for age, smoking status, and H. pylori and CagA sero-positivity. Summarized ORs in the total study population (428 cases and 390 controls) are presented using pooled-and meta-analyses. Results: Four SNPs had no heterogeneity across the phases: in the meta-analysis, DEFA6 rs13275170 and DEFB1 rs2738169 had both a 1.3-fold increased odds ratio (OR) for gastric cancer (95% CIs = 1.1-1.6; and 1.1-1.5, respectively). INSL3 rs10421916 and rs11088680 had both a 0.8-fold decreased OR for gastric cancer (95% CIs = 0.7-0.97; and 0.7-0.9, respectively). Conclusions: Our findings suggest that certain variants in the innate immunity and NHL-related genes affect the gastric cancer risk, perhaps by modulating infection-inflammation-immunity mechanisms that remain to be defined.	[Park, Sue K.; Yang, Jae Jeong; Cho, Lisa Y.; Ma, Seung Hyun; Yoo, Keun-Young; Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sue K.; Yang, Jae Jeong; Cho, Lisa Y.; Ma, Seung Hyun; Kang, Daehee] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Oh, Sohee; Park, Taesung] Seoul Natl Univ, Coll Nat Sci, Dept Stat, Seoul 151742, South Korea; [Shin, Aesun] Natl Canc Ctr, Natl Canc Control Res Inst, Goyang, South Korea; [Ko, Kwang-Pil] Gachon Univ, Dept Prevent Med, Grad Sch Med, Inchon, South Korea; [Park, Sue K.; Kang, Daehee] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); Gachon University; Seoul National University (SNU)	Kang, D (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	dhkang@snu.ac.kr	Park, Sue Kyung/J-2757-2012; Shin, Aesun/E-9145-2014; Yoo, Keun-Young/J-5548-2012; Kang, Dae Hee/E-8631-2012	Shin, Aesun/0000-0002-6426-1969; Kang, Daehee/0000-0003-4031-5878	Basic Science Research Program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2009-0066258, 2011-0001564]; BRL (Basic Research Laboratory) program through the National Research Foundation of Korea	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); BRL (Basic Research Laboratory) program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology [2009-0066258] and by BRL (Basic Research Laboratory) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology [2011-0001564]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Campopiano DJ, 2004, J BIOL CHEM, V279, P48671, DOI 10.1074/jbc.M404690200; Cragg MS, 2002, BLOOD, V100, P3068, DOI 10.1182/blood.V100.9.3068; Droin N, 2009, J PROTEOMICS, V72, P918, DOI 10.1016/j.jprot.2009.01.002; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; Essner R, 2001, J GASTROINTEST SURG, V5, P81, DOI 10.1016/S1091-255X(01)80017-2; Fellermann K, 2001, EUR J GASTROEN HEPAT, V13, P771, DOI 10.1097/00042737-200107000-00003; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gwack J, 2006, BRIT J CANCER, V95, P639, DOI 10.1038/sj.bjc.6603309; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hellmig S, 2005, LEUKEMIA LYMPHOMA, V46, P869, DOI 10.1080/1042819050086451; IARC (International Agency for Research on Cancer), 1994, IARC MON EV CARC RIS; Katoh M, 2003, INT J MOL MED, V11, P683; Kim NG, 2001, CANCER RES, V61, P36; Kon OL, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-54; Lee JY, 2009, CARCINOGENESIS, V30, P1528, DOI 10.1093/carcin/bgp084; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Lunet N, 2003, INT J CANCER, V106, P953, DOI 10.1002/ijc.11306; Maeda S, 2000, GASTROENTEROLOGY, V119, P97, DOI 10.1053/gast.2000.8540; Matsutani N, 2001, PATHOBIOLOGY, V69, P219, DOI 10.1159/000055946; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miwa H, 2002, AM J GASTROENTEROL, V97, P1106, DOI 10.1111/j.1572-0241.2002.05663.x; Motzkus D, 2006, FASEB J, V20, P1701, DOI 10.1096/fj.05-4970fje; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Park CY, 2002, J CLIN MICROBIOL, V40, P4753, DOI 10.1128/JCM.40.12.4753-4756.2002; Portal-Celhay C, 2006, CLIN SCI, V110, P305, DOI 10.1042/CS20050232; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Shin A, 2005, BRIT J CANCER, V92, P1273, DOI 10.1038/sj.bjc.6602467; Smith L, 2006, ONCOL RES, V15, P441; Soung YH, 2003, ONCOGENE, V22, P8048, DOI 10.1038/sj.onc.1206727; STEMMERMANN GN, 1994, J ENDOCRINOL, V140, P321, DOI 10.1677/joe.0.1400321; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Ture-Ozdemir F, 2008, ANTICANCER RES, V28, P3697; Uehara N, 2003, J MED MICROBIOL, V52, P41, DOI 10.1099/jmm.0.04985-0; Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P32, DOI 10.1097/MOG.0b013e32801182c2; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Yoo Keun Young, 2002, Asian Pac J Cancer Prev, V3, P85; Yoo NJ, 2004, APMIS, V112, P330; Zamar D, 2007, J STAT SOFTW, V21, P1	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45274	10.1371/journal.pone.0045274	http://dx.doi.org/10.1371/journal.pone.0045274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028900	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800034
J	Hsu, CY; Adams, JP; No, K; Liang, HY; Meilan, R; Pechanova, O; Barakat, A; Carlson, JE; Page, GP; Yuceer, C				Hsu, Chuan-Yu; Adams, Joshua P.; No, Kyoungok; Liang, Haiying; Meilan, Richard; Pechanova, Olga; Barakat, Abdelali; Carlson, John E.; Page, Grier P.; Yuceer, Cetin			Overexpression of Constans Homologs CO1 and CO2 Fails to Alter Normal Reproductive Onset and Fall Bud Set in Woody Perennial Poplar	PLOS ONE			English	Article							FLOWERING-TIME GENE; FLORAL INDUCTION; FT PROTEIN; PHOTOPERIODIC CONTROL; CIRCADIAN CLOCK; LOCUS-T; ARABIDOPSIS; EXPRESSION; ACTIVATION; SIGNAL	CONSTANS (CO) is an important flowering-time gene in the photoperiodic flowering pathway of annual Arabidopsis thaliana in which overexpression of CO induces early flowering, whereas mutations in CO cause delayed flowering. The closest homologs of CO in woody perennial poplar (Populus spp.) are CO1 and CO2. A previous report [1] showed that the CO2/FLOWERING LOCUS T1 (FT1) regulon controls the onset of reproduction in poplar, similar to what is seen with the CO/FLOWERING LOCUS T (FT) regulon in Arabidopsis. The CO2/FT1 regulon was also reported to control fall bud set. Our long-term field observations show that overexpression of CO1 and CO2 individually or together did not alter normal reproductive onset, spring bud break, or fall dormancy in poplar, but did result in smaller trees when compared with controls. Transcripts of CO1 and CO2 were normally most abundant in the growing season and rhythmic within a day, peaking at dawn. Our manipulative experiments did not provide evidence for transcriptional regulation being affected by photoperiod, light intensity, temperature, or water stress when transcripts of CO1 and CO2 were consistently measured in the morning. A genetic network analysis using overexpressing trees, microarrays, and computation demonstrated that a majority of functionally known genes downstream of CO1 and CO2 are associated with metabolic processes, which could explain their effect on tree size. In conclusion, the function of CO1 and CO2 in poplar does not appear to overlap with that of CO from Arabidopsis, nor do our data support the involvement of CO1 and CO2 in spring bud break or fall bud set.	[Hsu, Chuan-Yu; No, Kyoungok; Pechanova, Olga; Yuceer, Cetin] Mississippi State Univ, Dept Forestry, Mississippi State, MS 39762 USA; [Adams, Joshua P.] Univ Arkansas, Sch Forest Resources, Monticello, AR USA; [Liang, Haiying; Barakat, Abdelali] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Meilan, Richard] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Barakat, Abdelali; Carlson, John E.] Penn State Univ, Sch Forest Resources, University Pk, PA 16802 USA; [Carlson, John E.] Chonnam Natl Univ, Dept Bioenergy Sci & Technol, Kwangju, South Korea; [Page, Grier P.] Res Triangle Inst Int, Atlanta, GA USA	Mississippi State University; University of Arkansas System; University of Arkansas Fayetteville; Clemson University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Chonnam National University; Research Triangle Institute	Yuceer, C (corresponding author), Mississippi State Univ, Dept Forestry, Mississippi State, MS 39762 USA.	mcy1@msstate.edu	Meilan, Richard/T-9269-2017	Meilan, Richard/0000-0002-8680-1110; Page, Grier/0000-0003-2582-3786	National Science Foundation [DBI-0501890, IOS-0845834]; World Class University Project [R31-2009-000-20025-0]; Ministry of Education, Science, and Technology of South Korea	National Science Foundation(National Science Foundation (NSF)); World Class University Project; Ministry of Education, Science, and Technology of South Korea	This work was funded by National Science Foundation grants DBI-0501890 (CY, GPP, and JEC) and IOS-0845834 (CY). JEC was also partially supported by the World Class University Project R31-2009-000-20025-0 funded by the Ministry of Education, Science, and Technology of South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Almada R, 2009, PLANT CELL REP, V28, P1193, DOI 10.1007/s00299-009-0720-4; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ayre BG, 2004, PLANT PHYSIOL, V135, P2271, DOI 10.1104/pp.104.040592; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Datta S, 2006, PLANT CELL, V18, P70, DOI 10.1105/tpc.105.038182; DICKSON RE, 1991, RESPONSE PLANTS MULT, P3, DOI [10.1016/C2009-0-02664-6, DOI 10.1016/C2009-0-02664-6]; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Hattasch C, 2008, TREE PHYSIOL, V28, P1459, DOI 10.1093/treephys/28.10.1459; Han KH, 2000, PLANT CELL REP, V19, P315, DOI 10.1007/s002990050019; Hassidim M, 2009, PLANTA, V230, P481, DOI 10.1007/s00425-009-0958-7; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Holefors A, 2009, PLANT PHYSIOL BIOCH, V47, P105, DOI 10.1016/j.plaphy.2008.11.003; Hsu CY, 2006, PLANT CELL, V18, P1846, DOI 10.1105/tpc.106.041038; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jackson DP, 1991, MOL PLANT PATHOL, P163; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Janz D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-150; Jeong Dong-Hoon, 1999, Journal of Plant Biology, V42, P23; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim SJ, 2003, J EXP BOT, V54, P1879, DOI 10.1093/jxb/erg217; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lagercrantz U, 2000, MOL BIOL EVOL, V17, P1499, DOI 10.1093/oxfordjournals.molbev.a026249; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Ledger S, 2001, PLANT J, V26, P14; Liu JY, 2001, PLANT PHYSIOL, V125, P1821, DOI 10.1104/pp.125.4.1821; Martin J, 2004, PLANT MOL BIOL, V56, P159, DOI 10.1007/s11103-004-2647-z; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Nemoto Y, 2003, PLANT J, V36, P82, DOI 10.1046/j.1365-313X.2003.01859.x; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Roden LC, 2002, P NATL ACAD SCI USA, V99, P13313, DOI 10.1073/pnas.192365599; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Takata N, 2009, NEW PHYTOL, V181, P808, DOI 10.1111/j.1469-8137.2008.02714.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yuceer C, 2002, PLANT SCI, V163, P615, DOI 10.1016/S0168-9452(02)00169-3; Zhang XG, 2005, PLANT CELL, V17, P2314, DOI 10.1105/tpc.104.028670	56	40	44	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45448	10.1371/journal.pone.0045448	http://dx.doi.org/10.1371/journal.pone.0045448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029015	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400085
J	Mukai, R; Horikawa, H; Fujikura, Y; Kawamura, T; Nemoto, H; Nikawa, T; Terao, J				Mukai, Rie; Horikawa, Hitomi; Fujikura, Yutaka; Kawamura, Tomoyuki; Nemoto, Hisao; Nikawa, Takeshi; Terao, Junji			Prevention of Disuse Muscle Atrophy by Dietary Ingestion of 8-Prenylnaringenin in Denervated Mice	PLOS ONE			English	Article							HUMULUS-LUPULUS L.; FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; UBIQUITIN LIGASES; PRENYLATED FLAVONOIDS; POTENT PHYTOESTROGEN; SOPHORA-FLAVESCENS; IN-VITRO; KAPPA-B; HOPS	Flavonoids have attracted considerable attention in relation to their effects upon health. 8-Prenylnaringenin (8-PN) is found in the common hop (Humulus lupulus) and assumed to be responsible for the health impact of beer consumption. We wanted to clarify the effects of prenylation on the physiological functions of dietary flavonoids by comparing the effects of 8-PN with that of intact naringenin in the prevention of disuse muscle atrophy using a model of denervation in mice. Consumption of 8-PN (but not naringenin) prevented loss of weight in the gastrocnemius muscle further supported by the lack of induction of the protein content of a key ubiquitin ligase involved in muscle atrophy, atrogin-1, and by the activation of Akt phosphorylation. 8-PN content in the gastrocnemius muscle was tenfold higher than that of naringenin. These results suggested that, compared with naringenin, 8-PN was effectively concentrated into skeletal muscle to exert its preventive effects upon disuse muscle atrophy. It is likely that prenylation generates novel functions for 8-PN by enhancing its accumulation into muscle tissue through dietary intake.	[Mukai, Rie; Horikawa, Hitomi; Fujikura, Yutaka; Terao, Junji] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Food Sci, Tokushima 770, Japan; [Kawamura, Tomoyuki; Nemoto, Hisao] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmaceut Chem, Tokushima 770, Japan; [Nikawa, Takeshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nutr Physiol, Tokushima 770, Japan	Tokushima University; Tokushima University; Tokushima University	Terao, J (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Food Sci, Tokushima 770, Japan.	terao@nutr.med.tokushima-u.ac.jp		Mukai, Rie/0000-0003-3906-4848	Ministry of Education, Culture, Sports, Science and Technology; Program for the Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry in Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry in Japan	This work was supported in part by a Grant-in-Aid for Young Scientists (B) (to RM) and a Grant-in-Aid for Scientific Research (B) (to JT) from the Ministry of Education, Culture, Sports, Science and Technology, and by the Program for the Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry in Japan. The funders had only financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer DAM, 2010, J STEROID BIOCHEM, V120, P208, DOI 10.1016/j.jsbmb.2010.04.018; Arung ET, 2010, FITOTERAPIA, V81, P640, DOI 10.1016/j.fitote.2010.03.011; Barron D, 1996, ACTA BOT GALLICA, V143, P509, DOI 10.1080/12538078.1996.10515348; Barron D, 1996, PHYTOCHEMISTRY, V43, P921, DOI 10.1016/S0031-9422(96)00344-5; Bieger J, 2008, J NUTR, V138, P1417, DOI 10.1093/jn/138.8.1417; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bolca S, 2007, BRIT J NUTR, V98, P950, DOI 10.1017/S0007114507749243; Bolca S, 2010, MOL NUTR FOOD RES, V54, pS284, DOI 10.1002/mnfr.200900519; Botta B, 2005, CURR MED CHEM, V12, P713, DOI 10.2174/0929867053202241; Bowe J, 2006, J ENDOCRINOL, V191, P399, DOI 10.1677/joe.1.06919; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown M, 2005, AVIAT SPACE ENVIR MD, V76, P1012; Coldham NG, 2001, FOOD CHEM TOXICOL, V39, P1211, DOI 10.1016/S0278-6915(01)00081-3; English KL, 2010, CURR OPIN CLIN NUTR, V13, P34, DOI 10.1097/MCO.0b013e328333aa66; Fang TZ, 2006, J PHARMACEUT BIOMED, V40, P454, DOI 10.1016/j.jpba.2005.07.031; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guo J, 2006, DRUG METAB DISPOS, V34, P1152, DOI 10.1124/dmd.105.008250; Hsiu SL, 2002, LIFE SCI, V70, P1481, DOI 10.1016/S0024-3205(01)01491-6; Huang X, 2007, EUR J PHARMACOL, V564, P26, DOI 10.1016/j.ejphar.2007.02.039; Humpel M, 2005, J STEROID BIOCHEM, V97, P299, DOI 10.1016/j.jsbmb.2005.05.009; Kawamura T, 2012, SYNTHESIS-STUTTGART, V44, P1308, DOI 10.1055/s-0031-1290756; Kretzschmar G, 2010, J STEROID BIOCHEM, V118, P1, DOI 10.1016/j.jsbmb.2009.08.005; Kuroyanagi M, 1999, J NAT PROD, V62, P1595, DOI 10.1021/np990051d; Lee HJ, 2012, ARCH PHARM RES, V35, P163, DOI 10.1007/s12272-012-0118-7; Lee MH, 2005, BIOL PHARM BULL, V28, P2253, DOI 10.1248/bpb.28.2253; McClung JM, 2006, J APPL PHYSIOL, V100, P2012, DOI 10.1152/japplphysiol.01583.2005; Menendez C, 2011, MOL NUTR FOOD RES, V55, P1780, DOI 10.1002/mnfr.201100378; Milligan SR, 2000, J CLIN ENDOCR METAB, V85, P4912, DOI 10.1210/jc.85.12.4912; Milligan SR, 1999, J CLIN ENDOCR METAB, V84, P2249, DOI 10.1210/jc.84.6.2249; Mukai R, 2010, J NAT PROD, V73, P1708, DOI 10.1021/np100240y; Pang Y, 2007, MOL NUTR FOOD RES, V51, P872, DOI 10.1002/mnfr.200600252; Possemiers S, 2006, J NUTR, V136, P1862, DOI 10.1093/jn/136.7.1862; Rad M, 2006, BRIT J CLIN PHARMACO, V62, P288, DOI 10.1111/j.1365-2125.2006.02656.x; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Shimoi K, 2005, METHOD ENZYMOL, V400, P263, DOI 10.1016/S0076-6879(05)00015-7; Stevens JF, 1999, J CHROMATOGR A, V832, P97, DOI 10.1016/S0021-9673(98)01001-2; Stevens JF, 1999, J AGR FOOD CHEM, V47, P2421, DOI 10.1021/jf990101k; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Terao J, 2011, FOOD FUNCT, V2, P11, DOI 10.1039/c0fo00106f; Terao J, 2009, FORUM NUTR, V61, P87, DOI 10.1159/000212741; Tomas-Barberen FA, 2000, J SCI FOOD AGR, V80, P1073, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1073::AID-JSFA568>3.3.CO;2-2, 10.1002/(SICI)1097-0010(20000515)80:7&lt;1073::AID-JSFA568&gt;3.0.CO;2-B]; Williamson G, 2005, FREE RADICAL RES, V39, P457, DOI 10.1080/10715760500053610; Zhang P, 2007, MED HYPOTHESES, V69, P310, DOI 10.1016/j.mehy.2006.11.043	47	61	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45048	10.1371/journal.pone.0045048	http://dx.doi.org/10.1371/journal.pone.0045048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028754	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400058
J	Hou, HS; Liao, CL; Sytwu, HK; Liao, NS; Huang, TY; Hsieh, TY; Chu, HC				Hou, Hsein-San; Liao, Ching-Len; Sytwu, Huey-Kang; Liao, Nan-Shih; Huang, Tien-Yu; Hsieh, Tsai-Yuan; Chu, Heng-Cheng			Deficiency of Interleukin-15 Enhances Susceptibility to Acetaminophen-Induced Liver Injury in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; INDUCED HEPATOTOXICITY; IN-VIVO; ISCHEMIA-REPERFUSION; HEME OXYGENASE-1; REACTIVE OXYGEN; D-GALACTOSAMINE; PROTECTIVE ROLE; WILD-TYPE	Hepatocytes have a direct necrotic role in acetaminophen (APAP)-induced liver injury (AILI), prolonged secondary inflammatory response through innate immune cells and cytokines also significantly contributes to APAP hepatotoxicity. Interleukin 15 (IL-15), a multifunction cytokine, regulates the adaptive immune system and influences development and function of innate immune cells. To better understand the role of IL-15 in liver injury, we treated wild-type (WT) and IL-15-knockout (Il15(-/-)) mice with a hepatotoxic dose of APAP to induce AILI and evaluated animal survival, liver damage, APAP metabolism in livers and the inflammatory response. Production of pro-inflammatory cytokines/chemokines was greater in Il15(-/-) than WT mice. Subanalysis of hepatic infiltrated monocytes revealed greater neutrophil influx, along with greater hepatic induction of inducible nitric oxide synthase (iNOS), in Il15(-/-) than WT mice. In addition, the level of hepatic hemeoxygenase 1 (HO-1) was partially suppressed in Il15(-/-) mice, but not in WT mice. Interestingly, elimination of Kupffer cells and neutrophils did not alter the vulnerability to excess APAP in Il15(-/-) mice. However, injection of galactosamine, a hepatic transcription inhibitor, significantly reduced the increased APAP sensitivity in Il15(-/-) mice but had minor effect on WT mice. We demonstrated that deficiency of IL-15 increased mouse susceptibility to AILI. Moreover, Kupffer cell might affect APAP hepatotoxicity through IL-15.	[Hou, Hsein-San; Liao, Ching-Len; Sytwu, Huey-Kang; Liao, Nan-Shih; Chu, Heng-Cheng] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Liao, Ching-Len; Sytwu, Huey-Kang] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Liao, Nan-Shih] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Huang, Tien-Yu; Hsieh, Tsai-Yuan; Chu, Heng-Cheng] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Academia Sinica - Taiwan; National Defense Medical Center; Tri-Service General Hospital	Chu, HC (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	dr.chu0803@gmail.com	Liao, Nan-Shih/ABE-7580-2020	Liao, Nan-Shih/0000-0003-3707-4145	National Science Council [NSC94-2314-B-016-047]; Tri-Service General Hospital, National Defense Medical Center [TSGH-C97-44, TSGH-C98-48, TSGH-C99-61]; Department of Defense, Taiwan [P98-25, I-3]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, National Defense Medical Center; Department of Defense, Taiwan(United States Department of Defense)	This study was supported in part by the National Science Council (NSC94-2314-B-016-047), Tri-Service General Hospital, National Defense Medical Center (TSGH-C97-44, TSGH-C98-48 and TSGH-C99-61) and the Department of Defense, Taiwan (P98-25 and I-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Alleva DG, 1997, J IMMUNOL, V159, P2941; BLAZKA ME, 1995, TOXICOL APPL PHARM, V133, P43, DOI 10.1006/taap.1995.1125; Bouchard A, 2004, J LEUKOCYTE BIOL, V75, P893, DOI 10.1189/jlb.1103585; Bourdi M, 2002, HEPATOLOGY, V35, P289, DOI 10.1053/jhep.2002.30956; Bourdi M, 2011, CHEM RES TOXICOL, V24, P794, DOI 10.1021/tx200143x; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; BulfonePaus S, 1997, NAT MED, V3, P1124, DOI 10.1038/nm1097-1124; Chiu H, 2002, TOXICOL APPL PHARM, V181, P106, DOI 10.1006/taap.2002.9409; Connolly MK, 2011, HEPATOLOGY, V54, P959, DOI 10.1002/hep.24429; Conti F, 2003, TRANSPLANTATION, V76, P210, DOI 10.1097/01.TP.0000067530.95852.67; Cover C, 2006, TOXICOL APPL PHARM, V216, P98, DOI 10.1016/j.taap.2006.04.010; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; Ferret PJ, 2001, HEPATOLOGY, V33, P1173, DOI 10.1053/jhep.2001.24267; Gomez-Nicola D, 2010, EXP NEUROL, V222, P235, DOI 10.1016/j.expneurol.2009.12.034; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Harstad EB, 2002, TOXICOL APPL PHARM, V180, P178, DOI 10.1006/taap.2002.9385; Hinson JA, 2002, NITRIC OXIDE-BIOL CH, V6, P160, DOI 10.1006/niox.2001.0404; Hoetzel A, 2001, HEPATOLOGY, V33, P925, DOI 10.1053/jhep.2001.23431; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ishida Y, 2002, FASEB J, V16, DOI 10.1096/fj.02-0046com; JAESCHKE H, 1990, J PHARMACOL EXP THER, V255, P935; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976; Kakumu S, 1997, CLIN EXP IMMUNOL, V109, P458, DOI 10.1046/j.1365-2249.1997.4861382.x; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Knight TR, 2002, TOXICOL APPL PHARM, V181, P133, DOI 10.1006/taap.2002.9407; Kon K, 2004, HEPATOLOGY, V40, P1170, DOI 10.1002/hep.20437; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Le Moine O, 2000, HEPATOLOGY, V31, P1266, DOI 10.1053/jhep.2000.7881; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; Li BF, 2006, HEPATOLOGY, V43, P1211, DOI 10.1002/hep.21174; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; MALEY F, 1968, BIOCHEM J, V107, P637, DOI 10.1042/bj1070637; Masson MJ, 2008, HEPATOLOGY, V48, P889, DOI 10.1002/hep.22400; Masubachi Y, 2003, BIOCHEM BIOPH RES CO, V304, P207, DOI 10.1016/S0006-291X(03)00572-2; Meazza R, 1996, ONCOGENE, V12, P2187; Michael SL, 1999, HEPATOLOGY, V30, P186, DOI 10.1002/hep.510300104; Mirghomizadeh F, 2009, J BIOL CHEM, V284, P32635, DOI 10.1074/jbc.M109.015446; Misra I, 1998, PROTEIN EXPRES PURIF, V13, P268, DOI 10.1006/prep.1998.0897; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Musikadharoen T, 2005, BLOOD, V105, P711, DOI 10.1182/blood-2004-03-0842; Nakamura R, 2010, J VIROL, V84, P5574, DOI 10.1128/JVI.02030-09; Nishimura H, 1998, J IMMUNOL, V160, P936; NUSSLER AK, 1995, HEPATOLOGY, V21, P1552, DOI 10.1016/0270-9139(95)90459-X; Ohteki T, 2001, NAT IMMUNOL, V2, P1138, DOI 10.1038/ni729; Ohteki T, 2006, J EXP MED, V203, P2329, DOI 10.1084/jem.20061297; Onu A, 1997, J IMMUNOL, V158, P255; Possamai LA, 2010, WORLD J GASTROENTERO, V16, P1811, DOI 10.3748/wjg.v16.i15.1811; Ruckert R, 2009, IMMUNOLOGY, V126, P63, DOI 10.1111/j.1365-2567.2008.02878.x; Sakamoto N, 2003, LIVER TRANSPLANT, V9, P940, DOI 10.1053/jlts.2003.50182; Shinozaki M, 2002, J CLIN INVEST, V109, P951, DOI 10.1172/JCI200214574; Sumioka I, 2004, LIFE SCI, V74, P2551, DOI 10.1016/j.lfs.2003.10.011; Suzuki A, 2006, J HEPATOL, V45, P410, DOI 10.1016/j.jhep.2006.04.008; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; Yee SB, 2007, CHEM RES TOXICOL, V20, P734, DOI 10.1021/TX600349f; Yoshihara K, 2006, GUT, V55, P334, DOI 10.1136/gut.2005.076000	60	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44880	10.1371/journal.pone.0044880	http://dx.doi.org/10.1371/journal.pone.0044880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028657	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900048
J	Meng, H; Zhang, XJ; Yu, GG; Lee, SJ; Chen, YE; Prudovsky, I; Wang, MM				Meng, He; Zhang, Xiaojie; Yu, Genggeng; Lee, Soo Jung; Chen, Y. Eugene; Prudovsky, Igor; Wang, Michael M.			Biochemical Characterization and Cellular Effects of CADASIL Mutants of NOTCH3	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT ARTERIOPATHY; SMOOTH-MUSCLE-CELLS; INHIBITS TUMOR-GROWTH; SUBCORTICAL INFARCTS; MAMMALIAN NOTCH; VASCULAR DEVELOPMENT; EMBRYONIC LETHALITY; DEPENDENT PATHWAY; TRANSGENIC MICE; LIGAND-BINDING	Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is the best understood cause of dominantly inherited stroke and results from NOTCH3 mutations that lead to NOTCH3 protein accumulation and selective arterial smooth muscle degeneration. Previous studies show that NOTCH3 protein forms multimers. Here, we investigate protein interactions between NOTCH3 and other vascular Notch isoforms and characterize the effects of elevated NOTCH3 on smooth muscle gene regulation. We demonstrate that NOTCH3 forms heterodimers with NOTCH1, NOTCH3, and NOTCH4. R90C and C49Y mutant NOTCH3 form complexes which are more resistant to detergents than wild type NOTCH3 complexes. Using quantitative NOTCH3-luciferase clearance assays, we found significant inhibition of mutant NOTCH3 clearance. In coculture assays of NOTCH function, overexpressed wild type and mutant NOTCH3 significantly repressed NOTCH-regulated smooth muscle transcripts and potently impaired the activity of three independent smooth muscle promoters. Wildtype and R90C recombinant NOTCH3 proteins applied to cell cultures also blocked canonical Notch fuction. We conclude that CADASIL mutants of NOTCH3 complex with NOTCH1, 3, and 4, slow NOTCH3 clearance, and that overexpressed wild type and mutant NOTCH3 protein interfere with key NOTCH-mediated functions in smooth muscle cells.	[Meng, He; Zhang, Xiaojie; Yu, Genggeng; Lee, Soo Jung; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Chen, Y. Eugene] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Prudovsky, Igor] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME USA; [Wang, Michael M.] VA Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Maine Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Wang, MM (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	micwang@umich.edu	Prudovsky, Igor/GVU-1521-2022		National Institutes of Health [NS041342, NS054724, HL068878, HL89544, HL035627]; American Heart Association [0726004Z]; Burroughs Wellcome Fund Career Award in Biomedical Sciences; Maine Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068878, R01HL035627, R01HL089544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS054724, K08NS041342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Burroughs Wellcome Fund Career Award in Biomedical Sciences(Burroughs Wellcome Fund); Maine Cancer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by grants from the National Institutes of Health (NS041342 and NS054724 to MMW; HL068878 and HL89544 to YEC; HL035627 to IP), the American Heart Association (postdoctoral fellowship 0726004Z to HM), a Burroughs Wellcome Fund Career Award in Biomedical Sciences (MMW), and a Maine Cancer Foundation grant (IP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CHABRIAT H, 1995, NEUROLOGY, V45, P1086, DOI 10.1212/WNL.45.6.1086; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DELAMO FF, 1992, DEVELOPMENT, V115, P737; Dichgans M, 2000, EUR J HUM GENET, V8, P280, DOI 10.1038/sj.ejhg.5200460; Dichgans M, 1998, ANN NEUROL, V44, P731, DOI 10.1002/ana.410440506; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Duering M, 2011, HUM MOL GENET; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Ishiko A, 2006, ACTA NEUROPATHOL, V112, P333, DOI 10.1007/s00401-006-0116-2; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jia LJ, 2009, INT J BIOCHEM CELL B, V41, P2594, DOI 10.1016/j.biocel.2009.08.019; Joutel A, 2000, NEUROLOGY, V54, P1874, DOI 10.1212/WNL.54.9.1874; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Joutel A, 2004, AM J HUM GENET, V74, P338, DOI 10.1086/381506; Joutel A, 1997, LANCET, V350, P1511, DOI 10.1016/S0140-6736(97)08083-5; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Joutel A, 2010, J CLIN INVEST, V120, P433, DOI 10.1172/JCI39733; Karlstrom H, 2002, P NATL ACAD SCI USA, V99, P17119, DOI 10.1073/pnas.252624099; Krebs LT, 2000, GENE DEV, V14, P1343; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Markus HS, 2002, NEUROLOGY, V59, P1134, DOI 10.1212/WNL.59.8.1134; McCright B, 2001, DEVELOPMENT, V128, P491; Meng H, 2010, J BIOL CHEM, V285, P23045, DOI 10.1074/jbc.M110.144634; Meng H, 2009, J BIOL CHEM, V284, P7866, DOI 10.1074/jbc.M803650200; Monet M, 2007, HUM MOL GENET, V16, P982, DOI 10.1093/hmg/ddm042; Monet-Lepretre M, 2009, BRAIN, V132, P1601, DOI 10.1093/brain/awp049; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nazarenko I, 2007, J CELL SCI, V120, P1393, DOI 10.1242/jcs.000018; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oberstein SAJL, 1999, NEUROLOGY, V52, P1913, DOI 10.1212/WNL.52.9.1913; Opherk C, 2009, HUM MOL GENET, V18, P2761, DOI 10.1093/hmg/ddp211; Peters N, 2004, EXP CELL RES, V299, P454, DOI 10.1016/j.yexcr.2004.06.004; Proweller A, 2007, P NATL ACAD SCI USA, V104, P16275, DOI 10.1073/pnas.0707950104; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500; Sakamoto K, 2005, EXP CELL RES, V302, P281, DOI 10.1016/j.yexcr.2004.09.016; Shawber C, 1996, DEVELOPMENT, V122, P3765; Small D, 2003, J BIOL CHEM, V278, P16405, DOI 10.1074/jbc.M300464200; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Takahashi K, 2010, HUM MOL GENET, V19, P79, DOI 10.1093/hmg/ddp468; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhang YM, 2007, BIOCHEM BIOPH RES CO, V355, P245, DOI 10.1016/j.bbrc.2007.01.151	64	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44964	10.1371/journal.pone.0044964	http://dx.doi.org/10.1371/journal.pone.0044964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028706	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900058
J	Wu, PJ; Zhang, N; Wang, X; Zhang, C; Li, T; Ning, XH; Gong, K				Wu, Pengjie; Zhang, Ning; Wang, Xi; Zhang, Chi; Li, Teng; Ning, Xianghui; Gong, Kan			The Erythropoietin/Erythropoietin Receptor Signaling Pathway Promotes Growth and Invasion Abilities in Human Renal Carcinoma Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; HYPOXIA-INDUCIBLE FACTORS; HIPPEL-LINDAU-DISEASE; ERYTHROPOIETIN RECEPTOR; EXPRESSION; COEXPRESSION; HEMANGIOBLASTOMA; PROLIFERATION; ACTIVATION; MUTATIONS	Co-expression of erythropoietin (Epo) and erythropoietin receptor (EpoR) has been found in various non-hematopoietic cancers including hereditary and sporadic renal cell carcinomas (RCC), but the Epo/EpoR autocrine and paracrine mechanisms in tumor progression have not yet been identified. In this study, we used RNA interference method to down-regulate EpoR to investigate the function of Epo/EpoR pathway in human RCC cells. Epo and EpoR co-expressed in primary renal cancer cells and 6 human RCC cell lines. EpoR signaling was constitutionally phosphorylated in primary renal cancer cells, 786-0 and Caki-1 cells, and recombinant human Epo (rhEpo) stimulation had no significant effects on further phosphorylation of EpoR pathway, proliferation, and invasiveness of the cells. Down-regulation of EpoR expression in 7860 cells by lentivirus-introduced siRNA resulted in inhibition of growth and invasiveness in vitro and in vivo, and promotion of cell apoptosis. In addition, rhEpo stimulation slightly antagonized the anti-tumor effect of Sunitinib on 786-0 cells. Sunitinib could induce more apoptotic cells in 786-0 cells with knockdown EpoR expression. Our results suggested that Epo/EpoR pathway was involved in cell growth, invasion, survival, and sensitivity to the multi-kinases inhibitor Sunitinib in RCC cells.	[Wu, Pengjie; Wang, Xi; Li, Teng; Ning, Xianghui; Gong, Kan] Peking Univ, Natl Urol Canc Ctr, Dept Urol, Inst Urol,Hosp 1, Beijing 100871, Peoples R China; [Zhang, Ning] Capital Univ Med Sci, Dept Urol, Beijing Chaoyang Hosp, Beijing, Peoples R China; [Zhang, Chi] Peking Univ, Dept Gen Surg, Hosp 1, Beijing 100871, Peoples R China	Peking University; Capital Medical University; Peking University	Gong, K (corresponding author), Peking Univ, Natl Urol Canc Ctr, Dept Urol, Inst Urol,Hosp 1, Beijing 100871, Peoples R China.	gongkan2004@yahoo.com.cn	Gong, Kan/AAA-5915-2020	Gong, Kan/0000-0001-7195-677X	National Natural Science Foundation of China [30872560, 81172418]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Numbers: 30872560 and 81172418) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan CC, 2005, MOL VIS, V11, P697; Chan CC, 2007, RETINA-J RET VIT DIS, V27, P1, DOI 10.1097/01.iae.0000244659.62202.ee; Gallou C, 1999, HUM MUTAT, V13, P464, DOI 10.1002/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A; Gong K, 2006, CANCER BIOL THER, V5, P582, DOI 10.4161/cbt.5.6.2709; Gong K, 2010, INT J MOL MED, V26, P907, DOI 10.3892/ijmm_00000541; Hardee ME, 2006, CLIN CANCER RES, V12, P332, DOI 10.1158/1078-0432.CCR-05-1771; KOUREMBANAS S, 1990, J CLIN INVEST, V86, P670, DOI 10.1172/JCI114759; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Kumar SM, 2012, ONCOGENE, V31, P1649, DOI 10.1038/onc.2011.366; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lee YS, 2005, CLIN CANCER RES, V11, P1059; Levy AP, 1997, KIDNEY INT, V51, P575, DOI 10.1038/ki.1997.82; Liang K, 2010, CANCER CELL, V18, P423, DOI 10.1016/j.ccr.2010.10.025; Lombardero M, 2011, PATHOBIOLOGY, V78, P41, DOI 10.1159/000322975; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Michael A, 2007, BJU INT, V100, P291, DOI 10.1111/j.1464-410X.2007.06978.x; Miyauchi Y, 2008, J BIOL CHEM, V283, P16622, DOI 10.1074/jbc.M710599200; Paragh G, 2009, AM J PATHOL, V174, P1504, DOI 10.2353/ajpath.2009.080592; Park DM, 2007, PLOS MED, V4, P333, DOI 10.1371/journal.pmed.0040060; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sacko O, 2010, NEUROCHIRURGIE, V56, P382, DOI 10.1016/j.neuchi.2009.11.006; Sakamoto H, 2000, J BIOL CHEM, V275, P35857, DOI 10.1074/jbc.M006317200; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; Sinha S, 2009, J BIOL CHEM, V284, P32610, DOI 10.1074/jbc.M109.058065; Um M, 2006, J BIOL CHEM, V281, P5648, DOI 10.1074/jbc.M510943200; Vogel TWA, 2005, J NEUROSURG, V103, P284, DOI 10.3171/jns.2005.103.2.0284; Vogel TWA, 2005, J CLIN ENDOCR METAB, V90, P3747, DOI 10.1210/jc.2004-1899; Vortmeyer AO, 2003, CANCER RES, V63, P7051; Westenfelder C, 2000, KIDNEY INT, V58, P647, DOI 10.1046/j.1523-1755.2000.00211.x; Wiesener MS, 2007, INT J CANCER, V121, P2434, DOI 10.1002/ijc.22961; Yasuda Y, 2003, CARCINOGENESIS, V24, P1021, DOI 10.1093/carcin/bgg060; Yasuda Y, 2002, CARCINOGENESIS, V23, P1797, DOI 10.1093/carcin/23.11.1797	32	19	19	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45122	10.1371/journal.pone.0045122	http://dx.doi.org/10.1371/journal.pone.0045122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028796	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900082
J	Alic, N; Hoddinott, MP; Foley, A; Slack, C; Piper, MDW; Partridge, L				Alic, Nazif; Hoddinott, Matthew P.; Foley, Andrea; Slack, Cathy; Piper, Matthew D. W.; Partridge, Linda			Detrimental Effects of RNAi: A Cautionary Note on Its Use in Drosophila Ageing Studies	PLOS ONE			English	Article							LIFE-SPAN; C-ELEGANS; LONG DSRNAS; EXPRESSION; LONGEVITY; SYSTEM; INTERFERENCE; MELANOGASTER; PATHWAYS; SCREEN	RNA interference (RNAi) provides an important tool for gene function discovery. It has been widely exploited in Caenorhabditis elegans ageing research because it does not appear to have any non-specific effects on ageing-related traits in that model organism. We show here that ubiquitous, adult-onset activation of the RNAi machinery, achieved by expressing a double stranded RNA targeting GFP or lacZ for degradation, or by increasing expression of Dicer substantially reduces lifespan in Drosophila melanogaster. Induction of GFPRNAi construct also alters the response of lifespan to nutrition, exacerbating the lifespan-shortening effects of food containing a high quantity of yeast. Our study indicates that activation of the RNAi machinery may have sequence-independent side-effects on lifespan, and that caution needs to be exercised when employing ubiquitous RNAi in Drosophila ageing studies. However, we also show that RNAi restricted to certain tissues may not be detrimental to lifespan.	[Alic, Nazif; Hoddinott, Matthew P.; Foley, Andrea; Slack, Cathy; Piper, Matthew D. W.; Partridge, Linda] UCL, Inst Hlth Ageing, London, England; [Alic, Nazif; Hoddinott, Matthew P.; Foley, Andrea; Slack, Cathy; Piper, Matthew D. W.; Partridge, Linda] UCL, GEE, London, England; [Hoddinott, Matthew P.; Partridge, Linda] Max Planck Inst Biol Ageing, Cologne, Germany	University of London; University College London; University of London; University College London; Max Planck Society	Alic, N (corresponding author), UCL, Inst Hlth Ageing, London, England.	n.alic@ucl.ac.uk	Piper, Matthew/C-1714-2008; Partridge, Linda/E-7342-2015; Alic, Nazif/B-4665-2009; Partridge, Linda/A-5501-2010	Piper, Matthew/0000-0003-3245-7219; Alic, Nazif/0000-0003-0356-6600; Slack, Cathy/0000-0002-7949-4079; Partridge, Linda/0000-0001-9615-0094	Wellcome Trust; Max Planck; Excellence in Life Sciences (EMBO) Fellowship; Marie Currie Fellowship; BBSRC [BB/I011544/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I011544/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Max Planck(Max Planck Society); Excellence in Life Sciences (EMBO) Fellowship; Marie Currie Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust and Max Planck (L. P.) and Excellence in Life Sciences (EMBO) and Marie Currie Fellowships (N.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Bulow MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015171; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; COX DR, 1972, J R STAT SOC B, V34, P187; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Moffat J, 2007, TRENDS PHARMACOL SCI, V28, P149, DOI 10.1016/j.tips.2007.02.009; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Poirier L, 2008, AGING CELL, V7, P758, DOI 10.1111/j.1474-9726.2008.00421.x; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Slack C, 2011, AGING CELL, V10, P735, DOI 10.1111/j.1474-9726.2011.00707.x; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987	28	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45367	10.1371/journal.pone.0045367	http://dx.doi.org/10.1371/journal.pone.0045367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028964	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000309742800058
J	Wangensteen, OS; Turon, X; Perez-Portela, R; Palacin, C				Wangensteen, Owen S.; Turon, Xavier; Perez-Portela, Rocio; Palacin, Creu			Natural or Naturalized? Phylogeography Suggests That the Abundant Sea Urchin Arbacia lixula Is a Recent Colonizer of the Mediterranean	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCES; PARACENTROTUS-LIVIDUS; POPULATION-STRUCTURE; PHENOTYPIC ASSOCIATIONS; PAIRWISE COMPARISONS; SURFACE CIRCULATION; CLADISTIC-ANALYSIS; ALGAL ASSEMBLAGES; NORTH-ATLANTIC; GENUS	We present the global phylogeography of the black sea urchin Arbacia lixula, an amphi-Atlantic echinoid with potential to strongly impact shallow rocky ecosystems. Sequences of the mitochondrial cytochrome c oxidase gene of 604 specimens from 24 localities were obtained, covering most of the distribution area of the species, including the Mediterranean and both shores of the Atlantic. Genetic diversity measures, phylogeographic patterns, demographic parameters and population differentiation were analysed. We found high haplotype diversity but relatively low nucleotide diversity, with 176 haplotypes grouped within three haplogroups: one is shared between Eastern Atlantic (including Mediterranean) and Brazilian populations, the second is found in Eastern Atlantic and the Mediterranean and the third is exclusively from Brazil. Significant genetic differentiation was found between Brazilian, Eastern Atlantic and Mediterranean regions, but no differentiation was found among Mediterranean sub-basins or among Eastern Atlantic sub-regions. The star-shaped topology of the haplotype network and the unimodal mismatch distributions of Mediterranean and Eastern Atlantic samples suggest that these populations have suffered very recent demographic expansions. These expansions could be dated 94-205 kya in the Mediterranean, and 31-67 kya in the Eastern Atlantic. In contrast, Brazilian populations did not show any signature of population expansion. Our results indicate that all populations of A. lixula constitute a single species. The Brazilian populations probably diverged from an Eastern Atlantic stock. The present-day genetic structure of the species in Eastern Atlantic and the Mediterranean is shaped by very recent demographic processes. Our results support the view (backed by the lack of fossil record) that A. lixula is a recent thermophilous colonizer which spread throughout the Mediterranean during a warm period of the Pleistocene, probably during the last interglacial. Implications for the possible future impact of A. lixula on shallow Mediterranean ecosystems in the context of global warming trends must be considered.	[Wangensteen, Owen S.; Perez-Portela, Rocio; Palacin, Creu] Univ Barcelona, Dept Anim Biol, Barcelona, Spain; [Turon, Xavier; Perez-Portela, Rocio] Ctr Adv Studies Blanes CEAB CSIC, Blanes, Girona, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Wangensteen, OS (corresponding author), Univ Barcelona, Dept Anim Biol, Barcelona, Spain.	owenwangensteen@ub.edu	Pérez-Portela, Rocío/I-9911-2014; Wangensteen, Owen S./E-3559-2018; Palacín, Creu/F-7175-2016; Wangensteen, Owen S./E-9552-2012; Turon, Xavier/J-9211-2012	Pérez-Portela, Rocío/0000-0003-3697-6526; Wangensteen, Owen S./0000-0001-5593-348X; Palacín, Creu/0000-0003-1721-1077; Wangensteen, Owen S./0000-0001-5593-348X; Turon, Xavier/0000-0002-9229-5541	Spanish Government [CTM2010-22218]; Catalan Government [2009SGR-484]; BBVA Foundation [BIOCON 08-187/09]; COCONET of the European Community [287844]; "Juan de la Cierva" contract (Ministry of Science and Technology, Spanish Government)	Spanish Government(Spanish GovernmentEuropean Commission); Catalan Government; BBVA Foundation(BBVA Foundation); COCONET of the European Community; "Juan de la Cierva" contract (Ministry of Science and Technology, Spanish Government)	This work was funded by projects CTM2010-22218 from the Spanish Government, 2009SGR-484 from the Catalan Government, BIOCON 08-187/09 from BBVA Foundation and 287844 (COCONET) of the European Community's Seventh Framework Programme (FP7/2007-2013). RPP is supported in part by a "Juan de la Cierva" contract (Ministry of Science and Technology, Spanish Government). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila SP, 2008, J BIOGEOGR, V35, P1123, DOI 10.1111/j.1365-2699.2008.01881.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bardaji T, 2009, GEOMORPHOLOGY, V104, P22, DOI 10.1016/j.geomorph.2008.05.027; Belluomini G, 2002, QUATERNARY SCI REV, V21, P525, DOI 10.1016/S0277-3791(01)00097-X; Benjamini Y, 2001, ANN STAT, V29, P1165; Borrero-Perez GH, 2011, MOL ECOL, V20, P1964, DOI 10.1111/j.1365-294X.2011.05068.x; Bulleri F, 2002, MAR ECOL PROG SER, V243, P101, DOI 10.3354/meps243101; Bulleri F, 1999, J EXP MAR BIOL ECOL, V241, P81, DOI 10.1016/S0022-0981(99)00073-8; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Calderon I, 2008, MAR BIOL, V154, P137, DOI 10.1007/s00227-008-0908-0; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; Chao A, 2010, PROGRAM USERS GUIDE; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corander J, 2007, MATH BIOSCI, V205, P19, DOI 10.1016/j.mbs.2006.09.015; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Cox T. F, 1994, MULTIDIMENSIONAL SCA; Crandall Keith A., 1994, Systematics Association Special Volume Series, V52, P273; Cuerda J., 1986, Bolleti de la Societat d'Historia Natural de les Balears, V30, P95; Cuerda J., 1957, B SOC HIST NATURAL B, V3, P3; DeGiorgi C, 1996, MOL PHYLOGENET EVOL, V5, P323, DOI 10.1006/mpev.1996.0027; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenanx L., 1968, Vie et Milieu, V19, P1; FRANCOUR P, 1994, MAR POLLUT BULL, V28, P523, DOI 10.1016/0025-326X(94)90071-X; Fu YX, 1997, GENETICS, V147, P915; Gianguzza P, 2011, CHEM ECOL, V27, P129, DOI 10.1080/02757540.2010.547484; GUILCHER A, 1969, EARTH-SCI REV, V5, P69, DOI 10.1016/0012-8252(69)90079-8; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harmelin JG, 1995, COMP ENTRE ANN 1982; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hart MW, 2012, MOL ECOL, V21, P26, DOI 10.1111/j.1365-294X.2011.05375.x; Haydar D, 2012, DIVERS DISTRIB, V18, P101, DOI 10.1111/j.1472-4642.2011.00863.x; Hereu B, 2004, THESIS U BARCELONA B; HILLAIREMARCEL C, 1986, GEOLOGY, V14, P613, DOI 10.1130/0091-7613(1986)14<613:TDOSBM>2.0.CO;2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JACOBS HT, 1988, J MOL BIOL, V202, P185, DOI 10.1016/0022-2836(88)90452-4; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; JUKES T H, 1969, P21; Kempf M., 1962, Recueil Sta mar Endoume No 39, P47; Kroh A, 2010, J SYST PALAEONTOL, V8, P147, DOI 10.1080/14772011003603556; Lario J., 1993, REV SOC GEOL ESPA OL, V6, P41; Lessios HA, 2012, MOL ECOL, V21, P130, DOI 10.1111/j.1365-294X.2011.05303.x; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Lessios HA, 1999, EVOLUTION, V53, P806, DOI 10.1111/j.1558-5646.1999.tb05374.x; Lessios HA, 2003, EVOLUTION, V57, P2026, DOI 10.1554/02-681; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lillo-Carpio MJ, 1988, PAPELES GEOGRAFIA, V14, P51; Lumpkin R, 2005, DEEP-SEA RES PT I, V52, P495, DOI 10.1016/j.dsr.2004.09.001; Maddison WP, 2009, MESQUITE MODULAR SYS; Madeira P, 2011, ACTA GEOL POL, V61, P243; Maltagliati F, 2010, BIOL J LINN SOC, V100, P910, DOI 10.1111/j.1095-8312.2010.01482.x; Marion A.F, 1883, ANN MUS HIST NAT M, V1, P6; MARJORAM P, 1994, GENETICS, V136, P673; Martins CS, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000345; McCartney MA, 2000, MOL ECOL, V9, P1391, DOI 10.1046/j.1365-294x.2000.01022.x; Metz EC, 1998, MOL BIOL EVOL, V15, P185, DOI 10.1093/oxfordjournals.molbev.a025914; Mortensen T., 1935, MONOGRAPH ECHINOIDEA; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; NEI M, 1986, MOL BIOL EVOL, V3, P418; Neraudeau D, GEODIVERSITAS, V30, P211; Occhipinti-Ambrogi A, 2004, MAR POLLUT BULL, V49, P688, DOI 10.1016/j.marpolbul.2004.08.011; Palacin C, 1998, J SEA RES, V39, P281, DOI 10.1016/S1385-1101(97)00061-0; Palacin C, 1998, MAR ECOL-P S Z N I, V19, P163, DOI 10.1111/j.1439-0485.1998.tb00460.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Perez-Portela R, 2010, MAR BIOL, V157, P2015, DOI 10.1007/s00227-010-1470-0; Petit G., 1950, Vie et Milieu Paris, V1, P356; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Privitera D, 2008, J SEA RES, V60, P184, DOI 10.1016/j.seares.2008.07.001; Privitera D, 2011, J EXP MAR BIOL ECOL, V407, P6, DOI 10.1016/j.jembe.2011.06.030; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RIEDL R., 1983, FAUNA FLORA MITTELME; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 1997, GENETICS, V145, P1219; Rozen S, 2000, Methods Mol Biol, V132, P365; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Schneider S, 1999, GENETICS, V152, P1079; Scicchitano G, 2011, QUATERN INT, V232, P201, DOI 10.1016/j.quaint.2010.06.028; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1995, GENETICS, V139, P457; Stefanini G, 1911, RIV ITAL PALEONTOL S, V17, P51; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1993, GENETICS, V134, P659; Tortonese E., 1965, ECHINODERMATA FAUNA, VVI; Verlaque MV, 1987, C INT PAR LIV OURS C, P5; Villalba-Curras MP, 2007, REV C G, V21, P133; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wangensteen OS, 2011, MAR ECOL PROG SER, V441, P117, DOI 10.3354/meps09359; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Zigler KS, 2004, EVOLUTION, V58, P1225, DOI 10.1111/j.0014-3820.2004.tb01702.x	96	38	38	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45067	10.1371/journal.pone.0045067	http://dx.doi.org/10.1371/journal.pone.0045067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028765	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800033
J	Bernardi, G; Beldade, R; Holbrook, SJ; Schmitt, RJ				Bernardi, Giacomo; Beldade, Ricardo; Holbrook, Sally J.; Schmitt, Russell J.			Full-Sibs in Cohorts of Newly Settled Coral Reef Fishes	PLOS ONE			English	Article							GENETIC-HETEROGENEITY; DASCYLLUS-TRIMACULATUS; 3-SPOT DAMSELFISH; KIN AGGREGATION; RECRUITMENT; POPULATIONS; SOFTWARE; PACIFIC; CONNECTIVITY; POLYMORPHISM	Reef fishes exhibit a bipartite life cycle where a benthic adult stage is preceded by a pelagic dispersal phase during which larvae are presumed to be mixed and transported by oceanic currents. Genetic analyses based on twelve microsatellite loci of 181 three-spot dascyllus (Dascyllus trimaculatus) that settled concurrently on a small reef in French Polynesia revealed 11 groups of siblings (1 full sibs and 10 half-sibs). This is the first evidence that fish siblings can journey together throughout their entire planktonic dispersal phase (nearly a month long for three-spot dascyllus). Our findings have critical implications for the dynamics and genetic structure of fish populations, as well as for the design of marine protected areas and management of fisheries.	[Bernardi, Giacomo; Beldade, Ricardo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Beldade, Ricardo] Univ Lisbon, Fac Ciencias, Ctr Oceanog, P-1699 Lisbon, Portugal; [Holbrook, Sally J.; Schmitt, Russell J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Holbrook, Sally J.; Schmitt, Russell J.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Cruz; Universidade de Lisboa; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Bernardi, G (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	bernardi@ucsc.edu	Bernardi, Giacomo/F-6346-2011; Beldade, Ricardo/B-3724-2012	Bernardi, Giacomo/0000-0002-8249-4678; Beldade, Ricardo/0000-0003-1911-0122	Foundation (Moorea Coral Reef LTER) [OCE04-17412, OCE 10-26851]; Gordon and Betty Moore Foundation; FCT (Fundacao para a Ciencia e Tecnologia) [SFRH/BPD/26901/2006]	Foundation (Moorea Coral Reef LTER); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology)	Foundation (Moorea Coral Reef LTER OCE04-17412, OCE 10-26851) and the Gordon and Betty Moore Foundation. R. Beldade was funded by FCT (Fundacao para a Ciencia e Tecnologia) (SFRH/BPD/26901/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beldade R, 2012, P ROY SOC B-BIOL SCI, V279, P2116, DOI 10.1098/rspb.2011.2433; Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Bernardi G, 2002, P ROY SOC B-BIOL SCI, V269, P599, DOI 10.1098/rspb.2001.1922; Berumen ML, 2010, CORAL REEFS, V29, P883, DOI 10.1007/s00338-010-0652-z; Buston PM, 2009, MOL ECOL, V18, P4707, DOI 10.1111/j.1365-294X.2009.04383.x; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Dixson DL, 2008, P ROY SOC B-BIOL SCI, V275, P2831, DOI 10.1098/rspb.2008.0876; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fautin DG, 1997, ANEMONEFISHES THEIR; Francis RC, 2011, FISHERIES, V32, P217; FRICKE HW, 1974, NATURWISSENSCHAFTEN, V61, P367, DOI 10.1007/BF00600312; Gaines SD, 2003, ECOL APPL, V13, pS32; Garnaud J., 1957, Bulletin de l'Institut Oceanographique Monaco, VNo. 1096, P1; Hauser L, 2011, MOL ECOL RESOUR, V11, P150, DOI 10.1111/j.1755-0998.2010.02961.x; Hedgecock D, 2007, OCEANOGRAPHY, V20, P70, DOI 10.5670/oceanog.2007.30; Hench JL, 2008, LIMNOL OCEANOGR, V53, P2681, DOI 10.4319/lo.2008.53.6.2681; Johnson MS, 1999, MAR BIOL, V135, P133, DOI 10.1007/s002270050610; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Leis JM., 1991, ECOLOGY FISHES CORAL, P182, DOI DOI 10.1016/B978-0-08-092551-6.50013-1; Leray M, 2010, EVOLUTION, V64, P1218, DOI 10.1111/j.1558-5646.2009.00917.x; Leray M, 2009, MOL ECOL RESOUR, V9, P213, DOI 10.1111/j.1755-0998.2008.02380.x; Li G, 1998, CAN J FISH AQUAT SCI, V55, P1025, DOI 10.1139/cjfas-55-4-1025; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Moberg PE, 2000, MAR BIOL, V136, P773, DOI 10.1007/s002270000281; Palumbi SR, 2003, ECOL APPL, V13, pS146; Planes S, 2002, J FISH BIOL, V61, P1033, DOI 10.1006/jfbi.2002.2123; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Saenz-Agudelo P, 2009, MOL ECOL, V18, P1765, DOI 10.1111/j.1365-294X.2009.04109.x; Saenz-Agudelo P, 2011, P ROY SOC B-BIOL SCI, V278, P2954, DOI 10.1098/rspb.2010.2780; Schmitt RJ, 1999, OECOLOGIA, V118, P76, DOI 10.1007/s004420050705; Schmitt RJ, 1996, MAR FRESHWATER RES, V47, P449, DOI 10.1071/MF9960449; Schmitt RJ, 2000, ECOLOGY, V81, P3479, DOI 10.1890/0012-9658(2000)081[3479:HLROCR]2.0.CO;2; Schmitt RJ, 1999, ECOL LETT, V2, P294, DOI 10.1046/j.1461-0248.1999.00086.x; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Thresher RE, 1984, REPROD REEF FISHES; Toonen RJ, 2001, EVOLUTION, V55, P2439; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veliz D, 2006, MOL ECOL, V15, P4193, DOI 10.1111/j.1365-294X.2006.03078.x; WELLINGTON GM, 1989, MAR BIOL, V101, P557, DOI 10.1007/BF00541659; [No title captured]	44	53	53	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44953	10.1371/journal.pone.0044953	http://dx.doi.org/10.1371/journal.pone.0044953			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028700	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700063
J	Zhou, SL; Shen, DD; Wang, YJ; Gong, LL; Tang, XY; Yu, B; Gu, XS; Ding, F				Zhou, Songlin; Shen, Dingding; Wang, Yongjun; Gong, Leilei; Tang, Xiaoyan; Yu, Bin; Gu, Xiaosong; Ding, Fei			microRNA-222 Targeting PTEN Promotes Neurite Outgrowth from Adult Dorsal Root Ganglion Neurons following Sciatic Nerve Transection	PLOS ONE			English	Article							INTRINSIC GROWTH-STATE; CONDITIONING LESION; AXONAL REGENERATION; IN-VITRO; PERIPHERAL REGENERATION; GENE-EXPRESSION; CELL-SURVIVAL; SENSORY AXONS; INHIBITION; MIR-222	Dorsal root ganglia (DRG) neurons spontaneously undergo neurite growth after nerve injury. MicroRNAs (miRNAs), as small, non-coding RNAs, negatively regulate gene expression in a variety of biological processes. The roles of miRNAs in the regulation of responses of DRG neurons to injury stimuli, however, are not fully understood. Here, microarray analysis was performed to profile the miRNAs in L4-L6 DRGs following rat sciatic nerve transection. The 26 known miRNAs were differentially expressed at 0, 1, 4, 7, 14 d post injury, and the potential targets of the miRNAs were involved in nerve regeneration, as analyzed by bioinformatics. Among the 26 miRNAs, microRNA-222 (miR-222) was our research focus because its increased expression promoted neurite outgrowth while it silencing by miR-222 inhibitor reduced neurite outgrowth. Knockdown experiments confirmed that phosphatase and tensin homolog deleted on chromosome 10 (PTEN), a major inhibitor of nerve regeneration, was a direct target of miR-222 in DRG neurons. In addition, we found that miR-222 might regulate the phosphorylation of cAMP response element binding protein (CREB) through PTEN, and c-Jun activation might enhance the miR-222 expression. Collectively, our data suggest that miR-222 could regulate neurite outgrowth from DRG neurons by targeting PTEN.	[Zhou, Songlin; Shen, Dingding; Wang, Yongjun; Gong, Leilei; Yu, Bin; Gu, Xiaosong; Ding, Fei] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China; [Tang, Xiaoyan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Nantong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, SL (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China.	neurongu@public.nt.js.cn; shengdd@public.nt.js.cn			National Natural Science Foundation of China [81130080, 81171180, 30870811]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by National Natural Science Foundation of China (Grant No. 81130080, 81171180, and 30870811), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BISBY MA, 1983, J NEUROBIOL, V14, P467, DOI 10.1002/neu.480140607; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gao Y, 2003, J NEUROSCI, V23, P11770; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gu TT, 2011, CANCER RES, V71, P2821, DOI 10.1158/0008-5472.CAN-10-3399; Hoffman PN, 2010, EXP NEUROL, V223, P11, DOI 10.1016/j.expneurol.2009.09.006; Izumi B, 2011, NEUROSCI LETT, V492, P114, DOI 10.1016/j.neulet.2011.01.068; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Makwana M, 2005, FEBS J, V272, P2628, DOI 10.1111/j.1742-4658.2005.04699.x; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Neumann S, 2005, P NATL ACAD SCI USA, V102, P16848, DOI 10.1073/pnas.0508538102; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; Ouyang YB, 2012, NEUROBIOL DIS, V45, P555, DOI 10.1016/j.nbd.2011.09.012; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Rishal I, 2010, EXP NEUROL, V223, P5, DOI 10.1016/j.expneurol.2009.08.010; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Shim S, 2010, EXP NEUROL, V223, P38, DOI 10.1016/j.expneurol.2009.10.001; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Strickland ER, 2011, NEUROSCIENCE, V186, P146, DOI 10.1016/j.neuroscience.2011.03.063; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Sun T, 2009, CELL CYCLE, V8, P2315, DOI 10.4161/cc.8.15.9221; Sun Y, 2007, MOL CANCER THER, V6, P2477, DOI 10.1158/1535-7163.MCT-07-0186; Vinciguerra M, 2009, HEPATOLOGY, V49, P1176, DOI 10.1002/hep.22737; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wu D, 2011, NEUROSCIENCE, V190, P386, DOI 10.1016/j.neuroscience.2011.06.017; Wu D, 2012, EXP NEUROL, V233, P555, DOI 10.1016/j.expneurol.2011.11.041; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024612; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhou SL, 2011, NEUROSCI LETT, V494, P89, DOI 10.1016/j.neulet.2011.02.064	50	84	87	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44768	10.1371/journal.pone.0044768	http://dx.doi.org/10.1371/journal.pone.0044768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028614	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700037
J	Sem, X; Rhen, M				Sem, XiaoHui; Rhen, Mikael			Pathogenicity of Salmonella enterica in Caenorhabditis elegans Relies on Disseminated Oxidative Stress in the Infected Host	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; PHAGOCYTE OXIDASE; VIRULENCE FACTORS; NADPH-OXIDASE; TYPHIMURIUM; THIOREDOXIN; COLONIZATION; REPLICATION; MACROPHAGES; INTESTINE	Feeding Caenorhabditis elegans with Salmonella enterica serovar Typhimurium significantly shortens the lifespan of the nematode. S. Typhimurium-infected C. elegans, stained with 2',7'-dichlorodihydrofluorescein diacetate which fluoresces upon exposure to reactive oxygen species, revealed intestinal luminal staining that along with the time of infection progressed to a strong staining in the hypodermal tissues of the nematode. Still, we could not detect invasion beyond the nematode's intestinal epithelium at any stage of the infection. A similar dispersion of oxidative response was also noted in nematodes infected with S. Dublin, but not with non-pathogenic Escherichia coli or the defined pathogen Burkholderia thailandensis. Addition of catalase or the reductant ascorbic acid significantly restored the lifespan of S. Typhimurium-infected nematodes. Mutational inactivation of the bacterial thioredoxin 1 resulted in total ablation of the hypodermal oxidative response to infection, and in a strong attenuation of virulence. Virulence of the thioredoxin 1 mutant was restored by trans-complementation with redox-active variants of thioredoxin 1 or, surprisingly, by exposing the thioredoxin 1 mutant to sublethal concentrations of the disulphide catalyst copper chloride prior to infection. In summary, our observations define a new aspect in virulence of S. enterica that apparently does not involve the classical invasive or intracellular phenotype of the pathogen, but that depends on the ability to provoke overwhelming systemic oxidative stress in the host through the redox activity of bacterial thioredoxin 1.	[Sem, XiaoHui; Rhen, Mikael] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Karolinska Institutet	Rhen, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Mikael.Rhen@ki.se			Swedish Medical Research Council	Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This study was supported by research grants from the Swedish Medical Research Council to MR. XS is a Ph.D. fellow of Agency for Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aguirre A, 2006, J BACTERIOL, V188, P6889, DOI 10.1128/JB.00804-06; Alegado RA, 2003, CELL MICROBIOL, V5, P435, DOI 10.1046/j.1462-5822.2003.00287.x; Andrades Michael Everton, 2009, Front Biosci (Elite Ed), V1, P277; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Aslund F, 1999, J BACTERIOL, V181, P1375; Berger MM, 2007, CRIT CARE MED, V35, pS584, DOI 10.1097/01.CCM.0000279189.81529.C4; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Bjur E, 2006, INFECT IMMUN, V74, P5140, DOI 10.1128/IAI.00449-06; Bolm M, 2004, INFECT IMMUN, V72, P1192, DOI 10.1128/IAI.72.2.1192-1194.2004; BRENNER S, 1974, GENETICS, V77, P71; Cadenas S, 2002, TOXICOLOGY, V180, P45, DOI 10.1016/S0300-483X(02)00381-5; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Clark MA, 1998, INFECT IMMUN, V66, P724, DOI 10.1128/IAI.66.2.724-731.1998; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; GINSBURG I, 1993, FREE RADICAL BIO MED, V14, P495, DOI 10.1016/0891-5849(93)90106-5; Gulig PA, 1998, INFECT IMMUN, V66, P2471, DOI 10.1128/IAI.66.6.2471-2485.1998; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Halliwell B., 2007, FREE RADICALS BIOL M; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; Hiniker A, 2005, J BIOL CHEM, V280, P33785, DOI 10.1074/jbc.M505742200; HOHMANN AW, 1978, INFECT IMMUN, V22, P763, DOI 10.1128/IAI.22.3.763-770.1978; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jansen WTM, 2002, INFECT IMMUN, V70, P5202, DOI 10.1128/IAI.70.9.5202-5207.2002; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; KENYON C, 1988, SCIENCE, V240, P1448, DOI 10.1126/science.3287621; Kern R, 2003, BIOCHEM J, V371, P965, DOI 10.1042/BJ20030093; King CG, 1932, SCIENCE, V75, P357, DOI 10.1126/science.75.1944.357-a; Kingsley RA, 2000, MOL MICROBIOL, V36, P1006, DOI 10.1046/j.1365-2958.2000.01907.x; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; Negrea A, 2009, J BACTERIOL, V191, P6918, DOI 10.1128/JB.00532-09; NEVOLA JJ, 1985, INFECT IMMUN, V50, P152, DOI 10.1128/IAI.50.1.152-159.1985; OYAMA Y, 1994, BRAIN RES, V635, P113, DOI 10.1016/0006-8993(94)91429-X; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Schikora A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024112; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Tezcan-Merdol D, 2004, APPL ENVIRON MICROB, V70, P3706, DOI 10.1128/AEM.70.6.3706-3714.2004; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Wilson John X, 2012, Subcell Biochem, V56, P67, DOI 10.1007/978-94-007-2199-9_5; Xu X, 2011, NAT REV GENET, V12, P793, DOI 10.1038/nrg3050	57	37	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45417	10.1371/journal.pone.0045417	http://dx.doi.org/10.1371/journal.pone.0045417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028994	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900040
J	Bliss, LA; Sams, MR; Deep-Soboslay, A; Ren-Patterson, R; Jaffe, AE; Chenoweth, JG; Jaishankar, A; Kleinman, JE; Hyde, TM				Bliss, Lindsay A.; Sams, Malik R.; Deep-Soboslay, Amy; Ren-Patterson, Renee; Jaffe, Andrew E.; Chenoweth, Josh G.; Jaishankar, Amritha; Kleinman, Joel E.; Hyde, Thomas M.			Use of Postmortem Human Dura Mater and Scalp for Deriving Human Fibroblast Cultures	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; IN-VITRO; IPS CELLS; EXPRESSION; DISORDERS; INDUCTION; TIME	Fibroblasts can be collected from deceased individuals, grown in culture, reprogrammed into induced pluripotent stem cells (iPSCs), and then differentiated into a multitude of cell types, including neurons. Past studies have generated iPSCs from somatic cell biopsies from either animal or human subjects. Previously, fibroblasts have only been successfully cultured from postmortem human skin in two studies. Here we present data on fibroblast cell cultures generated from 146 scalp and/or 53 dura mater samples from 146 postmortem human brain donors. In our overall sample, the odds of successful dural culture was almost two-fold compared with scalp (OR = 1.95, 95% CI: [1.01, 3.9], p = 0.047). Using a paired design within subjects for whom both tissues were available for culture (n = 53), the odds of success for culture in dura was 16-fold as compared to scalp (OR = 16.0, 95% CI: [2.1-120.6], p = 0.0007). Unattended death, tissue donation source, longer postmortem interval (PMI), and higher body mass index (BMI) were associated with unsuccessful culture in scalp (all p, 0.05), but not in dura. While scalp cells proliferated more and grew more rapidly than dura cells [F (1, 46) = 12.94, p, 0.008], both tissues could be generated and maintained as fibroblast cell lines. Using a random sample of four cases, we found that both postmortem scalp and dura could be successfully reprogrammed into iPSC lines. Our study demonstrates that postmortem dura mater, and to a lesser extent, scalp, are viable sources of living fibroblasts for culture that can be used to generate iPSCs. These tissues may be accessible through existing brain tissue collections, which is critical for studying disorders such as neuropsychiatric diseases.	[Jaffe, Andrew E.; Chenoweth, Josh G.; Jaishankar, Amritha; Hyde, Thomas M.] Lieber Inst Brain Dev, Baltimore, MD USA; [Bliss, Lindsay A.; Sams, Malik R.; Deep-Soboslay, Amy; Ren-Patterson, Renee; Kleinman, Joel E.] NIMH, Sect Neuropathol, Clin Brain Disorders Branch, Div Intramural Res Programs,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Hyde, TM (corresponding author), Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD USA.	hydetm@aol.com	Jaffe, Andrew/GPF-5693-2022; Jaffe, Andrew/L-3089-2016	Jaffe, Andrew/0000-0001-6886-1454; Jaffe, Andrew/0000-0001-6886-1454	Intramural Research Program at the National Institute of Mental Health, National Institutes of Health	Intramural Research Program at the National Institute of Mental Health, National Institutes of Health	This work was supported by the Intramural Research Program at the National Institute of Mental Health, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borgmann-Winter KE, 2009, NEUROSCIENCE, V158, P642, DOI 10.1016/j.neuroscience.2008.09.059; Carter DA, 2007, BRIT J OPHTHALMOL, V91, P1216, DOI 10.1136/bjo.2007.118141; Chamberlain SJ, 2008, NEUROGENETICS, V9, P227, DOI 10.1007/s10048-008-0147-z; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Hjelm BE, 2011, NEUROSCI LETT, V502, P219, DOI 10.1016/j.neulet.2011.07.048; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Meske V, 1999, J NEURAL TRANSM, V106, P537, DOI 10.1007/s007020050177; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; Ren-Patterson RF, 2005, FASEB J, V19, P1537, DOI 10.1096/fj.04-3657fje; Singh M, 2011, IN VITRO CELL DEV-AN, V47, P290, DOI 10.1007/s11626-011-9395-6; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Stacey GN, 2011, METHODS MOL BIOL, V731, P79, DOI 10.1007/978-1-61779-080-5_7; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamura S, 2007, BIOCHEM BIOPH RES CO, V358, P226, DOI 10.1016/j.bbrc.2007.04.124; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108	15	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45282	10.1371/journal.pone.0045282	http://dx.doi.org/10.1371/journal.pone.0045282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028905	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517500025
J	Stringer, AM; Singh, N; Yermakova, A; Petrone, BL; Amarasinghe, JJ; Reyes-Diaz, L; Mantis, NJ; Wade, JT				Stringer, Anne M.; Singh, Navjot; Yermakova, Anastasiya; Petrone, Brianna L.; Amarasinghe, Jayaleka J.; Reyes-Diaz, Lucia; Mantis, Nicholas J.; Wade, Joseph T.			FRUIT, a Scar-Free System for Targeted Chromosomal Mutagenesis, Epitope Tagging, and Promoter Replacement in Escherichia coli and Salmonella enterica	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; COMPLETE GENOME SEQUENCE; EFFICIENT; GENES; DELETIONS; SELECTION; OVERLAP; MARKER	Recombineering is a widely-used approach to delete genes, introduce insertions and point mutations, and introduce epitope tags into bacterial chromosomes. Many recombineering methods have been described, for a wide range of bacterial species. These methods are often limited by (i) low efficiency, and/or (ii) introduction of "scar'' DNA into the chromosome. Here, we describe a rapid, efficient, PCR-based recombineering method, FRUIT, that can be used to introduce scar-free point mutations, deletions, epitope tags, and promoters into the genomes of enteric bacteria. The efficiency of FRUIT is far higher than that of the most widely-used recombineering method for Escherichia coli. We have used FRUIT to introduce point mutations and epitope tags into the chromosomes of E. coli K-12, Enterotoxigenic E. coli, and Salmonella enterica. We have also used FRUIT to introduce constitutive and inducible promoters into the chromosome of E. coli K-12. Thus, FRUIT is a versatile, efficient recombineering approach that can be applied in multiple species of enteric bacteria.	[Stringer, Anne M.; Singh, Navjot; Petrone, Brianna L.; Amarasinghe, Jayaleka J.; Mantis, Nicholas J.; Wade, Joseph T.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Yermakova, Anastasiya; Mantis, Nicholas J.; Wade, Joseph T.] SUNY Albany, Dept Biomed Sci, Albany, NY USA; [Reyes-Diaz, Lucia] SUNY Albany, UASRP CSTEP Program, Albany, NY 12222 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Wade, JT (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.	jwade@wadsworth.org		Mantis, Nicholas/0000-0002-5083-8640; Wade, Joseph/0000-0002-9779-3160	National Institutes of Health (NIH) [DP2OD007188, R03AI094245, R01HD061916]; NIH training grant [T32AI055429]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI094245, T32AI055429] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007188] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants DP2OD007188 (JTW), R03AI094245 (JTW), and R01HD061916 (NJM). JJA and AY were supported by NIH training grant T32AI055429. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blank K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015763; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Burr T, 2000, NUCLEIC ACIDS RES, V28, P1864, DOI 10.1093/nar/28.9.1864; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cho BK, 2006, BIOTECHNIQUES, V40, P67, DOI 10.2144/000112039; Cox MM, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-59; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeVito JA, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1084; Dornenburg JE, 2010, MBIO, V1, DOI 10.1128/mBio.00024-10; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Forbes SJ, 2008, INFECT IMMUN, V76, P4137, DOI 10.1128/IAI.00416-08; Gerlach RG, 2009, APPL ENVIRON MICROB, V75, P1575, DOI 10.1128/AEM.02509-08; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Lee DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-252; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Moqtaderi Z, 2008, YEAST, V25, P287, DOI 10.1002/yea.1581; MORALEJO P, 1993, J BACTERIOL, V175, P5585, DOI 10.1128/JB.175.17.5585-5594.1993; Rintoul MR, 2002, J MOL BIOL, V324, P599, DOI 10.1016/S0022-2836(02)01134-8; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Thomason L, 2005, CURRENT PROTOCOLS MO, P11611; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wong QNY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni059; Yu BJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn359	33	41	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44841	10.1371/journal.pone.0044841	http://dx.doi.org/10.1371/journal.pone.0044841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028641	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500009
J	Fujikane, R; Sanada, M; Sekiguchi, M; Hidaka, M				Fujikane, Ryosuke; Sanada, Masayuki; Sekiguchi, Mutsuo; Hidaka, Masumi			The Identification of a Novel Gene, MAPO2, That Is Involved in the Induction of Apoptosis Triggered by O-6-Methylguanine	PLOS ONE			English	Article							O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; COMPLEMENTARY-DNA; MISMATCH REPAIR; MUTL-ALPHA; MGMT; MICE; MUTAGENESIS; PROTEIN; CLONING; ROLES	O-6-Methylguanine, one of alkylated DNA bases, is especially mutagenic. Cells containing this lesion are eliminated by induction of apoptosis, associated with the function of mismatch repair (MMR) proteins. A retrovirus-mediated gene-trap mutagenesis was used to isolate new genes related to the induction of apoptosis, triggered by the treatment with an alkylating agent, N-methyl-N-nitrosourea (MNU). This report describes the identification of a novel gene, MAPO2 (O-6-methylguanine-induced apoptosis 2), which is originally annotated as C1orf201. The MAPO2 gene is conserved among a wide variety of multicellular organisms and encodes a protein containing characteristic PxPxxY repeats. To elucidate the function of the gene product in the apoptosis pathway, a human cell line derived from HeLa MR cells, in which the MAPO2 gene was stably knocked down by expressing specific miRNA, was constructed. The knockdown cells grew at the same rate as HeLa MR, thus indicating that MAPO2 played no role in the cellular growth. After exposure to MNU, HeLa MR cells and the knockdown cells underwent cell cycle arrest at G(2)/M phase, however, the production of the sub-G1 population in the knockdown cells was significantly suppressed in comparison to that in HeLa MR cells. Moreover, the activation of BAK and caspase-3, and depolarization of mitochondrial membrane, hallmarks for the induction of apoptosis, were also suppressed in the knockdown cells. These results suggest that the MAPO2 gene product might positively contribute to the induction of apoptosis triggered by O-6-methylguanine.	[Fujikane, Ryosuke; Sanada, Masayuki; Hidaka, Masumi] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka, Japan; [Sekiguchi, Mutsuo] Fukuoka Dent Coll, Adv Sci Res Ctr, Fukuoka, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC)	Hidaka, M (corresponding author), Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Fukuoka, Japan.	hidaka@college.fdcnet.ac.jp		Fujikane, Ryosuke/0000-0002-6621-3848	Fukuoka Foundation for Sound Health; MEXT	Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Cancer Research Fund from Fukuoka Foundation for Sound Health (to RF), MEXT-Grants-in-Aid and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2008-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COSSARIZZA A, 1994, EXP CELL RES, V214, P323, DOI 10.1006/excr.1994.1264; COULONDRE C, 1977, J MOL BIOL, V117, P577, DOI 10.1016/0022-2836(77)90059-6; de Carvalho CE, 2002, BIOL REPROD, V66, P785, DOI 10.1095/biolreprod66.3.785; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Glassner BJ, 1999, MUTAGENESIS, V14, P339, DOI 10.1093/mutage/14.3.339; HAYAKAWA H, 1990, J MOL BIOL, V213, P739, DOI 10.1016/S0022-2836(05)80260-8; Hickman MJ, 1999, P NATL ACAD SCI USA, V96, P10764, DOI 10.1073/pnas.96.19.10764; Hidaka M, 2005, NUCLEIC ACIDS RES, V33, P5703, DOI 10.1093/nar/gki878; ITO T, 1994, MUTAT RES, V314, P273, DOI 10.1016/0921-8777(94)90071-X; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; Kawate H, 1998, P NATL ACAD SCI USA, V95, P5116, DOI 10.1073/pnas.95.9.5116; Komori K, 2009, ONCOGENE, V28, P1142, DOI 10.1038/onc.2008.462; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Margison GP, 2002, BIOESSAYS, V24, P255, DOI 10.1002/bies.10063; Ochs K, 2000, CANCER RES, V60, P5815; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; Pepponi R, 2003, J PHARMACOL EXP THER, V304, P661, DOI 10.1124/jpet.102.043950; Sakumi K, 1997, CANCER RES, V57, P2415; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Takagi Y, 2003, DNA REPAIR, V2, P1135, DOI 10.1016/S1568-7864(03)00134-4; Takagi Y, 2008, BIOCHEM PHARMACOL, V76, P303, DOI 10.1016/j.bcp.2008.05.008; Tsuzuki T, 1996, CARCINOGENESIS, V17, P1215, DOI 10.1093/carcin/17.6.1215; Wei MC, 2000, GENE DEV, V14, P2060; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023	27	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44817	10.1371/journal.pone.0044817	http://dx.doi.org/10.1371/journal.pone.0044817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028632	gold, Green Submitted, Green Published			2022-12-27	WOS:000309554700017
J	Wilding, TA				Wilding, Thomas A.			Changes in Sedimentary Redox Associated with Mussel (Mytilus edulis L.) Farms on the West-Coast of Scotland	PLOS ONE			English	Article							MACROBENTHIC COMMUNITY STRUCTURE; MACROFAUNAL COMMUNITIES; SHELLFISH AQUACULTURE; ORGANIC ENRICHMENT; SESTON DEPLETION; SALDANHA BAY; CULTURE; IMPACTS; BIODEPOSITION; GEOCHEMISTRY	Aquaculture is growing rapidly in response to an increasing demand for protein and the over-exploitation of wild fisheries. Mussel (family Mytilidae) production has doubled over the last decade and currently stands at 1.5 million tonnes production per annum. Mussels produce organic biodeposits which are dispersed around the production site and, potentially, impact the receiving environment in a number of inter-linked ways. The reported benthic impacts that occur, primarily through the accumulation of these biodeposits and associated organic enrichment, vary widely between studies. The objectives of this research were to determine the nature of the relationship between sediment redox (a proxy for oxygenation) and farm-proximity and covariables whilst accounting for, and quantifying, differences in redox between sites. Sediment cores (N = 159) were taken remotely around a random sample of mussel farms, redox was measured at 10 mm sediment depth and linked to farm-distance and sediment organic/ shell content and particle size, using an additive, mixed, weighted regression model. Redox varied considerably between sites and there was a highly significant reduction (50 mV) in redox adjacent to the mussel lines. Redox increased non-linearly with distance, rising rapidly at >7 m from the farm edge. The modest reduction in sediment oxygenation in close proximity to mussel farms reported here suggests that farms located over sediments characterised by pre-existing oxygen stress are likely to exacerbate benthic species impoverishment associated with reducing sedimentary conditions whilst those located over highly oxygenated sediments are likely to increase benthic productivity.	Scottish Assoc Marine Sci, Scottish Marine Inst, Dept Ecol, Oban, Argyll, Scotland	UHI Millennium Institute	Wilding, TA (corresponding author), Scottish Assoc Marine Sci, Scottish Marine Inst, Dept Ecol, Oban, Argyll, Scotland.	Tom.wilding@sams.ac.uk	Wilding, Tom/AAN-8904-2020	Wilding, Thomas/0000-0002-4946-4020	Scottish Aquaculture Research Forum [SARF053]; NERC [dml011001] Funding Source: UKRI; Natural Environment Research Council [dml011001] Funding Source: researchfish	Scottish Aquaculture Research Forum; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Scottish Aquaculture Research Forum (Project SARF053) for which the author is grateful. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alonso-Perez F, 2010, J EXP MAR BIOL ECOL, V382, P96, DOI 10.1016/j.jembe.2009.11.008; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Asche Frank, 2008, P271, DOI 10.1007/978-1-4020-6810-2_9; Bale A.J., 2005, METHODS STUDY MARINE, V3, P43, DOI DOI 10.1002/9780470995129.CH2; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BLACK KD, 1998, BIOL FARMED FISH, P284; Boyd AJ, 1998, J SHELLFISH RES, V17, P25; Callier MD, 2008, AQUACULTURE, V278, P77, DOI 10.1016/j.aquaculture.2008.03.026; Callier MD, 2007, MAR ECOL PROG SER, V348, P103, DOI 10.3354/meps07034; Callier MD, 2006, MAR ECOL PROG SER, V322, P129, DOI 10.3354/meps322129; Cao L, 2007, ENVIRON SCI POLLUT R, V14, P452, DOI 10.1065/espr2007.05.426; Carranza A, 2009, REV FISH BIOL FISHER, V19, P349, DOI 10.1007/s11160-009-9108-3; Chamberlain J, 2001, ICES J MAR SCI, V58, P411, DOI 10.1006/jmsc.2000.1037; Christensen PB, 2003, AQUACULTURE, V218, P567, DOI 10.1016/S0044-8486(02)00587-2; CRAIB J. S., 1965, J CONS CONS PERMA INT EXPLOR MER, V30, P34; Cranford PJ, 2009, AQUACULTURE, V292, P189, DOI 10.1016/j.aquaculture.2009.04.039; da Costa KG, 2006, AQUACULTURE, V258, P655, DOI 10.1016/j.aquaculture.2006.04.023; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dumbauld BR, 2009, AQUACULTURE, V290, P196, DOI 10.1016/j.aquaculture.2009.02.033; Fehling J, 2006, MAR ECOL PROG SER, V323, P91, DOI 10.3354/meps323091; Grant J, 2008, J MARINE SYST, V73, P155, DOI 10.1016/j.jmarsys.2007.10.007; Grant J, 2007, CAN J FISH AQUAT SCI, V64, P387, DOI 10.1139/F07-021; Hall-Spencer J, 2006, MAR ECOL PROG SER, V326, P1, DOI 10.3354/meps326001; Hargrave BT, 2008, MAR ECOL PROG SER, V365, P137, DOI 10.3354/meps07636; Inglis GJ, 2003, J APPL ECOL, V40, P1077, DOI 10.1111/j.1365-2664.2003.00860.x; Jiang WM, 2005, AQUACULTURE, V244, P171, DOI 10.1016/j.aquaculture.2004.11.050; Kaiser MJ, 1998, J SHELLFISH RES, V17, P59; Keeley N, 2009, 1476 MIN FISH; Lasiak TA, 2006, AQUAT CONSERV, V16, P289, DOI 10.1002/aqc.710; Loh PS, 2008, HYDROL EARTH SYST SC, V12, P811, DOI 10.5194/hess-12-811-2008; MATTSSON J, 1983, SARSIA, V68, P97, DOI 10.1080/00364827.1983.10420561; McKindsey CW, 2011, CAN J ZOOL, V89, P622, DOI [10.1139/Z11-037, 10.1139/z11-037]; Miron G, 2005, AQUACULTURE, V250, P138, DOI 10.1016/j.aquaculture.2005.01.030; Mirto S, 2000, MAR POLLUT BULL, V40, P244, DOI 10.1016/S0025-326X(99)00209-X; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Olsen Y, 2011, AQUACULT ENV INTERAC, V1, P187, DOI 10.3354/aei00019; Otero XL, 2009, ESTUAR COAST SHELF S, V81, P83, DOI 10.1016/j.ecss.2008.10.006; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Piumsombun S., 2005, Aquaculture Economics and Management, V9, P265, DOI 10.1080/13657300590961582; Plew DR, 2005, IEEE J OCEANIC ENG, V30, P95, DOI 10.1109/JOE.2004.841387; Rees DG, 2001, ESSENTIAL STAT; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; SEPA, 2021, FLOOD MOD GUID RESP; Smaal AC, 2002, HYDROBIOLOGIA, V484, P89, DOI 10.1023/A:1021352904712; Somerfield PJ, 2000, RAFFLES B ZOOL, V48, P263; Stenton-Dozey JME, 1999, MAR POLLUT BULL, V39, P357, DOI 10.1016/S0025-326X(98)00180-5; Strohmeier T, 2005, J SHELLFISH RES, V24, P15; TENORE KR, 1982, J MAR RES, V40, P701; VANIPEREN J, 1985, MAR GEOL, V64, P179, DOI 10.1016/0025-3227(85)90167-7; Weise AM, 2009, AQUACULTURE, V288, P239, DOI 10.1016/j.aquaculture.2008.12.001; Wildish DJ, 2001, ICES J MAR SCI, V58, P469, DOI 10.1006/jmsc.2000.1030; Wong KLC, 2011, NEW ZEAL J MAR FRESH, V45, P187, DOI 10.1080/00288330.2010.550628; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Ysebaert T, 2009, HELGOLAND MAR RES, V63, P59, DOI 10.1007/s10152-008-0136-5; ZOBELL CE, 1946, AAPG BULL, V30, P477; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1; 2009, LANGUAGE ENV STAT CO	60	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45159	10.1371/journal.pone.0045159	http://dx.doi.org/10.1371/journal.pone.0045159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028817	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700026
J	Smith, TH; Grider, JR; Dewey, WL; Akbarali, HI				Smith, Tricia H.; Grider, John R.; Dewey, William L.; Akbarali, Hamid I.			Morphine Decreases Enteric Neuron Excitability via Inhibition of Sodium Channels	PLOS ONE			English	Article							GUINEA-PIG ILEUM; LOCUS COERULEUS NEURONS; MYENTERIC NEURONS; NERVOUS-SYSTEM; MORPHOLOGICAL-CHARACTERISTICS; SLOW AFTERHYPERPOLARIZATION; POTASSIUM CONDUCTANCE; SMALL-INTESTINE; MOUSE COLON; PLEXUS	Gastrointestinal peristalsis is significantly dependent on the enteric nervous system. Constipation due to reduced peristalsis is a major side-effect of morphine, which limits the chronic usefulness of this excellent pain reliever in man. The ionic basis for the inhibition of enteric neuron excitability by morphine is not well characterized as previous studies have mainly utilized microelectrode recordings from whole mount myenteric plexus preparations in guinea pigs. Here we have developed a Swiss-Webster mouse myenteric neuron culture and examined their electrophysiological properties by patch-clamp techniques and determined the mechanism for morphine-induced decrease in neuronal excitability. Isolated neurons in culture were confirmed by immunostaining with pan-neuronal marker, beta-III tubulin and two populations were identified by calbindin and calretinin staining. Distinct neuronal populations were further identified based on the presence and absence of an afterhyperpolarization (AHP). Cells with AHP expressed greater density of sodium currents. Morphine (3 mu M) significantly reduced the amplitude of the action potential, increased the threshold for spike generation but did not alter the resting membrane potential. The decrease in excitability resulted from inhibition of sodium currents. In the presence of morphine, the steady-state voltage dependence of Na channels was shifted to the left with almost 50% of channels unavailable for activation from hyperpolarized potentials. During prolonged exposure to morphine (two hours), action potentials recovered, indicative of the development of tolerance in single enteric neurons. These results demonstrate the feasibility of isolating mouse myenteric neurons and establish sodium channel inhibition as a mechanism for morphine-induced decrease in neuronal excitability.	[Smith, Tricia H.; Dewey, William L.; Akbarali, Hamid I.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Grider, John R.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Akbarali, HI (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	hiakbarali@vcu.edu	Akbarali, Hamid/Q-9344-2019	Akbarali, Hamid/0000-0003-1423-0774	National Institutes of Health [DA024009, DK046367, T32DA007027]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046367, R01DK046367, R01DK034153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007027, R01DA024009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants DA024009, DK046367, and T32DA007027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo H, 2010, FASEB J, V24, P1082, DOI 10.1096/fj.09-139519; AKBARALI HI, 1993, J PHYSIOL-LONDON, V460, P117, DOI 10.1113/jphysiol.1993.sp019462; Catterall WA, 2002, NOVART FDN SYMP, V241, P206; CHERUBINI E, 1984, BRIT J PHARMACOL, V81, P617, DOI 10.1111/j.1476-5381.1984.tb16126.x; Clerc N, 1998, NEUROSCIENCE, V82, P899; COLLIER HOJ, 1981, BRIT J PHARMACOL, V73, P921, DOI 10.1111/j.1476-5381.1981.tb08747.x; Cornelissen W, 1999, EUR J MORPHOL, V37, P241, DOI 10.1076/ejom.37.4.241.4730; Costa M, 1996, NEUROSCIENCE, V75, P949, DOI 10.1016/0306-4522(96)00275-8; DeLuca A, 1996, PHARMACOL THERAPEUT, V69, P103, DOI 10.1016/0163-7258(95)02053-5; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; FURUKAWA K, 1986, J NEUROPHYSIOL, V55, P1395, DOI 10.1152/jn.1986.55.6.1395; GALLIGAN JJ, 1991, J AUTONOM NERV SYST, V32, P1, DOI 10.1016/0165-1838(91)90229-V; Gershon MD, 1999, HOSP PRACT, V34, P31, DOI 10.3810/hp.1999.07.153; GRIDER JR, 1994, AM J PHYSIOL, V266, pG1139, DOI 10.1152/ajpgi.1994.266.6.G1139; HIRST GDS, 1974, J PHYSIOL-LONDON, V236, P303, DOI 10.1113/jphysiol.1974.sp010436; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Johnson LR, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P1; Kang MH, 2012, J PHARMACOL EXP THER, V340, P567, DOI 10.1124/jpet.111.186320; KARRAS PJ, 1979, BRIT J PHARMACOL, V65, P647, DOI 10.1111/j.1476-5381.1979.tb07877.x; KUNZE WAA, 1995, NEUROSCIENCE, V66, P1, DOI 10.1016/0306-4522(95)00067-S; Lomax AEG, 1999, J AUTONOM NERV SYST, V76, P45, DOI 10.1016/S0165-1838(99)00008-9; Mao YK, 2006, J NEUROPHYSIOL, V96, P998, DOI 10.1152/jn.00204.2006; Neylon CB, 2004, J NEUROCHEM, V90, P1414, DOI 10.1111/j.1471-4159.2004.02593.x; Niwa H, 2012, BRIT J ANAESTH, V108, P530, DOI 10.1093/bja/aes015; NORTH RA, 1976, NEUROPHARMACOLOGY, V15, P719, DOI 10.1016/0028-3908(76)90043-5; NORTH RA, 1977, BRIT J PHARMACOL, V61, P541, DOI 10.1111/j.1476-5381.1977.tb07546.x; NORTH RA, 1985, J PHYSIOL-LONDON, V364, P265, DOI 10.1113/jphysiol.1985.sp015743; NORTH RA, 1977, EUR J PHARMACOL, V45, P23; Nurgali K, 2004, J COMP NEUROL, V468, P112, DOI 10.1002/cne.10948; Nurgali K, 2009, NEUROGASTROENT MOTIL, V21, P903, DOI 10.1111/j.1365-2982.2009.01329.x; Pan H, 2000, J NEUROSCI, V20, P3295, DOI 10.1523/JNEUROSCI.20-09-03295.2000; PATON WDM, 1957, BRIT J PHARM CHEMOTH, V12, P119, DOI 10.1111/j.1476-5381.1957.tb01373.x; PEPPER CM, 1980, SCIENCE, V209, P394, DOI 10.1126/science.7384811; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Ross GR, 2008, J PHARMACOL EXP THER, V327, P561, DOI 10.1124/jpet.108.143438; Ross GR, 2012, AM J PHYSIOL-CELL PH, V302, pC1152, DOI 10.1152/ajpcell.00171.2011; Rugiero F, 2002, J PHYSIOL-LONDON, V538, P447, DOI 10.1113/jphysiol.2001.013051; SCHAUMANN W, 1955, BRIT J PHARM CHEMOTH, V10, P456, DOI 10.1111/j.1476-5381.1955.tb00105.x; SCHMIDHAMMER H, 1989, J MED CHEM, V32, P418, DOI 10.1021/jm00122a021; Shah MM, 2001, BRIT J PHARMACOL, V132, P889, DOI 10.1038/sj.bjp.0703895; SURPRENANT A, 1985, NEUROSCIENCE, V16, P425, DOI 10.1016/0306-4522(85)90014-4	42	27	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45251	10.1371/journal.pone.0045251	http://dx.doi.org/10.1371/journal.pone.0045251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028881	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800033
J	Varma, A; Das, A; Hoke, NN; Durrant, DE; Salloum, FN; Kukreja, RC				Varma, Amit; Das, Anindita; Hoke, Nicholas N.; Durrant, David E.; Salloum, Fadi N.; Kukreja, Rakesh C.			Anti-Inflammatory and Cardioprotective Effects of Tadalafil in Diabetic Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; K-ATP CHANNELS; ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL INFARCT SIZE; PHOSPHODIESTERASE-5 INHIBITOR; ENDOTHELIAL FUNCTION; ERECTILE DYSFUNCTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; CARDIAC MYOCYTES	Background: Insulin resistance impairs nitric oxide (NO) bioavailability and obesity promotes a state of chronic inflammation and damages the vascular endothelium. Phosphodiesterase-5 inhibitors restore NO signaling and may reduce circulating inflammatory markers, and improve metabolic parameters through a number of mechanisms. We hypothesized that daily administration of the PDE-5 inhibitor, tadalafil (TAD) will attenuate inflammation, improve fasting plasma glucose and triglyceride levels, body weight, and reduce infarct size after ischemia/reperfusion injury in obese, diabetic mice. Methods: Twenty leptin receptor null (db/db) mice underwent treatment with TAD (1 mg/Kg) or 10% DMSO for 28 days. Body weight and fasting plasma glucose levels were determined weekly. Upon completion, hearts were isolated and subjected to 30 min global ischemia followed by 60 min reperfusion in a Langendorff model. Plasma samples were taken for cytokine analysis and fasting triglyceride levels. Infarct size was measured using computer morphometry of tetrazolium stained sections. Additionally, ventricular cardiomyocytes were isolated and subjected to 40 min of simulated ischemia and reoxygenation. Necrosis was determined using trypan blue exclusion and LDH release assay and apoptosis was assessed by TUNEL assay after 1 h or 18 h of reoxygenation, respectively. Results: Treatment with TAD caused a reduction in infarct size in the diabetic heart (23.2 +/- 1.5 vs. 47.8 +/- 3.7%, p<0.01, n = 6/group), reduced fasting glucose levels (292 +/- 31.8 vs. 511 +/- 19.3 mg/dL, p<0.001) and fasting triglycerides (43.3 +/- 21 vs. 129.7 +/- 29 mg/dL, p<0.05) as compared to DMSO, however body weight was not significantly reduced. Circulating tumor necrosis factor-a and interleukin-1 beta were reduced after treatment compared to control (257 +/- 16.51 vs. 402.3 +/- 17.26 and 150.8 +/- 12.55 vs. 264 +/- 31.85 pg/mL, respectively; P<0.001) Isolated cardiomyocytes from TAD-treated mice showed reduced apoptosis and necrosis. Conclusion: We have provided the first evidence that TAD therapy ameliorates circulating inflammatory cytokines and chemokines in a diabetic animal model while improving fasting glucose levels and reducing infarct size following ischemia-reperfusion injury in the heart.	[Varma, Amit; Das, Anindita; Hoke, Nicholas N.; Durrant, David E.; Salloum, Fadi N.; Kukreja, Rakesh C.] Virginia Commonwealth Univ, Div Cardiol, Dept Internal Med, VCU Pauley Heart Ctr, Richmond, VA 23284 USA	Virginia Commonwealth University	Kukreja, RC (corresponding author), Virginia Commonwealth Univ, Div Cardiol, Dept Internal Med, VCU Pauley Heart Ctr, Richmond, VA 23284 USA.	rakesh@vcu.edu	Salloum, Fadi N/C-2391-2008; Das, Anindita/K-8003-2013	Salloum, Fadi N/0000-0002-8947-9315; Das, Anindita/0000-0003-4422-7277	National Institutes of Health [HL-51045, HL-79424, HL-93685]; American Heart Association [10SDG3770011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL051045, R01HL051045, R01HL079424, R01HL093685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL-51045, HL-79424, HL-93685) to Rakesh C. Kukreja and a National Scientist Development Grant from the American Heart Association (10SDG3770011) to Fadi N. Salloum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abozguia K, 2006, NAT CLIN PRACT CARD, V3, P490, DOI 10.1038/ncpcardio0583; Ahn GJ, 2005, INT J ANDROL, V28, P260, DOI 10.1111/j.1365-2605.2005.00537.x; Aversa A, 2008, DIABETIC MED, V25, P37, DOI 10.1111/j.1464-5491.2007.02298.x; Aversa A, 2007, INT J IMPOT RES, V19, P200, DOI 10.1038/sj.ijir.3901513; Ayala JE, 2007, DIABETES, V56, P1025, DOI 10.2337/db06-0883; BARON AD, 1995, AM J PHYSIOL-ENDOC M, V269, pE709, DOI 10.1152/ajpendo.1995.269.4.E709; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bugger H, 2008, CLIN SCI, V114, P195, DOI 10.1042/CS20070166; Capurso C, 2012, VASCUL PHARM; Carroll R, 2005, AM J PHYSIOL-ENDOC M, V288, pE900, DOI 10.1152/ajpendo.00491.2004; Chau VQ, 2011, AM J PHYSIOL-HEART C, V300, pH2272, DOI 10.1152/ajpheart.00654.2010; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Cook S, 2003, SWISS MED WKLY, V133, P360; Cosentino F, 1997, CIRCULATION, V96, P25; Cui RZ, 2007, ATHEROSCLEROSIS, V190, P423, DOI 10.1016/j.atherosclerosis.2006.02.032; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Das A, 2010, P NATL ACAD SCI USA, V107, P18202, DOI 10.1073/pnas.1006965107; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Daugan A, 2003, J MED CHEM, V46, P4525, DOI 10.1021/jm030056e; Desouza C, 2002, DIABETES CARE, V25, P1336, DOI 10.2337/diacare.25.8.1336; Deyoung L, 2012, J ANDROL, V33, P176, DOI 10.2164/jandrol.111.013367; Ding H, 2007, J CELL PHYSIOL, V212, P682, DOI 10.1002/jcp.21063; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fisher PW, 2005, CIRCULATION, V111, P1601, DOI 10.1161/01.CIR.0000160359.49478.C2; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Franks PW, 2005, DIABETES, V54, P2795, DOI 10.2337/diabetes.54.9.2795; Frey Maria Klara, 2012, Expert Opin Pharmacother, V13, P747, DOI 10.1517/14656566.2012.662220; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Gazzaruso C, 2008, J AM COLL CARDIOL, V51, P2040, DOI 10.1016/j.jacc.2007.10.069; Ghanim H, 2010, DIABETES CARE, V33, P1103, DOI 10.2337/dc09-2193; Gillies HC, 2002, INT J CARDIOL, V86, P131, DOI 10.1016/S0167-5273(02)00421-7; Haas B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000511; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Hwang YC, 2001, FASEB J, V15, P243, DOI 10.1096/fj.01-0368fje; Kaneko M, 2005, ANN NY ACAD SCI, V1043, P702, DOI 10.1196/annals.1333.081; Koka S, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0249-5; Koka S, 2010, J PHARMACOL EXP THER, V334, P1023, DOI 10.1124/jpet.110.170191; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Luo L, 2011, J PHARM PHARMACOL, V63, P943, DOI 10.1111/j.2042-7158.2011.01268.x; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; McGaffin KR, 2008, CARDIOVASC RES, V77, P54, DOI 10.1093/cvr/cvm023; McGaffin KR, 2009, CARDIOVASC RES, V83, P313, DOI 10.1093/cvr/cvp071; Miki T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-67; Montorsi F, 2006, EUR UROL, V49, P979, DOI 10.1016/j.eururo.2005.12.055; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Nisoli E, 1998, BRIT J PHARMACOL, V125, P888, DOI 10.1038/sj.bjp.0702131; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Roy D, 1998, AM J PHYSIOL-ENDOC M, V274, pE692, DOI 10.1152/ajpendo.1998.274.4.E692; Rui T, 2012, CARDIOVASC RES, V94, P370, DOI 10.1093/cvr/cvs015; Sabatini S, 2011, ACTA BIOCHIM POL, V58, P237; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Salloum FN, 2007, J MOL CELL CARDIOL, V42, P453, DOI 10.1016/j.yjmcc.2006.10.015; Salloum FN, 2012, AM J PHYSIOL-HEART C, V302, pH1347, DOI 10.1152/ajpheart.00544.2011; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Salloum FN, 2006, J MOL CELL CARDIOL, V40, P405, DOI 10.1016/j.yjmcc.2005.10.002; Schafer A, 2008, BRIT J PHARMACOL, V153, P886, DOI 10.1038/sj.bjp.0707459; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Solomon H, 2003, HEART, V89, P251, DOI 10.1136/heart.89.3.251; Van der Mieren G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-89; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Wen Y, 2002, DIABETES OBES METAB, V4, P305, DOI 10.1046/j.1463-1326.2002.00212.x; Xiao RP, 1999, CIRC RES, V84, P43; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	68	61	62	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45243	10.1371/journal.pone.0045243	http://dx.doi.org/10.1371/journal.pone.0045243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028874	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800032
J	Liu, L; Wu, XM; Liu, LM; Geng, J; Yuan, Z; Shan, ZY; Chen, L				Liu, Lei; Wu, Xiaomei; Liu, Limin; Geng, Jin; Yuan, Zhe; Shan, Zhongyan; Chen, Lei			Prevalence of Diabetic Retinopathy in Mainland China: A Meta-Analysis	PLOS ONE			English	Article							RISK-FACTORS; VISUAL IMPAIRMENT; POPULATION; DISEASE; URBAN	Background: Although diabetic retinopathy (DR) is considered to be a major cause of blindness, this is the first meta-analysis to investigate the pooled prevalence of DR in mainland China. Methodology/Principal Findings: We conducted a search of all English reports on population-based studies for the prevalence of DR using Medline, EMbase, Web of Science, Google (scholar), and all Chinese reports were identified manually and on-line using CBMDisc, Chongqing VIP database, and CNKI database. A meta-analysis was carried out. The fixed effects model or random effects model was used as a statistical test for homogeneity. Nineteen studies were included. The prevalence of DR, non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) in the pooled general population was 1.3% (95% CI: 0.5%-3.2%), 1.1% (95% CI: 0.6%-2.1%), and 0.1% (95% CI: 0.1%-0.3%), respectively, but was 23% (95% CI: 17.8%-29.2%), 19.1% (95% CI: 13.6%-26.3%), and 2.8% (95% CI: 1.9%-4.2%) in the diabetic group. The prevalence rate of DR in the pooled rural population was higher than that in the urban population, 1.6% (95% CI: 1.3%-2%), and the diabetic population, 29.1% (95% CI: 20.9%-38.9%). The prevalence of DR was higher in the Northern region compared with the Southern region. Conclusions/Significance: The prevalence of DR in mainland China appeared a little high, and varied according to area. NPDR was more common. This study highlights the necessity for DR screening in the rural areas of China.	[Liu, Lei; Liu, Limin; Geng, Jin; Yuan, Zhe; Chen, Lei] China Med Univ, Hosp 1, Dept Ophthalmol, Shenyang, Peoples R China; [Wu, Xiaomei] China Med Univ, Hosp 1, Dept Clin Epidemiol & Evidence Med, Shenyang, Peoples R China; [Liu, Lei; Geng, Jin; Shan, Zhongyan; Chen, Lei] China Med Univ, Hosp 1, Key Lab Endocrine Dis Liaoning Prov, Shenyang, Peoples R China; [Liu, Lei; Liu, Limin; Geng, Jin; Chen, Lei] China Med Univ, Hosp 1, Liaoning Diabet Eye Ctr, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Chen, L (corresponding author), China Med Univ, Hosp 1, Dept Ophthalmol, Shenyang, Peoples R China.	carol1422@163.com	yuan, zhe/GYE-0922-2022; liu, li/HGC-0900-2022		Liaoning Science and Technology Project [2009225005]; Liaoning Department of Health Medical Peak of Construction Project [2010016]; Important Platform of Science and Technology Foundation for Universities, Department of Education, Liaoning Province government, China [2011195]	Liaoning Science and Technology Project; Liaoning Department of Health Medical Peak of Construction Project; Important Platform of Science and Technology Foundation for Universities, Department of Education, Liaoning Province government, China	This work has been supported by three grants: (1) Liaoning Science and Technology Project, (Project Number: 2009225005); (2) Liaoning Department of Health Medical Peak of Construction Project, (Project Number: 2010016); (3) The Important Platform of Science and Technology Foundation for Universities, Department of Education, Liaoning Province government, China, (Project Number: 2011195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang CJ, 2000, DIABETES RES CLIN PR, V50, pS49, DOI 10.1016/S0168-8227(00)00179-0; Chiang PPC, 2011, INVEST OPHTH VIS SCI, V52, P7586, DOI 10.1167/iovs.11-7698; Cockram C. S., 2000, Hong Kong Medical Journal, V6, P43; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong HL, 2010, MED INFORM, V10, P2701; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; He S, 1997, Zhonghua Yan Ke Za Zhi, V33, P381; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HU YH, 1991, ACTA DIABETOL, V28, P169, DOI 10.1007/BF00579721; Lee KMC, 2011, CLIN EXP OPTOM, V94, P371, DOI 10.1111/j.1444-0938.2010.00574.x; [李炳震 LI Bingzhen], 2011, [中华实验眼科杂志, Chinese Journal of Experimental Ophthalmology], V29, P747; Li SL, 1998, CHIN J OCUL FUNDUS D, V14, P119; Liu L, 2009, SHANDONG MED J, V49, P52; MANTEL N, 1959, J NATL CANCER I, V22, P719; Pang C, 2012, DIABETES-METAB RES, V28, P276, DOI 10.1002/dmrr.1307; Rani PK, 2007, BRIT J OPHTHALMOL, V91, P1425, DOI 10.1136/bjo.2007.120659; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Sanchez-Thorin JC, 1998, INT OPHTHALMOL CLIN, V38, P11; [舒相汶 SHU Xiang-Wen], 2010, [中华眼底病杂志, Chinese Journal of Ocular Fundus Diseases], V26, P113; Teng Yan, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P856; Wang FH, 2011, ACTA OPHTHALMOL, V89, pE336, DOI 10.1111/j.1755-3768.2010.02062.x; Wang GL, 2001, OPHTHALMOL CHN, V10, P180; [王红波 WANG Hong-bo], 2010, [中华眼底病杂志, Chinese Journal of Ocular Fundus Diseases], V26, P109; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Xie Xiwei, 2009, International Ophthalmology, V29, P485, DOI 10.1007/s10792-008-9272-9; Xu J, 2012, RETINA-J RET VIT DIS, V32, P322, DOI 10.1097/IAE.0b013e31821c4252; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yamada M, 2010, OPHTHAL EPIDEMIOL, V17, P50, DOI 10.3109/09286580903450346; Yang MZ, 2010, HEBEI MED J, V32, P844; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Ye XQ, 2010, GUIDE CHINA MED, V8, P27; Zhang L, 2012, INT J GERIATR PSYCH, V27, P900, DOI 10.1002/gps.2821; Zhong X, 2010, CLIN FOCUS, V25, P672; [邹海东 ZOU Hai dong], 2006, [中华眼底病杂志, Chinese Journal of Ocular Fundus Diseases], V22, P31; 梁先军, 2006, [广东医学, Guangdong Medical Journal], V27, P1552	35	68	84	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45264	10.1371/journal.pone.0045264	http://dx.doi.org/10.1371/journal.pone.0045264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028893	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388900035
J	Traub, S; Demaria, O; Chasson, L; Serra, F; Desnues, B; Alexopoulou, L				Traub, Stephanie; Demaria, Olivier; Chasson, Lionel; Serra, Fabienne; Desnues, Benoit; Alexopoulou, Lena			Sex Bias in Susceptibility to MCMV Infection: Implication of TLR9	PLOS ONE			English	Article							MURINE CYTOMEGALOVIRUS-INFECTION; PLASMACYTOID DENDRITIC CELLS; VIRAL-INFECTION; IMMUNE-RESPONSES; GENDER-DIFFERENCES; NATURAL-KILLER; STRANDED-RNA; WHITE PULP; NEUTROPHILS; VIRUS	Toll-like receptor (TLR)-dependent pathways control the activation of various immune cells and the production of cytokines and chemokines that are important in innate immune control of viruses, including mouse cytomegalovirus (MCMV). Here we report that upon MCMV infection wild-type and TLR7(-/-) male mice were more resistant than their female counterparts, while TLR9(-/-) male and female mice showed similar susceptibility. Interestingly, 36 h upon MCMV infection TLR9 mRNA expression was higher in male than in female mouse spleens. MCMV infection led to stronger reduction of marginal zone (MZ) B cells, and higher infiltration of plasmacytoid dendritic cells and neutrophils in wild-type male than female mice, while no such sex differences were observed in TLR9(-/-) mice. In accordance, the serum levels of KC and MIP-2, major neutrophil chemoattractants, were higher in wild-type, but not in TLR9(-/-), male versus female mice. Wild-type MCMV-infected female mice showed more severe liver inflammation, necrosis and steatosis compared to infected male mice. Our data demonstrate sex differences in susceptibility to MCMV infection, accompanied by a lower activation of the innate immune system in female mice, and can be attributed, at least in a certain degree, to the lower expression of TLR9 in female than male mice.	[Traub, Stephanie; Demaria, Olivier; Chasson, Lionel; Serra, Fabienne; Desnues, Benoit; Alexopoulou, Lena] Aix Marseille Univ UM 2, CIML, Marseille, France; [Traub, Stephanie; Demaria, Olivier; Chasson, Lionel; Serra, Fabienne; Desnues, Benoit; Alexopoulou, Lena] INSERM, UMR 1104, F-13258 Marseille, France; [Traub, Stephanie; Demaria, Olivier; Chasson, Lionel; Serra, Fabienne; Desnues, Benoit; Alexopoulou, Lena] CNRS, UMR 7280, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Alexopoulou, L (corresponding author), Aix Marseille Univ UM 2, CIML, Marseille, France.	alexopoulou@ciml.univ-mrs.fr	Desnues, Benoit/P-4725-2016; Alexopoulou, Lena/A-5041-2017	Desnues, Benoit/0000-0003-1422-4294; Alexopoulou, Lena/0000-0003-4619-697X	Action Thematique et Incitative sur le Programme (ATIP) from the Centre National de la Recherche Scientifique (CNRS); French Ministry of Research; CNRS	Action Thematique et Incitative sur le Programme (ATIP) from the Centre National de la Recherche Scientifique (CNRS); French Ministry of Research(Ministry of Research, FranceEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	L.A. was supported by an Action Thematique et Incitative sur le Programme (ATIP) from the Centre National de la Recherche Scientifique (CNRS) and a chair of Excellence grant from the French Ministry of Research. S.T. was supported by a CNRS Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; BALE JF, 1983, J INFECT DIS, V148, P518, DOI 10.1093/infdis/148.3.518; BALE JF, 1985, J LEUKOCYTE BIOL, V38, P723, DOI 10.1002/jlb.38.6.723; Barna M, 1996, J NEUROIMMUNOL, V67, P31, DOI 10.1016/0165-5728(96)00022-7; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Bennouna S, 2006, INFECT IMMUN, V74, P4274, DOI 10.1128/IAI.01573-05; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Card JW, 2006, J IMMUNOL, V177, P621, DOI 10.4049/jimmunol.177.1.621; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Delale T, 2005, J IMMUNOL, V175, P6723, DOI 10.4049/jimmunol.175.10.6723; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Fuller AC, 2005, J IMMUNOL, V175, P3955, DOI 10.4049/jimmunol.175.6.3955; Geurs TL, 2012, J AUTOIMMUN, V38, pJ245, DOI 10.1016/j.jaut.2011.12.003; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Grundy JE, 1998, J INFECT DIS, V177, P1465, DOI 10.1086/515300; Han X, 2001, J VIROL, V75, P3048, DOI 10.1128/JVI.75.6.3048-3052.2001; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Kesteman N, 2008, J LEUKOCYTE BIOL, V83, P640, DOI 10.1189/jlb.0807578; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; LEMP GF, 1992, J INFECT DIS, V166, P74, DOI 10.1093/infdis/166.1.74; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Naas T, 2005, J GEN VIROL, V86, P2185, DOI 10.1099/vir.0.80969-0; Nolte MA, 2000, EUR J IMMUNOL, V30, P626; Orange JS, 1997, J VIROL, V71, P9248, DOI 10.1128/JVI.71.12.9248-9258.1997; Picone O, 2005, PRENATAL DIAG, V25, P34, DOI 10.1002/pd.944; Rubtsov AV, 2008, J IMMUNOL, V180, P3882, DOI 10.4049/jimmunol.180.6.3882; Salazar-Mather TP, 2006, CURR TOP MICROBIOL, V303, P29, DOI 10.1007/978-3-540-33397-5_2; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; SHANLEY JD, 1993, J INFECT DIS, V167, P264, DOI 10.1093/infdis/167.2.264; Skarman PJ, 2006, MICROBES INFECT, V8, P1592, DOI 10.1016/j.micinf.2006.01.017; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Villacres MC, 2004, HUM IMMUNOL, V65, P476, DOI 10.1016/j.humimm.2004.02.021; Yoon Eugene J, 2006, Int J Med Sci, V3, P53; YOURTEE EL, 1982, INFECT IMMUN, V36, P11, DOI 10.1128/IAI.36.1.11-16.1982; Zucchini N, 2008, INT IMMUNOL, V20, P45, DOI 10.1093/intimm/dxm119; Zucchini N, 2008, J IMMUNOL, V180, P5799, DOI 10.4049/jimmunol.180.9.5799	48	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45171	10.1371/journal.pone.0045171	http://dx.doi.org/10.1371/journal.pone.0045171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028824	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900027
J	Bogle, G; Dunbar, PR				Bogle, Gib; Dunbar, P. Rod			On-Lattice Simulation of T Cell Motility, Chemotaxis, and Trafficking in the Lymph Node Paracortex	PLOS ONE			English	Article							PRIMARY IMMUNE-RESPONSE; LYMPHOCYTES IN-VIVO; DENDRITIC CELLS; 2-PHOTON MICROSCOPY; MIGRATION; EGRESS; DYNAMICS; ANTIGEN; ACTIVATION; RECEPTOR	Agent-based simulation is a powerful method for investigating the complex interplay of the processes occurring in a lymph node during an adaptive immune response. We have previously established an agent-based modeling framework for the interactions between T cells and dendritic cells within the paracortex of lymph nodes. This model simulates in three dimensions the "random-walk" T cell motility observed in vivo, so that cells interact in space and time as they process signals and commit to action such as proliferation. On-lattice treatment of cell motility allows large numbers of densely packed cells to be simulated, so that the low frequency of T cells capable of responding to a single antigen can be dealt with realistically. In this paper we build on this model by incorporating new numerical methods to address the crucial processes of T cell ingress and egress, and chemotaxis, within the lymph node. These methods enable simulation of the dramatic expansion and contraction of the T cell population in the lymph node paracortex during an immune response. They also provide a novel probabilistic method to simulate chemotaxis that will be generally useful in simulating other biological processes in which chemotaxis is an important feature.	[Bogle, Gib; Dunbar, P. Rod] Univ Auckland, Maurice Wilkins Ctr, Auckland, New Zealand; [Dunbar, P. Rod] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Bogle, Gib] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland	Bogle, G (corresponding author), Univ Auckland, Maurice Wilkins Ctr, Auckland, New Zealand.	g.bogle@auckland.ac.nz	Dunbar, Rod/C-2570-2012	Dunbar, Rod/0000-0001-9626-2600; Bogle, Gib/0000-0002-9528-5162	Auckland Bioengineering Institute	Auckland Bioengineering Institute	This work was funded by the Auckland Bioengineering Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Beauchemin C, 2007, J IMMUNOL, V178, P5505, DOI 10.4049/jimmunol.178.9.5505; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Bogle G, 2010, WIRES SYST BIOL MED, V2, P107, DOI 10.1002/wsbm.47; Bogle G, 2010, IMMUNOL CELL BIOL, V88, P172, DOI 10.1038/icb.2009.78; Bogle G, 2008, IMMUNOL CELL BIOL, V86, P676, DOI 10.1038/icb.2008.60; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Cahalan MD, 2006, NAT IMMUNOL, V7, P329, DOI 10.1038/ni0406-329; Cahalan MD, 2003, CURR OPIN IMMUNOL, V15, P372, DOI 10.1016/S0952-7915(03)00079-7; CAHILL RNP, 1976, J EXP MED, V143, P870, DOI 10.1084/jem.143.4.870; Catron DM, 2004, IMMUNITY, V21, P341, DOI 10.1016/j.immuni.2004.08.007; CEBRIAN M, 1988, J EXP MED, V168, P1621, DOI 10.1084/jem.168.5.1621; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dustin ML, 2008, IMMUNITY, V28, P15, DOI 10.1016/j.immuni.2008.01.001; FORD WL, 1972, CELL TISSUE KINET, V5, P175, DOI 10.1111/j.1365-2184.1972.tb01014.x; Germain RN, 2005, SEMIN IMMUNOL, V17, P431, DOI 10.1016/j.smim.2005.09.003; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; HAY JB, 1977, J EXP MED, V145, P31, DOI 10.1084/jem.145.1.31; HE Y, 1985, ARCH HISTOL JAPON, V48, P1, DOI 10.1679/aohc.48.1; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; HERMAN PG, 1972, J EXP MED, V136, P697, DOI 10.1084/jem.136.4.697; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; MCCUTCHEON M, 1955, ANN NY ACAD SCI, V59, P941, DOI 10.1111/j.1749-6632.1955.tb45992.x; MCCUTCHEON M, 1946, PHYSIOL REV, V26, P319, DOI 10.1152/physrev.1946.26.3.319; Mempel TR, 2006, IMMUNITY, V25, P867, DOI 10.1016/j.immuni.2006.11.002; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Ohtani O, 2003, ARCH HISTOL CYTOL, V66, P261, DOI 10.1679/aohc.66.261; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Rosen H, 2003, IMMUNOL REV, V195, P160, DOI 10.1034/j.1600-065X.2003.00068.x; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; STEEBER DA, 1987, SCANNING MICROSCOPY, V1, P831; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; WESTERMANN J, 1988, SCAND J IMMUNOL, V28, P203, DOI 10.1111/j.1365-3083.1988.tb02432.x; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706; Worbs T, 2009, CURR TOP MICROBIOL, V334, P71, DOI 10.1007/978-3-540-93864-4_4; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	59	19	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45258	10.1371/journal.pone.0045258	http://dx.doi.org/10.1371/journal.pone.0045258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028887	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388400068
J	Koyama, K; Hidaka, Y; Ushio, M				Koyama, Kohei; Hidaka, Yoshiki; Ushio, Masayuki			Dynamic Scaling in the Growth of a Non-Branching Plant, Cardiocrinum cordatum	PLOS ONE			English	Article							LEAF-AREA; PATTERNS; RESPIRATION; ALLOCATION; MORPHOLOGY; FOREST; MODEL; WHOLE; SIZE	We investigated whole-plant leaf area in relation to ontogenetic variation in leaf-size for a forest perennial herb, Cardiocrinum cordatum. The 200-fold ontogenetic variability in C. cordatum leaf area followed a power-law dependence on total leaf number, a measure of developmental stage. When we normalized for plant size, the function describing the size of single leaves along the stem was similar among different-sized plants, implying that the different-sized canopies observed at different times in the growth trajectory were fundamentally similar to each other. We conclude that the growth trajectory of a population of C. cordatum plant leaves obeyed a dynamic scaling law, the first reported for a growth trajectory at the whole-plant level.	[Koyama, Kohei] Ishikawa Prefectural Univ, Dept Environm Sci, Nonoichi, Ishikawa, Japan; [Koyama, Kohei; Ushio, Masayuki] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Hidaka, Yoshiki] Kyushu Univ, Grad Sch Engn, Dept Appl Quantum Phys & Nucl Engn, Fukuoka 812, Japan	Ishikawa Prefecture University; Kyoto University; Kyushu University	Koyama, K (corresponding author), Ishikawa Prefectural Univ, Dept Environm Sci, Nonoichi, Ishikawa, Japan.	konpei.koyama@gmail.com	Koyama, Kohei/J-4153-2015; Ushio, Masayuki/F-8667-2010	Koyama, Kohei/0000-0001-6707-3130; Ushio, Masayuki/0000-0003-4831-7181	JSPS Research Fellowship for Young Scientists	JSPS Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	KK was funded by the JSPS Research Fellowship for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2010, BOTANY, V88, P745, DOI 10.1139/B10-041; Bange MP, 2000, AGRON J, V92, P761, DOI 10.2134/agronj2000.924761x; Barabasi A.-L., 1995, FRACTAL CONCEPTS SUR; Brienen RJW, 2006, J ECOL, V94, P481, DOI 10.1111/j.1365-2745.2005.01080.x; Cao GX, 2008, PLANT ECOL, V194, P99, DOI 10.1007/s11258-007-9277-x; Chitwood DH, 2012, PLANT PHYSIOL, V158, P1230, DOI 10.1104/pp.111.192518; Duursma RA, 2010, FUNCT ECOL, V24, P723, DOI 10.1111/j.1365-2435.2010.01690.x; Enquist B.J., 2012, METAB ECOL SCALING A, P164, DOI [10.1002/, DOI 10.1002/9781119968535.CH14]; Enquist BJ, 2007, NATURE, V449, P218, DOI 10.1038/nature06061; ERICKSON RO, 1957, AM J BOT, V44, P297, DOI 10.2307/2438380; Falster D.S., 2006, USERS GUIDE SMATR ST; Galeano J, 2003, EUROPHYS LETT, V63, P83, DOI 10.1209/epl/i2003-00481-1; Granier C, 2009, PLANT CELL ENVIRON, V32, P1175, DOI 10.1111/j.1365-3040.2009.01955.x; Kaneko Y, 2006, PLANT SPEC BIOL, V21, P147, DOI 10.1111/j.1442-1984.2006.00160.x; Kishinawa K, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.024802; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; Koontz TL, 2009, AM J BOT, V96, P877, DOI 10.3732/ajb.0800380; Koyama K, 2011, ECOL RES, V26, P999, DOI 10.1007/s11284-011-0859-7; Koyama K, 2010, OECOLOGIA, V164, P53, DOI 10.1007/s00442-010-1638-9; Koyama K, 2009, AM NAT, V173, P640, DOI 10.1086/597604; LAMOREAUX RJ, 1978, AM J BOT, V65, P586, DOI 10.2307/2442595; LINDENMAYER A, 1968, J THEOR BIOL, V18, P300, DOI 10.1016/0022-5193(68)90080-5; Miyashita A, 2012, AGR FOREST METEOROL, V152, P1, DOI 10.1016/j.agrformet.2011.08.001; NAGAYA T, 1992, J PHYS SOC JPN, V61, P3511, DOI 10.1143/JPSJ.61.3511; Niklas KJ, 2008, AM J BOT, V95, P549, DOI 10.3732/ajb.0800034; Noda H, 2007, J PLANT RES, V120, P375, DOI 10.1007/s10265-006-0066-8; Ogawa K, 1995, J PLANT RES, V108, P511, DOI 10.1007/BF02344241; Ohara M, 2006, PLANT SPEC BIOL, V21, P201, DOI 10.1111/j.1442-1984.2006.00166.x; Price CA, 2006, FUNCT ECOL, V20, P11, DOI 10.1111/j.1365-2435.2006.01078.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Sugiura D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022236; Thomas SC, 2010, TREE PHYSIOL, V30, P555, DOI 10.1093/treephys/tpq005; Van Iersel MW, 2003, PLANT CELL ENVIRON, V26, P1441, DOI 10.1046/j.0016-8025.2003.01067.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107	36	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45317	10.1371/journal.pone.0045317	http://dx.doi.org/10.1371/journal.pone.0045317			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028928	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400073
J	Cipriano, LE; Zaric, GS; Holodniy, M; Bendavid, E; Owens, DK; Brandeau, ML				Cipriano, Lauren E.; Zaric, Gregory S.; Holodniy, Mark; Bendavid, Eran; Owens, Douglas K.; Brandeau, Margaret L.			Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HEALTH STATE UTILITIES; US METROPOLITAN-AREAS; PEGYLATED INTERFERON; RISK BEHAVIORS; UNITED-STATES; SEXUAL TRANSMISSION; ABUSE TREATMENT; HETEROSEXUAL TRANSMISSION	Objective: To estimate the cost, effectiveness, and cost effectiveness of HIV and HCV screening of injection drug users IDUs) in opioid replacement therapy (ORT). Design: Dynamic compartmental model of HIV and HCV in a population of IDUs and non-IDUs for a representative U.S. urban center with 2.5 million adults (age 15-59). Methods: We considered strategies of screening individuals in ORT for HIV, HCV, or both infections by antibody or antibody and viral RNA testing. We evaluated one-time and repeat screening at intervals from annually to once every 3 months. We calculated the number of HIV and HCV infections, quality-adjusted life years (QALYs), costs, and incremental cost-effectiveness ratios (ICERs). Results: Adding HIV and HCV viral RNA testing to antibody testing averts 14.8-30.3 HIV and 3.7-7.7 HCV infections in a screened population of 26,100 IDUs entering ORT over 20 years, depending on screening frequency. Screening for HIV antibodies every 6 months costs $30,700/QALY gained. Screening for HIV antibodies and viral RNA every 6 months has an ICER of $65,900/QALY gained. Strategies including HCV testing have ICERs exceeding $100,000/QALY gained unless awareness of HCV-infection status results in a substantial reduction in needle-sharing behavior. Discussion: Although annual screening for antibodies to HIV and HCV is modestly cost effective compared to no screening, more frequent screening for HIV provides additional benefit at less cost. Screening individuals in ORT every 3-6 months for HIV infection using both antibody and viral RNA technologies and initiating ART for acute HIV infection appears cost effective.	[Cipriano, Lauren E.; Brandeau, Margaret L.] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Zaric, Gregory S.] Univ Western Ontario, Richard Ivey Sch Business, London, ON, Canada; [Holodniy, Mark; Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Holodniy, Mark; Bendavid, Eran] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Div Gen Med Disciplines, Stanford, CA 94305 USA; [Bendavid, Eran; Owens, Douglas K.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran; Owens, Douglas K.] Stanford Univ, Ctr Primary Care & Outcomes Res, Dept Med, Stanford, CA 94305 USA	Stanford University; Western University (University of Western Ontario); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University; Stanford University	Cipriano, LE (corresponding author), Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA.	Lauren.Cipriano@gmail.com	Cipriano, Lauren E/C-3521-2017; Zaric, Gregory/B-7665-2013	Cipriano, Lauren E/0000-0001-5568-4516; Holodniy, Mark/0000-0002-6655-7982	National Institute on Drug Abuse [R01-DA15612]; Social Science and Humanities Research Council of Canada; Department of Veterans Affairs; Seth Bonder Scholarship for Applied Operations Research in Health Services; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Department of Veterans Affairs(US Department of Veterans Affairs); Seth Bonder Scholarship for Applied Operations Research in Health Services; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant R01-DA15612 from the National Institute on Drug Abuse. LEC is supported by a doctoral fellowship from the Social Science and Humanities Research Council of Canada (http://www.sshrc-crsh.gc.ca) and the Seth Bonder Scholarship for Applied Operations Research in Health Services (http://www.informs.org). DKO and MH are supported by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M, 2005, AM J PUBLIC HEALTH, V95, P502, DOI 10.2105/AJPH.2003.020388; Alberti A, 2002, HEPATOLOGY, V36, pS195, DOI 10.1053/jhep.2002.36808; Alistar SS, 2011, PLOS MED IN PRESS; Alter MJ, 2005, AM FAM PHYSICIAN, V72, P576; Amon JJ, 2008, CLIN INFECT DIS, V46, P1852, DOI 10.1086/588297; Anglemyer A., 2011, COCHRANE DATABASE SY; [Anonymous], HIV INFECT US HOUSEH; [Anonymous], 2000, PREV BLOOD BORN INF; [Anonymous], 1988, PUBLIC HLTH REP S1, V103, P66; [Anonymous], 2002, NIH CONSENS STATE SC, V19, P1; Arias E, 2007, NATL VITAL STAT REPO, V56; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bailey SL, 2007, DRUG ALCOHOL DEPEN, V91, pS18, DOI 10.1016/j.drugalcdep.2007.02.014; Barnett PG, 2001, ADDICTION, V96, P1267, DOI 10.1046/j.1360-0443.2001.96912676.x; Bayoumi AM, 2008, CAN MED ASSOC J, V179, P1143, DOI 10.1503/cmaj.080808; Beardsley M, 1999, J ACQ IMMUN DEF SYND, V20, P283, DOI 10.1097/00042560-199903010-00011; Beckwith Curt G, 2009, Med Health R I, V92, P231; Berg AO, 2004, ANN INTERN MED, V140, P462, DOI 10.7326/0003-4819-140-6-200403160-00013; Bonkovsky HL, 2008, AM J GASTROENTEROL, V103, P2757, DOI 10.1111/j.1572-0241.2008.02065.x; Booth RE, 2000, DRUG ALCOHOL DEPEN, V58, P219, DOI 10.1016/S0376-8716(99)00094-0; Booth RE, 2010, AIDS BEHAV; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Brogly SB, 2002, AIDS EDUC PREV, V14, P17, DOI 10.1521/aeap.14.1.17.24333; Brown LS, 2006, J SUBST ABUSE TREAT, V30, P315, DOI 10.1016/j.jsat.2006.02.006; Buchanan D, 2006, DRUG ALCOHOL DEPEN, V81, P221, DOI 10.1016/j.drugalcdep.2005.07.011; Bureau of Economic Analysis U.S. Department of Commerce, 2009, IMPL PRIC DEFL GROSS; Burt RD, 2007, J URBAN HEALTH, V84, P436, DOI 10.1007/s11524-007-9178-2; Burt RD, 2009, DRUG ALCOHOL DEPEN, V105, P215, DOI 10.1016/j.drugalcdep.2009.07.005; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; *CDCP, 2004, HIV TEST SURV 2002; Centers for Disease Control and Prevention, 2008, EST NEW HIV INF US; Centers for Medicare & Medicaid Services, 2009, MED FEE FOR SERV PAY; Chary A, 2010, REV RECENT CLIN TRIA, V5, P158, DOI 10.2174/157488710792007293; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; Chung H, 2003, J GASTROENTEROL, V38, P877, DOI 10.1007/s00535-003-1156-1; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Coon JT, 2006, FAM PRACT, V23, P393, DOI 10.1093/fampra/cml032; Cotler SJ, 2001, AM J GASTROENTEROL, V96, P2730, DOI 10.1111/j.1572-0241.2001.04132.x; Cox J, 2009, SUBST USE MISUSE, V44, P548, DOI 10.1080/10826080802544349; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; DeSimone J, 2005, J POLICY ANAL MANAG, V24, P559, DOI 10.1002/pam.20115; Dijkgraaf MGW, 2005, BMJ-BRIT MED J, V330, P1297, DOI 10.1136/bmj.330.7503.1297; Dominguez S, 2006, AIDS, V20, P1157, DOI 10.1097/01.aids.0000226956.02719.fd; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; DORE GJ, 2009, GASTROENTEROLOGY; Dubrow Robert, 2009, Conn Med, V73, P325; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Farnham PG, 2008, PUBLIC HEALTH REP, V123, P51, DOI 10.1177/00333549081230S307; Ferenci P, 2004, J ANTIMICROB CHEMOTH, V53, P15, DOI 10.1093/jac/dkh015; Gibson DR, 1999, AIDS, V13, P1807, DOI 10.1097/00002030-199910010-00002; Gilleece YC, 2005, JAIDS-J ACQ IMM DEF, V40, P41, DOI 10.1097/01.qai.0000174930.64145.a9; Goedert JI, 2001, AIDS, V15, P1295, DOI 10.1097/00002030-200107060-00012; Gold MR, 1996, COST EFFECTIVENESS H; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grebely J, 2006, HEPATOLOGY, V44, P1139, DOI 10.1002/hep.21376; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hagan H, 2006, PUBLIC HEALTH REP, V121, P710, DOI 10.1177/003335490612100611; Hamid SS, 1999, INFECT CONT HOSP EP, V20, P63, DOI 10.1086/501547; Heller DI, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-1; Hightow-Weidman LB, 2009, AIDS BEHAV, V13, P1075, DOI 10.1007/s10461-008-9519-5; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Juusola JL, 2011, AIDS, V25, P1779, DOI 10.1097/QAD.0b013e328349f067; Kao JH, 2000, J GASTROEN HEPATOL, V15, P391, DOI 10.1046/j.1440-1746.2000.02165.x; Kapadia F, 2007, DRUG ALCOHOL DEPEN, V91, pS56, DOI 10.1016/j.drugalcdep.2007.01.004; Kapadia F, 2009, AIDS BEHAV; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; Kauf TL, 2008, VALUE HEALTH, V11, P1144, DOI 10.1111/j.1524-4733.2008.00326.x; Kelly JA, 2009, AIDS BEHAV, V13, P1068, DOI 10.1007/s10461-009-9579-1; Kerndt PR, 2009, AIDS BEHAV, V13, P1037, DOI 10.1007/s10461-009-9580-8; Kimber J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3172; Knudsen HK, 2009, AIDS CARE, V21, P1238, DOI 10.1080/09540120902803182; Kresina Thomas F, 2007, Recent Pat Antiinfect Drug Discov, V2, P79, DOI 10.2174/157489107779561652; Laguno M, 2009, HEPATOLOGY, V49, P22, DOI 10.1002/hep.22598; Latkin CA, 2008, JAIDS-J ACQ IMM DEF, V49, P447, DOI 10.1097/QAI.0b013e31818a6546; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Licata A, 2003, J HEPATOL, V39, P1056, DOI 10.1016/S0168-8278(03)00461-6; Liu S, 2011, NEW PROTEASE INHIBIT; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027625; Long EF, 2009, VACCINE, V27, P5402, DOI 10.1016/j.vaccine.2009.06.063; Longshore D, 1998, J ACQ IMMUN DEF SYND, V18, P64, DOI 10.1097/00042560-199805010-00010; Lott DC, 2006, J SUBST ABUSE TREAT, V31, P187, DOI 10.1016/j.jsat.2006.04.005; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Mark TL, 2001, DRUG ALCOHOL DEPEN, V61, P195, DOI 10.1016/S0376-8716(00)00162-9; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marshall BDL, 2009, SEX TRANSM INFECT, V85, P121, DOI 10.1136/sti.2008.032524; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Mitra D, 2010, VALUE HEALTH, V13, P479, DOI 10.1111/j.1524-4733.2009.00691.x; Mizuno Y, 2010, AIDS BEHAV, V14, P92, DOI 10.1007/s10461-009-9548-8; National Opinion Research Center General Social Surveys (GSS), 1972, NAT DAT PROGR SCI; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Office of the Medical Director, 2010, DIAGN MAN AC HIV INF; Ompad DC, 2002, CLIN INFECT DIS, V35, P783, DOI 10.1086/342063; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Patel P, 2010, ARCH INTERN MED, V170, P66, DOI 10.1001/archinternmed.2009.445; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Pilcher Christopher D, 2006, Curr HIV/AIDS Rep, V3, P160, DOI 10.1007/s11904-006-0011-4; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Remien RH, 2009, AIDS BEHAV, V13, P1046, DOI 10.1007/s10461-009-9581-7; Rodger AJ, 1999, HEPATOLOGY, V30, P1299, DOI 10.1002/hep.510300504; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sasase N, 2010, INTERVIROLOGY, V53, P49, DOI 10.1159/000252784; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Semaan S, 2010, DRUG ALCOHOL DEPEN, V106, P7, DOI 10.1016/j.drugalcdep.2009.07.015; Simpson KN, 2004, HIV CLIN TRIALS, V5, P294, DOI 10.1310/WT81-MEM4-5C4L-CHPK; Singer ME, 2001, AM J MED, V111, P614, DOI 10.1016/S0002-9343(01)00951-2; Sorensen JL, 2000, DRUG ALCOHOL DEPEN, V59, P17, DOI 10.1016/S0376-8716(99)00104-0; Stein K, 2004, J PUBLIC HEALTH-UK, V26, P61, DOI 10.1093/pubmed/fdh109; Stein K, 2003, J HEPATOL, V39, P814, DOI 10.1016/S0168-8278(03)00392-1; Stekler J, 2005, AIDS, V19, P1323, DOI 10.1097/01.aids.0000180105.73264.81; Stekler JD, 2009, CLIN INFECT DIS, V49, P444, DOI 10.1086/600043; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Strauss SM, 2006, J DRUG EDUC, V36, P141, DOI 10.2190/3EMQ-N350-W4XN-WT1X; Stroffolini T, 2001, AM J GASTROENTEROL, V96, P3138, DOI 10.1111/j.1572-0241.2001.05267.x; Sullivan LE, 2008, J SUBST ABUSE TREAT, V35, P87, DOI 10.1016/j.jsat.2007.08.004; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Sutton AJ, 2008, J VIRAL HEPATITIS, V15, P797, DOI 10.1111/j.1365-2893.2008.01008.x; Tempalski B, 2009, J URBAN HEALTH, V86, P132, DOI 10.1007/s11524-008-9328-1; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Thein HH, 2005, AM J GASTROENTEROL, V100, P643, DOI 10.1111/j.1572-0241.2005.40976.x; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thiede H, 2007, DRUG ALCOHOL DEPEN, V91, pS39, DOI 10.1016/j.drugalcdep.2007.03.001; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Tramarin A, 2008, CURR PHARM DESIGN, V14, P1655, DOI 10.2174/138161208784746833; Tsui JI, 2009, DRUG ALCOHOL DEPEN, V105, P160, DOI 10.1016/j.drugalcdep.2009.05.022; US. Census Bureau Population Division, 2009, RES POP EST 2000S MO; Van Thiel DH, 2003, AM J GASTROENTEROL, V98, P2281, DOI [10.1016/S0002-9270(03)00708-1, 10.1111/j.1572-0241.2003.07702.x]; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; Vogel M, 2006, ANTIVIR THER, V11, P1097; Vogel M, 2010, ANTIVIR THER, V15, P267, DOI 10.3851/IMP1501; Watson J C, 1998, MMWR Recomm Rep, V47, P1; Weinhardt LS, 2004, JAIDS-J ACQ IMM DEF, V36, P1057, DOI 10.1097/00126334-200408150-00009; Weis SH, 2003, HIV ERA OCCUPATIONAL, P811; Wiegand J, 2006, HEPATOLOGY, V43, P250, DOI 10.1002/hep.21043; Wiegand J, 2008, J ANTIMICROB CHEMOTH, V62, P860, DOI 10.1093/jac/dkn346; Wong JB, 2006, PHARMACOECONOMICS, V24, P661, DOI 10.2165/00019053-200624070-00005; Zanis DA, 1998, DRUG ALCOHOL DEPEN, V52, P257, DOI 10.1016/S0376-8716(98)00097-0; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100; Zarkin GA, 2004, EVAL PROGRAM PLANN, V27, P35, DOI 10.1016/j.evalprogplan.2003.09.002	159	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45176	10.1371/journal.pone.0045176	http://dx.doi.org/10.1371/journal.pone.0045176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040HS	23028828	Green Published, gold			2022-12-27	WOS:000311313900091
J	Solverson, P; Murali, SG; Litscher, SJ; Blank, RD; Ney, DM				Solverson, Patrick; Murali, Sangita G.; Litscher, Suzanne J.; Blank, Robert D.; Ney, Denise M.			Low Bone Strength Is a Manifestation of Phenylketonuria in Mice and Is Attenuated by a Glycomacropeptide Diet	PLOS ONE			English	Article							MINERAL DENSITY; NUTRITIONAL MANAGEMENT; CHILDREN; OSTEOPENIA; GROWTH; PKU	Purpose: Phenylketonuria (PKU), caused by phenylalanine (phe) hydroxylase loss of function mutations, requires a low-phe diet plus amino acid (AA) formula to prevent cognitive impairment. Glycomacropeptide (GMP), a low-phe whey protein, provides a palatable alternative to AA formula. Skeletal fragility is a poorly understood chronic complication of PKU. We sought to characterize the impact of the PKU genotype and dietary protein source on bone biomechanics. Procedures: Wild type (WT; Pah(+/+)) and PKU (Pah(enu2/enu2)) mice on a C57BL/6J background were fed high-phe casein, low-phe AA, and low-phe GMP diets between 3 to 23 weeks of age. Following euthanasia, femur biomechanics were assessed by 3-point bending and femoral diaphyseal structure was determined. Femoral ex vivo bone mineral density (BMD) was assessed by dual-enengy x-ray absorptiometry. Whole bone parameters were used in prinicipal component analysis. Data were analyzed by 3-way ANCOVA with genotype, sex, and diet as the main factors. Findings: Regardless of diet and sex, PKU femora were more brittle, as manifested by lower post-yield displacement, weaker, as manifested by lower energy and yield and maximal loads, and showed reduced BMD compared with WT femora. Four principal components accounted for 87% of the variance and all differed significantly by genotype. Regardless of genotype and sex, the AA diet reduced femoral cross-sectional area and consequent maximal load compared with the GMP diet. Conclusions: Skeletal fragility, as reflected in brittle and weak femora, is an inherent feature of PKU. This PKU bone phenotype is attenuated by a GMP diet compared with an AA diet.	[Solverson, Patrick; Murali, Sangita G.; Ney, Denise M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Litscher, Suzanne J.; Blank, Robert D.] William S Middleton Vet Hosp, Geriatr Res Educ & Clin Ctr, Madison, WI USA; [Litscher, Suzanne J.; Blank, Robert D.] Univ Wisconsin, Sch Med & Publ Hlth, Div Endocrinol Diabet & Metab, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison	Ney, DM (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	ney@nutrisci.wisc.edu	Blank, Robert D./V-5995-2019; Solverson, Patrick/AAM-4697-2021	Blank, Robert D./0000-0003-2950-1944; Solverson, Patrick/0000-0003-0858-9844	National Phenylketonuria Alliance, United States Department of Agriculture HATCH Grant [WIS01517]; National Institutes of Health [R01- AR-54753]; Office of Research and Development, Biomedical Laboratory R&D Service, Department of Veterans Affairs (RDB); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054753] Funding Source: NIH RePORTER	National Phenylketonuria Alliance, United States Department of Agriculture HATCH Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, Biomedical Laboratory R&D Service, Department of Veterans Affairs (RDB)(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Phenylketonuria Alliance, United States Department of Agriculture HATCH Grant WIS01517, and National Institutes of Health Grant R01- AR-54753. This material is based upon work supported by the Office of Research and Development, Biomedical Laboratory R&D Service, Department of Veterans Affairs (RDB) and performed in part in the Geriatrics Research, Education, and Clinical Center at the William S. Middleton Memorial Veterans Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qadreh A, 1998, ACTA PAEDIATR, V87, P1162; ALLEN JR, 1994, AM J CLIN NUTR, V59, P419, DOI 10.1093/ajcn/59.2.419; Ambroszkiewicz J, 2004, EUR J PEDIATR, V163, P177, DOI 10.1007/s00431-003-1394-5; [Anonymous], 2000, NIH Consens Statement, V17, P1; Becker R, 1988, COMPUTER SCI SERIES; Blank R. D., 2008, P447, DOI 10.1007/978-0-387-73906-9_16; BONADIO J, 1993, J CLIN INVEST, V92, P1697, DOI 10.1172/JCI116756; de Groot MJ, 2012, MOL GENET METAB, V105, P566, DOI 10.1016/j.ymgme.2012.01.006; Enns GM, 2010, MOL GENET METAB, V101, P99, DOI 10.1016/j.ymgme.2010.05.017; Franco GEL, 2004, J CLIN DENSITOM, V7, P326; Fratzl P., 2008, P1, DOI 10.1007/978-0-387-73906-9_1; Frost HM, 2001, ANAT RECORD, V262, P398, DOI 10.1002/ar.1049; Greeves LG, 1997, ACTA PAEDIATR, V86, P242, DOI 10.1111/j.1651-2227.1997.tb08882.x; Harding CO, 2006, GENE THER, V13, P457, DOI 10.1038/sj.gt.3302678; Koch R, 2002, J INHERIT METAB DIS, V25, P333, DOI 10.1023/A:1020158631102; Koura HM, 2011, ARCH MED SCI, V7, P493, DOI 10.5114/aoms.2011.23417; LaClair CE, 2009, J FOOD SCI, V74, pE199, DOI 10.1111/j.1750-3841.2009.01134.x; LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0; Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017; MacDonald A, 2004, J INHERIT METAB DIS, V27, P363, DOI 10.1023/B:BOLI.0000031099.79046.65; MacDonald A, 2000, EUR J PEDIATR, V159, pS136, DOI 10.1007/PL00014375; Macleod Erin L, 2010, Ann Nestle Eng, V68, P58, DOI 10.1159/000312813; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; MCDONALD JD, 1990, P NATL ACAD SCI USA, V87, P1965, DOI 10.1073/pnas.87.5.1965; MCMURRY MP, 1992, AM J CLIN NUTR, V55, P997, DOI 10.1093/ajcn/55.5.997; Millet P, 2005, CLIN BIOCHEM, V38, P1127, DOI 10.1016/j.clinbiochem.2005.09.002; Modan-Moses D, 2007, J INHERIT METAB DIS, V30, P202, DOI 10.1007/s10545-007-0462-9; Nagasaka H, 2011, J BONE MINER METAB, V29, P737, DOI 10.1007/s00774-011-0276-6; Ney DM, 2009, J INHERIT METAB DIS, V32, P32, DOI 10.1007/s10545-008-0952-4; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Perez-Duenas B, 2002, ACTA PAEDIATR, V91, P899, DOI 10.1080/080352502760148603; Roato I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014167; Robey P.G., 2008, PRIMER METABOLIC BON, V7, P32; ROGERS QR, 1965, J NUTR, V87, P267, DOI 10.1093/jn/87.3.267; Saless N, 2011, BONE, V48, P647, DOI 10.1016/j.bone.2010.10.165; Saless N, 2009, FASEB J, V23, P2142, DOI 10.1096/fj.08-118679; Schwahn B, 1998, ACTA PAEDIATR, V87, P61, DOI 10.1080/08035259850157886; Sievanen H, 2007, PLOS MED, V4, P407, DOI 10.1371/journal.pmed.0040027; Solverson P, 2012, AM J PHYSIOL-ENDOC M, V302, pE885, DOI 10.1152/ajpendo.00647.2011; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; van Calcar SC, 2009, AM J CLIN NUTR, V89, P1068, DOI 10.3945/ajcn.2008.27280; Van Calcar SC, 2012, J ACAD NUTR IN PRESS; Venables WN., 2002, MODERN APPL STAT S 4; Walter JH, 2002, LANCET, V360, P55, DOI 10.1016/S0140-6736(02)09334-0; Yannicelli S, 2002, J INHERIT METAB DIS, V25, P347, DOI 10.1023/A:1020191515173; Zeman J, 1999, ACTA PAEDIATR, V88, P1348, DOI 10.1080/080352599750030068	48	41	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45165	10.1371/journal.pone.0045165	http://dx.doi.org/10.1371/journal.pone.0045165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028819	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900088
J	Tandon, M; Wang, LR; Xu, Q; Xie, XQ; Wipf, P; Wang, QJ				Tandon, Manuj; Wang, Lirong; Xu, Qi; Xie, Xiangqun; Wipf, Peter; Wang, Qiming Jane			A Targeted Library Screen Reveals a New Inhibitor Scaffold for Protein Kinase D	PLOS ONE			English	Article							CANCER CELL-GROWTH; PROSTATE-CANCER; IN-VIVO; SIGNALING PATHWAY; C-MU; POTENT; INVASION; RECEPTOR; IDENTIFICATION; PROLIFERATION	Protein kinase D (PKD) has emerged as a potential therapeutic target in multiple pathological conditions, including cancer and heart diseases. Potent and selective small molecule inhibitors of PKD are valuable for dissecting PKD-mediated cellular signaling pathways and for therapeutic application. In this study, we evaluated a targeted library of 235 small organic kinase inhibitors for PKD1 inhibitory activity at a single concentration. Twenty-eight PKD inhibitory chemotypes were identified and six exhibited excellent PKD1 selectivity. Five of the six lead structures share a common scaffold, with compound 139 being the most potent and selective for PKD vs PKC and CAMK. Compound 139 was an ATP-competitive PKD1 inhibitor with a low double-digit nanomolar potency and was also cell-active. Kinase profiling analysis identified this class of small molecules as pan-PKD inhibitors, confirmed their selectivity again PKC and CAMK, and demonstrated an overall favorable selectivity profile that could be further enhanced through structural modification. Furthermore, using a PKD homology model based on similar protein kinase structures, docking modes for compound 139 were explored and compared to literature examples of PKD inhibition. Modeling of these compounds at the ATP-binding site of PKD was used to rationalize its high potency and provide the foundation for future further optimization. Accordingly, using biochemical screening of a small number of privileged scaffolds and computational modeling, we have identified a new core structure for highly potent PKD inhibition with promising selectivity against closely related kinases. These lead structures represent an excellent starting point for the further optimization and the design of selective and therapeutically effective small molecule inhibitors of PKD.	[Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Wipf, Peter] Univ Pittsburgh, Ctr Chem Methodol & Lib Dev, Pittsburgh, PA USA; [Tandon, Manuj; Wang, Qiming Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Wang, Lirong; Xu, Qi; Xie, Xiangqun; Wipf, Peter] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wipf, P (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	pwipf@pitt.edu; qjw1@pitt.edu	Wipf, Peter/AAG-1771-2021; Wang, Qiming Jane/B-6064-2012	Wipf, Peter/0000-0001-7693-5863; Wang, Qiming Jane/0000-0002-9502-4851	National Institutes of Health [R01CA129127-01, R01CA142580-01, P50-GM067082]; NATIONAL CANCER INSTITUTE [R01CA142580, R01CA129127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM067082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health (R01CA129127-01, R01CA142580-01, and P50-GM067082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoitei N, 2011, NEURO-ONCOLOGY, V13, P710, DOI 10.1093/neuonc/nor084; Biswas MHU, 2010, CANCER RES, V70, P2095, DOI 10.1158/0008-5472.CAN-09-4155; Bossuyt J., 2008, CIRC RES; Bravo-Altamirano K, 2011, ACS MED CHEM LETT, V2, P154, DOI 10.1021/ml100230n; Chen JZ, 2007, J CHEM INF MODEL, V47, P1626, DOI 10.1021/ci7000814; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Chen SQ, 2007, BIOORG MED CHEM LETT, V17, P2134, DOI 10.1016/j.bmcl.2007.01.081; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Evans IM, 2010, BIOCHEM J, V429, P565, DOI 10.1042/BJ20100578; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Gamber GG, 2011, BIOORG MED CHEM LETT, V21, P1447, DOI 10.1016/j.bmcl.2011.01.014; George Kara M, 2011, Pharmaceutics, V3, P186, DOI 10.3390/pharmaceutics3020186; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Ivison SM, 2007, J IMMUNOL, V178, P5735, DOI 10.4049/jimmunol.178.9.5735; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; Kim YI, 2010, J IMMUNOL, V184, P3145, DOI 10.4049/jimmunol.0903718; LaValle CR, 2010, BBA-REV CANCER, V1806, P183, DOI 10.1016/j.bbcan.2010.05.003; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Meredith EL, 2010, J MED CHEM, V53, P5400, DOI 10.1021/jm100075z; Meredith EL, 2010, J MED CHEM, V53, P5422, DOI 10.1021/jm100076w; Meurice N, 2010, J MED CHEM, V53, P669, DOI 10.1021/jm901247a; Monovich L, 2010, FEBS LETT, V584, P631, DOI 10.1016/j.febslet.2009.12.014; Ochi N, 2011, J CELL PHYSIOL, V226, P1074, DOI 10.1002/jcp.22421; Park JE, 2009, J IMMUNOL, V182, P6316, DOI 10.4049/jimmunol.0804239; Rennecke J, 1999, INT J CANCER, V80, P98, DOI 10.1002/(SICI)1097-0215(19990105)80:1<98::AID-IJC19>3.3.CO;2-4; Ristich VL, 2006, BRIT J DERMATOL, V154, P586, DOI 10.1111/j.1365-2133.2005.07073.x; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Sharlow ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025134; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sundram V, 2011, MOL CANC RES; Tan MQ, 2009, ARTERIOSCL THROM VAS, V29, P1376, DOI 10.1161/ATVBAHA.109.191585; Trejo A, 2003, J MED CHEM, V46, P4702, DOI 10.1021/jm0301787; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Xie XQ, 2003, PROTEINS, V53, P307, DOI 10.1002/prot.10511; Yamashita K, 2010, INT IMMUNOPHARMACOL, V10, P277, DOI 10.1016/j.intimp.2009.11.011; Yera ER, 2011, J MED CHEM, V54, P6771, DOI 10.1021/jm200666a; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu HH, 2008, PAIN, V137, P574, DOI 10.1016/j.pain.2007.10.025; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	47	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44653	10.1371/journal.pone.0044653	http://dx.doi.org/10.1371/journal.pone.0044653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028574	gold, Green Published, Green Accepted			2022-12-27	WOS:000311313900033
J	Tien, J; Truslow, JG; Nelson, CM				Tien, Joe; Truslow, James G.; Nelson, Celeste M.			Modulation of Invasive Phenotype by Interstitial Pressure-Driven Convection in Aggregates of Human Breast Cancer Cells	PLOS ONE			English	Article							MURINE TUMOR-CELLS; IN-VITRO; SUBCUTANEOUS TUMORS; GLUCOSE STARVATION; SOLID TUMORS; FLOW; DIFFUSION; MIGRATION; MORPHOGENESIS; MECHANISMS	This paper reports the effect of elevated pressure on the invasive phenotype of patterned three-dimensional (3D) aggregates of MDA-MB-231 human breast cancer cells. We found that the directionality of the interstitial pressure profile altered the frequency of invasion by cells located at the surface of an aggregate. In particular, application of pressure at one end of an aggregate suppressed invasion at the opposite end. Experimental alteration of the configuration of cell aggregates and computational modeling of the resulting flow and solute concentration profiles revealed that elevated pressure inhibited invasion by altering the chemical composition of the interstitial fluid near the surface of the aggregate. Our data reveal a link between hydrostatic pressure, interstitial convection, and invasion.	[Tien, Joe; Truslow, James G.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Nelson, Celeste M.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Nelson, Celeste M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Boston University; Princeton University; Princeton University	Tien, J (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	jtien@bu.edu; celesten@princeton.edu	Nelson, Celeste/AAT-7612-2021	Nelson, Celeste/0000-0001-9973-8870	Breast Cancer Research Program of the Department of Defense [W81XWH-09-1-0565]; National Institutes of Health/National Cancer Institute (NIH/NCI) Physical Sciences-Oncology Center at Princeton University [U54CA143803]; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [U54CA143803] Funding Source: NIH RePORTER	Breast Cancer Research Program of the Department of Defense(United States Department of Defense); National Institutes of Health/National Cancer Institute (NIH/NCI) Physical Sciences-Oncology Center at Princeton University; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Concept Award W81XWH-09-1-0565 from the Breast Cancer Research Program of the Department of Defense (to JT), and by pilot project funding from the National Institutes of Health/National Cancer Institute (NIH/NCI) Physical Sciences-Oncology Center at Princeton University (U54CA143803) and a Career Award at the Scientific Interface from the Burroughs Wellcome Fund (to CMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artemov D, 1998, NMR BIOMED, V11, P395, DOI 10.1002/(SICI)1099-1492(199812)11:8<395::AID-NBM536>3.0.CO;2-R; BOUCHER Y, 1990, CANCER RES, V50, P4478; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; Cuvier C, 1997, CLIN EXP METASTAS, V15, P19; Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Ganapathy R, 1997, Z ANGEW MATH MECH, V77, P871, DOI 10.1002/zamm.19970771113; Gjorevski N, 2012, BIOPHYS J, V103, P152, DOI 10.1016/j.bpj.2012.05.048; GULLINO PM, 1964, CANCER RES, V24, P780; Helm CLE, 2005, P NATL ACAD SCI USA, V102, P15779, DOI 10.1073/pnas.0503681102; Jain R, 1999, IEEE MULTIMEDIA, V6, P1, DOI 10.1109/MMUL.1999.809225; Kim DH, 2011, P NATL ACAD SCI USA, V108, P6693, DOI 10.1073/pnas.1103983108; LESS JR, 1992, CANCER RES, V52, P6371; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; Polacheck WJ, 2011, P NATL ACAD SCI USA, V108, P11115, DOI 10.1073/pnas.1103581108; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; SCHLAPPACK OK, 1991, BRIT J CANCER, V64, P663, DOI 10.1038/bjc.1991.378; Shieh AC, 2011, CANCER RES, V71, P790, DOI 10.1158/0008-5472.CAN-10-1513; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Walenta S, 2000, CANCER RES, V60, P916; Zancan P, 2010, MOL GENET METAB, V100, P372, DOI 10.1016/j.ymgme.2010.04.006	31	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45191	10.1371/journal.pone.0045191	http://dx.doi.org/10.1371/journal.pone.0045191			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028839	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900097
J	Zhang, WF; Guo, YX; Zhang, C; Ji, HY; Meng, WP; Wang, DY; Li, X; Mao, QW; Xia, HB				Zhang, Weifeng; Guo, Yuanxu; Zhang, Chen; Ji, Haiyan; Meng, Wenpeng; Wang, Dongyang; Li, Xing; Mao, Qinwen; Xia, Haibin			Rescue the Failed Half-ZFN by a Sensitive Mammalian Cell-Based Luciferase Reporter System	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; TRANSCRIPTION FACTORS; GENE-EXPRESSION; DNA-DAMAGE; GENOME; 53BP1; CONSTRUCTION; DROSOPHILA; SELECTION; CLEAVAGE	ZFN technology is a powerful research tool and has been used for genome editing in cells lines, animals and plants. The generation of functional ZFNs for particular targets in mammalian genome is still challenging for an average research group. The modular-assembly method is relatively fast, easy-to-practice but has a high failure rate. Some recent studies suggested that a ZFP with low binding activity might be able to form a working ZFN pair with another binding active half-ZFP. In order to unveil the potential ZFP candidates among those with low binding activities, this paper established a highly sensitive mammalian cell-based transcriptional reporter system to assess the DNA binding activities of ZFPs by inserting multiple copies of ZFN target sequence fragment (TSF) of an interested gene (e.g., hPGRN or hVEGF). Our results showed that this system increased the screening sensitivity up to 50-fold and markedly amplified the differences in the binding activities between different ZFPs. We also found that the targeted chromosomal gene repair efficiency of each hPGRN or hVEGF ZFN pair was in proportion with the combination of the binding activities of the ZFL (Left zinc finger) and ZFR (Right zinc finger). A hPGRN ZFR with low binding ability was able to form a biological active ZFN if combined with a hPGRN ZFL with relatively high binding ability. Lastly, site-specific genome editing by hPGRN ZFNs generated by this system was confirmed by sequencing, and the PGRN knock-out cell line showed significantly decreased cell growth compared with the control. Our system will provide a valuable tool for further optimizing the nucleases with regard to specificity and cytotoxicity.	[Mao, Qinwen] Northwestern Univ, Dept Pathol, Feinberg Sch Med Chicago, Chicago, IL 60611 USA; [Zhang, Weifeng; Guo, Yuanxu; Zhang, Chen; Ji, Haiyan; Meng, Wenpeng; Wang, Dongyang; Li, Xing; Xia, Haibin] Shaanxi Normal Univ, Lab Gene Therapy, Dept Biochem, Coll Life Sci, Xian, Shaanxi, Peoples R China	Northwestern University; Feinberg School of Medicine; Shaanxi Normal University	Mao, QW (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med Chicago, Chicago, IL 60611 USA.	q-mao@northwestern.edu; hbxia2001@163.com	Zhang, Weifeng/ABB-2212-2020	Zhang, Weifeng/0000-0002-6176-4907; Mao, Qinwen/0000-0001-7876-2046	"Foundation for Excellent Doctor Degree Dissertation'' of Shaanxi Normal University [X2010YB03]; National Natural Science Foundation of China [30872993, 31070137]; Ministry of Agriculture [2009ZX08010-023B]	"Foundation for Excellent Doctor Degree Dissertation'' of Shaanxi Normal University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by the "Foundation for Excellent Doctor Degree Dissertation'' [X2010YB03] of Shaanxi Normal University; Research grants to HX from National Natural Science Foundation of China [No. 30872993, No. 31070137] and Sub-project of major projects Foundation from Ministry of Agriculture [2009ZX08010-023B]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Herrmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020913; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; Isalan M, 2012, NAT METHODS, V9, P32, DOI 10.1038/nmeth.1805; Kim JS, 2010, NAT METHODS, V7, P91, DOI 10.1038/nmeth0210-91a; Li C, 2009, GENE THER, V16, P43, DOI 10.1038/gt.2008.134; Liu Q, 2002, J BIOL CHEM, V277, P3850, DOI 10.1074/jbc.M110669200; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pruett-Miller SM, 2008, MOL THER, V16, P707, DOI 10.1038/mt.2008.20; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sedivy JM, 1999, TRENDS GENET, V15, P88, DOI 10.1016/S0168-9525(98)01689-8; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Segal DJ, 2003, BIOCHEMISTRY-US, V42, P2137, DOI 10.1021/bi026806o; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259	34	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45169	10.1371/journal.pone.0045169	http://dx.doi.org/10.1371/journal.pone.0045169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028823	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900090
J	Dunn, JF; Wu, Y; Zhao, ZH; Srinivasan, S; Natah, SS				Dunn, Jeff F.; Wu, Ying; Zhao, Zonghang; Srinivasan, Sathya; Natah, Sirajedin S.			Training the Brain to Survive Stroke	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; FOCAL CEREBRAL-ISCHEMIA; NEURAL STEM-CELLS; RAT-BRAIN; HIGH-ALTITUDE; ANGIOGENIC FACTORS; HYPOBARIC HYPOXIA; MILD HYPOXIA; FACTOR-I; NEUROPROTECTION	Background: Presently, little can be done to repair brain tissue after stroke damage. We hypothesized that the mammalian brain has an intrinsic capacity to adapt to low oxygen which would improve outcome from a reversible hypoxic/ischemic episode. Acclimation to chronic hypoxia causes increased capillarity and tissue oxygen levels which may improve the capacity to survive ischemia. Identification of these adaptations will lead to protocols which high risk groups could use to improve recovery and reduce costs. Methods and Findings: Rats were exposed to hypoxia (3 weeks living at K an atmosphere). After acclimation, capillary density was measured morphometrically and was increased by 30% in the cortex. Novel implantable oxygen sensors showed that partial pressure of oxygen in the brain was increased by 40% in the normal cortex. Infarcts were induced in brain with 1 h reversible middle cerebral artery occlusions. After ischemia (48 h) behavioural scores were improved and T2 weighted MRI lesion volumes were reduced by 52% in acclimated groups. There was a reduction in inflammation indicated by reduced lymphocytes (by 27-33%), and ED1 positive cells (by 35-45%). Conclusions: It is possible to stimulate a natural adaptive mechanism in the brain which will reduce damage and improve outcome for a given ischemic event. Since these adaptations occur after factors such as HIF-1 alpha have returned to baseline, protection is likely related more to morphological changes such as angiogenesis. Such pre-conditioning, perhaps with exercise or pharmaceuticals, would not necessarily reduce the incidence of stroke, but the severity of damage could be reduced by 50%.	[Dunn, Jeff F.; Wu, Ying; Srinivasan, Sathya; Natah, Sirajedin S.] Univ Calgary, Fac Med, Dept Radiol, Calgary, AB, Canada; [Dunn, Jeff F.; Zhao, Zonghang] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Natah, Sirajedin S.] Univ Um Alqura, Fac Med & Med Sci, Dept Physiol, Mecca, Saudi Arabia	University of Calgary; University of Calgary; Umm Al Qura University	Dunn, JF (corresponding author), Univ Calgary, Fac Med, Dept Radiol, Calgary, AB, Canada.	dunnj@ucalgary.ca	Srinivasan, Sathya/AAJ-8410-2021		National Institutes of Health [RT732043m]; Canadian Institutes of Health Research; Canadian Foundation for Innovation; Alberta Heritage Foundation; Canadian National Sciences and Engineering Research Council	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); Canadian National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Institutes of Health (RT732043m www.nih.gov); Canadian Institutes of Health Research (www.cihr.ca); the Canadian Foundation for Innovation (www.innovation.ca); the Alberta Heritage Foundation (www.albertainnovates.ca) and the Canadian National Sciences and Engineering Research Council (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand AC, 2001, NATL MED J INDIA, V14, P197; Ara J, 2011, NEUROBIOL DIS, V43, P473, DOI 10.1016/j.nbd.2011.04.021; Ashioti M, 2007, BRAIN RES, V1145, P177, DOI 10.1016/j.brainres.2007.01.111; Benderro GF, 2011, BRAIN RES, V1389, P50, DOI 10.1016/j.brainres.2011.03.016; Boero JA, 1999, J APPL PHYSIOL, V86, P1211, DOI 10.1152/jappl.1999.86.4.1211; CAMARATA PJ, 1994, NEUROSURGERY, V34, P144, DOI 10.1227/00006123-199401000-00021; Chavez JC, 2000, J APPL PHYSIOL, V89, P1937, DOI 10.1152/jappl.2000.89.5.1937; Cheng XW, 2010, CIRCULATION, V122, P707, DOI 10.1161/CIRCULATIONAHA.109.909218; Colbourne F, 2000, J CEREBR BLOOD F MET, V20, P1702, DOI 10.1097/00004647-200012000-00009; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Ding GL, 2010, J NEUROSCI RES, V88, P3206, DOI 10.1002/jnr.22470; Ding YH, 2004, CURR NEUROVASC RES, V1, P411, DOI 10.2174/1567202043361875; Drew KL, 2007, J NEUROCHEM, V102, P1713, DOI 10.1111/j.1471-4159.2007.04675.x; Dunn JF, 2011, HIGH ALT MED BIOL, V12, P71, DOI 10.1089/ham.2010.1038; Dunn JF, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3000431; Dunn JF, 2004, MAGN RESON MED, V51, P55, DOI 10.1002/mrm.10660; Dunn JF, 2000, J CEREBR BLOOD F MET, V20, P1632, DOI 10.1097/00004647-200012000-00002; Endres M, 2003, ANN NEUROL, V54, P582, DOI 10.1002/ana.10722; Fan YY, 2011, J CEREBR BLOOD F MET, V31, P305, DOI 10.1038/jcbfm.2010.94; Flynn EP, 2002, ANN NEUROL, V52, P566, DOI 10.1002/ana.10322; Garau A, 2005, CYTOKINE, V30, P125, DOI 10.1016/j.cyto.2004.12.014; Gonzalez CLR, 2003, EUR J NEUROSCI, V18, P1950, DOI 10.1046/j.1460-9568.2003.02928.x; Grinberg OY, 2005, ADV EXP MED BIOL, V566, P111; Hochachka PW, 1999, COMP BIOCHEM PHYS A, V124, P1, DOI 10.1016/S1095-6433(99)00079-3; Hoenig MR, 2008, CURR MOL MED, V8, P754, DOI 10.2174/156652408786733685; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Jha SK, 2002, HIGH ALT MED BIOL, V3, P21, DOI 10.1089/152702902753639513; LAMANNA JC, 1992, J APPL PHYSIOL, V72, P2238, DOI 10.1152/jappl.1992.72.6.2238; Li Yun-Xia, 2008, Neurosci Bull, V24, P89, DOI 10.1007/s12264-008-0089-3; Liu J, 2005, STROKE, V36, P1264, DOI 10.1161/01.STR.0000166180.91042.02; Liu J, 2000, AM J PHYSIOL-CELL PH, V278, pC144, DOI 10.1152/ajpcell.2000.278.1.C144; Ma YL, 2009, COMP BIOCHEM PHYS A, V154, P315, DOI 10.1016/j.cbpa.2009.06.016; Masada T, 2001, J CEREBR BLOOD F MET, V21, P22, DOI 10.1097/00004647-200101000-00004; Mergenthaler P, 2011, J PHYSIOL-LONDON, V589, P4147, DOI 10.1113/jphysiol.2011.209718; MILLIGAN CE, 1991, J COMP NEUROL, V314, P125, DOI 10.1002/cne.903140112; Mouton PR, 2002, J MICROSC-OXFORD, V206, P54, DOI 10.1046/j.1365-2818.2002.01006.x; Nagel S, 2011, J CEREBR BLOOD F MET, V31, P132, DOI 10.1038/jcbfm.2010.60; Ndubuizu OI, 2010, BRAIN RES, V1366, P101, DOI 10.1016/j.brainres.2010.09.064; NIAZI GA, 1994, ACTA NEUROL SCAND, V89, P439; Ortiz-Prado E, 2010, J NEUROSCI METH, V193, P217, DOI 10.1016/j.jneumeth.2010.08.019; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Pichiule P, 2002, J APPL PHYSIOL, V93, P1131, DOI 10.1152/japplphysiol.00318.2002; Poli S, 2009, CURR MOL MED, V9, P227, DOI 10.2174/156652409787581619; Ratan RR, 2007, J MOL MED, V85, P1331, DOI 10.1007/s00109-007-0283-1; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenza GL, 2006, EXP PHYSIOL, V91, P803, DOI 10.1113/expphysiol.2006.033498; SEVERINGHAUS JW, 1966, CIRC RES, V19, P274, DOI 10.1161/01.RES.19.2.274; Stowe AM, 2011, ANN NEUROL, V69, P975, DOI 10.1002/ana.22367; Tang Y, 2006, NEUROBIOL DIS, V21, P18, DOI 10.1016/j.nbd.2005.06.002; Veldhuis TB, 2003, J CEREBR BLOOD F MET, V23, P1029, DOI 10.1097/01.WCB.0000080703.47016.B6; Ward NL, 2007, J APPL PHYSIOL, V102, P1927, DOI 10.1152/japplphysiol.00909.2006; Yin W, 2007, STROKE, V38, P1017, DOI 10.1161/01.STR.0000258102.18836.ca; Zhou F, 2001, AM J PATHOL, V158, P2145, DOI 10.1016/S0002-9440(10)64686-X; Zhu CZ, 2004, J NEUROSURG, V101, P664, DOI 10.3171/jns.2004.101.4.0664	56	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45108	10.1371/journal.pone.0045108	http://dx.doi.org/10.1371/journal.pone.0045108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028788	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700087
J	Molins, CR; Delorey, MJ; Young, JW; Yockey, BM; Belisle, JT; Schriefer, ME; Petersen, JM				Molins, Claudia R.; Delorey, Mark J.; Young, John W.; Yockey, Brook M.; Belisle, John T.; Schriefer, Martin E.; Petersen, Jeannine M.			Use of Temperature for Standardizing the Progression of Francisella tularensis in Mice	PLOS ONE			English	Article							BODY-TEMPERATURE; UNITED-STATES; MURINE MODEL; TULAREMIA; INFECTION; VIRULENCE; SHOCK	The study of infectious agents, their pathogenesis, the host response and the evaluation of newly developed countermeasures often requires the use of a living system. Murine models are frequently used to undertake such investigations with the caveat that non-biased measurements to assess the progression of infection are underutilized. Instead, murine models predominantly rely on symptomology exhibited by the animal to evaluate the state of the animal's health and to determine when euthanasia should be performed. In this study, we used subcutaneous temperature as a non-subjective measurement to follow and compare infection in mice inoculated with Francisella tularensis, a Gram-negative pathogen that produces an acute and fatal illness in mice. A reproducible temperature pattern defined by three temperature phases (normal, febrile and hypothermic) was identified in all mice infected with F. tularensis, regardless of the infecting strain. More importantly and for the first time a non-subjective, ethical, and easily determined surrogate endpoint for death based on a temperature, termed drop point, was identified and validated with statistical models. In comparative survival curve analyses for F. tularensis strains with differing virulence, the drop point temperature yielded the same results as those obtained using observed time to death. Incorporation of temperature measurements to evaluate F. tularensis was standardized based on statistical models to provide a new level of robustness for comparative analyses in mice. These findings should be generally applicable to other pathogens that produce acute febrile disease in animal models and offers an important tool for understanding and following the infection process.	[Molins, Claudia R.; Delorey, Mark J.; Young, John W.; Yockey, Brook M.; Schriefer, Martin E.; Petersen, Jeannine M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Belisle, John T.] Colorado State Univ, Microbiol Immunol & Pathol Dept, Ft Collins, CO 80523 USA	Centers for Disease Control & Prevention - USA; Colorado State University	Molins, CR (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.	CMolins@cdc.gov	Belisle, John T/B-8944-2017	Belisle, John T/0000-0002-2539-2798	American Society for Microbiology; Coordinating Center for Infectious Diseases; National Institutes of Health, National Institute of Allergy and Infectious Diseases [U54AIO65357-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER	American Society for Microbiology; Coordinating Center for Infectious Diseases(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Claudia Molins was funded by the American Society for Microbiology and the Coordinating Center for Infectious Diseases as a postdoctoral fellow while the work was being performed. Funding was provided by National Institutes of Health, National Institute of Allergy and Infectious Diseases grant number U54AIO65357-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY D, 1993, J AM STAT ASSOC, V88, P309, DOI 10.1080/01621459.1993.10594323; Bast DJ, 2004, ANTIMICROB AGENTS CH, V48, P3343, DOI 10.1128/AAC.48.9.3343-3348.2004; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; England K, 2009, J ANTIMICROB CHEMOTH, V64, P1052, DOI 10.1093/jac/dkp307; Kort WJ, 1998, LAB ANIM-UK, V32, P260, DOI 10.1258/002367798780559329; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; KuoLee R, 2007, INFECT IMMUN, V75, P1651, DOI 10.1128/IAI.01834-06; Molins CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010205; National Research Council, 1996, GUIDE CARE USE LAB A, P1; Ogoina Dimie, 2011, J Infect Public Health, V4, P108, DOI 10.1016/j.jiph.2011.05.002; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Reese SM, 2010, AM J TROP MED HYG, V83, P645, DOI 10.4269/ajtmh.2010.10-0127; SJOSTEDT AB, 2005, PROTEOBACTERIA B, V2, P200; SOOTHILL JS, 1992, INT J EXP PATHOL, V73, P95; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; Staples JE, 2006, EMERG INFECT DIS, V12, P1113; Stiles BG, 1999, INFECT IMMUN, V67, P1521, DOI 10.1128/IAI.67.3.1521-1525.1999; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004; Vlach KD, 2000, COMPARATIVE MED, V50, P160; Warn PA, 2003, LAB ANIM-UK, V37, P126, DOI 10.1258/00236770360563769; Wong JP, 1997, LAB ANIM SCI, V47, P143	21	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45310	10.1371/journal.pone.0045310	http://dx.doi.org/10.1371/journal.pone.0045310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028924	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700032
J	Bryan, R; Perona, P; Adolphs, R				Bryan, Ronnie; Perona, Pietro; Adolphs, Ralph			Perspective Distortion from Interpersonal Distance Is an Implicit Visual Cue for Social Judgments of Faces	PLOS ONE			English	Article							PERSONAL-SPACE; TRUSTWORTHINESS; IMPRESSIONS; AMYGDALA; TRUST; MODEL	The basis on which people make social judgments from the image of a face remains an important open problem in fields ranging from psychology to neuroscience and economics. Multiple cues from facial appearance influence the judgments that viewers make. Here we investigate the contribution of a novel cue: the change in appearance due to the perspective distortion that results from viewing distance. We found that photographs of faces taken from within personal space elicit lower investments in an economic trust game, and lower ratings of social traits (such as trustworthiness, competence, and attractiveness), compared to photographs taken from a greater distance. The effect was replicated across multiple studies that controlled for facial image size, facial expression and lighting, and was not explained by face width-to-height ratio, explicit knowledge of the camera distance, or whether the faces are perceived as typical. These results demonstrate a novel facial cue influencing a range of social judgments as a function of interpersonal distance, an effect that may be processed implicitly.	[Bryan, Ronnie; Perona, Pietro; Adolphs, Ralph] CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA; [Perona, Pietro; Adolphs, Ralph] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Adolphs, R (corresponding author), CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	radolphs@hss.caltech.edu			National Institutes of Health; Moore Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded by grants from National Institutes of Health and the Moore Foundation (R. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS L, 1991, J GEN PSYCHOL, V118, P335, DOI 10.1080/00221309.1991.9917794; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Beaulieu CMJ, 2004, J APPL SOC PSYCHOL, V34, P794, DOI 10.1111/j.1559-1816.2004.tb02571.x; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; Duarte J, 2009, AFA 2010 ATL M; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Evans GW, 2007, J ENVIRON PSYCHOL, V27, P90, DOI 10.1016/j.jenvp.2006.10.002; EVANS GW, 1973, PSYCHOL BULL, V80, P334, DOI 10.1037/h0034946; Hall E.T., 1966, HIDDEN DIMENSION, V609; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Houser D, 2006, DISCUSSION PAPERS EC, P38; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kramer R, 2006, HARVARD BUS REV, V84, P164; Kramer RM, 2006, HARVARD BUS REV, V84, P88; LANGLOIS JH, 1994, PSYCHOL SCI, V5, P214, DOI 10.1111/j.1467-9280.1994.tb00503.x; Li S, 2007, ENVIRON BEHAV, V39, P317, DOI 10.1177/0013916506290956; Oosterhof NN, 2009, EMOTION, V9, P128, DOI 10.1037/a0014520; PATTERSON ML, 1976, PSYCHOL REV, V83, P235, DOI 10.1037/0033-295X.83.3.235; Perona P, 2007, J VISION, V7; Rhodes G, 1996, PSYCHOL SCI, V7, P105, DOI 10.1111/j.1467-9280.1996.tb00338.x; Rubenstein A.J., 2002, FACIAL ATTRACTIVENES; Schlicht EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011663; SKOTKO VP, 1977, SOCIOMETRY, V40, P178, DOI 10.2307/3033520; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Tajadura-Jimenez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026083; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Uzzell D, 2006, BRIT J SOC PSYCHOL, V45, P579, DOI 10.1348/014466605X58384; Verhoff MA, 2008, FORENSIC SCI INT, V178, P153, DOI 10.1016/j.forsciint.2008.03.011; Vranic A, 2003, ENVIRON BEHAV, V35, P550, DOI 10.1177/0013916503035004006; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Zebrowitz L. A., 1997, READING FACES WINDOW	38	35	68	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45301	10.1371/journal.pone.0045301	http://dx.doi.org/10.1371/journal.pone.0045301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23028918	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000309392800037
J	Ishimaru, Y; Abe, M; Asakura, T; Imai, H; Abe, K				Ishimaru, Yoshiro; Abe, Miki; Asakura, Tomiko; Imai, Hiroo; Abe, Keiko			Expression Analysis of Taste Signal Transduction Molecules in the Fungiform and Circumvallate Papillae of the Rhesus Macaque, Macaca mulatta	PLOS ONE			English	Article							TRANSIENT RECEPTOR; MAMMALIAN SWEET; MOUSE TONGUE; ACID TASTE; CELLS; FAMILY; BITTER; GUSTDUCIN; SENSE; REVEALS	The molecular mechanisms of the mammalian gustatory system have been examined in many studies using rodents as model organisms. In this study, we examined the mRNA expression of molecules involved in taste signal transduction in the fungiform papillae (FuP) and circumvallate papillae (CvP) of the rhesus macaque, Macaca mulatta, using in situ hybridization. TAS1R1, TAS1R2, TAS2Rs, and PKD1L3 were exclusively expressed in different subsets of taste receptor cells (TRCs) in the FuP and CvP. This finding suggests that TRCs sensing different basic taste modalities are mutually segregated in macaque taste buds. Individual TAS2Rs exhibited a variety of expression patterns in terms of the apparent level of expression and the number of TRCs expressing these genes, as in the case of human TAS2Rs. GNAT3, but not GNA14, was expressed in TRCs of FuP, whereas GNA14 was expressed in a small population of TRCs of CvP, which were distinct from GNAT3- or TAS1R2-positive TRCs. These results demonstrate similarities and differences between primates and rodents in the expression profiles of genes involved in taste signal transduction.	[Ishimaru, Yoshiro; Abe, Miki; Asakura, Tomiko; Abe, Keiko] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Imai, Hiroo] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan	University of Tokyo; Kyoto University	Ishimaru, Y (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.	ayishi@mail.ecc.u-tokyo.ac.jp; aka7308@mail.ecc.u-tokyo.ac.jp	Ishimaru, Yoshiro/AAI-3049-2020; Imai, Hiroo/AAP-2393-2020	Imai, Hiroo/0000-0003-0729-0322	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22688010, 20380183]; Cooperation Research Program of the Primate Research Institute, Kyoto University; Research and Development Program for New Bio-industry Initiatives	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cooperation Research Program of the Primate Research Institute, Kyoto University; Research and Development Program for New Bio-industry Initiatives	This work was supported in part by a Grant-in-Aid for Young Scientists (A) 22688010 to Y.I. and Grants-in-Aid for Scientific Research 20380183 to K. A. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Cooperation Research Program of the Primate Research Institute, Kyoto University to Y.I.; and a Research and Development Program for New Bio-industry Initiatives to K. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Behrens M, 2007, J NEUROSCI, V27, P12630, DOI 10.1523/JNEUROSCI.1168-07.2007; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Hellekant G, 1997, J NEUROPHYSIOL, V77, P978, DOI 10.1152/jn.1997.77.2.978; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Ishimaru Y, 2009, J DENT RES, V88, P212, DOI 10.1177/0022034508330212; Ishimaru Y, 2005, MECH DEVELOP, V122, P1310, DOI 10.1016/j.mod.2005.07.005; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Ishimaru Y, 2009, ODONTOLOGY, V97, P1, DOI 10.1007/s10266-008-0095-y; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Kawaguchi H, 2010, J BIOL CHEM, V285, P17277, DOI 10.1074/jbc.C110.132944; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Moyer BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007682; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Shindo Y, 2008, BIOCHEM BIOPH RES CO, V376, P504, DOI 10.1016/j.bbrc.2008.09.035; Tizzano M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-110; Wang H, 2009, J COMP NEUROL, V512, P384, DOI 10.1002/cne.21899; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	33	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45426	10.1371/journal.pone.0045426	http://dx.doi.org/10.1371/journal.pone.0045426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029001	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800047
J	Jiang, L; Guo, R; Zhu, TC; Niu, XD; Guo, JX; Sun, W				Jiang, Li; Guo, Rui; Zhu, Tingcheng; Niu, Xuedun; Guo, Jixun; Sun, Wei			Water- and Plant-Mediated Responses of Ecosystem Carbon Fluxes to Warming and Nitrogen Addition on the Songnen Grassland in Northeast China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; TERRESTRIAL ECOSYSTEMS; SOIL RESPIRATION; INNER-MONGOLIA; CO2 EXCHANGE; TEMPERATURE; LIMITATION; MINERALIZATION; PRECIPITATION; METAANALYSIS	Background: Understanding how grasslands are affected by a long-term increase in temperature is crucial to predict the future impact of global climate change on terrestrial ecosystems. Additionally, it is not clear how the effects of global warming on grassland productivity are going to be altered by increased N deposition and N addition. Methodology/Principal Findings: In-situ canopy CO2 exchange rates were measured in a meadow steppe subjected to 4-year warming and nitrogen addition treatments. Warming treatment reduced net ecosystem CO2 exchange (NEE) and increased ecosystem respiration (ER); but had no significant impacts on gross ecosystem productivity (GEP). N addition increased NEE, ER and GEP. However, there were no significant interactions between N addition and warming. The variation of NEE during the four experimental years was correlated with soil water content, particularly during early spring, suggesting that water availability is a primary driver of carbon fluxes in the studied semi-arid grassland. Conclusion/Significance: Ecosystem carbon fluxes in grassland ecosystems are sensitive to warming and N addition. In the studied water-limited grassland, both warming and N addition influence ecosystem carbon fluxes by affecting water availability, which is the primary driver in many arid and semiarid ecosystems. It remains unknown to what extent the long-term N addition would affect the turn-over of soil organic matter and the C sink size of this grassland.	[Jiang, Li; Zhu, Tingcheng; Guo, Jixun; Sun, Wei] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China; [Guo, Rui] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Key Lab Dryland Agr, Minist Agr, Beijing 100193, Peoples R China; [Niu, Xuedun] Jilin Univ, Coll Life Sci, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin Province, Peoples R China	Northeast Normal University - China; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Jilin University	Guo, JX (corresponding author), NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Jilin Province, Peoples R China.	gjixun@nenu.edu.cn; sunwei@nenu.edu.cn			National Natural Science Foundation of China [31170303]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA 05050601]; Research Fund for the Doctoral Program of Higher Education of China [20090043110007]; State Key Laboratory of Vegetation and Environmental Change [LVEC2012kf01]; Fundamental Research Funds for the Central Universities [11NQJJ028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); State Key Laboratory of Vegetation and Environmental Change; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (31170303), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA 05050601), the Research Fund for the Doctoral Program of Higher Education of China (20090043110007), the State Key Laboratory of Vegetation and Environmental Change (LVEC2012kf01) and the Fundamental Research Funds for the Central Universities (11NQJJ028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AR6 Climate Change, 2021, SUMMARY POLICYMAKERS; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Baldocchi DD, 2004, AGR FOREST METEOROL, V123, P13, DOI 10.1016/j.agrformet.2003.11.006; Brueck H, 2010, PLANT SOIL, V328, P495, DOI 10.1007/s11104-009-0128-5; Dong G, 2011, ECOHYDROLOGY, V4, P211, DOI 10.1002/eco.200; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; ESWARAN H, 1993, SOIL SCI SOC AM J, V57, P192, DOI 10.2136/sssaj1993.03615995005700010034x; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; [韩梅 HAN Mei], 2006, [生态学报, Acta Ecologica Sinica], V26, P1825; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; Ineson P, 1998, GLOB CHANGE BIOL, V4, P153, DOI 10.1046/j.1365-2486.1998.00119.x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Li SG, 2005, GLOBAL CHANGE BIOL, V11, P1941, DOI 10.1111/j.1365-2486.2005.01047.x; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Qu GuoHui, 2003, Acta Prataculturae Sinica, V12, P18; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Ripley EA, 1996, INT J ECOLOGY ENV SC, V22, P1; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; SMITH TM, 1993, WATER AIR SOIL POLL, V70, P629, DOI 10.1007/BF01105026; Steduto P, 2002, AGR FOREST METEOROL, V111, P171, DOI 10.1016/S0168-1923(02)00023-0; Suyker AE, 2003, GLOBAL CHANGE BIOL, V9, P255, DOI 10.1046/j.1365-2486.2003.00567.x; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wan SQ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002315; Wang R, 2003, CHIN J APPL ECOL, V14, P892; Wang ZM, 2009, AGR ECOSYST ENVIRON, V129, P315, DOI 10.1016/j.agee.2008.10.009; Welker JM, 2004, GLOBAL CHANGE BIOL, V10, P1981, DOI 10.1111/j.1365-2486.2004.00857.x; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zhang Y, 2008, ATMOS ENVIRON, V42, P1035, DOI 10.1016/j.atmosenv.2007.12.015; Zhou XH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002526; Zhu T.-C., 1983, Proceedings of the XIV International Grassland Congress, held at Lexington, Kentucky, U.S.A., June 15-24, 1981 [Smith, J.A.; Hays, V.W. (Editors)], P429	42	27	30	17	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45205	10.1371/journal.pone.0045205	http://dx.doi.org/10.1371/journal.pone.0045205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028848	Green Published, gold			2022-12-27	WOS:000309388400065
J	Hirve, N; Levytskyy, RM; Rigaud, S; Guimond, DM; Zal, T; Sauer, K; Tsoukas, CD				Hirve, Nupura; Levytskyy, Roman M.; Rigaud, Stephanie; Guimond, David M.; Zal, Tomasz; Sauer, Karsten; Tsoukas, Constantine D.			A Conserved Motif in the ITK PH-Domain Is Required for Phosphoinositide Binding and TCR Signaling but Dispensable for Adaptor Protein Interactions	PLOS ONE			English	Article							X-LINKED AGAMMAGLOBULINEMIA; PLECKSTRIN HOMOLOGY DOMAIN; T-CELL-ACTIVATION; TEC FAMILY KINASES; CRYSTAL-STRUCTURE; TYROSINE; ASSOCIATION; DIFFERENTIATION; COMPLEXES; IMMUNITY	Binding of the membrane phospholipid phosphatidylinositol 3,4,5-trisphosphate (PIP3) to the Pleckstrin Homology (PH) domain of the Tec family protein tyrosine kinase, Inducible T cell Kinase (ITK), is critical for the recruitment of the kinase to the plasma membrane and its co-localization with the TCR-CD3 molecular complex. Three aromatic residues, termed the FYF motif, located in the inner walls of the phospholipid-binding pocket of the ITK PH domain, are conserved in the PH domains of all Tec kinases, but not in other PH-domain containing proteins, suggesting an important function of the FYF motif in the Tec kinase family. However, the biological significance of the FYF amino acid motif in the ITK-PH domain is unknown. To elucidate it, we have tested the effects of a FYF triple mutant (F26S, Y90F, F92S), henceforth termed FYF-ITK mutant, on ITK function. We found that FYF triple mutation inhibits the TCR-induced production of IL-4 by impairing ITK binding to PIP3, reducing ITK membrane recruitment, inducing conformational changes at the T cell-APC contact site, and compromising phosphorylation of ITK and subsequent phosphorylation of PLC gamma 1. Interestingly, however, the FYF motif is dispensable for the interaction of ITK with two of its signaling partners, SLP-76 and LAT. Thus, the FYF mutation uncouples PIP3-mediated ITK membrane recruitment from the interactions of the kinase with key components of the TCR signalosome and abrogates ITK function in T cells.	[Hirve, Nupura; Levytskyy, Roman M.; Guimond, David M.; Tsoukas, Constantine D.] San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA; [Hirve, Nupura; Levytskyy, Roman M.; Guimond, David M.; Tsoukas, Constantine D.] San Diego State Univ, Ctr Microbial Sci, Dept Biol, San Diego, CA 92182 USA; [Rigaud, Stephanie; Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Zal, Tomasz] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	California State University System; San Diego State University; California State University System; San Diego State University; Scripps Research Institute; University of Texas System; UTMD Anderson Cancer Center	Tsoukas, CD (corresponding author), San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA.	ctsoukas@sciences.sdsu.edu		Zal, Tomasz/0000-0002-3469-4261; Levytskyy, Roman/0000-0003-0750-0887	NIH [AI073636, GM088647, GM100785, CA137059]; Leukemia and Lymphoma Society Scholar Award [1440-11]; NATIONAL CANCER INSTITUTE [R01CA137059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073636, R01AI070845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100785, R01GM088647] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants AI073636 (CDT), AI070845, GM088647 and GM100785 (KS), and CA137059 (TZ). KS was supported by a Leukemia and Lymphoma Society Scholar Award, 1440-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yeung BB, 2006, J IMMUNOL, V176, P3895; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Brazin KN, 2000, J MOL BIOL, V302, P607, DOI 10.1006/jmbi.2000.4091; Ching KA, 1999, J IMMUNOL, V163, P6006; Ching KA, 2000, J IMMUNOL, V165, P256, DOI 10.4049/jimmunol.165.1.256; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Fowell DJ, 2009, CYTOKINE, V46, P1, DOI 10.1016/j.cyto.2008.12.023; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; Grasis J.A., 2011, J SIGNAL TRANSDUCT; Grasis JA, 2010, MOL CELL BIOL, V30, P3596, DOI 10.1128/MCB.01657-09; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Kabouridis PS, 2011, MOL MEMBR BIOL, V28, P487, DOI 10.3109/09687688.2011.624990; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Levytskyy R. M., 2012, J SIGNAL TRANSDUCT, V2012; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Min L, 2010, J IMMUNOL, V184, P4228, DOI 10.4049/jimmunol.0901908; Montoya MC, 2002, NAT IMMUNOL, V3, P159, DOI 10.1038/ni753; Murayama K, 2008, BIOCHEM BIOPH RES CO, V377, P23, DOI 10.1016/j.bbrc.2008.09.055; Qi Q, 2006, J BIOL CHEM, V281, P38529, DOI 10.1074/jbc.M609180200; Sanzenbacher R, 1999, J IMMUNOL, V163, P3143; Sauer K., 2009, CURR PROTOC IMMUNOL, V11; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schulz KR, 2007, CURR PROTOC IMMUNOL; Singleton KL, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001821; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Takesono A, 2002, J CELL SCI, V115, P3039; VIHINEN M, 1995, BIOCHEMISTRY-US, V34, P1475, DOI 10.1021/bi00005a002; VORECHOVSKY I, 1995, HUM MOL GENET, V4, P51, DOI 10.1093/hmg/4.1.51; Yang WC, 2000, IMMUNITY, V12, P373, DOI 10.1016/S1074-7613(00)80189-2; Zal T, 2004, CURR OPIN IMMUNOL, V16, P418, DOI 10.1016/j.coi.2004.05.019; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zal T, 2002, IMMUNITY, V16, P521, DOI 10.1016/S1074-7613(02)00301-1	41	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45158	10.1371/journal.pone.0045158	http://dx.doi.org/10.1371/journal.pone.0045158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028816	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900087
J	Janssen, SF; Gorgels, TGMF; Bossers, K; ten Brink, JB; Essing, AHW; Nagtegaal, M; van der Spek, PJ; Jansonius, NM; Bergen, AAB				Janssen, Sarah F.; Gorgels, Theo G. M. F.; Bossers, Koen; ten Brink, Jacoline B.; Essing, Anke H. W.; Nagtegaal, Martijn; van der Spek, Peter J.; Jansonius, Nomdo M.; Bergen, Arthur A. B.			Gene Expression and Functional Annotation of the Human Ciliary Body Epithelia	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; GENOME-WIDE ASSOCIATION; RETINAL STEM-CELLS; AQUEOUS-HUMOR; INTRAOCULAR-PRESSURE; PROGENITOR CELLS; MOLECULAR CHARACTERIZATION; MATRIX METALLOPROTEINASES; DIFFERENTIAL EXPRESSION; OCULAR MANIFESTATIONS	Purpose: The ciliary body (CB) of the human eye consists of the non-pigmented (NPE) and pigmented (PE) neuro-epithelia. We investigated the gene expression of NPE and PE, to shed light on the molecular mechanisms underlying the most important functions of the CB. We also developed molecular signatures for the NPE and PE and studied possible new clues for glaucoma. Methods: We isolated NPE and PE cells from seven healthy human donor eyes using laser dissection microscopy. Next, we performed RNA isolation, amplification, labeling and hybridization against 44xk Agilent microarrays. For microarray conformations, we used a literature study, RT-PCRs, and immunohistochemical stainings. We analyzed the gene expression data with R and with the knowledge database Ingenuity. Results: The gene expression profiles and functional annotations of the NPE and PE were highly similar. We found that the most important functionalities of the NPE and PE were related to developmental processes, neural nature of the tissue, endocrine and metabolic signaling, and immunological functions. In total 1576 genes differed statistically significantly between NPE and PE. From these genes, at least 3 were cell-specific for the NPE and 143 for the PE. Finally, we observed high expression in the (N)PE of 35 genes previously implicated in molecular mechanisms related to glaucoma. Conclusion: Our gene expression analysis suggested that the NPE and PE of the CB were quite similar. Nonetheless, cell-type specific differences were found. The molecular machineries of the human NPE and PE are involved in a range of neuro-endocrinological, developmental and immunological functions, and perhaps glaucoma.	[Janssen, Sarah F.; Gorgels, Theo G. M. F.; ten Brink, Jacoline B.; Essing, Anke H. W.; Nagtegaal, Martijn; Bergen, Arthur A. B.] Royal Netherlands Acad Arts & Sci, Dept Clin & Mol Ophthalmogenet, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Bossers, Koen] Royal Netherlands Acad Arts & Sci, Lab Neuroregenerat, Netherlands Inst Neurosci, Amsterdam, Netherlands; [van der Spek, Peter J.] Erasmus Univ, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands; [Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Bergen, Arthur A. B.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [Bergen, Arthur A. B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Bergen, AAB (corresponding author), Royal Netherlands Acad Arts & Sci, Dept Clin & Mol Ophthalmogenet, Netherlands Inst Neurosci, Amsterdam, Netherlands.	A.Bergen@nin.knaw.nl	Bergen, Arthur/J-3637-2013; Bossers, Koen/I-4002-2013	Bergen, Arthur/0000-0002-6333-9576; Bossers, Koen/0000-0002-0272-4518; Jansonius, Nomdo/0000-0002-6495-6568	General Dutch Foundation Preventing Blindness; National Foundation for Blinds and Low Vision; Foundation Blinden-Penning; Foundation Glaucoomfonds; Rotterdam Foundation of Blinds; Professor Mulder Foundation; UitZicht [UitZicht2008-7]	General Dutch Foundation Preventing Blindness; National Foundation for Blinds and Low Vision; Foundation Blinden-Penning; Foundation Glaucoomfonds; Rotterdam Foundation of Blinds; Professor Mulder Foundation; UitZicht	This study was supported by grants from the General Dutch Foundation Preventing Blindness, the National Foundation for Blinds and Low Vision, the Foundation Blinden-Penning, the Foundation Glaucoomfonds, the Rotterdam Foundation of Blinds and the Professor Mulder Foundation (all together cooperated by UitZicht, project # UitZicht2008-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-21; Agapova OA, 2003, BRAIN RES, V967, P132, DOI 10.1016/S0006-8993(02)04234-8; Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Ando Y, 1996, TRANSPLANTATION, V62, P1037, DOI 10.1097/00007890-199610150-00028; Angius A, 1998, ARCH OPHTHALMOL-CHIC, V116, P793, DOI 10.1001/archopht.116.6.793; ARMALY MF, 1963, ARCH OPHTHALMOL-CHIC, V70, P482, DOI 10.1001/archopht.1963.00960050484010; Ayyagari R, 2005, INVEST OPHTH VIS SCI, V46, P3363, DOI 10.1167/iovs.05-0159; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Bayer AU, 2002, EUR NEUROL, V47, P165, DOI 10.1159/000047976; Bayer AU, 2002, AM J OPHTHALMOL, V133, P135, DOI 10.1016/S0002-9394(01)01196-5; Bejjani BA, 2002, EXP EYE RES, V75, P249, DOI 10.1006/exer.2002.2025; Bertazolli R, 2003, BIOCHEM BIOPH RES CO, V305, P820, DOI 10.1016/S0006-291X(03)00825-8; Bertazolli R, 2001, BIOCHEM BIOPH RES CO, V284, P317, DOI 10.1006/bbrc.2001.4970; Bertazolli-Filho R, 2007, CURR EYE RES, V32, P751, DOI 10.1080/02713680701573381; Bhatia B, 2009, EXP EYE RES, V89, P373, DOI 10.1016/j.exer.2009.04.005; BIGGER JF, 1972, INVEST OPHTH VISUAL, V11, P832; Bishop PN, 2002, EYE, V16, P454, DOI 10.1038/sj.eye.6700199; Boehm N, 2012, BRAIN BEHAV IMMUN, V26, P96, DOI 10.1016/j.bbi.2011.07.241; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Booij Judith C, 2010, PLoS One, V5, pe9341, DOI 10.1371/journal.pone.0009341; Booij JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-164; Browne JG, 2011, INVEST OPHTHALMOL VI; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Calera MR, 2006, J CELL SCI, V119, P4510, DOI 10.1242/jcs.03202; CasaroliMarano RP, 1996, J LIPID RES, V37, P1037; Chan CY, 2007, AM J PHYSIOL-CELL PH, V292, pC1087, DOI 10.1152/ajpcell.00048.2006; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Coca-Prados M, 2007, PROG RETIN EYE RES, V26, P239, DOI 10.1016/j.preteyeres.2007.01.002; COCAPRADOS M, 1992, CURR EYE RES, V11, P113, DOI 10.3109/02713689209000061; Coffey KL, 2002, EXP EYE RES, V75, P9, DOI 10.1006/exer.2002.1187; Comes N, 2009, PHYSIOL GENOMICS, V38, P205, DOI 10.1152/physiolgenomics.90261.2008; CUNHAVAZ J, 1979, SURV OPHTHALMOL, V23, P279, DOI 10.1016/0039-6257(79)90158-9; Das AV, 2005, VISION RES, V45, P1653, DOI 10.1016/j.visres.2004.12.017; Decembrini S, 2011, STEM CELLS DEV, V20, P851, DOI 10.1089/scd.2010.0291; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Doshi M, 2006, EXP EYE RES, V82, P24, DOI 10.1016/j.exer.2005.04.016; Duan XM, 2010, MOL VIS, V16, P2839; Duncan KG, 2009, BRIT J OPHTHALMOL, V93, P1116, DOI 10.1136/bjo.2008.144006; Dunn JJ, 2001, INVEST OPHTH VIS SCI, V42, P343; Fischer AJ, 2001, DEV NEUROSCI-BASEL, V23, P268, DOI 10.1159/000048710; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Gao B, 2005, EXP EYE RES, V80, P61, DOI 10.1016/j.exer.2004.08.013; GAO EK, 1995, INVEST OPHTH VIS SCI, V36, P2322; Genini S, 2010, INVEST OPHTH VIS SCI, V51, P6038, DOI 10.1167/iovs.10-5443; Gerashchenko DY, 1998, INVEST OPHTH VIS SCI, V39, P198; Gerometta R, 2010, INVEST OPHTH VIS SCI, V51, P3139, DOI 10.1167/iovs.09-4862; GHOSH S, 1990, J BIOL CHEM, V265, P2935; Gibson J, 2012, MOL VIS, V18, P1083; Goldhagen B, 2012, J GLAUCOMA, P10; Grus FH, 2008, MOL VIS, V14, P1437; Gualdoni S, 2010, STEM CELLS, V28, P1048, DOI 10.1002/stem.423; Ha A, 2012, MOL VIS, V18, P645; HASEGAWA H, 1994, AM J PHYSIOL, V266, pC893, DOI 10.1152/ajpcell.1994.266.4.C893; HAYASAKA S, 1986, JPN J OPHTHALMOL, V30, P32; Hochgesand DH, 2001, EXP EYE RES, V72, P1, DOI 10.1006/exer.2000.0927; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007; Igarashi T, 2001, J AM SOC NEPHROL, V12, P713, DOI 10.1681/ASN.V124713; Inoue T, 2010, STEM CELLS, V28, P489, DOI 10.1002/stem.279; Ishikawa K, 2005, MOL VIS, V11, P431; Kalesnykas G, 2007, NEUROSCIENCE, V150, P692, DOI 10.1016/j.neuroscience.2007.09.078; KASS MA, 1977, SURV OPHTHALMOL, V22, P153, DOI 10.1016/0039-6257(77)90053-4; Khor CC, 2011, HUM MOL GENET, V20, P1864, DOI 10.1093/hmg/ddr060; Kim S, 2006, MOL VIS, V12, P1016; Kimura A, 2003, ARCH OPHTHALMOL-CHIC, V121, P351, DOI 10.1001/archopht.121.3.351; KIMURA R, 1982, ACTA OPHTHALMOL, V60, P584; Kumar A, 2007, MOL VIS, V13, P667; Lan J, 2003, BRIT J OPHTHALMOL, V87, P208, DOI 10.1136/bjo.87.2.208; Lebon S, 2007, MOL GENET METAB, V90, P379, DOI 10.1016/j.ymgme.2006.12.007; Libby RT, 2003, SCIENCE, V299, P1578, DOI 10.1126/science.1080095; Liu H, 2007, DEV BIOL, V308, P54, DOI 10.1016/j.ydbio.2007.04.052; Lord-Grignon J, 2006, GENE EXPR PATTERNS, V6, P992, DOI 10.1016/j.modgep.2006.04.003; MacNeil A, 2007, STEM CELLS, V25, P2430, DOI 10.1634/stemcells.2007-0035; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5505, DOI 10.1167/iovs.06-0312; Marcus MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029724; Martignoni M, 2008, AM J HUM GENET, V83, P127, DOI 10.1016/j.ajhg.2008.05.014; Martin SN, 2000, J MED GENET, V37, P422, DOI 10.1136/jmg.37.6.422; MARTINALONSO JM, 1993, EXP EYE RES, V56, P659, DOI 10.1006/exer.1993.1083; Martinez-Navarrete GC, 2008, J COMP NEUROL, V511, P557, DOI 10.1002/cne.21860; MCCARTY GR, 1982, INVEST OPHTH VIS SCI, V23, P525; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; MILLER D, 1965, AM J OPHTHALMOL, V59, P31, DOI 10.1016/0002-9394(65)95015-4; Miyara N, 2008, JPN J OPHTHALMOL, V52, P84, DOI 10.1007/s10384-007-0507-5; Murata M, 1997, OPHTHALMOLOGICA, V211, P301, DOI 10.1159/000310813; Musa FU, 2009, EYE, V23, P549, DOI 10.1038/eye.2008.77; Naka M, 2010, INVEST OPHTH VIS SCI, V51, P4618, DOI 10.1167/iovs.09-4712; Nelson GA, 1999, OPHTHALMOLOGY, V106, P1363, DOI 10.1016/S0161-6420(99)00726-5; Ortego J, 1997, EXP EYE RES, V65, P289, DOI 10.1006/exer.1997.0333; Ortego J, 1996, INVEST OPHTH VIS SCI, V37, P2759; Ortego J, 1996, J NEUROCHEM, V66, P787; Ortego J, 1997, J NEUROCHEM, V69, P1829; Ostojic J, 2008, J HISTOCHEM CYTOCHEM, V56, P863, DOI 10.1369/jhc.2008.951392; Pelis RM, 2009, J PHARMACOL EXP THER, V329, P479, DOI 10.1124/jpet.108.149625; PERESS NS, 1994, INVEST OPHTH VIS SCI, V35, P453; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Ramdas WD, 2012, EUR J EPIDEMIOL; Ramdas WD, 2011, OPHTHALMOLOGY, V118, P2389, DOI 10.1016/j.ophtha.2011.05.040; Rauz S, 2003, INVEST OPHTH VIS SCI, V44, P1643, DOI 10.1167/iovs.02-0514; Rodrigues MLP, 1998, CURR EYE RES, V17, P694, DOI 10.1080/02713689808951245; Saito K, 2010, CONNECTIVE TISSUE RE, P1; Salvador-Silva M, 2005, MOL VIS, V11, P356; Sandgren O, 2008, ACTA OPHTHALMOL, V86, P520, DOI 10.1111/j.1600-0420.2007.01098.x; Schlotzer-Schrehardt U, 2001, EXP EYE RES, V73, P765, DOI 10.1006/exer.2001.1084; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Siegfried CJ, 2010, INVEST OPHTH VIS SCI, V51, P5731, DOI 10.1167/iovs.10-5666; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sonsino J, 2002, EXP EYE RES, V74, P123, DOI 10.1006/exer.2001.1100; SOUTHREN AL, 1979, INVEST OPHTH VIS SCI, V18, P517; SRAMEK SJ, 1992, INVEST OPHTH VIS SCI, V33, P1627; Sugita S, 2009, ARCH IMMUNOL THER EX, V57, P263, DOI 10.1007/s00005-009-0030-0; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tamura H, 2006, J NEUROL SCI, V246, P79, DOI 10.1016/j.jns.2006.02.009; Taylor AW, 2009, EYE, V23, P1885, DOI 10.1038/eye.2008.382; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; TOATES FM, 1972, PHYSIOL REV, V52, P828, DOI 10.1152/physrev.1972.52.4.828; TRIPATHI RC, 1992, INVEST OPHTH VIS SCI, V33, P2866; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tserentsoodol N, 1998, HISTOCHEM CELL BIOL, V110, P543, DOI 10.1007/s004180050316; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; van Soest SS, 2007, MOL VIS, V13, P1608; Vasconcellos JPC, 2005, ARCH OPHTHALMOL-CHIC, V123, P1422, DOI 10.1001/archopht.123.10.1422; Vasconcellos JPC, 2000, J MED GENET, V37, P301, DOI 10.1136/jmg.37.4.301; Vickers JC, 2002, MOL VIS, V8, P389; VIRNO M, 1974, ANN OPHTHALMOL, V6, P983; WANG TH, 1994, INVEST OPHTH VIS SCI, V35, P3776; Wang X, 2000, BRAIN RES, V878, P136, DOI 10.1016/S0006-8993(00)02727-X; Wawrocka A, 2012, OPHTHALMIC GENET, V33, P44, DOI 10.3109/13816810.2011.615076; Weber P, 1998, J NEUROSCI, V18, P9192; Wetzel RK, 2001, INVEST OPHTH VIS SCI, V42, P763; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wu P, 2000, HISTOCHEM CELL BIOL, V114, P303; Xu HX, 2007, INVEST OPHTH VIS SCI, V48, P1674, DOI 10.1167/iovs.06-1034; Xue W, 2007, INVEST OPHTH VIS SCI, V48, P3184, DOI 10.1167/iovs.06-1403; Yanagi Y, 2006, EXP EYE RES, V82, P471, DOI 10.1016/j.exer.2005.08.005; Yang PZ, 2009, ACTA OPHTHALMOL, V87, P211, DOI 10.1111/j.1755-3768.2008.01194.x; Yenice O, 2008, PARKINSONISM RELAT D, V14, P193, DOI 10.1016/j.parkreldis.2007.07.018; Yuki K, 2011, INVEST OPHTH VIS SCI, V52, P4143, DOI 10.1167/iovs.10-6294; Zenkel M, 2005, INVEST OPHTH VIS SCI, V46, P3742, DOI 10.1167/iovs.05-0249; Zenkel M, 2006, INVEST OPHTH VIS SCI, V47, P1982, DOI 10.1167/iovs.05-1580; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhang YW, 2010, MOL VIS, V16, P200	147	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44973	10.1371/journal.pone.0044973	http://dx.doi.org/10.1371/journal.pone.0044973			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028713	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900062
J	Penna, F; Pin, F; Costamagna, D; Reffo, P; Baccino, FM; Bonelli, G; Costelli, P				Penna, Fabio; Pin, Fabrizio; Costamagna, Domiziana; Reffo, Patrizia; Baccino, Francesco Maria; Bonelli, Gabriella; Costelli, Paola			Caspase 2 Activation and ER Stress Drive Rapid Jurkat Cell Apoptosis by Clofibrate	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HEPATIC PEROXISOME PROLIFERATION; MEDROXYPROGESTERONE ACETATE; RECEPTOR-GAMMA; PPAR-ALPHA; COMBINED BEZAFIBRATE; INDUCE APOPTOSIS; GENE-EXPRESSION; CROSS-TALK; IN-VITRO	Differently from the antiapoptotic action most commonly assigned to peroxisome proliferators (PPs), we demonstrated that some of them, clofibrate (CF) in particular, display clearcut apoptogenic properties on rat hepatoma cell lines. We and others could confirm that CF as well as various other PPs can induce apoptosis in a variety of cells, including human liver, breast and lung cancer cell lines. The present study was aimed at investigating the cytotoxic action of CF on a neoplastic line of different origin, the human T leukemia Jurkat cells. We observed that CF rapidly triggers an extensive and morphologically typical apoptotic process on Jurkat cells, though not in primary T cells, which is completely prevented by the polycaspase inhibitor zVADfmk. Gene silencing studies demonstrated that CF-induced apoptosis in Jurkat cells is partially dependent on activation of caspase 2. Looking for a possible trigger of caspase 2 activation, we observed increased levels of phosphorylated eIF2 alpha and JNK in CF-treated cells. Moreover, intracellular Ca2+ homeostasis was perturbed. Together, these findings are suggestive for the occurrence of ER stress, an event that is known to have the potential to activate caspase 2. The present observations demonstrate that CF induces in Jurkat cells a very fast and extensive apoptosis, that involves induction of ER stress and activation of caspases 2 and 3. Since apoptosis in Jurkat cells occurs at pharmacologically relevant concentrations of CF, the present findings encourage further in depth analysis in order to work out the potential implications of CF cytotoxcity on leukemic cells.	[Penna, Fabio; Pin, Fabrizio; Costamagna, Domiziana; Reffo, Patrizia; Baccino, Francesco Maria; Bonelli, Gabriella; Costelli, Paola] Univ Turin, Dept Expt Med & Oncol, Turin, Italy	University of Turin	Costelli, P (corresponding author), Univ Turin, Dept Expt Med & Oncol, Turin, Italy.	paola.costelli@unito.it	Penna, Fabio/K-5090-2016	Penna, Fabio/0000-0002-2774-6027; Costamagna, Domiziana/0000-0001-7370-9385; Bonelli, Gabriella/0000-0002-5164-8902	Ministero per l'Universita e la Ricerca Scientifica (MIUR, Roma); University of Torino; Regione Piemonte, Compagnia di San Paolo, Torino; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) [MFAG6211, IG9153]	Ministero per l'Universita e la Ricerca Scientifica (MIUR, Roma)(Ministry of Education, Universities and Research (MIUR)); University of Torino; Regione Piemonte, Compagnia di San Paolo, Torino; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro)	Work supported by Ministero per l'Universita e la Ricerca Scientifica (MIUR, Roma; PRIN projects 2001 and 2003), University of Torino (ex-60% funds), Regione Piemonte, Compagnia di San Paolo, Torino, and Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano, MFAG6211, IG9153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarod EB, 2004, FREE RADICAL BIO MED, V37, P36, DOI 10.1016/j.freeradbiomed.2004.04.015; BENTLEY P, 1993, FOOD CHEM TOXICOL, V31, P857, DOI 10.1016/0278-6915(93)90225-N; Botton T, 2009, J INVEST DERMATOL, V129, P1208, DOI 10.1038/jid.2008.346; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Canuto RA, 2003, J LIPID RES, V44, P56, DOI 10.1194/jlr.M200072-JLR200; Canuto RA, 1997, CELL DEATH DIFFER, V4, P224, DOI 10.1038/sj.cdd.4400224; Cheung HH, 2006, EXP CELL RES, V312, P2347, DOI 10.1016/j.yexcr.2006.03.027; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; de Figueiredo P, 1999, CELL BIOL TOXICOL, V15, P311, DOI 10.1023/A:1007667802497; Del Bello B, 2007, ONCOGENE, V26, P2717, DOI 10.1038/sj.onc.1210079; Dorio A, 2007, ANN NY ACAD SCI, V1099, P512, DOI 10.1196/annals.1387.067; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elrod HA, 2008, PPAR RES, V2008, DOI 10.1155/2008/704165; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Fanelli C, 1999, FASEB J, V13, P95, DOI 10.1096/fasebj.13.1.95; Fenton SL, 1999, BRIT J HAEMATOL, V105, P448, DOI 10.1111/j.1365-2141.1999.01355.x; Fenton SL, 2003, LEUKEMIA, V17, P568, DOI 10.1038/sj.leu.2402843; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; HARVENGT C, 1977, INT J CLIN PHARM BI, V15, P1; Hayden RE, 2009, LEUKEMIA, V23, P292, DOI 10.1038/leu.2008.283; Khanim FL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008147; Kim KA, 2007, INT J PARASITOL, V37, P1209, DOI 10.1016/j.ijpara.2007.03.011; Kim SH, 2006, TOXICOL APPL PHARM, V215, P198, DOI 10.1016/j.taap.2006.03.001; Lai DY, 2004, J ENVIRON SCI HEAL C, V22, P37, DOI 10.1081/GNC-120038005; Lake BG, 2000, MUTAT RES-FUND MOL M, V448, P213, DOI 10.1016/S0027-5107(99)00238-9; Luci Sebastian, 2007, BMC Pharmacology, V7, P6, DOI 10.1186/1471-2210-7-6; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; Matsuyama M., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P76; Murray JA, 2010, BRIT J HAEMATOL, V149, P65, DOI 10.1111/j.1365-2141.2009.08055.x; Muzio G, 2006, APOPTOSIS, V11, P265, DOI 10.1007/s10495-006-3559-y; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nakamura M, 2001, BIOSCI BIOTECH BIOCH, V65, P1812, DOI 10.1271/bbb.65.1812; NILSSON A, 1995, EUR J CELL BIOL, V67, P379; Nishimura J, 2007, TOXICOL SCI, V97, P44, DOI 10.1093/toxsci/kfm011; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Ohmura T, 1996, AM J PATHOL, V148, P815; Penna F, 2009, BIOCHEM PHARMACOL, V77, P169, DOI 10.1016/j.bcp.2008.10.004; Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9; Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029; REDDY JK, 1976, CANCER RES, V36, P1211; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Scatena R, 1999, CELL DEATH DIFFER, V6, P781, DOI 10.1038/sj.cdd.4400551; Scatena R, 2008, PPAR RES, V2008, DOI 10.1155/2008/256251; Shabalina IG, 1999, CARCINOGENESIS, V20, P2237, DOI 10.1093/carcin/20.12.2237; SHACKLETON GL, 1995, TOXICOL APPL PHARM, V130, P294, DOI 10.1006/taap.1995.1034; Simbula G, 2004, LIFE SCI, V75, P271, DOI 10.1016/j.lfs.2003.10.039; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tomiyama N, 2007, CLIN EXP PHARMACOL P, V34, P876, DOI 10.1111/j.1440-1681.2007.04677.x; Troy CM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.138pe42; Tsubouchi Y, 2000, BIOCHEM BIOPH RES CO, V270, P400, DOI 10.1006/bbrc.2000.2436; Varghese J, 2001, EUR J IMMUNOL, V31, P2035, DOI 10.1002/1521-4141(200107)31:7<2035::AID-IMMU2035>3.0.CO;2-Y; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Xiao S, 2006, TOXICOL SCI, V92, P368, DOI 10.1093/toxsci/kfl002; Xu HE, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.148pe52	55	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45327	10.1371/journal.pone.0045327	http://dx.doi.org/10.1371/journal.pone.0045327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028936	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900119
J	Sudfeld, CR; Fawzi, WW; Lahariya, C				Sudfeld, Christopher R.; Fawzi, Wafaie W.; Lahariya, Chandrakant			Peer Support and Exclusive Breastfeeding Duration in Low and Middle-Income Countries: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED-TRIAL; HOME VISITS; PROMOTION; COUNSELORS; BANGLADESH; NUTRITION; EFFICACY; PROGRAM	Objective: To examine the effect of peer support on duration of exclusive breastfeeding (EBF) in low and middle-income countries (LMICs). Data Sources: Medline, EMBASE, and Cochrane Central Register for Controlled Trials were searched from inception to April 2012. Methods: Two authors independently searched, reviewed, and assessed the quality of randomized controlled trials utilizing peer support in LMICs. Meta-analysis and metaregression techniques were used to produce pooled relative risks and investigate sources of heterogeneity in the estimates. Results: Eleven randomized controlled trials conducted at 13 study sites met the inclusion criteria for systematic review. We noted significant differences in study populations, peer counselor training methods, peer visit schedule, and outcome ascertainment methods. Peer support significantly decreased the risk of discontinuing EBF as compared to control (RR: 0.71; 95% CI: 0.61-0.82; I-2 = 92%). The effect of peer support was significantly reduced in settings with >10% community prevalence of formula feeding as compared to settings with <10% prevalence (p = 0.048). There was no evidence of effect modification by inclusion of low birth weight infants (p = 0.367) and no difference in the effect of peer support on EBF at 4 versus 6 months postpartum (p = 0.398). Conclusions: Peer support increases the duration of EBF in LMICs; however, the effect appears to be reduced in formula feeding cultures. Future studies are needed to determine the optimal timing of peer visits, how to best integrate peer support into packaged intervention strategies, and the effectiveness of supplemental interventions to peer support in formula feeding cultures.	[Sudfeld, Christopher R.; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Lahariya, Chandrakant] GR Med Coll, Dept Community Med, Gwalior, MP, India	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Sudfeld, CR (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	csudfeld@hsph.harvard.edu	Sudfeld, Christopher/AAW-3856-2021	Sudfeld, Christopher/0000-0002-3203-3638; Lahariya, Chandrakant/0000-0003-2603-7090	National Institute of Allergy and Infectious Diseases [T32AI007358]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007358] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sudfeld was supported by Award Number T32AI007358 from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Allergy And Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrasada GV, 2005, ACTA PAEDIATR, V94, P1109, DOI 10.1080/08035250510025752; Aksu H, 2011, J MATERN-FETAL NEO M, V24, P354, DOI 10.3109/14767058.2010.497569; [Anonymous], 2009, HIV INF FEED REV PRI; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta Z.A., 2008, LANCET, V371, P417, DOI [10.1016/S0140-6736(07)61693-6, DOI 10.1016/S0140-6736(07)61693-6]; Chapman DJ, 2010, J HUM LACT, V26, P314, DOI 10.1177/0890334410369481; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; Davies-Adetugbo AA, 1997, J DIARRHOEAL DIS RES, V15, P161; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Desclaux A, 2009, SOC SCI MED, V69, P821, DOI 10.1016/j.socscimed.2009.06.007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faruque ASG, 2008, J HEALTH POPUL NUTR, V26, P325; Feldens CA, 2007, COMMUNITY DENT ORAL, V35, P215, DOI 10.1111/j.1600-0528.2006.00337.x; Guerrero ML, 1999, B WORLD HEALTH ORGAN, V77, P323; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jakobsen MS, 1999, ACTA PAEDIATR, V88, P741, DOI 10.1080/08035259950169026; Jolly K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8287; Leite AJM, 2005, ACTA PAEDIATR, V94, P741, DOI 10.1080/08035250410023854; Lewin S, 2010, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004015.PUB3; Mannan I, 2008, J PERINATOL, V28, P632, DOI 10.1038/jp.2008.64; Marriott BM, 2007, J NUTR, V137, p518S, DOI 10.1093/jn/137.2.518S; McInnes RJ, 2000, J PUBLIC HEALTH MED, V22, P138, DOI 10.1093/pubmed/22.2.138; Ministere de la Sante Publique et de la Population Unite de Coordination du Programme National d'Alimentation et de Nutrition, 2008, NORM NAT REL AL NOUR; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Naicker Saraladevi, 2009, Ethn Dis, V19, pS1; *NORD COCHR CTR CO, 2008, REV MAN REVMAN COMP; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; Renfrew Mary J, 2012, Cochrane Database Syst Rev, pCD001141, DOI 10.1002/14651858.CD001141.pub4; SADHS: Department of Health MRC OrcMacro, 2007, S AFR DEM HLTH SURV; Salud MALB, 2009, J HUM LACT, V25, P341, DOI 10.1177/0890334409334605; Scott Jane A, 2003, J Hum Lact, V19, P270, DOI 10.1177/0890334403255225; Sheeshka J, 2001, J Hum Lact, V17, P31, DOI 10.1177/089033440101700107; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; *UNICEF, 2008, OV BREASTF PATT; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; WHO, 2003, GLOB STRAT INF YOUNG; Wong EHY, 2007, INT BREASTFEED J, V2, DOI 10.1186/1746-4358-2-12; World Bank, 2012, COUNTR EC; World Health Organization Division of Child Health and Development, 1991, IND ASS BREASTF PRAC; Worugji I N E, 2005, Health Care Women Int, V26, P534, DOI 10.1080/07399330591004863	45	39	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45143	10.1371/journal.pone.0045143	http://dx.doi.org/10.1371/journal.pone.0045143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028810	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900085
J	Zhao, DH; Jiang, H; Cai, Y; An, SQ				Zhao, Dehua; Jiang, Hao; Cai, Ying; An, Shuqing			Artificial Regulation of Water Level and Its Effect on Aquatic Macrophyte Distribution in Taihu Lake	PLOS ONE			English	Article							VEGETATION; SHALLOW; IMAGERY; FLUCTUATIONS; EXPANSION; WETLANDS; TREE; BAY	Management of water levels for flood control, water quality, and water safety purposes has become a priority for many lakes worldwide. However, the effects of water level management on the distribution and composition of aquatic vegetation has received little attention. Relevant studies have used either limited short-term or discrete long-term data and thus are either narrowly applicable or easily confounded by the effects of other environmental factors. We developed classification tree models using ground surveys combined with 52 remotely sensed images (15-30 m resolution) to map the distributions of two groups of aquatic vegetation in Taihu Lake, China from 1989-2010. Type 1 vegetation included emergent, floating, and floating-leaf plants, whereas Type 2 consisted of submerged vegetation. We sought to identify both inter-and intra-annual dynamics of water level and corresponding dynamics in the aquatic vegetation. Water levels in the ten-year period from 2000-2010 were 0.06-0.21 m lower from July to September (wet season) and 0.22-0.27 m higher from December to March (dry season) than in the 1989-1999 period. Average intra-annual variation (CVa) decreased from 10.21% in 1989-1999 to 5.41% in 2000-2010. The areas of both Type 1 and Type 2 vegetation increased substantially in 2000-2010 relative to 1989-1999. Neither annual average water level nor CVa influenced aquatic vegetation area, but water level from January to March had significant positive and negative correlations, respectively, with areas of Type 1 and Type 2 vegetation. Our findings revealed problems with the current management of water levels in Taihu Lake. To restore Taihu Lake to its original state of submerged vegetation dominance, water levels in the dry season should be lowered to better approximate natural conditions and reinstate the high variability (i.e., greater extremes) that was present historically.	[Zhao, Dehua; Jiang, Hao; Cai, Ying; An, Shuqing] Nanjing Univ, Dept Biol Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Zhao, DH (corresponding author), Nanjing Univ, Dept Biol Sci & Technol, Nanjing, Jiangsu, Peoples R China.	dhzhao@nju.edu.cn			National Natural Science Foundation of China [31000226]; State Key Development Program for Basic Research of China [2008CB418004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This work was financially supported by the National Natural Science Foundation of China (No. 31000226)(http://www.nsfc.gov.cn) and the State Key Development Program for Basic Research of China (2008CB418004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2009, LECT CHINAS ENV YALE; Bain MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003806; Baker C, 2006, WETLANDS, V26, P465, DOI 10.1672/0277-5212(2006)26[465:MWARAU]2.0.CO;2; BLINDOW I, 1993, FRESHWATER BIOL, V30, P159, DOI 10.1111/j.1365-2427.1993.tb00796.x; Chambers PA, 2008, HYDROBIOLOGIA, V595, P9, DOI 10.1007/s10750-007-9154-6; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Coops H, 2004, LIMNOLOGICA, V34, P57, DOI 10.1016/S0075-9511(04)80022-7; Davranche A, 2010, REMOTE SENS ENVIRON, V114, P552, DOI 10.1016/j.rse.2009.10.009; de Colstoun ECB, 2003, REMOTE SENS ENVIRON, V85, P316, DOI 10.1016/S0034-4257(03)00010-5; Franklin P, 2008, SCI TOTAL ENVIRON, V400, P369, DOI 10.1016/j.scitotenv.2008.06.018; [谷孝鸿 Gu Xiaohong], 2005, [生态学报, Acta Ecologica Sinica], V25, P1541; Gullstrom M, 2006, ESTUAR COAST SHELF S, V67, P399, DOI 10.1016/j.ecss.2005.11.020; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Havens KE, 2003, HYDROBIOLOGIA, V493, P173, DOI 10.1023/A:1025497621547; He Jun, 2008, Hupo Kexue, V20, P790; Hu WP, 2008, ECOL ENG, V34, P30, DOI 10.1016/j.ecoleng.2008.05.018; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jin Xiangcan, 2007, Hupo Kexue, V19, P151; Kloiber SM, 2002, WATER RES, V36, P4330, DOI 10.1016/S0043-1354(02)00146-X; Li EH, 2010, ECOL ENG, V36, P427, DOI 10.1016/j.ecoleng.2009.11.009; Li YP, 2011, ECOL ENG, V37, P325, DOI 10.1016/j.ecoleng.2010.11.024; Liira J, 2010, AQUAT BOT, V93, P207, DOI 10.1016/j.aquabot.2010.08.001; [刘伟龙 LIU Weilong], 2007, [生态环境, Ecology and Environment], V16, P363; [刘伟龙 Liu Weilong], 2007, [生态学报, Acta Ecologica Sinica], V27, P159; Lorenz AW, 2012, J APPL ECOL, V49, P202, DOI 10.1111/j.1365-2664.2011.02082.x; Lu Na, 2009, Huanjing Kexue, V30, P2898; Ma RH, 2008, SENSORS-BASEL, V8, P3988, DOI 10.3390/s8063988; Michelan TS, 2010, FRESHWATER BIOL, V55, P1315, DOI 10.1111/j.1365-2427.2009.02355.x; Midwood JD, 2010, WETLANDS, V30, P1141, DOI 10.1007/s13157-010-0105-z; O'Farrell I, 2011, AQUAT SCI, V73, P275, DOI 10.1007/s00027-010-0175-2; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; Ot'ahel'ova H, 2011, LIMNOLOGICA, V41, P316, DOI 10.1016/j.limno.2011.01.005; Ozesmi Stacy L., 2002, Wetlands Ecology and Management, V10, P381, DOI 10.1023/A:1020908432489; Paillisson JM, 2011, ECOL ENG, V37, P241, DOI 10.1016/j.ecoleng.2010.11.017; Paillisson JM, 2006, AQUAT BOT, V84, P259, DOI 10.1016/j.aquabot.2005.10.004; Pan G, 2011, ECOL ENG, V37, P302, DOI 10.1016/j.ecoleng.2010.11.019; Qin BQ, 2009, ECOL ENG, V35, P1569, DOI 10.1016/j.ecoleng.2009.04.003; Qin Boqiang, 2009, Hupo Kexue, V21, P445; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, P NATL ACAD SCI USA, V100, P4040, DOI 10.1073/pnas.0737918100; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Schindler DW, 2006, LIMNOL OCEANOGR, V51, P356, DOI 10.4319/lo.2006.51.1_part_2.0356; Squires MM, 2002, FRESHWATER BIOL, V47, P2123, DOI 10.1046/j.1365-2427.2002.00959.x; Szabo S, 2010, FRESHWATER BIOL, V55, P681, DOI 10.1111/j.1365-2427.2009.02308.x; Tuckett RE, 2010, FRESHWATER BIOL, V55, P1118, DOI 10.1111/j.1365-2427.2010.02386.x; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; Van Geest GJ, 2005, HYDROBIOLOGIA, V539, P239, DOI 10.1007/s10750-004-4879-y; Van Geest GJ, 2005, J APPL ECOL, V42, P251, DOI 10.1111/j.1365-2664.2005.00995.x; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Wei AH, 2007, FISHERIES, V32, P167, DOI 10.1577/1548-8446(2007)32[167:UOIITM]2.0.CO;2; Wright C, 2007, REMOTE SENS ENVIRON, V107, P582, DOI 10.1016/j.rse.2006.10.019; Wu GF, 2007, WATER RES, V41, P3271, DOI 10.1016/j.watres.2007.05.018; Yang M, 2008, SCIENCE, V319, P158, DOI 10.1126/science.319.5860.158a; [杨英宝 Yang Yingbao], 2005, [湖泊科学, Scientia Limnologica Sinica], V17, P133; Zhang SY, 2010, ECOL ENG, V36, P1611, DOI 10.1016/j.ecoleng.2010.05.006; Zhang YL, 2009, WATER RES, V43, P4685, DOI 10.1016/j.watres.2009.07.024; Zhao DH, 2012, J ENVIRON MANAGE, V95, P98, DOI 10.1016/j.jenvman.2011.10.007; Zhao DH, 2011, ADV WATER RESOUR, V34, P165, DOI 10.1016/j.advwatres.2010.08.010; Zhu Guangwei, 2008, Hupo Kexue, V20, P21	60	31	34	4	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44836	10.1371/journal.pone.0044836	http://dx.doi.org/10.1371/journal.pone.0044836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028639	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900046
J	Goecke, F; Wiese, J; Nunez, A; Labes, A; Imhoff, JF; Neuhauser, S				Goecke, Franz; Wiese, Jutta; Nunez, Alejandra; Labes, Antje; Imhoff, Johannes F.; Neuhauser, Sigrid			A Novel Phytomyxean Parasite Associated with Galls on the Bull-Kelp Durvillaea antarctica (Chamisso) Hariot	PLOS ONE			English	Article							SP-NOV; LESSONIA-NIGRESCENS; PHAEOPHYCEAE; DURVILLEALES; INFECTIONS; ECOSYSTEMS; MACROALGAE; RHODOPHYTA; PHYLOGENY; EVOLUTION	Durvillaea antarctica (Fucales, Phaeophyceae) is a large kelp of high ecological and economic significance in the Southern Hemisphere. In natural beds along the central coast of Chile (Pacific Ocean), abnormal growth characterized by evident gall development and discolorations of the fronds/thallus was observed. Analysing these galls by light microscopy and scanning electron microscopy revealed the presence of endophytic eukaryotes showing typical characteristics for phytomyxean parasites. The parasite developed within enlarged cells of the subcortical tissue of the host. Multinucleate plasmodia developed into many, single resting spores. The affiliation of this parasite to the Phytomyxea (Rhizaria) was supported by 18S rDNA data, placing it within the Phagomyxida. Similar microorganisms were already reported once 23 years ago, indicating that these parasites are persistent and widespread in D. antarctica beds for long times. The symptoms caused by this parasite are discussed along with the ecological and economic consequences. Phytomyxean parasites may play an important role in the marine ecosystem, but they remain understudied in this environment. Our results demonstrate for the first time the presence of resting spores in Phagomyxida, an order in which resting spores were thought to be absent making this the first record of a phagomyxean parasite with a complete life cycle so far, challenging the existing taxonomic concepts within the Phytomyxea. The importance of the here described resting spores for the survival and ecology of the phagomyxid parasite will be discussed together with the impact this parasite may have on 'the strongest seaweed of the world', which is an important habitat forming and economic resource from the Southern Hemisphere.	[Goecke, Franz; Wiese, Jutta; Labes, Antje; Imhoff, Johannes F.] Helmholtz Ctr Ocean Res GEOMAR, Kieler Wirkstoff Zentrum, Kiel, Schleswig Holst, Germany; [Nunez, Alejandra] Univ Nacl Andres Bello, Fac Ecol & Recursos Nat, Santiago, Region Metropol, Chile; [Neuhauser, Sigrid] Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Tyrol, Austria	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Universidad Andres Bello; University of Innsbruck	Goecke, F (corresponding author), Helmholtz Ctr Ocean Res GEOMAR, Kieler Wirkstoff Zentrum, Kiel, Schleswig Holst, Germany.	fgoecke@geomar.de	Labes, Antje/AGK-3198-2022; Neuhauser, Sigrid/U-1603-2019; Imhoff, Johannes F./D-2515-2010; Imhoff, Johannes F./AAB-8765-2022; Neuhauser, Sigrid/C-8189-2014; Wiese, Jutta/B-9076-2012; Goecke, Franz/J-9142-2014	Labes, Antje/0000-0002-4807-3378; Neuhauser, Sigrid/0000-0003-0305-1615; Imhoff, Johannes F./0000-0001-8789-0728; Imhoff, Johannes F./0000-0001-8789-0728; Neuhauser, Sigrid/0000-0003-0305-1615; Goecke, Franz/0000-0003-0777-3156; Nunez Gallego, Alejandra Del Pilar/0000-0001-7493-2415	DAAD (German Academic Exchange Service); CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica, Chile); Austrian Science Fund (FWF) [T379-B16, J3175-B20]; Kieler Wirkstoff-Zentrum (KiWiZ) am GEOMAR, Germany; NERC [NE/H009426/1, NE/H000887/1] Funding Source: UKRI; Austrian Science Fund (FWF) [J 3175] Funding Source: researchfish; Natural Environment Research Council [NE/H000887/1, NE/H009426/1] Funding Source: researchfish	DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica, Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Kieler Wirkstoff-Zentrum (KiWiZ) am GEOMAR, Germany; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by the DAAD (German Academic Exchange Service), and the CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica, Chile). SN acknowledges funding by the Austrian Science Fund (FWF) grants T379-B16 and J3175-B20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the people of Coliumo. Also to the support given by the Kieler Wirkstoff-Zentrum (KiWiZ) am GEOMAR, Germany. Dr. Rolf Schmaljohann (GEOMAR) for kind helps in methodology and to Dr. Svenja Heesch (NUI Galway) for comments on the pathogen.	Aguilera M, 1988, GAYANA BOT, V45, P337; ANDREWS JH, 1976, BIOL REV, V51, P211, DOI 10.1111/j.1469-185X.1976.tb01125.x; APT KE, 1988, DIS AQUAT ORGAN, V4, P211, DOI 10.3354/dao004211; Bass D, 2009, PROTIST, V160, P75, DOI 10.1016/j.protis.2008.07.002; Braselton JP, 2001, MYCOTA, V7, P81; Bulman SR, 2001, PROTIST, V152, P43, DOI 10.1078/1434-4610-00042; Burki F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-377; BUSTAMANTE RH, 1990, BIOL CONSERV, V52, P205, DOI 10.1016/0006-3207(90)90126-A; Castilla JC, 2007, ECOL APPL, V17, P1511, DOI 10.1890/06-1285.1; CHESHIRE AC, 1995, J PHYCOL, V31, P644, DOI 10.1111/j.1529-8817.1995.tb02561.x; Cho GY, 2006, PHYCOLOGIA, V45, P512, DOI 10.2216/05-48.1; Collantes Gloria, 2002, Rev. biol. mar. oceanogr., V37, P83; CORREA JA, 1993, J PHYCOL, V29, P853, DOI 10.1111/j.0022-3646.1993.00853.x; Eggert A, 2010, CELL ORIG LIFE EXTRE, V15, P139, DOI 10.1007/978-90-481-8569-6_9; Gachon CMM, 2010, TRENDS PLANT SCI, V15, P633, DOI 10.1016/j.tplants.2010.08.005; Gleason Frank H., 2008, Fungal Biology Reviews, V22, P17, DOI 10.1016/j.fbr.2008.02.001; Gobierno de Chile Servicio Nacional de Geologia y Mineria, 2003, MAPA GEOL CHIL VERS; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Heesch S, 2008, EUR J PHYCOL, V43, P283, DOI 10.1080/09670260801911157; Herriott EM, 1923, T P NZ I, V54, P549; Hoffmann A., 1997, FLORA MARINA CHILE C; Jaffray AE, 1996, J APPL PHYCOL, V8, P409, DOI 10.1007/BF02178585; Jaramillo E, 2006, REV CHIL HIST NAT, V79, P337; Jobard M, 2010, AQUAT SCI, V72, P255, DOI 10.1007/s00027-010-0133-z; Karling J.S., 1968, PLASMODIOPHORALES; Karling JS, 1944, AM J BOT, V31, P38, DOI 10.2307/2437666; Kelly BJ, 2000, J APPL PHYCOL, V12, P317, DOI 10.1023/A:1008106723185; Lang G, 2006, J NAT PROD, V69, P621, DOI 10.1021/np0504917; Letcher PM, 2008, MYCOL RES, V112, P759, DOI 10.1016/j.mycres.2008.01.025; Li W, 2010, ACTA OCEANOL SIN, V29, P74, DOI 10.1007/s13131-010-0065-4; Maier I, 2000, PROTIST, V151, P225, DOI 10.1078/1434-4610-00021; MAIER I, 1989, PHYCOLOGIA, V28, P271, DOI 10.2216/i0031-8884-28-2-271.1; Muller D.G., 1999, PHYCOL RES, V47, P217, DOI DOI 10.1111/J.1440-1835.1999.TB00301.X; NAYLOR M, 1949, ANN BOT-LONDON, V13, P285, DOI 10.1093/oxfordjournals.aob.a083219; Nelson W. A., 1996, Phycological Research, V44, P19, DOI 10.1111/j.1440-1835.1996.tb00034.x; Neuhauser S, 2011, MAR FRESHWATER RES, V62, P365, DOI 10.1071/MF10282; Neuhauser S, 2011, HYDROBIOLOGIA, V659, P23, DOI 10.1007/s10750-010-0508-0; Neuhauser S, 2010, MOLECULAR IDENTIFICATION OF FUNGI, P51, DOI 10.1007/978-3-642-05042-8_3; Neuhauser S, 2009, PHYTOPATHOL MEDITERR, V48, P59; Ortiz J, 2006, FOOD CHEM, V99, P98, DOI 10.1016/j.foodchem.2005.07.027; Park CS, 2006, J APPL PHYCOL, V18, P295, DOI 10.1007/s10811-006-9031-0; Ramirez ME, 1991, MONOGRAFIAS BIOL, V5; Rasconi S, 2011, FUNGAL BIOL REV, V22, P17; ROBERTS M, 1979, NEW ZEAL J BOT, V17, P241, DOI 10.1080/0028825X.1979.10426898; SANTELICES B, 1980, MAR BIOL, V59, P119, DOI 10.1007/BF00405461; SCHIEL DR, 1990, HYDROBIOLOGIA, V204, P25, DOI 10.1007/BF00040211; Schnepf E, 2000, HELGOLAND MAR RES, V54, P237, DOI 10.1007/s101520000056; Sekimoto S, 2008, MYCOL RES, V112, P361, DOI 10.1016/j.mycres.2007.11.002; SOUTH G R, 1974, Journal of the Royal Society of New Zealand, V4, P455; Stevens CL, 2001, NWA WATER ATMOSPHERE, V9, P8; Taylor DI, 2005, MAR ECOL PROG SER, V288, P87, DOI 10.3354/meps288087; Vasquez JA, 1997, REV CHIL HIST NAT, V70, P41; Vasquez J, 2008, J APPL PHYCOL, V20, P457, DOI 10.1007/s10811-007-9308-y; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; WESTERMEIER R, 1994, MAR ECOL PROG SER, V110, P187, DOI 10.3354/meps110187; Womersley, 1984, MARINE BENTHIC FLORA	56	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45358	10.1371/journal.pone.0045358	http://dx.doi.org/10.1371/journal.pone.0045358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028958	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000309742800057
J	Accornero, P; Miretti, S; Bersani, F; Quaglino, E; Martignani, E; Baratta, M				Accornero, Paolo; Miretti, Silvia; Bersani, Francesca; Quaglino, Elena; Martignani, Eugenio; Baratta, Mario			Met Receptor Acts Uniquely for Survival and Morphogenesis of EGFR-Dependent Normal Mammary Epithelial and Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; IN-VITRO; C-MET; GLAND; KINASE; PROLIFERATION; AMPHIREGULIN; REQUIREMENT; ACTIVATION; MECHANISMS	Mammary gland development and breast cancer growth require multiple factors both of endocrine and paracrine origin. We analyzed the roles of Epidermal Growth Factor Receptor (EGFR) and Hepatocyte Growth Factor Receptor (Met) in mammary epithelial cells and mammary tumor cells derived from a mutated-ErbB2 transgenic mice. By using highly specific tyrosine kinase inhibitors we found that MCF-10A and NMuMG mammary epithelial cell lines are totally dependent on EGFR activation for their growth and survival. Proliferation and 3D-morphogenesis assays showed that HGF had no role in maintaining mammary cell viability, but was the only cytokine able to rescue EGFR-inhibited mammary cells. Insulin-Like Growth Factor-I (IGF-I), basic-Fibroblast Growth Factor (b-FGF) and Neuregulin, which are well known mammary morphogenic factors, did not rescue proliferation or morphogenesis in these cell lines, following EGFR inhibition. Similarly, ErbB2-driven tumor cells are EGFR-dependent and also display HGF-mediated rescue. Western-blot analysis of the signaling pathways involved in rescue after EGFR inhibition indicated that concomitant ERK1/2 and AKT activation was exclusively driven by Met, but not by IGF-I or b-FGF. These results describe a unique role for EGFR and Met in mammary epithelial cells by showing that similar pathways can be used by tumorigenic cells to sustain growth and resist to EGFR-directed anti-tumorigenic drugs.	[Accornero, Paolo; Miretti, Silvia; Martignani, Eugenio; Baratta, Mario] Univ Turin, Dept Vet Sci, Grugliasco, TO, Italy; [Bersani, Francesca] Univ Turin, Dept Oncol, Turin, Italy; [Bersani, Francesca] Univ Turin, Ctr Expt Res & Med Studies, Turin, Italy; [Quaglino, Elena] Univ Turin, Ctr Mol Biotechnol, Dept Clin & Biol Sci, Turin, Italy	University of Turin; University of Turin; University of Turin; University of Turin	Accornero, P (corresponding author), Univ Turin, Dept Vet Sci, Grugliasco, TO, Italy.	paolo.accornero@unito.it	Quaglino, Elena/I-9216-2012; Baratta, Mario/ABA-7749-2021; Accornero, Paolo/B-1396-2008; Baratta, Mario/AAP-8882-2021	Quaglino, Elena/0000-0002-8151-9124; Baratta, Mario/0000-0003-2537-6429; MIRETTI, SILVIA/0000-0002-6693-2527; Bersani, Francesca/0000-0002-0343-7078	national grants from Ministry of Instruction, University and Research, PRIN; local grant from Universita di Torino; local grant from Compagnia di San Paolo	national grants from Ministry of Instruction, University and Research, PRIN(Ministry of Education, Universities and Research (MIUR)); local grant from Universita di Torino; local grant from Compagnia di San Paolo(Compagnia di San Paolo)	This work was supported by national grants from Ministry of Instruction, University and Research, PRIN 2009 and by local grants from Universita di Torino and Compagnia di San Paolo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero P, 2007, J DAIRY SCI, V90, P4289, DOI 10.3168/jds.2007-0179; Ahmad T, 2004, J BIOL CHEM, V279, P1713, DOI 10.1074/jbc.M306156200; Bonine-Summers AR, 2007, CANC BIOL THER, V6; Brandt BH, 1999, FASEB J, V13, P1939, DOI 10.1096/fasebj.13.14.1939; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Brisken C, 2000, GENE DEV, V14, P650; Castro NE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2622; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Garcia SAD, 2011, CANCER MICROENVIRON, V4, P33, DOI 10.1007/s12307-010-0059-y; DiAugustine RP, 1997, J MAMMARY GLAND BIOL, V2, P109, DOI 10.1023/A:1026395513038; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Gastaldi S, 2012, ONCOGENE; Ishibe S, 2009, DEVELOPMENT, V136, P337, DOI 10.1242/dev.024463; Kamalati T, 1999, J MAMMARY GLAND BIOL, V4, P69, DOI 10.1023/A:1018756620265; Kleinberg DL, 2000, J MAMMARY GLAND BIOL, V5, P7, DOI 10.1023/A:1009507030633; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; Niemann C, 1998, J CELL BIOL, V143, P533, DOI 10.1083/jcb.143.2.533; Niemann C, 2000, ADV EXP MED BIOL, V480, P9; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; PEPPER MS, 1995, EXP CELL RES, V219, P204, DOI 10.1006/excr.1995.1220; Rodland KD, 2008, J BIOL CHEM, V283, P31477, DOI 10.1074/jbc.M800456200; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; Schroeder JA, 1998, CELL GROWTH DIFFER, V9, P451; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Song RXD, 2007, ENDOCRINOLOGY, V148, P4091, DOI 10.1210/en.2007-0240; Song RXD, 2010, J STEROID BIOCHEM, V118, P219, DOI 10.1016/j.jsbmb.2009.09.018; SORIANO JV, 1995, J CELL SCI, V108, P413; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Stern DF, 2003, EXP CELL RES, V284, P89, DOI 10.1016/S0014-4827(02)00103-9; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wiesen JF, 1999, DEVELOPMENT, V126, P335; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215; Zavizion B, 1996, IN VITRO CELL DEV-AN, V32, P138, DOI 10.1007/BF02723679; Zhang HZ, 2002, ENDOCRINOLOGY, V143, P3427, DOI 10.1210/en.2002-220007	44	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44982	10.1371/journal.pone.0044982	http://dx.doi.org/10.1371/journal.pone.0044982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028720	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700068
J	Melekhin, VV; Shepherd, BE; Stinnette, SE; Rebeiro, PF; Turner, MM; Sterling, TR				Melekhin, Vlada V.; Shepherd, Bryan E.; Stinnette, Samuel E.; Rebeiro, Peter F.; Turner, Megan M.; Sterling, Timothy R.			Hemoglobin May Contribute to Sex Differences in Mortality among HIV-Infected Persons in Care	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; WOMENS INTERAGENCY HIV; DISEASE PROGRESSION; GENDER-DIFFERENCES; IMMUNE ACTIVATION; ANEMIA; COHORT; SURVIVAL; IMMUNODEFICIENCY; AIDS	Background: Some retrospective studies have found that HIV-infected women have a higher mortality risk than men after adjusting for baseline characteristics, while others have not. Anemia is a known predictor of HIV-related mortality. We assessed whether anemia contributed to the sex difference in mortality in our cohort. Methods: We conducted a retrospective cohort study among HIV-infected persons in care at the Comprehensive Care Center (Nashville, TN) between 1998 and 2009. Cox proportional hazards models compared time from first clinic visit to death and AIDS-defining events (ADE), adjusted for baseline characteristics with and without baseline hemoglobin. Results: Of 3,633 persons, 879 (24%) were women. Women had lower median baseline hemoglobin compared to men: 12.4 g/dL (inter-quartile range (IQR) 11.3-13.4) vs. 14.4 (IQR 13.1-15.5), respectively (P<0.001). In multivariable models without hemoglobin, the risk of death was higher among women: hazard ratio (HR) 1.46 (95% confidence interval (CI) 1.17, 1.82; P = 0.001). In multivariable models with hemoglobin, the risk of death in women was diminished and no longer statistically significant: HR 1.2 (95% CI 0.93, 1.55; P = 0.17). The risk of ADE was higher among women in both models, but not statistically significant: HR 1.1 (95% CI 0.85-1.42; P = 0.46) in the model without hemoglobin and 1.11 (95% CI 0.82-1.48; P = 0.50) in the model with hemoglobin. Hemoglobin was a strong predictor of death: HR 0.88 per 1 g/dL increase (95% CI 0.83, 0.93; P<0.001). Conclusion: In our study population of HIV-infected persons in care, women had lower baseline hemoglobin, and lower hemoglobin contributed to their higher risk of ADE and death.	[Melekhin, Vlada V.; Stinnette, Samuel E.; Rebeiro, Peter F.; Turner, Megan M.; Sterling, Timothy R.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA; [Shepherd, Bryan E.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Stinnette, Samuel E.; Turner, Megan M.] Comprehens Care Ctr, Nashville, TN USA; [Sterling, Timothy R.] Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Melekhin, VV (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA.	vlada.melekhin@vanderbilt.edu		Rebeiro, Peter/0000-0003-1951-9104	National Institutes of Health: the Vanderbilt- Meharry Center for AIDS Research [P30 AI54999, K24 A1065298, K23AI080227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI065298, K23AI080227, P30AI054999] Funding Source: NIH RePORTER	National Institutes of Health: the Vanderbilt- Meharry Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health: the Vanderbilt- Meharry Center for AIDS Research (P30 AI54999) - BES, SES, PFR, MMT, TRS; K24 A1065298 - SES, TRS; K23AI080227 - VVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhane K, 2004, JAIDS-J ACQ IMM DEF, V37, P1245, DOI 10.1097/01.qai.0000134759.01684.27; Braga P, 2007, AIDS PATIENT CARE ST, V21, P321, DOI 10.1089/apc.2006.0111; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; Chene G, 1997, AIDS, V11, P209, DOI 10.1097/00002030-199702000-00012; de la Hera MG, 2004, J EPIDEMIOL COMMUN H, V58, P944, DOI 10.1136/jech.2003.017475; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Harris RJ, 2008, ANTIVIR THER, V13, P959; Hessol NA, 2007, CLIN INFECT DIS, V44, P287, DOI 10.1086/510488; Hoffman RM, 2007, HIV CLIN TRIALS, V8, P371, DOI 10.1310/hct0806-371; Lemly DC, 2009, J INFECT DIS, V199, P991, DOI 10.1086/597124; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; Obirikorang C, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-102; Perez-Hoyos S, 2003, AIDS, V17, P353, DOI 10.1097/00002030-200302140-00009; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Poundstone KE, 2001, AIDS, V15, P1115, DOI 10.1097/00002030-200106150-00006; Sarcletti M, 2003, EUR J HAEMATOL, V70, P17, DOI 10.1034/j.1600-0609.2003.02810.x; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Shah S, 2007, HIV MED, V8, P38, DOI 10.1111/j.1468-1293.2007.00434.x; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; Tedaldi EM, 2008, JAIDS-J ACQ IMM DEF, V47, P441, DOI 10.1097/QAI.0b013e3181609da8; Touloumi G, 2006, JAIDS-J ACQ IMM DEF, V42, P554, DOI 10.1097/01.qai.0000230321.85911.db; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a	24	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44999	10.1371/journal.pone.0044999	http://dx.doi.org/10.1371/journal.pone.0044999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028732	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700075
J	Patel, SD; Larson, E; Mbengashe, T; O'Bra, H; Brown, JW; Golman, TM; Klausner, JD				Patel, Sandeep D.; Larson, Elysia; Mbengashe, Thobile; O'Bra, Heidi; Brown, J. W.; Golman, Thurma M.; Klausner, Jeffrey D.			Increases in Pediatric Antiretroviral Treatment, South Africa 2005-2010	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; SUB-SAHARAN AFRICA; TREATMENT PROGRAMS; THERAPY; MORTALITY; OUTCOMES; CARE	Background: In South Africa in 2010, about 340,000 children under the age of 15 were infected with HIV. We describe the increase in the treatment of South African pediatric HIV-infected patients assisted by the President's Emergency Plan for AIDS Relief (PEPFAR) from 2004 to 2010. Methods: We reviewed routine program data from PEPFAR- funded implementing partners among persons receiving antiretroviral treatment age 15 years old and less. Data quality was assessed during the reporting period by program officials through routine analysis of trends and logic checks. Based on UNAIDS estimated mortality rates of untreated HIV-infected children, we calculated the number of deaths averted and life-years gained in children under five receiving PEPFAR-assisted antiretroviral treatment. Results: From October 2004 through September 2010, the number of children newly initiated on antiretroviral treatment in PEPFAR-assisted programs increased from 154 to 2,641 per month resulting in an increase from 2,412 children on antiretroviral treatment in September 2005 to 79,416 children in September 2010. Of those children who initiated antiretroviral treatment before September 2009, 0-4 year olds were 1.4 (95% CI: 1.3-1.5) times as likely to transfer out of the program or die as 5-14 year olds; males were 1.3 (95% CI: 1.0-1.7) times as likely to stop treatment as females. Approximately 27,548 years of life were added to children under-five years old from PEPFAR-assisted antiretroviral treatment. Conclusions: Pediatric antiretroviral treatment in South Africa has increased substantially. However, additional case-finding and a further acceleration in the implementation of pediatric care and treatment services is required to meet the current treatment need.	[Patel, Sandeep D.] US Indian Hlth Serv, Belcourt, ND USA; [Larson, Elysia] US Ctr Dis Control & Prevent, Amer Sch Publ Hlth, Pretoria, South Africa; [Mbengashe, Thobile] Natl Dept Hlth, Pretoria, South Africa; [O'Bra, Heidi; Golman, Thurma M.; Klausner, Jeffrey D.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Pretoria, South Africa; [Brown, J. W.] US Agcy Int Dev, Pretoria, South Africa	United States Agency for International Development (USAID)	Patel, SD (corresponding author), US Indian Hlth Serv, Belcourt, ND USA.	JDKlausner@mednet.ucla.edu						[Anonymous], 2004, GUID MAN HIV CHILDR; [Anonymous], PRESIDENTS EMERGENCY; [Anonymous], 2010, J GERONTOL B, V13, P1618; [Anonymous], 2008, NAT HIV SYPH ANT PRE; [Anonymous], 2010, GUID MAN HIV CHILDR; [Anonymous], HIV AIDS STI STRAT P; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Davies MA, 2009, SAMJ S AFR MED J, V99, P730; Davies MA, 2009, AJAR-AFR J AIDS RES, V8, P329, DOI 10.2989/AJAR.2009.8.3.9.930; Day C., 2010, S AFRICAN HLTH REV 2; Department of Health, 2003, OP PLAN COMPR HIV AI; Fenner L, 2010, JAIDS-J ACQ IMM DEF, V54, P524, DOI 10.1097/QAI.0b013e3181e0c4cf; Klausner JD, 2011, JAIDS-J ACQ IMM DEF, V56, P292, DOI 10.1097/QAI.0b013e3182067d99; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Nannan N, 2012, UNDER 5 MORTALITY ST; Shisana O., 2009, S AFRICAN NATL HIV P; Statistics South Africa, 2010, MORT CAUS DEATH S AF; Statistics South Africa, 2010, MID YEAR POP EST; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971	24	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44914	10.1371/journal.pone.0044914	http://dx.doi.org/10.1371/journal.pone.0044914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028677	gold, Green Published, Green Submitted			2022-12-27	WOS:000308788700055
J	Zhao, J; Yi, LN; Lu, J; Yang, ZR; Chen, Y; Zheng, CL; Huang, D; Li, YF; Chen, L; Cheng, JQ; Kung, HF; He, ML				Zhao, Jin; Yi, Lina; Lu, Jing; Yang, Zheng-Rong; Chen, Ying; Zheng, Chenli; Huang, Dan; Li, Yu-Feng; Chen, Lin; Cheng, Jinquan; Kung, Hsiang-fu; He, Ming-Liang			Transcriptomic Assay of CD8(+) T Cells in Treatment-Naive HIV, HCV-Mono-Infected and HIV/HCV-Co-Infected Chinese	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; IMMUNODEFICIENCY-VIRUS TYPE-1; MITOCHONDRIAL-DNA DEPLETION; SISTER-CHROMATID SEPARATION; INTERFERON PLUS RIBAVIRIN; INJECTION-DRUG USERS; MICROARRAY EXPERIMENTS; VIRAL-HEPATITIS; COINFECTION; SURVIVAL	Background: Co-infection with HIV and HCV is very common. It is estimated that over 5 million people are co-infected with HIV and HCV worldwide. Accumulated evidence shows that each virus alters the course of infection of the other one. CD8+ T cells play a crucial role in the eradication of viruses and infected target cells. To the best of our knowledge, no one has investigated the gene expression profiles in HIV/HCV-co-infected individuals. Methodology: Genome-wide transcriptomes of CD8+ T cells from HIV/HCV-co-infected or mono-infected treatment-naive individuals were analyzed by microarray assays. Pairwise comparisons were performed and differentially expressed genes were identified followed by quantitative real-time PCR (qRT-PCR) validation. Directed Acyclic Graphs (DAG) from Web-based Gene SeT AnaLysis Toolkit (WebGestalt) and DAVID bioinformatics resources 6.7 ( the Database for Annotation, Visualization, and Integrated Discovery) were used to discover the Gene Ontology ( GO) categories with significantly enriched gene numbers. The enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were also obtained by using WebGestalt software. Results and Conclusions: A total of 110, 24 and 72 transcript IDs were shown to be differentially expressed (> 2-fold and p<0.05) in comparisons between HCV- and HIV-mono-infected groups, HIV/HCV-co-infected and HIV-mono-infected groups, and HIV/HCV-co-infected and HCV-mono-infected groups, respectively. In qRT-PCR assay, most of the genes showed similar expressing profiles with the observation in microarray assays. Further analysis revealed that genes involved in cell proliferation, differentiation, transcriptional regulation and cytokine responses were significantly altered. These data offer new insights into HIV/HCV co-infections, and may help to identify new markers for the management and treatment of HIV/HCV co-infections.	[Zhao, Jin; Yi, Lina; Lu, Jing; Chen, Ying; Kung, Hsiang-fu; He, Ming-Liang] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Zhao, Jin; Yang, Zheng-Rong; Zheng, Chenli; Huang, Dan; Chen, Lin; Cheng, Jinquan] Shenzhen Ctr Dis Control & Prevent, Shenzhen, Peoples R China; [Huang, Dan; Li, Yu-Feng] Xihua Univ, Coll Bioengn, Chengdu, Peoples R China; [He, Ming-Liang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Shenzhen Center for Disease Control & Prevention (SZCDC); Xihua University; Chinese University of Hong Kong	Zhao, J (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Fac Med, Hong Kong, Hong Kong, Peoples R China.	mlhe7788@gmail.com	HE, Ming-Liang/AFK-4738-2022; HE, Ming-Liang/AAG-3397-2022	Yang, Zheng-Rong/0000-0001-9284-5593; HE, Mingliang/0000-0002-9942-9151	Research Fund for Control of Infectious Diseases (RFCID) [09080482]; Food and Health Bureau; Government of the Hong Kong Special Administrative Region, China	Research Fund for Control of Infectious Diseases (RFCID); Food and Health Bureau; Government of the Hong Kong Special Administrative Region, China	This work was supported by a Research Fund for Control of Infectious Diseases (RFCID, Ref. No. 09080482), the Food and Health Bureau, The Government of the Hong Kong Special Administrative Region, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; Ciuffreda D, 2008, EUR J IMMUNOL, V38, P2665, DOI 10.1002/eji.200838336; Daar ES, 2001, J ACQ IMMUN DEF SYND, V26, P466, DOI 10.1097/00126334-200104150-00011; de Mendoza C, 2005, ANTIVIR THER, V10, P557; de Mendoza C, 2007, AIDS, V21, P583, DOI 10.1097/QAD.0b013e32805e8742; England K, 2006, LANCET INFECT DIS, V6, P83, DOI 10.1016/S1473-3099(06)70381-4; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Hernandez JM, 2005, LEUKEMIA, V19, P1088, DOI 10.1038/sj.leu.2403753; Hisada M, 2005, HEPATOLOGY, V42, P1446, DOI 10.1002/hep.20938; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Kassu A, 2009, CLIN IMMUNOL, V132, P234, DOI 10.1016/j.clim.2009.03.531; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Klenerman P, 2007, PLOS MED, V4, P1608, DOI 10.1371/journal.pmed.0040240; Kovacs A, 2008, J INFECT DIS, V197, P1402, DOI 10.1086/587696; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Labarga P, 2007, J INFECT DIS, V196, P670, DOI 10.1086/520092; Lafeuillade A, 2001, LANCET, V357, P280, DOI 10.1016/S0140-6736(00)03618-7; Lauer GM, 2002, J VIROL, V76, P2817, DOI 10.1128/JVI.76.6.2817-2826.2002; Lee S, 2006, IMMUNOL CELL BIOL, V84, P390, DOI 10.1111/j.1440-1711.2006.01451.x; Liu FT, 2010, BLOOD, V115, P3079, DOI 10.1182/blood-2009-08-239483; Loko MA, 2011, J VIRAL HEPATITIS, V18, pE307, DOI 10.1111/j.1365-2893.2010.01417.x; Lu J, 2012, J VIROL, V86, P3767, DOI 10.1128/JVI.06687-11; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Mauboussin JM, 2004, HIV MED, V5, P151, DOI 10.1111/j.1468-1293.2004.00203.x; McGovern BH, 2007, JAIDS-J ACQ IMM DEF, V45, pS47, DOI 10.1097/QAI.0b013e318068d190; McGovern BH, 2007, J ACQUIR IMMUNE D S2, V45, pS66; Merchante N, 2006, AIDS, V20, P49, DOI 10.1097/01.aids.0000198087.47454.e1; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Monforte AD, 2009, CLIN INFECT DIS, V49, P612, DOI 10.1086/603557; Morsica G, 2007, J CLIN VIROL, V39, P82, DOI 10.1016/j.jcv.2007.03.007; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Racanelli V, 2011, REV MED VIROL, V21, P347, DOI 10.1002/rmv.702; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Shields PL, 1999, J IMMUNOL, V163, P6236; Shimura M, 2005, AIDS, V19, P1434, DOI 10.1097/01.aids.0000180788.92627.e7; Shimura M, 2011, J CELL BIOL, V194, P721, DOI 10.1083/jcb.201010118; Sulkowski Mark S, 2003, Clin Liver Dis, V7, P179, DOI 10.1016/S1089-3261(02)00074-0; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Walters KA, 2006, VIROLOGY, V350, P453, DOI 10.1016/j.virol.2006.02.030; WRIGHT TL, 1994, HEPATOLOGY, V20, P1152; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102; Zylberberg H, 2000, GUT, V47, P694, DOI 10.1136/gut.47.5.694	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45200	10.1371/journal.pone.0045200	http://dx.doi.org/10.1371/journal.pone.0045200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028845	Green Submitted, gold, Green Published			2022-12-27	WOS:000308788700094
J	Canonici, A; Pellegrino, E; Siret, C; Terciolo, C; Czerucka, D; Bastonero, S; Marvaldi, J; Lombardo, D; Rigot, V; Andre, F				Canonici, Alexandra; Pellegrino, Emilie; Siret, Carole; Terciolo, Chloe; Czerucka, Dorota; Bastonero, Sonia; Marvaldi, Jacques; Lombardo, Dominique; Rigot, Veronique; Andre, Frederic			Saccharomyces boulardii Improves Intestinal Epithelial Cell Restitution by Inhibiting alpha v beta 5 Integrin Activation State	PLOS ONE			English	Article							PROTEIN-KINASE ACTIVATION; GROWTH-FACTOR; IN-VITRO; SUCRASE-ISOMALTASE; MUCOSAL REPAIR; CROHNS-DISEASE; E-CADHERIN; ALPHA; VITRONECTIN; MIGRATION	Intestinal epithelial cell damage is frequently seen in the mucosal lesions of infectious or inflammatory bowel diseases such as ulcerative colitis or Crohn's disease. Complete remission of these diseases requires both the disappearance of inflammation and the repair of damaged epithelium. Saccharomyces boulardii (Sb, Biocodex) is a non-pathogenic yeast widely used as a preventive and therapeutic probiotic for the prevention and treatment of diarrhea and other gastrointestinal disorders. We recently showed that it enhances the repair of intestinal epithelium through activation of alpha 2 beta 1 integrin collagen receptors. In the present study, we demonstrated that alpha 2 beta 1 integrin is not the sole cell-extracellular matrix receptor involved during Sb-mediated intestinal restitution. Indeed, by using cell adhesion assays, we showed that Sb supernatant contains heat sensitive molecule(s), with a molecular weight higher than 9 kDa, which decreased alpha v beta 5 integrin-mediated adhesion to vitronectin by competing with the integrin. Moreover, Sb-mediated changes in cell adhesion to vitronectin resulted in a reduction of the alpha v beta 5signaling pathway. We used a monolayer wounding assay that mimics in vivo cell restitution to demonstrate that down-modulation of the alpha v beta 5 integrin-vitronectin interaction is related to Sb-induced cell migration. We therefore postulated that Sb supernatant contains motogenic factors that enhance cell restitution through multiple pathways, including the dynamic fine regulation of alpha v beta 5 integrin binding activity. This could be of major importance in diseases characterized by severe mucosal injury, such as inflammatory and infectious bowel diseases.	[Canonici, Alexandra; Pellegrino, Emilie; Siret, Carole; Terciolo, Chloe; Bastonero, Sonia; Marvaldi, Jacques; Lombardo, Dominique; Rigot, Veronique; Andre, Frederic] Aix Marseille Univ, Ctr Rech Oncol & Oncopharmacol, Marseille, France; [Canonici, Alexandra; Pellegrino, Emilie; Siret, Carole; Terciolo, Chloe; Bastonero, Sonia; Marvaldi, Jacques; Lombardo, Dominique; Rigot, Veronique; Andre, Frederic] INSERM, UMR 9111, F-13258 Marseille, France; [Czerucka, Dorota] Ctr Mediterrane Med Mol, INSERM, U895, Team 4, Nice, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Andre, F (corresponding author), Aix Marseille Univ, Ctr Rech Oncol & Oncopharmacol, Marseille, France.	frederic.andre@univ-amu.fr		terciolo, chloe/0000-0003-2185-485X	Institut National du Cancer (InCa, Canceropole PACA)	Institut National du Cancer (InCa, Canceropole PACA)(Institut National du Cancer (INCA) France)	This work was financed in part by an institutional grant from Institut National du Cancer (InCa, Canceropole PACA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adair JE, 2009, J BIOL CHEM, V284, P16922, DOI 10.1074/jbc.M808560200; Andre F, 1999, INT J CANCER, V83, P497, DOI 10.1002/(SICI)1097-0215(19991112)83:4<497::AID-IJC11>3.3.CO;2-4; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; BASSON MD, 1992, J CLIN INVEST, V90, P15, DOI 10.1172/JCI115828; Basson MD, 2001, LIFE SCI, V69, P3005, DOI 10.1016/S0024-3205(01)01408-4; Basson MD, 1996, YALE J BIOL MED, V69, P119; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Buts JP, 2010, SCAND J GASTROENTERO, V45, P175, DOI 10.3109/00365520903453141; Buts JP, 2009, DIGEST DIS SCI, V54, P15, DOI 10.1007/s10620-008-0322-y; Canonici A, 2008, INT J CANCER, V122, P572, DOI 10.1002/ijc.23164; Canonici A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018427; CHANTRET I, 1994, J CELL SCI, V107, P213; Chavakis T, 2000, BLOOD, V96, P514; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Dalmasso G, 2006, RES MICROBIOL, V157, P456, DOI 10.1016/j.resmic.2005.11.007; Defilles C, 2011, BIOL CELL, V103, P519, DOI 10.1042/BC20100147; Defilles C, 2009, EXP CELL RES, V315, P1840, DOI 10.1016/j.yexcr.2009.03.014; Dignass AU, 2001, INFLAMM BOWEL DIS, V7, P68, DOI 10.1097/00054725-200102000-00014; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Girard P, 2005, DIGEST DIS SCI, V50, P2183, DOI 10.1007/s10620-005-3029-3; Goke M, 1998, GASTROENTEROLOGY, V114, P697, DOI 10.1016/S0016-5085(98)70583-9; GORVEL JP, 1991, GASTROENTEROLOGY, V101, P618, DOI 10.1016/0016-5085(91)90517-O; Guslandi M, 2003, EUR J GASTROEN HEPAT, V15, P697, DOI 10.1097/00042737-200306000-00017; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Ido A, 2005, J GASTROENTEROL, V40, P925, DOI 10.1007/s00535-005-1705-x; Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086; Lee Sang Kil, 2005, Korean J Gastroenterol, V45, P328; Lussier C, 2000, MICROSC RES TECHNIQ, V51, P169; Mammen JMV, 2003, CRIT CARE MED, V31, pS532, DOI 10.1097/01.CCM.0000081429.89277.AF; Martins FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008925; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Mumy KL, 2008, AM J PHYSIOL-GASTR L, V294, pG599, DOI 10.1152/ajpgi.00391.2007; Owen KA, 2010, PLOS ONE, V6; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; PLEIN K, 1993, Z GASTROENTEROL, V31, P129; Pothoulakis C, 2009, ALIMENT PHARM THER, V30, P826, DOI 10.1111/j.1365-2036.2009.04102.x; Preissner KT, 2011, SEMIN THROMB HEMOST, V37, P408, DOI 10.1055/s-0031-1276590; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Swanson PA, 2011, P NATL ACAD SCI USA, V108, P8803, DOI 10.1073/pnas.1010042108; Thomas S, 2011, AM J PHYSIOL-GASTR L, V301, pG1083, DOI 10.1152/ajpgi.00217.2011; Upton Z, 2011, INT WOUND J, V8, P522, DOI 10.1111/j.1742-481X.2011.00859.x; VERMEULEN SJ, 1995, CANCER RES, V55, P4722; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zanello G, 2009, CURR ISSUES MOL BIOL, V11, P47; Zeeh JM, 1996, GASTROENTEROLOGY, V110, P1077, DOI 10.1053/gast.1996.v110.pm8612996; Zhang JH, 2006, GASTROENTEROLOGY, V131, P1179, DOI 10.1053/j.gastro.2006.08.007	52	22	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45047	10.1371/journal.pone.0045047	http://dx.doi.org/10.1371/journal.pone.0045047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028753	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900017
J	Dediu, D; Levinson, SC				Dediu, Dan; Levinson, Stephen C.			Abstract Profiles of Structural Stability Point to Universal Tendencies, Family-Specific Factors, and Ancient Connections between Languages	PLOS ONE			English	Article							HORIZONTAL TRANSMISSION; EVOLUTION; PHYLOGENY; DIVERSITY; FREQUENCY; INFERENCE; CLOVIS; GENES; SITE	Language is the best example of a cultural evolutionary system, able to retain a phylogenetic signal over many thousands of years. The temporal stability (conservatism) of basic vocabulary is relatively well understood, but the stability of the structural properties of language (phonology, morphology, syntax) is still unclear. Here we report an extensive Bayesian phylogenetic investigation of the structural stability of numerous features across many language families and we introduce a novel method for analyzing the relationships between the "stability profiles" of language families. We found that there is a strong universal component across language families, suggesting the existence of universal linguistic, cognitive and genetic constraints. Against this background, however, each language family has a distinct stability profile, and these profiles cluster by geographic area and likely deep genealogical relationships. These stability profiles seem to show, for example, the ancient historical relationships between the Siberian and American language families, presumed to be separated by at least 12,000 years, and possible connections between the Eurasian families. We also found preliminary support for the punctuated evolution of structural features of language across families, types of features and geographic areas. Thus, such higher-level properties of language seen as an evolutionary system might allow the investigation of ancient connections between languages and shed light on the peopling of the world.	[Dediu, Dan; Levinson, Stephen C.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Dediu, Dan] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen	Dediu, D (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	Dan.Dediu@mpi.nl	Dediu, Dan/E-3279-2012	Dediu, Dan/0000-0002-0704-6365	Max Planck Institute	Max Planck Institute(Foundation CELLEX)	This work was supported by the Max Planck Institute (http://www.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Aris-Brosou S, 2005, MOL BIOL EVOL, V22, P200, DOI 10.1093/molbev/msi006; Atkinson QD, 2008, SCIENCE, V319, P588, DOI 10.1126/science.1149683; Bapteste E, 2008, TRENDS MICROBIOL, V16, P200, DOI 10.1016/j.tim.2008.02.005; Bickel B, 2006, BERK CA P 32 ANN M B; Brussow H, 2009, PHILOS T R SOC B, V364, P2263, DOI 10.1098/rstb.2009.0036; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Campbell L, 2008, LANGUAGE CLASSIFICATION: HISTORY AND METHOD, P1, DOI 10.1017/CBO9780511486906; CAMPBELL L, 1986, LANGUAGE, V62, P530, DOI 10.2307/415477; Campbell Lyle., 2004, HIST LINGUISTICS INT, VSecondedition; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; Cox T. F, 1994, MULTIDIMENSIONAL SCA; Croft W, 2008, ANNU REV ANTHROPOL, V37, P219, DOI 10.1146/annurev.anthro.37.081407.085156; Currie TE, 2010, PHILOS T R SOC B, V365, P3903, DOI 10.1098/rstb.2010.0014; Cysouw M, 2008, STUF-LANG TYPOL UNIV, V61, P263; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Dediu D, 2011, HUM BIOL, V83, P279, DOI 10.3378/027.083.0208; Dediu D, 2011, P ROY SOC B-BIOL SCI, V278, P474, DOI 10.1098/rspb.2010.1595; Dryer Matthew S., 2013, WORLD ATLAS LANGUAGE; Dunn M, 2005, SCIENCE, V309, P2072, DOI 10.1126/science.1114615; Dunn M, 2011, NATURE, V473, P79, DOI 10.1038/nature09923; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Felsenstein J., 2004, INFERRING PHYLOGENIE; Greenhill SJ, 2010, P ROY SOC B-BIOL SCI, V277, P2443, DOI 10.1098/rspb.2010.0051; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Hammarstrom H, 2010, DIACHRONICA, V27, P197, DOI 10.1075/dia.27.2.02ham; Hartung J, 1999, BIOMETRICAL J, V41; Haspelmath M, 2009, LOANWORDS IN THE WORLD'S LANGUAGES, P1, DOI 10.1515/9783110218442; Haspelmath M., 2009, WORLD LOANWORD DATAB; Haspelmath Martin, 2005, WORLD ATLAS LANGUAGE; Haspelmath Martin, 2007, LINGUIST TYPOL, V11-1, P119, DOI DOI 10.1515/LINGTY.2007.011; Holman EW, 2008, FOLIA LINGUIST, V42, P331, DOI 10.1515/FLIN.2008.331; Holman EricW., 2007, LINGUIST TYPOL, V11, P393, DOI [DOI 10.1515/LINGTY.2007.027, 10.1515/lingty.2007.027]; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hunley K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000239; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; Kluckhohn C, 1953, PERSONALITY NATURE S, P53; Levinson SC, 2012, LINGUISTIC IN PRESS, V15; Levinson SC, 2010, LINGUA, V120, P2733, DOI 10.1016/j.lingua.2010.08.001; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Makambi KH, 2003, J APPL STAT, V30, P225, DOI 10.1080/0266476022000023767; MANTEL N, 1967, CANCER RES, V27, P209; Maslova E, 2000, LINGUIST TYPOL, V4; McMahon A., 2005, LANGUAGE CLASSIFICAT; Meade Andrew, 2006, PHYLOGENETIC METHODS, P173; Meillet A.., 1903, INTRO ETUDE COMP LAN; Nichols J., 1999, LINGUISTIC DIVERSITY; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Pagel M, 2006, SCIENCE, V314, P119, DOI 10.1126/science.1129647; Pagel M, 2009, NAT REV GENET, V10, P405, DOI 10.1038/nrg2560; Parkvall M, 2008, STUF-LANG TYPOL UNIV, V61, P234; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reesink G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000241; Reid L, 2006, ENCY LANGUAGE LINGUI, P740; Renfrew C., 2000, TIME DEPTH HIST LING; Renfrew C., 1999, NOSTRATIC EXAMINING; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schabenberger O, 2005, TEXTS STAT SCI; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Stouffer S. A., 1949, AM SOLDIER, V1; Swadesh M., 1952, P AM PHILOS SOC, V96, p452 ; Tadmor U, 2010, DIACHRONICA, V27, P226, DOI 10.1075/dia.27.2.04tad; Thomason S. G., 1988, LANGUAGE CONTACT CRE; Vajda Edward, 2010, ANTHR PAPERS U ALASK, V5, P100; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Waters MR, 2011, SCIENCE, V334, P351, DOI 10.1126/science.1207663; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855; Wichmann S, 2011, J LANGUAGE RELATIONS, V5, P130; Wichmann Soren, 2009, ASSESSING TEMPORAL S	74	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45198	10.1371/journal.pone.0045198	http://dx.doi.org/10.1371/journal.pone.0045198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	014PT	23028843	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388900028
J	Gumel, AM; Annuar, MSM; Heidelberg, T				Gumel, Ahmad Mohammed; Annuar, Mohamad Suffian Mohamad; Heidelberg, Thorsten			Biosynthesis and Characterization of Polyhydroxyalkanoates Copolymers Produced by Pseudomonas putida Bet001 Isolated from Palm Oil Mill Effluent	PLOS ONE			English	Article							CHAIN-LENGTH POLY(3-HYDROXYALKANOATES); FATTY-ACIDS; BACTERIA; STRAINS; PHAS	The biosynthesis and characterization of medium chain length poly-3-hydroxyalkanoates (mcl-PHA) produced by Pseudomonas putida Bet001 isolated from palm oil mill effluent was studied. The biosynthesis of mcl-PHA in this newly isolated microorganism follows a growth-associated trend. Mcl-PHA accumulation ranging from 49.7 to 68.9% on cell dry weight (CDW) basis were observed when fatty acids ranging from octanoic acid (C-8:0) to oleic acid (C-18:1) were used as sole carbon and energy source. Molecular weight of the polymer was found to be ranging from 55.7 to 77.7 kDa. Depending on the type of fatty acid used, the H-1 NMR and GCMSMS analyses of the chiral polymer showed a composition of even and odd carbon atom chain with monomer length of C4 to C14 with C8 and C10 as the principal monomers. No unsaturated monomer was detected. Thermo-chemical analyses showed the accumulated PHA to be semi-crystalline polymer with good thermal stability, having a thermal degradation temperature (T-d) of 264.6 to 318.8 (+/- 0.2) degrees C, melting temperature (T-m) of 43. (+/- 0.2) degrees C, glass transition temperature (T-g) of -1.0 (+/- 0.2) degrees C and apparent melting enthalpy of fusion (Delta H-f) of 100.9 (+/- 0.1) J g(-1).	[Gumel, Ahmad Mohammed; Annuar, Mohamad Suffian Mohamad] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Heidelberg, Thorsten] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia	Universiti Malaya; Universiti Malaya	Annuar, MSM (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	suffian_annuar@um.edu.my	GUMEL, AHMAD MOHAMMED/E-9906-2011; Gumel, Ahmad/Z-5376-2019; Gumel, Ahmad Mohammed/Z-5382-2019; HEIDELBERG, THORSTEN/B-9963-2010; MOHAMAD ANNUAR, MOHAMAD SUFFIAN/B-9031-2010	GUMEL, AHMAD MOHAMMED/0000-0002-2998-4088; Gumel, Ahmad Mohammed/0000-0002-2998-4088; HEIDELBERG, THORSTEN/0000-0003-4428-2233; MOHAMAD ANNUAR, MOHAMAD SUFFIAN/0000-0003-3387-0160	University of Malaya [RG165-11AFR, PV36/2012A, UM.C/625/1/HIR/MOHE/05, RP024-2012A]	University of Malaya(Universiti Malaya)	This study was funded by University of Malaya research grants RG165-11AFR, PV36/2012A, UM.C/625/1/HIR/MOHE/05 and RP024-2012A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaraonye E, 2010, J CHEM TECHNOL BIOT, V85, P732, DOI 10.1002/jctb.2392; Albuquerque MGE, 2011, J BIOTECHNOL, V151, P66, DOI 10.1016/j.jbiotec.2010.10.070; Allen AD, 2010, J IND MICROBIOL BIOT, V37, P849, DOI 10.1007/s10295-010-0732-7; Annuar M., 2008, ASIA PAC J MOL BIOL, V16, P11; Annuar MSM, 2007, FOOD BIOPROD PROCESS, V85, P104, DOI 10.1205/fbp06017; ANNUAR MSM, 2006, ASIA PACIFIC J MOL B, V14, P1; Bohmert-Tatarev K, 2010, US Patent App., Patent No. [20,100/229,258, 20100229258]; Bonduelle C, 2009, BIOMACROMOLECULES, V10, P3069, DOI 10.1021/bm9007343; BURDON KL, 1946, J BACTERIOL, V52, P665, DOI 10.1128/JB.52.6.665-678.1946; Chung AL, 2011, BIOMACROMOLECULES, V12, P3559, DOI 10.1021/bm200770m; Dai Y, 2008, J BIOTECHNOL, V134, P137, DOI 10.1016/j.jbiotec.2008.01.013; Dalal J, 2010, PEDOBIOLOGIA, V54, P25, DOI 10.1016/j.pedobi.2010.08.004; Elbahloul Y, 2009, APPL ENVIRON MICROB, V75, P643, DOI 10.1128/AEM.01869-08; Grothe E, 2000, BIOPROCESS ENG, V22, P441, DOI 10.1007/s004490050757; Gumel AM, 2012, POLYM DEGRAD STABIL, V97, P1224, DOI 10.1016/j.polymdegradstab.2012.05.041; Haba E, 2007, BIOCHEM ENG J, V35, P99, DOI 10.1016/j.bej.2006.11.021; HUIJBERTS GNM, 1992, APPL ENVIRON MICROB, V58, P536, DOI 10.1128/AEM.58.2.536-544.1992; Lee EY, 1997, BIOTECHNOL TECH, V11, P167; Liu Q, 2011, METAB ENG, V13, P11, DOI 10.1016/j.ymben.2010.10.004; Lopez-Cuellar MR, 2011, INT J BIOL MACROMOL, V48, P74, DOI 10.1016/j.ijbiomac.2010.09.016; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Marseno D. W., 1998, Indonesian Food and Nutrition Progress, V5, P79; Matsusaki H, 2000, BIOMACROMOLECULES, V1, P17, DOI 10.1021/bm9900040; Ni YY, 2010, BIORESOURCE TECHNOL, V101, P8485, DOI 10.1016/j.biortech.2010.06.033; Rai R, 2011, MAT SCI ENG R, V72, P29, DOI 10.1016/j.mser.2010.11.002; Randriamahefa S, 2003, BIOMACROMOLECULES, V4, P1092, DOI 10.1021/bm034104o; Reddy SV, 2009, WORLD J MICROB BIOT, V25, P391, DOI 10.1007/s11274-008-9903-3; Sha K, 2008, MACROMOLECULES, V41, P361, DOI 10.1021/ma0707234; Sin MC, 2010, POLYM DEGRAD STABIL, V95, P2334, DOI 10.1016/j.polymdegradstab.2010.08.027; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Spiekermann P, 1999, ARCH MICROBIOL, V171, P73, DOI 10.1007/s002030050681; Tan IKP, 1997, APPL MICROBIOL BIOT, V47, P207, DOI 10.1007/s002530050914; Thomson N, 2010, J CHEM TECHNOL BIOT, V85, P760, DOI 10.1002/jctb.2299; YAMANE T, 1992, FEMS MICROBIOL LETT, V103, P257, DOI 10.1111/j.1574-6968.1992.tb05846.x; Zhang HF, 2009, BIOTECHNOL BIOENG, V104, P582, DOI 10.1002/bit.22409	35	96	97	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45214	10.1371/journal.pone.0045214	http://dx.doi.org/10.1371/journal.pone.0045214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028854	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900029
J	Perkins, G; Hsiao, YH; Yin, SY; Tjong, J; Tran, MT; Lau, J; Xue, J; Liu, SQ; Ellisman, MH; Zhou, D				Perkins, Guy; Hsiao, Yu-hsin; Yin, Songyue; Tjong, Jonathan; Tran, My T.; Lau, Jenna; Xue, Jin; Liu, Siqi; Ellisman, Mark H.; Zhou, Dan			Ultrastructural Modifications in the Mitochondria of Hypoxia-Adapted Drosophila melanogaster	PLOS ONE			English	Article							SKELETAL-MUSCLE; ISCHEMIC-INJURY; EXPERIMENTAL SELECTION; SUPEROXIDE-PRODUCTION; POSTNATAL-DEVELOPMENT; REPERFUSION INJURY; DEVELOPING BRAIN; OXYGEN; PARAQUAT; DISEASE	Chronic hypoxia (CH) occurs under certain physiological or pathological conditions, including in people who reside at high altitude or suffer chronic cardiovascular or pulmonary diseases. As mitochondria are the predominant oxygen-consuming organelles to generate ATP through oxidative phosphorylation in cells, their responses, through structural or molecular modifications, to limited oxygen supply play an important role in the overall functional adaptation to hypoxia. Here, we report the adaptive mitochondrial ultrastructural modifications and the functional impacts in a recently generated hypoxia-adapted Drosophila melanogaster strain that survives severe, otherwise lethal, hypoxic conditions. Using electron tomography, we discovered increased mitochondrial volume density and cristae abundance, yet also cristae fragmentation and a unique honeycomb-like structure in the mitochondria of hypoxia-adapted flies. The homeostatic levels of adenylate and energy charge were similar between hypoxia-adapted and naive control flies and the hypoxia-adapted flies remained active under severe hypoxia as quantified by negative geotaxis behavior. The equilibrium ATP level was lower in hypoxia-adapted flies than those of the naive controls tested under severe hypoxia that inhibited the motion of control flies. Our results suggest that the structural rearrangement in the mitochondria of hypoxia-adapted flies may be an important adaptive mechanism that plays a critical role in preserving adenylate homeostasis and metabolism as well as muscle function under chronic hypoxic conditions.	[Hsiao, Yu-hsin; Lau, Jenna; Xue, Jin; Zhou, Dan] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Perkins, Guy; Tjong, Jonathan; Tran, My T.; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Yin, Songyue; Liu, Siqi] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Zhou, D (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	d2zhou@ucsd.edu	Zhou, Dan/T-7203-2017	Zhou, Dan/0000-0001-6401-9040; Perkins, Guy/0000-0002-1834-6646	American Heart Association [0835188N]; National Institutes of Health [5P41RR004050, P41GM103412-24]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103412] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by an American Heart Association award (0835188N) to DZ National Institutes of Health awards 5P41RR004050 and P41GM103412-24 to MHE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Ali SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036801; Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Baar K, 2006, MED SCI SPORT EXER, V38, P1939, DOI 10.1249/01.mss.0000233799.62153.19; BHIMJI S, 1986, ACTA ANAT, V127, P205; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Bier E, 2004, GENE, V342, P1, DOI 10.1016/j.gene.2004.07.018; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Calmettes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009306; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Cenacchi G, 2011, J NEUROL, V258, P746, DOI 10.1007/s00415-010-5823-x; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; COSTANTINI P, 1995, TOXICOLOGY, V99, P77, DOI 10.1016/0300-483X(94)02997-9; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; DAVID H, 1985, PATHOL RES PRACT, V179, P370, DOI 10.1016/S0344-0338(85)80146-1; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Feala JD, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-91; Ferretti G, 2003, EUR J APPL PHYSIOL, V90, P344, DOI 10.1007/s00421-003-0923-2; Fitzl G, 1998, EXP TOXICOL PATHOL, V50, P245; Gabriel AM, 2009, INT J BIOCHEM CELL B, V41, P2062, DOI 10.1016/j.biocel.2009.02.002; GANETZKY B, 1978, EXP GERONTOL, V13, P189, DOI 10.1016/0531-5565(78)90012-8; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; Hafen E, 2004, SWISS MED WKLY, V134, P711; Hagberg H, 2004, J BIOENERG BIOMEMBR, V36, P369, DOI 10.1023/B:JOBB.0000041770.00567.4f; Halestrap AP, 2009, J BIOENERG BIOMEMBR, V41, P113, DOI 10.1007/s10863-009-9206-x; HIRAI KI, 1992, TOXICOLOGY, V72, P1, DOI 10.1016/0300-483X(92)90081-O; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Howald H, 2003, EUR J APPL PHYSIOL, V90, P360, DOI 10.1007/s00421-003-0872-9; Jacobs HT, 2004, BBA-BIOENERGETICS, V1659, P190, DOI 10.1016/j.bbabio.2004.07.004; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; JONES DP, 1986, ANNU REV PHYSIOL, V48, P33; KAYSER B, 1991, J APPL PHYSIOL, V70, P1938, DOI 10.1152/jappl.1991.70.5.1938; Klawitter J, 2007, ANAL BIOCHEM, V365, P230, DOI 10.1016/j.ab.2007.03.018; Koechlin C, 2005, THORAX, V60, P834, DOI 10.1136/thx.2004.037531; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lawrence A, 2006, J STRUCT BIOL, V154, P144, DOI 10.1016/j.jsb.2005.12.012; Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301; Lemasters JJ, 2007, J GASTROEN HEPATOL, V22, pS31, DOI 10.1111/j.1440-1746.2006.04643.x; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Lundby C, 2003, TOXICOLOGY, V192, P229, DOI 10.1016/S0300-483X(03)00328-7; Lynn EG, 2007, ANTIOXID REDOX SIGN, V9, P1353, DOI 10.1089/ars.2007.1700; MARTINELLI M, 1990, EXPERIENTIA, V46, P672, DOI 10.1007/BF01939930; Matthews KA, 2005, NAT REV GENET, V6, P179, DOI 10.1038/nrg1554; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NEELY JR, 1981, AM J PATHOL, V102, P282; NEEMAN Z, 1990, CARDIOVASC RES, V24, P555, DOI 10.1093/cvr/24.7.555; Nouette-Gaulain K, 2005, CARDIOVASC RES, V66, P132, DOI 10.1016/j.cardiores.2004.12.023; Perkins GA, 1997, J STRUCT BIOL, V120, P219, DOI 10.1006/jsbi.1997.3920; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Saltin B, 1983, HDB PHYSL, P631; SCALETTAR BA, 1991, P NATL ACAD SCI USA, V88, P8057, DOI 10.1073/pnas.88.18.8057; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Tawara T, 1996, ARCH TOXICOL, V70, P585, DOI 10.1007/s002040050316; Toivonen JM, 2001, GENETICS, V159, P241; UEDA T, 1985, J ELECTRON MICROSC, V34, P85; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; VANEKEREN GJ, 1992, INT J EXP PATHOL, V73, P51; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Vigne Paul, 2010, BMC Physiology, V10, P8, DOI 10.1186/1472-6793-10-8; Wada J, 1998, P NATL ACAD SCI USA, V95, P144, DOI 10.1073/pnas.95.1.144; Wicks S, 2009, FREE RADICAL BIO MED, V46, P176, DOI 10.1016/j.freeradbiomed.2008.09.036; Zhang XF, 2010, CHINESE MED J-PEKING, V123, P2249, DOI 10.3760/cma.j.issn.0366-6999.2010.16.017; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490; Zhou D, 2011, P NATL ACAD SCI USA, V108, P2349, DOI 10.1073/pnas.1010643108; Zhou D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000221	72	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45344	10.1371/journal.pone.0045344	http://dx.doi.org/10.1371/journal.pone.0045344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028948	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400076
J	Saadat, H; Ziai, SA; Ghanemnia, M; Namazi, MH; Safi, M; Vakili, H; Dabbagh, A; Gholami, O				Saadat, Habibollah; Ziai, Seyed Ali; Ghanemnia, Maryam; Namazi, Mohammad Hasan; Safi, Morteza; Vakili, Hosein; Dabbagh, Ali; Gholami, Omid			Opium Addiction Increases Interleukin 1 Receptor Antagonist (IL-1Ra) in the Coronary Artery Disease Patients	PLOS ONE			English	Article							CHRONIC MORPHINE TREATMENT; UNSTABLE ANGINA; INFLAMMATORY CYTOKINES; HUMAN MONOCYTES; TISSUE FACTOR; CELLS; RISK; ATHEROSCLEROSIS; MYOCARDIUM; PECTORIS	Background: There is evidence that opium addiction has immunosuppressant effects. Coronary artery disease (CAD) is a condition resulted from atherosclerosis which is dependent on the immune response. Purpose: To evaluate plasma levels of interleukin-6 and interleukin-1Ra in 30 patients with three-vessel coronary artery disease, ejection fraction of more than 35% and to evaluate their changes after prognostic treadmill test in 15 opium addicted and 15 non-addicted patients. Methods: The participants underwent prognostic treadmill test and plasma levels of interleukin-6 (IL-6) and interleukin-1Ra (IL-1Ra) were evaluated with ELISA method before, just after and 4 hours after the test. Results: IL-1Ra (2183 pg/ml) tended to decrease over time in the opium addicted group (1372 pg/ml after prognostic treadmill test and 1034 pg/ml 4 hours after that), although such decrease did not reach the statistical significance. IL-1Ra levels were significantly higher in opium addicted than in non addicted patients. Opium addiction had no significant effect on IL-6 changes. Conclusion: Consumption of opium in CAD patients is associated with higher IL-1Ra levels.	[Ziai, Seyed Ali; Gholami, Omid] Shahid Beheshti Univ Med Sci, Dept Pharmacol, Sch Med, Tehran, Iran; [Saadat, Habibollah; Ghanemnia, Maryam; Namazi, Mohammad Hasan; Safi, Morteza; Vakili, Hosein] Shahid Beheshti Univ Med Sci, Cardiovasc Res Ctr, Tehran, Iran; [Dabbagh, Ali] Shahid Beheshti Univ Med Sci, Anesthesiol Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Ziai, SA (corresponding author), Shahid Beheshti Univ Med Sci, Dept Pharmacol, Sch Med, Tehran, Iran.	saziai@gmail.com	Dabbagh, Ali/AAC-9129-2019; safi, morteza/P-2932-2018; Ziai, Seyed Ali/R-8658-2019; vakili, hossein/P-4016-2018; Saadat, Habibollah/K-9221-2018; Dabbagh, Ali/B-1366-2018; gholami, omid/H-5938-2017; namazi, Mohammad Hasan/K-8925-2018	Dabbagh, Ali/0000-0003-4344-8131; Ziai, Seyed Ali/0000-0002-1102-8119; Dabbagh, Ali/0000-0003-4344-8131; gholami, omid/0000-0002-6757-4303; namazi, Mohammad Hasan/0000-0001-5801-9925; Saadat, Habibollah/0000-0001-6459-3317; vakili, hossien/0000-0003-3611-5670	Shahid Beheshti University of Medical Sciences (SBMU)	Shahid Beheshti University of Medical Sciences (SBMU)	This study has been supported by a grant from the Shahid Beheshti University of Medical Sciences (SBMU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis Stavros, 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P150, DOI 10.2174/187152508783955006; AREND WP, 1991, J IMMUNOL, V147, P1530; Azimzade-Sarwar B., 2005, American Journal of Applied Sciences, V2, P1134, DOI 10.3844/ajassp.2005.1134.1135; BAFGHI SMS, 2005, ACTA MED IRANICA, V43, P218; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Biasucci LM, 1999, CIRCULATION, V99, P2079, DOI 10.1161/01.CIR.99.16.2079; CHOMARAT P, 1995, J IMMUNOL, V154, P1432; Davoudi GR, 2006, J TEHRAN HEART CTR, V1, P43; Deng MC, 1996, INT J CARDIOL, V57, P129, DOI 10.1016/S0167-5273(96)02805-7; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; FENTON MJ, 1992, J IMMUNOL, V149, P1283; FINKEL MS, 1993, AM J CARDIOL, V71, P1231, DOI 10.1016/0002-9149(93)90654-U; Fiotti N, 1999, ATHEROSCLEROSIS, V145, P51, DOI 10.1016/S0021-9150(99)00013-1; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; Fisman EZ, 2006, AM J CARDIOL, V98, P14, DOI 10.1016/j.amjcard.2006.01.045; HELLE M, 1988, EUR J IMMUNOL, V18, P957, DOI 10.1002/eji.1830180619; Hoffmeister Albrecht, 2005, Eur J Intern Med, V16, P47, DOI 10.1016/j.ejim.2004.09.008; Holan V, 2003, CLIN EXP IMMUNOL, V132, P40, DOI 10.1046/j.1365-2249.2003.02103.x; Ikonomidis I, 2005, CIRCULATION, V112, P3272, DOI 10.1161/CIRCULATIONAHA.104.532259; Ikonomidis I, 2008, ATHEROSCLEROSIS, V199, P3, DOI 10.1016/j.atherosclerosis.2008.02.019; James SK, 2005, AM HEART J, V149, P619, DOI 10.1016/j.ahj.2004.08.026; Kleemann R, 2008, CARDIOVASC RES; Koukkunen H, 2001, ANN MED, V33, P37, DOI 10.3109/07853890109002058; KUKIELKA GL, 1995, CIRCULATION, V92, P1866, DOI 10.1161/01.CIR.92.7.1866; Kusuhara H, 1997, PROSTAG OTH LIPID M, V54, P795, DOI 10.1016/S0090-6980(97)00159-7; Peng XH, 2000, J LEUKOCYTE BIOL, V68, P723; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Roy S, 2004, J NEUROIMMUNOL, V147, P78, DOI 10.1016/j.jneuroim.2003.10.016; Szotowski B, 2005, CIRC RES, V96, P1233, DOI 10.1161/01.RES.0000171805.24799.fa; Wang JH, 2002, J LEUKOCYTE BIOL, V71, P782; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D	31	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44939	10.1371/journal.pone.0044939	http://dx.doi.org/10.1371/journal.pone.0044939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028694	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400051
J	Dai, BD; Wang, Y; Li, DD; Xu, Y; Liang, RM; Zhao, LX; Cao, YB; Jia, JH; Jiang, YY				Dai, BaoDi; Wang, Yan; Li, DeDong; Xu, Yi; Liang, RongMei; Zhao, LanXue; Cao, YongBing; Jia, JianHui; Jiang, YuanYing			Hsp90 Is Involved in Apoptosis of Candida albicans by Regulating the Calcineurin-Caspase Apoptotic Pathway	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; CYTOCHROME-C; EXPRESSION; RESISTANCE; GENE; EPIDEMIOLOGY; ACTIVATION; CHAPERONE; YCA1	Candida albicans is the most common human fungal pathogen. Recent evidence has revealed the occurrence of apoptosis in C. albicans that is inducible by environmental stresses such as hydrogen peroxide, acetic acid, and amphotericin B. Apoptosis is regulated by the calcineurin-caspase pathway in C. albicans, and calcineurin is under the control of Hsp90 in echinocandin resistance. However, the role of Hsp90 in apoptosis of C. albicans remains unclear. In this study, we investigated the role of Hsp90 in apoptosis of C. albicans by using an Hsp90-compromised strain tetO-HSP90/hsp90 and found that upon apoptotic stimuli, including hydrogen peroxide, acetic acid or amphotericin B treatment, less apoptosis occurred, less ROS was produced, and more cells survived in the Hsp90-compromised strain compared with the Hsp90/Hsp90 wild-type strain. In addition, Hsp90-compromised cells were defective in up-regulating caspase-encoding gene CaMCA1 expression and activating caspase activity upon the apoptotic stimuli. Investigations on the relationship between Hsp90 and calcineurin revealed that activation of calcineurin could up-regulate apoptosis but could not further downregulate apoptosis in Hsp90-compromised cells, indicating that calcineurin was downstream of Hsp90. Hsp90 inhibitor geldanamycin (GdA) could further decrease the apoptosis in calcineurin-pathway-defect strains, indicating that compromising Hsp90 function had a stronger effect than compromising calcineurin function on apoptosis. Collectively, this study demonstrated that compromised Hsp90 reduced apoptosis in C. albicans, partially through downregulating the calcineurin-caspase pathway.	[Dai, BaoDi; Wang, Yan; Li, DeDong; Zhao, LanXue; Cao, YongBing; Jiang, YuanYing] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Xu, Yi] Jinan Mil Command Reg, Dept Pharm, Gen Hosp, Jinan, Peoples R China; [Liang, RongMei] Chengdu Mil Command Reg, Dept Clin Pharm, Gen Hosp, Chengdu, Peoples R China; [Jia, JianHui] Shenyang Pharmaceut Univ, Dept Pharmacol, Sch Life Sci & Biopharmacol, Shenyang, Peoples R China	Naval Medical University; Shenyang Pharmaceutical University	Wang, Y (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	wangyancn@smmu.edu.cn; jiangyuanying@126.com	jiang, anyi/GPT-0379-2022; Li, Dedong/R-7044-2019	Wang, Yan/0000-0003-1084-1957	National Natural Science Foundation of China [81072678, 30825041, 90913008]; Postdoctoral Science Foundation of China [20110491851]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (81072678, 30825041 and 90913008) and Postdoctoral Science Foundation of China (20110491851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Baek YU, 2004, FEBS LETT, V556, P47, DOI 10.1016/S0014-5793(03)01363-2; Cao YY, 2009, FUNGAL GENET BIOL, V46, P183, DOI 10.1016/j.fgb.2008.11.001; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Dai BD, 2009, J MICROBIOL BIOTECHN, V19, P803, DOI 10.4014/jmb.0812.662; GaleaLauri J, 1996, J IMMUNOL, V157, P4109; Guaragnella N, 2006, FEBS LETT, V580, P6880, DOI 10.1016/j.febslet.2006.11.050; Hamza OJM, 2008, CLIN INFECT DIS, V47, P1270, DOI 10.1086/592578; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Lee M, 2001, ARIEL-REV INT ENGL, V32, P90; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015808; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Pandey P, 2000, EMBO J, V19, P4310, DOI 10.1093/emboj/19.16.4310; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Rezzani R, 2003, FEBS LETT, V552, P125, DOI 10.1016/S0014-5793(03)00898-6; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Santos M, 2005, CURR GENET, V48, P88, DOI 10.1007/s00294-005-0003-8; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Steinbach WJ, 2007, NAT REV MICROBIOL, V5, P418, DOI 10.1038/nrmicro1680; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Trompier D, 2004, CANCER RES, V64, P4950, DOI 10.1158/0008-5472.CAN-04-0143; Wang LM, 2011, MOL ENDOCRINOL, V25, P1376, DOI 10.1210/me.2011-0029; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhu JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028830	41	21	26	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45109	10.1371/journal.pone.0045109	http://dx.doi.org/10.1371/journal.pone.0045109			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028789	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900079
J	Higa, JK; Liang, ZB; Williams, PG; Panee, J				Higa, Jason K.; Liang, Zhibin; Williams, Philip G.; Panee, Jun			Phyllostachys edulis Compounds Inhibit Palmitic Acid-Induced Monocyte Chemoattractant Protein 1 (MCP-1) Production	PLOS ONE			English	Article							NF-KAPPA-B; INSULIN-RESISTANCE; ADIPOSE-TISSUE; BAMBOO EXTRACT; MACROPHAGE ACCUMULATION; INFLAMMATORY DISEASES; LETHEDON-TANNAENSIS; GENE-EXPRESSION; VAR.-HENONIS; IN-VITRO	Background: Phyllostachys edulis Carriere (Poaceae) is a bamboo species that is part of the traditional Chinese medicine pharmacopoeia. Compounds and extracts from this species have shown potential applications towards several diseases. One of many complications found in obesity and diabetes is the link between elevated circulatory free fatty acids (FFAs) and chronic inflammation. This study aims to present a possible application of P. edulis extract in relieving inflammation caused by FFAs. Monocyte chemoattractant protein 1 (MCP-1/CCL2) is a pro-inflammatory cytokine implicated in chronic inflammation. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) and activator protein 1 (AP-1) are transcription factors activated in response to inflammatory stimuli, and upregulate pro-inflammatory cytokines such as MCP-1. This study examines the effect of P. edulis extract on cellular production of MCP-1 and on the NF-kappa B and AP-1 pathways in response to treatment with palmitic acid (PA), a FFA. Methodology/Principal Findings: MCP-1 protein was measured by cytometric bead assay. NF-kappa B and AP-1 nuclear localization was detected by colorimetric DNA-binding ELISA. Relative MCP-1 mRNA was measured by real-time quantitative PCR. Murine cells were treated with PA to induce inflammation. PA increased expression of MCP-1 mRNA and protein, and increased nuclear localization of NF-kappa B and AP-1. Adding bamboo extract (BEX) inhibited the effects of PA, reduced MCP-1 production, and inhibited nuclear translocation of NF-kappa B and AP-1 subunits. Compounds isolated from BEX inhibited MCP-1 secretion with different potencies. Conclusions/Significance: PA induced MCP-1 production in murine adipose, muscle, and liver cells. BEX ameliorated PA-induced production of MCP-1 by inhibiting nuclear translocation of NF-kappa B and AP-1. Two O-methylated flavones were isolated from BEX with functional effects on MCP-1 production. These results may represent a possible therapeutic application of BEX and its compounds toward alleviating chronic inflammation caused by elevated circulatory FFAs.	[Higa, Jason K.; Panee, Jun] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Liang, Zhibin; Williams, Philip G.] Univ Hawaii Manoa, Dept Chem, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii System; University of Hawaii Manoa	Panee, J (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA.	junchen@hawaii.edu	Liang, Zhibin/B-9783-2015	Liang, Zhibin/0000-0002-8855-1696; Higa, Jason Kenji/0000-0002-0429-6254; Williams, Philip/0000-0001-8987-0683	National Center for Complementary and Alternative Medicine (NCCAM) [R21 AT003874, R21 AT005139]; National Center for Research Resources [U54RR022762, 5 G12 RR003061, 5P20RR016467-11]; National Institute on Minority Health and Health Disparities from the National Institutes of Health [8 G12 MD007601]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GMI 03466-11]; National Center on Minority Health and Health Disparities (NCMHD) [5P20 MD000173-08]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT005139, R21AT003874] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467, G12RR003061, U54RR022762] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584, G12MD007601, P20MD000173] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities from the National Institutes of Health; National Institute of General Medical Sciences from the National Institutes of Health(General Electric); National Center on Minority Health and Health Disparities (NCMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants R21 AT003874 (Panee) and R21 AT005139 (Panee) from the National Center for Complementary and Alternative Medicine (NCCAM); grant U54RR022762 (RTRN Small Grant Program) from the National Center for Research Resources; grants from the National Center for Research Resources (5 G12 RR003061) and the National Institute on Minority Health and Health Disparities (8 G12 MD007601) from the National Institutes of Health; grants from the National Center for Research Resources (5P20RR016467-11) and the National Institute of General Medical Sciences (8 P20 GMI 03466-11) from the National Institutes of Health; and grant 5P20 MD000173-08 from National Center on Minority Health and Health Disparities (NCMHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fayez M, 2006, CANCER CHEMOTH PHARM, V58, P816, DOI 10.1007/s00280-006-0228-3; ANDERSON JA, 1931, J CHEM SOC, P2624, DOI DOI 10.1039/JR9310002624; Ando C, 2009, FEBS LETT, V583, P3649, DOI 10.1016/j.febslet.2009.10.045; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bensasson RV, 1999, FREE RADICAL BIO MED, V27, P95, DOI 10.1016/S0891-5849(99)00039-8; Beutler B, 2003, CRIT CARE, V7, P39, DOI 10.1186/cc1828; Bhandare AM, 2010, FOOD CHEM TOXICOL, V48, P3412, DOI 10.1016/j.fct.2010.09.013; BICKOFF EM, 1964, J PHARM SCI, V53, P1411, DOI 10.1002/jps.2600531131; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Cai H, 2004, BRIT J CANCER, V91, P1364, DOI 10.1038/sj.bjc.6602124; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Choi YJ, 2008, EXP BIOL MED, V233, P580, DOI 10.3181/0707-RM-205; Chou CH, 1982, J CHEM ECOL, V8, P19; Conti P, 2001, ALLERGY ASTHMA PROC, V22, P133, DOI 10.2500/108854101778148737; Del Rosario A, 2012, BR J NUTR, P1; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Greenberg AS, 2006, AM J CLIN NUTR, V83, p461S; Ham I, 2009, IMMUNOPHARM IMMUNOT, V31, P439, DOI 10.1080/08923970902769638; Higa JK, 2011, CYTOKINE, V55, P18, DOI 10.1016/j.cyto.2011.02.019; Higa JK, 2011, BR J NUTR, P1; Hirai S, 2007, LIFE SCI, V81, P1272, DOI 10.1016/j.lfs.2007.09.001; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hong EJ, 2010, J ETHNOPHARMACOL, V128, P594, DOI 10.1016/j.jep.2010.01.045; Hu C, 2000, J AGR FOOD CHEM, V48, P3170, DOI 10.1021/jf0001637; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jiao JJ, 2007, J AGR FOOD CHEM, V55, P10086, DOI 10.1021/jf0716533; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kannan-Thulasiraman P, 2002, J BIOL CHEM, V277, P41230, DOI 10.1074/jbc.M200379200; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim DS, 2010, PLANTA MED, V76, P678, DOI 10.1055/s-0029-1240649; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim SH, 2007, IMMUNOPHARM IMMUNOT, V29, P131, DOI 10.1080/08923970701283476; Kong CH, 2010, PEST MANAG SCI, V66, P1018, DOI 10.1002/ps.1976; Kuwabara H, 2003, J NAT PROD, V66, P1273, DOI 10.1021/np030020p; Lee HJ, 2010, FOOD CHEM TOXICOL, V48, P1721, DOI 10.1016/j.fct.2010.03.052; LEE KH, 1981, J NAT PROD, V44, P530, DOI 10.1021/np50017a003; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; Middleton E, 2000, PHARMACOL REV, V52, P673; Miyata Y, 2011, LIFE SCI, V88, P613, DOI 10.1016/j.lfs.2011.01.024; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oliver E, 2010, P NUTR SOC, V69, P232, DOI 10.1017/S0029665110000042; Oyama T, 2009, CANCER PREV RES, V2, P1031, DOI 10.1158/1940-6207.CAPR-09-0061; Panee J, 2008, PHYTOTHER RES, V22, P675, DOI 10.1002/ptr.2395; Park HJ, 2012, J NUTR, V142, P57, DOI 10.3945/jn.111.148544; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; Sakai Asumi, 2008, Antiviral Chemistry & Chemotherapy, V19, P125; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; UEDA A, 1994, J IMMUNOL, V153, P2052; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; VANE JR, 1990, STROKE, V21, P12; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wenzig E, 2005, J NAT PROD, V68, P289, DOI 10.1021/np049636k; Xiao JN, 2005, INVEST OPHTH VIS SCI, V46, P3777, DOI 10.1167/iovs.05-0724; Yamazaki K, 2007, BIOCHEM SYST ECOL, V35, P743, DOI 10.1016/j.bse.2007.04.013; Yen GC, 2011, J AGR FOOD CHEM, V59, P546, DOI 10.1021/jf1036992; Zahir A, 1996, J NAT PROD, V59, P701, DOI 10.1021/np960336f; Zhang X, 2010, CHEM RES CHINESE U, V26, P161; Zhang Z.Y., 2000, WORLD SCI TECHNOL, V3, P54, DOI [10.3969/j.issn.1674-3849.2000.03.018, DOI 10.3969/J.ISSN.1674-3849.2000.03.018]	62	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45082	10.1371/journal.pone.0045082	http://dx.doi.org/10.1371/journal.pone.0045082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028772	gold, Green Published			2022-12-27	WOS:000311313900076
J	Umana, MN; Norden, N; Cano, A; Stevenson, PR				Natalia Umana, Maria; Norden, Natalia; Cano, Angela; Stevenson, Pablo R.			Determinants of Plant Community Assembly in a Mosaic of Landscape Units in Central Amazonia: Ecological and Phylogenetic Perspectives	PLOS ONE			English	Article							BETA-DIVERSITY; FLORISTIC COMPOSITION; FUNCTIONAL TRAITS; FOREST; PATTERNS; LIGHT; REGENERATION; COEXISTENCE; COMPETITION; TOLERANCE	The Amazon harbours one of the richest ecosystems on Earth. Such diversity is likely to be promoted by plant specialization, associated with the occurrence of a mosaic of landscape units. Here, we integrate ecological and phylogenetic data at different spatial scales to assess the importance of habitat specialization in driving compositional and phylogenetic variation across the Amazonian forest. To do so, we evaluated patterns of floristic dissimilarity and phylogenetic turnover, habitat association and phylogenetic structure in three different landscape units occurring in terra firme (Hilly and Terrace) and flooded forests (Igapo). We established two 1-ha tree plots in each of these landscape units at the Caparu Biological Station, SW Colombia, and measured edaphic, topographic and light variables. At large spatial scales, terra firme forests exhibited higher levels of species diversity and phylodiversity than flooded forests. These two types of forests showed conspicuous differences in species and phylogenetic composition, suggesting that environmental sorting due to flood is important, and can go beyond the species level. At a local level, landscape units showed floristic divergence, driven both by geographical distance and by edaphic specialization. In terms of phylogenetic structure, Igapo forests showed phylogenetic clustering, whereas Hilly and Terrace forests showed phylogenetic evenness. Within plots, however, local communities did not show any particular trend. Overall, our findings suggest that flooded forests, characterized by stressful environments, impose limits to species occurrence, whereas terra firme forests, more environmentally heterogeneous, are likely to provide a wider range of ecological conditions and therefore to bear higher diversity. Thus, Amazonia should be considered as a mosaic of landscape units, where the strength of habitat association depends upon their environmental properties.	[Natalia Umana, Maria; Norden, Natalia; Cano, Angela; Stevenson, Pablo R.] Univ Los Andes, Lab Ecol Bosques Trop & Primatol, Ctr Invest Ecol La Macarena, Bogota, Colombia; [Norden, Natalia] Pontificia Univ Javeriana, Dept Ecol & Terr, Bogota, Colombia	Universidad de los Andes (Colombia); Pontificia Universidad Javeriana	Umana, MN (corresponding author), Univ Los Andes, Lab Ecol Bosques Trop & Primatol, Ctr Invest Ecol La Macarena, Bogota, Colombia.	maumana@gmail.com	Cano, Ángela/N-9392-2017	Cano, Ángela/0000-0002-5090-7730	Facultad de Ciencias at Universidad de los Andes	Facultad de Ciencias at Universidad de los Andes	Facultad de Ciencias at Universidad de los Andes provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Baraloto C, 2007, ECOLOGY, V88, P478, DOI 10.1890/0012-9658(2007)88[478:SWSTAH]2.0.CO;2; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Bazzaz F. A., 1996, PLANTS CHANGING ENV; Cano A., 2009, Revista Colombia Forestal, V12, P63; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chust G, 2006, J VEG SCI, V17, P83, DOI 10.1111/j.1654-1103.2006.tb02426.x; CLAVIJO L., 2009, ESTACION BIOL MOSIRO, P55; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Davidar P, 2007, GLOBAL ECOL BIOGEOGR, V16, P510, DOI 10.1111/j.1466-8238.2007.00307.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Defler TR, 1996, INT J PRIMATOL, V17, P161, DOI 10.1007/BF02735446; Duque A, 2002, J TROP ECOL, V18, P499, DOI 10.1017/S0266467402002341; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Godoy JR, 1999, BIODIVERS CONSERV, V8, P551, DOI 10.1023/A:1008846531941; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ives AR, 2010, AM NAT, V176, pE128, DOI 10.1086/656486; Junk W.J., 1989, TROPICAL FORESTS BOT, P47, DOI [DOI 10.1016/B978-0-12-353550-4.50012-5, 10.1016/b978-0-12-353550-4.50012-5]; Kembel S, 2008, PICANTE PHYLOCOM INT; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McArthur RH, 1967, THEORY ISLAND BIOGEO; Metz MR, 2010, ECOLOGY, V91, P3675, DOI 10.1890/08-2323.1; Montgomery RA, 2004, BIOTROPICA, V36, P33, DOI 10.1646/02118; Muller-Landau H. C., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P35, DOI 10.1079/9780851995250.0035; Nicotra AB, 1999, ECOLOGY, V80, P1908, DOI 10.1890/0012-9658(1999)080[1908:SHOLAW]2.0.CO;2; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Palacios E, 2009, ESTACION BIOL MOSIRO, P55; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; Parolin P, 2004, BOT REV, V70, P357, DOI 10.1663/0006-8101(2004)070[0357:CAFFTA]2.0.CO;2; Parolin P, 2001, OECOLOGIA, V128, P326, DOI 10.1007/s004420100660; Parolin P, 1998, INT VER THEOR ANGEW, V26, P1106; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Poorter L, 2005, J ECOL, V93, P256, DOI 10.1111/j.1365-2745.2004.00956.x; R Core Team Development, 2011, R LANG ENV STAT COMP; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Stevens PF, 2008, ANGIOSPERM PHYLOGENY; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Ter Steege H, 2000, J TROP ECOL, V16, P801, DOI 10.1017/S0266467400001735; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tuomisto H, 2002, BIOTROPICA, V34, P516, DOI 10.1111/j.1744-7429.2002.tb00571.x; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Vormisto J, 2004, J ECOL, V92, P577, DOI 10.1111/j.0022-0477.2004.00904.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Webb CO, 2008, TROPICAL FOREST COMM, P79; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2011, ECOL LETT, V14, P643, DOI 10.1111/j.1461-0248.2011.01625.x; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Willis CG, 2010, ECOGRAPHY, V33, P565, DOI 10.1111/j.1600-0587.2009.05975.x	66	16	17	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45199	10.1371/journal.pone.0045199	http://dx.doi.org/10.1371/journal.pone.0045199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028844	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900099
J	Saenz, RA; Essen, SC; Brookes, SM; Iqbal, M; Wood, JLN; Grenfell, BT; McCauley, JW; Brown, IH; Gog, JR				Saenz, Roberto A.; Essen, Steve C.; Brookes, Sharon M.; Iqbal, Munir; Wood, James L. N.; Grenfell, Bryan T.; McCauley, John W.; Brown, Ian H.; Gog, Julia R.			Quantifying Transmission of Highly Pathogenic and Low Pathogenicity H7N1 Avian Influenza in Turkeys	PLOS ONE			English	Article							WITHIN-FLOCK TRANSMISSION; VIRUS; EPIDEMIC; CHICKENS; VACCINATION; POULTRY	Outbreaks of avian influenza in poultry can be devastating, yet many of the basic epidemiological parameters have not been accurately characterised. In 1999-2000 in Northern Italy, outbreaks of H7N1 low pathogenicity avian influenza virus (LPAI) were followed by the emergence of H7N1 highly pathogenic avian influenza virus (HPAI). This study investigates the transmission dynamics in turkeys of representative HPAI and LPAI H7N1 virus strains from this outbreak in an experimental setting, allowing direct comparison of the two strains. The fitted transmission rates for the two strains are similar: 2.04 (1.5-2.7) per day for HPAI, 2.01 (1.6-2.5) per day for LPAI. However, the mean infectious period is far shorter for HPAI (1.47 (1.3-1.7) days) than for LPAI (7.65 (7.0-8.3) days), due to the rapid death of infected turkeys. Hence the basic reproductive ratio, R-0 is significantly lower for HPAI (3.01 (2.2-4.0)) than for LPAI (15.3 (11.8-19.7)). The comparison of transmission rates and R-0 are critically important in relation to understanding how HPAI might emerge from LPAI. Two competing hypotheses for how transmission rates vary with population size are tested by fitting competing models to experiments with differing numbers of turkeys. A model with frequency-dependent transmission gives a significantly better fit to experimental data than density-dependent transmission. This has important implications for extrapolating experimental results from relatively small numbers of birds to the commercial poultry flock size, and for how control, including vaccination, might scale with flock size.	[Saenz, Roberto A.; Gog, Julia R.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 9EW, England; [Iqbal, Munir] Inst Anim Hlth, Compton Lab, Newbury, Berks, England; [Essen, Steve C.; Brookes, Sharon M.; Brown, Ian H.] Anim Hlth & Vet Labs Agcy, Addlestone, Surrey, England; [Essen, Steve C.; Brookes, Sharon M.; Brown, Ian H.] World Org Anim Hlth, European Union, Food & Agr Org Reference Lab Avian Influenza & Ne, Addlestone, Surrey, England; [Wood, James L. N.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [McCauley, John W.] Natl Inst Med Res, MRC, London NW7 1AA, England	University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Veterinary Laboratories Agency; Food & Agriculture Organization of the United Nations (FAO); University of Cambridge; Princeton University; MRC National Institute for Medical Research	Gog, JR (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Silver St, Cambridge CB3 9EW, England.	jrg20@cam.ac.uk	Wood, James/A-1626-2008; Brookes, Sharon M/C-8016-2011; Brookes, Sharon M/W-2128-2019; Brown, Ian H/E-1119-2011; Essen, Stephen/E-9721-2011	Wood, James/0000-0002-0258-3188; Brookes, Sharon M/0000-0001-9207-6659; Brookes, Sharon M/0000-0001-9207-6659; Iqbal, Munir/0000-0001-5165-5339; Gog, Julia/0000-0003-1240-7214	Biotechnology and Biological Sciences Research Council (BBSRC) Combatting Infectious Dieases of Livestock Initiative [BBS/B/00522, BBS/B/00093]; Department for Environment, Food and Rural Affairs [ROAME SE0776]; Royal Society University Research Fellowship; Alborada Trust; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health, United States of America; BBSRC [BB/E010849/1, BBS/B/00522] Funding Source: UKRI; MRC [MC_U117512723, MC_U117585868] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/00522, BBS/B/00093, BB/E010849/1] Funding Source: researchfish; Medical Research Council [MC_U117512723, MC_U117585868] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC) Combatting Infectious Dieases of Livestock Initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Royal Society University Research Fellowship(Royal Society of London); Alborada Trust; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health, United States of America; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was funded through the Biotechnology and Biological Sciences Research Council (BBSRC) Combatting Infectious Dieases of Livestock Initiative, through co-funding by the Department for Environment, Food and Rural Affairs ROAME SE0776 and by the BBSRC (awards BBS/B/00522 and BBS/B/00093). JRG was supported by a Royal Society University Research Fellowship. JLNW was supported by the Alborada Trust. JRG, BTG and JLNW were supported by the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous EW, 2010, AVIAN PATHOL, V39, P265, DOI 10.1080/03079457.2010.492825; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Bos MEH, 2010, PREV VET MED, V95, P297, DOI 10.1016/j.prevetmed.2010.04.006; Bos MEH, 2009, PREV VET MED, V88, P278, DOI 10.1016/j.prevetmed.2008.12.003; Bos MEH, 2008, VACCINE, V26, P6322, DOI 10.1016/j.vaccine.2008.09.022; Bouma A, 2009, PLOS PATHOG, V5, P554; Capua I, 2000, AVIAN PATHOL, V29, P537, DOI 10.1080/03079450020016779; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Comin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026935; Conlan AJK, 2011, J R SOC INTERFACE, V8, P1720, DOI 10.1098/rsif.2011.0125; de Jong M, 1995, EPIDEMIC MODELS THEI, P84; Defra, 2008, EP REP HIGHL PATH AV; Garske T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000349; Gonzales JL, 2011, VET MICROBIOL, V152, P187, DOI 10.1016/j.vetmic.2011.04.022; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Mannelli A, 2007, PREV VET MED, V81, P318, DOI 10.1016/j.prevetmed.2007.04.017; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; Mutinelli E, 2003, AVIAN DIS, V47, P844, DOI 10.1637/0005-2086-47.s3.844; Rice J., 1995, MATH STAT DATA ANAL; Slomka MJ, 2010, AVIAN DIS, V54, P591, DOI 10.1637/8947-052909-Reg.1; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067	23	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45059	10.1371/journal.pone.0045059	http://dx.doi.org/10.1371/journal.pone.0045059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028760	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900073
J	Cavalier, MC; Yim, YS; Asamizu, S; Neau, D; Almabruk, KH; Mahmud, T; Lee, YH				Cavalier, Michael C.; Yim, Young-Sun; Asamizu, Shumpei; Neau, David; Almabruk, Khaled H.; Mahmud, Taifo; Lee, Yong-Hwan			Mechanistic Insights into Validoxylamine A 7 '-Phosphate Synthesis by VldE Using the Structure of the Entire Product Complex	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; TREHALOSE SYNTHESIS; CRYSTAL-STRUCTURE; SYNTHASE; VALIDAMYCIN; GLUCOSYLTRANSFERASE; ANTIBIOTICS; REFINEMENT; GLUCOSE; FAMILY	The pseudo-glycosyltransferase VldE catalyzes non-glycosidic C-N coupling between an unsaturated cyclitol and a saturated aminocyclitol with the conservation of the stereochemical configuration of the substrates to form validoxylamine A 7'-phosphate, the biosynthetic precursor of the antibiotic validamycin A. To study the molecular basis of its mechanism, the three-dimensional structures of VldE from Streptomyces hygroscopicus subsp. limoneus was determined in apo form, in complex with GDP, in complex with GDP and validoxylamine A 7'-phosphate, and in complex with GDP and trehalose. The structure of VldE with the catalytic site in both an "open'' and "closed'' conformation is also described. With these structures, the preferred binding of the guanine moiety by VldE, rather than the uracil moiety as seen in OtsA could be explained. The elucidation of the VldE structure in complex with the entirety of its products provides insight into the internal return mechanism by which catalysis occurs with a net retention of the stereochemical configuration of the donated cyclitol.	[Cavalier, Michael C.; Yim, Young-Sun; Lee, Yong-Hwan] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Asamizu, Shumpei; Almabruk, Khaled H.; Mahmud, Taifo] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Neau, David] Cornell Univ, NE CAT, Argonne, IL USA	Louisiana State University System; Louisiana State University; Oregon State University; Cornell University	Cavalier, MC (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	yhlee@lsu.edu	Asamizu, Shumpei/GOJ-8839-2022; Mahmud, Taifo/A-1492-2015	Asamizu, Shumpei/0000-0002-7178-5410; Mahmud, Taifo/0000-0001-9639-526X; Cavalier, Michael/0000-0001-7336-1219	National Institutes of Health [R01 AI061528]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work at Oregon State University was supported by grants from the National Institutes of Health (R01 AI061528) (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2005, CCP4 NEWSLETTER CONT, P8; Asamizu S, 2011, J AM CHEM SOC, V133, P12124, DOI 10.1021/ja203574u; Bai L, 2006, CHEM BIOL, V13, P387, DOI 10.1016/j.chembiol.2006.02.002; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batt SM, 2010, J BIOL CHEM, V285, P37741, DOI 10.1074/jbc.M110.165407; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cropp TA, 2000, NAT BIOTECHNOL, V18, P980, DOI 10.1038/79479; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errey JC, 2010, ANGEW CHEM INT EDIT, V49, P1234, DOI 10.1002/anie.200905096; Flatt PM, 2007, NAT PROD REP, V24, P358, DOI 10.1039/b603816f; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Hansen SF, 2010, MOL BIOSYST, V6, P1773, DOI 10.1039/c000238k; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; IWASA T, 1971, J ANTIBIOT, V24, P107, DOI 10.7164/antibiotics.24.107; Iwasa T., 1970, J ANTIBIOT, V23, P595, DOI DOI 10.7164/ANTIBIOTICS.23.595; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kellogg BA, 1997, CURR OPIN CHEM BIOL, V1, P570, DOI 10.1016/S1367-5931(97)80054-3; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SS, 2011, NAT CHEM BIOL, V7, P631, DOI [10.1038/NCHEMBIO.628, 10.1038/nchembio.628]; Mahmud T, 2001, CHEM REC, V1, P300, DOI 10.1002/tcr.1015; Mahmud T, 2003, NAT PROD REP, V20, P137, DOI 10.1039/b205561a; Mahmud T, 2007, J NAT PROD, V70, P1384, DOI 10.1021/np070210q; Mahmud T, 2009, CURR OPIN CHEM BIOL, V13, P161, DOI 10.1016/j.cbpa.2009.02.030; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDaniel R, 1999, P NATL ACAD SCI USA, V96, P1846, DOI 10.1073/pnas.96.5.1846; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Parsonage D, 2010, BIOCHEMISTRY-US, V49, P8398, DOI 10.1021/bi100698n; Sanchez C, 2006, J IND MICROBIOL BIOT, V33, P560, DOI 10.1007/s10295-006-0092-5; Seo MJ, 2006, J MICROBIOL BIOTECHN, V16, P1311; Singh D, 2006, GENE, V376, P13, DOI 10.1016/j.gene.2005.12.035; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Thulasiram HV, 2006, J AM CHEM SOC, V128, P15819, DOI 10.1021/ja065573b; Tvaroska I, 2006, ACS SYM SER, V930, P285; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; VRIELINK A, 1994, EMBO J, V13, P3413, DOI 10.1002/j.1460-2075.1994.tb06646.x; Wehmeier UF, 2004, APPL MICROBIOL BIOT, V63, P613, DOI 10.1007/s00253-003-1477-2; Woo EJ, 2010, J MOL BIOL, V404, P247, DOI 10.1016/j.jmb.2010.09.056; XIA TH, 1986, SCI CHINA SER B, V29, P379; Xu H, 2008, J NAT PROD, V71, P1233, DOI 10.1021/np800185k; Zheng LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032033	54	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44934	10.1371/journal.pone.0044934	http://dx.doi.org/10.1371/journal.pone.0044934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028689	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700060
J	Comerford, I; Litchfield, W; Kara, E; McColl, SR				Comerford, Iain; Litchfield, Wendel; Kara, Ervin; McColl, Shaun R.			PI3K gamma Drives Priming and Survival of Autoreactive CD4(+) T Cells during Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; PHOSPHATIDYLINOSITOL 3-KINASE; CUTTING EDGE; RHEUMATOID-ARTHRITIS; MACROPHAGE-MIGRATION; EMBRYONIC LETHALITY; CHEMOKINE RECEPTORS; FACTOR-I	The class IB phosphoinositide 3-kinase gamma enzyme complex (PI3K gamma) functions in multiple signaling pathways involved in leukocyte activation and migration, making it an attractive target in complex human inflammatory diseases including MS. Here, using pik3cg(-/-) mice and a selective PI3K gamma inhibitor, we show that PI3K gamma promotes development of experimental autoimmune encephalomyelitis (EAE). In pik3cg(-/-) mice, EAE is markedly suppressed and fewer leukocytes including CD4(+) and CD8(+) T cells, granulocytes and mononuclear phagocytes infiltrate the CNS. CD4(+) T cell priming in secondary lymphoid organs is reduced in pik3cg(-/-) mice following immunisation. This is attributable to defects in DC migration concomitant with a failure of full T cell activation following TCR ligation in the absence of p110 gamma. Together, this results in suppressed autoreactive T cell responses in pik3cg(-/-) mice, with more CD4(+) T cells undergoing apoptosis and fewer cytokine-producing Th1 and Th17 cells in lymphoid organs and the CNS. When administered from onset of EAE, the orally active PI3K gamma inhibitor AS605240 caused inhibition and reversal of clinical disease, and demyelination and cellular pathology in the CNS was reduced. These results strongly suggest that inhibitors of PI3K gamma may be useful therapeutics for MS.	[Comerford, Iain; Litchfield, Wendel; Kara, Ervin; McColl, Shaun R.] Univ Adelaide, Sch Mol & Biomed Sci, Chemokine Biol Lab, Adelaide, SA, Australia	University of Adelaide	Comerford, I (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Chemokine Biol Lab, Adelaide, SA, Australia.	iain.comerford@adelaide.edu.au		Comerford, Iain/0000-0001-8753-4774	Multiple Sclerosis Research Australia	Multiple Sclerosis Research Australia	I.C. is the recipient of a fellowship from Multiple Sclerosis Research Australia (msra.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Barber DF, 2006, J IMMUNOL, V176, P589, DOI 10.4049/jimmunol.176.1.589; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Barbi J, 2008, BLOOD, V112, P3048, DOI 10.1182/blood-2008-02-135715; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Berod L, 2011, EUR J IMMUNOL, V41, P833, DOI 10.1002/eji.201040504; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Burman AC, 2007, BLOOD, V110, P1064, DOI 10.1182/blood-2006-12-063982; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Comerford I, 2010, BLOOD, V116, P4130, DOI 10.1182/blood-2010-01-264390; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Gollmer K, 2009, BLOOD, V114, P580, DOI 10.1182/blood-2009-01-200923; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gruen M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-63; Hawkins PT, 2007, SCIENCE, V318, P64, DOI 10.1126/science.1145420; Hayer S, 2009, FASEB J, V23, P4288, DOI 10.1096/fj.09-135160; Haylock-Jacobs S, 2011, J AUTOIMMUN, V36, P278, DOI 10.1016/j.jaut.2011.02.006; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Jones GE, 2003, EXP CELL RES, V290, P120, DOI 10.1016/S0014-4827(03)00318-5; Kobayashi N, 2011, P NATL ACAD SCI USA, V108, P5753, DOI 10.1073/pnas.1016430108; Kohler RE, 2008, BRAIN PATHOL, V18, P504, DOI 10.1111/j.1750-3639.2008.00154.x; Kohler RE, 2003, J IMMUNOL, V170, P6298, DOI 10.4049/jimmunol.170.12.6298; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Lim DH, 2009, AM J PHYSIOL-LUNG C, V296, pL210, DOI 10.1152/ajplung.90275.2008; Lim SY, 2010, INT J CLIN PRACT, V64, P637, DOI 10.1111/j.1742-1241.2009.02261.x; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Nanki T, 2000, J IMMUNOL, V164, P5010, DOI 10.4049/jimmunol.164.10.5010; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Okkenhaug K, 2002, SCIENCE, V297, P1031; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Reif K, 2004, J IMMUNOL, V173, P2236, DOI 10.4049/jimmunol.173.4.2236; Rodrigues DH, 2010, J NEUROIMMUNOL, V222, P90, DOI 10.1016/j.jneuroim.2010.02.016; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Rommel C, 2010, CURR TOP MICROBIOL, V346, P279, DOI 10.1007/82_2010_79; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Scott LJ, 2011, CNS DRUGS, V25, P673, DOI 10.2165/11207350-000000000-00000; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Smit MJ, 2003, BLOOD, V102, P1959, DOI 10.1182/blood-2002-12-3945; Smith DF, 2006, J LEUKOCYTE BIOL, V80, P1491, DOI 10.1189/jlb.0306227; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sporici R, 2010, EUR J IMMUNOL, V40, P2751, DOI 10.1002/eji.200939975; Steinman L, 2005, TRENDS IMMUNOL, V26, P565, DOI 10.1016/j.it.2005.08.014; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Swat W, 2006, BLOOD, V107, P2415, DOI 10.1182/blood-2005-08-3300; Thomas M, 2009, IMMUNOLOGY, V126, P413, DOI 10.1111/j.1365-2567.2008.02908.x; Thomas MS, 2008, J LEUKOCYTE BIOL, V84, P814, DOI 10.1189/jlb.0807561; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Webb LMC, 2005, J IMMUNOL, V175, P2783, DOI 10.4049/jimmunol.175.5.2783; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; Weiss-Haljiti C, 2004, J BIOL CHEM, V279, P43273, DOI 10.1074/jbc.M402924200; Williams O, 2010, CHEM BIOL, V17, P123, DOI 10.1016/j.chembiol.2010.01.010; Williams R, 2009, BIOCHEM SOC T, V37, P615, DOI 10.1042/BST0370615; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	61	14	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45095	10.1371/journal.pone.0045095	http://dx.doi.org/10.1371/journal.pone.0045095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028778	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700085
J	Fang, CC; Huang, JW; Shyu, RS; Yen, CJ; Shiao, CH; Chiang, CK; Hu, RH; Tsai, TJ				Fang, Cheng-Chung; Huang, Jenq-Wen; Shyu, Ren-Shi; Yen, Chung-Jen; Shiao, Cheng-Hsiang; Chiang, Chih-Kang; Hu, Rey-Heng; Tsai, Tun-Jun			Fibrin-Induced Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelial Cells as a Mechanism of Peritoneal Fibrosis: Effects of Pentoxifylline	PLOS ONE			English	Article							DIALYSIS PATIENTS; MORPHOLOGIC CHANGES; SCLEROSIS; MEMBRANE; PATHOGENESIS; GROWTH; PERMEABILITY; EXPRESSION; DIAGNOSIS; BIOLOGY	Excessive fibrin deposition in the peritoneum is thought to be involved in the development of encapsulating peritoneal sclerosis (EPS), an important cause of morbidity and mortality in peritoneal dialysis patients. We investigated fibrin-induced epithelial-to-mesenchymal transition (EMT) of peritoneal mesothelial cells (PMCs) as a possible mechanism of fibrin involvement in EPS. In vitro, fibrin overlay of PMCs altered their morphology; increased alpha-smooth muscle actin, fibronectin, fibroblast specific protein-1, and alpha(v)beta(3) integrin expression; and decreased cytokeratin 18 and E-cadherin expression. Fibrin overlay also increased focal adhesion kinase and Src kinase phosphorylation. Fibrin-induced changes were inhibited by treating the cells with alpha(v)beta(3) integrin antibody or pentoxifylline (PTX). In a rat model, intraperitoneal injection of Staphylococcus aureus and fibrinogen induced severe EPS features, which were attenuated by PTX treatment. PTX-treated rats also showed preserved peritoneal ultrafiltration function and lower concentrations of cytokines than the untreated rats. S. aureus- and fibrinogen-injected rats had higher percentage of cytokeratin-positive cells in the omentum fibrotic tissue than controls; this was also reduced by PTX treatment. Our results suggest that fibrin induces EMT of PMCs by engaging alpha(v)beta(3) integrin and activating associated kinases. Our EPS animal model showed that fibrin-induced EMT was involved in the pathogenesis of peritoneal fibrosis and was inhibited by PTX.	[Fang, Cheng-Chung] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Fang, Cheng-Chung; Huang, Jenq-Wen; Yen, Chung-Jen; Shiao, Cheng-Hsiang; Chiang, Chih-Kang; Hu, Rey-Heng; Tsai, Tun-Jun] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Fang, Cheng-Chung; Huang, Jenq-Wen; Yen, Chung-Jen; Chiang, Chih-Kang; Tsai, Tun-Jun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Shyu, Ren-Shi] Min Sheng Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Shiao, Cheng-Hsiang] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Hu, Rey-Heng] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Fang, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.	tjtsai@ntuh.gov.tw		YEN, CHUNG-JEN/0000-0001-5372-3657; HUANG, JENQ-WEN/0000-0001-8011-2317; CHIANG, CHIH-KANG/0000-0001-9021-4616; FANG, CHENG-CHUNG/0000-0001-5386-6674; TSAI, TUN-JUN/0000-0002-1666-8940; HU, REY-HENG/0000-0001-6709-031X	National Science Council [NSC92-2314-B-002-192, NSC93-2314-B-002-148]; Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Fund; Department of Medical Research in National Taiwan University Hospital	National Science Council(Ministry of Science and Technology, Taiwan); Ta-Tung Kidney Foundation; Mrs. Hsiu-Chin Lee Kidney Research Fund; Department of Medical Research in National Taiwan University Hospital	This study was supported by grants from the National Science Council NSC92-2314-B-002-192 and NSC93-2314-B-002-148, the Ta-Tung Kidney Foundation, the Mrs. Hsiu-Chin Lee Kidney Research Fund and by the Department of Medical Research in National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKharfy KM, 2000, SHOCK, V13, P346, DOI 10.1097/00024382-200005000-00002; Aroeira LS, 2005, AM J KIDNEY DIS, V46, P938, DOI 10.1053/j.ajkd.2005.08.011; Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Balasubramaniam G, 2009, NEPHROL DIAL TRANSPL, V24, P3209, DOI 10.1093/ndt/gfp008; Braun N, 2011, NEPHROL THER, V7, P162, DOI 10.1016/j.nephro.2010.12.011; De Vriese AS, 2001, PERITON DIALYSIS INT, V21, pS9; Del Paso G, 2005, INT J ARTIF ORGANS, V28, P135, DOI 10.1177/039139880502800209; del Peso G, 2008, KIDNEY INT, V73, pS26, DOI 10.1038/sj.ki.5002598; Dobbie JW, 1997, PERITON DIALYSIS INT, V17, P121; Fang CC, 2003, PERITON DIALYSIS INT, V23, P228; Fang CC, 2000, KIDNEY INT, V57, P2626, DOI 10.1046/j.1523-1755.2000.00123.x; Fang CC, 2006, AM J KIDNEY DIS, V48, P875, DOI 10.1053/j.ajkd.2006.07.026; Goedde M, 1997, PERITON DIALYSIS INT, V17, P162; Ha H, 2002, NEPHROLOGY, V7, P220, DOI 10.1046/j.1440-1797.2002.00122.x; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hendriks PMEM, 1997, PERITON DIALYSIS INT, V17, P136; Hoff CM, 2005, PERITON DIALYSIS INT, V25, pS57; Holmdahl L, 1999, LANCET, V353, P1456, DOI 10.1016/S0140-6736(99)90061-2; Honda K, 2005, PERITON DIALYSIS INT, V25, pS19; Hung KY, 2003, NEPHROL DIAL TRANSPL, V18, P670, DOI 10.1093/ndt/gfg141; Io H, 2004, KIDNEY INT, V65, P1927, DOI 10.1111/j.1523-1755.2004.00599.x; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kawaguchi Y, 2000, PERITON DIALYSIS INT, V20, pS43; Kawanishi H, 2005, INT J ARTIF ORGANS, V28, P150, DOI 10.1177/039139880502800211; Kawanishi H, 2004, AM J KIDNEY DIS, V44, P729, DOI 10.1053/j.ajkd.2004.06.020; Krediet RT, 1999, KIDNEY INT, V55, P341, DOI 10.1046/j.1523-1755.1999.00264.x; KREDIET RT, 1989, AM J KIDNEY DIS, V13, P299, DOI 10.1016/S0272-6386(89)80036-8; Krediet RT, 2000, PERITON DIALYSIS INT, V20, pS19; Lambie ML, 2010, KIDNEY INT, V78, P611, DOI 10.1038/ki.2010.186; Mandl-Weber S, 2001, AM J KIDNEY DIS, V37, P815, DOI 10.1016/S0272-6386(01)80131-1; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Margetts PJ, 2002, J AM SOC NEPHROL, V13, P2787, DOI 10.1681/ASN.V13112787; Margetts PJ, 2002, AM J PATHOL, V160, P2285, DOI 10.1016/S0002-9440(10)61176-5; Ng YY, 2009, AM J NEPHROL, V29, P43, DOI 10.1159/000150600; Park SH, 2008, PERITON DIALYSIS INT, V28, pS21; Polubinska A, 2000, KIDNEY INT, V57, P1182, DOI 10.1046/j.1523-1755.2000.00946.x; Reijnen MMPJ, 2003, BRIT J SURG, V90, P533, DOI 10.1002/bjs.4141; SAMLASKA CP, 1994, J AM ACAD DERMATOL, V30, P603, DOI 10.1016/S0190-9622(94)70069-9; WHAWELL SA, 1995, EUR J SURG, V161, P315; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Williams JD, 2003, KIDNEY INT, V64, pS43, DOI 10.1046/j.1523-1755.2003.08805.x; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809	42	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44765	10.1371/journal.pone.0044765	http://dx.doi.org/10.1371/journal.pone.0044765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028611	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700035
J	Hebar, A; Rutgen, BC; Selzer, E				Hebar, Alexandra; Ruetgen, Barbara C.; Selzer, Edgar			NVX-412, a New Oncology Drug Candidate, Induces S-Phase Arrest and DNA Damage in Cancer Cells in a p53-Independent Manner	PLOS ONE			English	Article							BREAST-CANCER; REPLICATION FORKS; GENE-EXPRESSION; TP53 MUTATION; P53 PATHWAY; LINE; LEUKEMIA; ESTABLISHMENT; LYMPHOMA; TOPOISOMERASE	The new molecular entity quinoxalinhydrazide derivative NVX-412 was identified as a promising drug candidate for the treatment of various cancer types due to its strong cytotoxic activity and relative specificity. Here, we provide first data about the mechanisms of action of NVX-412. We show that NVX-412 exerts its anti-neoplastic activity in a p53-independent manner and induces S-phase arrest and DNA damage as assessed by gamma H2AX staining. We suggest a bi-modal (dose-dependent) mode of action of NVX-412, being primarily cytostatic at lower and predominantly cytotoxic at higher concentrations. Based on the broad and consistent anti-neoplastic activity observed, NVX-412 holds promise as an effective drug candidate for the treatment of various cancer types, especially for hematological malignancies with highly unmet medical need.	[Hebar, Alexandra; Selzer, Edgar] Med Univ Vienna, Dept Radiat Oncol, Vienna, Austria; [Ruetgen, Barbara C.] Univ Vet Med Vienna, Dept Pathobiol, Inst Immunol, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna	Hebar, A (corresponding author), Med Univ Vienna, Dept Radiat Oncol, Vienna, Austria.	edgar.selzer@meduniwien.ac.at	Selzer, Edgar K/K-7547-2015; Rütgen, Barbara/ADM-6510-2022					Aakeroy CB, 2007, MOL PHARMACEUT, V4, P317, DOI 10.1021/mp060126o; Andersson A, 2005, LEUKEMIA, V19, P1042, DOI 10.1038/sj.leu.2403749; [Anonymous], 2022, TABLES 84F0209X MORT; Arya AK, 2010, BRIT J CANCER, V103, P186, DOI 10.1038/sj.bjc.6605739; AVEMANN K, 1988, MOL CELL BIOL, V8, P3026, DOI 10.1128/MCB.8.8.3026; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Dolstra H, 1999, J EXP MED, V189, P301, DOI 10.1084/jem.189.2.301; Dolznig H, 2004, NAT CELL BIOL, V6, P899, DOI 10.1038/ncb1166; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; FURLEY AJ, 1986, BLOOD, V68, P1101; Gasco M, 2003, DRUG RESIST UPDATE, V6, P323, DOI 10.1016/j.drup.2003.11.001; Goto H., 2012, CANC SCI; Grande F, 2007, BIOORGAN MED CHEM, V15, P288, DOI 10.1016/j.bmc.2006.09.073; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Kandioler-Eckersberger D, 2000, CLIN CANCER RES, V6, P50; Kisseberth WC, 2007, LEUKEMIA RES, V31, P1709, DOI 10.1016/j.leukres.2007.04.003; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Lamore SD, 2012, PHOTOCH PHOTOBIO SCI, V11, P163, DOI 10.1039/c1pp05131h; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu ML, 2001, LEUKEMIA RES, V25, P441, DOI 10.1016/S0145-2126(00)00148-X; Momoi Y, 1997, VET IMMUNOL IMMUNOP, V59, P11, DOI 10.1016/S0165-2427(97)00053-6; Nakaichi M, 1996, J VET MED SCI, V58, P469, DOI 10.1292/jvms.58.469; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Reyes-Reyes EM, 2010, CANCER RES, V70, P8617, DOI 10.1158/0008-5472.CAN-10-0920; Rucker FG, 2006, LEUKEMIA, V20, P994, DOI 10.1038/sj.leu.2404235; Rutgen BC, 2010, LEUKEMIA RES, V34, P932, DOI 10.1016/j.leukres.2010.01.021; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200	36	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45015	10.1371/journal.pone.0045015	http://dx.doi.org/10.1371/journal.pone.0045015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028738	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700077
J	Schmiegelow, C; Scheike, T; Oesterholt, M; Minja, D; Pehrson, C; Magistrado, P; Lemnge, M; Rasch, V; Lusingu, J; Theander, TG; Nielsen, BB				Schmiegelow, Christentze; Scheike, Thomas; Oesterholt, Mayke; Minja, Daniel; Pehrson, Caroline; Magistrado, Pamela; Lemnge, Martha; Rasch, Vibeke; Lusingu, John; Theander, Thor G.; Nielsen, Birgitte Bruun			Development of a Fetal Weight Chart Using Serial Trans-Abdominal Ultrasound in an East African Population: A Longitudinal Observational Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; BIRTH-WEIGHT; GESTATIONAL-AGE; PERINATAL-MORTALITY; INFANTS BORN; PREGNANCY; STANDARDS; RESTRICTION; PERCENTILES; MATTER	Objective: To produce a fetal weight chart representative of a Tanzanian population, and compare it to weight charts from Sub-Saharan Africa and the developed world. Methods: A longitudinal observational study in Northeastern Tanzania. Pregnant women were followed throughout pregnancy with serial trans-abdominal ultrasound. All pregnancies with pathology were excluded and a chart representing the optimal growth potential was developed using fetal weights and birth weights. The weight chart was compared to a chart from Congo, a chart representing a white population, and a chart representing a white population but adapted to the study population. The prevalence of SGA was assessed using all four charts. Results: A total of 2193 weight measurements from 583 fetuses/newborns were included in the fetal weight chart. Our chart had lower percentiles than all the other charts. Most importantly, in the end of pregnancy, the 10th percentiles deviated substantially causing an overestimation of the true prevalence of SGA newborns if our chart had not been used. Conclusions: We developed a weight chart representative for a Tanzanian population and provide evidence for the necessity of developing regional specific weight charts for correct identification of SGA. Our weight chart is an important tool that can be used for clinical risk assessments of newborns and for evaluating the effect of intrauterine exposures on fetal and newborn weight.	[Schmiegelow, Christentze; Minja, Daniel; Pehrson, Caroline; Magistrado, Pamela; Lusingu, John; Theander, Thor G.] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Schmiegelow, Christentze; Minja, Daniel; Pehrson, Caroline; Magistrado, Pamela; Lusingu, John; Theander, Thor G.] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Scheike, Thomas] Univ Copenhagen, Inst Publ Hlth, Dept Biostat, Copenhagen, Denmark; [Oesterholt, Mayke] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Minja, Daniel; Magistrado, Pamela; Lemnge, Martha; Lusingu, John] Natl Inst Med Res, Tanga Med Res Ctr, Tanga, Tanzania; [Pehrson, Caroline] Odense Univ Hosp, Dept Clin Pathol, DK-5000 Odense, Denmark; [Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, DK-5000 Odense, Denmark; [Nielsen, Birgitte Bruun] Aarhus Univ Hosp, Dept Obstet & Gynecol, Skejby, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Radboud University Nijmegen; National Institute of Medical Research; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Aarhus University	Schmiegelow, C (corresponding author), Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark.	christentzes@yahoo.dk	Theander, Thor/F-6714-2015; Lusingu, John P. A./GSJ-3228-2022; Rasch, Vibeke/G-9393-2019	Theander, Thor/0000-0002-3509-7514; Rasch, Vibeke/0000-0001-6557-0985; Lusingu, John P. A./0000-0002-9407-0602; Pehrson, Caroline/0000-0002-5736-4847; Scheike, Thomas/0000-0002-2148-4740; shmiegelow, christentze/0000-0002-9360-9741	European Union Framework 7 (STOPPAM, Tanzania) [200889]; Copenhagen University PhD school	European Union Framework 7 (STOPPAM, Tanzania); Copenhagen University PhD school	This study was funded by European Union Framework 7 (STOPPAM, Tanzania) (contract number 200889 and URL: http://cordis.europa.eu/fp7/capacities/research-sme_en.html) and by the Copenhagen University PhD school (URL: http://healthsciences.ku.dk/phd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYANGADE SO, 1986, INT J GYNECOL OBSTET, V24, P35, DOI 10.1016/0020-7292(86)90021-4; Bernstein I M, 1996, J Matern Fetal Med, V5, P124; Bernstein PS, 1997, CLIN OBSTET GYNECOL, V40, P723, DOI 10.1097/00003081-199712000-00006; BOERSMA ER, 1979, TROP GEOGR MED, V31, P7; BROMLEY B, 1993, ULTRASOUND OBST GYN, V3, P395, DOI 10.1046/j.1469-0705.1993.03060395.x; Castetbon K, 1999, J TROP PEDIATRICS, V45, P152, DOI 10.1093/tropej/45.3.152; CHITTY LS, 1994, BRIT J OBSTET GYNAEC, V101, P35, DOI 10.1111/j.1471-0528.1994.tb13007.x; Cisse R, 2000, Sante, V10, P169; Clausson B, 2001, BRIT J OBSTET GYNAEC, V108, P830, DOI 10.1111/j.1471-0528.2001.00205.x; de Jong CLD, 1999, ULTRASOUND OBST GYN, V13, P86, DOI 10.1046/j.1469-0705.1999.13020086.x; Fan J., 1996, LOCAL POLYNOMIAL MOD; Fry A G, 2002, J Matern Fetal Neonatal Med, V12, P247, DOI 10.1080/jmf.12.4.247.252; Gaillard R, 2011, EUR J EPIDEMIOL, V26, P919, DOI 10.1007/s10654-011-9629-7; GARDOSI J, 1995, ULTRASOUND OBST GYN, V6, P168, DOI 10.1046/j.1469-0705.1995.06030168.x; Graafmans WC, 2002, EPIDEMIOLOGY, V13, P569, DOI 10.1097/00001648-200209000-00013; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021; HADLOCK FP, 1992, RADIOLOGY, V182, P501, DOI 10.1148/radiology.182.2.1732970; Hendrix N, 2008, SEMIN PERINATOL, V32, P161, DOI 10.1053/j.semperi.2008.02.004; Hutcheon JA, 2008, BJOG-INT J OBSTET GY, V115, P1397, DOI 10.1111/j.1471-0528.2008.01870.x; Jacquemyn Y, 2000, EARLY HUM DEV, V57, P1, DOI 10.1016/S0378-3782(99)00049-3; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Landis SH, 2009, ULTRASOUND OBST GYN, V34, P379, DOI 10.1002/uog.6357; Mahajan S, 2008, BRIT J NUTR, V100, P408, DOI 10.1017/S000711450889438X; Merialdi M, 2005, ULTRASOUND OBST GYN, V26, P123, DOI 10.1002/uog.1954; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Mirghani HM, 2005, J OBSTET GYNAECOL RE, V31, P409, DOI 10.1111/j.1447-0756.2005.00311.x; Mongelli M, 1996, ACTA OBSTET GYN SCAN, V75, P28, DOI 10.3109/00016349609033279; Nahum GG, 2003, AM J OBSTET GYNECOL, V188, P566, DOI 10.1067/mob.2003.155; Narchi H, 2010, J MATERN-FETAL NEO M, V23, P48, DOI 10.3109/14767050903067352; National Bureau of Statistics Tanga Regional Commissioners office, 2008, TANG REG SOC PROF; Odibo AO, 2011, J MATERN-FETAL NEO M, V24, P411, DOI 10.3109/14767058.2010.506566; Ott WJ, 2006, CLIN OBSTET GYNECOL, V49, P295, DOI 10.1097/00003081-200606000-00011; OTT WJ, 1993, AM J OBSTET GYNECOL, V168, P1710, DOI 10.1016/0002-9378(93)90681-8; Overpeck MD, 1999, OBSTET GYNECOL, V93, P943, DOI 10.1016/S0029-7844(98)00553-5; Owen P, 1996, BRIT J OBSTET GYNAEC, V103, P60, DOI 10.1111/j.1471-0528.1996.tb09516.x; Raman S, 1996, INT J GYNECOL OBSTET, V54, P143, DOI 10.1016/0020-7292(96)02685-9; Rijken MJ, 2011, BJOG-INT J OBSTET GY, V118, P671, DOI 10.1111/j.1471-0528.2010.02880.x; Salomon LJ, 2007, ULTRASOUND OBST GYN, V29, P550, DOI 10.1002/uog.4019; Salpou Daniel, 2008, BMC Pregnancy Childbirth, V8, P48, DOI 10.1186/1471-2393-8-48; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Verhoeff FH, 2001, EUR J CLIN NUTR, V55, P682, DOI 10.1038/sj.ejcn.1601200; Zaw W, 2003, PEDIATRICS, V111, P1273, DOI 10.1542/peds.111.6.1273; Zhang J, 2011, AM J EPIDEMIOL, V173, P539, DOI 10.1093/aje/kwq411; Zhang J, 2010, AM J OBSTET GYNECOL, V202, P522, DOI 10.1016/j.ajog.2009.10.889; Zhang X, 2007, BJOG-INT J OBSTET GY, V114, P474, DOI 10.1111/j.1471-0528.2007.01273.x	46	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44773	10.1371/journal.pone.0044773	http://dx.doi.org/10.1371/journal.pone.0044773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028617	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800017
J	Wilbers, L; Deuker, L; Fell, J; Axmacher, N				Wilbers, Linda; Deuker, Lorena; Fell, Juergen; Axmacher, Nikolai			Are Autobiographical Memories Inherently Social? Evidence from an fMRI Study	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; BRAIN; SELF; CONSTRUCTION; METAANALYSIS; ACTIVATION; RETRIEVAL; NETWORK; MIND; MRI	The story of our lifetime - our narrative self - is constructed from our autobiographical memories. A central claim of social psychology is that this narrative self is inherently social: When we construct our lives, we do so in a real or imagined interaction. This predicts that self-referential processes which are involved in recall of autobiographical memories overlap with processes involved in social interactions. Indeed, previous functional MRI studies indicate that regions in the medial prefrontal cortex (mPFC) are activated during autobiographical memory recall and virtual communication. However, no fMRI study has investigated recall of autobiographical memories in a real-life interaction. We developed a novel paradigm in which participants overtly reported self-related and other-related memories to an experimenter, whose non-verbal reactions were being filmed and online displayed to the participants in the scanner. We found that recall of autobiographical vs. non-autobiographical memories was associated with activation of the mPFC, as was recall in the social as compared to a non-social control condition; however, both contrasts involved different non-overlapping regions within the mPFC. These results indicate that self-referential processes involved in autobiographical memory recall are different from processes supporting social interactions, and argue against the hypothesis that autobiographical memories are inherently social.	[Wilbers, Linda; Deuker, Lorena; Fell, Juergen; Axmacher, Nikolai] Univ Bonn, Dept Epileptol, Bonn, Germany; [Axmacher, Nikolai] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Axmacher, N (corresponding author), Univ Bonn, Dept Epileptol, Bonn, Germany.	nikolai.axmacher@ukb.uni-bonn.de		Deuker, Lorena/0000-0002-4939-5862; Axmacher, Nikolai/0000-0002-0475-6492	BONFOR dissertation stipend (University of Bonn); German Research foundation (DFG) [AX 82-1/2]; Emmy Noether grant of the German Research foundation (DFG)	BONFOR dissertation stipend (University of Bonn); German Research foundation (DFG)(German Research Foundation (DFG)); Emmy Noether grant of the German Research foundation (DFG)	LW received a BONFOR dissertation stipend (University of Bonn). LD was supported by the German Research foundation (DFG) grant AX 82-1/2. NA was supported by an Emmy Noether grant of the German Research foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, BRAIN, V130, P2327, DOI 10.1093/brain/awm166; [Anonymous], 1983, CANADIAN PSYCHOL; Axmacher N, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00211; Beike DR, 2004, STUDIES SELF IDENTIT; Bluck S, 2003, MEMORY, V11, P113, DOI 10.1080/741938206; Bluck S., 2008, SELF CONTINUITY INDI, P55, DOI DOI 10.4324/9780203888513; Cabeza R, 2004, J COGNITIVE NEUROSCI, V16, P1583, DOI 10.1162/0898929042568578; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Damasio A.R., 2000, FEELING WHAT HAPPENS; Frith C, 2005, CURR BIOL, V15, pR644, DOI 10.1016/j.cub.2005.08.041; Halbwachs M., 1992, COLLECTIVE MEMORY; Levine B, 2004, J COGNITIVE NEUROSCI, V16, P1633, DOI 10.1162/0898929042568587; Maguire EA, 1999, HIPPOCAMPUS, V9, P54, DOI 10.1002/(SICI)1098-1063(1999)9:1<54::AID-HIPO6>3.0.CO;2-O; Nelson K, 2003, MEMORY, V11, P125, DOI 10.1080/741938203; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Noulhiane M, 2007, BRAIN, V130, P3184, DOI 10.1093/brain/awm258; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Sassa Y, 2007, NEUROIMAGE, V37, P985, DOI 10.1016/j.neuroimage.2007.05.059; Saxe R, 2006, SOC COGN AFFECT NEUR, V1, P229, DOI 10.1093/scan/nsl034; St-Laurent M, 2011, HIPPOCAMPUS, V21, P409, DOI 10.1002/hipo.20757; Summerfield JJ, 2009, NEUROIMAGE, V44, P1188, DOI 10.1016/j.neuroimage.2008.09.033; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Viard A, 2007, CEREB CORTEX, V17, P2453, DOI 10.1093/cercor/bhl153; Welzer H., 2002, KOMMUNIKATIVE GEDACH; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	27	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45089	10.1371/journal.pone.0045089	http://dx.doi.org/10.1371/journal.pone.0045089			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028774	Green Published, Green Submitted, gold			2022-12-27	WOS:000309392800025
J	Janko, K; Kotusz, J; De Gelas, K; Slechtova, V; Opoldusova, Z; Drozd, P; Choleva, L; Popiolek, M; Balaz, M				Janko, Karel; Kotusz, Jan; De Gelas, Koen; Slechtova, Vera; Opoldusova, Zuzana; Drozd, Pavel; Choleva, Lukas; Popiolek, Marcin; Balaz, Marian			Dynamic Formation of Asexual Diploid and Polyploid Lineages: Multilocus Analysis of Cobitis Reveals the Mechanisms Maintaining the Diversity of Clones	PLOS ONE			English	Article							SPINED LOACHES COBITIS; MONOPHYLETIC ORIGIN; COMPUTER-PROGRAM; HYBRID ORIGIN; TELL US; TAENIA; TELEOSTEI; GENETICS; AGE; CLONALITY	Given the hybrid genomic constitutions and increased ploidy of many asexual animals, the identification of processes governing the origin and maintenance of clonal diversity provides useful information about the evolutionary consequences of interspecific hybridization, asexuality and polyploidy. In order to understand the processes driving observed diversity of biotypes and clones in the Cobitis taenia hybrid complex, we performed fine-scale genetic analysis of Central European hybrid zone between two sexual species using microsatellite genotyping and mtDNA sequencing. We found that the hybrid zone is populated by an assemblage of clonally (gynogenetically) reproducing di-, tri- and tetraploid hybrid lineages and that successful clones, which are able of spatial expansion, recruit from two ploidy levels, i.e. diploid and triploid. We further compared the distribution of observed estimates of clonal ages to theoretical distributions simulated under various assumptions and showed that new clones are most likely continuously recruited from ancestral populations. This suggests that the clonal diversity is maintained by dynamic equilibrium between origination and extinction of clonal lineages. On the other hand, an interclonal selection is implied by nonrandom spatial distribution of individual clones with respect to the coexisting sexual species. Importantly, there was no evidence for sexually reproducing hybrids or clonally reproducing non-hybrid forms. Together with previous successful laboratory synthesis of clonal Cobitis hybrids, our data thus provide the most compelling evidence that 1) the origin of asexuality is causally linked to interspecific hybridization; 2) successful establishment of clones is not restricted to one specific ploidy level and 3) the initiation of clonality and polyploidy may be dynamic and continuous in asexual complexes.	[Kotusz, Jan] Univ Wroclaw, Museum Nat Hist, Fac Biol Sci, PL-50138 Wroclaw, Poland; [Janko, Karel; Slechtova, Vera; Opoldusova, Zuzana; Choleva, Lukas; Balaz, Marian] AS CR, Lab Fish Genet, Dept Vertebrate Evolutionary Biol & Genet, Inst Anim Physiol & Genet,Vvi, Libechov, Czech Republic; [De Gelas, Koen] Res Inst Nat & Forest INBO, Brussels, Belgium; [De Gelas, Koen] KU Leuven Res & Dev, Biogen, Louvain, Belgium; [Drozd, Pavel] Univ Ostrava, Fac Nat Sci, CZ-70103 Ostrava, Czech Republic; [Popiolek, Marcin] Wroclaw Univ Environm & Life Sci, Dept Invertebrate Systemat & Ecol, Inst Biol, Wroclaw, Poland; [Janko, Karel] Univ Ostrava, Dept Biol & Ecol, Fac Nat Sci, Life Sci Res Ctr, CZ-70103 Ostrava, Czech Republic	University of Wroclaw; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Research Institute for Nature & Forest; KU Leuven; University of Ostrava; Wroclaw University of Environmental & Life Sciences; University of Ostrava	Kotusz, J (corresponding author), Univ Wroclaw, Museum Nat Hist, Fac Biol Sci, PL-50138 Wroclaw, Poland.	kotusz@biol.uni.wroc.pl	Slechtova, Vera/G-7190-2014; Popiolek, Marcin/B-1594-2017; Janko, Karel/G-7183-2014; Choleva, Lukas/G-7182-2014; Drozd, Pavel/J-3943-2013	Popiolek, Marcin/0000-0001-9123-1709; Drozd, Pavel/0000-0002-4602-8856; Kotusz, Jan/0000-0001-6229-7610	Grant Agency of the Czech Republic [206/09/1298]; Academy of Sciences of the Czech Republic [IRP IAPG AV0Z 50450515]; University of Wroclaw, Poland [10/19/S/MP]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); University of Wroclaw, Poland	The Grant Agency of the Czech Republic provided support with grant no. 206/09/1298. Further support was provided by the Academy of Sciences of the Czech Republic Grant IRP IAPG AV0Z 50450515 and University of Wroclaw, Poland by grant no. 10/19/S/MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2002, GENETICS, V160, P1217; Angers B, 2007, MOL ECOL, V16, P4562, DOI 10.1111/j.1365-294X.2007.03511.x; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Balloux F, 2003, GENETICS, V164, P1635; Beukeboom LW, 1998, J EVOLUTION BIOL, V11, P755, DOI 10.1007/s000360050117; Boron A, 2003, FOLIA BIOL-KRAKOW, V51, P49; Butlin RK, 1999, J EVOLUTION BIOL, V12, P1020; Choleva L, 2008, PHILOS T R SOC B, V363, P2911, DOI 10.1098/rstb.2008.0059; Choleva L, 2012, EVOLUTION, V66, P2191, DOI 10.1111/j.1558-5646.2012.01589.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corley LS, 1999, P ROY SOC B-BIOL SCI, V266, P471, DOI 10.1098/rspb.1999.0661; Culling MA, 2006, MOL ECOL, V15, P173, DOI 10.1111/j.1365-294X.2005.02790.X; D'Souza TG, 2005, BIOL J LINN SOC, V85, P191, DOI 10.1111/j.1095-8312.2005.00482.x; De Gelas K, 2008, MOL ECOL RESOUR, V8, P1001, DOI 10.1111/j.1755-0998.2008.02135.x; Douhovnikoff V, 2003, THEOR APPL GENET, V106, P1307, DOI 10.1007/s00122-003-1200-9; Grimanelli D, 2001, TRENDS GENET, V17, P597, DOI 10.1016/S0168-9525(01)02454-4; Guldbrandtsen B, 2000, J HERED, V91, P178, DOI 10.1093/jhered/91.2.178; Hakoyama H, 2001, BIOL J LINN SOC, V72, P401, DOI [10.1006/bjil.2000.0507, 10.1111/j.1095-8312.2001.tb01326.x]; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Chavez CH, 2007, MOL ECOL, V16, P1467, DOI 10.1111/j.1365-294X.2007.03239.x; HOTZ H, 1985, J EXP ZOOL, V236, P199, DOI 10.1002/jez.1402360210; Janko K, 2007, J FISH BIOL, V71, P387, DOI 10.1111/j.1095-8649.2007.01663.x; Janko K, 2005, FOLIA ZOOL, V54, P405; Janko K, 2005, MOL ECOL, V14, P2991, DOI 10.1111/j.1365-294X.2005.02583.x; Janko K, 2003, J EVOLUTION BIOL, V16, P1280, DOI 10.1046/j.1420-9101.2003.00627.x; Janko K, 2008, EVOLUTION, V62, P1264, DOI 10.1111/j.1558-5646.2008.00359.x; Janko K, 2007, GENETICA, V131, P185, DOI 10.1007/s10709-006-9130-5; Janko K, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-17; Johnson SG, 1999, J EVOLUTION BIOL, V12, P1056; Juchno D, 2007, J FISH BIOL, V70, P1392, DOI 10.1111/j.1095-8649.2007.01419.x; Kearney M, 2009, LOST SEX: THE EVOLUTIONARY BIOLOGY OF PARTHENOGENESIS, P447, DOI 10.1007/978-90-481-2770-2_21; King KC, 2011, EVOLUTION, V65, P1474, DOI 10.1111/j.1558-5646.2010.01215.x; Kotusz J, 2008, ANN ZOOL, V58, P891, DOI 10.3161/000345408X396800; KRAUS F, 1990, P NATL ACAD SCI USA, V87, P2235, DOI 10.1073/pnas.87.6.2235; Lampert KP, 2005, EVOLUTION, V59, P881; Law JH, 2002, EVOLUTION, V56, P1711, DOI 10.1111/j.0014-3820.2002.tb01484.x; Little TJ, 1996, TRENDS ECOL EVOL, V11, P296, DOI 10.1016/S0169-5347(96)91640-7; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Maciak S, 2011, FUNCT ECOL, V25, P1072, DOI 10.1111/j.1365-2435.2011.01870.x; MARTENS K, 2009, ELUSIVE CLONE SEARCH, P187, DOI DOI 10.1007/978-90-481-2770-2_9; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; MORITZ C, 1992, EVOLUTION, V46, P184, DOI 10.1111/j.1558-5646.1992.tb01993.x; Moritz C. C., 1989, EVOLUTION ECOLOGY UN, P87; NEIGEL JE, 1991, EVOLUTION, V45, P423, DOI [10.1111/j.1558-5646.1991.tb04415.x, 10.2307/2409675]; Neiman M, 2009, ANN NY ACAD SCI, V1168, P185, DOI 10.1111/j.1749-6632.2009.04572.x; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Pantel JH, 2011, J EVOLUTION BIOL, V24, P723, DOI 10.1111/j.1420-9101.2010.02196.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Polihronakis M, 2010, BIOL J LINN SOC, V101, P935, DOI 10.1111/j.1095-8312.2010.01542.x; Rogstad SH, 2002, PLANT ECOL, V161, P111, DOI 10.1023/A:1020301011283; Saat TV, 1991, SOVIET J DEV BIOL, V22, P332; Schwander T, 2009, MOL ECOL, V18, P28, DOI 10.1111/j.1365-294X.2008.03992.x; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Sinclair EA, 2010, EVOLUTION, V64, P1346, DOI 10.1111/j.1558-5646.2009.00893.x; Sousa-Santos C, 2006, J FISH BIOL, V68, P292, DOI 10.1111/j.0022-1112.2006.01081.x; Stock M, 2010, MOL ECOL, V19, P5204, DOI 10.1111/j.1365-294X.2010.04869.x; TEMPLETON AR, 1992, GENETICS, V132, P619; TOMIUK J, 1991, EVOLUTION, V45, P1685, DOI 10.1111/j.1558-5646.1991.tb02673.x; Vasil'ev V P, 2007, Dokl Biol Sci, V416, P360, DOI 10.1134/S0012496607050109; Vasil'ev VP, 2003, FOLIA BIOL-KRAKOW, V51, P67; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Whitton J, 2008, INT J PLANT SCI, V169, P169, DOI 10.1086/523369; Yue GH, 2007, GENETICA, V129, P329, DOI 10.1007/s10709-006-0003-8	64	52	53	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45384	10.1371/journal.pone.0045384	http://dx.doi.org/10.1371/journal.pone.0045384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028977	Green Published, gold			2022-12-27	WOS:000309388900044
J	Tseng, HK; Liu, CP; Price, MS; Jong, AY; Chang, JC; Toffaletti, DL; Betancourt-Quiroz, M; Frazzitta, AE; Cho, WL; Perfect, JR				Tseng, Hsiang-Kuang; Liu, Chang-Pan; Price, Michael S.; Jong, Ambrose Y.; Chang, Jui-Chih; Toffaletti, Dena L.; Betancourt-Quiroz, Marisol; Frazzitta, Aubrey E.; Cho, Wen-Long; Perfect, John R.			Identification of Genes from the Fungal Pathogen Cryptococcus neoformans Related to Transmigration into the Central Nervous System	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; BLOOD-BRAIN-BARRIER; SACCHAROMYCES-CEREVISIAE; IN-VIVO; VIRULENCE; INFECTION; PROTEIN; UREASE; INVASION; YEAST	Background: A mouse brain transmigration assessment (MBTA) was created to investigate the central nervous system (CNS) pathogenesis of cryptococcal meningoencephalitis. Methodology/Principal Findings: Two cryptococcal mutants were identified from a pool of 109 pre-selected mutants that were signature-tagged with the nourseothricin acetyltransferase (NAT) resistance cassette. These two mutants displayed abnormal transmigration into the central nervous system. One mutant displaying decreased transmigration contains a null mutation in the putative FNX1 gene, whereas the other mutant possessing a null mutation in the putative RUB1 gene exhibited increased transmigration into the brain. Two macrophage adhesion-defective mutants in the pool, 12F1 and 3C9, showed reduced phagocytosis by macrophages, but displayed no defects in CNS entry suggesting that transit within macrophages (the "Trojan horse" model of CNS entry) is not the primary mechanism for C. neoformans migration into the CNS in this MBTA. Conclusions/Significance: This research design provides a new strategy for genetic impact studies on how Cryptococcus passes through the blood-brain barrier (BBB), and the specific isolated mutants in this assay support a transcellular mechanism of CNS entry.	[Tseng, Hsiang-Kuang; Liu, Chang-Pan; Cho, Wen-Long] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Tseng, Hsiang-Kuang] Mackay Mem Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan; [Price, Michael S.; Toffaletti, Dena L.; Betancourt-Quiroz, Marisol; Frazzitta, Aubrey E.; Perfect, John R.] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA; [Jong, Ambrose Y.] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Div Hematol Oncol,Saban Res Inst,Dept Pediat, Los Angeles, CA 90033 USA; [Chang, Jui-Chih] Buddhist Tzu Chi Gen Hosp, Div Thorac & Cardiovasc Surg, Hualien, Taiwan; [Tseng, Hsiang-Kuang; Cho, Wen-Long] Mackay Med Coll, Dept Med, New Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Duke University; Children's Hospital Los Angeles; University of Southern California; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Mackay Medical College	Cho, WL (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	wenlong@ym.edu.tw; perfe001@mc.duke.edu		Price, Michael/0000-0001-6022-328X; Betancourt Quiroz, Marisol/0000-0002-6920-9182	National Institutes of Health (NIH) PHS [AI73896, AI28388, NIH NS047599, NSC100-2314-B-195-006, NSC100-2320-B-010-011, NSC101-2320-B-010-073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI028388, R01AI073896, R01AI028388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599, R56NS047599] Funding Source: NIH RePORTER	National Institutes of Health (NIH) PHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) PHS grants AI73896, AI28388, NIH NS047599 and grants of NSC100-2314-B-195-006, NSC100-2320-B-010-011, and NSC101-2320-B-010-073. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 2003, CURR GENET, V42, P301, DOI 10.1007/s00294-002-0364-1; Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; BAVA AJ, 1993, J MED VET MYCOL, V31, P87; Chang YC, 2006, INFECT IMMUN, V74, P3930, DOI 10.1128/IAI.00089-06; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; Chardwiriyapreecha S, 2008, FEBS LETT, V582, P2225, DOI 10.1016/j.febslet.2008.05.017; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Chretien F, 2002, J INFECT DIS, V186, P522, DOI 10.1086/341564; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Del Poeta M, 1999, INFECT IMMUN, V67, P1812; Dimitrov K, 1998, MOL CELL BIOL, V18, P5239, DOI 10.1128/MCB.18.9.5239; Harrison TS, 2009, AIDS, V23, P531, DOI 10.1097/QAD.0b013e328322ffc3; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; Hull CM, 2004, INFECT IMMUN, V72, P3643, DOI 10.1128/IAI.72.6.3643-3645.2004; Jarvis JN, 2008, CURR OPIN INFECT DIS, V21, P596, DOI 10.1097/QCO.0b013e3283177f6c; Jong A, 2008, CELL MICROBIOL, V10, P1854, DOI 10.1111/j.1462-5822.2008.01172.x; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Jong A, 2007, EUKARYOT CELL, V6, P1486, DOI 10.1128/EC.00120-07; Jong A, 2012, J BIOL CHEM, V287, P15298, DOI 10.1074/jbc.M112.353375; Jong AY, 2007, BIOCHEM BIOPH RES CO, V356, P899, DOI 10.1016/j.bbrc.2007.03.100; Laplaza JM, 2004, BIOCHEM J, V377, P459, DOI 10.1042/BJ20030755; Lee A, 2010, INFECT IMMUN, V78, P4213, DOI 10.1128/IAI.00551-10; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Moyrand F, 2007, MOL MICROBIOL, V64, P771, DOI 10.1111/j.1365-2958.2007.05695.x; Mukherjee S, 1996, J INFECT DIS, V173, P1222, DOI 10.1093/infdis/173.5.1222; Okagaki LH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000953; Okagaki LH, 2011, EUKARYOT CELL, V10, P1306, DOI 10.1128/EC.05179-11; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2005, FEMS IMMUNOL MED MIC, V45, P395, DOI 10.1016/j.femsim.2005.06.005; Price MS, 2008, INFECT IMMUN, V76, P5729, DOI 10.1128/IAI.00896-08; RUANE PJ, 1988, J CLIN MICROBIOL, V26, P2224, DOI 10.1128/JCM.26.10.2224-2225.1988; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Velegraki A, 1999, MED MYCOL, V37, P69; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wormley FL, 2005, METH MOLEC MED, V118, P193	46	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45083	10.1371/journal.pone.0045083	http://dx.doi.org/10.1371/journal.pone.0045083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028773	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388900019
J	Berent, I; Vaknin-Nusbaum, V; Balaban, E; Galaburda, AM				Berent, Iris; Vaknin-Nusbaum, Vered; Balaban, Evan; Galaburda, Albert M.			Dyslexia Impairs Speech Recognition but Can Spare Phonological Competence	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; LANGUAGE IMPAIRMENT; PERCEPTION DEFICITS; NONSPEECH SOUNDS; BRAIN RESPONSES; CHILDREN; DISCRIMINATION; REPRESENTATIONS; IDENTIFICATION; DIFFICULTIES	Dyslexia is associated with numerous deficits to speech processing. Accordingly, a large literature asserts that dyslexics manifest a phonological deficit. Few studies, however, have assessed the phonological grammar of dyslexics, and none has distinguished a phonological deficit from a phonetic impairment. Here, we show that these two sources can be dissociated. Three experiments demonstrate that a group of adult dyslexics studied here is impaired in phonetic discrimination (e. g., ba vs. pa), and their deficit compromises even the basic ability to identify acoustic stimuli as human speech. Remarkably, the ability of these individuals to generalize grammatical phonological rules is intact. Like typical readers, these Hebrew-speaking dyslexics identified ill-formed AAB stems (e. g., titug) as less wordlike than well-formed ABB controls (e. g., gitut), and both groups automatically extended this rule to nonspeech stimuli, irrespective of reading ability. The contrast between the phonetic and phonological capacities of these individuals demonstrates that the algebraic engine that generates phonological patterns is distinct from the phonetic interface that implements them. While dyslexia compromises the phonetic system, certain core aspects of the phonological grammar can be spared.	[Berent, Iris] Northeastern Univ, Dept Psychol, Boston, MA 02115 USA; [Vaknin-Nusbaum, Vered] Akko & Univ Haifa, Western Galilee Coll, Haifa, Israel; [Balaban, Evan] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Galaburda, Albert M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Neurol, Div Cognit Neurol,Med Sch, Boston, MA 02215 USA	Northeastern University; McGill University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Berent, I (corresponding author), Northeastern Univ, Dept Psychol, Boston, MA 02115 USA.	i.berent@neu.edu	Balaban, Evan/AAV-2353-2020; Vaknin-Nusbaum, Vered/AHD-9240-2022	Balaban, Evan/0000-0002-0391-3433; Vaknin-Nusbaum, Vered/0000-0003-3799-876X	National Institute on Deafness and Other Communication Disorders [R01DC003277]; Canadian Fund for Innovation [9908]; National Insitutes of Health [HD057853]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003277] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Canadian Fund for Innovation; National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Institute on Deafness and Other Communication Disorders grant R01DC003277 to IB, Canadian Fund for Innovation 9908 to EB and National Insitutes of Health grant HD057853 to AMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLER WL, 1989, J SOC BIOL STRUCT, V12, P1, DOI 10.1016/0140-1750(89)90015-8; Adlard A, 1998, Q J EXP PSYCHOL-A, V51, P153, DOI 10.1080/713755750; [Anonymous], 1995, HDB PHONOLOGICAL THE; Azadpour M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001966; Bat-El O, 2006, LINGUIST INQ, V37, P179, DOI 10.1162/ling.2006.37.2.179; Beaujean AA, 2006, PERS INDIV DIFFER, V41, P353, DOI 10.1016/j.paid.2006.01.014; Berent I, 2002, COGNITION, V83, P113, DOI 10.1016/S0010-0277(01)00167-6; Berent I, 1997, COGNITION, V64, P39, DOI 10.1016/S0010-0277(97)00016-4; Berent I, 2001, COGNITIVE PSYCHOL, V42, P1, DOI 10.1006/cogp.2000.0742; Berent I, 2001, J MEM LANG, V44, P644, DOI 10.1006/jmla.2000.2760; Berent I, 2012, PHONOLOGICAL MIND; Berent I, 2008, P NATL ACAD SCI USA, V105, P5321, DOI 10.1073/pnas.0801469105; Berent I, 2007, COGNITION, V104, P254, DOI 10.1016/j.cognition.2006.06.002; Berent I, 2012, LINGUIST INQ, V43, P97, DOI 10.1162/LING_a_00075; Berent I, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00182; Berent I, 2010, J EXP PSYCHOL GEN, V139, P418, DOI 10.1037/a0020094; Berent I, 2006, MENT LEX, V1, P201, DOI 10.1075/ml.1.2.03ber; Blomert L, 2004, J SPEECH LANG HEAR R, V47, P1030, DOI 10.1044/1092-4388(2004/077); BRADLEY L, 1978, NATURE, V271, P746, DOI 10.1038/271746a0; BRANDT J, 1980, BRAIN LANG, V9, P324, DOI 10.1016/0093-934X(80)90152-2; Brentari D, 2012, NATURAL LANGUAGE LIN, V30; Brentari Diane, 1998, PROSODIC MODEL SIGN; Breznitz Z, 2004, ELUL LEARNING DISABI; Buchwald AB, 2007, LANG COGNITIVE PROC, V22, P910, DOI 10.1080/01690960701273532; Chiappe P, 2001, J EXP CHILD PSYCHOL, V80, P58, DOI 10.1006/jecp.2000.2624; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Corina DP, 2001, NEUROREPORT, V12, P1195, DOI 10.1097/00001756-200105080-00029; de Lacy Paul, 2004, PHONOLOGY, V21, P145, DOI DOI 10.1017/S0952675704000193; Dehaene S., 2009, READING BRAIN SCI EV; Frey MC, 2004, PSYCHOL SCI, V15, P373, DOI 10.1111/j.0956-7976.2004.00687.x; Gabrieli JDE, 2009, SCIENCE, V325, P280, DOI 10.1126/science.1171999; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Gervain J, 2012, J COGNITIVE NEUROSCI, V24, P564, DOI 10.1162/jocn_a_00157; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; GODFREY JJ, 1981, J EXP CHILD PSYCHOL, V32, P401, DOI 10.1016/0022-0965(81)90105-3; Greenberg JH, 1950, WORD, V6, P162, DOI 10.1080/00437956.1950.11659378; Hayes Bruce, 1999, FUNCTIONALISM FORMAL, VI, P243, DOI DOI 10.1002/9780470756171.CH15; Hazan V, 2009, J SPEECH LANG HEAR R, V52, P1510, DOI 10.1044/1092-4388(2009/08-0220); Helenius P, 2002, J COGNITIVE NEUROSCI, V14, P603, DOI 10.1162/08989290260045846; Janse E, 2010, J PSYCHOLINGUIST RES, V39, P523, DOI 10.1007/s10936-010-9150-2; KEATING PA, 1984, LANGUAGE, V60, P286, DOI 10.2307/413642; Lalain M, 2003, BRAIN COGNITION, V53, P253, DOI 10.1016/S0278-2626(03)00121-0; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; Leppanen PHT, 2002, DEV NEUROPSYCHOL, V22, P407, DOI 10.1207/S15326942dn2201_4; LISKER L, 1964, WORD, V20, P384, DOI 10.1080/00437956.1964.11659830; Maassen B, 2001, CLIN LINGUIST PHONET, V15, P319; Maionchi-Pino N, 2012, COMPREHENSIVE INT AP; Marcus G., 2001, ALGEBRAIC MIND INTEG; Marshall CR, 2010, COGN NEUROPSYCHOL, V27, P563, DOI 10.1080/02643294.2011.588693; Marshall CR, 2009, LANGUAGE, V85, P39, DOI 10.1353/lan.0.0081; McArthur G, 2009, DEVELOPMENTAL SCI, V12, P768, DOI 10.1111/j.1467-7687.2008.00804.x; MCCARTHY JJ, 1981, LINGUIST INQ, V12, P373; MCCARTHY JJ, 1986, LINGUIST INQ, V17, P207; MCCARTHY JJ, 1989, LINGUIST INQ, V20, P71; Messaoud-Galusi S, 2011, J SPEECH LANG HEAR R, V54, P1682, DOI 10.1044/1092-4388(2011/09-0261); MESTER RA, 1989, LANGUAGE, V65, P258, DOI 10.2307/415333; Mody M, 1997, J EXP CHILD PSYCHOL, V64, P199, DOI 10.1006/jecp.1996.2343; Olson R., 1990, READING ITS DEV COMP, P261; Olson Richard K, 2002, Dyslexia, V8, P143, DOI 10.1002/dys.228; Ouimet T, 2009, DYSLEXIA CHICHESTER, V16, P45; Parviainen T, 2005, CEREB CORTEX, V15, P1054, DOI 10.1093/cercor/bhh206; Paul I, 2006, EUR J NEUROSCI, V24, P2945, DOI 10.1111/j.1460-9568.2006.05153.x; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Perrachione TK, 2011, SCIENCE, V333, P595, DOI 10.1126/science.1207327; Phillips C, 2000, J COGNITIVE NEUROSCI, V12, P1038, DOI 10.1162/08989290051137567; PINKER S, 1988, COGNITION, V28, P73, DOI 10.1016/0010-0277(88)90032-7; Poulsen M, 2011, APPL PSYCHOLINGUIST, V32, P245, DOI 10.1017/S0142716410000391; Prince Alan, 2004, OPTIMALITY THEORY CO; Pugh KR, 2000, PSYCHOL SCI, V11, P51, DOI 10.1111/1467-9280.00214; RACK JP, 1992, READ RES QUART, V27, P28, DOI 10.2307/747832; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Ramus F, 2012, COGN NEUROPSYCHOL, V29, P104, DOI 10.1080/02643294.2012.677420; Robertson EK, 2009, DEVELOPMENTAL SCI, V12, P753, DOI 10.1111/j.1467-7687.2009.00806.x; Rose S, 2004, LANGUAGE, V80, P475, DOI 10.1353/lan.2004.0144; Rosen S, 2001, J SPEECH LANG HEAR R, V44, P720, DOI 10.1044/1092-4388(2001/057); Sandler W, 2006, SIGN LANGUAGE AND LINGUISTIC UNIVERSALS, P1, DOI 10.2277/ 0521483956; Sandler W, 2011, NAT LANG LINGUIST TH, V29, P503, DOI 10.1007/s11049-011-9128-2; Savill NJ, 2011, BRAIN RES, V1385, P192, DOI 10.1016/j.brainres.2011.02.012; Serniclaes W, 2001, J SPEECH LANG HEAR R, V44, P384, DOI 10.1044/1092-4388(2001/032); Serniclaes WI, 2004, J EXP CHILD PSYCHOL, V87, P336, DOI 10.1016/j.jecp.2004.02.001; Shankweiler D., 2012, ENCY HUMAN BEHAV, V3, P249; Shany M, 2005, ALEPH TAPH ASSESSMEN; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Smolensky Paul, 2006, HARMONIC MIND NEURAL, P27; Soroli E, 2010, DYSLEXIA, V16, P318, DOI 10.1002/dys.415; SUZUKI K, 1998, TYPOLOGICAL INVESTIG; Szenkovits G, 2005, DYSLEXIA, V11, P253, DOI 10.1002/dys.308; Tanaka H, 2011, PSYCHOL SCI, V22, P1442, DOI 10.1177/0956797611419521; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Theodore RM, 2010, J ACOUST SOC AM, V128, P2090, DOI 10.1121/1.3467771; Theodore RM, 2009, J ACOUST SOC AM, V125, P3974, DOI 10.1121/1.3106131; van Herten M, 2008, BRAIN RES, V1201, P100, DOI 10.1016/j.brainres.2008.01.060; Vandermosten M, 2010, P NATL ACAD SCI USA, V107, P10389, DOI 10.1073/pnas.0912858107; WERKER JF, 1987, CAN J PSYCHOL, V41, P48, DOI 10.1037/h0084150; White S, 2006, DEVELOPMENTAL SCI, V9, P237, DOI 10.1111/j.1467-7687.2006.00483.x; Wolmetz M, 2011, J COGNITIVE NEUROSCI, V23, P552, DOI 10.1162/jocn.2010.21495; YIP M, 1988, LINGUIST INQ, V19, P65; Zeguers MHT, 2011, DEVELOPMENTAL SCI, V14, P1340, DOI 10.1111/j.1467-7687.2011.01091.x; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x; Zsiga EC, 2000, J PHONETICS, V28, P69, DOI 10.1006/jpho.2000.0109	101	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44875	10.1371/journal.pone.0044875	http://dx.doi.org/10.1371/journal.pone.0044875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028654	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400046
J	Fabina, NS; Putnam, HM; Franklin, EC; Stat, M; Gates, RD				Fabina, Nicholas S.; Putnam, Hollie M.; Franklin, Erik C.; Stat, Michael; Gates, Ruth D.			Transmission Mode Predicts Specificity and Interaction Patterns in Coral-Symbiodinium Networks	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ALGAL SYMBIOSIS; DIVERSITY; HOST; SPECIALIZATION; FLEXIBILITY; WINNERS; ECOLOGY	Most reef-building corals in the order Scleractinia depend on endosymbiotic algae in the genus Symbiodinium for energy and survival. Significant levels of taxonomic diversity in both partners result in numerous possible combinations of coral-Symbiodinium associations with unique functional characteristics. We created and analyzed the first coral-Symbiodinium networks utilizing a global dataset of interaction records from coral reefs in the tropical Indo-Pacific and Atlantic Oceans for 1991 to 2010. Our meta-analysis reveals that the majority of coral species and Symbiodinium types are specialists, but failed to detect any one-to-one obligate relationships. Symbiont specificity is correlated with a host's transmission mode, with horizontally transmitting corals being more likely to interact with generalist symbionts. Globally, Symbiodinium types tend to interact with only vertically or horizontally transmitting corals, and only a few generalist types are found with both. Our results demonstrate a strong correlation between symbiont specificity, symbiont transmission mode, and community partitioning. The structure and dynamics of these network interactions underlie the fundamental biological partnership that determines the condition and resilience of coral reef ecosystems.	[Fabina, Nicholas S.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Putnam, Hollie M.; Franklin, Erik C.; Stat, Michael; Gates, Ruth D.] Univ Hawaii, Hawaii Inst Marine Biol, Sch Ocean & Earth Sci & Technol, Kaneohe, HI USA; [Stat, Michael] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [Stat, Michael] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia; [Stat, Michael] Univ Western Australia, Australian Inst Marine Sci, Perth, WA 6009, Australia	University of California System; University of California Davis; University of Hawaii System; University of Western Australia; University of Western Australia; Australian Institute of Marine Science; University of Western Australia	Fabina, NS (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	nsfabina@ucdavis.edu	Stat, Michael/K-5290-2012; Fabina, Nicholas/L-5150-2013	Fabina, Nicholas/0000-0002-2592-1661; Putnam, Hollie/0000-0003-2322-3269; Stat, Michael/0000-0002-1663-3422; Franklin, Erik/0000-0002-8660-3085	National Science Foundation [OCE-0752604, OCE-1041673, EF-0928987, EF-0553768, 04-17412]; United States Environmental Protection Agency [FP-917096]; College of Biological Sciences; AIMS-CSIRO-UWA collaborative agreement; University of California Davis Center for Population Biology	National Science Foundation(National Science Foundation (NSF)); United States Environmental Protection Agency(United States Environmental Protection Agency); College of Biological Sciences; AIMS-CSIRO-UWA collaborative agreement; University of California Davis Center for Population Biology(University of California System)	Support was provided by the National Science Foundation (OCE-0752604 to RDG; OCE-1041673 to MJD; EF-0928987 to SJS; EF-0553768 to NCEAS; 04-17412 to MCR-LTER; www.nsf.gov), the United States Environmental Protection Agency (FP-917096 to ECF; www.epa.gov), start up funds from the Dean of the College of Biological Sciences to SJS, a postdoctoral fellowship to MS from the AIMS-CSIRO-UWA collaborative agreement, and the University of California Davis Center for Population Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Apprill AM, 2007, MOL ECOL, V16, P1127, DOI 10.1111/j.1365-294X.2006.03214.x; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2009, FRONT ECOL ENVIRON, V7, P429, DOI 10.1890/080026; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Correa AMS, 2009, CORAL REEFS, V28, P81, DOI 10.1007/s00338-008-0456-6; Douglas A.E., 2010, SYMBIOTIC HABIT; Douglas AE, 1998, HEREDITY, V81, P599, DOI 10.1038/sj.hdy.6884550; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Fautin DG, 2004, HYDROBIOLOGIA, V530, P459, DOI 10.1007/s10750-004-2642-z; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Freeman CJ, 2011, LIMNOL OCEANOGR, V56, P1577, DOI 10.4319/lo.2011.56.5.1577; Gates RD, 2011, J EXP MAR BIOL ECOL, V408, P94, DOI 10.1016/j.jembe.2011.07.029; Guimaraes PR, 2007, BIOL LETTERS, V3, P51, DOI 10.1098/rsbl.2006.0562; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Kaiser-Bunbury CN, 2009, PERSPECT PLANT ECOL, V11, P241, DOI 10.1016/j.ppees.2009.04.001; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Palmer TM, 2003, AM NAT, V162, pS63, DOI 10.1086/378682; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Putnam HM, 2012, P ROY SOC B-BIOL SCI, V279, P4352, DOI 10.1098/rspb.2012.1454; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stambler N, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P87, DOI 10.1007/978-94-007-0114-4_7; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2008, P NATL ACAD SCI USA, V105, P9256, DOI 10.1073/pnas.0801328105; Stat Michael, 2011, Journal of Marine Biology, V2011, P1; van Oppen MJH, 2004, MAR BIOL, V144, P1, DOI 10.1007/s00227-003-1187-4; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Venn AA, 2008, BIOL BULL-US, V215, P243, DOI 10.2307/25470708; Wicks LC, 2010, CORAL REEFS, V29, P989, DOI 10.1007/s00338-010-0649-7	56	44	44	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44970	10.1371/journal.pone.0044970	http://dx.doi.org/10.1371/journal.pone.0044970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028711	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900061
J	Rief, A; Knapp, BA; Seeber, J				Rief, Alexander; Knapp, Brigitte A.; Seeber, Julia			Palatability of Selected Alpine Plant Litters for the Decomposer Lumbricus rubellus (Lumbricidae)	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; PORCELLIO-SCABER ISOPODA; MACRO-DECOMPOSERS; LEAF; FOREST; COMMUNITIES; PREFERENCES; PASTURELAND; POLYPHENOLS; PHENOLICS	On alpine pastureland the decline in large-bodied earthworm numbers and biomass after abandonment of management might be the result of a shift from highly palatable grass litter to poorly digestible leaf litter of dwarf shrubs. To test this hypothesis, we analysed nitrogen, phosphorous and total phenolic contents of fresh and aged litter of eight commonly occuring alpine plant species and compared consumption rates of these food sources in a controlled feeding experiment with Lumbricus rubellus (Lumbricidae). Furthermore, we analysed the microbial community structure of aged litter materials to check for a relationship between the microbial characteristics of the different plant litter types and the food choice of earthworms. Plant litters differed significantly in their chemical composition, earthworms, however, showed no preference for any litter species, but generally rejected fresh litter material. Microbial community structures of the litter types were significantly different, but we could find no evidence for selective feeding of L. rubellus. We conclude that L. rubellus is a widespread, adaptable ubiquist, which is able to feed on a variety of food sources differing in quality and palatability, as long as they have been exposed to wheathering.	[Rief, Alexander; Seeber, Julia] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria; [Knapp, Brigitte A.] Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck	Seeber, J (corresponding author), Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria.	Julia.Seeber@uibk.ac.at	Seeber, Julia/R-3422-2017	Seeber, Julia/0000-0003-0189-7377	Austrian Science Fund [P18520, T441]; Tiroler Wissenschaftsfond [TWF 58411]; research focus Berglandwirtschaft of the University of Innsbruck [94404]; Austrian Science Fund (FWF) [T 441] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Tiroler Wissenschaftsfond; research focus Berglandwirtschaft of the University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Austrian Science Fund (grant number P18520 and T441), http://www.fwf.ac.at; Tiroler Wissenschaftsfond (grant number TWF 58411), http://www.tiroler-wissenschaftsfonds.at; research focus Berglandwirtschaft of the University of Innsbruck (grant number 94404), http://www.uibk.ac.at/berglandwirtschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Bardgett R, 2005, BIOL SOILS COMMUNITY; Berg M, 2001, OIKOS, V94, P130, DOI 10.1034/j.1600-0706.2001.09121.x; Bonkowski M, 2000, PEDOBIOLOGIA, V44, P666, DOI 10.1078/S0031-4056(04)70080-3; Brown George G., 2004, P213; Chapman SK, 2006, NEW PHYTOL, V169, P27, DOI 10.1111/j.1469-8137.2005.01571.x; Cornelissen JHC, 1997, NEW PHYTOL, V135, P109, DOI 10.1046/j.1469-8137.1997.00628.x; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Curry James P., 2004, P91; David JF, 2010, BIOL REV, V85, P881, DOI 10.1111/j.1469-185X.2010.00138.x; Drake HL, 2007, ANNU REV MICROBIOL, V61, P169, DOI 10.1146/annurev.micro.61.080706.093139; Edwards C.A., 1974, P533; ENRIQUEZ S, 1993, OECOLOGIA, V94, P457, DOI 10.1007/BF00566960; GUNNARSSON T, 1987, PEDOBIOLOGIA, V30, P161; Harborne J. B., 1980, Encyclopedia of Plant Physiology. New Series. Volume 8. Secondary plant products [Bell, A.E.; Charlwood, B.V. (Editors)]., P329; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Hattenschwiler S, 2003, BIOGEOCHEMISTRY, V64, P129, DOI 10.1023/A:1024966026225; HENDRIKSEN NB, 1990, BIOL FERT SOILS, V10, P17; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Ihnen K, 2008, PEDOBIOLOGIA, V51, P335, DOI 10.1016/j.pedobi.2007.06.001; Illmer P., 1996, METHODS SOIL BIOL, P412; Knapp BA, 2008, B ENTOMOL RES, V98, P271, DOI 10.1017/S0007485308006056; Knapp BA, 2009, SOIL BIOL BIOCHEM, V41, P2299, DOI 10.1016/j.soilbio.2009.08.011; Knapp BA, 2011, BIOL FERT SOILS, V47, P845, DOI 10.1007/s00374-011-0561-5; KUITERS AT, 1990, ACTA BOT NEERL, V39, P329, DOI 10.1111/j.1438-8677.1990.tb01412.x; Lavelle P., 2001, SOIL ECOLOGY; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Neilson R, 2003, PEDOBIOLOGIA, V47, P1, DOI 10.1078/S0031-4056(04)70173-0; NEUHAUSER EF, 1978, PEDOBIOLOGIA, V18, P99; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; SATCHELL J. E., 1967, P102; Schofield JA, 1998, J CHEM ECOL, V24, P1409, DOI 10.1023/A:1021287018787; Seeber J, 2005, PEDOBIOLOGIA, V49, P221, DOI 10.1016/j.pedobi.2004.10.003; Seeber J, 2009, APPL SOIL ECOL, V41, P178, DOI 10.1016/j.apsoil.2008.10.006; Seeber J, 2006, APPL SOIL ECOL, V34, P168, DOI 10.1016/j.apsoil.2006.02.004; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; TORRES AM, 1987, J AGR FOOD CHEM, V35, P921, DOI 10.1021/jf00078a018; Vainio EJ, 2000, MYCOL RES, V104, P927, DOI 10.1017/S0953756200002471; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wrubleski DA, 1997, AQUAT BOT, V58, P121, DOI 10.1016/S0304-3770(97)00016-8; Zhang CF, 2007, CAN J SOIL SCI, V87, P413, DOI 10.4141/S06-034; Zimmer M, 2003, EUR J SOIL BIOL, V39, P209, DOI 10.1016/j.ejsobi.2003.07.001; Zimmer M, 2002, BIOL REV, V77, P455, DOI 10.1017/S1464793102005912	43	12	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45345	10.1371/journal.pone.0045345	http://dx.doi.org/10.1371/journal.pone.0045345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028949	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900123
J	Zhang, XG; Zhang, XP; Li, W; Jiang, L; Zhang, XL; Guo, Y; Wang, XF				Zhang, Xingang; Zhang, Xinpeng; Li, Wei; Jiang, Li; Zhang, Xiaoli; Guo, Yun; Wang, Xiaofei			Clinical Analysis of 36 Cases of Autoimmune Pancreatitis in China	PLOS ONE			English	Article							INFLAMMATORY PSEUDOTUMOR; EXTRAPANCREATIC LESIONS; DIAGNOSTIC-CRITERIA; T-CELL; FEATURES; CT; CHOLANGITIS; EXPRESSION; PROPOSAL; ERCP	Background: To improve the early identification of autoimmune pancreatitis in China by a retrospective analysis of clinical data from AIP patients. Methodology/Principal Findings: The analysis included 36 patients admitted by the surgery department of our hospital from January 2003 to October 2011 whose postoperative pathological confirmations were consistent with the histological criteria of Honolulu Consensus Document. The clinical phenotypes associated with the histopathologic patterns of LPSP and IDCP were referred to as type 1 and type 2 of AIP, respectively. A retrospective analysis of clinical features, serological data, pathological findings and imageological records was performed in line with the subtypes of AIP. Type 1 showing a sex predilection (males) was commonly more dominant than type 2 in all AIP. Type 2 without a gender predilection was, on average, a decade younger than type 1. Type 1 was inferior to type 2 in ALT, ALP and gamma-GT with statistical significance (P= 0.044, 0.025 and 0.013). Type 1 was inferior to type 2 in AST with difference close to statistical significance (P = 0.072). Histopathology revealed frequent lymphoplasmacytic infiltration with less frequent infiltration of neutrophils, eosinophils and fibroblasts. Diffuse and intensive interstitial fibrosis could be seen. The changes of pancreatic head were more frequently seen in type 2 than in type 1 (P = 0.05). Plasma cells staining of IgG4 at a density of over 30 or more cells per high-power field appeared to be a specific finding in China with type 1. Imageology found a diffusely or focally enlarged pancreas, most frequently a mass or enlargement in the pancreatic head, characteristic capsule-like rim, calcification or pancreatic calculus and cystic degeneration. Conclusions/Significance: AIP is a unique type of chronic pancreatitis and has distinctive serological, pathological and imageological characteristics, which should be used for differentiation from pancreatic cancer.	[Zhang, Xingang; Jiang, Li; Zhang, Xiaoli; Guo, Yun; Wang, Xiaofei] China Med Univ, Shengjing Hosp, Dept Rheumatol, Shenyang, Liaoning Provin, Peoples R China; [Zhang, Xinpeng] Fourth Peoples Hosp Shenyang City, Dept Neurosurg, Shenyang, Liaoning Provin, Peoples R China; [Li, Wei] China Editorial Dept Chinese Pediat Emergency Med, Shenyang, Liaoning Provin, Peoples R China	China Medical University	Zhang, XG (corresponding author), China Med Univ, Shengjing Hosp, Dept Rheumatol, Shenyang, Liaoning Provin, Peoples R China.	18940257526@189.cn	zhang, xuan/GQO-8953-2022; zhang, xu/GRX-9733-2022; zhang, xuan/AAN-9914-2020; zhang, xian/GYA-0290-2022; zhang, xu/GYE-3558-2022; Zhang, xiaoyu/GXA-3206-2022	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; 	Medical Summit Project of Liaoning Province	Medical Summit Project of Liaoning Province	This work was supported by a grant from Medical Summit Project of Liaoning Province (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomew SV, 2006, J PEDIATR SURG, V41, DOI 10.1016/j.jpedsurg.2005.12.052; Bodily KD, 2009, AM J ROENTGENOL, V192, P431, DOI 10.2214/AJR.07.2956; BOVO P, 1987, PANCREAS, V2, P350, DOI 10.1097/00006676-198705000-00016; Breuer GS, 2006, AUTOIMMUN REV, V5, P314, DOI 10.1016/j.autrev.2005.11.004; Chan SK, 2009, AM J SURG PATHOL, V33, P1249, DOI 10.1097/PAS.0b013e3181abdfc2; Chari ST, 2010, PANCREAS, V39, P549, DOI 10.1097/MPA.0b013e3181e4d9e5; Esposito I, 2004, VIRCHOWS ARCH, V444, P119, DOI 10.1007/s00428-003-0949-1; Finkelberg DL, 2006, NEW ENGL J MED, V355, P2670, DOI 10.1056/NEJMra061200; Frulloni L, 2009, AM J GASTROENTEROL, V104, P2288, DOI 10.1038/ajg.2009.327; Fukumori K, 2005, INTERNAL MED, V44, P886, DOI 10.2169/internalmedicine.44.886; Ghazale A, 2008, GASTROENTEROLOGY, V134, P706, DOI 10.1053/j.gastro.2007.12.009; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Horiuchi A, 2002, GASTROINTEST ENDOSC, V55, P494, DOI 10.1067/mge.2002.122653; Hyodo N, 2003, J GASTROENTEROL, V38, P1155, DOI 10.1007/s00535-003-1223-7; Irie H, 1998, AM J ROENTGENOL, V170, P1323, DOI 10.2214/ajr.170.5.9574610; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Kamisawa T, 2005, J CLIN GASTROENTEROL, V39, P904, DOI 10.1097/01.mcg.0000180629.77066.6c; Kamisawa T, 2005, PANCREAS, V31, P28, DOI 10.1097/01.mpa.0000167000.11889.3a; Kamisawa T, 2004, PANCREAS, V29, P167, DOI 10.1097/00006676-200408000-00014; Kamisawa T, 2009, ABDOM IMAGING, V34, P381, DOI 10.1007/s00261-008-9401-y; Kamisawa T, 2007, J GASTROENTEROL, V42, P59, DOI 10.1007/s00535-007-2052-x; Kamisawa T, 2006, J CLIN GASTROENTEROL, V40, P847, DOI 10.1097/01.mcg.0000225604.10611.61; Kamisawa T, 2006, J GASTROENTEROL, V41, P613, DOI 10.1007/s00535-006-1862-6; Kamisawa T, 2008, EUR J GASTROEN HEPAT, V20, P1167, DOI 10.1097/MEG.0b013e3283069dc2; Kawa S, 2007, J GASTROENTEROL, V42, P9, DOI 10.1007/s00535-007-2044-x; Kawa S, 2006, AUTOIMMUNE DISEASES, 4TH EDITION, P779, DOI 10.1016/B978-012595961-2/50059-7; Kobayashi G, 2007, J GASTROENTEROL, V42, P650, DOI 10.1007/s00535-007-2068-2; Koga Y, 2002, J GASTROENTEROL, V37, P133, DOI 10.1007/s005350200009; Kojima M, 2007, AM J SURG PATHOL, V31, P521, DOI 10.1097/01.pas.0000213390.55536.47; Koyama R, 2008, PANCREAS, V37, P259, DOI 10.1097/MPA.0b013e31816b30e7; Kubota K, 2007, GASTROINTEST ENDOSC, V66, P1142, DOI 10.1016/j.gie.2007.06.059; Law R, 2009, CLEV CLIN J MED, V76, P607, DOI 10.3949/ccjm.76a.09039; Lin LF, 2008, J CHIN MED ASSOC, V71, P14, DOI 10.1016/S1726-4901(08)70067-4; Lu H, 2010, CHINESE J PANCREATOL, V10, P155; Lui PCW, 2009, HUM PATHOL, V40, P1611, DOI 10.1016/j.humpath.2009.04.016; Marcos M, 2009, AUTOIMMUN REV, V8, P616, DOI 10.1016/j.autrev.2009.02.007; Marrache F, 2005, AM J GASTROENTEROL, V100, P2808, DOI 10.1111/j.1572-0241.2005.00270.x; Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society, 2002, J JPN PANCREAS SOC, V17, P585; Miller A, 2008, AUTOIMMUN REV, V8, P170, DOI 10.1016/j.autrev.2008.07.001; Nishimori I, 2007, J GASTROENTEROL, V42, P6, DOI 10.1007/s00535-007-2043-y; Okazaki K, 2005, INTERNAL MED, V44, P1215, DOI 10.2169/internalmedicine.44.1215; Okazaki K, 2002, GUT, V51, P1, DOI 10.1136/gut.51.1.1; Okazaki K, 2001, J GASTROENTEROL, V36, P293, DOI 10.1007/s005350170094; Okazaki K, 2006, J GASTROENTEROL, V41, P626, DOI 10.1007/s00535-006-1868-0; Okazaki K, 2005, J PANCREAS, V6, P89; Park DH, 2009, GUT, V58, P1680, DOI 10.1136/gut.2008.155853; Robison LS, 2011, J HEPATO-BIL-PAN SCI, V18, P162, DOI 10.1007/s00534-010-0321-1; Sahani DV, 2009, RADIOLOGY, V250, P118, DOI 10.1148/radiol.2493080279; Sahani DV, 2004, RADIOLOGY, V233, P345, DOI 10.1148/radiol.2332031436; Sahin P, 2004, PANCREAS, V29, P162, DOI 10.1097/00006676-200408000-00012; SARLES H, 1961, AM J DIG DIS, V6, P688, DOI 10.1007/BF02232341; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Shinji A, 2004, GASTROINTEST ENDOSC, V59, P506, DOI 10.1016/S0016-5107(03)02874-8; Sugumar A, 2010, CURR OPIN GASTROEN, V26, P513, DOI 10.1097/MOG.0b013e32833d118b; Takahashi N, 2008, AM J ROENTGENOL, V190, P280, DOI 10.2214/AJR.07.2309; Takeda S, 2004, NEPHROL DIAL TRANSPL, V19, P474, DOI 10.1093/ndt/gfg477; Uchiyama-Tanaka Y, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2003.12.006; Vaishali MD, 2004, J CLIN GASTROENTEROL, V38, P887, DOI 10.1097/00004836-200411000-00011; Wong S, 2007, HUM PATHOL, V38, P1720, DOI 10.1016/j.humpath.2007.06.011; Yamamoto M, 2005, AUTOIMMUN REV, V4, P195, DOI 10.1016/j.autrev.2004.10.005; Yang DH, 2006, ABDOM IMAGING, V31, P94, DOI 10.1007/s00261-005-0047-8; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Youssef N, 2004, HISTOPATHOLOGY, V44, P453, DOI 10.1111/j.1365-2559.2004.01862.x; Zhang L, 2007, MODERN PATHOL, V20, P23, DOI 10.1038/modpathol.3800689; Zhang LZ, 2011, PANCREAS, V40, P1172, DOI 10.1097/MPA.0b013e318233bec5	65	7	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44808	10.1371/journal.pone.0044808	http://dx.doi.org/10.1371/journal.pone.0044808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028628	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900045
J	Ridge, PG; Maxwell, TJ; Corcoran, CD; Norton, MC; Tschanz, JT; O'Brien, E; Kerber, RA; Cawthon, RM; Munger, RG; Kauwe, JSK				Ridge, Perry G.; Maxwell, Taylor J.; Corcoran, Christopher D.; Norton, Maria C.; Tschanz, JoAnn T.; O'Brien, Elizabeth; Kerber, Richard A.; Cawthon, Richard M.; Munger, Ronald G.; Kauwe, John S. K.			Mitochondrial Genomic Analysis of Late Onset Alzheimer's Disease Reveals Protective Haplogroups H6A1A/H6A1B: The Cache County Study on Memory in Aging	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BRAIN GLUCOSE-METABOLISM; GENETIC-STRUCTURE; DNA HAPLOGROUPS; UTAH MORMONS; CASCADE HYPOTHESIS; MATERNAL HISTORY; HAPLOTYPE TREES; COMMON VARIANTS; FAMILY-HISTORY	Background: Alzheimer's disease (AD) is the most common cause of dementia and AD risk clusters within families. Part of the familial aggregation of AD is accounted for by excess maternal vs. paternal inheritance, a pattern consistent with mitochondrial inheritance. The role of specific mitochondrial DNA (mtDNA) variants and haplogroups in AD risk is uncertain. Methodology/Principal Findings: We determined the complete mitochondrial genome sequence of 1007 participants in the Cache County Study on Memory in Aging, a population-based prospective cohort study of dementia in northern Utah. AD diagnoses were made with a multi-stage protocol that included clinical examination and review by a panel of clinical experts. We used TreeScanning, a statistically robust approach based on haplotype networks, to analyze the mtDNA sequence data. Participants with major mitochondrial haplotypes H6A1A and H6A1B showed a reduced risk of AD (p = 0.017, corrected for multiple comparisons). The protective haplotypes were defined by three variants: m.3915G>A, m.4727A>G, and m.9380G>A. These three variants characterize two different major haplogroups. Together m.4727A>G and m.9380G>A define H6A1, and it has been suggested m.3915G>A defines H6A. Additional variants differentiate H6A1A and H6A1B; however, none of these variants had a significant relationship with AD case-control status. Conclusions/Significance: Our findings provide evidence of a reduced risk of AD for individuals with mtDNA haplotypes H6A1A and H6A1B. These findings are the results of the largest study to date with complete mtDNA genome sequence data, yet the functional significance of the associated haplotypes remains unknown and replication in others studies is necessary.	[Ridge, Perry G.; Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Ridge, Perry G.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Maxwell, Taylor J.] Univ Texas Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Corcoran, Christopher D.] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA; [Corcoran, Christopher D.; Norton, Maria C.; Tschanz, JoAnn T.; Munger, Ronald G.] Utah State Univ, Ctr Epidemiol Studies, Logan, UT 84322 USA; [Corcoran, Christopher D.] Utah State Univ, Dept Family Consumer & Human Dev, Logan, UT 84322 USA; [Norton, Maria C.; Tschanz, JoAnn T.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA; [O'Brien, Elizabeth; Kerber, Richard A.] Univ Louisville, Dept Epidemiol & Populat Hlth, Louisville, KY 40292 USA; [Cawthon, Richard M.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Munger, Ronald G.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA	Brigham Young University; Utah System of Higher Education; University of Utah; ARUP Laboratories; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Louisville; Utah System of Higher Education; University of Utah; Utah System of Higher Education; Utah State University	Kauwe, JSK (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	kauwe@byu.edu	Norton, Maria C/E-6994-2013; Tschanz, JoAnn T./E-5986-2010; Kauwe, John/B-2034-2009; Kauwe, John/AAC-6646-2021	Kauwe, John/0000-0001-8641-2468; Kauwe, John/0000-0001-8641-2468	National Institutes of Health [R01AG11380, R01AG21136, R01AG31272]; Alzheimer's Association [MNIRG-11-205368]; Utah Science, Technology, and Research Initiative (USTAR); Brigham Young University Gerontology Program; NATIONAL INSTITUTE ON AGING [R01AG021136, R01AG011380, R01AG031272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Utah Science, Technology, and Research Initiative (USTAR); Brigham Young University Gerontology Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding sources: National Institutes of Health grants: R01AG11380, R01AG21136, R01AG31272. The Alzheimer's Association: MNIRG-11-205368. The Utah Science, Technology, and Research Initiative (USTAR). -The Brigham Young University Gerontology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandatheerthavarada HK, 2007, NEUROSCIENTIST, V13, P626, DOI 10.1177/1073858407303536; [Anonymous], 2011, MITOMAP HUM MIT GEN; Brandstatter A, 2006, ELECTROPHORESIS, V27, P2541, DOI 10.1002/elps.200500772; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Breitner JCS, 1999, NEUROLOGY, V53, P321, DOI 10.1212/WNL.53.2.321; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chinnery PF, 2000, NEUROLOGY, V55, P302, DOI 10.1212/WNL.55.2.302; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Chou JL, 2011, J PROTEOMICS, V74, P466, DOI 10.1016/j.jprot.2010.12.012; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Coskun P, 2011, BIOCH BIOPHYS ACTA, DOI 10:1016/j.bbagen. 2011.08.008; Cruts M, 1998, HUM MUTAT, V11, P183, DOI 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.3.CO;2-M; Cupples LA, 2004, GENET MED, V6, P192, DOI 10.1097/01.GIM.0000132679.92238.58; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; DUARA R, 1993, NEUROLOGY, V43, P1377, DOI 10.1212/WNL.43.7.1377; Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254; FARRER LA, 1991, AM J HUM GENET, V48, P1026; Fesahat F, 2007, CELL MOL NEUROBIOL, V27, P329, DOI 10.1007/s10571-006-9126-9; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grupe A, 2006, AM J HUM GENET, V78, P78, DOI 10.1086/498851; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HEYMAN A, 1983, ANN NEUROL, V14, P507, DOI 10.1002/ana.410140503; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Honea RA, 2011, NEUROLOGY, V76, P822, DOI 10.1212/WNL.0b013e31820e7b74; Hudson G, 2012, NEUROLOGY; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; JORDE LB, 1987, AM J PHYS ANTHROPOL, V72, P403, DOI 10.1002/ajpa.1330720313; JORDE LB, 1982, HUM BIOL, V54, P583; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; KAMBOH MI, 2010, NEUROBIOL AGING; KERBER RA, 1995, GENET EPIDEMIOL, V12, P291, DOI 10.1002/gepi.1370120306; Khalimonchuk E, 2005, MITOCHONDRION, V5, P363, DOI 10.1016/j.mito.2005.08.002; Kruger J, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-8; Lakatos A, 2010, NEUROBIOL AGING, V31, P1355, DOI 10.1016/j.neurobiolaging.2010.04.031; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li YH, 2006, HUM MOL GENET, V15, P2560, DOI 10.1093/hmg/ddl178; LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6; Mancuso M, 2007, NEUROL SCI, V28, P142, DOI 10.1007/s10072-007-0807-z; Maruszak A, 2009, NEUROBIOL AGING, V30, P1749, DOI 10.1016/j.neurobiolaging.2008.01.004; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; Mosconi L, 2007, P NATL ACAD SCI USA, V104, P19067, DOI 10.1073/pnas.0705036104; Mosconi Lisa, 2010, Human Genomics, V4, P170; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nowotny P, 2005, AM J MED GENET B, V136B, P62, DOI 10.1002/ajmg.b.30186; OBRIEN E, 1994, HUM BIOL, V66, P743; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Posada D, 2005, BIOINFORMATICS, V21, P2130, DOI 10.1093/bioinformatics/bti293; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quintanilla RA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.007; Santoro A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012037; Santos RX, 2010, INT J CLIN EXP PATHO, V3, P570; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Silva DFF, 2011, CURR ALZHEIMER RES, V8, P563; Skolnick M, 1980, BANBURY REPORT, P285; Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Swerdlow RH, 2009, EXP NEUROL, V218, P308, DOI 10.1016/j.expneurol.2009.01.011; Takasaki S, 2009, J BIOENERG BIOMEMBR, V41, P407, DOI 10.1007/s10863-009-9240-8; Takasaki S, 2009, J GENET GENOMICS, V36, P425, DOI 10.1016/S1673-8527(08)60132-0; Templeton AR, 2005, GENETICS, V169, P441, DOI 10.1534/genetics.104.030080; TEMPLETON AR, 1987, GENETICS, V117, P343; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Zsurka G, 1998, BIOL PSYCHIAT, V44, P371, DOI 10.1016/S0006-3223(97)00461-7	72	38	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45134	10.1371/journal.pone.0045134	http://dx.doi.org/10.1371/journal.pone.0045134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028804	Green Submitted, gold, Green Published			2022-12-27	WOS:000309742800037
J	Schnatwinkel, C; Niswander, L				Schnatwinkel, Carsten; Niswander, Lee			Nubp1 Is Required for Lung Branching Morphogenesis and Distal Progenitor Cell Survival in Mice	PLOS ONE			English	Article							MOUSE EMBRYOS; PROTEIN; ORIENTATION; EXPRESSION; EPITHELIUM; DYNAMICS; POLARITY; ATPASES; BRAIN; TUBE	The lung is a complex system in biology and medicine alike. Whereas there is a good understanding of the anatomy and histology of the embryonic and adult lung, less is known about the molecular details and the cellular pathways that ultimately orchestrate lung formation and affect its health. From a forward genetic approach to identify novel genes involved in lung formation, we identified a mutated Nubp1 gene, which leads to syndactyly, eye cataract and lung hypoplasia. In the lung, Nubp1 is expressed in progenitor cells of the distal epithelium. Nubp1(m1Nisw) mutants show increased apoptosis accompanied by a loss of the distal progenitor markers Sftpc, Sox9 and Foxp2. In addition, Nubp1 mutation disrupts localization of the polarity protein Par3 and the mitosis relevant protein Numb. Using knock-down studies in lung epithelial cells, we also demonstrate a function of Nubp1 in regulating centrosome dynamics and microtubule organization. Together, Nubp1 represents an essential protein for lung progenitor survival by coordinating vital cellular processes including cell polarity and centrosomal dynamics.	[Niswander, Lee] Univ Colorado, Sch Med, Dept Pediat, Howard Hughes Med Inst, Aurora, CO 80045 USA; Childrens Hosp Colorado, Aurora, CO USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado	Niswander, L (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Howard Hughes Med Inst, Aurora, CO 80045 USA.	Lee.Niswander@ucdenver.edu	Niswander, Lee/D-3976-2013	Niswander, Lee/0000-0002-9959-0594	American Asthma Foundation award; National Institutes of Health (NIH) [R21HL089431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089431] Funding Source: NIH RePORTER	American Asthma Foundation award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by an American Asthma Foundation award and by National Institutes of Health (NIH) (R21HL089431). LN is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Christodoulou A, 2006, J CELL SCI, V119, P2035, DOI 10.1242/jcs.02922; El-Hashash AHK, 2011, DEVELOPMENT, V138, P1395, DOI 10.1242/dev.058479; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Holmes G, 2001, DEV DYNAM, V222, P301, DOI 10.1002/dvdy.1182; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Liu AM, 1999, DEVELOPMENT, V126, P4827; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Okuno T, 2010, MOL BIOL REP, V37, P1165, DOI 10.1007/s11033-009-9477-7; Perl AKT, 2005, GENESIS, V41, P23, DOI 10.1002/gene.20093; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Pyrgaki C, 2011, DEV BIOL, V353, P38, DOI 10.1016/j.ydbio.2011.02.027; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; THURLBEC.WM, 1967, AM REV RESPIR DIS, V95, P752; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	34	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44871	10.1371/journal.pone.0044871	http://dx.doi.org/10.1371/journal.pone.0044871			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028652	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800021
J	Gall, AJ; Todd, WD; Blumberg, MS				Gall, Andrew J.; Todd, William D.; Blumberg, Mark S.			Development of SCN Connectivity and the Circadian Control of Arousal: A Diminishing Role for Humoral Factors?	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; C-FOS EXPRESSION; IMMEDIATE-EARLY GENES; SUPRACHIASMATIC NUCLEUS; SLEEP-DEPRIVATION; LOCUS-COERULEUS; BRAIN-STEM; ELECTRICAL-STIMULATION; POSTNATAL-DEVELOPMENT; FACTOR RECEPTOR	The suprachiasmatic nucleus (SCN) is part of a wake-promoting circuit comprising the dorsomedial hypothalamus (DMH) and locus coeruleus (LC). Although widely considered a "master clock," the SCN of adult rats is also sensitive to feedback regarding an animal's behavioral state. Interestingly, in rats at postnatal day (P)2, repeated arousing stimulation does not increase neural activation in the SCN, despite doing so in the LC and DMH. Here we show that, by P8, the SCN is activated by arousing stimulation and that selective destruction of LC terminals with DSP-4 blocks this activational effect. We next show that bidirectional projections among the SCN, DMH, and LC are nearly absent at P2 but present at P8. Despite the relative lack of SCN connectivity with downstream structures at P2, day-night differences in sleep-wake activity are observed, suggesting that the SCN modulates behavior at this age via humoral factors. To test this hypothesis, we lesioned the SCN at P1 and recorded sleep-wake behavior at P2: Day-night differences in sleep and wake were eliminated. We next performed precollicular transections at P2 and P8 that isolate the SCN and DMH from the brainstem and found that day-night differences in sleep-wake behavior were retained at P2 but eliminated at P8. Finally, the SCN or DMH was lesioned at P8: When recorded at P21, rats with either lesion exhibited similarly fragmented wake bouts and no evidence of circadian modulation of wakefulness. These results suggest an age-related decline in the SCN's humoral influence on sleep-wake behavior that coincides with the emergence of bidirectional connectivity among the SCN, DMH, and LC.	[Gall, Andrew J.; Todd, William D.; Blumberg, Mark S.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA	University of Iowa	Gall, AJ (corresponding author), Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA.	mark-blumberg@uiowa.edu	Gall, Andrew/A-2443-2016	Gall, Andrew/0000-0003-1258-0658; Blumberg, Mark/0000-0001-6969-2955; Todd, William/0000-0002-0919-3043	Independent Scientist Award from the National Institutes of Health [MH66424];  [HD63071];  [MH50701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD063071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH066424, R01MH050701, R29MH050701] Funding Source: NIH RePORTER	Independent Scientist Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by research grants (HD63071, MH50701) and an Independent Scientist Award (MH66424) from the National Institutes of Health (MSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Adell A, 2002, BRAIN RES REV, V39, P154, DOI 10.1016/S0165-0173(02)00182-0; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alberts J.R., 1988, Handbook of Behavioral Neurobiology, V9, P1; Antle MC, 2000, J NEUROSCI, V20, P9326; Arrigoni E, 2009, ACTA PHYSL OXFORD, V198, P223; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Blumberg MS, 2010, FORM FUNCTION INFANT; Bottum K, 2010, EXP BIOL MED, V235, P237, DOI 10.1258/ebm.2009.009244; Briski K, 2001, BRAIN RES BULL, V55, P401, DOI 10.1016/S0361-9230(01)00532-9; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Chou TC, 2003, J NEUROSCI, V23, P10691; Cirelli C, 2000, SLEEP, V23, P453; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Deboer T, 2007, SLEEP, V30, P257, DOI 10.1093/sleep/30.3.257; Deurveilher S, 2005, NEUROSCIENCE, V130, P165, DOI 10.1016/j.neuroscience.2004.08.030; DICKENSON AH, 1979, J COMP NEUROL, V185, P203, DOI 10.1002/cne.901850112; EDELSTEIN K, 1995, BRAIN RES, V690, P254, DOI 10.1016/0006-8993(95)00736-A; EDGAR DM, 1993, J NEUROSCI, V13, P1065; FRANKEN P, 1992, PFLUG ARCH EUR J PHY, V420, P500, DOI 10.1007/BF00374625; FREDERICKSON CJ, 1970, ARCH ITAL BIOL, V108, P564; Friedland DR, 1996, LAB ANIM SCI, V46, P220; FRITSCHY JM, 1989, NEUROSCIENCE, V30, P181, DOI 10.1016/0306-4522(89)90364-3; FRITSCHY JM, 1991, EXP NEUROL, V111, P123, DOI 10.1016/0014-4886(91)90058-K; Gall AJ, 2008, J BIOL RHYTHM, V23, P232, DOI 10.1177/0748730408316954; Gall AJ, 2007, EUR J NEUROSCI, V25, P3367, DOI 10.1111/j.1460-9568.2007.05566.x; Gall AJ, 2009, SLEEP, V32, P920, DOI 10.1093/sleep/32.7.920; Gilbert J, 2009, BEHAV BRAIN RES, V198, P440, DOI 10.1016/j.bbr.2008.11.046; Hsieh KC, 2011, NEUROSCIENCE, V188, P55, DOI 10.1016/j.neuroscience.2011.05.016; IBUKA N, 1977, BRAIN RES, V122, P33, DOI 10.1016/0006-8993(77)90660-6; JANIK D, 1992, NEUROREPORT, V3, P575, DOI 10.1097/00001756-199207000-00007; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; JONSSON G, 1982, NEUROSCIENCE, V7, P2895, DOI 10.1016/0306-4522(82)90112-9; JONSSON G, 1981, EUR J PHARMACOL, V72, P173, DOI 10.1016/0014-2999(81)90272-7; KAITIN KI, 1986, BIOL PSYCHIAT, V21, P710, DOI 10.1016/0006-3223(86)90235-0; Karlsson KAE, 2005, PLOS BIOL, V3, P891, DOI 10.1371/journal.pbio.0030143; Karlsson KAE, 2004, NEUROSCIENCE, V123, P575, DOI 10.1016/j.neuroscience.2003.09.025; Ko EM, 2003, BRAIN RES, V992, P220, DOI 10.1016/j.brainres.2003.08.044; Kornblum HI, 1997, J COMP NEUROL, V380, P243, DOI 10.1002/(SICI)1096-9861(19970407)380:2<243::AID-CNE7>3.0.CO;2-3; Kowalska E, 2007, COLD SPRING HARB SYM, V72, P301, DOI 10.1101/sqb.2007.72.014; LEGORATTISANCHEZ MO, 1989, BRAIN RES BULL, V23, P283, DOI 10.1016/0361-9230(89)90210-4; LeSauter J, 1996, J BIOL RHYTHM, V11, P163, DOI 10.1177/074873049601100208; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Lu J, 2000, J NEUROSCI, V20, P3830, DOI 10.1523/JNEUROSCI.20-10-03830.2000; Maywood ES, 2011, P NATL ACAD SCI USA, V108, P14306, DOI 10.1073/pnas.1101767108; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Mendoza J, 2009, NEUROSCIENTIST, V15, P477, DOI 10.1177/1073858408327808; MERCHANTNANCY H, 1995, BRAIN RES, V681, P15, DOI 10.1016/0006-8993(95)00275-U; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; Mohns EJ, 2006, EUR J NEUROSCI, V23, P1301, DOI 10.1111/j.1460-9568.2006.04652.x; Muller C, 1998, DEV BRAIN RES, V110, P203, DOI 10.1016/S0165-3806(98)00108-4; Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pompeiano M, 1995, NEUROPHYSIOL CLIN, V25, P329, DOI 10.1016/0987-7053(96)84906-9; REPPERT SM, 1988, PSYCHONEUROENDOCRINO, V13, P63, DOI 10.1016/0306-4530(88)90007-8; ROMERO MT, 1993, DEV BRAIN RES, V71, P45, DOI 10.1016/0165-3806(93)90103-H; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Schwartz MD, 2009, CHRONOBIOL INT, V26, P1290, DOI 10.3109/07420520903415742; Seelke AMH, 2005, EUR J NEUROSCI, V22, P911, DOI 10.1111/j.1460-9568.2005.04322.x; SEROOGY KB, 1993, J NEUROCHEM, V60, P1777, DOI 10.1111/j.1471-4159.1993.tb13403.x; SEROOGY KB, 1995, BRAIN RES, V670, P157, DOI 10.1016/0006-8993(94)01300-7; SILVER R, 1993, J BIOL RHYTHM, V8, pS89; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Smith MA, 1997, ENDOCRINOLOGY, V138, P4622, DOI 10.1210/en.138.11.4622; Todd WD, 2010, BEHAV NEUROSCI, V124, P69, DOI 10.1037/a0018100; TONONI G, 1994, BRAIN RES BULL, V35, P589, DOI 10.1016/0361-9230(94)90173-2; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Vellani V, 2006, J NEUROSCI, V26, P5109, DOI 10.1523/JNEUROSCI.3870-05.2006; Zhou QY, 2005, FEBS J, V272, P5703, DOI 10.1111/j.1742-4658.2005.04984.x	75	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45338	10.1371/journal.pone.0045338	http://dx.doi.org/10.1371/journal.pone.0045338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028945	Green Published, gold			2022-12-27	WOS:000308788700103
J	Widger, J; Oliver, MR; O'Connell, M; Cameron, FJ; Ranganathan, S; Robinson, PJ				Widger, John; Oliver, Mark R.; O'Connell, Michele; Cameron, Fergus J.; Ranganathan, Sarath; Robinson, Phil J.			Glucose Tolerance during Pulmonary Exacerbations in Children with Cystic Fibrosis	PLOS ONE			English	Article							EPIDEMIOLOGY	Background: Patients with Cystic Fibrosis (CF) are relatively insulinopenic and are at risk of diabetes, especially during times of stress. There is a paucity of data in the literature describing glucose tolerance during CF pulmonary exacerbations. We hypothesised that glucose tolerance would be worse during pulmonary exacerbations in children with CF than during clinical stability. Methods: Patients with CF, 10 years or older, admitted with a pulmonary exacerbation underwent an OGTT within 48 hours of admission. A repeat OGTT was performed 4 to 6 weeks post discharge when the patients were well. Results: Nine patients completed the study. Four patients were found to have normal glucose tolerance, 3 with impaired and 2 with CF related diabetes during the exacerbation. Mean change in 2-hour glucose was 1.1 mmol (SD = 0.77). At the follow up OGTT, 8 of 9 (89%) remained within their respective glucose tolerance status groupings. Conclusion: The findings of this study show that there is little difference in glucose tolerance during CF exacerbations compared to clinical stability in the majority of patients.	[Widger, John; Ranganathan, Sarath; Robinson, Phil J.] Royal Childrens Hosp, Dept Resp Med, Melbourne, Vic, Australia; [Oliver, Mark R.] Royal Childrens Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [O'Connell, Michele; Cameron, Fergus J.] Royal Childrens Hosp, Dept Endocrinol, Melbourne, Vic, Australia; [Oliver, Mark R.; Cameron, Fergus J.; Ranganathan, Sarath; Robinson, Phil J.] Univ Melbourne, Melbourne, Vic, Australia; [Oliver, Mark R.; O'Connell, Michele; Cameron, Fergus J.; Ranganathan, Sarath; Robinson, Phil J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute	Widger, J (corresponding author), Royal Childrens Hosp, Dept Resp Med, Melbourne, Vic, Australia.	jwidger1@yahoo.com	Cameron, Fergus J/N-9535-2015	O'Connell, Michele/0000-0003-4003-956X; Widger, John/0000-0002-9348-2760; Ranganathan, Sarath/0000-0002-6975-0307	Royal Children's Cystic Fibrosis Research Trust	Royal Children's Cystic Fibrosis Research Trust	JW was supported by a grant from the Royal Children's Cystic Fibrosis Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battezzati A, 2011, EUR J ENDOCRINOL, V165, P69, DOI 10.1530/EJE-10-1003; Bell SC, 2000, EUR J CLIN INVEST, V30, P553; Downey DG, 2007, PEDIATR PULM, V42, P729, DOI 10.1002/ppul.20646; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moran A, 2010, DIABETES CARE, V33, P2697, DOI 10.2337/dc10-1768; Moran A, 2010, DIABETES CARE, V33, P2677, DOI 10.2337/dc10-1279; Moran A, 2009, DIABETES CARE, V32, P1626, DOI 10.2337/dc09-0586; Olansky L, 2010, DIABETES CARE, V33, P948, DOI 10.2337/dc10-0077; Preissig CM, 2009, CRIT CARE, V13, DOI 10.1186/cc7732; Sanders DB, 2010, PEDIATR PULM, V45, P127, DOI 10.1002/ppul.21117; Sc NNM, 2010, J CYST FIBROS, V9, P199, DOI 10.1016/j.jcf.2010.02.001; Soulsby N, 2009, INTERN MED J, V39, P527, DOI 10.1111/j.1445-5994.2008.01787.x; World Health Organization, 1980, WHO TECHN REP SER, V646, P1	16	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44844	10.1371/journal.pone.0044844	http://dx.doi.org/10.1371/journal.pone.0044844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028642	Green Published, gold			2022-12-27	WOS:000308788700045
J	Chen, CC; Greene, E; Bowers, SR; Mellone, BG				Chen, Chin-Chi; Greene, Elizabeth; Bowers, Sarion R.; Mellone, Barbara G.			A Role for the CAL1-Partner Modulo in Centromere Integrity and Accurate Chromosome Segregation in Drosophila	PLOS ONE			English	Article							CENP-A NUCLEOSOMES; CELLS; KINETOCHORE; PROTEIN; SCM3; CHROMATIN; NUCLEOLUS; HJURP; GENE; VARIEGATION	The relationship between the nucleolus and the centromere, although documented, remains one of the most elusive aspects of centromere assembly and maintenance. Here we identify the nucleolar protein, Modulo, in complex with CAL1, a factor essential for the centromeric deposition of the centromere-specific histone H3 variant, CID, in Drosophila. Notably, CAL1 localizes to both centromeres and the nucleolus. Depletion of Modulo, by RNAi, results in defective recruitment of newly-synthesized CAL1 at the centromere. Furthermore, depletion of Modulo negatively affects levels of CID at the centromere and results in chromosome missegregation. Interestingly, examination of Modulo localization during mitosis reveals it localizes to the chromosome periphery but not the centromere. Combined, the data suggest that rather than a direct regulatory role at the centromere, it is the nucleolar function of modulo which is regulating the assembly of the centromere by directing the localization of CAL1. We propose that a functional link between the nucleolus and centromere assembly exists in Drosophila, which is regulated by Modulo.	[Chen, Chin-Chi; Greene, Elizabeth; Bowers, Sarion R.; Mellone, Barbara G.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	Mellone, BG (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	barbara.mellone@uconn.edu		Bowers, Sarion/0000-0002-5687-5397; Mellone, Barbara/0000-0002-2785-5119	National Science Foundation [1024973]; Direct For Biological Sciences [1024973] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation award 1024973 to BGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MA, 2008, FEBS LETT, V582, P3839, DOI 10.1016/j.febslet.2008.10.023; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Blower MD, 2006, PLOS GENET, V2, P1025, DOI 10.1371/journal.pgen.0020110; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; BOUCHE G, 1984, NUCLEIC ACIDS RES, V12, P3025, DOI 10.1093/nar/12.7.3025; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Chang JH, 1998, BIOCHEM J, V329, P539; Chun Y, 2011, J BIOL CHEM, V286, P42758, DOI 10.1074/jbc.M111.228411; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; EGYHAZI E, 1988, EXP CELL RES, V178, P264, DOI 10.1016/0014-4827(88)90397-7; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; GARZINO V, 1992, EMBO J, V11, P4471, DOI 10.1002/j.1460-2075.1992.tb05548.x; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; GAUTIER T, 1992, J CELL SCI, V102, P729; Ginisty H, 1999, J CELL SCI, V112, P761; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guttenbach M, 1996, BIOL REPROD, V54, P980, DOI 10.1095/biolreprod54.5.980; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; KREJCI E, 1989, NUCLEIC ACIDS RES, V17, P8101, DOI 10.1093/nar/17.20.8101; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Mellone BG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002068; Mikhaylova LM, 2006, P NATL ACAD SCI USA, V103, P11975, DOI 10.1073/pnas.0605087103; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; OCHS RL, 1992, EXP CELL RES, V200, P339, DOI 10.1016/0014-4827(92)90181-7; PEREIRA A, 1992, J CELL BIOL, V116, P377, DOI 10.1083/jcb.116.2.377; Perrin L, 1998, J CELL SCI, V111, P2753; Perrin L, 1999, J BIOL CHEM, V274, P6315, DOI 10.1074/jbc.274.10.6315; Perrin L, 2003, MECH DEVELOP, V120, P645, DOI 10.1016/S0925-4773(03)00049-2; Phansalkar R, 2012, CHROMOSOME IN PRESS; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Pluta AF, 1996, J BIOL CHEM, V271, P18767, DOI 10.1074/jbc.271.31.18767; Roman G, 2000, GENETICS, V155, P1281; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Schittenhelm RB, 2010, J CELL SCI, V123, P3768, DOI 10.1242/jcs.067934; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SHAN B, 1992, MOL CELL BIOL, V12, P5620, DOI 10.1128/MCB.12.12.5620; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; WEIMER R, 1992, HUM GENET, V88, P673, DOI 10.1007/BF02265296; Wong LH, 2007, GENOME RES, V17, P1146, DOI 10.1101/gr.6022807	47	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45094	10.1371/journal.pone.0045094	http://dx.doi.org/10.1371/journal.pone.0045094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028777	gold, Green Submitted, Green Published			2022-12-27	WOS:000309392800026
J	Zheng, WH; Zhao, X; Xie, QR; Huang, QP; Zhang, CK; Zhai, HC; Xu, LP; Lu, GD; Shim, WB; Wang, ZH				Zheng, Wenhui; Zhao, Xu; Xie, Qiurong; Huang, Qingping; Zhang, Chengkang; Zhai, Huanchen; Xu, Liping; Lu, Guodong; Shim, Won-Bo; Wang, Zonghua			A Conserved Homeobox Transcription Factor Htf1 Is Required for Phialide Development and Conidiogenesis in Fusarium Species	PLOS ONE			English	Article							ASPERGILLUS-NIDULANS; MAGNAPORTHE-GRISEA; SIGNALING PATHWAY; PLANT INFECTION; GENOME SEQUENCE; HEAD-BLIGHT; GENE; GRAMINEARUM; OXYSPORUM; PATHOGENICITY	Conidia are primary means of asexual reproduction and dispersal in a variety of pathogenic fungi, and it is widely recognized that they play a critical role in animal and plant disease epidemics. However, genetic mechanisms associated with conidiogenesis are complex and remain largely undefined in numerous pathogenic fungi. We previously showed that Htf1, a homeobox transcription factor, is required for conidiogenesis in the rice pathogen Magnaporthe oryzae. In this study, our aim was to characterize how Htf1 homolog regulates common and also distinctive conidiogenesis in three key Fusarium pathogens: F. graminearm, F. verticillioides, and F. oxysporum. When compared to wild-type progenitors, the gene-deletion mutants in Fusarium species failed to form conventional phialides. Rather, they formed clusters of aberrant phialides that resembled elongated hyphae segments, and it is conceivable that this led to the obstruction of conidiation in phialides. We also observed that mutants, as well as wild-type Fusaria, can initiate alternative macroconidia production directly from hyphae through budding-like mechanism albeit at low frequencies. Microscopic observations led us to conclude that proper basal cell division and subsequent foot cell development of macroconidia were negatively impacted in the mutants. In F. verticillioides and F. oxysporum, mutants exhibited a 2- to 5-microconidia complex at the apex of monophialides resulting in a floral petal-like shape. Also, prototypical microconidia chains were absent in F. verticillioides mutants. F. graminearum and F. verticillioides mutants were complemented by introducing its native HTF1 gene or homologs from other Fusarium species. These results suggest that Fusarium Htf1 is functionally conserved homeobox transcription factor that regulates phialide development and conidiogenesis via distinct signaling pathways yet to be characterized in fungi.	[Zheng, Wenhui; Zhao, Xu; Xie, Qiurong; Huang, Qingping; Zhang, Chengkang; Zhai, Huanchen; Lu, Guodong; Shim, Won-Bo; Wang, Zonghua] Fujian Agr & Forestry Univ, Key Lab Biopesticide & Chem Biol, Minist Educ, Fuzhou, Fujian, Peoples R China; [Zheng, Wenhui; Xu, Liping; Wang, Zonghua] Fujian Agr & Forestry Univ, Key Lab Sugarcane Biol & Genet Breeding, Minist Agr, Fuzhou, Fujian, Peoples R China; [Zhai, Huanchen] Henan Univ Technol, Coll Life Sci, Zhengzhou 450000, Henan, Peoples R China; [Shim, Won-Bo] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Henan University of Technology; Texas A&M University System; Texas A&M University College Station	Shim, WB (corresponding author), Fujian Agr & Forestry Univ, Key Lab Biopesticide & Chem Biol, Minist Educ, Fuzhou, Fujian, Peoples R China.	wbshim@neo.tamu.edu; zonghuaw@163.com		Zheng, Wenhui/0000-0002-0208-2375; Wang, Zonghua/0000-0002-0869-9683	National Natural Science Foundation of China [31030004]; Ph.D. Programs Foundation of the Ministry of Education of China [K41110007]; Earmarked Fund for Modern Agro-industry Technology Research System	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); Earmarked Fund for Modern Agro-industry Technology Research System	This research was supported by the National Natural Science Foundation of China (No. 31030004), Ph.D. Programs Foundation of the Ministry of Education of China (No. K41110007), and the Earmarked Fund for Modern Agro-industry Technology Research System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; [Anonymous], 2006, BLACKWELL PUB PROF; Arnaise S, 2001, MOL MICROBIOL, V39, P54, DOI 10.1046/j.1365-2958.2001.02163.x; Badria FA, 1996, J TOXICOL-TOXIN REV, V15, P273, DOI 10.3109/15569549609016448; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Ruiz-Roldan MC, 2010, EUKARYOT CELL, V9, P1216, DOI 10.1128/EC.00040-10; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Choi YE, 2008, MICROBIOL-SGM, V154, P326, DOI 10.1099/mic.0.2007/011411-0; Choi YE, 2010, MOL PLANT MICROBE IN, V23, P522, DOI 10.1094/MPMI-23-4-0522; Chung DW, 2011, FUNGAL GENET BIOL, V48, P370, DOI 10.1016/j.fgb.2010.12.008; CLUTTERBUCK AJ, 1969, GENETICS, V63, P317; COLE GT, 1986, MICROBIOL REV, V50, P95, DOI 10.1128/MMBR.50.2.95-132.1986; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coppin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037488; COUTEAUDIER Y, 1990, CAN J MICROBIOL, V36, P551, DOI 10.1139/m90-096; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dahlberg KR, 1982, ANNU REV PHYTOPATHOL, V20, P218; Dahlgren MA, 2007, AM J OPHTHALMOL, V143, P940, DOI 10.1016/j.ajo.2007.02.030; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Ding SL, 2009, EUKARYOT CELL, V8, P867, DOI 10.1128/EC.00048-09; Dutton JR, 1997, EMBO J, V16, P5710, DOI 10.1093/emboj/16.18.5710; Etxebeste O, 2010, TRENDS MICROBIOL, V18, P569, DOI 10.1016/j.tim.2010.09.007; Fandohan P., 2003, African Journal of Biotechnology, V2, P570; Frandsen RJN, 2006, MOL MICROBIOL, V61, P1069, DOI 10.1111/j.1365-2958.2006.05295.x; Fuchs U, 2004, FUNGAL GENET BIOL, V41, P852, DOI 10.1016/j.fgb.2004.04.004; Gupta AK, 2000, CURR OPIN INFECT DIS, V13, P121, DOI 10.1097/00001432-200004000-00005; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Imamura Y, 2008, ANTIMICROB AGENTS CH, V52, P171, DOI 10.1128/AAC.00387-07; Jenczmionka NJ, 2003, CURR GENET, V43, P87, DOI 10.1007/s00294-003-0379-2; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028291; Katan T, 1997, PHYTOPATHOLOGY, V87, P712, DOI 10.1094/PHYTO.1997.87.7.712; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000757; LEACH CHARLES M., 1962, CANADIAN JOUR BOT, V40, P151, DOI 10.1139/b62-016; Lee SH, 2009, EUKARYOT CELL, V8, P116, DOI 10.1128/EC.00176-08; Lee YH, 2001, BIOCHEM BIOPH RES CO, V284, P133, DOI 10.1006/bbrc.2001.4904; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; Liu WD, 2010, MOL PLANT MICROBE IN, V23, P366, DOI 10.1094/MPMI-23-4-0366; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P54, DOI 10.1094/MPMI-03-10-0075; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mayayo E, 1999, J MED MICROBIOL, V48, P363, DOI 10.1099/00222615-48-4-363; Mehrabi R, 2008, EUKARYOT CELL, V7, P791, DOI 10.1128/EC.00009-08; Miller JD, 2002, ADV EXP MED BIOL, V504, P19; MILLER KY, 1992, GENE DEV, V6, P1770, DOI 10.1101/gad.6.9.1770; MILLER KY, 1991, MOL GEN GENET, V227, P285, DOI 10.1007/BF00259682; MIRABITO PM, 1989, CELL, V57, P859, DOI 10.1016/0092-8674(89)90800-3; Nelson P., 1983, FUSARIUM SPECIES ILL; Ohara T, 2004, EUKARYOT CELL, V3, P1412, DOI 10.1128/EC.3.6.1412-1422.2004; Ohara T, 2004, GENETICS, V166, P113, DOI 10.1534/genetics.166.1.113; Ortoneda M, 2004, INFECT IMMUN, V72, P1760, DOI 10.1128/IAI.72.3.1760-1766.2004; Sempere F, 2009, ANN MICROBIOL, V59, P663, DOI 10.1007/BF03179206; Seong KY, 2008, FUNGAL GENET BIOL, V45, P389, DOI 10.1016/j.fgb.2007.09.002; SEWALL TC, 1990, DEV BIOL, V138, P499, DOI 10.1016/0012-1606(90)90215-5; SEWALL TC, 1994, CAN J MICROBIOL, V40, P1035, DOI 10.1139/m94-164; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; TIEDT LR, 1992, MYCOL RES, V96, P187, DOI 10.1016/S0953-7562(09)80964-7; Tschopp P, 2011, ANNU REV GENET, V45, P145, DOI 10.1146/annurev-genet-102209-163429; VANWYK PS, 1987, T BRIT MYCOL SOC, V88, P347, DOI 10.1016/S0007-1536(87)80009-8; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wong P, 2011, NUCLEIC ACIDS RES, V39, pD637, DOI 10.1093/nar/gkq1016; Wu AB, 2005, MYCOPATHOLOGIA, V160, P75, DOI 10.1007/s11046-005-1153-4; Wu F, 2004, ENVIRON SCI TECHNOL, V38, P4049, DOI 10.1021/es035353n; Xu YB, 2010, FUNGAL GENET BIOL, V47, P205, DOI 10.1016/j.fgb.2009.11.003; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zange BJ, 2005, Z PFLANZENK PFLANZEN, V112, P52; Zhang DJ, 2010, MOL PLANT PATHOL, V11, P495, DOI [10.1111/J.1364-3703.2010.00626.X, 10.1111/j.1364-3703.2010.00626.x]; Zhao X., 2004, FUNGAL GENETICS REPO, V51, P17; Zhou XY, 2010, FUNGAL GENET BIOL, V47, P143, DOI 10.1016/j.fgb.2009.11.001	73	56	60	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45432	10.1371/journal.pone.0045432	http://dx.doi.org/10.1371/journal.pone.0045432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029006	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800048
J	Lemaitre, M; Carrat, F; Rey, G; Miller, M; Simonsen, L; Viboud, C				Lemaitre, Magali; Carrat, Fabrice; Rey, Gregoire; Miller, Mark; Simonsen, Lone; Viboud, Cecile			Mortality Burden of the 2009 A/H1N1 Influenza Pandemic in France: Comparison to Seasonal Influenza and the A/H3N2 Pandemic	PLOS ONE			English	Article							UNITED-STATES; A H1N1; EPIDEMICS; IMPACT; MORBIDITY; ENGLAND; DEATHS; PNEUMONIA; INFECTION; A(H1N1)	Background: The mortality burden of the 2009 A/H1N1 pandemic remains unclear in many countries due to delays in reporting of death statistics. We estimate the age- and cause-specific excess mortality impact of the pandemic in France, relative to that of other countries and past epidemic and pandemic seasons. Methods: We applied Serfling and Poisson excess mortality approaches to model weekly age-and cause-specific mortality rates from June 1969 through May 2010 in France. Indicators of influenza activity, time trends, and seasonal terms were included in the models. We also reviewed the literature for country-specific estimates of 2009 pandemic excess mortality rates to characterize geographical differences in the burden of this pandemic. Results: The 2009 A/H1N1 pandemic was associated with 1.0 (95% Confidence Intervals (CI) 0.2-1.9) excess respiratory deaths per 100,000 population in France, compared to rates per 100,000 of 44 (95% CI 43-45) for the A/H3N2 pandemic and 2.9 (95% CI 2.3-3.7) for average inter-pandemic seasons. The 2009 A/H1N1 pandemic had a 10.6-fold higher impact than inter-pandemic seasons in people aged 5-24 years and 3.8-fold lower impact among people over 65 years. Conclusions: The 2009 pandemic in France had low mortality impact in most age groups, relative to past influenza seasons, except in school-age children and young adults. The historical A/H3N2 pandemic was associated with much larger mortality impact than the 2009 pandemic, across all age groups and outcomes. Our 2009 pandemic excess mortality estimates for France fall within the range of previous estimates for high-income regions. Based on the analysis of several mortality outcomes and comparison with laboratory-confirmed 2009/H1N1 deaths, we conclude that cardio-respiratory and all-cause mortality lack precision to accurately measure the impact of this pandemic in high-income settings and that use of more specific mortality outcomes is important to obtain reliable age-specific estimates.	[Lemaitre, Magali; Miller, Mark; Simonsen, Lone; Viboud, Cecile] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lemaitre, Magali; Carrat, Fabrice] INSERM, UMR S 707, Paris, France; [Carrat, Fabrice] UPMC Paris 6, UMR S 707, Paris, France; [Carrat, Fabrice] Hop St Antoine, AP HP, Publ Hlth Unit, F-75571 Paris, France; [Rey, Gregoire] CepiDC, INSERM, Le Vesinet, France; [Simonsen, Lone] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Global Hlth, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); George Washington University	Lemaitre, M (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	maglemaitre@gmail.com	Simonsen, Lone/K-4531-2014; Carrat, Fabrice/AAU-8480-2020; Rey, Grégoire/AAD-8966-2019	Simonsen, Lone/0000-0003-1535-8526; Carrat, Fabrice/0000-0002-8672-7918; Rey, Gregoire/0000-0001-7291-9444	Fondation de la Recherche Medicale; Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health; International Influenza Unit, Office of Global Affairs, Department of Health and Human Services; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security	Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health; International Influenza Unit, Office of Global Affairs, Department of Health and Human Services; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security	This work was supported by a grant from Fondation de la Recherche Medicale (to M. Lemaitre) and by the in-house Influenza Research Program of the Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, which is funded by the International Influenza Unit, Office of Global Affairs, Department of Health and Human Services. L. S. acknowledges support from the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballester F, 1997, INT J EPIDEMIOL, V26, P551, DOI 10.1093/ije/26.3.551; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; Casalegno JS, 2010, EURO SURVEILL, V15; CASTILLA J, 2010, EURO SURVEILL, V15; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Centers for Disease Control and Prevention, 2010, MMWR-MORBID MORTAL W, V59, P1057; Charu V, 2011, CLIN INFECT DIS, V53, P985, DOI 10.1093/cid/cir644; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Crepey P, 2007, AM J EPIDEMIOL, V166, P1244, DOI 10.1093/aje/kwm266; Denoeud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000464; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Falchi A, 2011, J MED VIROL, V83, P1451, DOI 10.1002/jmv.22113; Goldstein E, 2012, EPIDEMIOLOG IN PRESS; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Guthmann J, 2010, BEH; Hardelid P, 2011, EPIDEMIOL INFECT, V139, P1431, DOI 10.1017/S0950268811000410; Lemaitre M, 2011, CLIN MICROBIOL INFEC, V17, P732, DOI 10.1111/j.1469-0691.2010.03352.x; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; LUI KJ, 1987, AM J PUBLIC HEALTH, V77, P712, DOI 10.2105/AJPH.77.6.712; Mazick A, 2010, EURO SURVEILL, V15; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller MA, 2008, J INFECT DIS, V198, P305, DOI 10.1086/589716; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Muscatello DJ, 2010, EMERG INFECT DIS, V16, P1396, DOI 10.3201/eid1609.091723; Nielsen J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-350; Pavillon G, 2004, WHO FAM INT CLASS NE; Rizzo C, 2007, EMERG INFECT DIS, V13, P694, DOI 10.3201/eid1305.061309; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2012, J INFECT DI IN PRESS; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; van den Wijngaard CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031197; Vaux S, 2010, BEH; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Viboud C, 2010, PLOS CURR; Vicente P, 2011, BEH, V1, P1; Wielders CCH, 2012, EUR J PUBLIC HEALTH, V22, P150, DOI 10.1093/eurpub/ckq187; Yang L, 2011, EPIDEMIOL INFECT, P1	45	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45051	10.1371/journal.pone.0045051	http://dx.doi.org/10.1371/journal.pone.0045051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028756	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900018
J	Zheng, SD; Wang, J; Feng, YG; Wang, JF; Ye, KQ				Zheng, Sanduo; Wang, Jia; Feng, Yingang; Wang, Jinfeng; Ye, Keqiong			Solution Structure of MSL2 CXC Domain Reveals an Unusual Zn(3)Cys(9) Cluster and Similarity to Pre-SET Domains of Histone Lysine Methyltransferases	PLOS ONE			English	Article							DOSAGE COMPENSATION COMPLEX; MALE-SPECIFIC LETHAL-2; DNA-BINDING PROTEIN; X-CHROMOSOME; RING FINGER; MACROMOLECULAR STRUCTURE; DROSOPHILA-MELANOGASTER; NMR STRUCTURE; GENE; METALLOTHIONEIN	The dosage compensation complex (DCC) binds to single X chromosomes in Drosophila males and increases the transcription level of X-linked genes by approximately twofold. Male-specific lethal 2 (MSL2) together with MSL1 mediates the initial recruitment of the DCC to high-affinity sites in the X chromosome. MSL2 contains a DNA-binding cysteine-rich CXC domain that is important for X targeting. In this study, we determined the solution structure of MSL2 CXC domain by NMR spectroscopy. We identified three zinc ions in the CXC domain and determined the metal-to-cysteine connectivities from H-1-Cd-113 correlation experiments. The structure reveals an unusual zinc-cysteine cluster composed of three zinc ions coordinated by six terminal and three bridging cysteines. The CXC domain exhibits unexpected structural homology to pre-SET motifs of histone lysine methyltransferases, expanding the distribution and structural diversity of the CXC domain superfamily. Our findings provide novel structural insight into the evolution and function of CXC domains.	[Feng, Yingang] Chinese Acad Sci, Shandong Prov Key Lab Energy Genet, Qingdao Inst BioEnergy & Bioproc Technol, Qingdao, Shangdong, Peoples R China; [Feng, Yingang; Wang, Jinfeng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zheng, Sanduo; Wang, Jia] Beijing Normal Univ, Dept Biochem & Mol Biol, Coll Life Sci, Beijing 100875, Peoples R China; [Zheng, Sanduo; Wang, Jia; Ye, Keqiong] Natl Inst Biol Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Beijing Normal University; National Institute of Biological Sciences, Beijing	Feng, YG (corresponding author), Chinese Acad Sci, Shandong Prov Key Lab Energy Genet, Qingdao Inst BioEnergy & Bioproc Technol, Qingdao, Shangdong, Peoples R China.	fengyg@qibebt.ac.cn; yekeqiong@nibs.ac.cn	Feng, Yingang/B-6304-2008	Feng, Yingang/0000-0002-0879-1316	National Basic Research Program of China (973 Program) [2010CB835402, 2012CB910900]; Beijing Municipal Government; National Natural Science Foundation of China [30970571]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Beijing Municipal Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	K.Y. was supported by the National Basic Research Program of China (973 Program) (2010CB835402 and 2012CB910900) and Beijing Municipal Government. Y.F. was supported by the National Natural Science Foundation of China (30970571). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; Blindauer CA, 2001, P NATL ACAD SCI USA, V98, P9593, DOI 10.1073/pnas.171120098; BRAUN W, 1992, P NATL ACAD SCI USA, V89, P10124, DOI 10.1073/pnas.89.21.10124; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Cvitanich C, 2000, P NATL ACAD SCI USA, V97, P8163, DOI 10.1073/pnas.090468497; Dahlsveen IK, 2006, PLOS GENET, V2, P104, DOI 10.1371/journal.pgen.0020005; DeLano WL, 2002, PYMOL USERS MANUAL; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Fauth T, 2010, NUCLEIC ACIDS RES, V38, P3209, DOI 10.1093/nar/gkq026; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Grimaud C, 2009, GENE DEV, V23, P2490, DOI 10.1101/gad.539509; Gu WG, 1998, DEV GENET, V22, P56, DOI 10.1002/(SICI)1520-6408(1998)22:1<56::AID-DVG6>3.0.CO;2-6; Hauser BA, 2000, DEVELOPMENT, V127, P2219; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hobert O, 1996, MOL CELL BIOL, V16, P3066; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lyman LM, 1997, GENETICS, V147, P1743; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; Meller VH, 2000, CURR BIOL, V10, P136, DOI 10.1016/S0960-9822(00)00311-0; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Munoz A, 2002, J BIOL INORG CHEM, V7, P713, DOI 10.1007/s00775-002-0345-3; NARULA SS, 1995, BIOCHEMISTRY-US, V34, P620, DOI 10.1021/bi00002a029; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Oh H, 2004, CURR BIOL, V14, P481, DOI 10.1016/j.cub.2004.03.004; Oh K, 2003, GENE DEV, V17, P1334, DOI 10.1101/gad.1082003; Park Y, 2003, MOL CELL, V11, P977, DOI 10.1016/S1097-2765(03)00147-3; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Riek R, 1999, J MOL BIOL, V291, P417, DOI 10.1006/jmbi.1999.2967; Schmit F, 2009, FEBS J, V276, P5703, DOI 10.1111/j.1742-4658.2009.07261.x; Scott MJ, 2000, EMBO J, V19, P144, DOI 10.1093/emboj/19.1.144; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Song JY, 2000, DEVELOPMENT, V127, P2207; Straub T, 2007, NAT REV GENET, V8, P47, DOI 10.1038/nrg2013; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; Sural TH, 2008, NAT STRUCT MOL BIOL, V15, P1318, DOI 10.1038/nsmb.1520; Vasak M, 1998, BIODEGRADATION, V9, P501, DOI 10.1023/A:1008346231847; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Wu LP, 2011, MOL CELL, V43, P132, DOI 10.1016/j.molcel.2011.05.015; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x	59	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45437	10.1371/journal.pone.0045437	http://dx.doi.org/10.1371/journal.pone.0045437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029009	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900053
J	Fehl, K; Sommerfeld, RD; Semmann, D; Krambeck, HJ; Milinski, M				Fehl, Katrin; Sommerfeld, Ralf D.; Semmann, Dirk; Krambeck, Hans-Juergen; Milinski, Manfred			I Dare You to Punish Me-Vendettas in Games of Cooperation	PLOS ONE			English	Article							PUBLIC-GOODS GAMES; ALTRUISTIC PUNISHMENT; COSTLY PUNISHMENT; ANTISOCIAL PUNISHMENT; INDIRECT RECIPROCITY; SOCIAL DILEMMAS; EVOLUTION; REVENGE; HUMANS; RETALIATION	Everybody has heard of neighbours, who have been fighting over some minor topic for years. The fight goes back and forth, giving the neighbours a hard time. These kind of reciprocal punishments are known as vendettas and they are a cross-cultural phenomenon. In evolutionary biology, punishment is seen as a mechanism for maintaining cooperative behaviour. However, this notion of punishment excludes vendettas. Vendettas pose a special kind of evolutionary problem: they incur high costs on individuals, i.e. costs of punishing and costs of being punished, without any benefits. Theoretically speaking, punishment should be rare in dyadic relationships and vendettas would not evolve under natural selection. In contrast, punishment is assumed to be more efficient in group environments which then can pave the way for vendettas. Accordingly, we found that under the experimental conditions of a prisoner's dilemma game, human participants punished only rarely and vendettas are scarce. In contrast, we found that participants retaliated frequently in the group environment of a public goods game. They even engaged in cost-intense vendettas (i.e. continuous retaliation), especially when the first punishment was unjustified or ambiguous. Here, punishment was mainly targeted at defectors in the beginning, but provocations led to mushrooming of counter-punishments. Despite the counter-punishing behaviour, participants were able to enhance cooperation levels in the public goods game. Few participants even seemed to anticipate the outbreak of costly vendettas and delayed their punishment to the last possible moment. Overall, our results highlight the importance of different social environments while studying punishment as a cooperation-enhancing mechanism.	[Fehl, Katrin; Semmann, Dirk] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Jr Res Grp Evolut Cooperat & Prosocial Behav, Gottingen, Germany; [Sommerfeld, Ralf D.; Krambeck, Hans-Juergen; Milinski, Manfred] Max Planck Inst Evolutionary Biol, Dept Evolutionary Ecol, Plon, Germany	University of Gottingen; Max Planck Society	Fehl, K (corresponding author), Univ Gottingen, Courant Res Ctr Evolut Social Behav, Jr Res Grp Evolut Cooperat & Prosocial Behav, Gottingen, Germany.	Katrin.Fehl@bio.uni-goettingen.de			German Initiative of Excellence of the German Science Foundation (DFG)	German Initiative of Excellence of the German Science Foundation (DFG)(German Research Foundation (DFG))	D.S. and K.F. are funded by the German Initiative of Excellence of the German Science Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JS, 1965, ADV EXP SOC PSYCHOL, V2, P267; AURELI F, 1992, ANIM BEHAV, V44, P283, DOI 10.1016/0003-3472(92)90034-7; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Brosnan SF, 2010, EVOL HUM BEHAV, V31, P279, DOI 10.1016/j.evolhumbehav.2010.02.003; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; ELSTER J, 1990, ETHICS, V100, P862, DOI 10.1086/293238; Ericksen K.P., 1992, CROSS-CULT RES, V26, P57, DOI DOI 10.1177/106939719202600103; Fehl K, 2011, ECOL LETT, V14, P546, DOI 10.1111/j.1461-0248.2011.01615.x; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gould RV, 2000, AM SOCIOL REV, V65, P682, DOI 10.2307/2657542; Greene W. H., 2012, ECONOMETRIC ANAL, V7th; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hellman Hal, 1998, GREAT FEUDS SCI 10 L; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; ICLI TG, 1994, BRIT J CRIMINOL, V34, P69; Janssen MA, 2008, J THEOR BIOL, V254, P541, DOI 10.1016/j.jtbi.2008.06.017; Jensen K, 2007, P NATL ACAD SCI USA, V104, P13046, DOI 10.1073/pnas.0705555104; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Johnstone RA, 2004, P ROY SOC B-BIOL SCI, V271, P1917, DOI 10.1098/rspb.2003.2581; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Melis AP, 2010, PHILOS T R SOC B, V365, P2663, DOI 10.1098/rstb.2010.0157; Milinski M, 2012, J THEOR BIOL, V299, P139, DOI 10.1016/j.jtbi.2011.03.014; Nikiforakis N, 2008, EXP ECON, V11, P358, DOI 10.1007/s10683-007-9171-3; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Nikiforakis N, 2011, J ECON BEHAV ORGAN, V78, P319, DOI 10.1016/j.jebo.2011.01.017; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Pennisi E, 2009, SCIENCE, V325, P1196, DOI 10.1126/science.325_1196; Raihani NJ, 2012, TRENDS ECOL EVOL, V27, P288, DOI 10.1016/j.tree.2011.12.004; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Rand DG, 2009, J THEOR BIOL, V256, P45, DOI 10.1016/j.jtbi.2008.09.015; Rapoport A., 1965, PRISONERS DILEMMA ST; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Semmann D, 2005, BEHAV ECOL SOCIOBIOL, V57, P611, DOI 10.1007/s00265-004-0885-3; Shakespeare William, 1954, TRAGEDY ROMEO JULIET; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Stillwell AM, 2008, BASIC APPL SOC PSYCH, V30, P253, DOI 10.1080/01973530802375094; The Local, 2010, LOCAL           0610; Wu JJ, 2009, P NATL ACAD SCI USA, V106, P17448, DOI 10.1073/pnas.0905918106; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	58	20	21	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45093	10.1371/journal.pone.0045093	http://dx.doi.org/10.1371/journal.pone.0045093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028776	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400059
J	Okamura-Oho, Y; Shimokawa, K; Takemoto, S; Hirakiyama, A; Nakamura, S; Tsujimura, Y; Nishimura, M; Kasukawa, T; Masumoto, K; Nikaido, I; Shigeyoshi, Y; Ueda, HR; Song, G; Gee, J; Himeno, R; Yokota, H				Okamura-Oho, Yuko; Shimokawa, Kazuro; Takemoto, Satoko; Hirakiyama, Asami; Nakamura, Sakiko; Tsujimura, Yuki; Nishimura, Masaomi; Kasukawa, Takeya; Masumoto, Koh-hei; Nikaido, Itoshi; Shigeyoshi, Yasufumi; Ueda, Hiroki R.; Song, Gang; Gee, James; Himeno, Ryutaro; Yokota, Hideo			Transcriptome Tomography for Brain Analysis in the Web-Accessible Anatomical Space	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; GENE-EXPRESSION; NEURONS; NEUROPATHOLOGY; VOXELATION; SEROTONIN; DATABASE	Increased information on the encoded mammalian genome is expected to facilitate an integrated understanding of complex anatomical structure and function based on the knowledge of gene products. Determination of gene expression-anatomy associations is crucial for this understanding. To elicit the association in the three-dimensional (3D) space, we introduce a novel technique for comprehensive mapping of endogenous gene expression into a web-accessible standard space: Transcriptome Tomography. The technique is based on conjugation of sequential tissue-block sectioning, all fractions of which are used for molecular measurements of gene expression densities, and the block-face imaging, which are used for 3D reconstruction of the fractions. To generate a 3D map, tissues are serially sectioned in each of three orthogonal planes and the expression density data are mapped using a tomographic technique. This rapid and unbiased mapping technique using a relatively small number of original data points allows researchers to create their own expression maps in the broad anatomical context of the space. In the first instance we generated a dataset of 36,000 maps, reconstructed from data of 61 fractions measured with microarray, covering the whole mouse brain (ViBrism: http://vibrism.riken.jp/3dviewer/ex/index.html) in one month. After computational estimation of the mapping accuracy we validated the dataset against existing data with respect to the expression location and density. To demonstrate the relevance of the framework, we showed disease related expression of Huntington's disease gene and Bdnf. Our tomographic approach is applicable to analysis of any biological molecules derived from frozen tissues, organs and whole embryos, and the maps are spatially isotropic and well suited to the analysis in the standard space (e.g. Waxholm Space for brain-atlas databases). This will facilitate research creating and using open-standards for a molecular-based understanding of complex structures; and will contribute to new insights into a broad range of biological and medical questions.	[Okamura-Oho, Yuko; Nakamura, Sakiko; Himeno, Ryutaro; Yokota, Hideo] RIKEN, ASI, Adv Computat Sci Dept, Saitama, Japan; [Takemoto, Satoko; Tsujimura, Yuki; Nishimura, Masaomi; Yokota, Hideo] RIKEN, ASI, Biores Infrastruct Construct Team, Saitama, Japan; [Okamura-Oho, Yuko; Shimokawa, Kazuro; Hirakiyama, Asami] RIKEN Yokohama Inst, GSC, Lab Genome Explorat Res Grp, Yokohama, Kanagawa, Japan; [Shimokawa, Kazuro] Tokyo Med Dent Univ, Univ Ctr Informat Med, Tokyo, Japan; [Kasukawa, Takeya; Nikaido, Itoshi; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Funct Genom Unit, Kobe, Hyogo, Japan; [Masumoto, Koh-hei; Nikaido, Itoshi; Ueda, Hiroki R.] RIKEN Ctr Dev Biol, Lab Syst Biol, Kobe, Hyogo, Japan; [Masumoto, Koh-hei; Shigeyoshi, Yasufumi] Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan; [Song, Gang; Gee, James] Univ Penn, Dept Radiol, Penn Image Comp & Sci Lab, Philadelphia, PA 19104 USA	RIKEN; RIKEN; RIKEN; Tokyo Medical & Dental University (TMDU); RIKEN; RIKEN; Kindai University (Kinki University); University of Pennsylvania		yoho@brent-research.org	Kasukawa, Takeya/N-5070-2015; Nikaido, Itoshi/K-2058-2014; Ueda, Hiroki R/C-5037-2014	Kasukawa, Takeya/0000-0001-5085-0802; Nikaido, Itoshi/0000-0002-7261-2570; Ueda, Hiroki R/0000-0001-8342-9176; Okamura-Oho, Yuko/0000-0002-2066-407X; Takemoto, Satoko/0000-0003-0258-6589	Strategic Programs for R&D (President's Discretionary Fund) RIKEN; National Institutes of Health [DA022807, EB006266]; Department of Health and Human Services [HHSN276201000492P]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022807] Funding Source: NIH RePORTER	Strategic Programs for R&D (President's Discretionary Fund) RIKEN; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by Strategic Programs for R&D (President's Discretionary Fund) RIKEN to H.Y., Y.O., K.S., S.N. and R.H., and by National Institutes of Health grants DA022807 and EB006266 and Department of Health and Human Services award HHSN276201000492P to J.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Baldock RA, 2003, NEUROINFORMATICS, V1, P309, DOI 10.1385/NI:1:4:309; Brown VM, 2002, PHYSIOL GENOMICS, V8, P159, DOI 10.1152/physiolgenomics.00090.2001; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chin MH, 2007, PHYSIOL GENOMICS, V30, P313, DOI 10.1152/physiolgenomics.00287.2006; DOM R, 1976, NEUROLOGY, V26, P64, DOI 10.1212/WNL.26.1.64; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Han I, 2010, J NEUROCHEM, V113, P1073, DOI 10.1111/j.1471-4159.2010.06672.x; Hawrylycz M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001065; HEINSEN H, 1994, ACTA NEUROPATHOL, V88, P320, DOI 10.1007/BF00310376; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Ichikawa M, 2008, BIOCHEM BIOPH RES CO, V368, P43, DOI 10.1016/j.bbrc.2008.01.041; JESTE DV, 1984, EXP NEUROL, V85, P78, DOI 10.1016/0014-4886(84)90162-6; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Kasukawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023228; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LI YW, 1995, J NEUROSCI, V15, P2888; Liu Z, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-19; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; MANN DMA, 1993, ACTA NEUROPATHOL, V85, P553, DOI 10.1007/BF00230496; OYANAGI K, 1989, ANN NEUROL, V26, P13, DOI 10.1002/ana.410260103; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Singh RP, 2003, J NEUROSCI METH, V125, P93, DOI 10.1016/S0165-0270(03)00045-1; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Thieben MJ, 2002, BRAIN, V125, P1815, DOI 10.1093/brain/awf179; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Yokota H., 2002, Medical Imaging Technology, V20, P660; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	33	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45373	10.1371/journal.pone.0045373	http://dx.doi.org/10.1371/journal.pone.0045373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028969	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400080
J	Buchan, SL; Al-Shamkhani, A				Buchan, Sarah L.; Al-Shamkhani, Aymen			Distinct Motifs in the Intracellular Domain of Human CD30 Differentially Activate Canonical and Alternative Transcription Factor NF-kappa B Signaling	PLOS ONE			English	Article							LARGE-CELL LYMPHOMA; RECEPTOR SUPERFAMILY; BINDING-SITES; PROTEIN TRADD; CYCLE ARREST; IKK-ALPHA; T-CELLS; IN-VIVO; TNF; KINASE	The TNF-receptor superfamily member CD30 is expressed on normal and malignant lymphocytes, including anaplastic large cell lymphoma (ALCL) cells. CD30 transmits multiple effects, including activation of NF-kappa B signaling, cell proliferation, growth arrest and apoptosis. How CD30 generates these pleiotropic effects is currently unknown. Herein we describe ALCL cells expressing truncated forms of the CD30 intracellular domain that allowed us to identify the key regions responsible for transmitting its biological effects in lymphocytes. The first region (CD30(519-537)) activated both the alternative and canonical NF-kappa B pathways as detected by p100 and I kappa B alpha degradation, IKK beta-dependent transcription of both IkBa and the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and induction of cell cycle arrest. In contrast, the second region of CD30 (CD30(538-595)) induced some aspects of canonical NF-kappa B activation, including transcription of I kappa B alpha, but failed to activate the alternative NF-kappa B pathway or drive p21(WAF1/CIP1)-mediated cell-cycle arrest. Direct comparison of canonical NF-kappa B activation by the two motifs revealed 4-fold greater p65 nuclear translocation following CD30(519-537) engagement. These data reveal that independent regions of the CD30 cytoplasmic tail regulate the magnitude and type of NF-kappa B activation and additionally identify a short motif necessary for CD30-driven growth arrest signals in ALCL cells.	[Buchan, Sarah L.; Al-Shamkhani, Aymen] Univ Southampton, Southampton Gen Hosp, Sch Med, Canc Sci Unit, Southampton, Hants, England	University of Southampton	Buchan, SL (corresponding author), Univ Southampton, Southampton Gen Hosp, Sch Med, Canc Sci Unit, Southampton, Hants, England.	slb@soton.ac.uk; aymen@soton.ac.uk	Buchan, Sarah/AGK-4217-2022	Buchan, Sarah/0000-0003-0913-8826; Al-Shamkhani, Aymen/0000-0003-0727-4189	University of Southampton Faculty of Medicine postdoctoral career track fellowship; Lymphoma and Leukaemia Research [07014]	University of Southampton Faculty of Medicine postdoctoral career track fellowship; Lymphoma and Leukaemia Research	This work was supported by a University of Southampton Faculty of Medicine postdoctoral career track fellowship (SLB) and by Lymphoma and Leukaemia Research (http://www.leukaemialymphomaresearch.org.uk; grant 07014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; Aizawa S, 1997, J BIOL CHEM, V272, P2042; Al-Shamkhani A, 2004, CURR OPIN PHARMACOL, V4, P355, DOI 10.1016/j.coph.2004.02.007; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Chiarle R, 1999, J IMMUNOL, V163, P194; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dai ZH, 2005, J IMMUNOL, V174, P1165, DOI 10.4049/jimmunol.174.3.1165; Duckett CS, 1997, MOL CELL BIOL, V17, P1535, DOI 10.1128/MCB.17.3.1535; FALINI B, 1995, BLOOD, V85, P1; Gedrich RW, 1996, J BIOL CHEM, V271, P12852, DOI 10.1074/jbc.271.22.12852; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; GRUSS HJ, 1994, BLOOD, V83, P2045; Hargreaves PG, 2002, EUR J IMMUNOL, V32, P163, DOI 10.1002/1521-4141(200201)32:1<163::AID-IMMU163>3.0.CO;2-T; Hellin AC, 2000, J PHARMACOL EXP THER, V295, P870; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Horie R, 1998, INT IMMUNOL, V10, P203, DOI 10.1093/intimm/10.2.203; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hubinger G, 2001, ONCOGENE, V20, P590, DOI 10.1038/sj.onc.1204128; Krysov SV, 2007, MOL CANCER THER, V6, P703, DOI 10.1158/1535-7163.MCT-06-0544; Lee SY, 1996, J EXP MED, V183, P669, DOI 10.1084/jem.183.2.669; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; LOMBARDI L, 1995, NUCLEIC ACIDS RES, V23, P2328, DOI 10.1093/nar/23.12.2328; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mir SS, 2000, BLOOD, V96, P4307; Nishikori M, 2005, CANCER SCI, V96, P487, DOI 10.1111/j.1349-7006.2005.00078.x; O'Mahony A, 2000, MOL CELL BIOL, V20, P1170, DOI 10.1128/MCB.20.4.1170-1178.2000; Pham LV, 2011, BLOOD, V117, P200, DOI 10.1182/blood-2010-06-290437; Pobezinskaya YL, 2011, J IMMUNOL, V186, P5212, DOI 10.4049/jimmunol.1002374; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Ramsby ML, 1999, METH MOL B, V112, P53; Rowley TF, 2004, J IMMUNOL, V172, P6039, DOI 10.4049/jimmunol.172.10.6039; Seitz CS, 2000, CANCER RES, V60, P4085; Slebioda TJ, 2011, EUR J IMMUNOL, V41, P2606, DOI 10.1002/eji.201141477; SMITH CA, 1993, CELL, V73, P1349, DOI 10.1016/0092-8674(93)90361-S; Taraban VY, 2002, EUR J IMMUNOL, V32, P3617, DOI 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Telford WG, 1997, CELL IMMUNOL, V182, P125, DOI 10.1006/cimm.1997.1228; TIAN ZG, 1995, CANCER RES, V55, P5335; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wright CW, 2007, J BIOL CHEM, V282, P10252, DOI 10.1074/jbc.M608817200; Wright CW, 2009, SCIENCE, V323, P251, DOI 10.1126/science.1162818; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	47	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45244	10.1371/journal.pone.0045244	http://dx.doi.org/10.1371/journal.pone.0045244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028875	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000311313900104
J	Kawabe, T; Kawabe, K; Sapru, HN				Kawabe, Tetsuya; Kawabe, Kazumi; Sapru, Hreday N.			Cardiovascular Responses to Chemical Stimulation of the Hypothalamic Arcuate Nucleus in the Rat: Role of the Hypothalamic Paraventricular Nucleus	PLOS ONE			English	Article							NERVOUS-SYSTEM CONTROL; NEUROPEPTIDE-Y; BLOOD-PRESSURE; NEURONS; GLUTAMATE; AREAS; GABA; MICROINJECTIONS; IDENTIFICATION; ENDOMORPHIN-2	The mechanism of cardiovascular responses to chemical stimulation of the hypothalamic arcuate nucleus (ARCN) was studied in urethane-anesthetized adult male Wistar rats. At the baseline mean arterial pressure (BLMAP) close to normal, ARCN stimulation elicited decreases in MAP and sympathetic nerve activity (SNA). The decreases in MAP elicited by ARCN stimulation were attenuated by either gamma-aminobutyric acid (GABA), neuropeptide Y (NPY), or beta-endorphin receptor blockade in the ipsilateral hypothalamic paraventricular nucleus (PVN). Combined blockade of GABA-A, NPY1 and opioid receptors in the ipsilateral PVN converted the decreases in MAP and SNA to increases in these variables. Conversion of inhibitory effects on the MAP and SNA to excitatory effects following ARCN stimulation was also observed when the BLMAP was decreased to below normal levels by an infusion of sodium nitroprusside. The pressor and tachycardic responses to ARCN stimulation at below normal BLMAP were attenuated by blockade of melanocortin 3/4 (MC3/4) receptors in the ipsilateral PVN. Unilateral blockade of GABA-A receptors in the ARCN increased the BLMAP and heart rate (HR) revealing tonic inhibition of the excitatory neurons in the ARCN. ARCN stimulation elicited tachycardia regardless of the level of BLMAP. ARCN neurons projecting to the PVN were immunoreactive for glutamic acid decarboxylase 67 (GAD67), NPY, and beta-endorphin. These results indicated that: 1) at normal BLMAP, decreases in MAP and SNA induced by ARCN stimulation were mediated via GABA-A, NPY1 and opioid receptors in the PVN, 2) lowering of BLMAP converted decreases in MAP following ARCN stimulation to increases in MAP, and 3) at below normal BLMAP, increases in MAP and HR induced by ARCN stimulation were mediated via MC3/4 receptors in the PVN. These results provide a base for future studies to explore the role of ARCN in cardiovascular diseases.	[Kawabe, Tetsuya; Kawabe, Kazumi; Sapru, Hreday N.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sapru, HN (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, 185 S Orange Ave, Newark, NJ 07103 USA.	sapru@umdnj.edu			NIH [HL024347, HL076248]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024347, R01HL076248] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grants HL024347 and HL076248 awarded to H.N. Sapru.	ALBERS HE, 1990, AM J PHYSIOL, V258, pR376, DOI 10.1152/ajpregu.1990.258.2.R376; [Anonymous], 2004, NEURAL MECH CARDIOVA, DOI DOI 10.1007/978-1-4419-9054-9_6; Antal-Zimanyi I, 2008, EUR J PHARMACOL, V590, P224, DOI 10.1016/j.ejphar.2008.06.032; Arakawa H, 2011, AM J PHYSIOL-HEART C, V300, pH951, DOI 10.1152/ajpheart.01144.2010; Badoer E, 2001, CLIN EXP PHARMACOL P, V28, P95, DOI 10.1046/j.1440-1681.2001.03413.x; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Biebermann Heike, 2012, Handb Exp Pharmacol, P47, DOI 10.1007/978-3-642-24716-3_3; Chen QH, 2003, HYPERTENSION, V42, P725, DOI 10.1161/01.HYP.0000085197.20043.44; CHRONWALL BM, 1985, PEPTIDES, V6, P1, DOI 10.1016/0196-9781(85)90128-7; Ciofi P, 2009, ENDOCRINOLOGY, V150, P5509, DOI 10.1210/en.2009-0584; Dampney RAL, 2011, J PHYSIOL-LONDON, V589, P2109, DOI 10.1113/jphysiol.2011.208579; Dampney RAL, 2005, CLIN EXP PHARMACOL P, V32, P419, DOI 10.1111/j.1440-1681.2005.04205.x; Dicken MS, 2012, J NEUROSCI, V32, P4042, DOI 10.1523/JNEUROSCI.6032-11.2012; Dun SL, 2006, PEPTIDES, V27, P1949, DOI 10.1016/j.peptides.2005.10.027; Ghamari-Langroudi M, 2012, MOL NEUROBIOL, V45, P258, DOI 10.1007/s12035-012-8241-5; GROSS PM, 1992, PROG BRAIN RES, V91, P219; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hentges ST, 2009, J NEUROSCI, V29, P13684, DOI 10.1523/JNEUROSCI.3770-09.2009; HOLSTEGE G, 1987, J COMP NEUROL, V260, P98, DOI 10.1002/cne.902600109; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; IBATA Y, 1985, BRAIN RES, V341, P233, DOI 10.1016/0006-8993(85)91062-5; KANNAN H, 1988, BRAIN RES BULL, V20, P779, DOI 10.1016/0361-9230(88)90091-3; Kasamatsu K, 2004, AM J PHYSIOL-REG I, V287, pR715, DOI 10.1152/ajpregu.00642.2003; Kawabe T, 2008, NEUROSCIENCE, V153, P605, DOI 10.1016/j.neuroscience.2008.02.076; Kawabe T, 2006, BRAIN RES, V1102, P117, DOI 10.1016/j.brainres.2006.05.002; KOW LM, 1989, PHYSIOL BEHAV, V46, P265, DOI 10.1016/0031-9384(89)90266-7; LANTOS TA, 1995, BRAIN RES REV, V20, P209, DOI 10.1016/0165-0173(94)00013-F; Li C, 1998, REGUL PEPTIDES, V75-6, P93, DOI 10.1016/S0167-0115(98)00057-3; Li SJ, 1996, J NEUROSCI, V16, P5182; Li YF, 2006, AM J PHYSIOL-HEART C, V291, pH2847, DOI 10.1152/ajpheart.00625.2005; Mao L, 2005, NEUROSCIENCE, V132, P1009, DOI 10.1016/j.neuroscience.2005.01.037; MARTIN DS, 1993, AM J PHYSIOL, V265, pH1727, DOI 10.1152/ajpheart.1993.265.5.H1727; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Mendelowitz D, 1999, NEWS PHYSIOL SCI, V14, P155; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nakamura T, 2009, HYPERTENSION, V54, P1369, DOI 10.1161/HYPERTENSIONAHA.109.140715; NICHOLSON C, 1985, BRAIN RES, V333, P325, DOI 10.1016/0006-8993(85)91586-0; Ovesjo ML, 2001, J NEUROENDOCRINOL, V13, P505, DOI 10.1046/j.1365-2826.2001.00662.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pennock RL, 2011, J NEUROSCI, V31, P281, DOI 10.1523/JNEUROSCI.4654-10.2011; Pritchard LE, 2002, J ENDOCRINOL, V172, P411, DOI 10.1677/joe.0.1720411; Pyner S, 1999, NEUROSCIENCE, V88, P949, DOI 10.1016/S0306-4522(98)00255-3; Pyner S, 2000, NEUROSCIENCE, V100, P549, DOI 10.1016/S0306-4522(00)00283-9; Rahmouni K, 2007, HYPERTENSION, V49, P647, DOI 10.1161/01.HYP.0000254827.59792.b2; Sanchez-Lasheras C, 2010, FRONT NEUROENDOCRIN, V31, P4, DOI 10.1016/j.yfrne.2009.08.002; Sapru HN, 2002, CLIN EXP PHARMACOL P, V29, P491, DOI 10.1046/j.1440-1681.2002.03661.x; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Stern J., 2004, NEURAL MECH CARDIOVA, P147; Taylor K, 2007, PHYSIOL BEHAV, V90, P744, DOI 10.1016/j.physbeh.2006.12.014; Viard E, 2006, BRAIN RES, V1073, P365, DOI 10.1016/j.brainres.2005.12.102; Yang Z, 1998, J PHYSIOL-LONDON, V513, P521, DOI 10.1111/j.1469-7793.1998.521bb.x; Yang Z, 2002, EXP PHYSIOL, V87, P663, DOI 10.1113/eph8702439; Yang Z, 2001, BRAIN RES, V908, P99, DOI 10.1016/S0006-8993(01)02593-8; Ye ZY, 2011, REGUL PEPTIDES, V166, P112, DOI 10.1016/j.regpep.2010.10.001	54	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45180	10.1371/journal.pone.0045180	http://dx.doi.org/10.1371/journal.pone.0045180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028831	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800040
J	Liu, HT; Kuo, HC				Liu, Hsin-Tzu; Kuo, Hann-Chorng			Increased Urine and Serum Nerve Growth Factor Levels in Interstitial Cystitis Suggest Chronic Inflammation Is Involved in the Pathogenesis of Disease	PLOS ONE			English	Article							LUMBOSACRAL SPINAL-CORD; NEUROTROPHIC FACTOR; BLADDER DYSFUNCTION; INJURED RATS; STRESS; IMMUNONEUTRALIZATION; PATHOPHYSIOLOGY; CELL	Objective: Interstitial cystitis/bladder pain syndrome (IC/BPS) is considered a bladder disorder due to localized chronic inflammation. This study investigated the nerve growth factor (NGF) levels in serum and urine in patients with IC/BPS. Materials and Methods: Thirty patients with IC/BPS and 28 normal subjects without lower urinary tract symptoms were recruited from an outpatient clinic. IC/BPS was diagnosed by frequency, bladder pain, and the presence of glomerulations during cystoscopic hydrodistention. Serum and urine were collected before any treatment was given. Serum NGF and urinary NGF/Cr levels were compared between IC/BPS and the controls. Results: Urinary NGF levels were significantly higher in patients with IC/PBS (26.3 +/- 11.2 pg/ml) than in controls (1.40 +/- 0.63 pg) (p = 0.014). After normalization, the urinary NGF/Cr levels were significantly greater in IC/BPS (0.69 +/- 0.38 pg/mg) than controls (0.20 +/- 0.01, p = 0.011). Relative to the levels in control subjects (1.90 +/- 0.38 pg/mL), the mean serum NGF levels were higher in patients IC/BPS patients (3.48 +/- 0.55 pg/mL) (p = 0.015). No significant correlation was found between the serum and urinary NGF levels in IC/BPS patients. However, the clinical characteristics and medical co-morbidities did not show significant difference between IC/BPS patients with a higher and lower serum NGF level. Conclusions: Increased urinary NGF levels in IC/BPS patients suggest that chronic inflammation is involved in this bladder disorder. Increased circulating serum NGF levels were noted in over half of patients with IC/BPS, however, the urinary and serum NGF were not inter-correlated and elevated serum NGF did not relate with clinical features.	[Liu, Hsin-Tzu; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualin, Taiwan; [Liu, Hsin-Tzu; Kuo, Hann-Chorng] Tzu Chi Univ, Hualin, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Tzu Chi University; Tzu Chi University	Liu, HT (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualin, Taiwan.	htl1@ms43.hinet.net; hck@tzuchi.com.tw						Alleva E, 2001, PHYSIOL BEHAV, V73, P313, DOI 10.1016/S0031-9384(01)00498-X; Antunes-Lopes T, 2011, ADV UROL, V2011, DOI 10.1155/2011/382431; Bonini S, 1999, INT ARCH ALLERGY IMM, V118, P159, DOI 10.1159/000024055; Rodriguez MAB, 2009, J UROLOGY, V182, P2123, DOI 10.1016/j.juro.2009.07.036; Chuang YC, 2001, J UROLOGY, V165, P975, DOI 10.1016/S0022-5347(05)66587-1; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Joachim RA, 2008, CLIN EXP ALLERGY, V38, P283, DOI 10.1111/j.1365-2222.2007.02899.x; Jockers-Scherubl MC, 2007, PROG NEURO-PSYCHOPH, V31, P200, DOI 10.1016/j.pnpbp.2006.09.006; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Liu HT, 2009, NEUROUROL URODYNAM, V28, P78, DOI 10.1002/nau.20599; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; Nickel JC, 2010, J UROLOGY, V184, P1358, DOI 10.1016/j.juro.2010.06.005; Okragly AJ, 1999, J UROLOGY, V161, P438, DOI 10.1016/S0022-5347(01)61915-3; Orita S, 2010, J ORTHOP RES, V28, P1614, DOI 10.1002/jor.21170; Peters EMJ, 2011, J INVEST DERMATOL, V131, P735, DOI 10.1038/jid.2010.317; Rothrock NE, 2001, UROLOGY, V57, P422, DOI 10.1016/S0090-4295(00)00988-2; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; Seki S, 2004, J UROLOGY, V171, P478, DOI 10.1097/01.ju.0000088340.26588.74; Seki S, 2002, J UROLOGY, V168, P2269, DOI 10.1016/S0022-5347(05)64369-8; Southgate J, 2007, BJU INT, V99, P1506, DOI 10.1111/j.1464-410X.2007.06795.x; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; Steers William D, 2002, Rev Urol, V4 Suppl 4, pS7; Tyagi P, 2010, INT UROL NEPHROL, V42, P629, DOI 10.1007/s11255-009-9647-5; Van De Merwe JP, 2000, BJU INT, V85, P995, DOI 10.1046/j.1464-410x.2000.00646.x; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254	27	44	45	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44687	10.1371/journal.pone.0044687	http://dx.doi.org/10.1371/journal.pone.0044687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028581	gold, Green Published, Green Submitted			2022-12-27	WOS:000309742800015
J	Mellergard, J; Tisell, A; Leinhard, OD; Blystad, I; Landtblom, AM; Blennow, K; Olsson, B; Dahle, C; Ernerudh, J; Lundberg, P; Vrethem, M				Mellergard, Johan; Tisell, Anders; Leinhard, Olof Dahlqvist; Blystad, Ida; Landtblom, Anne-Marie; Blennow, Kaj; Olsson, Bob; Dahle, Charlotte; Ernerudh, Jan; Lundberg, Peter; Vrethem, Magnus			Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple Sclerosis	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; BRAIN; QUANTIFICATION; CYTOKINES; PROTEIN; ABNORMALITIES; DEMYELINATION; ASTROCYTES; DISABILITY; EVOLUTION	Background: Multiple sclerosis (MS) is associated not only with focal inflammatory lesions but also diffuse pathology in the central nervous system (CNS). Since there is no firm association between the amount of focal inflammatory lesions and disease severity, diffuse pathology in normal appearing white matter (NAWM) may be crucial for disease progression. Immunomodulating treatments for MS reduce the number of focal lesions, but possible effects on diffuse white matter pathology are less studied. Furthermore, it is not known whether intrathecal levels of inflammatory or neurodegenerative markers are associated with development of pathology in NAWM. Methods: Quantitative proton magnetic resonance spectroscopy (H-1-MRS) was used to investigate NAWM in 27 patients with relapsing MS before and after one year of treatment with natalizumab as well as NAWM in 20 healthy controls at baseline. Changes in H-1-MRS metabolite concentrations during treatment were also correlated with a panel of intrathecal markers of inflammation and neurodegeneration in 24 of these 27 patients. Results: The group levels of H-1-MRS metabolite concentrations were unchanged pre-to posttreatment, but a pattern of high magnitude correlation coefficients (r = 0.43-0.67, p<0.0005-0.03) were found between changes in individual metabolite concentrations (total creatine and total choline) and levels of pro-inflammatory markers (IL-1 beta and CXCL8). Conclusions: Despite a clinical improvement and a global decrease in levels of inflammatory markers in cerebrospinal fluid during treatment, high levels of pro-inflammatory CXCL8 and IL-1 beta were associated with an increase in H-1-MRS metabolites indicative of continued gliosis development and membrane turnover in NAWM.	[Mellergard, Johan; Landtblom, Anne-Marie] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Neurosci, Linkoping, Sweden; [Mellergard, Johan; Landtblom, Anne-Marie] Cty Council Ostergotland, Dept Neurol, Linkoping, Sweden; [Tisell, Anders; Leinhard, Olof Dahlqvist; Lundberg, Peter] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Radiat Phys, Linkoping, Sweden; [Tisell, Anders; Leinhard, Olof Dahlqvist; Lundberg, Peter] Cty Council Ostergotland, Dept Radiat Phys UHL, Linkoping, Sweden; [Tisell, Anders; Leinhard, Olof Dahlqvist; Blystad, Ida; Lundberg, Peter] Linkoping Univ, CMIV, Linkoping, Sweden; [Blystad, Ida; Lundberg, Peter] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Radiol, Linkoping, Sweden; [Blystad, Ida; Lundberg, Peter] Cty Council Ostergotland, Dept Radiol UHL, Linkoping, Sweden; [Blennow, Kaj; Olsson, Bob] Univ Gothenburg, Sahlgrenska Acad, Clin Neurochem Lab, Dept Psychiat & Neurochem,Inst Neurosci & Physiol, Molndal, Sweden; [Dahle, Charlotte; Ernerudh, Jan] Linkoping Univ, Fac Hlth Sci, Dept Clin Immunol & Transfus Med, Dept Clin & Expt Med,Cty Council Ostergotland, Linkoping, Sweden; [Vrethem, Magnus] Cty Council Ostergotland, Dept Neurol & Neurophysiol, Linkoping, Sweden	Linkoping University; City Council Ostergotland; Linkoping University; City Council Ostergotland; Linkoping University; Linkoping University; City Council Ostergotland; University of Gothenburg; City Council Ostergotland; Linkoping University; City Council Ostergotland	Mellergard, J (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Neurosci, Linkoping, Sweden.	johan.mellergard@lio.se	Lundberg, Peter/AGD-9679-2022; Calabrese, Massimiliano/I-6195-2012; Dahlqvist Leinhard, Olof/K-4228-2013	Dahlqvist Leinhard, Olof/0000-0002-6189-0807; Landtblom, Anne-Marie/0000-0001-9567-470X; Olsson, Bob/0000-0002-6368-6172	Swedish Society of Neurologically Disabled; Swedish Society of Medicine; National Research Council (VR/NT); University Hospital of Linkoping; County Council of Ostergotland; Teva; Biogen Idec	Swedish Society of Neurologically Disabled; Swedish Society of Medicine; National Research Council (VR/NT)(Swedish Research Council); University Hospital of Linkoping; County Council of Ostergotland; Teva(Teva Pharmaceutical Industries); Biogen Idec(Biogen)	The study was supported by grants from the Swedish Society of Neurologically Disabled, the Swedish Society of Medicine, The National Research Council (VR/NT), the University Hospital of Linkoping and the County Council of Ostergotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following authors report competing interests: A-M Landtblom received speaker honoraria from Merck Serono, Bayer, Teva and Biogen Idec, and also research grants from Teva and Biogen Idec. C. Dahle has received speaker honoraria from Biogen Idec and Merck Serono. J. Mellergard has received speaking honorary from Biogen Idec. M. Vrethem has received an unrestricted grant for research from Biogen Idec and speaker honoraria from Biogen Idec and Merck Serono. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ALOISI F, 1992, J IMMUNOL, V149, P2358; ARNOLD DL, 1992, ANN NEUROL, V31, P235, DOI 10.1002/ana.410310302; Bagory M, 2011, IEEE T BIOMED ENG; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; BRENNER RE, 1993, MAGNET RESON MED, V29, P737, DOI 10.1002/mrm.1910290605; BRETT FM, 1995, J NEUROPATH EXP NEUR, V54, P766, DOI 10.1097/00005072-199511000-00003; Caramanos Z, 2005, BRAIN, V128, P2483, DOI 10.1093/brain/awh640; Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240; Cree B, 2007, NEUROLOGY, V68, pA54; Dahlqvist O, 2010, QUANTITATIVE MAGNETI; De Keyser J, 2004, NEUROBIOL DIS, V15, P331, DOI 10.1016/j.nbd.2003.10.012; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Fernando KTM, 2004, BRAIN, V127, P1361, DOI 10.1093/brain/awh153; Filippi M, 2002, NEUROLOGY, V58, P1147, DOI 10.1212/WNL.58.8.1147; Gunnarsson M., 2010, ANN NEUROL; Hattingen E, 2011, NMR BIOMED, V24, P536, DOI 10.1002/nbm.1621; Henderson APD, 2009, ANN NEUROL, V66, P739, DOI 10.1002/ana.21800; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Inglese M, 2003, MAGNET RESON MED, V50, P190, DOI 10.1002/mrm.10481; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; Kirov II, 2009, J NEUROL NEUROSUR PS, V80, P1330, DOI 10.1136/jnnp.2009.176263; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Li BSY, 2003, MAGN RESON IMAGING, V21, P923, DOI 10.1016/S0730-725X(03)00181-4; Lundin F, 2011, J NEUROL NEUROSUR PS, V82, P772, DOI 10.1136/jnnp.2010.223529; Mader I, 2000, AM J NEURORADIOL, V21, P1220; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Miller DH, 2003, J NEUROL, V250, P1407, DOI 10.1007/s00415-003-0243-9; Narayanan S, 2001, J NEUROL, V248, P979, DOI 10.1007/s004150170052; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Parry A, 2003, J NEUROL, V250, P171, DOI 10.1007/s00415-003-0965-8; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Provencher S, 2011, LCMODEL LCMGUIDE USE; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Rigotti DJ, 2011, AM J NEURORADIOL, V32, P1011, DOI 10.3174/ajnr.A2452; Ropper AH, 2006, NEW ENGL J MED, V354, P965, DOI 10.1056/NEJMe068002; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Sajja BR, 2009, NEUROIMAG CLIN N AM, V19, P45, DOI 10.1016/j.nic.2008.08.002; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Tiberio M, 2006, J NEUROL, V253, P224, DOI 10.1007/s00415-005-0964-z; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Vrenken H, 2005, MAGNET RESON MED, V53, P256, DOI 10.1002/mrm.20366; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; Zhao LX, 2004, J NEUROSCI, V24, P2226, DOI 10.1523/JNEUROSCI.4922-03.2004	50	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44739	10.1371/journal.pone.0044739	http://dx.doi.org/10.1371/journal.pone.0044739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028598	Green Published, gold			2022-12-27	WOS:000309742800016
J	Sugiura, D; Denda-Nagai, K; Takashima, M; Murakami, R; Nagai, S; Takeda, K; Irimura, T				Sugiura, Daisuke; Denda-Nagai, Kaori; Takashima, Mitsuyo; Murakami, Ryuichi; Nagai, Shigenori; Takeda, Kazuyoshi; Irimura, Tatsuro			Local Effects of Regulatory T Cells in MUC1 Transgenic Mice Potentiate Growth of MUC1 Expressing Tumor Cells In Vivo	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHIC EPITHELIAL MUCIN; IMMORTALIZED B-CELLS; COMPLEMENTARY-DNA; DENDRITIC CELLS; WILD-TYPE; CANCER; CARCINOMA; ANTIGEN; VACCINATION	MUC1 transgenic (MUC1.Tg) mice have widely been used as model recipients of cancer immunotherapy with MUC1. Although MUC1.Tg mice have previously been shown to be immunologically tolerant to MUC1, the involvement of regulatory T (Treg) cells in this phenotype remains unclear. Here, we showed that numbers of Treg cells in MUC1-expressing tumors were greater in MUC1.Tg mice than in control C57BL/6 (B6) mice, and that the growth of tumor cells expressing MUC1, but not that of control cells, in MUC1.Tg mice was faster than in B6 mice. The MUC1.Tg mice appeared to develop MUC1-specific peripheral tolerance, as transferred MUC1-specific T cells were unable to function in MUC1.Tg mice but were functional in control B6 mice. The suppressive function of CD4(+)CD25(high) cells from MUC1.Tg mice was more potent than that of cells from control B6 mice when Treg cell activity against MUC1-specific T cells was compared in vitro. Therefore, the enhanced growth of MUC1-expressing tumor cells in MUC1.Tg mice is likely due to the presence of MUC1-specific Treg cells.	[Sugiura, Daisuke; Denda-Nagai, Kaori; Takashima, Mitsuyo; Murakami, Ryuichi; Irimura, Tatsuro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo, Japan; [Nagai, Shigenori] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Takeda, Kazuyoshi] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	University of Tokyo; Keio University; Juntendo University	Denda-Nagai, K (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo, Japan.	denda@mol.f.u-tokyo.ac.jp; irimura@mol.f.u-tokyo.ac.jp		Sugiura, Daisuke/0000-0002-3865-3889; Murakami, Ryuichi/0000-0001-8257-585X; Nagai, Shigenori/0000-0002-5018-5942; Denda-Nagai, Kaori/0000-0001-8325-3289	Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [24659029, 23300355] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Daisuke Sugiura was a Research Fellow of the Japan Society for the Promotion of Science, and this work was supported grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addey C, 2011, J IMMUNOL, V186, P4557, DOI 10.4049/jimmunol.1003797; BARND DL, 1989, P NATL ACAD SCI USA, V86, P7159, DOI 10.1073/pnas.86.18.7159; Bonertz A, 2009, J CLIN INVEST, V119, P3311, DOI 10.1172/JCI39608; Bos R, 2005, CANCER RES, V65, P6443, DOI 10.1158/0008-5472.CAN-05-0666; Bos R, 2008, CANCER RES, V68, P8446, DOI 10.1158/0008-5472.CAN-08-1864; Budiu RA, 2009, DIS MODEL MECH, V2, P593, DOI 10.1242/dmm.002535; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Denda-Nagai K, 2000, GLYCOCONJUGATE J, V17, P649, DOI 10.1023/A:1011039013134; Denda-Nagai K, 2002, GLYCOBIOLOGY, V12, P443, DOI 10.1093/glycob/cwf061; HAHN S, 1995, IMMUNOL REV, V146, P57, DOI 10.1111/j.1600-065X.1995.tb00684.x; Hamanaka Y, 2003, INT J CANCER, V103, P97, DOI 10.1002/ijc.10801; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; JEROME KR, 1993, J IMMUNOL, V151, P1654; JEROME KR, 1992, CANCER RES, V52, P5985; Kamata M, 2002, CLIN EXP METASTAS, V19, P689, DOI 10.1023/A:1021332932531; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Merlo A, 2010, J IMMUNOL, V184, P5895, DOI 10.4049/jimmunol.0902850; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; NAKAMORI S, 1994, GASTROENTEROLOGY, V106, P353, DOI 10.1016/0016-5085(94)90592-4; Rocha B, 2004, CURR OPIN IMMUNOL, V16, P259, DOI 10.1016/j.coi.2004.03.004; Rolla S, 2006, J IMMUNOL, V177, P7626, DOI 10.4049/jimmunol.177.11.7626; Rowse GJ, 1998, CANCER RES, V58, P315; Ryan SO, 2010, CANCER RES, V70, P5788, DOI 10.1158/0008-5472.CAN-09-4519; Sugiura D, 2010, CANCER SCI, V101, P1965, DOI 10.1111/j.1349-7006.2010.01634.x; Sugiura D, 2008, CANCER SCI, V99, P2477, DOI 10.1111/j.1349-7006.2008.00967.x; Szymczak-Workman AL, 2009, J IMMUNOL, V182, P5188, DOI 10.4049/jimmunol.0803123; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Turner MS, 2007, J IMMUNOL, V178, P2787, DOI 10.4049/jimmunol.178.5.2787; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Vlad AM, 2004, ADV IMMUNOL, V82, P249, DOI 10.1016/S0065-2776(04)82006-6; Vlad AM, 2002, J EXP MED, V196, P1435, DOI 10.1084/jem.20020493; von Mensdorff-Pouilly S, 2000, J CLIN ONCOL, V18, P574, DOI 10.1200/JCO.2000.18.3.574; Zhou G, 2006, BLOOD, V107, P628, DOI 10.1182/blood-2005-07-2737; Zhou G, 2007, J IMMUNOL, V178, P2155, DOI 10.4049/jimmunol.178.4.2155; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	36	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44770	10.1371/journal.pone.0044770	http://dx.doi.org/10.1371/journal.pone.0044770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028615	Green Submitted, Green Published, gold			2022-12-27	WOS:000309742800018
J	Zander, SAL; Sol, W; Greenberger, L; Zhang, YX; van Tellingen, O; Jonkers, J; Borst, P; Rottenberg, S				Zander, Serge A. L.; Sol, Wendy; Greenberger, Lee; Zhang, Yixian; van Tellingen, Olaf; Jonkers, Jos; Borst, Piet; Rottenberg, Sven			EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; THERAPEUTIC-EFFICACY; DRUG-RESISTANCE; CANCER; BREAST; PROTEIN; INHIBITOR; GENE; TRANSPORTERS; SENSITIVITY	BRCA1 dysfunction in hereditary breast cancer causes defective homology-directed DNA repair and sensitivity towards DNA damaging agents like the clinically used topoisomerase I inhibitors topotecan and irinotecan. Using our conditional K14cre; Brca1(F/F);p53(F/F) mouse model, we showed previously that BRCA1;p53-deficient mammary tumors initially respond to topotecan, but frequently acquire resistance by overexpression of the efflux transporter ABCG2. Here, we tested the pegylated SN38 compound EZN-2208 as a novel approach to treat BRCA1-mutated tumors that express ABCG2. We found that EZN-2208 therapy resulted in more pronounced and durable responses of ABCG2-positive tumors than topotecan or irinotecan therapy. We also evaluated tumor-specific ABCG2 inhibition by Ko143 in Abcg2(-/-) host animals that carried tumors with topotecan-induced ABCG2 expression. Addition of Ko143 moderately increased overall survival of these animals, but did not yield tumor responses like those seen after EZN-2208 therapy. Our results suggest that pegylation of Top1 inhibitors may be a useful strategy to circumvent efflux transporter-mediated resistance and to improve their efficacy in the clinic.	[Zander, Serge A. L.; Sol, Wendy; Borst, Piet; Rottenberg, Sven] Netherlands Canc Inst, Div Mol Oncol, Amsterdam, Netherlands; [Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Greenberger, Lee; Zhang, Yixian] Enzon Pharmaceut Inc, Dept Pharmacol, Piscataway, NJ USA; [van Tellingen, Olaf] Netherlands Canc Inst, Dept Clin Chem, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Rottenberg, S (corresponding author), Netherlands Canc Inst, Div Mol Oncol, Amsterdam, Netherlands.	s.rottenberg@nki.nl	Jonkers, Jos/AAG-3246-2019	Jonkers, Jos/0000-0002-9264-9792; Rottenberg, Sven/0000-0003-2044-9844; Zander, Serge/0000-0003-4756-843X; Zhang, Yixian/0000-0002-6429-3127	Dutch Cancer Society [NKI 2009-4303, NKI 2011-5220]; European Union [037665-CHEMORES]; TI Center for Translational Molecular Medicine (CTMM Breast Care); Netherlands Organisation for Scientific Research NWO [VIDI-91711302]; ENZON Pharmaceuticals Inc.	Dutch Cancer Society(KWF Kankerbestrijding); European Union(European Commission); TI Center for Translational Molecular Medicine (CTMM Breast Care); Netherlands Organisation for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); ENZON Pharmaceuticals Inc.	This work was supported by grants from the Dutch Cancer Society (www.dcs.kwfkankerbestrijding.nl) NKI 2009-4303 to SR, JJ, PB, NKI 2011-5220 to SR, JJ, the European Union FP6 Integrated Project 037665-CHEMORES (www.chemores.org) to PB, SR and TI Center for Translational Molecular Medicine (CTMM Breast Care) (www.ctmm.nl) to JJ, SR. SR is supported by The Netherlands Organisation for Scientific Research NWO VIDI-91711302 (www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sven Rottenberg has received research funding from ENZON Pharmaceuticals Inc. to perform the experiments with EZN-2208, Yixian Zhang is an employee of ENZON Pharmaceuticals Inc., who is sponsoring the clinical development of EZN-2208. Yixian Zhang and Lee Greenberger own shares of Enzon Pharmaceuticals Inc.	Allen JD, 2002, MOL CANCER THER, V1, P417; Allen JD, 1999, CANCER RES, V59, P4237; Allikmets R, 1998, CANCER RES, V58, P5337; Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Ando Y, 2000, CANCER RES, V60, P6921; Beretta GL, 2006, CURR MED CHEM, V13, P3291, DOI 10.2174/092986706778773121; Bibeau F, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.11004; Caliceti P, 2003, ADV DRUG DELIVER REV, V55, P1261, DOI 10.1016/S0169-409X(03)00108-X; de Bruin M, 1999, CANCER LETT, V146, P117, DOI 10.1016/S0304-3835(99)00182-2; de Vries NA, 2007, BIOMED CHROMATOGR, V21, P1191, DOI 10.1002/bmc.874; de Vries NA, 2007, CLIN CANCER RES, V13, P6440, DOI 10.1158/1078-0432.CCR-07-1335; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Fedier A, 2003, INT J ONCOL, V22, P1169; Gabizon A, 2002, J DRUG TARGET, V10, P539, DOI 10.1080/1061186021000072447; Gabizon A, 2012, EUR J PHARM SCI, V45, P388, DOI 10.1016/j.ejps.2011.09.006; Gabizon A, 2010, CANCER CHEMOTH PHARM, V66, P43, DOI 10.1007/s00280-009-1132-4; Goren D, 2000, CLIN CANCER RES, V6, P1949; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Henrich CJ, 2007, MOL CANCER THER, V6, P3271, DOI 10.1158/1535-7163.MCT-07-0352; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kawabata S, 2001, BIOCHEM BIOPH RES CO, V280, P1216, DOI 10.1006/bbrc.2001.4267; Kawabata S, 2003, CLIN CANCER RES, V9, P3052; Kummar S, 2011, CANCER RES, V71, P5626, DOI 10.1158/0008-5472.CAN-11-1227; Kurzrock R, 2009, MOL CANC THER S, V8; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maliepaard M, 1999, CANCER RES, V59, P4559; Miyake K, 1999, CANCER RES, V59, P8; Pastorino F, 2010, CLIN CANCER RES, V16, P4809, DOI 10.1158/1078-0432.CCR-10-1354; Peng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015276; Peng H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005676; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rabindran SK, 1998, CANCER RES, V58, P5850; Rabindran SK, 2000, CANCER RES, V60, P47; Robey RW, 2011, CURR PHARM BIOTECHNO, V12, P595; Robey RW, 2010, ANTI-CANCER AGENT ME, V10, P625; Robey RW, 2004, CANCER RES, V64, P1242, DOI 10.1158/0008-5472.CAN-03-3298; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Rottenberg S, 2007, P NATL ACAD SCI USA, V104, P12117, DOI 10.1073/pnas.0702955104; Rottenberg S, 2012, DRUG RESIST UPDATE, V15, P81, DOI 10.1016/j.drup.2012.01.001; Samol J, 2011, INVEST NEW DRUGS; Sapra P, 2008, CLIN CANCER RES, V14, P1888, DOI 10.1158/1078-0432.CCR-07-4456; Sapra P, 2009, HAEMATOL-HEMATOL J, V94, P1456, DOI 10.3324/haematol.2009.008276; Shukla S, 2008, EXPERT OPIN DRUG MET, V4, P205, DOI 10.1517/17425255.4.2.205; Vlaming MLH, 2009, ADV DRUG DELIVER REV, V61, P14, DOI 10.1016/j.addr.2008.08.007; Zander SAL, 2010, CANCER RES, V70, P1700, DOI 10.1158/0008-5472.CAN-09-3367; Zhao H, 2008, BIOCONJUGATE CHEM, V19, P849, DOI 10.1021/bc700333s	50	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45248	10.1371/journal.pone.0045248	http://dx.doi.org/10.1371/journal.pone.0045248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028879	gold, Green Submitted, Green Published			2022-12-27	WOS:000309742800044
J	Pontes, D; Innocentin, S; del Carmen, S; Almeida, JF; LeBlanc, JG; de LeBlanc, AD; Blugeon, S; Cherbuy, C; Lefevre, F; Azevedo, V; Miyoshi, A; Langella, P; Chatel, JM				Pontes, Daniela; Innocentin, Silvia; del Carmen, Silvina; Almeida, Juliana Franco; LeBlanc, Jean-Guy; de LeBlanc, Alejandra de Moreno; Blugeon, Sebastien; Cherbuy, Claire; Lefevre, Francois; Azevedo, Vasco; Miyoshi, Anderson; Langella, Philippe; Chatel, Jean-Marc			Production of Fibronectin Binding Protein A at the Surface of Lactococcus lactis Increases Plasmid Transfer In Vitro and In Vivo	PLOS ONE			English	Article							MAMMALIAN EPITHELIAL-CELLS; LISTERIA-MONOCYTOGENES; BETA-LACTOGLOBULIN; DELIVER DNA; EXPRESSION; INTERNALIN; INTEGRINS; BACTERIA; ENTRY	Lactococci are noninvasive lactic acid bacteria frequently used as protein delivery vectors and, more recently, as DNA delivery vehicles. We previously showed that Lactococcus lactis (LL) expressing the Fibronectin-Binding Protein A of Staphylococcus aureus (LL-FnBPA+) showed higher internalization rates in vitro in Caco-2 cells than the native (wt) lactococci and were able to deliver a eukaryotic Green Fluorescent Protein (GFP) expression plasmid in 1% of human Caco-2 cells. Here, using the bovine beta-lactoglobulin (BLG), one of the major cow's milk allergen, and GFP we characterized the potential of LL-FnBPA+ as an in vivo DNA vaccine delivery vehicle. We first showed that the invasive strain LL-FnBPA+ carrying the plasmid pValac:BLG (LL-FnBPA + BLG) was more invasive than LL-BLG and showed the same invasivity as LL-FnBPA+. Then we demonstrated that the Caco-2 cells, co-incubated with LL-FnBPA+ BLG produced up to 30 times more BLG than the Caco-2 cells co-incubated with the non invasive LL-BLG. Using two different gene reporters, BLG and GFP, and two different methods of detection, EIA and fluorescence microscopy, we showed in vivo that: i) in order to be effective, LL-FnBPA+ required a pre-coating with Fetal Calf Serum before oral administration; ii) plasmid transfer occurred in enterocytes without regard to the strains used (invasive or not); iii) the use of LL-FnBPA+ increased the number of mice producing BLG, but not the level of BLG produced. We thus confirmed the good potential of invasive recombinant lactic acid bacteria as DNA delivery vector in vivo.	[Pontes, Daniela; Innocentin, Silvia; Almeida, Juliana Franco; Blugeon, Sebastien; Cherbuy, Claire; Langella, Philippe; Chatel, Jean-Marc] INRA, UMR1319 Micalis, Jouy En Josas, France; [Pontes, Daniela; Innocentin, Silvia; Almeida, Juliana Franco; Blugeon, Sebastien; Cherbuy, Claire; Langella, Philippe; Chatel, Jean-Marc] AgroParisTech, UMR Micalis, Jouy En Josas, France; [del Carmen, Silvina; LeBlanc, Jean-Guy; de LeBlanc, Alejandra de Moreno] CERELA CONICET, San Miguel De Tucuman, Tucuman, Argentina; [Lefevre, Francois] INRA, VIM, Jouy En Josas, France; [Azevedo, Vasco; Miyoshi, Anderson] Fed Univ Minas Gerais UFMG ICB, Inst Biol Sci, Belo Horizonte, MG, Brazil	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Chatel, JM (corresponding author), INRA, UMR1319 Micalis, Jouy En Josas, France.	jean-marc.chatel@jouy.inra.fr	LeBlanc, Alejandra de Moreno de/R-1242-2018; Azevedo, Vasco/B-1556-2019; PONTES, DANIELA SANTOS/O-2040-2015; Azevedo, Vasco A.C/F-4315-2011; LeBlanc, Jean Guy/R-1193-2018; Miyoshi, Anderson/C-3119-2013; Langella, Philippe/N-8368-2017; Chatel, Jean-Marc/F-9450-2013; Chatel, Jean-marc/ABB-9837-2020	LeBlanc, Alejandra de Moreno de/0000-0003-0352-374X; Azevedo, Vasco/0000-0002-4775-2280; Azevedo, Vasco A.C/0000-0002-4775-2280; LeBlanc, Jean Guy/0000-0002-4634-8630; Langella, Philippe/0000-0001-5960-4341; 	European Marie Curie Ph.D grant from LABHEALTH program [MEST-CT-2004-514428]; French-Brazilian CAPES COFECUB project [539/06, 720/11]; Region Ile de France DIM ASTREA	European Marie Curie Ph.D grant from LABHEALTH program; French-Brazilian CAPES COFECUB project; Region Ile de France DIM ASTREA(Region Ile-de-France)	Silvia Innocentin is a recipient of a European Marie Curie Ph.D grant from the LABHEALTH program (MEST-CT-2004-514428). Daniela Pontes is a recipient of grants from the French-Brazilian CAPES COFECUB project no 539/06 and from Region Ile de France DIM ASTREA. Juliana Franco Almeida is a recipient of a grant from the French-Brazilian CAPES COFECUB project no 720/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatel JM, 2008, GENE THER, V15, P1184, DOI 10.1038/gt.2008.59; Chatel JM, 1999, PROTEIN EXPRES PURIF, V16, P70, DOI 10.1006/prep.1999.1055; DARCYVRILLON B, 1994, PEDIATR RES, V36, P175, DOI 10.1203/00006450-199408000-00007; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Dziewanowska K, 2000, INFECT IMMUN, V68, P6321, DOI 10.1128/IAI.68.11.6321-6328.2000; Guimaraes Valeria, 2009, Genet Vaccines Ther, V7, P4, DOI 10.1186/1479-0556-7-4; Guimaraes VD, 2006, APPL ENVIRON MICROB, V72, P7091, DOI 10.1128/AEM.01325-06; Guimaraes VD, 2005, MICROBES INFECT, V7, P836, DOI 10.1016/j.micinf.2005.02.012; Innocentin S, 2009, APPL ENVIRON MICROB, V75, P4870, DOI 10.1128/AEM.00825-09; LANGELLA P, 1993, J BACTERIOL, V175, P5806, DOI 10.1128/JB.175.18.5806-5813.1993; Negroni L, 1998, J IMMUNOL METHODS, V220, P25, DOI 10.1016/S0022-1759(98)00150-1; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Que YA, 2001, INFECT IMMUN, V69, P6296, DOI 10.1128/IAI.69.10.6296-6302.2001; Schoen C, 2004, INT J MED MICROBIOL, V294, P319, DOI 10.1016/j.ijmm.2004.03.001; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Zelmer A, 2005, J GENE MED, V7, P1097, DOI 10.1002/jgm.764	17	32	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44892	10.1371/journal.pone.0044892	http://dx.doi.org/10.1371/journal.pone.0044892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028664	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500010
J	Hayashi, R; Ishikawa, Y; Ito, M; Kageyama, T; Takashiba, K; Fujioka, T; Tsujikawa, M; Miyoshi, H; Yamato, M; Nakamura, Y; Nishida, K				Hayashi, Ryuhei; Ishikawa, Yuki; Ito, Miyuki; Kageyama, Tomofumi; Takashiba, Kuniko; Fujioka, Tsuyoshi; Tsujikawa, Motokazu; Miyoshi, Hiroyuki; Yamato, Masayuki; Nakamura, Yukio; Nishida, Kohji			Generation of Corneal Epithelial Cells from Induced Pluripotent Stem Cells Derived from Human Dermal Fibroblast and Corneal Limbal Epithelium	PLOS ONE			English	Article							DOPAMINERGIC-NEURONS; EPIGENETIC MEMORY; DNA METHYLATION; RETINAL CELLS; ES CELLS; TISSUE; INDUCTION; DIFFERENTIATION; EXPRESSION; MOUSE	Induced pluripotent stem (iPS) cells can be established from somatic cells. However, there is currently no established strategy to generate corneal epithelial cells from iPS cells. In this study, we investigated whether corneal epithelial cells could be differentiated from iPS cells. We tested 2 distinct sources: human adult dermal fibroblast (HDF)-derived iPS cells (253G1) and human adult corneal limbal epithelial cells (HLEC)-derived iPS cells (L1B41). We first established iPS cells from HLEC by introducing the Yamanaka 4 factors. Corneal epithelial cells were successfully induced from the iPS cells by the stromal cell-derived inducing activity (SDIA) differentiation method, as Pax6(+)/K12(+) corneal epithelial colonies were observed after prolonged differentiation culture (12 weeks or later) in both the L1B41 and 253G1 iPS cells following retinal pigment epithelial and lens cell induction. Interestingly, the corneal epithelial differentiation efficiency was higher in L1B41 than in 253G1. DNA methylation analysis revealed that a small proportion of differentially methylated regions still existed between L1B41 and 253G1 iPS cells even though no significant difference in methylation status was detected in the specific corneal epithelium-related genes such as K12, K3, and Pax6. The present study is the first to demonstrate a strategy for corneal epithelial cell differentiation from human iPS cells, and further suggests that the epigenomic status is associated with the propensity of iPS cells to differentiate into corneal epithelial cells.	[Hayashi, Ryuhei; Ishikawa, Yuki; Kageyama, Tomofumi; Takashiba, Kuniko; Tsujikawa, Motokazu; Nishida, Kohji] Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan; [Ito, Miyuki] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Fujioka, Tsuyoshi; Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Tsukuba, Ibaraki, Japan; [Miyoshi, Hiroyuki] RIKEN BioResource Ctr, Subteam Cell Fate Manipulat, Tsukuba, Ibaraki, Japan; [Yamato, Masayuki] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan	Osaka University; Tohoku University; RIKEN; RIKEN; Tokyo Women's Medical University	Nishida, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Ophthalmol, Suita, Osaka, Japan.	knishida@ophthal.med.osaka-u.ac.jp	Nakamura, Yukio/A-5263-2016; Hayashi, Ryuhei/AAW-4737-2020; Miyoshi, Hiroyuki/G-9808-2013	Nakamura, Yukio/0000-0001-8056-4946; Nishida, Kohji/0000-0001-9069-3610; Hayashi, Ryuhei/0000-0002-4699-8617	Ministry of Education, Culture, Sports, Science, and Technology in Japan	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in-Aid for Scientific Research and the project for the realization of regenerative medicine from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Collinson JM, 2001, P NATL ACAD SCI USA, V98, P9688, DOI 10.1073/pnas.161144098; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Faber SC, 2002, DEVELOPMENT, V129, P3727; Fujioka T, 2010, HUM CELL, V23, P113, DOI 10.1111/j.1749-0774.2010.00091.x; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hayashi R, 2007, STEM CELLS, V25, P289, DOI 10.1634/stemcells.2006-0167; Hayashi R, 2010, TISSUE ENG PART C-ME, V16, P553, DOI [10.1089/ten.tec.2009.0277, 10.1089/ten.TEC.2009.0277]; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6; Liang P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-231; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Nagae G, 2011, HUM MOL GENET, V20, P2710, DOI 10.1093/hmg/ddr170; Nishida K, 2003, CORNEA, V22, pS28, DOI 10.1097/00003226-200310001-00005; OGUIN WM, 1987, CURR TOP DEV BIOL, V22, P97; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Sakurai M, 2011, J ARTIF ORGANS, V14, P58, DOI 10.1007/s10047-010-0547-3; Samson CM, 2002, OPHTHALMOLOGY, V109, P862, DOI 10.1016/S0161-6420(02)00994-6; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Yokoo N, 2009, BIOCHEM BIOPH RES CO, V387, P482, DOI 10.1016/j.bbrc.2009.07.052; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	106	114	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45435	10.1371/journal.pone.0045435	http://dx.doi.org/10.1371/journal.pone.0045435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029008	Green Submitted, Green Published, gold			2022-12-27	WOS:000309554700040
J	Ma, CQ; Ding, JR; Li, J; Guo, WB; Long, ZL; Liu, F; Gao, Q; Zeng, L; Zhao, JP; Chen, HF				Ma, Chaoqiong; Ding, Jurong; Li, Jun; Guo, Wenbin; Long, Zhiliang; Liu, Feng; Gao, Qing; Zeng, Ling; Zhao, Jingping; Chen, Huafu			Resting-State Functional Connectivity Bias of Middle Temporal Gyrus and Caudate with Altered Gray Matter Volume in Major Depression	PLOS ONE			English	Article							MOOD-REGULATING CIRCUIT; TREATMENT-REFRACTORY DEPRESSION; TREATMENT-RESISTANT DEPRESSION; TREATMENT-RESPONSE; REWARD; BRAIN; CORTEX; 1ST-EPISODE; DISORDER; NETWORKS	Magnetic resonance imaging (MRI) studies have indicated that the structure deficits and resting-state functional connectivity (FC) imbalances in cortico-limbic circuitry might underline the pathophysiology of MDD. Using structure and functional MRI, our aim is to investigate gray matter abnormalities in patients with treatment-resistant depression (TRD) and treatment-responsive depression (TSD), and test whether the altered gray matter is associated with altered FC. Voxel-based morphometry was used to investigate the regions with gray matter abnormality and FC analysis was further conducted between each gray matter abnormal region and the remaining voxels in the brain. Using one-way analysis of variance, we found significant gray matter abnormalities in the right middle temporal cortex (MTG) and bilateral caudate among the TRD, TSD and healthy controls. For the FC of the right MTG, we found that both the patients with TRD and TSD showed altered connectivity mainly in the default-mode network (DMN). For the FC of the right caudate, both patient groups showed altered connectivity in the frontal regions. Our results revealed the gray matter reduction of right MTG and bilateral caudate, and disrupted functional connection to widely distributed circuitry in DMN and frontal regions, respectively. These results suggest that the abnormal DMN and reward circuit activity might be biomarkers of depression trait.	[Guo, Wenbin; Zhao, Jingping] Cent S Univ Changsha, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Ma, Chaoqiong; Ding, Jurong; Li, Jun; Long, Zhiliang; Liu, Feng; Gao, Qing; Zeng, Ling; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Guo, Wenbin] Guangxi Med Univ, Affiliated Hosp 1, Mental Hlth Ctr, Nanning, Guangxi, Peoples R China	Central South University; University of Electronic Science & Technology of China; Guangxi Medical University	Zhao, JP (corresponding author), Cent S Univ Changsha, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China.	zhaojingpingcsu@163.com; chenhf@uestc.edu.cn	Liu, Feng/W-7572-2019; zhao, jing/B-3868-2019	Liu, Feng/0000-0002-3570-4222; 	973 project [2012CB517901]; Natural Science Foundation of China [61125304, 61035006, 81171406, 30900483, 91132721]; Ministry of Health of the peoples' Republic of China [201002003]	973 project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health of the peoples' Republic of China	This work was supported by 973 project 2012CB517901, the Natural Science Foundation of China (Grant Nos. 61125304, 61035006, 81171406, 30900483 and 91132721), and the special funding by Ministry of Health of the peoples' Republic of China (Grant No. 201002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Association AP, 1994, DSM 4 DIAGN STAT MAN; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Cardenas L, 2002, J PHARMACOL EXP THER, V302, P1265, DOI 10.1124/jpet.302.3.1265; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damasio AR, 1997, NATURE, V386, P769, DOI 10.1038/386769a0; Dannlowski U, 2009, INT J NEUROPSYCHOPH, V12, P11, DOI 10.1017/S1461145708008973; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Fagiolini A, 2003, BIOL PSYCHIAT, V53, P640, DOI 10.1016/S0006-3223(02)01670-0; Forbes EE, 2006, J CHILD PSYCHOL PSYC, V47, P1031, DOI 10.1111/j.1469-7610.2006.01673.x; Forbes EE, 2009, AM J PSYCHIAT, V166, P64, DOI 10.1176/appi.ajp.2008.07081336; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Furtado CP, 2008, PSYCHIAT RES-NEUROIM, V163, P133, DOI 10.1016/j.pscychresns.2007.11.005; Gong QY, 2011, NEUROIMAGE, V55, P1497, DOI 10.1016/j.neuroimage.2010.11.079; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; Hamilton JP, 2008, BIOL PSYCHIAT, V63, P1155, DOI 10.1016/j.biopsych.2007.12.015; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Iidaka T, 1997, PSYCHIAT RES-NEUROIM, V68, P143, DOI 10.1016/S0925-4927(96)02969-1; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; KRISHNAN KRR, 1992, ARCH GEN PSYCHIAT, V49, P553; Lemogne C, 2009, SOC COGN AFFECT NEUR, V4, P305, DOI 10.1093/scan/nsp008; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; May JC, 2004, BIOL PSYCHIAT, V55, P359, DOI 10.1016/j.biopsych.2003.11.008; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Montgomery SA, 2006, INT CLIN PSYCHOPHARM, V21, pS1, DOI 10.1097/01.yic.0000199455.39552.1c; Murphy JM, 2000, ARCH GEN PSYCHIAT, V57, P209, DOI 10.1001/archpsyc.57.3.209; NIERENBERG A A, 1990, Journal of Clinical Psychiatry, V51, P39; NIERENBERG AA, 1991, J CLIN PSYCHIAT, V52, P40; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Peng J, 2011, EUR J RADIOL, V80, P395, DOI 10.1016/j.ejrad.2010.04.006; Pillay SS, 1998, PSYCHIAT RES-NEUROIM, V84, P61, DOI 10.1016/S0925-4927(98)00048-1; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; Schmidt K, 2001, PHARMACOPSYCHIATRY, V34, P66, DOI 10.1055/s-2001-15184; Shah PJ, 2002, BRIT J PSYCHIAT, V180, P434, DOI 10.1192/bjp.180.5.434; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Smoski MJ, 2009, J AFFECT DISORDERS, V118, P69, DOI 10.1016/j.jad.2009.01.034; Staudinger MR, 2011, CEREB CORTEX, V21, P2578, DOI 10.1093/cercor/bhr041; Stimpson N, 2002, BRIT J PSYCHIAT, V181, P284, DOI 10.1192/bjp.181.4.284; Tao H, 2011, MOL PSYCHIAT; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Vasic N, 2009, PSYCHOL MED, V39, P977, DOI 10.1017/S0033291708004443; *WHO, 2001, WORLD HLTH REP 2001, pCH2; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yan CG, 2010, FRONTIERS SYSTEMS NE, V14, P13, DOI [10.3389/fnsys.2010.00013, DOI 10.3389/FNSYS.2010.00013]; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhou Y, 2010, J AFFECT DISORDERS, V121, P220, DOI 10.1016/j.jad.2009.05.029; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	62	98	103	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45263	10.1371/journal.pone.0045263	http://dx.doi.org/10.1371/journal.pone.0045263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028892	gold, Green Submitted, Green Published			2022-12-27	WOS:000309554700030
J	Mencarelli, A; Cipriani, S; Renga, B; Bruno, A; D'Amore, C; Distrutti, E; Fiorucci, S				Mencarelli, Andrea; Cipriani, Sabrina; Renga, Barbara; Bruno, Angela; D'Amore, Claudio; Distrutti, Eleonora; Fiorucci, Stefano			VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; FARNESOID X RECEPTOR; METABOLIC SYNDROME; GUT MICROBIOTA; BACTERIAL OVERGROWTH; ADIPOSE-TISSUE; PPAR-GAMMA; DISEASE; PATHOGENESIS; RESISTANCE	Background: Signals generated by the inflammed intestine are thought to contribute to metabolic derangement. The intestinal microbiota contributes to instructing the immune system beyond the intestinal wall and its modulation is a potential target for treating systemic disorders. Aims: To investigate the pathogenetic role of low grade intestinal inflammation in the development of steatohepatitis and atherosclerosis in a model of genetic dyslipidemia and to test the therapeutic potential of a probiotics intervention in protecting against development of these disorders. Results: ApoE(-/-) mice were randomized to receive vehicle or VSL#3, a mixture of eight probiotics, at the dose of 20X10(9) colony-forming units/kg/day for three months alone or in combination with 0.2% of dextran sulfate sodium (DSS) in drinking water. Administering DSS to ApoE(-/-) mice failed to induce signs and symptoms of colitis but increased intestinal permeability to dextran FITC and, while had no effect on serum lipids, increased the blood levels of markers of liver injury and insulin resistance. DSS administration associated with low level inflammation of intestinal and mesenteric adipose tissues, caused liver histopathology features of steatohepatitis and severe atherosclerotic lesions in the aorta. These changes were prevented by VSL#3 intervention. Specifically, VSL#3 reversed insulin resistance, prevented development of histologic features of mesenteric adipose tissue inflammation, steatohepatitis and reduced the extent of aortic plaques. Conditioned media obtained from cultured probiotics caused the direct transactivation of peroxisome proliferator-activated receptor-c, Farnesoid-X-receptors and vitamin D receptor. Conclusions: Low grade intestinal inflammation drives a transition from steatosis to steatohepatitis and worsens the severity of atherosclerosis in a genetic model of dyslipidemia. VSL#3 intervention modulates the expression of nuclear receptors, corrects for insulin resistance in liver and adipose tissues and protects against development of steatohepatitis and atherosclerosis.	[Mencarelli, Andrea; Cipriani, Sabrina; Renga, Barbara; Bruno, Angela; D'Amore, Claudio; Fiorucci, Stefano] Univ Perugia, Dipartimento Med Clin & Sperimentale, Fac Med & Chirurg, I-06100 Perugia, Italy; [Distrutti, Eleonora] Azienda Osped Perugia, Perugia, Italy	University of Perugia; University of Perugia; Azienda Ospedaliera di Perugia	Fiorucci, S (corresponding author), Univ Perugia, Dipartimento Med Clin & Sperimentale, Fac Med & Chirurg, I-06100 Perugia, Italy.	fiorucci@unipg.it	Fiorucci, Stefano/I-1251-2012	D'Amore, Claudio/0000-0001-9217-9404				Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Ali K, 2005, CIRC RES, V97, P922, DOI 10.1161/01.RES.0000187467.67684.43; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031238; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Carlberg C, 2012, EXPERT OPIN THER PAT, V22, P417, DOI 10.1517/13543776.2012.673590; Cheng X, 2008, J MOL CELL CARDIOL, V45, P168, DOI 10.1016/j.yjmcc.2008.04.003; Day CP, 2006, LIVER INT, V26, P1021, DOI 10.1111/j.1478-3231.2006.01323.x; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Ewaschuk J, 2007, HEPATOLOGY, V46, P841, DOI 10.1002/hep.21750; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fiorucci S, 2011, MINI-REV MED CHEM, V11, P753, DOI 10.2174/138955711796355258; Fiorucci S, 2010, CURR MOL MED, V10, P579; Fiorucci S, 2010, PROG LIPID RES, V49, P171, DOI 10.1016/j.plipres.2009.11.001; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; King VL, 2010, OBESITY, V18, P35, DOI 10.1038/oby.2009.176; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482; Lakhdari O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013092; Li HT, 2012, DIABETES, V61, P797, DOI 10.2337/db11-0846; Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048; LICHTMAN SN, 1991, GASTROENTEROLOGY, V100, P513, DOI 10.1016/0016-5085(91)90224-9; LICHTMAN SN, 1990, GASTROENTEROLOGY, V98, P414, DOI 10.1016/0016-5085(90)90833-M; Lirussi F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005165.pub2; Loria P, 2005, DIGEST DIS, V23, P72, DOI 10.1159/000084728; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Mencarelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022978; Mencarelli A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013238; Mencarelli A, 2010, J CELL MOL MED, V14, P79, DOI 10.1111/j.1582-4934.2009.00997.x; Mencarelli A, 2009, J IMMUNOL, V183, P6657, DOI 10.4049/jimmunol.0901347; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; Menendez-Gutierrez MP, 2012, CURR TOP MED CHEM, V12, P548; Methe H, 2005, J AM COLL CARDIOL, V45, P1939, DOI 10.1016/j.jacc.2005.03.040; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Musso G, 2008, DIABETES CARE, V31, P562, DOI 10.2337/dc07-1526; Nair S, 2001, AM J GASTROENTEROL, V96, P1200, DOI 10.1111/j.1572-0241.2001.03702.x; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reiff C, 2009, INFLAMM BOWEL DIS, V15, P1721, DOI 10.1002/ibd.20999; Reinhard W, 2006, AM J CARDIOL, V97, P964, DOI 10.1016/j.amjcard.2005.10.063; Sakaguchi S, 2011, DRUG METAB PHARMACOK, V26, P30, DOI 10.2133/dmpk.DMPK-10-RV-087; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Stepankova R, 2010, J ATHEROSCLER THROMB, V17, P796, DOI 10.5551/jat.3285; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Velayudham A, 2009, HEPATOLOGY, V49, P989, DOI 10.1002/hep.22711; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Yoneda M, 2007, J GASTROENTEROL, V42, P573, DOI 10.1007/s00535-007-2060-x	67	71	75	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45425	10.1371/journal.pone.0045425	http://dx.doi.org/10.1371/journal.pone.0045425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029000	Green Submitted, gold, Green Published			2022-12-27	WOS:000309392800046
J	Wang, Y; Lin, B				Wang, Yan; Lin, Bo			In Silico Investigations of the Anti-Catabolic Effects of Pamidronate and Denosumab on Multiple Myeloma-Induced Bone Disease	PLOS ONE			English	Article							BREAST-CANCER; BISPHOSPHONATE PAMIDRONATE; POSTMENOPAUSAL WOMEN; MONOCLONAL-ANTIBODY; ZOLEDRONIC ACID; DOUBLE-BLIND; RESORPTION; EFFICACY; CELLS; MODEL	It is unclear whether the new anti-catabolic agent denosumab represents a viable alternative to the widely used anti-catabolic agent pamidronate in the treatment of Multiple Myeloma (MM)-induced bone disease. This lack of clarity primarily stems from the lack of sufficient clinical investigations, which are costly and time consuming. However, in silico investigations require less time and expense, suggesting that they may be a useful complement to traditional clinical investigations. In this paper, we aim to (i) develop integrated computational models that are suitable for investigating the effects of pamidronate and denosumab on MM-induced bone disease and (ii) evaluate the responses to pamidronate and denosumab treatments using these integrated models. To achieve these goals, pharmacokinetic models of pamidronate and denosumab are first developed and then calibrated and validated using different clinical datasets. Next, the integrated computational models are developed by incorporating the simulated transient concentrations of pamidronate and denosumab and simulations of their actions on the MM-bone compartment into the previously proposed MM-bone model. These integrated models are further calibrated and validated by different clinical datasets so that they are suitable to be applied to investigate the responses to the pamidronate and denosumab treatments. Finally, these responses are evaluated by quantifying the bone volume, bone turnover, and MM-cell density. This evaluation identifies four denosumab regimes that potentially produce an overall improved bone-related response compared with the recommended pamidronate regime. This in silico investigation supports the idea that denosumab represents an appropriate alternative to pamidronate in the treatment of MM-induced bone disease.	[Wang, Yan] Univ Melbourne, Sch Engn, Dept Infrastructure Engn, Melbourne, Vic, Australia; [Lin, Bo] Henan Univ, Sch Med, Kaifeng, Peoples R China	University of Melbourne; Henan University	Wang, Y (corresponding author), Univ Melbourne, Sch Engn, Dept Infrastructure Engn, Melbourne, Vic, Australia.	wangyan00@tsinghua.org.cn						Abrahamsen B, 2005, CURR OPIN MOL THER, V7, P604; Aghaloo TL, 2010, J ORAL MAXIL SURG, V68, P959, DOI 10.1016/j.joms.2009.10.010; Aparicio A, 1998, LEUKEMIA, V12, P220, DOI 10.1038/sj.leu.2400892; BELCH AR, 1991, J CLIN ONCOL, V9, P1397, DOI 10.1200/JCO.1991.9.8.1397; Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; Body JJ, 2006, CLIN CANCER RES, V12, P1221, DOI 10.1158/1078-0432.CCR-05-1933; Cheng A, 2005, AUST DENT J, V50, pS4, DOI 10.1111/j.1834-7819.2005.tb00384.x; Cremers S, 2002, EUR J CLIN PHARMACOL, V57, P883, DOI 10.1007/s00228-001-0411-8; Cremers SCLM, 2005, J BONE MINER RES, V20, P1543, DOI 10.1359/JBMR.050522; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Diamond T, 1997, BRIT J HAEMATOL, V97, P641, DOI 10.1046/j.1365-2141.1997.1042920.x; Elad S, 2006, CLIN LAB HAEMATOL, V28, P393, DOI 10.1111/j.1365-2257.2006.00841.x; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Gordon S, 2002, BRIT J HAEMATOL, V119, P475, DOI 10.1046/j.1365-2141.2002.03824.x; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Henry DH, 2011, J CLIN ONCOL, V29, P1125, DOI 10.1200/JCO.2010.31.3304; International myeloma working group, 2007, MAYO CLIN P, V86; Kendler DL, 2010, J BONE MINER RES, V25, P72, DOI 10.1359/jbmr.090716; Kitano M, 2005, J BONE MINER METAB, V23, P48, DOI 10.1007/s00774-004-0540-0; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Kunzmann V, 2000, BLOOD, V96, P384; KYLE RA, 1975, NEW ENGL J MED, V293, P1334, DOI 10.1056/NEJM197512252932602; Kyle RA, 2007, J CLIN ONCOL, V25, P2464, DOI 10.1200/JCO.2007.12.1269; Lipton A, 2007, J CLIN ONCOL, V25, P4431, DOI 10.1200/JCO.2007.11.8604; Marathe A, 2008, J PHARMACOL EXP THER, V326, P555, DOI 10.1124/jpet.108.137703; Mundy GR, 1993, PHYSL PHARM BONE; Nau KC, 2008, AM FAM PHYSICIAN, V78, P853; Reid IR, 2010, J BONE MINER RES, V25, P2256, DOI 10.1002/jbmr.149; Riggs BL, 2005, J BONE MINER RES, V20, P177, DOI 10.1359/JBMR.041114; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; Rosen LS, 2001, CANCER J, V7, P377; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; Silbermann R, 2010, CURR CLIN ONCOL, P1, DOI 10.1007/978-1-60761-554-5_1; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Srivastava AK, 2001, CALCIFIED TISSUE INT, V69, P327, DOI 10.1007/s00223-001-1034-x; Stresing V, 2007, CANCER LETT, V257, P16, DOI 10.1016/j.canlet.2007.07.007; Terpos E, 2000, EUR J HAEMATOL, V65, P331, DOI 10.1034/j.1600-0609.2000.065005331.x; Terpos E, 2007, LEUKEMIA, V21, P1875, DOI 10.1038/sj.leu.2404843; Toutain PL, 2002, AAPS PHARMSCI, V4; Vanderkerken K, 2003, CANCER RES, V63, P287; Vij R, 2009, AM J HEMATOL, V84, P650, DOI 10.1002/ajh.21509; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027494; Woitge HW, 1999, J BONE MINER RES, V14, P792, DOI 10.1359/jbmr.1999.14.5.792; Yaccoby S, 2002, BRIT J HAEMATOL, V116, P278, DOI 10.1046/j.1365-2141.2002.03257.x; Yeh HS, 2006, EUR J CANCER, V42, P1554, DOI 10.1016/j.ejca.2005.11.035	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44868	10.1371/journal.pone.0044868	http://dx.doi.org/10.1371/journal.pone.0044868			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028650	Green Published, gold			2022-12-27	WOS:000309392800020
J	Betcher, MA; Fung, JM; Han, AW; O'Connor, R; Seronay, R; Concepcion, GP; Distel, DL; Haygood, MG				Betcher, Meghan A.; Fung, Jennifer M.; Han, Andrew W.; O'Connor, Roberta; Seronay, Romell; Concepcion, Gisela P.; Distel, Daniel L.; Haygood, Margo G.			Microbial Distribution and Abundance in the Digestive System of Five Shipworm Species (Bivalvia: Teredinidae)	PLOS ONE			English	Article							LYRODUS-PEDICELLATUS BIVALVIA; WOOD-BORING BIVALVES; BACTERIAL ENDOSYMBIONTS; TERMITE; SYMBIONT; LIGNOCELLULOSE; HYBRIDIZATION; BIOFUELS; MOLLUSCA; TEREDO	Marine bivalves of the family Teredinidae (shipworms) are voracious consumers of wood in marine environments. In several shipworm species, dense communities of intracellular bacterial endosymbionts have been observed within specialized cells (bacteriocytes) of the gills (ctenidia). These bacteria are proposed to contribute to digestion of wood by the host. While the microbes of shipworm gills have been studied extensively in several species, the abundance and distribution of microbes in the digestive system have not been adequately addressed. Here we use Fluorescence In-Situ Hybridization (FISH) and laser scanning confocal microscopy with 16S rRNA directed oligonucleotide probes targeting all domains, domains Bacteria and Archaea, and other taxonomic groups to examine the digestive microbiota of 17 specimens from 5 shipworm species (Bankia setacea, Lyrodus pedicellatus, Lyrodus massa, Lyrodus sp. and Teredo aff. triangularis). These data reveal that the caecum, a large sac-like appendage of the stomach that typically contains large quantities of wood particles and is considered the primary site of wood digestion, harbors only very sparse microbial populations. However, a significant number of bacterial cells were observed in fecal pellets within the intestines. These results suggest that due to low abundance, bacteria in the caecum may contribute little to lignocellulose degradation. In contrast, the comparatively high population density of bacteria in the intestine suggests a possible role for intestinal bacteria in the degradation of lignocellulose.	[Betcher, Meghan A.; Han, Andrew W.; Haygood, Margo G.] Oregon Hlth & Sci Univ, Div Environm & Biomol Syst, Beaverton, OR USA; [Fung, Jennifer M.; O'Connor, Roberta; Distel, Daniel L.] Ocean Genome Legacy, Ipswich, MA USA; [Seronay, Romell; Concepcion, Gisela P.] Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines	Oregon Health & Science University; University of the Philippines System; University of the Philippines Diliman	Haygood, MG (corresponding author), Oregon Hlth & Sci Univ, Div Environm & Biomol Syst, Beaverton, OR USA.	haygoodm@ebs.ogi.edu	Distel, Daniel/A-8047-2017; OConnor, Roberta/AAG-6277-2020	Distel, Daniel/0000-0002-3860-194X; OConnor, Roberta/0000-0003-2757-754X	National Institutes of Health [IU01TW008163-01]; National Science Foundation award [0920540]; Division Of Integrative Organismal Systems [1442676] Funding Source: National Science Foundation; FOGARTY INTERNATIONAL CENTER [U19TW008163, U01TW008163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation award(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the National Institutes of Health grant IU01TW008163-01 (http://grants.nih.gov/grants/oer.htm) and the National Science Foundation award #0920540 to D. Distel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; BAZYLINSKI DA, 1983, VELIGER, V25, P251; Brune A, 1998, TRENDS BIOTECHNOL, V16, P16, DOI 10.1016/S0167-7799(97)01151-7; Brune Andreas, 2006, V41, P39; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DEAN RC, 1978, BIOL BULL-US, V155, P297, DOI 10.2307/1540954; Distel DL, 2011, MOL PHYLOGENET EVOL, V61, P245, DOI 10.1016/j.ympev.2011.05.019; Distel DL, 2003, ACS SYM SER, V845, P253; DISTEL DL, 1991, APPL ENVIRON MICROB, V57, P2376, DOI 10.1128/AEM.57.8.2376-2382.1991; Distel DL, 2002, APPL ENVIRON MICROB, V68, P6292, DOI 10.1128/AEM.68.12.6292-6299.2002; Distel DL, 1997, BIOL BULL, V192, P253, DOI 10.2307/1542719; Ekborg NA, 2007, APPL ENVIRON MICROB, V73, P7785, DOI 10.1128/AEM.00876-07; GALLAGER SM, 1981, J EXP MAR BIOL ECOL, V52, P63, DOI 10.1016/0022-0981(81)90171-4; GREENFIELD LJ, 1953, J BIOL CHEM, V204, P669; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Lazier EL., 1924, U CALIF PUBL ZOOL, V22, P455; Lechene CP, 2007, SCIENCE, V317, P1563, DOI 10.1126/science.1145557; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luyten YA, 2006, APPL ENVIRON MICROB, V72, P412, DOI 10.1128/AEM.72.1.412-417.2006; Morton B, 1970, P MALACOL SOC LONDON, P151; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; POPHAM JD, 1973, MAR BIOL, V19, P338, DOI 10.1007/BF00348904; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Turner R.D., 1966, PROVIDES GORGEOUSLY; WALLACE RJ, 1994, J ANIM SCI, V72, P2992, DOI 10.2527/1994.72112992x; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085; Zheng DD, 1996, APPL ENVIRON MICROB, V62, P4504, DOI 10.1128/AEM.62.12.4504-4513.1996	36	37	37	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45309	10.1371/journal.pone.0045309	http://dx.doi.org/10.1371/journal.pone.0045309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028923	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900038
J	Du, DL; Lee, CF; Li, XQ				Du, Donglei; Lee, Connie F.; Li, Xiu-Qing			Systematic Differences in Signal Emitting and Receiving Revealed by PageRank Analysis of a Human Protein Interactome	PLOS ONE			English	Article							SUBCELLULAR REDISTRIBUTION; INTERACTION NETWORKS; TRANSDUCTION; PHOSPHATASES; ALIGNMENT; PATHWAYS; 2-HYBRID; PROMOTES; RANKING; CANCER	Most protein PageRank studies do not use signal flow direction information in protein interactions because this information was not readily available in large protein databases until recently. Therefore, four questions have yet to be answered: A) What is the general difference between signal emitting and receiving in a protein interactome? B) Which proteins are among the top ranked in directional ranking? C) Are high ranked proteins more evolutionarily conserved than low ranked ones? D) Do proteins with similar ranking tend to have similar subcellular locations? In this study, we address these questions using the forward, reverse, and non-directional PageRank approaches to rank an information-directional network of human proteins and study their evolutionary conservation. The forward ranking gives credit to information receivers, reverse ranking to information emitters, and non-directional ranking mainly to the number of interactions. The protein lists generated by the forward and non-directional rankings are highly correlated, but those by the reverse and non-directional rankings are not. The results suggest that the signal emitting/receiving system is characterized by key-emittings and relatively even receivings in the human protein interactome. Signaling pathway proteins are frequent in top ranked ones. Eight proteins are both informational top emitters and top receivers. Top ranked proteins, except a few species-related novel-function ones, are evolutionarily well conserved. Protein-subunit ranking position reflects subunit function. These results demonstrate the usefulness of different PageRank approaches in characterizing protein networks and provide insights to protein interaction in the cell.	[Li, Xiu-Qing] Agr & Agri Food Canada, Mol Genet Lab, Potato Res Ctr, Fredericton, NB, Canada; [Du, Donglei; Lee, Connie F.] Univ New Brunswick, Fac Business Adm, Quantiat Study Grp, Fredericton, NB, Canada; [Lee, Connie F.] Columbia Univ, Fu Fdn Sch Engn & Appl Sci, New York, NY USA	Agriculture & Agri Food Canada; CGIAR; International Potato Center (CIP); University of New Brunswick; Columbia University	Li, XQ (corresponding author), Agr & Agri Food Canada, Mol Genet Lab, Potato Res Ctr, Fredericton, NB, Canada.	Xiu-Qing.Li@agr.gc.ca		Du, Donglei/0000-0003-0111-8572; Li, Xiu-Qing/0000-0002-7308-0596				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ball P, 2006, NATURE, V439, P770, DOI 10.1038/439770a; Benmerah A, 2004, CURR BIOL, V14, pR314, DOI 10.1016/j.cub.2004.03.053; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chen Z., 2011, J COMPUT INFO SYS, V7, P3149; Denu JM, 1998, CURR OPIN CHEM BIOL, V2, P633, DOI 10.1016/S1367-5931(98)80095-1; Gough NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002601; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ivan G, 2011, BIOINFORMATICS, V27, P405, DOI 10.1093/bioinformatics/btq680; Krallinger M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S3; Kuang R, 2005, BIOINFORMATICS, V21, P3711, DOI 10.1093/bioinformatics/bti608; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Li F, 2002, FEBS LETT, V524, P49, DOI 10.1016/S0014-5793(02)02994-0; Li XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018615; Liao YC, 2009, CANCER RES, V69, P4563, DOI 10.1158/0008-5472.CAN-09-0117; Liu W, 2009, MOL CELL PROTEOMICS, V8, P2063, DOI 10.1074/mcp.M800354-MCP200; Liu ZG, 2007, BIOCHEM BIOPH RES CO, V353, P47, DOI 10.1016/j.bbrc.2006.11.133; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mochida S, 2012, EMBO REP, V13, P197, DOI 10.1038/embor.2011.263; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pelka P, 2007, J CELL PHYSIOL, V212, P13, DOI 10.1002/jcp.20983; Polden J, 2011, PROTEOMICS, V11, P3582, DOI 10.1002/pmic.201000182; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sebolt-Leopold JS, 2008, CLIN CANCER RES, V14, P3651, DOI 10.1158/1078-0432.CCR-08-0333; Shapiro MJ, 2005, J BIOL CHEM, V280, P38242, DOI 10.1074/jbc.M507441200; Siltberg-Liberles J, 2011, GENES-BASEL, V2, P748, DOI 10.3390/genes2040748; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Stenmark H, 2001, GENOME BIOL, V2; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	31	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44872	10.1371/journal.pone.0044872	http://dx.doi.org/10.1371/journal.pone.0044872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028653	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400045
J	Lanham, M; L'Engle, KL; Loolpapit, M; Oguma, IO				Lanham, Michele; L'Engle, Kelly L.; Loolpapit, Mores; Oguma, Isaac Onyango			Women's Roles in Voluntary Medical Male Circumcision in Nyanza Province, Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RANDOMIZED CONTROLLED-TRIAL; CONDOM USE; HIV PREVENTION; UGANDA; MEN; INFECTION; RAKAI; METAANALYSIS; PARTNERS	Women are an important audience for voluntary medical male circumcision (VMMC) communication messages so that they know that VMMC provides only partial protection against HIV. They may also be able to influence their male partners to get circumcised and practice other HIV protective measures after VMMC. This study was conducted in two phases of qualitative data collection. Phase 1 used in-depth interviews to explore women's understanding of partial protection and their role in VMMC. Phase 2 built on the findings from the Phase 1, using focus groups to test VMMC communication messages currently used in Nyanza Province and to further explore women's roles in VMMC. Sixty-four sexually active women between the ages of 18 and 35 participated. In Phase 1, all women said they had heard of partial protection, though some were not able to elaborate on what the concept means. When women in Phase 2 were exposed to messages about partial protection, however, participants understood the messages well and were able to identify the main points. In Phases 1 and 2, many participants said that they had discussed VMMC with their partner, and for several, it was a joint decision for the man to go for VMMC. These findings suggest that current VMMC messaging is reaching women, though communications could more effectively target women to increase their ability to communicate about partial HIV protection from VMMC. Also, women seem to be playing an important role in encouraging men to get circumcised, so reaching out to women could be a valuable intervention strategy for increasing VMMC uptake and promoting use of other HIV protective measures after VMMC.	[Lanham, Michele; L'Engle, Kelly L.] FHI 360, Social & Behav Hlth Sci, Res Triangle Pk, NC USA; [Loolpapit, Mores; Oguma, Isaac Onyango] FHI 360, Male Circumcis Consortium Project, Nairobi, Kenya	FHI 360	Lanham, M (corresponding author), FHI 360, Social & Behav Hlth Sci, Res Triangle Pk, NC USA.	mlanham@fhi360.org		Lanham, Michele/0000-0003-3012-5683	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study and manuscript preparation was funded by the Bill & Melinda Gates Foundation through a grant to FHI 360 to form the Male Circumcision Consortium (MCC). The MCC is a partnership between FHI 360, University of Illinois at Chicago working with the Nyanza Reproductive Health Society, and EngenderHealth. The MCC works with the Government of Kenya and other partners to prevent HIV by expanding access to safe and voluntary male circumcision services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baeten JM, 2009, LANCET, V374, P182, DOI 10.1016/S0140-6736(09)61311-8; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Berer M, 2008, REPROD HEALTH MATTER, V16, P171, DOI 10.1016/S0968-8080(08)32418-5; Cleland J, 2006, REPROD HEALTH MATTER, V14, P17, DOI 10.1016/S0968-8080(06)28250-8; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; de Walque D, 2011, STUD FAMILY PLANN, V42, P1, DOI 10.1111/j.1728-4465.2011.00259.x; Desgrees-du-Lou A, 2008, REPROD HEALTH MATTER, V16, P151, DOI 10.1016/S0968-8080(08)32407-0; Desgrees-Du-Lou A, 2009, AIDS BEHAV, V13, P348, DOI 10.1007/s10461-007-9316-6; Dickson KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001133; Ehrhardt AA, 2009, JAIDS-J ACQ IMM DEF, V51, pS96, DOI 10.1097/QAI.0b013e3181aafd54; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Guest G, 2012, APPLIED THEMATIC ANA; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018299; Holsti O., 1969, CONTENT ANALYSIS FOR; Kenya National Bureau of Statistics (KNBS) ICF Macro, 2010, KENYA DEMOGRAPHIC AN; MacQueen K, 2008, HANDBOOK FOR TEAM BA; Maharaj P, 2011, AIDS CARE; Matovu JKB, 2007, REPROD HEALTH MATTER, V15, P68, DOI 10.1016/S0968-8080(07)29306-1; McLellan E, FIELD METHODS, V15, P63; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; Noar SM, 2006, J HEALTH COMMUN, V11, P365, DOI 10.1080/10810730600671862; Obure A, 2011, GLOBAL J COMMUNITY P, V1, P1; Riess TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012366; Siegfried NMM, 2009, COCHRANE DATABASE OF; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Williamson NE, 2006, REPROD HEALTH MATTER, V14, P89, DOI 10.1016/S0968-8080(06)28268-5	31	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44825	10.1371/journal.pone.0044825	http://dx.doi.org/10.1371/journal.pone.0044825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028634	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400041
J	Shiogai, Y; Dhamala, M; Oshima, K; Hasler, M				Shiogai, Yuri; Dhamala, Mukesh; Oshima, Kumiko; Hasler, Martin			Cortico-Cardio-Respiratory Network Interactions during Anesthesia	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; LINEAR-DEPENDENCE; TIME-SERIES; OSCILLATIONS; AWARENESS; FEEDBACK; CORTEX; STATES; SLEEP	General anesthetics are used during medical and surgical procedures to reversibly induce a state of total unconsciousness in patients. Here, we investigate, from a dynamic network perspective, how the cortical and cardiovascular systems behave during anesthesia by applying nonparametric spectral techniques to cortical electroencephalography, electrocardiogram and respiratory signals recorded from anesthetized rats under two drugs, ketamine-xylazine (KX) and pentobarbital (PB). We find that the patterns of low-frequency cortico-cardio-respiratory network interactions may undergo significant changes in network activity strengths and in number of network links at different depths of anesthesia dependent upon anesthetics used.	[Dhamala, Mukesh] Georgia State Univ, Dept Phys & Astron, Neurosci Inst, Ctr Behav Neurosci, Atlanta, GA 30303 USA; [Shiogai, Yuri; Oshima, Kumiko; Hasler, Martin] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, Lausanne, Switzerland	University System of Georgia; Georgia State University; Ecole Polytechnique Federale de Lausanne	Dhamala, M (corresponding author), Georgia State Univ, Dept Phys & Astron, Neurosci Inst, Ctr Behav Neurosci, Atlanta, GA 30303 USA.	mdhamala@gsu.edu	Dhamala, Mukesh/AAX-3207-2021		FP6 NEST (Sixth Framework Programme New and Emerging science and technology) Tackling Complexity in science project BRACCIA (Brain, Respiratory and Cardiac Causalities in Anesthesia); National Foundation Career Award [BCS 0955037]; Division Of Behavioral and Cognitive Sci [0955037] Funding Source: National Science Foundation	FP6 NEST (Sixth Framework Programme New and Emerging science and technology) Tackling Complexity in science project BRACCIA (Brain, Respiratory and Cardiac Causalities in Anesthesia); National Foundation Career Award; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was supported by the FP6 NEST (Sixth Framework Programme New and Emerging science and technology) Tackling Complexity in science project BRACCIA (Brain, Respiratory and Cardiac Causalities in Anesthesia) to ICLANOS team. The author MD would also like to acknowledge National Foundation Career Award (BCS 0955037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan MS, 2008, NEW ENGL J MED, V358, P1097, DOI 10.1056/NEJMoa0707361; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Eckhorn R, 2001, VIS COGN, V8, P519, DOI 10.1080/13506280143000098; FELDMAN JL, 1988, ANNU REV PHYSIOL, V50, P593; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Foster BL, 2008, COGN NEURODYNAMICS, V2, P283, DOI 10.1007/s11571-008-9063-z; Galletly DC, 1998, BRIT J ANAESTH, V80, P164, DOI 10.1093/bja/80.2.164; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; GEWEKE JF, 1984, J AM STAT ASSOC, V79, P907, DOI 10.2307/2288723; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hales S, 1733, STATICAL ESSAYS HEAE; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Musizza B, 2007, J PHYSIOL-LONDON, V580, P315, DOI 10.1113/jphysiol.2006.126748; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Orser BA, 2008, NEW ENGL J MED, V358, P1189, DOI 10.1056/NEJMe0800998; Pattinson KTS, 2009, NEUROIMAGE, V44, P295, DOI 10.1016/j.neuroimage.2008.09.007; Raeder J, 2003, ADV EXP MED BIOL, V523, P269; Rosenblum MG, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041909; Rosenblum MG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.045202; Sebel PS, 2004, ANESTH ANALG, V99, P833, DOI 10.1213/01.ANE.0000130261.90896.6C; Stefanovska A, 2000, PHYS REV LETT, V85, P4831, DOI 10.1103/PhysRevLett.85.4831; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Wixson K, 1987, LAB ANIM SCI, V37, P736	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44634	10.1371/journal.pone.0044634	http://dx.doi.org/10.1371/journal.pone.0044634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028572	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400030
J	Almeida, RR; Rosa, DS; Ribeiro, SP; Santana, VC; Kallas, EG; Sidney, J; Sette, A; Kalil, J; Cunha-Neto, E				Almeida, Rafael Ribeiro; Rosa, Daniela Santoro; Ribeiro, Susan Pereira; Santana, Vinicius Canato; Kallas, Esper Georges; Sidney, John; Sette, Alessandro; Kalil, Jorge; Cunha-Neto, Edecio			Broad and Cross-Clade CD4(+) T-Cell Responses Elicited by a DNA Vaccine Encoding Highly Conserved and Promiscuous HIV-1 M-Group Consensus Peptides	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNE-RESPONSES; RHESUS-MONKEYS; DISCORDANT ASSOCIATIONS; LYMPHOCYTE RESPONSES; SIV REPLICATION; PATHOGENIC SIV; EPITOPES; GAG; IDENTIFICATION	T-cell based vaccine approaches have emerged to counteract HIV-1/AIDS. Broad, polyfunctional and cytotoxic CD4(+) T-cell responses have been associated with control of HIV-1 replication, which supports the inclusion of CD4(+) T-cell epitopes in vaccines. A successful HIV-1 vaccine should also be designed to overcome viral genetic diversity and be able to confer immunity in a high proportion of immunized individuals from a diverse HLA-bearing population. In this study, we rationally designed a multiepitopic DNA vaccine in order to elicit broad and cross-clade CD4(+) T-cell responses against highly conserved and promiscuous peptides from the HIV-1 M-group consensus sequence. We identified 27 conserved, multiple HLA-DR-binding peptides in the HIV-1 M-group consensus sequences of Gag, Pol, Nef, Vif, Vpr, Rev and Vpu using the TEPITOPE algorithm. The peptides bound in vitro to an average of 12 out of the 17 tested HLA-DR molecules and also to several molecules such as HLA-DP, -DQ and murine IA(b) and IA(d). Sixteen out of the 27 peptides were recognized by PBMC from patients infected with different HIV-1 variants and 72% of such patients recognized at least 1 peptide. Immunization with a DNA vaccine (HIVBr27) encoding the identified peptides elicited IFN-gamma secretion against 11 out of the 27 peptides in BALB/c mice; CD4(+) and CD8(+) T-cell proliferation was observed against 8 and 6 peptides, respectively. HIVBr27 immunization elicited cross-clade T-cell responses against several HIV-1 peptide variants. Polyfunctional CD4(+) and CD8(+) T cells, able to simultaneously proliferate and produce IFN-gamma and TNF-alpha, were also observed. This vaccine concept may cope with HIV-1 genetic diversity as well as provide increased population coverage, which are desirable features for an efficacious strategy against HIV-1/AIDS.	[Almeida, Rafael Ribeiro; Rosa, Daniela Santoro; Ribeiro, Susan Pereira; Santana, Vinicius Canato; Kallas, Esper Georges; Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, Sch Med, Lab Clin Immunol & Allergy LIM60, Div Clin Immunol & Allergy,Dept Med, Sao Paulo, Brazil; [Kalil, Jorge; Cunha-Neto, Edecio] Univ Sao Paulo, InCor, Sch Med, Inst Heart, Sao Paulo, Brazil; [Rosa, Daniela Santoro; Ribeiro, Susan Pereira; Kalil, Jorge; Cunha-Neto, Edecio] INCT, Inst Invest Immunol, Sao Paulo, Brazil; [Rosa, Daniela Santoro] Univ Fed Sao Paulo, UNIFESP, Div Immunol, Sao Paulo, Brazil; [Sidney, John] La Jolla Inst Allergy & Immunol, Ctr Infect Dis Allergy & Asthma Res, La Jolla, CA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); La Jolla Institute for Immunology	Cunha-Neto, E (corresponding author), Univ Sao Paulo, Sch Med, Lab Clin Immunol & Allergy LIM60, Div Clin Immunol & Allergy,Dept Med, Sao Paulo, Brazil.	edecunha@gmail.com	KALIL, JORGE/C-8029-2012; Cunha-Neto, Edecio/B-4157-2009; Rosa, Daniela S/D-2190-2012; Sette, Alessandro/AFO-8916-2022; Almeida, Rafael Ribeiro/F-8014-2014	KALIL, JORGE/0000-0001-8415-4274; Cunha-Neto, Edecio/0000-0002-3699-3345; Rosa, Daniela S/0000-0003-4536-891X; Almeida, Rafael Ribeiro/0000-0003-3984-7527; Kallas, Esper/0000-0003-2026-6925	Brazilian National Research Council (CNPq) [420166/2005-0]; Sao Paulo State Research Funding Agency (FAPESP) [2004/15856-9, 2006/50096-0, 2008/57881-0]; Brazilian Program for STD and AIDS, Ministry of Health [914/BRA/3014-UNESCO/Kallas]; Sao Paulo City Health Department [2004-0.168.922-7/Kallas]; Brazilian Council for Scientific and Technological Development - CNPq productivity awards	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Funding Agency (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Program for STD and AIDS, Ministry of Health; Sao Paulo City Health Department; Brazilian Council for Scientific and Technological Development - CNPq productivity awards(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This research was supported by the Brazilian National Research Council (CNPq), grant 420166/2005-0; Sao Paulo State Research Funding Agency (FAPESP), grants 2004/15856-9, 2006/50096-0 and 2008/57881-0; Brazilian Program for STD and AIDS, Ministry of Health (914/BRA/3014-UNESCO/Kallas); and the Sao Paulo City Health Department (2004-0.168.922-7/Kallas). RRA, SPR and VCS are recipients of Sao Paulo State Research Funding Agency (FAPESP) fellowships. EGK, JK and ECN are recipients of Brazilian Council for Scientific and Technological Development - CNPq productivity awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Bansal A, 2006, AIDS, V20, P353, DOI 10.1097/01.aids.0000206501.16783.67; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Batista MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005613; BenMohamed L, 2003, J VIROL, V77, P9463, DOI 10.1128/JVI.77.17.9463-9473.2003; Bian HJ, 2004, METHODS, V34, P468, DOI 10.1016/j.ymeth.2004.06.002; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Corey L, 2009, AIDS, V23, P3, DOI 10.1097/QAD.0b013e32830e6d6d; de Lalla C, 1999, J IMMUNOL, V163, P1725; Depil S, 2007, J IMMUNOTHER, V30, P215, DOI 10.1097/01.cji.0000211338.99137.4f; Depla E, 2008, J VIROL, V82, P435, DOI 10.1128/JVI.01505-07; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Egan MA, 2000, J VIROL, V74, P7485, DOI 10.1128/JVI.74.16.7485-7495.2000; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f; Fuller DH, 2007, VIROLOGY, V364, P245, DOI 10.1016/j.virol.2007.02.024; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gauduin MC, 2006, J EXP MED, V203, P2661, DOI 10.1084/jem.20060134; Gloster SE, 2004, AIDS, V18, P749, DOI 10.1097/00002030-200403260-00005; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Haynes BF, 2012, NEW ENGLAND J MED, P366; Hel Z, 2006, J IMMUNOL, V176, P85, DOI 10.4049/jimmunol.176.1.85; Ishioka GY, 1999, J IMMUNOL, V162, P3915; Iwai LK, 2007, CLIN VACCINE IMMUNOL, V14, P474, DOI 10.1128/CVI.00458-06; Iwai LK, 2003, MOL MED, V9, P209, DOI 10.1007/BF03402131; Kallas EG, 2004, BRAZ J INFECT DIS, V8, P8; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kovjazin R, 2011, VACCINE, V29, P4676, DOI 10.1016/j.vaccine.2011.04.103; Lacap PA, 2008, AIDS, V22, P1029, DOI 10.1097/QAD.0b013e3282ffb3db; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124; Pettersen FO, 2010, CLIN EXP IMMUNOL, V161, P315, DOI 10.1111/j.1365-2249.2010.04179.x; Porichis F, 2011, CURR OPIN HIV AIDS, V6, P174, DOI 10.1097/COH.0b013e3283454058; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ribeiro SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011072; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rosa DS, 2006, MICROBES INFECT, V8, P2130, DOI 10.1016/j.micinf.2006.03.012; Rosa DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016921; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Sa D, 2007, AIDS RES HUM RETROV, V23, P1087, DOI 10.1089/aid.2006.0173; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Samri A, 2006, CLIN VACCINE IMMUNOL, V13, P684, DOI 10.1128/CVI.00387-05; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Santra S, 2008, P NATL ACAD SCI USA, V105, P10489, DOI 10.1073/pnas.0803352105; Schroers R, 2002, CANCER RES, V62, P2600; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sidney J, 2001, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1803s31; Staprans SI, 2004, P NATL ACAD SCI USA, V101, P13026, DOI 10.1073/pnas.0404739101; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Suhrbier Andreas, 2002, Expert Rev Vaccines, V1, P207, DOI 10.1586/14760584.1.2.207; Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107; Vaccari M, 2008, J VIROL, V82, P9629, DOI 10.1128/JVI.00893-08; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Wilson CC, 2003, J IMMUNOL, V171, P5611, DOI 10.4049/jimmunol.171.10.5611; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW180, DOI 10.1093/nar/gki479; Zheng N, 2009, J VIROL, V83, P7668, DOI 10.1128/JVI.00513-09	72	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45267	10.1371/journal.pone.0045267	http://dx.doi.org/10.1371/journal.pone.0045267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028895	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900110
J	Eggert, LD; Sommer, J; Jansen, A; Kircher, T; Konrad, C				Eggert, Lucas D.; Sommer, Jens; Jansen, Andreas; Kircher, Tilo; Konrad, Carsten			Accuracy and Reliability of Automated Gray Matter Segmentation Pathways on Real and Simulated Structural Magnetic Resonance Images of the Human Brain	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; VALIDATION; SKULL; DISORDER; DISEASE; IMPACT	Automated gray matter segmentation of magnetic resonance imaging data is essential for morphometric analyses of the brain, particularly when large sample sizes are investigated. However, although detection of small structural brain differences may fundamentally depend on the method used, both accuracy and reliability of different automated segmentation algorithms have rarely been compared. Here, performance of the segmentation algorithms provided by SPM8, VBM8, FSL and FreeSurfer was quantified on simulated and real magnetic resonance imaging data. First, accuracy was assessed by comparing segmentations of twenty simulated and 18 real T1 images with corresponding ground truth images. Second, reliability was determined in ten T1 images from the same subject and in ten T1 images of different subjects scanned twice. Third, the impact of preprocessing steps on segmentation accuracy was investigated. VBM8 showed a very high accuracy and a very high reliability. FSL achieved the highest accuracy but demonstrated poor reliability and FreeSurfer showed the lowest accuracy, but high reliability. An universally valid recommendation on how to implement morphometric analyses is not warranted due to the vast number of scanning and analysis parameters. However, our analysis suggests that researchers can optimize their individual processing procedures with respect to final segmentation quality and exemplifies adequate performance criteria.	[Eggert, Lucas D.] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany; [Sommer, Jens; Jansen, Andreas; Kircher, Tilo; Konrad, Carsten] Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany	University Osnabruck; Philipps University Marburg	Eggert, LD (corresponding author), Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany.	leggert@uos.de	Kircher, Tilo/AAT-6480-2020; Jansen, Andreas/AAL-5264-2020	Kircher, Tilo/0000-0002-2514-2625; Jansen, Andreas/0000-0002-3140-8207				Acosta-Cabronero J, 2008, NEUROIMAGE, V39, P1654, DOI 10.1016/j.neuroimage.2007.10.051; [Anonymous], 2010, VBM8 TOOLBOX MANUAL; [Anonymous], FIL METH GROUP SPM8; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aubert-Broche B, 2006, IEEE T MED IMAGING, V25, P1410, DOI 10.1109/TMI.2006.883453; Bauer MHA, 2011, INT J COMPUT ASS RAD, V6, P1, DOI 10.1007/s11548-010-0423-x; Beeson P.M., 2011, J MOL NEUROSCI; Beste C, 2008, HUM BRAIN MAPP, V29, P121, DOI 10.1002/hbm.20374; Brieber S, 2007, J CHILD PSYCHOL PSYC, V48, P1251, DOI 10.1111/j.1469-7610.2007.01799.x; Clark KA, 2006, NEUROIMAGE, V29, P185, DOI 10.1016/j.neuroimage.2005.07.035; Clarkson MJ, 2011, NEUROIMAGE, V57, P856, DOI 10.1016/j.neuroimage.2011.05.053; Cocosco CA, 1997, NEUROIMAGE, P425; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dogdas B, 2005, HUM BRAIN MAPP, V26, P273, DOI 10.1002/hbm.20159; Egger J, 2011, J MED SYST; Fein G, 2006, NEUROIMAGE, V30, P1187, DOI 10.1016/j.neuroimage.2005.10.054; Heinzel A, 2011, J AFFECT DISORD; Ille R, 2011, J PSYCHIATR NEUROSCI, V36, P383, DOI 10.1503/jpn.100143; Jansen A, 2010, J NEUROIMAGING, V20, P148, DOI 10.1111/j.1552-6569.2009.00367.x; Kempton MJ, 2011, ARCH GEN PSYCHIAT, V68, P675, DOI 10.1001/archgenpsychiatry.2011.60; Klauschen F, 2009, HUM BRAIN MAPP, V30, P1310, DOI 10.1002/hbm.20599; Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072; Leube DT, 2008, INT J GERIATR PSYCH, V23, P1114, DOI 10.1002/gps.2036; Lim TS, 2010, J CLIN NEUROL, V6, P204, DOI 10.3988/jcn.2010.6.4.204; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Ortiz-Gil J, 2011, BR J PSYCHIAT; Riva D, 2011, AM J NEURORADIOL, V32, P1430, DOI 10.3174/ajnr.A2527; Schmansky N, 2011, RECON ALL; Schnack HG, 2010, HUM BRAIN MAPP, V31, P1967, DOI 10.1002/hbm.20991; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stone JM, 2011, EUR NEUROPSYCHOPHARM; Tavanti M, 2011, NEUROL SCI; Thomas AG, 2009, NEUROIMAGE, V48, P117, DOI 10.1016/j.neuroimage.2009.05.097; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zou K, 2010, BIOL PSYCHIAT, V67, P186, DOI 10.1016/j.biopsych.2009.09.014; Zou KH, 2004, STAT MED, V23, P1259, DOI 10.1002/sim.1723; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	41	87	89	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45081	10.1371/journal.pone.0045081	http://dx.doi.org/10.1371/journal.pone.0045081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028771	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900075
J	Roger, F; Godhe, A; Gamfeldt, L				Roger, Fabian; Godhe, Anna; Gamfeldt, Lars			Genetic Diversity and Ecosystem Functioning in the Face of Multiple Stressors	PLOS ONE			English	Article							GENOTYPIC DIVERSITY; SEPARATED CLONES; DIATOM; BIODIVERSITY; MIXTURES; ECOLOGY; BACILLARIOPHYCEAE; COMPLEMENTARITY; CHLAMYDOMONAS; PRODUCTIVITY	Species diversity is important for a range of ecosystem processes and properties, including the resistance to single and multiple stressors. It has been suggested that genetic diversity may play a similar role, but empirical evidence is still relatively scarce. Here, we report the results of a microcosm experiment where four strains of the marine diatom Skeletonema marinoi were grown in monoculture and in mixture under a factorial combination of temperature and salinity stress. The strains differed in their susceptibility to the two stressors and no strain was able to survive both stressors simultaneously. Strong competition between the genotypes resulted in the dominance of one strain under both control and salinity stress conditions. The overall productivity of the mixture, however, was not related to the dominance of this strain, but was instead dependent on the treatment; under control conditions we observed a positive effect of genetic richness, whereas a negative effect was observed in the stress treatments. This suggests that interactions among the strains can be both positive and negative, depending on the abiotic environment. Our results provide additional evidence that the biodiversity-ecosystem functioning relationship is also relevant at the level of genetic diversity.	[Roger, Fabian; Godhe, Anna; Gamfeldt, Lars] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Gothenburg	Roger, F (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	fabian.roger@bioenv.gu.se	Roger, Fabian/X-3391-2019	Roger, Fabian/0000-0001-9865-7542	Swedish research council VR [621-2009-5457]; European Community [227799]	Swedish research council VR(Swedish Research Council); European Community(European Commission)	This work was supported by grant 621-2009-5457 from the Swedish research council VR to Lars Gamfeldt (http://www.vr.se/), and Formas 2009-909 and European Community-RI Action ASSEMBLE (227799) to Anna Godhe (http://www.formas.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JD, 2012, ECOLOGY, V93, P1134, DOI 10.1890/11-1448.1; Almany GR, 2009, MOL ECOL RESOUR, V9, P1460, DOI 10.1111/j.1755-0998.2009.02759.x; Balzano S, 2011, J PLANKTON RES, V33, P937, DOI 10.1093/plankt/fbq150; BELL G, 1990, PROC R SOC SER B-BIO, V240, P323, DOI 10.1098/rspb.1990.0040; BELL G, 1991, EVOLUTION, V45, P1036, DOI 10.1111/j.1558-5646.1991.tb04368.x; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Claquin P, 2008, AQUAT MICROB ECOL, V51, P1, DOI 10.3354/ame01187; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Drummond EBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030314; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gamfeldt L, 2005, ECOLOGY, V86, P3219, DOI 10.1890/05-0377; Genz A., 2021, MVTNORM MULTIVARIATE; Godhe A, 2006, J PHYCOL, V42, P280, DOI 10.1111/j.1529-8817.2006.00197.x; Godhe A, 2010, MOL ECOL, V19, P4478, DOI 10.1111/j.1365-294X.2010.04841.x; Griffin John n., 2009, P78; GRIME JP, 1989, BIOL J LINN SOC, V37, P3, DOI 10.1111/j.1095-8312.1989.tb02002.x; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2011, J ECOL, V99, P445, DOI 10.1111/j.1365-2745.2010.01767.x; Hughes AR, 2010, MAR ECOL PROG SER, V403, P43, DOI 10.3354/meps08506; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Kooistra WHCF, 2003, J PHYCOL, V39, P185, DOI 10.1046/j.1529-8817.2003.02083.x; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Kremp A, 2012, ECOL EVOL, V2, P1195, DOI 10.1002/ece3.245; Lauritano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026850; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Parker JD, 2010, ECOL LETT, V13, P553, DOI 10.1111/j.1461-0248.2010.01452.x; PHINNEY DA, 1985, J PLANKTON RES, V7, P633, DOI 10.1093/plankt/7.5.633; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rauch G, 2008, OIKOS, V117, P399, DOI 10.1111/j.2007.0030-1299.16301.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Saravanan V, 2010, EUR J PHYCOL, V45, P177, DOI 10.1080/09670260903445146; Sarno D, 2005, J PHYCOL, V41, P151, DOI 10.1111/j.1529-8817.2005.04067.x; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Smithson JB, 1996, ANN APPL BIOL, V128, P127, DOI 10.1111/j.1744-7348.1996.tb07096.x; Takabayashi M, 2006, J PLANKTON RES, V28, P831, DOI 10.1093/plankt/fbl018; Taylor RL, 2009, J PHYCOL, V45, P46, DOI 10.1111/j.1529-8817.2008.00625.x; TITMAN D, 1976, SCIENCE, V192, P463, DOI 10.1126/science.192.4238.463; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; Vidoudez C, 2008, J PLANKTON RES, V30, P1305, DOI 10.1093/plankt/fbn085; Waite A, 1997, MAR ECOL PROG SER, V157, P97, DOI 10.3354/meps157097; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	56	35	38	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45007	10.1371/journal.pone.0045007	http://dx.doi.org/10.1371/journal.pone.0045007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028735	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900066
J	Sun, YM; Che, X; Zhu, LB; Zhao, MD; Fu, GF; Huang, XF; Xu, H; Hu, FQ; Zhang, XM				Sun, Yanmei; Che, Xuan; Zhu, Libo; Zhao, Mengdan; Fu, Guofang; Huang, Xiufeng; Xu, Hong; Hu, Fuqiang; Zhang, Xinmei			Pigment Epithelium Derived Factor Inhibits the Growth of Human Endometrial Implants in Nude Mice and of Ovarian Endometriotic Stromal Cells In Vitro	PLOS ONE			English	Article							PERITONEAL-FLUID; RAT MODEL; PEDF; ANGIOGENESIS; EXPRESSION; CANCER; SERUM; OVEREXPRESSION; THERAPY; WOMEN	Angiogenesis is a prerequisite for the formation and development of endometriosis. Pigment epithelium derived factor (PEDF) is a natural inhibitor of angiogenesis. We previously demonstrated a reduction of PEDF in the peritoneal fluid, serum and endometriotic lesions from women with endometriosis compared with women without endometriosis. Here, we aim to investigate the inhibitory effect of PEDF on human endometriotic cells in vivo and in vitro. We found that PEDF markedly inhibited the growth of human endometrial implants in nude mice and of ovarian endometriotic stromal cells in vitro by up-regulating PEDF expression and down-regulating vascular endothelial growth factor (VEGF) expression. Moreover, apoptotic index was significantly increased in endometriotic lesions in vivo and endometriotic stromal cells in vitro when treated with PEDF. In mice treated with PEDF, decreased microvessel density labeled by Von Willebrand factor but not by alpha-Smooth Muscle Actin was observed in endometriotic lesions. And it showed no increase in PEDF expression of the ovary and uterus tissues. These findings suggest that PEDF gene therapy may be a new treatment for endometriosis.	[Hu, Fuqiang] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Yanmei; Che, Xuan; Zhu, Libo; Zhao, Mengdan; Fu, Guofang; Huang, Xiufeng; Xu, Hong; Zhang, Xinmei] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Hu, FQ (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China.	hufq@zju.edu.cn; zhangxinm@zju.edu.cn			National Nature Science Foundation of China [81070468, 81173000, 30873174]; Nature Science Foundation of Zhejiang province [Y2090336, z207489]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province)	The authors appreciate the financial support of the National Nature Science Foundation of China (81070468, 81173000 and 30873174) and the Nature Science Foundation of Zhejiang province (Y2090336 and z207489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Abramson LP, 2003, J PEDIATR SURG, V38, P336, DOI 10.1053/jpsu.2003.50104; Becker CM, 2007, MICROVASC RES, V74, P121, DOI 10.1016/j.mvr.2007.04.008; Becker CM, 2005, FERTIL STERIL, V84, P1144, DOI 10.1016/j.fertnstert.2005.04.040; Bouck N, 2002, TRENDS MOL MED, V8, P330, DOI 10.1016/S1471-4914(02)02362-6; Broadhead ML, 2009, EXPERT OPIN THER TAR, V13, P1429, DOI 10.1517/14728220903307475; Chen LQ, 2012, REPROD SCI, V19, P64, DOI 10.1177/1933719111413300; Chen LQ, 2011, FERTIL STERIL, V95, P1798, DOI 10.1016/j.fertnstert.2010.10.042; Dass CR, 2008, CURR CANCER DRUG TAR, V8, P683, DOI 10.2174/156800908786733487; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Dechaud H, 2011, FERTIL STERIL, V76, P1012; Ek ETH, 2007, J ORTHOP RES, V25, P1671, DOI 10.1002/jor.20434; Ek ETH, 2006, TRENDS MOL MED, V12, P497, DOI 10.1016/j.molmed.2006.08.009; Ek ETH, 2006, MOL CANCER THER, V5, P1641, DOI 10.1158/1535-7163.MCT-06-0107; Elayappan B, 2009, ANGIOGENESIS, V12, P313, DOI 10.1007/s10456-009-9153-5; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Ricci AG, 2011, REPROD SCI, V18, P614, DOI 10.1177/1933719110395406; Grummer R, 2001, HUM REPROD, V16, P1736, DOI 10.1093/humrep/16.8.1736; Haribalaganesh R, 2010, EXP EYE RES, V90, P726, DOI 10.1016/j.exer.2010.03.005; Keenan JA, 1999, FERTIL STERIL, V72, P135, DOI 10.1016/S0015-0282(99)00157-0; Kirk D, 1980, Methods Cell Biol, V21B, P51; Krajewska M, 1996, AM J PATHOL, V148, P1567; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Machado DE, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-4; Machado DE, 2010, FERTIL STERIL, V93, P2674, DOI 10.1016/j.fertnstert.2009.11.037; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; May K, 2008, Minerva Ginecol, V60, P245; Nothnick W B, 2010, Minerva Ginecol, V62, P17; Pupo-Nogueira A, 2007, INT J GYNECOL OBSTET, V99, P33, DOI 10.1016/j.ijgo.2007.04.033; Sheikpranbabu S, 2010, VASC PHARMACOL, V52, P84, DOI 10.1016/j.vph.2009.12.002; Tan ML, 2010, BIOCHEM BIOPH RES CO, V398, P613, DOI 10.1016/j.bbrc.2010.05.098; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Tsuchiya T, 2009, GYNECOL ENDOCRINOL, V25, P104, DOI 10.1080/09513590802549841; Uchiide I, 2002, FERTIL STERIL, V78, P782, DOI 10.1016/S0015-0282(02)03327-7; Yang H, 2010, INVEST OPHTH VIS SCI, V51, P28, DOI 10.1167/iovs.09-4138; Yang HS, 2009, CANCER SCI, V100, P2419, DOI 10.1111/j.1349-7006.2009.01332.x; Yang LP, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-75; ZAMAH NM, 1984, AM J OBSTET GYNECOL, V149, P591, DOI 10.1016/0002-9378(84)90240-0; Zhang LJ, 2006, INT J MOL MED, V17, P937; Zhang XM, 2004, FERTIL STERIL, V81, P1229, DOI 10.1016/j.fertnstert.2003.09.074; Zhao MD, 2012, BIOMATERIALS, V33, P634, DOI 10.1016/j.biomaterials.2011.09.077	41	14	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45223	10.1371/journal.pone.0045223	http://dx.doi.org/10.1371/journal.pone.0045223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028859	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900101
J	Clarke, DN; Al Ahmad, A; Lee, B; Parham, C; Auckland, L; Fertala, A; Kahle, M; Shaw, CS; Roberts, J; Bix, GJ				Clarke, Douglas N.; Al Ahmad, Abraham; Lee, Boyeon; Parham, Christi; Auckland, Lisa; Fertala, Andrezj; Kahle, Michael; Shaw, Courtney S.; Roberts, Jill; Bix, Gregory J.			Perlecan Domain V Induces VEGf Secretion in Brain Endothelial Cells through Integrin alpha(5)beta(1) and ERK-Dependent Signaling Pathways	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HEPARAN-SULFATE PROTEOGLYCAN; TUMOR VASCULATURE; C-JUN; ENDOREPELLIN; ANGIOGENESIS; EXPRESSION; GROWTH; RECEPTOR; FIBRONECTIN	Perlecan Domain V (DV) promotes brain angiogenesis by inducing VEGF release from brain endothelial cells (BECs) following stroke. In this study, we define the specific mechanism of DV interaction with the alpha(5)beta(1) integrin, identify the downstream signal transduction pathway, and further investigate the functional significance of resultant VEGF release. Interestingly, we found that the LG3 portion of DV, which has been suggested to possess most of DV's angio-modulatory activity outside of the brain, binds poorly to alpha(5)beta(1) and induces less BEC proliferation compared to full length DV. Additionally, we implicate DV's DGR sequence as an important element for the interaction of DV with alpha(5)beta(1). Furthermore, we investigated the importance of AKT and ERK signaling in DV-induced VEGF expression and secretion. We show that DV increases the phosphorylation of ERK, which leads to subsequent activation and stabilization of eIF4E and HIF-1 alpha. Inhibition of ERK activity by U0126 suppressed DV-induced expression and secretion of VEGR in BECs. While DV was capable of phosphorylating AKT we show that AKT phosphorylation does not play a role in DV's induction of VEGF expression or secretion using two separate inhibitors, LY294002 and Akt IV. Lastly, we demonstrate that VEGF activity is critical for DV increases in BEC proliferation, as well as angiogenesis in a BEC-neuronal co-culture system. Collectively, our findings expand our understanding of DV's mechanism of action on BECs, and further support its potential as a novel stroke therapy.	[Kahle, Michael; Roberts, Jill; Bix, Gregory J.] Sanders Brown Ctr Aging, Dept Anat & Neurobiol, Lexington, KY USA; [Clarke, Douglas N.; Al Ahmad, Abraham; Lee, Boyeon; Parham, Christi; Auckland, Lisa] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX USA; [Clarke, Douglas N.] Harvard Univ, Sch Med, Dept Surg, Beth Israel Deaconess Med Ctr,Ctr Vasc Biol Res, Boston, MA 02115 USA; [Kahle, Michael; Shaw, Courtney S.] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, College Stn, TX USA; [Kahle, Michael; Roberts, Jill; Bix, Gregory J.] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Kentucky	Bix, GJ (corresponding author), Sanders Brown Ctr Aging, Dept Anat & Neurobiol, Lexington, KY USA.	gregorybix@uky.edu	Alahmad, Abraham/K-3031-2012; Al-Ahmad/Alahmad, Abraham Jacob/E-1088-2013	Alahmad, Abraham/0000-0002-7716-4412; Al-Ahmad/Alahmad, Abraham Jacob/0000-0001-7463-3204	National Institutes of Health (NIH) [R01NS065842-01A01, 5R01AR049537-06, 5R01AR048544]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048544, R01AR049537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065842] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) R01NS065842-01A01 to G. B. and 5R01AR049537-06 and 5R01AR048544 to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2010, CELL SIGNAL, V22, P1369, DOI 10.1016/j.cellsig.2010.05.006; Alfranca A, 2002, MOL CELL BIOL, V22, P12, DOI 10.1128/MCB.22.1.12-22.2002; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix GJ, 1998, J NEUROSCI, V18, P307; Bix G, 2008, MICROSC RES TECHNIQ, V71, P339, DOI 10.1002/jemt.20562; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Brittingham R, 2005, J BIOL CHEM, V280, P191, DOI 10.1074/jbc.M406210200; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Curnis F, 2008, CANCER RES, V68, P7073, DOI 10.1158/0008-5472.CAN-08-1272; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; del Zoppo GJ, 2006, ARTERIOSCL THROM VAS, V26, P1966, DOI 10.1161/01.ATV.0000232525.65682.a2; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Fukuda S, 2004, STROKE, V35, P998, DOI 10.1161/01.STR.0000119383.76447.05; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Grotta JC, 2008, STROKE, V39, P1364, DOI 10.1161/STROKEAHA.107.510776; Hermann DM, 2009, J CEREBR BLOOD F MET, V29, P1620, DOI 10.1038/jcbfm.2009.100; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Issbrucker K, 2002, FASEB J, V16, P262, DOI 10.1096/fj.02-0329fje; Kilic EO, 2005, TURK PSIKIYATR DERG, V16, P1; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358; MCGEER PL, 1990, J NEUROIMMUNOL, V26, P213, DOI 10.1016/0165-5728(90)90003-6; Milner R, 2008, MOL CELL NEUROSCI, V38, P43, DOI 10.1016/j.mcn.2008.01.013; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Ryu MH, 2010, BIOCHEM BIOPH RES CO, V393, P11, DOI 10.1016/j.bbrc.2010.01.060; Saini MG, 2011, J NEUROCHEM, V119, P760, DOI 10.1111/j.1471-4159.2011.07484.x; SAPATINO BV, 1993, IN VITRO CELL DEV-AN, V29A, P923; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Textor B, 2006, ANN NY ACAD SCI, V1091, P310, DOI 10.1196/annals.1378.076; Troup S, 2003, CLIN CANCER RES, V9, P207; Wang J, 2006, J NEUROCHEM, V96, P148, DOI 10.1111/j.1471-4159.2005.03521.x; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; Xu JL, 2010, J BIOL CHEM, V285, P8563, DOI 10.1074/jbc.M109.062646; Yu B, 2009, CANCER RES, V69, P7704, DOI 10.1158/0008-5472.CAN-09-0808; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhong H, 2000, CANCER RES, V60, P1541; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	49	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45257	10.1371/journal.pone.0045257	http://dx.doi.org/10.1371/journal.pone.0045257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028886	Green Submitted, gold, Green Published			2022-12-27	WOS:000309742800045
J	Bedolla, RG; Gong, JJ; Prihoda, TJ; Yeh, IT; Thompson, IM; Ghosh, R; Kumar, AP				Bedolla, Roble G.; Gong, Jingjing; Prihoda, Thomas J.; Yeh, I-Tien; Thompson, Ian M.; Ghosh, Rita; Kumar, Addanki P.			Predictive Value of Sp1/Sp3/FLIP Signature for Prostate Cancer Recurrence	PLOS ONE			English	Article							RECEPTOR-INDUCED APOPTOSIS; FAS-MEDIATED APOPTOSIS; C-FLIP EXPRESSION; TRANSGENIC ADENOCARCINOMA; RADICAL PROSTATECTOMY; MOUSE PROSTATE; STERNBERG CELLS; BIOMARKERS; DIAGNOSIS; SP3	Prediction of prostate cancer prognosis is challenging and predictive biomarkers of recurrence remain elusive. Although prostate specific antigen (PSA) has high sensitivity (90%) at a PSA level of 4.0 ng/mL, its low specificity leads to many false positive results and considerable overtreatment of patients and its performance at lower ranges is poor. Given the histopathological and molecular heterogeneity of prostate cancer, we propose that a panel of markers will be a better tool than a single marker. We tested a panel of markers composed of the anti-apoptotic protein FLIP and its transcriptional regulators Sp1 and Sp3 using prostate tissues from 64 patients with recurrent and non-recurrent cancer who underwent radical prostatectomy as primary treatment for prostate cancer and were followed with PSA measurements for at least 5 years. Immunohistochemical staining for Sp1, Sp3, and FLIP was performed on these tissues and scored based on the proportion and intensity of staining. The predictive value of the FLIP/Sp1/Sp3 signature for clinical outcome (recurrence vs. non-recurrence) was explored with logistic regression, and combinations of FLIP/Sp1/Sp3 and Gleason score were analyzed with a stepwise (backward and forward) logistic model. The discrimination of the markers was identified by sensitivity-specificity analysis and the diagnostic value of FLIP/Sp1/Sp3 was determined using area under the curve (AUC) for receiver operator characteristic curves. The AUCs for FLIP, Sp1, Sp3, and Gleason score for predicting PSA failure and non-failure were 0.71, 0.66, 0.68, and 0.76, respectively. However, this increased to 0.93 when combined. Thus, the "biomarker signature'' of FLIP/Sp1/Sp3 combined with Gleason score predicted disease recurrence and stratified patients who are likely to benefit from more aggressive treatment.	[Bedolla, Roble G.; Gong, Jingjing; Thompson, Ian M.; Ghosh, Rita; Kumar, Addanki P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [Prihoda, Thomas J.; Yeh, I-Tien] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Ghosh, Rita; Kumar, Addanki P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Thompson, Ian M.; Ghosh, Rita; Kumar, Addanki P.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Kumar, Addanki P.] Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Bedolla, RG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA.	kumara3@uthscsa.edu			Clinical Translational Science Award (CTSA) [UL1RR025767]; National Cancer Institute [R01 CA 135451]; Veterans Affairs-Merit Award [1 I01 BX 000766-01, R01 CA 149516]; EDRN [UO1 054174]; Cancer Therapy and Research Center at University of Texas Health Science Center San Antonio through the National Cancer Institute [2P30 CA 054174-7]; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA149516, R01CA135451] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER	Clinical Translational Science Award (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs-Merit Award(US Department of Veterans Affairs); EDRN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Therapy and Research Center at University of Texas Health Science Center San Antonio through the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by funds from Clinical Translational Science Award (CTSA) grant (UL1RR025767); National Cancer Institute R01 CA 135451 and Veterans Affairs-Merit Award 1 I01 BX 000766-01(APK); R01 CA 149516 (RG); and EDRN (UO1 054174; IT). The authors acknowledge support provided by Cancer Therapy and Research Center at University of Texas Health Science Center San Antonio through the National Cancer Institute support grant #2P30 CA 054174-7 (APK, IMT, and RG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Armstrong AJ, 2012, EUR UROL, V61, P549, DOI 10.1016/j.eururo.2011.11.009; Benesch M, 2003, LEUKEMIA, V17, P2460, DOI 10.1038/sj.leu.2403180; Bullani RR, 2001, J INVEST DERMATOL, V117, P360, DOI 10.1046/j.0022-202x.2001.01418.x; Essafi-Benkhadir K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004478; Fromont G, 2012, PROSTATE, V72, P1359, DOI 10.1002/pros.22485; Ganapathy M, 2009, CLIN CANCER RES, V15, P1601, DOI 10.1158/1078-0432.CCR-08-1389; Garcia GE, 2006, CLIN CANCER RES, V12, P980, DOI 10.1158/1078-0432.CCR-05-2068; Ghosh R, 2007, NEOPLASIA, V9, P893, DOI 10.1593/neo.07502; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Grizzle WE, 2004, UROL ONCOL-SEMIN ORI, V22, P337, DOI 10.1016/j.urolonc.2004.04.008; Herman CM, 2001, AM J SURG PATHOL, V25, P657, DOI 10.1097/00000478-200105000-00014; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Korkolopoulou P, 2007, HISTOPATHOLOGY, V51, P150, DOI 10.1111/j.1365-2559.2007.02723.x; Korkolopoulou P, 2004, UROLOGY, V63, P1198, DOI 10.1016/j.urology.2004.01.007; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Kristiansen G, 2012, HISTOPATHOLOGY, V60, P125, DOI 10.1111/j.1365-2559.2011.04083.x; Kumar AP, 2007, CLIN CANCER RES, V13, P2784, DOI 10.1158/1078-0432.CCR-06-2974; Lee SH, 2003, APMIS, V111, P309, DOI 10.1034/j.1600-0463.2003.1110203.x; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Li R, 2004, AM J SURG PATHOL, V28, P928, DOI 10.1097/00000478-200407000-00013; Lopergolo A, 2009, CANCER-AM CANCER SOC, V115, P3058, DOI 10.1002/cncr.24346; Lughezzani G, 2010, EUR UROL, V58, P687, DOI 10.1016/j.eururo.2010.07.034; Manne U, 2005, DRUG DISCOV TODAY, V10, P965, DOI 10.1016/S1359-6446(05)03487-2; Mathas S, 2004, J EXP MED, V199, P1041, DOI 10.1084/jem.20031080; Nielsen Matthew E, 2007, Rev Urol, V9, P57; Payton Sarah, 2012, Nat Rev Urol, V9, P59, DOI 10.1038/nrurol.2012.7; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Rippo MR, 2004, ONCOGENE, V23, P7753, DOI 10.1038/sj.onc.1208051; Rogers KMA, 2007, MOL CANCER THER, V6, P1544, DOI 10.1158/1535-7163.MCT-06-0673; Salagierski M, 2012, J UROLOGY, V187, P795, DOI 10.1016/j.juro.2011.10.133; Shariat Shohrokh F., 2011, Archivos Espanoles de Urologia, V64, P681; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Thomas RK, 2002, AM J PATHOL, V160, P1521, DOI 10.1016/S0002-9440(10)62578-3; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Ullenhag GJ, 2007, CLIN CANCER RES, V13, P5070, DOI 10.1158/1078-0432.CCR-06-2547; Yap TA, 2011, NAT REV CLIN ONCOL, V8, P597, DOI 10.1038/nrclinonc.2011.117	39	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44917	10.1371/journal.pone.0044917	http://dx.doi.org/10.1371/journal.pone.0044917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028678	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700056
J	Wong, KA; Russo, A; Wang, XR; Chen, YJ; Lavie, A; O'Bryan, JP				Wong, Katy A.; Russo, Angela; Wang, Xuerong; Chen, Yun-Ju; Lavie, Arnon; O'Bryan, John P.			A New Dimension to Ras Function: A Novel Role for Nucleotide-Free Ras in Class II Phosphatidylinositol 3-Kinase Beta (PI3KC2 beta) Regulation	PLOS ONE			English	Article							BINDING DOMAINS; FLUORESCENCE COMPLEMENTATION; GUANINE-NUCLEOTIDES; ADAPTER PROTEIN; FAMILY GTPASES; INTERSECTIN; ENDOCYTOSIS; PATHWAY; MUTANT; GENE	The intersectin 1 (ITSN1) scaffold stimulates Ras activation on endocytic vesicles without activating classic Ras effectors. The identification of Class II phosphatidylinositol 3-kinase beta, PI3KC2 beta, as an ITSN1 target on vesicles and the presence of a Ras binding domain (RBD) in PI3KC2 beta suggests a role for Ras in PI3KC2 beta activation. Here, we demonstrate that nucleotide-free Ras negatively regulates PI3KC2 beta activity. PI3KC2 beta preferentially interacts in vivo with dominant-negative (DN) Ras, which possesses a low affinity for nucleotides. PI3KC2 beta interaction with DN Ras is disrupted by switch 1 domain mutations in Ras as well as RBD mutations in PI3KC2 beta. Using purified proteins, we demonstrate that the PI3KC2 beta-RBD directly binds nucleotide-free Ras in vitro and that this interaction is not disrupted by nucleotide addition. Finally, nucleotide-free Ras but not GTP-loaded Ras inhibits PI3KC2 beta lipid kinase activity in vitro. Our findings indicate that PI3KC2 beta interacts with and is regulated by nucleotide-free Ras. These data suggest a novel role for nucleotide-free Ras in cell signaling in which PI3KC2 beta stabilizes nucleotide-free Ras and that interaction of Ras and PI3KC2 beta mutually inhibit one another.	[Wong, Katy A.; Russo, Angela; Wang, Xuerong; Chen, Yun-Ju; O'Bryan, John P.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA; [Lavie, Arnon; O'Bryan, John P.] Univ Illinois, Coll Med, Ctr Canc, Chicago, IL USA; [O'Bryan, John P.] Univ Illinois, Coll Med, Ctr Cardiovasc Res, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wong, KA (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60607 USA.	obryanj@uic.edu		O'Bryan, John/0000-0001-5386-1080; Lavie, Arnon/0000-0001-5591-8722	United States National Institutes of Health [HL090651]; Department of Defense [PR080428]; Foundation Jerome Lejeune; St. Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090651] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Foundation Jerome Lejeune; St. Baldrick's Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by grants to J.P.O from the United States National Institutes of Health (HL090651), Department of Defense (PR080428), the Foundation Jerome Lejeune, and the St. Baldrick's Foundation. K.A.W. was supported by a grant from the Foundation Jerome Lejeune. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 2000, J BIOL CHEM, V275, P27414; Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Chabu C, 2008, DEVELOPMENT, V135, P2739, DOI 10.1242/dev.024059; Das M, 2007, MOL CELL BIOL, V27, P7906, DOI 10.1128/MCB.01369-07; De Gregorio L, 1998, INT J CANCER, V79, P269, DOI 10.1002/(SICI)1097-0215(19980619)79:3<269::AID-IJC10>3.3.CO;2-J; Diaz R, 2002, CANCER RES, V62, P4514; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Guipponi M, 1998, CYTOGENET CELL GENET, V83, P218, DOI 10.1159/000015182; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; Kalhammer G, 1997, FEBS LETT, V414, P599, DOI 10.1016/S0014-5793(97)01076-4; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kibel AS, 1998, CANCER RES, V58, P5652; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Martin NP, 2006, MOL PHARMACOL, V70, P1643, DOI 10.1124/mol.106.028274; Mohney RP, 2003, J BIOL CHEM, V278, P47038, DOI 10.1074/jbc.M303895200; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; O'Bryan JP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3152re10; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P422, DOI 10.1016/S0968-0004(96)30038-8; PROUD CG, 1986, TRENDS BIOCHEM SCI, V11, P73, DOI 10.1016/0968-0004(86)90269-0; Quilliam LA, 1996, J BIOL CHEM, V271, P11076, DOI 10.1074/jbc.271.19.11076; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Russo A, 2012, ONCOGENE; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Shyu YJ, 2008, NAT PROTOC, V3, P588, DOI 10.1038/nprot.2008.16; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SPANDIDOS A, 1988, BRIT J CANCER, V58, P67; SPANDIDOS DA, 1990, ANTICANCER RES, V10, P1543; Stewart S, 2000, J BIOL CHEM, V275, P8854, DOI 10.1074/jbc.275.12.8854; Takeuchi S, 1996, CANCER RES, V56, P738; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Wong KA, 2011, JOVE-J VIS EXP, DOI 10.3791/2643; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	45	19	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45360	10.1371/journal.pone.0045360	http://dx.doi.org/10.1371/journal.pone.0045360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028960	Green Published, gold			2022-12-27	WOS:000308788700104
J	Chen, ZL; Gerhold-Ay, A; Gebhard, S; Boehm, D; Solbach, C; Lebrecht, A; Battista, M; Sicking, I; Cotarelo, C; Cadenas, C; Marchan, R; Stewart, JD; Gehrmann, M; Koelbl, H; Hengstler, JG; Schmidt, M				Chen, Zonglin; Gerhold-Ay, Aslihan; Gebhard, Susanne; Boehm, Daniel; Solbach, Christine; Lebrecht, Antje; Battista, Marco; Sicking, Isabel; Cotarelo, Christina; Cadenas, Cristina; Marchan, Rosemarie; Stewart, Joanna D.; Gehrmann, Mathias; Koelbl, Heinz; Hengstler, Jan G.; Schmidt, Marcus			Immunoglobulin Kappa C Predicts Overall Survival in Node-Negative Breast Cancer	PLOS ONE			English	Article							B-CELLS; PROGNOSTIC-SIGNIFICANCE; INVASIVE-CARCINOMA; ST-GALLEN; LYMPHOCYTES; RECURRENCE; EXPRESSION; INFLAMMATION; PATTERNS; IMMUNITY	Background: Biomarkers of the immune system are currently not used as prognostic factors in breast cancer. We analyzed the association of the B cell/plasma cell marker immunoglobulin kappa C (IGKC) and survival of untreated node-negative breast cancer patients. Material and Methods: IGKC expression was evaluated by immunostaining in a cohort of 335 node-negative breast cancer patients with a median follow-up of 152 months. The prognostic significance of IGKC for disease-free survival (DFS) and breast cancer-specific overall survival (OS) was evaluated with Kaplan-Meier survival analysis as well as univariate and multivariate Cox analysis adjusted for age at diagnosis, pT stage, histological grade, estrogen receptor (ER) status, progesterone receptor (PR) status, Ki-67 and human epidermal growth factor receptor 2 (HER-2) status. Results: 160 patients (47.7%) showed strong expression of IGKC. Univariate analysis showed that IGKC was significantly associated with DFS (P = 0.017, hazard ratio [HR] = 0.570, 95% confidence interval [CI] = 0.360-0.903) and OS (P = 0.011, HR = 0.438, 95% CI = 0.233-0.822) in the entire cohort. The significance of IGKC was especially strong in ER negative and in luminal B carcinomas. In multivariate analysis IGKC retained its significance independent of established clinical factors for DFS (P = 0.004, HR = 0.504, 95% CI = 0.315-0.804) as well as for OS (P = 0.002, HR = 0.371, 95% CI = 0.196-0.705). Conclusion: Expression of IGKC has an independent protective impact on DFS and OS in node-negative breast cancer.	[Chen, Zonglin; Gebhard, Susanne; Boehm, Daniel; Solbach, Christine; Lebrecht, Antje; Battista, Marco; Sicking, Isabel; Koelbl, Heinz; Schmidt, Marcus] Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, Mainz, Germany; [Gerhold-Ay, Aslihan] Johannes Gutenberg Univ Mainz, Dept Med Biometry Epidemiol & Informat, Mainz, Germany; [Cotarelo, Christina] Johannes Gutenberg Univ Mainz, Dept Pathol, D-6500 Mainz, Germany; [Cadenas, Cristina; Marchan, Rosemarie; Stewart, Joanna D.; Hengstler, Jan G.] Dortmund Univ Technol, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Gehrmann, Mathias] Bayer GmbH, Leverkusen, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Bayer AG	Schmidt, M (corresponding author), Johannes Gutenberg Univ Mainz, Dept Obstet & Gynecol, Mainz, Germany.	marcus.schmidt@unimedizin-mainz.de	Hengstler, Jan G./O-1415-2013; Lebrecht, Antje/F-6456-2014; Schmidt, Marcus/H-3383-2013; Stewart, Joanna Dawn/H-1614-2012	Lebrecht, Antje/0000-0002-8442-6505; Schmidt, Marcus/0000-0003-1365-2414; Stewart, Joanna Dawn/0000-0002-2608-1967; Hengstler, Jan/0000-0002-1427-5246; Marchan, Rosemarie/0000-0003-4414-1633	Federal Ministry of Education and Research (BMBF, NGFN project Oncoprofile); China Scholarship Council, Peking, China [2009616032]	Federal Ministry of Education and Research (BMBF, NGFN project Oncoprofile); China Scholarship Council, Peking, China(China Scholarship Council)	This work was supported by the Federal Ministry of Education and Research (BMBF, NGFN project Oncoprofile) and China Scholarship Council (financial support to ZC) (No. 2009616032; Peking, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Baker K, 2011, HISTOPATHOLOGY, V58, P1107, DOI 10.1111/j.1365-2559.2011.03846.x; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Calabro A, 2009, BREAST CANCER RES TR, V116, P69, DOI 10.1007/s10549-008-0105-3; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Kim S, 2008, J IMMUNOTHER, V31, P446, DOI 10.1097/CJI.0b013e31816d1d6a; Lee AHS, 2006, HISTOPATHOLOGY, V48, P692, DOI 10.1111/j.1365-2559.2006.02410.x; Li Q, 2011, CLIN CANCER RES, V17, P4987, DOI 10.1158/1078-0432.CCR-11-0207; Mahmoud SMA, 2012, BREAST CANCER RES TR, V132, P545, DOI 10.1007/s10549-011-1620-1; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Oh E, 2012, BREAST CANCER RES TR, V132, P499, DOI 10.1007/s10549-011-1626-8; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Rosenblatt J, 2007, CANCER RES, V67, P5058, DOI 10.1158/0008-5472.CAN-06-3903; Schmidt M, 2009, ANN ONCOL, V20, P258, DOI 10.1093/annonc/mdn590; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schmidt M, 2012, CLIN CANCER RES, V18, P2695, DOI 10.1158/1078-0432.CCR-11-2210; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tadmor T, 2011, CANCER IMMUNOL IMMUN, V60, P609, DOI 10.1007/s00262-011-0972-z; van 't Veer LJ, 2002, NATURE, V415, P530, DOI [DOI 10.1038/415530A, 10.1038/415530a]; Wang Y, 2007, BREAST CANCER RES TR, V104, P129, DOI 10.1007/s10549-006-9409-3; WEIKEL W, 1991, BREAST CANCER RES TR, V18, P149, DOI 10.1007/BF01990030	28	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44741	10.1371/journal.pone.0044741	http://dx.doi.org/10.1371/journal.pone.0044741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028600	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000309973900015
J	Miller, N; Marcovich, S; Susswein, AJ				Miller, Nimrod; Marcovich, Silvia; Susswein, Abraham J.			Variables Controlling Entry into and Exit from the Steady-State, One of Two Modes of Feeding in Aplysia	PLOS ONE			English	Article							UNDERLYING SATIATION; ACTIVITY PATTERNS; MOLLUSK APLYSIA; NEUROPEPTIDE-Y; FOOD AROUSAL; NITRIC-OXIDE; BEHAVIOR; FASCIATA; CALIFORNICA; STIMULI	Background: Aplysia feeding is a model system for examining the neural mechanisms by which changes in motivational state control behavior. When food is intermittently present, Aplysia eat large meals controlled by a balance between food stimuli exciting feeding and gut stimuli inhibiting feeding. However, when food is continuously present animals are in a state in which feeding is relatively inhibited and animals eat little. We examined which stimuli provided by food and feeding initiate steady-state inhibition of feeding, and which stimuli maintain the inhibition. Results: Multiple stimuli were found to control entry into the steady-state inhibition, and its maintenance. The major variable governing entry into the steady-state is fill of the gut with bulk provided by food, but this stimulus cannot alone cause entry into the steady-state. Food odor and nutritional stimuli such as increased hemolymph glucose and L-arginine concentrations also contribute to inhibition of feeding leading to entry into the steady-state. Although food odor can alone cause some inhibition of feeding, it does not amplify the effect of gut fill. By contrast, neither increased hemolymph glucose nor L-arginine alone inhibits feeding in hungry animals, but both amplify the inhibitory effects of food odor, and increased glucose also amplifies the effect of gut fill. The major variable maintaining the steady-state is the continued presence of food odor, which can alone maintain the steady-state for 48-72 hrs. Neither increased glucose nor L-arginine can alone preserve the steady-state, although they partially preserve it. Glucose and arginine partially extend the effect of food odor after 72 hrs. Conclusions: These findings show that control of Aplysia feeding is more complex than was previously thought, in that multiple inhibitory factors interact in its control.	[Miller, Nimrod; Marcovich, Silvia; Susswein, Abraham J.] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel	Bar Ilan University	Susswein, AJ (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel.	avy@mail.biu.ac.il		Susswein, Abraham J./0000-0001-6107-5901; Miller, Nimrod/0000-0002-2221-139X	Israel Science Foundation [420/06]	Israel Science Foundation(Israel Science Foundation)	The research was supported by the Israel Science Foundation [grant number 420/06; Website: http://www.isf.org.il/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHITUV Y, 1985, J EXP MAR BIOL ECOL, V85, P113, DOI 10.1016/0022-0981(85)90137-6; Acuna-Goycolea C, 2009, J NEUROSCI, V29, P1503, DOI 10.1523/JNEUROSCI.5147-08.2009; BABLANIAN GM, 1987, BEHAV NEURAL BIOL, V48, P394, DOI 10.1016/S0163-1047(87)90957-5; BERRY HH, 1982, Z TIERPSYCHOL, V59, P229; BOTZER D, 1991, BEHAV NEURAL BIOL, V56, P251, DOI 10.1016/0163-1047(91)90394-6; Douglas SJ, 2005, TRENDS NEUROSCI, V28, P644, DOI 10.1016/j.tins.2005.09.006; Elliott CJH, 2002, J EXP BIOL, V205, P877; Fu LY, 2008, J NEUROSCI, V28, P5433, DOI 10.1523/JNEUROSCI.0749-08.2008; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Horn CC, 1999, NEUROSCI LETT, V267, P161, DOI 10.1016/S0304-3940(99)00339-0; Horn CC, 1998, BEHAV NEUROSCI, V112, P1258, DOI 10.1037/0735-7044.112.5.1258; Horn CC, 2001, BRAIN RES, V918, P51, DOI 10.1016/S0006-8993(01)02919-5; Hurwitz I, 2006, J NEUROPHYSIOL, V95, P106, DOI 10.1152/jn.00705.2005; Hurwitz I, 2008, J NEUROPHYSIOL, V99, P814, DOI 10.1152/jn.00972.2007; JARMAN M V, 1973, East African Wildlife Journal, V11, P75; Jing J, 2007, J NEUROSCI, V27, P3490, DOI 10.1523/JNEUROSCI.0334-07.2007; KUPFERMA.I, 1974, BEHAV BIOL, V12, P317, DOI 10.1016/S0091-6773(74)91503-X; KUPFERMANN I, 1991, BIOL BULL, V180, P262, DOI 10.2307/1542396; KUPFERMANN I, 1974, BEHAV BIOL, V10, P1, DOI 10.1016/S0091-6773(74)91644-7; KUPFERMANN I, 1982, BRAIN RES, V241, P334, DOI 10.1016/0006-8993(82)91072-1; KUSLANSKY B, 1987, BEHAV NEURAL BIOL, V48, P278, DOI 10.1016/S0163-1047(87)90836-3; Levy M, 1997, NEUROSCI LETT, V225, P113, DOI 10.1016/S0304-3940(97)00200-0; MacGinnitie GE, 1933, BIOL BULL, V67, P300; Martinez-Rubio C, 2009, J COMP NEUROL, V514, P329, DOI 10.1002/cne.21991; Miller N, 2011, J NEUROPHYSIOL, V105, P1642, DOI 10.1152/jn.00827.2010; Miller N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017779; NAGAHAMA T, 1993, J NEUROPHYSIOL, V70, P1231, DOI 10.1152/jn.1993.70.3.1231; Nedvetzki Y, 1998, J COMP PHYSIOL A, V182, P183, DOI 10.1007/s003590050169; PRESTON RJ, 1973, J COMP PHYSIOL PSYCH, V82, P368, DOI 10.1037/h0034132; Proekt A, 2004, P NATL ACAD SCI USA, V101, P9447, DOI 10.1073/pnas.0402002101; ROSEN SC, 1991, J NEUROSCI, V11, P3630; ROSEN SC, 1982, BEHAV NEURAL BIOL, V35, P56, DOI 10.1016/S0163-1047(82)91279-1; SCHWARZ M, 1988, BEHAV NEUROSCI, V102, P124, DOI 10.1037/0735-7044.102.1.124; SCHWARZ M, 1986, J NEUROSCI, V6, P1528; SPINAGE C A, 1968, East African Wildlife Journal, V6, P89; SUSSWEIN AJ, 1983, ISRAEL J ZOOL, V32, P103; SUSSWEIN AJ, 1984, BEHAV NEURAL BIOL, V41, P7, DOI 10.1016/S0163-1047(84)90667-8; SUSSWEIN AJ, 1976, J COMP PHYSIOL, V108, P75, DOI 10.1007/BF00625442; SUSSWEIN AJ, 1978, J COMP PHYSIOL, V123, P31, DOI 10.1007/BF00657341; SUSSWEIN AJ, 1983, BEHAV NEURAL BIOL, V39, P203, DOI 10.1016/S0163-1047(83)90859-2; SUSSWEIN AJ, 1975, J COMP PHYSIOL, V101, P309, DOI 10.1007/BF00657048; SUSSWEIN AJ, 1975, BEHAV BIOL, V13, P203, DOI 10.1016/S0091-6773(75)91903-3; SUSSWEIN AJ, 1984, BEHAV NEURAL BIOL, V41, P90, DOI 10.1016/S0163-1047(84)90784-2; TEYKE T, 1990, SCIENCE, V247, P85, DOI 10.1126/science.2294596; TEYKE T, 1990, J NEUROSCI, V10, P3922, DOI 10.1523/JNEUROSCI.10-12-03922.1990; TEYKE T, 1992, J COMP PHYSIOL A, V170, P281; Teyke Thomas, 1997, Invertebrate Neuroscience, V2, P235, DOI 10.1007/BF02211936; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Zhurov Y, 2005, J NEUROSCI, V25, P1268, DOI 10.1523/JNEUROSCI.3361-04.2005	49	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45241	10.1371/journal.pone.0045241	http://dx.doi.org/10.1371/journal.pone.0045241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028872	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900036
J	Rignell-Hydbom, A; Lindh, CH; Dillner, J; Jonsson, BAG; Rylander, L				Rignell-Hydbom, Anna; Lindh, Christian H.; Dillner, Joakim; Jonsson, Bo A. G.; Rylander, Lars			A Nested Case-Control Study of Intrauterine Exposure to Persistent Organochlorine Pollutants and the Risk of Hypospadias	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; TESTICULAR DYSGENESIS SYNDROME; POLYCHLORINATED-BIPHENYLS; SEXUAL-DIFFERENTIATION; BREAST-MILK; MALE-RAT; CRYPTORCHIDISM; PESTICIDES; PHTHALATE; FISH	Background: Environmental exposures to endocrine disrupting chemicals have been suggested as a risk factor for male genital abnormalities such as hypospadias. The aim of this case-control study was to investigate the association between fetal exposure to persistent organochlorine pollutants (POP) and the risk for hypospadias. Methodology/Principal Findings: The Southern Sweden Maternity Cohort (SSMC) contains serum samples collected in early pregnancy among women in Southern Sweden. Linkages with the Medical Birth Register, the Malformation Register and the In-patient Register resulted in 390 SSMC mothers who had given birth to a boy with hypospadias in year 1986-2002 (mean 1995). For 237 of these (cases) sufficient amounts of serum for the chemical analyses were available. For each case, a control boy from the SSMC was randomly selected, matched for maternal age, birth year, parity and maternal smoking. PCB-153, p,p'-DDE and hexachlorbenzene (HCB) were used as biomarkers for POP exposure. The exposures were categorized into quartiles based on the distributions among the controls. There were no statistically significant trends between the a priori categorisation of the exposure variables and the risk for hypospadias. However, when the upper HCB quartile (>26 ng/ml) was compared to the other quartiles an odds ratio of 1.65 (95% CI 1.02 to 2.69) was obtained. p,p'-DDE levels above median (>1.0 ng/ml) compared to levels below 0.1 ng/ml gave an OR of 1.69 (95% CI 0.97 to 2.93). Conclusions: The present study suggests that fetal exposure to HCB and p,p'-DDE may be a risk factor for hypospadias.	[Rignell-Hydbom, Anna; Lindh, Christian H.; Jonsson, Bo A. G.; Rylander, Lars] Lund Univ, Div Occupat & Environm Med, Lund, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Lund University; Karolinska Institutet	Rignell-Hydbom, A (corresponding author), Lund Univ, Div Occupat & Environm Med, Lund, Sweden.	anna.rignell-hydbom@med.lu.se		Rylander, Lars/0000-0001-8288-8207; Jonsson, Bo/0000-0002-8767-0589; Lindh, Christian/0000-0001-7435-9890	Swedish Research Council [2008-32038-63634-60]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by a grant from the Swedish Research Council (2008-32038-63634-60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Aoki Y, 2001, ENVIRON RES, V86, P2, DOI 10.1006/enrs.2001.4244; Araneta MRG, 2003, BIRTH DEFECTS RES A, V67, P246, DOI 10.1002/bdra.10033; Bergonzi R, 2009, CHEMOSPHERE, V76, P747, DOI 10.1016/j.chemosphere.2009.05.026; Bhatia R, 2005, ENVIRON HEALTH PERSP, V113, P220, DOI 10.1289/ehp.7382; Brouwers MM, 2007, EUR J PEDIATR, V166, P671, DOI 10.1007/s00431-006-0304-z; Carbone P, 2007, INT J ANDROL, V30, P3, DOI 10.1111/j.1365-2605.2006.00703.x; Costa Lucio G., 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P367, DOI 10.2478/v10004-007-0025-3; Damgaard IN, 2006, ENVIRON HEALTH PERSP, V114, P1133, DOI 10.1289/ehp.8741; FEIN GG, 1984, J PEDIATR-US, V105, P315, DOI 10.1016/S0022-3476(84)80139-0; Fernandez MF, 2007, ENVIRON HEALTH PERSP, V115, P8, DOI 10.1289/ehp.9351; Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273; Giordano F, 2010, BIRTH DEFECTS RES A, V88, P241, DOI 10.1002/bdra.20657; Glynn AW, 2000, SCI TOTAL ENVIRON, V263, P197, DOI 10.1016/S0048-9697(00)00703-8; Grandjean P, 2008, ENVIRON SCI TECHNOL, V42, P6991, DOI 10.1021/es800778q; Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664; Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248; Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350; Grimvall E, 1997, ARCH ENVIRON CON TOX, V32, P329, DOI 10.1007/s002449900193; Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030; Krysiak-Baltyn K, 2010, INT J ANDROL, V33, P270, DOI 10.1111/j.1365-2605.2009.00996.x; Longnecker MP, 2002, AM J EPIDEMIOL, V155, P313, DOI 10.1093/aje/155.4.313; Manson JM, 2003, BIRTH DEFECTS RES A, V67, P825, DOI 10.1002/bdra.10084; McLachlan JA, 2001, APMIS, V109, P263, DOI 10.1034/j.1600-0463.2001.d01-119.x; Pierik FH, 2002, HUM REPROD, V17, P1112, DOI 10.1093/humrep/17.4.1112; Pierik PH, 2004, ENV HLTH PERSPECT, V112, P1570; Porta M, 2012, ENVIRON INT, V44, P106, DOI 10.1016/j.envint.2012.02.005; Sjodin A, 2000, ENVIRON HEALTH PERSP, V108, P1035, DOI 10.2307/3434955; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Virtanen HE, 2012, INT J ANDROL, V35, P283, DOI 10.1111/j.1365-2605.2011.01233.x; Vrijheid M, 2003, OCCUP ENVIRON MED, V60, P543, DOI 10.1136/oem.60.8.543; Weidner IS, 1998, ENVIRON HEALTH PERSP, V106, P793, DOI 10.2307/3434122; Wetterauer B, 2012, ENVIRON SCI POLLUT R, V19, P403, DOI 10.1007/s11356-011-0570-9	34	27	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44767	10.1371/journal.pone.0044767	http://dx.doi.org/10.1371/journal.pone.0044767			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028613	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500008
J	Gresa-Arribas, N; Vieitez, C; Dentesano, G; Serratosa, J; Saura, J; Sola, C				Gresa-Arribas, Nuria; Vieitez, Cristina; Dentesano, Guido; Serratosa, Joan; Saura, Josep; Sola, Carme			Modelling Neuroinflammation In Vitro: A Tool to Test the Potential Neuroprotective Effect of Anti-Inflammatory Agents	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-INDUCED NEUROTOXICITY; BINDING-PROTEIN DELTA; NITRIC-OXIDE; MICROGLIAL CELLS; MURINE MICROGLIA; INTERLEUKIN-10; INHIBITION; IL-10; BRAIN; EXPRESSION	Neuron-microglia co-cultures treated with pro-inflammatory agents are a useful tool to study neuroinflammation in vitro, where to test the potential neuroprotective effect of anti-inflammatory compounds. However, a great diversity of experimental conditions can be found in the literature, making difficult to select the working conditions when considering this approach for the first time. We compared the use of neuron-primary microglia and neuron-BV2 cells (a microglial cell line) co-cultures, using different neuron: microglia ratios, treatments and time post-treatment to induce glial activation and derived neurotoxicity. We show that each model requires different experimental conditions, but that both neuron-BV2 and neuron-primary microglia LPS/IFN-gamma-treated co-cultures are good to study the potential neuroprotective effect of anti-inflammatory agents. The contribution of different pro-inflammatory parameters in the neurotoxicity induced by reactive microglial cells was determined. IL-10 pre-treatment completely inhibited LPS/IFN-gamma-induced TNF-alpha and IL-6 release, and COX-2 expression both in BV2 and primary microglial cultures, but not NO production and iNOS expression. However, LPS/IFN-gamma induced neurotoxicity was not inhibited in IL-10 pre-treated co-cultures. The inhibition of NO production using the specific iNOS inhibitor 1400 W totally abolished the neurotoxic effect of LPS/IFN-gamma, suggesting a major role for NO in the neurotoxic effect of activated microglia. Consequently, among the anti-inflammatory agents, special attention should be paid to compounds that inhibit NO production.	[Gresa-Arribas, Nuria; Vieitez, Cristina; Dentesano, Guido; Serratosa, Joan; Sola, Carme] CSIC, Inst Invest Biomed Barcelona, IDIBAPS, Dept Cerebral Ischemia & Neurodegenerat, Barcelona, Spain; [Saura, Josep] Univ Barcelona, Biochem & Mol Biol Unit, Sch Med, IDIBAPS, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Sola, C (corresponding author), CSIC, Inst Invest Biomed Barcelona, IDIBAPS, Dept Cerebral Ischemia & Neurodegenerat, Barcelona, Spain.	carme.sola@iibb.csic.es	Serratosa, Joan/Q-8202-2019; Saura, Josep/I-4428-2012; Vieitez, Cristina/GOG-8655-2022	Serratosa, Joan/0000-0003-1360-6813; Vieitez, Cristina/0000-0002-6802-3845; Sola, Carme/0000-0002-4012-816X; Saura, Josep/0000-0002-5601-4466	Institut d'Investigacions Biomediques de Barcelona-Consejo Superior de Investigaciones Cientificas (CSIC); European Social Fund of the European Union; "La Caixa" foundation; Instituto Carlos III of the Ministerio de Ciencia e Innovacion of Spain [PI081396, PI100378]	Institut d'Investigacions Biomediques de Barcelona-Consejo Superior de Investigaciones Cientificas (CSIC); European Social Fund of the European Union; "La Caixa" foundation(La Caixa Foundation); Instituto Carlos III of the Ministerio de Ciencia e Innovacion of Spain	NGA was the recipient of a JAE-Predoc contract from Institut d'Investigacions Biomediques de Barcelona-Consejo Superior de Investigaciones Cientificas (CSIC) ("Junta para la Ampliacion de Estudios", partly funded by the European Social Fund of the European Union). CV was the recipient of a fellowship from "La Caixa" foundation. This study was supported by grants PI081396 and PI100378 from the Instituto Carlos III of the Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto T, 2007, NEUROBIOL AGING, V28, P894, DOI 10.1016/j.neurobiolaging.2006.04.011; Bal-Price A, 2002, J NEUROCHEM, V80, P73, DOI 10.1046/j.0022-3042.2001.00675.x; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325; Carson Monica J, 2008, Drug Discov Today Dis Models, V5, P19, DOI 10.1016/j.ddmod.2008.07.006; Chang RCC, 2000, NEUROSCIENCE, V97, P757, DOI 10.1016/S0306-4522(00)00059-2; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; de Jong EK, 2008, J NEUROCHEM, V105, P1726, DOI 10.1111/j.1471-4159.2008.05267.x; Ejarque-Ortiz A, 2010, J NEUROSCI RES, V88, P1113, DOI 10.1002/jnr.22272; FRANDSEN A, 1990, INT J DEV NEUROSCI, V8, P209, DOI 10.1016/0736-5748(90)90013-R; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gonzalez P, 2012, J NEUROSCI RES, V90, P143, DOI 10.1002/jnr.22741; Gorlovoy P, 2009, FASEB J, V23, P2502, DOI 10.1096/fj.08-123877; Gray E, 2011, EUR J NEUROSCI, V33, P1421, DOI 10.1111/j.1460-9568.2011.07637.x; Gresa-Arribas N, 2010, J NEUROCHEM, V115, P526, DOI 10.1111/j.1471-4159.2010.06952.x; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; Lee H, 2003, FASEB J, V17, P1943, DOI 10.1096/fj.03-0057fje; Li YC, 2009, NEUROPHARMACOLOGY, V56, P580, DOI 10.1016/j.neuropharm.2008.10.016; Lieb K, 2003, NEUROCHEM INT, V42, P131, DOI 10.1016/S0197-0186(02)00076-1; Mesples B, 2003, DEV BRAIN RES, V141, P25, DOI 10.1016/S0165-3806(02)00636-3; Minghetti L, 1998, J NEUROIMMUNOL, V82, P31, DOI 10.1016/S0165-5728(97)00185-9; Molina-Holgado F, 2001, GLIA, V33, P97, DOI 10.1002/1098-1136(200102)33:2<97::AID-GLIA1009>3.0.CO;2-N; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Pan XD, 2008, BIOCHEM PHARMACOL, V76, P362, DOI 10.1016/j.bcp.2008.05.018; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qian L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-23; Qian L, 2006, J PHARMACOL EXP THER, V319, P44, DOI 10.1124/jpet.106.106351; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; Stewart VC, 2003, FREE RADICAL BIO MED, V34, P287, DOI 10.1016/S0891-5849(02)01327-8; Szczepanik AM, 2001, J NEUROIMMUNOL, V113, P49, DOI 10.1016/S0165-5728(00)00404-5; Zhang L, 2006, PHARMACOL THERAPEUT, V109, P33, DOI 10.1016/j.pharmthera.2005.05.007; Zheng LT, 2008, EUR J PHARMACOL, V588, P106, DOI 10.1016/j.ejphar.2008.04.035; Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x	42	78	80	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45227	10.1371/journal.pone.0045227	http://dx.doi.org/10.1371/journal.pone.0045227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028862	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900030
J	Paschon, V; Higa, GSV; Resende, RR; Britto, LRG; Kihara, AH				Paschon, Vera; Vilar Higa, Guilherme Shigueto; Resende, Rodrigo Ribeiro; Britto, Luiz Roberto G.; Kihara, Alexandre Hiroaki			Blocking of Connexin-Mediated Communication Promotes Neuroprotection during Acute Degeneration Induced by Mechanical Trauma	PLOS ONE			English	Article							NEURONAL GAP-JUNCTIONS; DEVELOPING RETINA; MOUSE RETINA; EXPRESSION; CELLS; NEURODEGENERATION; HISTOGENESIS; APOPTOSIS; MICRORNA; MODELS	Accruing evidence indicates that connexin (Cx) channels in the gap junctions (GJ) are involved in neurodegeneration after injury. However, studies using KO animal models endowed apparently contradictory results in relation to the role of coupling in neuroprotection. We analyzed the role of Cx-mediated communication in a focal lesion induced by mechanical trauma of the retina, a model that allows spatial and temporal definition of the lesion with high reproducibility, permitting visualization of the focus, penumbra and adjacent areas. Cx36 and Cx43 exhibited distinct gene expression and protein levels throughout the neurodegeneration progress. Cx36 was observed close to TUNEL-positive nuclei, revealing the presence of this protein surrounding apoptotic cells. The functional role of cell coupling was assessed employing GJ blockers and openers combined with lactate dehydrogenase (LDH) assay, a direct method for evaluating cell death/viability. Carbenoxolone (CBX), a broad-spectrum GJ blocker, reduced LDH release after 4 hours, whereas quinine, a Cx36-channel specific blocker, decreased LDH release as early as 1 hour after lesion. Furthermore, analysis of dying cell distribution confirmed that the use of GJ blockers reduced apoptosis spread. Accordingly, blockade of GJ communication during neurodegeneration with quinine, but not CBX, caused downregulation of initial and effector caspases. To summarize, we observed specific changes in Cx gene expression and protein distribution during the progress of retinal degeneration, indicating the participation of these elements in acute neurodegeneration processes. More importantly, our results revealed that direct control of GJ channels permeability may take part in reliable neuroprotection strategies aimed to rapid, fast treatment of mechanical trauma in the retina.	[Paschon, Vera; Vilar Higa, Guilherme Shigueto; Kihara, Alexandre Hiroaki] Univ Fed ABC, Nucleo Cognicao & Sistemas Complexos, Ctr Matemat Comp & Cognicao, Sao Paulo, Brazil; [Paschon, Vera; Vilar Higa, Guilherme Shigueto; Britto, Luiz Roberto G.; Kihara, Alexandre Hiroaki] Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol & Biofis, BR-05508 Sao Paulo, Brazil; [Resende, Rodrigo Ribeiro] Univ Fed Minas Gerais, Dept Bioquim & Imunolgia, Belo Horizonte, MG, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Federal de Minas Gerais	Kihara, AH (corresponding author), Univ Fed ABC, Nucleo Cognicao & Sistemas Complexos, Ctr Matemat Comp & Cognicao, Sao Paulo, Brazil.	alexandrekihara@gmail.com	Kihara, Alexandre H/C-2458-2012; Paschon, Vera/F-7363-2013; Dragicevic, Tomislav/Q-3159-2017; Higa, Guilherme S. V./G-4282-2016; KIHARA, ALEXANDRE HIROAKI/T-9590-2019	Kihara, Alexandre H/0000-0002-4027-7261; Dragicevic, Tomislav/0000-0003-4755-2024; Higa, Guilherme S. V./0000-0001-7006-9263; KIHARA, ALEXANDRE HIROAKI/0000-0002-4027-7261; Resende, Rodrigo/0000-0002-2003-0739	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Universidade Federal do ABC (UFABC); Universidade de Sao Paulo (USP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do ABC (UFABC); Universidade de Sao Paulo (USP)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Universidade Federal do ABC (UFABC) and Universidade de Sao Paulo (USP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Belmonte MA, 2006, INVEST OPHTH VIS SCI, V47, P1193, DOI 10.1167/iovs.05-0446; Blankenship AG, 2011, J NEUROSCI, V31, P9998, DOI 10.1523/JNEUROSCI.5640-10.2011; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Cusato K, 2003, J NEUROSCI, V23, P6413; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Hall ED, 1989, J NEUROTRAUM, V6, P227, DOI 10.1089/neu.1989.6.227; Hennig MH, 2009, J NEUROSCI, V29, P1077, DOI 10.1523/JNEUROSCI.4880-08.2009; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; KEILHOFF G, 1993, NEUROREPORT, V5, P129, DOI 10.1097/00001756-199311180-00008; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; Kihara AH, 2008, DEV NEUROBIOL, V68, P1287, DOI 10.1002/dneu.20652; Kihara AH, 2009, J COMP NEUROL, V512, P651, DOI 10.1002/cne.21920; Kihara AH, 2005, J NEUROSCI METH, V148, P103, DOI 10.1016/j.jneumeth.2005.04.019; Kihara AH, 2010, INT J DEV NEUROSCI, V28, P39, DOI 10.1016/j.ijdevneu.2009.09.006; Kihara AH, 2006, J NEUROBIOL, V66, P1397, DOI 10.1002/neu.20299; Kihara AH, 2006, J NEUROSCI RES, V83, P1331, DOI 10.1002/jnr.20815; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Koizumi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000221; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Medhurst AD, 2000, J NEUROSCI METH, V98, P9, DOI 10.1016/S0165-0270(00)00178-3; Mesnil M, 1996, P NATL ACAD SCI USA, V93, P1831, DOI 10.1073/pnas.93.5.1831; Resende RR, 2010, BBA-MOL CELL RES, V1803, P246, DOI 10.1016/j.bbamcr.2009.11.008; ROMANO C, 1995, J NEUROCHEM, V65, P59; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Santos-Bredariol AS, 2006, J COMP NEUROL, V494, P976, DOI 10.1002/cne.20861; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Seigel G, 1999, MOL VIS, V5; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Sohl G, 2000, BRAIN RES REV, V32, P138, DOI 10.1016/S0165-0173(99)00074-0; Srinivas M, 2001, P NATL ACAD SCI USA, V98, P10942, DOI 10.1073/pnas.191206198; Vaney DI, 1998, J NEUROSCI, V18, P10594; Vessey JP, 2004, J NEUROPHYSIOL, V92, P1252, DOI 10.1152/jn.00148.2004	37	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45449	10.1371/journal.pone.0045449	http://dx.doi.org/10.1371/journal.pone.0045449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029016	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388900055
J	Chi, X; Zhi, L; Gelderman, MP; Vostal, JG				Chi, Xuan; Zhi, Li; Gelderman, Monique P.; Vostal, Jaroslav G.			Host Platelets and, in Part, Neutrophils Mediate Lung Accumulation of Transfused UVB-Irradiated Human Platelets in a Mouse Model of Acute Lung Injury	PLOS ONE			English	Article							ULTRAVIOLET-A LIGHT; RED-BLOOD-CELLS; PHOTOCHEMICAL INACTIVATION; PATHOGEN INACTIVATION; AMOTOSALEN HCL; IN-VITRO; MICE; RECEPTORS; ANTIBODIES; AGGREGATION	We previously reported that ultraviolet light B (UVB)-treated human platelets (hPLTs) can cause acute lung injury (ALI) in a two-event SCID mouse model in which the predisposing event was Lipopolysaccharide (LPS) injection and the second event was infusion of UVB-treated hPLTs. To delineate contributions of host mouse platelets (mPLTs) and neutrophils in the pathogenesis of ALI in this mouse model, we depleted mPLTs or neutrophils and measured hPLT accumulation in the lung. We also assessed lung injury by protein content in bronchoalveolar lavage fluid (BALF). LPS injection followed by infusion of UVB-treated hPLTs resulted in sequestration of both mPLTs and hPLTs in the lungs of SCID mice, although the numbers of neutrophils in the lung were not significantly different from the control group. Depletion of mouse neutrophils caused only a mild reduction in UVB-hPLTs accumulation in the lungs and a mild reduction in protein content in BALF. In comparison, depletion of mPLTs almost completely abolished hPLTs accumulation in the lung and significantly reduced protein content in BALF. UVB-treated hPLTs bound to host mPLTs, but did not bind to neutrophils in the lung. Aspirin treatment of hPLTs in vitro abolished hPLT accumulation in the lung and protected mice from lung injury. Our data indicate that host mPLTs accumulated in the lungs in response to an inflammatory challenge and subsequently mediated the attachment of transfused UVB-hPLTs. Neutrophils also recruited a small percentage of platelets to the lung. These findings may help develop therapeutic strategies for ALI which could potentially result from transfusion of UV illuminated platelets.	[Chi, Xuan; Zhi, Li; Gelderman, Monique P.; Vostal, Jaroslav G.] US FDA, Lab Cellular Hematol, Div Hematol, OBRR,Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Vostal, JG (corresponding author), US FDA, Lab Cellular Hematol, Div Hematol, OBRR,Ctr Biol Evaluat & Res, Rockville, MD 20857 USA.	Jaroslav.Vostal@fda.hhs.gov			Food and Drug Administration (FDA)	Food and Drug Administration (FDA)	This work was supported by the Food and Drug Administration's (FDA) Critical Path Research Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AuBuchon JP, 2005, TRANSFUSION, V45, P1335, DOI 10.1111/j.1537-2995.2005.00202.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Doerschuk CM, 1996, J IMMUNOL, V157, P4609; DUARTE APT, 1986, THROMB RES, V43, P33, DOI 10.1016/0049-3848(86)90042-3; Faust N, 2000, BLOOD, V96, P719; Gelderman MP, 2011, TRANSFUSION, V51, P2343, DOI 10.1111/j.1537-2995.2011.03135.x; Gibbs DF, 1999, AM J RESP CELL MOL, V20, P1145, DOI 10.1165/ajrcmb.20.6.3482; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Heal JM, 2004, BLOOD REV, V18, P149, DOI 10.1016/S0268-960X(03)00057-2; Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857; Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x; Lin L, 1997, TRANSFUSION, V37, P423, DOI 10.1046/j.1537-2995.1997.37497265344.x; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Lu SJ, 2011, CELL RES, V21, P530, DOI 10.1038/cr.2011.8; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Oktay K, 1998, HUM REPROD, V13, P1133, DOI 10.1093/humrep/13.5.1133; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Piper JT, 2007, TRANSFUSION, V47, P1540, DOI 10.1111/j.1537-2995.2007.01295.x; ROSENBLUM WI, 1982, THROMB RES, V28, P713, DOI 10.1016/0049-3848(82)90096-2; Ruane PH, 2004, TRANSFUSION, V44, P877, DOI 10.1111/j.1537-2995.2004.03355.x; Rumjantseva V, 2009, NAT MED, V15, P1273, DOI 10.1038/nm.2030; Salles II, 2009, BLOOD, V114, P5044, DOI 10.1182/blood-2009-02-205989; SCHNEIDER RC, 1980, AM REV RESPIR DIS, V122, P445; Sealey AL, 2002, J IMMUNOL METHODS, V260, P303, DOI 10.1016/S0022-1759(01)00524-5; Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841; Silliman CC, 1997, TRANSFUSION, V37, P719, DOI 10.1046/j.1537-2995.1997.37797369448.x; Silliman CC, 2007, BLOOD, V109, P1752, DOI 10.1182/blood-2006-05-025106; Snyder E, 2005, TRANSFUSION, V45, P1864, DOI 10.1111/j.1537-2995.2005.00639.x; Snyder E, 2004, TRANSFUSION, V44, P1732, DOI 10.1111/j.0041-1132.2004.04145.x; Strait RT, 2011, J EXP MED, V208, P2525, DOI 10.1084/jem.20110159; Ware J, 2004, THROMB HAEMOSTASIS, V92, P478, DOI 10.1160/TH04-05-0308; Weissman A, 1999, BIOL REPROD, V60, P1462, DOI 10.1095/biolreprod60.6.1462; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011	36	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44829	10.1371/journal.pone.0044829	http://dx.doi.org/10.1371/journal.pone.0044829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028636	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388400042
J	Eckhoff, P				Eckhoff, Philip			P. falciparum Infection Durations and Infectiousness Are Shaped by Antigenic Variation and Innate and Adaptive Host Immunity in a Mathematical Model	PLOS ONE			English	Article							TROPHOZOITE-INDUCED INFECTIONS; NATURALLY ACQUIRED-IMMUNITY; PLASMODIUM-FALCIPARUM; RETROSPECTIVE EXAMINATION; MALARIA TRANSMISSION; PROTECTIVE IMMUNITY; CYTOKINE PRODUCTION; CLINICAL IMMUNITY; GROWTH-RATES; NK CELLS	Many questions remain about P. falciparum within-host dynamics, immunity, and transmission-issues that may affect public health campaign planning. These gaps in knowledge concern the distribution of durations of malaria infections, determination of peak parasitemia during acute infection, the relationships among gametocytes and immune responses and infectiousness to mosquitoes, and the effect of antigenic structure on reinfection outcomes. The present model of intrahost dynamics of P. falciparum implements detailed representations of parasite and immune dynamics, with structures based on minimal extrapolations from first-principles biology in its foundations. The model is designed to quickly and readily accommodate gains in mechanistic understanding and to evaluate effects of alternative biological hypothesis through in silico experiments. Simulations follow the parasite from the liver-stage through the detailed asexual cycle to clearance while tracking gametocyte populations. The modeled immune system includes innate inflammatory and specific antibody responses to a repertoire of antigens. The mechanistic focus provides clear explanations for the structure of the distribution of infection durations through the interaction of antigenic variation and innate and adaptive immunity. Infectiousness to mosquitoes appears to be determined not only by the density of gametocytes but also by the level of inflammatory cytokines, which harmonizes an extensive series of study results. Finally, pre-existing immunity can either decrease or increase the duration of infections upon reinfection, depending on the degree of overlap in antigenic repertoires and the strength of the pre-existing immunity.	Intellectual Ventures, Bellevue, WA USA	Intellectual Ventures	Eckhoff, P (corresponding author), Intellectual Ventures, Bellevue, WA USA.	peckhoff@intven.com			Bill and Melinda Gates through the Global Good Fund	Bill and Melinda Gates through the Global Good Fund	This work was sponsored by Bill and Melinda Gates through the Global Good Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR JC, 1992, AM J TROP MED HYG, V47, P621; Al-Olayan EM, 2002, SCIENCE, V295, P677, DOI 10.1126/science.1067159; Alano P, 2005, MOLECULAR APPROACHES TO MALARIA, P191; ANDERSON R M, 1991; ANDERSON RM, 1989, PARASITOLOGY, V99, pS59, DOI 10.1017/S0031182000083426; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Austin DJ, 1998, J THEOR BIOL, V194, P313, DOI 10.1006/jtbi.1997.0438; Baird JK, 1998, ANN TROP MED PARASIT, V92, P367, DOI 10.1080/00034989859366; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BEIER JC, 1991, AM J TROP MED HYG, V44, P564, DOI 10.4269/ajtmh.1991.44.564; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Bonnet S, 2000, T ROY SOC TROP MED H, V94, P103, DOI 10.1016/S0035-9203(00)90456-5; Bruce MC, 2003, TRENDS PARASITOL, V19, P271, DOI 10.1016/S1471-4922(03)00116-8; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cheng Q, 1997, AM J TROP MED HYG, V57, P495, DOI 10.4269/ajtmh.1997.57.495; COATNEY GR, 1971, PRIMATE MALARIAS; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Collins WE, 1999, AM J TROP MED HYG, V61, P4, DOI 10.4269/tropmed.1999.61-04; Collins WE, 1999, AM J TROP MED HYG, V61, P20, DOI 10.4269/tropmed.1999.61-020; Collins WE, 1999, AM J TROP MED HYG, V61, P36, DOI 10.4269/tropmed.1999.61-036; COOKE BM, 1995, PARASITOL TODAY, V11, P282, DOI 10.1016/0169-4758(95)80040-9; Dietz K, 2006, AM J TROP MED HYG, V75, P46, DOI 10.4269/ajtmh.2006.75.46; Doolan DL, 1999, J IMMUNOL, V163, P884; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; Galinski MR, 2005, MOLECULAR APPROACHES TO MALARIA, P113; GRAVENOR MB, 1995, PARASITOLOGY, V110, P115, DOI 10.1017/S0031182000063861; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Hetzel C, 1996, PARASITOLOGY, V113, P25, DOI 10.1017/S0031182000066245; Holder AA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P409; Horrocks P, 2005, MOLECULAR APPROACHES TO MALARIA, P399; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; Kochin BF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010444; Kurtzhals JAL, 1998, LANCET, V351, P1768, DOI 10.1016/S0140-6736(97)09439-7; KWIATKOWSKI D, 1991, P NATL ACAD SCI USA, V88, P5111, DOI 10.1073/pnas.88.12.5111; KWIATKOWSKI D, 1993, Q J MED, V86, P91; Lange A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000536; Langhorne J, 2002, CHEM IMMUNOL, V80, P204; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; LANGRETH SG, 1985, INFECT IMMUN, V47, P760, DOI 10.1128/IAI.47.3.760-766.1985; Lawrence G, 2000, VACCINE, V18, P1925, DOI 10.1016/S0264-410X(99)00444-2; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; McKenzie FE, 1997, J THEOR BIOL, V188, P127, DOI 10.1006/jtbi.1997.0478; Metcalf CJE, 2011, SCIENCE, V333, P984, DOI 10.1126/science.1204588; MIGOT F, 1993, AM J TROP MED HYG, V48, P432, DOI 10.4269/ajtmh.1993.48.432; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mohan K, 1997, J IMMUNOL, V159, P4990; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; NAOTUNNE TD, 1993, IMMUNOLOGY, V78, P555; NAOTUNNE TD, 1991, J EXP MED, V173, P523, DOI 10.1084/jem.173.3.523; Ndungu FM, 2005, PARASITE IMMUNOL, V27, P373, DOI 10.1111/j.1365-3024.2005.00771.x; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Okell LC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-125; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Omer FM, 1998, J EXP MED, V188, P39, DOI 10.1084/jem.188.1.39; Omer FM, 2003, J IMMUNOL, V171, P5430, DOI 10.4049/jimmunol.171.10.5430; Paget-McNicol S, 2002, PARASITOLOGY, V124, P225, DOI 10.1017/S0031182001001160; Penny MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003193; PEYRON F, 1994, CLIN EXP IMMUNOL, V95, P300, DOI 10.1111/j.1365-2249.1994.tb06527.x; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; Recker M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001306; RENIA L, 1994, IMMUNOLOGY, V82, P164; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; Ross R., 1910, PREVENTION MALARIA; Sama W, 2006, T ROY SOC TROP MED H, V100, P811, DOI 10.1016/j.trstmh.2005.11.001; Sama W, 2004, AM J TROP MED HYG, V70, P625, DOI 10.4269/ajtmh.2004.70.625; Saul A, 1998, PARASITOLOGY, V117, P405, DOI 10.1017/S0031182098003230; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Scragg IG, 1999, EUR J IMMUNOL, V29, P2636, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2636::AID-IMMU2636&gt;3.0.CO;2-Y; Sherman IW, 2005, MOLECULAR APPROACHES TO MALARIA, P3; Simpson JA, 2002, PARASITOLOGY, V124, P247, DOI 10.1017/S0031182001001202; Sinden RE, 2009, PARASITOLOGY, V136, P1427, DOI 10.1017/S0031182009990667; Sinden RE, 2005, MOLECULAR APPROACHES TO MALARIA, P169; Sinden RE, 1996, ADV PARASIT, V38, P53, DOI 10.1016/S0065-308X(08)60033-0; Sinden RE, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P139; SMALLEY ME, 1977, PARASITOLOGY, V74, P1, DOI 10.1017/S0031182000047478; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; Smith T, 2008, PARASITOLOGY, V135, P1507, DOI 10.1017/S0031182008000371; Smith T, 2006, AM J TROP MED HYG, V75, P1; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tami A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-7; Tediosi F, 2006, AM J TROP MED HYG, V75, P90, DOI 10.4269/ajtmh.2006.75.90; THOMSON J. G., 1935, TRANS ROY SOC TROP MED AND HYG, V29, P31, DOI 10.1016/S0035-9203(35)90015-3; Verra F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P93; White LJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-212; Xu HJ, 2002, J EXP MED, V195, P881, DOI 10.1084/jem.20011174; Yoneto T, 1999, INFECT IMMUN, V67, P2349, DOI 10.1128/IAI.67.5.2349-2356.1999	107	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44950	10.1371/journal.pone.0044950	http://dx.doi.org/10.1371/journal.pone.0044950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028698	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400052
J	Hong, HS; Ahmad, F; Eberhard, J; Bhatnagar, N; Bollmann, BA; Keudel, P; Ballmaier, M; Zielinska-Skowronek, M; Schmidt, RE; Meyer-Olson, D				Hong, Henoch S.; Ahmad, Fareed; Eberhard, JohannaM.; Bhatnagar, Nupur; Bollmann, Benjamin A.; Keudel, Phillip; Ballmaier, Matthias; Zielinska-Skowronek, Margot; Schmidt, Reinhold E.; Meyer-Olson, Dirk			Loss of CCR7 Expression on CD56(bright) NK Cells Is Associated with a CD56(dim)CD16(+) NK Cell-Like Phenotype and Correlates with HIV Viral Load	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; VIRUS-INFECTION; SUBSET; CYTOTOXICITY; EXPANSION; IMMUNITY; TARGETS; INNATE	NK cells are pivotal sentinels of the innate immune system and distinct subpopulations in peripheral blood have been described. A number of studies addressed HIV-induced alterations of NK cell phenotype and functionality mainly focusing on CD56(dim)CD16(+) and CD56(-)CD16(+) NK cells. However, the impact of HIV-infection on CD56(bright) NK cells is less well understood. Here we report a rise of CD56(bright) NK cells in HIV-infected individuals, which lack CCR7-expression and strongly correlate with HIV viral load. CCR7(-)CD56(bright) NK cells were characterized by increased cytolytic potential, higher activation states and a more differentiated phenotype. These cells thus acquired a number of features of CD56(dim)CD16(+) NK cells. Furthermore, CD56 bright NK cells from HIV patients exhibited higher degranulation levels compared to uninfected individuals. Thus, chronic HIV-infection is associated with a phenotypic and functional shift of CD56(bright) NK cells, which provides a novel aspect of HIV-associated pathogenesis within the NK cell compartment.	[Hong, Henoch S.; Ahmad, Fareed; Eberhard, JohannaM.; Bhatnagar, Nupur; Bollmann, Benjamin A.; Keudel, Phillip; Zielinska-Skowronek, Margot; Schmidt, Reinhold E.; Meyer-Olson, Dirk] Hannover Med Sch, Klin Immunol & Rheumatol, D-30623 Hannover, Germany; [Hong, Henoch S.] Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough, MA 01772 USA	Hannover Medical School; Harvard University	Meyer-Olson, D (corresponding author), Hannover Med Sch, Klin Immunol & Rheumatol, D-30623 Hannover, Germany.	meyer.dirk@mh-hannover.de	Ballmaier, Matthias/J-4175-2014	Ballmaier, Matthias/0000-0002-1352-5995; Eberhard, Johanna Maria/0000-0002-8367-3870; Hong, Henoch/0000-0002-3367-1738	Bundesministerium fur Bildung und Forschung; Stiftung Zukunfts- und Innovationsfonds Niedersachsen; European AIDS Treatment Network (NEAT); Helmholtz-Zentrum fur Infektionsforschung [IG-SCID-TwinPro02]; MD/PhD program of the Hannover Biomedical Research School (HBRS) at Hannover Medical School; Deutsche Forschungsgemeinschaft [HO 4527/1-1]; Bundesministerium fur Bildung und Forschung [IND 06/20]; NEAT	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Stiftung Zukunfts- und Innovationsfonds Niedersachsen; European AIDS Treatment Network (NEAT); Helmholtz-Zentrum fur Infektionsforschung; MD/PhD program of the Hannover Biomedical Research School (HBRS) at Hannover Medical School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); NEAT	D.M.O. is supported by grants from the Bundesministerium fur Bildung und Forschung, Stiftung Zukunfts- und Innovationsfonds Niedersachsen, the European AIDS Treatment Network (NEAT) and the Helmholtz-Zentrum fur Infektionsforschung (IG-SCID-TwinPro02). H.S.H. is supported by a fellowship from the MD/PhD program of the Hannover Biomedical Research School (HBRS) at Hannover Medical School and by a post-doctoral fellowship from the Deutsche Forschungsgemeinschaft (HO 4527/1-1). R.E.S. is supported by grant IND 06/20 from Bundesministerium fur Bildung und Forschung and NEAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Altfeld M, 2007, NAT GENET, V39, P708, DOI 10.1038/ng0607-708; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Beziat V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011966; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Eller MA, 2009, JAIDS-J ACQ IMM DEF, V51, P380, DOI 10.1097/QAI.0b013e3181aa256e; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Freud AG, 2005, IMMUNITY, V22, P295, DOI 10.1016/j.immuni.2005.01.013; Hong HS, 2010, AIDS, V24, P1823, DOI 10.1097/QAD.0b013e32833b556f; Hong HS, 2010, J VIROL, V84, P1183, DOI 10.1128/JVI.01675-09; Hong HS, 2009, IMMUNOL LETT, V125, P100, DOI 10.1016/j.imlet.2009.06.008; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Kottilil S, 2007, JAIDS-J ACQ IMM DEF, V46, P151, DOI 10.1097/QAI.0b013e3180dc9909; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Meyer-Olson D, 2006, BLOOD, V107, P2373, DOI 10.1182/blood-2005-04-1636; Mirandola P, 2004, BLOOD, V104, P2418, DOI 10.1182/blood-2004-04-1294; NAGLER A, 1989, J IMMUNOL, V143, P3183; Penack O, 2005, LEUKEMIA, V19, P835, DOI 10.1038/sj.leu.2403704; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Reeves RK, 2010, J VIROL, V84, P8959, DOI 10.1128/JVI.01126-10; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491	32	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44820	10.1371/journal.pone.0044820	http://dx.doi.org/10.1371/journal.pone.0044820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028633	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400040
J	Kambas, K; Mitroulis, I; Apostolidou, E; Girod, A; Chrysanthopoulou, A; Pneumatikos, I; Skendros, P; Kourtzelis, I; Koffa, M; Kotsianidis, I; Ritis, K				Kambas, Konstantinos; Mitroulis, Ioannis; Apostolidou, Eirini; Girod, Andreas; Chrysanthopoulou, Akrivi; Pneumatikos, Ioannis; Skendros, Panagiotis; Kourtzelis, Ioannis; Koffa, Maria; Kotsianidis, Ioannis; Ritis, Konstantinos			Autophagy Mediates the Delivery of Thrombogenic Tissue Factor to Neutrophil Extracellular Traps in Human Sepsis	PLOS ONE			English	Article							INNATE IMMUNITY; COAGULATION; PATHWAY; ACTIVATION; INHIBITOR; MODEL; C5A; MICROPARTICLES; INFLAMMATION; MONOCYTES	Background: Sepsis is associated with systemic inflammatory responses and induction of coagulation system. Neutrophil extracellular traps (NETs) constitute an antimicrobial mechanism, recently implicated in thrombosis via platelet entrapment and aggregation. Methodology/Principal Findings: In this study, we demonstrate for the first time the localization of thrombogenic tissue factor (TF) in NETs released by neutrophils derived from patients with gram-negative sepsis and normal neutrophils treated with either serum from septic patients or inflammatory mediators involved in the pathogenesis of sepsis. Localization of TF in acidified autophagosomes was observed during this process, as indicated by positive LC3B and LysoTracker staining. Moreover, phosphatidylinositol 3-kinase inhibition with 3-MA or inhibition of endosomal acidification with bafilomycin A1 hindered the release of TF-bearing NETs. TF present in NETs induced thrombin generation in culture supernatants, which further resulted in protease activated receptor-1 signaling. Conclusions/Significance: This study demonstrates the involvement of autophagic machinery in the extracellular delivery of TF in NETs and the subsequent activation of coagulation cascade, providing evidence for the implication of this process in coagulopathy and inflammatory response in sepsis.	[Kambas, Konstantinos; Mitroulis, Ioannis; Apostolidou, Eirini; Chrysanthopoulou, Akrivi; Skendros, Panagiotis; Ritis, Konstantinos] Democritus Univ Thrace, Univ Gen Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece; [Girod, Andreas] Univ Luxembourg, Life Sci Res Unit FSTC, Walferdange, Luxembourg; [Pneumatikos, Ioannis] Democritus Univ Thrace, Univ Gen Hosp Alexandroupolis, Intens Care Unit, Alexandroupolis, Greece; [Kourtzelis, Ioannis] Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Greece; [Koffa, Maria] Democritus Univ Thrace, Lab Cellular & Mol Biol, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Kotsianidis, Ioannis] Democritus Univ Thrace, Sch Med, Dept Hematol, Alexandroupolis, Greece	Democritus University of Thrace; University of Luxembourg; Democritus University of Thrace; Aristotle University of Thessaloniki; Democritus University of Thrace; Democritus University of Thrace	Ritis, K (corresponding author), Democritus Univ Thrace, Univ Gen Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece.	ritis2@otenet.gr	Koffa, Maria/AAP-3999-2020; KOTSIANIDIS, IOANNIS/ABH-1436-2021; Mitroulis, Ioannis/AAB-7915-2021; Kotsianidis, Ioannis/AGH-1791-2022; Kourtzelis, Ioannis/G-1767-2012	KOTSIANIDIS, IOANNIS/0000-0001-7668-0186; Mitroulis, Ioannis/0000-0002-9991-2362; Kourtzelis, Ioannis/0000-0002-7292-5745; Kourtzelis, Ioannis/0000-0003-3006-8885; Chrysanthopoulou, Akrivi/0000-0002-0325-6146; Koffa, Maria (Margy)/0000-0003-2255-3426; Skendros, Panagiotis/0000-0003-0456-7015	Hellenic Ministry of Education and General Secretariat for Research and Technology (ESPA project) [898]	Hellenic Ministry of Education and General Secretariat for Research and Technology (ESPA project)	This study was supported by the Hellenic Ministry of Education and General Secretariat for Research and Technology (ESPA project/No 898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso L, 2008, J LEUKOCYTE BIOL, V84, P389, DOI 10.1189/jlb.0108018; Aras O, 2004, BLOOD, V103, P4545, DOI 10.1182/blood-2003-03-0713; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Egorina EM, 2008, BLOOD, V111, P1208, DOI 10.1182/blood-2007-08-107698; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Hussein MNA, 2003, J THROMB HAEMOST, V1, P2434; Kambas K, 2011, J IMMUNOL, V186, P6568, DOI 10.4049/jimmunol.1003756; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Loomis WF, 2010, J BIOL CHEM, V285, P21359, DOI 10.1074/jbc.M110.105858; Luo DY, 2011, J IMMUNOL, V187, P1866, DOI 10.4049/jimmunol.1101094; Lupu C, 2005, AM J PATHOL, V167, P1161, DOI 10.1016/S0002-9440(10)61204-7; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Mayer-Scholl A, 2004, CURR OPIN MICROBIOL, V7, P62, DOI 10.1016/j.mib.2003.12.004; Mihalache CC, 2011, J IMMUNOL, V186, P6532, DOI 10.4049/jimmunol.1004055; Mitroulis I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029318; Mitroulis I, 2011, EXPERT OPIN THER TAR, V15, P75, DOI 10.1517/14728222.2011.532788; Mitroulis I, 2010, EUR J IMMUNOL, V40, P1461, DOI 10.1002/eji.200940025; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Pawlinski R, 2004, BLOOD, V103, P1342, DOI 10.1182/blood-2003-09-3051; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Pawlinski R, 2010, THROMB RES, V125, pS70, DOI 10.1016/j.thromres.2010.01.042; Redecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Savi P, 2005, BLOOD, V105, P139, DOI 10.1182/blood-2004-05-2010; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Shimura M, 1997, AM J HEMATOL, V55, P169, DOI 10.1002/(SICI)1096-8652(199707)55:4<169::AID-AJH1>3.0.CO;2-Q; Taylor FB, 1998, BLOOD, V91, P1609, DOI 10.1182/blood.V91.5.1609.1609_1609_1615; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Wang JG, 2009, J THROMB HAEMOST, V7, P1092, DOI 10.1111/j.1538-7836.2009.03448.x; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	50	161	172	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45427	10.1371/journal.pone.0045427	http://dx.doi.org/10.1371/journal.pone.0045427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029002	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400084
J	Chen, NT; Wu, CY; Chung, CY; Hwu, Y; Cheng, SH; Mou, CY; Lo, LW				Chen, Nai-Tzu; Wu, Chia-Yan; Chung, Chao-Yu; Hwu, Yeukuang; Cheng, Shih-Hsun; Mou, Chung-Yuan; Lo, Leu-Wei			Probing the Dynamics of Doxorubicin-DNA Intercalation during the Initial Activation of Apoptosis by Fluorescence Lifetime Imaging Microscopy (FLIM)	PLOS ONE			English	Article							ANTHRACYCLINE ANTIBIOTICS; TRICHOSTATIN-A; HISTONE; PHOSPHORYLATION; ADRIAMYCIN; CANCER; INHIBITOR; TARGETS; BINDING; DAMAGE	Doxorubicin is a potent anthracycline antibiotic, commonly used to treat a wide range of cancers. Although postulated to intercalate between DNA bases, many of the details of doxorubicin's mechanism of action remain unclear. In this work, we demonstrate the ability of fluorescence lifetime imaging microscopy (FLIM) to dynamically monitor doxorubicin-DNA intercalation during the earliest stages of apoptosis. The fluorescence lifetime of doxorubicin in nuclei is found to decrease rapidly during the first 2 hours following drug administration, suggesting significant changes in the doxorubicin-DNA binding site's microenvironment upon apoptosis initiation. Decreases in doxorubicin fluorescence lifetimes were found to be concurrent with increases in phosphorylation of H2AX (an immediate signal of DNA double-strand breakage), but preceded activation of caspase-3 (a late signature of apoptosis) by more than 150 minutes. Time-dependent doxorubicin FLIM analyses of the effects of pretreating cells with either Cyclopentylidene-[4-(4-chlorophenyl) thiazol-2-yl)-hydrazine (a histone acetyltransferase inhibitor) or Trichostatin A (a histone deacetylase inhibitor) revealed significant correlation of fluorescence lifetime with the stage of chromatin decondensation. Taken together, our findings suggest that monitoring the dynamics of doxorubicin fluorescence lifetimes can provide valuable information during the earliest phases of doxorubicin-induced apoptosis; and implicate that FLIM can serve as a sensitive, high-resolution tool for the elucidation of intercellular mechanisms and kinetics of anti-cancer drugs that bear fluorescent moieties.	[Chen, Nai-Tzu; Mou, Chung-Yuan] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan; [Chen, Nai-Tzu; Wu, Chia-Yan; Cheng, Shih-Hsun; Lo, Leu-Wei] Natl Hlth Res Inst, Div Med Engn Res, Zhunan, Taiwan; [Chung, Chao-Yu] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan; [Hwu, Yeukuang] Acad Sinica, Inst Phys, Taipei, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; National Synchrotron Radiation Research Center; Academia Sinica - Taiwan	Mou, CY (corresponding author), Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan.	cymou@ntu.edu.tw; lwlo@nhri.org.tw	Hwu, Yeukuang/AAH-9947-2020; Lo, Leu-Wei/E-3943-2010; Hwu, Yeukuang/ABH-5311-2020	MOU, CHUNG-YUAN/0000-0001-7060-9899	National Health Research Institutes of Taiwan [MED-099-PP-04, NM-099-PP-01]; NSC [99-2113-M-400-001-MY3]; National Science Council of Taiwan	National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); NSC(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants MED-099-PP-04 and NM-099-PP-01 from the National Health Research Institutes of Taiwan, and grant NSC 99-2113-M-400-001-MY3 and the Biomedical NanoImaging Core Facility of the National Nanoscience and Nanotechnology Program from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablack JNG, 2012, J VIROL, V86, P8198, DOI 10.1128/JVI.00289-12; BLUM RH, 1974, ANN INTERN MED, V80, P249, DOI 10.7326/0003-4819-80-2-249; Carter SK, 1975, CANC CHEMOTHER REP, V63, P1877; CERA C, 1990, ANTI-CANCER DRUG DES, V5, P265; CHAIRES JB, 1983, BIOCHEMISTRY-US, V22, P284, DOI 10.1021/bi00271a009; Chimenti F, 2009, J MED CHEM, V52, P530, DOI 10.1021/jm800885d; Elangovan M, 2002, J MICROSC-OXFORD, V205, P3, DOI 10.1046/j.0022-2720.2001.00984.x; FREDERICK CA, 1990, BIOCHEMISTRY-US, V29, P2538, DOI 10.1021/bi00462a016; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Hrelia S, 2002, BBA-BIOMEMBRANES, V1567, P150, DOI 10.1016/S0005-2736(02)00612-0; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Ito T, 2009, PHOTOCH PHOTOBIO SCI, V8, P763, DOI 10.1039/b902341k; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Li ZX, 2008, ASIAN J ANDROL, V10, P749, DOI 10.1111/j.1745-7262.2008.00400.x; Lin HJ, 2003, CYTOM PART A, V52A, P77, DOI 10.1002/cyto.a.10028; Lleres D, 2007, CURRENT PROTOCOLS CY, V12, P1; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Murata S, 2000, CYTOMETRY, V41, P178, DOI 10.1002/1097-0320(20001101)41:3<178::AID-CYTO4>3.0.CO;2-N; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rabbani A, 2005, BIOESSAYS, V27, P50, DOI 10.1002/bies.20160; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Saxl T, 2009, BIOSENS BIOELECTRON, V24, P3229, DOI 10.1016/j.bios.2009.04.003; Schneckenburger H, 2011, J BIOPHOTONICS, V4, P143, DOI 10.1002/jbio.201000098; Smetana K, 2007, ACTA HISTOCHEM, V109, P413, DOI 10.1016/j.acthis.2007.04.003; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Vigushin DM, 2001, CLIN CANCER RES, V7, P971	27	67	67	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44947	10.1371/journal.pone.0044947	http://dx.doi.org/10.1371/journal.pone.0044947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028696	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900055
J	Hayden, EJ; Weikert, C; Wagner, A				Hayden, Eric J.; Weikert, Christian; Wagner, Andreas			Directional Selection Causes Decanalization in a Group I Ribozyme	PLOS ONE			English	Article							CRYPTIC GENETIC-VARIATION; MUTATIONAL ROBUSTNESS; RNA VIRUS; EVOLUTION; CANALIZATION; THERMOSTABILITY; EVOLVABILITY; POPULATION; PLASTICITY; DROSOPHILA	A canalized genotype is robust to environmental or genetic perturbations. Canalization is expected to result from stabilizing selection on a well-adapted phenotype. Decanalization, the loss of robustness, might follow periods of directional selection toward a new optimum. The evolutionary forces causing decanalization are still unknown, in part because it is difficult to determine the fitness effects of mutations in populations of organisms with complex genotypes and phenotypes. Here, we report direct experimental measurements of robustness in a system with a simple genotype and phenotype, the catalytic activity of an RNA enzyme. We find that the robustness of a population of RNA enzymes decreases during a period of directional selection in the laboratory. The decrease in robustness is primarily caused by the selective sweep of a genotype that is decanalized relative to the wild-type, both in terms of mutational robustness and environmental robustness (thermodynamic stability). Our results experimentally demonstrate that directional selection can cause decanalization on short time scales, and demonstrate co-evolution of mutational and environmental robustness.	[Hayden, Eric J.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Weikert, Christian; Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Wagner, Andreas] Swiss Inst Bioinformat, Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	Stanford University; University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Hayden, EJ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	ehayden@stanford.edu			Swiss National Science Foundation [315200-116814, 315200-119697, 315230-129708]; YeastX program of SystemsX.ch; University Research Priority Program: Systems Biology/Functional Genomics of the University of Zurich; ETH	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); YeastX program of SystemsX.ch; University Research Priority Program: Systems Biology/Functional Genomics of the University of Zurich; ETH(ETH Zurich)	The authors acknowledge funding from Swiss National Science Foundation grants 315200-116814, 315200-119697, and 315230-129708, from the YeastX program of SystemsX.ch, and from the University Research Priority Program: Systems Biology/Functional Genomics of the University of Zurich and the ETH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Borenstein E, 2006, P NATL ACAD SCI USA, V103, P6593, DOI 10.1073/pnas.0510600103; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Chauhan S, 2005, J MOL BIOL, V353, P1199, DOI 10.1016/j.jmb.2005.09.015; Cooper TF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-237; Corona E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012236; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Domingo-Calap P, 2010, J EVOLUTION BIOL, V23, P2453, DOI 10.1111/j.1420-9101.2010.02107.x; Elena SF, 2001, EVOLUTION, V55, P1746; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Gibson G, 1997, GENETICS, V147, P1155; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Hayden EJ, 2012, P R SOC B; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Hurek T, 2003, J BIOTECHNOL, V106, P169, DOI 10.1016/j.jbiotec.2003.07.010; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lehner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009035; Masel J, 2009, TRENDS GENET, V25, P395, DOI 10.1016/j.tig.2009.07.005; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Meyers LA, 2004, J MOL EVOL, V58, P681, DOI 10.1007/s00239-004-2590-2; Milton CC, 2003, P NATL ACAD SCI USA, V100, P13396, DOI 10.1073/pnas.1835613100; Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381; Price N, 2011, MOL BIOL EVOL, V28, P2115, DOI 10.1093/molbev/msr029; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sawyer SA, 2007, P NATL ACAD SCI USA, V104, P6504, DOI 10.1073/pnas.0701572104; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; Szollosi GJ, 2009, MOL BIOL EVOL, V26, P867, DOI 10.1093/molbev/msp008; Tanner MA, 1996, RNA, V2, P74; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner A, 1999, J EXP ZOOL, V285, P119; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wloch DM, 2001, GENETICS, V159, P441; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	39	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45351	10.1371/journal.pone.0045351	http://dx.doi.org/10.1371/journal.pone.0045351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028955	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000311313900125
J	Lee, D; Das Gupta, J; Gaughan, C; Steffen, I; Tang, N; Luk, KC; Qiu, XX; Urisman, A; Fischer, N; Molinaro, R; Broz, M; Schochetman, G; Klein, EA; Ganem, D; DeRisi, JL; Simmons, G; Hackett, J; Silverman, RH; Chiu, CY				Lee, Deanna; Das Gupta, Jaydip; Gaughan, Christina; Steffen, Imke; Tang, Ning; Luk, Ka-Cheung; Qiu, Xiaoxing; Urisman, Anatoly; Fischer, Nicole; Molinaro, Ross; Broz, Miranda; Schochetman, Gerald; Klein, Eric A.; Ganem, Don; DeRisi, Joseph L.; Simmons, Graham; Hackett, John, Jr.; Silverman, Robert H.; Chiu, Charles Y.			In-Depth Investigation of Archival and Prospectively Collected Samples Reveals No Evidence for XMRV Infection in Prostate Cancer	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; UNITED-STATES; RETROVIRUS XMRV; MITOCHONDRIAL-DNA; BLOOD-DONORS; RNASE-L; CELLS; PCR; CONTAMINATION	XMRV, or xenotropic murine leukemia virus (MLV)-related virus, is a novel gammaretrovirus originally identified in studies that analyzed tissue from prostate cancer patients in 2006 and blood from patients with chronic fatigue syndrome (CFS) in 2009. However, a large number of subsequent studies failed to confirm a link between XMRV infection and CFS or prostate cancer. On the contrary, recent evidence indicates that XMRV is a contaminant originating from the recombination of two mouse endogenous retroviruses during passaging of a prostate tumor xenograft (CWR22) in mice, generating laboratory-derived cell lines that are XMRV-infected. To confirm or refute an association between XMRV and prostate cancer, we analyzed prostate cancer tissues and plasma from a prospectively collected cohort of 39 patients as well as archival RNA and prostate tissue from the original 2006 study. Despite comprehensive microarray, PCR, FISH, and serological testing, XMRV was not detected in any of the newly collected samples or in archival tissue, although archival RNA remained XMRV-positive. Notably, archival VP62 prostate tissue, from which the prototype XMRV strain was derived, tested negative for XMRV on re-analysis. Analysis of viral genomic and human mitochondrial sequences revealed that all previously characterized XMRV strains are identical and that the archival RNA had been contaminated by an XMRV-infected laboratory cell line. These findings reveal no association between XMRV and prostate cancer, and underscore the conclusion that XMRV is not a naturally acquired human infection.	[Lee, Deanna; Urisman, Anatoly; Broz, Miranda; Chiu, Charles Y.] Univ San Francisco, Dept Lab Med, San Francisco, CA 94117 USA; [Lee, Deanna; Chiu, Charles Y.] Univ San Francisco, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94117 USA; [Das Gupta, Jaydip; Gaughan, Christina; Klein, Eric A.; Silverman, Robert H.] Cleveland Clin, Cleveland, OH 44106 USA; [Steffen, Imke; Simmons, Graham] Blood Syst Res Inst, San Francisco, CA USA; [Tang, Ning; Luk, Ka-Cheung; Qiu, Xiaoxing; Schochetman, Gerald; Hackett, John, Jr.] Abbott Labs, Abbott Pk, IL 60064 USA; [Fischer, Nicole] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Molinaro, Ross] Emory Univ, Sch Med, Atlanta, GA USA; [Ganem, Don] Novartis Inst Biomed Res, Emeryville, CA USA; [DeRisi, Joseph L.] Univ San Francisco, Dept Biochem & Biophys, San Francisco, CA 94117 USA; [DeRisi, Joseph L.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Chiu, Charles Y.] Univ San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94117 USA	University of San Francisco; University of San Francisco; Cleveland Clinic Foundation; Vitalant; Vitalant Research Institute; Abbott Laboratories; University of Hamburg; University Medical Center Hamburg-Eppendorf; Emory University; Novartis; University of San Francisco; Howard Hughes Medical Institute; University of San Francisco	Chiu, CY (corresponding author), Univ San Francisco, Dept Lab Med, San Francisco, CA 94117 USA.	charles.chiu@ucsf.edu	Simmons, Graham/G-3523-2012; Steffen, Imke/AAY-3266-2020	Simmons, Graham/0000-0002-9615-7023; Chiu, Charles/0000-0003-2915-2094; Steffen, Imke/0000-0001-6592-0332	NIH/NCI [CA103943]; Charlotte Geyer Foundation; Maltz Family Foundation; Abbott Laboratories; National Heart, Lung, and Blood Institute (NHLBI) [1R21HL109761]; Howard Hughes Medical Institute; NIH [R56-AI08952, R01-HL105704]; Abbott Viral Discovery Award; NATIONAL CANCER INSTITUTE [R01CA103943] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704, R21HL109761] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Charlotte Geyer Foundation; Maltz Family Foundation; Abbott Laboratories(Abbott Laboratories); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Viral Discovery Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors gratefully acknowledge support from NIH/NCI CA103943 (R. Silverman), as well as the Charlotte Geyer Foundation, the Maltz Family Foundation, and Abbott Laboratories (to R. Silverman and E. Klein). G. Simmons is supported by grant 1R21HL109761 from the National Heart, Lung, and Blood Institute (NHLBI). J. DeRisi is supported by the Howard Hughes Medical Institute. C. Chiu is supported by NIH grants R56-AI08952 and R01-HL105704, as well as an Abbott Viral Discovery Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Bittner ML, 1996, DIRECT LABEL TRANSAM; Bracho MA, 1998, J GEN VIROL, V79, P2921, DOI 10.1099/0022-1317-79-12-2921; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; Chen EC, 2011, JOVE-J VIS EXP, DOI 10.3791/2536; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Danielson BP, 2010, J INFECT DIS, V202, P1470, DOI 10.1086/656146; DasGupta J, 2012, PLOS ONE IN PRESS; Del Prete GQ, 2012, J VIROL, V86, P3152, DOI 10.1128/JVI.06886-11; Dey A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-531; Dodd RY, 2012, TRANSFUSION, V52, P298, DOI 10.1111/j.1537-2995.2011.03450.x; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dong BH, 2010, J VIROL, V84, P1648, DOI 10.1128/JVI.01763-09; Drummond A, 2010, GENEIOUS V5 5 6 GENE; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023484; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Groom HCT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034221; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Kearney MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030889; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200; Lo SC, 2012, P NATL ACAD SCI USA, V109, P346, DOI 10.1073/pnas.1119641109; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Malathi K, 2004, CANCER RES, V64, P9144, DOI 10.1158/0008-5472.CAN-04-2226; Mendoza R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036073; Mohan KVK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032853; Mount DW, 2007, CSH PROTOC; Onlamoon N, 2011, J VIROL, V85, P4547, DOI 10.1128/JVI.02411-10; Overbaugh J, 2001, SCIENCE, V292, P1106, DOI 10.1126/science.1059128; Pandhare-Dash J, 2011, PROSTATE; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Qiu XX, 2012, TRANSFUSION, V52, P307, DOI 10.1111/j.1537-2995.2011.03395.x; Qiu XX, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-68; Ravichandran V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-443; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Robinson MJ, 2011, ADV VIROL, V2011, DOI 10.1155/2011/782353; Sakuma T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-23; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Setty MKHG, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-423; Sfanos KS, 2012, NAT REV UROL, V9, P111, DOI 10.1038/nrurol.2011.225; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Silverman RH, 2011, SCIENCE; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; Simmons G, 2011, TRANSFUSION, V51, P643, DOI 10.1111/j.1537-2995.2011.03063.x; Slattery JP, 1999, GENOME RES, V9, P525; Spindler J, 2011, ADV VIROL, V2011, DOI 10.1155/2011/268214; Steffen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027870; Stieler K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025592; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Tang N, 2012, J VIROL METHODS, V179, P127, DOI 10.1016/j.jviromet.2011.10.010; Urisman A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r78; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Vaughan AE, 2012, J VIROL, V86, P1661, DOI 10.1128/JVI.06073-11; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Xiang Y, 2003, CANCER RES, V63, P6795; Zaragoza MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012295	73	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44954	10.1371/journal.pone.0044954	http://dx.doi.org/10.1371/journal.pone.0044954			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028701	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900057
J	Ducreux, S; Gregory, P; Schwaller, B				Ducreux, Sylvie; Gregory, Patrick; Schwaller, Beat			Inverse Regulation of the Cytosolic Ca2+ Buffer Parvalbumin and Mitochondrial Volume in Muscle Cells via SIRT1/PGC-1 alpha Axis	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; SKELETAL-MUSCLE; CALBINDIN D-28K; GENE-EXPRESSION; TWITCH MUSCLE; FIBER-TYPE; PGC-1-ALPHA; SIRT1; DEFICIENCY; KINASE	Skeletal muscles show a high plasticity to cope with various physiological demands. Different muscle types can be distinguished by the force, endurance, contraction/relaxation kinetics (fast-twitch vs. slow-twitch muscles), oxidative/glycolytic capacity, and also with respect to Ca2+-signaling components. Changes in Ca2+ signaling and associated Ca2+-dependent processes are thought to underlie the high adaptive capacity of muscle fibers. Here we investigated the consequences and the involved mechanisms caused by the ectopic expression of the Ca2+-binding protein parvalbumin (PV) in C2C12 myotubes in vitro, and conversely, the effects caused by its absence in in fast-twitch muscles of parvalbumin null-mutant (PV-/-) mice in vivo. The absence of PV in fast-twitch muscle tibialis anterior (TA) resulted in an increase in the peroxisome proliferator-activated receptor c coactivator 1 alpha (PGC-1 alpha) and of its positive regulator, the deacetylase sirtuin 1 (SIRT1). TA muscles from PV-/- mice also have an increased mitochondrial volume. Mild ionophore treatment of control (PV-devoid) C2C12 myotubes causing a moderate elevation in [Ca2+](c) resulted in an increase in mitochondrial volume, together with elevated PGC-1 alpha and SIRT1 expression levels, whilst it increased PV expression levels in myotubes stably transfected with PV. In PV-expressing myotubes the mitochondrial volume, PGC-1 alpha and SIRT1 were significantly lower than in control C2C12 myotubes already at basal conditions and application of ionophore had no effect on either one. SIRT1 activation causes a down-regulation of PV in transfected myotubes, whilst SIRT1 inhibition has the opposite effect. We conclude that PV expression and mitochondrial volume in muscle cells are inversely regulated via a SIRT1/PGC-1 alpha signaling axis.	[Ducreux, Sylvie; Gregory, Patrick; Schwaller, Beat] Univ Fribourg, Dept Med, Unit Anat, CH-1700 Fribourg, Switzerland	University of Fribourg	Ducreux, S (corresponding author), Univ Fribourg, Dept Med, Unit Anat, CH-1700 Fribourg, Switzerland.	Beat.Schwaller@unifr.ch	DUCREUX, SYLVIE/D-6257-2013	DUCREUX, SYLVIE/0000-0003-3207-9537; Schwaller, Beat/0000-0002-8277-7555	Swiss National Science Foundation [130680, 113518]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was supported by the Swiss National Science Foundation (grants #130680 and #113518 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2003, CELL CALCIUM, V33, P101, DOI 10.1016/S0143-4160(02)00203-8; Allen DL, 2002, J BIOL CHEM, V277, P45323, DOI 10.1074/jbc.M208302200; Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arif SH, 2009, BIOESSAYS, V31, P410, DOI 10.1002/bies.200800170; Arnold DB, 1997, P NATL ACAD SCI USA, V94, P8842, DOI 10.1073/pnas.94.16.8842; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blough E, 1999, BIOTECHNIQUES, V26, P202, DOI 10.2144/99262bm05; Chen G, 2006, NEUROSCIENCE, V142, P97, DOI 10.1016/j.neuroscience.2006.06.008; Chen GP, 2001, AM J PHYSIOL-CELL PH, V281, pC114, DOI 10.1152/ajpcell.2001.281.1.C114; Chen M, 2010, BIOCHEM BIOPH RES CO, V396, P894, DOI 10.1016/j.bbrc.2010.05.018; Chin ER, 2004, P NUTR SOC, V63, P279, DOI 10.1079/PNS2004335; Coutu P, 2004, CIRC RES, V94, P1235, DOI 10.1161/01.RES.0000126923.46786.FD; D'Orlando C, 2002, BRAIN RES, V945, P181, DOI 10.1016/S0006-8993(02)02753-1; D'Orlando C, 2001, BRAIN RES, V909, P145, DOI 10.1016/S0006-8993(01)02671-3; Day SM, 2008, PHYSIOL GENOMICS, V33, P312, DOI 10.1152/physiolgenomics.00302.2007; Farre-Castany MA, 2007, BEHAV BRAIN RES, V178, P250, DOI 10.1016/j.bbr.2007.01.002; Freyssenet D, 1999, J BIOL CHEM, V274, P9305, DOI 10.1074/jbc.274.14.9305; Freyssenet D, 2004, AM J PHYSIOL-CELL PH, V286, pC1053, DOI 10.1152/ajpcell.00418.2003; Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x; Gurd BJ, 2011, AM J PHYSIOL-REG I, V301, pR67, DOI 10.1152/ajpregu.00417.2010; Kubis HP, 1997, P NATL ACAD SCI USA, V94, P4205, DOI 10.1073/pnas.94.8.4205; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lucas EK, 2010, J NEUROSCI, V30, P7227, DOI 10.1523/JNEUROSCI.0698-10.2010; Maetzler W, 2004, EXP NEUROL, V186, P78, DOI 10.1016/j.expneurol.2003.10.014; Matsuoka Y, 2008, CELL TISSUE RES, V332, P123, DOI 10.1007/s00441-008-0582-z; Mazzucotelli A, 2007, DIABETES, V56, P2467, DOI 10.2337/db06-1465; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Racay P, 2006, FEBS J, V273, P96, DOI 10.1111/j.1742-4658.2005.05046.x; Rasouri S, 2007, M S-MED SCI, V23, P840, DOI 10.1051/medsci/20072310840; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Saarikettu J, 2004, J BIOL CHEM, V279, P41004, DOI 10.1074/jbc.M408120200; Schmidt U, 2005, CARDIOVASC RES, V66, P318, DOI 10.1016/j.cardiores.2004.06.028; Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395, DOI 10.1152/ajpcell.1999.276.2.C395; Schwaller B, BIOCH BIOPHYSICA ACT; Schwaller B., 2010, COLD SPRING HARB PER, V2; Schwaller B, 2012, ADV EXP MED BIOL, V740, P1, DOI 10.1007/978-94-007-2888-2_1; SRETER FA, 1987, AM J PHYSIOL, V253, pC296, DOI 10.1152/ajpcell.1987.253.2.C296; Summermatter S, 2012, AM J PHYSIOL-CELL PH, V302, pC88, DOI 10.1152/ajpcell.00190.2011; Tennen RI, 2012, CELL, V148, P387, DOI 10.1016/j.cell.2012.01.032; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Waser M, 1997, J CELL BIOL, V138, P547, DOI 10.1083/jcb.138.3.547; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamaguchi T, 2010, AM J PHYSIOL-CELL PH, V298, pC140, DOI 10.1152/ajpcell.00050.2009; Yi JX, 2011, J BIOL CHEM, V286, P32436, DOI 10.1074/jbc.M110.217711	50	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44837	10.1371/journal.pone.0044837	http://dx.doi.org/10.1371/journal.pone.0044837			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028640	gold, Green Published, Green Submitted			2022-12-27	WOS:000308788700044
J	Hoevenaar-Blom, MP; Nooyens, ACJ; Kromhout, D; Spijkerman, AMW; Beulens, JWJ; van der Schouw, YT; Bueno-de-Mesquita, B; Verschuren, WMM				Hoevenaar-Blom, Marieke P.; Nooyens, Astrid C. J.; Kromhout, Daan; Spijkerman, Annemieke M. W.; Beulens, Joline W. J.; van der Schouw, Yvonne T.; Bueno-de-Mesquita, Bas; Verschuren, W. M. Monique			Mediterranean Style Diet and 12-Year Incidence of Cardiovascular Diseases: The EPIC-NL Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY QUESTIONNAIRE; FOOD FREQUENCY QUESTIONNAIRE; VENOUS THROMBOEMBOLISM; RELATIVE VALIDITY; MYOCARDIAL-INFARCTION; RISK-FACTORS; 7 COUNTRIES; SURVIVAL; HEALTH	Background: A recent meta-analysis showed that a Mediterranean style diet may protect against cardiovascular diseases (CVD). Studies on disease-specific associations are limited. We evaluated the Mediterranean Diet Score (MDS) in relation to incidence of total and specific CVDs. Methods: The EPIC-NL Study is a cohort of 40,011 men and women aged 20-70 years, examined between 1993 and 1997, with 10-15 years of follow-up. Diet was assessed with a validated food frequency questionnaire and the MDS was based on the daily intakes of vegetables, fruits, legumes and nuts, grains, fish, fatty acids, meat, dairy, and alcohol. Cardiovascular morbidity and mortality were ascertained through linkage with national registries. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CI) adjusted for age, sex, cohort, smoking, physical activity, total energy intake, and educational level. Results: In 34,708 participants free of CVD at baseline, 4881 CVD events occurred, and 487 persons died from CVD. A two unit increment in MDS (range 0-9) was inversely associated with fatal CVD (HR: 0.78; 95% CI: 0.69-0.88), total CVD (HR: 0.95 (0.91-0.98)), myocardial infarction (HR: 0.86 (0.79-0.93)), stroke (HR: 0.88 (0.78-1.00)), and pulmonary embolism (HR: 0.74 (0.59-0.92)). The MDS was not related to incident angina pectoris, transient ischemic attack and peripheral arterial disease. Conclusion: Better adherence to a Mediterranean style diet was more strongly associated with fatal CVD than with total CVD. Disease specific associations were strongest for incident myocardial infarction, stroke and pulmonary embolism.	[Hoevenaar-Blom, Marieke P.; Nooyens, Astrid C. J.; Spijkerman, Annemieke M. W.; Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands; [Hoevenaar-Blom, Marieke P.; Kromhout, Daan] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Beulens, Joline W. J.; van der Schouw, Yvonne T.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bueno-de-Mesquita, Bas] Natl Inst Publ Hlth & Environm, Ctr Nutr & Hlth, NL-3720 BA Bilthoven, Netherlands; [Bueno-de-Mesquita, Bas] Univ Med Ctr, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Wageningen University & Research; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Hoevenaar-Blom, MP (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands.	marieke.hoevenaar@rivm.nl	Hoevenaar-Blom, Maria/AGI-1087-2022; Kromhout, Daan/A-8566-2014; van der Schouw, Yvonne T./F-8327-2014	van der Schouw, Yvonne T./0000-0002-4605-435X; Beulens, Joline/0000-0002-4181-0937	"Europe against Cancer" Programme of the European Commission (SANCO); Dutch Ministry of Health; Dutch Cancer Society; Netherlands Organization for Health Research and Development (ZonMW); World Cancer Research Fund (WCRF); ZonMw [40-00812-98-10040]	"Europe against Cancer" Programme of the European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Health; Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); World Cancer Research Fund (WCRF)(World Cancer Research Fund International (WCRF)); ZonMw(Netherlands Organization for Health Research and Development)	The EPIC-NL study was funded by "Europe against Cancer" Programme of the European Commission (SANCO), the Dutch Ministry of Health, the Dutch Cancer Society, the Netherlands Organization for Health Research and Development (ZonMW), and World Cancer Research Fund (WCRF). The analysis was also supported by a grant of ZonMw; grant no 40-00812-98-10040. None of the study sponsors had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Buckland G, 2009, AM J EPIDEMIOL, V170, P1518, DOI 10.1093/aje/kwp282; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DEBRUIN A, 2003, LINKING DATA NATL AM; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Gardener H, 2011, AM J CLIN NUTR, V94, P1458, DOI 10.3945/ajcn.111.012799; Harteloh P, 2010, EUR J EPIDEMIOL, V25, P531, DOI 10.1007/s10654-010-9445-5; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Joosten MM, 2010, AM J CLIN NUTR, V91, P1777, DOI 10.3945/ajcn.2010.29170; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; KROMHOUT D, 1989, AM J CLIN NUTR, V49, P889, DOI 10.1093/ajcn/49.5.889; Lutsey PL, 2012, AM J EPIDEMIOL, V175, P127, DOI 10.1093/aje/kwr379; Lutsey PL, 2009, AM HEART J, V157, P1081, DOI 10.1016/j.ahj.2009.04.003; Martinez-Gonzalez MA, 2010, NUTR METAB CARDIOVAS; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; Mitrou PN, 2007, ARCH INTERN MED, V167, P2461, DOI 10.1001/archinte.167.22.2461; Nordmann AJ, 2011, AM J MED, V124, P841, DOI 10.1016/j.amjmed.2011.04.024; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Steffen LM, 2007, CIRCULATION, V115, P188, DOI 10.1161/CIRCULATIONAHA.106.641688; Trichopoulou A, 2005, ARCH INTERN MED, V165, P929, DOI 10.1001/archinte.165.8.929; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; Varraso R, 2012, AM J EPIDEMIOL, V175, P114, DOI 10.1093/aje/kwr377; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; World Health Organization, 1977, INT CLASS DIS; World Health Organization, 1990, INT CLASS DIS, V10th; Zarraga IGE, 2006, CIRCULATION, V114, P961, DOI 10.1161/CIRCULATIONAHA.105.603910	34	93	95	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45458	10.1371/journal.pone.0045458	http://dx.doi.org/10.1371/journal.pone.0045458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029021	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900042
J	Der, G; Batty, GD; Benzeval, M; Deary, IJ; Green, MJ; McGlynn, L; McIntyre, A; Robertson, T; Shiels, PG				Der, Geoff; Batty, G. David; Benzeval, Michaela; Deary, Ian J.; Green, Michael J.; McGlynn, Liane; McIntyre, Alan; Robertson, Tony; Shiels, Paul G.			Is Telomere Length a Biomarker for Aging: Cross-Sectional Evidence from the West of Scotland?	PLOS ONE			English	Article							SELF-RATED HEALTH; AGE; MORTALITY; ASSOCIATION; NO	Background: The search for biomarkers of aging (BoAs) has been largely unsuccessful to-date and there is widespread skepticism about the prospects of finding any that satisfy the criteria developed by the American Federation of Aging Research. This may be because the criteria are too strict or because a composite measure might be more appropriate. Telomere length has attracted a great deal of attention as a candidate BoA. We investigate whether it meets the criteria to be considered as a single biomarker of aging, and whether it makes a useful contribution to a composite measure. Methodology/Principal Findings: Using data from a large population based study, we show that telomere length is associated with age, with several measures of physical and cognitive functioning that are related to normal aging, and with three measures of overall health. In the majority of cases, telomere length adds predictive power to that of age, although it was not nearly as good a predictor overall. We used principal components analysis to form two composites from the measures of functioning, one including telomere length and the other not including it. These composite BoAs were better predictors of the health outcomes than chronological age. There was little difference between the two composites. Conclusions: Telomere length does not satisfy the strict criteria for a BoA, but does add predictive power to that of chronological age. Equivocal results from previous studies might be due to lack of power or the choice of measures examined together with a focus on single biomarkers. Composite biomarkers of aging have the potential to outperform age and should be considered for future research in this area.	[Der, Geoff; Benzeval, Michaela; Green, Michael J.; Robertson, Tony] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [McGlynn, Liane; McIntyre, Alan; Shiels, Paul G.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Der, Geoff; Batty, G. David; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Edinburgh; University of London; University College London	Der, G (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	G.Der@sphsu.mrc.ac.uk	Benzeval, Michaela/J-3163-2015; Robertson, Tony/B-2731-2012; Robertson, Tony/L-5062-2015; Deary, Ian J/C-6297-2009; Batty, GD/Y-4401-2018	Benzeval, Michaela/0000-0002-0372-2098; Robertson, Tony/0000-0002-1962-5874; Deary, Ian J/0000-0002-1733-263X; Batty, GD/0000-0003-1822-5753; Green, Michael/0000-0003-3193-2452; Der, Geoff/0000-0002-8677-073X; Shiels, Paul/0000-0002-7577-9843	UK Medical Research Council (MRC) [WBS MC_US_A540_0080]; MRC [WBS MC_US_A540_0080]; UK research council call for Lifelong Health and Wellbeing [G0700704/84698]; Medical Research Council [MC_U130059821, G0700704B, MC_UP_A540_1021, MC_U130059823, G0700704] Funding Source: researchfish; Chief Scientist Office [SPHSU2] Funding Source: researchfish; MRC [MC_U130059821, MC_UP_A540_1021, MC_U130059823, G0700704] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK research council call for Lifelong Health and Wellbeing; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The West of Scotland Twenty-07 Study is funded by the UK Medical Research Council (MRC) (WBS MC_US_A540_0080) and the data were originally collected by the MRC Social and Public Health Sciences Unit. G. Der, M. Benzeval, M. Green, and T. Robertson are funded by the MRC (WBS MC_US_A540_0080). The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology is funded as part of the joint UK research council call for Lifelong Health and Wellbeing (G0700704/84698). G. David Batty is a Wellcome Trust Fellow. The funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER GT, 1988, EXP GERONTOL, V23, P223, DOI 10.1016/0531-5565(88)90025-3; Bendix L, 2011, MECH AGEING DEV, V132, P568, DOI 10.1016/j.mad.2011.10.003; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Deary I, 2001, INTELLIGENCE, V29, P1; Deary IJ, 2011, BEHAV RES METHODS, V43, P258, DOI 10.3758/s13428-010-0024-1; Der G., 1998, COMP W SCOTLAND 20 0; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Gore, 1987, HLTH LIFESTYLE SURVE; Harris SE, 2006, NEUROSCI LETT, V406, P260, DOI 10.1016/j.neulet.2006.07.055; Harris SE, 2010, NEUROBIOL AGING; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Heim A., 1970, MANUAL AH4 GROUP TES; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006; Martin-Ruiz C, 2011, MECH AGEING DEV, V132, P496, DOI 10.1016/j.mad.2011.08.001; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Mather KA, 2010, J GERONTOL A-BIOL, V65, P792, DOI 10.1093/gerona/glq050; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Peto R, 1997, BRIT MED J, V315, P1030, DOI 10.1136/bmj.315.7115.1030; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2005, CURR MOL MED, V5, P197; von Zglinicki T, 2012, BMJ, V344; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Yaffe K., 2009, NEUROBIOL AGING	26	40	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45166	10.1371/journal.pone.0045166	http://dx.doi.org/10.1371/journal.pone.0045166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028820	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000309554700027
J	Laug, R; Fehrholz, M; Schutze, N; Kramer, BW; Krump-Konvalinkova, V; Speer, CP; Kunzmann, S				Laug, Roderich; Fehrholz, Markus; Schuetze, Norbert; Kramer, Boris W.; Krump-Konvalinkova, Vera; Speer, Christian P.; Kunzmann, Steffen			IFN-gamma and TNF-alpha Synergize to Inhibit CTGF Expression in Human Lung Endothelial Cells	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; NECROSIS-FACTOR-ALPHA; INTERFERON-GAMMA; GENE-EXPRESSION; DOWN-REGULATION; IN-VITRO; T-CELLS; ALLERGIC RESPONSES; TGF-BETA	Connective tissue growth factor (CTGF/CCN2) is an angiogenetic and profibrotic factor, acting downstream of TGF-beta, involved in both airway-and vascular remodeling. While the T-helper 1 (Th1) cytokine interferon-gamma (IFN-gamma) is well characterized as immune-modulatory and anti-fibrotic cytokine, the role of IFN-gamma in lung endothelial cells (LEC) is less defined. Tumour necrosis factor alpha (TNF-alpha) is another mediator that drives vascular remodeling in inflammation by influencing CTGF expression. In the present study we investigated the influence of IFN-gamma and TNF-alpha on CTGF expression in human LEC (HPMEC-ST1.6R) and the effect of CTGF knock down on human LEC. IFN-gamma and TNF-alpha down-regulated CTGF in human LEC at the promoter-, transcriptional-and translational-level in a dose-and time-dependent manner. The inhibitory effect of IFN-gamma on CTGF-expression could be almost completely compensated by the Jak inhibitor AG-490, showing the involvement of the Jak-Stat signaling pathway. Besides the inhibitory effect of IFN-gamma and TNF-alpha alone on CTGF expression and LEC proliferation, these cytokines had an additive inhibitory effect on proliferation as well as on CTGF expression when administered together. To study the functional role of CTGF in LEC, endogenous CTGF expression was down-regulated by a lentiviral system. CTGF silencing in LEC by transduction of CTGF shRNA reduced cell proliferation, but did not influence the anti-proliferative effect of IFN-gamma and TNF-alpha. In conclusion, our data demonstrated that CTGF was negatively regulated by IFN-gamma in LEC in a Jak/Stat signaling pathway-dependent manner. In addition, an additive effect of IFN-gamma and TNF-alpha on inhibition of CTGF expression and cell proliferation could be found. The inverse correlation between IFN-gamma and CTGF expression in LEC could mean that screwing the Th2 response to a Th1 response with an additional IFN-gamma production might be beneficial to avoid airway remodeling in asthma.	[Fehrholz, Markus; Speer, Christian P.; Kunzmann, Steffen] Univ Wurzburg, Childrens Hosp, Wurzburg, Germany; [Laug, Roderich; Schuetze, Norbert] Univ Wurzburg, Orthoped Ctr Musculoskeletal Res, Wurzburg, Germany; [Kramer, Boris W.] Univ Hosp Maastricht, Dept Pediat, Maastricht, Netherlands; [Krump-Konvalinkova, Vera] Univ Munich, Inst Prevent Cardiovasc Dis, Munich, Germany	University of Wurzburg; University of Wurzburg; Maastricht University; Maastricht University Medical Centre (MUMC); University of Munich	Kunzmann, S (corresponding author), Univ Wurzburg, Childrens Hosp, Wurzburg, Germany.	kunzmann_s@kinderklinik.uni-wuerzburg.de	Kramer, Boris/AAO-3183-2021		Deutsche Forschungsgemeinschaft (DFG) [KU 1403/2-1]; Interdisciplinary Center for Clinical Research, University of Wurzburg [IZKF Z-08, A-58]; German Research Foundation (DFG); University of Wuerzburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research, University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant KU 1403/2-1, Interdisciplinary Center for Clinical Research, University of Wurzburg, Grant IZKF Z-08 and A-58. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Barbara Ottensmeier for the excellent technical work and Iliana Bersani for helping preparing the manuscript. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.	Angiolillo AL, 1996, ANN NY ACAD SCI, V795, P158, DOI 10.1111/j.1749-6632.1996.tb52664.x; Asosingh K, 2007, J IMMUNOL, V178, P6482, DOI 10.4049/jimmunol.178.10.6482; Asosingh K, 2009, BIOCHEM SOC T, V37, P805, DOI 10.1042/BST0370805; Baluk P, 2009, J CLIN INVEST, V119, P2954, DOI 10.1172/JCI37626; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; BOGUNIEWICZ M, 1995, J ALLERGY CLIN IMMUN, V95, P133, DOI 10.1016/S0091-6749(95)70162-1; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Burgess JK, 2005, CLIN EXP PHARMACOL P, V32, P988, DOI 10.1111/j.1440-1681.2005.04296.x; Burgess JK, 2003, AM J RESP CRIT CARE, V167, P71, DOI 10.1164/rccm.200205-416OC; CEMBRZYNSKANOWAK M, 1993, AM REV RESPIR DIS, V147, P291, DOI 10.1164/ajrccm/147.2.291; Cooker LA, 2007, AM J PHYSIOL-RENAL, V293, pF157, DOI 10.1152/ajprenal.00508.2006; Drew PD, 1995, J INTERF CYTOK RES, V15, P1037, DOI 10.1089/jir.1995.15.1037; Fitzner B, 2007, CELL SIGNAL, V19, P782, DOI 10.1016/j.cellsig.2006.10.002; FRIESEL R, 1987, J CELL BIOL, V104, P689, DOI 10.1083/jcb.104.3.689; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; GURUJEYALAKSHMI G, 1995, EXP LUNG RES, V21, P791, DOI 10.3109/01902149509050842; Hansen G, 1999, J CLIN INVEST, V103, P175, DOI 10.1172/JCI5155; Hardaker EL, 2004, FASEB J, V18, P191, DOI 10.1096/fj.03-0170fje; Hessel EM, 1997, AM J RESP CELL MOL, V16, P325, DOI 10.1165/ajrcmb.16.3.9070618; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Ishibuchi H, 2010, EXP DERMATOL, V19, pE111, DOI 10.1111/j.1600-0625.2009.00999.x; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Lack G, 1996, J IMMUNOL, V157, P1432; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li Q, 2008, SICHUAN DA XUE XUE B, V39, P943; Li Qin, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P895; Li X, 1997, AM J RESP CRIT CARE, V156, P229, DOI 10.1164/ajrccm.156.1.9607066; Li XM, 1996, J IMMUNOL, V157, P3216; Lin J, 1998, CARDIOVASC RES, V38, P802, DOI 10.1016/S0008-6363(98)00055-8; Liu Jia-qi, 2009, Zhonghua Shao Shang Za Zhi, V25, P454; Liu Xiaojing, 2008, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V25, P407; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAHESHWARI RK, 1991, J CELL PHYSIOL, V146, P164, DOI 10.1002/jcp.1041460121; Matsuda A, 2008, AM J RESP CELL MOL, V38, P168, DOI 10.1165/rcmb.2007-0162OC; Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618; Naldini A, 2003, CURR PHARM DESIGN, V9, P511, DOI 10.2174/1381612033391423; PRIOR C, 1991, AM REV RESPIR DIS, V143, P53, DOI 10.1164/ajrccm/143.1.53; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; Renzi PM, 1999, AM J RESP CRIT CARE, V159, P1417, DOI 10.1164/ajrccm.159.5.9805080; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; SATO N, 1990, J INVEST DERMATOL, V95, pS85, DOI 10.1111/1523-1747.ep12874809; Schmidt-Weber Carsten B, 2002, Curr Allergy Asthma Rep, V2, P259, DOI 10.1007/s11882-002-0028-8; Sobral LM, 2007, J CLIN PERIODONTOL, V34, P397, DOI 10.1111/j.1600-051X.2007.01063.x; Stewart RJ, 1996, J IMMUNOL, V156, P1221; TANG MLK, 1995, CLIN EXP ALLERGY, V25, P515, DOI 10.1111/j.1365-2222.1995.tb01088.x; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; TSURUOKA N, 1988, BIOCHEM BIOPH RES CO, V155, P429, DOI 10.1016/S0006-291X(88)81104-5; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; Villacorta L, 2003, CIRC RES, V92, P104, DOI 10.1161/01.RES.0000049103.38175.1B; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Ziesche R, 1999, NEW ENGL J MED, V341, P1264, DOI 10.1056/NEJM199910213411703	56	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45430	10.1371/journal.pone.0045430	http://dx.doi.org/10.1371/journal.pone.0045430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029004	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388900051
J	Aporta, A; Arbues, A; Aguilo, JI; Monzon, M; Badiola, JJ; de Martino, A; Ferrer, N; Marinova, D; Anel, A; Martin, C; Pardo, J				Aporta, Adriana; Arbues, Ainhoa; Aguilo, Juan I.; Monzon, Marta; Badiola, Juan J.; de Martino, Alba; Ferrer, Nadia; Marinova, Dessislava; Anel, Alberto; Martin, Carlos; Pardo, Julian			Attenuated Mycobacterium tuberculosis SO2 Vaccine Candidate Is Unable to Induce Cell Death	PLOS ONE			English	Article							DIFFERENTIAL INDUCTION; MACROPHAGE APOPTOSIS; PROTECTIVE IMMUNITY; ADAPTIVE IMMUNITY; PHOP MUTANT; NECROSIS; BACTERIAL; INFECTION; VIRULENCE; BCG	It has been proposed that Mycobacterium tuberculosis virulent strains inhibit apoptosis and trigger cell death by necrosis of host macrophages to evade innate immunity, while non-virulent strains induce typical apoptosis activating a protective host response. As part of the characterization of a novel tuberculosis vaccine candidate, the M. tuberculosis phoP mutant SO2, we sought to evaluate its potential to induce host cell death. The parental M. tuberculosis MT103 strain and the current vaccine against tuberculosis Bacillus Calmette-Guerin (BCG) were used as comparators in mouse models in vitro and in vivo. Our data reveal that attenuated SO2 was unable to induce apoptotic events neither in mouse macrophages in vitro nor during lung infection in vivo. In contrast, virulent MT103 triggers typical apoptotic events with phosphatidylserine exposure, caspase-3 activation and nuclear condensation and fragmentation. BCG strain behaved like SO2 and did not induce apoptosis. A clonogenic survival assay confirmed that viability of BCG- or SO2-infected macrophages was unaffected. Our results discard apoptosis as the protective mechanism induced by SO2 vaccine and provide evidence for positive correlation between classical apoptosis induction and virulent strains, suggesting apoptosis as a possible virulence determinant during M. tuberculosis infection.	[Pardo, Julian] Gobierno Aragon, Fdn Aragon I D ARAID, Zaragoza, Spain; [Aporta, Adriana; Anel, Alberto] Univ Zaragoza, Fac Ciencias, Dpto Bioquim & Biol Mol & Celular, Grp Apoptosis Inmunidad & Canc, E-50009 Zaragoza, Spain; [Arbues, Ainhoa; Aguilo, Juan I.; Ferrer, Nadia; Marinova, Dessislava; Martin, Carlos] Univ Zaragoza, Fac Med, Dpto Microbiol Med Prevent & Salud Publ, Grp Genet Micobacterias, Zaragoza, Spain; [Arbues, Ainhoa; Aguilo, Juan I.; Marinova, Dessislava; Martin, Carlos] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Monzon, Marta; Badiola, Juan J.] Univ Zaragoza, Res Ctr Encephalopathies & Transmissible Emerging, Zaragoza, Spain; [de Martino, Alba] IIS Aragon, Unidad Anat Patol, Zaragoza, Spain; [Martin, Carlos] IIS Aragon, Hosp Univ Miguel Servet, Microbiol Serv, Zaragoza, Spain; [Pardo, Julian] Univ Zaragoza, INA, Zaragoza, Spain; [Pardo, Julian] Univ Zaragoza, Fac Ciencias, Dpto Bioquim & Biol Mol & Celular, Grp Inmunidad Celular Efectora ICE,IIS Aragon, E-50009 Zaragoza, Spain	University of Zaragoza; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Zaragoza; Miguel Servet University Hospital; University of Zaragoza; University of Zaragoza	Pardo, J (corresponding author), Gobierno Aragon, Fdn Aragon I D ARAID, Zaragoza, Spain.	pardojim@unizar.es	MONZÓN, MARTA/R-6162-2017; AGUILO, NACHO/K-2750-2014; Pardo, Julián/K-6764-2014; Anel, Alberto/Z-3068-2019; Martin, Carlos/A-7283-2008	MONZÓN, MARTA/0000-0002-2787-9671; AGUILO, NACHO/0000-0001-7897-9173; Pardo, Julián/0000-0003-0154-0730; Martin, Carlos/0000-0003-2993-5478; De Martino Rodriguez, Alba/0000-0002-2436-9852	Spanish Ministery of Science and Innovation [SAF2007-65144, BIO2008-01561, BIO2011-23555, SAF2008-02139, SAF2011-25390]; grant FP7 European NEWTBVAC [241745]; Aragon I+D Foundation (ARAID); Cuenca Villoro Foundation;  [BES-2006-11950]	Spanish Ministery of Science and Innovation(European Commission); grant FP7 European NEWTBVAC; Aragon I+D Foundation (ARAID)(Gobierno de Aragon); Cuenca Villoro Foundation; 	This work was supported by grant SAF2007-65144 (AA), BIO2008-01561 (CM), BIO2011-23555 (CM), SAF2008-02139 (JP), and SAF2011-25390 (JP) from the Spanish Ministery of Science and Innovation and grant FP7 European NEWTBVAC 241745. Julian Pardo was supported by Aragon I+D Foundation (ARAID), Adriana Aporta was supported by a fellowship from Cuenca Villoro Foundation and Ainhoa Arbues by BES-2006-11950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Arcila ML, 2007, CELL IMMUNOL, V249, P80, DOI 10.1016/j.cellimm.2007.11.006; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Behar SM, 2011, MICROBES INFECT, V13, P749, DOI 10.1016/j.micinf.2011.03.002; Blomgran R, 2012, CELL HOST MICROBE, V11, P81, DOI 10.1016/j.chom.2011.11.012; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Cardona PJ, 2009, VACCINE, V27, P2499, DOI 10.1016/j.vaccine.2009.02.060; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; Danelishvili L, 2003, CELL MICROBIOL, V5, P649, DOI 10.1046/j.1462-5822.2003.00312.x; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fayyazi A, 2000, J PATHOL, V191, P417, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH664&gt;3.0.CO;2-R; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Ferrer NL, 2009, MICROBES INFECT, V11, P115, DOI 10.1016/j.micinf.2008.10.013; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gil DP, 2004, J INFECT DIS, V189, P2120, DOI 10.1086/386369; Gonzalo-Asensio J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003496; Grover A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040836; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Herbst S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019105; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kim SO, 2001, J ENDOTOXIN RES, V7, P292, DOI 10.1179/096805101101532873; Kim SO, 2001, AM J PHYSIOL-LUNG C, V281, pL1095, DOI 10.1152/ajplung.2001.281.5.L1095; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018367; Lee J, 2009, YONSEI MED J, V50, P1, DOI 10.3349/ymj.2009.50.1.1; Leong ASY, 2008, J CLIN PATHOL, V61, P366, DOI 10.1136/jcp.2007.050690; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Monack D, 2000, INT J MED MICROBIOL, V290, P7; Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249; Nambiar JK, 2012, EUR J IMMUNOL, V42, P385, DOI 10.1002/eji.201141903; Oddo M, 1998, J IMMUNOL, V160, P5448; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Rojas M, 1997, J IMMUNOL, V159, P1352; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Seimon TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012772; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Valle E, 2005, INFECT IMMUN, V73, P2835, DOI 10.1128/IAI.73.5.2835-2840.2005; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Welin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020302	59	24	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45213	10.1371/journal.pone.0045213	http://dx.doi.org/10.1371/journal.pone.0045213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028853	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400066
J	Garbin, G; Collina, S; Tabossi, P				Garbin, Gabriele; Collina, Simona; Tabossi, Patrizia			Argument Structure and Morphological Factors in Noun and Verb Processing: An fMRI Study	PLOS ONE			English	Article							GRAMMATICAL CLASS; NEURAL REPRESENTATION; BRAIN; DISSOCIATION; RETRIEVAL; EVENTS	In a functional MRI (fMRI) study, we have investigated the grammatical categories of object noun, event noun and verb in order to assess the cortical regions of activation supporting their processing. Twelve Italian healthy participants performed a lexical decision task. They had to decide whether a string was an Italian word or not. Words could be objects like medaglia (medal), or events like the noun pianto (cry); or the verb dormire (to sleep). Noun and verb comparison shows differences in regions of activation in the left Inferior Frontal cortex and in the extent of the same areas. We have found specific areas of activation for object noun, and similarities in the pattern of activation for event noun and verb. The activations induced by pseudowords highly resembled the areas activated by the corresponding word category. The implications of the results are discussed in light of the recent debate on the role of grammatical category in the brain.	[Garbin, Gabriele; Tabossi, Patrizia] Univ Trieste, Dept Psychol, Trieste, Italy; [Collina, Simona] Suor Orsola Benincasa Univ, Dept Psychol, Naples, Italy	University of Trieste; Suor Orsola Benincasa University Naples	Garbin, G (corresponding author), Univ Trieste, Dept Psychol, Trieste, Italy.	g@gabrielegarbin.it			Italian Ministry of University and Research (MiUR) [2008P3WB4P-003]	Italian Ministry of University and Research (MiUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Italian Ministry of University and Research (MiUR), Prot. no. 2008P3WB4P-003 to Patrizia Tabossi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedny M, 2006, BRAIN LANG, V98, P127, DOI 10.1016/j.bandl.2006.04.008; Berlingeri M, 2008, COGN NEUROPSYCHOL, V25, P528, DOI 10.1080/02643290701674943; Cappa SF, 1998, NEUROLOGY, V50, P351, DOI 10.1212/WNL.50.2.351; CARAMAZZA A, 1991, NATURE, V349, P788, DOI 10.1038/349788a0; Collina S, 2001, NEUROPSYCHOLOGIA, V39, P1125, DOI 10.1016/S0028-3932(01)00058-6; DAMASIO AR, 1993, P NATL ACAD SCI USA, V90, P4957, DOI 10.1073/pnas.90.11.4957; DANIELE A, 1994, NEUROPSYCHOLOGIA, V32, P1325, DOI 10.1016/0028-3932(94)00066-2; Frackowiak R.S.J., 2004, HUMAN BRAIN FUNCTION, V2nd ed, P793, DOI [10.1016/B978-012264841-0/50042-1, DOI 10.1016/B978-012264841-0/50042-1]; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Fujimaki N, 1999, HUM BRAIN MAPP, V8, P44, DOI 10.1002/(SICI)1097-0193(1999)8:1<44::AID-HBM4>3.0.CO;2-#; Graffi S, 1994, STRUTTURE LINGUAGGIO; Henson R., 2000, NEUROIMAGE, V11, P468, DOI [10.1016/ S1053- 8119( 00) 91399- 5, DOI 10.1016/S1053-8119(00)91399-5]; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; Laiacona M, 2004, COGN NEUROPSYCHOL, V21, P103, DOI 10.1080/02643290342000311; Liao CH, 2002, NEUROIMAGE, V16, P593, DOI 10.1006/nimg.2002.1096; MCCARTHY R, 1985, NEUROPSYCHOLOGIA, V23, P709, DOI 10.1016/0028-3932(85)90079-X; MICELI G, 1988, APHASIOLOGY, V2, P351, DOI 10.1080/02687038808248937; MICELI G, 1984, CORTEX, V20, P207, DOI 10.1016/S0010-9452(84)80038-6; Miceli G., 1994, BATTERIA LANALISI DE; Perani D, 1999, BRAIN, V122, P2337, DOI 10.1093/brain/122.12.2337; Pernet C, 2005, SPM2 USER GUIDE FMRI; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; Sahin NT, 2006, CORTEX, V42, P540, DOI 10.1016/S0010-9452(08)70394-0; Shapiro K, 2003, TRENDS COGN SCI, V7, P201, DOI 10.1016/S1364-6613(03)00060-3; Shapiro K, 2000, COGNITIVE NEUROPSYCH, V17, P665, DOI 10.1080/026432900750038281; Shapiro KA, 2005, NEUROIMAGE, V24, P1058, DOI 10.1016/j.neuroimage.2004.10.015; Shapiro KA, 2006, P NATL ACAD SCI USA, V103, P1644, DOI 10.1073/pnas.0504142103; Silveri MC, 1997, NEUROCASE, V3, P477, DOI 10.1093/neucas/3.6.477; Siri S, 2008, CEREB CORTEX, V18, P171, DOI 10.1093/cercor/bhm043; Tabossi P, 2010, COGN NEUROPSYCHOL, V27, P152, DOI 10.1080/02643294.2010.507945; Tyler LK, 2008, J COGNITIVE NEUROSCI, V20, P1381, DOI 10.1162/jocn.2008.20095; Tyler LK, 2004, NEUROPSYCHOLOGIA, V42, P512, DOI 10.1016/j.neuropsychologia.2003.10.001; Tyler LK, 2001, BRAIN, V124, P1619, DOI 10.1093/brain/124.8.1619; Vigliocco G, 2005, COGNITION, V94, pB91, DOI 10.1016/j.cognition.2004.06.004; Vigliocco G, 2008, BRAIN LANG, V105, P175, DOI 10.1016/j.bandl.2007.10.003; Vigliocco G, 2006, CEREB CORTEX, V16, P1790, DOI 10.1093/cercor/bhj115; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Warburton E, 1996, BRAIN, V119, P159, DOI 10.1093/brain/119.1.159	38	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45091	10.1371/journal.pone.0045091	http://dx.doi.org/10.1371/journal.pone.0045091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028775	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900077
J	Serrao, E; Thys, W; Demeulemeester, J; Al-Mawsawi, LQ; Christ, F; Debyser, Z; Neamati, N				Serrao, Erik; Thys, Wannes; Demeulemeester, Jonas; Al-Mawsawi, Laith Q.; Christ, Frauke; Debyser, Zeger; Neamati, Nouri			A Symmetric Region of the HIV-1 Integrase Dimerization Interface Is Essential for Viral Replication	PLOS ONE			English	Article							VIRUS TYPE-1 INTEGRASE; SMALL-MOLECULE INHIBITORS; N-TERMINAL DOMAIN; PEPTIDE INHIBITORS; INFECTED INDIVIDUALS; GENE-EXPRESSION; BINDING DOMAIN; IN-VITRO; T-CELLS; DESIGN	HIV-1 integrase (IN) is an important target for contemporary antiretroviral drug design research. Historically, efforts at inactivating the enzyme have focused upon blocking its active site. However, it has become apparent that new classes of allosteric inhibitors will be necessary to advance the antiretroviral field in light of the emergence of viral strains resistant to contemporary clinically used IN drugs. In this study we have characterized the importance of a close network of IN residues, distant from the active site, as important for the obligatory multimerization of the enzyme and viral replication as a whole. Specifically, we have determined that the configuration of six residues within a highly symmetrical region at the IN dimerization interface, composed of a four-tiered aromatic interaction flanked by two salt bridges, significantly contributes to proper HIV-1 replication. Additionally, we have utilized a quantitative luminescence assay to examine IN oligomerization and have determined that there is a very low tolerance for amino acid substitutions along this region. Even conservative residue substitutions negatively impacted IN multimerization, resulting in an inactive viral enzyme and a non-replicative virus. We have shown that there is a very low tolerance for amino acid variation at the symmetrical dimeric interface region characterized in this study, and therefore drugs designed to target the amino acid network detailed here could be expected to yield a significantly reduced number of drug-resistant escape mutations compared to contemporary clinically-evaluated antiretrovirals.	[Serrao, Erik; Al-Mawsawi, Laith Q.; Neamati, Nouri] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Thys, Wannes; Demeulemeester, Jonas; Christ, Frauke; Debyser, Zeger] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, Div Mol Med, Flanders, Belgium	University of Southern California; KU Leuven	Neamati, N (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	Neamati@usc.edu	Christ, Frauke/H-7513-2018; Demeulemeester, Jonas/J-6130-2014	Demeulemeester, Jonas/0000-0002-2660-2478; Christ, Frauke/0000-0001-9580-3874	NIH/NIAID [R21 AI081610]; Oakley Endowed Fellowship, University of Southern California; Fonds Voor Weten Schapelijke Onderzoek (FWO); Industrieel Onderzoeks Fond (IOF); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081610] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Oakley Endowed Fellowship, University of Southern California; Fonds Voor Weten Schapelijke Onderzoek (FWO); Industrieel Onderzoeks Fond (IOF); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was financially supported by funds from an NIH/NIAID (R21 AI081610) grant. ES was funded by the Oakley Endowed Fellowship, University of Southern California; JD was funded from the Fonds Voor Weten Schapelijke Onderzoek (FWO); and FC was funded by the Industrieel Onderzoeks Fond (IOF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelMalek S, 1996, J ETHNOPHARMACOL, V50, P157, DOI 10.1016/0378-8741(96)01380-3; Al-Mawsawi LQ, 2008, VIROLOGY, V377, P353, DOI 10.1016/j.virol.2008.04.030; Al-Mawsawi LQ, 2006, P NATL ACAD SCI USA, V103, P10080, DOI 10.1073/pnas.0511254103; Armon-Omer A, 2008, J MOL BIOL, V376, P971, DOI 10.1016/j.jmb.2007.11.095; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 2003, P NATL ACAD SCI USA, V100, P1908, DOI 10.1073/pnas.0437640100; Coiras M, 2010, AIDS REV, V12, P103; De Luca L, 2009, CHEMMEDCHEM, V4, P1311, DOI 10.1002/cmdc.200900070; De Rijck J, 2007, BIOESSAYS, V29, P441, DOI 10.1002/bies.20561; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Demeulemeester J., 2012, J BIOMOL SCREEN; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; ENGELMAN A, 1992, J VIROL, V66, P6361, DOI 10.1128/JVI.66.11.6361-6369.1992; FARNET CM, 1991, J VIROL, V65, P1910, DOI 10.1128/JVI.65.4.1910-1915.1991; Fitzkee NC, 2011, PROTEIN SCI, V20, P500, DOI 10.1002/pro.582; Fitzkee NC, 2010, J BIOL CHEM, V285, P18072, DOI 10.1074/jbc.M110.113407; Fletcher TM, 1997, EMBO J, V16, P5123, DOI 10.1093/emboj/16.16.5123; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Gijsbers R, 2010, MOL THER, V18, P552, DOI 10.1038/mt.2010.36; Hamamoto S, 2006, J VIROL, V80, P5670, DOI 10.1128/JVI.02471-05; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Kinoshita S, 1998, CELL, V95, P595, DOI 10.1016/S0092-8674(00)81630-X; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kong R, 2005, P ANN INT IEEE EMBS, P4743, DOI 10.1109/IEMBS.2005.1615531; Krajewski K, 2004, BIOORG MED CHEM LETT, V14, P5595, DOI 10.1016/j.bmcl.2004.08.061; Krajewski K, 2003, BIOORG MED CHEM LETT, V13, P3203, DOI 10.1016/S0960-894X(03)00679-6; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Lee SP, 1997, BIOCHEMISTRY-US, V36, P173, DOI 10.1021/bi961849o; Li HY, 2006, J MED CHEM, V49, P4477, DOI 10.1021/jm060307u; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maroun RG, 2001, BIOCHEMISTRY-US, V40, P13840, DOI 10.1021/bi011328n; Mouscadet JF, 2010, DRUG RESIST UPDATE, V13, P139, DOI 10.1016/j.drup.2010.05.001; Mouscadet JF, 2009, EUR J MED RES, V14, P5, DOI 10.1186/2047-783X-14-S3-5; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; PAUZA CD, 1990, VIROLOGY, V179, P886; Ramkumar K, 2010, MED RES REV, V30, P890, DOI 10.1002/med.20194; Robinson WE, 1998, J LEUKOCYTE BIOL, V63, P94, DOI 10.1002/jlb.63.1.94; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Serrao E, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-25; Sippel M, 2010, J CHEM INF MODEL, V50, P604, DOI 10.1021/ci900403s; Sluis-Cremer N, 2002, EUR J BIOCHEM, V269, P5103, DOI 10.1046/j.1432-1033.2002.03216.x; Tardif MR, 2005, J VIROL, V79, P4316, DOI 10.1128/JVI.79.7.4316-4328.2005; Tintori C, 2012, BIOORG MED CHEM LETT; van den Ent FMI, 1998, J VIROL, V72, P3916, DOI 10.1128/JVI.72.5.3916-3924.1998; van den Ent FMI, 1999, J VIROL, V73, P3176, DOI 10.1128/JVI.73.4.3176-3183.1999; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Wu XY, 1999, J VIROL, V73, P2126, DOI 10.1128/JVI.73.3.2126-2135.1999; Yerly S, 2000, AIDS, V14, P2805, DOI 10.1097/00002030-200012220-00001; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao L, 2003, BIOORG MED CHEM LETT, V13, P1175, DOI 10.1016/S0960-894X(03)00040-4; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	62	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45177	10.1371/journal.pone.0045177	http://dx.doi.org/10.1371/journal.pone.0045177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028829	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900092
J	Yu, Y; Kita, A; Udo, M; Katayama, Y; Shintani, M; Park, K; Hagihara, K; Umeda, N; Sugiura, R				Yu, Yang; Kita, Ayako; Udo, Masako; Katayama, Yuta; Shintani, Mami; Park, Kwihwa; Hagihara, Kanako; Umeda, Nanae; Sugiura, Reiko			Sip1, a Conserved AP-1 Accessory Protein, Is Important for Golgi/Endosome Trafficking in Fission Yeast	PLOS ONE			English	Article							TYROSINE KINASE SUBSTRATE; DOMAIN-CONTAINING PROTEIN; GDP-MANNOSE TRANSPORTER; SCHIZOSACCHAROMYCES-POMBE; GAMMA-ADAPTIN; SACCHAROMYCES-CEREVISIAE; VESICLE TRAFFICKING; DISTINCT PHENOTYPES; SECRETORY PATHWAY; CELL INTEGRITY	We had previously identified the mutant allele of apm1(+) that encodes a homolog of the mammalian mu 1A subunit of the clathrin-associated adaptor protein-1 (AP-1) complex and demonstrated that the AP-1 complex plays a role in Golgi/endosome trafficking, secretion, and vacuole fusion in fission yeast. Here, we isolated a mutant allele of its4(+)/sip1(+), which encodes a conserved AP-1 accessory protein. The its4-1/sip1-i4 mutants and apm1-deletion cells exhibited similar phenotypes, including sensitivity to the calcineurin inhibitor FK506, Cl- and valproic acid as well as various defects in Golgi/endosomal trafficking and cytokinesis. Electron micrographs of sip1-i4 mutants revealed vacuole fragmentation and accumulation of abnormal Golgi-like structures and secretory vesicles. Overexpression of Apm1 suppressed defective membrane trafficking in sip1-i4 mutants. The Sip1-green fluorescent protein (GFP) co-localized with Apm1-mCherry at Golgi/endosomes, and Sip1 physically interacted with each subunit of the AP-1 complex. We found that Sip1 was a Golgi/endosomal protein and the sip1-i4 mutation affected AP-1 localization at Golgi/endosomes, thus indicating that Sip1 recruited the AP-1 complex to endosomal membranes by physically interacting with each subunit of this complex. Furthermore, Sip1 is required for the correct localization of Bgs1/Cps1, 1,3-beta-D-glucan synthase to polarized growth sites. Consistently, the sip1-i4 mutants displayed a severe sensitivity to micafungin, a potent inhibitor of 1,3-beta-D-glucan synthase. Taken together, our findings reveal a role for Sip1 in the regulation of Golgi/endosome trafficking in coordination with the AP-1 complex, and identified Bgs1, required for cell wall synthesis, as the new cargo of AP-1-dependent trafficking.	[Yu, Yang; Kita, Ayako; Udo, Masako; Katayama, Yuta; Shintani, Mami; Park, Kwihwa; Hagihara, Kanako; Umeda, Nanae; Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 577, Japan	Kindai University (Kinki University)	Sugiura, R (corresponding author), Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 577, Japan.	sugiurar@phar.kindai.ac.jp		Hagihara, Kanako/0000-0002-9366-6172	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to R. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1999, FEBS LETT, V458, P309, DOI 10.1016/S0014-5793(99)01177-1; Abe M, 2004, J CELL SCI, V117, P5687, DOI 10.1242/jcs.01491; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; Cortes JCG, 2007, MOL MICROBIOL, V65, P201, DOI 10.1111/j.1365-2958.2007.05784.x; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Deng L, 2005, J BIOL CHEM, V280, P27561, DOI 10.1074/jbc.M502660200; Edamatsu M, 2003, BIOCHEM BIOPH RES CO, V301, P641, DOI 10.1016/S0006-291X(03)00017-2; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Fernandez GE, 2006, MOL BIOL CELL, V17, P3304, DOI 10.1091/mbc.E06-02-0096; Hirst J, 2005, MOL BIOL CELL, V16, P2554, DOI 10.1091/mbc.E04-12-1077; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; Jourdain I, 2009, BIOCHEM J, V420, P169, DOI 10.1042/BJ20081659; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Kent HM, 2002, STRUCTURE, V10, P1139, DOI 10.1016/S0969-2126(02)00801-8; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; Mattera R, 2004, J BIOL CHEM, V279, P8018, DOI 10.1074/jbc.M311873200; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; MORENO S, 1991, METHOD ENZYMOL, V194, P795; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; Ohno H, 2006, J BIOCHEM, V139, P943, DOI 10.1093/jb/mvj120; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; RIEZMAN H, 1985, CELL, V40, P1001, DOI 10.1016/0092-8674(85)90360-5; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Toda T, 1996, MOL CELL BIOL, V16, P6752; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WONG WT, 1994, ONCOGENE, V9, P1591	39	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45324	10.1371/journal.pone.0045324	http://dx.doi.org/10.1371/journal.pone.0045324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028933	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800051
J	Brune, M; Scheele, D; Heinisch, C; Tas, C; Wischniewski, J; Gunturkun, O				Bruene, Martin; Scheele, Dirk; Heinisch, Christine; Tas, Cumhur; Wischniewski, Julia; Guentuerkuen, Onur			Empathy Moderates the Effect of Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex on Costly Punishment	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; DECISION-MAKING; ULTIMATUM GAME; NEURAL BASIS; PSYCHOPATHY; COOPERATION; EVOLUTION; CHOICE; BASES	Humans incur considerable costs to punish unfairness directed towards themselves or others. Recent studies using repetitive transcranial magnetic stimulation (rTMS) suggest that the right dorsolateral prefrontal cortex (DLPFC) is causally involved in such strategic decisions. Presently, two partly divergent hypotheses are discussed, suggesting either that the right DLPFC is necessary to control selfish motives by implementing culturally transmitted social norms, or is involved in suppressing emotion-driven prepotent responses to perceived unfairness. Accordingly, we studied the role of the DLPFC in costly (i.e. third party) punishment by applying rTMS to the left and right DLPFC before playing a Dictator Game with the option to punish observed unfair behavior (DG-P). In addition, sham stimulation took place. Individual differences in empathy were assessed with the German version of the Interpersonal Reactivity Index. Costly punishment increased (non-significantly) upon disruption of the right - but not the left - DLPFC as compared to sham stimulation. However, empathy emerged as a highly significant moderator variable of the effect of rTMS over the right, but not left, DLPFC, suggesting that the right DLPFC is involved in controlling prepotent emotional responses to observed unfairness, depending on individual differences in empathy.	[Bruene, Martin; Heinisch, Christine; Tas, Cumhur; Wischniewski, Julia] Ruhr Univ Bochum, Landschaftsverband Westfalen Lippe Univ Hosp, Res Dept Cognit Neuropsychiat & Psychiat Prevent, Bochum, Germany; [Scheele, Dirk] Univ Bonn, Dept Psychol, Bonn, Germany; [Guentuerkuen, Onur] Ruhr Univ Bochum, Dept Biopsychol, Fac Psychol, Bochum, Germany	Ruhr University Bochum; University of Bonn; Ruhr University Bochum	Brune, M (corresponding author), Ruhr Univ Bochum, Landschaftsverband Westfalen Lippe Univ Hosp, Res Dept Cognit Neuropsychiat & Psychiat Prevent, Univ Str 150, Bochum, Germany.	martin.bruene@rub.de	Scheele, Dirk/K-1194-2015; Brüne, Martin/AAX-3202-2020	Scheele, Dirk/0000-0002-7613-0376; Brüne, Martin/0000-0002-2507-0561; Gunturkun, Onur/0000-0003-4173-5233	Friedrich Ebert Stiftung	Friedrich Ebert Stiftung	Julia Wischniewski was supported by the Friedrich Ebert Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2008, NEUROPSYCHOBIOLOGY, V57, P44, DOI 10.1159/000129666; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baumgartner T, 2011, NAT NEUROSCI, V14, P1468, DOI 10.1038/nn.2933; Brandstatter H, 2001, EUR J PERSONALITY, V15, pS53, DOI 10.1002/per.424; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Crockett MJ, 2010, EMOTION, V10, P855, DOI 10.1037/a0019861; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Glenn AL, 2009, MOL PSYCHIATR, V14, P909, DOI 10.1038/mp.2009.76; Gospic K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001054; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Herwig U, 2003, BRAIN TOPOGR, V16, P95, DOI 10.1023/B:BRAT.0000006333.93597.9d; Hobbes Thomas, 2008, LEVIATHAN-J MELVILLE; Judd CM, 2001, PSYCHOL METHODS, V6, P115, DOI 10.1037/1082-989X.6.2.115; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Lundqvist D., 1998, KAROLINSKA DIRECTED; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Paulus C., 2009, SAARBRUCKER PERSONLI; Rilling JK, 2007, BIOL PSYCHIAT, V61, P1260, DOI 10.1016/j.biopsych.2006.07.021; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Scheele D, 2012, BIOL PSYCHIAT; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Smith A, 1776, THEORY MORAL SENTIME; Solnick SJ, 1999, ORGAN BEHAV HUM DEC, V79, P199, DOI 10.1006/obhd.1999.2843; Strobel A, 2011, NEUROIMAGE, V54, P671, DOI 10.1016/j.neuroimage.2010.07.051; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van den Bergh B, 2006, P R SOC B, V273, P2091, DOI 10.1098/rspb.2006.3550; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wischniewski J, J PERSONAL IN PRESS	38	26	28	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44747	10.1371/journal.pone.0044747	http://dx.doi.org/10.1371/journal.pone.0044747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028601	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700033
J	Parikh, JR; Xia, Y; Marto, JA				Parikh, Jignesh R.; Xia, Yu; Marto, Jarrod A.			Multi-Edge Gene Set Networks Reveal Novel Insights into Global Relationships between Biological Themes	PLOS ONE			English	Article							PHOSPHORYLATION; IDENTIFICATION; COEXPRESSION; GLUTATHIONE; ENRICHMENT; CROSSTALK; PATHWAYS; DYNAMICS; DATABASE; COMPLEX	Curated gene sets from databases such as KEGG Pathway and Gene Ontology are often used to systematically organize lists of genes or proteins derived from high-throughput data. However, the information content inherent to some relationships between the interrogated gene sets, such as pathway crosstalk, is often underutilized. A gene set network, where nodes representing individual gene sets such as KEGG pathways are connected to indicate a functional dependency, is well suited to visualize and analyze global gene set relationships. Here we introduce a novel gene set network construction algorithm that integrates gene lists derived from high-throughput experiments with curated gene sets to construct co-enrichment gene set networks. Along with previously described co-membership and linkage algorithms, we apply the co-enrichment algorithm to eight gene set collections to construct integrated multi-evidence gene set networks with multiple edge types connecting gene sets. We demonstrate the utility of approach through examples of novel gene set networks such as the chromosome map co-differential expression gene set network. A total of twenty-four gene set networks are exposed via a web tool called MetaNet, where context-specific multi-edge gene set networks are constructed from enriched gene sets within user-defined gene lists. MetaNet is freely available at http://blaispathways.dfci.harvard.edu/metanet/.	[Parikh, Jignesh R.; Xia, Yu] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Xia, Yu] Boston Univ, Dept Chem, Boston, MA 02215 USA; [Xia, Yu] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Marto, Jarrod A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Marto, Jarrod A.] Dana Farber Canc Inst, Blais Prote Ctr, Boston, MA 02115 USA; [Marto, Jarrod A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Boston University; Boston University; Boston University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Parikh, JR (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	jarrod_marto@dfci.harvard.edu	Xia, Yu/W-6150-2019	Xia, Yu/0000-0002-5596-5518	Boston University Bioinformatics Program; Research Starter Grant in Informatics from the Pharmaceutical Research and Manufacturers of America Foundation	Boston University Bioinformatics Program; Research Starter Grant in Informatics from the Pharmaceutical Research and Manufacturers of America Foundation	JRP was supported by the Boston University Bioinformatics Program. YX was supported by a Research Starter Grant in Informatics from the Pharmaceutical Research and Manufacturers of America Foundation. Generous support for this work was provided to JAM by the Dana-Farber Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov AV, 2009, J PROTEOME RES, V8, P1193, DOI 10.1021/pr800804d; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bonin M, 2004, MOL BRAIN RES, V126, P88, DOI 10.1016/j.molbrainres.2004.03.025; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhillon IS, 2007, IEEE T PATTERN ANAL, V29, P1944, DOI 10.1109/TP'AMI.2007.1115; Dietmann S, 2010, NUCLEIC ACIDS RES, V38, pW118, DOI 10.1093/nar/gkq515; Dotan-Cohen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005313; Dumont JE, 2001, CELL SIGNAL, V13, P457, DOI 10.1016/S0898-6568(01)00168-1; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com; Fukuoka Y, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-4; Greco SJ, 2008, BIOCHEM BIOPH RES CO, V376, P536, DOI 10.1016/j.bbrc.2008.09.026; Hao HF, 2009, ONCOL REP, V22, P973, DOI 10.3892/or_00000524; Hauser RA, 2009, MOVEMENT DISORD, V24, P979, DOI 10.1002/mds.22401; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hu ZJ, 2009, NUCLEIC ACIDS RES, V37, pW115, DOI 10.1093/nar/gkp406; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang YZ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S32; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kelder T, 2011, NUCL ACIDS RES; Kelder T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-127; Kon N, 2008, NAT CELL BIOL, V10, P1463, DOI 10.1038/ncb1806; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Li Y, 2008, BIOINFORMATICS, V24, P1442, DOI 10.1093/bioinformatics/btn200; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Nindl I, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-30; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Sack GH, 2010, J BIOENERG BIOMEMBR, V42, P189, DOI 10.1007/s10863-010-9291-x; Sartor MA, 2010, BIOINFORMATICS, V26, P456, DOI 10.1093/bioinformatics/btp683; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sutcliffe JG, 2011, J NEUROSCI RES, V89, P808, DOI 10.1002/jnr.22603; Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102; Woo YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012158; Zhou F, 2010, J PROTEOME RES, V9, P6242, DOI 10.1021/pr1004696	53	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45211	10.1371/journal.pone.0045211	http://dx.doi.org/10.1371/journal.pone.0045211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028852	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700096
J	von Elverfeldt, D; von zur Muhlen, C; Wiens, K; Neudorfer, I; Zirlik, A; Meissner, M; Tilly, P; Charles, AL; Bode, C; Peter, K; Fabre, JE				von Elverfeldt, Dominik; von zur Muhlen, Constantin; Wiens, Kristina; Neudorfer, Irene; Zirlik, Andreas; Meissner, Mirko; Tilly, Peg; Charles, Anne-Laure; Bode, Christoph; Peter, Karlheinz; Fabre, Jean-Etienne			In Vivo Detection of Activated Platelets Allows Characterizing Rupture of Atherosclerotic Plaques with Molecular Magnetic Resonance Imaging in Mice	PLOS ONE			English	Article							CONTRAST AGENT; THROMBUS DETECTION; GPIIB/IIIA; BINDING	Background: Early and non-invasive detection of platelets on micro atherothrombosis provides a means to identify unstable plaque and thereby allowing prophylactic treatment towards prevention of stroke or myocardial infarction. Molecular magnetic resonance imaging (mMRI) of activated platelets as early markers of plaque rupture using targeted contrast agents is a promising strategy. In this study, we aim to specifically image activated platelets in murine atherothrombosis by in vivo mMRI, using a dedicated animal model of plaque rupture. Methods: An antibody targeting ligand-induced binding sites (LIBS) on the glycoprotein IIb/IIIa-receptor of activated platelets was conjugated to microparticles of iron oxide (MPIO) to form the LIBS-MPIO contrast agent causing a signalextinction in T2*-weighted MRI. ApoE(-/-) mice (60 weeks-old) were fed a high fat diet for 5 weeks. Using a small needle, the surface of their carotid plaques was scratched under blood flow to induce atherothrombosis. In vivo 9.4 Tesla MRI was performed before and repetitively after intravenous injection of either LIBS-MPIO versus non-targeted-MPIO. Results: LIBS-MPIO injected animals showed a significant signal extinction (p < 0.05) in MRI, corresponding to the site of plaque rupture and atherothrombosis in histology. The signal attenuation was effective for atherothrombosis occupying >= 2% of the vascular lumen. Histology further confirmed significant binding of LIBS-MPIO compared to control-MPIO on the thrombus developing on the surface of ruptured plaques (p < 0.01). Conclusion: in vivo mMRI detected activated platelets on mechanically ruptured atherosclerotic plaques in ApoE(-/-) mice with a high sensititvity. This imaging technology represents a unique opportunity for noninvasive detection of atherothrombosis and the identification of unstable atherosclerotic plaques with the ultimate promise to prevent strokes and myocardial infarctions.	[von Elverfeldt, Dominik; Meissner, Mirko] Univ Hosp, Dept Radiol Med Phys, Freiburg, Germany; [von zur Muhlen, Constantin; Wiens, Kristina; Neudorfer, Irene; Zirlik, Andreas; Bode, Christoph] Univ Heart Ctr, Dept Cardiol & Angiol 1, Freiburg, Germany; [Tilly, Peg; Charles, Anne-Laure; Fabre, Jean-Etienne] Univ Strasbourg, IGBMC, INSERM U694, CNRS UMR 7104, Illkirch Graffenstaden, France; [Peter, Karlheinz] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of Freiburg; Universitats Herzzentrum Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Baker Heart and Diabetes Institute	von Elverfeldt, D (corresponding author), Univ Hosp, Dept Radiol Med Phys, Freiburg, Germany.	jefabre@igbmc.fr	Peter, Karlheinz/E-8772-2010; /S-2765-2019; Zirlik, Andreas/A-6400-2011	Peter, Karlheinz/0000-0002-8040-2258; /0000-0002-8040-2258; Zirlik, Andreas/0000-0001-6290-3297; von Elverfeldt, Dominik/0000-0002-6219-3528	German Research Foundation, DFG-grant [MU2727/3-1]	German Research Foundation, DFG-grant(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation, DFG-grant No. MU2727/3-1 to Drs. von Elverfeldt and von zur Muhlen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigalke B, 2012, PLATELETS, V23, P1, DOI 10.3109/09537104.2011.585258; Choudhury RP, 2009, ARTERIOSCL THROM VAS, V29, P983, DOI 10.1161/ATVBAHA.108.165498; Choudhury RP, 2004, NAT REV DRUG DISCOV, V3, P913, DOI 10.1038/nrd1548; Corti R, 2002, AM J MED, V113, P668, DOI 10.1016/S0002-9343(02)01344-X; Dharmakumar R, 2006, PHYS MED BIOL, V51, P4201, DOI 10.1088/0031-9155/51/17/006; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gawaz M, 2005, THROMB HAEMOSTASIS, V93, P910, DOI 10.1160/TH04-10-0660; Gawaz M, 2004, CARDIOVASC RES, V61, P498, DOI 10.1016/j.cardiores.2003.11.036; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jansen CHP, 2011, CIRCULATION, V124, P416, DOI 10.1161/CIRCULATIONAHA.110.965442; Klink A, 2010, ARTERIOSCL THROM VAS, V30, P403, DOI 10.1161/ATVBAHA.109.198556; Langer HF, 2008, J AM COLL CARDIOL, V52, P1, DOI 10.1016/j.jacc.2008.03.036; Patil S, 2011, EUR RADIOL, V21, P214, DOI 10.1007/s00330-010-1909-1; Rogers IS, 2010, JACC-CARDIOVASC IMAG, V3, P388, DOI 10.1016/j.jcmg.2010.01.004; Rogers WJ, 2000, ARTERIOSCL THROM VAS, V20, P1824, DOI 10.1161/01.ATV.20.7.1824; Schwarz M, 2004, J PHARMACOL EXP THER, V308, P1002, DOI 10.1124/jpet.103.058883; Schwarz M, 2006, CIRC RES, V99, P25, DOI 10.1161/01.RES.0000232317.84122.0c; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Sirol M, 2005, ATHEROSCLEROSIS, V182, P79, DOI 10.1016/j.atherosclerosis.2005.02.013; Sirol M, 2005, CIRCULATION, V112, P1594, DOI 10.1161/CIRCULATIONAHA.104.522110; Stoll P, 2007, ARTERIOSCL THROM VAS, V27, P1206, DOI 10.1161/ATVBAHA.106.138875; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; von zur Muhlen C, 2008, CIRCULATION, V118, P258, DOI 10.1161/CIRCULATIONAHA.107.753657; von zur Muhlen C, 2008, MOL IMAGING, V7, P59, DOI 10.2310/7290.2008.0008; von zur Muhlen C, 2008, J CLIN INVEST, V118, P1198, DOI 10.1172/JCI33314; von zur Muhlen C, 2009, J VASC RES, V46, P6, DOI 10.1159/000135660; Weizenecker J, 2009, PHYS MED BIOL, V54, pL1, DOI 10.1088/0031-9155/54/5/L01	30	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45008	10.1371/journal.pone.0045008	http://dx.doi.org/10.1371/journal.pone.0045008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028736	Green Published, gold			2022-12-27	WOS:000308788700076
J	Blay, SL; Fillenbaum, GG; Andreoli, SB; Gastal, FL				Blay, Sergio L.; Fillenbaum, Gerda G.; Andreoli, Sergio B.; Gastal, Fabio L.			Prevalence and Concomitants of Arthritis in the Elderly in Rio Grande do Sul, Brazil	PLOS ONE			English	Article							HEALTH INTERVIEW SURVEY; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; NATIONAL-HEALTH; KNEE OSTEOARTHRITIS; REPORTING ARTHRITIS; SYMPTOMATIC KNEE; UNITED-STATES; CHRONIC PAIN; POPULATION	Objectives: Information on the prevalence and concomitants of arthritis in developing countries is sparse. It is unclear whether they are comparable to findings in developed countries. To ascertain the prevalence, demographic characteristics, and health-related concomitants of arthritis in older persons in the southern state of Rio Grande do Sul, Brazil, a middle income country. Methods: The state of Rio Grande do Sul, Brazil, was subdivided into nine regions. Stratified random sampling was used to identify 880 community residents age >= 60 years in each region. One region with suspect data was excluded. Of 7040 community residents contacted in eight regions, 6963 participated (1.1% refusal rate). In 1995, trained, monitored interviewers, using structured questionnaires, conducted in-home interviews gathering information on demographic characteristics (age, sex, race/ethnicity, education, income, living arrangements, employment status), health behaviors (physical activity, tobacco use, social activity), functional limitations, depression, and 15 self-reported health conditions, including arthritis. Data were analyzed using descriptive statistics and logistic regression. Results: Arthritis, reported by 43% of the sample, was more prevalent in women, among the less educated, those with lower income, and higher age. Severity, but not prevalence, differed by race/ethnicity. Controlled analyses indicated significant association with female gender, lower education, and less social activity. Arthritis was associated with reduced odds of stroke, but increased odds of hypertension, varicosities, bronchitis, renal problems, headache, gastrointestinal disorders, and depression. Arthritis was not significantly associated with age or functional limitations, and associations did not differ by gender. Conclusions: The prevalence, demographic and health characteristics associated with self-reported arthritis in this southern state in Brazil are similar to findings elsewhere in Brazil, and in developed countries.	[Blay, Sergio L.; Andreoli, Sergio B.] Univ Fed Sao Paulo, Dept Psychiat, Escola Paulista Med UNIFESP, Sao Paulo, Brazil; [Fillenbaum, Gerda G.] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Fillenbaum, Gerda G.] Vet Adm Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC USA; [Gastal, Fabio L.] Project Sci Comm, Porto Alegre, RS, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Blay, SL (corresponding author), Univ Fed Sao Paulo, Dept Psychiat, Escola Paulista Med UNIFESP, Sao Paulo, Brazil.	blay@uol.com.br	Andreoli, Sergio Baxter/M-7112-2019; Andreoli, Sergio Baxter/D-9568-2012	Andreoli, Sergio Baxter/0000-0002-1976-0881; Andreoli, Sergio Baxter/0000-0002-1976-0881; Gastal, Fabio/0000-0002-1016-3263	Conselho Estadual do Idoso, Secretaria do Trabalho, Cidadania e Assistencia Social; Governo do Estado do Rio Grande do Sul, the National Council for Scientific and Technological Development [470724/2011-0, 306156/2011-3]; National Institute on Aging [1P30 AG028716-02]; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	Conselho Estadual do Idoso, Secretaria do Trabalho, Cidadania e Assistencia Social; Governo do Estado do Rio Grande do Sul, the National Council for Scientific and Technological Development; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by Conselho Estadual do Idoso, Secretaria do Trabalho, Cidadania e Assistencia Social; by Governo do Estado do Rio Grande do Sul, the National Council for Scientific and Technological Development for a Research Grant for Dr. Sergio L. Blay (Grant number 470724/2011-0 and 306156/2011-3); National Institute on Aging [grant number 1P30 AG028716-02 Claude D. Pepper OAIC for GGF]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebajo A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-23; Andrianakos AA, 2006, J RHEUMATOL, V33, P2507; Antohe JL, 2012, ARTHRIT CARE RES, V64, P215, DOI 10.1002/acr.20657; Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Arnow BA, 2009, PSYCHIAT SERV, V60, P344, DOI 10.1176/appi.ps.60.3.344; Australian Bureau of Statistics, 2006, NAT HLTH SURV SUMM R; Beyreuther BK, 2007, NEUROPHARMACOLOGY, V52, P1312, DOI 10.1016/j.neuropharm.2007.01.012; Blay SL, 2007, AM J GERIAT PSYCHIAT, V15, P790, DOI 10.1097/JGP.0b013e3180654179; BLAY SL, 1988, J AM GERIATR SOC, V36, P687, DOI 10.1111/j.1532-5415.1988.tb07169.x; Bolen J, 2010, PREV CHRONIC DIS, V7; Bukulmez H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1878; Caughey GE, 2002, BMC PUBLIC HEALTH, V8, P221, DOI [10.1186/1471-2458-221, DOI 10.1186/1471-2458-221]; *CDC, 1994, MMWR-MORBID MORTAL W, V43, P433; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P1089; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P329; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1261; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P334; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Felson David T., 1998, Current Opinion in Rheumatology, V10, P269, DOI 10.1097/00002281-199805000-00019; Fillenbaum GG, 2010, J AGING HEALTH, V22, P362, DOI 10.1177/0898264309359307; Fransen M, 2011, INT J RHEUM DIS, V14, P113, DOI 10.1111/j.1756-185X.2011.01608.x; Gariepy G, 2009, CAN J PUBLIC HEALTH, V100, P467, DOI 10.1007/BF03404346; Giacomin KC, 2008, CAD SAUDE PUBLICA, V24, P1260, DOI 10.1590/S0102-311X2008000600007; Grumbach MM, 2000, J PEDIATR ENDOCR MET, V13, P1439; Hagen K, 2002, EUR J NEUROL, V9, P527, DOI 10.1046/j.1468-1331.2002.00451.x; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; HOOTMAN J, 2007, MMWR-MORBID MORTAL W, V56, P55; Jagger C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-156; Jordan JM, 2007, J RHEUMATOL, V34, P172; Kadam UT, 2004, ANN RHEUM DIS, V63, P408, DOI 10.1136/ard.2003.007526; Karpouzis KM, 1999, HEADACHE, V39, P317, DOI 10.1046/j.1526-4610.1999.3905317.x; Khasar SG, 2008, J NEUROSCI, V28, P5721, DOI 10.1523/JNEUROSCI.0256-08.2008; Kleinschnitz C, 2006, EXP NEUROL, V200, P480, DOI 10.1016/j.expneurol.2006.03.014; Kopec JA, 2007, J RHEUMATOL, V34, P386; Kraus VB, 2010, ABC RHEUMATOLOGY, P51; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lima MG, 2009, REV PANAM SALUD PUBL, V25, P314, DOI 10.1590/S1020-49892009000400005; Lima-Costa Maria Fernanda, 2003, Cad. Saúde Pública, V19, P735, DOI 10.1590/S0102-311X2003000300006; Lima-Costa MF, 2011, CIENC SAUDE COLETIVA, V16, P3689, DOI 10.1590/S1413-81232011001000006; Loughlin J, 2005, CURR OPIN RHEUMATOL, V17, P629, DOI 10.1097/01.bor.0000176687.85198.49; Machado GPM, 2006, J RHEUMATOL, V33, P342; Machado Gustavo Pinto da Matta, 2004, Rev. Assoc. Med. Bras., V50, P367, DOI 10.1590/S0104-42302004000400024; Mazzantini M, 2010, J RHEUMATOL, V37, P2232, DOI 10.3899/jrheum.100461; Mili F, 2003, J RHEUMATOL, V30, P160; Murphy LB, 2012, ARTHRIT CARE RES, V64, P968, DOI 10.1002/acr.21685; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Pereira AM, 2009, CLIN EXP RHEUMATOL, V27, P42; Perruccio AV, 2006, J RHEUMATOL, V33, P1856; Pilger C, 2011, REV LAT-AM ENFERM, V19, P1230, DOI 10.1590/S0104-11692011000500022; Richette P, 2003, JOINT BONE SPINE, V70, P257, DOI 10.1016/S1297-319X(03)00067-8; Sacks JJ, 2005, J RHEUMATOL, V32, P340; Senna TR, 2004, J RHEUMATOL, V31, P594; Shih M, 2006, AM J PREV MED, V30, P385, DOI 10.1016/j.amepre.2005.12.005; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Sudano I, 2010, CIRCULATION, V122, P1789, DOI 10.1161/CIRCULATIONAHA.110.956490; Toms TE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2765; Valdes AM, 2007, ARTHRITIS RHEUM-US, V56, P137, DOI 10.1002/art.22301; van Dijk GM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-95; Vogel C, 2006, J PERIPHER NERV SYST, V11, P294, DOI 10.1111/j.1529-8027.2006.00101.x; WALKER A, 2001, LIVING BRITAIN RESUL; Walker A, 2002, LIVING BRITAIN RESUL; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952	64	5	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45418	10.1371/journal.pone.0045418	http://dx.doi.org/10.1371/journal.pone.0045418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23028995	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900041
J	Li, Y; Liu, H; Wang, J; Li, Y; Yu, GP; Ma, XM; Liang, MH; Zhang, J; Zhao, LP				Li, Yi; Liu, Hui; Wang, Jing; Li, Yan; Yu, Guo-Pei; Ma, Xie-Min; Liang, Ming-Hui; Zhang, Jun; Zhao, Lue Ping			Variable Lengths of Stay among Ischemic Stroke Subtypes in Chinese General Teaching Hospitals	PLOS ONE			English	Article							ACADEMIC MEDICAL-CENTERS; QUALITY-OF-CARE; UNIT; MORTALITY; COSTS	Background: Length of stay (LOS) is one of the most important quantitative indexes that measures health service utilization within a hospital. Many studies have examined the association of three major stroke categories with LOS. Our aim is to investigate the differences of LOS among ischemic stroke subtypes, results from which are helpful to healthcare providers and government agencies to improve health care delivery efficiency. Methodology/Principal Findings: Using the Beijing Municipal Health Bureau's hospitalization summary reports, we performed a retrospective study among first-ever in-hospital patients with ischemic stroke (ICD-10 I63) in three general teaching hospitals in Beijing, China, from 2006 to 2010 with generalized linear model. In our study, 5,559 patients (female, 36.0%; age, 64.4 +/- 12.9 years) were included. The estimated mean LOS of ischemic stroke was 17.4 +/- 1.8 days. After adjusting for confounders, LOS of lacunar infarction (14.7 days; p<0.001) and LOS of small cerebral infarction (17.0 days; p = 0.393) were shorter than that of single cerebral infarction (17.9 days, p<0.001). LOS of multi-infarct (19.0 days; p = 0.028), brainstem infarction (19.3 days; p = 0.045), basal ganglia infarction (18.5 days; p = 0.452) and other subtypes of ischemic stroke (18.9 days; p = 0.327) were longer than that of single cerebral infarction. Conclusions: LOS of ischemic stroke patient differes across single cerebral infarction, lacunar infarction, multi-infarct and brainstem infarction patients. The ascending order of LOS was lacunar infarction, small cerebral infarction, single cerebral infarction, basal ganglia infarction, other subtypes of ischemic stroke, multi-infarct and brainstem infarction.	[Zhang, Jun] Peking Univ, Hosp 3, Hlth Sci Ctr, Dept Hosp Management,Dept Neurol, Beijing 100871, Peoples R China; [Li, Yan] Peking Univ, Hosp 1, Hlth Sci Ctr, Dept Hosp Management,Dept Neurol, Beijing 100871, Peoples R China; [Li, Yi; Liu, Hui; Wang, Jing; Yu, Guo-Pei; Zhao, Lue Ping] Peking Univ, Med Informat Ctr, Beijing 100871, Peoples R China; [Ma, Xie-Min] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100871, Peoples R China; [Liang, Ming-Hui] Minist Hlth, Inst Hosp Management, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University	Zhang, J (corresponding author), Peking Univ, Hosp 3, Hlth Sci Ctr, Dept Hosp Management,Dept Neurol, Beijing 100871, Peoples R China.	who626@163.com; lzhao@bjmu.edu.cn			"985" Project from Ministry of Education of China	"985" Project from Ministry of Education of China	This work is supported, in part, by the "985" Project from Ministry of Education of China. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beijing Health Bereau, 2011, 6 DIG COD CLASS STAN; Bonita R, 2004, LANCET NEUROL, V3, P391, DOI 10.1016/S1474-4422(04)00800-2; Candelise L, 2007, LANCET, V369, P299, DOI 10.1016/S0140-6736(07)60152-4; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; Chinese Medical Association Neurology Branch Cerebrovascular Disease Study Group, 2010, CHINESE J NEUROLOGY, V43, P146, DOI DOI 10.3969/J.ISSN.1672-7185.2013.08.004; Diringer MN, 1999, STROKE, V30, P724, DOI 10.1161/01.STR.30.4.724; Feigin VL, 2005, LANCET, V365, P2160, DOI 10.1016/S0140-6736(05)66755-4; George Mary G, 2011, Ann Neurol, V70, P713, DOI 10.1002/ana.22539; Gillum LA, 2001, STROKE, V32, P2137, DOI 10.1161/hs0901.094260; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Holloway RG, 1996, NEUROLOGY, V46, P854; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; JORGENSEN HS, 1995, STROKE, V26, P1178, DOI 10.1161/01.STR.26.7.1178; Koton S, 2010, NEUROLOGY, V74, P1511, DOI 10.1212/WNL.0b013e3181dd4dc5; Laloux P, 2003, ACTA NEUROL BELG, V103, P71; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Ma Y, 2010, EUR J NEUROL, V17, P1270, DOI 10.1111/j.1468-1331.2010.03007.x; Ministry of Health of the People's Republic of China, 2011, APPL DIS DIAGN REL G; Ministry of Health of the People's Republic of China, 2011, CHIN HLTH STAT YB, P160; Ministry of Health of the People's Republic of China, 2011, CHIN HLTH STAT YB, p[290, 329]; Palnum KD, 2009, STROKE, V40, P1134, DOI 10.1161/STROKEAHA.108.543819; Rao ML, 2007, GUIDELINES CEREBROVA; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Somerford PJ, 2004, ANN EPIDEMIOL, V14, P773, DOI 10.1016/j.annepidem.2004.02.003; Svendsen ML, 2009, MED CARE, V47, P575, DOI 10.1097/MLR.0b013e318195f852; Tirschwell D L, 1999, J Stroke Cerebrovasc Dis, V8, P336, DOI 10.1016/S1052-3057(99)80008-1; Yoneda Y, 2003, STROKE, V34, P718, DOI 10.1161/01.STR.0000056171.55342.FF; Zhu HF, 2009, STROKE, V40, P18, DOI 10.1161/STROKEAHA.108.527606	28	6	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45101	10.1371/journal.pone.0045101	http://dx.doi.org/10.1371/journal.pone.0045101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028783	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900026
J	Benisch, P; Schilling, T; Klein-Hitpass, L; Frey, SP; Seefried, L; Raaijmakers, N; Krug, M; Regensburger, M; Zeck, S; Schinke, T; Amling, M; Ebert, R; Jakob, F				Benisch, Peggy; Schilling, Tatjana; Klein-Hitpass, Ludger; Frey, Soenke P.; Seefried, Lothar; Raaijmakers, Nadja; Krug, Melanie; Regensburger, Martina; Zeck, Sabine; Schinke, Thorsten; Amling, Michael; Ebert, Regina; Jakob, Franz			The Transcriptional Profile of Mesenchymal Stem Cell Populations in Primary Osteoporosis Is Distinct and Shows Overexpression of Osteogenic Inhibitors	PLOS ONE			English	Article							BONE-MINERAL DENSITY; AGE-RELATED OSTEOPOROSIS; WNT SIGNALING PATHWAY; REPLICATIVE SENESCENCE; MORPHOGENETIC PROTEIN; ALKALINE-PHOSPHATASE; PARATHYROID-HORMONE; GROWTH-FACTOR; IN-VITRO; SKELETAL OVEREXPRESSION	Primary osteoporosis is an age-related disease characterized by an imbalance in bone homeostasis. While the resorptive aspect of the disease has been studied intensely, less is known about the anabolic part of the syndrome or presumptive deficiencies in bone regeneration. Multipotent mesenchymal stem cells (MSC) are the primary source of osteogenic regeneration. In the present study we aimed to unravel whether MSC biology is directly involved in the pathophysiology of the disease and therefore performed microarray analyses of hMSC of elderly patients (79-94 years old) suffering from osteoporosis (hMSC-OP). In comparison to age-matched controls we detected profound changes in the transcriptome in hMSC-OP, e.g. enhanced mRNA expression of known osteoporosis-associated genes (LRP5, RUNX2, COL1A1) and of genes involved in osteoclastogenesis (CSF1, PTH1R), but most notably of genes coding for inhibitors of WNT and BMP signaling, such as Sclerostin and MAB21L2. These candidate genes indicate intrinsic deficiencies in self-renewal and differentiation potential in osteoporotic stem cells. We also compared both hMSC-OP and non-osteoporotic hMSC-old of elderly donors to hMSC of similar to 30 years younger donors and found that the transcriptional changes acquired between the sixth and the ninth decade of life differed widely between osteoporotic and non-osteoporotic stem cells. In addition, we compared the osteoporotic transcriptome to long term-cultivated, senescent hMSC and detected some signs for pre-senescence in hMSC-OP. Our results suggest that in primary osteoporosis the transcriptomes of hMSC populations show distinct signatures and little overlap with non-osteoporotic aging, although we detected some hints for senescence-associated changes. While there are remarkable inter-individual variations as expected for polygenetic diseases, we could identify many susceptibility genes for osteoporosis known from genetic studies. We also found new candidates, e.g. MAB21L2, a novel repressor of BMP-induced transcription. Such transcriptional changes may reflect epigenetic changes, which are part of a specific osteoporosis-associated aging process.	[Benisch, Peggy; Schilling, Tatjana; Seefried, Lothar; Raaijmakers, Nadja; Krug, Melanie; Regensburger, Martina; Zeck, Sabine; Ebert, Regina; Jakob, Franz] Univ Wurzburg, Orthoped Ctr Musculoskeletal Res, Wurzburg, Germany; [Klein-Hitpass, Ludger] Univ Hosp Essen, Inst Cell Biol Tumor Res, Essen, Germany; [Frey, Soenke P.] Univ Hosp Wuerzburg, Dept Trauma Hand Plast & Reconstruct Surg, Wurzburg, Germany; [Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany	University of Wurzburg; University of Duisburg Essen; University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Jakob, F (corresponding author), Univ Wurzburg, Orthoped Ctr Musculoskeletal Res, Wurzburg, Germany.	f-jakob.klh@uni-wuerzburg.de	Ebert, Regina/D-5760-2016; Seefried, Lothar/AAU-2169-2021; Jakob, Franz/D-8526-2015; Jakob, Franz/F-9894-2015	Ebert, Regina/0000-0002-8192-869X; Seefried, Lothar/0000-0003-1154-3388; 	German Research Foundation [FOR793 JA506/9-1]; Lilly; Amgen; Novartis; Merck Sharp and Dohme (MSD); Nycomed; Servier; Medtronic; Roche	German Research Foundation(German Research Foundation (DFG)); Lilly(Eli Lilly); Amgen(Amgen); Novartis(Novartis); Merck Sharp and Dohme (MSD)(Merck & Company); Nycomed; Servier(Servier); Medtronic(Medtronic); Roche(Roche Holding)	This work was supported by the German Research Foundation [FOR793 JA506/9-1]( http://www.dfg.de/index.jsp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: F. Jakob has received honoraria and travel grants for lectures, advice and expert testimony from Lilly, Amgen, Novartis, Merck Sharp and Dohme (MSD), Nycomed, Servier, Medtronic and Roche. He has received unrestricted research grants from Novartis and is involved in clinical studies related to osteoporosis drugs initiated by Lilly, Amgen, Servier and Novartis. L. Seefried has received honoraria and travel grants for lectures from Lilly, Amgen and Novartis. He is involved in clinical studies related to osteoporosis drugs initiated by Amgen, Servier and Novartis. R. Ebert received honoraria and travel grants for lectures from Lilly and Novartis. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abe Y, 2004, J BONE MINER RES, V19, P1302, DOI 10.1359/JBMR.040408; Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Avnet S, 2011, EXP CELL RES, V317, P2147, DOI 10.1016/j.yexcr.2011.05.030; Baldessari D, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-48; Bartholin L, 2005, BIOL CELL, V97, P577; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Bonnet J, 2008, CELL CYCLE, V7, P1991, DOI 10.4161/cc.7.13.6095; Boukhechba F, 2009, J BONE MINER RES, V24, P1927, DOI [10.1359/JBMR.090517, 10.1359/jbmr.090517]; Bringold F, 2000, EXP GERONTOL, V35, P317, DOI 10.1016/S0531-5565(00)00083-8; Brunetti Giacomina, 2011, Front Biosci (Elite Ed), V3, P1154; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Carbonare LD, 2009, ARTHRITIS RHEUM-US, V60, P3356, DOI 10.1002/art.24884; Carron JA, 2000, BIOCHEM BIOPH RES CO, V270, P1124, DOI 10.1006/bbrc.2000.2574; Cheung CL, 2010, NAT REV RHEUMATOL, V6, P507, DOI 10.1038/nrrheum.2010.106; Cheung CL, 2011, OSTEOPOROS INT; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Dalvai M, 2011, ONCOGENE, V30, P2282, DOI 10.1038/onc.2010.588; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dingwall M, 2011, DIFFERENTIATION, V82, P57, DOI 10.1016/j.diff.2011.05.003; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Duque G, 2008, CURR OPIN RHEUMATOL, V20, P429, DOI 10.1097/BOR.0b013e3283025e9c; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Endoh M, 2009, BIOGERONTOLOGY, V10, P213, DOI 10.1007/s10522-008-9173-3; Estrada KD, 2011, J BONE MINER RES, V26, P2498, DOI 10.1002/jbmr.443; Farber CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002038; Fox SW, 2005, MOL CELL ENDOCRINOL, V243, P19, DOI 10.1016/j.mce.2005.09.008; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gaddy-Kurten D, 2002, ENDOCRINOLOGY, V143, P74, DOI 10.1210/en.143.1.74; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Giner M, 2009, J STEROID BIOCHEM, V113, P46, DOI 10.1016/j.jsbmb.2008.11.005; Guo Y, 2011, ANN HUM GENET, V75, P569, DOI 10.1111/j.1469-1809.2011.00663.x; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Heemstra KA, 2010, J BONE MINER RES, V25, P1385, DOI 10.1002/jbmr.27; Hopwood B, 2009, BONE, V44, P87, DOI 10.1016/j.bone.2008.08.120; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Hwang JY, 2009, BONE, V45, P1098, DOI 10.1016/j.bone.2009.07.080; Ideno H, 2009, EXP CELL RES, V315, P474, DOI 10.1016/j.yexcr.2008.11.019; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; Jilka RL, 2003, MED PEDIATR ONCOL, V41, P182, DOI 10.1002/mpo.10334; Kaji H, 1996, J BONE MINER RES, V11, P62; Karasik D, 2010, J BONE MINER RES, V25, P1555, DOI 10.1002/jbmr.38; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kawaguchi H, 2006, REV ENDOCR METAB DIS, V7, P17, DOI 10.1007/s11154-006-9011-3; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Koller DL, 2010, J CLIN ENDOCR METAB, V95, P1802, DOI 10.1210/jc.2009-1903; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Lee DY, 2010, MENOPAUSE, V17, P1064, DOI 10.1097/gme.0b013e3181da4da3; Li GHY, 2010, OSTEOPOROSIS INT, V21, P1009, DOI 10.1007/s00198-009-1043-6; Li WF, 2010, HUM GENET, V127, P249, DOI 10.1007/s00439-009-0773-z; Li XD, 2011, ENDOCRINOLOGY, V152, P3312, DOI 10.1210/en.2011-0252; Limbert C, 2010, STEM CELLS DEV, V19, P679, DOI 10.1089/scd.2009.0241; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; LONGO VD, 2004, SCI AGING KNOWLEDGE, pPE36; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Miraoui H, 2010, J CELL BIOCHEM, V110, P1147, DOI 10.1002/jcb.22628; Mirza FS, 2010, J CLIN ENDOCR METAB, V95, P1991, DOI 10.1210/jc.2009-2283; Misof B., 2012, J BONE MINER RES; Mitchell BD, 2011, J CLIN ENDOCR METAB, V96, P1258, DOI 10.1210/jc.2010-2865; Mlakar SJ, 2011, DIS MARKERS, V31, P279, DOI [10.1155/2011/521597, 10.3233/DMA-2011-0829]; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4; Palermo C, 2004, AM J PHYSIOL-ENDOC M, V286, pE648, DOI 10.1152/ajpendo.00049.2003; Park SJ, 2011, BONE, V49, P428, DOI 10.1016/j.bone.2011.05.012; Paternoster L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001217; Perez-Sayans M, 2010, ORAL SURG ORAL MED O, V109, P679, DOI 10.1016/j.tripleo.2009.10.042; Perrien DS, 2011, J ORTHOP RES; Pietschmann P, 2009, GERONTOLOGY, V55, P3, DOI 10.1159/000166209; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Pountos I, 2010, J ORTHOP TRAUMA, V24, P552, DOI 10.1097/BOT.0b013e3181efa8fe; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Ranuncolo SA, 2008, BLOOD CELL MOL DIS, V41, P95, DOI 10.1016/j.bcmd.2008.02.003; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rice R, 2005, DEV DYNAM, V233, P847, DOI 10.1002/dvdy.20430; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Roato I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000124; Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C; Saint-Pierre A, 2011, EUR J HUM GENET, V19, P710, DOI 10.1038/ejhg.2011.22; Sandhu C, 2000, ONCOGENE, V19, P5314, DOI 10.1038/sj.onc.1203908; Schulze J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010309; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; Seeman E, 2008, J BONE MINER METAB, V26, P1, DOI 10.1007/s00774-007-0793-5; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shaarawy Mohamed, 2003, Clin Lab, V49, P625; Shapses SA, 2003, CALCIFIED TISSUE INT, V73, P86, DOI 10.1007/s00223-002-1090-x; Shin HI, 2004, ENDOCRINOLOGY, V145, P1376, DOI 10.1210/en.2003-0839; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Sohr S, 2008, CELL CYCLE, V7, P3448, DOI 10.4161/cc.7.21.7014; Street John, 2009, J Orthop Surg Res, V4, P19, DOI 10.1186/1749-799X-4-19; Sun LQ, 2005, CELL CYCLE, V4, P3, DOI 10.4161/cc.4.1.1341; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Trost Z, 2010, BONE, V46, P72, DOI 10.1016/j.bone.2009.09.015; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yang QL, 2008, MATRIX BIOL, V27, P589, DOI 10.1016/j.matbio.2008.06.005; Yerges LM, 2010, J BONE MINER RES, V25, P330, DOI 10.1359/jbmr.090729; Zhang YP, 2010, OSTEOPOROSIS INT, V21, P785, DOI 10.1007/s00198-009-1014-y; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhou SH, 2011, J CELL BIOCHEM, V112, P1651, DOI 10.1002/jcb.23079; Zhu J, 2011, J CELL BIOCHEM, V112, P1749, DOI 10.1002/jcb.23094	121	139	144	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45142	10.1371/journal.pone.0045142	http://dx.doi.org/10.1371/journal.pone.0045142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028809	Green Submitted, gold, Green Published			2022-12-27	WOS:000309554700024
J	Charlton, BD; Reby, D; Ellis, WAH; Brumm, J; Fitch, WT				Charlton, Benjamin D.; Reby, David; Ellis, William A. H.; Brumm, Jacqui; Fitch, W. Tecumseh			Estimating the Active Space of Male Koala Bellows: Propagation of Cues to Size and Identity in a Eucalyptus Forest	PLOS ONE			English	Article							RED DEER; SOUND-TRANSMISSION; ACOUSTIC COMMUNICATION; INDIVIDUAL RECOGNITION; VOCAL COMMUNICATION; ANIMAL VOCALIZATION; RAIN-FOREST; BODY-SIZE; DEGRADATION; HABITAT	Examining how increasing distance affects the information content of vocal signals is fundamental for determining the active space of a given species' vocal communication system. In the current study we played back male koala bellows in a Eucalyptus forest to determine the extent that individual classification of male koala bellows becomes less accurate over distance, and also to quantify how individually distinctive acoustic features of bellows and size-related information degrade over distance. Our results show that the formant frequencies of bellows derived from Linear Predictive Coding can be used to classify calls to male koalas over distances of 1-50 m. Further analysis revealed that the upper formant frequencies and formant frequency spacing were the most stable acoustic features of male bellows as they propagated through the Eucalyptus canopy. Taken together these findings suggest that koalas could recognise known individuals at distances of up to 50 m and indicate that they should attend to variation in the upper formant frequencies and formant frequency spacing when assessing the identity of callers. Furthermore, since the formant frequency spacing is also a cue to male body size in this species and its variation over distance remained very low compared to documented inter-individual variation, we suggest that male koalas would still be reliably classified as small, medium or large by receivers at distances of up to 150 m.	[Charlton, Benjamin D.; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Charlton, Benjamin D.; Reby, David] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Ellis, William A. H.] Cent Queensland Univ, Koala Res Ctr Cent Queensland, Rockhampton, Qld 4702, Australia; [Brumm, Jacqui] Lone Pine Koala Sanctuary, Brisbane, Qld, Australia	University of Vienna; University of Sussex; Central Queensland University	Charlton, BD (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	b.d.charlton@sussex.ac.uk	reby, david/A-4227-2013; Ellis, William/AAP-8955-2021	Reby, David/0000-0001-9261-1711; Charlton, Benjamin/0000-0002-0218-7177; Ellis, William/0000-0001-6017-4692	University of Vienna start-up grant; European Research Council Advanced Grant SOMACCA [230604]	University of Vienna start-up grant; European Research Council Advanced Grant SOMACCA	BC was supported by a University of Vienna start-up grant and a European Research Council Advanced Grant SOMACCA (No. 230604) awarded to WTF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenrath SH, 2004, BEHAVIOUR, V141, P935, DOI 10.1163/1568539042360152; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; BRENOWITZ EA, 1982, J COMP PHYSIOL, V147, P511, DOI 10.1007/BF00612017; Briefer E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-35; BROWN CH, 1995, ANIM BEHAV, V50, P945, DOI 10.1016/0003-3472(95)80096-4; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Charlton BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020329; Charlton BD, 2010, ANIM BEHAV, V79, P1221, DOI 10.1016/j.anbehav.2010.02.018; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charlton BD, 2009, BIOL LETTERS, V5, P597, DOI 10.1098/rsbl.2009.0331; Charrier I, 2009, ANIM BEHAV, V78, P1127, DOI 10.1016/j.anbehav.2009.07.032; Darden SK, 2008, J ACOUST SOC AM, V124, P758, DOI 10.1121/1.2946704; EAST ML, 1991, ANIM BEHAV, V42, P651, DOI 10.1016/S0003-3472(05)80247-7; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Ellis WAH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1181, DOI 10.1007/s00265-009-0761-2; Embleton TFW, 1996, J ACOUST SOC AM, V100, P31, DOI 10.1121/1.415879; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; FORREST TG, 1994, AM ZOOL, V34, P644; Frommolt KH, 2003, ANIM BEHAV, V65, P509, DOI 10.1006/anbe.2003.2064; Handasyde, 1999, KOALA NATURAL HIST C; Holland J, 1998, J ACOUST SOC AM, V103, P2154, DOI 10.1121/1.421361; Kuczynski MC, 2010, J EXP BIOL, V213, P2840, DOI 10.1242/jeb.044628; Lameira AR, 2008, INT J PRIMATOL, V29, P615, DOI 10.1007/s10764-008-9253-x; Maciej P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023015; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P291, DOI 10.1007/BF00299741; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; Mathevon N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001580; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McElligott AG, 1999, ANIM BEHAV, V57, P1159, DOI 10.1006/anbe.1999.1076; Mitchell P., 1990, P151; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Nelson BS, 2003, J ACOUST SOC AM, V113, P2901, DOI 10.1121/1.1564817; Nemeth E, 2001, J ACOUST SOC AM, V110, P3263, DOI 10.1121/1.1420385; Nicholls JA, 2006, J ANIM ECOL, V75, P549, DOI 10.1111/j.1365-2656.2006.01075.x; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Padgham M, 2004, J ACOUST SOC AM, V115, P402, DOI 10.1121/1.1629304; Pitcher BJ, 2012, ANIM BEHAV, V83, P681, DOI 10.1016/j.anbehav.2011.12.012; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Reby D, 1999, ANIM BEHAV, V57, P1121, DOI 10.1006/anbe.1998.1056; Reby D, 1998, J ZOOL, V245, P79, DOI 10.1017/S0952836998005093; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2006, J ACOUST SOC AM, V120, P4080, DOI 10.1121/1.2358006; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; Smith DRR, 2005, J ACOUST SOC AM, V117, P305, DOI 10.1121/1.1828637; SMITH M, 1980, AUST WILDLIFE RES, V7, P13; Tabachnick B. G., 2001, USING MULTIVARIATE S; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; Townsend SW, 2012, BIOL LETTERS, V8, P179, DOI 10.1098/rsbl.2011.0844; Tripovich JS, 2008, BEHAV PROCESS, V79, P74, DOI 10.1016/j.beproc.2008.04.007; WASER PM, 1984, BEHAV ECOL SOCIOBIOL, V15, P73, DOI 10.1007/BF00310219; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; ZIMMERMANN E, 1993, ETHOLOGY, V93, P211	58	19	19	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45420	10.1371/journal.pone.0045420	http://dx.doi.org/10.1371/journal.pone.0045420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028996	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000309388900049
J	Gorostiza, A; Acunha-Alonzo, V; Regalado-Liu, L; Tirado, S; Granados, J; Samano, D; Rangel-Villalobos, H; Gonzalez-Martin, A				Gorostiza, Amaya; Acunha-Alonzo, Victor; Regalado-Liu, Lucia; Tirado, Sergio; Granados, Julio; Samano, David; Rangel-Villalobos, Hector; Gonzalez-Martin, Antonio			Reconstructing the History of Mesoamerican Populations through the Study of the Mitochondrial DNA Control Region	PLOS ONE			English	Article							GENETIC-STRUCTURE; MTDNA; PATTERNS; DIVERSITY; ANCESTRY; SOFTWARE; BARRIERS; MESTIZOS; AMERICA; ORIGIN	The study of genetic information can reveal a reconstruction of human population's history. We sequenced the entire mtDNA control region (positions 16.024 to 576 following Cambridge Reference Sequence, CRS) of 605 individuals from seven Mesoamerican indigenous groups and one Aridoamerican from the Greater Southwest previously defined, all of them in present Mexico. Samples were collected directly from the indigenous populations, the application of an individual survey made it possible to remove related or with other origins samples. Diversity indices and demographic estimates were calculated. Also AMOVAs were calculated according to different criteria. An MDS plot, based on FST distances, was also built. We carried out the construction of individual networks for the four Amerindian haplogroups detected. Finally, barrier software was applied to detect genetic boundaries among populations. The results suggest: a common origin of the indigenous groups; a small degree of European admixture; and inter-ethnic gene flow. The process of Mesoamerica's human settlement took place quickly influenced by the region's orography, which development of genetic and cultural differences facilitated. We find the existence of genetic structure is related to the region's geography, rather than to cultural parameters, such as language. The human population gradually became fragmented, though they remained relatively isolated, and differentiated due to small population sizes and different survival strategies. Genetic differences were detected between Aridoamerica and Mesoamerica, which can be subdivided into "East", "Center", "West" and "Southeast". The fragmentation process occurred mainly during the Mesoamerican Pre-Classic period, with the Otomi being one of the oldest groups. With an increased number of populations studied adding previously published data, there is no change in the conclusions, although significant genetic heterogeneity can be detected in Pima and Huichol groups. This result may be explained because populations historically assigned as belonging to the same group were, in fact, different indigenous populations.	[Gorostiza, Amaya; Regalado-Liu, Lucia; Tirado, Sergio; Gonzalez-Martin, Antonio] Univ Complutense Madrid, Fac Biol, Dept Zool & Phys Anthropol, Madrid, Spain; [Gorostiza, Amaya] GENOM SAU Grp Zeltia, Lab Identificac Genet, Madrid, Spain; [Acunha-Alonzo, Victor] Escuela Nacl Antropol & Hist, Genet Mol Lab, Mexico City, DF, Mexico; [Granados, Julio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Div Immunogenet, Dept Trasplantes, Mexico City, DF, Mexico; [Samano, David] Univ Autonoma Estado Mexico, Acad Cultura Cient Humanist, Mexico City, DF, Mexico; [Rangel-Villalobos, Hector] Univ Guadalajara, Ctr Univ Cienaga, Inst Invest Genet Mol, Ocotlan, Mexico	Complutense University of Madrid; PharmaMar; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Autonoma del Estado de Mexico; Universidad de Guadalajara	Gonzalez-Martin, A (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Zool & Phys Anthropol, Madrid, Spain.	antonio@bio.ucm.es	Acuna Alonzo, Victor/E-2312-2013; Gonzalez-Martin, Antonio/A-5489-2015; RANGEL-VILLALOBOS, HECTOR/C-5081-2018	Acuna Alonzo, Victor/0000-0003-2205-7625; Gonzalez-Martin, Antonio/0000-0003-0276-0778; RANGEL-VILLALOBOS, HECTOR/0000-0003-2641-8782	Mexican government (CONACyT) [129693]; Ministerio de Ciencia e Innovacion, Spain [HAR 2010-21963]	Mexican government (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by the Mexican government (CONACyT No129693 grant) to H. R.-V. and HAR 2010-21963 from Ministerio de Ciencia e Innovacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbujani G, 2006, HUM HERED, V61, P15, DOI 10.1159/000091832; Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104; Bolnick DA, 2003, AM J PHYS ANTHROPOL, V122, P336, DOI 10.1002/ajpa.10284; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; CAMPBELL L, 1986, LANGUAGE, V62, P530, DOI 10.2307/415477; Campbell Lyle, 1997, AM INDIAN LANGUAGES; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Comas D, 2000, HUM GENET, V107, P312, DOI 10.1007/s004390000370; Crawford MH, 2010, HUM BIOL, V82, P695, DOI 10.3378/027.082.0511; Duverger C, 2007, PRIMER MESTIZAJE CLA; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hedrick BC, 1974, MESOAMERICAN SW A RE; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Hernandez Montes M, 2004, TEPEHUAS PUEBLOS IND; Hope M, 2006, PIMAS; Hunley K, 2005, P NATL ACAD SCI USA, V102, P1312, DOI 10.1073/pnas.0409301102; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Kemp BM, 2005, BIOMOLECULAR ARCHAEO, P22; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kroeber AL, 1939, U CALIFORNIA PUBLICA; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Malhi RS, 2002, AM J HUM GENET, V70, P905, DOI 10.1086/339690; Malhi RS, 2001, HUM BIOL, V73, P17, DOI 10.1353/hub.2001.0008; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; MANTEL N, 1967, CANCER RES, V27, P209; Moctezuma Zamarron JL, 2007, MAYOS; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Nikolai G, 2006, MAYAS CIVILIZACION M; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Pailes RA, 1995, WORLDWIDE ARCHAEOLOG; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ramachandran S, 2011, AM J PHYS ANTHROPOL, V146, P515, DOI 10.1002/ajpa.21533; REYNOLDS J, 1983, GENETICS, V105, P767; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rubi-Castellanos R, 2009, AM J PHYS ANTHROPOL, V139, P284, DOI 10.1002/ajpa.20980; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Salazar-Flores J, 2010, AM J HUM BIOL, V22, P401, DOI 10.1002/ajhb.21013; Sanders William T., 1968, MESOAMERICA EVOLUTIO; Sandoval K, 2012, AM J PHYS ANTHROPOL, V148, P395, DOI 10.1002/ajpa.22062; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Tajima F, 1996, GENETICS, V143, P1457; Tajima F, 1993, MECH MOL EVOLUTION I; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; TORRONI A, 1993, AM J HUM GENET, V53, P563; Townsend RF, 1992, AZTECS; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185	55	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44666	10.1371/journal.pone.0044666	http://dx.doi.org/10.1371/journal.pone.0044666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028577	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400032
J	Rayman, MP; Blundell-Pound, G; Pastor-Barriuso, R; Guallar, E; Steinbrenner, H; Stranges, S				Rayman, Margaret P.; Blundell-Pound, Gabrielle; Pastor-Barriuso, Roberto; Guallar, Eliseo; Steinbrenner, Holger; Stranges, Saverio			A Randomized Trial of Selenium Supplementation and Risk of Type-2 Diabetes, as Assessed by Plasma Adiponectin	PLOS ONE			English	Article							SELENOPROTEIN P; INSULIN-RESISTANCE; METABOLIC SYNDROME; PROSTATE-CANCER; VITAMIN-E; EXPRESSION; PROTEIN; OBESITY; ASSOCIATION; POPULATION	Background: Evidence that selenium affects the risk of type-2 diabetes is conflicting, with observational studies and a few randomized trials showing both lower and higher risk linked to the level of selenium intake and status. We investigated the effect of selenium supplementation on the risk of type-2 diabetes in a population of relatively low selenium status as part of the UK PRECISE (PREvention of Cancer by Intervention with SElenium) pilot study. Plasma adiponectin concentration, a recognised independent predictor of type-2 diabetes risk and known to be correlated with circulating selenoprotein P, was the biomarker chosen. Methods: In a randomized, double-blind, placebo-controlled trial, five hundred and one elderly volunteers were randomly assigned to a six-month intervention with 100, 200 or 300 mu g selenium/d as high-selenium or placebo yeast. Adiponectin concentration was measured by ELISA at baseline and after six months of treatment in 473 participants with one or both plasma samples available. Results: Mean (SD) plasma selenium concentration was 88.5 ng/g (19.1) at baseline and increased significantly in the selenium-treatment groups. In baseline cross-sectional analyses, the fully adjusted geometric mean of plasma adiponectin was 14% lower (95% CI, 0-27%) in the highest than in the lowest quartile of plasma selenium (P for linear trend = 0.04). In analyses across randomized groups, however, selenium supplementation had no effect on adiponectin levels after six months of treatment (P = 0.96). Conclusions: These findings are reassuring as they did not show a diabetogenic effect of a six-month supplementation with selenium in this sample of elderly individuals of relatively low selenium status.	[Rayman, Margaret P.; Blundell-Pound, Gabrielle] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Pastor-Barriuso, Roberto] Carlos III Inst Hlth, Natl Ctr Epidemiol, Madrid, Spain; [Pastor-Barriuso, Roberto] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Guallar, Eliseo] Natl Ctr Cardiovasc Res CNIC, Madrid, Spain; [Steinbrenner, Holger] Univ Dusseldorf, Inst Biochem & Mol Biol 1, Dusseldorf, Germany; [Stranges, Saverio] Univ Warwick, Div Hlth Sci, Sch Med, Coventry CV4 7AL, W Midlands, England	University of Surrey; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Heinrich Heine University Dusseldorf; University of Warwick	Rayman, MP (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England.	m.rayman@surrey.ac.uk	Steinbrenner, Holger/AAD-6323-2019; Pastor-Barriuso, Roberto/AAA-6746-2019; Guallar, Eliseo/D-3807-2014	Pastor-Barriuso, Roberto/0000-0002-7325-3960; Guallar, Eliseo/0000-0002-4471-9565; Steinbrenner, Holger/0000-0003-2754-2435; Stranges, Saverio/0000-0001-5226-8373	Cancer Research UK; University of Surrey; Pharma Nord, Denmark; Deutsche Forschungsgemeinschaft (DFG; Bonn, Germany) [STE 1782/2-2]	Cancer Research UK(Cancer Research UK); University of Surrey; Pharma Nord, Denmark; Deutsche Forschungsgemeinschaft (DFG; Bonn, Germany)(German Research Foundation (DFG))	The authors acknowledge the financial support of Cancer Research UK (formerly the Cancer Research Campaign) for the UK PRECISE Pilot Trial. Funding for ELISA kits for adiponectin measurement was provided by the University of Surrey and by Pharma Nord, Denmark. The work of HS was supported by a grant (STE 1782/2-2) from Deutsche Forschungsgemeinschaft (DFG; Bonn, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-21; Alizadeh M, 2012, ANN NUTR METAB, V60, P157, DOI 10.1159/000335470; Bleys J, 2007, DIABETES CARE, V30, P829, DOI 10.2337/dc06-1726; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Czernichow S, 2006, AM J CLIN NUTR, V84, P395; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P2838, DOI 10.1210/jc.2002-021721; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hu Y, 2011, BRIT J NUTR, V106, P572, DOI 10.1017/S0007114511000420; Hurst R, 2010, AM J CLIN NUTR, V91, P923, DOI 10.3945/ajcn.2009.28169; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kantartzis K, 2005, OBES RES, V13, P1683, DOI 10.1038/oby.2005.206; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Labunskyy VM, 2011, ANTIOXID REDOX SIGN, V14, P2327, DOI 10.1089/ars.2010.3526; Laclaustra M, 2009, ENVIRON HEALTH PERSP, V117, P1409, DOI 10.1289/ehp.0900704; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Lide D. R., 1993, CRC HDB CHEM PHYS; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Misu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034952; Misu H, 2010, CELL METAB, V12, P483, DOI 10.1016/j.cmet.2010.09.015; Montonen J, 2011, EUR J EPIDEMIOL, V26, P29, DOI 10.1007/s10654-010-9539-0; Mueller AS, 2009, FREE RADICAL RES, V43, P1029, DOI 10.1080/10715760903196925; Mueller AS, 2009, J NUTR BIOCHEM, V20, P235, DOI 10.1016/j.jnutbio.2008.02.007; Pinto A, 2012, J INORG BIOCHEM, V114, P47, DOI 10.1016/j.jinorgbio.2012.04.011; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Rayman M, 2006, BIOL PSYCHIAT, V59, P147, DOI 10.1016/j.biopsych.2005.06.019; Rayman MP, 2008, AM J CLIN NUTR, V87, P370, DOI 10.1093/ajcn/87.2.370; Rayman MP, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P531, DOI 10.1007/978-1-4614-1025-6_42; Rayman MP, 2011, ANN INTERN MED, V154, P656, DOI 10.7326/0003-4819-154-10-201105170-00005; Salas-Salvado J, 2007, METABOLISM, V56, P1486, DOI 10.1016/j.metabol.2007.06.014; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Shand B, 2006, CLIN CHEM LAB MED, V44, P1264, DOI 10.1515/CCLM.2006.227; Speckmann B, 2009, BIOCHEM BIOPH RES CO, V387, P158, DOI 10.1016/j.bbrc.2009.06.143; Steinbrenner H, 2011, J CLIN BIOCHEM NUTR, V48, P40, DOI 10.3164/jcbn.11-002FR; Stenholm S, 2010, CLIN ENDOCRINOL, V73, P55, DOI 10.1111/j.1365-2265.2009.03742.x; Stranges S, 2010, NUTR METAB CARDIOVAS, V20, P754, DOI 10.1016/j.numecd.2010.10.001; Stranges S, 2007, ANN INTERN MED, V147, P217, DOI 10.7326/0003-4819-147-4-200708210-00175; Stranges S, 2011, ATHEROSCLEROSIS, V217, P274, DOI 10.1016/j.atherosclerosis.2011.03.027; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Wang XD, 2008, DIABETOLOGIA, V51, P1515, DOI 10.1007/s00125-008-1055-3; Yang SJ, 2011, J CLIN ENDOCR METAB, V96, pE1325, DOI 10.1210/jc.2011-0620; You TJ, 2008, J GERONTOL A-BIOL, V63, P414, DOI 10.1093/gerona/63.4.414; Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968; Zhang YY, 2011, AM J PHYSIOL-ENDOC M, V300, pE77, DOI 10.1152/ajpendo.00380.2010; Zhu N, 2010, J CLIN ENDOCR METAB, V95, P5097, DOI 10.1210/jc.2010-0716	48	68	70	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45269	10.1371/journal.pone.0045269	http://dx.doi.org/10.1371/journal.pone.0045269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028897	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400070
J	Ryoo, JH; Cho, SH; Kim, SW				Ryoo, Jae-Hong; Cho, Soo Hyun; Kim, Sang-Wook			Prediction of Risk Factors for Coronary Heart Disease Using Framingham Risk Score in Korean Men	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; CARDIOVASCULAR-DISEASE; LIPOPROTEIN CHOLESTEROL; LIFE-STYLE; ATHEROSCLEROSIS; THERAPY; TARGETS; RATIO	Background: Currently, there is sparse data available on the relationship between coronary heart disease (CHD) and its risk factors estimated by the Framingham Risk Score (FRS) in Korea. This is particularly true when looking at risk factors of CHD associated with the FRS after adjustment for other covariates especially in healthy subjects. Methodology/Principal Findings: We conducted a prospective cohort study to examine the association between the risk factors of CHD and the risk for CHD estimated by FRS in 15,239 men in 2005 and 2010. The FRS is based on six coronary risk factors: gender, age, total cholesterol, high-density lipoprotein (HDL)-cholesterol, systolic blood pressure (BP), and smoking habit. Multiple linear regression analysis was used to analyze the relationships between the FRS and risk factors for CHD. This study reported that apolipoproetein B (apoB), apoA-I, apoB/apoA-I, alcohol intake, log-transformed TG, log-transformed hsCRP, LDL-cholesterol, hypertension, diabetes, regular exercise, and BMI were significantly associated with the FRS. Above all, the partial R-square of apoB was 14.77%, which was overwhelmingly bigger than that of other variables in model V. This indicated that apoB accounted for 14.77% of the variance in FRS. Conclusion/Significance: In this study, apoB was found to be the most important determinant for the future development of CHD during a 5-year follow-up in healthy Korean men.	[Cho, Soo Hyun] Chung Ang Univ Hosp, Coll Med, Dept Family Med, Seoul, South Korea; [Ryoo, Jae-Hong] Kyung Hee Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kim, Sang-Wook] Chung Ang Univ Hosp, Heart Res Inst, Seoul, South Korea; [Ryoo, Jae-Hong] Sungkyunkwan Univ, Coll Med, Kangbuk Samsung Hosp, Dept Occupat Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Kyung Hee University; Chung Ang University; Chung Ang University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Cho, SH (corresponding author), Chung Ang Univ Hosp, Coll Med, Dept Family Med, Seoul, South Korea.	soohu@hanmail.net	Cho, Soo Hyun/AAZ-4770-2021	Cho, Soo Hyun/0000-0002-0054-2366; Ryoo, Jae-Hong/0000-0002-5232-1426				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bachorik PS, 1997, CLIN CHEM, V43, P2364; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Benn M, 2007, ARTERIOSCL THROM VAS, V27, P661, DOI 10.1161/01.ATV.0000255580.73689.8e; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Marcovina S, 2006, J INTERN MED, V259, P437, DOI 10.1111/j.1365-2796.2006.01648.x; MARCOVINA SM, 1994, CLIN CHEM, V40, P586; Miremadi S, 2002, CLIN CHEM, V48, P484; Mozaffarian D, 2008, CIRCULATION, V117, P3031, DOI 10.1161/CIRCULATIONAHA.107.738732; Olofsson SO, 2007, VASC HEALTH RISK MAN, V3, P491; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Poirier P, 2008, CIRCULATION, V117, P3057, DOI 10.1161/CIRCULATIONAHA.108.784389; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Shai I, 2004, CIRCULATION, V110, P2824, DOI 10.1161/01.CIR.0000146339.57154.9B; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Sierra-Johnson Justo, 2008, J Cardiometab Syndr, V3, P53, DOI 10.1111/j.1559-4572.2008.07610.x; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; TUNSTALLPEDOE H, 1991, BRIT MED J, V303, P744, DOI 10.1136/bmj.303.6805.744; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007; Vekic J, 2007, CLIN BIOCHEM, V40, P310, DOI 10.1016/j.clinbiochem.2006.11.013; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; Wannamethee SG, 2008, ATHEROSCLEROSIS, V201, P168, DOI 10.1016/j.atherosclerosis.2008.01.019; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X	29	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45030	10.1371/journal.pone.0045030	http://dx.doi.org/10.1371/journal.pone.0045030			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028747	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400057
J	Thomsen, N; Ali, RG; Ahmed, JN; Arkell, RM				Thomsen, Nicole; Ali, Radiya G.; Ahmed, Jehangir N.; Arkell, Ruth M.			High Resolution Melt Analysis (HRMA); a Viable Alternative to Agarose Gel Electrophoresis for Mouse Genotyping	PLOS ONE			English	Article							DNA; PLATFORM	Most mouse genetics laboratories maintain mouse strains that require genotyping in order to identify the genetically modified animals. The plethora of mutagenesis strategies and publicly available mouse alleles means that any one laboratory may maintain alleles with random or targeted insertions of orthologous or unrelated sequences as well as random or targeted deletions and point mutants. Many experiments require that different strains be cross bred conferring the need to genotype progeny at more than one locus. In contrast to the range of new technologies for mouse mutagenesis, genotyping methods have remained relatively static with alleles typically discriminated by agarose gel electrophoresis of PCR products. This requires a large amount of researcher time. Additionally it is susceptible to contamination of future genotyping experiments because it requires that tubes containing PCR products be opened for analysis. Progress has been made with the genotyping of mouse point mutants because a range of new high-throughput techniques have been developed for the detection of Single Nucleotide Polymorphisms. Some of these techniques are suitable for genotyping point mutants but do not detect insertion or deletion alleles. Ideally, mouse genetics laboratories would use a single, high-throughput platform that enables closed-tube analysis to genotype the entire range of possible insertion and deletion alleles and point mutants. Here we show that High Resolution Melt Analysis meets these criteria, it is suitable for closed-tube genotyping of all allele types and current genotyping assays can be converted to this technology with little or no effort.	[Thomsen, Nicole; Ali, Radiya G.; Ahmed, Jehangir N.; Arkell, Ruth M.] Australian Natl Univ, Res Sch Biol, Early Mammalian Dev Lab, Canberra, ACT, Australia	Australian National University	Arkell, RM (corresponding author), Australian Natl Univ, Res Sch Biol, Early Mammalian Dev Lab, Canberra, ACT, Australia.	ruth.arkell@anu.edu.au	Arkell, Ruth/AAR-8471-2021; arkell, ruth m/D-1525-2009	Arkell, Ruth/0000-0002-6213-7323; arkell, ruth m/0000-0002-6213-7323; Ahmed, Jehangir/0000-0002-3503-0467	NHMRC [366476, 1003648]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by NHMRC (http://www.nhmrc.gov.au) grants 366476 and 1003648 (to R.M.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkel RM, 2001, MAMM GENOME, V12, P687, DOI 10.1007/s00335-001-2066-2; Bogani D, 2005, P NATL ACAD SCI USA, V102, P12477, DOI 10.1073/pnas.0500584102; Delibato E, 2009, J SEP SCI, V32, P3817, DOI 10.1002/jssc.200900166; GENSAT, GEN EXPR NERV SYST A; Guan CM, 2010, GENESIS, V48, P73, DOI 10.1002/dvg.20594; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; Lay MJ, 1997, CLIN CHEM, V43, P2262; Li QB, 2002, ELECTROPHORESIS, V23, P1499, DOI 10.1002/1522-2683(200205)23:10<1499::AID-ELPS1499>3.0.CO;2-X; McPherson MJ, 2006, PCR; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Parant JM, 2009, DEV DYNAM, V238, P3168, DOI 10.1002/dvdy.22143; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Sambrook J., 2001, MOL CLONING LAB MANU; SCHNEEBERGER C, 1995, PCR METH APPL, V4, P234; Thomsen N, 2011, GENESIS, V49, P681, DOI 10.1002/dvg.20735; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101	22	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45252	10.1371/journal.pone.0045252	http://dx.doi.org/10.1371/journal.pone.0045252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028882	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388400067
J	Cheriyan, J; Mohanan, AG; Kurup, PK; Mayadevi, M; Omkumar, RV				Cheriyan, John; Mohanan, Archana G.; Kurup, Pradeep K.; Mayadevi, Madhavan; Omkumar, Ramakrishnapillai Vyomakesannair			Effect of Multimeric Structure of CaMKII in the GluN2B-Mediated Modulation of Kinetic Parameters of ATP	PLOS ONE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; NR2B SUBUNIT; SYNAPTIC PLASTICITY; RECEPTOR; BINDING; CALMODULIN; ALPHA; AUTOPHOSPHORYLATION; LOCALIZATION	Interaction of GluN2B subunit of N-methyl-D-aspartate receptor with calcium/calmodulin dependent protein kinase II (CaMKII) is critical for the induction of long term potentiation at hippocampal CA3-CA1 synapses. We have previously reported that CaMKII binding to GluN2B increases its affinity but abolishes the cooperativity for ATP. In the present study, we demonstrate that the reduction in S-0.5 for ATP of an individual CaMKII subunit seems to be directly induced by the binding of GluN2B to the same subunit, while any GluN2B induced effects on the cooperativity and maximal velocity would additionally require the CaMKII holoenzyme structure. We measured the apparent kinetic parameters for ATP using an association domain truncated monomeric CaMKII and a heteromultimeric CaMKII (having subunits that are either GluN2B binding defective or ATP binding defective), in the presence of GluN2A or GluN2B substrates. The S-0.5 value for ATP of monomeric CaMKII is reduced, similar to 3 fold by the presence of GluN2B suggesting that the induced change in affinity for ATP is independent of the holoenzyme structure. The heteromultimeric mutant of CaMKII, did not exhibit cooperativity of ATP binding probably because of the interspersing of ATP binding defective subunits in the holoenzyme. In contrast to the wild type holoenzyme, presence of GluN2B increased the Vmax of monomeric CaMKII which resulted in an approximately 4.0 fold increase in the apparent catalytic constant (V-max/S-0.5) as compared to GluN2A. The kinetic parameter values of the heteromultimeric CaMKII for ATP, on the other hand, did not show any significant difference between the phosphorylation of GluN2B and GluN2A suggesting that modulation requires binding of GluN2B to the same subunit. Overall, our present study provides insights into the role of multimeric structure of CaMKII in GluN2B-mediated regulation.	[Cheriyan, John; Mohanan, Archana G.; Kurup, Pradeep K.; Mayadevi, Madhavan; Omkumar, Ramakrishnapillai Vyomakesannair] Rajiv Gandhi Ctr Biotechnol, Mol Neurobiol Div, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Omkumar, RV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Mol Neurobiol Div, Thiruvananthapuram, Kerala, India.	omkumar@rgcb.res.in			Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology and Department of Science and Technology of Government of India; University Grants Commission Council of Scientific and Industrial Research of the Government of India	Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology and Department of Science and Technology of Government of India; University Grants Commission Council of Scientific and Industrial Research of the Government of India	Research grants from the Rajiv Gandhi Centre for Biotechnology, Department of Biotechnology and Department of Science and Technology of Government of India supported this work. JC and AGM received grants from University Grants Commission and Council of Scientific and Industrial Research of the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Cheriyan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016495; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mayadevi M., 2012, NEUROSCIENCE DEALING; Mironov SL, 2007, BIOPHYS J, V92, P2944, DOI 10.1529/biophysj.106.092981; MUKHERJI S, 1994, J BIOL CHEM, V269, P13744; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Rich RC, 1998, J BIOL CHEM, V273, P28424, DOI 10.1074/jbc.273.43.28424; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Yamagata Y, 2009, J NEUROSCI, V29, P7607, DOI 10.1523/JNEUROSCI.0707-09.2009; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	30	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45064	10.1371/journal.pone.0045064	http://dx.doi.org/10.1371/journal.pone.0045064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028764	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900074
J	Karki, HS; Shrestha, BK; Han, JW; Groth, DE; Barphagha, IK; Rush, MC; Melanson, RA; Kim, BS; Ham, JH				Karki, Hari S.; Shrestha, Bishnu K.; Han, Jae Woo; Groth, Donald E.; Barphagha, Inderjit K.; Rush, Milton C.; Melanson, Rebecca A.; Kim, Beom Seok; Ham, Jong Hyun			Diversities in Virulence, Antifungal Activity, Pigmentation and DNA Fingerprint among Strains of Burkholderia glumae	PLOS ONE			English	Article							CEPACIA COMPLEX; PATHOGEN; RICE; TOXOFLAVIN; DISEASE; SYSTEM; IDENTIFICATION; BIOSYNTHESIS; XANTHOMONAS; SECRETION	Burkholderia glumae is the primary causal agent of bacterial panicle blight of rice. In this study, 11 naturally avirulent and nine virulent strains of B. glumae native to the southern United States were characterized in terms of virulence in rice and onion, toxofalvin production, antifungal activity, pigmentation and genomic structure. Virulence of B. glumae strains on rice panicles was highly correlated to virulence on onion bulb scales, suggesting that onion bulb can be a convenient alternative host system to efficiently determine the virulence of B. glumae strains. Production of toxoflavin, the phytotoxin that functions as a major virulence factor, was closely associated with the virulence phenotypes of B. glumae strains in rice. Some strains of B. glumae showed various levels of antifungal activity against Rhizoctonia solani, the causal agent of sheath blight, and pigmentation phenotypes on casamino acid-peptone-glucose (CPG) agar plates regardless of their virulence traits. Purple and yellow-green pigments were partially purified from a pigmenting strain of B. glumae, 411gr-6, and the purple pigment fraction showed a strong antifungal activity against Collectotrichum orbiculare. Genetic variations were detected among the B. glumae strains from DNA fingerprinting analyses by repetitive element sequence-based PCR (rep-PCR) for BOX-A1R-based repetitive extragenic palindromic (BOX) or enterobacterial repetitive intergenic consensus (ERIC) sequences of bacteria; and close genetic relatedness among virulent but pigment-deficient strains were revealed by clustering analyses of DNA fingerprints from BOX- and ERIC-PCR.	[Karki, Hari S.; Shrestha, Bishnu K.; Barphagha, Inderjit K.; Rush, Milton C.; Melanson, Rebecca A.; Ham, Jong Hyun] Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA; [Groth, Donald E.] Louisiana State Univ, Ctr Agr, Rice Res Stn, Rayne, LA USA; [Han, Jae Woo; Kim, Beom Seok] Korea Univ, Div Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Korea University	Ham, JH (corresponding author), Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA.	jham@agcenter.lsu.edu	Karki, Hari Sharan/AAB-5819-2020		Louisiana State University Agricultural Center [LAB93918]; Louisiana Board of Regents Support Fund [LEQSF (2008-11)-RD-A-02]; Louisiana Rice Research Board [940-38-4158, 940-38-4173]	Louisiana State University Agricultural Center; Louisiana Board of Regents Support Fund; Louisiana Rice Research Board	This work was financially supported by the Louisiana State University Agricultural Center (LAB93918), the Research and Development Program of the Louisiana Board of Regents Support Fund (Grant number: LEQSF (2008-11)-RD-A-02), and the Louisiana Rice Research Board (Grant numbers: 940-38-4158 and 940-38-4173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Cha K.H., 2001, RES PLANT DIS, V7, P150; Chiarini L, 2006, TRENDS MICROBIOL, V14, P277, DOI 10.1016/j.tim.2006.04.006; Chun H, 2009, J BACTERIOL, V191, P4152, DOI 10.1128/JB.00227-09; Degrassi G, 2008, FEMS MICROBIOL ECOL, V65, P251, DOI 10.1111/j.1574-6941.2008.00516.x; Devescovi G, 2007, APPL ENVIRON MICROB, V73, P4950, DOI 10.1128/AEM.00105-07; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gassmann W, 2000, J BACTERIOL, V182, P7053, DOI 10.1128/JB.182.24.7053-7059.2000; Groth DE, 2007, J PLANT REGIST, V1, P63, DOI 10.3198/jpr2006.10.0677crg; Ham J H, 2011, BACTERIAL PANICLE BL, P16; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; Jacobs JL, 2008, APPL ENVIRON MICROB, V74, P3121, DOI 10.1128/AEM.01941-07; Jeong Y, 2003, PLANT DIS, V87, P890, DOI 10.1094/PDIS.2003.87.8.890; Jung WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022443; Kang Y, 2008, PROTEOMICS, V8, P106, DOI 10.1002/pmic.200700244; Karki HS, 2012, MOL PLANT PATHOL; Keith KE, 2007, J BACTERIOL, V189, P9057, DOI 10.1128/JB.00436-07; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; LEVENBERG B, 1966, J BIOL CHEM, V241, P846; LOUWS FJ, 1994, APPL ENVIRON MICROB, V60, P2286, DOI 10.1128/AEM.60.7.2286-2295.1994; Maeda Yukiko, 2004, Journal of General Plant Pathology, V70, P215, DOI 10.1007/s10327-003-0114-3; Maeda Y, 2006, INT J SYST EVOL MICR, V56, P1031, DOI 10.1099/ijs.0.64184-0; Mohr TJ, 2008, J BACTERIOL, V190, P2858, DOI 10.1128/JB.01757-07; Nandakumar R, 2009, PLANT DIS, V93, P896, DOI 10.1094/PDIS-93-9-0896; O'Grady EP, 2011, J BACTERIOL, V193, P163, DOI 10.1128/JB.00852-10; Parke JL, 2001, ANNU REV PHYTOPATHOL, V39, P225, DOI 10.1146/annurev.phyto.39.1.225; ROSS JP, 1995, CLIN INFECT DIS, V21, P1291, DOI 10.1093/clinids/21.5.1291; Sayler RJ, 2006, PLANT DIS, V90, P603, DOI 10.1094/PD-90-0603; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Suzuki Fumihiko, 2004, Journal of General Plant Pathology, V70, P97, DOI 10.1007/s10327-003-0096-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsushima Seiya, 1995, Annals of the Phytopathological Society of Japan, V61, P419, DOI 10.3186/jjphytopath.61.419; URAKAMI T, 1994, INT J SYST BACTERIOL, V44, P235, DOI 10.1099/00207713-44-2-235; Wang ZZ, 1996, BRIT J PHARMACOL, V117, P293, DOI 10.1111/j.1476-5381.1996.tb15189.x; Weinberg JB, 2007, J CLIN MICROBIOL, V45, P662, DOI 10.1128/JCM.02058-06; Zughaier SM, 1999, INFECT IMMUN, V67, P908, DOI 10.1128/IAI.67.2.908-913.1999	41	39	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45376	10.1371/journal.pone.0045376	http://dx.doi.org/10.1371/journal.pone.0045376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028972	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900131
J	Yang, Q; Makarkin, VN; Winterton, SL; Khramov, AV; Ren, D				Yang, Qiang; Makarkin, Vladimir N.; Winterton, Shaun L.; Khramov, Alexander V.; Ren, Dong			A Remarkable New Family of Jurassic Insects (Neuroptera) with Primitive Wing Venation and Its Phylogenetic Position in Neuropterida	PLOS ONE			English	Article							OVERLYING DAOHUGOU BED; GIANT LACEWINGS NEUROPTERA; CRETACEOUS CRATO-FORMATION; INNER-MONGOLIA; NORTHEASTERN CHINA; CLADISTIC-ANALYSIS; EARLY EOCENE; AGE; IGNIMBRITE; AETHEOGRAMMATIDAE	Background: Lacewings (insect order Neuroptera), known in the fossil record since the Early Permian, were most diverse in the Mesozoic. A dramatic variety of forms ranged in that time from large butterfly-like Kalligrammatidae to minute two-winged Dipteromantispidae. Principal Findings: We describe the intriguing new neuropteran family Parakseneuridae fam. nov. with three new genera and 15 new species from the Middle Jurassic of Daohugou (Inner Mongolia, China) and the Early/Middle Jurassic of Sai-Sagul (Kyrgyzstan): Parakseneura undula gen. et sp. nov., P. albomacula gen. et sp. nov., P. curvivenis gen. et sp. nov., P. nigromacula gen. et sp. nov., P. nigrolinea gen. et sp. nov., P. albadelta gen. et sp. nov., P. cavomaculata gen. et sp. nov., P. inflata gen. et sp. nov., P. metallica gen. et sp. nov., P. emarginata gen. et sp. nov., P. directa gen. et sp. nov., Pseudorapisma jurassicum gen. et sp. nov., P. angustipenne gen. et sp. nov., P. maculatum gen. et sp. nov. (Daohugou); Shuraboneura ovata gen. et sp. nov. (Sai-Sagul). The family comprises large neuropterans with most primitive wing venation in the order indicated by the presence of ScA and AA1+2, and the dichotomous branching of MP, CuA, CuP, AA3+4, AP1+2. The phylogenetic position of Parakseneuridae was investigated using a phylogenetic analysis of morphological scoring for 33 families of extinct and extant Neuropterida combined with DNA sequence data for representatives of all extant families. Parakseneuridae were recovered in a clade with Osmylopsychopidae, Prohemerobiidae, and Ithonidae. Conclusions/Significance: The presence of the presumed AA1+2 in wings of Parakseneuridae is a unique plesiomorphic condition hitherto unknown in Neuropterida, the clade comprising Neuroptera, Megaloptera, Raphidioptera. The relative uncertainty of phylogenetic position of Parakseneuridae and the majority of other families of Neuroptera reflects deficient paleontological data, especially from critical important periods for the order, earliest Triassic and latest Triassic/earliest Jurassic.	[Yang, Qiang; Makarkin, Vladimir N.; Ren, Dong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Makarkin, Vladimir N.] Russian Acad Sci, Inst Biol & Soil Sci, Far Eastern Branch, Vladivostok 690022, Russia; [Winterton, Shaun L.] Calif Dept Food & Agr, Calif State Collect Arthropods, Sacramento, CA 95814 USA; [Khramov, Alexander V.] Russian Acad Sci, Borissiak Paleontol Inst, Moscow, Russia	Capital Normal University; Russian Academy of Sciences; Federal Scientific Center of the East Asia Terrestrial Biodiversity, Far Eastern Branch of the Russian Academy of Sciences; California Department of Food & Agriculture; Russian Academy of Sciences; Paleontological Institute of the Russian Academy of Sciences	Makarkin, VN (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	vnmakarkin@mail.ru; rendong@mail.cnu.edu.cn	Winterton, Shaun L/C-3804-2009	Khramov, Alexander/0000-0002-6888-5162	National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [31071964, 31172143]; China Geological Survey [1212011120116]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Geological Survey(China Geological Survey)	This research is supported by the National Basic Research Program of China (973 Program) (2012CB821906), the National Natural Science Foundation of China (No. 31071964, 31172143) and China Geological Survey (1212011120116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PHILLIP A., 1958, PSYCHE, V65, P115, DOI 10.1155/1958/26768; Archibald SB, 2006, J SYST PALAEONTOL, V4, P119, DOI 10.1017/S1477201906001817; ASPOCK H, 1991, MONOGRAPHISCHE DARST, V1; Aspock U, 2002, ZOOL SCR, V31, P51, DOI 10.1046/j.0300-3256.2001.00087.x; Aspock U, 2001, SYST ENTOMOL, V26, P73, DOI 10.1046/j.1365-3113.2001.00136.x; Aspock U, 2008, SYST ENTOMOL, V33, P97, DOI 10.1111/j.1365-3113.2007.00396.x; Aspock Ulrike, 1992, P63; Bethoux O., 2010, ALAVESIA, V3, P87; Bethoux Olivier, 2005, Illiesia, V1, P52; Beutel RG, 2010, ZOOL J LINN SOC-LOND, V158, P533, DOI 10.1111/j.1096-3642.2009.00560.x; [陈文 Chen Wen], 2004, [地质通报, Geological Bulletin of China], V23, P1165; Comstock JH, 1918, WINGS INSECTS; Contreras-Ramos A, 2011, ZOOTAXA, P1; Engel Michael S., 2005, Transactions of the Kansas Academy of Science, V108, P59, DOI 10.1660/0022-8443(2005)108[0059:ARKLFT]2.0.CO;2; Engel MS, 2011, J KANSAS ENTOMOL SOC, V84, P315, DOI 10.2317/JKES110623.1; Engel Michael S., 2008, Nova Supplementa Entomologica, V20, P1; Gao KQ, 2006, ACTA GEOL SIN-ENGL, V80, P42; Gao KQ, 2003, NATURE, V422, P424, DOI 10.1038/nature01491; Grimaldi David, 2005, pi; Handlirsch A, 1906, HDB PALAEONTOLOGEN Z; Haring E, 2004, SYST ENTOMOL, V29, P415, DOI 10.1111/j.0307-6970.2004.00263.x; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; He HY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022787; Jepson JE, 2007, PALAEOGEOGR PALAEOCL, V248, P109, DOI 10.1016/j.palaeo.2006.11.015; Jepson JE, 2009, CRETACEOUS RES, V30, P1325, DOI 10.1016/j.cretres.2009.07.012; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; [季强 Ji Qiang], 2002, [地质论评, Geological Review], V48, P221; Ji Qiang, 2005, Geological Review (Beijing), V51, P609; Khramov AV, 2010, PALEONTOL J+, V44, P188, DOI 10.1134/S0031030110020103; Krivokhatsky VA, 1998, THESIS RUSS ACAD SCI; Kukalova-Peck J, 2004, EUR J ENTOMOL, V101, P95, DOI 10.14411/eje.2004.018; Kukalova-Peck J., 1991, P141; KUKALOVAPECK J, 1983, CAN J ZOOL, V61, P1618, DOI 10.1139/z83-217; Kuzichkina YM, 1958, C UN STRAT CHARTS CE, P112; Labandeira CC, 2010, ANN MO BOT GARD, V97, P469, DOI 10.3417/2010037; Lambkin Kevin J., 1992, Memoirs of the Queensland Museum, V32, P183; [柳永清 Liu Yanxue], 2004, [地质通报, Geological Bulletin of China], V23, P1180; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; Liu YQ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022466; MacLeod E.G., 1964, THESIS HARVARD U CAM; Makarkin V.N., 1990, NOVOSTI FAUNISTIKI S, P63; Makarkin Vladimir N., 1993, Tropical Zoology, V6, P217; Makarkin VN, 2007, CRETACEOUS RES, V28, P743, DOI 10.1016/j.cretres.2006.11.003; Makarkin VN, 2012, CRETACEOUS RES, V35, P57, DOI 10.1016/j.cretres.2011.11.013; Makarkin VN, 2011, ZOOKEYS, P199, DOI 10.3897/zookeys.130.1418; Makarkin VN, 2010, ACTA GEOL SIN-ENGL, V84, P655, DOI 10.1111/j.1755-6724.2010.00238.x; Makarkin VN, 2010, ANN SOC ENTOMOL FR, V46, P254, DOI 10.1080/00379271.2010.10697666; Makarkin VN, 2009, ANN ENTOMOL SOC AM, V102, P964, DOI 10.1603/008.102.0606; Makarkin VN, 2005, CRETACEOUS RES, V26, P801, DOI 10.1016/j.cretres.2005.05.009; Makarkin VN, 2005, ZOOTAXA, P15; Makarkin VN, 2003, CAN ENTOMOL, V135, P637; Makarkin VN, 2003, ANN ENTOMOL SOC AM, V96, P171, DOI 10.1603/0013-8746(2003)096[0171:FAOTGP]2.0.CO;2; Makarkin VN, 2012, FOSSIL RECO IN PRESS; Makarkin VN, 2012, ACTA PALAEO IN PRESS; Martynov AV, 1937, T PALEONT I AKAD NAU, V7; Martynova O.M, 1949, T PALEONTOLOGICHESKO, V20, P150; Martynova OM, 1952, T PALEONTOL I AN SSS, V40, P197; Menon F, 2008, PALAEONTOLOGY, V51, P149, DOI 10.1111/j.1475-4983.2007.00740.x; Mi J.R., 1996, EARLY MIDDLE JURASSI; Nel A, 2005, ANN SOC ENTOMOL FR, V41, P29, DOI 10.1080/00379271.2005.10697440; Nel Andre, 2003, Geodiversitas, V25, P109; Novokshonov V.G., 1996, PALEONTOL J, V30, P38; OSWALD JD, 1993, J NEW YORK ENTOMOL S, V101, P143; Panfilov D.V., 1968, P166; Peng YY, 2010, ZOOTAXA, P59; Peng YY, 2011, ZOOKEYS, P217, DOI 10.3897/zookeys.130.1576; Ponomarenko A. G., 1992, T JOINT SOVIET MONGO, V41, P101; Ponomarenko A.G., 2002, HIST INSECTS, P176; PONOMARENKO AG, 1992, PALEONTOL J, V26, P56; Ren D, 2003, J NEW YORK ENTOMOL S, V111, P1, DOI 10.1664/0028-7199(2003)111[0001:NOFNFT]2.0.CO;2; Ren D, 2002, J KANSAS ENTOMOL SOC, V75, P188; Ren D., 2010, SILENT STORIES INSEC; Ren D, 2008, J KANSAS ENTOMOL SOC, V81, P161, DOI 10.2317/JKES-0804.15.1; [任东 Ren Dong], 2002, [地质通报, Geological Bulletin of China], V21, P584; Ren Dong, 2002, Entomologia Sinica, V9, P53; Ren D, 2010, ZOOTAXA, P50; Ren D, 2009, CRETACEOUS RES, V30, P1217, DOI 10.1016/j.cretres.2009.06.004; Schluter T., 1986, P103; Selden PA, 2008, J ARACHNOL, V36, P306, DOI 10.1636/CA07-106.1; Shen Yan-bin, 2003, Journal of Stratigraphy, V27, P311; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Sukacheva ID, 2004, PALEONTOL J+, V38, P182; Swofford DL, 1999, PAUP PHYL AN US PARS; Sziraki G., 1996, Folia Entomologica Hungarica, V57, P277; Tan Jing-Jing, 2002, Acta Zootaxonomica Sinica, V27, P428; Tillyard R. J., 1919, Proceedings of the Linnean Society of New South Wales, V44; Tjeder B., 1992, ENTOMOLOGICA SCAND S, V41, P3; Vilesov, 1995, PALEONTOL J, V29, P115; Vshivkova TS, 2010, P 10 INT S NEUR PIR, P278; Wang B, 2010, J PALEONTOL, V84, P774, DOI 10.1666/09-162.1; Wang XL, 2005, CHINESE SCI BULL, V50, P2369, DOI 10.1360/982005-581; Wang YJ, 2011, 11 INT S NEUR PONT D, P24; Wang YJ, 2010, THESIS CHINESE AGR U; Wang YJ, 2010, P NATL ACAD SCI USA, V107, P16212, DOI 10.1073/pnas.1006460107; Whitfield JB, 2008, ANNU REV ENTOMOL, V53, P449, DOI 10.1146/annurev.ento.53.103106.093304; Winterton Shaun L., 2003, Entomologische Abhandlungen (Dresden), V61, P158; Winterton SL, 2010, ANN ENTOMOL SOC AM, V103, P511, DOI 10.1603/AN10026; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; Winterton SL, 2011, 11 INT S NEUR PONT D, P20; Withycombe C. L., 1925, Transactions of the Entomological Society of London, V1924, P303; Wu Q.C., 2002, FOSSIL TREASURES LIA; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Yang Q, 2012, PALAEONTOLO IN PRESS; Yang Q, 2011, ZOOTAXA, P60; Yang W, 2004, S PETR GEOD CHIN HAI, P326; Zhang JF, 2006, CAN J EARTH SCI, V43, P9, DOI 10.1139/E05-092; Zhang JF, 2003, ORIENT INSECTS, V37, P301, DOI 10.1080/00305316.2003.10417351; Zhang Jun-feng, 2002, Journal of Stratigraphy, V26, P173; Zhang W.-t., 1987, Acta Palaeontologica Sinica, V26, P111; Zherikhin V. V., 1978, DEV CHANGES CRETACEO; Zimmerman E. C., 1957, INSECTS HAWAII, V6, P19; Zimmermann D, 2011, ARTHROPOD STRUCT DEV, V40, P571, DOI 10.1016/j.asd.2011.06.003	112	82	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44762	10.1371/journal.pone.0044762	http://dx.doi.org/10.1371/journal.pone.0044762			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028608	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900040
J	Aragao, F; Vera, J; Pinto, IV				Aragao, Filipa; Vera, Jose; Pinto, Ines Vaz			Cost-Effectiveness of the Third-Agent Class in Treatment-Naive Human Immunodeficiency Virus-Infected Patients in Portugal	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; CELL COUNT; HIV; PREDICTORS; PROTEASE; REGIMEN; EMTRICITABINE; INDIVIDUALS; LAMIVUDINE	Introduction: Current Portuguese HIV treatment guidelines recommend initiating antiretroviral therapy with a regimen composed of two Nucleoside Reverse Transcriptase Inhibitors plus one Non-nucleoside Reverse Transcriptase Inhibitor (2NRTI+NNRTI) or two Nucleoside Reverse Transcriptase Inhibitors plus one boosted protease inhibitor (2NRTI+PI/r). Given the lower daily cost of NNRTI as the third agent when compared to the average daily costs of PI/r, it is relevant to estimate the long term impact of each treatment option in the Portuguese context. Methods: We developed a microsimulation discrete events model for cost-effectiveness analysis of HIV treatment, simulating individual paths from ART initiation to death. Four driving forces determine the course of events: CD4+ cell count, viral load, resistance and adherence. Distributions of time to event are conditional to individuals' characteristics and past history. Time to event was modeled using parametric survival analysis using Stata 11 (R). Disease progression was structured according to therapy lines and the model was parameterized with cohort Portuguese observational data. All resources were valued at 2009 prices. The National Health Service's perspective was assumed considering a lifetime horizon and a 5% annual discount rate. Results: In this analysis, initiating therapy with two Nucleoside Reverse Transcriptase Inhibitors plus one Non-nucleoside Reverse Transcriptase Inhibitor reduces the average number of switches by 17%, saves 19.573(sic) per individual and increases life expectancy by 1.7 months showing to be a dominant strategy in 57% of the simulations when compared to two Nucleoside Reverse Transcriptase Inhibitors plus one boosted protease inhibitor. Conclusion: This study suggests that, when clinically valid, initiating therapy with two Nucleoside Reverse Transcriptase Inhibitors plus one Non-nucleoside Reverse Transcriptase Inhibitor is a cost-saving strategy and equally effective when compared to two Nucleoside Reverse Transcriptase Inhibitors plus one boosted protease inhibitor as the first regimen.	[Aragao, Filipa] Univ Nova Lisboa, Escola Nacl Saude Publ, P-1200 Lisbon, Portugal; [Aragao, Filipa] Associacao SER, Cascais, Portugal; [Vera, Jose; Pinto, Ines Vaz] HPP Hosp Cascais, Alcabideche, Cascais, Portugal	Universidade Nova de Lisboa	Aragao, F (corresponding author), Univ Nova Lisboa, Escola Nacl Saude Publ, P-1200 Lisbon, Portugal.	filipaaragao@gmail.com	Pinto, Inês/GVT-4690-2022	Vaz-Pinto, Ines/0000-0002-6281-8591; Aragao, Filipa/0000-0003-3446-6725; Vaz, Ines Regio/0000-0003-2410-7307	Fundacao para a Ciencia e Tecnologia, Programa Operacional "Ciencia, Tecnologia, Inovacao" [XXI/BD/19954/99]; Gilead Sciences; Fundacao para a Ciencia e Tecnologia; ViiV Healthcare; Boheringer Ingelheim; MSD; Gilead Sciencies; BMS; Abbott; Janssen	Fundacao para a Ciencia e Tecnologia, Programa Operacional "Ciencia, Tecnologia, Inovacao"; Gilead Sciences(Gilead Sciences); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); ViiV Healthcare; Boheringer Ingelheim; MSD; Gilead Sciencies(Gilead Sciences); BMS(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This work was financially supported by Fundacao para a Ciencia e Tecnologia, Programa Operacional "Ciencia, Tecnologia, Inovacao"- Formar e Qualificar - Medida 1.1., grant Praxis XXI/BD/19954/99 as part of FA's PhD grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors' have read the journal's policy and have the following conflicts: FA has received consultancy fees and travel grants from Gilead Sciences, paid scientific work from Escola Nacional de Saude Publica and Janssen-Cilag. FA has received grants from Fundacao para a Ciencia e Tecnologia. FA is a volunteer at the non-governmental organization Associacao SER+ and earns no financial or other benefits as a result of such affiliation. JV has received consultancy fees, travel grants and honoraria for speaking or participation at meetings from ViiV Healthcare, Boheringer Ingelheim, MSD, Gilead Sciencies, BMS, Abbott and Janssen. IVP has received travel grants and honoraria for speaking or participation at meetings from ViiV Healthcare, Boheringer Ingelheim, MSD, Gilead Sciencies, BMS, Abbott and Janssen. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Administracao Central do Sistema de Saude IP, 2009, CAT APR PUBL SAUD; Aragao F, 2010, ARQUIVOS MED, V24, P209; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Barth-Jones DC, 2000, PROCEEDINGS OF THE 2000 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P1985, DOI 10.1109/WSC.2000.899196; Barton P, 2004, HEALTH TECHNOL ASSES, V8, P1; Barton Pelham, 2004, J Health Serv Res Policy, V9, P110, DOI 10.1258/135581904322987535; Beck EJ, 2008, INT J STD AIDS, V19, P297, DOI 10.1258/ijsa.2007.007236; Beck EJ, 2010, PLOS ONE, V6; Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; Centro de Vigilancia Epidemiologica de Doencas Transmissiveis, 2011, SIT INF HIV SID PORT; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Coordenacao Nacional para a Infeccao VIH/sida, 2009, REC PORT TRAT INF VI; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; EMEA-European Medicines Agency, 2009, REP PREZ SCI DISC; European AIDS Clinical Society, 2009, GUID CLIN MAN TREATM; [European Centre for Disease Prevention and Control WHO Regional Office for Europe], 2011, HIV AIDS SURV EUR 20; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Geretti AM, 2008, ANTIVIR THER, V13, P927; Greenbaum AH, 2008, AIDS, V22, P2331, DOI 10.1097/QAD.0b013e32831883f9; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; INFARMED Autoridade Nacional do Medicamento e Produtos de Saude I. P., 2011, CONS MED MEIO HOSP D; INFARMED Autoridade Nacional do Medicamento e Produtos de Saude I.P, 2010, AN MERC MED AMB SERV; Instituto Nacional de Estatistica, 2009, TAB COMPL MORT PORT; Johnston KM, 2010, AIDS, V24, P1929, DOI 10.1097/QAD.0b013e32833af85d; Kagay CR, 2002, PHARMACOECONOMICS, V20, P215; Krentz HB, 2003, CAN MED ASSOC J, V169, P106; Kuhne FC, 2010, HIV CLIN TRIALS, V11, P80, DOI 10.1310/hct1102-80; Kuhne FC, 2007, IHEA 2007 6 WORLD C; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Liddy J, 2007, TIME VIRAL SUPPRESSI; Llibre-Codina JM, 2007, ENFERM INFEC MICR CL, V25, P98, DOI 10.1157/13098570; Lozano F, 2011, DOCUMENTO CONSENSO G; May M, 2005, J CLIN EPIDEMIOL, V58, P1033, DOI 10.1016/j.jclinepi.2005.02.015; McDowell Allen, 2004, DO YOU FIT MODEL DEP; Panel on Antiretroviral Guidelines for Adults and Adolescent, 2011, PAN ANT GUID AD AD G; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Phillips AN, 2008, J INT AIDS SOC S1, pO17; Reis A, 2007, ADESAO TERAPEUTICA I; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Silva EA, 1999, ORIENTACOES METODOLO; Simpson KN, 2009, PHARMACOECONOMICS, V27, P159, DOI 10.2165/00019053-200927020-00006; Simpson KN, 2004, HIV CLIN TRIALS, V5, P294, DOI 10.1310/WT81-MEM4-5C4L-CHPK; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; United Nations Economic Commission for Europe, 2010, UNECE STAT DAT EC ST; United Nations Programme on HIV/AIDS, 2009, AIDS EP UPD; Vieira IT, 2003, J OPER RES SOC, V54, P713, DOI 10.1057/palgrave.jors.2601566; Walensky RP, 2007, AIDS, V21, P973, DOI 10.1097/QAD.0b013e328011ec53; WHO Regional Office for Europe, 2011, EUR HLTH ALL DAT; Ying H, 2007, IEEE T SYST MAN CY B, V37, P966, DOI 10.1109/TSMCB.2007.895360; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	57	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44774	10.1371/journal.pone.0044774	http://dx.doi.org/10.1371/journal.pone.0044774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028618	Green Published, gold, Green Submitted			2022-12-27	WOS:000309742800019
J	Kraus, PD; Wolff, D; Grauer, O; Angstwurm, K; Jarius, S; Wandinger, KP; Holler, E; Schulte-Mattler, W; Kleiter, I				Kraus, Peter D.; Wolff, Daniel; Grauer, Oliver; Angstwurm, Klemens; Jarius, Sven; Wandinger, Klaus P.; Holler, Ernst; Schulte-Mattler, Wilhelm; Kleiter, Ingo			Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; CONSENSUS DEVELOPMENT PROJECT; BONE-MARROW TRANSPLANT; CLINICAL-TRIALS; POLYNEUROPATHY; CRITERIA; COMPLICATIONS; MANIFESTATION; ORGAN	Objective: Graft-versus-host disease (GVHD) is an immune-mediated multisystemic disorder and the leading cause of morbidity after allogeneic hematopoietic stem cell transplantation. Peripheral nervous system manifestations of GVHD are rare but often disabling. Whereas immune-mediated neuropathies are an established feature of GVHD, muscle cramps are not well characterized. Methods: In a single-centre retrospective cohort we studied 27 patients (age 23 to 69 years) with GVHD (acute n = 6, chronic n = 21) who complained of symptoms suggestive of peripheral nervous system complications. Clinical, laboratory and neurophysiological findings were evaluated by descriptive statistics and regression analysis to detect factors associated with muscle cramps. Patient's sera were examined for anti-neuronal antibodies. Results: Nine patients had polyneuropathy, 4 had muscle cramps, and 14 had both. Median onset of polyneuropathy and muscle cramps was 6 and 9 months after allogeneic hematopoietic stem cell transplantation, respectively. Neurophysiology revealed a predominantly axonal polyneuropathy in 20 of 26 patients. In 4 of 19 patients electromyography showed signs of myopathy or myositis. Muscle cramps were more frequent during chronic than acute GVHD and affected muscles other than calves in 15 of 18 patients. They typically occurred daily, lasted 1 to 10 minutes with medium to severe pain intensity, compromised daily activity or sleep in 12, and were refractory to therapy in 4 patients. Muscle cramps were less likely with tacrolimus treatment and signs of severe polyneuropathy, but more likely with myopathic changes in electromyography and with incipient demyelinating polyneuropathy, shown by increased high frequency attenuation of the tibial nerve. Serological studies revealed antinuclear or antimitochondrial antibodies in a subset of patients. Two of 16 patients had a serum reactivity against peripheral nervous tissue. Conclusion: Muscle cramps are associated with chronic GVHD, often compromise daily activity, and correlate negatively with axonal polyneuropathy and positively with myopathy and incipient demyelination.	[Kleiter, Ingo] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany; [Kraus, Peter D.; Grauer, Oliver; Angstwurm, Klemens; Schulte-Mattler, Wilhelm] Univ Med Ctr Regensburg, Dept Neurol, Regensburg, Germany; [Wolff, Daniel; Holler, Ernst] Univ Med Ctr Regensburg, Dept Hematol & Clin Oncol, Regensburg, Germany; [Jarius, Sven] Heidelberg Univ, Dept Neurol, Div Mol Neuroimmunol, Heidelberg, Germany; [Wandinger, Klaus P.] Euroimmun, Inst Expt Neuroimmunol, Lubeck, Germany	Ruhr University Bochum; University of Regensburg; University of Regensburg; Ruprecht Karls University Heidelberg; EUROIMMUN	Kleiter, I (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany.	ingo.kleiter@rub.de	Kleiter, Ingo/AAD-1132-2020; Schulte-Mattler, Wilhelm/B-1015-2008	Kleiter, Ingo/0000-0002-8249-4408; Schulte-Mattler, Wilhelm/0000-0001-7701-9648				AMATO AA, 1993, NEUROLOGY, V43, P1513, DOI 10.1212/WNL.43.8.1513; Barba P, 2009, BIOL BLOOD MARROW TR, V15, P1439, DOI 10.1016/j.bbmt.2009.07.013; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Bulsara KR, 2001, TRANSPLANTATION, V71, P1169, DOI 10.1097/00007890-200104270-00026; Busch V, 2010, CLIN NEUROPHYSIOL, V121, P890, DOI 10.1016/j.clinph.2010.01.027; ELIASHIV S, 1991, BONE MARROW TRANSPL, V8, P315; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fujisaki G, 2006, BONE MARROW TRANSPL, V37, P617, DOI 10.1038/sj.bmt.1705283; Gabriel CM, 1999, J NEUROL SCI, V168, P68, DOI 10.1016/S0022-510X(99)00172-0; Grauer O, 2010, BRAIN, V133, P2852, DOI 10.1093/brain/awq245; GREENSPAN A, 1990, BONE MARROW TRANSPL, V5, P349; Herzberg PY, 2010, BIOL BLOOD MARROW TR, V16, P1707, DOI 10.1016/j.bbmt.2010.05.018; Heub D, 2008, LEITLINIEN DIAGNOSTI; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; LAYZER RB, 1994, MUSCLE NERVE, V17, P1243, DOI 10.1002/mus.880171102; Lorenzoni PJ, 2007, ARQ NEURO-PSIQUIAT, V65, P700, DOI 10.1590/S0004-282X2007000400031; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Miller TM, 2005, MUSCLE NERVE, V32, P431, DOI 10.1002/mus.20341; Mulrooney DA, 2003, BONE MARROW TRANSPL, V32, P953, DOI 10.1038/sj.bmt.1704248; Mumm F, 2008, ONKOLOGIE, V31, P46; Nagashima T, 2002, NEUROPATHOLOGY, V22, P1; Openshaw H, 1997, Biol Blood Marrow Transplant, V3, P202; Openshaw H, 2009, CHRONIC GRAFT VERSUS HOST DISEASE: INTERDISCIPLINARY MANAGEMENT, P243, DOI 10.1017/CBO9780511576751.024; Padovan CS, 2003, NERVENARZT, V74, P159, DOI 10.1007/s00115-002-1465-2; Padovan CS, 1998, ANN NEUROL, V43, P627, DOI 10.1002/ana.410430511; Pavletic SZ, 2006, BIOL BLOOD MARROW TR, V12, P252, DOI 10.1016/j.bbmt.2006.01.008; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rabinstein AA, 2003, MUSCLE NERVE, V28, P733, DOI 10.1002/mus.10485; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; Rubio-Agusti I, 2011, NEUROLOGY, V76, P172, DOI 10.1212/WNL.0b013e3182061b1e; Schulte-Mattler W., 2006, CONDUCTION VELOCITY, P405; Schulte-Mattler WJ, 1999, CLIN NEUROPHYSIOL, V110, P740, DOI 10.1016/S1388-2457(98)00068-6; Shlomchik WD, 2007, NAT REV IMMUNOL, V7, P340, DOI 10.1038/nri2000; Sostak P, 2003, NEUROLOGY, V60, P842, DOI 10.1212/01.WNL.0000046522.38465.79; Suzuki S, 2007, BONE MARROW TRANSPL, V40, P289, DOI 10.1038/sj.bmt.1705716; Thone J, 2010, J NEUROL SCI, V292, P114, DOI 10.1016/j.jns.2010.01.020; Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x; Van der Meche FGA, 2001, EUR NEUROL, V45, P133, DOI 10.1159/000052111; Wada Sayoko, 2008, Rinsho Shinkeigaku, V48, P426; Wen PY, 1997, NEUROLOGY, V49, P1711, DOI 10.1212/WNL.49.6.1711; Wolff D, 2010, BIOL BLOOD MARROW TR, V16, P1611, DOI 10.1016/j.bbmt.2010.06.015; Wolff D, 2011, BIOL BLOOD MARROW TR, V17, P1, DOI 10.1016/j.bbmt.2010.05.011	43	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44922	10.1371/journal.pone.0044922	http://dx.doi.org/10.1371/journal.pone.0044922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028681	gold, Green Submitted, Green Published			2022-12-27	WOS:000309742800024
J	Parsons, MP; Burt, J; Cranford, A; Alberto, C; Zipperlen, K; Hirasawa, M				Parsons, Matthew P.; Burt, Julia; Cranford, Amanda; Alberto, Christian; Zipperlen, Katrin; Hirasawa, Michiru			Nociceptin Induces Hypophagia in the Perifornical and Lateral Hypothalamic Area	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SENSITIVE POTASSIUM CHANNELS; RECTIFYING K+ CONDUCTANCE; NUCLEUS-ACCUMBENS; OREXIN NEURONS; ORPHANIN FQ; OREXIN/HYPOCRETIN NEURONS; PHOSPHOINOSITIDE 3-KINASE; RECEPTOR ANTAGONIST; ARCUATE NUCLEUS	Nociceptin/orphanin FQ (N/OFQ) is known to induce food intake when administered into the lateral ventricle or certain brain areas. This is somewhat contradictory to its reward-suppressing role, as food is a strong rewarding stimulus. This discrepancy may be due to the functional diversity of N/OFQ's target brain areas. N/OFQ has been shown to inhibit orexin and melanin-concentrating hormone (MCH) neurons, both of which are appetite-inducing cells. As the expression of these neurons is largely confined to the lateral hypothalamus/perifornical area (LH/PFA), we hypothesized that N/OFQ inhibits food intake by acting in this area. To test this hypothesis, we examined the effect of local N/OFQ infusion within the LH/PFA on food intake in the rat and found that N/OFQ decreased sugar pellet as well as chow intake. This effect was not seen when the injection site was outside of the LH/PFA, suggesting a site-specific effect. Next, to determine a possible cellular mechanism of N/OFQ action on food intake, whole cell patch clamp recordings were performed on rat orexin neurons. As previously reported in mice, N/OFQ induced a strong and long lasting hyperpolarization. Pharmacological study indicated that N/OFQ directly inhibited orexin neurons by activating ATP-sensitive potassium (KATP) channels. This effect was partially but significantly attenuated by the inhibitors of PI3K, PKC and PKA, suggesting that the N/OFQ signaling is mediated by these protein kinases. In summary, our results demonstrate a KATP channel-dependent N/OFQ signaling and that N/OFQ is a site-specific anorexic peptide.	[Parsons, Matthew P.; Burt, Julia; Cranford, Amanda; Alberto, Christian; Zipperlen, Katrin; Hirasawa, Michiru] Mem Univ Newfoundland, Div Biomed Sci, Fac Med, St John, NF, Canada	Memorial University Newfoundland	Hirasawa, M (corresponding author), Mem Univ Newfoundland, Div Biomed Sci, Fac Med, St John, NF, Canada.	michiru@mun.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Institutes of Health Research. The funder had no role in study design, data collection and analysis, decision to publish or preparatino of the manuscript.	Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Burt J, 2011, AM J PHYSL REGUL INT; Ciccocioppo R, 2000, PEPTIDES, V21, P1071, DOI 10.1016/S0196-9781(00)00245-X; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; Di Giannuario A, 2000, PEPTIDES, V21, P1125, DOI 10.1016/S0196-9781(00)00250-3; Drews E, 2010, PROG NEUROBIOL, V90, P1, DOI 10.1016/j.pneurobio.2009.09.004; Eggermann E, 2003, J NEUROSCI, V23, P1557; Emmerson PJ, 1999, J PHYSIOL-LONDON, V517, P431, DOI 10.1111/j.1469-7793.1999.0431t.x; Erlanson-Albertsson C, 2005, BASIC CLIN PHARMACOL, V97, P61, DOI 10.1111/j.1742-7843.2005.pto_179.x; Fukuda K, 1997, FEBS LETT, V412, P290, DOI 10.1016/S0014-5793(97)00815-6; Gerashchenko D, 2010, NEUROPHARMACOLOGY; Guan JL, 2002, INT J OBESITY, V26, P1523, DOI 10.1038/sj.ijo.0802155; Hahn JD, 2010, NEUROSCI LETT, V468, P12, DOI 10.1016/j.neulet.2009.10.047; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Hawes BE, 1998, J NEUROCHEM, V71, P1024; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Ikeda K, 1997, MOL BRAIN RES, V45, P117, DOI 10.1016/S0169-328X(96)00252-5; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Kim MS, 2002, BIOCHEM BIOPH RES CO, V291, P663, DOI 10.1006/bbrc.2002.6503; Kotlinska J, 2003, EUR J PHARMACOL, V474, P233, DOI 10.1016/S0014-2999(03)02081-8; Leopoldt D, 1998, J BIOL CHEM, V273, P7024, DOI 10.1074/jbc.273.12.7024; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Li Y, 2006, J NEUROSCI, V26, P13037, DOI 10.1523/JNEUROSCI.3380-06.2006; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lin YF, 2004, P NATL ACAD SCI USA, V101, P7799, DOI 10.1073/pnas.0402496101; Lou LG, 1997, BIOCHEM BIOPH RES CO, V240, P304, DOI 10.1006/bbrc.1997.7654; Lutfy K, 2001, PSYCHOPHARMACOLOGY, V154, P1, DOI 10.1007/s002130000609; Maolood N, 2010, J NEUROENDOCRINOL, V22, P75, DOI 10.1111/j.1365-2826.2009.01946.x; Meis S, 2002, J NEUROSCI, V22, P718, DOI 10.1523/JNEUROSCI.22-03-00718.2002; Meunier JC, 1997, EUR J PHARMACOL, V340, P1, DOI 10.1016/S0014-2999(97)01411-8; Mogil JS, 1996, NEUROSCIENCE, V75, P333, DOI 10.1016/0306-4522(96)00338-7; Morens C, 2005, BRAIN RES, V1062, P32, DOI 10.1016/j.brainres.2005.09.005; Narayanan S, 2004, J PSYCHIATR NEUROSCI, V29, P116; Neal CR, 1999, J COMP NEUROL, V406, P503; Parsons MP, 2011, J NEUROPHYSIOL, V105, P1179, DOI 10.1152/jn.00791.2010; Parsons MP, 2010, J NEUROSCI, V30, P8061, DOI 10.1523/JNEUROSCI.5741-09.2010; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Polidori C, 2000, PEPTIDES, V21, P1051, DOI 10.1016/S0196-9781(00)00224-2; Pomonis JD, 1996, NEUROREPORT, V8, P369, DOI 10.1097/00001756-199612200-00072; Roberson ED, 1999, J NEUROSCI, V19, P4337; Schone C, 2011, J PHYSIOL-LONDON, V589, P2767, DOI 10.1113/jphysiol.2011.208637; Slugg RM, 1999, NEUROENDOCRINOLOGY, V69, P385, DOI 10.1159/000054441; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; STELLAR E, 1994, PSYCHOL REV, V101, P301, DOI 10.1037//0033-295X.101.2.301; Stratford TR, 1997, NEUROREPORT, V8, P423, DOI 10.1097/00001756-199701200-00009; Tsujino N, 2005, J NEUROSCI, V25, P7459, DOI 10.1523/JNEUROSCI.1193-05.2005; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wagner EJ, 1998, NEUROENDOCRINOLOGY, V67, P73, DOI 10.1159/000054301; Xie XM, 2008, J CLIN INVEST, V118, P2471, DOI 10.1172/JCI35115; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908; Zheng H, 2007, J NEUROSCI, V27, P11075, DOI 10.1523/JNEUROSCI.3542-07.2007	57	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45350	10.1371/journal.pone.0045350	http://dx.doi.org/10.1371/journal.pone.0045350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028954	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000309742800055
J	Grecchi, S; Mazzini, G; Lisa, A; Armentero, MT; Bergamaschi, R; Romani, A; Blandini, F; Di Perri, C; Scovassi, AI				Grecchi, Sabrina; Mazzini, Giuliano; Lisa, Antonella; Armentero, Marie-Therese; Bergamaschi, Roberto; Romani, Alfredo; Blandini, Fabio; Di Perri, Carol; Scovassi, Anna Ivana			Search for Cellular Stress Biomarkers in Lymphocytes from Patients with Multiple Sclerosis: A Pilot Study	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1; HISTONE H2AX; DNA-DAMAGE; ACTIVATION; APOPTOSIS; DISEASE; REPAIR; CELLS	Multiple Sclerosis (MS) is a chronic disease of the central nervous system, the etiology of which, although not completely known, involves inflammation and autoimmunity. In the present study we aimed at identifying molecular markers of apoptosis, cellular stress and DNA damage in isolated peripheral blood mononuclear cells (PBMCs) of MS patients. The analysis was carried on 19 relapsing-remitting untreated MS patients and 13 healthy individuals. We investigated the emergency-driven synthesis of poly(ADP-ribose) (PAR), the expression level of the constitutive enzyme poly(ADP-ribose) polymerase-1 (PARP-1) and the DNA damage-induced phosphorylation of histone H2AX. PAR accumulation, PARP-1 and phosphorylated H2AX (gamma H2AX) were detected by immunofluorescence experiments on PBMCs isolated from 19 patients and 13 healthy volunteers. Our results show for the first time a net increased amount in PAR and gamma H2AX in MS patients compared to healthy individuals. Patients were further subdivided in three groups, according to the neuroimaging (MRI)based classification of disease phase. Remarkably, we found a positive correlation between the level of gamma H2AX and MS aggressiveness. In addition, apoptosis in PBMCs was monitored by flow cytometry of both phosphatidylserine exposure (revealed by Annexin V-FITC labeling) and membrane permeability to propidium iodide. Our observations provide the evidence that the number of apoptotic cells was significantly higher in patients compared to healthy individuals, thus suggesting that apoptosis could affect MS lymphocyte function.	[Grecchi, Sabrina; Mazzini, Giuliano; Lisa, Antonella; Scovassi, Anna Ivana] IGM CNR, Pavia, Italy; [Armentero, Marie-Therese; Bergamaschi, Roberto; Romani, Alfredo; Blandini, Fabio; Di Perri, Carol] IRCCS Ist Neurol Nazl C Mondino, Pavia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Fondazione Casimiro Mondino	Grecchi, S (corresponding author), IGM CNR, Pavia, Italy.	scovassi@igm.cnr.it	Lisa, Antonella/B-3117-2015; Blandini, Fabio/J-2658-2016	Lisa, Antonella/0000-0003-2458-5499; Blandini, Fabio/0000-0002-0178-1289; Scovassi, Anna Ivana/0000-0003-3484-9881; Di Perri, Carol/0000-0003-0284-770X; Romani, Alfredo/0000-0002-8359-0477; Fuzzati-Armentero, Marie/0000-0002-6386-2885	SEpiAS project from the Italian Ministry of Health	SEpiAS project from the Italian Ministry of Health	SG is supported by the SEpiAS project from the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Cavone L, 2012, TRENDS MOL MED, V18, P92, DOI 10.1016/j.molmed.2011.10.002; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Giansanti V, 2010, BIOCHEM PHARMACOL, V80, P1869, DOI 10.1016/j.bcp.2010.04.022; Gonsette R, 2008, MULT SCLER J, V14, P22, DOI 10.1177/1352458507080111; Goverman JM, 2011, IMMUNOL REV, V241, P228, DOI 10.1111/j.1600-065X.2011.01016.x; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kauppinen TM, 2005, J NEUROSCI RES, V81, P190, DOI 10.1002/jnr.20525; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Penberthy WT, 2009, CURR PHARM DESIGN, V15, P64, DOI 10.2174/138161209787185751; Prieto A, 2006, J CLIN IMMUNOL, V26, P101, DOI 10.1007/s10875-006-9007-5; R Development Core, 2011, LANG ENV STAT; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Stadelmann C, 2011, CURR OPIN NEUROL, V24, P224, DOI 10.1097/WCO.0b013e328346056f; Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X; Zipp F, 2000, CELL TISSUE RES, V301, P163, DOI 10.1007/s004410000179	20	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44935	10.1371/journal.pone.0044935	http://dx.doi.org/10.1371/journal.pone.0044935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028690	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700061
J	Kohli, R; Purohit, V; Karve, L; Bhalerao, V; Karvande, S; Rangan, S; Reddy, S; Paranjape, R; Sahay, S				Kohli, Rewa; Purohit, Vidula; Karve, Latika; Bhalerao, Vinod; Karvande, Shilpa; Rangan, Sheela; Reddy, Srikanth; Paranjape, Ramesh; Sahay, Seema			Caring for Caregivers of People Living with HIV in the Family: A Response to the HIV Pandemic from Two Urban Slum Communities in Pune, India	PLOS ONE			English	Article							HIV/AIDS; POWER	Introduction: In low resource settings, the vast majority of 'Person/people Living with HIV' (PLHIV/s) and inadequate healthcare delivery systems to meet their treatment and care needs, caregivers play a vital role. Home based caregivers are often unrecognized with limited AIDS policies and programs focusing on them. We explored the perceptions and norms regarding care being provided by family caregivers of PLHIVs in India. Methodology: A community based qualitative study to understand the issues pertaining to home based care for PLHIV was conducted in urban settings of Pune city, in Maharashtra, India. Eight Focus Group Discussions (FGDs) among men, women and peer educators were carried out. A total of 44 in-depth Interviews (IDIs) with PLHIVs (20) and their caregivers (24), were conducted using separate guides respectively. Data was analyzed thematically. Results: Home based care was perceived as economically viable option available for PLHIVs. 'Care' comprised of emotional, adherence, nursing and financial support to PLHIV. Home based care was preferred over hospital based care as it ensured confidentiality and patient care without hampering routine work at home. Women emerged as more vital primary caregivers compared to men. Home based care for men was almost unconditional while women had no such support. The natal family of women also abandoned. Their marital families seemed to provide support. Caregivers voiced the need for respite care and training. Discussion: Gender related stigma and discrimination existed irrespective of women being the primary family caregivers. The support from marital families indicates a need to explore care and support issues at natal and marital homes of the women living with HIV respectively. Home based care training and respite care for the caregivers is recommended. Gender sensitive interventions addressing gender inequity and HIV related stigma should be modeled while designing interventions for PLHIVs and their family caregivers.	[Kohli, Rewa; Karve, Latika; Bhalerao, Vinod; Reddy, Srikanth; Paranjape, Ramesh; Sahay, Seema] Natl AIDS Res Inst, Pune, Maharashtra, India; [Purohit, Vidula; Karvande, Shilpa; Rangan, Sheela] Maharashtra Assoc Anthropol Sci, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Kohli, R (corresponding author), Natl AIDS Res Inst, Pune, Maharashtra, India.	ssahay@nariindia.org	Kohli, Rewa/AAD-6052-2021	Reddy, Srikanth/0000-0002-8035-9034; Paranjape, Ramesh/0000-0003-2948-9148; Sahay, Seema/0000-0001-6064-827X	DFID under 'Evidence for Action'	DFID under 'Evidence for Action'	The study was conducted intramurally at National AIDS Research Institute (NARI), Pune, India. Funds received by NARI from DFID under 'Evidence for Action' were used for local fieldwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton P, 1999, HOUSEHOLD COMMUNITY; Akintola O, 2003, 10 CAN C INT HLTH 26; Akintola Olagoke, 2004, GENDERED ANAL BURDEN; Amaro H, 2000, SEX ROLES, V42, P723, DOI 10.1023/A:1007059708789; [Anonymous], 1997, CONFR AIDS PUBL PRIO; Bharat S, 1999, AIDS CARE, V11, P31, DOI 10.1080/09540129948180; Colton T, 2006, COMMUNITY HOME BASED; D'Cruz P, 2004, QUALITATIVE REPORT, V9, P413; Drimie S, 2008, FAMILIES EFFORTS SEC; Fieire P, 1974, ED CRITICAL CONSCIOU; Freire P., 2013, PEDAGOGY OPPRESSED T; Gangakhedkar RR, 1997, JAMA-J AM MED ASSOC, V278, P2090, DOI 10.1001/jama.278.23.2090; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Kakar S., 1981, INNER WORLD PSYCHO A, V2nd ed.; Karvande S, 2010, HLTH PROVIDERS INDIA; Lalthanmawia R, 2008, 17 INT AIDS C 2008; Lips HM, 1999, NEW PSYCHOL WOMEN GE; Majumdar B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-20; Miller J.B., 1986, NEW PSYCHOL WOMEN; Muyinda H, 1997, HEALTH PLACE, V3, P143, DOI 10.1016/S1353-8292(97)00010-5; National AIDS Control Origination Operational Guidelines for Community Care Centers 2007 Ministry of Health and Family Welfare Government of India, OP GUID COMM CAR CTR; Ogden J, 2006, HEALTH POLICY PLANN, V21, P333, DOI 10.1093/heapol/czl025; Orner P, 2006, AIDS CARE, V18, P236, DOI 10.1080/09540120500456565; Pallikadavath S, 2005, J BIOSOC SCI, V37, P641, DOI 10.1017/S0021932004006893; PANOS, 1990, 3 EP REP FEAR AIDS; Panwar M, 2004, 15 INT AIDS C; Parker R.G., 2002, HIV AIDS RELATED STI; RAMU GN, 1988, J COMP FAM STUD, V19, P207, DOI 10.3138/jcfs.19.2.207; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Russel Michele, 2000, RAPID APPRAISAL COMM; Sahay S, 2011, INDIAN J MED RES, V134, P835, DOI 10.4103/0971-5916.92629; Sahay Seema, 2011, East J Med, V16, P168; Sangath, EXP CONT CAR PROGR S; Sinha D, 1988, HLTH CROSS CULTURAL; Taylor L, 1996, Health Transit Rev, V6, P49; UNAIDS, 2000, AIDS PALL CAR UNAIDS; UNICEF, 1989, CHILDR WOM UG KAMP S; UNICEF, IND HIV AIDS; Uwimana J, 2007, SAHARA J, V4, P575; Warwick I, 1998, CRITICAL PUBLIC HLTH, V8, P291; WHO, 2002, COMM HOM BAS CAR RES	41	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44989	10.1371/journal.pone.0044989	http://dx.doi.org/10.1371/journal.pone.0044989			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005ZK	23028725	Green Submitted, Green Published, gold			2022-12-27	WOS:000308788700072
J	Wick, WD; Yang, OO				Wick, W. David; Yang, Otto O.			Biologically-Directed Modeling Reflects Cytolytic Clearance of SIV-Infected Cells In Vivo in Macaques	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; COMBINATION ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY VIRUS CHALLENGE; RHESUS MACAQUES; NONCYTOLYTIC MECHANISMS; IMMUNE-RESPONSES; TYPE-1 INFECTION; HIV REPLICATION; ESCAPE VARIANTS; PRIMARY VIREMIA	The disappointing outcomes of cellular immune-based vaccines against HIV-1 despite strong evidence for the protective role of CD8(+) T lymphocytes (CTLs) has prompted revisiting the mechanisms of cellular immunity. Prior data from experiments examining the kinetics of Simian Immunodeficiency Virus (SIV) clearance in infected macaques with or without in vivo CD8 depletion were interpreted as refuting the concept that CTLs suppress SIV/HIV by direct killing of infected cells. Here we briefly review the biological evidence for CTL cytolytic activity in viral infections, and utilize biologically-directed modeling to assess the possibility of a killing mechanism for the antiviral effect of CTLs, taking into account the generation, proliferation, and survival of activated CD4(+) and CD8(+) T lymphocytes, as well as the life cycle of the virus. Our analyses of the published macaque data using these models support a killing mechanism, when one considers T lymphocyte and HIV-1 lifecycles, and factors such as the eclipse period before release of virions by infected cells, an exponential pattern of virion production by infected cells, and a variable lifespan for acutely infected cells. We conclude that for SIV/HIV pathogenesis, CTLs deserve their reputation as being cytolytic.	[Wick, W. David] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Dept Med,Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wick, WD (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	wdavid.wick@gmail.com			National Institutes of Health [AI054280, AI051970, AI043203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054280, R01AI043203, R01AI051970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors would like to acknowledge support from grants AI054280 (WDW), AI051970 (OOY), and AI043203 (OOY) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Antia R, 2003, J THEOR BIOL, V221, P585, DOI 10.1006/jtbi.2003.3208; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buseyne F, 1996, VIROLOGY, V225, P248, DOI 10.1006/viro.1996.0597; Chen HY, 2007, P NATL ACAD SCI USA, V104, P19079, DOI 10.1073/pnas.0707449104; Davenport MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000728; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; KALAMS SA, 1994, J EXP MED, V179, P1261, DOI 10.1084/jem.179.4.1261; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; Koibuchi T, 2005, J VIROL, V79, P8171, DOI 10.1128/JVI.79.13.8171-8181.2005; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707; McMichael AJ, 2000, PHILOS T R SOC B, V355, P363, DOI 10.1098/rstb.2000.0575; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nowak MA, 1997, J VIROL, V71, P7518, DOI 10.1128/JVI.71.10.7518-7525.1997; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Planelles V, 1996, J VIROL, V70, P2516, DOI 10.1128/JVI.70.4.2516-2524.1996; PLATA F, 1987, NATURE, V328, P348, DOI 10.1038/328348a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104; Rinaldo CR, 2000, J VIROL, V74, P4127, DOI 10.1128/JVI.74.9.4127-4138.2000; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sopper S, 2003, BLOOD, V101, P1213, DOI 10.1182/blood-2002-06-1644; SRIVASTAVA KK, 1991, J VIROL, V65, P3900, DOI 10.1128/JVI.65.7.3900-3902.1991; Sun Y, 2006, J VIROL, V80, P10950, DOI 10.1128/JVI.01458-06; TOUGH DF, 1995, IMMUNOL RES, V14, P1, DOI 10.1007/BF02918494; TSUBOTA H, 1989, J EXP MED, V169, P1421, DOI 10.1084/jem.169.4.1421; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; WALKER CM, 1989, IMMUNOLOGY, V66, P628; Wick D, 2002, J THEOR BIOL, V219, P19, DOI 10.1006/yjtbi.3103; Wick D, 1999, MATH BIOSCI, V158, P127, DOI 10.1016/S0025-5564(99)00003-6; Wick WD, 2006, PLOS COMPUT BIOL, V2, P564, DOI 10.1371/journal.pcbi.0020064; Wick WD, 2005, DETERMINISTIC AND STOCHASTIC MODELS OF AIDS EPIDEMICS AND HIV INFECTIONS WITH INTERVENTION, P189, DOI 10.1142/9789812569264_0009; Wick WD, 2009, J VIROL, V83, P2349, DOI 10.1128/JVI.00821-08; Wick WD, 2005, J VIROL, V79, P13579, DOI 10.1128/JVI.79.21.13579-13586.2005; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Zhang LQ, 1999, J VIROL, V73, P855, DOI 10.1128/JVI.73.1.855-860.1999	64	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44778	10.1371/journal.pone.0044778	http://dx.doi.org/10.1371/journal.pone.0044778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028619	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700039
J	Vazquez-Calvo, A; Sobrino, F; Martin-Acebes, MA				Vazquez-Calvo, Angela; Sobrino, Francisco; Martin-Acebes, Miguel A.			Plasma Membrane Phosphatidylinositol 4,5 Bisphosphate Is Required for Internalization of Foot-and-Mouth Disease Virus and Vesicular Stomatitis Virus	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; AMINO-ACID SUBSTITUTION; MONOCLONAL-ANTIBODIES; CULTURED-CELLS; EARLY EVENTS; TYPE-1 GAG; ENTRY; RECEPTOR; BINDING; 4,5-BISPHOSPHATE	Phosphatidylinositol-4,5-bisphosphate, PI(4,5)P-2, is a phospholipid which plays important roles in clathrin-mediated endocytosis. To investigate the possible role of this lipid on viral entry, two viruses important for animal health were selected: the enveloped vesicular stomatitis virus (VSV) - which uses a well characterized clathrin mediated endocytic route 2 and two different variants of the non-enveloped foot-and-mouth disease virus (FMDV) with distinct receptor specificities. The expression of a dominant negative dynamin, a PI(4,5)P-2 effector protein, inhibited the internalization and infection of VSV and both FMDV isolates. Depletion of PI(4,5)P-2 from plasma membrane using ionomycin or an inducible system, and inhibition of its de novo synthesis with 1-butanol revealed that VSV as well as FMDV C-S8c1, which uses integrins as receptor, displayed a high dependence on PI(4,5)P-2 for internalization. Expression of a kinase dead mutant (KD) of phosphatidylinositol-4-phosphate-5-kinase I alpha (PIP5K-I alpha), an enzyme responsible for PI(4,5)P-2 synthesis that regulates clathrin-dependent endocytosis, also impaired entry and infection of VSV and FMDV C-S8c1. Interestingly FMDV MARLS variant that uses receptors other than integrins for cell entry was less sensitive to PI(4,5)P-2 depletion, and was not inhibited by the expression of the KD PIP5K-I alpha mutant suggesting the involvement of endocytic routes other than the clathrin-mediated on its entry. These results highlight the role of PI(4,5)P-2 and PIP5K-I alpha on clathrin-mediated viral entry.	[Vazquez-Calvo, Angela; Sobrino, Francisco; Martin-Acebes, Miguel A.] Ctr Biol Mol Severo Ochoa UAM CSIC, Madrid, Spain; [Sobrino, Francisco] INIA, Ctr Invest Sanidad Anim, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Sobrino, F (corresponding author), Ctr Biol Mol Severo Ochoa UAM CSIC, Madrid, Spain.	fsobrino@cbm.uam.es	Martin-Acebes, Miguel A./L-2258-2014; Vázquez-Calvo, Ángela/G-8795-2015	Martin-Acebes, Miguel A./0000-0001-6015-3613; Vázquez-Calvo, Ángela/0000-0003-3172-2762; Sobrino, Francisco/0000-0003-4968-8291	Fundacion Ramon Areces;  [BIO2008-0447-C03-01];  [BIO2011-24351]	Fundacion Ramon Areces; ; 	This work was supported by Spanish grants BIO2008-0447-C03-01 and BIO2011-24351, and by an institutional grant from Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2008, J CELL SCI, V121, P1488, DOI 10.1242/jcs.020792; Adjobo-Hermans MJW, 2008, J CELL SCI, V121, P3770, DOI 10.1242/jcs.029785; Altan-Bonnet N, 2012, TRENDS BIOCHEM SCI, V37, P293, DOI 10.1016/j.tibs.2012.03.004; Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Arendt KL, 2010, NAT NEUROSCI, V13, P36, DOI 10.1038/nn.2462; Arita M, 2011, J VIROL, V85, P2364, DOI 10.1128/JVI.02249-10; Baranowski E, 1998, J VIROL, V72, P6362, DOI 10.1128/JVI.72.8.6362-6372.1998; Baranowski E, 2000, J VIROL, V74, P1641, DOI 10.1128/JVI.74.4.1641-1647.2000; Barbieri MA, 2001, J BIOL CHEM, V276, P47212, DOI 10.1074/jbc.C100490200; Barrero-Villar M, 2008, J IMMUNOL, V181, P6882, DOI 10.4049/jimmunol.181.10.6882; Bartholomeusz C, 2012, EXPERT OPIN THER TAR, V16, P121, DOI 10.1517/14728222.2011.644788; BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Berryman S, 2005, J VIROL, V79, P8519, DOI 10.1128/JVI.79.13.8519-8534.2005; Bethoney KA, 2009, P NATL ACAD SCI USA, V106, P13359, DOI 10.1073/pnas.0906945106; Bianco A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002576; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Chaudhry A, 2008, TRAFFIC, V9, P1925, DOI 10.1111/j.1600-0854.2008.00802.x; Chu H, 2009, CURR TOP MICROBIOL, V339, P67, DOI 10.1007/978-3-642-02175-6_4; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2012, CURR OPIN MICROBIOL, V15, P512, DOI 10.1016/j.mib.2012.05.013; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Eisfeld AJ, 2011, J VIROL, V85, P6117, DOI 10.1128/JVI.00378-11; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Jackson T, 2000, J GEN VIROL, V81, P1383, DOI 10.1099/0022-1317-81-5-1383; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; Jackson T, 2002, J VIROL, V76, P935, DOI 10.1128/JVI.76.3.935-941.2002; Jackson T, 1996, J VIROL, V70, P5282, DOI 10.1128/JVI.70.8.5282-5287.1996; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Johns HL, 2009, J VIROL, V83, P6247, DOI 10.1128/JVI.02460-08; Johnson CM, 2008, J BIOL CHEM, V283, P29920, DOI 10.1074/jbc.M805921200; King MA, 2000, J IMMUNOL METHODS, V243, P155, DOI 10.1016/S0022-1759(00)00232-5; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Lamm GM, 1997, NUCLEIC ACIDS RES, V25, P4855, DOI 10.1093/nar/25.23.4855; LEFRANCOIS L, 1982, VIROLOGY, V121, P168, DOI 10.1016/0042-6822(82)90126-X; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Martin-Acebes MA, 2012, LIPID METAB IN PRESS; Martin-Acebes MA, 2007, VIROLOGY, V369, P105, DOI 10.1016/j.virol.2007.07.021; Martin-Acebes MA, 2010, VIROLOGY, V403, P47, DOI 10.1016/j.virol.2010.04.005; Martin-Acebes MA, 2009, J VIROL, V83, P4216, DOI 10.1128/JVI.02436-08; Martin-Belmonte F, 2003, J CELL BIOL, V163, P155, DOI 10.1083/jcb.200304053; MATEU MG, 1990, J GEN VIROL, V71, P629, DOI 10.1099/0022-1317-71-3-629; MATEU MG, 1987, VIRUS RES, V8, P261, DOI 10.1016/0168-1702(87)90020-7; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Novella IS, 1996, J VIROL, V70, P6414, DOI 10.1128/JVI.70.9.6414-6417.1996; Nunez JI, 2001, J VIROL, V75, P3977, DOI 10.1128/JVI.75.8.3977-3983.2001; Nunez JI, 2007, J VIROL, V81, P8497, DOI 10.1128/JVI.00340-07; O'Donnell V, 2005, J VIROL, V79, P8506, DOI 10.1128/JVI.79.13.8506-8518.2005; O'Donnell V, 2008, J VIROL, V82, P9075, DOI 10.1128/JVI.00732-08; Prestwich GD, 2004, CHEM BIOL, V11, P619, DOI 10.1016/j.chembiol.2004.03.025; Richard JP, 2011, BIOCH J; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SOBRINO F, 1983, VIROLOGY, V128, P310, DOI 10.1016/0042-6822(83)90258-1; Sobrino F, 2001, VET RES, V32, P1, DOI 10.1051/vetres:2001106; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Vidricaire G, 2005, J IMMUNOL, V175, P6517, DOI 10.4049/jimmunol.175.10.6517; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	77	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45172	10.1371/journal.pone.0045172	http://dx.doi.org/10.1371/journal.pone.0045172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028825	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900028
J	Hossain, S; Quaiyum, MA; Zaman, K; Banu, S; Husain, MA; Islam, MA; Cooreman, E; Borgdorff, M; Lonnroth, K; Salim, AH; van Leth, F				Hossain, Shahed; Quaiyum, Mohammad Abdul; Zaman, Khalequ; Banu, Sayera; Husain, Mohammad Ashaque; Islam, Mohammad Akramul; Cooreman, Erwin; Borgdorff, Martien; Loennroth, Knut; Salim, Abdul Hamid; van Leth, Frank			Socio Economic Position in TB Prevalence and Access to Services: Results from a Population Prevalence Survey and a Facility-Based Survey in Bangladesh	PLOS ONE			English	Article							TUBERCULOSIS PATIENTS; RISK-FACTORS; CARE; COUNTRIES; PRIVATE; POOR; DOTS; OPPORTUNITIES; INEQUALITIES; PROGRAM	Background: In Bangladesh DOTS has been provided free of charge since 1993, yet information on access to TB services by different population group is not well documented. The objective of this study was to assess and compare the socio economic position (SEP) of actively detected cases from the community and the cases being routinely detected under National Tuberculosis Control Programme (NTP) in Bangladesh. Methods and Findings: SEP was assessed by validated asset item for each of the 21,427 households included in the national tuberculosis prevalence survey 2007-2009. A principal component analysis generated household scores and categorized in quartiles. The distribution of 33 actively identified cases was compared with the 240 NTP cases over the identical SEP quartiles to evaluate access to TB services by different groups of the population. The population prevalence of tuberculosis was 5 times higher in the lowest quartiles of population (95.4, 95% CI: 48.0-189.7) to highest quartile population (19.5, 95% CI: 6.9-55.0). Among the 33 cases detected during survey, 25 (75.8%) were from lower two quartiles, and the rest 8 (24.3%) were from upper two quartiles. Among TB cases detected passively under NTP, more than half of them 137 (57.1%) were from uppermost two quartiles, 98 (41%) from the second quartile, and 5 (2%) in the lowest quartile of the population. This distribution is not affected when adjusted for other factors or interactions among them. Conclusions: The findings indicate that despite availability free of charge, DOTS is not equally accessed by the poorer sections of the population. However, these figures should be interpreted with caution since there is a need for additional studies that assess in-depth poverty indicators and its determinants in relation to access of the TB services provided in Bangladesh.	[Hossain, Shahed; Quaiyum, Mohammad Abdul; Zaman, Khalequ; Banu, Sayera] Int Ctr Diarrhoeal Dis Res Bangladesh ICDDR B, Dhaka, Bangladesh; [Husain, Mohammad Ashaque] DGHS, Natl TB Control Programme NTP, Dhaka, Bangladesh; [Islam, Mohammad Akramul] BRAC, Hlth Programme, Dhaka, Bangladesh; [Cooreman, Erwin] WHO, Dhaka, Bangladesh; [Borgdorff, Martien; van Leth, Frank] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Loennroth, Knut] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; [Salim, Abdul Hamid] Damien Fdn, Dhaka, Bangladesh; [van Leth, Frank] KNCV TB Fdn, The Hague, Netherlands	International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Rural Advancement Committee BRAC; World Health Organization; University of Amsterdam; Academic Medical Center Amsterdam; World Health Organization; KNCV Tuberculosis Foundation	Hossain, S (corresponding author), Int Ctr Diarrhoeal Dis Res Bangladesh ICDDR B, Dhaka, Bangladesh.	shahed@icddrb.org	Lonnroth, Knut/H-5470-2017; Hossain, Shahed/HDN-7819-2022; Lönnroth, Knut/L-2339-2014	Lonnroth, Knut/0000-0001-6944-0256; Lönnroth, Knut/0000-0001-5054-8240; van Leth, Frank/0000-0002-5490-8968; Banu, Sayera/0000-0002-5121-1962	World Health Organization (WHO); United States Agency for International Development (USAID); Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) [SEBAN TUB 001 XW06U]; National Tuberculosis Control Programme (NTP) of Bangladesh; KNCV Tuberculosis Foundation, The Netherlands; Stop TB Department, World Health Organization, Geneva, Switzerland	World Health Organization (WHO)(World Health Organization); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM); National Tuberculosis Control Programme (NTP) of Bangladesh; KNCV Tuberculosis Foundation, The Netherlands(Netherlands Government); Stop TB Department, World Health Organization, Geneva, Switzerland	This research study was funded by the World Health Organization (WHO), United States Agency for International Development (USAID) and Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), grant number SEBAN TUB 001 XW06U. International Centre for Diarrhoeal Disease Research, Bangladesh (ICCDR, B), http://www.icddrb.org, acknowledges with gratitude the commitment of WHO, USAID and GFATM to its research efforts. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; We acknowledge with gratitude the contribution of the National Tuberculosis Control Programme (NTP) of Bangladesh for their support in conducting this study. The study team is deeply indebted to the technical assistance and support provided by KNCV Tuberculosis Foundation, The Netherlands and the Stop TB Department, World Health Organization, Geneva, Switzerland. We also wish to express our sincere thanks and appreciation to BRAC, Damien Foundation, National Institute of Diseases of Chest and Hospital (NIDCH), and all other organizations and individuals involved for their effective participation in all steps of implementation of the study. Finally we would humbly like to acknowledge the contribution of all the project staff, participants, Government and NGO partners and the community members throughout the country, without their contribution this study would never have been completed.	Alam N, 2011, 118 ICDDRB BRAC; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; [Anonymous], 2003, NAT HLTH ACC 1996 20; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; *BDHS, 2001, BANGL DEM HLTH SURV; Boccia D, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P37, DOI 10.5588/ijtld.10.0438; Bumburidi Ekaterina, 2006, MMWR Suppl, V55, P11; Chowdhury AMR, 2003, J HEALTH POPUL NUTR, V21, P193; Croft RA, 1998, INT J TUBERC LUNG D, V2, P252; Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224; Dewan PK, 2004, INT J TUBERC LUNG D, V8, P598; Directorate General of Health Services, 2011, TUB CONTR BANGL ANN; Enarson DA, 2007, B WORLD HEALTH ORGAN, V85, P395, DOI 10.2471/BLT.06.035378; Finnie RKC, 2011, TROP MED INT HEALTH, V16, P394, DOI 10.1111/j.1365-3156.2010.02718.x; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hanson CL, 2002, TUBERCULOSIS POVERTY; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hossain S, 2010, World Health Popul, V12, P5; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Jaiswal A, 2003, TROP MED INT HEALTH, V8, P265; Kamolratanakul P, 1999, INT J TUBERC LUNG D, V3, P596; Khan A, 2000, SOC SCI MED, V50, P247, DOI 10.1016/S0277-9536(99)00279-8; Lienhardt C, 2004, TROP MED INT HEALTH, V9, P833, DOI 10.1111/j.1365-3156.2004.01273.x; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lonnroth K, 2001, HEALTH POLICY PLANN, V16, P47, DOI 10.1093/heapol/16.1.47; Lonnroth K, 2007, HEALTH POLICY PLANN, V22, P156, DOI 10.1093/heapol/czm007; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Makinen M, 2000, B WORLD HEALTH ORGAN, V78, P55; McKenzie DJ, 2003, 142 BREAD HARV U CTR; Mitra and Associates Dhaka Bangladesh, 2001, MEAS DHS; Muniyandi M, 2006, J Commun Dis, V38, P204; Muniyandi M, 2008, EXPERT OPIN PHARMACO, V9, P1623, DOI 10.1517/14656566.9.10.1623 ; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Nhlema B, 2003, SYSTEMATIC ANAL TB P; Pine D., 2010, CMF THESIS SERIES, V6; Pinto LM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-357; Pradhan A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-263; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Rifat M, 2011, INT J TUBERC LUNG D, V15, P647, DOI 10.5588/ijtld.10.0205; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Stop TB Partnership, 2002, 10 STOP TB PARTN STO; Tupasi TE, 2000, INT J TUBERC LUNG D, V4, P4; van Leth F, 2011, INT J TUBERC LUNG D, V15, P1566, DOI 10.5588/ijtld.11.0654; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; World Health Organization, 2005, WHOHTMTB2005352; World Health Organization, 2010, BANTUB45 WHO; World Health Organization, 1994, FRAM EFF TUB CONTR; World Health Organization, 2010, WHOHTMTB201116, P16; Xu B, 2006, HEALTH POLICY PLANN, V21, P365, DOI 10.1093/heapol/czl019; Zaman K, 2011, EPIDEMIOL INFECT, P1; Zhang TH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-19	53	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e44980	10.1371/journal.pone.0044980	http://dx.doi.org/10.1371/journal.pone.0044980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KQ	23028718	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500015
J	Hu, D; Cai, D; Rangan, AV				Hu, Dan; Cai, David; Rangan, Aaditya V.			Blood Vessel Adaptation with Fluctuations in Capillary Flow Distribution	PLOS ONE			English	Article							MICROVASCULAR RAREFACTION; SHEAR-STRESS; STRUCTURAL ADAPTATION; VASCULAR NETWORKS; SKELETAL-MUSCLE; EXERCISE; OXYGEN; ANGIOGENESIS; RECRUITMENT; MICROCIRCULATION	Throughout the life of animals and human beings, blood vessel systems are continuously adapting their structures - the diameter of vessel lumina, the thickness of vessel walls, and the number of micro-vessels - to meet the changing metabolic demand of the tissue. The competition between an ever decreasing tendency of luminal diameters and an increasing stimulus from the wall shear stress plays a key role in the adaptation of luminal diameters. However, it has been shown in previous studies that the adaptation dynamics based only on these two effects is unstable. In this work, we propose a minimal adaptation model of vessel luminal diameters, in which we take into account the effects of metabolic flow regulation in addition to wall shear stresses and the decreasing tendency of luminal diameters. In particular, we study the role, in the adaptation process, of fluctuations in capillary flow distribution which is an important means of metabolic flow regulation. The fluctuation in the flow of a capillary group is idealized as a switch between two states, i.e., an open-state and a close-state. Using this model, we show that the adaptation of blood vessel system driven by wall shear stress can be efficiently stabilized when the open time ratio responds sensitively to capillary flows. As micro-vessel rarefaction is observed in our simulations with a uniformly decreased open time ratio of capillary flows, our results point to a possible origin of micro-vessel rarefaction, which is believed to induce hypertension.	[Hu, Dan; Cai, David] Shanghai Jiao Tong Univ, Dept Math, MOE LSC, Shanghai 200030, Peoples R China; [Hu, Dan; Cai, David] Shanghai Jiao Tong Univ, Inst Nat Sci, Shanghai 200030, Peoples R China; [Cai, David; Rangan, Aaditya V.] NYU, Courant Inst Math Sci, New York, NY USA; [Cai, David] NYU, Ctr Neural Sci, New York, NY 10003 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; New York University; New York University	Hu, D (corresponding author), Shanghai Jiao Tong Univ, Dept Math, MOE LSC, Shanghai 200030, Peoples R China.	hudan80@sjtu.edu.cn			Natural Science Foundation of China (NSFC) [11004131]; NSFC [11071161]; National Science Foundation [DMS-0506396]; Swartz foundation	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); Swartz foundation	The work of Dan Hu is supported by Natural Science Foundation of China (NSFC) grant 11004131. The work of David Cai is supported by NSFC grant 11071161, National Science Foundation grant DMS-0506396 and a grant from the Swartz foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonios TFT, 2003, HEART, V89, P175, DOI 10.1136/heart.89.2.175; Arvola P, 1999, CARDIOVASC RES, V43, P992, DOI 10.1016/S0008-6363(99)00141-8; BANCHERO N, 1987, ANNU REV PHYSIOL, V49, P465; Bartha K, 2006, J THEOR BIOL, V241, P903, DOI 10.1016/j.jtbi.2006.01.022; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Clark MG, 2008, J APPL PHYSIOL, V104, P889, DOI 10.1152/japplphysiol.00779.2007; DELASHAW JB, 1988, MICROVASC RES, V36, P162, DOI 10.1016/0026-2862(88)90016-7; Desplanches D, 1997, INT J SPORTS MED, V18, pS259, DOI 10.1055/s-2007-972722; DOBRIN PB, 1995, HYPERTENSION, V26, P38, DOI 10.1161/01.HYP.26.1.38; DULING BR, 1972, CIRC RES, V31, P481, DOI 10.1161/01.RES.31.4.481; Eitenmuller I, 2006, CIRC RES, V99, P656, DOI 10.1161/01.RES.0000242560.77512.dd; FOLKOW B, 1963, ACTA PHYSIOL SCAND, V57, P270, DOI 10.1111/j.1748-1716.1963.tb02591.x; Frisbee JC, 2006, AM J PHYSIOL-HEART C, V291, pH2483, DOI 10.1152/ajpheart.00566.2006; Godde R, 2001, DEV DYNAM, V220, P387, DOI 10.1002/dvdy.1118; GRANGER DN, 1983, AM J PHYSIOL, V245, pG786, DOI 10.1152/ajpgi.1983.245.6.G786; GRANGER DN, 1982, AM J PHYSIOL, V242, pG570, DOI 10.1152/ajpgi.1982.242.6.G570; GREENE AS, 1989, AM J PHYSIOL, V256, pH126, DOI 10.1152/ajpheart.1989.256.1.H126; Hacking WJG, 1996, AM J PHYSIOL-HEART C, V270, pH364, DOI 10.1152/ajpheart.1996.270.1.H364; HUDETZ AG, 1992, MICROVASC RES, V43, P334, DOI 10.1016/0026-2862(92)90029-O; KAMIYA A, 1984, B MATH BIOL, V46, P127, DOI 10.1016/S0092-8240(84)80038-5; Kano Y, 2000, ACTA PHYSIOL SCAND, V169, P271; KLITZMAN B, 1982, CIRC RES, V51, P711, DOI 10.1161/01.RES.51.6.711; KOLLER A, 1993, CIRC RES, V72, P1276, DOI 10.1161/01.RES.72.6.1276; KOLLER A, 1991, AM J PHYSIOL, V260, pH862, DOI 10.1152/ajpheart.1991.260.3.H862; KUO L, 1991, AM J PHYSIOL, V261, pH1706, DOI 10.1152/ajpheart.1991.261.6.H1706; LASH JM, 1992, J APPL PHYSIOL, V72, P2052, DOI 10.1152/jappl.1992.72.6.2052; Lee DS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058104; Levy BI, 2001, CIRCULATION, V104, P735, DOI 10.1161/hc3101.091158; Lewis AM, 1999, AM J PHYSIOL-HEART C, V277, pH756, DOI 10.1152/ajpheart.1999.277.2.H756; LINDBOM L, 1980, MICROVASC RES, V19, P197, DOI 10.1016/0026-2862(80)90040-0; LIPOWSKY HH, 1974, MICROVASC RES, V7, P73, DOI 10.1016/0026-2862(74)90038-7; Lundby C, 2006, J PHYSIOL-LONDON, V573, P535, DOI 10.1113/jphysiol.2006.106765; MathieuCostello O, 1997, RESP PHYSIOL, V109, P39, DOI 10.1016/S0034-5687(97)84028-5; MCDONALD KS, 1992, J APPL PHYSIOL, V72, P2210, DOI 10.1152/jappl.1992.72.6.2210; Mellander S, 1968, PHARMACOL REV, V20, P1170; Mulvany MJ, 2002, NEWS PHYSIOL SCI, V17, P105, DOI 10.1152/nips.01366.2001; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; PAWLIK WW, 1980, AM J PHYSIOL, V239, pG12, DOI 10.1152/ajpgi.1980.239.1.G12; Pladys P, 2005, AM J PHYSIOL-REG I, V289, pR1580, DOI 10.1152/ajpregu.00031.2005; POHL U, 1986, HYPERTENSION, V8, P37, DOI 10.1161/01.HYP.8.1.37; PREWITT RL, 1986, J HYPERTENS, V4, P735, DOI 10.1097/00004872-198612000-00008; PREWITT RL, 1982, AM J PHYSIOL, V243, pH243, DOI 10.1152/ajpheart.1982.243.2.H243; Pries AR, 2005, AM J PHYSIOL-HEART C, V288, pH1010, DOI 10.1152/ajpheart.00752.2004; Pries AR, 2001, HYPERTENSION, V38, P1476, DOI 10.1161/hy1201.100592; Pries AR, 1998, AM J PHYSIOL-HEART C, V275, pH349; RODBARD S, 1975, CARDIOLOGY, V60, P4, DOI 10.1159/000169701; Serebrovskaya TV, 2008, EXP BIOL MED, V233, P627, DOI 10.3181/0710-MR-267; SHEPHERD AP, 1979, AM J PHYSIOL, V237, pE548, DOI 10.1152/ajpendo.1979.237.6.E548; SHEPHERD AP, 1982, AM J PHYSIOL, V242, pG435, DOI 10.1152/ajpgi.1982.242.5.G435; SWEENEY TE, 1989, CIRC RES, V64, P112, DOI 10.1161/01.RES.64.1.112; Thoma R., 1893, UNTERSUCHUNGEN HISTO; Widmer RJ, 2007, AM J PHYSIOL-REG I, V292, pR2312, DOI 10.1152/ajpregu.00873.2006	52	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45444	10.1371/journal.pone.0045444	http://dx.doi.org/10.1371/journal.pone.0045444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029014	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517500030
J	Marsolier-Kergoat, MC				Marsolier-Kergoat, Marie-Claude			Asymmetry Indices for Analysis and Prediction of Replication Origins in Eukaryotic Genomes	PLOS ONE			English	Article							COMPOSITIONAL BIASES; BASE COMPOSITION; STRAND-BIAS; YEAST; TERMINATION; PROFILE; OCCURS; SKEWS; SITE	DNA replication was recently shown to induce the formation of compositional skews in the genomes of the yeasts Saccharomyces cerevisiae and Kluyveromyces lactis. In this work, I have characterized further GC and TA skew variations in the vicinity of S. cerevisiae replication origins and termination sites, and defined asymmetry indices for origin analysis and prediction. The presence of skew jumps at some termination sites in the S. cerevisiae genome was established. The majority of S. cerevisiae replication origins are marked by an oriented consensus sequence called ACS, but no evidence could be found for asymmetric origin firing that would be linked to ACS orientation. Asymmetry indices related to GC and TA skews were defined, and a global asymmetry index I-GC,I-TA was described. I-GC,I-TA was found to strongly correlate with origin efficiency in S. cerevisiae and to allow the determination of sets of intergenes significantly enriched in origin loci. The generalized use of asymmetry indices for origin prediction in naive genomes implies the determination of the direction of the skews, i.e. the identification of which strand, leading or lagging, is enriched in G and which one is enriched in T. Recent work indicates that in Candida albicans and in several related species, centromeres contain early and efficient replication origins. It has been proposed that the skew jumps observed at these positions would reflect the activity of these origins, thus allowing to determine the direction of the skews in these genomes. However, I show here that the skew jumps at C. albicans centromeres are not related to replication and that replication-associated GC and TA skews in C. albicans have in fact the opposite directions of what was proposed.	CEA Saclay, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay	Marsolier-Kergoat, MC (corresponding author), CEA Saclay, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France.	mcmk@cea.fr			Commissariat a l'Energie Atomique (CEA/France)	Commissariat a l'Energie Atomique (CEA/France)(French Atomic Energy Commission)	This work was supported by the Commissariat a l'Energie Atomique (CEA/France, http://www.cea.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agier N, 2012, MOL BIOL EVOL; Arneodo A, 2011, PHYS REP, V498, P45, DOI 10.1016/j.physrep.2010.10.001; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272; Chen CL, 2011, MOL BIOL EVOL, V28, P2327, DOI 10.1093/molbev/msr056; Duggin IG, 2009, J MOL BIOL, V387, P532, DOI 10.1016/j.jmb.2009.02.027; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; Gierlik A, 2000, J THEOR BIOL, V202, P305, DOI 10.1006/jtbi.1999.1062; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Hendrickson H, 2007, MOL MICROBIOL, V64, P42, DOI 10.1111/j.1365-2958.2007.05596.x; Huvet M, 2007, GENOME RES, V17, P1278, DOI 10.1101/gr.6533407; KEARSEY S, 1984, CELL, V37, P299, DOI 10.1016/0092-8674(84)90326-X; Koren A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001068; LOBRY JR, 1995, J MOL EVOL, V40, P326, DOI 10.1007/BF00163237; Lobry JR, 1996, SCIENCE, V272, P745, DOI 10.1126/science.272.5262.745; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Marsolier-Kergoat MC, 2012, MOL BIOL EVOL, V29, P893, DOI 10.1093/molbev/msr240; McLean MJ, 1998, J MOL EVOL, V47, P691, DOI 10.1007/PL00006428; Mrazek J, 1998, P NATL ACAD SCI USA, V95, P3720, DOI 10.1073/pnas.95.7.3720; Nieduszynski CA, 2007, NUCLEIC ACIDS RES, V35, pD40, DOI 10.1093/nar/gkl758; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Pavlov YI, 2002, MOL CELL, V10, P207, DOI 10.1016/S1097-2765(02)00567-1; R Core Team, 2018, R LANG ENV STAT COMP; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313; ROBERTS JD, 1994, J BIOL CHEM, V269, P1711; Rocha EPC, 2006, GENOME RES, V16, P1537, DOI 10.1101/gr.5525106; Santamaria D, 2000, NUCLEIC ACIDS RES, V28, P2099, DOI 10.1093/nar/28.10.2099; Stinchcomb D. T, 1981, INITIATION DNA REPLI, P473, DOI 10.1016/b978-0-12-583580-0.50036-4; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Touchon M, 2005, P NATL ACAD SCI USA, V102, P9836, DOI 10.1073/pnas.0500577102; Touchon M, 2008, BIOCHIMIE, V90, P648, DOI 10.1016/j.biochi.2007.09.015; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x; Yang SCH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.61	36	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45050	10.1371/journal.pone.0045050	http://dx.doi.org/10.1371/journal.pone.0045050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028755	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500018
J	Mir, K; Neuhaus, K; Scherer, S; Bossert, M; Schober, S				Mir, Katharina; Neuhaus, Klaus; Scherer, Siegfried; Bossert, Martin; Schober, Steffen			Predicting Statistical Properties of Open Reading Frames in Bacterial Genomes	PLOS ONE			English	Article							PROTEIN-CODING GENES; COLI O157-H7; OVERLAPPING GENES; SEQUENCE; DNA	An analytical model based on the statistical properties of Open Reading Frames (ORFs) of eubacterial genomes such as codon composition and sequence length of all reading frames was developed. This new model predicts the average length, maximum length as well as the length distribution of the ORFs of 70 species with GC contents varying between 21% and 74%. Furthermore, the number of annotated genes is predicted with high accordance. However, the ORF length distribution in the five alternative reading frames shows interesting deviations from the predicted distribution. In particular, long ORFs appear more often than expected statistically. The unexpected depletion of stop codons in these alternative open reading frames cannot completely be explained by a biased codon usage in the +1 frame. While it is unknown if the stop codon depletion has a biological function, it could be due to a protein coding capacity of alternative ORFs exerting a selection pressure which prevents the fixation of stop codon mutations. The comparison of the analytical model with bacterial genomes, therefore, leads to a hypothesis suggesting novel gene candidates which can now be investigated in subsequent wet lab experiments.	[Mir, Katharina; Bossert, Martin; Schober, Steffen] Univ Ulm, Inst Commun Engn, Ulm, Germany; [Neuhaus, Klaus; Scherer, Siegfried] Tech Univ Munich, Chair Microbial Ecol, Freising Weihenstephan, Germany	Ulm University; Technical University of Munich	Mir, K (corresponding author), Univ Ulm, Inst Commun Engn, Ulm, Germany.	katharina.mir@uni-ulm.de	Scherer, Siegfried/I-1320-2013	Scherer, Siegfried/0000-0002-0394-9890; Neuhaus, Klaus/0000-0002-6020-2814	Deutsche Forschungsgemeinschaft (DFG) [BO867/23-1, SCHE316/3-1, SPP 1395]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work has been funded by the Deutsche Forschungsgemeinschaft (DFG) under the grants BO867/23-1 and SCHE316/3-1 in the priority program SPP 1395 "Informations-und Kommunikationstheorie in der Molekularbiologie (InKoMBio)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens M, 2002, INFECT IMMUN, V70, P2915, DOI 10.1128/IAI.70.6.2915-2925.2002; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67; Carpena P, 2002, GENE, V300, P97, DOI 10.1016/S0378-1119(02)01041-7; Chirico N, 2010, P ROY SOC B-BIOL SCI, V277, P3809, DOI 10.1098/rspb.2010.1052; CORNISHBOWDEN A, 1985, NUCLEIC ACIDS RES, V13, P3021, DOI 10.1093/nar/13.9.3021; Delaye L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-31; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Feller W., 1968, INTRO PROBABILITY TH, V1; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Gualerzi CO, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P477; GUIGO R, 1995, J MOL BIOL, V253, P51, DOI 10.1006/jmbi.1995.0535; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hemm MR, 2010, J BACTERIOL, V192, P46, DOI 10.1128/JB.00872-09; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jensen KT, 2006, FEMS MICROBIOL LETT, V265, P106, DOI 10.1111/j.1574-6968.2006.00480.x; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; Kim W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008455; Li WT, 1999, COMPUT CHEM, V23, P283, DOI 10.1016/S0097-8485(99)00014-5; Li WT, 1998, GENOME RES, V8, P916, DOI 10.1101/gr.8.9.916; Makalowska I, 2005, COMPUT BIOL CHEM, V29, P1, DOI 10.1016/j.compbiolchem.2004.12.006; McCoy MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006456; McDaniel LD, 2010, SCIENCE, V330, P50, DOI 10.1126/science.1192243; McVeigh A, 2000, INFECT IMMUN, V68, P5710, DOI 10.1128/IAI.68.10.5710-5715.2000; MERINO E, 1994, NUCLEIC ACIDS RES, V22, P1903, DOI 10.1093/nar/22.10.1903; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Neuhaus K, 2012, SHADOW OPEN RE UNPUB; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Razin S, 2006, PROKARYOTES HDB BIOL, P896; Reva O, 2008, ENVIRON MICROBIOL, V10, P768, DOI 10.1111/j.1462-2920.2007.01500.x; Sabath N, 2010, J MOL EVOL, V71, P308, DOI 10.1007/s00239-010-9386-3; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Silby MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000094; Silby MW, 2004, MICROBIOL-SGM, V150, P518, DOI 10.1099/mic.0.26871-0; Silke J, 1997, GENE, V194, P143, DOI 10.1016/S0378-1119(97)00199-6; Sousa C. P., 2003, J. Venom. Anim. Toxins incl. Trop. Dis, V9, P4, DOI 10.1590/S1678-91992003000100002; Sussman JK, 1996, MOL MICROBIOL, V21, P347, DOI 10.1046/j.1365-2958.1996.6371354.x; Tunca S, 2009, FEBS J, V276, P4814, DOI 10.1111/j.1742-4658.2009.07182.x; Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131; WILK MB, 1968, BIOMETRIKA, V55, P1; Yoon JW, 2008, J VET SCI, V9, P219, DOI 10.4142/jvs.2008.9.3.219; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8	47	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45103	10.1371/journal.pone.0045103	http://dx.doi.org/10.1371/journal.pone.0045103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028785	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700022
J	Porter, G; Leonards, U; Troscianko, T; Haworth, J; Bayer, A; Tales, A				Porter, Gillian; Leonards, Ute; Troscianko, Tom; Haworth, Judy; Bayer, Antony; Tales, Andrea			Dealing with Illumination in Visual Scenes: Effects of Ageing and Alzheimer's Disease	PLOS ONE			English	Article							REVERSED-CONTRAST CHARTS; PERCEPTUAL ORGANIZATION; SEARCH; ORIENTATION; SHADOWS; VISION; ACUITY; LIGHT; SIZE; CAST	Various visual functions decline in ageing and even more so in patients with Alzheimer's disease (AD). Here we investigated whether the complex visual processes involved in ignoring illumination-related variability (specifically, cast shadows) in visual scenes may also be compromised. Participants searched for a discrepant target among items which appeared as posts with shadows cast by light-from-above when upright, but as angled objects when inverted. As in earlier reports, young participants gave slower responses with upright than inverted displays when the shadow-like part was dark but not white (control condition). This is consistent with visual processing mechanisms making shadows difficult to perceive, presumably to assist object recognition under varied illumination. Contrary to predictions, this interaction of "shadow" colour with item orientation was maintained in healthy older and AD groups. Thus, the processing mechanisms which assist complex light-independent object identification appear to be robust to the effects of both ageing and AD. Importantly, this means that the complexity of a function does not necessarily determine its vulnerability to age- or AD-related decline. We also report slower responses to dark than light "shadows" of either orientation in both ageing and AD, in keeping with increasing light scatter in the ageing eye. Rather curiously, AD patients showed further slowed responses to "shadows" of either colour at the bottom than the top of items as if they applied shadow-specific rules to non-shadow conditions. This suggests that in AD, shadow-processing mechanisms, while preserved, might be applied in a less selective way.	[Porter, Gillian; Leonards, Ute; Troscianko, Tom; Tales, Andrea] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England; [Haworth, Judy] Avon & Wiltshire Mental Hlth Partnership, S Glos Memory Serv, Bristol, Avon, England; [Bayer, Antony] Cardiff Univ, Dept Geriatr Med, Cardiff, S Glam, Wales	University of Bristol; Cardiff University	Porter, G (corresponding author), Univ Bristol, Dept Expt Psychol, Bristol, Avon, England.	gillian.porter@bristol.ac.uk	Bayer, Antony/H-4434-2019; Bayer, Antony/H-4376-2019	Bayer, Antony/0000-0002-7514-248X; Leonards, Ute/0000-0001-6143-7466; Tales, Andrea/0000-0003-4825-4555	BRACE Charity (Bristol Research into Alzheimer's and Care of the Elderly)	BRACE Charity (Bristol Research into Alzheimer's and Care of the Elderly)	The research was funded by a grant awarded to Andrea Tales by The BRACE Charity (Bristol Research into Alzheimer's and Care of the Elderly). http://www.alzheimers-brace.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva H, 2004, BRAIN, V127, P949, DOI 10.1093/brain/awh045; Armstrong RA, 1996, OPTOMETRY VISION SCI, V73, P677, DOI 10.1097/00006324-199611000-00001; Becchio C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010582; Betts LR, 2009, J VISION, V9, DOI 10.1167/9.1.25; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Castiello U, 2003, J COGNITIVE NEUROSCI, V15, P862, DOI 10.1162/089892903322370780; Del Viva MM, 2007, INVEST OPHTH VIS SCI, V48, P2940, DOI 10.1167/iovs.06-0729; Delahunt PB, 2008, J VISION, V8, DOI 10.1167/8.3.5; DRIVER J, 1994, NEUROPSYCHOLOGIA, V32, P1353, DOI 10.1016/0028-3932(94)00068-9; Eglin M, 1991, CEREB CORTEX, V1, P262, DOI 10.1093/cercor/1.3.262; Elder JH, 2004, PERCEPTION, V33, P1319, DOI 10.1068/p5323; ELLIOTT DB, 1987, OPHTHAL PHYSL OPT, V7, P415, DOI 10.1111/j.1475-1313.1987.tb00771.x; Faubert J, 2002, CAN J EXP PSYCHOL, V56, P164, DOI 10.1037/h0087394; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gilchrist A, 1999, PSYCHOL REV, V106, P795, DOI 10.1037/0033-295X.106.4.795; Grahame M, 2004, HUM FACTORS, V46, P385, DOI 10.1518/hfes.46.3.385.3808; Haegerstrom-Portnoy G, 1999, OPTOMETRY VISION SCI, V76, P141, DOI 10.1097/00006324-199903000-00014; Ho G, 2001, HUM FACTORS, V43, P194, DOI 10.1518/001872001775900922; Kingdom FAA, 2008, VISION RES, V48, P2090, DOI 10.1016/j.visres.2008.03.020; Kirby E, 2010, J ALZHEIMERS DIS, V21, P15, DOI 10.3233/JAD-2010-080785; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Kurylo DD, 2006, EXP AGING RES, V32, P137, DOI 10.1080/03610730600553901; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Lovell PG, 2009, J VISION, V9, DOI 10.1167/9.1.37; Lovell PG, 2005, J OPT SOC AM A, V22, P2060, DOI 10.1364/JOSAA.22.002060; McKendrick AM, 2010, J VISION, V10, DOI 10.1167/10.2.1; Norman JF, 2007, PERCEPT PSYCHOPHYS, V69, P23, DOI 10.3758/BF03194450; Porter G, 2010, J VISION, V10, DOI 10.1167/10.3.13; Porter G, 2010, CORTEX, V46, P637, DOI 10.1016/j.cortex.2009.04.014; Rensink RA, 2004, PERCEPTION, V33, P1339, DOI 10.1068/p5322; Rossini PM, 2007, PROG NEUROBIOL, V83, P375, DOI 10.1016/j.pneurobio.2007.07.010; Roudaia E, 2008, VISION RES, V48, P2767, DOI 10.1016/j.visres.2008.07.026; Schmolesky MT, 2000, NAT NEUROSCI, V3, P384, DOI 10.1038/73957; SEKULER R, 1980, J GERONTOL, V35, P692, DOI 10.1093/geronj/35.5.692; Tales A, 2006, NEUROREPORT, V17, P887, DOI 10.1097/01.wnr.0000223383.42295.fa; Tales A, 2008, REV CLIN GERONTOL, V18, P229, DOI 10.1017/S0959259809002792; TRICK GL, 1995, NEUROLOGY, V45, P68, DOI 10.1212/WNL.45.1.68; Uhlhaas PJ, 2008, DEMENT GERIATR COGN, V25, P465, DOI 10.1159/000125671; Westheimer G, 2003, OPTOMETRY VISION SCI, V80, P749, DOI 10.1097/00006324-200311000-00011; Westheimer G, 2003, OPTOMETRY VISION SCI, V80, P745, DOI 10.1097/00006324-200311000-00010; Whittaker KW, 2002, EYE, V16, P206, DOI 10.1038/sj/EYE/6700037; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132	42	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45104	10.1371/journal.pone.0045104	http://dx.doi.org/10.1371/journal.pone.0045104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23028786	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700023
J	Ihlefeld, A; Litovsky, RY				Ihlefeld, Antje; Litovsky, Ruth Y.			Interaural Level Differences Do Not Suffice for Restoring Spatial Release from Masking in Simulated Cochlear Implant Listening	PLOS ONE			English	Article							SPEECH RECOGNITION; COCKTAIL-PARTY; SOUND LOCALIZATION; ACOUSTIC HEARING; TIME DIFFERENCES; NOISE; SEPARATION; CUES; INTELLIGIBILITY; PERCEPTION	Spatial release from masking refers to a benefit for speech understanding. It occurs when a target talker and a masker talker are spatially separated. In those cases, speech intelligibility for target speech is typically higher than when both talkers are at the same location. In cochlear implant listeners, spatial release from masking is much reduced or absent compared with normal hearing listeners. Perhaps this reduced spatial release occurs because cochlear implant listeners cannot effectively attend to spatial cues. Three experiments examined factors that may interfere with deploying spatial attention to a target talker masked by another talker. To simulate cochlear implant listening, stimuli were vocoded with two unique features. First, we used 50-Hz low-pass filtered speech envelopes and noise carriers, strongly reducing the possibility of temporal pitch cues; second, co-modulation was imposed on target and masker utterances to enhance perceptual fusion between the two sources. Stimuli were presented over headphones. Experiments 1 and 2 presented high-fidelity spatial cues with unprocessed and vocoded speech. Experiment 3 maintained faithful long-term average interaural level differences but presented scrambled interaural time differences with vocoded speech. Results show a robust spatial release from masking in Experiments 1 and 2, and a greatly reduced spatial release in Experiment 3. Faithful long-term average interaural level differences were insufficient for producing spatial release from masking. This suggests that appropriate interaural time differences are necessary for restoring spatial release from masking, at least for a situation where there are few viable alternative segregation cues.	[Ihlefeld, Antje; Litovsky, Ruth Y.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Ihlefeld, Antje] NYU, Ctr Neural Sci, New York, NY 10003 USA	University of Wisconsin System; University of Wisconsin Madison; New York University	Ihlefeld, A (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	ai33@nyu.edu; litovsky@waisman.wisc.edu	Ihlefeld, Antje/ABA-3468-2020	Ihlefeld, Antje/0000-0001-7185-5848	NIH-NIDCD [5R01-DC003083, 2P30-HD003352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003083] Funding Source: NIH RePORTER	NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work described in this manuscript was supported by grant 5R01-DC003083 from the NIH-NIDCD (PI: Litovsky) and 2P30-HD003352 from the NIH-NIDCD (PI: Seltzer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast TL, 2005, J ACOUST SOC AM, V117, P2169, DOI 10.1121/1.1861598; Best V, 2006, J ACOUST SOC AM, V120, P1506, DOI 10.1121/1.2234849; Bingabr M, 2008, HEARING RES, V241, P73, DOI 10.1016/j.heares.2008.04.012; Brungart DS, 2001, J ACOUST SOC AM, V109, P1101, DOI 10.1121/1.1345696; Carlyon RP, 2007, JARO-J ASSOC RES OTO, V8, P119, DOI 10.1007/s10162-006-0068-1; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; CULLING JF, 1995, J ACOUST SOC AM, V98, P785, DOI 10.1121/1.413571; Culling JF, 2004, J ACOUST SOC AM, V116, P1057, DOI 10.1121/1.1772396; Darwin CJ, 2000, J ACOUST SOC AM, V107, P970, DOI 10.1121/1.428278; Fishman KE, 1997, J SPEECH LANG HEAR R, V40, P1201, DOI 10.1044/jslhr.4005.1201; Freyman RL, 1999, J ACOUST SOC AM, V106, P3578, DOI 10.1121/1.428211; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Garadat SN, 2010, J ACOUST SOC AM, V127, P977, DOI 10.1121/1.3273897; Grantham DW, 2007, EAR HEARING, V28, P524, DOI 10.1097/AUD.0b013e31806dc21a; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Hancock KE, 2010, J NEUROSCI, V30, P14068, DOI 10.1523/JNEUROSCI.3213-10.2010; Hawley ML, 2004, J ACOUST SOC AM, V115, P833, DOI 10.1121/1.1639908; Hilkhuysen G, 2012, J ACOUST SOC AM, V131, P531, DOI 10.1121/1.3665996; HIRSH IJ, 1948, J ACOUST SOC AM, V20, P536, DOI 10.1121/1.1906407; HUKIN RW, 1995, J ACOUST SOC AM, V98, P1380, DOI 10.1121/1.414348; Ihiefeld A, 2008, J ACOUST SOC AM, V123, P4369, DOI 10.1121/1.2904826; IHLEFELD A, 2007, P DAGA GERM AC SOC S; Ihlefeld A, 2008, J ACOUST SOC AM, V124, P2224, DOI 10.1121/1.2973185; Ihlefeld A, 2011, J ACOUST SOC AM, V130, P324, DOI 10.1121/1.3596476; Ihlefeld A, 2010, J ACOUST SOC AM, V128, P870, DOI 10.1121/1.3458817; Ives DT, 2010, J ACOUST SOC AM, V127, P3729, DOI 10.1121/1.3377051; Jones GL, 2011, J ACOUST SOC AM, V130, P1463, DOI 10.1121/1.3613928; Kidd G, 2009, J ACOUST SOC AM, V126, pEL196, DOI 10.1121/1.3258062; Kidd G, 2008, J ACOUST SOC AM, V124, P3793, DOI 10.1121/1.2998980; Kohlrausch A, 1997, ACUSTICA, V83, P659; Litovsky R. Y., 2009, EAR HEARING, V27, P714; Litovsky R, 2006, EAR HEARING, V27, P714, DOI 10.1097/01.aud.0000246816.50820.42; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Loizou PC, 2009, J ACOUST SOC AM, V125, P372, DOI 10.1121/1.3036175; Long CJ, 2006, JARO-J ASSOC RES OTO, V7, P352, DOI 10.1007/s10162-006-0049-4; Lu T, 2010, J ACOUST SOC AM, V127, P1479, DOI 10.1121/1.3290994; Maddox RK, 2012, JARO-J ASSOC RES OTO, V13, P119, DOI 10.1007/s10162-011-0299-7; Marrone Nicole, 2008, Trends Amplif, V12, P300, DOI 10.1177/1084713808325880; Neher T, 2009, INT J AUDIOL, V48, P758, DOI 10.3109/14992020903079332; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Seeber BU, 2008, J ACOUST SOC AM, V123, P1030, DOI 10.1121/1.2821965; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shinn-Cunningham BG, 2007, P NATL ACAD SCI USA, V104, P12223, DOI 10.1073/pnas.0704641104; van Hoesel RJM, 2004, AUDIOL NEURO-OTOL, V9, P234, DOI 10.1159/000078393; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; ZUREK PM, 1993, ACOUSTICAL FACTORS A, P255	47	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45296	10.1371/journal.pone.0045296	http://dx.doi.org/10.1371/journal.pone.0045296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028914	gold, Green Published			2022-12-27	WOS:000309388900036
J	Raine, NE; Chittka, L				Raine, Nigel E.; Chittka, Lars			No Trade-Off between Learning Speed and Associative Flexibility in Bumblebees: A Reversal Learning Test with Multiple Colonies	PLOS ONE			English	Article							HONEY-BEES MEMORY; LONG-TERM; BEHAVIORAL PLASTICITY; FORAGING BUMBLEBEES; HYMENOPTERA; EVOLUTION; APIDAE; COST; RECONSOLIDATION; RESPONSIVENESS	Potential trade-offs between learning speed and memory-related performance could be important factors in the evolution of learning. Here, we test whether rapid learning interferes with the acquisition of new information using a reversal learning paradigm. Bumblebees (Bombus terrestris) were trained to associate yellow with a floral reward. Subsequently the association between colour and reward was reversed, meaning bees then had to learn to visit blue flowers. We demonstrate that individuals that were fast to learn yellow as a predictor of reward were also quick to reverse this association. Furthermore, overnight memory retention tests suggest that faster learning individuals are also better at retaining previously learned information. There is also an effect of relatedness: colonies whose workers were fast to learn the association between yellow and reward also reversed this association rapidly. These results are inconsistent with a trade-off between learning speed and the reversal of a previously made association. On the contrary, they suggest that differences in learning performance and cognitive (behavioural) flexibility could reflect more general differences in colony learning ability. Hence, this study provides additional evidence to support the idea that rapid learning and behavioural flexibility have adaptive value.	[Raine, Nigel E.; Chittka, Lars] Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England	University of London	Raine, NE (corresponding author), Univ London, Sch Biol Sci, Surrey, England.	nigel.raine@rhul.ac.uk	Raine, Nigel/AAK-6425-2020; Chittka, Lars/C-3110-2012	Raine, Nigel/0000-0001-6343-2829; Chittka, Lars/0000-0001-8153-1732	NERC [NER/A/S/2003/00469]; Natural Environment Research Council [NER/A/S/2003/00469] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the NERC (NER/A/S/2003/00469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alghamdi A, 2008, BIOL LETTERS, V4, P479, DOI 10.1098/rsbl.2008.0331; Alghamdi A, 2009, BIOL LETTERS, V5, P55, DOI 10.1098/rsbl.2008.0514; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; BITTERMAN ME, 1976, SCIENCE, V192, P380, DOI 10.1126/science.1257773; BITTERMAN ME, 1965, AM PSYCHOL, V20, P396, DOI 10.1037/h0022328; BOLHUIS JJ, 1991, BIOL REV, V66, P303, DOI 10.1111/j.1469-185X.1991.tb01145.x; Bond AB, 2007, J COMP PSYCHOL, V121, P372, DOI 10.1037/0735-7036.121.4.372; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BRANDES C, 1988, BEHAV GENET, V18, P119, DOI 10.1007/BF01067081; Briffa M, 2008, P R SOC B, V275, P1305, DOI 10.1098/rspb.2008.0025; Brown V., 2010, ENCY PSYCHOPHARMACOL, P209, DOI DOI 10.1007/978-3-540-68706-1_340; Chittka L, 1998, J EXP BIOL, V201, P515; Chittka L, 1997, BEHAV ECOL SOCIOBIOL, V41, P385, DOI 10.1007/s002650050400; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Cnaani J, 2006, ETHOLOGY, V112, P278, DOI 10.1111/j.1439-0310.2006.01174.x; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Deary I. J., 2020, INTELLIGENCE VERY SH, V2nd; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; DUKAS R, 1993, ANIM BEHAV, V45, P37, DOI 10.1006/anbe.1993.1004; Dukas R, 2000, BEHAV ECOL, V11, P536, DOI 10.1093/beheco/11.5.536; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Dukas Reuven, 1998, P129; Eisenhardt D, 2007, NEUROBIOL LEARN MEM, V87, P167, DOI 10.1016/j.nlm.2006.09.005; Hadar R, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00186; HEINRICH B, 1976, ECOL MONOGR, V46, P105, DOI 10.2307/1942246; HEINRICH B, 1979, ECOLOGY, V60, P245, DOI 10.2307/1937652; Ings TC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1207, DOI 10.1007/s00265-009-0731-8; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Komischke B, 2002, LEARN MEMORY, V9, P122, DOI 10.1101/lm.44602; Laloi D, 2010, APIDOLOGIE, V41, P436, DOI 10.1051/apido/2009080; Latshaw JS, 2005, BEHAV ECOL SOCIOBIOL, V58, P200, DOI 10.1007/s00265-004-0904-4; Lunau K, 1996, J COMP PHYSIOL A, V178, P477, DOI 10.1007/BF00190178; Mallon EB, 2003, P ROY SOC B-BIOL SCI, V270, P2471, DOI 10.1098/rspb.2003.2456; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MENZEL R, 1993, APIDOLOGIE, V24, P157, DOI 10.1051/apido:19930301; MENZEL R, 1968, Z VERGL PHYSIOL, V60, P82, DOI 10.1007/BF00737097; MENZEL R, 1969, Z VERGL PHYSIOL, V63, P290, DOI 10.1007/BF00298164; Menzel Randolf, 1993, P79; Mery F, 2003, P ROY SOC B-BIOL SCI, V270, P2465, DOI 10.1098/rspb.2003.2548; Mery F, 2004, ANIM BEHAV, V68, P589, DOI 10.1016/j.anbehav.2003.12.005; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Mota T, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00048; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Papaj DR, 2007, P NATL ACAD SCI USA, V104, P13539, DOI 10.1073/pnas.0706165104; Parker MO, 2012, BEHAV BRAIN RES, V232, P264, DOI 10.1016/j.bbr.2012.04.035; Pavlov IP., 1927, LECT CONDITIONED REF; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2007, ENTOMOL GEN, V30, P191; Raine NE, 2006, ADV STUD BEHAV, V36, P305, DOI 10.1016/S0065-3454(06)36007-X; Raine NE, 2007, ENTOMOL GEN, V29, P179; Raine NE, 2006, ENTOMOL GEN, V28, P241; Reader SM, 2011, PHILOS T R SOC B, V366, P1017, DOI 10.1098/rstb.2010.0342; Riveros AJ, 2009, NATURWISSENSCHAFTEN, V96, P851, DOI 10.1007/s00114-009-0532-y; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Rygula R, 2010, J NEUROSCI, V30, P14552, DOI 10.1523/JNEUROSCI.2631-10.2010; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Spaethe J, 2007, NATURWISSENSCHAFTEN, V94, P733, DOI 10.1007/s00114-007-0251-1; Stollhoff N, 2005, J NEUROSCI, V25, P4485, DOI 10.1523/JNEUROSCI.0117-05.2005; TIGHE TJ, 1965, J EXP PSYCHOL, V70, P13, DOI 10.1037/h0022053; Willmer PG, 2004, ADV STUD BEHAV, V34, P347, DOI 10.1016/S0065-3454(04)34009-X; WOODWARD GL, 1992, ANIM BEHAV, V44, P1045, DOI 10.1016/S0003-3472(05)80316-1; Worden BD, 2005, J EXP BIOL, V208, P2045, DOI 10.1242/jeb.01582	67	54	54	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45096	10.1371/journal.pone.0045096	http://dx.doi.org/10.1371/journal.pone.0045096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028779	Green Published, gold			2022-12-27	WOS:000309388900020
J	van Wijk, B; Gunst, QD; Moorman, AFM; van den Hoff, MJB				van Wijk, Bram; Gunst, Quinn D.; Moorman, Antoon F. M.; van den Hoff, Maurice J. B.			Cardiac Regeneration from Activated Epicardium	PLOS ONE			English	Article							ZEBRAFISH HEART REGENERATION; BONE MORPHOGENETIC PROTEIN; FOLLISTATIN-LIKE 1; MYOCARDIAL-INFARCTION; MATRICELLULAR PROTEINS; CORONARY VASCULATURE; MOUSE EPICARDIUM; PROGENITOR CELLS; PRECURSOR POOL; STEM-CELLS	In contrast to lower vertebrates, the mammalian heart has a very limited regenerative capacity. Cardiomyocytes, lost after ischemia, are replaced by fibroblasts. Although the human heart is able to form new cardiomyocytes throughout its lifespan, the efficiency of this phenomenon is not enough to substitute sufficient myocardial mass after an infarction. In contrast, zebrafish hearts regenerate through epicardial activation and initiation of myocardial proliferation. With this study we obtain insights into the activation and cellular contribution of the mammalian epicardium in response to ischemia. In a mouse myocardial infarction model we analyzed the spatio-temporal changes in expression of embryonic epicardial, EMT, and stem cell markers and the contribution of cells of the Wt1-lineage to the infarcted area. Though the integrity of the epicardial layer overlaying the infarct is lost immediately after the induction of the ischemia, it was found to be regenerated at three days post infarction. In this regenerated epicardium, the embryonic gene program is transiently re-expressed as well as proliferation. Concomitant with this activation, Wt1-lineage positive subepicardial mesenchyme is formed until two weeks post-infarction. These mesenchymal cells replace the cardiomyocytes lost due to the ischemia and contribute to the fibroblast population, myofibroblasts and coronary endothelium in the infarct, and later also to the cardiomyocyte population. We show that in mice, as in lower vertebrates, an endogenous, epicardium-dependent regenerative response to injury is induced. Although this regenerative response leads to the formation of new cardiomyocytes, their number is insufficient in mice but sufficient in lower vertebrates to replace lost cardiomyocytes. These molecular and cellular analyses provide basic knowledge essential for investigations on the regeneration of the mammalian heart aiming at epicardium-derived cells.	[van Wijk, Bram; Gunst, Quinn D.; Moorman, Antoon F. M.; van den Hoff, Maurice J. B.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van den Hoff, MJB (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.j.vandenhoff@amc.uva.nl		van den Hoff, Maurice/0000-0002-3837-8055	Netherlands Heart Foundation [1996M002]; European Community [LSHM-CT-2005-018630]	Netherlands Heart Foundation(Netherlands Heart Foundation); European Community(European Commission)	The presented work was supported by Netherlands Heart Foundation grant 1996M002 and the European Community's Sixth Framework Program contract ("HeartRepair") grant LSHM-CT-2005-018630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Barnett P, 2011, MED BIOL ENG COMPUT, V49, P723, DOI 10.1007/s11517-011-0776-5; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bornstein P, 2000, MATRIX BIOL, V19, P555, DOI 10.1016/S0945-053X(00)00103-7; Buermans HPJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015504; Carmona R, 2001, CELL TISSUE RES, V303, P173, DOI 10.1007/s004410000307; Di Meglio F, 2010, J MOL CELL CARDIOL, V49, P719, DOI 10.1016/j.yjmcc.2010.05.013; Di Nardo P, 2010, J CELL PHYSIOL, V224, P590, DOI 10.1002/jcp.22165; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Haenig B, 2004, DEV GENES EVOL, V214, P407, DOI 10.1007/s00427-004-0415-3; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Kuhn EN, 2010, J CELL PHYSIOL, V225, P321, DOI 10.1002/jcp.22281; Lavine KJ, 2007, TRENDS CARDIOVAS MED, V17, P77, DOI 10.1016/j.tcm.2007.01.002; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Manner J, 1999, ANAT RECORD, V255, P212; Markwald RR, 2010, ANN NY ACAD SCI, V1188, P177, DOI 10.1111/j.1749-6632.2009.05098.x; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Munoz-Chapuli R, 2002, TEX HEART I J, V29, P243; Munoz-Chapuli R, 2002, REV ESP CARDIOL, V55, P1070, DOI 10.1016/S0300-8932(02)76758-4; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Perez-Pomares JM, 2009, INT J DEV BIOL, V53, P1427, DOI 10.1387/ijdb.072409jp; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Scheinowitz M, 1997, INT J CARDIOL, V59, P1, DOI 10.1016/S0167-5273(96)02902-6; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Snarr BS, 2007, CIRC RES, V101, P971, DOI 10.1161/CIRCRESAHA.107.162206; Somi S, 2006, J HISTOCHEM CYTOCHEM, V54, P649, DOI 10.1369/jhc.5A6846.2006; Song YH, 2011, CELL CYCLE, V10, P2281, DOI 10.4161/cc.10.14.16513; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sylva M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022616; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Van Amerongen MJ, 2008, J PATHOL, V214, P377, DOI 10.1002/path.2281; van Wijk B, 2007, CARDIOVASC RES, V74, P244, DOI 10.1016/j.cardiores.2006.11.022; van Wijk B, 2010, TRENDS CARDIOVAS MED, V20, P1, DOI 10.1016/j.tcm.2010.02.011; van Wijk B, 2009, CIRC RES, V105, P431, DOI 10.1161/CIRCRESAHA.109.203083; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Wessels A, 2004, ANAT REC PART A, V276A, P43, DOI 10.1002/ar.a.10129; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	63	132	136	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44692	10.1371/journal.pone.0044692	http://dx.doi.org/10.1371/journal.pone.0044692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028582	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900011
J	Zha, MW; Zhong, C; Ou, Y; Han, L; Wang, JC; Ding, JP				Zha, Manwu; Zhong, Chen; Ou, Ying; Han, Li; Wang, Jianchuan; Ding, Jianping			Crystal Structures of Human CaMKI alpha Reveal Insights into the Regulation Mechanism of CaMKI	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; CALMODULIN; COMPLEX; ACTIVATION; PHOSPHORYLATION; TRANSCRIPTION; POTENTIATION; BINDING; CYCLIN	Human calcium/calmodulin-dependent protein kinase I (CaMKI) plays pivotal roles in the nervous system. The activity of human CaMKI is regulated by a regulatory region including an autoinhibitory segment and a CaM-binding segment. We report here four structures of three CaMKI alpha truncates in apo form and in complexes with ATP. In an apo, autoinhibited structure, the activation segment adopts a unique helical conformation which together with the autoinhibitory segment constrains helices alpha C and alpha D in inactive conformations, sequesters Thr177 from being phosphorylated, and occludes the substrate-binding site. In an ATP-bound, inactive structure, the activation segment is largely disordered and the CaM-binding segment protrudes out ready for CaM binding. In an ATP-bound, active structure, the regulatory region is dissociated from the catalytic core and the catalytic site assumes an active conformation. Detailed structural analyses reveal the interplay of the regulatory region, the activation segment, and the nucleotide-binding site in the regulation of CaMKI.	[Zha, Manwu; Zhong, Chen; Ou, Ying; Han, Li; Wang, Jianchuan; Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Ding, JP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China.	jpding@sibs.ac.cn		ding, jian ping/0000-0001-7029-7346	National Natural Science Foundation of China [30800171]; Ministry of Science and Technology of China [2011CB966301, 2011CB911102]; Science and Technology Commission of Shanghai Municipality [10JC1416500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Natural Science Foundation of China (30800171), the Ministry of Science and Technology of China (2011CB966301 and 2011CB911102), and the Science and Technology Commission of Shanghai Municipality (10JC1416500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang ESM, 2007, J CELL PHYSIOL, V212, P787, DOI 10.1002/jcp.21076; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang CW, 2011, MOL CELL BIOL, V31, P3820, DOI 10.1128/MCB.05582-11; Clapperton JA, 2002, BIOCHEMISTRY-US, V41, P14669, DOI 10.1021/bi026660t; Davare MA, 2009, J NEUROSCI, V29, P9794, DOI 10.1523/JNEUROSCI.1544-09.2009; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; de Diego I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000552; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kranz JK, 2002, J BIOL CHEM, V277, P16351, DOI 10.1074/jbc.C200139200; LEE JC, 1994, P NATL ACAD SCI USA, V91, P6413, DOI 10.1073/pnas.91.14.6413; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Wayman GA, 2011, CELL CALCIUM, V50, P1, DOI 10.1016/j.ceca.2011.02.007; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Westwood I, 2009, J MOL BIOL, V386, P476, DOI 10.1016/j.jmb.2008.12.033; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; YOKOKURA H, 1995, J BIOL CHEM, V270, P23851, DOI 10.1074/jbc.270.40.23851; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	39	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e44828	10.1371/journal.pone.0044828	http://dx.doi.org/10.1371/journal.pone.0044828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028635	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388900012
J	Cerbai, F; Lana, D; Nosi, D; Petkova-Kirova, P; Zecchi, S; Brothers, HM; Wenk, GL; Giovannini, MG				Cerbai, Francesca; Lana, Daniele; Nosi, Daniele; Petkova-Kirova, Polina; Zecchi, Sandra; Brothers, Holly M.; Wenk, Gary L.; Giovannini, Maria Grazia			The Neuron-Astrocyte-Microglia Triad in Normal Brain Ageing and in a Model of Neuroinflammation in the Rat Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; FRACTALKINE-RECEPTOR; REACTIVE ASTROCYTES; AMYLOID DEPOSITION; ALZHEIMERS-DISEASE; FOOD RESTRICTION; OXIDATIVE STRESS; PROTECTIVE ROLES; DENTATE GYRUS	Ageing is accompanied by a decline in cognitive functions; along with a variety of neurobiological changes. The association between inflammation and ageing is based on complex molecular and cellular changes that we are only just beginning to understand. The hippocampus is one of the structures more closely related to electrophysiological, structural and morphological changes during ageing. In the present study we examined the effect of normal ageing and LPS-induced inflammation on astroglia-neuron interaction in the rat hippocampus of adult, normal aged and LPS-treated adult rats. Astrocytes were smaller, with thicker and shorter branches and less numerous in CA1 Str. radiatum of aged rats in comparison to adult and LPS-treated rats. Astrocyte branches infiltrated apoptotic neurons of aged and LPS-treated rats. Cellular debris, which were more numerous in CA1 of aged and LPS-treated rats, could be found apposed to astrocytes processes and were phagocytated by reactive microglia. Reactive microglia were present in the CA1 Str. Radiatum, often in association with apoptotic cells. Significant differences were found in the fraction of reactive microglia which was 40% of total in adult, 33% in aged and 50% in LPS-treated rats. Fractalkine (CX3CL1) increased significantly in hippocampus homogenates of aged and LPS-treated rats. The number of CA1 neurons decreased in aged rats. In the hippocampus of aged and LPS-treated rats astrocytes and microglia may help clearing apoptotic cellular debris possibly through CX3CL1 signalling. Our results indicate that astrocytes and microglia in the hippocampus of aged and LPS-infused rats possibly participate in the clearance of cellular debris associated with programmed cell death. The actions of astrocytes may represent either protective mechanisms to control inflammatory processes and the spread of further cellular damage to neighboring tissue, or they may contribute to neuronal damage in pathological conditions.	[Cerbai, Francesca; Lana, Daniele; Giovannini, Maria Grazia] Univ Florence, Dept Pharmacol, Florence, Italy; [Nosi, Daniele; Zecchi, Sandra] Univ Florence, Dept Anat Histol & Legal Med, Florence, Italy; [Petkova-Kirova, Polina] Bulgarian Acad Sci, Inst Biophys, Sofia, Bulgaria; [Brothers, Holly M.; Wenk, Gary L.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA	University of Florence; University of Florence; Bulgarian Academy of Sciences; University System of Ohio; Ohio State University	Giovannini, MG (corresponding author), Univ Florence, Dept Pharmacol, Florence, Italy.	mariagrazia.giovannini@unifi.it	Petkova-Kirova, Polina/Y-5451-2019; Brothers, Holly/D-2148-2009	Brothers, Holly/0000-0001-8116-2682; Petkova-Kirova, Polina/0000-0001-7086-9498; Lana, Daniele/0000-0002-5193-0019	Banco S. Paolo [2008.1282]; Universita di Firenze; CNR-BAN; United States Public Health Service [RO1 AG030331, AG037320]; NATIONAL INSTITUTE ON AGING [R01AG037320, R01AG030331] Funding Source: NIH RePORTER	Banco S. Paolo; Universita di Firenze; CNR-BAN; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was partly funded by Banco S. Paolo (Grant 2008.1282), PRIN 40% (2007), Universita di Firenze (ex 60%). PP-K was recipient of a CNR-BAN Grant (2010-2012). GLW and HMB were supported by the United States Public Health Service, RO1 AG030331 and AG037320. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Bachstetter AD, 2011, NEUROBIOL AGING, V32, P2030, DOI 10.1016/j.neurobiolaging.2009.11.022; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bernal GM, 2011, AGING CELL, V10, P466, DOI 10.1111/j.1474-9726.2011.00694.x; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bhatnagar M, 1997, NEUROBIOL AGING, V18, P319, DOI 10.1016/S0197-4580(97)80314-4; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; FRIEDE RL, 1961, EXP NEUROL, V4, P197, DOI 10.1016/0014-4886(61)90041-3; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Giovannini MG, 2001, J NEUROSCI, V21, P7053, DOI 10.1523/JNEUROSCI.21-18-07053.2001; Giovannini MG, 2002, METHOD ENZYMOL, V345, P426; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hauss-Wegrzyniak B, 2000, EXP NEUROL, V165, P347, DOI 10.1006/exnr.2000.7469; Hauss-Wegrzyniak B, 1998, BRAIN RES, V780, P294, DOI 10.1016/S0006-8993(97)01215-8; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; Iacono RF, 1995, NEUROSCI LETT, V200, P175, DOI 10.1016/0304-3940(95)12105-D; KRAIG RP, 1990, J CEREBR BLOOD F MET, V10, P104, DOI 10.1038/jcbfm.1990.13; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Long JM, 1998, NEUROBIOL AGING, V19, P497, DOI 10.1016/S0197-4580(98)00088-8; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Menet V, 2000, GLIA, V31, P267, DOI 10.1002/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Miller KR, 2007, NEURON GLIA BIOL, V3, P245, DOI 10.1017/S1740925X08000136; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Morgan TE, 1997, FREE RADICAL BIO MED, V23, P524, DOI 10.1016/S0891-5849(97)00120-2; Morgan TE, 1999, NEUROSCIENCE, V89, P687, DOI 10.1016/S0306-4522(98)00334-0; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nedzvetskii VS, 1999, NEUROPHYSIOLOGY+, V31, P94, DOI 10.1007/BF02515043; Nelson PT, 2002, ANN MED, V34, P491, DOI 10.1080/078538902321117698; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Noda M, 2011, J BIOL CHEM, V286, P2308, DOI 10.1074/jbc.M110.169839; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Penfield S.W., 1928, SPECIAL CYTOLOGY FOR, P1033; Rezaie P, 2002, EXP CELL RES, V274, P68, DOI 10.1006/excr.2001.5431; Rosi S, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-12; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Turrin NP, 2006, MOL NEUROBIOL, V34, P221, DOI 10.1385/MN:34:3:221; Wenk GL, 2000, EUR J PHARMACOL, V402, P77, DOI 10.1016/S0014-2999(00)00523-9; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	62	171	177	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45250	10.1371/journal.pone.0045250	http://dx.doi.org/10.1371/journal.pone.0045250			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028880	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900106
J	Ho, A; Kennedy, J; Dimitropoulos, A				Ho, Alan; Kennedy, James; Dimitropoulos, Anastasia			Neural Correlates to Food-Related Behavior in Normal-Weight and Overweight/Obese Participants	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; LIFE-STYLE MODIFICATION; PRADER-WILLI-SYNDROME; DORSAL STRIATUM; RHESUS-MONKEYS; CALORIE FOODS; OBESITY; HUNGER; REWARD; HUMANS	Two thirds of US adults are either obese or overweight and this rate is rising. Although the etiology of obesity is not yet fully understood, neuroimaging studies have demonstrated that the central nervous system has a principal role in regulating eating behavior. In this study, functional magnetic resonance imaging and survey data were evaluated for correlations between food-related problem behaviors and the neural regions underlying responses to visual food cues before and after eating in normal-weight individuals and overweight/obese individuals. In normal-weight individuals, activity in the left amygdala in response to high-calorie food vs. nonfood object cues was positively correlated with impaired satiety scores during fasting, suggesting that those with impaired satiety scores may have an abnormal anticipatory reward response. In overweight/obese individuals, activity in the dorsolateral prefrontal cortex (DLPFC) in response to low-calorie food cues was negatively correlated with impaired satiety during fasting, suggesting that individuals scoring lower in satiety impairment were more likely to activate the DLPFC inhibitory system. After eating, activity in both the putamen and the amygdala was positively correlated with impaired satiety scores among obese/overweight participants. While these individuals may volitionally suggest they are full, their functional response to food cues suggests food continues to be salient. These findings suggest brain regions involved in the evaluation of visual food cues may be mediated by satiety-related problems, dependent on calorie content, state of satiation, and body mass index.	[Ho, Alan; Kennedy, James; Dimitropoulos, Anastasia] Case Western Reserve Univ, Dept Psychol Sci, Cleveland, OH 44106 USA	Case Western Reserve University	Dimitropoulos, A (corresponding author), Case Western Reserve Univ, Dept Psychol Sci, Cleveland, OH 44106 USA.	anastasia.dimitropoulos@case.edu			National Institutes of Health [RO3HD058766-01, UL1 RR024989]; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058766] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by grants RO3HD058766-01 and UL1 RR024989 from the National Institutes of Health, and the Academic Careers in Education and Science (ACES) Opportunity Grant from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 1982, J COMP PHYSIOL PSYCH, V96, P71, DOI 10.1037/h0077861; AMARAL D G, 1992, P1; Benoit SC, 2010, BRAIN RES, V1350, P71, DOI 10.1016/j.brainres.2010.06.009; Burke LE, 2009, CONTEMP CLIN TRIALS, V30, P540, DOI 10.1016/j.cct.2009.07.003; Davis C, 2004, APPETITE, V42, P131, DOI 10.1016/j.appet.2003.07.004; Del Parigi A, 2002, ANN NY ACAD SCI, V967, P389; Dimitropoulos A, 2011, APPETITE; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fuehrer D, 2008, OBESITY, V16, P945, DOI 10.1038/oby.2008.33; Gearhardt AN, 2011, ARCH GEN PSYCHIAT AR, V2011, p32v1; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Goldstone AP, 2009, EUR J NEUROSCI, V30, P1625, DOI 10.1111/j.1460-9568.2009.06949.x; Grundmann SJ, 2005, AM J PHYSIOL-REG I, V288, pR702, DOI 10.1152/ajpregu.00460.2004; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Kelley AE, 2002, PHYSIOL BEHAV, V76, P365, DOI 10.1016/S0031-9384(02)00751-5; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; KIYATKIN EA, 1994, BRAIN RES, V652, P225, DOI 10.1016/0006-8993(94)90231-3; Kringelbach ML, 2004, NEUROSCIENCE, V126, P807, DOI 10.1016/j.neuroscience.2004.04.035; Lean MEJ, 1998, LANCET, V351, P853, DOI 10.1016/S0140-6736(97)10004-6; Leidy HJ, 2011, OBESITY, V19, P2019, DOI 10.1038/oby.2011.108; Lieberman LS, 2006, APPETITE, V47, P3, DOI 10.1016/j.appet.2006.02.011; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lowe MR, 2006, APPETITE, V46, P16, DOI 10.1016/j.appet.2005.01.014; Lutter M, 2009, J NUTR, V139, P629, DOI 10.3945/jn.108.097618; Martin LE, 2010, OBESITY, V18, P254, DOI 10.1038/oby.2009.220; Matsuda M, 1999, DIABETES, V48, P1801, DOI 10.2337/diabetes.48.9.1801; MATTES RD, 1993, DIGEST DIS, V11, P65, DOI 10.1159/000171402; Miller JL, 2008, AM J MED GENET A, V146A, P570, DOI 10.1002/ajmg.a.31677; Murray EA, 1996, BEHAV NEUROSCI, V110, P30, DOI 10.1037/0735-7044.110.1.30; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Passamonti L, 2009, J NEUROSCI, V29, P43, DOI 10.1523/JNEUROSCI.4966-08.2009; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Pelchat ML, 2004, NEUROIMAGE, V23, P1486, DOI 10.1016/j.neuroimage.2004.08.023; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Piech RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006581; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Russell H, 2003, BRIT J CLIN PSYCHOL, V42, P379, DOI 10.1348/014466503322528928; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Solomon MB, 2010, J NEUROENDOCRINOL, V22, P13, DOI 10.1111/j.1365-2826.2009.01933.x; Stevens J, 2002, AM J EPIDEMIOL, V156, P832, DOI 10.1093/aje/kwf114; Stice E, 2008, J ABNORM PSYCHOL, V117, P924, DOI 10.1037/a0013600; Stice E, 2006, PSYCHOL BULL, V132, P667, DOI 10.1037/0033-2909.132.5.667; Talairach J., 1988, COPLANAR STEREOTAXIC; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Volkow ND, 2002, SYNAPSE, V44, P175, DOI 10.1002/syn.10075; Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282; Wadden TA, 2007, GASTROENTEROLOGY, V132, P2226, DOI 10.1053/j.gastro.2007.03.051; Zametkin AJ, 2004, J AM ACAD CHILD PSY, V43, P134, DOI 10.1097/00004583-200402000-00008; Zheng HY, 2007, CURR OPIN PHARMACOL, V7, P607, DOI 10.1016/j.coph.2007.10.011	55	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45403	10.1371/journal.pone.0045403	http://dx.doi.org/10.1371/journal.pone.0045403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028988	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900134
J	Leung, ES; Chilvers, BL; Nakagawa, S; Moore, AB; Robertson, BC				Leung, Elaine S.; Chilvers, B. Louise; Nakagawa, Shinichi; Moore, Antoni B.; Robertson, Bruce C.			Sexual Segregation in Juvenile New Zealand Sea Lion Foraging Ranges: Implications for Intraspecific Competition, Population Dynamics and Conservation	PLOS ONE			English	Article							PHOCARCTOS-HOOKERI; BEHAVIOR; SIZE; DIET; ANESTHESIA; DIMORPHISM; MANAGEMENT; PATTERNS; MODELS	Sexual segregation (sex differences in spatial organisation and resource use) is observed in a large range of taxa. Investigating causes for sexual segregation is vital for understanding population dynamics and has important conservation implications, as sex differences in foraging ecology may affect vulnerability to area-specific human activities. Although behavioural ecologists have proposed numerous hypotheses for this phenomenon, the underlying causes of sexual segregation are poorly understood. We examined the size-dimorphism and niche divergence hypotheses as potential explanations for sexual segregation in the New Zealand (NZ) sea lion (Phocarctos hookeri), a nationally critical, declining species impacted by trawl fisheries. We used satellite telemetry and linear mixed effects models to investigate sex differences in the foraging ranges of juvenile NZ sea lions. Male trip distances and durations were almost twice as long as female trips, with males foraging over the Auckland Island shelf and in further locations than females. Sex was the most important variable in trip distance, maximum distance travelled from study site, foraging cycle duration and percent time at sea whereas mass and age had small effects on these characteristics. Our findings support the predictions of the niche divergence hypothesis, which suggests that sexual segregation acts to decrease intraspecific resource competition. As a consequence of sexual segregation in foraging ranges, female foraging grounds had proportionally double the overlap with fisheries operations than males. This distribution exposes female juvenile NZ sea lions to a greater risk of resource competition and bycatch from fisheries than males, which can result in higher female mortality. Such sex-biased mortality could impact population dynamics, because female population decline can lead to decreased population fecundity. Thus, effective conservation and management strategies must take into account sex differences in foraging behaviour, as well as differential threat-risk to external impacts such as fisheries bycatch.	[Leung, Elaine S.; Nakagawa, Shinichi; Robertson, Bruce C.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Leung, Elaine S.; Moore, Antoni B.] Univ Otago, Sch Surveying, Dunedin, New Zealand; [Chilvers, B. Louise] Dept Conservat, Aquat & Threats Unit, Wellington, New Zealand	University of Otago; University of Otago	Leung, ES (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	elaineswleung@gmail.com	Chilvers, B. Louise/AAV-1965-2021; Nakagawa, Shinichi/B-5571-2011	Chilvers, B. Louise/0000-0002-7657-4217; Nakagawa, Shinichi/0000-0002-7765-5182	Department of Conservation (DOC) [1638, 2007/01]; University of Otago Zoology Department; University of Otago Postgraduate Scholarship	Department of Conservation (DOC); University of Otago Zoology Department; University of Otago Postgraduate Scholarship	This research was funded by the Department of Conservation (DOC) investigation no. 1638, University of Otago Zoology Department and in parallel with fieldwork undertaken for the Marine Conservation Services Program, DOC project Pop 2007/01. EL was supported by the University of Otago Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Baker CS, 2010, NEW ZEAL J MAR FRESH, V44, P101, DOI 10.1080/00288330.2010.482970; Barton K., 2010, **DATA OBJECT**; Beck CA, 2003, J ANIM ECOL, V72, P979, DOI 10.1046/j.1365-2656.2003.00761.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cawthorn, 1985, 7 WRLG; Chilvers BL, 2008, J ZOOL, V276, P28, DOI 10.1111/j.1469-7998.2008.00463.x; Chilvers BL, 2006, J ZOOL, V269, P233, DOI 10.1111/j.1469-7998.2006.00059.x; Chilvers BL, 2007, POLAR BIOL, V30, P459, DOI 10.1007/s00300-006-0203-9; Chilvers B. Louise, 2008, Endangered Species Research, V5, P193, DOI 10.3354/esr00086; Chilvers BL, 2005, MAR ECOL PROG SER, V304, P235, DOI 10.3354/meps304235; CLUTTONBROCK TH, 1983, J ANIM ECOL, V52, P367, DOI 10.2307/4560; DESROCHERS A, 1989, ECOLOGY, V70, P636, DOI 10.2307/1940215; ESRI, 2009, ARCGIS DESKT 9 3 1; Gales N. J., 1995, THREATENED SPECIES R, V17; Gales NJ, 1998, MAR MAMMAL SCI, V14, P355, DOI 10.1111/j.1748-7692.1998.tb00727.x; Geschke K, 2009, WILDLIFE RES, V36, P666, DOI 10.1071/WR09133; Hughes R.N., 1980, Oceanography and Marine Biology an Annual Review, V18, P423; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Kato A, 1996, POLAR BIOL, V16, P75, DOI 10.1007/BF02388738; Magurran AE, 2000, J FISH BIOL, V57, P839, DOI [10.1006/jfbi.2000.1391, 10.1111/j.1095-8649.2000.tb02196.x]; Main MB, 2008, ECOLOGY, V89, P693, DOI 10.1890/07-0645.1; McIntyre T, 2010, MAR ECOL PROG SER, V412, P293, DOI 10.3354/meps08680; Meynier L, 2009, MAR MAMMAL SCI, V25, P302, DOI 10.1111/j.1748-7692.2008.00252.x; Nakagawa S, 2011, BEHAV ECOL SOCIOBIOL, V65, P103, DOI 10.1007/s00265-010-1044-7; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Orians G.H., 1979, P155; Page B, 2005, MAR ECOL PROG SER, V293, P283, DOI 10.3354/meps293283; Pearson D, 2002, BIOL J LINN SOC, V77, P113, DOI 10.1046/j.1095-8312.1999.00075.x; Perry G, 1996, CAN J ZOOL, V74, P1238, DOI 10.1139/z96-137; PETERS WD, 1983, ECOLOGY, V64, P1437, DOI 10.2307/1937498; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Robertson BC, 2006, BIOL CONSERV, V127, P227, DOI 10.1016/j.biocon.2005.08.011; Robertson BC, 2011, MAMMAL REV, V41, P253, DOI 10.1111/j.1365-2907.2011.00186.x; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Ruckstuhl KE, 2007, INTEGR COMP BIOL, V47, P245, DOI 10.1093/icb/icm030; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; SCHOENER TW, 1969, AM NAT, V103, P277, DOI 10.1086/282602; Spiegelhalter D., 2004, WINBUGS USER MANUAL; Stokke S, 2000, ECOGRAPHY, V23, P70, DOI 10.1034/j.1600-0587.2000.230108.x; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Weimerskirch H, 1997, ECOLOGY, V78, P2051; Wirtz P, 2001, J MAR BIOL ASSOC UK, V81, P187, DOI 10.1017/S0025315401003629; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Xavier Jose C., 2005, P74; [No title captured]; [No title captured]	50	27	26	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45389	10.1371/journal.pone.0045389	http://dx.doi.org/10.1371/journal.pone.0045389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028978	Green Published, Green Submitted, gold			2022-12-27	WOS:000311313900132
J	Liu, Z; Zhou, C; Liu, YZ; Wang, SH; Ye, P; Miao, XP; Xia, JH				Liu, Zheng; Zhou, Cheng; Liu, Yuzhou; Wang, Sihua; Ye, Ping; Miao, Xiaoping; Xia, Jiahong			The Expression Levels of Plasma micoRNAs in Atrial Fibrillation Patients	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIRCULATING MICRORNA; ISCHEMIC-STROKE; HEART-FAILURE; INFLAMMATION; BIOMARKERS; CANCER; SERUM; FIBROSIS; MARKERS	Background: MicroRNA (miRNA) has been found in human blood. It has been increasingly suggested that miRNAs may serve as biomarkers for diseases. We examined the potential of circulating miRNA to serve as predictors of atrial fibrillation (AF). Methodology/Principal Findings: During the discovery stage of this project, we used massively parallel signature sequencing (MPSS) to carry out an in-depth analysis of the miRNA expression profile (miRNome) in 5 healthy controls, 5 patients with paroxysmal atrial fibrillation (PAF) alone, and 5 patients with persistent atrial fibrillation (PersAF) alone. Twenty-two specific miRNAs were found to be dysregulated in each PAF group, PersAF group, or control group. Four candidate microRNAs (miRNA-146a, miRNA-150, miRNA-19a, and miRNA-375) met our selection criteria and were evaluated in an independent cohort of 90 plasma samples using TaqMan miRNA quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). We found miRNA-150 levels to be reduced by a factor of approximately 17 in PAF relative to controls and a factor of approximately 20 in PersAF relative to controls (P < 0001). Logistic regression analyses were carried out to evaluate the reduced miRNA-150 expression levels (odds ratio [OR] 1.96, 95% confidence interval [CI] 1.5 to 3.57, P < 0.001), age (OR 1.1, 95% CI 1.36 to 2.73, P < 0.001), and Left atrial diameter (LAD) (OR 1.5, 95% CI 1.36 to 1.8, P < 0.001). Each was independently associated with AF. Much of the identified target genes related to AF were part of the inflammatory response system. We found that plasma levels of CRP were negatively correlated with the plasma levels of miRNA-150. Conclusions/Significance: In summary, we firstly found that plasma miRNA-150 levels in from AF patients were substantially lower than that from healthy people. Circulating reduced miRNA-150 was significantly associated with AF.	[Liu, Zheng; Zhou, Cheng; Wang, Sihua; Ye, Ping; Xia, Jiahong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Surg, Wuhan 430074, Peoples R China; [Liu, Yuzhou] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Dis, Wuhan 430074, Peoples R China; [Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xia, JH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Surg, Wuhan 430074, Peoples R China.	jiahong.xia@mail.hust.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722	State Key Development Program of Basic Research of China [2010CB535012]	State Key Development Program of Basic Research of China(State Key Development Program for Basic Research of China)	This work was supported by State Key Development Program of Basic Research of China Grant 2010CB535012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bugnicourt JM, 2010, EUR NEUROL, V63, P24, DOI 10.1159/000258679; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Dobrev D, 2012, NAT REV DRUG DISCOV, V11, P275, DOI 10.1038/nrd3682; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gaita F, 2005, ACC CURRENT J REV, V14, P32; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gramley F, 2010, INT J CARDIOL, V143, P405, DOI 10.1016/j.ijcard.2009.03.110; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Latini R, 2011, J INTERN MED, V269, P160, DOI 10.1111/j.1365-2796.2010.02287.x; Laufs OABR, 2012, BASIC RES CARDIOL, P278; Lee KW, 2006, CIRCULATION, V114, P1703, DOI 10.1161/CIRCULATIONAHA.106.624320; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Li J, 2010, HEART RHYTHM, V7, P438, DOI 10.1016/j.hrthm.2009.12.009; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; LIP GYH, 1995, LANCET, V346, P1313, DOI 10.1016/S0140-6736(95)92339-X; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luan Y, 2010, EUROPACE, V12, P1713, DOI 10.1093/europace/euq321; Marcus GM, 2008, AM HEART J, V155, P303, DOI 10.1016/j.ahj.2007.09.006; Marcus GM, 2010, HEART RHYTHM, V7, P149, DOI 10.1016/j.hrthm.2009.10.004; Masson S, 2010, HEART, V96, P1909, DOI 10.1136/hrt.2009.191460; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Oral H, 2002, ACC CURRENT J REV, V11, P83; Patton KK, 2009, CIRCULATION, V120, P1768, DOI 10.1161/CIRCULATIONAHA.109.873265; Pretorius M, 2007, CIRCULATION, V116, pI1, DOI 10.1161/CIRCULATIONAHA.106.677906; Qu YC, 2009, SCAND CARDIOVASC J, V43, P292, DOI 10.1080/14017430802651803; Roldan V, 2003, EUR HEART J, V24, P1373, DOI 10.1016/S0195-668X(03)00239-2; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schnabel RB, 2009, AM J CARDIOL, V104, P92, DOI 10.1016/j.amjcard.2009.02.053; Seet RCS, 2011, CIRCULATION, V124, P477, DOI 10.1161/CIRCULATIONAHA.111.029801; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Srivastava SK, 2011, CARCINOGENESIS, V32, P1832, DOI 10.1093/carcin/bgr223; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; VENUGOPAL SK, 2009, AM J PHYSL GASTROINT; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang ZG, 2011, CARDIOVASC RES, V89, P710, DOI 10.1093/cvr/cvq350; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao L, 2008, CIRCULATION, V118, P983, DOI 10.1161/CIRCULATIONAHA.107.758672; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	52	68	73	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44906	10.1371/journal.pone.0044906	http://dx.doi.org/10.1371/journal.pone.0044906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028671	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900052
J	Martinez-Malaxetxebarria, I; Muts, R; van Dijk, L; Parker, CT; Miller, WG; Huynh, S; Gaastra, W; van Putten, JPM; Fernandez-Astorga, A; Wosten, MSM				Martinez-Malaxetxebarria, Irati; Muts, Rudy; van Dijk, Linda; Parker, Craig T.; Miller, William G.; Huynh, Steven; Gaastra, Wim; van Putten, Jos P. M.; Fernandez-Astorga, Aurora; Wosten, Marcm. S. M.			Regulation of Energy Metabolism by the Extracytoplasmic Function (ECF) sigma Factors of Arcobacter butzleri	PLOS ONE			English	Article							2-COMPONENT SYSTEM; ESCHERICHIA-COLI; NONHUMAN PRIMATE; STRESS-RESPONSE; CAMPYLOBACTER; SUSCEPTIBILITY; PREVALENCE; TRANSPORT; ABORTIONS; BACTERIA	The extracytoplasmic function (ECF) sigma factors are fundamental for bacterial adaptation to distinct environments and for survival under different stress conditions. The emerging pathogen Arcobacter butzleri possesses seven putative pairs of sigma/anti-sigma factors belonging to the ECF family. Here, we report the identification of the genes regulated by five out of the seven A. butzleri ECF sigma factors. Three of the ECF sigma factors play an apparent role in transport, energy generation and the maintenance of redox balance. Several genes like the nap, sox and tct genes are regulated by more than one ECF sigma factor, indicating that the A. butzleri ECF sigma factors form a network of overlapping regulons. In contrast to other eubacteria, these A. butzleri ECF regulons appear to primarily regulate responses to changing environments in order to meet metabolic needs instead of an obvious role in stress adaptation.	[Martinez-Malaxetxebarria, Irati; Muts, Rudy; van Dijk, Linda; Gaastra, Wim; van Putten, Jos P. M.; Wosten, Marcm. S. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Martinez-Malaxetxebarria, Irati; Fernandez-Astorga, Aurora] Univ Basque Country UPV EHU, Fac Pharm, Dept Immunol Microbiol & Parasitol, Vitoria, Spain; [Parker, Craig T.; Miller, William G.; Huynh, Steven] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA	Utrecht University; University of Basque Country; United States Department of Agriculture (USDA)	Wosten, MSM (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	M.Wosten@uu.nl	Malax-etxebarria, Irati Martinez/AAB-4230-2019; FERNANDEZ ASTORGA, AURORA/L-6415-2014	Malax-etxebarria, Irati Martinez/0000-0002-6576-6707; van Putten, Jos/0000-0002-4126-8172; Parker, Craig/0000-0002-7719-8882; FERNANDEZ ASTORGA, AURORA/0000-0003-0509-3093; Wosten, Marc/0000-0002-7464-7232	Basque Government [IT-528-10, BF106.85, EC-2009-1-4]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-Vidi) grant [917.66.330]; US Department of Agriculture Current Research Information System (USDA-CRIS) project [5325-42000-047-00D]; European Molecular Biology Organization (EMBO) Short Term Fellowship [ASTF29-2010]	Basque Government(Basque Government); Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-Vidi) grant; US Department of Agriculture Current Research Information System (USDA-CRIS) project; European Molecular Biology Organization (EMBO) Short Term Fellowship	This work was supported in part by the Basque Government (IT-528-10) through a Predoctoral Fellowship of the Basque Government for the Training of Researches (BF106.85); by a parallel incentive within the Predoctoral Fellowship of the Basque Government for short stays in different Research Centers (EC-2009-1-4); and by a European Molecular Biology Organization (EMBO) Short Term Fellowship (ASTF29-2010) to IMM. This work was also supported by a fellowship of Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-Vidi) grant 917.66.330 to MMSMW and by funds from US Department of Agriculture Current Research Information System (USDA-CRIS) project 5325-42000-047-00D. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x; ANDERSON KF, 1993, INFECT IMMUN, V61, P2220, DOI 10.1128/IAI.61.5.2220-2223.1993; Atabay HI, 2001, LETT APPL MICROBIOL, V33, P430, DOI 10.1046/j.1472-765X.2001.01025.x; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Brito B, 2002, MOL PLANT MICROBE IN, V15, P109, DOI 10.1094/MPMI.2002.15.2.109; Brocker M, 2009, J BACTERIOL, V191, P3869, DOI 10.1128/JB.00113-09; Campagne S, 2012, P NATL ACAD SCI USA, V109, pE1405, DOI 10.1073/pnas.1117003109; Collado L, 2011, CLIN MICROBIOL REV, V24, P174, DOI 10.1128/CMR.00034-10; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Higgins R, 1999, LAB ANIM, V33, P87, DOI 10.1258/002367799780578499; Ho HTK, 2008, FEMS IMMUNOL MED MIC, V53, P85, DOI 10.1111/j.1574-695X.2008.00405.x; Houf K, 2004, MICROB DRUG RESIST, V10, P243, DOI 10.1089/mdr.2004.10.243; ICMSF, 2002, AN MICR TEST FOOD SA, P175; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; Koebnik R, 2005, TRENDS MICROBIOL, V13, P343, DOI 10.1016/j.tim.2005.06.005; LERNER J, 1994, EUR J CLIN MICROBIOL, V13, P660, DOI 10.1007/BF01973994; Levican A, 2012, SYST APPL MICROBIOL, V35, P133, DOI 10.1016/j.syapm.2012.01.002; Llamas MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000572; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; Luo Y, 2010, J BACTERIOL, V192, P5736, DOI 10.1128/JB.00826-10; Miller WG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001358; Moreno Y, 2003, APPL ENVIRON MICROB, V69, P1181, DOI 10.1128/AEM.69.2.1181-1186.2003; Musmanno RA, 1997, MICROBIOLOGICA, V20, P63; NEILL SD, 1979, RES VET SCI, V27, P180, DOI 10.1016/S0034-5288(18)32825-X; On SLW, 2002, VET MICROBIOL, V85, P159, DOI 10.1016/S0378-1135(01)00503-X; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Raivio TL, 2001, ANNU REV MICROBIOL, V55, P591, DOI 10.1146/annurev.micro.55.1.591; Rice EW, 1999, LETT APPL MICROBIOL, V28, P31, DOI 10.1046/j.1365-2672.1999.00483.x; Samie A, 2007, J INFECTION, V54, P558, DOI 10.1016/j.jinf.2006.10.047; Schmittgen TD, 2001, METHODS, V25, P383, DOI 10.1006/meth.2001.1260; Sellars MJ, 2002, J BACTERIOL, V184, P4187, DOI 10.1128/JB.184.15.4187-4196.2002; Shaw LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003844; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Wosten MMSM, 2006, MOL MICROBIOL, V62, P278, DOI 10.1111/j.1365-2958.2006.05372.x; Wosten MM, 1997, INITIATION TRANSCRIP, P120; Wybo I, 2004, J CLIN MICROBIOL, V42, P1851, DOI 10.1128/JCM.42.4.1851-1852.2004; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	38	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44796	10.1371/journal.pone.0044796	http://dx.doi.org/10.1371/journal.pone.0044796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028624	Green Published, gold, Green Submitted			2022-12-27	WOS:000311313900042
J	Milovanovic, M; Volarevic, V; Ljujic, B; Radosavljevic, G; Jovanovic, I; Arsenijevic, N; Lukic, ML				Milovanovic, Marija; Volarevic, Vladislav; Ljujic, Biljana; Radosavljevic, Gordana; Jovanovic, Ivan; Arsenijevic, Nebojsa; Lukic, Miodrag L.			Deletion of IL-33R (ST2) Abrogates Resistance to EAE in BALB/C Mice by Enhancing Polarization of APC to Inflammatory Phenotype	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; DENDRITIC CELLS; TYPE-2; CYTOKINE; INDUCTION; MOLECULE; T1/ST2; GENE; ACTIVATION	The administration of interleukin 33 and deletion of IL-33 receptor, ST2 molecule, affects the induction of autoimmunity in different experimental models of human autoimmune diseases. The aim of this study was to analyze the effect of ST2 deletion on the induction of experimental autoimmune encephalomyelitis (EAE) in resistant BALB/c mice. Mice were immunized with MOG(35-55) peptide or disease was induced by passive transfer of encephalitogenic singenic cells and EAE was clinically and histologically evaluated. Expression of intracellular inflammatory cytokines, markers of activation and chemokine receptors on lymphoid tissue and CNS infiltrating mononuclear cells was analyzed by flow cytometry. We report here that deletion of ST2(-/-) molecule abrogates resistance of BALB/c mice to EAE induction based on clinical and histopathological findings. Brain and spinal cord infiltrates of ST2(-/-) mice had significantly higher number of CD4(+) T lymphocytes containing inflammatory cytokines compared to BALB/c WT mice. Adoptive transfer of ST2(-/-) primed lymphocytes induced clinical signs of the disease in ST2(-/-) as well as in WT mice. MOG(35-55) restimulated ST2(-/-) CD4(+) cells as well as ex vivo analyzed lymph node cells had higher expression of T-bet and IL-17, IFN-gamma, TNF-alpha and GM-CSF in comparison with WT CD4(+) cells. ST2(-/-) mice had higher percentages of CD4(+) cells expressing chemokine receptors important for migration to CNS in comparison with WT CD4+ cells. Draining lymph nodes of ST2(-/-) mice contained higher percentage of CD11c(+)CD11b(+)CD8(-) cells containing inflammatory cytokines IL-6 and IL-12 with higher expression of activation markers. Transfer of ST2(-/-) but not WT dendritic cells induced EAE in MOG(35-55) immunized WT mice. Our results indicate that ST2 deficiency attenuates inherent resistance of BALB/c mice to EAE induction by enhancing differentiation of proinflammatory antigen presenting cells and consecutive differentiation of encephalitogenic T cells in the draining lymph node rather than affecting their action in the target tissue.	[Milovanovic, Marija; Volarevic, Vladislav; Ljujic, Biljana; Radosavljevic, Gordana; Jovanovic, Ivan; Arsenijevic, Nebojsa; Lukic, Miodrag L.] Univ Kragujevac, Fac Med Sci, Ctr Mol Med & Stem Cell Res, Kragujevac, Serbia	University of Kragujevac	Lukic, ML (corresponding author), Univ Kragujevac, Fac Med Sci, Ctr Mol Med & Stem Cell Res, Kragujevac, Serbia.	miodrag.lukic@medf.kg.ac.rs	Volarevic, Vladislav/ABH-8934-2020; Lukic, Miodrag/U-8848-2019	Radosavljevic, Gordana/0000-0001-6016-0725; Jovanovic, Ivan/0000-0002-1169-2378; Volarevic, Vladislav/0000-0002-9057-9460; Volarevic, Vladislav/0000-0001-5948-9902; Lukic, Miodrag/0000-0002-3563-632X; Arsenijevic, Nebojsa/0000-0002-2107-3490; Milovanovic, Marija/0000-0002-6894-1275	Ministry of Science, Republic of Serbia [ON175069, ON175071, ON175103]; Faculty of Medical Science [24/10]	Ministry of Science, Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); Faculty of Medical Science	This work was supported by the Ministry of Science, Republic of Serbia, grants ON175069, ON175071 and ON175103; and Faculty of Medical Science, junior project number 24/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Bagaeva LV, 2006, J IMMUNOL, V176, P7676, DOI 10.4049/jimmunol.176.12.7676; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; BERGERS G, 1994, EMBO J, V13, P1176, DOI 10.1002/j.1460-2075.1994.tb06367.x; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; CEBRIAN M, 1988, J EXP MED, V168, P1621, DOI 10.1084/jem.168.5.1621; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chevalier N, 2004, J NEUROIMMUNOL, V148, P11; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hudson CA, 2008, J LEUKOCYTE BIOL, V84, P631, DOI 10.1189/jlb.1207830; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Jiang HR, 2009, J IMMUNOL, V182, P1167, DOI 10.4049/jimmunol.182.2.1167; Jones LA, 2010, EUR J IMMUNOL, V40, P426, DOI 10.1002/eji.200939705; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kohler RE, 2008, BRAIN PATHOL, V18, P504, DOI 10.1111/j.1750-3639.2008.00154.x; Kropf P, 2003, INFECT IMMUN, V71, P1961, DOI 10.1128/IAI.71.4.1961-1971.2003; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Li MC, 2012, J NEUROIMMUNOL, V247, P25, DOI 10.1016/j.jneuroim.2012.03.016; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; Liu JH, 2010, J IMMUNOL, V184, P5802, DOI 10.4049/jimmunol.0904127; Maron R, 1999, INT IMMUNOL, V11, P1573, DOI 10.1093/intimm/11.9.1573; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; O'Connor RA, 2012, J IMMUNOL, V188, P2093, DOI 10.4049/jimmunol.1101118; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Ohno T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018404; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Raich-Regue D, 2012, EUR J IMMUNOL, V42, P771, DOI 10.1002/eji.201141835; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rothhammer V, 2011, J EXP MED, V208, P2465, DOI 10.1084/jem.20110434; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sporici R, 2010, EUR J IMMUNOL, V40, P2751, DOI 10.1002/eji.200939975; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Stromnes IM, 2006, NAT PROTOC, V1, P1952, DOI 10.1038/nprot.2006.284; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Syrbe U, 1999, SPRINGER SEMIN IMMUN, V21, P263, DOI 10.1007/BF00812257; TOMINAGA S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P1, DOI 10.1016/0167-4781(91)90029-L; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Volarevic V, 2012, J HEPATOL, V56, P26, DOI 10.1016/j.jhep.2011.03.022; Wraith DC, 2009, P NATL ACAD SCI USA, V106, P15466, DOI 10.1073/pnas.0903360106; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787; Xu D, 2008, P NATL ACAD SCI USA, V105, P10913, DOI 10.1073/pnas.0801898105; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685; Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; Zdravkovic N, 2009, MOL IMMUNOL, V47, P28, DOI 10.1016/j.molimm.2008.12.023	56	54	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45225	10.1371/journal.pone.0045225	http://dx.doi.org/10.1371/journal.pone.0045225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028861	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900102
J	Monaco, A; Cattaneo, R; Mesin, L; Ciarrocchi, I; Sgolastra, F; Pietropaoli, D				Monaco, Annalisa; Cattaneo, Ruggero; Mesin, Luca; Ciarrocchi, Irma; Sgolastra, Fabrizio; Pietropaoli, Davide			Dysregulation of the Autonomous Nervous System in Patients with Temporomandibular Disorder: A Pupillometric Study	PLOS ONE			English	Article							BETA-ADRENERGIC RECEPTORS; PUPILLARY LIGHT REFLEX; BOVINE IRIS SPHINCTER; HEART-RATE; CARDIOVASCULAR REGULATION; SYMPATHETIC-STIMULATION; INTRAOCULAR-PRESSURE; HEALTHY-VOLUNTEERS; PAIN SENSITIVITY; TIMOLOL MALEATE	The role of the autonomic nervous system (ANS) was recently investigated in Temporomandibular disorders (TMD). Several authors argue that in subjects with TMD there is a dysregulation of ANS. Recent literature support that Pupillometry is a simple non-invasive tool to study ANS. The aim of this study was to investigate the relationship between TMD and ANS activity using pupillometry recording in Infrared light at rest Mandible Position (RP); Infrared light at Forced Habitual Occlusion (FHO); Yellow-green light at RP; Yellow-green light at FHO. Forty female subjects were enrolled: 20 case patients showed TMD based on the Research Diagnostic Criteria for TMD, and 20 control patients, aged matched, had no signs or symptoms of TMD. Statistical analysis was performed on average pupil size. Ratio between pupil size in FHO and RP (FHO/RP ratio) and yellow-green and infrared (light/darkness ratio) lighting were carried out. Within group differences of pupil size and of "ratio'' were analyzed using a paired t test, while differences of pupil size between groups were tested using an unpaired t test. Statistical comparisons between groups showed no significant differences of absolute values of pupil dimension in RP and FHO, both in yellow-green and in infrared lighting. In addition, there were no significant differences within groups comparing RP and FHO in yellow-green light. In within group comparison of pupil size, differences between RP and FHO were significant in infrared conditions. Control subjects increased, whereas TMD patients decreased pupil size at FHO in infrared lightening. FHO/RP ratio in darkness and light/darkness ratio in RP were significantly different between groups. Taken together, these data suggest that TMD subjects have an impairment of the sympathetic-adrenergic component of the ANS to be activated under stress. The present study provides preliminary pupillometric data confirming that adrenergic function is dysregulated in patients with TMD.	[Monaco, Annalisa; Cattaneo, Ruggero; Ciarrocchi, Irma; Sgolastra, Fabrizio; Pietropaoli, Davide] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Mesin, Luca] Politecn Torino, Dept Elect & Telecommun, Turin, Italy	University of L'Aquila; Polytechnic University of Turin	Pietropaoli, D (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy.	davide.pietropaoli@univaq.it	mesin, luca/B-7457-2013; Pietropaoli, Davide/V-6668-2019; Sgolastra, Fabrizio/H-7732-2013	mesin, luca/0000-0002-8239-2348; Pietropaoli, Davide/0000-0001-9585-1809; Monaco, Annalisa/0000-0002-9567-4459; Sgolastra, Fabrizio/0000-0002-0527-388X				Bar KJ, 2008, CLIN NEUROPHYSIOL, V119, P2209, DOI 10.1016/j.clinph.2008.06.012; Bar KJ, 2009, J NEUROL SCI, V279, P9, DOI 10.1016/j.jns.2009.01.010; BAKES A, 1990, BRIT J CLIN PHARMACO, V30, P377, DOI 10.1111/j.1365-2125.1990.tb03787.x; Bremner F, 2009, CLIN AUTON RES, V19, P88, DOI 10.1007/s10286-009-0515-2; Celic R, 2006, INT J PROSTHODONT, V19, P28; Chapman CR, 2008, J PAIN, V9, P122, DOI 10.1016/j.jpain.2007.09.006; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Dutsch M, 2004, J NEUROL SCI, V222, P75, DOI 10.1016/j.jns.2004.04.008; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Eze-Nliam CM, 2011, J OROFAC PAIN, V25, P232; Filipe JAC, 2003, AUTON NEUROSCI-BASIC, V104, P66, DOI 10.1016/S1566-0702(02)00268-0; Fliegert F, 2005, EUR J CLIN PHARMACOL, V61, P257, DOI 10.1007/s00228-005-0920-y; GRASSI C, 1993, J PHYSIOL-LONDON, V469, P601, DOI 10.1113/jphysiol.1993.sp019832; Hasegawa Y, 2007, J DENT RES, V86, P64, DOI 10.1177/154405910708600110; Hayashi N, 2010, J PHYSIOL ANTHROPOL, V29, P119, DOI 10.2114/jpa2.29.119; Jain S, 2011, PARKINSONISM RELAT D, V17, P119, DOI 10.1016/j.parkreldis.2010.11.005; KAHLE G, 1990, EXP EYE RES, V51, P503, DOI 10.1016/0014-4835(90)90080-E; Keivanidou A, 2010, CARDIOL J, V17, P65; Korszun A, 2002, J DENT RES, V81, P279, DOI 10.1177/154405910208100411; Koudas V, 2009, PSYCHOPHARMACOLOGY, V205, P1, DOI 10.1007/s00213-009-1508-5; Lajnert V, 2010, COLLEGIUM ANTROPOL, V34, P1415; Latalova K, 2010, NEUROENDOCRINOL LETT, V31, P829; Light KC, 2009, J PAIN, V10, P542, DOI 10.1016/j.jpain.2008.12.006; Matouskova O, 2011, J CLIN PHARM THER, V36, P513, DOI 10.1111/j.1365-2710.2010.01203.x; MATSUO R, 1995, J PHYSIOL-LONDON, V483, P239, DOI 10.1113/jphysiol.1995.sp020581; Mitchelson F., 2012, HDB EXP PHARM, V208, P263; Mujakperuo HR, 2010, COCHRANE DB SYST REV, V6; Murillo R, 2004, METHOD FIND EXP CLIN, V26, P271; Nackley AG, 2010, METHODS MOL BIOL, V617, P375, DOI 10.1007/978-1-60327-323-7_28; Nackley AG, 2007, PAIN, V128, P199, DOI 10.1016/j.pain.2006.09.022; Passatore M, 2007, ARCH ORAL BIOL, V52, P343, DOI 10.1016/j.archoralbio.2006.11.013; PATIL PN, 1991, J OCUL PHARMACOL, V7, P297, DOI 10.1089/jop.1991.7.297; Patwari PP, 2012, PEDIATR RES, V71, P280, DOI 10.1038/pr.2011.38; Pistorio E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-192; Pittasch D, 2002, DIABETES CARE, V25, P1545, DOI 10.2337/diacare.25.9.1545; Player MS, 2011, INT J PSYCHIAT MED, V41, P365, DOI 10.2190/PM.41.4.f; Roatta S, 2005, EXP BRAIN RES, V162, P14, DOI 10.1007/s00221-004-2102-z; Sarlani E, 2004, J OROFAC PAIN, V18, P41; Schulz S, 2010, PHYSIOL MEAS, V31, P303, DOI 10.1088/0967-3334/31/3/003; Servant D, 2009, ENCEPHALE, V35, P423, DOI 10.1016/j.encep.2008.06.016; TACHADO SD, 1989, INVEST OPHTH VIS SCI, V30, P2232; Takahata T, 2011, AVIAT SPACE ENVIR MD, V82, P442, DOI 10.3357/ASEM.2741.2011; Tarjan R., 1972, SIAM J COMPUT, V2, P146; Tchivileva IE, 2010, PHARMACOGENET GENOM, V20, P239, DOI 10.1097/FPC.0b013e328337f9ab; Topalkara A, 2006, EUR J PHARMACOL, V548, P144, DOI 10.1016/j.ejphar.2006.08.014; Tsukiyama Y, 1999, J DENT RES, V78, P1727, DOI 10.1177/00220345990780111001; WILKIE DA, 1991, AM J VET RES, V52, P432; WILKIE DA, 1991, AM J VET RES, V52, P436; Yap AUJ, 2002, J PROSTHET DENT, V88, P479, DOI 10.1067/mpr.2002.129375; Zhang M, 2012, PHYSIOL BEHAV, V105, P292, DOI 10.1016/j.physbeh.2011.07.028	50	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45424	10.1371/journal.pone.0045424	http://dx.doi.org/10.1371/journal.pone.0045424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028999	Green Submitted, gold, Green Published			2022-12-27	WOS:000311313900135
J	Wang, JW; Chen, Q; Zhou, JL; Wen, J; Bian, FH; Li, G; Mu, XY; Han, YY; Xia, GL; Zhang, MJ				Wang, Jianwei; Chen, Qian; Zhou, Jinlian; Wen, Jing; Bian, Fenghua; Li, Ge; Mu, Xinyi; Han, Yingying; Xia, Guoliang; Zhang, Meijia			Specific Protein Kinase C Isoforms alpha And beta I Are Involved in Follicle-Stimulating Hormone-Induced Mouse Follicle-Enclosed Oocytes Meiotic Resumption	PLOS ONE			English	Article							ACTIVATING STEROL MAS; GRANULOSA-CELLS; MEIOSIS RESUMPTION; PORCINE OOCYTES; CYCLIC-AMP; MATURATION; GONADOTROPINS; EXPRESSION; CALCIUM; ARREST	Protein kinase C (PKC) is involved in gonadotrophin-induced oocyte maturation. In the present study, we investigated the role of specific PKC isoforms in the process of follicle-stimulating hormone (FSH)-induced oocyte meiotic resumption. Small antral follicles (200-300 mu m in diameter) were isolated from immature mice and cultured in vitro. FSH significantly induced follicle-enclosed oocytes (FEOs) meiotic resumption after 8 hr culture. However, the induced effect of FSH was dose-dependently inhibited by the specific PKC alpha and beta I inhibitor Go6976, and 100 nM Go6976 completely blocked FSH function in oocyte meiotic resumption. Furthermore, FSH dramatically induced the expression of transcripts encoding epidermal growth factor (EGF)-like growth factors Areg, Btc, and Ereg mRNA levels, and up-regulated tyrosine phosphorylation level of EGF receptor (EGFR) in granulosa cells. Blocking the function of EGFR by AG1478 eliminated the effect of FSH-induced FEOs meiotic resumption, suggesting that FSH induced oocyte maturation through the activation of EGFR. FSH-induced phosphorylation of EGFR could also be inhibited by Go6976. Next, we examined the effect of FSH on the expression and phosphorylation PKC alpha and beta I. FSH induced the expression of PKC alpha at mRNA and protein level, and also up-regulated its phosphorylation level in granulosa cells after 8 hr culture. However, FSH had no effect on the expression of PKC beta I but down-regulated its phosphorylation level. In conclusion, FSH-induced activation of PKC alpha alone, or together with the inactivation of PKC beta I in granulosa cells, participates in mouse oocyte meiotic resumption, possibly by the activation of EGFR signaling pathway.	[Wang, Jianwei; Chen, Qian; Wen, Jing; Bian, Fenghua; Li, Ge; Mu, Xinyi; Han, Yingying; Xia, Guoliang; Zhang, Meijia] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China; [Zhou, Jinlian] 306 Hosp PLA, Dept Pathol, Beijing, Peoples R China	China Agricultural University	Zhang, MJ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	zmeijia@cau.edu.cn			National Basic Research Program of China [2012CB944401, 2012CB944701]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (no. 2012CB944401, 2012CB944701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andric N, 2006, MOL ENDOCRINOL, V20, P3308, DOI 10.1210/me.2006-0241; Avazeri N, 2004, J CELL SCI, V117, P4969, DOI 10.1242/jcs.01375; Chen XF, 2008, J ENDOCRINOL, V197, P409, DOI 10.1677/JOE-07-0592; DEKEL N, 1988, BIOL REPROD, V38, P517, DOI 10.1095/biolreprod38.3.517; Denys A, 2007, MOL REPROD DEV, V74, P1575, DOI 10.1002/mrd.20748; Downs SM, 2001, MOL REPROD DEV, V58, P101, DOI 10.1002/1098-2795(200101)58:1&lt;101::AID-MRD13&gt;3.0.CO;2-J; Downs SM, 2008, MOL REPROD DEV, V75, P105, DOI 10.1002/mrd.20781; Fan Heng Yu, 2003, Shi Yan Sheng Wu Xue Bao, V36, P37; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Fan HY, 2004, BIOL REPROD, V70, P1178, DOI 10.1095/biolreprod.103.024737; Fan HY, 2002, ACTA BIOCH BIOPH SIN, V34, P259; Gangeswaran R, 1997, FEBS LETT, V412, P309, DOI 10.1016/S0014-5793(97)00782-5; HILLENSJO T, 1976, ACTA ENDOCRINOL-COP, V82, P809; HOMA ST, 1995, MOL REPROD DEV, V40, P122, DOI 10.1002/mrd.1080400116; Jin SY, 2006, MOL CELL ENDOCRINOL, V249, P64, DOI 10.1016/j.mce.2006.01.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu ZX, 2001, MOL CELL ENDOCRINOL, V182, P225, DOI 10.1016/S0303-7207(01)00564-0; Luria A, 2000, BIOL REPROD, V62, P1564, DOI 10.1095/biolreprod62.6.1564; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Quan HM, 2003, ZYGOTE, V11, P329, DOI 10.1017/S0967199403002399; Richards JS, 2001, ENDOCRINOLOGY, V142, P2184, DOI 10.1210/en.142.6.2184; Sela-Abramovich S, 2005, ENDOCRINOLOGY, V146, P1236, DOI 10.1210/en.2004-1006; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Sriraman V, 2008, MOL CELL ENDOCRINOL, V294, P52, DOI 10.1016/j.mce.2008.07.011; Su YQ, 1999, MOL REPROD DEV, V53, P51, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;51::AID-MRD6&gt;3.0.CO;2-4; Su YQ, 2002, MOL REPROD DEV, V61, P560, DOI 10.1002/mrd.10034; Sugiura K, 2007, DEVELOPMENT, V134, P2593, DOI 10.1242/dev.006882; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; TORNELL J, 1995, HUM REPROD, V10, P1619; TSAFRIRI A, 1972, J REPROD FERTIL, V31, P39, DOI 10.1530/jrf.0.0310039; Tsafriri A, 2002, MOL CELL ENDOCRINOL, V187, P197, DOI 10.1016/S0303-7207(01)00685-2; Xie HR, 2004, MOL CELL ENDOCRINOL, V218, P155, DOI 10.1016/j.mce.2003.11.030; Yamashita Y, 2007, ENDOCRINOLOGY, V148, P6164, DOI 10.1210/en.2007-0195; Yang PX, 2006, BIOL REPROD, V75, P149, DOI 10.1095/biolreprod.105.050153; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031	40	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45043	10.1371/journal.pone.0045043	http://dx.doi.org/10.1371/journal.pone.0045043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028752	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900071
J	Ribeiro, CA; Saraiva, MJ; Cardoso, I				Ribeiro, Carlos A.; Saraiva, Maria Joao; Cardoso, Isabel			Stability of the Transthyretin Molecule as a Key Factor in the Interaction with A-Beta Peptide - Relevance in Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID FIBRIL FORMATION; RETINOL-BINDING-PROTEIN; THYROXINE-BINDING; TETRAMER STABILIZATION; CEREBROSPINAL-FLUID; CRYSTAL-STRUCTURE; POLYNEUROPATHY; INHIBITORS; PREALBUMIN; DEPOSITION	Transthyretin (TTR) protects against A-Beta toxicity by binding the peptide thus inhibiting its aggregation. Previous work showed different TTR mutations interact differently with A-Beta, with increasing affinities correlating with decreasing amyloidogenecity of the TTR mutant; this did not impact on the levels of inhibition of A-Beta aggregation, as assessed by transmission electron microscopy. Our work aimed at probing differences in binding to A-Beta by WT, T119M and L55P TTR using quantitative assays, and at identifying factors affecting this interaction. We addressed the impact of such factors in TTR ability to degrade A-Beta. Using a dot blot approach with the anti-oligomeric antibody A11, we showed that A-Beta formed oligomers transiently, indicating aggregation and fibril formation, whereas in the presence of WT and T119M TTR the oligomers persisted longer, indicative that these variants avoided further aggregation into fibrils. In contrast, L55PTTR was not able to inhibit oligomerization or to prevent evolution to aggregates and fibrils. Furthermore, apoptosis assessment showed WT and T119M TTR were able to protect against A-Beta toxicity. Because the amyloidogenic potential of TTR is inversely correlated with its stability, the use of drugs able to stabilize TTR tetrameric fold could result in increased TTR/A-Beta binding. Here we showed that iododiflunisal, 3-dinitrophenol, resveratrol, [2-(3,5-dichlorophenyl)amino] (DCPA) and [4(3,5-difluorophenyl)] (DFPB) were able to increase TTR binding to A-Beta; however only DCPA and DFPB improved TTR proteolytic activity. Thyroxine, a TTR ligand, did not influence TTR/A-Beta interaction and A-Beta degradation by TTR, whereas RBP, another TTR ligand, not only obstructed the interaction but also inhibited TTR proteolytic activity. Our results showed differences between WT and T119M TTR, and L55PTTR mutant regarding their interaction with A-Beta and prompt the stability of TTR as a key factor in this interaction, which may be relevant in AD pathogenesis and for the design of therapeutic TTR-based therapies.	[Ribeiro, Carlos A.; Saraiva, Maria Joao; Cardoso, Isabel] IBMC, Mol Neurobiol Unit, Oporto, Portugal; [Ribeiro, Carlos A.; Saraiva, Maria Joao] ICBAS, Oporto, Portugal; [Cardoso, Isabel] Inst Politecn Porto, Escola Super Tecnol Saude Porto, Vila Nova De Gaia, Portugal	Universidade do Porto; Universidade do Porto; Polytechnic Institute of Porto	Cardoso, I (corresponding author), IBMC, Mol Neurobiol Unit, Oporto, Portugal.	icardoso@ibmc.up.pt	Cardoso, Isabel/K-3903-2013; Saraiva, Maria João/K-3907-2013	Cardoso, Isabel/0000-0003-2472-7055; Saraiva, Maria João/0000-0002-3360-6899	FEDER funds through the Operational Competitiveness Programme COMPETE; POCI (Programa Operacional Ciencia e Inovacao); national funds through FCT Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-022718 (PEst-C/SAU/LA0002/2011), PTDC/SAU-NEU/64593/2006]	FEDER funds through the Operational Competitiveness Programme COMPETE; POCI (Programa Operacional Ciencia e Inovacao); national funds through FCT Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	This work is funded by FEDER funds through the Operational Competitiveness Programme COMPETE, by POCI 2010 (Programa Operacional Ciencia e Inovacao 2010) and by national funds through FCT Fundacao para a Ciencia e a Tecnologia under the projects FCOMP-01-0124-FEDER-022718 (PEst-C/SAU/LA0002/2011), and PTDC/SAU-NEU/64593/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MR, 2004, BIOCHEM J, V381, P351, DOI 10.1042/BJ20040011; Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; ALTLAND K, 1981, ELECTROPHORESIS, V2, P148, DOI 10.1002/elps.1150020305; Alzheimer A, 1995, Clin Anat, V8, P429; Association As, 2010, ALZHEIMERS DEMENT, V6, P158; Baures PW, 1998, BIOORGAN MED CHEM, V6, P1389, DOI 10.1016/S0968-0896(98)00130-8; Baures PW, 1999, BIOORGAN MED CHEM, V7, P1339, DOI 10.1016/S0968-0896(99)00066-8; BLAKE CCF, 1971, J MOL BIOL, V61, P217, DOI 10.1016/0022-2836(71)90218-X; Boutajangout A, 2002, NEUROSCI LETT, V318, P29, DOI 10.1016/S0304-3940(01)02461-2; Cardoso I, 2007, BIOCHEM J, V408, P131, DOI 10.1042/BJ20070689; Cardoso I, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-74; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Costa R, 2008, FEBS LETT, V582, P936, DOI 10.1016/j.febslet.2008.02.034; Costa R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002899; Ferreira N, 2012, PLOS ONE, V7, P232, DOI 10.1371/journal.pone.0029933; Ferreira N, 2011, FEBS LETT, V585, P2424, DOI 10.1016/j.febslet.2011.06.030; Ferreira N, 2009, FEBS LETT, V583, P3569, DOI 10.1016/j.febslet.2009.10.062; Filteau SM, 2000, BRIT J NUTR, V83, P513; FURUYA H, 1991, BIOCHEMISTRY-US, V30, P2415, DOI 10.1021/bi00223a017; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Liz MA, 2004, J BIOL CHEM, V279, P21431, DOI 10.1074/jbc.M402212200; Liz MA, 2009, BIOCHEM J, V419, P467, DOI 10.1042/BJ20082090; Macedo B, 2008, BBA-MOL BASIS DIS, V1782, P517, DOI 10.1016/j.bbadis.2008.05.005; Magalhaes J, 2010, INT J EXP PATHOL, V91, P515, DOI 10.1111/j.1365-2613.2010.00735.x; MCCUTCHEN SL, 1993, BIOCHEMISTRY-US, V32, P12119, DOI 10.1021/bi00096a024; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Miyata M, 2010, BIOCHEMISTRY-US, V49, P6104, DOI 10.1021/bi1004409; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Morais-de-Sa E, 2004, J BIOL CHEM, V279, P53483, DOI 10.1074/jbc.M408053200; NILSSON SF, 1971, J BIOL CHEM, V246, P6098; Oza VB, 2002, J MED CHEM, V45, P321, DOI 10.1021/jm010257n; Palha JA, 1996, NEUROSCI LETT, V204, P212, DOI 10.1016/0304-3940(96)12334-X; Peterson SA, 1998, P NATL ACAD SCI USA, V95, P12956, DOI 10.1073/pnas.95.22.12956; Potter MA, 1999, CLIN INVEST MED, V22, P44; Radovic B, 2006, BRIT J NUTR, V95, P1171, DOI 10.1079/BJN20061779; Raghu P, 2002, ARCH BIOCHEM BIOPHYS, V400, P43, DOI 10.1006/abbi.2002.2779; Schwarzman AL, 1996, CIBA F SYMP, V199, P146; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; Serot JM, 1997, J NEUROL NEUROSUR PS, V63, P506, DOI 10.1136/jnnp.63.4.506; SHOJI S, 1988, EUR NEUROL, V28, P191, DOI 10.1159/000116264; Stein TD, 2002, J NEUROSCI, V22, P7380; Trivella DBB, 2010, J STRUCT BIOL, V170, P522, DOI 10.1016/j.jsb.2010.03.002; Velayudhan L, 2011, J ALZHEIMERS DIS JAD	45	32	34	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45368	10.1371/journal.pone.0045368	http://dx.doi.org/10.1371/journal.pone.0045368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028965	Green Submitted, Green Published, gold			2022-12-27	WOS:000309742800059
J	Dunne, JV; van Eeden, SF; Keen, KJ				Dunne, James V.; van Eeden, Stephan F.; Keen, Kevin J.			L-selectin and Skin Damage in Systemic Sclerosis	PLOS ONE			English	Article							SOLUBLE L-SELECTIN; ADHESION MOLECULES; PERIPHERAL-BLOOD; THICKNESS SCORE; SERUM LEVELS; T-CELLS; EXPRESSION; DISEASE; INFLAMMATION; LYMPHOCYTES	Background: L-selectin ligands are induced on the endothelium of inflammatory sites. L-selectin expression on neutrophils and monocytes may mediate the primary adhesion of these cells at sites of inflammation by mediating the leukocyte-leukocyte interactions that facilitate their recruitment. L-selectin retains functional activity in its soluble form. Levels of soluble L-selectin have been reported as both elevated and lowered in patients with systemic sclerosis (SSc). This preliminary study seeks to discern amongst these disparate results and to discover whether there is an association between L-selectin concentrations in plasma and skin damage in SSc patients. Methodology and Principal Findings: Nineteen cases with limited systemic sclerosis (lSSc) and 11 cases with diffuse systemic sclerosis (dSSc) were compared on a pairwise basis to age- and sex-matched controls. Criteria of the American College of Rheumatology were used to diagnose SSc. Skin involvement was assessed using the modified Rodnan skin score (mRSS). We find no association between mRSS and plasma L-selectin concentration in lSSc cases (p = 0.9944) but a statistically significant negative correlation in dSSc cases (R-2 = 73.11 per cent, p = 0.0008). The interpretation of the slope for dSSc cases is that for each increase of 100 ng/ml in soluble L-selectin concentration, the mRSS drops 4.22 (95 per cent CI: 2.29, 6.16). There was also a highly statistically significant negative correlation between sL-selectin and disease activity (p = 0.0007) and severity (p = 0.0007) in dSSc cases but not in lSSc cases (p = 0.2596, p = 0.7575, respectively). Conclusions and Significance: No effective treatments exist for skin damage in SSc patients. Nor is there a laboratory alternative to the modified Rodnan skin score as is the case for other organs within the body. Modulation of circulating L-selectin is a promising target for reducing skin damage in dSSc patients. Plasma levels of soluble L-selectin could serve as an outcome measure for dSSc patients in clinical trials.	[Dunne, James V.; van Eeden, Stephan F.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Dunne, James V.] British Columbia Scleroderma Clin, Vancouver, BC, Canada; [van Eeden, Stephan F.] James Hogg Heart & Lung Inst, Vancouver, BC, Canada; [Keen, Kevin J.] Univ No British Columbia, Dept Math & Stat, Prince George, BC V2L 5P2, Canada	University of British Columbia; University of Northern British Columbia	Dunne, JV (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	James.Dunne@VCH.ca	Dunne, James/ABF-6157-2021; Keen, Kevin J/D-5628-2013	Keen, Kevin J/0000-0001-5695-0505	Scleroderma Association of British Columbia; Heart and Stroke Foundation of Canada; Actelion Pharmaceuticals; Merck Canada Inc.	Scleroderma Association of British Columbia; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Actelion Pharmaceuticals; Merck Canada Inc.	This work was supported by research grants from the Scleroderma Association of British Columbia and the Heart and Stroke Foundation of Canada. Actelion Pharmaceuticals provides a grant-in-aid to the British Columbia Scleroderma Clinic. KJK received financial support from Merck Canada Inc. for an honorarium and travel. SvE is a Senior Scholar of the Michael Smith Foundation for Health Research, a Career Investigator of the American Lung Association and the Canadian Institutes of Health Research(CIHR/GSK) Professor in Chronic obstructive pulmonary disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Ates A, 2004, SCAND J IMMUNOL, V59, P315, DOI 10.1111/j.0300-9475.2004.01389.x; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; Blann AD, 1996, BRIT J HAEMATOL, V95, P192, DOI 10.1046/j.1365-2141.1996.7562378.x; Catalina MD, 1999, BLOOD, V93, P580, DOI 10.1182/blood.V93.2.580.402k16_580_589; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Daoussis D, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/214013; Distler JHW, 2011, CLIN EXP RHEUMATOL, V29, pS40; DONNELLY SC, 1994, LANCET, V344, P215, DOI 10.1016/S0140-6736(94)92995-5; Dunne JV, 2013, RHEUMATOL INT, V33, P475, DOI 10.1007/s00296-012-2378-4; Elhai M, 2012, RHEUMATOLOGY, V51, P1017, DOI 10.1093/rheumatology/ker269; Gazitt Y, 2001, STEM CELLS, V19, P134, DOI 10.1634/stemcells.19-2-134; Haught WH, 1996, AM HEART J, V132, P1; Hirata T, 2002, J IMMUNOL, V169, P4307, DOI 10.4049/jimmunol.169.8.4307; Hothorn T, 2008, J STAT SOFTW, V28, P1; Inaoki M, 2001, J DERMATOL SCI, V25, P78, DOI 10.1016/S0923-1811(00)00108-0; Jordan S, 2012, RHEUMATOLOGY, V51, P25, DOI 10.1093/rheumatology/ker490; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Keen KJ, 2012, RHEUMATOLOGY CURRE S; LEROY EC, 1988, J RHEUMATOL, V15, P202; Matsushita T, 2006, J RHEUMATOL, V33, P275; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Mitsuo A, 2006, RHEUMATOLOGY, V45, P1477, DOI 10.1093/rheumatology/kel119; Mommsen P, 2011, PATHOL RES PRACT, V207, P142, DOI 10.1016/j.prp.2010.12.003; Phumethum V, 2011, J RHEUMATOL, V38, P289, DOI 10.3899/jrheum.100361; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; SCHLEIFFENBAUM B, 1992, J CELL BIOL, V119, P229, DOI 10.1083/jcb.119.1.229; Sfikakis PP, 1999, CLIN RHEUMATOL, V18, P28, DOI 10.1007/s100670050047; Shimada Y, 2001, CLIN EXP IMMUNOL, V124, P474, DOI 10.1046/j.1365-2249.2001.01514.x; SPERTINI O, 1992, J IMMUNOL METHODS, V156, P115, DOI 10.1016/0022-1759(92)90017-N; Tang MLK, 1998, J IMMUNOL, V160, P5113; Valentini G, 2003, CLIN EXP RHEUMATOL, V21, pS39; Vela-Ojeda J, 2010, STEM CELLS DEV, V19, P333, DOI 10.1089/scd.2009.0216; Yoshizaki A, 2010, J IMMUNOL, V185, P2502, DOI 10.4049/jimmunol.0901778; Zhou LX, 2007, J INVEST DERMATOL, V127, P281, DOI 10.1038/sj.jid.5700517	38	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44814	10.1371/journal.pone.0044814	http://dx.doi.org/10.1371/journal.pone.0044814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028631	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700042
J	Su, GS; Christensen, OF; Ostersen, T; Henryon, M; Lund, MS				Su, Guosheng; Christensen, Ole F.; Ostersen, Tage; Henryon, Mark; Lund, Mogens S.			Estimating Additive and Non-Additive Genetic Variances and Predicting Genetic Merits Using Genome-Wide Dense Single Nucleotide Polymorphism Markers	PLOS ONE			English	Article							COMMON SNPS EXPLAIN; DOMINANCE VARIANCE; BREEDING VALUES; FULL PEDIGREE; QUANTITATIVE TRAITS; RELATIONSHIP MATRIX; LARGE PROPORTION; EPISTATIC QTL; DAIRY-CATTLE; HUMAN HEIGHT	Non-additive genetic variation is usually ignored when genome-wide markers are used to study the genetic architecture and genomic prediction of complex traits in human, wild life, model organisms or farm animals. However, non-additive genetic effects may have an important contribution to total genetic variation of complex traits. This study presented a genomic BLUP model including additive and non-additive genetic effects, in which additive and non-additive genetic relation matrices were constructed from information of genome-wide dense single nucleotide polymorphism (SNP) markers. In addition, this study for the first time proposed a method to construct dominance relationship matrix using SNP markers and demonstrated it in detail. The proposed model was implemented to investigate the amounts of additive genetic, dominance and epistatic variations, and assessed the accuracy and unbiasedness of genomic predictions for daily gain in pigs. In the analysis of daily gain, four linear models were used: 1) a simple additive genetic model (MA), 2) a model including both additive and additive by additive epistatic genetic effects (MAE), 3) a model including both additive and dominance genetic effects (MAD), and 4) a full model including all three genetic components (MAED). Estimates of narrow-sense heritability were 0.397, 0.373, 0.379 and 0.357 for models MA, MAE, MAD and MAED, respectively. Estimated dominance variance and additive by additive epistatic variance accounted for 5.6% and 9.5% of the total phenotypic variance, respectively. Based on model MAED, the estimate of broad-sense heritability was 0.506. Reliabilities of genomic predicted breeding values for the animals without performance records were 28.5%, 28.8%, 29.2% and 29.5% for models MA, MAE, MAD and MAED, respectively. In addition, models including non-additive genetic effects improved unbiasedness of genomic predictions.	[Su, Guosheng; Christensen, Ole F.; Lund, Mogens S.] Aarhus Univ, Dept Mol Biol & Genet, AU Foulum, Tjele, Denmark; [Ostersen, Tage; Henryon, Mark] Danish Agr & Food Council, Pig Res Ctr, Copenhagen, Denmark; [Henryon, Mark] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	Aarhus University; University of Western Australia	Su, GS (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, AU Foulum, Tjele, Denmark.	guosheng.su@agrsci.dk	Lund, Mogens S/I-4321-2016; Christensen, Ole F/HAF-7113-2022	Christensen, Ole F/0000-0002-8230-8062	Danish Ministry of Food, Agriculture and Fisheries [3405-11-0279]; Pig Research Centre; Aarhus University	Danish Ministry of Food, Agriculture and Fisheries; Pig Research Centre; Aarhus University	The work was performed in the project (grant no. 3405-11-0279) funded by the Danish Ministry of Food, Agriculture and Fisheries, Pig Research Centre and Aarhus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar I, 2010, J DAIRY SCI, V93, P743, DOI 10.3168/jds.2009-2730; Carlborg O, 2003, GENOME RES, V13, P413, DOI 10.1101/gr.528003; Carlborg R, 2004, GENET RES, V83, P197, DOI 10.1017/S0016672304006779; Christensen OF, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-2; Culbertson MS, 1998, J ANIM SCI, V76, P448; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Duangjinda M, 2001, J ANIM SCI, V79, P2997; DUNN OJ, 1971, J AM STAT ASSOC, V66, P904, DOI 10.2307/2284252; Duthie C, 2010, J ANIM SCI, V88, P2219, DOI 10.2527/jas.2009-2266; Estelle J, 2008, J ANIM SCI, V86, P3290, DOI 10.2527/jas.2008-1034; Gengler N, 1998, J ANIM SCI, V76, P2515; Gengler N, 1997, J ANIM SCI, V75, P2885; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Grosse-Brinkhaus C, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-39; Guo G, 2010, J ANIM BREED GENET, V127, P423, DOI 10.1111/j.1439-0388.2010.00878.x; Harris BL, 2010, J DAIRY SCI, V93, P1243, DOI 10.3168/jds.2009-2619; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; Henderson CR, 1985, J ANIM SCI, V60, P7; HOESCHELE I, 1991, J DAIRY SCI, V74, P1743, DOI 10.3168/jds.S0022-0302(91)78337-9; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; Lund M. S., 2009, BMC P S1, V3, pS1, DOI DOI 10.1186/1753-6561-3-S1-S1; Lund MS, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-43; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Misztal I, 1997, J DAIRY SCI, V80, P965, DOI 10.3168/jds.S0022-0302(97)76021-1; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Norris D, 2010, LIVEST SCI, V131, P144, DOI 10.1016/j.livsci.2010.03.005; Ostersen T, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-38; Palucci V, 2007, GENET SEL EVOL, V39, P181, DOI 10.1051/gse:2006041; Pettersson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002180; Sahana G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027061; Stiger JH, 1980, PSYCHOL BULL, V87, P245; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; Su G, 2012, J DAIRY SCI, V95, P909, DOI 10.3168/jds.2011-4804; Su G, 2010, J DAIRY SCI, V93, P1175, DOI 10.3168/jds.2009-2192; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; VanRaden PM, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-7; Varona L, 1999, J DAIRY SCI, V82, P2186, DOI 10.3168/jds.S0022-0302(99)75463-9; Varona L, 1998, J DAIRY SCI, V81, P1126, DOI 10.3168/jds.S0022-0302(98)75675-9; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Xu SZ, 2007, GENETICS, V175, P1955, DOI 10.1534/genetics.106.066571; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	48	207	209	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45293	10.1371/journal.pone.0045293	http://dx.doi.org/10.1371/journal.pone.0045293			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028912	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700102
J	Weiss, M; Kiefer, S; Kipper, S				Weiss, Michael; Kiefer, Sarah; Kipper, Silke			Buzzwords in Females' Ears? The Use of Buzz Songs in the Communication of Nightingales (Luscinia megarhynchos)	PLOS ONE			English	Article							BROAD-BAND TRILLS; REPERTOIRE SIZE; COMMON NIGHTINGALES; VOCAL PERFORMANCE; SPARROWS MODULATE; PIED FLYCATCHERS; MATING SUCCESS; BIRD SONG; CHOICE; EVOLUTION	Differences in individual male birds' singing may serve as honest indicators of male quality in male-male competition and female mate choice. This has been shown e.g. for overall song output and repertoire size in many bird species. More recently, differences in structural song characteristics such as the performance of physically challenging song components were analysed in this regard. Here we show that buzz elements in the song of nightingales (Luscinia megarhynchos) hold the potential to serve as indicators of male quality and may therefore serve a communicative function. Buzzes were produced with considerable differences between males. The body weight of the males was correlated with one measure of these buzzes, namely the repetition rate of the buzz subunits, and individuals with larger repertoires sang buzzes at higher subunit-rates. A model of buzz performance constraints suggested that buzzes were sung with different proficiencies. In playback experiments, female nightingales showed more active behaviour when hearing buzz songs. The results support the idea that performance differences in the acoustic fine structure of song components are used in the communication of a large repertoire species such as the nightingale.	[Weiss, Michael; Kiefer, Sarah; Kipper, Silke] Free Univ Berlin, Inst Biol, Behav Biol Grp, Berlin, Germany	Free University of Berlin	Weiss, M (corresponding author), Free Univ Berlin, Inst Biol, Behav Biol Grp, Berlin, Germany.	miweiss@zedat.fu-berlin.de						Amrhein V, 2002, ANIM BEHAV, V64, P939, DOI 10.1006/anbe.2002.1974; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Ballentine B, 2009, ANIM BEHAV, V77, P973, DOI 10.1016/j.anbehav.2008.12.027; Bartsch C, 2012, ETHOLOGY, V118, P876, DOI 10.1111/j.1439-0310.2012.02081.x; BLACKBURN TM, 1992, OIKOS, V65, P107, DOI 10.2307/3544892; Botero CA, 2009, ANIM BEHAV, V77, P701, DOI 10.1016/j.anbehav.2008.11.020; BRACKENBURY JH, 1978, J ZOOL, V184, P187; Brumm H, 2004, ANIM BEHAV, V67, P281, DOI 10.1016/j.anbehav.2003.06.006; Buchanan KL, 1997, P ROY SOC B-BIOL SCI, V264, P521, DOI 10.1098/rspb.1997.0074; Byers BE, 2009, ANIM BEHAV, V77, P13, DOI 10.1016/j.anbehav.2008.10.003; Cardoso GC, 2007, BEHAV ECOL, V18, P1051, DOI 10.1093/beheco/arm078; Caro SP, 2010, BEHAV ECOL, V21, P562, DOI 10.1093/beheco/arq022; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; de Kort SR, 2009, P ROY SOC B-BIOL SCI, V276, P2315, DOI 10.1098/rspb.2009.0127; DEVOOGD TJ, 1993, P ROY SOC B-BIOL SCI, V254, P75, DOI 10.1098/rspb.1993.0129; Draganoiu TI, 2002, P ROY SOC B-BIOL SCI, V269, P2525, DOI 10.1098/rspb.2002.2192; DuBois AL, 2009, BIOL LETTERS, V5, P163, DOI 10.1098/rsbl.2008.0626; Everitt B. S., 2006, HDB STAT ANAL USING; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Galeotti P, 1997, ANIM BEHAV, V53, P687, DOI 10.1006/anbe.1996.0304; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Glutz von Blotzheim U. N., 1988, HDB VOGEL MITTELEURO, V11; Hauber ME, 2002, ANIM COGN, V5, P129, DOI 10.1007/s10071-002-0143-x; HOILEITNER M, 1995, BEHAV ECOL SOCIOBIOL, V37, P399, DOI 10.1007/BF00170587; Hothorn T, 2008, J STAT SOFTW, V28, P1; HULTSCH H, 1981, BEHAV ECOL SOCIOBIOL, V8, P183, DOI 10.1007/BF00299828; Hultsch H., 1999, LEARNING, P89, DOI [10.1515/9783110803488.89, DOI 10.1515/9783110803488.89]; Hurd PL, 2005, ANIM BEHAV, V70, P1155, DOI 10.1016/j.anbehav.2005.02.014; Jensen KK, 2007, P R SOC B, V274, P2703, DOI 10.1098/rspb.2007.0781; Kiefer S, 2006, ETHOLOGY, V112, P1217, DOI 10.1111/j.1439-0310.2006.01283.x; Kiefer S, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-29; Kiefer S, 2010, ETHOLOGY, V116, P619, DOI 10.1111/j.1439-0310.2010.01774.x; Kiefer S, 2009, J AVIAN BIOL, V40, P231, DOI 10.1111/j.1600-048X.2009.04500.x; Kipper S, 2006, ANIM BEHAV, V71, P211, DOI 10.1016/j.anbehav.2005.04.011; Kipper S, 2004, BEHAVIOUR, V141, P371, DOI 10.1163/156853904322981914; LAMPE HM, 1995, P ROY SOC B-BIOL SCI, V262, P163, DOI 10.1098/rspb.1995.0191; LAMPE HM, 1994, ANIM BEHAV, V47, P869, DOI 10.1006/anbe.1994.1118; LARSEN ON, 1997, BIOACOUSTICS, V8, P323; Logue DM, 2008, AM NAT, V172, P34, DOI 10.1086/587849; Marler P., 2004, NATURES MUSIC SCI BI; Marler P. R., 1960, ANIMAL SOUNDS COMMUN, V7, P348; Mountjoy DJ, 1996, BEHAV ECOL SOCIOBIOL, V38, P65, DOI 10.1007/s002650050218; Mundry Roger, 2007, Limicola, V21, P131; Naguib M, 2002, BEHAV ECOL SOCIOBIOL, V52, P216, DOI 10.1007/s00265-002-0511-1; Naguib M, 2011, ADV STUD BEHAV, V43, P239, DOI 10.1016/B978-0-12-380896-7.00005-8; Nolan PM, 2004, ANIM BEHAV, V67, P403, DOI 10.1016/j.anbehav.2003.03.018; Podos J, 1997, EVOLUTION, V51, P537, DOI 10.1111/j.1558-5646.1997.tb02441.x; Podos J, 2009, ADV STUD BEHAV, V40, P159, DOI 10.1016/S0065-3454(09)40005-6; R Core Team, 2020, R LANG ENV STAT COMP; Rehsteiner U, 1998, ANIM BEHAV, V55, P1471, DOI 10.1006/anbe.1998.0733; Reid JM, 2004, ANIM BEHAV, V68, P1055, DOI 10.1016/j.anbehav.2004.07.003; Schmidt R, 2008, BEHAV ECOL, V19, P635, DOI 10.1093/beheco/arn021; Sokal R.R., 2012, BIOMETRY; Soma M, 2011, BEHAV ECOL, V22, P363, DOI 10.1093/beheco/arq219; Sprau P, 2010, ETHOLOGY, V116, P300, DOI 10.1111/j.1439-0310.2010.01743.x; SUTHERS RA, 1994, J NEUROBIOL, V25, P917, DOI 10.1002/neu.480250803; Suthers RA, 1997, CURR ORNITHOL, V14, P235; Suthers Roderick A., 2004, P272, DOI 10.1016/B978-012473070-0/50012-8; Svensson L., 1992, IDENTIFICATION GUIDE; TODT D, 1979, Z TIERPSYCHOL, V51, P23; Trillo PA, 2005, ANIM BEHAV, V70, P921, DOI 10.1016/j.anbehav.2005.02.004; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; WASSERMAN FE, 1991, BEHAV ECOL SOCIOBIOL, V29, P55, DOI 10.1007/BF00164295; Weber, 1999, MATH METHODS STAT, V8, P220, DOI DOI 10.1007/s10551-011-0925-7; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; Zuur Alain F., 2009, P1	67	24	24	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45057	10.1371/journal.pone.0045057	http://dx.doi.org/10.1371/journal.pone.0045057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028759	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700080
J	Marshall, MC; Binderup, AJ; Zandona, E; Goutte, S; Bassar, RD; El-Sabaawi, RW; Thomas, SA; Flecker, AS; Kilham, SS; Reznick, DN; Pringle, CM				Marshall, Michael C.; Binderup, Andrew J.; Zandona, Eugenia; Goutte, Sandra; Bassar, Ronald D.; El-Sabaawi, Rana W.; Thomas, Steven A.; Flecker, Alexander S.; Kilham, Susan S.; Reznick, David N.; Pringle, Cathy M.			Effects of Consumer Interactions on Benthic Resources and Ecosystem Processes in a Neotropical Stream	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; TOP-DOWN; TRINIDADIAN GUPPIES; COMMUNITY STRUCTURE; TROPICAL STREAM; FOOD-WEB; HABITAT QUALITY; PREDATION; BREAKDOWN; FISHES	The effect of consumers on their resources has been demonstrated in many systems but is often confounded by trophic interactions with other consumers. Consumers may also have behavioral and life history adaptations to each other and to co-occurring predators that may additionally modulate their particular roles in ecosystems. We experimentally excluded large consumers from tile periphyton, leaves and natural benthic substrata using submerged electrified frames in three stream reaches with overlapping consumer assemblages in Trinidad, West Indies. Concurrently, we assessed visits to (non-electrified) control frames by the three most common large consumers-primarily insectivorous killifish (Rivulus hartii), omnivorous guppies (Poecilia reticulata) and omnivorous crabs (Eudaniela garmani). Consumers caused the greatest decrease in final chlorophyll a biomass and accrual rates the most in the downstream reach containing all three focal consumers in the presence of fish predators. Consumers also caused the greatest increase in leaf decay rates in the upstream reach containing only killifish and crabs. In the downstream reach where guppies co-occur with predators, we found significantly lower benthic invertebrate biomass in control relative to exclosure treatments than the midstream reach where guppies occur in the absence of predators. These data suggest that differences in guppy foraging, potentially driven by differences in their life history phenotype, may affect ecosystem structure and processes as much as their presence or absence and that interactions among consumers may further mediate their effects in these stream ecosystems.	[Marshall, Michael C.; Binderup, Andrew J.; Pringle, Cathy M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Zandona, Eugenia; Kilham, Susan S.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Goutte, Sandra] Ecole Normale Super, F-75231 Paris, France; [Bassar, Ronald D.; Reznick, David N.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [El-Sabaawi, Rana W.; Flecker, Alexander S.] Cornell Univ, Ithaca, NY USA; [Thomas, Steven A.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA	University System of Georgia; University of Georgia; Drexel University; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of California System; University of California Riverside; Cornell University; University of Nebraska System; University of Nebraska Lincoln	Marshall, MC (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	drmikemarshall@gmail.com	goutte, sandra/M-2633-2014; Zandona, Eugenia/GQH-9518-2022; Zandona, Eugenia/ABG-8207-2020; Zandona, Eugenia/B-3449-2013	Zandona, Eugenia/0000-0003-4754-5326; Zandona, Eugenia/0000-0003-4754-5326; Zandona, Eugenia/0000-0003-4754-5326; reznick, david/0000-0002-1144-0568; Marshall, Michael/0000-0002-1270-9717	National Science Foundation Frontiers in Integrative Biological Research Grant (NSF-FIBR) [DEB-0623632]	National Science Foundation Frontiers in Integrative Biological Research Grant (NSF-FIBR)	This work was supported by a National Science Foundation Frontiers in Integrative Biological Research Grant to DNR (NSF-FIBR, DEB-0623632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Belancic A, 2009, INT REV HYDROBIOL, V94, P391, DOI 10.1002/iroh.200811162; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Dolan CR, 2003, T AM FISH SOC, V132, P969, DOI 10.1577/T02-055; DUSSAULT GV, 1981, CAN J ZOOL, V59, P684, DOI 10.1139/z81-098; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Feller R.J., 1988, P181; Flecker AS, 2004, ECOLOGY, V85, P2267, DOI 10.1890/03-0194; Flecker AS, 2002, ECOLOGY, V83, P1831, DOI 10.2307/3071768; Flecker AS, 1996, ECOLOGY, V77, P1845, DOI 10.2307/2265788; FRASER DF, 1995, ECOLOGY, V76, P1461, DOI 10.2307/1938148; Fraser DF, 1999, ECOLOGY, V80, P597, DOI 10.2307/176638; FRASER DF, 1987, BEHAV ECOL SOCIOBIOL, V21, P203, DOI 10.1007/BF00292500; Fraser DF, 2011, BEHAV ECOL SOCIOBIOL, V65, P1113, DOI 10.1007/s00265-010-1123-9; FRETWELL SD, 1977, PERSPECT BIOL MED, V20, P169; Friberg N, 2009, FRESHWATER BIOL, V54, P2051, DOI 10.1111/j.1365-2427.2009.02234.x; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; GILLIAM JF, 1993, ECOLOGY, V74, P1856, DOI 10.2307/1939943; Gilliam JF, 2001, ECOLOGY, V82, P258, DOI 10.2307/2680101; Graca MAS, 2001, J N AM BENTHOL SOC, V20, P408, DOI 10.2307/1468038; Grether GF, 2001, ECOLOGY, V82, P1546, DOI 10.1890/0012-9658(2001)082[1546:RFCCRA]2.0.CO;2; Gulis V, 2003, FRESHWATER BIOL, V48, P123, DOI 10.1046/j.1365-2427.2003.00985.x; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hillebrand H, 2009, J PHYCOL, V45, P798, DOI 10.1111/j.1529-8817.2009.00702.x; Huber J.H., 1992, REV RIVULUS ECOBIOGE; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Kenny JS, 1995, VIEWS BRIDGE MEMOIR; Kohler TJ, FRESHWATER IN PRESS; LAWTON JH, 1970, J ANIM ECOL, V39, P669, DOI 10.2307/2859; Liley NR, 1975, FUNCTION EVOLUTION B, P92; MAGURRAN AE, 1994, P ROY SOC B-BIOL SCI, V258, P89, DOI 10.1098/rspb.1994.0147; MALONEY DC, 1995, AM MIDL NAT, V133, P184, DOI 10.2307/2426360; March JG, 2003, BIOTROPICA, V35, P84, DOI 10.1111/j.1744-7429.2003.tb00265.x; March JG, 2001, CAN J FISH AQUAT SCI, V58, P470, DOI 10.1139/cjfas-58-3-470; McIntyre PB, 2008, ECOLOGY, V89, P2335, DOI 10.1890/07-1552.1; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Merritt R. W., 2008, INTRO AQUATIC INSECT; Moss B, 2005, INT VER THEOR ANGEW, V29, P147; Moulton TP, 2004, J N AM BENTHOL SOC, V23, P868, DOI 10.1899/0887-3593(2004)023<0868:EOEASO>2.0.CO;2; Newbold J.D., 1992, P379; Nordhaus I, 2006, ESTUAR COAST SHELF S, V67, P239, DOI 10.1016/j.ecss.2005.11.022; Owens DC, 2010, SEASONAL VARIATION T; Palkovacs EP, 2009, PHILOS T R SOC B, V364, P1617, DOI 10.1098/rstb.2009.0016; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Post DM, 2008, ECOLOGY, V89, P2019, DOI 10.1890/07-1216.1; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; POWER ME, 1984, J ANIM ECOL, V53, P357, DOI 10.2307/4521; Pringle CM, 1997, ECOLOGY, V78, P2432; Pringle CM, 1998, ECOLOGY, V79, P269, DOI 10.1890/0012-9658(1998)079[0269:TROOIA]2.0.CO;2; PRINGLE CM, 1994, CAN J FISH AQUAT SCI, V51, P1443, DOI 10.1139/f94-144; REZNICK D, 1982, EVOLUTION, V36, P1236, DOI 10.1111/j.1558-5646.1982.tb05493.x; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Robinson CT, 2000, OECOLOGIA, V122, P258, DOI 10.1007/PL00008854; Rodriguez G, 2005, REV BRAS ZOOL, V22, P354, DOI 10.1590/S0101-81752005000200009; Rosemond AD, 1998, FRESHWATER BIOL, V39, P515, DOI 10.1046/j.1365-2427.1998.00301.x; Rosemond AD, 2001, ECOLOGY, V82, P2279, DOI 10.1890/0012-9658(2001)082[2279:ATOTDA]2.0.CO;2; Rostant GW, 2005, FRESHWATER DECAPOD C; Sandin L, 2009, FRESHWATER BIOL, V54, P2017, DOI 10.1111/j.1365-2427.2009.02313.x; *SAS I, 2002, SAS VERS 9 2; Schofield KA, 2008, FRESHWATER BIOL, V53, P2587, DOI 10.1111/j.1365-2427.2008.02085.x; Steinman Alan D., 2007, P357, DOI 10.1016/B978-012332908-0.50024-3; Taylor BW, 2006, SCIENCE, V313, P833, DOI 10.1126/science.1128223; Torres-Dowdall J, 2012, FUNCT ECOL, V26, P616, DOI 10.1111/j.1365-2435.2012.01980.x; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Walsh M. R., 2010, FUNCTIONAL ECOLOGY, V25, P227; Walsh MR, 2008, P NATL ACAD SCI USA, V105, P594, DOI 10.1073/pnas.0710051105; Walsh MR, 2011, EVOLUTION, V65, P1021, DOI 10.1111/j.1558-5646.2010.01188.x; WEBSTER JR, 1986, ANNU REV ECOL SYST, V17, P567, DOI 10.1146/annurev.es.17.110186.003031; WOLCOTT DL, 1992, AM ZOOL, V32, P370; Woodward G, 2008, OIKOS, V117, P683, DOI 10.1111/j.0030-1299.2008.16500.x; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Young RG, 2008, J N AM BENTHOL SOC, V27, P605, DOI 10.1899/07-121.1; Zandona E, 2011, FUNCT ECOL, V25, P964, DOI 10.1111/j.1365-2435.2011.01865.x	78	18	18	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45230	10.1371/journal.pone.0045230	http://dx.doi.org/10.1371/journal.pone.0045230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028865	Green Published, gold			2022-12-27	WOS:000309973900034
J	Culasso, ACA; Elizalde, M; Campos, RH; Barbini, L				Culasso, Andres C. A.; Elizalde, Mercedes; Campos, Rodolfo H.; Barbini, Luciana			Molecular Survey of Hepatitis C Virus in the Touristic City of Mar Del Plata, Argentina	PLOS ONE			English	Article							EPIDEMIOLOGY; INFECTION; INFERENCE; GENOTYPES	The global epidemiology of Hepatitis C Virus (HCV) may be roughly described by two groups of genotypes: the worldwide distributed ones (subtypes 1a, 1b, 2a and 3a, among others) and the endemic ones (subtypes 4a, 5a, 6a, among others). Epidemiological and population dynamic studies of the worldwide distributed genotypes have shown that subtypes 1a and 3a are common among intravenous drug users (IDUs) and that they are also in expansion in some countries. The molecular survey of HCV provides some clues about the epidemiological status of the infections in a local scale and the phylogenetic and demographic reconstruction analyses complement this study by inferring whether the infections of certain subtypes are in a steady state or expanding. Here, a molecular survey of the HCV variants that circulate in the touristic city of Mar del Plata (Buenos Aires, Argentina) was performed in samples obtained from 42 patients. The subtypes detected were 1a (32 patients), 3a (8 patients) and 1b (2 patients). The demographic history of subtype 1a inferred using the sequence data showed an exponential growth in the 1990's. The period of viral expansion was delayed compared with that observed for the same genotype in other countries where the transmission was associated with IDUs. Also, the phylogeographic analysis of HCV-1a showed a statistically significant association between the location of the samples and the phylogeny, which may be the result of the local transmission of HCV in the city. The molecular analysis helped in the description of the complex epidemiological context of a touristic city, and pointed out that some sanitary measures should be taken in order to reduce the transmission of HCV (and maybe of HIV) among IDUs.	[Culasso, Andres C. A.; Elizalde, Mercedes; Campos, Rodolfo H.; Barbini, Luciana] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Campos, RH (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina.	rcampos@ffyb.uba.ar		Elizalde, Maria Mercedes/0000-0002-0533-4283	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112-200801-01169]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2006-00285]; Universidad de Buenos Aires [UBACyT 2008-B601]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This study was carried out thanks to the financial support of the grants: PIP 112-200801-01169 (Consejo Nacional de Investigaciones Cientificas y Tecnicas), PICT 2006-00285 (Agencia Nacional de Promocion Cientifica y Tecnologica) and UBACyT 2008-B601 (Universidad de Buenos Aires). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; DAVIDSON F, 1995, J GEN VIROL, V76, P1197, DOI 10.1099/0022-1317-76-5-1197; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Frost SDW, 2010, PHILOS T R SOC B, V365, P1879, DOI 10.1098/rstb.2010.0060; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kershenobich D, 2011, LIVER INT, V31, P18, DOI 10.1111/j.1478-3231.2011.02538.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Nakano T, 2004, J INFECT DIS, V190, P1098, DOI 10.1086/422606; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quarleri Jorge F., 2007, Acta Gastroenterologica Latinoamericana, V37, P76; Re VE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019471; SILINI E, 1995, J HEPATOL, V22, P691, DOI 10.1016/0168-8278(95)80225-8; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44757	10.1371/journal.pone.0044757	http://dx.doi.org/10.1371/journal.pone.0044757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028605	gold, Green Published			2022-12-27	WOS:000309554700015
J	Srinivasan, S; Simms, JA; Nielsen, CK; Lieske, SP; Bito-Onon, JJ; Yi, H; Hopf, FW; Bonci, A; Bartlett, SE				Srinivasan, Subhashini; Simms, Jeffrey A.; Nielsen, Carsten K.; Lieske, Steven P.; Bito-Onon, Jade J.; Yi, Henry; Hopf, Frederic Woodward; Bonci, Antonello; Bartlett, Selena E.			The Dual Orexin/Hypocretin Receptor Antagonist, Almorexant, in the Ventral Tegmental Area Attenuates Ethanol Self-Administration	PLOS ONE			English	Article							LONG-EVANS RATS; ALCOHOL DEPENDENCE; INDUCED REINSTATEMENT; OREXIN-A; MESOLIMBIC DOPAMINE; NALTREXONE RESPONSE; REWARD-SEEKING; FOOD-INTAKE; NEURONS; INVOLVEMENT	Recent studies have implicated the hypocretin/orexinergic system in reward-seeking behavior. Almorexant, a dual orexin/hypocretin R-1 and R-2 receptor antagonist, has proven effective in preclinical studies in promoting sleep in animal models and was in Phase III clinical trials for sleep disorders. The present study combines behavioral assays with in vitro biochemical and electrophysiological techniques to elucidate the role of almorexant in ethanol and sucrose intake. Using an operant self-administration paradigm, we demonstrate that systemic administration of almorexant decreased operant self-administration of both 20% ethanol and 5% sucrose. We further demonstrate that intra-ventral tegmental area (VTA) infusions, but not intra-substantia nigra infusions, of almorexant reduced ethanol self-administration. Extracellular recordings performed in VTA neurons revealed that orexin-A increased firing and this enhancement of firing was blocked by almorexant. The results demonstrate that orexin/hypocretin receptors in distinct brain regions regulate ethanol and sucrose mediated behaviors.	[Srinivasan, Subhashini; Simms, Jeffrey A.; Nielsen, Carsten K.; Lieske, Steven P.; Bito-Onon, Jade J.; Yi, Henry; Hopf, Frederic Woodward; Bartlett, Selena E.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Bartlett, Selena E.] Queensland Univ Technol, Translat Res Inst, Brisbane, Qld 4001, Australia; [Bonci, Antonello] NIDA, Intramural Res Program, Baltimore, MD USA; [Bonci, Antonello] Univ Calif San Francisco, Dept Neurol, Emeryville, CA USA; [Bonci, Antonello] Johns Hopkins Univ, Solomon Snyder Dept Neurosci, Baltimore, MD USA; [Lieske, Steven P.] San Francisco VA Med Ctr, Dept Mental Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Queensland University of Technology (QUT); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of California System; University of California San Francisco; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Bartlett, SE (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	selena.bartlett@qut.edu.au	Bartlett, Selena/J-1345-2012	Bartlett, Selena/0000-0002-1741-3958; Srinivasan, Subhashini/0000-0003-0117-7839	Department of Defense, TATRC grant [W81XWH-10-1-0247]; state funding for medical research through UCSF	Department of Defense, TATRC grant; state funding for medical research through UCSF	The research was carried out with the help of Department of Defense, TATRC grant W81XWH-10-1-0247 (www.tatrc.org) awarded to S. E. B. and A. B. and the state funding for medical research through UCSF to S. E. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton RF, 2008, ARCH GEN PSYCHIAT, V65, P135, DOI 10.1001/archpsyc.65.2.135; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; Aston-Jones G, 2010, BRAIN RES, V1314, P74, DOI 10.1016/j.brainres.2009.09.106; Balcita-Pedicino JJ, 2007, J COMP NEUROL, V503, P668, DOI 10.1002/cne.21420; Barson JR, 2011, PHYSIOL BEHAV, V104, P128, DOI 10.1016/j.physbeh.2011.04.054; Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2008, EUR J NEUROSCI, V28, P1545, DOI 10.1111/j.1460-9568.2008.06397.x; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dayas CV, 2008, BIOL PSYCHIAT, V63, P152, DOI 10.1016/j.biopsych.2007.02.002; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Georgescu D, 2003, J NEUROSCI, V23, P3106; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Heilig M, 2006, PHARMACOL THERAPEUT, V111, P855, DOI 10.1016/j.pharmthera.2006.02.001; James MH, 2011, INT J NEUROPSYCHOPH, V14, P684, DOI 10.1017/S1461145711000423; Jupp B, 2011, BRAIN RES, V1391, P54, DOI 10.1016/j.brainres.2011.03.045; Kilduff TS, 2001, J COMP NEUROL, V435, P1, DOI 10.1002/cne.1189; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Korotkova TM, 2003, J NEUROSCI, V23, P7; Korotkova TM, 2002, REGUL PEPTIDES, V104, P83, DOI 10.1016/S0167-0115(01)00323-8; Krystal JH, 2001, NEW ENGL J MED, V345, P1734, DOI 10.1056/NEJMoa011127; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Madhavan A, 2010, J NEUROSCI, V30, P14029, DOI 10.1523/JNEUROSCI.3366-10.2010; Malherbe P, 2009, MOL PHARMACOL, V76, P618, DOI 10.1124/mol.109.055152; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Moorman DE, 2010, J NEUROSCI, V30, P15585, DOI 10.1523/JNEUROSCI.2871-10.2010; Moorman DE, 2009, ALCOHOL, V43, P379, DOI 10.1016/j.alcohol.2009.07.002; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; Neubauer DN, 2010, CURR OPIN INVEST DR, V11, P101; Novick A, 2008, LIFE SCI, V83, P74, DOI 10.1016/j.lfs.2008.05.006; Oslin DW, 2003, NEUROPSYCHOPHARMACOL, V28, P1546, DOI 10.1038/sj.npp.1300219; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peyron C, 1998, J NEUROSCI, V18, P9996; Richards JK, 2008, PSYCHOPHARMACOLOGY, V199, P109, DOI 10.1007/s00213-008-1136-5; Rodgers RJ, 2001, EUR J NEUROSCI, V13, P1444, DOI 10.1046/j.0953-816x.2001.01518.x; Rodgers RJ, 2000, REGUL PEPTIDES, V96, P71, DOI 10.1016/S0167-0115(00)00203-2; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Samson H H, 1993, Alcohol Alcohol Suppl, V2, P469; SAMSON HH, 1992, ANN N Y ACAD SCI, V654, P242; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Shoblock JR, 2011, PSYCHOPHARMACOLOGY, V215, P191, DOI 10.1007/s00213-010-2127-x; Simms JA, 2012, NEUROPSYCHOPHARMACOL, V37, P906, DOI 10.1038/npp.2011.268; Simms JA, 2010, NEUROPSYCHOPHARMACOL, V35, P1453, DOI 10.1038/npp.2010.15; Steiner MA, 2011, NEUROPSYCHOPHARMACOL, V36, P848, DOI 10.1038/npp.2010.224; Stuber GD, 2010, CURR TOP BEHAV NEURO, V3, P3, DOI 10.1007/7854_2009_23; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Vittoz NM, 2006, NEUROPSYCHOPHARMACOL, V31, P384, DOI 10.1038/sj.npp.1300807; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Wanat MJ, 2008, J PHYSIOL-LONDON, V586, P2157, DOI 10.1113/jphysiol.2007.150078; Wanat MJ, 2009, BIOL PSYCHIAT, V65, P646, DOI 10.1016/j.biopsych.2008.10.042; Yamada H, 2000, BIOCHEM BIOPH RES CO, V267, P527, DOI 10.1006/bbrc.1999.1998; Zhu Y, 2003, J PHARMACOL SCI, V92, P259	60	49	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e44726	10.1371/journal.pone.0044726	http://dx.doi.org/10.1371/journal.pone.0044726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23028593	Green Submitted, Green Published, gold			2022-12-27	WOS:000309392800013
J	Timm, L; Agrawal, D; Viola, FC; Sandmann, P; Debener, S; Buchner, A; Dengler, R; Wittfoth, M				Timm, Lydia; Agrawal, Deepashri; Viola, Filipa C.; Sandmann, Pascale; Debener, Stefan; Buechner, Andreas; Dengler, Reinhard; Wittfoth, Matthias			Temporal Feature Perception in Cochlear Implant Users	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; MELODIC CONTOUR IDENTIFICATION; INDEPENDENT COMPONENT ANALYSIS; MISMATCH NEGATIVITY MMN; MUSIC PERCEPTION; TIMBRE; HEARING; SPEECH; SOUND; RECOGNITION	For the perception of timbre of a musical instrument, the attack time is known to hold crucial information. The first 50 to 150 ms of sound onset reflect the excitation mechanism, which generates the sound. Since auditory processing and music perception in particular are known to be hampered in cochlear implant (CI) users, we conducted an electroencephalography (EEG) study with an oddball paradigm to evaluate the processing of small differences in musical sound onset. The first 60 ms of a cornet sound were manipulated in order to examine whether these differences are detected by CI users and normal-hearing controls (NH controls), as revealed by auditory evoked potentials (AEPs). Our analysis focused on the N1 as an exogenous component known to reflect physical stimuli properties as well as on the P2 and the Mismatch Negativity (MMN). Our results revealed different N1 latencies as well as P2 amplitudes and latencies for the onset manipulations in both groups. An MMN could be elicited only in the NH control group. Together with additional findings that suggest an impact of musical training on CI users' AEPs, our findings support the view that impaired timbre perception in CI users is at partly due to altered sound onset feature detection.	[Timm, Lydia; Agrawal, Deepashri; Dengler, Reinhard; Wittfoth, Matthias] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Viola, Filipa C.; Sandmann, Pascale; Debener, Stefan] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Neuropsychol Lab, Oldenburg, Germany; [Buechner, Andreas] Hannover Med Sch, Dept Otorhinolaryngol, D-3000 Hannover, Germany; [Wittfoth, Matthias] NeuroImaging & Clin Applicat NICA, Hannover, Germany	Hannover Medical School; Carl von Ossietzky Universitat Oldenburg; Hannover Medical School	Timm, L (corresponding author), Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany.	timm.lydia@mh-hannover.de		Sandmann, Pascale/0000-0001-8251-7852	Lower Saxony, Germany; Fundacao para a Ciencia e Tecnologia, Lisbon, Portugal [SFRH/BD/37662/2007]	Lower Saxony, Germany; Fundacao para a Ciencia e Tecnologia, Lisbon, Portugal(Portuguese Foundation for Science and Technology)	This work and its first author were supported by the Georg Christoph Lichtenberg Stipendium of Lower Saxony, Germany. F. C. V. was funded by the Fundacao para a Ciencia e Tecnologia, Lisbon, Portugal (SFRH/BD/37662/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken SJ, 2008, EAR HEARING, V29, P139, DOI 10.1097/AUD.0b013e31816453dc; *ANSI, 1973, AM NAT STAND PSYCH T; BERGER KW, 1964, J ACOUST SOC AM, V36, P1888, DOI 10.1121/1.1919287; Billings CJ, 2007, AUDIOL NEURO-OTOL, V12, P234, DOI 10.1159/000101331; Bishop DVM, 2010, PSYCHOPHYSIOLOGY, V47, P697, DOI 10.1111/j.1469-8986.2009.00970.x; Caclin A, 2006, J COGNITIVE NEUROSCI, V18, P1959, DOI 10.1162/jocn.2006.18.12.1959; Cooper WB, 2008, EAR HEARING, V29, P618, DOI 10.1097/AUD.0b013e318174e787; Debener S, 2008, PSYCHOPHYSIOLOGY, V45, P20, DOI 10.1111/j.1469-8986.2007.00610.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Drennan WR, 2008, J REHABIL RES DEV, V45, P779, DOI 10.1682/JRRD.2007.08.0118; Driscoll VD, 2009, J AM ACAD AUDIOL, V20, P71, DOI 10.3766/jaaa.20.1.7; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Galvin JJ, 2008, J ACOUST SOC AM, V124, pEL189, DOI 10.1121/1.2961171; Galvin JJ, 2009, J ACOUST SOC AM, V125, pEL98, DOI 10.1121/1.3062148; Gfeller K, 1998, J Am Acad Audiol, V9, P1; Gfeller K, 2005, EAR HEARING, V26, P237, DOI 10.1097/00003446-200506000-00001; Gfeller K, 2000, J Am Acad Audiol, V11, P390; Gfeller K, 2008, J AM ACAD AUDIOL, V19, P120, DOI 10.3766/jaaa.19.2.3; Gfeller Kate, 2002, J Am Acad Audiol, V13, P132; Giraud AL, 2001, AUDIOL NEURO-OTOL, V6, P381, DOI 10.1159/000046847; Heng J, 2011, HEARING RES, V280, P192, DOI 10.1016/j.heares.2011.05.017; IVERSON P, 1993, J ACOUST SOC AM, V94, P2595, DOI 10.1121/1.407371; Kelly AS, 2005, CLIN NEUROPHYSIOL, V116, P1235, DOI 10.1016/j.clinph.2005.02.011; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koelsch S, 2004, CLIN NEUROPHYSIOL, V115, P966, DOI 10.1016/j.clinph.2003.11.032; Kong YY, 2011, J SPEECH LANG HEAR R, V54, P981, DOI 10.1044/1092-4388(2010/10-0196); Kong YY, 2004, EAR HEARING, V25, P173, DOI 10.1097/01.AUD.0000120365.97792.2F; KRAUS N, 1993, HEARING RES, V65, P118, DOI 10.1016/0378-5955(93)90206-G; Leal MC, 2003, ACTA OTO-LARYNGOL, V123, P826, DOI 10.1080/00016480310000386; Limb CJ, 2012, OTOLARYNG CLIN N AM, V45, P129, DOI 10.1016/j.otc.2011.08.021; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; McDermott Hugh J, 2004, Trends Amplif, V8, P49, DOI 10.1177/108471380400800203; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1992, NEUROREPORT, V3, P493; Naatanen R, 2004, CLIN NEUROPHYSIOL, V115, P140, DOI 10.1016/j.clinph.2003.04.001; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Naatanen R, 2011, CLIN NEUROPHYSIOL; Naatanen R, 2011, PSYCHOPHYSIOLOGY, V48, P4, DOI 10.1111/j.1469-8986.2010.01114.x; Ollen J. E., 2006, CRITERION RELATED VA; Pakarinen S, 2009, BIOL PSYCHOL, V82, P219, DOI 10.1016/j.biopsycho.2009.07.008; Pressnitzer D, 2005, ANN NY ACAD SCI, V1060, P343, DOI 10.1196/annals.1360.050; Sandmann P, 2010, CLIN NEUROPHYSIOL, V121, P2070, DOI 10.1016/j.clinph.2010.04.032; Sandmann P, 2009, BRAIN, V132, P1967, DOI 10.1093/brain/awp034; SCHROGER E, 1994, ELECTROEN CLIN NEURO, V92, P140, DOI 10.1016/0168-5597(94)90054-X; Shahin A, 2003, J NEUROSCI, V23, P5545; Sharma Anu, 2006, Adv Otorhinolaryngol, V64, P66, DOI 10.1159/000094646; Stoody TM, 2011, PERCEPT MOTOR SKILL, V113, P268, DOI 10.2466/22.24.27.PMS.113.4.268-276; Terhaar J, 2011, PAIN, V152, P1796, DOI 10.1016/j.pain.2011.03.027; Torppa R, 2012, CLIN NEUROPHYSIOL; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tremblay KL, 2009, CLIN NEUROPHYSIOL, V120, P128, DOI 10.1016/j.clinph.2008.10.005; Viola FC, 2011, PSYCHOPHYSIOLOGY, V48, P1470, DOI 10.1111/j.1469-8986.2011.01224.x; Viola FC, 2012, HEARING RES, V284, P6, DOI 10.1016/j.heares.2011.12.010; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Weise A, 2012, BRAIN RES, V1464, P30, DOI 10.1016/j.brainres.2012.04.046; WINKLER I, 1990, PSYCHOPHYSIOLOGY, V27, P228, DOI 10.1111/j.1469-8986.1990.tb00374.x; Won JH, 2010, EAR HEARING, V31, P796, DOI 10.1097/AUD.0b013e3181e8b7bd; ZENG FG, 1994, J ACOUST SOC AM, V96, P2127, DOI 10.1121/1.410154; Zhang FW, 2011, HEARING RES, V275, P17, DOI 10.1016/j.heares.2010.11.007	60	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45375	10.1371/journal.pone.0045375	http://dx.doi.org/10.1371/journal.pone.0045375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23028971	Green Published, gold, Green Submitted			2022-12-27	WOS:000309392800042
J	Ceriani, SA; Roth, JD; Evans, DR; Weishampel, JF; Ehrhart, LM				Ceriani, Simona A.; Roth, James D.; Evans, Daniel R.; Weishampel, John F.; Ehrhart, Llewellyn M.			Inferring Foraging Areas of Nesting Loggerhead Turtles Using Satellite Telemetry and Stable Isotopes	PLOS ONE			English	Article							CARETTA-CARETTA; SEA-TURTLES; MARINE TURTLES; CHELONIA-MYDAS; MOVEMENT PATTERNS; HABITAT QUALITY; MIGRATION; TRACKING; ECOLOGY; CARBON	In recent years, the use of intrinsic markers such as stable isotopes to link breeding and foraging grounds of migratory species has increased. Nevertheless, several assumptions still must be tested to interpret isotopic patterns found in the marine realm. We used a combination of satellite telemetry and stable isotope analysis to (i) identify key foraging grounds used by female loggerheads nesting in Florida and (ii) examine the relationship between stable isotope ratios and post-nesting migration destinations. We collected tissue samples for stable isotope analysis from 14 females equipped with satellite tags and an additional 57 untracked nesting females. Telemetry identified three post-nesting migratory pathways and associated non-breeding foraging grounds: (1) a seasonal continental shelf-constrained migratory pattern along the northeast U. S. coastline, (2) a non-breeding residency in southern foraging areas and (3) a residency in the waters adjacent to the breeding area. Isotopic variability in both delta C-13 and delta N-15 among individuals allowed identification of three distinct foraging aggregations. We used discriminant function analysis to examine how well delta C-13 and delta N-15 predict female post-nesting migration destination. The discriminant analysis classified correctly the foraging ground used for all but one individual and was used to predict putative feeding areas of untracked turtles. We provide the first documentation that the continental shelf of the Mid-and South Atlantic Bights are prime foraging areas for a large number (61%) of adult female loggerheads from the largest loggerhead nesting population in the western hemisphere and the second largest in the world. Our findings offer insights for future management efforts and suggest that this technique can be used to infer foraging strategies and residence areas in lieu of more expensive satellite telemetry, enabling sample sizes that are more representative at the population level.	[Ceriani, Simona A.; Weishampel, John F.; Ehrhart, Llewellyn M.] Univ Cent Florida, Marine Turtle Res Grp, Orlando, FL 32816 USA; [Ceriani, Simona A.; Weishampel, John F.; Ehrhart, Llewellyn M.] Univ Cent Florida, Dept Biol Sci, Orlando, FL 32816 USA; [Roth, James D.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Evans, Daniel R.] Sea Turtle Conservancy, Gainesville, FL USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; University of Manitoba	Ceriani, SA (corresponding author), Univ Cent Florida, Marine Turtle Res Grp, Orlando, FL 32816 USA.	simona.ceriani@gmail.com	Roth, James/N-4178-2016	Roth, James/0000-0002-0296-2786	Sea Turtle Grants Program [09-055R, 10-020R, 10-023R]; Florida Sea Turtle License Plate; Disney's Animal Programs; Brevard County; Florida Fish and Wildlife Conservation Commission; United States Fish and Wildlife Service; United States National Marine Fisheries Service	Sea Turtle Grants Program; Florida Sea Turtle License Plate; Disney's Animal Programs; Brevard County; Florida Fish and Wildlife Conservation Commission; United States Fish and Wildlife Service(US Fish & Wildlife Service); United States National Marine Fisheries Service	This work was supported by several grants awarded from the Sea Turtle Grants Program (09-055R, 10-020R, 10-023R). The Sea Turtle Grants Program is funded from proceeds from the sale of the Florida Sea Turtle License Plate. Learn more at www.helpingseaturtles.org. Additional funding was provided by Disney's Animal Programs. Sea turtle monitoring at the Archie Carr National Wildlife Refuge was coordinated through the University of Central Florida Marine Turtle Research Group, with funding from Brevard County, the Florida Fish and Wildlife Conservation Commission, the United States Fish and Wildlife Service, and the United States National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt MD, 2012, MAR BIOL, V159, P101, DOI 10.1007/s00227-011-1793-5; Bentaleb I, 2011, MAR ECOL PROG SER, V438, P285, DOI 10.3354/meps09269; Bjorndal Karen A., 1997, P199; Bolten A.B., 2003, LOGGERHEAD SEA TURTL, P63; Bolten AB, 2011, FRONT ECOL ENVIRON, V9, P295, DOI 10.1890/090126; BRACE KC, 1955, AM J PHYSIOL, V183, P91, DOI 10.1152/ajplegacy.1955.183.1.91; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Brower LP, 2002, CONSERV BIOL, V16, P346, DOI 10.1046/j.1523-1739.2002.00572.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Casciotti KL, 2001, ENCY OCEAN SCI, P1884, DOI [10.1006/rwos.2001.0172, DOI 10.1006/RWOS.2001.0172]; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Clementz MT, 2001, OECOLOGIA, V129, P461, DOI 10.1007/s004420100745; CMS Medicare Program, 2011, FED REG, V76, P26490; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dodd C.K., 1988, US FISH WILDLIFE SER, V88, P110; Dodd C. Kenneth Jr, 2003, Chelonian Conservation and Biology, V4, P530; Dodge KL, 2011, MAR BIOL, P1; Ehrhart L.M., 2003, LOGGERHEAD SEA TURTL, P157; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; Fennel K, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002456; Florida Fish and Wildlife Conservation Commission, 2011, TRENDS NEST FLOR LOG; Foley A., 2008, P 25 ANN S SEA TURTL, P75; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Girard C, 2009, MAR BIOL, V156, P1827, DOI 10.1007/s00227-009-1216-z; Godley BJ, 1998, MAR ECOL PROG SER, V166, P277, DOI 10.3354/meps166277; GOERICKE R, 1994, GLOBAL BIOGEOCHEM CY, V8, P85, DOI 10.1029/93GB03272; Gonzalez-Solis J, 2011, MAR ECOL PROG SER, V435, P251, DOI 10.3354/meps09233; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hatase H, 2002, MAR ECOL PROG SER, V233, P273, DOI 10.3354/meps233273; Hatch J.J., 2002, BIRDS N AM; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hopkins-Murphy SR, 2003, LOGGERHEAD SEA TURTL, P79; IUCN, 2012, IUCN RED LIST THREAT; Jaeger A, 2010, RAPID COMMUN MASS SP, V24, P3456, DOI 10.1002/rcm.4792; Johnson Craig R., 1993, Oceanography and Marine Biology an Annual Review, V31, P177; LAWSON PW, 1993, FISHERIES, V18, P6, DOI 10.1577/1548-8446(1993)018<0006:CIOPTI>2.0.CO;2; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; Logan JM, 2011, MAR BIOL, V158, P73, DOI 10.1007/s00227-010-1543-0; Roscales JL, 2011, MAR ECOL PROG SER, V434, P1, DOI 10.3354/meps09211; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; McClellan CM, 2007, BIOLOGY LETT, V3, P592, DOI 10.1098/rsbl.2007.0355; McClellan CM, 2010, J EXP MAR BIOL ECOL, V387, P44, DOI 10.1016/j.jembe.2010.02.020; McKinney RA, 2010, ESTUAR COAST SHELF S, V89, P287, DOI 10.1016/j.ecss.2010.08.004; McMahon KW, LIMNOL OCEA IN PRESS; MEYLAN AB, 1983, BIOL CONSERV, V26, P79, DOI 10.1016/0006-3207(83)90050-2; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Moncada F, 2006, J HERPETOL, V40, P22, DOI 10.1670/39-05A.1; Moncada F., 2010, Endangered Species Research, V11, P61, DOI 10.3354/esr00248; Montoya JP, 2007, BIOGEOSCIENCES, V4, P369, DOI 10.5194/bg-4-369-2007; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; National Marine Fisheries Service U.S. Fish Wildlife Service, 2008, REC PLAN NW ATL POP; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; OWENS DW, 1980, HERPETOLOGICA, V36, P17; Pajuelo M, 2012, MAR BIOL, P1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Plotkin PT, 2002, ORYX, V36, P396, DOI 10.1017/S0030605302000753; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Ramos R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006236; Rappole JH, 2003, ECOL APPL, V13, P735, DOI 10.1890/1051-0761(2003)013[0735:WVBLFA]2.0.CO;2; RAPPOLE JH, 1994, AUK, V111, P652; Reich KJ, 2008, OECOLOGIA, V155, P651, DOI 10.1007/s00442-007-0949-y; Reich KJ, 2010, MAR BIOL, V157, P113, DOI 10.1007/s00227-009-1300-4; Revelles M, 2008, SCI MAR, V72, P511; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; SAKAMOTO W, 1990, NIPPON SUISAN GAKK, V56, P1435; Schroeder B.A., 2003, LOGGERHEAD SEA TURTL, P114; Seminoff JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037403; Takai N, 2000, J MAR BIOL ASSOC UK, V80, P675, DOI 10.1017/S0025315400002502; Troeng S, 2005, MAR BIOL, V148, P435, DOI 10.1007/s00227-005-0076-4; Turtle Expert Working Group, 2009, NMFSSEFSC575 NOAA TU; Urquhart FA., 1960, MONARCH BUTTERFLY; Vander Zanden HB, 2010, BIOL LETTERS, V6, P711, DOI 10.1098/rsbl.2010.0124; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1; Witteveen BH, 2009, MAR ECOL PROG SER, V393, P173, DOI 10.3354/meps08231; Zbinden JA, 2008, MAR BIOL, V153, P899, DOI 10.1007/s00227-007-0862-2; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871	87	64	64	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45335	10.1371/journal.pone.0045335	http://dx.doi.org/10.1371/journal.pone.0045335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028943	gold, Green Published			2022-12-27	WOS:000309388900042
J	Merabet, LB; Connors, EC; Halko, MA; Sanchez, J				Merabet, Lotfi B.; Connors, Erin C.; Halko, Mark A.; Sanchez, Jaime			Teaching the Blind to Find Their Way by Playing Video Games	PLOS ONE			English	Article							PERCEPTION; NAVIGATION; VISION; PEOPLE	Computer based video games are receiving great interest as a means to learn and acquire new skills. As a novel approach to teaching navigation skills in the blind, we have developed Audio-based Environment Simulator (AbES); a virtual reality environment set within the context of a video game metaphor. Despite the fact that participants were naive to the overall purpose of the software, we found that early blind users were able to acquire relevant information regarding the spatial layout of a previously unfamiliar building using audio based cues alone. This was confirmed by a series of behavioral performance tests designed to assess the transfer of acquired spatial information to a large-scale, real-world indoor navigation task. Furthermore, learning the spatial layout through a goal directed gaming strategy allowed for the mental manipulation of spatial information as evidenced by enhanced navigation performance when compared to an explicit route learning strategy. We conclude that the immersive and highly interactive nature of the software greatly engages the blind user to actively explore the virtual environment. This in turn generates an accurate sense of a large-scale three-dimensional space and facilitates the learning and transfer of navigation skills to the physical world.	[Merabet, Lotfi B.; Connors, Erin C.] Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA; [Halko, Mark A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Dept Neurol,Med Sch, Boston, MA 02215 USA; [Sanchez, Jaime] Univ Chile, Dept Comp Sci, Santiago, Chile; [Sanchez, Jaime] Univ Chile, CARE, Santiago, Chile	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Universidad de Chile; Universidad de Chile	Merabet, LB (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA.	lotfi_merabet@meei.harvard.edu	Merabet, Lotfi B./V-2735-2017; merabet, lotfi/AAU-8259-2020; Halko, Mark A./G-8633-2016; , CIAE/R-5423-2017	Merabet, Lotfi B./0000-0002-8094-9536; merabet, lotfi/0000-0002-8094-9536; Halko, Mark A./0000-0002-7427-0789; 	National Institutes of Health/National Eye Institute [RO1 EY019924]; NATIONAL EYE INSTITUTE [R01EY019924] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health/National Eye Institute grant RO1 EY019924 to LBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMEAD DH, 1989, PERCEPT PSYCHOPHYS, V46, P425, DOI 10.3758/BF03210857; Bavelier D, 2011, NAT REV NEUROSCI, V12, P763, DOI 10.1038/nrn3135; Bavelier D, 2010, NEURON, V67, P692, DOI 10.1016/j.neuron.2010.08.035; Blasch B. B., 1997, FDN ORIENTATION MOBI; Cattaneo Z, 2008, NEUROSCI BIOBEHAV R, V32, P1346, DOI 10.1016/j.neubiorev.2008.05.002; Chebat DR, 2011, NEUROREPORT, V22, P342, DOI 10.1097/WNR.0b013e3283462def; Dede C, 2009, SCIENCE, V323, P66, DOI 10.1126/science.1167311; Fortin M, 2008, BRAIN, V131, P2995, DOI 10.1093/brain/awn250; Gagnon L, 2012, NEUROPSYCHOLOGIA, V50, P1663, DOI 10.1016/j.neuropsychologia.2012.03.022; Giudice NA, 2007, PSYCHOL RES-PSYCH FO, V71, P347, DOI 10.1007/s00426-006-0089-8; Johnson Lise A, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P6289; Kalia AA, 2010, J VISUAL IMPAIR BLIN, V104, P135, DOI 10.1177/0145482X1010400303; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; Lahav O, 2011, DISABILITY REHABILIT; Lahav O, 2006, CYBERPSYCHOL BEHAV, V9, P174, DOI 10.1089/cpb.2006.9.174; Lange B, 2012, DISABILITY REHABILIT; LEDERMAN SJ, 1985, J EXP PSYCHOL GEN, V114, P33, DOI 10.1037/0096-3445.114.1.33; Loomis JM, 2001, OPTOMETRY VISION SCI, V78, P282, DOI 10.1097/00006324-200105000-00011; Merabet L. B., 2009, AER J RES PRACTICE V, V2, P128; Shaffer DW, 2005, PHI DELTA KAPPAN, V87, P104, DOI 10.1177/003172170508700205; Siegel A W, 1975, Adv Child Dev Behav, V10, P9, DOI 10.1016/S0065-2407(08)60007-5; STRELOW ER, 1985, PSYCHOL REV, V92, P226, DOI 10.1037/0033-295X.92.2.226; ThinusBlanc C, 1997, PSYCHOL BULL, V121, P20, DOI 10.1037/0033-2909.121.1.20; von Senden M., 1960, SPACE SIGHT PERCEPTI; Wolbers T, 2011, CURR BIOL, V21, P984, DOI 10.1016/j.cub.2011.04.038	25	50	50	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44958	10.1371/journal.pone.0044958	http://dx.doi.org/10.1371/journal.pone.0044958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23028703	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388400054
J	Carmona-Mora, P; Canales, CP; Cao, L; Perez, IC; Srivastava, AK; Young, JI; Walz, K				Carmona-Mora, Paulina; Canales, Cesar P.; Cao, Lei; Perez, Irene C.; Srivastava, Anand K.; Young, Juan I.; Walz, Katherina			RAI1 Transcription Factor Activity Is Impaired in Mutants Associated with Smith-Magenis Syndrome	PLOS ONE			English	Article							ACID-INDUCED 1; 17P11.2 DELETIONS; GENE; MUTATIONS; PHENOTYPE; PHD; AUTISM; DUP(17)(P11.2P11.2); IDENTIFICATION; SCHIZOPHRENIA	Smith-Magenis Syndrome (SMS) is a complex genomic disorder mostly caused by the haploinsufficiency of the Retinoic Acid Induced 1 gene (RAI1), located in the chromosomal region 17p11.2. In a subset of SMS patients, heterozygous mutations in RAI1 are found. Here we investigate the molecular properties of these mutated forms and their relationship with the resulting phenotype. We compared the clinical phenotype of SMS patients carrying a mutation in RAI1 coding region either in the N-terminal or the C-terminal half of the protein and no significant differences were found. In order to study the molecular mechanism related to these two groups of RAI1 mutations first we analyzed those mutations that result in the truncated protein corresponding to the N-terminal half of RAI1 finding that they have cytoplasmic localization (in contrast to full length RAI1) and no ability to activate the transcription through an endogenous target: the BDNF enhancer. Similar results were found in lymphoblastoid cells derived from a SMS patient carrying RAI1 c.3103insC, where both mutant and wild type products of RAI1 were detected. The wild type form of RAI1 was found in the chromatin bound and nuclear matrix subcellular fractions while the mutant product was mainly cytoplasmic. In addition, missense mutations at the C-terminal half of RAI1 presented a correct nuclear localization but no activation of the endogenous target. Our results showed for the first time a correlation between RAI1 mutations and abnormal protein function plus they suggest that a reduction of total RAI1 transcription factor activity is at the heart of the SMS clinical presentation.	[Carmona-Mora, Paulina; Canales, Cesar P.; Perez, Irene C.; Young, Juan I.; Walz, Katherina] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Cao, Lei; Young, Juan I.; Walz, Katherina] Univ Miami, Miller Sch Med, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL 33136 USA; [Srivastava, Anand K.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Srivastava, Anand K.] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Walz, Katherina] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami; Greenwood Genetic Center; Clemson University; University of Miami	Walz, K (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	kwalz@med.miami.edu	Carmona-Mora, Paulina/H-9055-2019	Carmona-Mora, Paulina/0000-0001-8560-1232	Le Jerome Foundation	Le Jerome Foundation	This work was supported in part by Le Jerome Foundation (KW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bi W, 2006, AM J MED GENET A, V140A, P2454, DOI 10.1002/ajmg.a.31510; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Burns B, 2010, HUM MOL GENET, V19, P4026, DOI 10.1093/hmg/ddq317; Carmona-Mora P, 2010, CURR GENOMICS, V11, P607, DOI 10.2174/138920210793360952; Carmona-Mora P, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-63; Darvekar S, 2012, BIOCHEM J, V442, P65, DOI 10.1042/BJ20111230; Edelman EA, 2007, CLIN GENET, V71, P540, DOI 10.1111/j.1399-0004.2007.00815.x; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Girirajan S, 2009, CLIN GENET, V75, P364, DOI 10.1111/j.1399-0004.2008.01135.x; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; Gropman AL, 2007, CURR OPIN NEUROL, V20, P125, DOI 10.1097/WCO.0b013e3280895dba; Hayes S, 2000, HUM MOL GENET, V9, P1753, DOI 10.1093/hmg/9.12.1753; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Joober R, 1999, AM J MED GENET, V88, P694, DOI 10.1002/(SICI)1096-8628(19991215)88:6<694::AID-AJMG20>3.3.CO;2-9; Juyal RC, 1996, AM J HUM GENET, V58, P998; Laje G, 2010, AM J MED GENET C, V154C, P456, DOI 10.1002/ajmg.c.30275; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; Peng J, 2008, TRENDS BIOCHEM SCI, V33, P191, DOI 10.1016/j.tibs.2008.02.003; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Seranski P, 2001, GENE, V270, P69, DOI 10.1016/S0378-1119(01)00415-2; SILVER PA, 1984, P NATL ACAD SCI-BIOL, V81, P5951, DOI 10.1073/pnas.81.19.5951; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; Truong HT, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-142; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Vieira GH, 2012, EUR J HUM GENET, V20, P148, DOI 10.1038/ejhg.2011.167; Vilboux T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022861; Vlangos CN, 2003, MOL GENET METAB, V79, P134, DOI 10.1016/S1096-7192(03)00048-9; Walz K, 2006, J CLIN INVEST, V116, P3035, DOI 10.1172/JCI28953; Zhang F, 2010, AM J HUM GENET, V86, P462, DOI 10.1016/j.ajhg.2010.02.001	36	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45155	10.1371/journal.pone.0045155	http://dx.doi.org/10.1371/journal.pone.0045155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028815	gold, Green Submitted, Green Published			2022-12-27	WOS:000311313900086
J	Duarte, S; Seena, S; Barlocher, F; Cassio, F; Pascoal, C				Duarte, Sofia; Seena, Sahadevan; Baerlocher, Felix; Cassio, Fernanda; Pascoal, Claudia			Preliminary Insights into the Phylogeography of Six Aquatic Hyphomycete Species	PLOS ONE			English	Article							GENETIC DIVERSITY; RECOGNITION; COMMUNITIES; CONFIDENCE; LIMITS	Aquatic hyphomycetes occur worldwide on a wide range of plant substrates decomposing in freshwaters, and are known to play a key role in organic matter turnover. The presumed worldwide distribution of many aquatic hyphomycete species has been based on morphology-based taxonomy and identification, which may overlook cryptic species, and mask global-scale biogeographical patterns. This might be circumvented by using DNA sequence data. The internal transcribed spacer (ITS) region from rDNA was recently designated as the most suitable barcode for fungal identification. In this study, we generated ITS barcodes of 130 isolates belonging to 6 aquatic hyphomycete species (Anguillospora filiformis, Flagellospora penicillioides, Geniculospora grandis, Lunulospora curvula, Tetrachaetum elegans and Tricladium chaetocladium), and collected from streams of Southwest Europe (86 isolates) and East Australia (44 isolates). European and Australian populations of 4 species (A. filiformis, F. penicillioides, G. grandis and T. elegans) grouped into different clades, and molecular diversity indices supported significant differentiation. Continents did not share haplotypes, except for T. chaetocladium. Overall results show substantial population diversity for all tested species and suggests that the biogeography of aquatic hyphomycetes may be species-specific.	[Duarte, Sofia; Seena, Sahadevan; Cassio, Fernanda; Pascoal, Claudia] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal; [Baerlocher, Felix] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada	Universidade do Minho; Mount Allison University	Duarte, S (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Campus Gualtar, Braga, Portugal.	sduarte@bio.uminho.pt	Baerlocher, Felix/C-1307-2011; Cassio, Fernanda/A-6653-2011; Duarte, Sofia/H-3323-2013; Pascoal, Claudia/C-4072-2009; Duarte, Sofia/ABD-8278-2021	Baerlocher, Felix/0000-0003-2404-625X; Cassio, Fernanda/0000-0003-3924-3280; Duarte, Sofia/0000-0002-0181-0676; Pascoal, Claudia/0000-0002-2018-4201; Duarte, Sofia/0000-0002-0181-0676; sahadevan, seena/0000-0002-5598-4794	European Regional Development Fund - Operational Competitiveness Programme (FEDER-POFC-COMPETE); Portuguese Foundation for Science and Technology; Natural Sciences and Engineering Research Council of Canada (NSERC);  [PEst-C/BIA/UI4050/2011];  [PTDC/AAC-AMB/113746/2009];  [SFRH/BPD/47574/2008]; Fundação para a Ciência e a Tecnologia [PTDC/AAC-AMB/113746/2009] Funding Source: FCT	European Regional Development Fund - Operational Competitiveness Programme (FEDER-POFC-COMPETE); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); ; ; ; Fundação para a Ciência e a Tecnologia	The European Regional Development Fund - Operational Competitiveness Programme (FEDER-POFC-COMPETE) and the Portuguese Foundation for Science and Technology supported this study (PEst-C/BIA/UI4050/2011 and PTDC/AAC-AMB/113746/2009) and SD (SFRH/BPD/47574/2008). The Natural Sciences and Engineering Research Council of Canada (NSERC) also supported this study and FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015908; Baas-Becking LGM, 1934, GEOBILOGIE INLEIDING; Barlocher F, 2009, MYCOSCIENCE, V50, P3, DOI 10.1007/s10267-008-0449-x; Baerlocher Felix, 2011, Czech Mycology, V63, P113; Barlocher F, 2010, J N AM BENTHOL SOC, V29, P1027, DOI 10.1899/09-081.1; Barlocher F, 2010, FUNGAL ECOL, V3, P115, DOI 10.1016/j.funeco.2009.08.003; Barlocher F, 2010, ASSESSMENT SPECIES D; Barlocher F, 2006, MICROBIAL ROOT ENDOP; BARLOCHER F, 1992, ECOLOGY AQUATIC HYPH; BARLOCHER F, 2005, FUNGAL COMMUNITY ITS, P39, DOI DOI 10.1201/9781420027891.CH3; Baschien C, 2006, NOVA HEDWIGIA, V83, P311, DOI 10.1127/0029-5035/2006/0083-0311; Belliveau MJR, 2005, MYCOL RES, V109, P1407, DOI 10.1017/S0953756205004119; Braha B, 2007, BIOMETALS, V20, P93, DOI 10.1007/s10534-006-9018-y; BROWN JKM, 1991, P ROY SOC B-BIOL SCI, V246, P83, DOI 10.1098/rspb.1991.0128; Charcosset JY, 1999, MYCOL RES, V103, P736, DOI 10.1017/S0953756298007606; Dettman JR, 2006, MYCOLOGIA, V98, P436, DOI 10.3852/mycologia.98.3.436; Edwards Robert A, 2006, BMC Genomics, V7, P57; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fernandes I, 2011, OECOLOGIA, V166, P1019, DOI 10.1007/s00442-011-1930-3; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Gessner M. O., 2007, P301; Hibbett DS, 2001, J BIOGEOGR, V28, P231, DOI 10.1046/j.1365-2699.2001.00528.x; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; IQBAL SH, 1995, CAN J BOT, V73, P538, DOI 10.1139/b95-055; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krauss GJ, 2011, FEMS MICROBIOL REV, V35, P620, DOI 10.1111/j.1574-6976.2011.00266.x; Lachance MA, 2004, BIOSCIENCE, V54, P884, DOI 10.1641/0006-3568(2004)054[0884:HATOE]2.0.CO;2; Laitung B, 2004, MOL ECOL, V13, P1679, DOI 10.1111/j.1365-294X.2004.02135.x; Letourneau A, 2010, FUNGAL DIVERS, V40, P51, DOI 10.1007/s13225-009-0006-8; Martin R, 2011, AZORES FINEST WALKS; Nikolcheva Liliya G., 2002, Czech Mycology, V53, P285; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Pascoal C, 2005, FUNGAL DIVERS, V19, P109; Pegler D.N., 1983, SYDOWIA, V36, P227; RANZONI FV, 1979, MYCOLOGIA, V71, P786, DOI 10.2307/3759189; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035884; Seena S, 2010, FUNGAL DIVERS, V44, P77, DOI 10.1007/s13225-010-0056-y; Shearer CA, 2007, BIODIVERS CONSERV, V16, P49, DOI 10.1007/s10531-006-9120-z; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vijaykrishna D, 2006, FUNGAL DIVERS, V23, P351; Watson I. A., 1983, Proceedings of the Linnean Society of New South Wales, V106, P311; WEBSTER J, 1991, NOVA HEDWIGIA, V52, P65; Webster J, 1992, ECOLOGY AQUATIC HYPH; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WOODEGGENSCHWIL.S, 1985, VERH INT VER THEOR A, V22, P2780, DOI DOI 10.1080/03680770.1983.11897774	54	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45289	10.1371/journal.pone.0045289	http://dx.doi.org/10.1371/journal.pone.0045289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028909	Green Submitted, Green Published, gold			2022-12-27	WOS:000311313900114
J	Ichimura, K; Bubenshchikova, E; Powell, R; Fukuyo, Y; Nakamura, T; Tran, U; Oda, S; Tanaka, M; Wessely, O; Kurihara, H; Sakai, T; Obara, T				Ichimura, Koichiro; Bubenshchikova, Ekaterina; Powell, Rebecca; Fukuyo, Yayoi; Nakamura, Tomomi; Tran, Uyen; Oda, Shoji; Tanaka, Minoru; Wessely, Oliver; Kurihara, Hidetake; Sakai, Tatsuo; Obara, Tomoko			A Comparative Analysis of Glomerulus Development in the Pronephros of Medaka and Zebrafish	PLOS ONE			English	Article							NEWBORN RAT-KIDNEY; INTUSSUSCEPTIVE ANGIOGENESIS; ORYZIAS-LATIPES; EMBRYONIC-DEVELOPMENT; THY-1.1 NEPHRITIS; CAPILLARY GROWTH; RENAL CORPUSCLE; FOOT PROCESSES; PODOCYTES; DIFFERENTIATION	The glomerulus of the vertebrate kidney links the vasculature to the excretory system and produces the primary urine. It is a component of every single nephron in the complex mammalian metanephros and also in the primitive pronephros of fish and amphibian larvae. This systematic work highlights the benefits of using teleost models to understand the pronephric glomerulus development. The morphological processes forming the pronephric glomerulus are astoundingly different between medaka and zebrafish. (1) The glomerular primordium of medaka - unlike the one of zebrafish - exhibits a C-shaped epithelial layer. (2) The C-shaped primordium contains a characteristic balloon-like capillary, which is subsequently divided into several smaller capillaries. (3) In zebrafish, the bilateral pair of pronephric glomeruli is fused at the midline to form a glomerulus, while in medaka the two parts remain unmerged due to the interposition of the interglomerular mesangium. (4) Throughout pronephric development the interglomerular mesangial cells exhibit numerous cytoplasmic granules, which are reminiscent of renin-producing (juxtaglomerular) cells in the mammalian afferent arterioles. Our systematic analysis of medaka and zebrafish demonstrates that in fish, the morphogenesis of the pronephric glomerulus is not stereotypical. These differences need be taken into account in future analyses of medaka mutants with glomerulus defects.	[Ichimura, Koichiro; Bubenshchikova, Ekaterina; Powell, Rebecca; Fukuyo, Yayoi; Nakamura, Tomomi; Obara, Tomoko] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Ichimura, Koichiro; Kurihara, Hidetake; Sakai, Tatsuo] Juntendo Univ, Sch Med, Dept Anat & Life Struct, Tokyo 113, Japan; [Nakamura, Tomomi] Tokyo Univ Sci, Dept Biol Sci & Technol, Grad Sch Ind Sci & Technol, Noda, Chiba 278, Japan; [Tran, Uyen; Wessely, Oliver] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Oda, Shoji] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Tanaka, Minoru] Natl Inst Basic Biol, Lab Mol Genet Reprod, Okazaki, Aichi, Japan	University of Oklahoma System; University of Oklahoma Health Sciences Center; Juntendo University; Tokyo University of Science; Cleveland Clinic Foundation; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Obara, T (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA.	tomoko-obara@ouhsc.edu		TANAKA, MINORU/0000-0001-9100-1487	University of Oklahoma Health Science Center (OUHSC); Ministry of Education, Culture, Sports, Science and Technology of Japan [23590226]; NIH [R21-DK069604, R01-DK078209]; NIH/NIDDK [7R01DK080745-03]; DMEI/NEI Image Acquisition Core Facility at the OUHSC [NIH: P30-EY12190, COBRE-P20 RR017703]; MetroHealth Medical Center; Diabetes Histology and Image Acquisition and Analysis Core Facility at OUHSC [NIH: COBRE-1P20RR024215]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024215, P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069604, R01DK080745, R01DK078209] Funding Source: NIH RePORTER	University of Oklahoma Health Science Center (OUHSC); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DMEI/NEI Image Acquisition Core Facility at the OUHSC; MetroHealth Medical Center; Diabetes Histology and Image Acquisition and Analysis Core Facility at OUHSC; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	TO acknowledges financial support from the University of Oklahoma Health Science Center (OUHSC) and MetroHealth Medical Center. KI was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 23590226). TO was supported by NIH grants R21-DK069604, and R01-DK078209. OW is supported by a grant from NIH/NIDDK (7R01DK080745-03). This work is supported in part by the DMEI/NEI Image Acquisition Core Facility at the OUHSC (NIH: P30-EY12190, COBRE-P20 RR017703) and in part by the Diabetes Histology and Image Acquisition and Analysis Core Facility at OUHSC (NIH: COBRE-1P20RR024215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL S, 1988, Journal of Animal Morphology and Physiology, V35, P17; Burlend TH, 1913, ZOOL JB, V26, P1; Burri PH, 2004, DEV DYNAM, V231, P474, DOI 10.1002/dvdy.20184; BURRI PH, 1990, ANAT REC, V228, P35, DOI 10.1002/ar.1092280107; DAVIS LE, 1976, J MORPHOL, V149, P279, DOI 10.1002/jmor.1051490302; DITRICH H, 1992, J MORPHOL, V213, P335, DOI 10.1002/jmor.1052130306; Djonov V, 2003, CELL TISSUE RES, V314, P107, DOI 10.1007/s00441-003-0784-3; Djonov V, 2000, CIRC RES, V86, P286, DOI 10.1161/01.RES.86.3.286; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Elger M, 1998, Adv Anat Embryol Cell Biol, V139, P1; Fedorova S, 2008, DEV DYNAM, V237, P2342, DOI 10.1002/dvdy.21687; Hall TE, 2004, J MORPHOL, V259, P255, DOI 10.1002/jmor.10222; Hashimoto H, 2011, MEDAKA: A MODEL FOR ORGANOGENESIS, HUMAN DISEASE, AND EVOLUTION, P111, DOI 10.1007/978-4-431-92691-7_8; Hashimoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006299; Hauptmann G, 2000, METH MOL B, V137, P139; Hiruma T, 2003, J ANAT, V203, P539, DOI 10.1046/j.1469-7580.2003.00245.x; Holstvoogd C, 1936, THESIS U AMSTERDAM; Howland RB, 1916, P NATL ACAD SCI USA, V2, P231, DOI 10.1073/pnas.2.4.231; Ichimura K, 2007, CELL TISSUE RES, V329, P541, DOI 10.1007/s00441-007-0440-4; Ichimura K, 2006, J HISTOCHEM CYTOCHEM, V54, P1291, DOI 10.1369/jhc.6A7000.2006; Ichimura K, 2010, CELL TISSUE RES, V341, P197, DOI 10.1007/s00441-010-0983-7; Ichimura K, 2009, ARCH HISTOL CYTOL, V72, P165, DOI 10.1679/aohc.72.165; Inokuchi S, 1998, VIRCHOWS ARCH, V433, P349, DOI 10.1007/s004280050259; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Jollie M, 1973, CHORDATE MORPHOLOGY; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kobayashi T, 2009, NEPHRON EXP NEPHROL, V113, pE89, DOI 10.1159/000235245; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Kriz W, 2003, J AM SOC NEPHROL, V14, P1904, DOI 10.1097/01.ASN.0000070073.79690.57; Kriz W, 2007, SELDIN GIEBISCHS KID, V1, P479; Majumdar A, 1999, DEV GENET, V24, P220, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<220::AID-DVG5>3.3.CO;2-T; Majumdar A, 2000, DEV BIOL, V222, P147, DOI 10.1006/dbio.2000.9642; MESEGUER J, 1987, CELL TISSUE RES, V248, P381; Mobjerg N, 2004, J MORPHOL, V262, P583, DOI 10.1002/jmor.10244; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; NADKARNI V. B., 1966, ACTA ZOOL [STOCKHOLM], V47, P201; NAITO I, 1984, ARCH HISTOL JAPON, V47, P441, DOI 10.1679/aohc.47.441; Nakamura S, 2006, DEV BIOL, V295, P678, DOI 10.1016/j.ydbio.2006.03.052; Neal CR, 2005, J AM SOC NEPHROL, V16, P1223, DOI 10.1681/ASN.2004100822; Nebel C, 2005, ANAT EMBRYOL, V209, P193, DOI 10.1007/s00429-004-0438-6; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Notoya M, 2003, KIDNEY INT, V63, P1365, DOI 10.1046/j.1523-1755.2003.00876.x; Ojeda JL, 2006, ANAT REC PART A, V288A, P609, DOI 10.1002/ar.a.20333; Oshima Y, 2011, J AM SOC NEPHROL, V22, P2203, DOI 10.1681/ASN.2011020202; Owen BB, 1938, BIOL BULL-US, V74, P349, DOI 10.2307/1537809; PATAN S, 1992, ARCH HISTOL CYTOL, V55, P65, DOI 10.1679/aohc.55.Suppl_65; REEVES W, 1978, LAB INVEST, V39, P90; REEVES WH, 1980, J CELL BIOL, V85, P735, DOI 10.1083/jcb.85.3.735; Saxen L., 1987, ORGANOGENESIS KIDNEY; SCHNABEL E, 1989, EUR J CELL BIOL, V48, P313; SCHWARZ R, 1981, ZBL VET MED C, V10, P167; SENOO A, 1978, STAIN TECHNOL, V53, P123, DOI 10.3109/10520297809111454; Serluca FC, 2001, DEVELOPMENT, V128, P2233; Stroer WFH, 1923, Q J MICROSC SCI, V75, P557; Takahashi-Iwanaga H, 2002, MICROSC RES TECHNIQ, V57, P196, DOI 10.1002/jemt.10073; TYTLER P, 1988, J MORPHOL, V195, P189, DOI 10.1002/jmor.1051950206; Tytler P, 1996, MAR FRESHW BEHAV PHY, V28, P3, DOI 10.1080/10236249609378975; Vize PD, 1997, DEV BIOL, V188, P189, DOI 10.1006/dbio.1997.8629; Watanabe N, 2009, DEV GROWTH DIFFER, V51, P135, DOI 10.1111/j.1440-169X.2009.01090.x; Wessely O, 2008, FRONT BIOSCI-LANDMRK, V13, P1866, DOI 10.2741/2806; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White JT, 2010, DEVELOPMENT, V137, P1863, DOI 10.1242/dev.042887; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Wnuk M, 2011, AM J PATHOL, V178, P1899, DOI 10.1016/j.ajpath.2010.12.049; YOUSON JH, 1970, AM J ANAT, V127, P207, DOI 10.1002/aja.1001270302; ZUASTI A, 1983, CELL TISSUE RES, V228, P99	70	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45286	10.1371/journal.pone.0045286	http://dx.doi.org/10.1371/journal.pone.0045286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028906	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900113
J	Peixoto-Santos, JE; Galvis-Alonso, OY; Velasco, TR; Kandratavicius, L; Assirati, JA; Carlotti, CG; Scandiuzzi, RC; Serafini, LN; Leite, JP				Peixoto-Santos, Jose Eduardo; Galvis-Alonso, Orfa Yineth; Velasco, Tonicarlo Rodrigues; Kandratavicius, Ludmyla; Assirati, Joao Alberto; Carlotti, Carlos Gilberto; Scandiuzzi, Renata Caldo; Serafini, Luciano Neder; Leite, Joao Pereira			Increased Metallothionein I/II Expression in Patients with Temporal Lobe Epilepsy	PLOS ONE			English	Article							ACID-INDUCED SEIZURES; CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL SCLEROSIS; BRAIN-INJURY; EXTRACELLULAR METALLOTHIONEINS; SYNAPTIC REORGANIZATION; OXIDATIVE STRESS; MOSSY FIBERS; ZINC; NEURONS	In the central nervous system, zinc is released along with glutamate during neurotransmission and, in excess, can promote neuronal death. Experimental studies have shown that metallothioneins I/II (MT-I/II), which chelate free zinc, can affect seizures and reduce neuronal death after status epilepticus. Our aim was to evaluate the expression of MT-I/II in the hippocampus of patients with temporal lobe epilepsy (TLE). Hippocampi from patients with pharmacoresistant mesial temporal lobe epilepsy (MTLE) and patients with TLE associated with tumor or dysplasia (TLE-TD) were evaluated for expression of MT-I/II, for the vesicular zinc levels, and for neuronal, astroglial, and microglial populations. Compared to control cases, MTLE group displayed widespread increase in MT-I/II expression, astrogliosis, microgliosis and reduced neuronal population. In TLE-TD, the same changes were observed, except that were mainly confined to fascia dentata. Increased vesicular zinc was observed only in the inner molecular layer of MTLE patients, when compared to control cases. Correlation and linear regression analyses indicated an association between increased MT-I/II and increased astrogliosis in TLE. MT-I/II levels did not correlate with any clinical variables, but MTLE patients with secondary generalized seizures (SGS) had less MT-I/II than MTLE patients without SGS. In conclusion, MT-I/II expression was increased in hippocampi from TLE patients and our data suggest that it is associated with astrogliosis and may be associated with different seizure spread patterns.	[Peixoto-Santos, Jose Eduardo; Velasco, Tonicarlo Rodrigues; Kandratavicius, Ludmyla; Scandiuzzi, Renata Caldo; Leite, Joao Pereira] Univ Sao Paulo, Dept Neurosci & Behav, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil; [Assirati, Joao Alberto; Carlotti, Carlos Gilberto] Univ Sao Paulo, Dept Neurosurg, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil; [Serafini, Luciano Neder] Univ Sao Paulo, Dept Pathol, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil; [Galvis-Alonso, Orfa Yineth] Sao Jose do Rio Preto Med Sch, Dept Mol Biol, Sao Jose Do Rio Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	Leite, JP (corresponding author), Univ Sao Paulo, Dept Neurosci & Behav, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil.	jpleite@fmrp.usp.br	Galvis-Alonso, Orfa Yineth/AAZ-7872-2021; Galvis-Alonso, Orfa Yineth/AAZ-4868-2021; Kandratavicius, Ludmyla/H-2494-2013; Velasco, Tonicarlo R/Q-2170-2016; Carlotti, Carlos G/C-1608-2012; Leite, Joao/B-9070-2012; Peixoto-Santos, Jose Eduardo/L-5123-2013	Galvis-Alonso, Orfa Yineth/0000-0002-1173-5200; Kandratavicius, Ludmyla/0000-0003-4387-5977; Velasco, Tonicarlo R/0000-0001-7756-8882; Carlotti, Carlos G/0000-0002-7055-0564; Leite, Joao/0000-0003-0558-3519; Peixoto-Santos, Jose Eduardo/0000-0001-7461-1902	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/56447-7, 2009/53447-7, 2008/52657-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, research grants 2005/56447-7 and 2009/53447-7 to JPL and master's grant 2008/52657-5 to JEPS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Amaral D., 2006, HIPPOCAMPUS BOOK, VVolume 1, P37, DOI DOI 10.1093/ACPROF:OSO/9780195100273.001.0001; Aschner M, 1997, TOXICOL APPL PHARM, V142, P229, DOI 10.1006/taap.1996.8054; BABB TL, 1984, EPILEPSIA, V25, P729, DOI 10.1111/j.1528-1157.1984.tb03484.x; BABB TL, 1991, NEUROSCIENCE, V42, P351, DOI 10.1016/0306-4522(91)90380-7; Berg AT, 2009, NEUROL CLIN, V27, P1003, DOI 10.1016/j.ncl.2009.06.001; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Brown CE, 2004, J COMP NEUROL, V479, P156, DOI 10.1002/cne.20308; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Colvin RA, 2003, EUR J PHARMACOL, V479, P171, DOI 10.1016/j.ejphar.2003.08.067; Crespel A, 2002, BRAIN RES, V952, P159, DOI 10.1016/S0006-8993(02)03050-0; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; Dominguez MI, 2006, EPILEPSIA, V47, P887, DOI 10.1111/j.1528-1167.2006.00501.x; Ebadi M, 2005, MOL BRAIN RES, V134, P67, DOI 10.1016/j.molbrainres.2004.09.011; EBADI M, 1995, NEUROCHEM INT, V27, P1, DOI 10.1016/0197-0186(94)00164-P; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Erickson JC, 1997, J NEUROSCI, V17, P1271; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Gomi F, 2005, BRAIN RES, V1033, P113, DOI 10.1016/j.brainres.2004.11.028; HAUG FMS, 1967, HISTOCHEMISTRY, V8, P355, DOI 10.1007/BF00401978; Hidalgo Juan, 2004, Environ Health Prev Med, V9, P87, DOI 10.1007/BF02898066; Kandratavicius L, 2012, PSYCHIAT RES, V195, P144, DOI 10.1016/j.psychres.2011.06.005; KILLE P, 1994, BBA-PROTEIN STRUCT M, V1205, P151, DOI 10.1016/0167-4838(94)90228-3; Kim EY, 1999, EUR J NEUROSCI, V11, P327, DOI 10.1046/j.1460-9568.1999.00437.x; KIM JH, 1990, ACTA NEUROPATHOL, V80, P41, DOI 10.1007/BF00294220; Kobayashi E, 2002, ARCH NEUROL-CHICAGO, V59, P1891, DOI 10.1001/archneur.59.12.1891; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; Lee JY, 2000, J NEUROSCI, V20; Leite JP, 2000, NEUROLOGY, V55, P1485, DOI 10.1212/WNL.55.10.1485; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Marijic VF, 2006, COMP BIOCHEM PHYS C, V143, P382, DOI 10.1016/j.cbpc.2005.05.019; MATHERN GW, 1994, DEV BRAIN RES, V78, P70, DOI 10.1016/0165-3806(94)90011-6; MATHERN GW, 1995, J NEUROSURG, V82, P228, DOI 10.3171/jns.1995.82.2.0228; Mathern GW, 1996, NEUROREPORT, V7, P1029, DOI 10.1097/00001756-199604100-00015; MATHERN GW, 1995, J NEUROSURG, V82, P211, DOI 10.3171/jns.1995.82.2.0211; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Mathern GW, 1996, EPILEPSY RES, V26, P151, DOI 10.1016/S0920-1211(96)00052-6; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Montpied P, 1998, NEUROREPORT, V9, P79, DOI 10.1097/00001756-199801050-00016; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; NISHIMURA N, 1992, J HISTOCHEM CYTOCHEM, V40, P309, DOI 10.1177/40.2.1552172; O'Dwyer R, 2007, EPILEPSIA, V48, P524, DOI 10.1111/j.1528-1167.2006.00967.x; Palumaa P, 2005, BBA-PROTEINS PROTEOM, V1747, P205, DOI 10.1016/j.bbapap.2004.11.007; Pazdernik TL, 2001, J APPL TOXICOL, V21, pS87, DOI 10.1002/jat.818; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Penkowa M, 2001, NEUROSCIENCE, V102, P805, DOI 10.1016/S0306-4522(00)00515-7; PerezClausell J, 1996, J CHEM NEUROANAT, V11, P99, DOI 10.1016/0891-0618(96)00131-7; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Pitkanen A, 2002, EPILEPSY RES, V50, P141, DOI 10.1016/S0920-1211(02)00076-1; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Prayson RA, 2007, ANN DIAGN PATHOL, V11, P22, DOI 10.1016/j.anndiagpath.2006.03.004; Proper EA, 2001, ACTA NEUROPATHOL, V101, P405; RASSENDREN FA, 1990, NEURON, V4, P733, DOI 10.1016/0896-6273(90)90199-P; Salanova V, 1999, PEDIATR NEUROL, V20, P179, DOI 10.1016/S0887-8994(98)00128-3; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Sonn K, 2010, J NEUROSCI RES, V88, P1074, DOI 10.1002/jnr.22281; Surges R, 2008, J NEUROL NEUROSUR PS, V79, P924, DOI 10.1136/jnnp.2007.129387; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; SUZUKI K, 1992, ACTA HISTOCHEM CYTOC, V25, P617, DOI 10.1267/ahc.25.617; Suzuki Keiji, 1994, Biological Signals, V3, P188; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Szabo CA, 2006, AM J NEURORADIOL, V27, P2155; Takeda A, 2006, BIOMETALS, V19, P565, DOI 10.1007/s10534-005-6145-9; Treiber C, 2005, SCI AGING KNOWLEDGE, V2005, pe27; WAALKES MP, 1984, TOXICOL APPL PHARM, V74, P314, DOI 10.1016/0041-008X(84)90284-9; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Wiese L, 2006, EXP NEUROL, V200, P216, DOI 10.1016/j.expneurol.2006.02.011; Zatta P, 2008, J CHEM NEUROANAT, V36, P1, DOI 10.1016/j.jchemneu.2008.02.008	78	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e44709	10.1371/journal.pone.0044709	http://dx.doi.org/10.1371/journal.pone.0044709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028585	gold, Green Published, Green Submitted			2022-12-27	WOS:000311313900036
J	Byrne, DP; Dart, C; Rigden, DJ				Byrne, Dominic P.; Dart, Caroline; Rigden, Daniel J.			Evaluating Caveolin Interactions: Do Proteins Interact with the Caveolin Scaffolding Domain through a Widespread Aromatic Residue-Rich Motif?	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; COUPLED RECEPTOR KINASES; INSULIN-RECEPTOR; FUNCTIONAL INTERACTION; TYROSINE KINASE; LIPID RAFTS; WEB SERVER; SUBCELLULAR-LOCALIZATION; SOLVENT ACCESSIBILITY; SECONDARY STRUCTURE	Caveolins are coat proteins of caveolae, small flask-shaped pits of the plasma membranes of most cells. Aside from roles in caveolae formation, caveolins recruit, retain and regulate many caveolae-associated signalling molecules. Caveolin-protein interactions are commonly considered to occur between a similar to 20 amino acid region within caveolin, the caveolin scaffolding domain (CSD), and an aromatic-rich caveolin binding motif (CBM) on the binding partner (phi X phi XXXX phi, phi XXXX phi XX phi or phi X phi XXXX phi XX phi, where phi is an aromatic and X an unspecified amino acid). The CBM resembles a typical linear motif - a short, simple sequence independently evolved many times in different proteins for a specific function. Here we exploit recent improvements in bioinformatics tools and in our understanding of linear motifs to critically examine the role of CBMs in caveolin interactions. We find that sequences conforming to the CBM occur in 30% of human proteins, but find no evidence for their statistical enrichment in the caveolin interactome. Furthermore, sequence- and structure-based considerations suggest that CBMs do not have characteristics commonly associated with true interaction motifs. Analysis of the relative solvent accessible area of putative CBMs shows that the majority of their aromatic residues are buried within the protein and are thus unlikely to interact directly with caveolin, but may instead be important for protein structural stability. Together, these findings suggest that the canonical CBM may not be a common characteristic of caveolin-target interactions and that interfaces between caveolin and targets may be more structurally diverse than presently appreciated.	[Byrne, Dominic P.; Dart, Caroline; Rigden, Daniel J.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Rigden, DJ (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	drigden@liv.ac.uk		Dart, Caroline/0000-0002-3509-8349; Rigden, Daniel/0000-0002-7565-8937	British Heart Foundation New Horizons Award [NH/11/2/28923]; British Heart Foundation [NH/11/2/28923] Funding Source: researchfish	British Heart Foundation New Horizons Award; British Heart Foundation(British Heart Foundation)	This work was supported by a British Heart Foundation New Horizons Award [grant number: NH/11/2/28923]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Adebiyi A, 2011, J BIOL CHEM, V286, P4341, DOI 10.1074/jbc.M110.179747; Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bilderback TR, 1999, J BIOL CHEM, V274, P257, DOI 10.1074/jbc.274.1.257; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boyanapalli M, 2006, BIOCHEM BIOPH RES CO, V340, P1200, DOI 10.1016/j.bbrc.2005.12.129; Brainard AM, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-131; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Burgermeister E, 2011, MOL CELL BIOL, V31, P3497, DOI 10.1128/MCB.01421-10; Cabrita MA, 2006, J BIOL CHEM, V281, P29201, DOI 10.1074/jbc.M603921200; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Caselli A, 2002, BIOCHEM BIOPH RES CO, V296, P692, DOI 10.1016/S0006-291X(02)00928-2; Caselli A, 2007, BIOCHEMISTRY-US, V46, P6383, DOI 10.1021/bi0620858; Cha SH, 2004, IUBMB LIFE, V56, P621, DOI 10.1080/15216540400020353; Chambaut-Guerin AM, 2005, BIOL CELL, V97, P339, DOI 10.1042/BC200400062; Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633; Chun J, 2005, BIOCHEM BIOPH RES CO, V326, P136, DOI 10.1016/j.bbrc.2004.10.208; Chun J, 2005, CELL SIGNAL, V17, P751, DOI 10.1016/j.cellsig.2004.10.016; Coleman DE, 1999, J BIOL CHEM, V274, P16669, DOI 10.1074/jbc.274.24.16669; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Davey NE, 2010, NUCLEIC ACIDS RES, V38, pW534, DOI 10.1093/nar/gkq440; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; Davies LM, 2010, J PHYSIOL-LONDON, V588, P3254, DOI 10.1113/jphysiol.2010.194779; de Marco MD, 2001, J BIOL CHEM, V276, P23009; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Di Vizio D, 2008, CELL CYCLE, V7, P2257, DOI 10.4161/cc.7.14.6475; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Escriche M, 2003, EXP CELL RES, V285, P72, DOI 10.1016/S0014-4827(02)00090-3; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Feng L, 2012, J CELL PHYSIOL, V227, P2480, DOI 10.1002/jcp.22984; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gaillard S, 2001, FEBS LETT, V508, P49, DOI 10.1016/S0014-5793(01)03020-4; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Galvagni F, 2007, BIOCHEMISTRY-US, V46, P3998, DOI 10.1021/bi061400n; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gaudreault SB, 2004, J BIOL CHEM, V279, P356, DOI 10.1074/jbc.M304777200; Gingras D, 1998, BIOCHEM BIOPH RES CO, V247, P888, DOI 10.1006/bbrc.1998.8885; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Hong YH, 2009, J NEUROCHEM, V111, P61, DOI 10.1111/j.1471-4159.2009.06289.x; Ikezu T, 1998, J BIOL CHEM, V273, P10485, DOI 10.1074/jbc.273.17.10485; IMAMURA T, 1994, J BIOL CHEM, V269, P31019; Imamura T, 1998, J BIOL CHEM, V273, P11183, DOI 10.1074/jbc.273.18.11183; IWANISHI M, 1993, DIABETOLOGIA, V36, P414, DOI 10.1007/BF00402277; Jablonski EM, 2006, BIOL CELL, V98, P33, DOI 10.1042/BC20040131; Jodoin J, 2003, J NEUROCHEM, V87, P1010, DOI 10.1046/j.1471-4159.2003.02081.x; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karpen HE, 2001, J BIOL CHEM, V276, P19503, DOI 10.1074/jbc.M010832200; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Komander D, 2004, STRUCTURE, V12, P215, DOI 10.1016/j.str.2004.01.005; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kwak JO, 2005, IUBMB LIFE, V57, P109, DOI 10.1080/15216540500104750; Kwiatek AM, 2006, MOL PHARMACOL, V70, P1174, DOI 10.1124/mol.105.021741; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; LeClerc PC, 2002, ENDOCRINOLOGY, V143, P4702, DOI 10.1210/en.2002-220679; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee KW, 2004, J BIOL CHEM, V279, P469, DOI 10.1074/jbc.M307316200; Lee WK, 2008, EXP MOL MED, V40, P505, DOI 10.3858/emm.2008.40.5.505; Levin AM, 2006, PROTEIN SCI, V15, P478, DOI 10.1110/ps.051911706; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Lin DB, 2003, INVEST OPHTH VIS SCI, V44, P5259, DOI 10.1167/iovs.03-0296; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; Martinez-Marmol R, 2008, J CELL PHYSIOL, V217, P667, DOI 10.1002/jcp.21538; Mayer G, 2004, CELL TISSUE RES, V316, P55, DOI 10.1007/s00441-004-0866-x; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Miyagawa Y, 2003, BIOCHEM BIOPH RES CO, V300, P669, DOI 10.1016/S0006-291X(02)02888-7; Moh MC, 2009, BIOCHEM BIOPH RES CO, V378, P755, DOI 10.1016/j.bbrc.2008.11.119; Mooney C, 2012, J MOL BIOL, V415, P193, DOI 10.1016/j.jmb.2011.10.025; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Nilsson R, 2006, CELL SIGNAL, V18, P1713, DOI 10.1016/j.cellsig.2006.01.010; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Panetta D, 2004, BIOCHEM BIOPH RES CO, V316, P240, DOI 10.1016/j.bbrc.2004.02.037; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128; Ramirez CM, 2009, MOL CELL NEUROSCI, V42, P172, DOI 10.1016/j.mcn.2009.07.001; Rashid-Doubell F, 2007, PLACENTA, V28, P139, DOI 10.1016/j.placenta.2005.12.005; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Razani B, 2001, AM J PHYSIOL-CELL PH, V281, pC1241, DOI 10.1152/ajpcell.2001.281.4.C1241; Santibanez JF, 2008, CARDIOVASC RES, V77, P791, DOI 10.1093/cvr/cvm097; Sasaki N, 2011, STEM CELLS, V29, P641, DOI 10.1002/stem.615; Sato Y, 2004, J BIOL CHEM, V279, P8827, DOI 10.1074/jbc.M310327200; Sbaa E, 2005, TRENDS CARDIOVAS MED, V15, P157, DOI 10.1016/j.tcm.2005.05.006; Schilling K, 2006, MOL BIOL CELL, V17, P3870, DOI 10.1091/mbc.E05-08-0709; Schlegel A, 2001, BIOCHEM J, V359, P203, DOI 10.1042/0264-6021:3590203; Schubert AL, 2002, BIOCHEMISTRY-US, V41, P5754, DOI 10.1021/bi0121656; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; Spisni E, 2001, EXP CELL RES, V266, P31, DOI 10.1006/excr.2001.5198; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Storch CH, 2007, J PHARMACOL EXP THER, V323, P257, DOI 10.1124/jpet.107.122994; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Taira J, 2011, BIOCHEMISTRY-US, V50, P6824, DOI 10.1021/bi200601t; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Vargas L, 2002, J BIOL CHEM, V277, P9351, DOI 10.1074/jbc.M108537200; Vihanto MM, 2006, J CELL SCI, V119, P2299, DOI 10.1242/jcs.02946; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Weatheritt RJ, 2012, BIOINFORMATICS, V28, P976, DOI 10.1093/bioinformatics/bts072; Wu JH, 2008, NAT STRUCT MOL BIOL, V15, P251, DOI 10.1038/nsmb.1388; Wyse BD, 2003, J BIOL CHEM, V278, P23738, DOI 10.1074/jbc.M212892200; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Yamaguchi T, 2003, EUR J BIOCHEM, V270, P1816, DOI 10.1046/j.1432-1033.2003.03544.x; Yamaguchi Y, 2011, J CELL MOL MED, V15, P957, DOI 10.1111/j.1582-4934.2010.01063.x; Yamamoto M, 1999, EXP CELL RES, V247, P380, DOI 10.1006/excr.1998.4379; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Yao Q, 2005, J MOL BIOL, V348, P491, DOI 10.1016/j.jmb.2005.02.003; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yue LL, 2011, J LIPID RES, V52, P489, DOI 10.1194/jlr.M011809; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031; Zhang XM, 2007, J BIOL CHEM, V282, P33284, DOI 10.1074/jbc.M705089200; Zheng WJ, 2003, P NATL ACAD SCI USA, V100, P13253, DOI 10.1073/pnas.2235686100	134	80	81	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44879	10.1371/journal.pone.0044879	http://dx.doi.org/10.1371/journal.pone.0044879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028656	gold, Green Submitted, Green Published			2022-12-27	WOS:000309742800022
J	Xu, CJ; Poh, YKC; Roes, I; O'Cearbhaill, ED; Matthiesen, ME; Mu, LY; Yang, SY; Miranda-Nieves, D; Irimia, D; Karp, JM				Xu, Chenjie; Poh, Yuk Kee C.; Roes, Isaac; O'Cearbhaill, Eoin D.; Matthiesen, Mads Emil; Mu, Luye; Yang, Seung Yun; Miranda-Nieves, David; Irimia, Daniel; Karp, Jeffrey M.			A Portable Chemotaxis Platform for Short and Long Term Analysis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CONCENTRATION GRADIENTS; PLATELET RELEASATE; SHEAR-STRESS; BONE-MARROW; MIGRATION; GENERATION; SYSTEMS; ASSAYS	Flow-based microfluidic systems have been widely utilized for cell migration studies given their ability to generate versatile and precisely defined chemical gradients and to permit direct visualization of migrating cells. Nonetheless, the general need for bulky peripherals such as mechanical pumps and tubing and the complicated setup procedures significantly limit the widespread use of these microfluidic systems for cell migration studies. Here we present a simple method to power microfluidic devices for chemotaxis assays using the commercially available ALZET (R) osmotic pumps. Specifically, we developed a standalone chemotaxis platform that has the same footprint as a multiwell plate and can generate well-defined, stable chemical gradients continuously for up to 7 days. Using this platform, we validated the short-term (24 hours) and long-term (72 hours) concentration dependent PDGF-BB chemotaxis response of human bone marrow derived mesenchymal stem cells.	[Xu, Chenjie; Poh, Yuk Kee C.; Roes, Isaac; O'Cearbhaill, Eoin D.; Matthiesen, Mads Emil; Mu, Luye; Yang, Seung Yun; Miranda-Nieves, David; Karp, Jeffrey M.] Harvard Univ, Sch Med,Brigham & Womens Hosp, Div Biomed Engn,Dept Med,Ctr Regenerat Therapeut, Div Hlth Sci & Technol,Harvard Stem Cell Inst,Har, Cambridge, MA 02138 USA; [Irimia, Daniel] Shriners Hosp Children, Massachusetts Gen Hosp, BioMEMS Resource Ctr, Ctr Engn Med & Surg Serv, Boston, MA USA; [Irimia, Daniel] Harvard Univ, Sch Med, Boston, MA USA; [Xu, Chenjie] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore, Singapore	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Karp, JM (corresponding author), Harvard Univ, Sch Med,Brigham & Womens Hosp, Div Biomed Engn,Dept Med,Ctr Regenerat Therapeut, Div Hlth Sci & Technol,Harvard Stem Cell Inst,Har, Cambridge, MA 02138 USA.	jkarp@rics.bwh.harvard.edu	Irimia, Daniel/A-4095-2008; xu, chenjie/E-4075-2012; O'Cearbhaill, Eoin/W-9687-2018; O'Cearbhaill, Eoin/Q-8947-2019; Yang, Seung Yun/B-5974-2016; Irimia, Daniel/S-5404-2019	Irimia, Daniel/0000-0001-7347-2082; O'Cearbhaill, Eoin/0000-0002-4666-5863; O'Cearbhaill, Eoin/0000-0002-4666-5863; Yang, Seung Yun/0000-0002-1233-8960; Irimia, Daniel/0000-0001-7347-2082; Xu, Chenjie/0000-0002-8278-3912	Harvard Stem Cell Institute; United States National Institutes of Health [HL095722, HL097172]; MIT-UROP; John Reed Fund; NIBIB [P41 EB 002503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097172, R01HL095722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092804] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT-UROP; John Reed Fund; NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Harvard Stem Cell Institute and the United States National Institutes of Health grants HL095722 and HL097172 to JMK. DMN is supported by MIT-UROP program and the John Reed Fund. Fabrication of the devices was possible with support from the NIBIB funded, BioMEMS Resource Center (P41 EB 002503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Cimetta E, 2010, LAB CHIP, V10, P3277, DOI 10.1039/c0lc00033g; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Gaver DP, 1998, BIOPHYS J, V75, P721, DOI 10.1016/S0006-3495(98)77562-9; Irimia D, 2006, ANAL CHEM, V78, P3472, DOI 10.1021/ac0518710; Irimia D, 2010, ANNU REV BIOMED ENG, V12, P259, DOI 10.1146/annurev-bioeng-070909-105241; Kark LR, 2006, CLIN ORAL IMPLAN RES, V17, P321, DOI 10.1111/j.1600-0501.2005.01189.x; Karp JM, 2005, BONE, V37, P337, DOI 10.1016/j.bone.2005.04.022; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Khademhosseini A., 2008, MICRO NANOENGINEERIN, P396; KRETZMER G, 1991, APPL MICROBIOL BIOT, V34, P613, DOI 10.1007/BF00167909; KUNDRA V, 1995, J CELL BIOL, V130, P725, DOI 10.1083/jcb.130.3.725; LAUFFENBURGER DA, 1981, J IMMUNOL METHODS, V40, P45, DOI 10.1016/0022-1759(81)90079-X; LAWRENCE JR, 1994, APPL ENVIRON MICROB, V60, P1166, DOI 10.1128/AEM.60.4.1166-1173.1994; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Oprea WE, 2003, J CRANIOFAC SURG, V14, P292, DOI 10.1097/00001665-200305000-00006; Paguirigan AL, 2008, BIOESSAYS, V30, P811, DOI 10.1002/bies.20804; Park JY, 2007, LAB CHIP, V7, P1673, DOI 10.1039/b710777c; Park JY, 2010, BIORHEOLOGY, V47, P165, DOI 10.3233/BIR-2010-0567; Pujic Z, 2009, COMB CHEM HIGH T SCR, V12, P580, DOI 10.2174/138620709788681952; Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9; Takagi M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2779350	23	9	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44995	10.1371/journal.pone.0044995	http://dx.doi.org/10.1371/journal.pone.0044995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028729	Green Published, gold			2022-12-27	WOS:000309742800029
J	Banni, S; Carta, G; Murru, E; Cordeddu, L; Giordano, E; Marrosu, F; Puligheddu, M; Floris, G; Asuni, GP; Cappai, AL; Deriu, S; Follesa, P				Banni, Sebastiano; Carta, Gianfranca; Murru, Elisabetta; Cordeddu, Lina; Giordano, Elena; Marrosu, Francesco; Puligheddu, Monica; Floris, Gabriele; Asuni, Gino Paolo; Cappai, Angela Letizia; Deriu, Silvia; Follesa, Paolo			Vagus Nerve Stimulation Reduces Body Weight and Fat Mass in Rats	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; CEREBELLAR TREMOR; ENERGY-BALANCE; FOOD-INTAKE; ACTIVATION; EXPRESSION; OBESITY; SYSTEM; METABOLISM; THERAPY	Among the manifold effects of vagus nerve stimulation (VNS) delivered as an add-on treatment to patients with drug-resistant epilepsy, a moderate loss of body weight has been observed in some individuals. We have now investigated this effect in rats. Exposure of rats to VNS for 4 weeks reduced feed conversion efficiency as well as body weight gain (by similar to 25%) and the amount of mesenteric adipose tissue (by similar to 45%) in comparison with those in sham-operated control animals. A pair-fed experiment showed that both lower dietary intake and increase energy expenditure independently contributed to the reduction of body weight and mesenteric adipose tissue. Moreover, VNS increased the level of non-esterified fatty acids in plasma and mesenteric adipose tissue by similar to 50 and 80%, respectively, without affecting that in the liver. In addition, VNS reduced the amounts of endocannabinoids and increased N-palmitoylethanolamide, an endogenous ligand of the transcription factor PPAR alpha (peroxisome proliferator-activated receptor alpha) in mesenteric adipose tissue but not in the hypothalamus. These effects were accompanied by increased expression of the gene for brain-derived neurotrophic factor (BDNF) in the hypothalamus and up-regulation of the abundance of PPAR alpha in the liver. Our results suggest that the reduction in body fat induced by VNS in rats may result from the action of both central and peripheral mediators. The reduced feed conversion efficiency associated with VNS may be mediated by hypothalamic BDNF, down-regulation of endocannabinoid tone in mesenteric adipose tissue and a PPAR alpha-dependent increase in fatty acid oxidation in the liver, which in concerted action may account for the anorexic effect and increased energy expenditure.	[Banni, Sebastiano; Carta, Gianfranca; Murru, Elisabetta; Cordeddu, Lina; Giordano, Elena] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Marrosu, Francesco; Puligheddu, Monica] Univ Cagliari, Dept Publ Hlth & Clin & Mol Med, Cagliari, Italy; [Floris, Gabriele; Asuni, Gino Paolo; Cappai, Angela Letizia; Deriu, Silvia; Follesa, Paolo] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Floris, Gabriele; Asuni, Gino Paolo; Cappai, Angela Letizia; Deriu, Silvia; Follesa, Paolo] Univ Cagliari, Ctr Excellence Neurobiol Dependence, Cagliari, Italy	University of Cagliari; University of Cagliari; University of Cagliari; University of Cagliari	Banni, S (corresponding author), Univ Cagliari, Dept Biomed Sci, Cagliari, Italy.	banni@unica.it	Murru, Elisabetta/AAW-4909-2021; Carta, Gianfranca/AAB-8947-2022; Follesa, Paolo/K-5416-2015; Banni, Sebastiano/F-1906-2018; Puligheddu, Monica/AGD-8274-2022; Puligheddu, Monica/AAB-8503-2019	Carta, Gianfranca/0000-0002-3527-4197; Banni, Sebastiano/0000-0003-4805-1387; Follesa, Paolo/0000-0003-4857-476X; Floris, Gabriele/0000-0002-5818-774X; Murru, Maria Elisabetta/0000-0002-7394-5780	Italian Ministry of Instruction, Universities, and Research (M.I.U.R.), Project Centre of Excellence for the Neurobiology of Dependence [CE00042735]	Italian Ministry of Instruction, Universities, and Research (M.I.U.R.), Project Centre of Excellence for the Neurobiology of Dependence	This study was supported in part by the Italian Ministry of Instruction, Universities, and Research (M.I.U.R.), Project Centre of Excellence for the Neurobiology of Dependence, D.M. January 2001, grant protocol CE00042735. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakr A, 2008, J CLIN NEUROSCI, V15, P127, DOI 10.1016/j.jocn.2007.07.083; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Banni S, 1996, J NUTR BIOCHEM, V7, P150, DOI 10.1016/0955-2863(95)00193-X; Banni S, 2001, J LIPID RES, V42, P1056; Ben-Menachem E, 2002, LANCET NEUROL, V1, P477, DOI 10.1016/S1474-4422(02)00220-X; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Biggio F, 2009, INT J NEUROPSYCHOPH, P1; Bugajski AJ, 2007, J PHYSIOL PHARMACOL, V58, P5; Burdyga G, 2010, AM J PHYSIOL-GASTR L, V299, pG63, DOI 10.1152/ajpgi.00059.2010; Burneo JG, 2002, NEUROLOGY, V59, P463, DOI 10.1212/WNL.59.3.463; Cao L, 2009, NAT MED, V15, P447, DOI 10.1038/nm.1933; CHIANG S. P., 1955, LARYNGOSCOPE, V65, P927; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 1998, NATURE, V396, P636, DOI 10.1038/25267; Di Marzo V, 2008, NAT CLIN PRACT CARD, V5, P610, DOI 10.1038/ncpcardio1319; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; FOLCH J, 1957, J BIOL CHEM, V226, P497; Follesa P, 2007, BRAIN RES, V1179, P28, DOI 10.1016/j.brainres.2007.08.045; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Gaetani S, 2008, Eat Weight Disord, V13, pe42; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kirkham T C, 2006, CNS Neurol Disord Drug Targets, V5, P272; Koren MS, 2006, EPILEPSY BEHAV, V8, P246, DOI 10.1016/j.yebeh.2005.10.001; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Marrosu F, 2007, MULT SCLER, V13, P1200, DOI 10.1177/1352458507078399; Marrosu F, 2005, NEUROLOGY, V65, P490, DOI 10.1212/01.wnl.0000172343.45110.79; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; Morimoto C, 1997, J LIPID RES, V38, P132; Ono M, 1997, BIOCHEM BIOPH RES CO, V238, P633, DOI 10.1006/bbrc.1997.7220; Pardo JV, 2007, INT J OBESITY, V31, P1756, DOI 10.1038/sj.ijo.0803666; Piscitelli F, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-51; RAMSAY RE, 1994, EPILEPSIA, V35, P627, DOI 10.1111/j.1528-1157.1994.tb02483.x; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; de Oliveira LCS, 2007, AUTON NEUROSCI-BASIC, V136, P63, DOI 10.1016/j.autneu.2007.04.004; Sobocki J, 2006, SURGERY, V139, P209, DOI 10.1016/j.surg.2005.06.025; Thabuis C, 2008, LIPIDS, V43, P887, DOI 10.1007/s11745-008-3217-y; VANDERTUIG JG, 1982, LIFE SCI, V30, P913, DOI 10.1016/0024-3205(82)90619-1; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR992, DOI 10.1152/ajpregu.00516.2006; Wang CF, 2010, BRAIN RES, V1336, P66, DOI 10.1016/j.brainres.2010.04.013; Wisse BE, 2003, NAT NEUROSCI, V6, P655, DOI 10.1038/nn0703-655; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; YOSHIDA T, 1984, AM J PHYSIOL, V246, pR558, DOI 10.1152/ajpregu.1984.246.4.R558	46	35	36	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e44813	10.1371/journal.pone.0044813	http://dx.doi.org/10.1371/journal.pone.0044813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028630	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900018
J	Li, J; Staats, WL; Spieker, A; Sung, M; Rutkove, SB				Li, Jia; Staats, Wayne L.; Spieker, Andrew; Sung, Minhee; Rutkove, Seward B.			A Technique for Performing Electrical Impedance Myography in the Mouse Hind Limb: Data in Normal and ALS SOD1 G93A Animals	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DISEASE; ANISOTROPY; MUSCLE	Objective: To test a method for performing electrical impedance myography (EIM) in the mouse hind limb for the assessment of disease status in neuromuscular disease models. Methods: An impedance measuring device consisting of a frame with electrodes embedded within an acrylic head was developed. The head was rotatable such that data longitudinal and transverse to the major muscle fiber direction could be obtained. EIM measurements were made with this device on 16 healthy mice and 14 amyotrophic lateral sclerosis (ALS) animals. Repeatability was assessed in both groups. Results: The technique was easy to perform and provided good repeatability in both healthy and ALS animals, with intra-session repeatability (mean +/- SEM) of 5% +/- 1% and 12% +/- 2%, respectively. Significant differences between healthy and ALS animals were also identified (e. g., longitudinal mean 50 kHz phase was 18 +/- 0.6 degrees for the healthy animals and 14 +/- 1.0 degrees for the ALS animals, p = 0.0025). Conclusions: With this simple device, the EIM data obtained is highly repeatable and can differentiate healthy from ALS animals. Significance: EIM can now be applied to mouse models of neuromuscular disease to assess disease status and the effects of therapy.	[Li, Jia; Spieker, Andrew; Sung, Minhee; Rutkove, Seward B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA; [Staats, Wayne L.] MIT, Dept Mech Engn, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Rutkove, SB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol, Boston, MA 02215 USA.	srutkove@bidmc.harvard.edu		Rutkove, Seward/0000-0002-6375-3312	NIH/NINDS [R01 NS055099]; Convergence Medical Devices Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055099] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Convergence Medical Devices Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH/NINDS grant R01 NS055099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Rutkove has equity interest and receives consulting income from Convergence Medical Devices Inc., a company that develops impedance-measuring devices. Dr. Rutkove is named as an inventor on two patent applications in the field of electrical impedance. Neither the first patent (entitled "electrical impedance myography'') or the second patent (entitled a "device for performing electrical impedacne myography") are directly relevant to this publication, as both relate to the development of an automated device for human use. However, since both are in the field of electrical impedance, the author has disclosed them. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ahad MA, 2010, CLIN NEUROPHYSIOL, V121, P882, DOI 10.1016/j.clinph.2010.01.017; Ahad MA, 2009, CLIN NEUROPHYSIOL, V120, P1534, DOI 10.1016/j.clinph.2009.05.017; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chin AB, 2008, MUSCLE NERVE, V37, P560, DOI 10.1002/mus.20981; Douglass CP, 2010, J NEUROL NEUROSUR PS, V81, P646, DOI 10.1136/jnnp.2009.197434; Esper GJ, 2006, MUSCLE NERVE, V34, P595, DOI 10.1002/mus.20626; Garmirian LP, 2009, MUSCLE NERVE, V39, P16, DOI 10.1002/mus.21115; Li J, 2010, MEASURING MULTIFREQU; Ono S, 2000, AMYOTROPH LATERAL SC, V1, P191, DOI 10.1080/14660820050515188; Rutkove SB, 2012, OFFICIAL PUBLICATION; Rutkove SB, 2007, CLIN NEUROPHYSIOL, V118, P2413, DOI 10.1016/j.clinph.2007.08.004; Rutkove SB, 2010, MUSCLE NERVE, V42, P915, DOI 10.1002/mus.21784; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Tarulli A, 2005, NEUROLOGY, V65, P451, DOI 10.1212/01.wnl.0000172338.95064.cb; Wang LL, 2011, CLIN NEUROPHYSIOL, V122, P2505, DOI 10.1016/j.clinph.2011.04.021	15	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45004	10.1371/journal.pone.0045004	http://dx.doi.org/10.1371/journal.pone.0045004			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23028733	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900022
J	Pisaneschi, S; Strigini, FAL; Sanchez, AM; Begliuomini, S; Casarosa, E; Ripoli, A; Ghirri, P; Boldrini, A; Fink, B; Genazzani, AR; Coceani, F; Simoncini, T				Pisaneschi, Silvia; Strigini, Francesca A. L.; Sanchez, Angel M.; Begliuomini, Silvia; Casarosa, Elena; Ripoli, Andrea; Ghirri, Paolo; Boldrini, Antonio; Fink, Bruno; Genazzani, Andrea R.; Coceani, Flavio; Simoncini, Tommaso			Compensatory Feto-Placental Upregulation of the Nitric Oxide System during Fetal Growth Restriction	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; ADHESION MOLECULE-1; ADULT; PREECLAMPSIA; RETARDATION; EXPRESSION; PREGNANCY; SYNTHASE; HYPOXIA; ORIGINS	Background: Fetal Growth Restriction is often associated with a feto-placental vascular dysfunction conceivably involving endothelial cells. Our study aimed to verify this pathogenic role for feto-placental endothelial cells and, coincidentally, demonstrate any abnormality in the nitric oxide system. Methods: Prenatal assessment of feto-placental vascular function was combined with measurement of nitric oxide (in the form of S-nitrosohemoglobin) and its nitrite byproduct, and of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. Umbilical vein endothelial cells were also harvested to determine their gene profile. The study comprised term pregnancies with normal (n = 40) or small-for-gestational-age (n = 20) newborns, small-for-gestational-age preterm pregnancies (n = 15), and bi-chorial, bi-amniotic twin pregnancies with discordant fetal growth (n = 12). Results: Umbilical blood nitrite (p < 0.001) and S-nitrosohemoglobin (p = 0.02) rose with fetal growth restriction while asymmetric dimethylarginine decreased (p = 0.003). Nitrite rise coincided with an abnormal Doppler profile from umbilical arteries. Fetal growth restriction umbilical vein endothelial cells produced more nitrite and also exhibited reciprocal changes in vasodilator (upwards) and vasoconstrictor (downwards) transcripts. Elevation in blood nitrite and S-nitrosohemoglobin persisted postnatally in the fetal growth restriction offspring. Conclusion: Fetal growth restriction is typified by increased nitric oxide production during pregnancy and after birth. This response is viewed as an adaptative event to sustain placental blood flow. However, its occurrence may modify the endothelial phenotype and may ultimately represent an element of risk for cardiovascular disease in adult life.	[Pisaneschi, Silvia; Strigini, Francesca A. L.; Sanchez, Angel M.; Begliuomini, Silvia; Casarosa, Elena; Genazzani, Andrea R.; Simoncini, Tommaso] Univ Pisa, Div Obstet & Gynecol, Dept Reprod Med & Child Dev, Pisa, Italy; [Ghirri, Paolo; Boldrini, Antonio] Univ Pisa, Div Neonatol, Dept Reprod Med & Child Dev, Pisa, Italy; [Ripoli, Andrea] CNR, Inst Clin Physiol, Pisa, Italy; [Fink, Bruno] Noxygen Sci Transfer & Diagnost, Elzach, Germany; [Pisaneschi, Silvia; Coceani, Flavio] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy	University of Pisa; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna	Simoncini, T (corresponding author), Univ Pisa, Div Obstet & Gynecol, Dept Reprod Med & Child Dev, Pisa, Italy.	tommaso.simoncini@med.unipi.it	strigini, francesca/J-2929-2012; Simoncini, Tommaso/AAC-1879-2019	Simoncini, Tommaso/0000-0002-2971-0079	University of Pisa; Scuola Superiore Sant'Anna	University of Pisa; Scuola Superiore Sant'Anna	Supported by grants of the University of Pisa to T. S. and A. R. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S. Pisaneschi is the recipient of a graduate studentship of the Scuola Superiore Sant'Anna.	Alexander BT, 2006, AM J PHYSIOL-REG I, V290, pR1, DOI 10.1152/ajpregu.00417.2005; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Casanello P, 2002, CIRC RES, V91, P127, DOI 10.1161/01.RES.0000027813.55750.E7; DAVIES DP, 1980, P NUTR SOC, V39, P25, DOI 10.1079/PNS19800005; Fink Bruno, 2006, Pharmacol Rep, V58 Suppl, P8; Ismail-Beigi F, 2006, AM J PHYSIOL-ENDOC M, V291, pE439, DOI 10.1152/ajpendo.00105.2006; Jaszewski AR, 2003, FREE RADICAL BIO MED, V35, P444, DOI 10.1016/S0891-5849(03)00324-1; Manukhina EB, 2006, EXP BIOL MED, V231, P343, DOI 10.1177/153537020623100401; Mata-Greenwood E, 2006, AM J PHYSIOL-LUNG C, V290, pL232, DOI 10.1152/ajplung.00393.2004; Miller J, 2008, SEMIN PERINATOL, V32, P274, DOI 10.1053/j.semperi.2008.04.010; Mochizuki S, 2005, AM J PHYSIOL-HEART C, V288, pH553, DOI 10.1152/ajpheart.00408.2004; Morton JS, 2011, J APPL PHYSIOL, V110, P1073, DOI 10.1152/japplphysiol.01174.2010; Myatt L, 1997, HUM REPROD, V12, P167, DOI 10.1093/humrep/12.1.167; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; Rajashekhar G, 2003, J SOC GYNECOL INVEST, V10, P352, DOI 10.1016/S1071-5576(03)00121-7; Rodford JL, 2008, J PHYSIOL-LONDON, V586, P4709, DOI 10.1113/jphysiol.2008.156976; SALAFIA CM, 1993, AM J OBSTET GYNECOL, V169, P830, DOI 10.1016/0002-9378(93)90012-8; Savvidou MD, 2003, LANCET, V361, P1511, DOI 10.1016/S0140-6736(03)13177-7; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Sladek SM, 1997, AM J PHYSIOL-REG I, V272, pR441, DOI 10.1152/ajpregu.1997.272.2.R441; Stuhlinger MC, 2005, CURR DRUG METAB, V6, P3, DOI 10.2174/1389200052997393; Wathen KA, 2006, J CLIN ENDOCR METAB, V91, P180, DOI 10.1210/jc.2005-1076	23	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45294	10.1371/journal.pone.0045294	http://dx.doi.org/10.1371/journal.pone.0045294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23028913	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500027
J	Berec, V				Berec, Vesna			Quantum Entanglement and Spin Control in Silicon Nanocrystal	PLOS ONE			English	Article							ELECTRON-SPIN; IONS	Selective coherence control and electrically mediated exchange coupling of single electron spin between triplet and singlet states using numerically derived optimal control of proton pulses is demonstrated. We obtained spatial confinement below size of the Bohr radius for proton spin chain FWHM. Precise manipulation of individual spins and polarization of electron spin states are analyzed via proton induced emission and controlled population of energy shells in pure Si-29 nanocrystal. Entangled quantum states of channeled proton trajectories are mapped in transverse and angular phase space of Si-29 < 100 > axial channel alignment in order to avoid transversal excitations. Proton density and proton energy as impact parameter functions are characterized in single particle density matrix via discretization of diagonal and nearest off-diagonal elements. We combined high field and low densities (1 MeV/92 nm) to create inseparable quantum state by superimposing the hyperpolarizationed proton spin chain with electron spin of Si-29. Quantum discretization of density of states (DOS) was performed by the Monte Carlo simulation method using numerical solutions of proton equations of motion. Distribution of gaussian coherent states is obtained by continuous modulation of individual spin phase and amplitude. Obtained results allow precise engineering and faithful mapping of spin states. This would provide the effective quantum key distribution (QKD) and transmission of quantum information over remote distances between quantum memory centers for scalable quantum communication network. Furthermore, obtained results give insights in application of channeled protons subatomic microscopy as a complete versatile scanning-probe system capable of both quantum engineering of charged particle states and characterization of quantum states below diffraction limit linear and in-depth resolution. PACS numbers: 03.65. Ud, 03.67. Bg, 61.85.+p, 67.30.hj	[Berec, Vesna] Univ Belgrade, Fac Phys, Dept Condensed Matter Phys, Belgrade 11001, Serbia; [Berec, Vesna] Inst Nucl Sci, Belgrade, Serbia	University of Belgrade; University of Belgrade	Berec, V (corresponding author), Univ Belgrade, Fac Phys, Dept Condensed Matter Phys, POB 550, Belgrade 11001, Serbia.	bervesn@gmail.com			Ministry of Science, Republic of Serbia	Ministry of Science, Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work is supported by the Ministry of Science, Republic of Serbia (project no. OI174014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M, 1965, HDB MATH FUNCTIONS, P896; [Anonymous], 1993, MODERN QUANTUM MECH, P109; Appelbaum I, 2007, NATURE, V447, P295, DOI 10.1038/nature05803; Assmann W, 1999, PHYS REV LETT, V83, P1759, DOI 10.1103/PhysRevLett.83.1759; BARRETT JH, 1973, PHYS REV LETT, V31, P1542, DOI 10.1103/PhysRevLett.31.1542; Bellucci S, 2003, PHYS REV SPEC TOP-AC, V6, DOI 10.1103/PhysRevSTAB.6.033502; Biryukov VM, 2005, NUCL INSTRUM METH B, V231, P70, DOI 10.1016/j.nimb.2005.01.037; Broer HW, 2004, B AM MATH SOC, V41, P507, DOI 10.1090/S0273-0979-04-01009-2; Charles Kittel, 1995, INTRO WAVELETS, P66; DEABAJO FJG, 1992, PHYS REV B, V46, P2663, DOI 10.1103/PhysRevB.46.2663; Demkov YN, 2004, EUR PHYS J B, V42, P361, DOI 10.1140/epjb/e2004-00391-6; Demkov YN, 2009, PHYS ATOM NUCL+, V72, P779, DOI 10.1134/S1063778809050056; Diederich Hinrichsen, 2005, TEXTS APPL MATH, V48; Elzerman JM, 2004, NATURE, V430, P431, DOI [10.1038/nature02693, 10.1039/nature02693]; Foletti S, 2009, NAT PHYS, V5, P903, DOI 10.1038/NPHYS1424; Frankand W M, 1971, REV MOD PHYS, V43, P1; Friesen M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.121301; GEMMELL DS, 1974, REV MOD PHYS, V46, P129, DOI 10.1103/RevModPhys.46.129; Guidi V, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.014801; HAAKENAASEN R, 1995, PHYS REV LETT, V75, P1650, DOI 10.1103/PhysRevLett.75.1650; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Heiss D., 2002, FUNDAMENTALS QUANTUM; Horodecki R, 2009, REV MOD PHYS, V81, P865, DOI 10.1103/RevModPhys.81.865; Kane BE, 2000, FORTSCHR PHYS, V48, P1023, DOI 10.1002/1521-3978(200009)48:9/11<1023::AID-PROP1023>3.0.CO;2-J; Krasheninnikov A V, 2007, NAT MATER, V6; KRAUSE HF, 1986, PHYS REV B, V33, P6036, DOI 10.1103/PhysRevB.33.6036; Krause HF, 1996, ADV ATOM MOL OPT PHY, V37, P139; KUMAKHOV MA, 1979, RADIAT EFF DEFECT S, V41, P1, DOI 10.1080/00337577908237931; Langford R M, 2007, MRS BULL, P32; Levi AFJ, 2008, P IEEE, V96, P335, DOI 10.1109/JPROC.2007.911071; Lindhard J, 1965, DANSKE VID SELSK MAT, V34, P14; Liu HW, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.073310; Mattis D. C., 2006, THEORY MAGNETISM MAD; Mitrikas G, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.020305; Neskovic N, 2009, NUCL INSTRUM METH B, V267; Nielsen M A, 2002, QUANTUM COMPUTATION, P403; Nordberg EP, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115331; Nowack KC, 2007, SCIENCE, V318, P1430, DOI 10.1126/science.1148092; Orloff J, 2002, HIGH RESOLUTION FOCU, P123; Parker T S, 1989, PRACTICAL NUMERICAL, P278; Petrovic S, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.032901; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Rosler M, 1996, PHYS REV B, V54, P17158, DOI 10.1103/PhysRevB.54.17158; Sah C.-T., 1991, FUNDAMENTALS SOLID S, P90; Simmons MY, 2008, NAT PHYS, V4, P165, DOI 10.1038/nphys902; Skillman Herman, 1968, QUANTUM THEORY MATTE, p[145, 150]; Surhone Lambert M, 2010, LIOUVILLES THEOREM C; Van Vliet D, 1971, RADIAT EFF DEFECT S, V10, P3137; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	49	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45254	10.1371/journal.pone.0045254	http://dx.doi.org/10.1371/journal.pone.0045254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23028884	Green Submitted, gold, Green Published			2022-12-27	WOS:000309554700029
J	Pello, OM; Chevre, R; Laoui, D; De Juan, A; Lolo, F; Andres-Manzano, MJ; Serrano, M; Van Ginderachter, JA; Andres, V				Pello, Oscar M.; Chevre, Raphael; Laoui, Damya; De Juan, Alba; Lolo, Fidel; Jesus Andres-Manzano, Maria; Serrano, Manuel; Van Ginderachter, Jo A.; Andres, Vicente			In Vivo Inhibition of c-MYC in Myeloid Cells Impairs Tumor-Associated Macrophage Maturation and Pro-Tumoral Activities	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; M-CSF; EXPRESSION; ANGIOGENESIS; SURVIVAL; BINDING; CANCER; DIFFERENTIATION; INFLAMMATION; POLARIZATION	Although tumor-associated macrophages (TAMs) are involved in tumor growth and metastasis, the mechanisms controlling their pro-tumoral activities remain largely unknown. The transcription factor c-MYC has been recently shown to regulate in vitro human macrophage polarization and be expressed in macrophages infiltrating human tumors. In this study, we exploited the predominant expression of LysM in myeloid cells to generate c-Myc(fl/fl) LysM(cre/+) mice, which lack c-Myc in macrophages, to investigate the role of macrophage c-MYC expression in cancer. Under steady-state conditions, immune system parameters in c-Myc(fl/fl) LysM(cre/+) mice appeared normal, including the abundance of different subsets of bone marrow hematopoietic stem cells, precursors and circulating cells, macrophage density, and immune organ structure. In a model of melanoma, however, TAMs lacking c-Myc displayed a delay in maturation and showed an attenuation of pro-tumoral functions (e. g., reduced expression of VEGF, MMP9, and HIF1 alpha) that was associated with impaired tissue remodeling and angiogenesis and limited tumor growth in c-Myc(fl/fl) LysM(cre/+) mice. Macrophage c-Myc deletion also diminished fibrosarcoma growth. These data identify c-Myc as a positive regulator of the pro-tumoral program of TAMs and suggest c-Myc inactivation as an attractive target for anti-cancer therapy.	[Pello, Oscar M.; Chevre, Raphael; De Juan, Alba; Jesus Andres-Manzano, Maria; Andres, Vicente] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Lab Mol & Genet Cardiovasc Pathophysiol, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain; [Laoui, Damya; Van Ginderachter, Jo A.] Vrije Univ Brussel, Cellular & Mol Immunol Lab, Brussels, Belgium; [Laoui, Damya; Van Ginderachter, Jo A.] VIB, Myeloid Cell Immunol Lab, Brussels, Belgium; [Lolo, Fidel; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Centro Nacional de Investigaciones Oncologicas (CNIO)	Andres, V (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Lab Mol & Genet Cardiovasc Pathophysiol, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain.	vandres@cnic.es	Lolo, Fidel-Nicolás/R-6039-2018; Serrano, Manuel/H-2634-2015; Van Ginderachter, Jo A/H-5473-2013; Andres, Vicente/I-6440-2014; Pello, Oscar M/Y-6272-2019	Serrano, Manuel/0000-0001-7177-9312; Van Ginderachter, Jo A/0000-0002-4442-7474; Andres, Vicente/0000-0002-0125-7209; Pello, Oscar M/0000-0002-8718-9920; Lolo, Fidel-Nicolas/0000-0003-1635-4770; de Juan, Alba/0000-0003-0174-4389	Spanish Ministry of Science and Innovation (MICINN) [SAF2010-16044]; European Regional Development Fund; RECAVA, Instituto de Salud Carlos III [RD06/0014/0021]; Spanish Ministry of Economy and Competition (MINECO); MINECO; Pro-CNIC Foundation; Ministerio de Economia y Competitividad (MINECO) [AF2010-16044]; Instituto de Salud Carlos III (RECAVA) [RD06/14/21]; European Commision (Marie Curie Career Integration Grant) [PCIG10-GA-2011-303850]; OVlaamse Liga tegen KankerO; OStichting tegen KankerO; IWT-Vlaanderen	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); RECAVA, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Spanish Ministry of Economy and Competition (MINECO)(Spanish Government); MINECO(Spanish Government); Pro-CNIC Foundation; Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Instituto de Salud Carlos III (RECAVA)(Instituto de Salud Carlos III); European Commision (Marie Curie Career Integration Grant); OVlaamse Liga tegen KankerO; OStichting tegen KankerO; IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The V.A. lab is supported by grant SAF2010-16044 from the Spanish Ministry of Science and Innovation (MICINN) and the European Regional Development Fund, grant RD06/0014/0021 (RECAVA, Instituto de Salud Carlos III), and the Dr. Leon Dumont Prize 2010 (Belgian Society of Cardiology). O.M.P. holds a Juan de la Cierva contract from the Spanish Ministry of Economy and Competition (MINECO). The CNIC is supported by the MINECO and the Pro-CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to colleagues for providing reagents (Mercedes Ricote: LysM<SUP>cre/+</SUP> mice, Maria Soengas: B16 melanoma cells, Carlos Zaragoza: MAECs), Ines Ortega and staff from the CNICs Animal Facility for mouse care, and Simon Bartlett for English editing. Work supported by Ministerio de Economia y Competitividad (MINECO) (grant SAF2010-16044 to VA), Instituto de Salud Carlos III (RECAVA, grant RD06/14/21 to VA), European Commision (Marie Curie Career Integration Grant PCIG10-GA-2011-303850 to OMP), Emmanuel van der Schueren grant of the OVlaamse Liga tegen KankerO to DL, and a grant from OStichting tegen KankerO to JAVG. OMP holds a Juan de la Cierva contract from MINECO and DL is supported by a doctoral grant from IWT-Vlaanderen.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Arpa L, 2009, EUR J IMMUNOL, V39, P514, DOI 10.1002/eji.200838283; Baena E, 2007, EXP HEMATOL, V35, P1333, DOI 10.1016/j.exphem.2007.05.015; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Bianchi T, 2006, BLOOD, V107, P3992, DOI 10.1182/blood-2005-09-3851; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Cohen PE, 1999, J LEUKOCYTE BIOL, V66, P765, DOI 10.1002/jlb.66.5.765; de Alboran IM, 2004, CELL DEATH DIFFER, V11, P61, DOI 10.1038/sj.cdd.4401319; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; Dominguez-Caceres MA, 2004, ONCOGENE, V23, P7378, DOI 10.1038/sj.onc.1208002; Efeyan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005475; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hansen BD, 2006, ACTA ONCOL, V45, P400, DOI 10.1080/02841860500471798; He C, 2008, DEVELOPMENT, V135, P2467, DOI 10.1242/dev.020131; Hume DA, 2011, J LEUKOCYTE BIOL, V89, P525, DOI 10.1189/jlb.0810472; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; KLEMSZ MJ, 1989, J IMMUNOL, V143, P1032; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Laoui D, 2011, IMMUNOBIOLOGY, V216, P1192, DOI 10.1016/j.imbio.2011.06.007; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lebel R, 2007, BIOCHEMISTRY-US, V46, P10279, DOI 10.1021/bi700076m; Levens DL, 2003, GENE DEV, V17, P1071, DOI 10.1101/gad.1095203; Lopez-Rivera E, 2005, P NATL ACAD SCI USA, V102, P3685, DOI 10.1073/pnas.0408217102; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mezquita P, 2005, ONCOGENE, V24, P889, DOI 10.1038/sj.onc.1208251; Montet X, 2007, RADIOLOGY, V242, P751, DOI 10.1148/radiol.2423052065; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sipkins DA, 1998, NAT MED, V4, P623, DOI 10.1038/nm0598-623; Snoeks TJA, 2010, ANGIOGENESIS, V13, P135, DOI 10.1007/s10456-010-9168-y; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Tiffen JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-299; Tormo D, 2009, CANCER CELL, V16, P103, DOI 10.1016/j.ccr.2009.07.004; Valledor AF, 2008, BLOOD, V112, P3274, DOI 10.1182/blood-2007-11-123604; Zhu XW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2195	55	38	40	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45399	10.1371/journal.pone.0045399	http://dx.doi.org/10.1371/journal.pone.0045399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028984	Green Published, gold			2022-12-27	WOS:000309388900046
J	Van Belle, TL; Dooms, H; Boonefaes, T; Wei, XQ; Leclercq, G; Grooten, J				Van Belle, Tom L.; Dooms, Hans; Boonefaes, Tom; Wei, Xiao-Qing; Leclercq, Georges; Grooten, Johan			IL-15 Augments TCR-Induced CD4(+) T Cell Expansion In Vitro by Inhibiting the Suppressive Function of CD25(High) CD4(+) T Cells	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; INTERLEUKIN 15; RECEPTOR-ALPHA; SELECTIVE STIMULATION; MEDIATED SUPPRESSION; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; DENDRITIC CELLS; GROWTH-FACTOR; HUMAN NAIVE	Due to its critical role in NK cell differentiation and CD8(+) T cell homeostasis, the importance of IL-15 is more firmly established for cytolytic effectors of the immune system than for CD4(+) T cells. The increased levels of IL-15 found in several CD4(+) T cell-driven (auto-) immune diseases prompted us to examine how IL-15 influences murine CD4(+) T cell responses to low dose TCR-stimulation in vitro. We show that IL-15 exerts growth factor activity on both CD4(+) and CD8+ T cells in a TCR-dependent and Cyclosporin A-sensitive manner. In CD4(+) T cells, IL-15 augmented initial IL-2-dependent expansion and once IL-15R alpha was upregulated, IL-15 sustained the TCR-induced expression of IL-2/15R beta, supporting proliferation independently of secreted IL-2. Moreover, IL-15 counteracts CD4(+) T cell suppression by a gradually expanding CD25(High)CD4(+) T cell subset that expresses Foxp3 and originates from CD4(+)CD25(+) Tregs. These in vitro data suggest that IL-15 may dramatically strengthen the T cell response to suboptimal TCR-triggering by overcoming an activation threshold set by Treg that might create a risk for autoimmune pathology.	[Van Belle, Tom L.; Boonefaes, Tom; Grooten, Johan] Univ Ghent, Lab Mol Immunol, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Dooms, Hans] Boston Univ, Sch Med, Ctr Arthritis, Rheumatol Sect, Boston, MA 02118 USA; [Wei, Xiao-Qing] Cardiff Univ, Tissue Engn & Reparat Dent Dent Sch, Cardiff, S Glam, Wales; [Leclercq, Georges] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	Ghent University; Boston University; Cardiff University; Ghent University	Van Belle, TL (corresponding author), Univ Ghent, Lab Mol Immunol, Dept Biomed Mol Biol, B-9000 Ghent, Belgium.	tom.vanbelle@med.kuleuven.be; Johan.Grooten@UGent.be		Dooms, Hans/0000-0001-7964-0876	Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie (IWT) Vlaanderen; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0063.09N10]; Interuniversitaire Attractiepolen [IAP5/12, IAP6/18]	Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie (IWT) Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); Interuniversitaire Attractiepolen	This study was supported by grants from the Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie (IWT) Vlaanderen to TLVB, and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (G.0063.09N10) and the Interuniversitaire Attractiepolen (IAP5/12, IAP6/18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MB, 2009, J IMMUNOL, V182, P6763, DOI 10.4049/jimmunol.0801792; Ajjan RA, 1997, J CLIN ENDOCR METAB, V82, P666, DOI 10.1210/jc.82.2.666; Alves NL, 2003, BLOOD, V102, P2541, DOI 10.1182/blood-2003-01-0183; Aringer M, 2001, RHEUMATOLOGY, V40, P876, DOI 10.1093/rheumatology/40.8.876; Azimi N, 1998, P NATL ACAD SCI USA, V95, P2452, DOI 10.1073/pnas.95.5.2452; Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; Barron L, 2010, J IMMUNOL, V185, P6426, DOI 10.4049/jimmunol.0903940; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Calarota SA, 2008, VACCINE, V26, P5188, DOI 10.1016/j.vaccine.2008.03.067; Cope AP, 2002, ARTHRITIS RES THER, V4, pS197, DOI 10.1186/ar557; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Di Sabatino A, 2011, CYTOKINE GROWTH F R, V22, P19, DOI 10.1016/j.cytogfr.2010.09.003; Dooms H, 2000, BLOOD, V96, P1006, DOI 10.1182/blood.V96.3.1006.015k27_1006_1012; Dooms H, 1998, J IMMUNOL, V161, P2141; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Georger TC, 2003, EUR J IMMUNOL, V33, P502, DOI 10.1002/immu.200310026; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hoyer KK, 2007, J IMMUNOL, V179, P2844, DOI 10.4049/jimmunol.179.5.2844; Jakobisiak M, 2011, CYTOKINE GROWTH F R, V22, P99, DOI 10.1016/j.cytogfr.2011.04.001; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Jullien D, 1997, J IMMUNOL, V158, P800; Kanegane H, 1996, BLOOD, V88, P230; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Kim JJ, 1998, EUR J IMMUNOL, V28, P1089, DOI 10.1002/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L; Kuczynski S, 2005, DIABETES RES CLIN PR, V69, P231, DOI 10.1016/j.diabres.2005.02.007; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Leclercq G, 1996, J EXP MED, V184, P325, DOI 10.1084/jem.184.2.325; Lee JM, 2004, J IMMUNOL, V173, P3155, DOI 10.4049/jimmunol.173.5.3155; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Ma LJ, 2009, J IMMUNOL, V183, P1044, DOI 10.4049/jimmunol.0900420; Mattei F, 2001, J IMMUNOL, V167, P1179, DOI 10.4049/jimmunol.167.3.1179; McInnes IB, 1998, IMMUNOL TODAY, V19, P75, DOI 10.1016/S0167-5699(97)01205-X; McInnes IB, 1996, NAT MED, V2, P175, DOI 10.1038/nm0296-175; Niedbala W, 2002, EUR J IMMUNOL, V32, P341, DOI 10.1002/1521-4141(200202)32:2<341::AID-IMMU341>3.0.CO;2-X; Nishimura H, 1996, J IMMUNOL, V156, P663; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Rubinstein MP, 2008, BLOOD, V112, P3704, DOI 10.1182/blood-2008-06-160945; Ruchatz H, 1998, J IMMUNOL, V160, P5654; Ruckert R, 2009, IMMUNOLOGY, V126, P63, DOI 10.1111/j.1365-2567.2008.02878.x; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sandau MM, 2010, J IMMUNOL, V184, P35, DOI 10.4049/jimmunol.0803355; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Sprent J, 1999, IMMUNOL LETT, V65, P21, DOI 10.1016/S0165-2478(98)00119-9; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; STEIGER J, 1995, J IMMUNOL, V155, P489; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Van Belle T, 2005, ARCH IMMUNOL THER EX, V53, P115; Vang KB, 2008, J IMMUNOL, V181, P3285, DOI 10.4049/jimmunol.181.5.3285; Verbist KC, 2011, J IMMUNOL, V186, P174, DOI 10.4049/jimmunol.1002613; Villinger F, 2004, VACCINE, V22, P3510, DOI 10.1016/j.vaccine.2003.07.022; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wei XQ, 2001, J IMMUNOL, V167, P277, DOI 10.4049/jimmunol.167.1.277; Xin KQ, 1999, VACCINE, V17, P858, DOI 10.1016/S0264-410X(98)00271-0; Yoshikai Y, 2000, MICROBES INFECT, V2, P381, DOI 10.1016/S1286-4579(00)00329-4; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	80	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45299	10.1371/journal.pone.0045299	http://dx.doi.org/10.1371/journal.pone.0045299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028916	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000309388900037
J	Weisenberg, SA; Mediavilla, JR; Chen, L; Alexander, EL; Rhee, KY; Kreiswirth, BN; Jenkins, SG				Weisenberg, Scott A.; Mediavilla, Jose R.; Chen, Liang; Alexander, Elizabeth L.; Rhee, Kyu Y.; Kreiswirth, Barry N.; Jenkins, Stephen G.			Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae in International Travelers and Non-Travelers in New York City	PLOS ONE			English	Article							ESCHERICHIA-COLI; MULTIPLEX PCR; INTESTINAL ENTEROBACTERIACEAE; COLONIZATION; GENES; INFECTIONS; EMERGENCE; RESISTANCE; DIVERSITY; FECES	Background: We performed this study 1) to determine the prevalence of community-associated extended spectrum beta-lactamase producing Enterobacteriaceae (ESBLPE) colonization and infection in New York City (NYC); 2) to determine the prevalence of newly-acquired ESBLPE during travel; 3) to look for similarilties in contemporaneous hospital-associated bloodstream ESBLPE and travel-associated ESBLPE. Methods: Subjects were recruited from a travel medicine practice and consented to submit pre- and post-travel stools, which were assessed for the presence of ESBLPE. Pre-travel stools and stools submitted for culture were used to estimate the prevalence of community-associated ESBLPE. The prevalence of ESBLPE-associated urinary tract infections was calculated from available retrospective data. Hospital-associated ESBLPE were acquired from saved bloodstream isolates. All ESBLPE underwent multilocus sequence typing (MLST) and ESBL characterization. Results: One of 60 (1.7%) pre- or non-travel associated stool was colonized with ESBLPE. Among community-associated urine specimens, 1.3% of Escherichia coli and 1.4% of Klebsiella pneumoniae were identified as ESBLPE. Seven of 28 travelers (25.0%) acquired a new ESBLPE during travel. No similarities were found between travel-associated ESBLPE and hospital-associated ESBLPE. A range of imported ESBL genes were found, including CTX-M-14 and CTX-15. Conclusion: ESBL colonization and infection were relatively low during the study period in NYC. A signficant minority of travelers acquired new ESBLPE during travel.	[Weisenberg, Scott A.] Alta Bates Summit Med Ctr, Dept Med, Oakland, CA USA; [Mediavilla, Jose R.; Chen, Liang; Kreiswirth, Barry N.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Alexander, Elizabeth L.; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Jenkins, Stephen G.] Weill Cornell Med Coll, Dept Pathol, New York, NY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Cornell University; Cornell University	Weisenberg, SA (corresponding author), Alta Bates Summit Med Ctr, Dept Med, Oakland, CA USA.	scottweisenberg@gmail.com		Chen, Liang/0000-0001-5845-2235; Weisenberg, Scott/0000-0002-4839-1296	Merck	Merck(Merck & Company)	Merck provided funding for an Investigator Initiated Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck was allowed to see a copy of the manuscript prior to submissions ( with no edits). Merck has agreed to pay the submission fee as per the Grant contract.	Chaudhuri B N, 2011, J Assoc Physicians India, V59, P287; Chen LA, 2011, J CLIN MICROBIOL, V49, P579, DOI 10.1128/JCM.01588-10; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI; Costa D, 2009, VET MICROBIOL, V138, P339, DOI 10.1016/j.vetmic.2009.03.029; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P1005, DOI 10.1093/jac/dkr041; GAARSLEV K, 1985, CURR MED RES OPIN, V9, P384, DOI 10.1185/03007998509109608; Hawkey PM, 2008, CLIN MICROBIOL INFEC, V14, P159, DOI 10.1111/j.1469-0691.2007.01855.x; Herindrainy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022738; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; KOZICKI M, 1985, INT J EPIDEMIOL, V14, P169, DOI 10.1093/ije/14.1.169; Kuster SP, 2010, INFECTION, V38, P33, DOI 10.1007/s15010-009-9207-z; Laupland KB, 2008, J INFECTION, V57, P441, DOI 10.1016/j.jinf.2008.09.034; Lee JC, 2012, J MICROBIOL IMMUNOL, V45, P127, DOI 10.1016/j.jmii.2011.09.029; Li B, 2011, SCAND J INFECT DIS, V43, P170, DOI 10.3109/00365548.2010.538856; Meier S, 2011, INFECTION, V39, P333, DOI 10.1007/s15010-011-0132-6; MURRAY BE, 1982, NEW ENGL J MED, V306, P130, DOI 10.1056/NEJM198201213060302; Niki M, 2011, INFECTION, V39, P467, DOI 10.1007/s15010-011-0128-2; Park SH, 2011, MICROB DRUG RESIST, V17, P537, DOI 10.1089/mdr.2011.0072; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Rahman EMA, 2011, J INVEST MED, V59, P1284, DOI 10.2130/JIM.0b013e318238748e; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Tangden T, 2010, ANTIMICROB AGENTS CH, V54, P3564, DOI 10.1128/AAC.00220-10; Tham J, 2010, SCAND J INFECT DIS, V42, P275, DOI 10.3109/00365540903493715; Valverde A, 2008, J CLIN MICROBIOL, V46, P2796, DOI 10.1128/JCM.01008-08; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004	31	42	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45141	10.1371/journal.pone.0045141	http://dx.doi.org/10.1371/journal.pone.0045141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23028808	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388900025
J	Vapniarsky, N; Lame, M; McDonnel, S; Murphy, B				Vapniarsky, Natalia; Lame, Michael; McDonnel, Samantha; Murphy, Brian			A Lentiviral Gene Therapy Strategy for the In Vitro Production of Feline Erythropoietin	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; CHRONIC-RENAL-FAILURE; METACHROMATIC LEUKODYSTROPHY; AUTOIMMUNE ANEMIA; EXPRESSION; CELLS; VECTORS; CATS; MACAQUES; DELIVERY	Nonregenerative anemia due to chronic renal failure is a common problem in domestic cats. Unfortunately, administration of recombinant human erythropoietin often only improves anemia temporarily due to antibody development. In this in vitro study, feline erythropoietin cDNA was cloned from feline renal tissue and utilized in the construction of a replication-defective lentiviral vector. The native recombinant feline erythropoietin (rfEPO) sequence was confirmed by sequencing. Upon viral vector infection of human 293H cells, Crandall Renal Feline Kidney cell line and primary feline peripheral blood mononuclear cells, bioactive rfEPO protein was produced. The presence of cellular rfEPO cDNA was confirmed by standard PCR, production of abundant rfEPO mRNA was confirmed by real-time PCR, and secretion of rfEPO protein was demonstrated by Western blot analyses, while rfEPO protein bioactivity was confirmed via an MTT proliferation bioassay. This in vitro study demonstrates the feasibility of a replication-defective lentiviral vector delivery system for the in vitro production of biologically active feline erythropoietin. Anemic cats with chronic renal failure represent a potential in vivo application of a lentiviral gene therapy system.	[Vapniarsky, Natalia; Murphy, Brian] Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA; [Lame, Michael] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [McDonnel, Samantha] Univ Calif Davis, Grad Grp Comparat Pathol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Vapniarsky, N (corresponding author), Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA.	vapniarsky@ucdavis.edu		Evans, Samantha/0000-0003-2182-0684	Morris Animal Foundation [D12FE803]; Winn Feline Foundation [W11-035]	Morris Animal Foundation; Winn Feline Foundation	The work was supported by the following: Morris Animal Foundation http://www.morrisanimalfoundation.org award #D12FE803; and Winn Feline Foundation http://www.winnfelinehealth.org award #W11-035 and matched by Center of Companion Animal Health http://www.vetmed.ucdavis.edu/ccah/index.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Individuals employed or contracted by the funders played no any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abordo-Adesida E, 2005, HUM GENE THER, V16, P741, DOI 10.1089/hum.2005.16.741; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Baldwin SL, 2003, AM J VET RES, V64, P1465, DOI 10.2460/ajvr.2003.64.1465; Beall CJ, 2000, GENE THER, V7, P534, DOI 10.1038/sj.gt.3301126; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Binley K, 2002, BLOOD, V100, P2406, DOI 10.1182/blood-2002-02-0605; Bischof CK, 2010, FLEXIBILITY CELL TAR; BLOOMBERG RM, 1992, CAN VET J, V33, P612; Carpentier DCJ, 2012, GENE THER, V19, P761, DOI 10.1038/gt.2011.124; Chalhoub S, J FELINE MED SURG, V13, P629; Chenuaud P, 2004, BLOOD, V103, P3303, DOI 10.1182/blood-2003-11-3845; Consiglio A, 2001, NAT MED, V7, P310, DOI 10.1038/85454; Cowgill L, 1995, CVT UPDATE USE RECOM; Cowgill LD, 1998, J AM VET MED ASSOC, V212, P521; Cowgill LD, 1992, PATHOPHYSIOLOGY MANA; Cowgill LD, 1992, APPL RECOMBINANT HUM; DIBARTOLA SP, 1987, J AM VET MED ASSOC, V190, P1196; Elliott J, 1998, J SMALL ANIM PRACT, V39, P78, DOI 10.1111/j.1748-5827.1998.tb03598.x; Elliott S, 1997, BLOOD, V89, P493, DOI 10.1182/blood.V89.2.493; Fisher JW, 1996, BRIT J HAEMATOL, V95, P27, DOI 10.1046/j.1365-2141.1996.d01-1864.x; Gao GP, 2004, BLOOD, V103, P3300, DOI 10.1182/blood-2003-11-3852; Giger, 1992, COMPEND CONTIN ED PR, V14, P25; Ginn SL, 2010, MOL THER, V18, P965, DOI 10.1038/mt.2010.50; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Knight S, 2010, J VIROL, V84, P4856, DOI 10.1128/JVI.02476-09; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; KOURY ST, 1988, BLOOD, V71, P524; Langston RN, 2003, USE ERYTHROPOIETIN; Lee CL, 2011, VIRUS RES, V160, P340, DOI 10.1016/j.virusres.2011.07.010; LULICH JP, 1992, COMP CONT EDUC PRACT, V14, P127; Oh TK, 2006, AM J NEPHROL, V26, P326, DOI 10.1159/000094401; Polzin OC, 2000, CHRONIC RENAL FAILUR; Randolph JF, 2004, AM J VET RES, V65, P1355, DOI 10.2460/ajvr.2004.65.1355; Richard-Fiardo P, 2008, HUM GENE THER, V19, P331, DOI 10.1089/hum.2006.0101; Sebestyen MG, 2007, HUM GENE THER, V18, P269, DOI 10.1089/hum.2006.186; Seppen J, 2001, BLOOD, V98, P594, DOI 10.1182/blood.V98.3.594; Walker MC, 2005, AM J VET RES, V66, P450, DOI 10.2460/ajvr.2005.66.450; WEN D, 1993, BLOOD, V82, P1507; Yi Y, 2011, CURR GENE THER, V11, P218	39	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45099	10.1371/journal.pone.0045099	http://dx.doi.org/10.1371/journal.pone.0045099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028782	gold, Green Submitted, Green Published			2022-12-27	WOS:000311313900078
J	Wisshak, M; Schonberg, CHL; Form, A; Freiwald, A				Wisshak, Max; Schoenberg, Christine H. L.; Form, Armin; Freiwald, Andre			Ocean Acidification Accelerates Reef Bioerosion	PLOS ONE			English	Article							CORAL-REEFS; CARBONATE BUDGETS; CALCIFICATION; SEAWATER; PACIFIC; SPONGE	In the recent discussion how biotic systems may react to ocean acidification caused by the rapid rise in carbon dioxide partial pressure (pCO(2)) in the marine realm, substantial research is devoted to calcifiers such as stony corals. The antagonistic process - biologically induced carbonate dissolution via bioerosion - has largely been neglected. Unlike skeletal growth, we expect bioerosion by chemical means to be facilitated in a high-CO2 world. This study focuses on one of the most detrimental bioeroders, the sponge Cliona orientalis, which attacks and kills live corals on Australia's Great Barrier Reef. Experimental exposure to lowered and elevated levels of pCO(2) confirms a significant enforcement of the sponges' bioerosion capacity with increasing pCO(2) under more acidic conditions. Considering the substantial contribution of sponges to carbonate bioerosion, this finding implies that tropical reef ecosystems are facing the combined effects of weakened coral calcification and accelerated bioerosion, resulting in critical pressure on the dynamic balance between biogenic carbonate build-up and degradation.	[Wisshak, Max; Freiwald, Andre] SENCKENBERG Meer, Marine Res Dept, Wilhelmshaven, Germany; [Schoenberg, Christine H. L.] Univ Western Australia, Oceans Inst, Australian Inst Marine Sci AIMS, Crawley, WA, Australia; [Form, Armin] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany	Senckenberg Gesellschaft fur Naturforschung (SGN); University of Western Australia; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Wisshak, M (corresponding author), SENCKENBERG Meer, Marine Res Dept, Wilhelmshaven, Germany.	max.wisshak@senckenberg.de	Freiwald, Andre/C-2061-2018; Wisshak, Max/A-3418-2011; Schönberg, Christine/B-3925-2009	Freiwald, Andre/0000-0002-2335-4042; Wisshak, Max/0000-0001-7531-3317; Schönberg, Christine/0000-0001-6286-8196	Deutsche Forschungsgemeinschaft (DFG) [Fr 1134/19]; Australian Institute of Marine Science (AIMS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Australian Institute of Marine Science (AIMS)	This study was financially supported by the Deutsche Forschungsgemeinschaft (DFG) grant Fr 1134/19, and fieldwork was co-funded by the Australian Institute of Marine Science (AIMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKER KL, 1985, J SEDIMENT PETROL, V55, P705; Andersson AJ, 2009, BIOGEOSCIENCES, V6, P1811, DOI 10.5194/bg-6-1811-2009; Andersson A. J., 2011, OCEAN ACIDIFICATION, P122; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; DAVIES PS, 1989, MAR BIOL, V101, P389; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fang JKH, MAR ECOL IN PRESS; Fine M, 2002, P ROY SOC B-BIOL SCI, V269, P1205, DOI 10.1098/rspb.2002.1983; Gagliano M, 2010, MAR BIOL, V157, P1849, DOI 10.1007/s00227-010-1456-y; Gattuso J.-P., 2010, GUIDE BEST PRACTICES, P41, DOI DOI 10.1016/J.JOMS.2003.10.009; Gattuso J-P, 2011, OCEAN ACIDIFICATION; Glynn Peter W., 1997, P68; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Mallela J, 2007, CORAL REEFS, V26, P129, DOI 10.1007/s00338-006-0169-7; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Nava H, 2008, J EXP BIOL, V211, P2827, DOI 10.1242/jeb.019216; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Perry CT, 2008, CORAL REEFS, V27, P853, DOI 10.1007/s00338-008-0418-z; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; RISK MJ, 1995, CORAL REEFS, V14, P79, DOI 10.1007/BF00303427; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Schonberg CHL, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P165, DOI 10.1007/978-3-540-77598-0_9; Schoenberg Christine H. L., 2007, V28, P569; Schonberg CHL, 2008, MAR ECOL-EVOL PERSP, V29, P247, DOI 10.1111/j.1439-0485.2007.00216.x; Schoenberg Christine Hanna Lydia, 2000, Senckenbergiana Maritima, V30, P161; Schonberg CHL, 2002, MAR ECOL-P S Z N I, V23, P313, DOI 10.1046/j.1439-0485.2002.02811.x; Schonberg CHL, 2001, CORAL REEFS, V20, P69; Tribollet A, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003286; Veron John E.N., 2011, Diversity, V3, P262; Wisshak M., 2008, CURRENT DEV BIOEROSI	36	145	146	10	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45124	10.1371/journal.pone.0045124	http://dx.doi.org/10.1371/journal.pone.0045124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23028797	Green Accepted, Green Published, gold			2022-12-27	WOS:000311313900083
J	Khamis, FM; Masiga, DK; Mohamed, SA; Salifu, D; de Meyer, M; Ekesi, S				Khamis, Fathiya M.; Masiga, Daniel K.; Mohamed, Samira A.; Salifu, Daisy; de Meyer, Marc; Ekesi, Sunday			Taxonomic Identity of the Invasive Fruit Fly Pest, Bactrocera invadens: Concordance in Morphometry and DNA Barcoding	PLOS ONE			English	Article							DIPTERA TEPHRITIDAE; CERATITIS-CAPITATA; FLIES DIPTERA; PHYLOGENETIC-RELATIONSHIPS; DORSALIS COMPLEX; DISCRIMINATION; DACINAE; IDENTIFICATION; HISTORY; REGION	In 2003, a new fruit fly pest species was recorded for the first time in Kenya and has subsequently been found in 28 countries across tropical Africa. The insect was described as Bactrocera invadens, due to its rapid invasion of the African continent. In this study, the morphometry and DNA Barcoding of different populations of B. invadens distributed across the species range of tropical Africa and a sample from the pest's putative aboriginal home of Sri Lanka was investigated. Morphometry using wing veins and tibia length was used to separate B. invadens populations from other closely related Bactrocera species. The Principal component analysis yielded 15 components which correspond to the 15 morphometric measurements. The first two principal axes contributed to 90.7% of the total variance and showed partial separation of these populations. Canonical discriminant analysis indicated that only the first five canonical variates were statistically significant. The first two canonical variates contributed a total of 80.9% of the total variance clustering B. invadens with other members of the B. dorsalis complex while distinctly separating B. correcta, B. cucurbitae, B. oleae and B. zonata. The largest Mahalanobis squared distance (D-2 = 122.9) was found to be between B. cucurbitae and B. zonata, while the lowest was observed between B. invadens populations against B. kandiensis (8.1) and against B. dorsalis s.s (11.4). Evolutionary history inferred by the Neighbor-Joining method clustered the Bactrocera species populations into four clusters. First cluster consisted of the B. dorsalis complex (B. invadens, B. kandiensis and B. dorsalis s.s.), branching from the same node while the second group was paraphyletic clades of B. correcta and B. zonata. The last two are monophyletic clades, consisting of B. cucurbitae and B. oleae, respectively. Principal component analysis using the genetic distances confirmed the clustering inferred by the NJ tree.	[Khamis, Fathiya M.; Mohamed, Samira A.; Salifu, Daisy; Ekesi, Sunday] Int Ctr Insect Physiol & Ecol Icipe, African Fruit Fly Programme, Nairobi, Kenya; [Khamis, Fathiya M.] Kenyatta Univ, Dept Biochem & Biotechnol, Nairobi, Kenya; [Masiga, Daniel K.] Int Ctr Insect Physiol & Ecol Icipe, Mol Biol & Biotechnol Dept, Nairobi, Kenya; [de Meyer, Marc] Royal Museum Cent Africa, Tervuren, Belgium	International Centre of Insect Physiology & Ecology (ICIPE); Kenyatta University; International Centre of Insect Physiology & Ecology (ICIPE); Royal Museum for Central Africa	Khamis, FM (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, African Fruit Fly Programme, Nairobi, Kenya.	fkhamis@icipe.org	Ekesi, Sunday/P-8944-2019	Masiga, Daniel/0000-0001-7513-0887	International Atomic Energy Agency (IAEA) Vienna, Austria [16072]; German Ministry of Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) [81132021]	International Atomic Energy Agency (IAEA) Vienna, Austria(International Atomic Energy Agency); German Ministry of Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	The authors are grateful to the International Atomic Energy Agency (IAEA) Vienna, Austria (Contract number 16072), and the German Ministry of Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) (Contract number 81132021) for grant support for this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda FXN, 2008, FRUITS, V63, P19, DOI 10.1051/fruits:2007041; Adsavakulchai A., 1999, Biotropia, V13, P37; Armstrong Karen F., 2000, P703; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Armstrong KF, 1997, B ENTOMOL RES, V87, P111, DOI 10.1017/S0007485300027243; Barr NB, 2006, B ENTOMOL RES, V96, P505, DOI 10.1079/BER2006452; Barr NB, 2012, ANN ENTOMOL SOC AM, V105, P339, DOI 10.1603/AN11100; Barr NB, 2009, J ECON ENTOMOL, V102, P401, DOI 10.1603/029.102.0153; Bartlett MS, 1950, B J PSYCHOL-STAT SEC, V3, P77, DOI 10.1111/j.2044-8317.1950.tb00285.x; Bartlett MS, 1951, B J PSYCHOL-STAT SEC, V4, P1, DOI 10.1111/j.2044-8317.1951.tb00299.x; BAXTER MJ, 1995, J R STAT SOC C-APPL, V44, P513, DOI 10.2307/2986142; Billah M. K., 2005, International Journal of Tropical Insect Science, V25, P168, DOI 10.1079/IJT200573; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; De Meyer M, 2005, INSECT SYST EVOL, V36, P459, DOI 10.1163/187631205794761012; De Meyer M, 2000, ZOOL J LINN SOC-LOND, V128, P439, DOI 10.1111/j.1096-3642.2000.tb01523.x; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Drew RAI, 2005, AFR ENTOMOL, V13, P149; Drew RAI, 2008, BIOL J LINN SOC, V93, P217, DOI 10.1111/j.1095-8312.2007.00952.x; Drew RAI, 2006, J ECON ENTOMOL, V99, P1651, DOI 10.1603/0022-0493-99.5.1651; Ekesi S, 2006, B ENTOMOL RES, V96, P379, DOI 10.1079/BER2006442; Ekesi S, 2007, FIELD GUIDE MANAGEME; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; French C, 2005, INSECT PEST CONTROL, P19; Goergen G, 2011, ENVIRON ENTOMOL, V40, P844, DOI 10.1603/EN11017; Hajibabaei M, 2007, SCI DIRECT, V10, P1; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez-Ortiz V, 2012, ANN ENTOMOL SOC AM, V105, P305, DOI 10.1603/AN11123; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lawson AE, 2003, DORSALIS INTERACTIVE; Lux Slawomir A., 2003, Insect Science and its Application, V23, P355; MCNAMEE S, 1993, SYST ENTOMOL, V18, P231, DOI 10.1111/j.1365-3113.1993.tb00663.x; McPheron BA, 1996, FRUIT FLY PESTS WORL; McPheron Bruce A., 2000, P483; Morrow J, 2000, EVOLUTION, V54, P899, DOI 10.1111/j.0014-3820.2000.tb00090.x; Muraji M, 2002, APPL ENTOMOL ZOOL, V37, P437, DOI 10.1303/aez.2002.437; Muraji M, 2001, INSECT MOL BIOL, V10, P549, DOI 10.1046/j.0962-1075.2001.00294.x; Mwatawala Maulid W., 2006, Fruits, V61, P321, DOI 10.1051/fruits:2006031; Mwatawala MW, 2009, B ENTOMOL RES, P1; Nakahara Shigehito, 2001, Research Bulletin of the Plant Protection Service Japan, V37, P69; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perero JG, 1984, AN 2 C INT BIOM FAC, P421; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reyment RA, 1984, MULTIVARIATE MORPHOM; Rwomushana I, 2008, ANN ENTOMOL SOC AM, V101, P331, DOI 10.1603/0013-8746(2008)101[331:HPAHPP]2.0.CO;2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schutze MK, 2012, B ENTOMOL RES, V102, P103, DOI 10.1017/S0007485311000423; Selivon D, 1996, THESIS U SAO PAULO B, P137; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Sonvico A, 1996, J ECON ENTOMOL, V89, P1208, DOI 10.1093/jee/89.5.1208; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan KH, 2011, CHEMOECOLOGY, V21, P25, DOI 10.1007/s00049-010-0063-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Houdt JKJ, 2010, MOL ECOL RESOUR, V10, P459, DOI 10.1111/j.1755-0998.2009.02800.x; Vayssieres Jean-Francois, 2005, Fruits, V60, P371, DOI 10.1051/fruits:2005042; Vayssieres JF, 2009, CROP PROT, V28, P477, DOI 10.1016/j.cropro.2009.01.010; Virgilio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031581; WILLIG MR, 1986, SYST ZOOL, V35, P195, DOI 10.2307/2413430; Zar J.H., 2010, BIOSTAT ANAL	62	41	49	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44862	10.1371/journal.pone.0044862	http://dx.doi.org/10.1371/journal.pone.0044862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028649	Green Published, Green Submitted, gold			2022-12-27	WOS:000309742800020
J	LaVinka, PC; Park, TJ				LaVinka, Pamela Colleen; Park, Thomas J.			Blunted Behavioral and C Fos Responses to Acidic Fumes in the African Naked Mole-Rat	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; HYPOXIA TOLERANCE; CARBON-DIOXIDE; NASAL-MUCOSA; NEURONS; ACTIVATION; NUCLEUS; BRAIN; STIMULATION; EXPRESSION	Acidosis in the skin triggers activation of pain pathways and behaviors indicative of pain in vertebrates. The exception is the naked mole-rat, the only known vertebrate to show physiological and behavioral insensitivity to acid pain in the skin. The goal of the present study was to determine behavioral and physiological responses of this species to airborne acidic fumes, which would be expected to affect the trigeminal pain pathway in other species. Behaviorally, naked mole-rats did not avoid fumes from moderately high concentrations of acetic acid (10 and 20%), and c Fos labeling showed no increase in activity in the trigeminal nuclei and nucleus tractus solitarius. In contrast, these concentrations triggered behavioral aversion and increased Fos activity in other laboratory rodents. For a very high concentration of acetic acid (50%), naked mole-rats showed significant avoidance behavior and increased Fos labeling in the nucleus tractus solitarius caudal region, which receives vagal chemosensory information. However, there was no increase in trigeminal labeling, and in fact, activity significantly decreased. This pattern is opposite of that associated with another irritant, ammonia fumes, which elicited an increase in trigeminal but not nucleus tractus solitarius Fos labeling, and no behavioral avoidance. Behavioral avoidance of acidic fumes, but no increased labeling in the trigeminal pain nucleus is consistent with the notion of adaptations to blunt acid pain, which would be advantageous for naked mole-rats as they normally live under chronically high levels of acidosis-inducing CO2.	[Park, Thomas J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; Univ Illinois, Lab Integrat Neurosci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Park, TJ (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	TPark@uic.edu			National Science Foundation [0744979]; Direct For Biological Sciences [0744979] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by National Science Foundation grant number 0744979. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheid GF, 2011, NEUROSCIENCE, V190, P207, DOI 10.1016/j.neuroscience.2011.06.005; Alimohammadi H, 2000, CHEM SENSES, V25, P61, DOI 10.1093/chemse/25.1.61; ANTON F, 1992, PAIN, V49, P53, DOI 10.1016/0304-3959(92)90187-G; ANTON F, 1991, NEUROSCIENCE, V41, P629, DOI 10.1016/0306-4522(91)90355-R; ANTON F, 1991, NEUROSCIENCE, V41, P617, DOI 10.1016/0306-4522(91)90354-Q; Arai T, 2010, NEUROSCIENCE, V165, P1476, DOI 10.1016/j.neuroscience.2009.11.051; Artwohl J, 2002, LAB ANIMAL, V31, P32; Baraniuk JN, 2007, CURR ALLERGY ASTHM R, V7, P105, DOI 10.1007/s11882-007-0007-1; BENNETT NC, 2000, AFRICAN MOLE RATS EC, P29; Brand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015162; Brett R.A., 1991, P97; Bryant BP, 2005, CHEM SENSES, V30, pI196, DOI 10.1093/chemse/bjh182; Burn CC, 2006, LAB ANIM-UK, V40, P353, DOI 10.1258/002367706778476460; Carstens E, 1998, J NEUROPHYSIOL, V80, P465, DOI 10.1152/jn.1998.80.2.465; CHEN XJ, 1995, EUR J NEUROSCI, V7, P1154, DOI 10.1111/j.1460-9568.1995.tb01105.x; Corson J, 2012, J COMP NEUROL, V520, P495, DOI 10.1002/cne.22715; Cruz JD, 2010, AUTON NEUROSCI-BASIC, V152, P27, DOI 10.1016/j.autneu.2009.08.016; Dhaka A, 2009, J NEUROSCI, V29, P153, DOI 10.1523/JNEUROSCI.4901-08.2009; Ernstgard L, 2006, TOXICOL LETT, V165, P22, DOI 10.1016/j.toxlet.2006.01.010; Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957; GEPPETTI P, 1991, REGUL PEPTIDES, V33, P321, DOI 10.1016/0167-0115(91)90234-8; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JOHANSEN K, 1976, RESP PHYSIOL, V28, P303, DOI 10.1016/0034-5687(76)90025-6; Kaise T, 2001, JPN J PHARMACOL, V86, P258, DOI 10.1254/jjp.86.258; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf; LaVinka PC, 2009, J COMP PHYSIOL A, V195, P419, DOI 10.1007/s00359-009-0420-0; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; LIPSKI J, 1991, J PHYSIOL-LONDON, V443, P55, DOI 10.1113/jphysiol.1991.sp018822; LIU L, 1993, BRAIN RES, V617, P37, DOI 10.1016/0006-8993(93)90609-Q; LUNDBLAD L, 1983, ACTA OTO-LARYNGOL, V96, P485, DOI 10.3109/00016488309132735; McCulloch PF, 1997, NEUROSCIENCE, V78, P913, DOI 10.1016/S0306-4522(96)00633-1; MIURA M, 1994, NEUROSCI LETT, V178, P227, DOI 10.1016/0304-3940(94)90765-X; Niel L, 2007, APPL ANIM BEHAV SCI, V107, P100, DOI 10.1016/j.applanim.2006.08.002; O'Connor TP, 2002, COMP BIOCHEM PHYS A, V133, P835, DOI 10.1016/S1095-6433(02)00198-8; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Park TJ, 2003, J COMP NEUROL, V465, P104, DOI 10.1002/cne.10824; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Peterson BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031568; Peterson BL, 2012, NEUROSCI LETT, V506, P342, DOI 10.1016/j.neulet.2011.11.042; SEKIZAWA S, 1994, RESP PHYSIOL, V96, P37, DOI 10.1016/0034-5687(94)90104-X; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Silverman J, 2009, LAB ANIMAL, V38, P16, DOI 10.1038/laban0109-16; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; Smith ES, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-29; Takada SH, 2011, J NEUROSCI METH, V198, P62, DOI 10.1016/j.jneumeth.2011.03.009; Takakura ACT, 2006, J PHYSIOL-LONDON, V572, P503, DOI 10.1113/jphysiol.2005.103788; Takeda M, 1999, ARCH HISTOL CYTOL, V62, P165, DOI 10.1679/aohc.62.165; Taylor-Clark TE, 2005, J ALLERGY CLIN IMMUN, V116, P1282, DOI 10.1016/j.jaci.2005.08.043; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Xiao J, 2006, NEUROSCIENCE, V141, P1415, DOI 10.1016/j.neuroscience.2006.03.077	55	13	13	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45060	10.1371/journal.pone.0045060	http://dx.doi.org/10.1371/journal.pone.0045060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028761	Green Published, gold			2022-12-27	WOS:000309742800032
J	Xing, YF; Niu, T; Wang, WJ; Li, JQ; Li, SY; Janicki, JS; Ruiz, S; Meyer, CJ; Wang, XL; Tang, DQ; Zhao, YX; Cui, TX				Xing, Yifan; Niu, Ting; Wang, Wenjuan; Li, Jinqing; Li, Siying; Janicki, Joseph S.; Ruiz, Stacey; Meyer, Colin J.; Wang, Xing Li; Tang, Dongqi; Zhao, Yuxia; Cui, Taixing			Triterpenoid Dihydro-CDDO-Trifluoroethyl Amide Protects against Maladaptive Cardiac Remodeling and Dysfunction in Mice: A Critical Role of Nrf2	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; OXIDATIVE STRESS; HEART-FAILURE; IN-VITRO; DISEASE; CARDIOMYOCYTES; CONTRIBUTES; METHYL; CELLS; VIVO	Background and Aims: Nuclear factor E2-related factor 2 (Nrf2) appears to be an attractive therapeutic target for the treatment of cardiac disease. We investigated whether a synthetic triterpenoid derivative of dihydro-CDDO-trifluoroethylamide (dh404), a novel Nrf2 activator, protects against pathological cardiac responses to hemodynamic stress in mice. Methods: Cardiac maladaptive remodeling and dysfunction were established by transverse aortic constriction (TAC) in mice. Hypertrophic growth of rat neonatal cardiomyocytes was induced by angiotensin II (Ang II). Cell death of rat neonatal cardiomyocytes was induced with hydrogen peroxide (H2O2). Cellular proliferation of rat neonatal cardiac fibroblasts was induced by Ang II, norepinephrine (NE) and phenylephrine (PE). Protein expression was assessed by immunochemical staining and Western blots. Gene expression was determined by real time reverse transcription-polymerase chain reaction (Q-PCR). Results: TAC suppressed myocardial Nrf2 expression, increased myocardial 4-hydroxy-2-nonenal and 8-hydroxydeoxyguanosine levels, and induced cardiac hypertrophy, fibrosis and apoptosis, and overt heart failure and death in mice. Administration of dh404 inhibited the pathological cardiac remodeling and dysfunction, and reduced the mortality. Moreover, dhd404 elevated myocardial levels of Nrf2 and Nrf2 nuclear translocation with a dramatic suppression of the oxidative stress in the heart. Dh404 inhibited hypertrophic growth and death in primary culture of rat neonatal cardiomyocytes and suppressed proliferation in primary culture of rat neonatal cardiac fibroblasts. However, these effects of dh404 were blunted by knocking down of Nrf2. Conclusion: These findings demonstrate that dh404 prevents pathological cardiac remodeling and dysfunction by activating Nrf2, indicating a therapeutic potential of dh404 for cardiac disease.	[Xing, Yifan; Zhao, Yuxia] Shandong Univ, Qilu Hosp, Dept Tradit Med, Jinan 250100, Peoples R China; [Xing, Yifan; Niu, Ting; Wang, Wenjuan; Li, Siying; Wang, Xing Li; Tang, Dongqi; Cui, Taixing] Shandong Univ, Qilu Hosp, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China; [Xing, Yifan; Wang, Wenjuan; Li, Jinqing; Li, Siying; Janicki, Joseph S.; Tang, Dongqi; Cui, Taixing] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC USA; [Ruiz, Stacey; Meyer, Colin J.] Reata Pharmaceut Inc, Dept Pharmacol, Irving, TX USA	Shandong University; Shandong University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Zhao, YX (corresponding author), Shandong Univ, Qilu Hosp, Dept Tradit Med, Jinan 250100, Peoples R China.	yuxia_zhao@126.com; yuxia_zhao@126.com; taixing.cui@uscmed.sc.edu		Cui, Taixing/0000-0002-9528-7299	American Heart Association [10GRNT4020019]; National Institutes of Health [P20 GM103499]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Heart Association (10GRNT4020019) and the National Institutes of Health (P20 GM103499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; Hu CM, 2004, CIRCULATION, V110, P309, DOI 10.1161/01.CIR.0000135475.35758.23; Ichikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008391; Jialal I, 2003, CIRCULATION, V107, P926, DOI 10.1161/01.CIR.0000048966.26216.4C; Landmesser U, 2009, CARDIOVASC RES, V81, P519, DOI 10.1093/cvr/cvn317; Li JQ, 2011, CARDIOVASC RES, V90, P315, DOI 10.1093/cvr/cvr010; Li JQ, 2010, J ETHNOPHARMACOL, V130, P222, DOI 10.1016/j.jep.2010.03.040; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Li JQ, 2009, EXPERT OPIN THER TAR, V13, P785, DOI 10.1517/14728220903025762; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Lu Z, 2008, HYPERTENSION, V51, P19, DOI 10.1161/HYPERTENSIONAHA.107.098186; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Matsushima S, 2006, AM J PHYSIOL-HEART C, V291, pH2237, DOI 10.1152/ajpheart.00427.2006; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Murdoch CE, 2006, CARDIOVASC RES, V71, P208, DOI 10.1016/j.cardiores.2006.03.016; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Piao CS, 2010, PHARMACOL RES, V61, P342, DOI 10.1016/j.phrs.2009.11.009; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Wiesel P, 2001, CIRC RES, V88, P1088, DOI 10.1161/hh1001.091521; Xie ZL, 2011, AUTOPHAGY, V7, P1254, DOI 10.4161/auto.7.10.16740; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702; Zhang Y, 2010, J MOL CELL CARDIOL, V49, P576, DOI 10.1016/j.yjmcc.2010.05.011	31	49	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44899	10.1371/journal.pone.0044899	http://dx.doi.org/10.1371/journal.pone.0044899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028668	Green Submitted, Green Published, gold			2022-12-27	WOS:000309742800023
J	Zhao, J; Yang, PY; Li, F; Tao, L; Ding, H; Rui, YC; Cao, ZW; Zhang, WD				Zhao, Jing; Yang, Pengyuan; Li, Fan; Tao, Lin; Ding, Hong; Rui, Yaocheng; Cao, Zhiwei; Zhang, Weidong			Therapeutic Effects of Astragaloside IV on Myocardial Injuries: Multi-Target Identification and Network Analysis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CARDIAC-HYPERTROPHY; CONVERTING-ENZYME; HYPERTENSIVE-RATS; CRYSTAL-STRUCTURE; CALCINEURIN; PATHWAY; MECHANISMS; ISCHEMIA; SYSTEM	Astragaloside IV (AGS-IV) is a main active ingredient of Astragalus membranaceus Bunge, a medicinal herb used for cardiovascular diseases (CVD). In this work, we investigated the therapeutic mechanisms of AGS-IV at a network level by computer-assisted target identification with the in silico inverse docking program (INVDOCK). Targets included in the analysis covered all signaling pathways thought to be implicated in the therapeutic actions of all CVD drugs approved by US FDA. A total of 39 putative targets were identified. Three of these targets, calcineurin (CN), angiotensin-converting enzyme (ACE), and c-Jun N-terminal kinase (JNK), were experimentally validated at a molecular level. Protective effects of AGS-IV were also compared with the CN inhibitor cyclosporin A (CsA) in cultured cardiomyocytes exposed to adriamycin. Network analysis of protein-protein interactions (PPI) was carried out with reference to the therapeutic profiles of approved CVD drugs. The results suggested that the therapeutic effects of AGS-IV are based upon a combination of blocking calcium influx, vasodilation, anti-thrombosis, anti-oxidation, anti-inflammation and immune regulation.	[Yang, Pengyuan; Li, Fan; Rui, Yaocheng] Second Mil Med Univ, Coll Pharm, Dept Pharmacol, Shanghai, Peoples R China; [Zhao, Jing; Zhang, Weidong] Second Mil Med Univ, Coll Pharm, Dept Nat Med Chem, Shanghai, Peoples R China; [Tao, Lin; Cao, Zhiwei] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Ding, Hong] Chengdu Univ TCM, Teaching Hosp, Chengdu, Peoples R China; [Cao, Zhiwei] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Zhao, Jing] Logist Engn Univ, Dept Math, Chongqing, Peoples R China	Naval Medical University; Naval Medical University; Chinese Academy of Sciences; Chengdu University of Traditional Chinese Medicine; Tongji University	Rui, YC (corresponding author), Second Mil Med Univ, Coll Pharm, Dept Pharmacol, Shanghai, Peoples R China.	ruiyc@smmu.edu.cn; zwcao@tongji.edu.cn; wdzhangy@hotmail.com	Zhao, Jing/S-3581-2019; Zhang, Weidong/E-6563-2016	Zhao, Jing/0000-0002-2439-2876; Zhang, Weidong/0000-0002-2433-6823; Tao, Lin/0000-0001-7494-4758	Ministry of Science and Technology China [2010CB833601]; National Natural Science Foundation of China [10971227, 30972713, 31171272]; Ministry of Health [2012ZX10005001]; National Major Project of China [2011ZX09307 -002-03]; National Key Technology R&D Program of China [2012BAI29B06]; NCET Foundation; NSFC [30725045]; Scientific Foundation of Shanghai [09DZ1975700, 09DZ1971500, 10DZ1971700, 10DZ1971400]; Global Research Network for Medicinal Plants (GRNMP); King Saud University; Shanghai Leading Academic Discipline Project [B906]; FP7-PEOPLE-IRSES-2008 [TCMCANCER 230232]; PLA Key laboratory of drug research for special environments; Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products [10DZ2251300]	Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health; National Major Project of China; National Key Technology R&D Program of China(National Key Technology R&D Program); NCET Foundation; NSFC(National Natural Science Foundation of China (NSFC)); Scientific Foundation of Shanghai; Global Research Network for Medicinal Plants (GRNMP); King Saud University(King Saud University); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); FP7-PEOPLE-IRSES-2008; PLA Key laboratory of drug research for special environments; Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products	The work was supported by grants from Ministry of Science and Technology China (2010CB833601), National Natural Science Foundation of China (10971227, 30972713, 31171272), Ministry of Health (2012ZX10005001), National Major Project of China (2011ZX09307 -002-03), National Key Technology R&D Program of China (2012BAI29B06), NCET Foundation, NSFC (30725045), Scientific Foundation of Shanghai (09DZ1975700, 09DZ1971500, 10DZ1971700, 10DZ1971400), also partially supported by Global Research Network for Medicinal Plants (GRNMP), King Saud University, Shanghai Leading Academic Discipline Project (B906), FP7-PEOPLE-IRSES-2008 (TCMCANCER 230232), PLA Key laboratory of drug research for special environments and Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products (10DZ2251300).	Agoston V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051909; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Ananthakrishnan R, 2005, VASC PHARMACOL, V43, P353, DOI 10.1016/j.vph.2005.08.020; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barandier C, 2003, NEWS PHYSIOL SCI, V18, P18, DOI 10.1152/nips.01407.2002; Cai YH, 1994, J CLINNEUROL, V7, P216; Ceconi C, 2007, EUR J PHARMACOL, V577, P1, DOI 10.1016/j.ejphar.2007.07.061; Chen YZ, 2001, PROTEINS, V43, P217, DOI 10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Curtis RK, 2005, TRENDS BIOTECHNOL, V23, P429, DOI 10.1016/j.tibtech.2005.05.011; Dai WD, 2011, POSTGRAD MED, V123, P49, DOI 10.3810/pgm.2011.03.2263; Epstein JA, 2002, ENDOCRINOLOGY, V143, P2045, DOI 10.1210/en.143.6.2045; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hu JY, 2009, CLIN EXP PHARMACOL P, V36, P351, DOI 10.1111/j.1440-1681.2008.05059.x; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kimura Yataka, 1992, Heart and Vessels, V7, P189, DOI 10.1007/BF01744603; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; KLEIN P, 1995, J ALGORITHM, V19, P104, DOI 10.1006/jagm.1995.1029; Kung L, 2001, AM J TRANSPLANT, V1, P325, DOI 10.1034/j.1600-6143.2001.10407.x; Lakshmikuttyamma A, 2005, INT J ANGIOL, V14, P1, DOI 10.1007/s00547-005-2005-2; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; LIKENS GE, 1960, SCIENCE, V131, P1674, DOI 10.1126/science.131.3414.1674; Luedde Mark, 2006, Recent Pat Cardiovasc Drug Discov, V1, P1, DOI 10.2174/157489006775244290; Luo YM, 2004, NEUROSCI LETT, V363, P218, DOI 10.1016/j.neulet.2004.03.036; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pandya N, 2005, CARDIOVASC DRUG REV, V23, P247; Peng X, 2006, J BIOL CHEM; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rajalakshmi Dhanya Chandrasekharan, 2008, V3, P301, DOI 10.1007/978-0-387-09552-3_16; ROHR S, 1991, CIRC RES, V68, P114, DOI 10.1161/01.RES.68.1.114; Rousseau-Ralliard D, 2010, J DAIRY SCI, V93, P2906, DOI 10.3168/jds.2010-3060; Sreejit P, 2008, IN VITRO CELL DEV-AN, V44, P45, DOI 10.1007/s11626-007-9079-4; STEMMER PM, 1994, BIOCHEMISTRY-US, V33, P6859, DOI 10.1021/bi00188a015; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Wang H, 1987, ZHONGCAOYAO, V18, P5; [王建 WANG Jian], 2007, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V27, P384; Wattanapitayakul SK, 2001, PHARMACOL THERAPEUT, V89, P187, DOI 10.1016/S0163-7258(00)00114-5; Wheeler-Jones CPD, 2005, HEART, V91, P1366, DOI 10.1136/hrt.2005.072280; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xu XiaoLe, 2007, Journal of China Pharmaceutical University, V38, P451; Yang J, 2009, MOL CELL BIOCHEM, V330, P39, DOI 10.1007/s11010-009-0098-1; Yang X, 2005, AM J PHYSIOL-HEART C, V289, pH1069, DOI 10.1152/ajpheart.00143.2005; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhang C, 2007, CLIN EXP PHARMACOL P, V34, P387, DOI 10.1111/j.1440-1681.2007.04564.x; Zhang WD, 2006, PLANTA MED, V72, P4, DOI 10.1055/s-2005-873126; Zhang WD, 2006, PLANTA MED, V72, P621, DOI 10.1055/s-2006-931572; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136; Zhao J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-311; Zhao J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S4; Zhao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024306; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063; Zhao Zhuanyou, 2009, Chin Med, V4, P6, DOI 10.1186/1749-8546-4-6	66	46	57	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e44938	10.1371/journal.pone.0044938	http://dx.doi.org/10.1371/journal.pone.0044938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	23028693	Green Submitted, gold, Green Published			2022-12-27	WOS:000309742800027
J	Li, Y; Zhang, Y; Li, R; Chen, W; Howell, M; Zhang, R; Chen, GX				Li, Yang; Zhang, Yan; Li, Rui; Chen, Wei; Howell, Meredith; Zhang, Rui; Chen, Guoxun			The Hepatic Raldh1 Expression Is elevated in Zucker Fatty Rats and Its Over-Expression Introduced the Retinal-Induced Srebp-1c Expression in INS-1 Cells	PLOS ONE			English	Article							ACID RESPONSE ELEMENT; ALDEHYDE DEHYDROGENASE; INSULIN-RESISTANCE; GENE-EXPRESSION; RECEPTOR; OBESITY; CLONING; LIVER; CDNA; TRANSCRIPTION	The roles of vitamin A (VA) in the development of metabolic diseases remain unanswered. We have reported that retinoids synergized with insulin to induce the expression of sterol-regulatory element-binding protein 1c gene (Srebp-1c) expression in primary rat hepatocytes. Additionally, the hepatic Srebp-1c expression is elevated in Zucker fatty (ZF) rats, and reduced in those fed a VA deficient diet. VA is metabolized to retinoic acid (RA) for regulating gene expression. We hypothesized that the expression of RA production enzymes contributes to the regulation of the hepatic Srebp-1c expression. Therefore, we analyzed their expression levels in Zucker lean (ZL) and ZF rats. The mRNA levels of retinaldehyde dehydrogenase family 1 gene (Raldh1) were found to be higher in the isolated and cultured primary hepatocytes from ZF rats than that from ZL rats. The RALDH1 protein level was elevated in the liver of ZF rats. Retinol and retinal dose- and time-dependently induced the expression of RA responsive Cyp26a1 gene in hepatocytes and hepatoma cells. INS-1 cells were identified as an ideal tool to study the effects of RA production on the regulation of gene expression because only RA, but not retinal, induced Srebp-1c mRNA expression in them. Recombinant adenovirus containing rat Raldh1 cDNA was made and used to infect INS-1 cells. The over-expression of RALDH1 introduced the retinal-mediated induction of Srebp-1c expression in INS-1 cells. We conclude that the expression levels of the enzymes for RA production may contribute to the regulation of RA responsive genes, and determine the responses of the cells to retinoid treatments. The elevated hepatic expression of Raldh1 in ZF rats may cause the excessive RA production from retinol, and in turn, result in higher Srebp-1c expression. This excessive RA production may be one of the factors contributing to the elevated lipogenesis in the liver of ZF rats.	[Li, Yang; Zhang, Yan; Li, Rui; Chen, Wei; Howell, Meredith; Zhang, Rui; Chen, Guoxun] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Li, Y (corresponding author), Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA.	gchen6@utk.edu		Chen, Guoxun/0000-0001-6226-4050; Chen, Wei/0000-0002-6383-7540	Allen Foundation Inc; University of Tennessee at Knoxville; Scientist Development Grant from American Heart Association [09SDG2140003]; China Scholarship Council	Allen Foundation Inc; University of Tennessee at Knoxville; Scientist Development Grant from American Heart Association(American Heart Association); China Scholarship Council(China Scholarship Council)	This work was financially supported by research grant from Allen Foundation Inc (to GC), startup fund from the University of Tennessee at Knoxville (to GC), and Scientist Development Grant from American Heart Association (09SDG2140003, to GC). The authors also thank China Scholarship Council for the financial support (to Y. L. and R. L.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Bhat PV, 1995, GENE, V166, P303, DOI 10.1016/0378-1119(96)81752-5; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Chen GX, 2007, BIOCHEM BIOPH RES CO, V361, P805, DOI 10.1016/j.bbrc.2007.07.108; Chen GX, 2009, BIOCHEM J, V419, P645, DOI 10.1042/BJ20082368; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen GX, 2000, DIABETES, V49, P562, DOI 10.2337/diabetes.49.4.562; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; FOREST CD, 1990, MOL ENDOCRINOL, V4, P1302, DOI 10.1210/mend-4-9-1302; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Fujiwara K, 2009, ENDOCR J, V56, P963, DOI 10.1507/endocrj.K09E-115; Gaulton KJ, 2008, DIABETES, V57, P3136, DOI 10.2337/db07-1731; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Huq MDM, 2006, EMBO J, V25, P3203, DOI 10.1038/sj.emboj.7601181; Jones D, 2008, NAT REV DRUG DISCOV, V7, P961, DOI 10.1038/nrd2775; KEIDEL S, 1994, MOL CELL BIOL, V14, P287, DOI 10.1128/MCB.14.1.287; Li R, 2011, BIOCHEM BIOPH RES CO, V406, P268, DOI 10.1016/j.bbrc.2011.02.031; Lin M, 2003, J BIOL CHEM, V278, P9856, DOI 10.1074/jbc.M211417200; LUCAS PC, 1991, P NATL ACAD SCI USA, V88, P2184, DOI 10.1073/pnas.88.6.2184; LUCAS PC, 1991, MOL CELL BIOL, V11, P5164, DOI 10.1128/MCB.11.10.5164; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Mic FA, 2000, MECH DEVELOP, V97, P227, DOI 10.1016/S0925-4773(00)00434-2; Mukhopadhyay B, 2010, J BIOL CHEM, V285, P19002, DOI 10.1074/jbc.M109.068460; Napoli JL, 2011, BIOCHIM BIOPHYS ACTA, V1821, P152; O'Rahilly S, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.239; Ross AC, 2003, J NUTR, V133, p291S, DOI 10.1093/jn/133.1.291S; Schulze MB, 2005, ANNU REV PUBL HEALTH, V26, P445, DOI 10.1146/annurev.publhealth.26.021304.144532; Scott DK, 1996, J BIOL CHEM, V271, P6260, DOI 10.1074/jbc.271.11.6260; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Sporn M.B., 1994, RETINOIDS BIOL CHEM; Starkey JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011095; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Unger RH, 1997, TRENDS ENDOCRIN MET, V8, P276, DOI 10.1016/S1043-2760(97)00094-5; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; Wang YP, 2002, ARCH BIOCHEM BIOPHYS, V401, P235, DOI 10.1016/S0003-9861(02)00043-7; Wolf G, 2010, NUTR REV, V68, P689, DOI 10.1111/j.1753-4887.2010.00323.x; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; Zhang Y, 2011, MOL CELL BIOCHEM, V355, P1, DOI 10.1007/s11010-011-0831-4; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhao S, 2012, BIOCHEM CELL BIOL, V90, P142, DOI [10.1139/O11-079, 10.1139/o11-079]; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	45	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45210	10.1371/journal.pone.0045210	http://dx.doi.org/10.1371/journal.pone.0045210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028851	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700095
J	Marshall, BDL; Paczkowski, MM; Seemann, L; Tempalski, B; Pouget, ER; Galea, S; Friedman, SR				Marshall, Brandon D. L.; Paczkowski, Magdalena M.; Seemann, Lars; Tempalski, Barbara; Pouget, Enrique R.; Galea, Sandro; Friedman, Samuel R.			A Complex Systems Approach to Evaluate HIV Prevention in Metropolitan Areas: Preliminary Implications for Combination Intervention Strategies	PLOS ONE			English	Article							INJECTION-DRUG-USERS; ACTIVE ANTIRETROVIRAL THERAPY; NEW-YORK-CITY; HUMAN-IMMUNODEFICIENCY-VIRUS; SUBSTANCE-ABUSE TREATMENT; AGENT-BASED MODELS; OUT-OF-TREATMENT; CONCURRENT SEXUAL PARTNERSHIPS; UNITED-STATES; RISK BEHAVIORS	Background: HIV transmission among injecting and non-injecting drug users (IDU, NIDU) is a significant public health problem. Continuing propagation in endemic settings and emerging regional outbreaks have indicated the need for comprehensive and coordinated HIV prevention. We describe the development of a conceptual framework and calibration of an agent-based model (ABM) to examine how combinations of interventions may reduce and potentially eliminate HIV transmission among drug-using populations. Methodology/Principal Findings: A multidisciplinary team of researchers from epidemiology, sociology, geography, and mathematics developed a conceptual framework based on prior ethnographic and epidemiologic research. An ABM was constructed and calibrated through an iterative design and verification process. In the model, "agents" represent IDU, NIDU, and non-drug users who interact with each other and within risk networks, engaging in sexual and, for IDUs, injection-related risk behavior over time. Agents also interact with simulated HIV prevention interventions (e. g., syringe exchange programs, substance abuse treatment, HIV testing) and initiate antiretroviral treatment (ART) in a stochastic manner. The model was constructed to represent the New York metropolitan statistical area (MSA) population, and calibrated by comparing output trajectories for various outcomes (e. g., IDU/NIDU prevalence, HIV prevalence and incidence) against previously validated MSA-level data. The model closely approximated HIV trajectories in IDU and NIDU observed in New York City between 1992 and 2002, including a linear decrease in HIV prevalence among IDUs. Exploratory results are consistent with empirical studies demonstrating that the effectiveness of a combination of interventions, including syringe exchange expansion and ART provision, dramatically reduced HIV prevalence among IDUs during this time period. Conclusions/Significance: Complex systems models of adaptive HIV transmission dynamics can be used to identify potential collective benefits of hypothetical combination prevention interventions. Future work will seek to inform novel strategies that may lead to more effective and equitable HIV prevention strategies for drug-using populations.	[Marshall, Brandon D. L.; Paczkowski, Magdalena M.; Galea, Sandro] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Marshall, Brandon D. L.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Seemann, Lars] Univ Houston, Dept Phys, Houston, TX USA; [Tempalski, Barbara; Pouget, Enrique R.; Friedman, Samuel R.] Natl Dev & Res Inst Inc, New York, NY USA; [Tempalski, Barbara; Pouget, Enrique R.; Friedman, Samuel R.] Inst AIDS Res, New York, NY USA	Columbia University; Brown University; University of Houston System; University of Houston; National Development & Research Institutes, Inc	Marshall, BDL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	brandon_marshall@brown.edu	Pouget, Enrique Rodriguez/AAJ-5786-2020; Marshall, Brandon/B-4895-2010; Galea, Sandro/GLR-6066-2022	Pouget, Enrique Rodriguez/0000-0002-5907-1909; Marshall, Brandon/0000-0002-0134-7052; Friedman, Sam/0000-0003-2083-1226; Galea, Sandro/0000-0002-7534-0945; Tempalski, Barbara/0000-0002-6128-2510	National Institutes of Health [R01-DA013336]; Canadian Institutes of Health Research; National Science Foundation [0840889]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project is funded by the National Institutes of Health (R01-DA013336, http://www.nih.gov/) as part of the Community Vulnerability and Responses to Drug-User Related HIV/AIDS (CVAR) study. Brandon Marshall is supported by a Postdoctoral Fellowship from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/). Lars Seemann is supported by the National Science Foundation (Award Number 0840889, http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon J, 2006, AIDS BEHAV, V10, P707, DOI 10.1007/s10461-006-9082-x; Adimora AA, 2002, EPIDEMIOLOGY, V13, P320, DOI 10.1097/00001648-200205000-00013; Adimora AA, 2007, AM J PUBLIC HEALTH, V97, P2230, DOI 10.2105/AJPH.2006.099069; Anderson JE, 2000, AM J PUBLIC HEALTH, V90, P1089, DOI 10.2105/AJPH.90.7.1089; [Anonymous], 2007, PREV HIV INF INJ DRU; Aral SO, 2010, SEX TRANSM INFECT, V86, P1, DOI 10.1136/sti.2010.047373; Arasteh K, 2008, DRUG ALCOHOL DEPEN, V95, P54, DOI 10.1016/j.drugalcdep.2007.12.008; Arroyo J, 2010, COMPUT MATH ORGAN TH, V16, P416, DOI 10.1007/s10588-010-9078-y; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Auchincloss AH, 2011, AM J PREV MED, V40, P303, DOI 10.1016/j.amepre.2010.10.033; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Bagni R, 2002, JASSS-J ARTIF SOC S, V5; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bell AV, 2006, AM J PUBLIC HEALTH, V96, P1066, DOI 10.2105/AJPH.2004.061077; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Booth RE, 1996, DRUG ALCOHOL DEPEN, V42, P11, DOI 10.1016/0376-8716(96)01257-4; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Brooner R, 1998, Public Health Rep, V113 Suppl 1, P129; Brown LS, 1996, J NATL MED ASSOC, V88, P37; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; Celentano DD, 2001, AIDS, V15, P1707, DOI 10.1097/00002030-200109070-00015; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P916; Cioffi-Revilla C, 2002, P NATL ACAD SCI USA, V99, P7314, DOI 10.1073/pnas.082081499; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen J, 2011, SCIENCE, V334, P1338, DOI 10.1126/science.334.6061.1338; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Colfax G, 2005, J URBAN HEALTH, V82, pI62, DOI 10.1093/jurban/jti025; Copeland L, 2004, ARCH INTERN MED, V164, P1214, DOI 10.1001/archinte.164.11.1214; DeBeck K, 2009, CAN MED ASSOC J, V181, P585, DOI 10.1503/cmaj.082054; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; DeGruttola V, 2010, CLIN INFECT DIS, V50, pS102, DOI 10.1086/651480; Des Jarlais DC, 2000, AM J PUBLIC HEALTH, V90, P1112; Des Jarlais DC, 2007, SEX TRANSM DIS, V34, P923, DOI 10.1097/OLQ.0b013e3180ca9647; Des Jarlais DC, 2007, AIDS, V21, P231, DOI 10.1097/QAD.0b013e3280114a15; Des Jarlais DC, 2011, SUBST USE MISUSE, V46, P131, DOI 10.3109/10826084.2011.521456; Des Jarlais DC, 2010, SEX TRANSM DIS, V37, P637, DOI 10.1097/OLQ.0b013e3181e1a64a; Des Jarlais DC, 2010, DRUG ALCOHOL DEPEN, V109, P154, DOI 10.1016/j.drugalcdep.2009.12.028; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; Epstein J.M., 2006, GENERATIVE SOCIAL SC; Foster J, 2005, CAMB J ECON, V29, P873, DOI 10.1093/cje/bei083; Friedman S. R., 2010, SOCIAL NETWORKS DRUG; Friedman SR, 2007, AIDS BEHAV, V11, P641, DOI 10.1007/s10461-006-9166-7; Friedman SR, 2009, INT J DRUG POLICY, V20, P283, DOI 10.1016/j.drugpo.2008.10.006; FRIEDMAN SR, 1994, AIDS, V8, P357, DOI 10.1097/00002030-199403000-00010; Frohlich KL, 2008, AM J PUBLIC HEALTH, V98, P216, DOI 10.2105/AJPH.2007.114777; Fuller CM, 2002, DRUG ALCOHOL DEPEN, V66, P189, DOI 10.1016/S0376-8716(01)00200-9; Galea S, 2006, J ADDICT DIS, V25, P79, DOI 10.1300/J069v25n03_10; Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296; Galea S, 2009, INT J DRUG POLICY, V20, P209, DOI 10.1016/j.drugpo.2008.08.005; Gibson DR, 2001, AIDS, V15, P1329, DOI 10.1097/00002030-200107270-00002; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Gorman DM, 2006, AM J PUBLIC HEALTH, V96, P2055, DOI 10.2105/AJPH.2005.063289; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hagan H, 2000, J SUBST ABUSE TREAT, V19, P247, DOI 10.1016/S0740-5472(00)00104-5; Halkitis PN, 2007, ADDICTION, V102, P76, DOI 10.1111/j.1360-0443.2007.01769.x; Halperin DT, 2009, LANCET, V373, P544, DOI 10.1016/S0140-6736(09)60200-2; Hamilton DT, 2008, SEX TRANSM DIS, V35, P30, DOI 10.1097/OLQ.0b013e3181453a84; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Heidari S, 2011, J INT AIDS SOC, V14, DOI [10.1186/1758-2652-14-11, 10.1186/1758-2652-14-S2-S1]; Heimer R, 1998, J SUBST ABUSE TREAT, V15, P183, DOI 10.1016/S0740-5472(97)00220-1; Heimer R, 2007, AM J PUBLIC HEALTH, V97, P110, DOI 10.2105/AJPH.2005.078105; Howard DL, 2006, JAIDS-J ACQ IMM DEF, V42, P325, DOI 10.1097/01.qai.0000214819.88163.22; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Jarlais DC, 2005, AM J PUBLIC HEALTH, V95, P1439, DOI 10.2105/AJPH.2003.036517; Jarlais DCD, 2008, PSYCHOSOM MED, V70, P606, DOI 10.1097/PSY.0b013e3181772157; Jenness SM, 2010, AIDS PATIENT CARE ST, V24, P175, DOI 10.1089/apc.2009.0227; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Joint United Nations Programme on HIV/AIDS, 2009, JOINT ACT RES UNAIDS; Jones GT, 2007, AM J PUBLIC HEALTH, V97, P780, DOI 10.2105/AJPH.2006.109058; Jose B, 1996, RACIAL ETHNIC VARIAT; Kapadia F, 2005, ADDICTION, V100, P990, DOI 10.1111/j.1360-0443.2005.01098.x; KAPLAN EH, 1992, J ACQ IMMUN DEF SYND, V5, P1116; KARIM QA, 2010, LOGIC CIRCUITS CARBO, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Kerr T, 2005, AIDS CARE, V17, P539, DOI 10.1080/09540120412331319778; Kerr T, 2010, AM J PUBLIC HEALTH, V100, P1449, DOI 10.2105/AJPH.2009.178467; Khan MR, 2009, JAIDS-J ACQ IMM DEF, V51, P470, DOI 10.1097/QAI.0b013e3181a2810a; Knight KR, 2007, JAIDS-J ACQ IMM DEF, V46, pS80, DOI 10.1097/QAI.0b013e3181576828; Kottiri BJ, 2002, J ACQ IMMUN DEF SYND, V30, P95, DOI 10.1097/00042560-200205010-00013; Kral AH, 1997, J ACQ IMMUN DEF SYND, V16, P211, DOI 10.1097/00042560-199711010-00011; Kral AH, 2005, J URBAN HEALTH, V82, pI43, DOI 10.1093/jurban/jti023; Kuo I, 2011, DRUG ALCOHOL DEPEN, V117, P139, DOI 10.1016/j.drugalcdep.2011.01.006; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Latkin CA, 2003, SOC SCI MED, V56, P465, DOI 10.1016/S0277-9536(02)00047-3; LEIGH BC, 1993, AM J PUBLIC HEALTH, V83, P1400, DOI 10.2105/AJPH.83.10.1400; LEMP GF, 1995, AM J PUBLIC HEALTH, V85, P1549, DOI 10.2105/AJPH.85.11.1549; Lieb S, 2004, J URBAN HEALTH, V81, P401, DOI 10.1093/jurban/jth126; Lieb S, 2011, PUBLIC HEALTH REP, V126, P60, DOI 10.1177/003335491112600110; Lloyd JJ, 2008, AM J ADDICTION, V17, P414, DOI 10.1080/10550490802268165; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; MacQueen Kathleen M, 2011, J Int AIDS Soc, V14 Suppl 2, pS3, DOI 10.1186/1758-2652-14-S2-S3; Maglio PP, 2011, AM J PREV MED, V40, P392, DOI 10.1016/j.amepre.2010.11.010; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marshall BDL, 2009, SEX TRANSM INFECT, V85, P121, DOI 10.1136/sti.2008.032524; Marshall BDL, 2007, JAIDS-J ACQ IMM DEF, V46, P248, DOI 10.1097/QAI.0b013e31814a5533; Maslow CB, 2002, AM J PUBLIC HEALTH, V92, P382, DOI 10.2105/AJPH.92.3.382; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; McGowan CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018462; Mercer CH, 2007, AM J PUBLIC HEALTH, V97, P1126, DOI 10.2105/AJPH.2006.086439; Merson M, 2008, LANCET, V372, P1805, DOI 10.1016/S0140-6736(08)61752-3; METZGER DS, 1993, J ACQ IMMUN DEF SYND, V6, P1049; Miller JH, 2007, PRINC STUD COMPLEX, P1, DOI 10.1007/1-4020-5602-8_1; Miller M, 2002, AIDS CARE, V14, P801, DOI 10.1080/0954012021000031877; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Molitor F, 1998, WESTERN J MED, V168, P93; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Moore D, 2009, ADDICTION, V104, P1991, DOI 10.1111/j.1360-0443.2009.02709.x; Morris John D, 2007, AIDS Res Ther, V4, P12, DOI 10.1186/1742-6405-4-12; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; MOSS AR, 1989, AIDS, V3, P55, DOI 10.1097/00002030-198902000-00001; Nagoski E, 2012, ARCH SEX BEHAV, V41, P849, DOI 10.1007/s10508-011-9867-5; New York State Department of Health, 1994, HIV INF NEW YORK STA; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Ompad DC, 2011, SUBST USE MISUSE, V46, P274, DOI 10.3109/10826084.2011.523284; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; Padian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Potterat JJ, 1999, INT J STD AIDS, V10, P182, DOI 10.1258/0956462991913853; Potterat JJ, 2002, SEX TRANSM INFECT, V78, pI159, DOI 10.1136/sti.78.suppl_1.i159; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raboud JM, 2003, J URBAN HEALTH, V80, P302, DOI 10.1093/jurban/jtg033; Rotheram-Borus MJ, 2009, ANNU REV CLIN PSYCHO, V5, P143, DOI 10.1146/annurev.clinpsy.032408.153530; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; SELL RL, 1995, ARCH SEX BEHAV, V24, P235, DOI 10.1007/BF01541598; Shah NG, 2006, DRUG ALCOHOL DEPEN, V83, P147, DOI 10.1016/j.drugalcdep.2005.11.007; Sherman SG, 2001, DRUG ALCOHOL DEPEN, V64, P97, DOI 10.1016/S0376-8716(00)00236-2; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Sorensen JL, 2000, DRUG ALCOHOL DEPEN, V59, P17, DOI 10.1016/S0376-8716(99)00104-0; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; STERMAN JD, 1994, SYST DYNAM REV, V10, P291, DOI 10.1002/sdr.4260100214; Strathdee SA, 1999, J URBAN HEALTH, V76, P448, DOI 10.1007/BF02351502; Strathdee SA, 2003, J URBAN HEALTH, V80, P7; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Substance Abuse and Mental Health Services Administration, 2010, NAT PREV EST TOP 20; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Tempalski B, 2009, J URBAN HEALTH, V86, P132, DOI 10.1007/s11524-008-9328-1; Tempalski B, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-23; Uhlmann S, 2010, ADDICTION, V105, P907, DOI 10.1111/j.1360-0443.2010.02905.x; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; van Kesteren NMC, 2007, PATIENT EDUC COUNS, V65, P5, DOI 10.1016/j.pec.2006.09.003; vanHaastrecht HJA, 1996, AM J EPIDEMIOL, V143, P380; VANICHSENI S, 1993, AIDS, V7, P887, DOI 10.1097/00002030-199306000-00020; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Vlahov D, 2005, AM J EPIDEMIOL, V161, P999, DOI 10.1093/aje/kwi133; WARNER LA, 1995, ARCH GEN PSYCHIAT, V52, P219; WATKINS KE, 1992, AM J DRUG ALCOHOL AB, V18, P389, DOI 10.3109/00952999209051037; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Windrum P, 2007, JASSS-J ARTIF SOC S, V10; Wolitski RJ, 2001, AM J PUBLIC HEALTH, V91, P883, DOI 10.2105/AJPH.91.6.883; Wood E, 2003, CAN MED ASSOC J, V169, P656; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; World Health Organisation (WHO), 2009, WHO UNODC UNAIDS TEC; Xu FJ, 2010, SEX TRANSM DIS, V37, P407, DOI 10.1097/OLQ.0b013e3181db2e18; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b; Yang Y, 2011, AM J PREV MED, V40, P353, DOI 10.1016/j.amepre.2010.11.017; Young RM, 2000, J DRUG ISSUES, V30, P499, DOI 10.1177/002204260003000302; Zaccarelli M, 2002, AIDS PATIENT CARE ST, V16, P67, DOI 10.1089/10872910252806117; ZACCARELLI M, 1994, AIDS, V8, P345, DOI 10.1097/00002030-199403000-00008; Zanette D, 2008, J BIOL PHYS, V34, P135, DOI 10.1007/s10867-008-9060-9; Zule WA, 2000, AM J DRUG ALCOHOL AB, V26, P247, DOI 10.1081/ADA-100100603	179	32	32	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44833	10.1371/journal.pone.0044833	http://dx.doi.org/10.1371/journal.pone.0044833			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005ZK	23028637	Green Published, Green Submitted, gold			2022-12-27	WOS:000308788700043
J	Mook-Kanamori, BB; Fritz, D; Brouwer, MC; van der Ende, A; van de Beek, D				Mook-Kanamori, Barry B.; Fritz, Daan; Brouwer, Matthijs C.; van der Ende, Arie; van de Beek, Diederik			Intracerebral Hemorrhages in Adults with Community Associated Bacterial Meningitis in Adults: Should We Reconsider Anticoagulant Therapy?	PLOS ONE			English	Article							PNEUMOCOCCAL MENINGITIS; INFECTIVE ENDOCARDITIS; STAPHYLOCOCCUS-AUREUS; PROGNOSTIC-FACTORS; CLINICAL-FEATURES; COMPLICATIONS; STROKE; COAGULATION; DIAGNOSIS; SPECTRUM	Objective: To study the incidence, clinical presentation and outcome of intracranial hemorrhagic complications in adult patients with community associated bacterial meningitis. Methods: Nationwide prospective cohort study from all hospitals in the Netherlands, from 1 March 2006, through 31 December 2010. Results: Of the 860 episodes of bacterial meningitis that were included, 24 were diagnosed with intracranial hemorrhagic complications: 8 upon presentation and 16 during clinical course. Clinical presentation between patients with or without intracranial hemorrhage was similar. Causative bacteria were Streptococcus pneumoniae in 16 patients (67%), Staphylococcus aureus in 5 (21%), Pseudomonas aeruginosa and Listeria monocytogenes both in 1 patient (4%). Occurrence of intracranial hemorrhage was associated with death (63% vs. 15%, P<0.001) and unfavorable outcome (94% vs. 34%, P<0.001). The use of anticoagulants on admission was associated with a higher incidence of intracranial hemorrhages (odds ratio 5.84, 95% confidence interval 2.17-15.76). Conclusion: Intracranial hemorrhage is a rare but devastating complication in patients with community-associated bacterial meningitis. Since anticoagulant therapy use is associated with increased risk for intracranial hemorrhage, physicians may consider reversing or temporarily discontinuing anticoagulation in patients with bacterial meningitis.	[Mook-Kanamori, Barry B.; Fritz, Daan; Brouwer, Matthijs C.; van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Mook-Kanamori, BB (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X; van der Ende, Arie/0000-0003-1298-3086	European Research Council (ERC Starting Grant] [281156]; Netherlands Organization for Health Research and Development (ZonMw; NWOVeni grant) [916.76.023, 016.116.358]; Academic Medical Center (AMC Fellowship)	European Research Council (ERC Starting Grant](European Research Council (ERC)); Netherlands Organization for Health Research and Development (ZonMw; NWOVeni grant); Academic Medical Center (AMC Fellowship)	This study has been funded by grants from the European Research Council (ERC Starting Grant [Proposal/Contract no. 281156] to DB), Netherlands Organization for Health Research and Development (ZonMw; NWOVeni grant 2006 [Proposal/Contract no. 916.76.023], NWO-Vidi grant 2010 [Proposal/Contract no. 016.116.358] to DB), the Academic Medical Center (AMC Fellowship 2008 to DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Brouwer MC, 2009, SCAND J INFECT DIS, V41, P375, DOI 10.1080/00365540902744766; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Jennett B, 1981, MANAGEMENT HEAD INJU, Vvii, P361; Jim KK, 2012, J INFECTION, V64, P236, DOI 10.1016/j.jinf.2011.11.011; Kasanmoentalib ES, 2010, NEUROLOGY, V75, P918, DOI 10.1212/WNL.0b013e3181f11e10; Kastenbauer S, 2003, BRAIN, V126, P1015, DOI 10.1093/brain/awg113; Kowalik MM, 2007, J INFECTION, V55, P141, DOI 10.1016/j.jinf.2007.02.002; MACFARLANE JT, 1977, BRIT MED J, V2, P1522, DOI 10.1136/bmj.2.6101.1522; Molina CA, 2011, STROKE, V42, P1799, DOI 10.1161/STROKEAHA.111.622423; Mook-Kanamori BB, 2011, CLIN MICROBIOL REV, V24, P557, DOI 10.1128/CMR.00008-11; PFISTER HW, 1993, ARCH NEUROL-CHICAGO, V50, P575, DOI 10.1001/archneur.1993.00540060015010; Rasmussen RV, 2009, CARDIOLOGY, V114, P284, DOI 10.1159/000235579; Rasmussen RV, 2011, STROKE, V42, P1795, DOI 10.1161/STROKEAHA.110.611681; Schut ES, 2012, NEUROCRIT CARE, V16, P421, DOI 10.1007/s12028-011-9634-4; Sila C, 2011, STROKE, V42, P1797, DOI 10.1161/STROKEAHA.110.611699; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; Tornos P, 1999, ARCH INTERN MED, V159, P473, DOI 10.1001/archinte.159.5.473; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Vergouwen MDI, 2010, NEUROCRIT CARE, V13, P217, DOI 10.1007/s12028-010-9387-5; Vincent JL, 2005, CRIT CARE, V9, pR331, DOI 10.1186/cc3538; Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X; Weisfelt M, 2007, J INFECTION, V54, P545, DOI 10.1016/j.jinf.2006.11.016; Winkler F, 2002, NEUROLOGY, V59, P1350, DOI 10.1212/01.WNL.0000031427.81898.96	27	35	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45271	10.1371/journal.pone.0045271	http://dx.doi.org/10.1371/journal.pone.0045271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028898	gold, Green Published, Green Submitted			2022-12-27	WOS:000308788700101
J	Shriner, D; Herbert, A; Doumatey, AP; Zhou, J; Huang, HX; Erdos, MR; Chen, GJ; Gerry, NP; Christman, MF; Adeyemo, A; Rotimi, CN				Shriner, Daniel; Herbert, Alan; Doumatey, Ayo P.; Zhou, Jie; Huang, Hanxia; Erdos, Michael R.; Chen, Guanjie; Gerry, Norman P.; Christman, Michael F.; Adeyemo, Adebowale; Rotimi, Charles N.			Multiple Loci Associated with Renal Function in African Americans	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; POPULATION-STRUCTURE; SERUM CREATININE; VARIANTS; ANCESTRY; TIME; MYH9; RISK; GENE; GFR	The incidence of chronic kidney disease varies by ethnic group in the USA, with African Americans displaying a two-fold higher rate than European Americans. One of the two defining variables underlying staging of chronic kidney disease is the glomerular filtration rate. Meta-analysis in individuals of European ancestry has identified 23 genetic loci associated with the estimated glomerular filtration rate (eGFR). We conducted a follow-up study of these 23 genetic loci using a population-based sample of 1,018 unrelated admixed African Americans. We included in our follow-up study two variants in APOL1 associated with end-stage kidney disease discovered by admixture mapping in admixed African Americans. To address confounding due to admixture, we estimated local ancestry at each marker and global ancestry. We performed regression analysis stratified by local ancestry and combined the resulting regression estimates across ancestry strata using an inverse variance-weighted fixed effects model. We found that 11 of the 24 loci were significantly associated with eGFR in our sample. The effect size estimates were not significantly different between the subgroups of individuals with two copies of African ancestry vs. two copies of European ancestry for any of the 11 loci. In contrast, allele frequencies were significantly different at 10 of the 11 loci. Collectively, the 11 loci, including four secondary signals revealed by conditional analyses, explained 14.2% of the phenotypic variance in eGFR, in contrast to the 1.4% explained by the 24 loci in individuals of European ancestry. Our findings provide insight into the genetic basis of variation in renal function among admixed African Americans.	[Shriner, Daniel; Doumatey, Ayo P.; Zhou, Jie; Huang, Hanxia; Chen, Guanjie; Adeyemo, Adebowale; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Herbert, Alan] Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA; [Erdos, Michael R.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Gerry, Norman P.; Christman, Michael F.] Coriell Inst Med Res, Camden, NJ USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Coriell Institute for Medical Research	Shriner, D (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA.	shrinerda@mail.nih.gov; rotimic@mail.nih.gov	Herbert, Alan/AAY-4286-2020	Adeyemo, Adebowale/0000-0002-3105-3231; Shriner, Daniel/0000-0003-1928-5520; Herbert, Alan/0000-0002-0093-1572	National Institutes of Health [S06GM008016-320107, S06GM008016-380111]; National Institutes of Health grant [2M01RR010284]; Intramural Research Program of the Center for Research on Genomics and Global Health; National Human Genome Research Institute; National Institute of Diabetes and Digestive and Kidney Diseases; Center for Information Technology; Office of the Director at the National Institutes of Health [Z01HG200362]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010284] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200362, ZIAHG200362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008016] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Center for Research on Genomics and Global Health; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Information Technology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); Office of the Director at the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The Howard University Family Study was supported by National Institutes of Health grants S06GM008016-320107 and S06GM008016-380111. Enrollment was carried out at the Howard University General Clinical Research Center, supported by National Institutes of Health grant 2M01RR010284. This research was supported in part by the Intramural Research Program of the Center for Research on Genomics and Global Health. The Center for Research on Genomics and Global Health is supported by the National Human Genome Research Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the Center for Information Technology, and the Office of the Director at the National Institutes of Health (Z01HG200362). Genotyping support was provided by the Coriell Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-417; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Falush D, 2003, GENETICS, V164, P1567; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Langefeld CD, 2004, AM J KIDNEY DIS, V43, P796, DOI 10.1053/j.ajkd.2003.12.043; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; McClellan J, 2010, CELL, V142, P353, DOI 10.1016/j.cell.2010.07.027; Qin HZ, 2010, BIOINFORMATICS, V26, P2961, DOI 10.1093/bioinformatics/btq560; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramos E, 2011, DIABETOLOGIA, V54, P783, DOI 10.1007/s00125-010-2002-7; Rosenberg NA, 2006, GENETICS, V173, P1665, DOI 10.1534/genetics.105.055335; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Shriner D, 2011, HEREDITY, V107, P413, DOI 10.1038/hdy.2011.26; Shriner D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002325; Shriner D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-223; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; Wang XX, 2011, BIOINFORMATICS, V27, P670, DOI 10.1093/bioinformatics/btq709	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e45112	10.1371/journal.pone.0045112	http://dx.doi.org/10.1371/journal.pone.0045112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028791	Green Published, gold			2022-12-27	WOS:000308788700088
J	Yu, Y; Zhang, Y; Hu, SZ; Jin, DD; Chen, XC; Jin, Q; Liu, HY				Yu, Yang; Zhang, Yan; Hu, Shizong; Jin, Dongdong; Chen, Xinchun; Jin, Qi; Liu, Haiying			Different Patterns of Cytokines and Chemokines Combined with IFN-gamma Production Reflect Mycobacterium tuberculosis Infection and Disease	PLOS ONE			English	Article							T-CELL RESPONSES; INTERFERON-GAMMA; ACTIVE TUBERCULOSIS; LATENT TUBERCULOSIS; IMMUNE-RESPONSES; DIAGNOSIS; EXPRESSION; IMMUNOLOGY; GENERATION; BIOMARKERS	Background: IFN-gamma is presently the only soluble immunological marker used to help diagnose latent Mycobacterium tuberculosis (M.tb) infection. However, IFN-gamma is not available to distinguish latent from active TB infection. Moreover, extrapulmonary tuberculosis, such as tuberculous pleurisy, cannot be properly diagnosed by IFN-gamma release assay. As a result, other disease- or infection-related immunological biomarkers that would be more effective need to be screened and identified. Methodology: A panel of 41 soluble immunological molecules (17 cytokines and 24 chemokines) was tested using Luminex liquid array-based multiplexed immunoassays. Samples, including plasma and pleural effusions, from healthy donors (HD, n = 12) or patients with latent tuberculosis infection (LTBI, n = 20), pulmonary tuberculosis (TB, n = 12), tuberculous pleurisy (TP, n = 15) or lung cancer (LC, n = 15) were collected and screened for soluble markers. Peripheral blood mononuclear cells (PBMCs) and pleural fluid mononuclear cells (PFMCs) were also isolated to investigate antigen-specific immune factors. Principal Findings: For the 41 examined factors, our results indicated that three patterns were closely associated with infection and disease. (1) Significantly elevated plasma levels of IL-2, IP-10, CXCL11 and CXCL12 were present in both patients with tuberculosis and in a sub-group participant with latent tuberculosis infection who showed a higher level of IFN-gamma producing cells by ELISPOT assay compared with other latently infected individuals. (2) IL-6 and IL-9 were only significantly increased in plasma from active TB patients, and the two factors were consistently highly secreted after M.tb antigen stimulation. (3) When patients developed tuberculous pleurisy, CCL1, CCL21 and IL-6 were specifically increased in the pleural effusions. In particular, these three factors were consistently highly secreted by pleural fluid mononuclear cells following M.tb-specific antigen stimulation. In conclusion, our data imply that the specific secretion of soluble immunological factors, in addition to IFN-gamma, may be used to evaluate M.tb infection and tuberculosis disease.	[Yu, Yang; Zhang, Yan; Hu, Shizong; Jin, Dongdong; Jin, Qi; Liu, Haiying] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Yu, Yang; Zhang, Yan; Hu, Shizong; Jin, Dongdong; Jin, Qi; Liu, Haiying] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Xinchun] Guangdong Med Coll, Shenzhen Peoples Hosp 3, Shenzhen Hong Kong Inst Infect Dis, Shenzhen, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Guangdong Medical University	Yu, Y (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	jinqi@ipbcams.ac.cn; haiyingbj@gmail.com			National Eleven-fifth Mega-Scientific Project on the "prevention and treatment of AIDS, viral hepatitis and other infectious diseases" [2008ZX10003-012, 2012ZX10003-002]; National Natural Science Foundation of China PR [81000716, 81171533]	National Eleven-fifth Mega-Scientific Project on the "prevention and treatment of AIDS, viral hepatitis and other infectious diseases"; National Natural Science Foundation of China PR(National Natural Science Foundation of China (NSFC))	This work is sponsored by the National Eleven-fifth Mega-Scientific Project on the "prevention and treatment of AIDS, viral hepatitis and other infectious diseases" (2008ZX10003-012, 2012ZX10003-002) and the National Natural Science Foundation of China PR (81000716, 81171533), and Basic R&D expenses were provided by Institute of Pathogen Biology (2010IPB103), Chinese Academy of Medical Sciences. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; Chen XC, 2009, J INFECT DIS, V200, P399, DOI 10.1086/600075; Chen XC, 2009, CLIN VACCINE IMMUNOL, V16, P879, DOI 10.1128/CVI.00044-09; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dheda K, 2010, RESPIROLOGY, V15, P433, DOI 10.1111/j.1440-1843.2010.01739.x; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferrara G, 2009, ARCH IMMUNOL THER EX, V57, P425, DOI 10.1007/s00005-009-0050-9; Fuss Ivan J, 2009, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0701s85; Guimar~aes T, 2012, ISRN IMMUNOLOGY; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005158; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; Kanof M E, 2001, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0703s00; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Khatami K, 2002, SHIRAZ E MED J, V3, P78; Kurashima K, 1997, AM J RESP CRIT CARE, V155, P1474, DOI 10.1164/ajrccm.155.4.9105097; Liu K, 2012, PLOS ONE, P7; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; MARAIS BJ, 2010, J GERONTOL B-PSYCHOL, V375, P2179, DOI DOI 10.1016/S0140-6736(10)60554-5; McGrath EE, 2010, EUR J CLIN MICROBIOL, V29, P1187, DOI 10.1007/s10096-010-0986-z; Mohammed KA, 1998, J INFECT DIS, V178, P1450, DOI 10.1086/314442; Nemeth J, 2011, CLIN IMMUNOL, V138, P50, DOI 10.1016/j.clim.2010.09.005; Nolen BM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2096; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2010, NAT REV MICROBIOL, V8, P242, DOI 10.1038/nrmicro2236-c1; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Pokkali S, 2008, CYTOKINE, V41, P307, DOI 10.1016/j.cyto.2007.12.009; Qiu ZG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00216; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; Schreiber T, 2006, J IMMUNOL, V176, P1131, DOI 10.4049/jimmunol.176.2.1131; SEIBERT AF, 1991, CHEST, V99, P883, DOI 10.1378/chest.99.4.883; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Sia IG, 2011, MAYO CLIN PROC, V86, P348, DOI 10.4065/mcp.2010.0820; Siawaya JFD, 2009, CYTOKINE, V47, P132, DOI 10.1016/j.cyto.2009.05.016; Supriya P, 2008, DIAGN MICR INFEC DIS, V62, P186, DOI 10.1016/j.diagmicrobio.2008.05.011; Herrera MT, 2009, TUBERCULOSIS, V89, P38, DOI 10.1016/j.tube.2008.08.002; Tsao T.C.Y., 1999, Tubercle and Lung Disease, V79, P279, DOI 10.1054/tuld.1999.0215; Villegas MV, 2000, CHEST, V118, P1355, DOI 10.1378/chest.118.5.1355; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Warier A, 2010, INDIAN PEDIATR, V47, P90, DOI 10.1007/s13312-010-0011-8; WHO, 2010, REP GLOB TUB CONTR; WHO, 2008, REP STOP TB PARTN; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; Wu B, 2008, CLIN IMMUNOL, V126, P202, DOI 10.1016/j.clim.2007.09.009; Wu B, 2007, J IMMUNOL, V178, P3688, DOI 10.4049/jimmunol.178.6.3688; Wu SH, 2010, DIAGN MICR INFEC DIS, V68, P395, DOI 10.1016/j.diagmicrobio.2010.08.008; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	55	41	44	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44944	10.1371/journal.pone.0044944	http://dx.doi.org/10.1371/journal.pone.0044944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028695	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700062
J	Singh, A; Baranwal, V; Shankar, A; Kanwar, P; Ranjan, R; Yadav, S; Pandey, A; Kapoor, S; Pandey, GK				Singh, Amarjeet; Baranwal, Vinay; Shankar, Alka; Kanwar, Poonam; Ranjan, Rajeev; Yadav, Sandeep; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.			Rice Phospholipase A Superfamily: Organization, Phylogenetic and Expression Analysis during Abiotic Stresses and Development	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; PATATIN-RELATED PHOSPHOLIPASES; LIPID ACYL HYDROLASE; GENE FAMILY; SHOOT GRAVITROPISM; PHOSPHATIDIC-ACID; DROUGHT STRESS; GUARD-CELL; REPRODUCTIVE DEVELOPMENT; SIGNAL-TRANSDUCTION	Background: Phospholipase A (PLA) is an important group of enzymes responsible for phospholipid hydrolysis in lipid signaling. PLAs have been implicated in abiotic stress signaling and developmental events in various plants species. Genome-wide analysis of PLA superfamily has been carried out in dicot plant Arabidopsis. A comprehensive genome-wide analysis of PLAs has not been presented yet in crop plant rice. Methodology/Principal Findings: A comprehensive bioinformatics analysis identified a total of 31 PLA encoding genes in the rice genome, which are divided into three classes; phospholipase A(1) (PLA(1)), patatin like phospholipases (pPLA) and low molecular weight secretory phospholipase A(2) (sPLA(2)) based on their sequences and phylogeny. A subset of 10 rice PLAs exhibited chromosomal duplication, emphasizing the role of duplication in the expansion of this gene family in rice. Microarray expression profiling revealed a number of PLA members expressing differentially and significantly under abiotic stresses and reproductive development. Comparative expression analysis with Arabidopsis PLAs revealed a high degree of functional conservation between the orthologs in two plant species, which also indicated the vital role of PLAs in stress signaling and plant development across different plant species. Moreover, sub-cellular localization of a few candidates suggests their differential localization and functional role in the lipid signaling. Conclusion/Significance: The comprehensive analysis and expression profiling would provide a critical platform for the functional characterization of the candidate PLA genes in crop plants.	[Singh, Amarjeet; Baranwal, Vinay; Shankar, Alka; Kanwar, Poonam; Ranjan, Rajeev; Yadav, Sandeep; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.] Dept Plant Mol Biol, New Delhi, India		Singh, A (corresponding author), Dept Plant Mol Biol, Univ Delhi S Campus, New Delhi, India.	gkpandey@south.du.ac.in	Sharma, Prabhat/AAW-6558-2021; Ranjan, Rajeev/AAY-3243-2021	Ranjan, Rajeev/0000-0002-1344-4044; Kapoor, Sanjay/0000-0002-0283-1137; Pandey, Amita/0000-0001-8717-3227; SINGH, ASHUTOSH/0000-0002-0995-6696; Singh, Abhishek/0000-0001-6263-4410; SHARMA, PRABHAT/0000-0002-2638-2321; Kanwar, Poonam/0000-0002-9328-9274; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117	Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India	Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India	This work was supported by the Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Agarwal P, 2007, PLANT MOL BIOL, V65, P467, DOI 10.1007/s11103-007-9199-y; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bahn SC, 2003, FEBS LETT, V553, P113, DOI 10.1016/S0014-5793(03)00982-7; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; Boss WF, 2008, ANNU PLANT REV, V33, P202, DOI 10.1111/b.9781405160025.2008.00008.x; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Chen GQ, 2011, CRIT REV PLANT SCI, V30, P239, DOI 10.1080/07352689.2011.572033; Clewley J P, 1997, Methods Mol Biol, V70, P119; Cusack BP, 2007, TRENDS GENET, V23, P270, DOI 10.1016/j.tig.2007.03.010; Dessen A, 2000, BBA-MOL CELL BIOL L, V1488, P40, DOI 10.1016/S1388-1981(00)00108-6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Holk A, 2002, PLANT PHYSIOL, V130, P90, DOI 10.1104/pp.006288; Hong YY, 2008, PLANT CELL, V20, P803, DOI 10.1105/tpc.107.056390; Hong YY, 2009, PLANT J, V58, P376, DOI 10.1111/j.1365-313X.2009.03788.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang SS, 2001, PLANT PHYSIOL, V125, P573, DOI 10.1104/pp.125.2.573; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Kato T, 2002, PLANT CELL, V14, P33, DOI 10.1105/tpc.010215; Kim HJ, 2011, PLANT CELL, V23, P94, DOI 10.1105/tpc.110.074799; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Lee HY, 2005, PROG LIPID RES, V44, P52, DOI 10.1016/j.plipres.2004.10.002; Lee HY, 2003, PLANT CELL, V15, P1990, DOI 10.1105/tpc.014423; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Li MY, 2011, PLANT CELL, V23, P1107, DOI 10.1105/tpc.110.081240; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mansfeld J, 2006, BIOCHEMISTRY-US, V45, P5687, DOI 10.1021/bi052563z; Matos AR, 2008, PHYSIOL PLANTARUM, V134, P110, DOI 10.1111/j.1399-3054.2008.01123.x; Matos AR, 2009, PLANT PHYSIOL BIOCH, V47, P491, DOI 10.1016/j.plaphy.2009.02.011; Matos AR, 2001, FEBS LETT, V491, P188, DOI 10.1016/S0014-5793(01)02194-9; Matsui K, 2004, FEBS LETT, V569, P195, DOI 10.1016/j.febslet.2004.05.064; MAY C, 1998, BBA-LIPID LIPID MET, V1393, P267; Morita MT, 2002, PLANT CELL, V14, P47, DOI 10.1105/tpc.010216; Munnik T, 2001, FEBS LETT, V498, P172, DOI 10.1016/S0014-5793(01)02492-9; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Narusaka Y, 2003, PLANT CELL PHYSIOL, V44, P1246, DOI 10.1093/pcp/pcg138; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; O'Luanaigh N, 2002, MOL BIOL CELL, V13, P3730, DOI 10.1091/mbc.E02-04-0213; Paul RU, 1998, PLANT J, V16, P601, DOI 10.1046/j.1365-313x.1998.00333.x; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Rietz S, 2010, MOL PLANT, V3, P524, DOI 10.1093/mp/ssp109; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Ryu SB, 2004, TRENDS PLANT SCI, V9, P229, DOI 10.1016/j.tplants.2004.03.004; Scherer GFE, 2002, PLANT MOL BIOL, V49, P357, DOI 10.1023/A:1015290510483; Scherer GFE, 2010, TRENDS PLANT SCI, V15, P693, DOI 10.1016/j.tplants.2010.09.005; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; Stahl U, 1998, PLANT PHYSIOL, V117, P197, DOI 10.1104/pp.117.1.197; Stahl U, 1999, PLANT MOL BIOL, V41, P481, DOI 10.1023/A:1006323405788; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang XM, 2001, ANNU REV PLANT PHYS, V52, P211, DOI 10.1146/annurev.arplant.52.1.211; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	67	174	181	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30947	10.1371/journal.pone.0030947	http://dx.doi.org/10.1371/journal.pone.0030947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	23028594	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600094
J	Singh, A; Dey, AB; Mohan, A; Sharma, PK; Mitra, DK				Singh, Amar; Dey, Aparajita Ballave; Mohan, Anant; Sharma, Prabhat Kumar; Mitra, Dipendra Kumar			Foxp(3+) Regulatory T Cells among Tuberculosis Patients: Impact on Prognosis and Restoration of Antigen Specific IFN-gamma Producing T Cells	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PD-1 EXPRESSION; ACTIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSES; TH1 RESPONSES; INFECTION; SUPPRESSION; EXPANSION; LIGANDS	CD(4+)CD(25+)Foxp(3+) Regulatory T cells (Treg) and programmed death-1 (PD-1) molecules have emerged as pivotal players in immune suppression of chronic diseases. However, their impact on the disease severity, therapeutic response and restoration of immune response in human tuberculosis remains unclear. Here, we describe the possible role of Treg cells, their M. tuberculosis driven expansion and contribution of PD-1 pathway to the suppressive function of Treg cells among pulmonary tuberculosis (PTB) patients. Multicolor flow cytometry, cell culture, cells sorting and ELISA were employed to execute the study. Our results showed significant increase in frequency of antigen-reactive Treg cells, which gradually declined during successful therapy and paralleled with decline of M. tuberculosis-specific IL-10 along with elevation of IFN-gamma production, and raising the IFN-gamma/IL-4 ratio. Interestingly, persistence of Treg cells tightly correlated with MDR tuberculosis. Also, we show that blocking PD-1/PD-L1 pathway abrogates Treg-mediated suppression, suggesting that the PD-1/PD-L1 pathway is required for Treg-mediated suppression of the antigen-specific T cells. Treg cells possibly play a role in dampening the effector immune response and abrogating PD-1 pathway on Treg cells significantly rescued protective T cell response, suggesting its importance in immune restoration among tuberculosis patients.	[Singh, Amar; Sharma, Prabhat Kumar; Mitra, Dipendra Kumar] All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India; [Dey, Aparajita Ballave; Mohan, Anant] All India Inst Med Sci, Dept Med, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Mitra, DK (corresponding author), All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India.	salilmitra1@yahoo.com	Sharma, Prabhat/AAW-6558-2021; Ranjan, Rajeev/AAY-3243-2021	Ranjan, Rajeev/0000-0002-1344-4044; Kapoor, Sanjay/0000-0002-0283-1137; Pandey, Amita/0000-0001-8717-3227; SINGH, ASHUTOSH/0000-0002-0995-6696; Singh, Abhishek/0000-0001-6263-4410; SHARMA, PRABHAT/0000-0002-2638-2321; Kanwar, Poonam/0000-0002-9328-9274; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117	Department of Biotechnology; Indian Council of Medical Research, Government of India, New Delhi, India	Department of Biotechnology; Indian Council of Medical Research, Government of India, New Delhi, India(Indian Council of Medical Research (ICMR))	The study was supported by the Department of Biotechnology and the Indian Council of Medical Research, Government of India, New Delhi, India. For this study the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Antas PRZ, 2007, AM J RESP CRIT CARE, V176, P214, DOI 10.1164/ajrccm.176.2.214; Aramaki O, 2004, TRANSPLANTATION, V77, P6, DOI 10.1097/01.TP.0000108637.65091.4B; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Burl S, 2007, CLIN EXP IMMUNOL, V149, P117, DOI 10.1111/j.1365-2249.2007.03399.x; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 1999, NAT MED, V5, P1365; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Green AM, 2010, J INFECT DIS, V202, P533, DOI 10.1086/654896; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Handzel ZT, 2007, ISR MED ASSOC J, V9, P479; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Katara GK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001171; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Kitazawa Y, 2007, TRANSPLANTATION, V83, P774, DOI 10.1097/01.tp.0000256293.90270.e8; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Mitra DK, 2009, MICROBES INFECT, V11, P1122, DOI 10.1016/j.micinf.2009.08.006; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Sharma S, 2009, AM J RESP CRIT CARE, V179; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shen T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-279; TOOSSI Z, 1986, J EXP MED, V163, P1162, DOI 10.1084/jem.163.5.1162; TORRES M, 1994, CLIN EXP IMMUNOL, V96, P75, DOI 10.1111/j.1365-2249.1994.tb06233.x; Totsuka T, 2005, EUR J IMMUNOL, V35, P1773, DOI 10.1002/eji.200425109; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	49	174	181	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44728	10.1371/journal.pone.0044728	http://dx.doi.org/10.1371/journal.pone.0044728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028594	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400035
J	Li, CY; Zhang, XT; Cao, RL; Yu, BH; Liang, HS; Zhou, M; Li, DY; Wang, YH; Liu, EZ				Li, Changyu; Zhang, Xiangtong; Cao, Ronglong; Yu, Bohai; Liang, Hongsheng; Zhou, Min; Li, Dayong; Wang, Yuehua; Liu, Enzhong			Allografts of the Acellular Sciatic Nerve and Brain-Derived Neurotrophic Factor Repair Spinal Cord Injury in Adult Rats	PLOS ONE			English	Article							SUPERIOR COLLICULUS; CHEMICAL-EXTRACTION; REGENERATION; GRAFTS; CELLS; MOTOR; TRANSECTION; IMPROVEMENT; SCAFFOLDS; MEMBRANE	Objective: We aimed to investigate whether an innovative growth factor-laden scaffold composed of acellular sciatic nerve (ASN) and brain-derived neurotrophic factor (BDNF) could promote axonal regeneration and functional recovery after spinal cord injury (SCI). Methods: Following complete transection at the thoracic level (T9), we immediately transplanted the grafts between the stumps of the severed spinal cords. We evaluated the functional recovery of the hindlimbs of the operated rats using the BBB locomotor rating scale system every week. Eight weeks after surgery, axonal regeneration was examined using the fluorogold (FG) retrograde tracing method. Electrophysiological analysis was carried out to evaluate the improvement in the neuronal circuits. Immunohistochemistry was employed to identify local injuries and recovery. Results: The results of the Basso-Beattie-Bresnahan (BBB) scale indicated that there was no significant difference between the individual groups. The FG retrograde tracing and electrophysiological analyses indicated that the transplantation of ASN-BDNF provided a permissive environment to support neuron regeneration. Conclusion: The ASN-BDNF transplantation provided a promising therapeutic approach to promote axonal regeneration and recovery after SCI, and can be used as part of a combinatory treatment strategy for SCI management.	[Li, Changyu; Zhang, Xiangtong; Cao, Ronglong; Liang, Hongsheng; Wang, Yuehua; Liu, Enzhong] Harbin Med Univ, Affiliated Hosp 1, Key Lab Cell Transplantat, Minist Hlth China,Dept Neurosurg, Harbin, Heilongjiang Pr, Peoples R China; [Yu, Bohai] Harbin Med Univ, Dept Microbiol, Immun & Infect Pathogen Biol Key Lab, Harbin, Heilongjiang Pr, Peoples R China; [Zhou, Min] Harbin Med Univ, Affiliated Hosp 1, Dept Pathol, Harbin, Heilongjiang Pr, Peoples R China; [Li, Dayong] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, CY (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Key Lab Cell Transplantat, Minist Hlth China,Dept Neurosurg, Harbin, Heilongjiang Pr, Peoples R China.	enzhongliu@163.com			HeiLongJiang Province Sanitation Department Scientific Research Topic [2010-027]; Science Foundation of the China Postdoctor [2011M500687]	HeiLongJiang Province Sanitation Department Scientific Research Topic; Science Foundation of the China Postdoctor	This work was supported by HeiLongJiang Province Sanitation Department Scientific Research Topic (2010-027), and the Science Foundation of the China Postdoctor (2011M500687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; CARTER DA, 1989, J NEUROSCI, V9, P4042; Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782; Cote MP, 2011, NEUROTHERAPEUTICS, V8, P294, DOI 10.1007/s13311-011-0024-6; Cote MP, 2010, EXP NEUROL, V225, P173, DOI 10.1016/j.expneurol.2010.06.011; Fang MR, 2011, ANAT REC, V294, P24, DOI 10.1002/ar.21281; Guzen FP, 2012, RESTOR NEUROL NEUROS, V30, P265, DOI 10.3233/RNN-2012-110184; Horste GMZ, 2008, MUSCLE NERVE, V37, P3, DOI 10.1002/mus.20893; Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; Koopmans G, 2009, INT REV NEUROBIOL, V87, P363, DOI 10.1016/S0074-7742(09)87019-0; Lee YS, 2010, EXP NEUROL, V224, P429, DOI 10.1016/j.expneurol.2010.05.003; Levi ADO, 2002, J NEUROSURG, V96, P197, DOI 10.3171/spi.2002.96.2.0197; Liang HS, 2009, ACTA NEUROCHIR, V151, P1113, DOI 10.1007/s00701-009-0322-5; Nordblom J, 2009, RESTOR NEUROL NEUROS, V27, P285, DOI 10.3233/RNN-2009-0478; Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6; Sieck GC, 2009, RESP PHYSIOL NEUROBI, V169, P218, DOI 10.1016/j.resp.2009.08.008; Sondell M, 1998, BRAIN RES, V795, P44, DOI 10.1016/S0006-8993(98)00251-0; Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039; Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948; VIDALSANZ M, 1987, J NEUROSCI, V7, P2894; Zhang YJ, 2010, BIOMATERIALS, V31, P5312, DOI 10.1016/j.biomaterials.2010.03.029; Zhong HB, 2007, J RECONSTR MICROSURG, V23, P479, DOI 10.1055/s-2007-992340	23	45	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2012	7	8							e42813	10.1371/journal.pone.0042813	http://dx.doi.org/10.1371/journal.pone.0042813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	998CA	23028587	gold, Green Published, Green Submitted			2022-12-27	WOS:000308213600008
J	Kim, J; Cho, YA; Choi, IJ; Lee, YS; Kim, SY; Shin, A; Cho, SJ; Kook, MC; Nam, JH; Ryu, KW; Lee, JH; Kim, YW				Kim, Jeongseon; Cho, Young Ae; Choi, Il Ju; Lee, Yeon-Su; Kim, Sook-Young; Shin, Aesun; Cho, Soo-Jeong; Kook, Myeong-Cherl; Nam, Ji Hyung; Ryu, Keun Won; Lee, Jun Ho; Kim, Young-Woo			Effects of Interleukin-10 Polymorphisms, Helicobacter pylori Infection, and Smoking on the Risk of Noncardia Gastric Cancer	PLOS ONE			English	Article							CYTOKINE GENE POLYMORPHISMS; MESSENGER-RNA; INFLAMMATION; ASSOCIATION; CARCINOMA; IL-10; CARCINOGENESIS; METAANALYSIS; EXPRESSION; DISEASES	Objective: Both variations in the interleukin-10 (IL10) gene and environmental factors are thought to influence inflammation and gastric carcinogenesis. Therefore, we investigated the associations between IL10 polymorphisms, Helicobacter pylori (H. pylori) infection, and smoking in noncardia gastric carcinogenesis in Koreans. Methods: We genotyped three promoter polymorphisms (-1082A>G, -819T>C, and -592 A>C) of IL10 in a case-control study of 495 noncardia gastric cancer patients and 495 sex-and age-matched healthy controls. Multiple logistic regression models were used to detect the effects of IL10 polymorphisms, H. pylori infection, and smoking on the risk of gastric cancer, which was stratified by the histological type of gastric cancer. Results: The IL10-819C and -592C alleles were found to have complete linkage disequilibrium, and all three IL10 polymorphisms were associated with an increased risk of intestinal-type noncardia gastric cancer. These associations were observed only in H. pylori-positive subjects and current smokers. A statistically significant interaction between the IL10-592 genotype and H. pylori infection on the risk of intestinal-type gastric cancer was observed (P for interaction = 0.047). In addition, H. pylori-positive smokers who were carriers of either the IL10-1082G (OR [95% CI] = 17.76 [6.17-51.06]) or the -592C (OR [95% CI] = 8.37 [2.79-25.16]) allele had an increased risk of intestinal-type gastric cancer compared to H. pylorinegative nonsmokers homozygous for IL10-1082A and -592A, respectively. The interaction between the IL10-1082 polymorphism and the combined effects of H. pylori infection and smoking tended towards significance (P for interaction = 0.080). Conclusions: Inflammation-related genetic variants may interact with H. pylori infection and smoking to increase the risk of noncardia gastric cancer, particularly the intestinal-type. These findings may be helpful in identifying individuals at an increased risk for developing noncardia gastric cancer.	[Kim, Jeongseon; Cho, Young Ae; Shin, Aesun] Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea; [Choi, Il Ju; Cho, Soo-Jeong; Kook, Myeong-Cherl; Ryu, Keun Won; Lee, Jun Ho; Kim, Young-Woo] Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; [Lee, Yeon-Su; Kim, Sook-Young] Natl Canc Ctr, Funct Genom Branch, Goyang, South Korea; [Nam, Ji Hyung] Ctr Canc Prevent & Detect, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, J (corresponding author), Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea.	cij1224@ncc.re.kr	Shin, Aesun/E-9145-2014; Kim, Seongman/N-6910-2014; KIM, JEONGSEON/AAA-4643-2022	Shin, Aesun/0000-0002-6426-1969; Kim, Young-Woo/0000-0002-1559-9672; Kim, Hye Young/0000-0001-5978-512X; CHO, SOO-JEONG/0000-0001-7144-0589	National Cancer Center, Korea [1010190]	National Cancer Center, Korea	This study was supported by the National Cancer Center, Korea (Grant number:1010190). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger K, 1997, GUT, V40, P739, DOI 10.1136/gut.40.6.739; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Brenner H, 2002, INT J CANCER, V98, P446, DOI 10.1002/ijc.10201; Chang YW, 2002, INT J CANCER, V101, P469, DOI 10.1002/ijc.10637; CORREA P, 1992, CANCER RES, V52, P6735; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Vita F, 1999, CANCER, V86, P1936, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; Epplein M, 2008, CANCER CAUSE CONTROL, V19, P869, DOI 10.1007/s10552-008-9149-2; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Garcia-Gonzalez MA, 2007, AM J GASTROENTEROL, V102, P1878, DOI 10.1111/j.1572-0241.2007.01423.x; Hamilton SR, 2000, PATHOLOGY GENETICS T; Howell WM, 2002, P NUTR SOC, V61, P447, DOI 10.1079/PNS2002186; Huang JQ, 2003, GASTROENTEROLOGY, V125, P1636, DOI 10.1053/j.gastro.2003.08.033; IWATA F, 1995, DIGEST DIS SCI, V40, P1118, DOI 10.1007/BF02064209; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kim CG, 2009, J GASTROEN HEPATOL, V24, P469, DOI 10.1111/j.1440-1746.2008.05679.x; Ko KP, 2009, J NUTR, V139, P1008, DOI 10.3945/jn.108.101865; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JY, 2005, CANCER LETT, V225, P207, DOI 10.1016/j.canlet.2004.11.028; Levitzky YS, 2008, ATHEROSCLEROSIS, V201, P217, DOI 10.1016/j.atherosclerosis.2007.12.058; Lopez P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/838390; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Moy KA, 2010, CANCER EPIDEM BIOMAR, V19, P2287, DOI 10.1158/1055-9965.EPI-10-0362; Persson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017404; Pyo CW, 2003, HUM IMMUNOL, V64, P979, DOI 10.1016/S0198-8859(03)00173-3; Rad R, 2004, GUT, V53, P1082, DOI 10.1136/gut.2003.029736; Shikata K, 2008, AM J EPIDEMIOL, V168, P1409, DOI 10.1093/aje/kwn276; Shimoyama T, 2001, J CLIN PATHOL, V54, P332, DOI 10.1136/jcp.54.4.332; Sipponen Pentti, 2002, Gastric Cancer, V5, P213, DOI 10.1007/s101200200037; Suarez A, 2003, TRANSPLANTATION, V75, P711, DOI 10.1097/01.TP.0000055216.19866.9A; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P1443, DOI 10.1111/j.1440-1746.2006.04613.x; Szkaradkiewicz A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/901564; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Wu HY, 2009, CANCER EPIDEM BIOMAR, V18, P1945, DOI 10.1158/1055-9965.EPI-09-0250; Wu MS, 2003, INT J CANCER, V104, P617, DOI 10.1002/ijc.10987; Wu MS, 2005, CANCER EPIDEM BIOMAR, V14, P1878, DOI 10.1158/1055-9965.EPI-04-0792; Yamaoka Y, 1997, GUT, V41, P442, DOI 10.1136/gut.41.4.442; Yim JY, 2007, HELICOBACTER, V12, P333, DOI 10.1111/j.1523-5378.2007.00504.x; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zhou Y, 2008, EUR J CANCER, V44, P2648, DOI 10.1016/j.ejca.2008.07.017; Zhuang W, 2010, DIGEST DIS SCI, V55, P1525, DOI 10.1007/s10620-009-0922-1	47	37	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 3	2012	7	1							e29643	10.1371/journal.pone.0029643	http://dx.doi.org/10.1371/journal.pone.0029643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	903NK	22235320	gold, Green Published, Green Submitted			2022-12-27	WOS:000301123400082
J	Wang, W; Ao, L; Rayburn, ER; Xu, HX; Zhang, XR; Zhang, X; Nag, SA; Wu, XM; Wang, MH; Wang, H; Van Meir, EG; Zhang, R				Wang, Wei; Ao, Lin; Rayburn, Elizabeth R.; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Nag, Subhasree Ashok; Wu, Xuming; Wang, Ming-Hai; Wang, Hui; Van Meir, Erwin G.; Zhang, Ruiwen			KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PRIVILEGED STRUCTURES; HIF-1 INHIBITORS; TUMOR HYPOXIA; HIF-1-ALPHA; PATHWAY; BIOLOGY; IDENTIFICATION; ANGIOGENESIS; CHECKPOINTS	The purpose of the present study was to determine the in vitro and in vivo anti-cancer activity and pharmacological properties of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, KCN1. In the present study, we investigated the in vitro activity of KCN1 on cell proliferation and cell cycle distribution of pancreatic cancer cells, using the MTT and BrdUrd assays, and flow cytometry. The in vivo anti-cancer effects of KCN1 were evaluated in two distinct xenograft models of pancreatic cancer. We also developed an HPLC method for the quantitation of the compound, and examined its stability in mouse plasma, plasma protein binding, and degradation by mouse S9 microsomal enzymes. Furthermore, we examined the pharmacokinetics of KCN1 following intravenous or intraperitoneal injection in mice. Results showed that, in a dose-dependent manner, KCN1 inhibited cell growth and induced cell cycle arrest in human pancreatic cancer cells in vitro, and showed in vivo anticancer efficacy in mice bearing Panc-1 or Mia Paca-2 tumor xenografts. The HPLC method provided linear detection of KCN1 in all of the matrices in the range from 0.1 to 100 mu M, and had a lower limit of detection of 0.085 mu M in mouse plasma. KCN1 was very stable in mouse plasma, extensively plasma bound, and metabolized by S9 microsomal enzymes. The pharmacokinetic studies indicated that KCN1 could be detected in all of the tissues examined, most for at least 24 h. In conclusion, our preclinical data indicate that KCN1 is a potential therapeutic agent for pancreatic cancer, providing a basis for its future development.	[Wang, Wei; Ao, Lin; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Nag, Subhasree Ashok; Wu, Xuming; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Wang, Wei; Wang, Ming-Hai; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX USA; [Wang, Wei; Ao, Lin; Rayburn, Elizabeth R.; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Zhang, Ruiwen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Div Clin Pharmacol, Birmingham, AL USA; [Wu, Xuming] Nantong Univ, Nantong Canc Hosp, Nantong, Peoples R China; [Wang, Ming-Hai] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX USA; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Van Meir, Erwin G.] Emory Univ, Winship Canc Ctr, Atlanta, GA 30322 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Alabama System; University of Alabama Birmingham; Nantong University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Emory University; Emory University; Emory University	Wang, W (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA.	evanmei@emory.edu; ruiwen.zhang@ttuhsc.edu	Nag, subhasree/T-1505-2019; Xu, Hongxia/AAN-8608-2021	Nag, subhasree/0000-0001-6933-4349; xu, hongxia/0000-0001-5215-734X; Van Meir, Erwin G./0000-0003-2444-7707	National Institutes of Health grant [R01 CA116804, R01 CA91980]; National Institutes of Health [R01 CA112029, R01 CA121211]; EmTechBio; University Research Committee of Emory University; Brain Tumor Foundation for Children; V Foundation for Cancer Research; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715, 81025017]; Ministry of Science and Technology of China [2007CB947100]; National Science and Technology Major Project Key New Drug Creation and Manufacturing Program [2009ZX09102-114, 2009ZX09301-011]; NATIONAL CANCER INSTITUTE [R01CA112029, R01CA091980, R01CA116804, R01CA121211] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EmTechBio; University Research Committee of Emory University; Brain Tumor Foundation for Children; V Foundation for Cancer Research; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project Key New Drug Creation and Manufacturing Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health grant R01 CA116804 (to EGVM). RZ was also supported by National Institutes of Health grants R01 CA112029 and R01 CA121211. EGVM was also supported by EmTechBio, the University Research Committee of Emory University, the Brain Tumor Foundation for Children, and the V Foundation for Cancer Research. HW was supported by the One Hundred Talents Program, Chinese Academy of Sciences, grants from National Nature Science Foundation (30870513, 31070680, 91029715 and 81025017) and Ministry of Science and Technology of China (2007CB947100), National Science and Technology Major Project Key New Drug Creation and Manufacturing Program 2009ZX09102-114, 2009ZX09301-011). MW was supported by National Institutes of Health grant R01 CA91980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 1998, J DRUG TARGET, V5, P303, DOI 10.3109/10611869808995883; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bayraktar S, 2010, WORLD J GASTROENTERO, V16, P673, DOI 10.3748/wjg.v16.i6.673; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; Belozerov VE, 2006, CURR OPIN INVEST DR, V7, P1067; BOWERS VD, 1991, TRANSPLANTATION, V51, P847, DOI 10.1097/00007890-199104000-00021; Brat DJ, 2002, ADV ANAT PATHOL, V9, P24, DOI 10.1097/00125480-200201000-00004; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dorr R T, 1994, Ann Pharmacother, V28, pS11; Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Knisely JPS, 2002, NEUROIMAG CLIN N AM, V12, P525, DOI 10.1016/S1052-5149(02)00032-1; Koh MY, 2010, RECENT RESULTS CANC, V180, P15, DOI 10.1007/978-3-540-78281-0_3; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mooring SR, 2011, J MED CHEM, V54, P8471, DOI 10.1021/jm201018g; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mun J, 2012, J MED CHEM, V55, P6738, DOI 10.1021/jm300752n; Mun JY, 2012, BIOORGAN MED CHEM, V20, P4590, DOI 10.1016/j.bmc.2012.04.064; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Nicolaou KC, 2000, J AM CHEM SOC, V122, P9939, DOI 10.1021/ja002033k; Nicolaou KC, 2000, J AM CHEM SOC, V122, P9954, DOI 10.1021/ja002034c; Nojima Hiroshi, 2004, Methods Mol Biol, V280, P3; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Pancreatic Cancer. National Cancer Institute, PANCR CANC; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Shi Q, 2012, ACS MED CHEM LETT, V3, P620, DOI 10.1021/ml300042k; Tan C, 2005, CANCER RES, V65, P605; Tan C, 2011, BIOORG MED CHEM LETT, V21, P5528, DOI 10.1016/j.bmcl.2011.06.099; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P239, DOI 10.1097/00005072-199803000-00005; Tsaioun K, 2009, ATLA-ALTERN LAB ANIM, V37, P47, DOI 10.1177/026119290903701S10; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang JL, 2009, CURR PHARM DESIGN, V15, P2195, DOI 10.2174/138161209788682514; Wang W, 2009, CANCER LETT, V278, P241, DOI 10.1016/j.canlet.2009.01.005; Weinmann M, 2004, ONKOLOGIE, V27, P83, DOI 10.1159/000075611; Wilson GD, 2007, FRONT BIOSCI-LANDMRK, V12, P3502, DOI 10.2741/2330; Yin S, 2012, CLIN CANC R IN PRESS; Zhang XR, 2012, MAR DRUGS, V10, P1138, DOI 10.3390/md10051138	46	50	53	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44883	10.1371/journal.pone.0044883	http://dx.doi.org/10.1371/journal.pone.0044883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028659	Green Published, gold, Green Submitted			2022-12-27	WOS:000308788700049
J	Kim, SS; Williams, DR				Kim, Seung-Sup; Williams, David R.			Perceived Discrimination and Self-Rated Health in South Korea: A Nationally Representative Survey	PLOS ONE			English	Article							ASIAN-AMERICANS NATIONWIDE; WHITEHALL-II; RACIAL-DISCRIMINATION; ETHNIC-MINORITIES; MENTAL-DISORDERS; SON PREFERENCE; GENDER; WORK; MORTALITY; WOMEN	Background: There is mounting evidence that discriminatory experiences can harm health. However, previous research has mainly focused on the health effects of racial discrimination in U.S. or European countries although there is pervasive discrimination by gender, age, education and other factors in Asian countries. Methods: We analyzed the data from the 7th wave of Korean Labor and Income Panel Study to investigate the association between perceived discriminatory experience and poor self-rated health in South Korea. Perceived discriminatory experiences were measured in eight situations through a modified Experience of Discrimination questionnaire. In each of eight situations, the lifetime prevalence of perceived discriminatory experience was compared between men and women and the main causes of those experiences were identified separately by gender. After adjusting for potential confounders, we examined the association between perceived discriminatory experience and poor self-rated health in each of eight social situations and also checked the association using the number of situations of perceived discriminatory experiences. Results: For both men and women, education level and age were the main sources of work-related perceived discriminatory experiences. Gender was one of the main causes among women across eight situations and more than 90% of women reported their gender as a main cause of discriminatory experience in getting higher education and at home. Discriminatory experiences in four situations were positively associated with poor self-rated health. The odds ratio for poor self-rated health for those exposed to one, two, three or four or more social situations of perceived discrimination were respectively 1.06 (95% CI : 0.87-1.29), 1.15 (95% CI : 0.96-1.55), 1.59 (95% CI : 1.19-2.14), and 1.78 (95% CI : 1.26-2.51). Conclusion: There is consistent association between perceived discriminatory experience and poor self-rated health across eight social situations in South Korea.	[Kim, Seung-Sup] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Environm & Occupat Hlth, Washington, DC 20052 USA; [Williams, David R.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	George Washington University; Harvard University; Harvard T.H. Chan School of Public Health	Kim, SS (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Environm & Occupat Hlth, Washington, DC 20052 USA.	sskim@gwu.edu	Tinker, Martin/D-3249-2018	Tinker, Martin/0000-0002-3314-839X				Albert MA, 2008, AM HEART J, V156, P1103, DOI 10.1016/j.ahj.2008.07.027; Amnesty Internatonal, 2006, S KOR MIGR WORK HUM; Asakura T, 2008, AM J PUBLIC HEALTH, V98, P743, DOI 10.2105/AJPH.2007.117309; Berik G., 2004, REV DEV ECON, V8, P237, DOI [10.1111/j.1467-9361.2004.00230.x, DOI 10.1111/J.1467-9361.2004.00230.X]; Bhui K, 2005, AM J PUBLIC HEALTH, V95, P496, DOI 10.2105/AJPH.2003.033274; Borrell C, 2010, PREV MED, V50, P86, DOI 10.1016/j.ypmed.2009.10.016; Chang D-H, 2007, COMMITTEE ELIMINATIO; Choe S-H, 2009, NY TIMES SEOUL; Choi Jang Jip, 1993, STATE SOC CONT KOREA; Chun H, 2006, INT J HEALTH SERV, V36, P575, DOI 10.2190/6GUV-FBBA-W1B5-U79B; Chung W, 2007, J BIOSOC SCI, V39, P707, DOI 10.1017/s0021932007001988; CROSBY F, 1984, AM BEHAV SCI, V27, P371, DOI 10.1177/000276484027003008; de Castro AB, 2008, AM J PUBLIC HEALTH, V98, P520, DOI 10.2105/AJPH.2007.110163; De Vogli R, 2007, J PSYCHOSOM RES, V63, P413, DOI 10.1016/j.jpsychores.2007.04.006; De Vogli R, 2007, J EPIDEMIOL COMMUN H, V61, P513, DOI 10.1136/jech.2006.052563; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Din-Dzietham R, 2004, SOC SCI MED, V58, P449, DOI 10.1016/S0277-9536(03)00211-9; Ferrie JE, 2006, OCCUP ENVIRON MED, V63, P443, DOI 10.1136/oem.2005.022269; Gee GC, 2007, SOC SCI MED, V64, P1984, DOI 10.1016/j.socscimed.2007.02.013; Gee GC, 2009, EPIDEMIOL REV, V31, P130, DOI 10.1093/epirev/mxp009; Hahm HC, 2010, WOMEN HEALTH ISS, V20, P350, DOI 10.1016/j.whi.2010.05.002; Hanam SP, 2004, KOREA J, V44, P42; Hunte HER, 2009, AM J PUBLIC HEALTH, V99, P1285, DOI 10.2105/AJPH.2007.128090; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jang SN, 2009, J GERONTOL B-PSYCHOL, V64, P677, DOI 10.1093/geronb/gbp014; Jean A, 2003, NEW POLIT SCI, V25, P159; Jones RS, 2005, EC DEP WORKING PAPER; Khang YH, 2004, INT J EPIDEMIOL, V33, P299, DOI 10.1093/ije/dyg244; Kim IH, 2008, AM J IND MED, V51, P748, DOI 10.1002/ajim.20626; Kim MH, 2007, NEW SOLUT, V17, P325, DOI 10.2190/NS.17.4.h; Kim MH, 2008, SOC SCI MED, V67, P1982, DOI 10.1016/j.socscimed.2008.09.051; Kim S, 2004, HAKBUL SOC; Kim Y, 2010, MAGNITUDE REALITY PR; KRIEGER N, 1990, SOC SCI MED, V30, P1273, DOI 10.1016/0277-9536(90)90307-E; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Lam Amy Mong Chow, 2005, Int J Adolesc Med Health, V17, P157; Larsen U, 1998, POP STUD-J DEMOG, V52, P317, DOI 10.1080/0032472031000150496; Lin D, 2009, COMMUNITY MENT HLTH; Liu JX, 2006, AIDS BEHAV, V10, pS25, DOI 10.1007/s10461-006-9123-5; MONKTURNER E, 1994, AM J ECON SOCIOL, V53, P433, DOI 10.1111/j.1536-7150.1994.tb02615.x; Moomal H, 2009, SAMJ S AFR MED J, V99, P383; OECD, 2010, SICKN DIS WORK BREAK; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Pavalko EK, 2003, J HEALTH SOC BEHAV, V44, P18, DOI 10.2307/1519813; Rogers AE, 2004, HEALTH AFFAIR, V23, P202, DOI 10.1377/hlthaff.23.4.202; Rogers WH, 1993, STATA TECHNICAL B, P19; Seguino S, 1997, J DEV STUD, V34, P102, DOI 10.1080/00220389708422513; Shin Gi-Wook, 2006, ETHNIC NATL KOREA GE; SOH CHS, 1993, SEX ROLES, V28, P73, DOI 10.1007/BF00289748; Son M, 2004, INT J EPIDEMIOL, V33, P308, DOI 10.1093/ije/dyh017; TAYLOR DM, 1994, ONT SYMP P, V7, P233; TAYLOR DM, 1991, J SOC PSYCHOL, V131, P847, DOI 10.1080/00224545.1991.9924672; Veling W, 2008, SOC PSYCH PSYCH EPID, V43, P953, DOI 10.1007/s00127-008-0381-6; Veling W, 2007, INT J EPIDEMIOL, V36, P761, DOI 10.1093/ije/dym085; Williams DR, 2008, SOC SCI MED, V67, P441, DOI 10.1016/j.socscimed.2008.03.021; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	58	177	182	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30501	10.1371/journal.pone.0030501	http://dx.doi.org/10.1371/journal.pone.0030501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	907XU	23028766	Green Published, gold, Green Submitted			2022-12-27	WOS:000301454400135
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	22808095	Green Submitted, gold, Green Published			2022-12-27	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	22808095	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Sun, Fen/I-8516-2016; Zeng, Maomao/M-1422-2013; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Prokopenko, Mikhail/A-3995-2008; Wang, X. Rosalind/B-7097-2008	Pausch, Hubert/0000-0002-0501-6760; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Tang, Hailiang/0000-0003-1852-3128; SUN, FEN/0000-0003-2094-9494; Wurmser, Christine/0000-0003-0649-6206; Yu, Zhuowei/0000-0002-9152-6491; Wang, Xuelong/0000-0003-4616-1531; Kou, Xiaoxing/0000-0001-9680-0077; Prokopenko, Mikhail/0000-0002-4215-0344; Miller, Jennifer/0000-0003-2110-3693; Wang, X. Rosalind/0000-0001-5454-6197; Fries, Ruedi/0000-0002-4657-1787; Mao, Ying/0000-0001-8055-115X	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	34	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	22808095	gold, Green Submitted, Green Published			2022-12-27	WOS:000306362400093
